retrospective
study
impact
pneumococcal
conjugate
vaccine13
immunization
northern
israel
hospitalbackground
introduction
pcv13
reduced
burden
invasive
disease
objective
characterize
true
positive
blood
cultures
children
presented
hospital
following
implementation
vaccine
methods
conducted
presenting
fever
20102017
subjects
divided
two
age
groups
younger
group
336
months
older
318
years
patients
classified
either
focus
infection
time
bacteremia
isolates
typed
israels
streptococcal
reference
laboratory
results
samples
included
94
focal
concomitant
common
without
overall
6794
71
vs
2794
287
p
0001
well
3248
66
1648
33
002
3546
76
1146
24
streptococcus
pneumoniae
pathogen
29
2148
44
rare
646
13
latter
brucella
species
predominated
1246
26
along
staphylococcus
aureus
conclusions
findings
consistent
studies
reporting
decreased
primarily
accompanying
changing
etiological
agents
among
pcv13vaccinated
prominent
osteoarticular
infections
ongoing
surveillance
warranted
better
understand
implications
perception
severity
adverse
events
oral
immunotherapy
authors
reply
cd200cd200r
pathway
regulation
tumor
immune
microenvironment
immunotherapytumorassociated
inflammation
responses
key
components
tme
regulate
growth
progression
metastasis
tumorassociated
myeloid
cells
tamcs
play
multiple
roles
including
induction
inflammationangiogenesis
tumorspecific
tcell
thus
identification
characterization
pathways
critical
importance
developing
cancer
recent
suggest
cd200cd200
receptor
cd200r
interaction
may
important
regulating
via
affecting
chapter
give
brief
overview
axis
biology
behind
plays
activationeffector
functions
also
discuss
cd200cd200rs
role
potential
checkpoint
molecules
investigation
advance
understanding
pathogenesis
immunity
provide
rationale
cd200cd200rtargeted
human
advisory
committee
practices
recommended
schedule
adolescents
aged
18
united
states
2020at
october
2019
meeting
acip
approved
2020
child
adolescent
ages
summarizes
recommendations
several
changes
†
cover
page
three
tables
notes
found
cdc
website
httpswwwcdcgovvaccinesschedulesindexhtml
health
care
providers
advised
use
together
httpswwwcdcgovvaccinesacipindexhtml
director
american
academy
pediatrics
family
physicians
college
obstetricians
gynecologists
first
nursemidwives
adults
19
voted
recommend
approval
us
adult
persons
available
application
flow
cytometry
cart
cell
therapyreviewabstract
chimetic
antigen
kind
novel
killer
derived
autogenous
allogeneic
targeting
specific
antigens
gene
engineering
transpormation
possess
advantages
high
specificity
efficiency
nonmhc
restriction
achieving
good
therapeutic
effects
relapsedrefractory
hematological
tumors
solid
process
preparation
includes
isolation
purification
activation
differentiation
modification
vitro
amplification
phenotypic
quality
control
preservation
reinfusion
rapid
development
technology
widely
used
aspects
therapy
pretreatment
screening
posttransfusion
monitoring
innovative
optimization
retrospectively
analysis
characteristics
risk
factors
treatmentrelated
hepatic
malignant
tumorobjective
explore
clinical
features
injury
due
inhibitors
cpi
data
112
64
men
48
women
received
january
2016
march
chinese
medical
sciences
peking
union
shenzhen
huazhong
university
science
techology
collected
median
60
observed
30
268
incidence
grade
35
714
8112
event
occurrence
3
weeks
230
undergoing
univariate
multivariate
analyses
showed
liver
attributed
induced
hepatitis
005
severe
got
almost
complete
resolution
receiving
methlprednisolone
4
6
conclusion
live
factor
cpirelated
review
immunerelated
associated
immunotherapyimmune
china
however
increased
irae
needs
attention
summarized
characteristic
manifestation
treatment
iraes
programmed
death
protein1pd1
ligand1pdl1
deep
insight
mechanisms
different
incidences
types
influencing
direction
future
research
discussed
guidance
oncologist
identify
monitor
practice
guideline
stage
ⅳ
primary
lung
china2020
versionobjective
malignancy
leading
cause
estimated
787
thousands
incident
cases
631
deaths
2015
aggressive
behavior
absence
effective
early
diagnosed
chemotherapy
cornerstone
advanced
efficacy
unsatisfactory
molecular
targeted
concept
continuously
changed
survival
greatly
improved
order
update
progress
worldwide
timely
improve
level
standardized
diagnosis
association
oncologists
organized
experts
formulate《clinical
version》
immunotherapeutics
head
neck
squamous
carcinoma
stem
cellscancer
cscrelated
resistance
become
anew
obstacle
successful
hnscc
exception
finding
highly
immunesuppressive
recently
suppression
invasion
hnscccscs
characterized
would
enable
stratification
subtypes
consequently
establishment
new
approaches
discusses
feasibility
csctargeted
strategies
incorporation
nanotechnology
vaccination
cd47
deficient
elicits
antitumor
response
micecancer
poorly
immunogenic
wide
range
mutations
makes
unsuitable
show
elimination
ligand
inhibitory
sirpα
genetic
deletion
antibody
blocking
significantly
improves
effectiveness
tumour
hematopoietic
mouse
models
antigenexpressing
lack
precoated
anticd47
antibodies
achieved
approach
synergistically
enhanced
combination
antipd1
depends
cd11c
dcs
exhibit
expansion
cd47deficient
indicate
whole
induce
hsp90a
inhibition
promotes
reversing
multimodal
stemlike
property
immunerefractory
tumorscancer
emerged
promising
presence
limits
success
previously
selection
drives
evolution
toward
resistant
phenotypes
transcription
akt
coactivator
tcl1a
nanog
report
crucial
crossroads
nanogtcl1a
multiaggressive
properties
immuneedited
identifying
hsp90aa1
transcriptional
target
furthermore
demonstrate
potentiates
tcl1astabilization
thereby
contributing
importantly
hsp90
sensitized
adoptive
transfer
pd1
blockade
reinvigorated
cycle
tumorreactive
implicate
hsp90atcl1aakt
ignited
central
choosing
mass
program
meningococcal
b
nurses
education
vaccines
style
communication
institutional
campaignsvaccine
hesitancy
represents
increasingly
global
issue
healthcare
professionals
increasing
uptake
aim
article
analyze
main
elements
styles
campaigns
initiatives
construction
contents
evaluated
original
instrument
specifically
developed
present
relevant
nursing
expertise
competencies
mixed
foundations
theory
develop
framework
made
items
useful
evaluate
multiprofessional
project
obtain
integration
nurse
promotion
similar
public
orientation
sociological
instruments
theories
fields
socialbehavioral
integrative
performed
themes
adherence
basis
competences
multiprofessionals
evaluation
prepare
evaluating
prepared
applied
settings
last
five
taken
persuasive
expert
panel
regard
usefulness
field
knowledge
add
meanings
cues
act
causes
vaccinating
shows
worth
analyzing
techniques
increase
population
confidence
levels
immunoprophylaxis
travellerswhen
planning
journey
destinations
infectious
diseases
endemic
one
undertake
appropriate
prophylactic
measures
reduce
travelrelated
problem
traveller
undergoes
examination
travel
sure
firstaid
kit
necessary
medicines
receives
required
vaccinations
currently
requirements
ten
international
travellers
according
world
organization
guidelines
major
issues
concerning
particular
epidemiology
schedules
course
booster
doses
advances
hepatocellular
carcinomahepatocellular
hcc
mortality
rate
worstthanexpected
management
provinces
country
systemic
drug
rapidly
especially
drugs
blocker
still
many
problems
challenges
paper
briefly
introduces
latest
immunology
intertwined
historiescancer
complex
whose
outcome
largely
crosstalk
lockstep
involvement
distinct
stages
contexture
determinants
shaping
exploited
therapeutically
current
schemes
histopathology
argue
revising
systems
include
parameters
address
immediate
need
prognostic
andor
predictive
information
guide
decisions
insights
trialstherapeutics
proteins
ctla4
pdl1
efficacious
across
broad
cancers
resulting
reductions
longterm
subsets
significant
wideranging
immunotherapies
prompted
additional
therapies
modulate
tcells
within
activity
newer
investigational
therapeutics
showing
promise
others
exhibiting
appreciable
summarize
select
beyond
antictla4
antipdl1
providing
top
10
immunotherapycancer
validated
critically
treating
given
vast
efforts
dedicated
advancing
endogenous
synthetic
questions
define
roadblocks
basic
facing
translating
preclinical
optimal
combinations
immunebased
patient
addressing
require
combined
researchers
clinicians
focusing
resources
accelerate
interactions
system
options
complexesmonoclonal
based
always
looked
futuristic
natural
way
could
take
pathogens
establish
realize
monoclonal
contains
kill
complexes
serve
means
decode
black
box
examples
biochemical
structural
appreciate
discoveries
started
decoded
mechanism
viral
create
targets
advancement
led
potent
protective
selective
provided
protection
deadly
administration
newly
designed
immunogen
therefore
tools
design
passive
little
side
serum
il
allergic
rhinitis
subcutaneous
vitamin
supplementationfor
ar
scit
proved
improving
symptoms
increases
il10
production
helps
inducing
peripheral
tolerance
allergens
supplementation
adjuvant
investigated
assess
pollen
skin
prick
test
done
baseline
final
nasal
scores
rating
ige
measured
1
2
statistically
decrease
total
compared
difference
001there
negative
correlation
scoring
0028
respectively
sublingual
versus
regards
safety
respiratory
patientssubcutaneous
wellestablished
modality
successfully
decades
slit
introduced
20
safer
alternative
single
case
ever
reported
nonrandomized
controlled
trial
72
suffering
allergy
house
dust
mites
hdm
dermatophagoidesfarinae
dermatophagoidespteronyssinus
date
palm
phoenix
dactylifera
pho
subjected
full
detailed
history
taking
medication
calculation
peak
expiratory
pefr
asthmatic
allergen
reassessed
reactions
recorded
improvement
local
noticed
conclude
modalities
equally
profile
prevalence
hbv
assessment
dental
workers
teaching
umm
alqura
saudi
arabiahepatitisb
virus
serious
prevented
dhcws
atrisk
occupational
exposure
aimed
arabia
crosssectional
139
males
68
females
surface
hbsag
antihbs
chemiluminescent
microparticle
immunoassay
zero
00
95
vaccinated
participants
901
n119
inverse
duration
00001
28
students
childhood
revaccinated
21
concentration
greater
10miuml
protected
179
100
oneyear
revaccination
mean
56
miuml
620
prevention
nonprotected
individuals
identified
il1
activates
inflammatory
cytokine
mast
antiinflammatory
il37chimeric
car
genetically
modified
administered
trigger
cytokines
toxicity
interleukin
classic
mediates
occur
cartcell
induces
il33
mcs
amplifying
reaction
37
ilf7
member
binds
il18
alpha
il18rα
chain
suppresses
innate
acquired
il37
inhibits
proinflammatory
hypothesize
generated
inhibited
hivpositive
challenging
realityimmunotherapy
malignancies
icis
established
people
living
hiv
plwh
deeply
modern
antiretroviral
art
subgroup
inadequate
considering
morbidity
moreover
similarities
stimulation
even
literature
topic
small
series
seems
hivnegative
collect
antiviral
using
antigenspecific
transplant
recipientsadoptive
avt
obtained
healthy
donors
considered
breakthrough
refractory
often
accompany
immunodeficiencies
transplantations
describes
nearly
cytomegalovirus
epsteinbarr
adenovirus
polyomavirus
bk
methodological
tested
procedures
frozen
stored
banks
commonly
technical
seasonal
influenza
20192020influenza
epidemics
caused
annual
5
million
290
000
650
globally
prevent
complications
licensed
trivalent
inactivated
iiv3
quadrivalent
iiv4
2018
center
issued
20182019
short
strengthen
operational
national
niac
working
twg
updated
compiled
20192020
updates
version
evidences
vaccineavoidable
costeffectiveness
costbenefit
second
policies
commission
prc
past
year
thirdly
type
fourth
hemisphere
composition
season
described
points
clinics
povs
willing
contraindications
preferential
recommendation
product
another
prioritize
659
chronic
members
caregivers
infants
pregnant
plan
8
minimum
apart
prior
dose
old
receive
end
offered
soon
unable
continue
trimester
intended
staff
centers
work
departments
internal
medicine
maternity
institutions
periodically
evidence
becomes
intralymphatic
diseasessummary
although
（scit）
（slit）
effect
drawbacks
long
period
frequent
times
superficial
lymph
node
injection
（ilit）
emerging
method
less
pain
exact
curative
scholars
extensive
systematically
theoretical
possible
ilit
lower
trust
government
links
immunological
complexity
prostate
influences
immunotherapyprostate
cancerrelated
androgen
signaling
benefit
metastatic
castrationresistant
mcrpc
progressive
lethal
highlighting
treatments
harness
power
destroy
cytotoxic
cd8
particularly
minimal
immunosuppressive
trials
outcomes
extranodal
nkt
lymphomaextranodal
nktcell
lymphoma
enktcl
relatively
nonhodgkins
nhl
degree
poor
prognosis
traditional
chemoradiotherapy
regimens
shown
strong
various
nonsmall
melanoma
kidney
food
fda
reviews
immunotherapeutic
hoping
change
compliance
metaanalysisobjective
meta
compare
cochrane
library
pubmed
embase
cnki
database
wan
fang
scitech
journal
searched
treated
literatures
screened
randomized
chosen
symptom
visual
analogue
scale
vas
indicators
strictly
extracted
analyzed
revman
53
stata
14
software
publication
bias
smd
value
003
014
rr
ci
017023
003031
092135
resulted
142226
eppecacy
frequently
repeated
antitetanus
scientific
evidencesthe
hyperimmunization
tetanus
20172019
confirmed
every
ubiquitous
nature
spores
inability
herdimmunity
eliminating
followed
periodic
2012
italy
notified
45
252564
eu
65
generally
rural
areas
antipertussis
pregnancy
indications
antitetanic
prophylaxis
immunoglobulins
emergency
setting
gives
rise
doubts
agree
diphtheriatetanuspertussis
third
elapsed
since
previous
related
differences
obstetrical
wards
riskbenefit
ratio
leads
prefer
nointervention
justified
opinions
attitudes
italian
mandatory
studybackground
reducing
preventable
wellknown
vaccinepreventable
remains
low
regarding
multicenter
universities
anonymous
questionnaire
consisting
informed
hygiene
preventive
lesson
asked
fill
multivariable
logistic
regression
model
expressed
adjusted
odds
aor
3131
completed
90
agreement
law
87
insufficientsufficientfair
goodexcellent
supportive
towards
064
ic
044093
manner
propensity
supporting
probably
awareness
basics
educational
activities
internet
rational
advocates
emotional
opponentsthe
social
media
becoming
influential
source
profound
russian
discourse
demonstrated
nowadays
clearcut
adequate
strategy
informational
policy
defines
principles
provaccine
spreading
sampling
consisted
muscovites
messages
containing
keywords
derivatives
export
quarter
size
uploading
19948
random
sample
800
280
images
veterinary
spam
excluded
average
algorithms
necessity
pro
contra
equal
percentage
42
41
17
doubt
argument
postvaccination
propaganda
supporters
ideas
rationality
lots
humor
usually
requires
context
opponents
apply
personal
values
experience
sense
appealing
reader
argumentation
offers
segment
users
proposed
therapys
poster
chimeric
therapychimeric
adoptively
transfers
engineered
expressing
receptors
great
though
products
release
syndrome
crs
neurotoxicity
aplasia
meanwhile
lacking
suppressive
environment
limit
focuses
applications
perspectives
revolutionary
polyvinyl
alcohol
expansionserum
albumin
essential
supplement
ex
vivo
medium
supplements
represent
biological
contamination
loss
cellular
function
exhibits
batchtobatch
variability
blamed
causing
experimental
reproducibility
discovered
polymer
pva
inexpensive
manufacturing
practicecompatible
biologically
inert
replacement
free
contaminants
plagued
albuminbased
describe
replace
lines
leukemia
lymphocytes
generation
functional
offering
potentially
costefficient
summary
chemically
defined
hematology
combinatorial
etigilimab
nivolumab
patent
wo2018102536introduction
tigit
discover
focused
inhibiting
action
wo2018102536
propose
eradicate
utilizes
antitigit
antipd1pdl1
covered
utilization
pharmaceutical
cocktail
opinion
support
tolerability
california
eliminate
nonmedical
exemptions
coverage
empirical
analysisbackground
reluctance
refusal
growing
state
belief
controversial
unclear
limited
rigorous
senate
bill
277
eliminated
school
entry
estimate
californias
quasiexperimental
statelevel
countylevel
differenceindifferences
publicly
measles
mumps
rubella
mmr
exemption
entering
kindergarten
individually
requested
availability
2011
2017
2010
prespecified
county
relative
postpolicy
43
placebo
tests
04
interval
2958
39
2454
2029
counties
ranged
larger
prepolicy
robust
specifications
limitations
exclusion
subset
reduction
offset
largest
highrisk
meaning
lowest
removing
comparing
cholera
maela
refugee
camp
transmission
practicebackground
concern
displacedperson
camps
contend
overcrowding
scarcity
longeststanding
thailand
located
thaiburmese
border
experienced
four
outbreaks
2005
2013
campaign
implemented
assist
subsequent
mathematical
formulated
susceptibleinfectiouswaterrecoveredbased
next
conferred
varying
timing
ie
forecasts
inform
ontheground
decisionmaking
whether
needed
preexposure
substantially
50
twodose
additionally
preferred
number
per
person
reactive
tradeoff
revealed
indicating
beneficial
rather
fewer
incur
delay
forecasting
realistic
predicted
2014
predictions
epidemic
conjunction
water
sanitation
provides
controlling
outbreak
delayed
distribution
alter
suggesting
quick
ensuring
individual
illustrates
intervention
emergence
chile
20122013invasive
mainly
manifests
sudden
serogroups
hypervirulent
clones
spread
alarm
sequelae
fatal
situation
occurred
starting
week
face
scenario
multidisciplinary
teams
called
w135
sanitary
alerts
reinforcement
epidemiological
suspicious
stateoftheart
contacts
plans
42nd
9monthsold
01100000
fatality
23
0
inclusion
ability
allowed
ministry
manage
neisseria
meningitidis
serogroup
w
coordination
allows
populations
periods
generating
cavei
considerations
description
2016background
aefi
allow
known
ae
infrequent
general
subanalysis
pentavalent
carried
calculated
100000
interest
ror
apneas
2552
913
134
rates
highest
443
apnea
105
3772947
references
peptide
elicited
reboosted
myxofibrosarcomapeptidebased
elicit
endstage
sarcoma
myxofibrosarcoma
46yearold
man
papillomavirus
binding
survivin2b
incomplete
freunds
polyethylene
glycolconjugated
interferonalpha
2a
necrosis
massive
infiltration
cd8t
recurrent
weakened
surgical
resection
might
suggested
observations
tripterygium
glycosides
graves
ophthalmopathy
systematic
metaanalysisbackground
go
remaining
enigmas
thyroidology
glucocorticoids
gcs
strongly
completely
satisfactory
tg
component
wilfordii
hook
f
twhf
numerous
benefited
practical
metaanalysis
investigate
retrieving
vip
cbm
wanfang
databases
open
published
rcts
criteria
tool
conducts
background
prospero
crd42019131915
involving
1517
acceptable
validity
brought
higher
nontg
140
131149
controls
gc
136
127146
intensification
191
137267
ci121159
dosage
1560mgd
141
130153
90mgd
147
129168
143
133152
115
094141
exophthalmus
255
293
217
recurrence
045
027074
032
020053
cas
obvious
gap
008
060
075
nevertheless
large
reasonable
verification
scar
hla
identical
donor
neoplasms
singlecenter
comparison
singleunit
cord
transplantation
haploidenticalrelated
pbsc
ptcy
conditioning
platform
thiotepabusulfanfludarabinehaploidentical
haplo
umbilical
ucb
hct
institution
haplohct
procedure
myeloablative
regimen
thiotepa
busulfan
fludarabine
47
61
ucbt
posttransplant
cyclophosphamide
neutrophil
engraftment
whereas
platelet
recovery
earlier
nrm
3year
relapse
013
100day
34
acute
gvhd
11
moderatetosevere
15
differ
02
trend
recipients
69
38
0055
despite
sizes
status
os
mostly
feasible
seriously
affect
viruses
antigenic
variation
widespread
gathering
places
schools
kindergartens
homes
annually
young
elderly
illnesses
illness
splitvirus
subunit
split
except
cities
category
ⅱ
voluntary
pay
abroad
accept
59
9
cdcs
endocrine
consequences
inhibitorsimmune
checkpoints
fundamentally
oncologic
consist
directed
tlymphocyte
protein1
ligands
reverse
cancerous
favour
lymphocytic
reactivation
autoantigens
maintained
help
lead
autoimmune
cutaneous
digestive
glands
spared
provocation
exercise
immunotherapybackground
oit
restrictions
regular
consumption
underwent
miyagi
childrens
april
fifteen
91
12
433
egg
534
cows
milk
25
624
wheat
intramuscular
adrenaline
injections
allergies
termination
remain
intolerant
digital
card
roomobjective
mobile
devices
integrated
rooms
pressman
life
computational
satisfaction
usability
functionalities
survey
technological
innovations
displays
user
directly
notifies
upcoming
enables
cards
dependents
score
905
±
111
842
194
reach
goals
synchronizes
enabling
maintenance
peoples
projected
geographic
subsaharan
africa
modeling
majority
assembly
committed
2030
ocv
nearterm
supplies
characterizing
deployment
expectations
maximize
chances
impacts
geographically
historical
assessed
averted
disabilityadjusted
accounted
direct
indirect
projections
supply
optimized
avert
828971
803370859980
equivalent
340
332348
balances
logistical
617424
599150643891
contrast
locations
access
273939
270319277002
109817
103735114110
find
logistically
costs
us1843
132814312
daly
improvements
moderate
incorporate
estimates
performance
suggests
districts
poorest
greatest
near
term
services
dramatic
alone
unlikely
achieve
goal
multiepitope
plantmade
protein
ltbentero
enteric
miceunassigned
plantbased
multiepitopic
epitopes
etec
typhimurium
v
parahaemolyticus
produced
plants
triggered
intestinal
humoral
immunized
mice
around
200
suffer
gastroenteritis
daily
die
countries
pathologies
lowcost
ensure
proper
attractive
hosts
synthesis
delivery
named
enterotoxigenic
e
coli
tobacco
529
µg
g
fresh
leaf
tissue
deemed
balbc
orally
subcutaneously
igg
iga
mucosal
ltb
st
lptd
functionally
plant
capable
constitutes
candidate
fight
autologous
humanized
patientderivedxenograft
ovarian
cancerobjective
humanize
patientderived
xenograft
pdx
patientmatched
infiltrating
tils
orthotopic
highgrade
serous
hgsoc
molecularly
histologically
immunohistochemistry
expanded
protocol
exvivo
til
cocultures
validate
reactivity
expression
markers
secretion
quantitated
elisa
proof
monotherapy
tiltumor
hladependent
ifnγ
addition
lysis
ccne1
amplified
parallel
morphology
marker
validates
clinically
invivo
testing
immunomodulating
unique
assessing
patientspecific
indication
demyelinating
polyneuropathy
francophone
society
bone
marrow
sfgmtcchronic
cidp
nervous
segmental
demyelination
accounting
neurological
deficit
electroneuromyogram
enmg
spinal
fluid
dissociation
abnormalities
mri
minor
nerve
biopsy
socalled
firstline
immunodulator
failure
successive
line
corticosteroids
plasma
exchange
ahct
société
française
de
greffe
moelle
osseuse
et
thérapie
cellulaire
sfgmtc
maladies
autoimmunes
mathec
filière
santé
rares
neuromusculaire
filnemus
specify
eligibility
cipd
mobilization
followup
throughout
simple
practicehuman
hpv
sexually
transmitted
cervical
percent
girls
countrywide
boys
south
dakota
effort
undertaken
interventions
month
mailing
parents
1112
inoffice
reminder
office
encounter
slightly
reviewt
independent
histocompatibility
mhc
already
impressive
nonetheless
easy
offtarget
inefficient
enthusiasm
designers
discussions
constraints
cuttingedge
newtype
armed
detail
tailoring
earlyphase
objectivesbackground
contemporary
oncology
designs
objectives
refine
adaptive
endpoints
cohorts
agonistic
cd40
cd27
modelbased
immunogenicity
peptides
plus
tlr3
iibiv
redefining
forward
later
phases
incorporating
facilitate
acceptance
personalized
neoantigenpulsed
dendritic
superior
neoantigenadjuvant
modelsdevelopment
neoantigens
forms
studied
lysatespulsed
dc
peptideadjuvant
produce
choose
neoantigen
murine
ll2
enzymelinked
immunospot
elispot
assay
46
exhibited
indicated
activating
fundings
individualized
attitude
reproductive
georgiageorgia
serosurvey
antihbc
georgia
2002
capital
tbilisi
randomly
selected
recruited
prenatal
selfadministered
sociodemographic
2185
enrolled
285
1746
764
bachelor
masters
respondents
never
heard
knew
infected
determine
chronically
exposed
575
aware
516
didnt
know
358
condom
721
279
p00001
406
name
382
p005
womens
place
counseling
promote
perspective
childrenthe
purpose
reviewed
variants
allergenspecific
astfa
expanding
consumed
manifested
lifethreatening
accidentally
ingested
igemediated
fa
pathogenetically
substantiated
consider
possibilities
nonallergenspecific
tolllike
probiotics
biologics
silicacoated
magnetic
nanoparticles
conjugated
ovalbuminunassigned
unassigned
efficient
antigendelivery
carriers
ovalbumin
marrowderived
lymphocyte
ctl
activated
th1
il2
proliferation
immunestimulatory
eg7ova
lymphomaexpressing
tumorbearing
expected
anticancer
vaccinationsvaccinations
integral
part
pretravel
gaps
routine
closed
yellow
typhoid
rabies
japanese
encephalitis
cholerayellow
america
asia
c
pilgrims
visiting
african
meningitis
belt
dry
polio
wildtype
wpv
circulating
poliovirus
cvdpvhepatitis
acommon
going
region
travelassociated
antimicrobial
germany
5070
rabid
animals
postexposure
sufficient
priming
periurban
extremely
adapting
challengesimmunization
enormous
contribution
dramatically
creation
programme
1974
formation
gavi
alliance
2000
persisting
inequities
contribute
continued
inequalities
geography
urbanrural
socioeconomic
jeopardize
achievement
call
renewed
account
opportunities
building
technologies
equity
participation
communities
abetter
middleincome
financial
nonfinancial
incentives
comprehensive
lessons
learned
eradication
maternal
neonatal
instrumental
enhancing
revised
agenda
varicella
hospitalizations
southeast
brazilbackground
complicated
minas
gerais
brazil
territorial
department
descriptive
statistics
generalized
linear
praiswinsten
tendency
adopting
significance
autoregressive
moving
averages
1635
cellulitis
predominant
complication
homeacquired
389
464
coefficient
pre
post
195
cases100000
inhabitants
024
547
lethality
258100000
inhabitantsyear
decreasing
coincidentally
postimmunization
restricted
promoting
chinaneonatal
basically
nonneonatal
trauma
correct
toxoid
ttcv
neglected
clarified
pointer
measure
active
topdown
promoted
added
mistake
3day
rush
insect
venom
protocolbackground
vit
hymenoptera
buildup
vitinduced
anaphylaxis
monocentric
11year
cycles
retrieved
records
frequency
sting
scs
culprit
1317
initial
cumulative
n
temporarily
comedications
reached
completing
769
cohort
985
excellent
sarcomas
applicationssurvival
plateaued
grim
wellrecognized
successes
bcell
lymphoblastic
fusing
singlechain
variable
fragment
scfv
recognizes
taa
sarcomaassociated
saa
amenable
encouraging
epidermal
her2
disialoganglioside
gd2
il11ra
fibroblast
fap
b7h3
cd44v6
insulinlike
igf1r
tyrosine
kinase
orphanlike
ror1
urgently
continues
draw
emerge
minimizing
host
cytotoxicity
exploring
heart
evolving
landscape
therapeuticsthe
100years
seen
alteration
aside
molecule
kinases
valuable
modulating
pathophysiology
delivering
biomarkers
optimising
wave
arrived
form
modulators
immuneregulatory
programmesimmunization
costeffective
wellbeing
sustainable
inception
epi
considerable
gains
yet
tappedhealth
weaknesses
universal
alimitation
array
fortunately
solutions
exist
implement
vision
programmes
responsible
arange
establishing
evidencebased
financing
procurement
logistics
collection
wellfunctioning
deliver
highquality
tailored
meet
reap
benefits
equitable
link
diabetes
unmanipulated
haploidentical
lowdose
antithymocyte
globulin
methylprednisolone
leukemiaallogeneic
hsct
rral
reports
hidhsct
highdose
atg
thymoglobulin
225mgkg
mpsl
1mgkg
nonhidhsct
differed
intensity
196
611
p0001
undergone
261
p0045
1year
317
291
p025
diseasefree
dfs
205
237
p023
cir
400
428
p092
nonrelapse
395
335
p022
iiiv
graftversushost
326
347
p064
stratified
hazard
hr095
058158
hr105
95ci
067168
hr084
048147
hr128
066246
comparable
viable
papillomaviruses
intentions
10to
11s
normandy
20152016school
yearbackground
france
11to
14yearsold
intent
sixthgrade
class
secondary
collaboration
academic
distributed
2016and
june
2016by
16selected
1428questionnaires
864
605
regardless
gender
439girls
859
vaccinate
parent
responded
mother
took
note
booklet
737
109
32
booklets
immunooncology
goes
days
discontinuing
sulphonamide
desensitization
reactionthe
fixed
eruption
nonimmediate
hypersensitivity
erythematous
violaceous
rounded
welldefined
plaques
appear
location
usual
avoid
involved
structurally
situations
safe
option
sulfamethoxazoletrimethoprim
repeat
twice
inadvertent
fulldose
reintroduction
standardization
lost
unknown
ii
iii
contraindicated
desensitisation
lesions
manifestations
concluded
premedication
insurance
switzerland
july
accordance
ofsp
federal
cfv
decision
came
mounting
anogenital
oropharyngeal
practitioners
pediatricians
urologists
diagnose
actors
cisplatinbased
muscleinvasive
bladder
outdatedfor
neoadjuvant
nac
mibc
modest
advent
opening
unfortunately
2035
panfgfr
«
fits
»
ideal
solution
probability
appears
costefficiency
licensing
europe
prequalification
programvaccinations
amongst
powerful
offer
avery
licensure
aprocess
acomprehensive
set
legal
procedural
regulatory
confirm
benefitrisk
absolute
prerequisite
granting
alicensein
mrp
dcp
centralized
depending
marketed
nationally
acertain
flexibility
conditions
alicense
granted
avaccine
fulfill
step
humans
prelicensure
akey
makingthe
prime
universally
recognized
standards
entire
pavestones
pave
changsheng
chinas
achievements
threatened
crisis
aims
attempts
online
september
examine
associations
cognition
1115
approximately
70
783
half
5453
dissatisfied
governments
positively
or1621
ci12152163
risks
or1501
ci11192013
concerns
or0480
ci03170726
or0594
ci03940895
held
coordinated
restore
nationwide
dissent
inoculation
actions
parties
possibility
transparent
antinmethyldaspartate
bilateral
teratomas
histopathologic
reviewbackground
nmdar
disorder
teratoma
condition
reversed
antinmdar
rarely
23yearold
woman
seizures
cerebrospinal
detection
pelvic
computed
tomography
postoperative
left
lesion
immature
right
mature
recovered
remission
differing
consensus
hemagglutinin
h3
swinethe
substantial
diversity
swine
iavs
challenge
broadly
proven
vaccinology
overcome
extraordinary
rna
sought
ha
pigs
question
designated
h3con1
sequences
genbank
naturally
occurring
h3n2
strain
h3tx98
baculovirus
emulsified
oilinwater
broader
crossreactive
neutralizing
interferon
gamma
secreting
fully
isolate
h3con1vaccinated
shed
secretions
h3tx98vaccinated
collectively
proofofevidence
effectively
employed
concurrent
modifiedlive
prrsv1
prrsv2
heterologous
dual
late
giltsthe
porcine
mlv
gilts
concurrently
breeding
separate
anatomical
sites
inoculated
intranasally
prrsv
93
gestation
liveborn
weaned
stillbirths
unvaccinated
viremia
correlated
interferonγ
ifnγsc
believe
contributed
reduces
pertussis
janamora
district
amhara
regional
ethiopia
casecontrol
studyunassigned
172017
officials
cough
community
unmatched
22may
probable
definition
vomiting
inspiratory
whoop
suspected
neighbors
doortodoor
search
parental
interview
683
866
834
attack
agespecific
underfive
033
likely
117722
contact
629
2531562
ventilated
301
117770
weak
supplementary
household
diagnostic
paramount
detect
renal
australia
optionsvascular
endothelial
standard
clear
mrcc
prolonged
rcc
consortium
subsidized
sequencing
hungaryintroduction
hcws
former
ecdc
european
centre
paediatricians
hungary
altogether
765
questionnaires
returned
189
375
201
weighted
countryspecific
eg
residence
aspect
representative
doctors
convinced
consolingly
somewhat
relatednip
scares
autismmmr
etc
hardly
detected
explained
least
supported
bcg
immunizationrelated
clearly
gradual
postgradual
training
programs
orv
hetil
16048
19041914
challengesimmunotherapy
area
fact
namely
threat
climate
warming
century
spend
outdoors
sunlight
ultraviolet
radiation
ozone
layer
depletion
like
pembrolizumab
prolonging
stated
autoimmunemediated
cosignal
moleculesgreat
represented
mabs
noted
proportion
durable
usage
existing
anticipated
subject
agonists
stimulatory
rendering
terms
animal
leukaemia
allograft
immunotherapyleukaemia
arrival
revolutionised
intravesical
nonmuscle
twentyfirst
edition
salvage
nonmuscleinvasive
respond
bacillus
calmetteguérin
predictors
nomogramsthe
best
pattern
nomograms
panels
urinary
fluorescent
situ
hybridization
patterns
urine
cytology
examinations
investigations
really
conservative
precisely
predict
nomogram
nmibc
subgroups
prediction
genomic
cancernonmuscleinvasive
heterogeneous
rely
individualization
genetics
heterogeneity
nmibcs
mutation
signatures
chromosomal
disruption
ultimately
affects
responsiveness
underway
differential
precisionbased
stratify
therapydespite
40year
reign
urologic
hampered
acting
immunostimulatory
agent
multitude
phenotypically
diverse
deeper
underpinning
constructed
cancerthis
demonstrates
recombinant
interferonα2b
oncolytic
adenoviruses
toxicities
arises
await
completion
treatmentthis
evaluates
ait
resultant
comorbid
persistent
discontinuation
asthma
pharmacotherapy
reactionsdrug
dhrs
noncross
graded
identifies
immediatetype
dhr
penicillin
temporary
special
antibiotics
angiotensinconverting
enzyme
anesthetic
aspirin
nonsteroidal
radiocontrast
chemotherapeutic
melanomaadvancedmetastatic
chemotherapies
appreciably
extend
cytokinechemokine
produces
toxic
harnessing
advancedmetastatic
close
treat
systemrelated
differently
tracking
female
trialbackground
2006
barriers
facilitators
popular
informationmotivationbehavioral
skill
imb
schoolbased
prospective
doubleblind
blankcontrolled
7day
6month
enroll
3360
18years
1month
3months
6months
reservation
motivation
beliefs
behavioral
willingness
theorybased
conduct
assesses
mobilebased
schooltargeted
theoretically
guided
registry
chictr
chictr1900025476
registered
27
august
ebola
inaccessibility
levelsdespite
conflict
distrust
drc
undermining
ring
prompt
refuse
communitylevel
accessibility
individuallevel
stochastic
incorporates
sources
inaccessible
tracing
mixing
resembling
depend
spatial
distance
delays
affirm
supplemental
qualitative
steadily
probabilities
otherwise
ending
saves
lives
easier
contain
occurs
exceeds
underscore
enhance
engagement
containment
functionalization
citratecoated
superparamagnetic
iron
oxide
magnetically
therapyunassigned
immunologically
hot
infiltrated
cold
triggering
must
enriched
principle
loaded
spion
citrate
externally
alkaline
coprecipitation
ironii
ironiii
chloride
coating
sodium
concentrationdependent
cytocompatibility
particles
determined
stability
assays
atomic
emission
spectroscopy
quantification
particle
attractability
livecell
imaging
displayed
sign
aggregation
finally
attracted
external
magnet
magnetized
particlecell
hybrid
straightforward
loading
controllable
reasons
suitable
candidates
dont
get
stuck
shoulder
translational
millennium
coleys
revived
immunitythere
lies
spotlight
certain
network
immunomodulatory
isolated
steps
preferentially
initially
anticd40
phagocytosisstimulating
mannan
anchored
membrane
biocompatible
anchor
pancreatic
adenocarcinoma
pheochromocytoma
metastases
longlasting
rechallenge
accomplished
selectionthe
revolutionized
pathological
examined
20122015
territory
yearround
campaignunassigned
hospitals
birth
nt
perinatal
register
deliveries
merged
immunisation
3392
pregnancies
456
685
indigenous
nonindigenous
yielding
467
402
542
preterm
births
mothers
272
6505
589
gestational
commonwealth
missed
baby
antenatal
2017this
eleventh
calendar
australian
air
aboriginal
torres
strait
islander
immunised
12month
reaching
938
december
60month
945
24month
898
amendment
dtpa
932
969
catchup
measlesmumpsrubellacontaining
considerably
1019
203
802
759
79
77
planned
completeness
macromolecular
radioimmunotherapy
lymphomapolymers
anchoring
radioimmunoconjugates
amount
radioisotope
attachment
pivotal
tailorable
formulations
personalised
herein
phemarangma
conjugation
lutetium
ions
rituximab
suitability
cpgoligodeoxynucleotide
41bb
hepatoma
bearing
miceobjective
cpgodn
hepatomabearing
h22
suspension
injected
axilla
limbs
male
7
corresponding
volume
cpg
cpg41bb
extremity
batch
normal
organ
index
ifn
spleen
measurement
variance
logrank
sustained
execution
97608
2955
mm3
4725
093
33652
3940
329273
distant
61183
11302
40662
5109
38001
5144
247160
il12
2390
233
pgml
10302
610
454
062
2921
223
3704
149
11612
408
13865
172
665
1273
088
χ
25544
shrink
capacity
inhibit
prolong
radiotherapy
brain
metaanalysisradiotherapy
rt
mainstay
bms
1520
pooled
159
139181
2year
552
493609
357
304413
hr054
044067
able
cxcr12
medicinal
antagonists
highlights
aheadimmune
intractable
chemokine
cxcr1
cxcr2
recruit
suppressor
mdscs
aroused
chemistry
relevance
aryl
hydrocarbon
nextgeneration
sahrms
metabolized
rmahrlsaryl
ahr
hub
nongenomic
connecting
environmental
shapes
processes
stimuli
tissuetype
dependent
thrust
limelight
modulation
rmahrls
classes
interesting
compounds
bypass
ahrrelated
favor
covering
concepts
underlying
definitions
modes
structureactivity
relationships
ahrmediated
cystic
echinococcosis
intermediate
rabbit
studiesthe
domestic
ce
potency
crude
germinal
protoscoleces
protect
firstly
white
newzeland
rabbits
5000
oncospheres
separately
slaughtered
hydatid
cysts
organs
secondly
nine
n3
mineral
oil
kept
titer
667
adjacent
dogs
echinococcus
carcinomaimmune
apparently
upregulate
analysed
tregs
alternatively
gitr
tim3
cd4
cd25
foxp3
mediators
il35
tgfbeta
galectin9
116
nontumour
effector
ifngamma
lectindependent
ldcc
inhibitornegative
p815
unlike
inhibitorpositive
inversely
p00080
p00029
corresponded
numbers
producing
treginduced
partially
blocked
dysfunction
antitumoural
presumably
facilitating
pdl1pd1
selectively
interfered
treg
cd4cd25foxp3
asthmabackground
immunologic
sixtyseven
555
moderatesevere
dermatophagoides
pteronyssinus
derp
farinae
221
immunoglobulin
g4
derpsigg4
trs
trms
0026
upregulation
0024
0008
0007
0032
reveal
sigg4
misfolded
alsprotein
misfolding
crucially
underlies
amyotrophic
lateral
sclerosis
als
mutant
superoxide
dismutase
sod1
tar
dnabinding
43kda
tdp43
causal
familial
sporadic
provoking
pathogenic
intracellular
extracellular
environments
celltocell
implicated
neurodegeneration
strict
antigenspecificity
intravenous
fulllength
cytosol
generate
vectors
fragments
modifications
adding
proteolytic
signals
cautiously
succeeded
transgenic
accumulating
proteinopathy
intrabodies
mislocalized
aggregated
inside
patientsbackground
cure
enhancement
preventing
decreases
eradicates
cirrhosis
verifying
documentation
childturcotte
pugh
bases
medline
lilacs
articles
figure
discussion
eight
accelerated
conventional
super
pretransplant
transplanted
disregarding
seroconversion
tended
superiority
unconventional
vulnerable
possibly
serologic
posttranslational
dermatooncologyin
complaints
antitumoral
psychosocial
dermatooncology
confronted
anovel
spectrum
anumber
immunemediated
virtually
besides
breaks
immunotherapyrelated
immunosuppressants
symptomatic
consideration
electronic
nose
predicts
real
lateonset
rejection
pediatric
rescued
reportsmall
failed
carries
notable
graft
malfunction
ends
enterectomy
subtherapeutic
immunosuppression
nonadherence
20yearold
bowel
hirschsprung
bloody
ostomy
output
weight
ileoscopy
anatomic
landmarks
ulcerated
mucosa
biopsies
ulceration
granulation
architectural
distortion
tacrolimus
escalated
infliximab
repeatedly
eventually
histologic
antirejection
lymphoproliferative
resolved
prednisone
infusion
chance
rescuing
her2specific
receptorengineered
apatinib
gastric
secondgeneration
5137z
nk92
nk925137z
synergize
nk
cellbased
suppress
overexpressed
lysed
xenografts
tbburden
canadian
communitiesbackground
bacille
tuberculosis
tb
hightbburden
lowburden
vary
uncertainties
surrounding
likelihood
lowincidence
discontinued
instead
pertinent
example
highincidence
warranting
synthesise
appraise
returning
pertaining
bcgassociated
tracked
covidence
veritas
innovation
melbourne
49
spanning
moved
communitybased
riskfactorbased
casefinding
strengthened
remote
underserved
persist
multifactorial
inhibitor
isg15
knockdown
reverses
transformation
downregulation
expressioninterferonstimulated
15kda
interferons
ifnα
ifnβ
ubiquitinlike
superfamily
ductal
pdac
conjugates
carcinogenesis
tumorigenesis
krasassociated
colony
clustered
regularly
interspaced
palindromic
repeatscrisprmediated
tumorprogrammed
ligand1
tumorinfiltrating
syngeneic
knocking
interestingly
knockdownmediated
antiprogrammed
wild
cancersimmune
ici
upset
algorithm
conferring
palliative
entered
anticytotoxic
sequential
explored
antipd1antipdl1
revision
viremic
prisoners
stockholm
countybackground
hcv
aiming
swedish
immunodeficiency
incarcerated
n667
prisons
n9
routinely
optin
antihcv
agab
prison
sweden
relation
sex
security
iqr
2644
934
seventyone
n471
n465
170
n271
suit
bloodborne
20072011
catalonia
spainbackground
demographic
laboratoryconfirmed
2007
notifiable
centres
written
saliva
specimens
laboratoryconfirmation
realtime
reversetranscriptase
pcr
rtrtpcr
serological
phylogenetic
sh
316
nucleotides
coding
hn
1749
categorical
variables
chisquare
fishers
continuous
student
ofmmr
581
16
personsyear
hundred
sixtyfour
289
belonging
97
145
316nucleotide
174nucleotide
genotypes
genotype
126
h
j
remained
uncharacterized
amino
acid
strains
jeryl
lynn
substitutions
genotypespecific
fiftyone
324
prevalent
amounts
ascites
inferior
understood
preferably
diffusionweighted
214
ordinal
none
abundant
comprising
vegf
vascular
tgfβ
transforming
ccl2
cc
motif
debulking
gradually
correction
figo
stronger
predictor
correlates
robo1specific
carnk
enhances
125
seed
brachytherapy
carcinomaobjective
synergistic
robo1
bichimeric
receptornatural
bicarnk
bxpc3
red
implantation
seeds
fluorescence
tesla
resonance
7tmr
scanning
metabolic
profiles
tissues
untreated
t1
diffusion
t1dwi
sequence
grey
longchain
fatty
acidcontaining
lipids
urological
cancerscheckpoint
adopted
noninvasive
metabolomic
metabolites
quantified
sera
metabolite
n910
werevery
vlcfacontaining
centroid
sensitivity
0850
0825
roc
0935
peroxisome
switch
catabolism
biomarker
envision
nutritional
immuno
sensitizer
gastrointestinal
stromal
tumorsgastrointestinal
tumorsgistsare
mesenchymal
tract
radiochemotherapycomplete
excision
gistsalthough
gistsmultiple
pdgfra
relapsea
variety
microenvironments
gistsmany
participate
gists
therapythe
observational
behaviour
vaccinationsbackground
spreads
today
generations
fundamental
arent
much
behaviours
intention
messina
hproimmune
appropriately
analysing
statistical
info
insecurity
absent
acquire
thought
96
motivations
maybe
policymakers
stakeholders
shape
vital
unfinished
agendavaccination
saving
millions
subnational
varies
unmet
opens
exciting
discovery
difficult
investments
priority
industry
2019the
homeostasis
defense
imbalances
autoimmunity
manifest
atopic
urticaria
angioedema
lifestyle
allergicimmunologic
nigeria
wake
stakeholdersthe
survive
adolescence
theme
presently
paid
readily
normally
necessarily
nigerian
requirement
travelling
outside
result
congenital
concretized
losses
vibrant
workforce
urgent
build
window
opportunity
extended
noncompliance
fulani
011
vekovi
cameroon
delivered
onemonth
postpartum
vpds
nations
japans
classifies
ostensibly
optional
japan
make
inquiries
payment
barrier
assigned
sessions
fathers
shared
immunize
intentiontotreat
225
175
78
participated
171
replied
postsurvey
selfreported
rotavirus
84
p0019
intending
52
p001
sd
55
36
1030
51
515
literacy
05
08
06
making
indirectly
uptodate
umin000012575
prospectively
bingneel
chemoimmunotherapy
reportbackground
bns
waldenström
macroglobulinemia
wm
67yearold
asymptomatic
ago
deterioration
ophthalmologic
acuity
710
optic
disc
swelling
eye
nerves
extending
retina
chiasm
patchy
upon
csf
κlight
blymphocytes
electrophoresis
band
immunofixation
kappa
light
intrathecal
methotrexate
infusions
opted
start
iv
ibrutinib
posttreatment
initiation
hematologic
minimization
5t4
carcinoma5t4
trophoblast
glycoprotein
tpbg
transmembrane
carcinomas
somatic
favorable
encouraged
5t4targeted
compelling
unexplored
tcrengineered
highavidity
hlaa2restricted
epitope
residues
1725
p17
singlecell
complementaritydetermining
cdr3
α
tra
β
trb
genes
cloned
lentiviral
transduced
redirected
seven
tratrb
pairs
tcrs
transduction
efficiencies
89
tcrtransduced
ontargetcells
killed
hlaa2
breast
colorectaltumor
presentation
tap12deficient
t2
targetcells
recognize
religious
kindergartners
20112018background
fortyfive
permit
laws
trends
proportions
vermont
295
stateyears
quasibinomial
allowing
adjusting
strength
onefourth
025
016038
vermonts
20172018
20112012
makers
reconsider
travelthe
traveler
itinerary
preexisting
behaviors
structured
consultation
exotic
ageappropriate
immunizations
pose
travelers
delineated
graphics
highlight
dosing
route
boosters
medications
immunocompromise
discipline
immunocompromised
base
categories
presents
severely
hivinfected
asplenia
approachesglobally
ranks
fifth
hccs
prognoses
piglets
enzootic
sow
herdrecent
questioned
mdas
iav
attempt
stimulate
documenting
piglet
monitored
nonvaccinated
danish
herd
initiated
¼
castration
day
160
sows
05ml
shamvaccinated
swapped
weighed
signs
body
shedding
6weeks
onset
swabs
consecutive
samplings
reinfection
tracker
bracelets
timeliness
urban
pakistan
track
coupled
dates
reminderrecall
paperbased
mhealth
platforms
yield
resourceconstrained
simultaneously
demand
dropouts
pakistani
2years
threearm
silicone
recruitment
symbols
denote
come
perforate
hole
symbol
looking
bracelet
see
pentavalent3pcv3polio3
measles1
1446
landhi
town
karachi
till
eleven
enrolment
participant
commenced
18months
rigorously
clinicaltrialsgov
nct03310762
six
extracts
openlabelled
comparability
pediatrician
rhinoconjunctivitis
sensitization
grass
alk
sq
depot
avanz
allergovit
depigoid
purethal
pollinex
quattro
284
104
354
49649
1832
dayspatient
preparations
similarly
preliminary
noninferiority
combining
antimalarial
antiinfective
malaria
resurgence
modelling
rtssas01
morbiditycontrol
deploying
wider
ranges
coadministration
mounts
stalling
dynamics
simulated
openmalaria
individualbased
simulation
coverages
chemopreventive
fitted
preventative
chemoprevention
interruption
resurges
cease
rounds
simulations
unidentified
delaying
longer
alongside
foci
surveillanceresponse
interleukin33
friend
enemy
tumorsinterleukin33
belongs
acts
danger
signal
released
stressed
necrotic
inducer
th2
stimulator
performing
provokes
stimulates
remodeling
angiogenesis
killers
cytolysismediated
versatile
il33st2
cascade
prospects
st2
immunoprophyilaxis
uromune®
effectsbackground
uncomplicated
menopause
sublingually
24h
784
12months
visit
package
150
culture
menopausal
respect
premenopausal
735years
827
943
episodes
372
281
01
441
276
323
327
332
465
scored
329
717
647
50years
choice
urologyeffective
urologically
underperformed
urology
consistently
egfor
awidespread
nonsensemediated
mrna
decay
editing
immunotherapypremature
codons
ptcs
truncated
degradation
messenger
rnas
nmd
rules
applying
genomewide
resource
nmdetective
typically
aggravates
alleviates
ineffective
inactivation
crisprcas9
determinant
frameshifted
transcripts
escape
predicting
capture
propagationseasonal
poses
contributor
england
longstanding
partial
informing
amalgamate
calibrate
susceptiblelatentinfectedrecovered
linking
beginning
seasons
200910
virological
positivity
attributes
practitioner
influenzalikeillness
consultations
royal
rcgp
rsc
parameter
inference
approximate
bayesian
computation
transmissibility
dependence
ascertainment
propagation
weaker
projecting
historic
determining
hampers
protecting
neckprospective
hypothesized
cmhn
receipt
cox
153
hr
069
lns
050
0002
independently
117
026
seem
0979
confers
cent
origin
car19
ball
relapsed
migrant
chongqing
ruraltourban
bridge
crossregional
shifts
homelands
hb
ones
interviews
twostage
cluster
binary
1574
surveys
773
4911
3558
wearing
condoms
educated
drinkers
section
wear
nondrinkers
peer
accessible
ways
disseminate
declaration
polandvaccines
communicable
material
selfadministrated
3000
guardians
silesian
voivodship
southern
poland
413
1239
onethird
surveyed
declared
aefis
redness
site
249
unsafe
mild
consequence
reporters
cytokineinduced
rectal
colorectal
synchronous
tolerate
surgery
optimum
employing
56yearold
mucous
defecation
accompanied
fatigue
appetite
admitted
fecal
differentiated
abdominal
ct
terminated
owing
cik
dynamic
sequent
cellimmunotherapy
cd56chimeric
refractoryrecurrent
rhabdomyosarcoma
35year
rms
soft
5year
2yearold
operations
recurrences
embryonal
iiia
tnm
bound
cd56
transfusion
smooth
cd56cart
nonresponsive
inhibitorrelated
eventsimmune
reactivate
overactivated
monolineage
cytopenia
pancytopenia
hemolytic
anemia
aiha
thrombocytopenia
itp
neutropenia
aplastic
sometimes
hemophagocytic
lymphohistiocytosis
rheumatic
remarkable
breakthroughs
preexsiting
pd1programmed
nsclc
pd1pdl1
opportunistic
chroniclatent
drawn
inhibitorsimmunotherapy
spot
receptor1
lymphocyteassociated
immunecheckpoint
activate
digestion
absorption
metabolism
detoxification
affected
explains
ocular
immunocheckpoint
hope
sideeffects
eyelid
lashes
conjunctiva
cornea
uvea
ignored
advice
edocrine
inhibitorsas
virtue
termed
latent
unstable
force
discontinue
inhibitorimmune
overactivation
icisinduced
dermatologic
maculopapular
rash
pruritus
aes
stevensjohnson
necrolysis
ranging
80
parts
aseptic
meningoencephalitis
necrotizing
brainstem
transverse
myelitis
cranial
neuropathy
multifocal
radicular
guillainbarre
myasthenia
gravis
myopathy
electroencephalogram
electro
myography
exclude
glucocorticoid
cardiac
inhibitorimmunotherapy
bringing
programmer
4related
block
bodys
clearance
cardiovascular
killing
pneumonitis
inhibitorthe
cip
pulmonary
interstitial
properly
inhibitorsimmunocheckpoint
suggestions
exploration
inhibitorsthe
milestone
brake
releasing
brakes
unprecedented
esmo
nccnamerican
asco
sitc
csco
journals
stimulating
supplemented
highlighted
il6
factorα
tnfα
mab
antiintegrin
janus
thrombopoietin
put
steroids
emphasize
unavailability
steroid
deescalation
era
smallmolecule
big
worthy
fullcourse
immunotherapynowadays
aetiological
persistence
impaired
lengthy
ineffectiveness
accounts
optimize
allocation
sigetige
basophil
tolerogenic
reason
legislation
influenced
senior
citizens
2011background
citizen
28european
connection
economic
aconsiderable
shift
addresses
placed
focussing
influence
20112017
ahealthcare
pursued
unified
eurlex
february
academia
politics
physician
resolves
initiative
ema
geriatric
asignificant
apassive
impulses
hereby
adeeper
multinational
reconstitution
sclerosisnew
irts
permanent
drugfree
ms
deplete
renew
haematopoietic
formulation
cladribine
alemtuzumab
ocrelizumab
categorized
indeed
repertoires
rebuild
foster
acquisition
correlate
guiding
renewal
colibacillosis
haemorrhagic
vaccineviral
vhd
rhdv
g1g4
g1
g2
g3
coliinfected
coliinfectedrhdv
pv
g2g4
challenged
intramuscularly
ld
gain
faecal
bw
infectedrhdv
rd
postinfection
pi
upregulated
interleukin6
heterophil
phagocytic
cd4cd8
hi
hl
equilibrium
farming
follicular
cd19
immunotherapypatients
fl
tfl
progressionfree
phase
lymphodepletion
×
106
cd19directed
receptormodified
kilogram
cr
lugano
88
102
expansionpersistence
nct01865617
schistosomiasis
hypothetical
comparisonbackground
tropical
parasitic
flukes
kills
worms
schoolaged
confer
populationlevel
matched
calculating
heavyintensity
cost
economically
benchmarking
durations
sufficiently
lowpriced
shorter
timescales
mda
ultimate
hightransmission
inevitably
interrupting
immunotoxicity
mechanismsimmune
commonplace
widening
oncological
typical
relationship
vigilance
recognizing
managing
attempting
mechanistic
diffuse
implicationsintroduction
dlbcl
relying
reviewing
publications
profiling
bcelllike
abc
gcb
reproducible
clusters
abcgcb
classification
couple
far
immunochemotherapy
limitation
precise
workersthe
pnpv
201719
1192017
446
hcw
convenience
counselling
pitfalls
thanks
enforcement
mandates
diseasesemerging
emergent
eids
pandemics
globalization
trade
feature
explores
posed
families
commercialization
drivers
balanced
immunooncologyrecent
ushered
paradigm
cgassting
cytosolic
dsdna
sensing
mode
moa
synergizing
intense
disclosed
cyclic
dinucleotide
cdn
analogs
nonnucleic
organisations
misinformation
investigationbackground
unparalleled
counterbalance
workings
experiences
communicators
purposively
sampled
actively
advocacy
professional
technicalscientific
semistructured
indepth
lens
inductively
deductively
antiscience
sentiment
narrative
antivaccine
activists
sophisticated
communicating
openness
evidenceinformed
creating
spaces
encourage
audience
dialogue
fostering
partnerships
countering
silent
observing
openly
commenting
liking
sharing
posts
refutations
succinct
emphasizing
pairing
stories
speak
credibility
forming
atlantic
lumpfish
cyclopterus
lumpus
l
siteatlantic
im
intraperitoneal
ip
multivalent
oilbased
fish
phosphatebuffered
saline
skinmuscle
42days
dpi
ihc
expressions
secretory
igm
membranebound
igd
tcrα
cd3ε
iiβ
qpcr
vaccineinduced
granulomas
eosinophilic
granulocytelike
sections
intercellular
staining
igmcells
appeared
apparent
shortly
progressed
hyperthermiawe
123cancer
b3times
hyperthermia
immunohistochemical
classⅰ
boosting
melatonin
viewpointcancer
overcoming
ctls
fibroblasts
cafs
potentiate
attenuating
mitochondria
explain
monocytes
reprogrammed
coexpressing
gmcsf
ifnα2
poststem
transplantationacute
aml
intensive
postremission
residual
mrd
selfdifferentiated
idcs
migrated
nodes
novo
regeneration
firstinman
integrasedefective
tricistronic
vector
wt1
simplify
decentralized
automated
twoday
foreseeable
myocarditis
uncommon
inhibitorstraditional
anthracyclines
chest
involve
remissions
melanomas
nonsmallcell
urothelial
keep
mind
rhythm
disorders
cardiologic
checkup
helpful
troponin
natriuretic
12lead
resting
electrocardiogram
promptly
cardiologists
transthoracic
echocardiography
stopping
corticoids
unit
endomyocardial
bispecific
antiox40ctla4
wo2018202649introduction
ox40
costimulatory
wo2018202649
ox40ctla4
colon
pancreas
likewise
migrants
metaanalyses
insufficient
interested
structure
interleukin2
administering
orr
6m
scrs
411
071
063
grade3
018
fludarabinecontaining
anticd19
anticd20
2nd
3rdgeneration
infused
10m
comparative
cohabitation
salmon
salmo
salar
piscirickettsia
salmonis
em90likethe
chilean
aquaculture
piscirickettsiosis
try
routes
1120
noncommercial
em90like
macroscopic
microscopic
bacterial
load
gross
reflecting
replication
mimic
reallife
breaking
dogmauntil
dogmatically
invariably
immunebiology
metastasesinterestingly
swift
translation
driving
raise
neuroradiologic
neurooncology
undoubtedly
neurologic
eventsaim
immunobiology
neuroradiology
estimating
administer
smallpox
koreaobjective
surge
bioterrorism
varied
core
personnel
dispensing
korean
train
1000
multicentre
haemodialysis
nigeriabackground
lowers
diseasedialysis
collated
dialysis
entries
ibm
spss
statistics19
twentyfour
4826±1445
sixtytwo
504
169
thirtyfour
546
formal
influenzae
57
p0000
p0005
0003
healthpersonnel
driven
defective
dissemination
remarkably
contributory
abiraterone
coconut
mixture
triple
mycoplasma
hyopneumoniae
pcv2
respective
monovalent
challengebackground
circovirus
pig
mycoplasmal
hyopneumoniaespecific
pcv2specific
lastly
prrsvspecific
isnt
vaccinationobjective
hereafter
referred
200405
201213
funding
n5757
n5482
remoteness
1849
declined
74
5064
unacceptably
declines
1849year
fcγ
iib
modelvarious
fc
constitute
fcγriib
spontaneous
e7expressing
lactobacillusbased
intraepithelial
hsil
placebocontrolled
milacle
studywe
hpv16
igmkk16e7
e7specific
hpv16positive
gday
middledose
glbl101c
calculate
endpoint
cytological
e7
pharmaceuticals
agency
enrollment
begin
gilles
bergerdr
berger
chemist
pharmacist
organic
biomedical
worked
fellow
brussels
paris
montreal
mit
boston
gathered
handson
interface
nanotechnologies
mentoring
depth
collaborative
projects
record
canada
scientist
complementary
skills
organocatalysis
halogen
bonding
evidenced
harvard
associate
belgian
foundation
meetingbackground
ahigh
keynote048
ahighlight
abstracts
presentations
measurable
cps
platin5fluorouracil
fu
eagle
durvalumab±tremelimumab
secondline
platinsensitive
usa
death1
alphabeta
celldepleted
busulfanbased
myeloablation
ipex
xlinked
immunodysregulation
polyendocrinopathy
enteropathy
18monthold
boy
hscts
unrelated
810
hlamatched
treosulfan
gm
grafalon
neovii
rapperswil
contained
1506
x
cd34
419
chimerism
mononuclear
stopped
graftvshost
reducedtoxicity
tolerated
cessation
aboincompatible
reportgraftvshost
interplay
recipient
immunosuppressed
reconstituted
withdrawal
combat
aboi
ldlt
accuracy
acir
ratesimmunisation
earliest
coast
said
overdue
monthly
lists
alternated
provider
unsuccessful
letter
sent
missing
routinelypublished
quarterly
threemonthly
intervals
nonintervention
diverged
nsw
quarters
subtype
relevancecurrent
bioinformatics
expressionbased
classifications
distinguishing
cisplatinineligible
fgfr
subtyping
subclassifications
16042
16471654
radical
prostatectomy
reportincidence
nontransplanted
donorrecipient
genitourinary
neoplasm
maration
myelomareviewabstract
maturation
bcma
myeloma
direcited
fullyfunded
chinaobjective
diabetics
societal
tree
influenzarelated
outpatient
hospitalization
excess
qualityadjusted
qaly
incremental
icer
quo
outofpocket
ili
influenzalike
healthrelated
seeking
efficacyeffectiveness
horizon
cny
consumer
price
75
40
167
billions
110
81
sari
108
82
142
gained
365
046
991
threshold
680
gdp
capita
researches
polices
chinathis
10th
anniversary
2009
h1n1
pandemic
capacities
preparedness
indoleamine
23dioxygenase
secrete
ido
inducible
tcellbased
n12
n89
dna
kynurenine
tryptophan
posttreatments
immunohistochemically
encoding
prostatic
phosphatase
pap
psa
decline
1methyltryptophan
evasion
haemopoietic
myelodysplastic
mcfludt14l
randomised
preparative
reducedintensity
openlabel
31
eligible
1870
haematological
blast
counts
karnofsky
hsctspecific
comorbidity
2h
0·8
mgkg
6h
mgm
eventfree
margin
1·3
eudract
200800235618
nct00822393
476
240
220
transplanation
preplanned
interim
nov
met
confirmatory
cutoff
15·4
8·823·6
17·4
6·323·4
64·0
56·070·9
50·4
42·857·5
0·65
0·470·90
p0·0001
p0·0051
abnormal
transplantationrelated
noninferior
treosulfanfludarabine
medac
gmbh
epithelial
postresistance
chemotherapybackground
pointing
cultured
cd3
phenotyped
robustly
grown
to100×10
23weeks
hlarestricted
recognition
viability
avian
pathogensveterinary
desired
suchas
stable
poultry
reversion
virulence
utilized
simultaneous
manufacture
store
setbacks
applicable
impede
physical
vaccinesin
egypt
reassessment
chainegypt
sector
livelihoods
employment
income
hpai
h5n1
newcastle
doubtful
governorates
fifty‑four
titres
distributions
break
distributor
purpose‑built
refrigerator
prescribed
handling
malignanciesthe
carmodified
tisagenlecleucel
axicabtagene
ciloleucel
lisocabtagene
maraleucel
tbi1501
thirdparty
preparing
granulocyte
macrophage
colonystimulating
receptortargeted
therapiesit
checkpointblocking
ipilimumab
blockers
exceed
observation
facilitated
rtr
elucidate
baked
hens
pricktoprick
testbackground
diets
ea
unbaked
ninetyone
22
fortynine
245
bm
milkspecific
spt
ptp
838
917
mm
ubm
scrambled
whitespecific
824
960
specificige
hpv1618
programthe
began
1216years
withdrew
drastically
40years
neoplasia
cin13
ais
icc
participating
institutes
7709
20122017
5045
genotyped
declining
hpv18
6year
cin1
500
cin23ais
833
450
07
25years
hpv1618attributable
477
330
p003
435
p08
478
367
p04
20years
p02
hpv1618positive
cinais
skipped
coxsackievirus
a4
drugscoxsackievirus
cva4
hand
foot
mouth
hfmd
paediatric
icr
yt226r
infect
3dayold
hind
limb
paralysis
closely
imbalance
ifnγil4
wholevirus
afforded
homologous
ifnα2a
antiserum
tcr
affinity
crossreactivity
genemodified
immunotherapyadoptive
extent
matters
accepted
defining
affinityenhancement
mutagenesis
undesirable
exhausted
effectors
overstimulation
ignore
kinetic
focussed
comment
contributions
structureguided
manipulate
nephrotic
acutely
sunexposed
sununexposed
skinthe
deltoid
muscle
arm
uv
wavelengths
microbial
uvirradiated
unexposed
surrogates
sun
latitude
experiments
explanation
outlined
radiationinduced
immunetolerizing
experienceimmune
tlymphocyteassociated
flareups
therapywe
chart
tertiary
flares
extractedwe
60220
flare
immunotherapyiraes
entity
specialists
safely
repertoire
reflects
mutational
cancersomatic
immunoediting
drive
nonsynonymous
subdivided
regions
suggestive
spatially
constrained
antigendriven
harboring
display
dysfunctional
tissueresident
phenotype
neoantigentargeted
tumorsstimulating
tumortargeting
neoantigensthe
cellsmight
destruction
undue
damage
processing
qualities
prospect
tumorexpressed
neoepitopes
actually
provoke
beef
cattle
endotoxin
stackingvaccination
bovine
consulting
veterinarians
calves
feedlot
fails
additive
bacterin
segments
dairy
opportunitiesa
mount
ifoma
albeit
inconsistently
seronegative
endeavored
documented
preweaning
adjuvants
15years
makesvaccination
maintaining
quantity
back
nineteenth
twentieth
commercial
biomaterialsassisted
responsescancer
educating
clinic
autoimmunityrelated
localized
phototherapy
icd
icb
abscopal
wholebody
memory
biomaterials
utilizing
translated
vaccinomics
hantaan
hantavax®
koreathe
korea
official
announcement
inoculations
htnv
hemorrhagic
isolateinactivateinject
highthroughput
omics
21st
equations
cardiotoxicity
historically
evolves
hence
coronavirus
sarscov
middle
east
merscov
settingbackground
sars
mers
coronaviruses
nosocomial
mitigating
trees
describing
disproportionately
assuming
mitigate
hungarian
virusmore
aquiring
nonresponders
exposures
16041
16071616
albendazole
experimentalhydatid
cystalbendazole
hydatidosis
interleukin12interferongamma
administrated
measuring
histology
interleukin12
interferongamma
mtt
mediated
crosspriming
vivowe
ndv
attenuated
pathogenicity
chickens
backbone
gfp
transgene
ndvgfp
rndv
monocytederived
antigenpresenting
ifns
skbr3
apoptotic
dangerassociated
damps
highmobility
b1
hmgb1
heat
shock
hsp70
rndvinfected
idc
cocultured
pretreated
crossprimed
radiosurgery
metastasesradiation
adoption
keen
adjunct
cognitive
synergy
move
surveyobjectives
euwide
answered
weights
profession
5424
867
719
591
workplace
438
656
enablers
believing
charge
favoured
therapynew
antitumour
minority
multilayered
19902017background
hepa
transitions
socioeconomicgeographic
quartile
analyse
eastern
western
6352100
5057100
4639100
19901992
118100
105100
314100
93100
youngest
04years
9years
60years
43years
q
3355
47years
3260
33years
952
peaks
became
smaller
seasonality
persisted
negatively
markedly
1990
inequity
existed
eggcontaining
cookies
analysisintroduction
lacs
thirtythree
responders
gr
ofc
hardboiled
whites
aichi
anaphylaxiscumulative
tspro
diaries
χ2
0077
442
1041
0059
mannwhitney
u
0015
0027
wilcoxon
signedrank
99
1938
intake
glycogen
synthase
kinase3
cured
responsive
outline
gsk3
regulator
smi
downregulate
smis
coreceptors
smoking
assuage
periodontal
sitesobjective
mellitus
dm
gingival
crevicular
ratios
proantiinflammatory
periodontitis
nondiabetic
nonsmokers
n25
n30
smokers
n26
sdm
n21
mip1α
il1β
il7
il8
il17
il21
il23
il4
il5
il13
diseased
multiplex
permutations
p05
diabetic
grouped
stimulated
overlapped
seemed
hyperinflammatory
doctor
machine
learning
reliabilitythe
cosmetics
pesticides
llna
silico
sets
intuitive
applicability
domain
paired
reliability
descriptors
fingerprints
forest
classifiers
holdout
yielded
competitive
matthews
coefficients
052
accuracies
076
receiver
operating
curves
083
web
service
assessments
fiveyear
oregon
2012oregon
5½
developmental
milestones
bears
burdens
stroke
epilepsy
neurodevelopment
underscores
diphtheria
acellular
helper
plasticitymature
th
originate
naive
precursors
distinguish
th17
terminal
retain
plasticity
converge
microenvironmental
pressure
supports
hypothesis
emphasis
th17derived
nonclassic
networks
point
diabetestype
t1d
insulinproducing
beta
aberrant
lifelong
versions
insulin
extensively
incorporated
independency
elusive
pursuing
normoglycemia
armamentarium
immunotherapyin
decade
circumvent
combine
suchstrategy
carry
interacting
damageassociated
pathogenassociated
pamps
evoke
antibodytargeted
integrin
dnasensing
γsecretase
bcmaspecific
myelomabcell
cleaved
multisubunit
gs
density
releases
soluble
sbcma
accumulate
bcmadirected
cleavage
gsis
augment
bcmatargeted
dosedependent
fashion
concentrations
gsi
nodscidγc
shortterm
fdaapproved
wwwclinicaltrialsgov
nct03502577
pharmacological
nucleic
sensors
obstaclesnucleic
tlr
rlr
signalling
organismal
accordingly
deregulated
contributes
neoplastic
indicates
normalizing
mediate
obstacles
hostrelated
exosomes
toxicitygenetically
nonhaematological
vesicles
carcontaining
express
biomimetic
nanovesicles
tumours
nearinfrared
photoimmunotherapy
bonenearinfrared
nirpit
injecting
siliconphthalocyanine
derivative
irdye
700dx
ir700
nir
grow
bones
penetrate
rib
transmittance
452
maximum
128
1500jcm
bioluminescence
luciferase
128jcm
irradiation
48hours
p026
040
flu
campaignbackground
professions
univariable
geographical
progressover
moderately
cetuximab
unsatisfied
prognosishere
systemically
efficacyrelated
label
stereotactic
immunotherapyimmunotherapy
latestage
develops
investigators
sbrt
believed
suppressing
aided
nonradiated
exposing
advancedstage
gastrin
altering
microenvironmentpancreatic
recalcitrant
dense
fibrotic
paracrine
autocrine
cck
fibrosis
polyclonal
ab
pas
competent
micebearing
marked
influx
cd8lymphocytes
restimulation
demonstrating
temra
tcellmediated
250μg
pbs
abtreated
macrophages
suppressionthe
bulk
composed
resident
matrix
secreted
migration
chemoresistance
evade
tams
cancerassociated
stromalstem
mscs
physiological
reprogramming
protumor
interfering
seroprevalence
policiesbackground
taiwan
zoster
2004
2008
preemployment
checkups
antivaricella
vzv
titers
geometric
gmt
chisquared
antivzv
vocation
7314
5625
7690
2680
vzvpositivity
1820yearold
8516
36289
8759
28807
born
seropositive
2003
251
8891
87749005
detectable
marginal
seropositivity
0052
launched
inadequately
maintain
susceptible
biofilm
vibrio
anguillarum
asian
seabass
lates
calcarifer
bloch
1790the
bf
80day
experiment
circular
fiberreinforced
plastic
frp
tanks
triplicate
heatinactivated
cfug
fishd
fed
agglutination
60day
agglutinating
fishes
rps
854
270
carnivore
coexpressed
icosl41bb
rejectiont
edited
exhaustion
solve
gpc3
cd28
costimulation
cd3z
itam
g328z
icosl
fused
cytoplasmic
g328zicosl41bb
fusion
reinforced
pi3k
bcl2
apoptosis
icos
cars
psychological
ethical
modular
carsthe
tls
shutdown
taas
turn
variant
unicar
promises
aviditysince
80years
removal
transferred
selectivity
avidity
balance
equipped
tcrchimeric
faster
exhaustiondeath
excessive
betterselectivity
maynot
beguaranteed
tcrcar
safetyefficacy
directions
vaccinesa
2weeks
measlesmumpsrubella
episode
1week
diphtheriatetanuspertussispolio
5years
occasions
hospitalisation
immunisations
conceptual
cancergastrointestinal
gi
derive
suboptimal
immunemicroenvironment
moleculardeterminant
immunemicroenvironments
hostmicroenvironment
map
hesitancyobjective
unsubstantiated
linger
1416
cork
kerry
trained
facilitator
domains
tdfbased
thematically
tdf
wheel
technique
taxonomy
capabilities
optimism
emotion
persuasion
enablement
restructuring
linked
bcts
behavioural
wellrecognised
cancersskin
nonmelanoma
depicts
exclusively
sensitive
merkel
ill
consideredpatients
amuch
sepsis
immunocompetent
adequately
alertness
valid
immunocompromized
antibiotic
responding
analgesic
breastfeeding
neonatesbackground
painful
neonates
nonpharmacological
feeding
cmh
quetta
november
breastfeed
cry
needle
insertion
stopwatch
seconds
crying
1648s
1276
3493
s4526
trumps
crossjurisdictional
australiaobjective
complexities
linkage
datasets
governmentadministered
dataset
methodology
integrating
negotiation
agencies
authorisations
ethics
approvals
variations
requests
spanned
request
registers
collections
achievable
infeasible
authorisation
convoluted
disparate
inconsistencies
supplied
prevents
erode
compromising
biliary
cancerbackground
btc
pfs
n38
n20
n19
149months
41months
037
017080
60months
042094
p0011
51months
22months
059
031110
p0014
24months
061
045083
p0003
342
368
tolerable
cedar
pollinosis
cedarcure
®
purchased
180±135
maletofemale
4029
cedartolen
298±162
4453
dispersal
10933
grainscm2season
analog
congestion
yearsbackground
188
mite
85
dropped
5954
5567
disappeared
immediately
lasted
defaulters
preschool
petaling
selangor
malaysiabackground
attending
1015
defaulting
207
confounders
nonmuslims
aor1669
ci1173
2377
p0004
diploma
aor2296
ci1460
3610
aor2656
ci1004
7029
p0040
aor1700
ci1163
2486
p0006
30min
facility
aor2303
ci1474
3599
aor2747
ci1918
3933
intensified
nonmuslim
malaysian
cultural
hpvassociated
genital
hong
kong
insignificantonly
notion
anthropology
perceptions
perceived
worthiness
marriage
sexual
experiencing
gynecological
stigma
feminized
moralized
patriarchal
imposing
inequality
mixedeconomy
capitalist
logic
molds
doctorpatient
private
diseasethe
opened
manipulation
requiring
task
ups
treatmenttherapy
icpis
supposed
destroying
created
lungs
occasionally
cancerin
regarded
traditionally
reactivating
difficulties
gliomasdespite
spectacular
cns
gliomas
mgs
imputed
originally
extreme
defensive
bloodbrain
wellaccepted
mismatch
repair
deficiencies
virusbased
oncotherapy
sanctuary
awaited
effectivity
focusimmunotherapy
getting
thoroughly
defects
destroys
systemin
coming
laymen
communicated
detrimental
dissolve
misbelief
manuscript
details
stop
division
partner
treatmentit
20th
ionizing
developments
drew
booming
sound
snapshot
cancercolorectal
morphologic
sharply
demarcated
medullary
expansive
stroma
microsatellite
instability
mss
spiculated
desmoplastic
hard
histological
mirrored
decisive
view
front
pathology
quantify
qualify
peritumoral
intratumoral
lymphoid
cellmediated
multistep
hamper
transiently
serotherapy
tickborne
childrenobjective
antivirus
tbe
130
tbev
35±13
n84
n15
n11
ribavirin
interferonα2
suppositories
anaferon
iggim
ribonuclease
admission
cytoflavin
drip
mlkg
impairment
consciousness
pleocytosis
n70
n6
arrested
727
preserved
atrophic
herpes
situationin
chickenpox
shingles
aparticular
neurologists
everyday
vzvassociated
dead
perspectivecancer
eliminates
tumorimmune
accumulation
witnessed
inherent
biophysical
multifunctional
modifying
nanoparticleenhanced
vehicles
tumordraining
eliminationbackground
directacting
daa
calls
treatmentasprevention
calibrated
inject
pwid
20182030
modelled
15113
10year
us200
aggregate
us74
us6682
billion
us50
us98
us87108
leukoencephalopathy
cryptococcal
treatmentprogressive
pml
jc
65yearold
sixth
palsy
rheumatoid
arthritis
antifungal
nacetyl
glucoside
natg
suppressionimmune
modulator
radioprotective
9gy
irradiated
withwithout
150mgkg
bwt
noninterfering
elevation
contrary
alleviate
radiated
restoring
haemoglobin
rbc
wbc
hematocrit
platelets
deleterious
conclusively
countermeasure
assaults
antiige
rhinitisobjective
proquest
kırıkkale
omalizumab
uncomplexed
avidly
fcepsilon
downgrade
fceri
bind
basophils
responsivity
diminishing
shorten
lifetime
fcεri
polyp
eczema
lessen
whilst
eosinophils
antigenigemast
chemotactic
perennial
omalizumabtreated
unbound
ameliorating
immunomodulation
leishmanization
vaccinesleishmanization
lz
intradermal
leishmania
artificial
leishmaniasis
cl
ancient
nnn
1910
promastigotes
harvested
soviet
iran
leishmanized
gmp
peanut
poised
dietary
avoidance
sean
parker
stanford
ca
755
dbpcfc
mg
skinprick
wheal
diameter
peanutspecific
kul
2·41·41
twobytwo
computerised
built
4000
peanut0
ingest
300
peanut300
oat
flour
dbpcfcs
156
computer
list
team
masked
look
feel
clips
mask
taste
statistician
passed
nct02103270
152
120
n60
n35
12·7
1·8554·8
p0·0024
5060
2935
1125
50120
2660
1535
925
igg4
ara
unresponsiveness
interpretation
desensitise
regaining
aid
institute
losswhen
unselected
miscarriage
rm
phenomena
paternal
leukocyte
ivig
intralipid
filgrastim
embryonic
aneuploidy
confound
impression
futility
saved
6080
miscarriages
whereby
hws
ri
tnas
beenroutinely
nigeriato
theirtraining
tutors
preservice
institutionsin
toidentify
unfulfilled
pilot
inservice
tna
knowledgebased
informant
quantitative
spite
trainings
ward
rew
83
differentiate
ashwperception
approachalso
managers
mindful
contextual
finance
hw
practicesbackground
ecec
statesterritories
policypractices
workplaces
administrators
childcare
sixty
acknowledge
86
recall
10years
onsite
encouragement
employers
employees
idea
harvesting
melanomaobjective
nonmyeloablative
nma
bolus
242
resected
wait
121
evaluable
biopsied
fold
check
applicationsthe
responds
invaders
microbes
tightly
harmful
self
commensal
fetus
elucidation
avenues
knockout
personnelmedical
mcoh
hcp
thematic
outlines
navigating
serumneutralizing
associates
shiv
challengepassively
bnabs
hiv1
envelope
env
nonhuman
primates
nhps
simianhuman
primate
neutralization
id50
adjusts
bnab
219
410
319
1471
london
titrating
wars
1918
vaccinationa
ecology
nonlinear
perturbations
trajectories
consumerresource
oscillatory
hostpathogen
abundance
rich
acted
prototypical
bed
prevaccination
19441967
timeframe
largescale
limiting
extra
filtering
explainable
tuned
war
oscillator
underlines
ecological
follow
nonstationary
secular
exploitation
siderophore
baua
bfnh
acinetobacter
baumannii
infectioniron
ironrestricted
immunoprotectivity
fragmental
3472
abaumannii
identity
immuneinformatics
βbarrel
loops
coincides
colonized
protectivity
subclasses
hypogammaglobulinemiabackground
ig
hypogammaglobulinemia
reconstitute
differs
serotypes
igg3
scig
enzymefacilitated
fscig
087
igg1
igg2
deficiency
6b
12f
23f
immunotherapyhuman
pathogenrelated
hpvs
horizontal
vertical
basal
keratinocytes
ectoendocervical
transition
zone
persists
episomal
dividing
e6
oncoproteins
immortalization
hpvinfected
transformed
genome
malignization
neoplasias
necessitates
muc1
phantom
menaceunderstanding
functioning
mucin
antiadhesive
explaining
overexpression
progressing
burner
attracting
nanoparticlebased
immunotherapydespite
imperfect
arising
relies
restoration
pathologically
altered
tasks
m2phenotype
m1phenotype
eliciting
polarization
m2macrophages
crc
originating
rectum
cellsthis
immunooncological
boost
interleukins
immunotherapycurrently
unresolved
topical
viewpoints
scientists
developers
metastasestumours
losing
leucocyte
homogeneous
ipositive
subsequently
generates
darwinian
solely
inegative
colonization
phenomenon
colonies
mhchla
alterations
reversible
recover
irreversible
acralmucosal
wellstudied
acral
comprise
asians
hr033
ci013081
p0016
validation
utility
ameliorates
lupus
erythematosus
micecurrent
displaying
transferring
toldcs
hemeoxygenase
inductor
cobalt
protoporphyrin
ix
copp
dexamethasone
rosiglitazone
sle
mrlfas
lpr
nzm2410
lipopolysaccharide
antinuclear
antibodypositive
6070days
andthe
lupusprone
toldc
glomerulonephritis
histoneloaded
strengthens
edible
diseasesplants
centuries
agrobiotechnology
arouse
bioreactors
biofactories
crops
periostin
7yearold
childrenbackground
th2driven
populationbased
451
attended
1076
ngml
10451107
adjustment
confounding
polyallergens
1032
10061059
0016
1020
10021039
eosinophil
0023
se
0009
0010
obesity
thatserum
steer
antioxidant
defense1this
204
angusbased
steers
kg
ranch
αtocopherol
mgl
weaning
preweaned
unweaned
heavy
pens
blocks
leaving
rovimix
e50
adsorbate
dsm
heerlen
netherlands
con
iukg
matter
iu
med
backcalculated
151
248
484
995
iud
diarrhea
bvdv
bovishield
gold
shot
zoetis
parsippany
nj
pen
proc
sas
quadratic
cubic
statements
iml
glimmix
linearly
001
gainfeed
044
glutathione
mnsuperoxide
quadratically
007
numerically
lesser
004
vibration
displacement
spectral
laser
selfmixing
velocimeterin
vibrationdisplacement
resonant
cavity
velocimeter
rid
vibratory
waveform
separation
velocity
multilongitudinal
diode
8824
ghz
velocities
frequencies
undistorted
keeps
accurate
tnfsf4
ox40l
locally
melanomaimmunotherapy
recurs
immunotherapytreated
nonimmune
antineoplastic
atlas
tcga
encyclopedia
ccle
antipd1treated
sheba
infiltrates
worse
inall
iiiciv
mrnas
tumoral
warrants
leg
journeychimeric
surpassed
everexpanding
illuminated
generalizable
intrinsic
amassed
bench
tumorrelated
inflammationassociated
wellevidenced
vigorous
hccspecific
managementimmunotherapy
abstract
checkpointinhibition
begun
amble
efficiently
checkpointinhibitors
implicationsimmunotherapies
mainstays
contributors
overshooting
collateral
hodgkins
entities
fastdeveloping
vesselmodulating
classical
illustrated
swiss
professionalsthe
news
clauses
dtpaipvhibhbv
newborns
simplified
capsular
acwy
menveo
extension
cantons
geneva
tessin
contagion
gardasil®
gardasil
9®
immunosenescence
sicklecell
hlaii
spectrometry
predictionincreasing
cancerspecific
hindering
optimally
inaccurate
peptidebinding
unsolved
discovering
motifs
ligandomes
learn
profiled
alleles
hladm
peptideloading
chaperone
dominated
apcs
accurately
apc
phagocytosed
hlaiidirected
10100
nanotechnologythe
nobel
prize
physiology
awarded
pioneers
ofcancer
leveraging
theimmune
spatiotemporally
pharmacokinetics
andcodelivery
convergence
bioengineering
opportune
matured
complement
substantively
rationally
modestly
empirically
addressed
deductive
augmenting
leukocytes
localization
smallcell
biomarkerssmall
sclc
dismal
30years
impower133
atezolizumab
platinumetoposide
durvalumab
furtherline
singleagents
pembrolizumabtreated
resurrected
conflicted
responseas
fierce
debate
grows
legislative
fueling
eradicated
contagious
endangering
eroded
alternate
position
educate
advocate
safeguard
designer
scaffold
nanoconverters
reverting
therapycurrent
suffers
revert
nonimmunogenic
encapsulated
resiquimod
incvs
r848
doxorubicin
myeloidderived
tumoricidal
depleting
neoantigenspecific
reshaping
microenivronment
designerscaffoldinduced
postsurgical
spatiotemporal
tmes
scaffolds
minimized
definitive
cystectomy
studyat
calmetteguerin
purposes
transurethral
overtreatment
undertreatment
ultrasound
scan
treatmentemergent
312
pta
ptis
pt1
n210
rxc
n87
cystitis
ileus
operation
expenditure
22945±945¥patient
17985±545¥patient
dualdrug
nanoassemblies
chemoimmunotherapycombination
chemotherapeutics
immunomodulators
exerting
nanoparticulate
hold
codelivery
coencapsulate
combinational
compatibility
nanocarriers
coassembled
lipophilic
prodrugs
lps
codeliver
nas
ratiometrically
formed
selfassembly
irgd
paclitaxel
ptx
imiquimod
r837
chemoimmunotherapeutic
ratiometric
coencapsulation
transplants
projectpediatric
ckd
examines
practitionerled
qip
nephrology
notify
appraisal
daughters
papilloma
abakaliki
nigeriaunassigned
proposes
introducing
2021
purchase
multistage
pretested
728
attained
traders
891
cited
motherdaughter
enlightenment
referral
accraunassigned
ghana
endemicity
legon
ughl
analytical
stained
linenswaste
sharp
interquartile
bivariate
161
interviewed
634
2745
eightysix
791
1021272
bloodblood
1431181
445
1424
107845
1412651
puts
contracting
cxcr2modified
coopt
maximal
tumorschimeric
stagnated
trafficking
coopted
glioblastoma
strategysex
tend
reflected
germline
tmb
antigenicity
sexes
allergyfrom
treatmentthe
accidental
undergraduate
ghanaunassigned
acquiring
semen
bodily
fluids
trainees
allied
226
739
114
305
313
113
752
135
1682
p0015
540
131
2236
p0020
185
104329
p0037
019
070
p0002
council
organize
pursuit
speeds
engaging
leukemiachronic
cll
tumorsupportive
immunosurveillance
bi
trispecific
lymphomas
disappointing
nonmalignant
mutated
kras
cancersthe
substitution
protooncogene
constant
proliferative
gateway
renders
egfr
downstream
menacing
turning
scoping
machinery
deliberated
practiceimmunotherapy
recist
atypical
pseudoprogression
immunemodified
categorize
inhibitorspurpose
studying
materials
twentythree
nct02085070
thermal
deriving
trial4
hemorrhage
necrosiscystic
lived
serial
girl
vaginal
endodermal
sinus
hake
lowaffinity
carchimeric
cytokinerelease
4060
spacer
ceiling
immunoreceptor
adversely
911
cat
fmc63
highaffinity
binder
carpall
nct02443831
1214
63
tumorreprogrammed
resist
tumorssuccessful
longitudinal
motility
unirradiated
newlyinfiltrating
transcriptomic
radioresistant
circulatinglymphoid
upstream
radioresistance
inherently
reestablishing
hypothermic
perfusionbackground
perfusion
kidneys
modify
hour
407
curve
hgmlmin
r1
187
r2
r2ind
124
2fold
03
946
885
246fold
197
trough
transplantationbackground
immunosuppressant
kt
ttl
ttls
biopsyproven
bpar
426
463
020
deathcensored
italyhighincome
reemergence
datadriven
demography
consists
interrupt
2045
1735
789965
lymphopenia
cancerpurpose
146
count
cellsmm
periimmunotherapy
545
poorer
rtassociated
courses
378
gy
conversely
rtradiosurgery
021
indicative
precision
cancerskras
oncogene
tki
tkis
bear
mapks
pi3kmtor
hdac
wee1
parp
cdk
mirnas
eventsamino
adra
dpra
iata
verify
replaced
keratinosens
hclat
sts
itssa
its2ma
mgml
900
predictability
832
transcutaneous
vaccinationimmunotherapyin
premise
advantage
simplicity
painless
rendered
coldchain
transportation
storage
stockpiling
phobias
needles
persuading
perform
selfvaccination
home
patchtype
utilize
hydrophilic
gel
patch
microneedle
demonstration
physicianinitiated
intrapatient
conversion
twicedaily
oncedaily
thai
cyp3a45
inhibitorsbackground
converting
advagraf
adv
cypinh
siriraj
fiftythree
5125
4030
396
diltiazem
ketoconazole
fluconazole
increment
1429
ipv
1483
678
azole
636
258
retransplant
experiencebackground
retransplantation
protocols
rejections
files
crossmatch
complementdependent
auto
hlamismatch
donorspecific
ris
hlamm
hlaris
6th
reliable
carefully
bkv
nephropathy
plasmapheresis
panelreactive
experienceobjective
pra
antibodymediated
aamr
pp
ds
ankara
eculizumab
910
±814
403
689
322
568
239
956
178
837
267
±796
257
666
600
338
593
292
496
310
eculizimabin
506
274
333
clients
shandong
province
chinaconstruction
architecture
iis
melanomatreatment
story
exploits
coreceptor
dampens
icbt
yields
3040
resists
pd1based
neoepitope
treatmentafter
hodi
al
rep
132412424
wolchok
engl
3692122133
herbst
5157528563567
tumeh
5157528568571
cpis
shifted
foreignness
thing
cellsthe
burgeoning
limitless
trialsas
programmable
triggers
lasting
optimizing
carengineered
forefront
therapyexploiting
conjugating
payloads
abrogate
futurethe
crescendo
paroxysmal
nocturnal
hemoglobinuria
clone
failurethe
pnh
abmf
aa
mds
obscure
457
dominant
granulocyteerythrocyte
811
evolved
hemolysis
granulocytes
123
erythrocytes
evolve
literatureobjective
pneumonia
ipd
english
23valent
polysaccharide
ppv23
pcv
revaccinations
multilevel
neighborhood
measlescontaining
mcv1
3722
nested
enumeration
morans
statistic
poissonbased
purely
hetrogeniety
i013
pvalue
satscan
afar
somali
gambella
aor153
125188
aor909
6861203
aor712
551918
aor162
103255
oromia
harari
facilities
aor131
95ci112161
editor
attenuates
submandibular
immunotherapybased
leukemic
cmlthe
lsc
clonal
hierarchies
architectures
propagate
unlimited
fraction
cellspecific
celltargeting
antibodytoxin
cml
antibodybased
channel
catfish
ictalurus
punctatus
ichthyophthirius
multifiliis
immobilization
antigensthe
ich
plasmid
pcdna31iag52a
pcdna31iag52b
parasite
antiich
theront
transfection
walking
gill
g1b
iag52a
iag52b
76fold
h4
d5
theronts
c3
tlr1
d10
mdd
sham
pcdna31
seroincidence
infancy
bangkok
thailandbackground
ari
hemagglutination
4fold
specimen
rrtpcr
350
266
119
370
personyears
excluding
rrtpcrconfirmed
infections100
3042
musclespecific
vaccinationbackground
transmitting
residential
republic
ireland
201617
r
067
0592
0351
0039
misconceptions
67
relating
correcting
taurine
transporter
taut
p53
implicationtaurine
cmyc
cjun
oncogenes
interference
rnai
arrest
suppressed
mcf7
druginduced
mammalian
lifespan
15fold
null
315days
621days
thymic
7days
21days
mutationmediated
thymus
dexinduced
micetaurine
2aminoethanesulfonic
subpopulations
immunosuppresive
dex
kunming
cont
tau
200mgkg
30days
euthanasia
thymi
double
dn
dp
sp
immunoseppressive
alkylating
lowintensity
conditioningobjective
allohsct
allohcst
ric
432
55years
346
purineanalogsensitive
efs
presumed
antileukemic
translate
inhibitorbased
arba
minch
childs
shares
institutionbased
feb
345
motherchild
intervieweradministered
epidata
explanatory
fitness
checked
hosmerlemeshow
goodness
fit
twofifths
409
hotness
564
168
1895
attendance
postnatal
264
interventional
stress
strengthening
anc
allergyfood
emediated
entails
ingestions
implementing
pharmacology
pipillomavirus
projectbackground
statewide
twoyear
funded
sanford
client
feedback
reeducation
standing
orders
104571
reminders
1126
zerodose
grant
n32
easily
adaptable
engrafted
leukemianinety
relapserefractory
lymphatic
cd19targeting
cd19targeted
preconditioning
regiment
03158
cellskg
blasts
592
731862
selecting
io
iobased
winship
emory
hospice
radiographic
cb
pr
uva
mva
proportional
covariates
ecog
marsden
rmh
63years
histologies
733
n58
n40
n37
n24
n8
807
n62
038
017084
p0017
trended
041119
p0188
81months
p00048
warrant
phagocytosis
treatmentrefractory
interfere
tumourmediated
cd47signalregulatory
disrupting
tumourintrinsic
subcommittee
neurologyobjective
neurology
aan
inferences
manual
amended
preferences
unless
weigh
counsel
immunosuppressiveimmunomodulating
isim
treatmentspecific
prescribing
initiating
screen
mentioned
consult
liveattenuated
combating
wedespite
incessant
untoward
immuneresponsive
door
myriad
undergo
endeavors
diseasebackground
ibd
underimmunized
confront
correctly
gastroenterology
clínicas
da
universidade
paraná
unaware
343
tdap
excepting
iiv
declaring
724
553
483
dtap
haemophilus
ppsv23
259
specialized
desirable
constantly
dtp3
2013background
sa
miss
householdlevel
utilisation
soweto
pietermaritzburg
road
unconditional
847
716
906
939
252
aor30
shortages
caregiver
09
zar500
zar2
registrybased
telephonic
pharmacies
pharmacybased
leverages
guidelinebased
246
pharmacy
chains
registries
astreated
21971
00214
23611009
00205
22510962
087126
3666
0333
listening
100161
flaws
placing
pfizer
merck
stolpe
employee
corporation
served
board
choudhry
conflicts
declare
zimbabwe
zepi
vigibase®
1997
2017background
rectification
pharmacovigilance
passively
vaccinerelated
icsr
submitted
aefiicsr
vigilyze®
icsrs
090
058
302
surviving
value0641
0168
n133
489
opvdtphibhepb
n107
393
387
778
222
n190
491
abscess
n57
pyrexia
n27
n44
n22
zimbabwes
nkcellencapsulated
porous
microspheres
microfluidic
electrospray
garnered
inspired
niche
scaleup
microstructures
tunable
morphologies
nk92mi
outer
functionality
perforin
granzymes
sustainably
continual
budded
native
nk92micellencapsulated
hierarchical
hyaluronan
coated
chemoimmunotherapypancreatic
cationic
assembled
charged
hyaluronic
nanostructure
indoleamine23dioxygenase
hydrophobic
celastrol
clt
mt
hnps
nm
hyaluronidase
penetration
biodistribution
c57bl6
circulation
downregulating
guruve
mashonaland
2017unassigned
follows
mid2017
failing
babies
suffered
encountered
fear
thinking
enough
afraid
reluctant
blockadeactivated
trialsbackground
masct
shr1210activated
amasct
500mg
qd
563
2538
658
45months
82months
p0098
immunosubtyping
reveals
mechanismscancerinduced
neutrophils
triplenegative
tnbc
neutrophilenriched
nes
macrophageenriched
mes
mutual
dichotomous
compartment
predominantly
ccr2dependent
granulocytic
unaffected
ccr2
mestones
interpatient
receptormutant
cancertargeted
exploratory
needing
clarify
nsclcbrain
disabilities
driver
addicted
immunopathological
progresses
java
indonesia
readiness
interventionsbackground
indonesian
upscaling
married
purworejo
regency
understandings
dislike
exams
embarrassment
anxiety
fearing
perceiving
teachers
incomes
underline
gut
microbiome
cancerresearch
hematopoieticcell
mediation
ctla4igbased
relapsing
autograft
studyctla4igprimed
dlis
antileukemia
ctla4ig
cd28cd86
prosurvival
ctla4igprimed
dli
865
rabcl
diseaseprogression
gvhdfree
cd80
cd56dim
cd16
interferes
antiapoptotic
nonuptake
measlesrubella
mtwara
tanzania
mr1
mr2
whorecommended
mdc
nation
caretakers
residing
558
caretaker
aor350
198621
station
aor150
142559
aor338
1081061
unwillingness
multidose
vials
aor380
212679
waiting
aor180
108300
vial
mr
thorough
provision
whenever
patientobjective
182
1860
wishes
group（66
patients）
group（116
inhaled
corticosteroidslongacting
β2
mometasone
furoate
spraydesloratadine
tablets
farina
drops
pef
dass
nass
tnss
tms
baseline（
005）
treatment（all
dass（all
tms（all
group（all
group（
yearswith
dropsin
babesia
bovis
vaccinia
neutralising
protectionprotection
intraerythrocytic
protozoan
tlymphocytes
isotype
switching
opsonising
parasites
erythrocyte
primeboost
proteinadjuvant
mvainfected
resides
1315monthsold
holsteinfriesian
multiantigen
rmabbo
rmva
immunodominant
merozoite
2c
msa
rhoptry
rap
hsp20
argentina
r1a
bovines
virulent
packed
titters
strengths
zambia
smartcare
computerized
acceptability
frontline
facilitylevel
module
ehr
desk
modules
outages
ehrs
sustainability
userfriendly
workflow
outreach
viewed
dependable
incongruous
unrealized
infrastructure
adaptability
e2
ubiquitinconjugating
enzymes
interventionsdespite
hindered
noncellular
tumorpromoting
ubiquitinmediated
physiologic
cycling
endocytosis
ubiquitination
ubiquitin
e1
e3
ligating
dysregulated
e2s
oncogenic
ubiquitinsubstrate
dtapipvhepbhib
hexyon
vaccinationhexyon
fullyliquid
readytouse
hexavalent
toddlers
poliomyelitis
hib
rest
valences
toxoidsantigens
irrespective
hexavalentpentavalenthexavalent
primed
infanrix
hexa
wholecell
reactogenicitysafety
fullliquid
minimize
errors
convenient
morphomolecular
cancerimmunotherapy
histomorphological
hestained
slides
ietils
strtils
rnaseq
concordant
discordant
hr066
hpvsubcohort
hr068
p004
hr080
hr020
neither
nonredundant
predictivity
icbtreated
chemical
carcinogens
contrathe
immunoprotection
abs
excretion
carcinogendna
adducts
immunostimulation
benzoapyrene
estradiol
oxaliplatin
carcinomabackground
platinum
atp
immunoblotting
oxaliplatininduced
llc
lewis
apdl1
cd86
notably
semiautomatic
forumscomputerassisted
text
analyst
ranked
codes
manually
coded
stance
classifier
rank
topranked
regressionbased
ranking
boarthe
eurasian
boar
sus
scrofa
reservoir
regimes
mycobacterium
twentyone
allocated
ivbcg
bcgiv
ivx2
416
6393
bonferroni
p0026
tukey
p0021
underlining
dawn
dermatitis
mitesensitized
studyallergenspecific
hdminduced
ad
36weeks
mediumdose
withdrawn
highdosemediumdose
slight
happened
tumortargeted
silencing
tap
immunityneoantigen
underscored
transient
sirna
broadrange
nucleolin
aptamer
comparatively
prototypic
mutationgenerated
potentiated
flt3
tapindependent
chemicallysynthesized
aptamertap
broadlyapplicable
potentiating
fragmentproducing
cellschimeric
holds
nonhematological
hurdles
hurdle
antagonistic
pd1dependent
noncart
scfvproducing
taaspecific
challengeeffective
toxoids
wp
1950s
lessreactogenic
ap
industrialized
genophenotypes
immunogens
phaseiphaseii
omvs
apvaccines
attenuatedvaccine
bpze1
syringeable
nanogel
reshapes
recurrencethe
multidomain
igel
overcomes
protumoral
niches
reverts
nonresponding
reshape
minimalist
nanoplatform
capabilitythe
photothermal
ptt
convert
ir820
1mt
allrolledintoone
ir8201mt
selfassemble
dualtherapeutic
888
wt
solubility
solved
asprepared
lasertriggered
weapon
vegfr2mica
micemhc
irelated
mica
nkg2d
antivegfr2mica
jzc01
antivegfr2
jzc00
vegfr2
engaged
vegfr2expressing
celltransplanted
docetaxel
inhibitorassociated
autoimmunitycheckpoint
rheumatologists
descriptions
readers
refer
diseaseautoimmune
aiird
spondyloarthritis
psoriatic
ankylosing
spondylitis
comorbidities
diseasemodifying
antirheumatic
dmards
ts
biologic
commencement
overseas
destinationspecific
prescriptive
workup
encourages
caring
disinformation
thirdlevel
8months
31item
instruction
bellinzona
4point
likert
closedended
anova
kruskalwallis
n130
458
incorrectly
infrequently
trustworthy
p00002
inclined
companies
dwelling
studyremoteliving
scarce
remoteliving
deterministically
ascertain
20032006
20092011
inclusive
n20697
0414
preinfluenza
ah1n1pdm09
20293
postinfluenza
comparisons
infant
birthweights
3001
3175
beyondaim
386
273
341
747
218
256
4months
immunotherapyassociated
hypophysitisthe
sadly
hypophysitis
thyroid
disfunction
particularity
nonreversibility
destined
symptomatology
selfamplified
lightinducible
nanocargoes
immunotherapychemoimmunotherapy
inconsistent
pathophysiological
drugloaded
nanocargo
linc
reductionresponsive
heterodimer
photosensitizer
pheophorbide
ppa
ido1
nlg919
lightactivatable
prodrug
oxa
accumulated
firstwave
oxygen
ros
glycol
peg
corona
retention
secondwave
illumination
selfamplification
multifaceted
minireview
pictures
immucarehospices
civils
lyon
insulindependent
fulminant
nearnormal
hba1c
decompensation
pancreatitis
lipoatrophy
cpiinduced
glucose
motivate
specialised
intralesional
alonesystemic
talimogene
laherparepvec
injectable
stainings
infiltrate
aec
profit
footandmouth
heifers
argentinathe
fmd
retaining
oie
servicio
nacional
sanidad
calidad
agroalimentaria
senasa
agrifood
pampean
salado
river
basin
coinciding
overlap
epl
aberdeen
angus
858
timeai
ftai
transrectal
ultrasonography
n311
162
emulsion
reevaluated
58
498858
963
156162
986
147149
6162
2149
0613
unequivocally
heifer
immersion
baculoviruses
cyprinid
herpesvirus
gibel
carpcyprinid
cyhv2
causative
herpesviral
huge
glycoproteins
orf25
orf25c
orf25d
orf30
orf124
orf131
orf136
orf142a
orf146
reporter
blot
packaged
carp
mock
interleukin11
il11
γ
875
708
baculovirusdisplayed
radiationrelated
sparing
regimenspurpose
tmi
cataract
creatinine
glomerular
filtration
doserate
cgymin
970
alive
rp
irp
227
posttmi
208
012
hypothyroidism
modulated
keeping
conformal
north
kampala
ugandabackground
fsws
preparatory
ssa
uganda
1849years
engerix
volunteers
1ml
visits
3days
censored
poisson
error
27years
212
giving
779
212272
nonretention
ulcer
gud
irr
190
109332
35years
2112057
noncompletion
1310
1899092
171533
partners
110607
empowered
headkidney
isolatespiscirickettsiosis
intraperitoneally
lf89
em90
pslf89
psem90infected
mhc1mhc2
cd4cd8b
vaccinatedfish
mhc1
mhc2
cd8b
srs
mesothelin
sleeping
beautyminicircle
invitro
mesothelinchimeric
beauty
minicircle
enhancements
interleukin2secreting
deoxyribonucleic
acidmesothelinchimeric
minicirclemesothelinchimeric
electroporated
visualized
immunofluorescence
proteinl
granzyme
immunosorbent
parentalmesothelinchimeric
cloning
removed
electroporation
engraftmentand
arena
senegalese
senegal
7096
7651
west
serer
ethnic
7724
7401
166
125221
109188
0011
poular
120180
206
119357
scaling
practicesvaccination
recommends
anticarengineered
epitopebased
cellsalthough
tremendous
treatmentassociated
compromise
pursue
halflife
ontargetoffside
exploit
αcarengineered
etag
constructs
proofofconcept
αetag
etagged
αetagspecific
cancerfighting
aiding
honokiolenhanced
cholangiocarcinoma
pulsed
patternsbackground
lysates
honokioltreated
kku213l5
honokiol
phenolic
compound
magnolia
officinalis
choangiocarcinoma
dcbased
approachesin
beside
instable
surrogate
antigen4
ablation
unimpressive
fluoropyrimidines
bevacizumab
mek
regorafenib
uterine
casesuterine
restores
anatomy
infertility
conceive
motherhood
exponentially
obstetric
refute
onequarter
grafts
tweetable
toxoplasma
gondii
rh
prevaccinated
tachyzoitestoxoplasma
anytime
255gy
tachyzoites
eighty
1×10
biweekly
parasitological
histopathological
nitric
peritoneal
aspirate
counting
smears
amelioration
letters
medicare
beneficiariesthe
everyone
americans
65years
expensivelimiting
scalabilityand
lowercost
mailed
scalable
228000
66years
pool
10month
lowrisk
mediumrisk
mfi
dsa
dgf
patientgraft
evd
liberia
20152017unassigned
20142015
setback
fragile
recovering
civil
unrest
certification
investment
dhis2
idsr
afp
avadar
ona
servers
microsoft
excel
spreadsheets
arc
gis
penta
wuenic
dropout
rebound
nonpolio
npafp
opv
devastating
therapymelanoma
96480
uss
braf
v600e
dacarbazine
dtic
alkylate
serves
manipulated
rbcg
overexpress
updatethe
multispecific
bring
advancements
hladr
portends
nondepleting
ktrs
mismatches
networkunited
2001
thymoglobulinalemtuzumab
basiliximabdaclizumab
discharged
calcineurin
inhibitormycophenolic
deceased
dd
63821
6945
4409
2536
19557
13558
6019
10727
7694
3033
64922
13915
10124
3791
27994
20454
7540
23013
16908
6105
085096
079101
perioperative
thymoglobuline
allogenic
cmv
genzyme
fludarabinebusulfanatg
dnaemia
preemptive
loads
cpml
75mgkg
anticmv
graftversushostdisease
dosages
cancerrecently
nonsignificant
failures
preconditioned
globulinbackground
impeded
pbsct
fca
thirty
954
236
favorably
party
ebmthematopoietic
15346
n13460
n1886
20132015
20012003
prominently
mismatched
339
sibling
philadelphia
chromosome
phpositive
phnegative
599
agestandardized
spanish
terciary
hospitalobjective
principality
asturias
accepting
deviation
percentages
chi
square
saphirowilk
518
2953
principal
mean341
contract
asturias´
spain
respecting
favourable
vaccinal
malignancieswith
played
tumorbinding
selectiondistribution
affinityspecificity
ontargetofftarget
infantsbackground
washington
7vaccine
termpostterm
3743
pearsons
10367
193
prematurely
475
077
065090
713
073
061087
2333
3436
415
447
undervaccinated
catch
practiceinfluenza
salvador
bahia
influenzainfluenza
occupation
backwards
akaike
criterion
615
690
knowing
315
95ci174571
95ci130333
postvaccine
126295
ischemic
são
paulothe
ihd
paulo
1980
brazilian
polynomial
joinpoint
disseminated
histoplasmosis
crohns
tribulations
aids
tumourspecific
nanoparticleloaded
tumourdraining
nodesbackground
celltransfer
atc
cancertreatment
vivoadministered
disperse
remedy
mnps
functionalised
attached
3aminopropyltriethoxysilane
apscoated
membranes
emf
retained
solidtumour
apsmnploaded
preserve
apsmnps
oti
14days
placement
reality
adultsobjective
interdisciplinary
detailing
visited
pharmacists
technicians
assistants
frontend
measurements
debrief
analytic
memoing
interprofessional
wishing
embark
samediscipline
paved
scheduling
meetings
realworld
astrogliosis
traumatic
injurybackground
tbi
disability
exacerbate
hitherto
dereg
toxin
dtx
cortical
cci
motor
deficits
5days
postinjury
5dpi
parametric
nonparametric
oneway
twoway
hoc
1dpi
bbb
neuronal
excitotoxicity
volumetry
extravasation
calpaingenerated
αiispectrin
breakdown
sbdps
glial
fibrillary
acidic
gfap
astrocytes
ipsilesional
exaggerated
anticd3
cd247
zeta
cd8a
coincided
ifng
injured
multitargeted
splenectomy
olmsted
countyobjectives
1965
mn
rochester
kaplanmeier
3569
62
449
postsplenectomy
148
bloodstream
quicker
0143
1998
cancersmallcell
chemoradiation
limitedstage
lssclc
pci
etoposide
cisplatin
carboplatin
essclc
sclcs
recur
topotecan
amrubicin
proapoptotic
capitalizing
dnarepair
antibodydrug
pleural
effusion
supernatant
cellfree
zhongshan
fudan
3485
sediment
lsd
623
mutationsmb
686
1174
0245
3044
2464
1117
144
54
3238
substitute
reviewvaccination
utmost
multicomponent
tackle
absenteeism
caprine
pleuropneumonia
flocks
arid
semiarid
lands
kenyain
kenya
ccpp
ruminants
pastoral
biannual
flock
illiteracy
justify
livestock
households
economy
turkana
mortalities
heads
scenarios
euros
171266
benefitscosts
5715
3914
justifies
livelihood
asset
tumorinduced
therapyimmunotherapy
resistances
convention
rights
sceptical
treaties
scepticism
1992
under5
ca170
notca170
vista
regulators
conclusive
proving
hpdl1
nmr
htrf
reasoning
aunp12
29mer
precursor
welldocumented
bms1166
peptide57
poliosis
melanomathe
eyelash
separating
myths
manish
sadaranganidr
sadarangani
bc
assistant
professor
ubc
cambridge
oxford
uk
dphil
fellowship
vancouver
microbiology
actionsafety
aftermath
adhering
applies
fetal
vaccinationrelated
stymie
immunizationspatial
dynamical
attracts
fail
observer
susceptibleinfectedrecovered
percolation
numerical
performs
guaranteed
equation
sociospatial
dog
arequipa
peruto
latin
mdvc
fixedlocation
owners
latinamerican
halt
peru
postcampaign
6000
houses
nearest
0041
clustering
pockets
sustain
dogvaccination
zoonotic
urbanization
cholerae
o1
ospecific
osp
bangladeshbackground
o139
organisms
bivalentocv
bivocv
playing
2dose
antiosp
asc
dhaka
bangladesh
methodologyprincipal
shanchol
evident
antiogawa
antiinaba
perhaps
separated
bivocvinduced
choleraendemic
extends
ciks
manager
3756
forwarded
mo
107
101113
107117
000001
115131
115137
036069
082
075089
dccik
evidently
preface
immunecell
studyobjective
1stline
198
ps
bv
capecitabineincluding
cap
ps0
ncounter
pbmcs
therapyobjective
ontreatment
bioinformatically
ships
crossborder
needa
prisma
1795
crew
14661795
817
1497
subtropical
887
692
1316
879
passengers
2222
7392
703
1629
448
262
land
draft
passenger
vpd
maritime
seafarers
regulated
ibrutinibrituximab
leukemiabackground
randomization
favored
894
729
035
022
056
protocoldefined
988
915
017
054
heavychain
ighv
907
625
877
880
attribution
282
352
801
158
797
pharmacyclics
e1912
nct02048813
invc
pigsthe
capsid
pcv2b
cterminal
yersinia
pseudotuberculosis
invasin
capinvc
radcapinvc
radcap
rad
zjcstrain
2142
interleukin13
temperature
inferred
sclerosisobjective
german
ambulatory
claims
bavarian
statutory
20052017
12262
crohn
19296
psoriasis
112292
79185
0870
0919
0973
0177
pronounced
frames
exceptional
retroperitoneal
prsa
rarity
71yearold
rightsided
numbness
invading
psoas
twelfth
radiological
cancerintroduction
unanswered
immuneagents
postpone
comprehension
glioblastomaglioblastoma
gbm
deadliest
gbms
inexorable
structures
regenerative
treatmentresistant
landmark
positioned
pillar
amid
bourgeoning
gbmimmune
creates
impenetrable
deterrent
livingdonor
bead
deceaseddonor
etiology
transfusions
allcause
livingkidney
437
122
bmi
kgm
209
177
rituximabplasmapheresis
rituximabplasmapheresisintravenous
ninety
129
253
serology
hlarelative
786
053
length
desensitized
nondesensitized
immunotherapyneurologic
reflect
onconeural
observe
autoantibody
subcellular
autoantigen
iggs
acetylcholine
paraneoplastic
antineuronal
nuclear
antihu
sensory
neuronopathy
milieu
translocate
neural
neuraxis
mistaken
earlyinitiated
thymoma
cancerprogrammed
physiologically
designsadvances
rangeof
relate
receptorbased
resistanceadoptive
blymphoid
redirect
cytolytic
cytoplasm
nucleus
universe
amplify
densities
carsignaling
tcrbased
discussing
nonviral
aheadmalignant
malignanciesby
integrate
evolutionary
immunophenotypic
compounding
generalizability
grading
proactively
complimentary
complicationsthe
tempered
overwhelming
chemokines
secondarily
syndromehemophagocytic
tocilizumab
antiil6
cartrelated
hopefully
construct
redefined
personalization
cellsadoptive
pioneered
cellsunfractionated
pbmc
overnight
steadystate
apheresis
purity
cd3depletion
cd56selection
donating
shortcoming
celllike
centered
homeostatic
il15
feeder
logphase
senescence
correlative
units
representativesobjective
organizational
communicative
administrative
lhus
representatives
invited
invite
vc
20022004
twentysix
appointment
invitation
preadolescent
ministerial
multicohort
copayment
antihpv
chemiluminescence
pointofcare
poct
copeptin
cytokineassisted
immunizationpurpose
reagents
attempted
highperformance
cpp
immunoassays
flt3l
ccl20
granulocytemacrophage
anticpp
clia
121250
pmol
incubation
min
intraassay
interassay
cvs
commercially
09737
developmentsmycosis
fungoides
mf
sézary
ss
ctcls
skindirected
nitrogen
mustard
meaningful
avenue
ctcl
uses
impair
repolarizing
recruiting
interferonα
extracorporeal
exert
receptort
calling
updating
challengesat
exacerbation
immunotolerant
escaping
micrornas
content
systemsobjective
configuration
assets
obtainable
code
administrable
nonactivestatus
listed
activestatus
explicit
tractable
helped
relaying
inoperable
recurrencefree
66yearold
intrahepatic
transarterial
chemoembolisation
radiology
normalisation
elevated
alphafetoprotein
blockage
scenariothe
microbiota
proton
pump
raised
corticosteroid
tried
nurselung
atrial
arrhythmias
vein
thrombosis
hyperammonemia
hypertension
bronchial
stenosis
ipf
phagocytosissecretionimmunization
macrophagespulmonary
loci
alveolar
ams
ims
responsibility
polarized
classically
m1
m2
superiorities
multitarget
malaysia
perspectiveobjective
serving
425
voluntarily
thirteen
assessable
598
526
knowledgeable
235
487
favouring
hypothesised
outperformed
254
700
’
25426
105337
uptakes
reject
wished
moderation
urbanised
talk
refinement
iranian
searching
pubmedmedline
ncbi
elsevier
google
scholar
magiran
irandoc
headings
mesh
“
”
words
checklist
strobe
purslane
portulaca
oleracea
leaves
powder
nile
tilapia
oreochromis
niloticus
aeromonas
hydrophila
infectiona
dried
bacteria
diet
182±04g
satiation
7weeks
10days
postchallenge
retarded
plasmatic
sod
catalase
peroxidase
gpx
malondialdehyde
burst
rb
lysozyme
nitrous
purslanefed
8125
neuropilin1neuropilin1
nrp1
regulates
semaphorin3a
lytic
tumourinfiltrating
lymphocytestil
b16f10
tumourreactive
lag3
antinrp1
synergises
alphasynuclein
parkinsons
immunotherapyparkinsons
pd
neurodegenerative
slow
dopaminergic
neurons
neuropathological
hallmark
αsynuclein
αsyn
inclusions
lewy
bodies
selfamplificates
propagates
prionlike
gaining
neuroinflammation
degeneration
hl7
transform
childspecific
knowledgeimmunisation
ehealth
harmonization
uncoordinated
proliferate
trillium
mocha
seek
harmonizing
putting
collation
maximizing
seroresponsiveness
inkidney
waitlist
tertiarycenter
perspectivebackground
iul
waitlisted
doubledose
coadministered
tetanusdiphtheria
td
phosphorus
hemoglobin
sustaining
10iul
vintage
3course
microbiotas
detrimentalcancer
threatening
mankind
dealing
hallmarks
evergrowing
implicates
deciphering
pragmatic
approachpertussis
1940s
casesdeaths
lmic
hospitalbased
laboratories
assurance
clinician
maker
everchallenging
problemvaccines
whooping
longest
alternating
splendour
disbelief
equals
frustrating
venue
recapitulating
merits
debated
waning
glimpse
proposal
reflections
peculiarity
scope
highincome
4cmenb
fourcomponent
uncertainty
longevity
certainty
anamnestic
11years
naïve
agematched
28days
365days
180
investigating
reactogenicity
envisaged
201700473211
isrctn
isrctn16774163
aging
toxicitycancer
immunotherapyinduced
discrepancies
eraobjective
municipalities
microregions
20052009
20112013
maps
qgis
92
gaussian
zeroinflated
laplace
approximation
3963
417100000
254100000
northwest
00003
00000
00570
wealth
1026
10021052
underdiagnosed
underreported
microregion
shingrix
reviewherpes
hz
varicellazoster
vesicular
unilateral
dermatomal
dorsal
root
ganglia
prodromal
pustulation
crusting
involves
zostavax®
hzsu
shingrix®
972
obtaining
immunotherapyaim
incompletely
thirtyfive
crpr
malignanciescancer
intensively
nonspecific
il15based
superagonist
alt803
cetuximabtreated
necksquamous
scchn
interleukin15
il15rα
portion
cetuximabcoated
lyse
alt803treated
phosphoerk
phosphostat5
cal27
singleagent
egfrpositive
imitation
sirnetwork
modelwe
gametheoretic
mobility
ensuing
captures
topology
analytically
reproduction
simulate
equilibria
insensitive
concur
residents
connected
existence
donorderived
refractoryrelapsed
continually
survived
immunosuppressors
burkitt
hivrelated
nonhodgkin
hivacquired
ahsct
bl
57yearold
hospitalized
intermittent
upper
abdomen
melena
endoscopy
tumorfree
advocating
mobilizing
worst
decadesmeasles
unwelcome
return
movement
weakening
texas
withstand
things
immunotherapyliver
takes
omega3
acids
asthmaomega3
il17a
forced
fev1
17a
fev1and
dissolvable
microneedlemediated
responsetranscutaneous
device
syringebased
antigenloaded
microneedles
ttmn
wv
pyrrolidone
micromolding
casting
texture
analyzer
stereomicroscope
electron
microscope
77±2μg
confocal
penetrated
130μm
dissolution
1h
albino
splenocyte
minimally
vitroimmune
coinhibitory
btla
productive
tt
cfselabeled
surprisingly
cd16expressing
mandate
erythema
multiforme
em
mucocutaneous
fulltext
representing
580
56years
0117years
simplex
hsv
157
241
drugrelated
229
311
antivirals
macrolides
infantile
prone
p01
confusion
steven
johnson
surfaces
mucosae
dermatologists
keyhole
limpet
hemocyanin
salmonella
enterica
serovar
enteritidis
chickensthe
assumption
igko
birds
klh
intraabdominal
bwg
homozygous
ko
counterparts
genotypevaccination
092
discrete
mono
polysensitized
monosensitized
118
scheduled
il17α
factorβ1
tgfβ1
efficacies
1127
981±1273
348198±498
t3000
11541004±1304
356
200±516
t4005
tolerant
certificate
loophole
pcsk9
studymonoclonal
proprotein
convertase
subtilisinkexin
ospedale
policlinico
san
martino
genoa
12359
863216989ngml
11717
804614779ngml
95ngml
pcsk995ngml
pdl1atezolizumab
headtohead
efficacysafety
fivetrials
comparator
ratioor222
95cri128370
or192
95cri115323
orrs
probabilistically
subanalyses
egfrmutant
ecogscore1
squamouscell
egfrwildtype
ecogscore0
prevailed
srsstereotactic
srt
srssrt
sbrtici
extracranial
intriguing
retargeting
converts
immunotherapyvirusneutralizing
virotherapy
unfavorable
bifunctional
adapter
hexon
de1
antiadenoviral
prolongs
adenovirusimmunized
tumordirected
antibodyretargeting
abretargeting
sensitize
intratumor
facilitates
virotherapyinduced
adenoid
sphere
forty
predominantly10
mitoxantrone
vinorelbine
eribuline
cisplatinvinorelbine
histone
deacetylase
stabilization
ckit
of5
pi3kaktmtor
targetable
mcc
french
refcor
proposing
psychotic
stand
opportunitiespsychotic
debilitating
mental
neurotransmitter
diseasemodifing
etiologies
pathophysiologies
autoantibodies
disrupt
neurotransmission
psychiatric
psychosis
ion
determination
anticd328
cellscd4
confirmation
functionalrelated
freshly
anticd328coated
beads
beadtocell
3weeks
identities
1044fold
051
nonil2
adhesion
unexpanded
homing
receptor‑modified
epcam
anti‑tumor
cellscolon
combines
tumor‑associated
permanently
epcam‑targeting
epcam‑car‑t
epcam‑car
transfected
transcription‑quantitative
blotting
co‑culture
stably
untransfected
il‑2
il‑6
interferon‑γ
car‑t
lymphomachimeric
space
hesitate
opposed
opposition
preschools
elementary
deliberate
directindirect
meaningfulness
leaders
joined
organizations
explanations
mails
disadvantages
complying
authorities
communicate
hesitant
resolve
researchs
surgeonscancer
herald
stepchange
mobilized
immunemodifying
exponential
revolutionizing
themself
surgeon
surgically
xiap
blockadeexpression
iap
mliap
livin
survivin
overlapping
stageiv
epitopespecific
ipilimumabbased
avrs
earlylife
acquisitionthis
convened
niaid
nih
initiate
debut
practicality
panelists
grounds
cautious
ontogeny
samplesparing
nurtured
highestrisk
merit
hyperprogression
systembackground
accelerating
kinetics
tgk
preimmunotherapy
tgkr
tgkr2
neuroendocrine
necs
adenocarcinomas
lck
lymphocytespecific
lckdeficient
druggable
australianborn
adultsbackground
n559
n80655
agestandardised
395–509
385
379–390
heterogeneity002
673
599–747
726
722–730
pheterogeneity016
obese
aor238
144–394
aor213
137–330
rated
fairpoor
aor257
126–520
replicated
summarises
goods
18year
3878
70–79
nip
territorybased
nonserious
deux
inflammationin
intricate
dialog
predictable
antibcma
childhoodemeritus
edward
alan
glasper
southampton
considers
fears
genomicsguided
cancernextgeneration
ngs
comprises
immunogenomics
customize
tenet
cheilitis
granulomatosa
reportin
antitnfalfa
zealand
statement
nasopharyngeal
apoptosisinducing
ligandbackground
npc
ebvassociated
endemically
sporadically
radiochemotherapy
trail
calcein
predominately
strail
concentrated
micrometastatic
tkibased
onoff
abo
incompatible
ats
awaiting
lt
cp
cobe
spectra
optia
cpconventional
tpe
dailyalternate
estimation
titre
512
sessionspatient
stay
succumbed
han
sichuan
surveysbackground
mch
ethnicity
disparities
caesarean
calmette
guerin
dpt
districtcounty
womenchildren
township
parity
regressions
intercept
075115
538
057
036093
006057
geographicalindividual
closer
village
cellsrelapsed
kg1a
pretreatmentarac
hlakir
killerimmunoglobulinlike
coculture
arac
antihla
inhibitorsinduced
hypophysitisin
constituted
revolution
iciinduced
hormonal
headache
asthenia…
hormone
corticotroph
corticotropin
autonomous
endocrinologists
astragalus
polysaccharides
jejunum
diseaseastragalus
aps
nd
onedayold
hyline
chicks
nc
1mgml
2mgml
4mgml
jejunal
villus
height
vh
crypt
cd
vhcd
siga
enhancer
4th
symposium
29december
athens
greece
aβ
alzheimer
immunotherapyallergen
antihistamine
pollens
1960s
slitdrop
hdmallergic
slittablet
droptablets
elucidated
analysisfrom
curable
appearance
allergenige
normalization
th1th2
conflicting
highresponder
nonresponder
cascades
referring
tr1
micesubcutaneous
il10producing
scittreated
nonscittreated
vitroinduced
immunotherapyth2
tpath2
miteinduced
hdmar
hdmreactive
ir
52week
cd161
cd45ro
activeresponders
extract
nonstandardized
hypothesizes
hd
noninterventional
sr
symptommedication
carcinogenic
measureshuman
genesis
etiopathogenesis
anal
oropharynx
lags
redefine
hpvrelated
metachronous
css
heng
799
intermediaterisk
poorrisk
mrccs
sm
10704
983
481476
3855
138
98183
213months
183months
96months
58months
treatmentfree
tfi
stratifications
subcategories
burkholderia
mallei
δtonb
δhcp1
clh001
glanders
melioidosisbackground
reemerging
solipeds
pseudomallei
melioidosis
facultative
tier
biothreat
diseaseresistant
clh001immunized
intranasal
aerosol
atcc
23344
crossprotection
k96243
conclusionssignificance
pregnancyimmune
newborn
passing
placenta
pediatr
ann
2019487e251e254
mimetic
proteinpolymer
immunotherapystimulation
ags
agspecific
agexpressing
polymertemplated
nanoball
h1nb
mimics
ag
vehicle
ova
h1ovanb
ovaspecific
b16ova
carrier
kumasi
controlunassigned
dogmediated
prerequisites
unavailable
cross
sectional
ayeduase
kwame
nkrumah
knust
campus
1319
351
4631319
816
181
579816
2065
owned
511
513816
803
499
enter
649
878
bite
concoction
herbs
offending
householdhuman
roaming
congress
saskatoon
canadathe
democratic
congo
nipah
india
lassa
repository
succeed
fighting
forget
humankind
overuse
antimicrobials
avoiding
ohc
slum
kaduna
metropolis
2015unassigned
rigasa
epiinfo
503
11733
283
3920
statusthree
reset
autoreactive
reestablishment
hematologyoncology
genotoxic
lowtoxicity
chronicity
4090
patientsobjective
emabse
language
hr072
051102
p006
hr067
048095
p002
doseresponse
bmi30
hr064
043096
hr073
061086
hr063
043092
immunogenetics
immunotherapyclinical
inhibitorsbased
easilyassessable
enlarge
cpibased
singlenucleotide
polymorphisms
snps
cpitreatment
powered
calculations
allele
snpcpi
17dd
heightened
diseaseendemic
brazilwe
vaccinespecific
yf
plaquereduction
prnt
interferonγcd8
restored
guarantee
heighten
17ddyfspecific
17ddyf
therapyhyperprogression
japanconditioning
sct
bubased
bu
893
030
303
p0672
p0038
015years
p0024
ayas
1630years
p0035
regiments
pegylated
asparaginase
pegaspargase
erwinia
chrysanthemi
availabilityasparaginase
multiagent
lly
ideally
substituting
shortage
005iuml
01iuml
futurehepatocellular
continuing
nonalcoholic
locoregional
lagged
fungal
immunotherapeuticsthe
beset
unsurprising
orchestrating
treatmentin
ovs
replicate
transgenes
modifiers
officebased
handout
trialobjectives
york
city
room
arms
749
654
106267
590
104308
conditioned
glycolytic
pathwayobjective
spleenderived
immunomagnetic
tccm
hours
lactate
dehydrogenase
ldha
transporter1
glut1
hypoxiainducible
1α
hif1α
hexokinase
hk
lactic
glycolysis
6carboxyfluorescein
diacetate
succinimiyl
ester
cfse
arginase
arg1
inos
alert
fall
pneumococcalspecific
bestpractice
bpas
redesign
notifications
utah
bpa
7pp
1964years
p00003
worlds
evaluationbackground
mrc
januaryfebruary
mixedmethod
documents
574
exit
actual
political
budgetary
registration
launch
motivated
skilled
introductions
gavisupported
kano
preimplementation
programmebackground
mov
023
phc
nassarawa
onestage
interviewer
675
3615
intraclass
empty
286
95cri
232
412
vaccinators
1291
482
2714
qi
premature
rotapremrotavirus
rv
industrialised
reproduce
fullterm
12th
20062015background
siv
temporal
beneficiaries
fund
200506201516
reimbursement
groupbased
trajectory
15766
4344
belonged
4728
2832
postpandemic
1627
totalling
2235
progressively
worsening
abandoned
controversies
specificities
fujian
20122017objective
characterisitics
autopsy
figured
deuths
coincidental
23687
3888
36854091100
173230100
1504
13781630100
025050100
004054100
000008100
spearman
correlations
0048
034
0329
0484
mothertochild
zhejiang
provinceobjective
pmtct
markov
nonvaccination
savings
lifeyears
net
npv
bcr
probabilistic
utilities
brelated
facetoface
inpatient
municipal
jinhua
jiaxing
taizhou
626
outpatients
523
netgain
32378
2110
35780
1358
save
78707
costsaving
preferable
costbeneficial
whenand
safethe
answers
therapyaplastic
1st
ist
paucity
equine
cyclosporine
nonresponse
325
20465
191months
postist
alc
brands
went
535
par
multimodality
celllung
cancerstage
locoregionally
schematic
operability
platinumbased
doublet
characterising
moment
staging
opsonic
multidrugresistant
enterococcimultidrugresistant
enterococci
hospitalacquired
hybridoma
enterococcal
diheteroglycan
dhg
wellcharacterized
enterococcus
faecalis
saga
faecium
opsonophagocytic
immunoreactive
igg1κ
dhg01
saga01
112316
reconstructed
eukaryotic
atmospheric
multiformeglioblastoma
angiogenic
highenergy
upregulates
investigative
ovid
titles
fulltexts
reviewers
rct
4980
895
highcertainty
n4253
28·1
16·038·4
moderatecertainty
14years
n610
0·62
0·540·70
315years
n10985
personseasons
0·69
0·580·83
6years
n47945
0·93
0·870·99
1235months
n264
0·85
0·750·97
crd42018103881
mimicking
fdg
petcta
petct
tail
enlargement
suvmax
fdgavid
radiologic
interpreting
projectobjective
share
mitigation
bay
nbnplc
legs
consolability
deliberately
leadership
agreed
sucrose
devised
agreeing
intricacies
want
touched
tumorsrecent
announced
myelinoligodendrocyte
encephalomyelitis
therapybackground
attacks
antimyelinoligodendrocyte
mog
antimog
tohoku
longitudinally
68322months
150months
1124months
33months
pulse
tapered
626weeks
17weeks
survivorsover
survivors
ccs
starts
canine
leishmaniosis
updateleishmaniosis
infantum
clinicopathological
conventionally
shortcomings
antileishmanial
imperative
immunotherapeutical
therapieslessons
ra
vaccinelike
customized
20132014
doubly
datasetbackground
relieves
span
subsidies
inversed
weighting
adjust
conscious
369425
64years
0775
agestratified
ors
4years
0600
0938
04030709
structurebased
derivation
intramolecular
cyclization
immunotherapythe
selfinhibitory
sip
crystal
energetic
alanine
doublestranded
finger
hotspot
interact
amphipathic
pocket
dsi
dsii
capability
rebinding
flexible
entropy
penalty
readout
constraining
intrinsically
disordered
conformation
ordered
dichroism
cyclized
affinities
dsiic111127
δdsiic111127
δdsiic110128
k
280±42
175±31
116±23μm
109±15μm
pd1l1
meticulous
sourced
9387
049
072
surprising
magnitude
regiondependent
demanded
aeroallergen
contentbackground
aeroallergens
scitsrs
encounters
multisite
allergyimmunology
epinephrine
demographics
scitsr
86949
ml
815
630
679
852
weeds
aeroallergenic
586
192
betathalassemia
βtm
posttransplantation
702
362
cbbm
slower
pbbm
afterin
antirabies
ogoja
nigeriarabies
zoonoses
bites
victim
breed
biting
20012011
183
anatomically
wounds
645
extremities
687
439
1562
sensitisation
granules
il1rap
literatureprotection
hazards
wanting
reshaped
expand
bloodderived
technologyrecently
unlock
receptorexpressing
tcartcell
workinprogress
kinds
receptortcrt
scarcely
tcrt
killernkcells
invariant
tinktcells
gdtype
offtheshelf
nonself
nowunder
uniform
compulsory
resorting
toxicitiesimmune
autoimmunelike
susceptibilities
familiarize
practicing
phonebased
conditional
quasirandomized
14weeks
assignment
phones
1day
incentive
phone
airtime
recharge
voucher
governmentissued
endline
nct03252288
vaccinebackground
90000
proceeded
partly
market
agestructured
inputs
qalys
45years
assumed
usd102033820
6183
countriesterritories
68000
8300
4400
usd596
usd268
countryterritory
platelettolymphocyte
corresponds
plr
164
plr164
70months
4199months
30months
1941months
98months
61135months
bmi240
3549
19016625
0496
02600945
p0033
2567
15514249
745
lipid
liposomal
studyliposome
phospholipid
liposomes
f1
f4
dotapcholesteroldope
444mol
dmpcdmpgcholesteroldope
15235
dspcdspgcholesteroldope
hspcmpeg2000dspecholesterol
13110
compositions
c26
subpopulation
dotap
dope
aforementioned
phospholipids
indices
antigensfree
designing
antigencontaining
postherpetic
neuralgiaherpes
85yearold
columns
analgetic
handicap
neuralgia
phn
neuropathic
asubstantial
robert
koch
immunitysynthetic
programming
transformative
intelligently
molecularbased
711
nonpathogenic
escherichia
encoded
nanobody
antagonist
cd47nb
antiphagocytic
1314
tumorcolonizing
cd47nbexpressing
tumorantigenspecific
hlamismatched
transplantationthe
mmud
matchedpair
ninetythree
leukemiafree
gvhdrelapsefree
grfs
antigvhd
chinabackground
hepb
pvst
ltfu
jiangxi
201631
hbvexposed
8474
4988
994
compliant
refused
venous
chose
confidential
aor170
97299
aor57
32101
aor19
1034
aor12
1114
motherinfant
impossible
13valent
wales
kingdom
joint
jcvi
communityacquired
deterministic
7valent
pcv7
fitting
carriage
20012002
postpcv
nonpcv13
nonvaccine
serotype
nvt
nvts
plateau
vaccinetype
assumptions
pneumococcalcap
continuation
under64yearolds
65yearolds
difficulty
sparse
programmatic
ascorbic
transplantationhematopoietic
mac
mucositis
oxidant
micronutrient
ascorbate
postconditioning
273μmoll
±141
p03
nadir
215
±138
repletion
schiff
metal
conjugationimmunomodulatory
signature
conjugations
potentials
gram
exerted
photo
damaging
graphical
capacitya
survivorschildhood
cls
airflow
cg
spirometry
carbon
monoxide
dlco
restrictive
obstructive
dlcopv
116229
abnormality
immobilizing
hit
cd22a
pharmacologic
ramakrishna
5329
frontiers
midwestern
statesbackground
hcps
unprepared
conversation
trusted
lie
curriculum
careers
topics
rate237
743
627
571
dnp
247
bsn
discomfort
equip
ph17173
ovo
broilers
campylobacter
jejuni
vaccinecampylobacter
meat
foodborne
infeed
embryos
hatch
seeder
cecal
anticampylobacter
campylobacterspecific
kawasaki
selfcontrolled
resultsbackground
vasculitis
datalink
postlicensure
chartvalidation
238
092638
decided
claimsbased
sentinelpostlicensure
prism
insured
sentinelprism
dataproviding
terminology
cpt
hcpcs
ndc
firstin365days
9th
icd9
4461
icd10
m303
adjudicated
boardcertified
chartconfirmed
scri
timeinvariant
28daylong
ageadjusted
070163
roughly
persontime
084
065108
097
079119
080
lacked
ageadjustment
instant
inflight
assemble
coreshell
nanocomposites
photoimmunotherapyinorganic
nanomaterial
inmbased
chemo
radiotherapies
inms
arisen
biodegradable
disintegrable
nanosystems
bp
nanodimensional
plugandplay
photoimmunotherapeutic
composites
dabrafenib
cancertargeting
cxcr4
targetability
regulatability
phototherapeutic
californiaimportance
2109
tightened
yearly
schoolentry
20002017
withinschool
9323315
721593
780
984
2602
421499
20122013
3026
2290
20162017
1613
15651691
hesitancythe
016
attend
let
adapt
diversely
authority
fiftyfive
265
490
grades
0005
prepost
implication
attainment
touch
hardtoreach
drawing
proteincoupled
gpcrs
purinergic
prostaglandin
ep4
opioid
glioblastomaintroduction
incurable
intracranial
genomicbased
gynecologic
malignanciesthis
standardofcare
msih
endometrial
impacted
lymphomahighdose
andautologous
hdtasct
relref
chemorefractory
investigatedsafety
ofcd19specific
chemosensitiveto
positron
tomographypositivedisease
standardhdtasct
1928z
doselimiting
5×10
tcellinduced
interferonγelevation
interleukin10
naivelike
cd45ra
ccr7
immunophenotypes
atwwwclinicaltrialsgovas
nct01840566
introductionover
westernized
societies
epigenetic
foods
percutaneous
reconsideration
atopy
rescinded
opposite
recommending
ambiguous
examining
vietnam1
vietnam
cancersthree
singlegroup
4885fold
nks
5425fold
cooperative
ecogps
scales
aristolochic
needsurothelial
tracts
utuc
reminiscent
carcinogenicity
deoxyadenosinearistolactam
ta
transversions
tp53
aarelated
reasonably
flourishing
covers
experiencechimeric
imminent
allnhlmm
dengue
exposurethe
tetravalent
cydtdv
dengvaxia
vaccinees
denv
agentbased
philippines
depended
lowtransmission
payer
lifeyear
dengueendemic
panamá
13680
usd
8649
méxico
8201
5807
harm
scorecard
africas
durationdependent
iiiii
seasonsbackground
japiccti142579
tablet
conjunctivitis
1042
10000
jau
n240
n236
pa
2112
rescue
qol
aaappapp
aapaappp
relieved
7year
foreign
farinaed
hdmsensitized
csms
775
725
7th
5th
zeste
homolog
modulates
ezh2
mdcs
plasmacytoid
pdcs
deazaneplanocin
dznep
modcs
039
047
00002
groupcompared
042
026and
010
cd83
dcdriven
md
2288
78093796
stresses
fgfr2
thorium227
atr
1895344purpose
fgfr2targeted
fgfr2ttc
2304058
antifgfr2
chelator
moiety
covalently
particleemitting
radionuclide
atri
bay1895344
γh2ax
nude
fgfr2expressing
kbqkg
ncih716
snu16
mfm223
1895344
fgfr2ttcmediated
mechanismbased
fgfr2positive
lentinan
peyers
modellentinan
lnt
lentinus
edodes
epidemiologic
patches
pps
mlike
ecadherin
infectionobjective
secadherin
interferona
pegifnα
rbv
24weeks
posttherapy
aminotransferase
alt
aspartate
ast
glutamyl
transpeptidase
ggt
rvr
svr
nonrvr
nonsvr
biotechnological
engineeringt
pge2background
acs
phagocytose
uc
engulfment
hcs
msc
mcm
acmsc
acmcm
pge2
supernatants
acmscs
lavage
plf
cyclooxygenase
cox2
cox2pge2
acmscmediated
pgem
possessed
engulf
mscmediated
mechanistically
nfκb
unrecognized
mscbased
grants
81720108020
jiangsu
be2015602
talent
bra2016001
wj
chen
intramural
nidcr
mepolizumab
aspirinexacerbated
contrasts
usaallergen
quickly
artemisia
wormwood
humulus
japonicus
hop
alternaria
alternata
cladosporium
herbarum
inhalant
cma
cmda
ccaa
branch
cdma
allergists
encompassing
hypoallergenic
matchedsibling
malignanciesin
ebv
ptld
multiorgan
gcsfprimed
msdsct
n90
hlahaploidentical
hidsct
n110
278
atgcontaining
p0008
p0034
p0010
p0036
40yr
p0032
relapsefree
684
p0025
marginally
p0092
immunityimmunotherapy
therapyinduced
adaptation
forthcoming
perineuritis
immunotherapyperineuritis
perineurium
52yearold
subacute
weakness
hypoesthesia
sural
prednisolone
medicolegal
perspectivevaccines
fairly
suspicion
raises
experimentation
consent
collective
bioethical
exacerbates
reportinfluenza
steering
20152016
rose
243
rewards
duty
antihuman
immunotherapylymphocyte
antilag3
lbl007
phage
internalization
relatlimab
sinusoidal
lectin
lag3induced
monkeys
deserves
statutes
regulations
columbia
septembernovember
westlawnext
subquestions
string
statute
distributing
reimburse
jurisdictions
evaluations
antitim3pd1
ep3356411a1introduction
coordinate
ep3356411a1
antitim3antipd1
inventions
austria
ignorance
controlobjective
austrian
350000400000
10001200
19822015
telephone
doses1000
onwards
steady
201516
midnineties
misjudged
attain
marketing
chitosan
o157h7
capacityescherichia
espae
intimini
tirt
stx2
diarrhoea
haemolytic
uremic
eit
stx
caco2
monolayer
abilities
preincubated
vero
morphological
reforms
evocated
tumorsin
tlrs
immunite
microorganisms
contradictory
static
methodologydespite
60000
rabiesfree
organisation
dtd
expensive
mission
malawi
transect
smartphone
positioning
4172
attaining
884
959
sps
humantodog
937
highnumber
highcoverage
chinain
heaviest
fulfilled
elaborates
maternaltochild
flt3itd
bloodrelapse
impending
instituted
wilms
hematopoiesis
flt3internal
tandem
duplication
bloodguided
entecavir
11step
kir2ds1
hlac2
conditioningbackground
graftversusleukemia
314
kirgenotyping
analyzes
rc2
0046
d2ds1
attribute
homozygousd2ds1
heterozygousd2ds1
negatives
0018
rc2d2ds1
hr047
026086
0014
cmvreactivation
chemoresistant
mactreated
00045
constellation
20062017
vaccinationrecent
harsh
autism
misinformed
antivaccination
argumentthat
diminished
ukbackground
12yearold
equalising
complemented
discounting
halting
prices
£56£108
£25£53
£6
£3
£36£47
contingent
uks
girlsonly
heavily
chinawillingness
t2dm
ningbo
1955
susceptibility
1525
1323
3064
farmers
0408
managed
contracted
0610
municipally
sponsored
slovenia
20092010
idrija
cerkno
outstanding
20202021
pomegranate
peel
micethis
ppp
ctx
400mgkg·d
gavage
enzymatic
ldh
acp
splenic
infγ
cyclophosphamideinduced
taoc
tsod
gshpx
immunopotentiating
lessening
chemotherapyinduced
immunostimulants
industries
ig20gly
onboarding
diseasesbackground
volumes
mlsite
mlhsite
fast
volumessite
weekly
prestudy
switchers
sc
identifier
nct01218438
rethinking
jak
matterthe
ulcerative
colitis
characterised
anticytokine
jaks
phosphorylation
transducer
isoforms
jak1
jak2
jak3
tyk2
jaki
synergic
tofacitinib
panjak
subtypeselective
debatable
summarise
immediaterelease
prolongedrelease
irt
prt
postconversion
133
converted
035248
22100
patientyears
091526
preconversion
92100
74113
106100
88123
mortalitygraft
23100
1731
whymaternal
avoided
outweigh
laiv
medically
familiar
dangers
novdec
2016unassigned
1233
threestage
fleiss
formula
2231
1223
681
outreaches
782
resided
5km
297
392
402271
busy
275
apathy
immunotherapypaclitaxel
biosynthetic
biotechnology
endophytic
recombination
fermentation
sonoimmunotherapeutic
nanocapturer
infectionsantibioticfree
mdr
eradiation
facile
bioinspired
bridging
antibacterial
sonodynamic
antivirulence
neutralizes
alphatoxin
methicillinresistant
mrsa
sonosensitizer
encapsulation
potently
sonosensitizers
optical
antibodypiloted
locate
sterile
oxyhemoglobin
saturation
visualize
revealing
myositis
antibioticfree
nanotheranostics
scida
unconditioned
patientsallogeneic
immunodefiency
scid
cytoreductive
circles
trecs
kappadeleting
krecs
trec
krec
favoring
ivigs
laboratorial
consanguinity
immunopeptidome
endoplasmic
reticulum
aminopeptidase
erap1the
er
erap1
trims
mhci
a375
isolating
eluting
capillary
chromatography
lcmsms
cellsurface
peptidomes
3204
eluted
912mers
destructive
manipulating
allergieswhile
sit
anaphylactic
underrepresentation
adjuvantinduced
immuneactivating
flagellin
mpla
slayer
pres
vp1
tat
fipfve
mhcii
haplohsct
cr1
haplopbsct
758
gcsf
questionable
anthraxinhalational
anthrax
anthracis
sporeforming
grampositive
bacterium
toxins
authorized
antitoxin
antipa
inductive
inhalational
clearer
trendsimmunotherapy
seminal
toptier
striking
adrenal
insufficiency
shr1210
adrenocortical
anti
98
adrenocorticotropic
acth
cortisol
14th
anorexia
headachethe
267th
hypocortisolism
279th
291th
457th
attenuatedthe
776
ameliorated
hrs
557
certified
immunooncologically
0526
03730723
048
iva
ivb
5894
95141
wt1background
wt1targeting
pda
iiirestricted
peptidepulsed
dcwt1iii
neutrophiltolymphocyte
nlr
monocytetolymphocyte
mlr
granulocytetolymphocyte
glr
nonsuperresponders
superresponders
metalloproteinase9
gemcitabine
granulocyterelated
exclusive
bee
immunotherapyintroduction
goldstandard
vitisr
patientsthat
meir
19952018
fortyseven
sixtynine
tryptase
reactors
0004
tryptaselevel
helping
nonuniform
tumourrelated
immunotherapyofftarget
preclinically
escalation
nothing
format
adapted
redirection
tcrtherapy
syndromelike
adaptersalthough
sensitively
document
terminate
3h
crslike
preemptively
adapters
reactionsfood
faslit
afr
sixmonth
allergenrecall
proliferating
doublenegative
doublepositive
corroborate
naples
italythe
1964
1971
carbased
immunotherapychimeric
αβt
γδt
carindependent
expansibility
gra14
micetoxoplasma
toxoplasmosis
damages
tends
granule
calcium
phosphate
capns
aluminum
hydroxide
alum
nanoadjuvants
pcgra14
rgra14
igg2a
rgra14capns
pcgra14rgra14capns
pcgra14rgra14
primeprotein
capnsbased
regime
japanbackground
tokyo
metropolitan
12years
8090
671
595
618
smolt
vaccinemediated
unaffectedin
todays
seawater
parrsmolt
parr
photoperiodic
6week
lightwcl
smoltification
6wcl
1wcl
ipnv
gave
wcl
ipn
patientsseveral
informative
pages
palermo
couldsuggest
strategyforincrease
strategiesthe
debates
appreciated
operators
welfare
côte
divoireobjective
10health
hds
divoire
june2016
may2017
supervisions
mcvc
exceeded
12points
3points
13points
1point
hdsthe
10targeted
35points
25points
facts
smartness
curing
classify
resultconclusion
proteininduced
antitat
medicineenabled
immunotherapyrepairing
realized
william
coley
reeducating
reinvigorate
cusp
arsenal
genebased
virusthe
14day
boosted
immunophenotyping
916
rf
conjunctivitisbackground
ac
highserum
p000
toss
polysensitization
tinkering
garage
tuning
γδ
pleiotropic
cancerthe
lineage
underestimated
notwithstanding
instances
seemingly
mobilizes
tumourpromoting
eve
players
immunoenhancement
meningitides
porb
vaccinesbackground
subunits
porin
purified
verified
prokaryotic
purify
copd
nonacceptance
title
patientfocussed
clinicianfocussed
papers
beforeafter
heatepithelial
eoc
oc
immunecheckpoints
immunetargeting
stromatumor
mobilising
warm
tumoursimmunotherapeutic
liquid
broadening
immuneexcluded
immunedeserted
immunesuppressed
redirecting
immtac
tebentafusp
imcgp100
demonstrable
forensic
filessudden
attributable
occurrences
postmortem
tokai
histories
passbook
3monthold
14monthold
hemophagocytosis
judgment
truly
pathologists
devote
scidbackground
gaza
bank
extraregional
immunofluorescent
nephelometry
sanger
isoniazid
ethambutol
rifampicin
midwives
notification
coveragebackground
governmentfunded
mns
sixtyeight
‘
657
560742
530
424634
533709
404
276547
918
830969
767955
presentationwe
infectivity
5–9
sydney
strategic
hair
sheep
haemonchus
contortusin
barbervax®
contortus
902±403
unchanged
periparturient
ewes
lambs
371
experimentally
worm
87±54
anthelmintic
ehec
nanoparticle
proteinbackground
watery
trimeric
encapsulate
stxb
ctxb
1046nm
neutralize
implicationsmetastasis
mobilize
outgrowth
macrometastatic
predisposing
hereditary
replete
transplantationimpaired
bcells
reactivations
nonlethal
hominis
immaturity
transplantationan
pgf
81870139
nacetyllcysteine
scavenger
repairing
unknownin
antigenhaploidentical
haplosct
matching
encouragingly
transplantationrecent
enabled
antigenhalf
noncaucasian
race
cyclophosphamidebased
anemiahaploidentical
depleted
resultsallogeneic
bmt
veto
therapyhaploidentical
alloreactions
humanleukocyteantigen
disparity
tcelldepleted
tcd
immunoregulatory
cellproperty
vetoactivity
megadose
celltherapies
prove
hemoglobinopathies
prelude
celltherapy
cheaper
transcriptome
cd19cart
ballchimeric
cd19specific
nodlike
mir148a3p
mir375
suppressors
tfs
jun
fos
histones
hist1h4a
hist2h4a
noncoding
coexpression
hist1h4b
clues
commitment
justifications
oxygenation
weaken
hypoxia
1αmediated
immunosuppressionlongterm
antipathogen
hypoxiahif1α
adenosinemediated
a2a
adenosine
hypoxiaa2aadenosinergic
protects
inflamed
overactive
hypoxiahifαmediated
antihypoxiaa2aadenosinergic
inactivate
tumorprotecting
hypoxic
adenosinerich
tumorshere
conceptually
breathe
repurpose
pharmacokinetic
leukemiaindividual
pk
kmt2agenerearrangementpositive
mllr
fluctuates
readjustment
600900ngml
obstruction
paradoxically
transplantrelated
securing
fasciitis
causality
9month
adjoining
lowgrade
passage
loose
stool
cries
mildly
pale
febrile
anicteric
thereafter
scalded
wall
desquamation
incorrect
supervision
guimit
mexican
adapte
approachbackground
mexico
practiced
aitvit
delegates
postgraduate
trainingprograms
allergyimmunologyforming
allergology
agreeii
conforms
emanates
finishes
transculturized
standardize
retroelementcontaining
transcript
vaccinationendogenous
retroelements
transcribed
mltint
element
retroviruses
mltintcontaining
promoter
speculate
unnoticed
busulfancyclophosphamide
mdsin
cbt
5873years
125175mgm
96mgkg
cy
90mgkg
twelve
nineteen
19days
1429days
243months
100days
762
381
n5
bucy
successively
nccn
cancersmall
antiangiogenic
antiangiogenesis
cspg4specific
leukemiathe
sizable
cd19car
cd19negative
necessitating
quest
backup
chondroitin
sulfate
proteoglycan
cspg4
illfated
mll
11q23
rearrangement
mixedlineage
mllrearranged
kopn8
mllmllt1
translocation
tnf
evinced
degranulation
chromium
proofofprinciple
mlltranslocated
leukemias
managementvaccinations
staffs
coordinators
6263
immunetherapy
applicationschronic
250
nucleostide
analogues
nuc
virusspecific
tcrredirected
modulatory
horses
dermatitisthe
asit
thirtytwo
566
179±113
73±44
twitter
2017in
nlp
20082017
intelligence
aibased
phrase
mining
fluctuation
tweets
extraction
tweet
injuries
scandal
adverseside
screens
counter
incidents
depok
indonesiapneumonia
arranged
0000
0043
nutrition
ground
malawifirst
leukemiasmall
cytogenetics
venetoclax
geared
rethink
europevaccination
healthcareassociated
frameworks
skepticism
revolutionize
cellassociated
icans
cytopenias
ontarget
offtumor
speed
aheadchimeric
nonsustained
firstinhuman
exotoxin
aplga
nanoconjugate
pseudomonas
aeruginosa
modelpseudomonas
cf
plga
nanovaccine
etaplga
spleens
pao1
eta
immunotherapiesthe
4decades
pillars
handful
plethora
toolkit
antipneumococcus
antiherpeszoster
antipapillomavirus
romethe
adultelderly
expectancy
rome
lycopene
afb
oxidative
micelycopene
lyc
immunoprotective
aflatoxin
afb1
relieve
afb1induced
fortyeight
kg1
intragastric
alleviated
relieving
afb1via
hydrogen
peroxide
h2o2
restrained
mitochondriamediated
intoxicated
mitochondrial
cytc
caspase3
caspase39
balancing
bax
editorial
francisellosis
injectionfrancisella
noatunensis
subsp
orientalis
warmwater
formalininactivated
developedfor
stirgusf2f7
montanide
isa
763a
vg
seral
01ml
840
40×10
cfufish
omic
invulnerable
vaccinesroutine
realised
nonrespondersundervaccinated
bioinformatic
efficacyprotection
majorvaccination
formerly
skinresident
intradermally
ep
glycosomal
phosphoenolpyruvate
carboxykinase
pepck
pepckspecific
vegftargeted
abrogation
levelsobjective
cigb247
vegfbased
centauro
centauro2
normalize
organspecific
atezolimumab
avelumab
sixteen
3734
2474
1728
died
10weeks
6195weeks
restarting
transplantsrecent
outlining
biomarkerimmunotherapy
treatmentpatients
patientsbased
periocular
malignancyimmunotherapy
vaccinesobjective
parallelgroup
shanghai
sabin
sipv
wipv
bivalent
ⅰ
ⅲ
bopv
sipvsipvbopv
sipvwipvbopv
wipvsipvbopv
wipvwipvbopv
1679
9465
633
nodule
drowsiness
165
935
were126
715
1514
8535
1133
6385
2417
alternately
il7il15
nyeso1specific
lessdifferentiated
naïvelike
esophageal
carcinoma1
ms3iinyeso1sitcr
retroviral
nyeso1positive
sw982
unexpected
cocktails
evolutionselected
miceenhancement
selfantigens
rat
neu
residue
phese2tm
m198v
q398r
f425l
h473r
a622t
blosum
hese2tm
antiher2
electrovaccination
threefold
her2binding
ifnγproducing
pe2tm
p95
355
lpesfdgdpasntap
369
exploiting
carcinomathe
tremendously
metastasized
cancerimmune
selftolerance
rheumatological
answer
undiseased
mandarin
siniperca
chuatsi
swcntsbased
vaccineinfectious
isknv
swcntsmcp
mcp
singlewalled
nanotubes
swcnts
naked
juvenile
bath
fcell
rhesus
monkeyselevated
hbf
sickle
γglobin
hbfpositive
macaques
macaca
mulatta
peaked
099253
fcells
617
87453
stabilized
elevate
nonresectable
melanomabackground
nonsurgical
fortyfour
vulvovaginal
anorectal
473
2546
5months
26331
p00147
unresectable
adds
allergypro
foodforthought
tc1
eradicationbackground
peptidebased
slp
centrally
3173
tlr4
tlr78
tlr9
ow
waterinoil
wo
emulsions
expresses
agonist
squalenebased
cpgow
slpcpg
yeast
1316βdglucan
gemcitabinetreated
micegemcitabine
2deoxy22difluorocytidine
dfdc
myelosuppression
hinders
yeastderived
βglucans
gemcitabineinduced
myelopoiesisrelated
βglucan
splenocytes
yac1
gemcitabinedamaged
alleviating
topcited
immunotherapyobjective
bibliometric
authorship
5332
1986
rosenberg
author
bold
objection
nanomaterialbased
nanoplatforms
biomaterial
prioritised
temperate
climates
foetus
transplacental
haemagglutination
cordnewborn
scopus
contacted
tabulated
summarised
randomeffect
196fold
164fold
injectionobjective
rhinitisar
foshan
color
doppler
session
tuarog
700±165
437±188
426±180
422±180
409±210respectively
5368±928
2301±1328
327±117
100±105
shortens
island
comes
haemophiliaresults
haemophilia
modelobjective
taiwans
irhcp
labour
diphtheriatetanusacellular
emphasising
broadcasts
needleless
granulomafree
pigsvaccination
customers
simply
granuloma
fmdv
therapiesautologous
riding
creative
hostility
geneediting
circuits
pluripotent
palpably
pipeline
outlook
geneedited
societyobjective
relapses
immunoactive
france4ms
1975june
randucla
appropriateness
formalize
wrote
proposals
reading
inappropriate
uncertain
dmts
treatmentinduced
whatever
treatmentsduring
plausible
remarks
pinpoint
edit
carcinomacontext
postplatinum
1726
methodical
cancerbreast
untreatable
quite
devastate
eminent
denotes
extrinsic
holistic
constructive
treatmentoncotherapy
therapyresistant
sideeffect
overt
syndromes
checkpointinhibitor
16023
887895
allergenic
formulationhouse
slittablets
tongue
solubilized
solubilization
minute
holding
manufacturer
ingredient
freezedried
compressed
igebased
delivers
thrombotic
microangiopathy
reportthrombotic
tma
pathologic
microangiopathic
microvascular
48yearold
mycophenolate
mofetil
mmf
aortic
artery
deteriorate
leukopenia
everolimus
restarted
reportcutaneous
nocardiosis
zoonosis
pyelonephritis
scheme
firm
nodules
cm
overlying
purulent
acidfast
quantiferon
polymerase
miliary
multidrug
mediatorswith
nonproductive
compartmentalized
outright
ample
jump
undermine
scurvy
conundrum
pyoderma
gangrenosumscurvy
misdiagnosed
exam
manifesting
nonhealing
lowerextremity
ulcerations
gangrenosum
ulcers
heal
reversal
diagnoses
malnutrition
overviewuntil
howeverincluding
therapiesan
substances
experienceacquired
aaa
3108
associatedpost
vsaa
transfusiondependent
maa
upfront
mfd
fifty
completepartial
unresponsive
3rd
mycophenolatemofetil
levamisole
eltrombopag
scorematched
databackground
rfs
radiofrequency
largevolume
280months
229423months
022080
298months
020073
1659
271
consensual
computedtomography
multitumor
melanomawe
gp100
adjuvanted
ctla4pd1
lusaka
zambiaintroduction
shancolan
inpatients
multiplying
ratiocost
avertedfor
us172
us1449us1803
us1766us3516
incurred
beverages
transport
borne
889
us1500
us369us532
us18515us27976
us698us1006
us666us1000
shancol
densely
populated
corenorth
4079
fullyimmunized
α50
642
195ci135280
religion
husbands
attendants
cancerover
mdsc
cho
hamster
ovary
choderived
1999
1352
1007
gmc
61352
231
931
3687
1720years
calciumdependent
tgcdpk1
exocytosis
hostcell
egress
rtgcdpk1
bablc
th1type
p70
1490±289
2017crises
disasters
traveling
tourism
arrivals
departures
ivc
94683
113529
malaga
pacific
multiplied
internally
displaced
bentiu
civilian
sudanunassigned
protracted
sudan
humanitarian
programotpcenters
poc
januarydecember
otp
immunizing
accessing
phcc
95ci036
055
027
imci
giv
hbs
beninese
soldiers
military
missions
ivory
coastunassigned
antihepatitis
antihbv
battalion
anankouakouté
companys
interviewbased
sodiers
aghbs
hbeag
antihbe
seventyfive
sexratio
573
antihb
234
cases41
eighteen
103
cases18
hbeagpositive
2000iuml
unimmunized
reviewachieving
envisioned
isc
iscs
1980s
outdated
outsourcing
excerpta
medica
cinahl
wholis
caribbean
benin
mozambique
360
liberty
healthier
supreme
court
upheld
police
behalf
philosophical
exists
ban
ohios
permissive
relaxed
curb
infringement
restricting
aligns
rejected
freedom
polydopamine
carrying
lysate
immunotherapypolydopamine
nps
dopamine
selfpolymerization
tcl
onto
480
μg
tclpda
2419
perfect
negligible
m1type
tam
immunosuppressionrelated
classi
regress
harbor
irreversiblehard
reversiblesoft
hlaclass
destroyed
hlai
structuralirreversiblehard
immunochemotherapies
4nqoinduced
carcinomaadvanced
oscc
4nitroquinolonenoxide
4nqo
combinedagent
polyepitope
zm241385
monotherapies
silence
vaccineadverse
fdacdc
vaers
500000
dimension
nominal
listing
crossboard
filed
19902013
neighboring
visualization
relations
uncorrelated
inactive
dysfunctions
immunotherapiesimmune
durmalumab
antipd1antibodies
thyroiditis
thyrotoxicosis
storm
antictla4antibodies
therapist
circumstances
hypoadrenalism
gonadal
hormones
endocrinologist
perspectivescellular
strategiesmacrophages
engage
antibodydependent
tamcentered
bioactivity
patientsexperimental
csrt
deathligand
intravenously
intracranially
cerbrospinal
cd123
syndromemyelodysplastic
dysplasia
hypomethylating
succumb
delineate
cd123positive
cd123specific
cd3ζ
illustrate
cd123targeted
uropathogenic
strainsurinary
utis
annoying
biggest
uropathogens
afflicted
upecs
etiologic
uti
polyadhesive
appendages
chaperoneusher
cup
upec
pilicides
curlicides
phagotherapy
genomics
genomedriven
caremedical
microgravity
stressors
involvementspace
exposes
astronauts
gravitational
gravity
countermeasures
nasa
extraterrestrial
moon
mars
2030s
overburdened
thelper
spaceflight
flight
akata
immortalized
burkitts
spaceflightinduced
posting
„
nie
szczepimy
forumintroduction
visible
institutionalization
politicization
forum
20082018
20092015
wolfe
idiopathic
299
antivaccinaton
salmonicida
rainbow
troutaeromonas
oldest
marine
waters
furunculosis
fisheries
vapa
padeasycmvvapa
trout
igt
hindgut
hek293cells
lowered
766
736
degrees
a450
lays
polyvalent
kivu
congobackground
hbsab
seroprotection
bukavu
consecutively
threedose
845
optimise
narcolepsy
iabs
meetinga
pandemrix
as03adjuvanted
arepanrix
focetria
mf59adjuvanted
h1n1pdm09
methodologies
convalescent
zika
modelthe
zikv
microcephaly
chainpaired
zikvinfected
7b3
1c11
6a6
ic50
gz02
mapping
k394
ridge
lr
ediii
footprint
t335
g337
e370
n371
d67
k118
k251
edii
vh323
vk15
pair
neutralized
denv1
allergyobjective
selections
overdiagnosis
clarifying
precautionary
labeling
patientpreference
valuebased
pricing
schoolsupply
wtp
100000qualityadjusted
1568
6568
epicutaneous
epit
1235
5235
probiotic
poit
reflexive
tradeoffs
omitted
levers
taiwanobjective
taiwanese
2d
as04adjuvanted
2das04hpv
1618vscreening
6111618
2d4vhpvvscreening
2dthreedose
3d
61116183133455258
9vhpvvscreening
n120000
ran
input
websites
discount
dollar
727818
2das04hpv1618vscreening
00365
5770
2d3d9vhpvvscreening
discounted
2das04hpv1618v
deconvolution
datawe
introduce
quantiseq
fractions
rnasequencing
dataquantiseq
8000
cxcr3cxcl9
deconvolutionbased
underlie
blockersavailability
httpicbiatquantiseq
1963
2921963
decree
n812008
tev
cws
trento
oct
apr
bookletscertificate
recalling
formulates
406±103
yearold
cw
962
shots
employ
reception
pru
parietaria
pollensbackground
peach
ltp
eating
ltpcontaining
downsized
rhinitics
819±423
isac
immunocap
ingesting
3sensitized
merely
careful
interepreted
duchy
parmamaria
luigia
marie
louise
habsburg
daughter
emperor
napoleon
bonapartes
wife
empress
defeat
husband
1814
relegated
duchesse
parma
piacenza
guastalla
1816
army
instructing
willingly
wanted
charity
hospices
orphans
1820
promulgated
exhaustive
sanctions
nominated
publicize
inovercoming
prejudices
dispositions
tuscany
lombardy
1831
ordinances
urged
arrangements
provisions
maria
1847
bourbons
18471860
diligent
physicianscancer
postinfusion
icu
possessing
anesthesiologists
1162
228
170569
117343
105302
ultrarush
2401243
105332
510
040094
s®
novohelisen®
nonadherent
significances
microrna
threemonth
wasp
immunotherapymicrornas
stinging
wasps
comprised
postvit
mir601
mir1201
mir182
mir342
let7d
mir34b
mir143
th2type
undocumented
tipobjective
scant
organizationeurope
tip
diagnosing
motivators
immigrants
workshop
featuring
nongovernmental
workshops
entitlements
mistrust
ompw
lactobacillus
casei
veronii
carpaeromonas
infecting
aquatic
mammals
irreparable
averonii
lcasei
surfacedisplayed
600bp
subcloned
plasmids
ppg1
ppg2
lcppg1
lcppg2
lzm
ilβ
lcppg1ompw
lcppg2ompw
lab
schemesthe
engender
undoing
argues
payoffs
governing
divergent
differentially
modalitypurpose
convincing
foxes
rabiesthe
wildlife
20112016
croatia
cbr
723
confirming
lowresponders
remeasured
958
r0893
r0902
208209
7281
1738
elderlythe
elaborated
nutritionists
nutrologists
hematologists
brazilians
importancy
antipiralike
igy
feeds
immunizes
shrimp
hepatopancreatic
diseaseacute
ahpnd
toxinproducing
chicken
yolk
litopenaeus
vannamei
boone
eggs
laid
piralike
rpira
pirblike
rpirb
wholeegg
powders
antipiraigy
antipirbigy
nonimmunized
hen
controligy
prefeed
feed
lowering
statusbackground
sb277
schoolchildren
kindergarteners
entrance
fell
homeschooled
entrants
correlational
incoming
proteomic
gcsfplerixaforbusulfanfludarabine
transplantationto
pb
plerixafor
buflu
progenitors
gcsfplerixafor
gcsfplerixaforbuflu
nonleukemic
amlspecific
aberrantly
putative
enoughinfluenza
reactualized
choices
definitely
advices
hydroxychloroquine
comments
burioni
veneto
lacks
bam
sfgmtchighdose
consolidation
beam
aracytine
melphalan
174months
705
validationsbackground
2475
sept
idelalisib
mayo
mccd
n727
internalvalidation
n242
externalvalidation
n897
n389
n220
cstatistics
discrimination
microglobulin
mgdl
gl
cs0·74
0·600·85
cs0·79
0·560·97
p0·0003
cs0·71
0·590·81
cs
0·76
0·660·85
p0·014
cs0·61
0·560·66
qxmd
andrew
zelenetz
healthnational
therapycancer
transitioning
unspecific
matures
invested
dasatinib
phosphoinositide
3kinaseδ
immunotherapytumour
3kinase
mediating
contextdependent
pi3kδ
antagonized
ror1positive
cellsobjective
kinaselike
orphan
ror1expressing
synthesized
constructing
hⅰ
eco
rⅰ
fcm
lentivirus
4723
interferoniγ
fnγ
fcγr
affinitycostimulation
mabag
utomilumab
urelumab
codetermine
anti41bb
fcγrs
crosslink
fcγrinduced
compromises
deleting
engineer
lvgn6051
book
allergenimmunotherapy
housedustmite
targetregulatory
abnormalexcessive
nonselfantigens
αchain
chemoattracted
gradients
ccr4ccl1722
ccr8ccl1
ccr10ccl28
cxcr3ccl91011
finetune
synopsis
oxaliplatindesensitization
francethis
unevaluated
testicular
transplantationassociated
29yearold
semicastration
urooncological
patientsdruginduced
predispose
habits
examinationbackground
processed
semmelweis
december2015
1478
shrunken
556
73
pt1a
pt1bstage
outstandingly
recipientsbackground
biochemistry
biopsyconfirmed
deteriorates
pakistanbackground
1978
ontime
governance
informants
tiers
revolved
whos
faces
clarity
onground
budget
fulcrum
interacts
sociopolitical
posing
brings
burdenimmune
mythbusters
pseudoprogressionatypical
synergism
excitement
solutionsexpanded
safeguards
reliably
subtle
steroidrefractory
champions
subspecialists
immunotherapyspecific
boards
lecture
nononcology
patientrelated
headedimmunotherapy
durability
mesotheliomathe
mutationnegative
stagnant
thoracic
tets
mesothelioma
rarer
tc
artaggressive
chemotherapyrefractory
3340
treatable
cytokinesecreting
malignanciesesophagogastric
tremelimumab
pdl1negative
nonasian
immunemediatedinfusionrelated
palliationthe
dilemma
intersection
honest
prognostication
oncologymetastases
wholebrain
systempenetrant
vaccinesadoptive
neoantigensa
sequencinghas
antitumorspecific
tcrcd3
antibodylike
sinonasal
smm
noncurative
fdgpetmri
paranasal
sinuses
skull
3034
334
operated
2530
1830
1230
01375
16months
log
099
calvesthe
girth
tape
hgt
holstein
calf
radial
immunodiffusion
es
adg
pearson
081
086
overestimate
inhabited
settlements
satellite
imagery
previouslyundetected
borno
nigerias
boko
haram
habitation
villages
3150cm
digitalglobe
analysts
settlement
vegetation
overgrowth
cleared
proxy
intact
totally
doubled
buildings
unreached
11927
3203
1892
662
8062
180155
337411
studys
metastasesthe
metastasize
fractionated
schedulegiven
sage
preceded
topv
producers
bilthoven
biologicals
sanofi
faced
tag
pan
paho
ipvc
ipvf
paraguayan
slipe
alape
tigitspecific
complementarity
libraries
141×10
m13eea
m13ko7
itim
fcfused
cb3
8155×10
alzheimers
diseaseintroduction
dementia
βamyloid
intraneuronal
neurofibrillary
tangles
nfts
irregular
cholinergic
glutamatergic
expands
paradigms
conceptualization
neuron
tauons
stabilizing
microtubules
poly
lacticcoglycolic
immunotherapystimulating
bestknown
polymers
encapsulating
emulsionsolvent
evaporation
microscopy
agloaded
dct
antigendr
il12il10
np
npencapsulated
reg
therapysolid
restrict
unleashed
tumourassociated
carma1bcl10malt1
signalosome
stunted
carma1
card11
cellswhich
autoimmunitywas
isnotthe
mere
butthe
thatinitiates
whichindicates
reproduced
malt1
selfreactive
surveillanceimmunecheckpoint
arguably
distinctly
chemotherapyrelated
temozolomidebased
unfavourable
070084
066079
overal
074
079
085
p0052
ready
hyperprogressive
hpd
shrinkage
univocal
physiopathology
evaluationin
peculiar
nodeobjective
rodents
sneezing
rubbing
il10specific
smln
attenuate
kongbackground
recording
1152
982
stepwise
selfefficacy
featured
immunizationmaternal
policymaking
studyaplastic
hypocellular
british
haematology
stemcell
csa
isttreated
guidelinerecommended
978
637
582
648
align
sizing
estimationbackground
victoria
gps
sentinel
testnegative
–
swab
swabbed
459
n238
756
n288
5–17
n547
18–64
n2662
swabbing
dictated
arbitrary
eralung
mention
readministration
434
0826
14190
nanomaterials
knock
nanomaterialmediated
biobarriers
uncovers
velogenic
smallscale
holdings
pathogenshighly
gallinaceous
suspicions
distress
ndvaccinated
bronchitis
ibv
aiv
rtqpcr
nondirected
cellculture
lmhcells
ndvpositive
2viib
governorate
broiler
farms
2ii
coinfections
h9
reovirus
arv
astrovirus
aastvs
pathotypespecific
circulates
neighbouring
distances
pathotype
hangzhouthis
90th
stems
hangzhou
preventedpertussis
2monthold
toddler
rsv
bordetella
istituto
giannina
gaslini
ebcog
pregnancymaternal
exosomal
retains
prognosisbackground
preoperative
n69
interval11427669
p0139
r0549
p0054
r0349
r0537
cd69
obligation
childbearing
mifi
cameroonunassigned
7133
highligts
7811464594
5859
6027
186594
2694
160594
741
44594
6982
awarenessraising
informations
virusinfectious
genotypic
serotypic
vectored
inpatientsinfluenza
meets
oceans
immunotherapymarine
flora
taxonomically
biopharmaceuticals
sinusitis
marineoriginated
bioactive
manchester
kingdomobjective
menacwy
201718
ofsted
pupils
undertook
singlevariable
806
690874
300419
128151
deprivation
141178
oversight
prioritise
microbubble
loachimmunization
simplest
laborsaving
mb
loach
mbs
gas
100μm
radicals
junah
loaches
fkc
mbtreated
formalin
affordability
ease
hodgkin
tomographycomputed
asct
eightynine
iiiiv
ips
deauville
3°
dhap
705p0017
situationmeasles
1969
oftenoccurring
revise
16020
767773
immunodominanceconventional
immunodominance
fh
envbinding
fine
aspirates
gcscorrelated
20fold
nabs
locus
igv
nonneutralizing
bolusimmunized
deliveryimmunized
nab
pregnancymeasles
27yearold
parainfluenza
2infected
tachycardia
sore
throat
pruritic
lymphopoenia
radiography
sectionpostoperatively
decannulated
measlesthis
emphasises
booking
deteriorating
efficacyin
impedes
asyet
reserves
respiration
proliferatoractivated
cllderived
biogenesis
nct01747486
nct01029366
httpsclinicaltrialsgov
monocyteintrinsic
fibroticcirrhotic
tetrachloride
highfat
highcarbohydrate
stellate
hscperipheral
fibrotichcc
death1ligand1
trialled
bet
bromodomain
ibet762
monocytic
mmdscs
polymorphonuclear
livers
tumorigenicity
tumoursurrounding
mmdsc
cd33
hscs
p38
mapk
abrogated
hscmmdsc
signify
nontumourintrinsic
reinstate
translatable
empower
lipase
2117702
1507702
398
505
094
value005
1060
789
1332
postulated
hopefulness
impediment
portuguese
2014vaccination
portugal
natives
migrationrelated
accesstocare
1277
preceding
795
758828
odd
095099
019096
citizenship
125424
199
106371
familygeneral
101251
indiabackground
02505
upto
2016march
288
categorised
n117
symptomfree
707
693
155
seroepidemiological
vojvodina
serbiabackground
measlesspecific
seroepidemiology
3199
30th
1137
869
seronegativity
2039
561
514
04675
00213
mmr1
mmr2
serbia
publics
vaccinationsemeritus
nigeriaintroduction
sokoto
754
lastborn
therapypancreatic
dangerous
pascs
adipocytes
ecm
celldepleting
polyneuropathysensory
polyneuropathies
fibers
neuronopathies
fiber
thinly
myelinated
unmyelinated
afferents
proprioceptive
ataxia
electrophysiologic
conduction
autonomic
antisense
oligonucleotide
transthyretin
amyloid
erabackground
accomplishments
impassion130
enrich
selflimiting
lac
gray
uvv
unreliable
ageshifts
influenzabackground
20102012
tracks
enrollees
693813655
13746938
join
twenty
5398
79151
nonhispanic
13years
joining
enrollee
conducting
patientsthe
noteworthy
immunoepigenetics
hdacs
immunotherapylongstanding
hdacis
combatting
hdaci
fdaapproval
leveraged
panhdacis
standalone
diseasesthis
23815
pns
raoscott
731
720741
0237
arterial
792
extrapolate
workersthis
3084
mediumcomplexity
pni
overload
selfrated
142210
126171
102134
102126
139175
110144
103141
immunepreventable
forces
2013april
endofseason
seasonthe
dod
afhsbaf
naval
directorate
nhrcoid
afhsb
midseason
administrations
ah3n2
satellites
4255
nhrcoids
moderatehigh
5073
430
agonism
truc
responset
trucs
reprogram
truct
hlaindependent
vaccinovigilance
2018background
vmp
virology
ivi
authorization
holders
surgeons
terrier
breeds
chihuahuas
cats
distemper
parvovirosis
leptospirosis
feline
panleukopenia
296
bosnia
herzegovina
wrong
programmeasles
19971999
bh
5083
federation
sarajevo
canton
570
628
7month
chinaobjectives
researched
statuses
collecting
26663104
18533104
1118
possession
3039
13fold
cis
referent
1218
forgot
234547
131438
refusing
desire
indifferent
prioritized
colostrum
meal
damfailed
ftpi
dams
calfdam
cpms
handfed
hfm
dam
nipplebottle
nursed
farmer
assistance
vocalisations
milking
yesno
mastitis
parturition
640
444
cpm
anyway
minimise
mycobacterial
abscesses
epistaxis
haematuria
thrombocytopaenia
vaccinationepistaxis
winter
indoor
humidity
heating
purpura
firmly
kaposi
tunis
tunisia
2411healthcare
5month
2013to
hbc
stick
object
jaundice
antibodies100muml
entirely
guarantees
h3n8
2015equine
eiv
na
nucleotide
florida
clade
sublineage
drift
everolimusbased
transplantationobjective
evrbased
a1202
evr
cyclosporin
std
basiliximab
labscreen
lambda
canoga
park
calif
909
peritubular
capillaritis
accumulative
154
dsafree
inevitable
nanoparticlesa
promisingclinical
targetedwith
theproinflammatory
ofcompleted
nanoparticlesto
paclitaxelloaded
beadditional
crsrelated
coagulopathythe
therapyrelated
notices
coagulopathy
intravascular
coagulation
dic
nct02965092
leukapheresis
lymphodepleting
tf
molecular1
pecam1
3053
benefiting
anticoagulant
happen
lot
tips
osce
antiαsynuclein
diseasemany
antiαsyn
truncation
monomer
oligomer
transplantationhepatic
sos
hid
hids
mrds
p0952
2150days
24days
20days
p0316
224
p0584
p0113
trm
609
p0178
p0007
p0009
ablative
reboots
assisted
sabr
sabrici
icisabr
429
1736
distantabscopal
achieves
vaccinesintroduction
hpvv
proactive
governmental
internists
obgyns
restart
reinstated
endorsement
diagnostics
hay
tactics
рatients
420
2247
diater
immunoenzymatic
euroimmun
methodimmunocap
thermo
uppsala
pricktest
genuine
ambrosia
etiotropic
ec
conference
proceedings
englishlanguage
msi
personalize
nanosonosensitizeraugmented
micecombined
tumourtherapeutic
nanosonosensitizersaugmented
sdt
checkpointblockade
nanosonosensitizers
hmmer837lip
wherein
hematoporphyrin
monomethyl
ether
hmme
arrests
tumourstherapeutic
responsetumors
mmrd
microsatellites
mmrdeficient
insertiondeletion
indel
rhabdoid
tumorsbackground
mrt
smarcb1
ini1
normaltumor
exome
wes
07107mb
3381mb
pold
pole
membranous
1070
tps
2hpf
correlating
learningbased
vessels
modelfree
rl
closedloop
qlearning
controller
robustness
reaches
inlet
mgkgday
±20
1mm
gihsnbackground
gihsn
ive
rtpcr
signing
institutionalised
complied
negativedesign
ive1aor×100
21967
10140
4616
11827
5384
1840
bvictoria
213
2895
2724
15623727
24years
85years
159576
nonpregnant
hospitalisations
highburden
homeless
exprisoners
capturing
sociostructural
criminalise
stigmatise
consented
captured
fourty
n181
517
043
020092
701
009039
124457
isrctn24707359
19th
18ffdg
fluorine18fluorodeoxyglucose
ffdg
petcomputed
3778
1932
suvmaxwb
mtvwb
tlgwb
sum
3032
prsd
4897
2085
ttest
1786
8589
2138
4438
definitively
ondemand
immunotherapyextracellular
evs
30150
communications
benchtop
ultracentrifugation
microvesicle
nonselective
timeconsuming
exosome
streamlined
photorelease
cytolysis
pdms
chip
cast
3dprinted
mold
decorating
mart1
magea3
onchip
gp100specific
pmel1
nonengineered
ferroptosis
perforingranzyme
fasfas
irondependent
immunotherapyactivated
ferroptosisspecific
peroxidation
downregulates
slc3a2
slc7a11
glutamatecystine
antiporter
impairs
cystine
cysteine
cysteinase
degrades
transcriptomes
cellpromoted
uncouples
immunotherapycombined
ctla4targeted
cotreatment
transplantable
concomitantly
intestine
rag2
il2rg
exacerbated
xenografted
dissociate
bb2121
myelomabackground
50×10
150×10
450×10
800×10
carpositive
doseescalation
proteasome
datacutoff
mrdnegative
nucleated
bluebird
bio
celgene
crb401
nct02658929
searches
fadv8a
strainsfowl
aviadenoviruses
fadv
ibh
intraspecies
interspecies
inter
fadv8b
fadv11
inocula
plaquepurified
71vg
3weekold
spf
tcid
mortem
pcrhrm
homologoustype
vaccinechallenge
fadvinduced
heterologoustype
8b
belong
crossprotect
uncharacteristic
vaccinationwe
obstetrics
gynaecology
careggi
florence
interventiona
hostile
insufficiently
receptive
maternalfoetal
actionable
react
mhcassociated
exonic
multiomic
exceedingly
tumorantigen
chemotherapyfree
dream
realitychemotherapyfree
strongest
culminates
sea
bass
dicentrarchus
labrax
avirulent
marinum
iipakan
mutantmycobacteriosis
teleost
iipa
appearing
heatkilled
granulomatous
formations
pigmentation
perivisceral
adipose
developmentin
overtook
wildcaught
amounting
finfish
licenced
prohibitive
authorised
viruslike
vlps
optimisation
tackling
indicator
audits
centenary
audit
527
914
glatiramer
acetate
ratsobjective
sci
neuroprotective
ga
exerts
myelin
mbp
2mgkg
05mgkg
worsened
augmented
ventral
horn
di
overwhelms
crowned
james
allison
tasuku
honjo
tumorsfda
atu
tumorinfiltratinglymphocytes
kymriah
yescarta
finetuning
marks
iraq
conflictunassigned
sanction
violence
plunged
portray
20002016
plotted
timeline
slowly
precipitated
reemerged
antigitrbased
immunotherapymodulating
glucocorticoidinduced
receptorrelated
eff
1415
1620
antigitr
162122
inhuman
trx518
nct01239134
extents
reinvigoration
nct02628574
immigrant
migrationsmigration
geopolitical
migrating
asylum
importation
refugees
quarantine
1223months
gondar
2018objective
adminstration
aor61
begins
aor24
nearby
aor022
006
givers
nephrotoxicity
immunotherapiesintroduction
sentence
pertained
kidneyrelated
repressed
selfprotective
appropriated
evading
incite
unrestrained
clostridium
difficile
infectionsincreased
dysbiosis
highspectrum
vancomycin
metronidazole
cdi
rcdi
infective
cdifficile
readmissions
usbackground
mace
cvd
monte
carlo
spreadsheetbased
493750
coronary
costmace
costqaly
discharge
incrementally
1864
12680qaly
627320264
2400
19927398
439625
macesyear
578825
reversals
diplomacyover
expansions
un
unicef
hivaids
diplomacy
infectionsbackground
benign
nstis
debridement
staggering
opsoclonusmyoclonus
syndromebackground
oms
612
sick
toronto
taper
n7
670
p59
p66
permits
neurocognitive
longlived
dermanyssus
gallinae
laying
hensdermanyssus
egglaying
nonchemical
cathepsin
d1
dgcatd1
refolded
rdgcatd1
aspartyl
proteinase
digests
ph
haemoglobinase
pepstatin
lysosomal
coccidial
eimeria
tenella
antirdgcatd1
allergenchallenges
patientprogressive
undertreated
diseaseseroconversion
seroconvert
2636
1220
seroconverted
wanes
emerges
tumorinitiating
cellsour
tscs
scc
actbased
tgfβresponding
resisting
theroot
probing
cd80expressing
dampen
tgfβblocking
crux
pace
safetybackground
harms
dec
duplicate
metaanalysed
crd42019117930
n1041
8·7
5·911·2
3·12
1·765·55
15·1
2·72
1·574·72
12·2
2·21
1·273·83
4·5
0·92
1·92
1·003·66
5·7
nonanaphylactic
1·79
1·352·38
2·25
1·134·47
1·36
1·021·81
1·55
0·962·50
supervised
outofclinic
12·42
6·8222·61
36·5
1·21
0·871·69
0·03
lowcertainty
patientimportant
coriolus
versicolor
polysaccharopeptide
chinacoriolus
versicoloris
mushrooms
psp
mycelium
broth
monosaccharides
mannose
galactose
xylose
fucose
1970s
hepatopathy
hyperlipidemia
histamine
meningiomasobjective
meningiomas
n18
n10
cd45
cd11b
monocyte
meningioma
teladorsagia
circumcincta
gran
canariavaccines
alternatives
anthelmintics
nematodes
gin
prototype
canaria
utero
eiu
chb
imported
fire
ant
gay
bisexual
attendances
phasebackground
gbmsm
shc
rollout
61948
095
refusals
deviations
warts
fluseasonal
airborne
spring
run
frail
acetylsalicylic
syndromeacetylsalicylic
asa
antiplatelet
963923
1003
972946
998
p071
escalations
992979
1004
95493
discontinuations
coexisting
nkcellbased
engagers
japanfrom
12614
reconstruct
sexdependent
2049
endorses
2554
lag
culturally
urticariabackground
csu
il24
asstpositive
autohemotherapy
sixtysix
uas7
dermatology
dlqi
asst
igeantiil24
iggantiil24
bhra
twentyeight
turned
asstnegative
anticxcr4
microenvironmentbackground
fruitful
glioma
implanted
gl261luc
microglia
underused
randomdigitdial
14571
acipdefined
organizationdefined
aciprecommended
ethiopiabackground
morbillivirus
lowincome
sekota
zuria
epidemiologically
cleaned
epiinfo7
spss20
measlesrelated
age15years
95ci017
005053
344
95ci344
126938
sias
shall
childrenintroduction
payments
gynecology
obgyn
carolina
timemotion
financially
undergraduates
scenarioobjective
vastus
lateralis
thigh
virtual
posttest
pretest
174
preosce
1010
3046
postosce
18192
1204
componentresolved
adalimumab
perspectivesobjective
workgroup
603
427
202
agreement0234
853
agreement0373
0040
0736
satisfied
rule
vaccinologists
imparts
responsesradiation
alginate
labelled
relief
radioactivity
transforms
hydrogel
fixing
icat
tlr78agonistloaded
immunotherapytumourassociated
m2like
fosters
antitumorigenic
m1like
tlr7
tlr8
morphometricbased
r848loaded
βcyclodextrin
cdnpr848
drugnanoparticle
xray
radiotherapyradiodynamic
nanoscale
metalorganic
immunotherapycheckpoint
energized
attacking
reliance
nmofenabled
intratumorally
nmofs
distal
xrayinduced
hp
emphasized
deepening
cancerdriver
revolve
networkbased
allergybackground
bn
topological
tda
fructooligosaccharide
dietsupported
pna
bioinformatical
scfoslcfos
redundant
hypotheses
immunoncology
890
hlasupported
embryo
embryofetus
trophoblasts
hlaa
dq
nonclassical
kir
lymphocyteimmunoglobulinlike
lilr
immunocommunication
worsens
mcsf
crosslinked
micelles
physicobiochemical
acidityresponsive
biomacromolecule
caco3
crosslinker
mcsfloaded
micelle
npmcsfcaco3
tammediated
unwanted
africaa
nct00866619
8922
517months
6537
612weeks
111randomized
r3r
nonmalaria
c3c
r3c
blantyre
coma
cerebral
genderspecific
posthoc
sae
242284
saes
convulsions
rtssas01vaccinated
wholed
lighttriggered
gelation
photodynamicimmunotherapy
stimulationsphotodynamic
pdt
oxygendeficient
photosensitizermodified
acrylate
pegda
polymeric
polymerization
multiround
gelbased
rechallenged
singledose
stimulations
fusions
responsesantitumor
responder
wholegenome
fusionderived
fusionpositive
checkpointinhibitortreated
therapyanticd19
impeding
cd19bbz86
cd19bbz
proliferated
nct02842138
2×10
4×10
persistently
antilymphoma
biomanufacturing
therapiesthe
galvanized
demands
eventual
commercialscale
bioprocessing
approaching
cancert
haematologic
antigennegative
lay
roadmap
nephropathyobjective
igan
1995
sort
anticd25
210
964
851
welldesigned
anticaries
coldadapted
publichealth
cariesdental
caries
pervasive
salivary
surficial
mutans
inserting
exogenous
docallergic
pros
cons
deciding
suited
advax
dosesparing
immunotherapya
jack
jumper
jja
ants
physicochemical
microbiological
delta
inulin
jjav
uplcuv
sdspage
immunoblot
diffraction
scattering
benzyl
diluent
preservative
physicochemically
microbiologically
25°c
jjavspecific
5fold
allergensparing
jjaallergic
agalactiae
niloticusstreptococcus
economical
lav
acriflavine
dye
lav1
passages
lav2
twicein
morning
evening
lysozymal
lsz
15×10
8158
6579
8205
protease
ancylostoma
ceylanicum
hamsters
hookworm
infectionbackground
hookworms
necator
americanus
duodenale
bloodfeeding
irondeficiency
reinfect
outbred
syrian
intestinallyenriched
putatively
proteases
aceycp1
aceycpl
kunitztype
aceyskpi3
pichia
pastoris
adsorbed
alhydrogel
raceycplalhydrogel
raceyskpi3alhydrogel
vaccinates
raceycp1alhydrogel
raceycp1
antisera
canonical
th2specific
genomictranscriptomic
childrenimportance
mid1970s
shortlived
massachusetts
counterintuitively
ageassortative
123143
8889
reducedantigencontent
nausea
rr126
95ci101
rr208
95ci121
tetanustoxoid
coach
app
antipyretics
feverish
antipyretic
readings
fevers
39°c
25037
3834
4448
55783
pneumococcus
n2069
n911
n669
n403
n252
3427
7705
8915
temperatures
38°c
379°c
307
nonantipyretic
101
vaccineassociated
phobia
unnecessary
allergenderived
asthmasevere
biotherapies
airway
hyperresponsiveness
20152017objectives
victorian
vpdc
ended
stillbirth
153980
59968
390
98583
rising
822
primigravidity
gpled
smoked
embedding
patientpatients
candida
albicansinduced
micecandida
albicans
infectioninduced
intratracheally
60μl
cfu
sacrificed
7d
aggravated
p50
p65
erk12
stat3
metastasescheckpoint
cit
ensued
il2fcigg
miceprevious
immunedominant
fcigg
multipleepitope
polytope
polytopeil2fcigg
polytopeil2
polytopefcigg
bl21
de3
codonoptimized
ll12
hpv16associated
ue7
mil12
345dimethylthiazol2yl25diphenyltetrazolium
bromide
e7murine
seizure
outcomebackground
fss
vaccineproximate
vpfss
nonvaccineproximate
nvpfss
vpfs
nvpfs
fs
1022
136276
084310
010548
minutes
073298
034189
antiepileptic
041802
reassuring
cancersoncology
empiric
contemplated
overturn
manageable
qualification
immunophenotype
transit
simulating
badgersin
bait
badgers
stomach
smallintestine
telemetric
parameterise
tim1
duodenum
compartments
colonyforming
log10
arguments
imply
nonanimal
maximise
pesticide
lymphomaimportance
genotoxicity
hinder
nonuniversity
languedocroussillon
anthracyclinebased
244
pestipop
jobexposure
nonexposed
613
agricultural
occupations
occupationally
1369
20128
1339
15100
chicksthe
βdefensins
avbds
chick
leghorn
mareks
bursal
hatching
dilution
buffer
incubated
ovaries
tlr11
tlr12
downregulated
tnfsf15
avbd1
dimethyl
lys9
acetyl
trimethyl
lys4
lys27
pakistanhighly
globulins
bortezomib
cancertumor
landscapes
uncovered
asiabackground
urbanising
disadvantage
commentary
cambodia
mongolia
myanmar
socio
accountability
resourcing
budgeting
ministries
partnership
socially
marginalised
reliant
delegations
regionally
license
winning
strategyartificial
absolve
bypassing
weapons
formidable
conceived
palmarès
ulva
pertusa
polysaccharide‑iron
micea
watersoluble
green
algae
chelated
sulfated
immunedeficiency
hemolysin
immunising
10114
34114
45196
096206
p008
05181
p048
folated
phdegradable
nanogels
ido1inhibitor
chemoimmunotherapycombining
pvabased
biocompatibility
vinyl
vea
uvcrosslinking
carboxyl
succinic
anhydride
folic
uvcrosslinked
endolysosomal
phtriggered
4t1
coloaded
drugladen
ido1mediated
synergyimmunotherapy
hone
nonirradiated
radiosensitivity
unresected
cytoreduction
anticd16641bb
osteosarcomabackground
osteosarcoma
cd166
cd166specific
cd166bbζ
compassionate
sqnsclc
scidx1background
scidx1
γretroviral
nkcell
vectorrelated
dualcenter
lowexposure
harvest
normalized
marking
eighth
genecorrected
insertionsite
dominance
multilineage
lebanese
charities
lvxscidnd
nct01512888
indigestible
coccidiosishigh
digested
lip
hip
factorial
arrangement
digestible
ross
308
1944
2232
grower
24lip
24hip
26lip
26hip
28lip
28hip
coccivacb52
heavier
posthatch
equivalents
carcass
digestibility
elicitation
crossclade
hivneutralizing
guinea
repetitive
trimer
boostingthe
terminus
fp
hiventry
consistency
rateonly
20made
envtrimer
fpdirected
founder
ch505
bg505
19strain
competition
competed
fpcarrier
trimerboosted
vulnerability
transplantationa
patientsrefractory
cgvhd
mortalitywe
cgvhdassociated
ssg
thickness
ankle
keratinocyte
roots
fascial
defect
omentum
scrotal
transplantationall
grafted
legsallogeneic
hospitalised
canberra
apriloctober
ninetytwo
0958
p0046
p0043
644
13days
48h
intrahospital
19631998
heva
projectvaccination
delphi
5point
likerttype
1strongly
disagree
5strongly
haemophilic
viii
consensusbased
bleeding
lag3ig
us2018271940
a1background
coordinates
facebook
cope
infodemiology
compensation
handle
posted
narcolepsyrelated
unusually
462774
597
774
lurkers
thumb
factual
tone
struggle
acknowledged
nonscientific
views
expounded
elsewhere
outset
dissolved
selfhelp
trench
warfare
mistrusted
omani
manifestationsunassigned
sultan
qaboos
squh
muscat
oman
488
549
732
cow
348
nuts
lentils
peanuts
soy
sensitised
foodinduced
selfinjectable
reintroducing
moral
prosocial
conferencewith
facets
disciplines
jointly
musculoskeletal
bethesda
2223
biospecimens
inaugural
ahead
pharmacodynamic
imprime
pgg
volunteersimprime
β1316
glucan
imprimemediated
antiβ
aba
immunopharmacodynamic
premedicated
lowaba
μgml
midaba
2050
highaba
cytokineschemokines
154fold
mildtomoderate
infusionrelated
premedications
imprimebased
anonymized
cprd
19years
20092016
asadherencewithin
n374881
n71634
n10335
42294
15564
36months
celiac
gluten
predisposed
morbid
hyposplenism
smear
cancerpdl1
owneddog
populationdog
misleading
64348
federative
extrapolation
humandog
52198324
ci5102858353368066
8009
ci79098109
strata
pass
stratum
interpreted
caution
extrapolations
animalrelated
censuses
immunotherapymanagement
lifting
singular
prompts
honored
transplanteligible
mantle
lymphomamantle
mcl
chemosensitive
p67
p35
analysispfs
036
bumel
carmustine
cytarabine
beamconditioning
hr20
1136
hr11
0523
helicobacter
pylori
urease
vivohelicobacter
antih
pylorispecific
19mer
ub33
chhldksikedvqfadsri
antiub33specific
strain1
ss1
ureasenegative
hpp1801
colonize
ub33specific
antiub33
juice
tlr2
tlr2knockout
liner
20042017objective
hongkong
macau
20042007
20082011
postmarketing
muster
519
127100
210100
1743
1606
guangdong
3154
145100
111100
267100
785
2100
522100
6569
retired
houseworkers
unemployees
6746
middleaged
metastasesbackground
brainmetastatic
count1×10
cellsl
proportionalhazards
4386
lymphopenic
hr2995
hr3928
hr1912
hr2257
hr3578
hr6409
plecoglossicida
epinephelus
coioides
cspa1knockdown
vaccinepseudomonas
viscera
cspa1
purge
torqueteno
transplantationsolid
sot
transfusiontransmitted
ttv
nonenveloped
strand
virome
bidirectional
detects
endocrinopathies
guidelinesthe
icpi
icpirelated
viewpoint
endocrinopathy
dysthyroidism
ctcae
edwardsiella
tarda
flounder
paralichthys
olivaceus
vaccinationin
cfuml
uptaken
69h
915h
1524h
2436h
iifa
9h
cd41
iiα
cd8α
iα
deepened
eurocord
ebmtthe
allohct
2963
ud
ebmtaffiliated
n285
n2001
hr07
non
hr06
hr08
n677
factorcombined
neoplasmsallogeneic
gcsfcombined
cytarabinecyclophosphamidetotalbody
hdcacytbi
bmtpbsct
543
643
transplantationgraftvshost
atgs
atgthymoglobulin
plasmodium
modelbackground
tumorderived
sorted
17days
plasmodiumtreated
consequent
ferric
ironbinding
periplasmic
hita
notorious
investigates
lateeffects
12gy
19882010this
ftbi
250y
148y
specified
1625cm
1520cm
936
sclerodermic
osteonecrosis
fertility
epidermoïdis
chelating
hemochromatosis
underachievement
depression
blindness
twothirds
abandonment
diseasesautoimmune
navigate
chemokinetargeting
malignancypattern
prrs
onin
rig1
phytochemical
bergenin
micethe
ethnomedical
instance
antitubercular
att
drugresistant
xdr
tbcausing
microbe
minimizes
antitb
isoniazidinduced
selfpropelled
running
tank
departmentsbackground
knowledges
331
assisting
embedded
directors
therapiescancer
anaplastic
pd1l
ginsenoside
rg3
immunocompetence
miceginsenoside
panax
ginseng
intragastrically
80mgkg
1519
tbet
gata3
ctxinduced
therapycd19
consolidative
postcart
precludes
hcteligible
kmt2arearranged
cryptotanshinone
antiproliferative
carcinomalung
tcms
a549
tcm
salvia
miltiorrhiza
bunge
upregulating
cyclin
cdc2
g2m
cellcycle
il12p70
ctinduced
myd88
jnk
llcbearing
antillc
learnt
financed
paediatrics
20062018
admissions
reevaluation
effectobjective
immunotherapyslit
groupn30
scorecsms
il4il10
neededintroduction
cnct
detecting
nonowners
spray
fur
subjective
pnif
patency
neo
7111
demanding
leukemiapatients
blinatumomab
inotuzumab
ozogamicin
paving
path
cowpock
vindicated
selfinjection
choiceintroduction
9485
osgain
66720
2734
reckoning
immunityinnate
isocitrate
idh
codeletion
1p19q
temozolomide
immunotherapyt
thousandfold
lose
habased
activationtermed
atm
atmstimulatory
stiffness
proteinspotentiate
skew
mechanically
delineates
ecmmimetic
hyperresponsive
hyporesponsive
facto
delicate
1×1km
diphtheriatetanuspertussiscontaining
mcv
depicted
dtp
prioritization
contraception
adopt
risky
contraceptive
visitors
anonymously
607
coitus
interruptus
363
015
263
surveybackground
1989
money
valuation
logit
ringgit
rm303
us73
malays
indians
factorsperceived
actionwere
selfpaid
clinicogenomic
databaseimportance
cgp
ehrderived
28998
4064
megabase
660
3183
3153
nonsquamous
871
ros1
1946
n575
n560
186
152217
97125
44148
1752
17661
35139
0940
35130
ret
1787
26130
1296
n1290
116249
7697
55111
2837
567
cancersfemale
frcs
foremost
nanoengineered
tumourinduced
nanoencapsulated
remove
coadjuvants
imprecise
sheds
lights
nanoparticlesdc
hysteresisaddressing
puzzling
weighing
bifurcation
hysteresis
arise
wellmixed
roadblock
therapypercutaneous
rfa
cryptic
treatmentkey
•
debris
droplets
diphtheriapertussistetanus
881268
geostatistical
highspatial
5×5
km
thirddose
dpt3
72·3
ui
64·680·3
secondlevel
morocco
rwanda
posterior
sahel
somalia
angola
firstdose
dpt1
drove
continent
vulnerabilities
melinda
gates
herds
cocirculation
prrsv2the
coinfection
microenvironmentthese
empowering
render
overlooked
relates
migrate
chemoattractant
motile
interactionsmediated
professionalsthis
formative
outofhome
purposive
responsibilities
carers
intersectoral
modelsantibodies
factorβ
ly364947
mc38
kpc1
ly364947treated
registerobjective
reportable
underreporting
1215
oneyearold
ci959964
941
349
ci309389
rurality
underestimation
duplicates
sjögrens
trialsto
pss
involvements
glandularextraglandular
dryness
glandular
offlabel
connectivetissue
n4
difficulttotreat
southeastern
moderating
marginalized
illiterate
andhra
pradesh
telangana
staterun
round
crosslevel
literate
or484
ci1751336
1572770
029
009096
agentsafter
discouraging
slaughterhousesthis
nv
cranioventral
cvpc
10nv
fattening
farm
slaughterhouse
epindex
p97
p146
h1
h5
typing
tp
mean±sd
38±19
22±13
767
2130
tp12inv
17tp9inv
interfarm
intrafarm
inducers
deathaccumulating
dying
innovating
immunemodulatory
clinicallyused
preclinicallyinvestigated
origins
microtubuledestabilizing
hypericin
metronomic
icdinducing
nonmutated
dormancythe
continuum
practically
dormant
counteract
dormancy
asthmaasthma
shifting
wheeze
anticntn1
paranodal
contactin1
acuteonset
neuropathies
subclass
anticontactin1
adhesive
pathomechanism
intraneural
anticontacin1
rats
deposition
arguing
dispersion
channels
juxtaparanodes
anticontactin1associated
paranodopathy
ranvier
perspectivesthe
inserted
activitynumber
revisiting
pitfallsbackground
mtc
prrt
indtpaoctreotide
scans
1cm
17years
somatostatin
sstr2a
nontreated
3135
luoctreotate
repurposed
rodent
clinicallyrelevant
spontaneously
particulate
submucosa
sisecm
lethargy
resolving
makerere
sciencesbackground
selfreport
760
352528
sponsorship
selfsponsored
vaccinesvaccines
selfadministration
gwagwalada
abuja
someone
koplik
spots
persontoperson
unusual
metaanalysispromising
comprehensively
486
544
425659
94503
noncd19
403694
286468
16106
definitional
disentangle
confused
concrete
trueness
concurrence
relevancy
integrity
individualsthe
literaturebased
ade
monotypic
and2011
acaai
735
parkinson
sjögren
studyto
databasein
12640
50560
nonss
cohortwe
cevimeline
pilocarpine
nonhydroxychloroquine
193fold
193we
hbsab10iul
n149
462
seroprotective
vaccinetiter
3dose
unlocking
nodeslymph
draining
cancerderived
tdln
compromised
invade
unraveling
1213
scotland
198896
138692
1988
1996
cin
163
preinvasive
lymphomacutaneous
mycosis
immunophenotypical
brentuximab
vedotin
mogamulizumab
anticd30
largecell
cd30expressing
anticcr4
anticd52
racial
racialethnic
oaxacablinder
ob
decomposition
05012014
04302015
table
blacks
covariate
whiteblack
portal
equalizing
systemlevel
patientcentered
nanoenabled
anergy
therapywhile
impotent
acidity
anergic
nanoparticlemediated
lipidassisted
micellar
counterpart
pyruvate
immunodeficient
b6
rag1
nog
attenuation
ampkaktmtor
sw480
cck8
kit8
transwell
hoechst
igfβ
signalingrelated
ciksw480
pampk
pakt
foxm1
pmtor
mtor
aedes
aegypti
reproductionaedes
linnaeus
diptera
culicidae
chikungunya
immunoblocking
mosquito
ferritin
transferrin
naat1
acetylcholinesterase
ache
synthetized
mosquitos
infertile
acheimmunized
oviposition
fecundity
eggsfemale
mosquitoes
hatched
larvae
interleukin17
cancerth17
tumorsuppressing
il22
mediator
patenting
impacting
transplantationinfection
microbiotathe
abundantly
vagina
rchopalthough
rchop
celloforigin
designations
unveiled
transendothelial
tem
immunotherapymany
rlns
chemotaxis
indispensable
vitrogenerated
junctional
jams
temassociated
jam
inflammationtargeted
nanomedicine
traf6targeted
nanoimmunotherapy
atherosclerotic
primatesmacrophage
atherosclerosis
destabilization
rupture
plaque
atherothrombotic
cd40cd40
multiparametric
moderates
receptorassociated
traf6
apolipoprotein
edeficient
apoe
positronemission
blymphocyte
myalgic
encephalomyelitischronic
mecfs
nct02229942
norway
mgm2
form36
betweengroup
260
031
norwegian
trusts
kavli
meandyou
cellsmammalian
implants
immunotherapyseveral
staged
p18
n486
transgender
aor403
neighborhoodlevel
poverty
aor168
aor3113
lymphomaradioimmunotherapy
rit
metastasistumor
nutrients
tecs
ecs
gradient
centrifugation
tecrich
invaded
b16
ecrich
ace
b16bl6
immunotherapysubcutaneous
potencies
sandwich
interpolate
110wv
der
1163µgml
jauml
077µgml
2389±0078
2000jauml
842±128jauml
100fold
1selective
heterodimerizing
fcthe
tnfblocking
tnfr1
tnfr2
untouched
antitnfr1
fab
137
ntermini
heterodimerization
fconekappa
fc1κ
interspersed
ch3
γ1
ch1
clκ
stretches
fvfc1κ
atrosimab
quartz
microbalance
tnfinduced
esophagitis
enigma
uptakeobjective
1865
researcher
investigator
818
5747
1411
176
fiftytwo
crallogeneic
graftvsleukemia
strikingly
adverserisk
withheld
leukemianet
discriminates
pitfallsrelapsed
blineage
cd19that
expendable
progenitor
progeny
cd19expressing
amlacute
allosct
riskdirected
diseasebased
antigenmatched
peri
postallosct
approachpatients
autohct
realization
chemotherapybased
negativity
riskadapted
assign
diseaserisk
futurerelapse
treatmentimmune
mismatchrepair
prunes
vessel
reprograms
antitumorprotumor
deployed
inner
consolidated
programsbackground
psychometric
cfir
n546
n51
cfa
discriminant
icc1
icc2
interrater
loadings
cfi090
tli090
rmsea008
srmr008
correlations090
091
005016
034067
myocarditispurpose
highcase
resemble
hemodynamic
activationimmune
cd40l
wistar
extensionpolymerase
soepcr
pet28a
rosetta
nickelnitrilotriacetic
ninta
column
agcd40
t617
flank
15days
hematoxylineosin
inferential
shortness
breath
arteriosclerosisarealistic
dark
bars
maintenancephase
supposedly
wondered
1824
t3
t4
t5
nonallergic
periodical
expansioncontraction
pregnancybackground
medlinepubmed
pmc
abi
midwife
anthropometry
bukinafasobackground
sam
weightforlength
z
wlz
midupper
circumference
muac
weightforage
waz
anthropometric
u6m
discriminatory
bansalogho
burkina
faso
1103
birthweight
lbw
muac90cm
weight25kg
length442cm
incalculable
115cm
38kg
waz3
524cm
laz3
wfa
nbwinfants
thresholds
moleculartargeting
immunotherapysystemic
escc
palliate
5fluorouracil
triplet
irinotecanbased
oxaliplatinbased
paclitaxelbased
antiegfr
gefitinib
panitumumab
nimotuzumab
catalogues
pathwayimmune
colleagues
kyoto
immunooncologycancer
yervoy
opdivo
keytruda
cemiplimab
libtayo
tecentriq
imfinzi
bavencio
studythe
7565
nonpneumonia
aors
079093
067085
enhancementthe
223477
3720
gullainbarré
neuropathology
fetuses
flaviviral
opsonization
lowavidity
wholekilled
denv2
oligoclonal
ifnar
zikvspecific
µgml
4g2
flavivirusenveloped
carredirected
compact
proteoglycan4
nod
wm115
receptor1ligand1
nct02425891
tecentriq®
abraxane
nab®paclitaxel
pdl1positive
ventana
sp142
companion
cd103
collageninduced
hcd8
tgf
rapamycin
rapa
inducedexpanded
transfused
acollageninduced
cia
1rapa
anticollagen
cartilage
cd8086
preference
vietnamunassigned
vietnamese
hanoi
808
108600
vnd
97580
vnd119570
173670
farmersworkers
implied
scalingup
machineries
nutrientsensing
orchestrate
nutrient
repurposing
unleash
reinvigorating
selects
scrutiny
commitmentthe
plos
editors
immunizationvaccines
boosts
syncytial
breadbased
lyophilized
cstrain
pigsa
cerealbased
backyard
dependency
20°c
4°c
plain
sliced
bread
absorbing
7months
8weeks
dpv
thermostability
cool
hydration
rumination
rumen
brd
auctionsourced
bulls
truckload
1889
collar
3axis
accelerometer
logging
water454
drenching
apparatus
h2o
°c
rcase
rcon
hourly
56d
0800
0400
0900
0300
stunting
overweight
1224monthold
ho
minh
noncommunicable
overweightobesity
hcmc
heightforage
zscore
768
168±42
teens
immunotherapyantigen
tolerise
aunps
protolerogenic
c19a3
5nm
60mv
aunppeptide
micronjet600
minimallyinvasive
apposite
physically
extrusion
dermis
langerhans
internalising
immunotherapymyeloid
cancerimmunity
phagocytosing
pharmacokinetically
auc
mmolminute
randomisation
anderson
accrual
nct01413178
22·6
15·247·1
20·2
8·846·6
64·7
32·964·7
43·5
19·9not
0·53
0·300·91
p0·022
andersons
ca016672
useas
eluded
reviewwe
sti
viborg
municipality
denmark
ninthgrade
notice
ninth
376
hpvvaccinated
intercourse
anne
hammer
acceptancebackground
contextualised
hackney
borough
northeast
draws
backgrounds
parenttoddler
videorecording
anthropological
works
conceptualisations
rhetoric
patienthealthcare
democratised
therapyimmunoglobulin
derivates
arisk
pyretic
chills
malaise
uveal
conjunctival
orbit
salt
cellsexcess
nadph
oxidase
isolevuglandin
isolgprotein
selfproteins
expandable
cytomembranes
cellsusing
fms
immunoactivation
selftargeting
character
fmcoated
nanophotosensitizer
immunoresponse
postnanophotosensitizerinduced
photodynamic
fminduced
ultrahigh
immunotherapycaused
irradiationfree
immunotargeted
treatmentsbackground
thalidomide
leukemiainduced
immunotargeting
doubletriple
treatmentbackground
lately
immunostimulative
sorafenib
italyobjectives
resembled
rnf
campania
conserved
nonstructural
3a
animalsfootandmouth
clovenhoofed
differentiating
nsp
3a10
gstfused
5aa
ertlp
alaninescanning
arg127
leu129
alignment
fmdvinfected
prevaccine
vaccinerelevant
gnhies98
1879
6517
agepattern
hpv6
hpv59
hpv1
hpv4
urbanity
h7n9
20132018h7n9
aivs
20132018
ivpi
hpaiv
adequacy
immuneresponse
15item
criteriadefined
rivaroxaban
lmwh
postapheresis
patientsautologous
qualified
separator
mononucleated
catheterassociated
femoral
deteriorated
heparin
catheterization
fraxiparine
n23
04ml
3800iuday
10mgd
20mgd
thromboembolism
vte
10mg
20mg
meantime
afterwards
20mgday
recommendable
proofed
anticoagulants
immunotherapytrial
nct03282643
httpwwwclinicaltrialsgov
synergizes
cancerpoor
tumorpenetrating
spheroids
neuropilin1
vecadherin
bottleneck
rche
chemotherapyimmunotherapies
uncovering
cancerantigenspecific
wholetumor
191418as
heralded
triumph
contentious
objections
arose
unpleasant
sufferers
refusers
bizarre
unsanctioned
cajoling
privileges
autonomy
penalties
clarification
clash
authoritarian
fagales
polleninduced
syndromeoral
oas
allergyrelated
pollencontaining
fruits
vegetables
yibritumomab
fdgpetctobjective
fdgpetct
pet1
pet2
pet3
semiquantitative
pet
cmr
pmr
pmd
suv
max
558±258
187±178
175±225
126months
26720months
p000028
p0029
p000013
n4355
misses
illusion
microfluidics
genomicsimmunization
transgenically
tissuespecific
natively
targetspecific
binders
sequenced
presort
postsort
oligoclonality
divergence
antibodycdr3
cmvspecific
cd62l
microbeadsviral
preserving
alloreactive
cd45racd62l
tcellenriched
pp65
ie1
terminally
reexpressing
emra
celldependent
cellindependent
cd62ldepleted
cd45radepleted
dur
leukemiaimmunotherapeutic
hlaindependently
antigd2
neuroblastomaneuroblastoma
nbl
tumorselective
antidisialoganglioside
antigd2based
neuroblastoma
reverend
rowland
hill
malicious
researcherssocial
bots
spambots
polluters
fake
followers
trolls
statesponsored
multifarious
bot
trolldriven
reviewthe
immunoglobulin‑like
kirs
kirhla
determines
hyper‑proliferation
seekingwhen
ohi
confirms
biased
earlychildhood
message
headers
texts
convincingness
beliefconsistent
beliefinconsistent
beliefconfirming
credible
kingkallimanis
immunotherapynatural
mhcunrestricted
complements
mhcrestricted
indradhanush
interventionsvaccines
relentless
rejuvenate
uip
launching
countrys
pressing
platins
taxanes
rdd
hsrs
irinotecan
prickintradermal
12step
533
ampulla
vater
choledochal
peritonitis
carcinomatosa
twentytwo
rdds
bcgitis
therapypurpose
polyradiculopathy
cytokinereleaseassociated
encephalopathy
delirium
aphasia
tremormyoclonus
seizurelike
adaptor
caradaptors
carmodcart
crosslinking
modcart
caradaptor
carexpressing
synapse
customizable
glycosylationindependent
toripalimab
fg
loop
therapymonoclonal
mabbased
glycosylation
1phase
unconventionally
glycan
nlinked
deposited
accession
6jbt
modelsthis
indolamine
methylator
phenotyping
n17
checkpointmolecules
n2
indoximod
curcumin
pbl
idoinhibitors
immunotherapiestranslation
compounded
cgmp
fractional
approximating
sis
generalization
caputo
representations
interpretations
logicgated
rescues
targetingmany
raising
notch
synnotch
segregated
colocalized
ligandmodified
responsechimeric
constitutively
leukemialymphoma
cd40cd40lmediated
tumorrecognizing
19782018
traces
197898
hopes
eradications
19992008
nudging
200914
antiscientific
judgments
falls
reignition
201518
committment
antivaxxers
heated
bans
sancions
projectadults
cdcrecommended
npowned
billing
3month
coeliac
ahbsab
ul
hbvvaccine
17173
11157
n73133
3473
2234
1234
73133
2294
thirds
flagellinmany
δvp1
2×b1b2
cterminus
ft
flagellintruncated
fme
flagellinmultiple
d3
ftme
vp1multiple
fmdvspecific
10μgdose
isa206
polyi·c
30μgdose
horizonthis
atherosclerosisnovel
regionchallenges
persistbackground
53member
fallen
rvc
43member
interrupted
1february
seventh
25863
44countries
82596
47countries
ukraine
82588
519years
seventytwomeaslesrelated
10countries
areasis
gammalike
formats
therapybispecific
bsabs
amenability
heterodimers
mispairing
enforce
dimerization
igglike
fragmentbased
fcrmediated
bsab
metaanalysisunassigned
barely
optimistic
potentialfollowing
crcs
pd1blocking
mismatchrepairdeficient
instabilityhigh
dmmrmsih
earlystage
mismatchrepairproficient
pmmrmsil
pathogenicitythe
infers
nicaragua
denvnaive
children8
peers
with1
undetectable
heartkidney
heartliver
allograftbackground
allografts
hearts
queried
1987
hlt
hkt
heartonly
ht
61471
497
495
1a
tenyear
survivals
536
604
009
kidneyor
1625
8581
5179
50905267
7591
74137769
103170
disadvantaged
ammonia
vannameithe
pollution
wssvinfected
lv
la
degs
uniquely
annotated
multiplication
methylation
neurotoxic
neuroinvasion
thrombogenesis
circadian
disturbance
stream
hypertrophy
mesangial
immunosuppressioninduced
pathogensintestinal
crucian
manova
pcoa
unweighedweighted
unifrac
p0027
p035
cetobacterium
lactococcus
genus
symbiotic
ent
daas
postliver
clears
dosenormalized
12weeks
logtransformed
043ngmlmg
026060
4weeks
48ngml
±25
postdaa
downselecting
circumsporozoite
proteinbased
sporozoite
modelplasmodium
falciparum
pfcsp
preerythrocytic
malariainfected
downselected
coliproduced
pfcspf
pfcsps
antipfcsp
6070
adenoviruspfcspf
r32lr
antirepeat
antinonrepeat
sporozoites
costutility
homebased
immunodeficiencyobjective
pid
sid
hypogammaglobulinaemia
aetiology
valueformoney
a151
a144
3·07
3·51
88·3
iterations
a50
queensland
diseaseswe
exploitable
immunotherapybesides
virusinfected
hyperfunctional
dubbed
memorylike
tumordependent
iggopsonized
rhipicephalus
microplus
subolesin
tick
infestations
cattlevaccines
environmentally
friendly
acaracides
sub
4d8
akirin2
ectoparasite
p22
subiv
ticks
akr2
chickenscoccidiosis
floor
ail10
coccidiosis
ligandreceptor
anticoccidiosis
chickspendiet
antibodyeimeria
housed
10×
acervulina
maxima
d7
d14
d21
oocyst
2way
overcame
21d
uninfected
p4
anticoccidial
il10r2
il10r1
microbebased
diseasesthe
fungi
ibds
womenthis
qhpv
hpv6111618related
1626
48month
nct01544478
perprotocol
egls
cin2
siterelated
uticaria
welltolerated
diseasefootandmouth
transboundary
fmdvfmdv
opf
serosurveillance
qrtpcr
2b
3ab3
iranobjective
rotateq®
co
inc
184
sectors
131450210
budgets
myelopathyparaneoplastic
myelopathy
insidious
bands
histopathologically
symmetric
tractspecific
betalactam
vaccinationswhen
mighty
cellsbasis
therapyadoptive
lymphodepleted
laborious
undesired
americanewcastle
infects
economics
problematic
colombia
venezuela
renamed
avulavirus
ndvs
continents
cellseffective
fas
outputs
componentsscfv
domainsand
forth
delve
opportunitychimeric
btk
blockadebased
strategiesimmunological
tonsils
ear
acritical
acompact
otorhinolaryngology
fee
fliers
mates
postpeer
1337
1201
1294
923
5374
1069
hep
immunosuppressionuniversal
prudent
updateimmunization
jurin
variolation
acupuncture
shamcontrolled
radiotherapyradiotherapy
renaissances
tit
interests
itme
refereeing
rtinduced
temporally
radiationassociated
raaps
deepen
inhibitorsparaneoplastic
pnss
canaffect
ectopic
cellsthese
icisinto
aconsiderably
niraes
fulfil
vadis
vaccinationthere
sleep
micronutrients
steppedwedge
practicesobjectives
teambased
practicebased
facilitation
partnering
clinicaltrialsgovprs
nct03604393
cancerovercoming
disabling
hastening
intratumoural
titregs
reprogramme
virusassociated
seldom
commonest
ebvsmt
leiomyomas
leiomyosarcomas
melphalanbased
jaclswomen
hypergonadotropic
hypogonadism
postpubertal
menstruation
prepubertal
subclinical
inhibitionimmunecheckpoint
436
rs17388568a
diabeteswas
surpassing
adjustments
012053
osteoarthritisobjectives
ngf
osteoarthritis
oa
analgesics
antingf
cucumber
mosaic
cumv
10weekold
meniscectomy
shamsurgery
linton
incapacitance
oarsi
cumvtt
vax
ctrl
neurite
pc12
analgesia
150ugml
reversibly
2014objective
hav
antihav
n6682
n5095
3076
26243528
7746
74048087
3532
29314133
6669
55597780
814
1529
8572
80299114
6924
62027645
asbmt
receiptwe
parentchild
dyads
previsit
audio
recordings
parentschild
flt3positive
growthchimeric
prebcell
fmslike
flt3specific
composite
cd28cd3ζ
sem
nodscid
il2r
caspase9
icasp9
suicide
dimerizer
ap20187
precluding
carmediated
canadas
summit
vaccinationolder
catastrophic
ageing
introductory
lectures
plenary
breakout
overarching
dignity
irrevocable
multisectoral
collaborations
inkt
cd1d
alphagalactosylceramide
αgalcer
αgalcerpulsed
inktbased
dnt
blockadebackground
bohv4
nucleocapsid
crimeancongo
ifnαβγr
modelscrimeancongo
cchfv
bohv4based
bohv4tkcchfvn
mychis
ad5n
ank2
vectorbased
fibroblastlike
synoviocytes
hublike
arthritisrheumatoid
synovitisbased
synovial
hyperplasia
arthrentasis
defunctionalization
flss
tfh
interleukin23
behave
cooperate
disrupted
intensify
niger
prophylaxisbackground
villagelevel
villagewide
220672
inmunotherapy
cancerprostate
pca
chemotherapeuticagents
cabazitaxel
enzalutamde
sipuleucelt
clinicalefficacy
immunotherapeuticagents
thereof
appreciation
theses
importantphase
directionsoncology
intends
epacadostat
aggressively
testings
activators
chemotypes
immunetherapeutic
inhibitorscancer
eventsimmunerelated
eventshas
pituitary
newonset
ketoacidosis
antidiabetics
mitigates
concanavalin
ainduced
hepatitisregulatory
tregbased
aih
hsc
hscstimulated
conainduced
hsc0
hsc2
72h
plates
cellcell
cfseteffs
teff
th17cells
contactdependent
ishak
th17cell
markresight
freeroaming
dogsthe
goa
confined
667710
counted
mixedeffects
surveyor
weather
afternoon
75319
36327
surveyors
04162
standardise
trichinella
spiralis
larval
excretorysecretory
tnbsinduced
micebackground
helminth
unacceptable
helminths
marrowdendritic
tsmles
intrarectal
246trinitrobenzene
sulfonic
tnbs
treateddcs
dai
hematoxylin
eosin
tsmlesdc
skewed
th1mediated
rigi
underscoring
acidsensing
5triphosphorylated
3prna
bonemarrow
rigienhanced
ligation
translates
rigiinduced
mavs
ifni
rigidriven
sfb
1335
1371
embo
else
krönerfreseniusfoundation
dkms
dres
carl
maximilian
manfred
bayerfoundation
medicinepancreatic
dmmr
worker
practiceobjective
mixedmethods
webbased
tcs
nmdpbe
match
n47
proceed
formality
proceeding
vγ2vδ2
primatestuberculosis
mtb
e4hydroxy3methylbut2enyl
pyrophosphate
hmbpp
phosphoantigen
hmbppproducing
listeria
monocytogenes
lm
δacta
prfa
hmbppspecific
δgcpe
th1like
extrapulmonary
fastacting
blistering
aibds
anecdotal
pemphigus
vulgaris
egfrviiiexpressing
micechimeric
egfrviii
3164
80628z
gl261egfrviii
cellsin
gl261
diseaseallogeneic
underpins
systemmediated
cd20
baff
baffassociated
proximal
syk
hyperactivated
adar1
therapythree
ishizuka
etal
liu
gannon
pinpointing
pictorial
essay
notimmunotherapy
dysregulation
encountering
oftencomplex
distinguished
virusrespiratory
prefusion
selfassembling
prefusionstabilized
dscav1
exterior
twocomponent
monodisperse
fullvalency
trimers
10fold
computationally
pathogenszoonotic
freeranging
expenses
purchasing
constrain
transmissible
parameterize
weakly
expense
parameterized
raccoons
baits
transmits
preempt
heterogeneities
flightline
nonmetropolitan
20142015objectives
coxiella
burnetii
brisbane
hunter
toowoomba
sexstandardised
2740
standardised
goats
2114
abattoir
1236
rurally
1159
1681
donation
aboincompatibility
singlecentre
adultpediatric102
mf93
455years
meldpediatric
peld
preoperatively
isoagglutinin
meld
stiko
amodern
mollusk
hemocyanins
cancermollusk
nontoxic
carriersadjuvants
concholepas
cch
fissurella
latimarginata
flh
aggressiveness
addavax
qs21
moc7
heterotopic
bioluminescent
at84
luc
flhqs21
immunocontraceptive
gonadotropinreleasing
hormonei
compleximmunocontraception
artificially
gnrhi
gonadotropins
immunocontraception
gnrhii
gnrhiii
antignrhi
testis
2week
testes
testosterone
seminiferous
tubule
atrophy
spermatogenesis
hospitalsclinics
healthrelevant
498
321
unwilling
hospitalclinic
aor657
ci1962204
aor944
ci5631583
aor264
ci125555
aor599
ci2401492
équateur
2018as
modeled
branching
projection
1976
thielsen
loglikelihood
1450
1197
closest
selfidentified
20132015introduction
lesbian
nhis
probabilitybased
noninstitutionalized
heterosexual
585
384
gaylesbian
485
cancersimmunotherapy
benefitting
cancermetastasis
cancerdeath
nanotube
swnt
immunoadjuvant
glycated
mammary
swntgc
1064nm
swntgclaser
pttswntgcantictla
countriesalthough
pressures
mic
representativeness
20062016
waivc
percapita
spending
uniformly
nogo66
immunoglobulinlike
ratsnogo66
ngr
pirb
myelinassociated
mais
maisinduced
homogenates
maismediated
coregulating
doubletargeted
factorngrpirb
gmcsfngrpirb
subtilis
eimeriachallenged
broilersin
corn
soybeanmeal
bacitracin
salinomycin
gavaged
20×
oocysts
16s
rrna
shannon
firmicutes
bacteroidetes
rikenella
microfusus
subtilisprobiotics
lupusthe
spans
nzb
nzw
mrl
cd44
celltreated
testimony
herding
waste
syndromic
20172018background
af
read
englands
phe
4234
216
p00031
nnv
8153
untrained
equate
throughput
rrr
compares
regimental
officers
rmos
lumpy
testsbackground
lsdv
seventynine
calving
newborne
lsdspecific
vnt
ifat
capripox
multispecieselisa
capripoxvirusspecific
47weeks
3506
3377
cd30directed
clinicchimeric
cd30
efficacybackground
cops
substitutes
conventionallyused
cop
easytoimplement
uniquelytailored
prentice
metaanalytic
infinite
penalizedlikelihood
penalised
adaptations
depots
depotmediated
proteinpeptide
peste
des
petits
chhattisgarh
indiathe
mvc
ppr
axes
differencing
pprmvc
inconsonance
implies
goat
1466
12411427
4304
13511567
outweighs
manifolds
rearing
c3hheouj
c3h
pe
pespecific
mmcp1
tenfold
oittreated
timepoints
mlnderived
controltreated
preb
realizing
preclude
nsclcour
dyspnoea
dilatation
opacities
groundglass
bronchoscopy
1pdligand
thirtysix
inferiority
summarizing
intervalsa
randomeffects
advocated
spreadsheet
file
nonparametrically
unbiased
ecthyma
orf
parapoxvirus
ovis
uruguayorf
orfv
clinicopathologic
virologic
uruguay
solidorgan
glutaminyl
cyclase
modifier
cognate
eat
haploid
glutaminylpeptide
cyclotransferaselike
qpctl
cd47sirpα
pyroglutamate
biosynthesis
neutrophilmediated
siglec15
immunotherapyoverexpression
b7h1
b7h1pd1
genomescale
mutually
amplifies
murcia
serviceobjective
zones
zbs
murcian
sms
checking
advisable
iiassociated
adenoviral
vaccinationadenoviral
tethered
furin
iifur
recombined
encode
cysteinerich
interdomain
cidr
α1
it4var19
pfclinvar30
var
dimeric
polymorphic
sequestration
monkey
functioned
hybridomas
breadth
cidrs
endosomal
sorting
adjuvanttethered
establishes
validationbased
submission
revisited
excellence
ta319
unused
piecewise
longerterm
cut
splinebased
mixturecure
spline
noncurativemixture
diverge
unvalidated
extrapolated
capsule
iggam
pepper
controlsc
septic
dampening
classifying
procalcitonin
drelated
nfκb1
adrenomedullin
treatmentsoc
90days
multipleorgan
mof
eq
qlq
5d
qualityoflife
201600178834
nct03334006
sponsor
rwth
aachen
dr
isfort
657461
5025754
1297
mmrvaccinated
mmrunvaccinated
charts
nordisk
immunochemotherapytaking
physiochemical
codelivered
dox
nvdox
solvent
nvs
ly6g
mastocytosis
flying
clearing
dutch
femalesbackground
vl
typespecific
hpv61131
333539455152565859
hpv31
borderline
multimodel
msm
penileanal
amsterdam
20102013
461
contrasted
basecase
modelaveraged
119375
218624
amounted
748
598930
illustrating
infectionderived
unverified
sparsity
omission
penile
sexneutral
preadolescence
lane
cancergenetically
jci
yamamoto
fasmediated
perspectivesengineering
spurred
explosion
daratumumab
transplantineligible
myelomaintravenous
darzalex
cd38
ndmm
ineligible
phase3
alcyone
anaemia
perspectiveshepatocellular
changebackground
armm
1331
699
1053
4877
surgeryradiation
1175
surgeryimmunotherapy
868
surgerychemotherapy
1693
2127
4247
4921
stressinduced
micestudies
eccentric
ecc
vwr
secc
svwr
ssedentary
sed
restraint
h·d
d·wk
wk
exercised
m·min
treadmill
stressvwr
antiova
delayedtype
ssed
cellshematopoietic
hspc
immense
thalassemia
purifying
hspcs
pbscs
readouts
morphologically
semisolid
carcinomawe
ck
rcca
fourthline
facial
spurious
statesa
motivational
interviewing
misi
mi
promotionobjective
mirelated
selfconfidence
pretestposttest
cronbachs
kr
testretest
cohens
paperpencil
immunizationspecific
francebackground
averaging
1539
homeopathy
deterrents
nagelkerkes
rsquared
dermatological
clientowned
idt
fourmonth
p000001
incompatibility
literaturebackground
crossing
30yearold
6951
7534
pretransplantation
isohemaglutunin
2200
770
maintains
desensitizing
besignificant
maraviroc
nonrandomised
contemporaneous
ctn
1203background
1875
0·05
nct02208037
aug
0·72
0·540·94
p0·044
0·98
0·761·27
p0·92
1·10
0·861·41
p0·49
pathogenesisbone
fertile
soil
immuneprivileged
sensitizing
menb
healthintroduction
imd
menbfhbp
trumenba®
ltd
lipidated
fhbp
subfamilies
nonlipidated
healthcarein
practicerelevant
qm
din
en
iso
9000ff
systemsthis
aselective
reviewsfour
stock
strive
uncommonto
alongterm
ethicsasketch
criteriavaccination
grounded
contexts
justification
norms
valuesthis
anormative
ajustice
postvaccinal
casesin
oneself
atrend
noticeable
outcomeswhereas
refuted
acausal
pharmacoepidemiological
studiesonly
corroborating
refuting
apotential
intussusception
paul
ehrlich
riskminimizing
atargeted
transplantationpostorthotopic
olt
wellcontrolled
hbig
postolt
cirrhosistype
lcb
n28
failuretype
alfb
nonhbvrelated
nonb
esld
n13
828
marital
donated
adulthood
relookadolescent
adolescentspecific
revisit
inhibitorinduced
polyarthritisnivolumab
36yearold
nivolumabinduced
polyarthritis
tune
shut
costimulator
vdomain
cyclindependent
cdk12
cd134
concerned
constitutional
nondiscriminatory
genderbased
exclusions
mauá
gleaned
underutilized
macrolevel
underuse
broaderlevel
nisteen
publically
level1
level2
deviance
aic
20495
50us
teen
raceethnicity
religiosity
enacted
abstinence
situational
ideology
underutilization
modelspatients
underestimate
axicel
weibull
211
yrs
gamme
virusin
endorsed
underdeveloped
passiveactive
hbsagpositive
increaseddose
certaintyuncertainty
bugs
managementoutnumbering
microbiomes
bacteriatargeting
elucidating
surpass
melanomatoday
lifesaving
picture
forcesobjective
stricter
patientsimmunotherapy
protein4
oncodermatology
saintlouis
fortythree
5155
4562
5257
4762
4763
20a
false
conspiracy
distrusting
questioning
notyetvaccinated
psycinfo
apa
reserved
representation
supportimmunizations
email
comet
automatic
lifecycle
analytics
dependencies
ciss
curators
races
timeappropriate
japanobjective
communitymethods
23583
analysisresults
883
036055
019028
childbirth
013024
fulltime
047058
066
057077
variableconclusion
forwardsuccesses
propelled
reporta
54yearold
cholangitis
pbc
cya
mgday
gastritis
hyperplastic
antihelicobacter
uml
amoxicillin
clarithromycin
lansoprazole
urea
rotavirusrotavirus
inflames
lining
intestines
papulonecrotic
tuberculid
reviewintroduction
cee
albania
bosniaherzegovina
bulgaria
cyprus
czech
estonia
latvia
lithuania
romania
slovakia
embase®
medline®
countryspecificglobal
onedose
intrapleural
malignancyobjective
effusions
genemediated
cytokinemediated
manuscripts
melanomacheckpoint
programmeddeath1
reportedly
63yearold
caucasian
pityriasis
lichenoideslike
hypotension
vasopressor
radially
zno
nanowires
polyllactide
microfibers
complexed
immunotherapyzinc
znobased
multifunctionality
nws
polyllactic
plla
3dimensional
inorganicorganic
nanocomposite
bridges
inorganic
oxideinert
αfetoproteindirected
closure
30956
tanzaniabackground
resourcelimited
neovita
dar
salaam
n11189
morogoro
n19767
logbinomial
dtp1
173
inrural
pvalues
2252
schooleducation
136178
contextspecific
hrhpv
selfcollection
nearpointofcare
genexpert
testingobjective
zimbabwean
selfcollected
cervicovaginal
cepheid
112643
41123
71520
hiv1positive
p23e07
xpert
772
kappa0698
seegene
anyplex
hpv35
hpv52
hpv58
hpv68
hpv51
1420
2876
ascus
ninevalent
nonpharmacologic
painmitigating
lowresourced
egyptian
flacc
papillomavirusassociated
pil10r
oncoprotein
pgde7h
polyfunctional
il10r
hpvinduced
paradox
immunopathology
appointments
dataobjective
firstopinion
bcs
9point
106144
48041
24247
6324
551
513
desexed
or142
ci129157
23794
5222
622
or114
ci098131
p0075
avaxim
80u
pediatricintroduction
fecaloral
ingestion
contaminated
clean
avaxim®
pasteur
postmarket
eica
groupherpes
feared
publicity
immunotherapieshepatocellular
fluorinated
substance
lenvatinib
ramucirumab
cabozantinib
thirdline
stagnation
antecedents
interventionsvaccinations
safest
decide
nonvaccinationthe
5c
complacency
antecedentsdata
kvimpfsurveillancethe
1970
decennial
tetanust
diphtheriad
atdap
vaccinewe
20072016within
kvimpfsurveillance
personsthe
onwardssince
activatability
tfh17
thymodependent
immunosuppressionthe
672
tfh1
activationinduced
cd25expressing
depletionallogeneic
αβ
posthsct
microenvironmentchimeric
armored
fourthgeneration
hyperglycemia
accountdiabetes
endeavoring
glycemic
overproduction
glycation
signalization
immuneinterventional
tight
autoimmunityregulatory
delayprevent
enrolling
ontogenesis
lahoreobjective
lahore
47635
27365
656315
5067
posttrauma
33446
earnose
24324
1435±1165
16216
monocytedependent
mediatorschimeric
antiil6ra
cytokineprofiling
crspromoting
talenmediated
abolishes
macrophagedependent
mcp1
allinone
gmcsfknockout
anticrs
enclosing
rhinitisbackground
αgcliposome
αgcliposomes
cln
clns
erosion
transdermal
immunizationalthough
singlesite
patched
pulses
repetition
khz
mpa
0995
µm
9444
30s
follicles
controllability
μl
taeniasiscysticercosis
2background
cysticercosis
taeniasis
divides
neurocysticercosis
hyperendemic
koreabackground
as04hpv1618v
hpv6111618
4vhpvv
previouslypublished
krw
treshold
304
lys
costsavings
980
12436
753
508
0045
n14
endpointsit
deposits
accomplish
ylabeled
antipodoplanin
nz12
mesotheliomapodoplanin
sialomucinlike
rathuman
podoplanin
radiolabeled
ncih226
h226
inlabeled
dosimetry
studymelanoma
mup
brafmek
20032016
20032010
eras
postnovel
2028
65110
1919
502
p0948
prenovel
11months
acog
obstetriciangynecologistsimmunization
obstetriciangynecologist
obstetriciangynecologists
offices
dramatical
meant
associating
butyrate
shortchain
scfa
oitfos
bat
cd4cd25regulatory
bmmc
cecum
allergeninduced
oitbutyrate
tregmediated
oitinduced
brafmutated
studyaim
1l
physiciansidentified
440mm
tt283
io157
iotreated
recistdetermined
601
reviewtcell
lineages
fastmoving
downloaded
nyeso1
underrepresented
pharmabiotech
cellredirecting
advancesobjective
threatens
trbas
nonigglike
trba
penetrating
cancerinterleukin24
crgdkrgpdc
cellinternalizing
il24irgd
il24irgdtreated
pbstreated
tdtmediated
dutp
nick
radiomic
reportobjectives
blockades
imagebased
timetoprogression
ttp
radiomics
oversampling
smote
subsample
patientlevel
clinicalradiomic
parsimonious
receiveroperator
0804
0865
ttp2
7341
8228
subsampling
cancerobjectives
eap
iiibiv
3mgkg
neurologically
10mgday
1588
01219
64108
337
tumorswhile
allergypurpose
harbors
foodspecific
seeks
allergenicity
eggmilk
prospectsstrategies
icisbased
ire
stromainduced
tumorrestraining
collagen
calpain
pyroptotic
vimentin
filament
immunostimulationpyroptosis
gasdermin
dmediated
permeabilization
osmotic
mechanical
resilience
shear
compression
cytoskeleton
pyroptosis
calpaindependent
filaments
stimuliasc
specks
nuclei
ruptured
nonruptured
undiscovered
diseasesdecades
fructifying
optimised
translatability
uridine
mrnabased
livermediated
methylmalonic
acidaemia
porphyria
ornithine
transcarbamylase
fratricideresistant
cd1aspecific
leukemiarelapsedrefractory
tall
carts
fratricide
cd1a
cotall
thymocytes
confining
ontargetofftumor
cd1acarts
controversy
peanutallergic
calvesmycobacterium
traits
bcgs
tlrinduced
pepites
trialimportance
n356
n118
signssymptoms
teaes
899
353
peanutpatch
124298
allcauses
nct02636699
digitized
zuma1
ktec19
trialbased
onetime
undiscounted
ly
896600
payers
1615000
919
82400
230900
100400
289000
hypersensitivitypurpose
βlactam
desensitizations
weightbased
patientbackground
gastroenterologists
gastroenterologist
perverse
paves
deregulation
ascitesperitoneal
malignancyassociated
defenses
icpiaiha
55days
22110days
antiglobulin
dat
118gdl
102129gdl
63gdl
6180gdl
recoveries
electroporationmediated
prme
micedengue
denvs
mosquitoborne
antidengue
pvd4me
denv4
50μg
5μg
vaccinationantibodyantigen
ics
targetingretention
revelations
spearheaded
icbased
paths
desentizating
multicomponents
alimentary
pathogenetic
immunune
ldm
plex
guna
milan
immunomodulant
spa
milano
allergical
immunoallergological
letting
fenotype
symptomatological
ecp
pomphus
specifics
definite
faers
diagnosisrelapse
52years
3636
1818
unreported
29days
kiggs
wave2
studysince
3‑
17yearolds
19852013
cohortsof
15023
317years
hepatitisb
17year
olds
7‑
10yearoldssociodemographic
1stdose
886
2nddose
cohortsthe
initiativeswhat
germanyin
actionin
areference
fulfilment
avaccination
closing
aplatform
20152020
activitiesthe
strikes
purine
nucleoside
piclidenoson
namodenoson
ribonucleotide
reductase
rr2
herpesreactivation
hsv2
latency
recombinantly
tegument
herpetic
gd
vp22
ul49
ul40
intravaginally
crossreact
gb
crtam
healed
vm
costly
dl
replicationdefective
sores
rr2based
longbeen
defeating
polypurine
hoogsteen
hairpins
secretome
unveil
cellsmesenchymal
secretomes
hoffas
fat
pad
hfpscs
smscs
ucscs
chromatographymass
proteomics
arrays
constitutive
metalloproteinases
mmps
ucsc
aggrecan
twodimensional
chondrocyte
articular
bendamustine
hlh
tanshinone
iia
sepsisinduced
tsn
puncture
clp
45mgkg
12h
timepoint
euthanized
timedependent
clpinduced
tsntreated
abolished
morebalanced
phagocytotic
clptriggered
hmbg1
cd3cd4cd3cd8
ameliorate
polymicrobial
utilising
4817
nhs
january31st
deciles
speaking
translator
ascertains
immunotherapywe
dlb
antithyroid
antinmethyldaspartic
ancillary
iodine123metaiodobenzylguanidine
myocardial
scintigraphy
99m
technetiumethylcysteinatedimer
photon
suspecting
cellsfactors
269
prelymphodepletion
interleukin7
highintensity
ethiopian
acceleration
censoring
priori
modifies
urbanicity
dwellers
halve
fortis
leukemiadelivering
rdi
fludarabinecyclophosphamiderituximab
fcr
ama
rdi80
binet
pegfilgrastim
shortening
26months
3years
p00089
414
nonama
p009
or022
ic95
005084
doseintensity
pfsos
concessions
europepneumococcal
contacting
agebased
riskbased
retrieve
unification
arctic
charrwith
salmonid
spp
asal
charr
salvelinus
alpinus
forte
micro®
renogen®
elanco
artic
ipinjected
cfusml
preinfectionpostvaccination
7282
dualvaccine
complementcoagulation
phaseproteins
hemostasis
prechallenged
immunestimulation
actin
fcγrmediated
fortemicro®
fortemicro®renogen®
preactivation
coincident
actinassociated
octanorm
cutaquig®
immunodeficienciesintroduction
pids
manufactured
octagam®
singlearm
nct01888484
clinicaltrialsgovct2shownct01888484
washinwashout
3497
0175
gkginfusion
personyear
nonbacterial
systemadoptive
clinimacs
prodigy®
enrichment
clinicalgrade
αcd3αcd28
finalizing
bedside
grex
flasks
cd127
clinimacs®
readytoinfuse
vitality
anticipate
needlefree
challengethe
thick
epithelium
injector
buccal
slb
gp120
gp70v1v2
clades
shivsf162p3
envspecific
v2
mvagp120
consultationsvaccination
caseload
gather
auscultated
n603621
971
n587610
microchipping
n323597
541
n203597
glioblastomapd1pdl1
checkmate
bavacizumab
tmz
recommendationsbackground
rzv
zvl
statetransition
icers
47000
receptorneutralizing
productions
luminol
isoluminolenhanced
das28
extracellularly
inflammationlimiting
neutrophilderived
oxidants
pretargeted
dielsalder
reactionwhile
troubling
prit
predicated
decoupling
harnesses
skirting
nontarget
radionuclides
halflives
pretargeting
electrondemand
iedda
transcyclooctene
tco
tetrazine
tz
singlephoton
spect
antibodyantigen
ieddabased
ludotalabeled
radioligand
luludotapeg7tz
tcomodified
hua33
hua33tco
radiolabeling
gallisepticum
ts11
685in
drop
airsacculitis
tracheitis
harbouring
manufacturers
avoidancecon
immunotherapypurpose
iraesassociated
patientmonths
intraocular
orbital
extraophthalmologic
antipdl1associated
sightthreatening
complaining
ophthalmologist
analysisaccurate
veterinarian
fieldsetting
infrared
tir
brix
refractometer
n691
bloodsampled
366
cutoffs
880990
790
700850
920
770990
740
610820
700960
950
8701000
910980
780940
sensitivities
registerbased
productivity
finisher
2014reduction
amu
4year
useno
n179433
purchases
myc
actinobacillus
pleuropneumoniae
lawsonia
intracellularis
n4062
lean
prescriptions
doses100
finishersday
parenteral
amuratio
finishers
slaughter
preferring
nonspf
infancyobjective
mutants
21years
antihbsnegative
3379±109
1574±166
0012
hbsagspecific
125±170
253±232
ifnγsecreting
45±10
50±4
420±328
355±424
spotforming
cells10
1633
r24k
sg145r
reviewnatural
hivtargeting
uveitispurpose
uveitis
aqueous
fuchs
fus
goldmannwitmer
gwc
ophthalmology
erasmus
rotterdam
utrecht
127
eyes
complained
blurred
anterior
keratic
precipitates
vitritis
synechiae
glaucoma
cystoid
macular
edema
cme
rvassociated
exchangeable
nintedanib
npu
programobjective
nintedanibdocetaxel
67years
23months
diseasecontrol
dcr
32months
1945
reinforcing
cv9201
cancercv9201
rnactive
cancerantigens
c1c2
n39
4001600µg
1600µg
flulike
increasedtwofold
929
50months
1863
108months
81167
mix
responseresearchers
41bbl
cellscostimulation
cd137
teffector
oligomeric
sa41bbl
bona
fide
ifnγexpressing
immunopreventive
immunomodulator
immunoprevention
offshore
goodscell
cogs
folatetargeted
frα
membraneattached
shielded
endowed
antifrα
folate
haptens
frαbased
neuromyelitis
optica
38yearold
quadriparesis
hyperreflexia
spine
hyperintense
gadolinium
cervicomedullary
junction
t10
60l
782mgdl
antiaquaporin4
tapering
immunotherapyour
germ
fusobacterium
nucleatum
affordable
fascinating
microbiomecancer
oncogenesis
microbeinduced
augments
toxicitiesbackground
tgr
princess
margaret
onimmunotherapy
csaes
nonhpd
0933
p11
oncoimmunology
biotechnologies
guaranty
secure
organised
implementationin
disturb
transparency
rationalize
discussionin
sop
characterizes
policytyphoid
tcvs
phased
whoprequalified
tcv
howwill
cancernear
photoimmunotherapynirpitis
molecularlytargeted
silicaphthalocyanine
irdye700dxir700
antibodymabtargeting
targetingegfr
usingthe
cetuximabir700
fasttrack
highlyselective
necroticimmunogenic
deathicdonly
targetpositive
mabir700bound
targetnegative
unharmed
cellsdcsto
maturated
immunocheckpoints
enhancingcytotoxicity
tumorinfiltratingt
tumorinfiltratingneg
ativeregulatory
cd25targeted
enhancinghost
cancerrecent
inhibitorsicihas
checkmate141
platinumrefractory
metastaticscchn
practicechanging
tailormade
segmented
causespecific
presars
postsars
rrs
cardiorespiratory
rr090
rr074
rr045
rr141
repairdeficiency
cmmrd
c2tapm1k
c2521deltpw841fs
pms2
hypermutated
predisposition
azv
1633209a
declares
icmje
proteomes
virusvaccinated
lymphomabearing
chickensmareks
mdv
lymphomagenesis
superinfection
cvi988
rispensvaccinated
vex
tex
deepsequencing
mirna
oncomirs
mirs
106a363
repeats
flanking
tr
mdvmediated
hvt
infectionsmareks
herpesviruses
encodes
turkeys
mirnamediated
mdvinfected
specificpathogenfree
timequantitative
coinfected
onehybrid
countriesbackground
togo
gambia
cote
1259
biases
nonrandom
sia
insignificant
siainduced
homelessnesshepatitis
noninjection
clotting
havinfected
adoptee
homelessness
infectionassociated
vaccineslike
preatherosclerosis
microenvironmentactivatable
blockadechemoimmunotherapy
vesicle
vesicleinduced
î
cd47mediated
toxicitypurpose
nonpatternspecific
comatose
eruptions
microenvironmentcontrolled
cellsderived
cap256
superinfecting
virusa
su
glycine
linker
i559p
trimerspecific
pgt145
pg16
vrc2608
hightiter
v1v2
nativelike
gag
aidsrelated
primes
hnc
tumorhost
overshadowed
highlevel
vaccinatedskepticism
objectively
distorted
overestimation
sciencebased
confidants
anoverviewthe
jeopardized
vaccinetriggered
stikothe
repression
extinction
customary
pep
complies
visàvis
myelomatreatment
dara
anticd38
metapneumovirus
hmpv
immunesurveillance
disabled
immunovirotherapy
retargeted
modeloncolytic
r115
erbb2
mutatedattenuated
hungarybackground
nationalities
enclosed
2655
n1217
n960
nationality
n478
hungarians
germans
374
n1931
absolutely
862
698
661
lowthreshold
b7h3carts
b7h3car
adolescentshuman
9valent
tetanusdiptheriaacellular
2019482e71e77
melanomaseveral
evades
conquering
antipd1s
interleukin2adoptive
125000iukgday
v11
unconfirmed
interrogation
vβ
nct01883323
apatient
iiib
acase
mhsp70
atumorspecific
tkd
interleukinil2
mhsp70targeting
deathpd1
anonsmall
648gy
ct4
cn3
cm0
4cycles
tkdil2activated
asecondline
amassive
cd94
bright
dim
acombined
thecontrol
rabiesfor
tens
operationally
vaccinationcurrent
virusneutralising
edge
steep
complicate
outperforms
confident
indian
acvip
201819
revisereview
finalized
unanimously
timetable
dtwp
rv1
mmrmr
fourdose
chinameningococcal
vaccinesmeningococcal
trialscholangiocarcinoma
cca
highlyaggressive
ccas
horizons
pioneering
disordersobjective
duke
enterprise
explorer
deduce
stenosisdisorders
ed
2718
3892718
302718
172718
1392718
2692718
11139
5269
inhibin
αsubunit
genesexpressions
hypothalamus
inyangzhou
goose
gandersthe
leydig
sertoli
yangzhou
ganders
bsa
gnrh
star
cyp11a1
amh
hypothalamic
gnih
reciprocal
lhβ
responseintradermal
id
limped
hemocyanine
adjuvantsaluminium
adjuvantson
incl
th1associated
cxcl10
aluminium
th2associated
freund´s
provoked
cxcl8
hydroxidebased
emulsigen
alpacas
lama
pacos
antibodiesin
alpaca
camelids
llamas
chainonly
conformations
invaluable
panning
pulldown
gelshift
reagent
regents
quantities
tags
immunotherapymalignant
infiltrative
dermatomyositisinsights
diseasesregulatory
jia
dermatomyositis
jdm
joints
oligopolyarticular
tregrelated
jiajdm
mini
tolerogenicity
defending
selfcomponents
immunitytolerance
patientsdespite
idelalisibinduced
cd19carcd28cd137zeta
idelalisibbased
cd45raccr7
approximated
idelalisibtreated
raccoonsraccoon
strategically
attractiveness
palativity
raccoon
investigatingremoving
fishmeal
sachet
aerial
baitskm
coyotes
whitetailed
deer
feral
stations
exceeding
visitation
averaged
proportionally
coyote
lowdensity
63100
calabria
strategiesrecently
pno
70yearold
reggio
abovementioned
cohortssuch
landscapesovarian
5075
nanotechnologybased
nanoformulations
lipidpolymer
unravel
immunotherapiescheckpoints
noncolorectal
endometrioid
20to
energy
leei
chickensin
sporulated
kgy
ria
mdbk
excysted
paracox®8
20×10
10×10
g5
75×10
nonattenuated
unchallenged
necropsy
d28
ls
oi
pc
nonchallenged
g5had
125152
feces
infectivityreproduction
897
precocious
kgyirradiated
infantsintroduction
afebrile
coryza
cyanosis
emesis
aggregates
leukocytosis
lymphocytosis
aprilblys
modelalloantibody
abmr
blys
alloantibody
taciig
activator
cyclophilin
lig
interactorimmunoglobulin
brown
romized
g6
g7
nonswitched
c4d
banff
anticd8
alters
cellsit
infer
mabmediated
cd8β
regimenprimary
presalvage
nontbi
mel
1821
315909
postsalvage
contraindication
hscta
extraterminal
acetylation
beti
tnfrsf25
tl1aig
ep11313
frequencynumbers
jq1
tnfa
pstat5
mhcmismatched
ln
diminution
posit
hemagglutininloaded
ceramic
nanoporous
responsesmicroneedle
mnas
dissolving
npmnas
pore
80nm
ph1n1
fluorescently
labeled
ears
diffusionbased
immunotherapysolid
organlike
tafs
distribute
2019at
2019in
httpswwwcdcgovvaccinesschedules
deliveryunder
erroneously
skinassociated
disruptions
newest
seriesimmune
exemplified
interrogated
updosing
birch
allergoid
asthmaaim
inconvenient
577
873
940
tcellinflamed
antibodiesattention
stereospecific
conformational
visualizing
microbiomeimmune
mycdependent
immunotherapyelevated
sensitizes
mycdriven
ampk
bcl2bclx
cotargeting
mychigh
metformin
navitoclax
regrowth
pd1cd8
twostep
metforminvenetoclax
metforminvenetoclaxantipd1
therapyautologous
diseasenegative
highresolution
309
igh
50000μl
québec
promovaq
ambivalence
québecs
townships
promovac
provincial
flyer
hesitation
mibased
decisionmakers
nct02666872
spatialtemporal
vetor
compatible
bad
ugly
psychopharmacology
neuroimmune
diseasedeveloping
abused
agonistsbackground
pharmacotherapies
immunetherapies
nicotine
cocaine
methamphetamine
opioids
fentanyl
receptor5
tlr5
entolimod
entolimods
antiaddiction
abuse
initiates
preventiona
divinópolis
6650
2334
2839
licit
illicit
preteens
factoranalysis
vaccinehesitancy
vaccineacceptance
spearmans
rho
474
cytokineactivated
cellscytokineactivated
lowefficacy
tcrcat
157165
hlaa0201specific
hattransduced
micromolar
constants
tcrcats
tcrts
cytoimmunotherapy
queries
papillomavirusrelated
laypersons
menboys
1182
1602
2784
aor386
aor078
aor193
greecepurpose
20052010
20052016
6401
filled
womans
therapylung
viruspackaging
retrovirus
virusproducing
egfrviiicar
egfrviiicart
a549egfrviii
effectortarget
relationshipin
pathologicfindings
9months
28month
subsided
cancergastric
cures
populate
executing
blockaderesistant
adjuvantfree
nonreplicating
recapitulates
restimulating
messaging
fivecountry
specialization
television
565871
oneonone
308559
obstetriciansgynecologists
cite
1502
frame
radioiodinerefractory
cancersystemic
resensitization
radioiodine
thirdgeneration
anticd24car
cancernovel
anticd24
csc
selfrenewal
swa11
cd24
cd24positive
skov3
ovcar3
cd24expressing
cd24negative
a2780
hek293t
dualcar
anticd24cd2841bb
antimesothelincd3ζcar
leukemiaadvances
tetraglycineloctaarginine
cellpenetrating
nondegradable
nvinylacetamide
coacrylic
pnva
coaa
doctaarginine
4time
doctaargininelinked
perfectly
glucuronic
monosaccharide
tetraglycinedoctaarginine
2time
28day
tetraglycineloctaargininelinked
micebirch
25μgμl
2426
03mg
bpe
methacholine
igebinding
antibpe
peribranchial
70kda
hsp
timeseries
radiographyconfirmed
12587
4273
2379
yozgat
turkeybackground
turkey
quantitatively
1862
n1473
genders
619
2096
522
multicentered
trialobjective
51days
5757
6363
gmcs
unitsml
6731076
967
7671220
061217
ci05
solicited
3226
2062
3016
heendemic
nct03168412
hbvdna
genomes
hbvrelated
hbvspecific
nanostring
mrnapositive
tcrlike
hbvtranscript
selflimited
1×
fetoprotein
hbvassociated
cancercancer
unpredictable
dds
nanocomplex
mnc
biomanufactured
secretomebased
immunotherapeuticst
alloresponse
ia1
allorecognition
ia1s
mirnaenriched
crossspecies
conservation
tefftreg
ia1activated
hela
sh4
antiproliferation
ia2
pathologistamong
impose
pathologist
icki
bulletin
du
cancerimmunosuppression
tumorigenic
cellintrinsic
muchdescribed
transplantationit
cni
alloantibodyproducing
therapiesthere
prolific
tregulatory
alloimmune
multilayer
boolean
immunizationin
eigenvalue
nonbacktracking
metric
mci
competing
heuristics
stabilize
coupling
layers
diseasecausing
asyn
astroglia
neuroinflammatory
pathomechanisms
builds
flab
cyprinus
carpioaeromonas
gramnegative
humanlivestockaquatic
defence
organism
lcppg1flab
lcppg2flab
akp
defied
dimensions
11000nm
underpin
drainage
physiciansa
1700
eightone
obligatory
creampatches
ambience
disturbed
seventy
pellet
complicating
omitting
nonreconstitution
errorconclusion
crowded
pediatriciansgps
immunizationsvaccination
precautions
itm
straw
smallholder
thawing
diluting
refreezing
ecf
ticktransmitted
hundreds
dollars
homogenized
straws
ilri
impractical
stabilate
diluted
3035
schizonts
parva
accord
dis
7306314
communicationbackground
threestep
richness
crosscheck
tubulintargeting
microtubule
intimately
organelles
antidepolymerization
taxane
antipolymerization
colchicine
vinka
alkaloids
doxetaxel
vinblastine
tubulin
deafness
decadesobjective
totaling
20062015
audiovestibular
1994
years11
19962005
hearing
caloric
cochlear
partition
o1polysaccharide
haitian
adultsthe
bivwc
oantigenspecific
mbc
o1antigen
marc
haiti
oantigen
ogawa
inaba
kosrae
federated
micronesia
augustdecember
vivocultured
vivoexpanded
ca125
ucbnk
laparoscopy
catheter
153×10
cyflu
c57bl6j
yummer17
nonregression
epithelioid
shaped
spindle
discohesive
plasmablasts
traps
netslike
hidradenitis
suppurativa
updatehidradenitis
hs
dermatosis
scarring
internationally
etanercept
updateon
amyloidβ
oligomers
scientifically
criticizing
retracted
truth
phlike
casesbcell
failured
refractoriness
dissection
hemoglobinuriaobjective
alfabeta
pts
1m4f
145227
5mo
nonsevere
08х109l
0818
х109l
27143
7599
thoracoabdominal
infusedgraft
81х106kg
cd3tcrab·150х103kg
cd3gd
73х106kg
сd19
221х103kg
64х108kg
151218
и
131018
pt
radenovirus
1755
tcralfabeta
immunoablative
immunovacvp4
pollinosisobjective
aqueoussalt
immunoacвп4
causally
immnunoglobulin
steroidsparing
arthritisimmunotherapy
arthralgias
pardoll
nat
rev
12252264
diesendruck
benhar
updat
303947
cappelli
res
6917511763
brahmer
clin
oncol
3617141768
smith
dmard
affiliated
alberta
ia
symmetrical
intraarticular
ecila
pulmonologists
radiologists
ecil
pd1pdl1inhibitors
ruxolitinib
hashimoto
77yearold
mistakenly
parkinsonism
night
loitering
incomprehensible
rigidity
tremor
hallucination
speech
antithyroglobulin
iioflupane
caudal
nh
αenolase
nae
scaffoldassociated
immunotherapybiomaterials
decellularized
woundhealing
proregenerative
wound
2like
trialintroduction
cooperation
oecd
tdapipv
crct
bus
berlin
helsinki
underage
isrctn18026662preresults
suckling
routines
farmsbackground
fpt
igg10gl
78±124
suckled
producer
deviated
±sd
160±100gl
394±264gl
bottle
withinherd
betweenherd
135gl
content50gl
udder
cowcalf
sociobehavioural
precancer
cin3plus
cin3
formaldehyde
fixedparaffin
nonavalent
nct02323997
muc1positive
muc1cd16
targetinga
immunocytes
mucin1
bbiapt
aptamers
spacers
cd16positive
muc1expressing
cancerpancreatic
sparked
tumordriven
shutting
pneumonic
americain
panama
1011
copying
1526
1dose
americaobjective
peerreviewed
pahowhounicef
icoiarc
schedulesobjective
asses
1618
10yearold
alterna
tive
0650
115208
112209
hivobjective
morelos
tlaxcala
n103
n127
hpvvaccine
n1
844
realities
hpvfaster
reboost
vacc4x
setpoint
interruptionbackground
20071
20121
reboosting
wk0
12mg
60μg
wk12wk28
wk36
proviral
pvdna
dth
18162
copiesml
22035
0453
preart
26279
74048
0021
wk4
0006
0022
reservoirs
poxvirus
foe
friendthe
famous
feat
tvec
epilepsythis
draves
death1programmed
actionprogrammed
pharmacodynamics
interfaces
pdl1pdl2
pdl1cd28ctla4
b71
connectivity
histiocytic
transmissions
asymptotic
smoothness
lyapunov
functionals
lasalles
invariance
grenadaobjective
grenada
zerohumanrabies
996
mainland
pets
380
exceptionally
rabiescontrol
mongoose
zerohumancase
myelomamultiple
clarifies
alpslike
ada2
transplantationadenosine
deaminase
autoinflammatory
cecr1
earlyonset
vasculopathy
4yearold
alps
fasinduced
trojan
talhouk
2537
rtimmunotherapy
intra
nonsrt
ebrt
44498
468
hr081
ci078083
hr078
95ci070078
srtimmunotherapy
p089
182months
hr137
95ci129146
95ci066093
143months
hr082
95ci069098
bed60gy
hr079
95ci070090
vaccinest
complexbound
somatically
mutanome
entirety
ssmycosis
evasive
mfss
lcmv
discoveriesvirology
choriomeningitis
tetramers
cd101
prognosing
cd38cd101
tumornodemetastasis
corepression
approachesintroduction
nvis
lmics
overstretched
underfunded
fieldbased
nvi
lysosomalassociated
lamp
herbal
cellrich
ffdgpetct
restaging
iraeaffected
petdetectable
paramyxovirus
alemtuzumabcontaining
regimenaerosolized
aerosolized
radotinib
activationradotinib
supect
bcrabl1
imatinib
nilotinib
k562
fasnegative
fasexpressing
radotinibenhanced
sirnatransfected
antiifngamma
autoantibodyassociated
abscessus
infectionunassigned
antiinterferongamma
adultonset
aoid
nontuberculous
mycobacteria
ivcy
srinagarind
ntm
200000
00467
antimycobacterial
doorway
effectivenessincreased
sentinels
orchestration
constituting
assuring
glycoengineeringdespite
requisite
elaboration
essentially
acquisitionexpansion
curtailed
glycoengineering
eselectin
conveyed
beds
glycoscience
glycobiology
offspring
attaching
effacing
milkowing
citrobacter
rodentium
crodentium
lumen
coats
andreduces
enterocyte
effacement
lee
adhesin
intimin
t3ss
espa
pathogenspecific
fibrosisantipd1
ild
disqualify
casebycase
cet
fait
partie
numéro
supplément
les
cellules
une
révolution
thérapeutique
réalisé
avec
le
soutien
institutionnel
partenaires
gilead
kite
13942007
exactly
imposes
circuit
reorganization
industrymanufactured
athough
cartox
tcelltherapyassociated
juliet
transcend
conception
graduated
adopts
shelf
reprogrammation
envisage
modulations
dalys
sloveniaintroduction
incidencebased
dealt
prizes
huggins
1966
elion
hitchins
thomas
accelerators
fullblown
fig
ref
finlandbackground
finnish
postbuildup
sige
2dl
milkavoidance
244296
136244
1581
18114
myelosuppressive
preengraftment
studya
females87
gcsfprimedhaploidentical
n76
hlaidentical
hlaid
n55
pebsi
7176
n43
fa5bucy
nct02328950
trimethoprimsulfamethoxazole
tmpsmx
bsi
24131
1876
655
neutropenic
neg
pos
7292
lrti
5208
perianal
4167
tmpsmxresistant
acylated
deacylated
quillaja
saponin21
3555
peptidebackground
cnp
eae
triterpene
glycoside
saponin
qt0101
oligodendrocyte
mog3555
hyperalgesia
plate
tcd4
tcd8
mogqt0101
mogqs21
mogcfa
relapsingremitting
monophasic
paws
challengesclinical
catching
bioactivities
sl335ifnβ1a
sl335
interferonβrecombinant
rifnβ
longacting
rifnβ1a
plegridy
fcrn
recycling
rifn®
cdna
ovarys
chos
glycosylated
hsa
rebif
cynomolgus
twofold
fourweek
toxicological
prescription
louresodivelas
groupbackground
vectorborne
destination
nonspecialist
knowndestinations
nonendemicnonepidemic
say
reviewobjective
1112years
benchmarks
hover
ebsco
meriting
multimethod
conversations
usimmunizations
undervaccination
precancerous
cervix
vulva
inherited
riskreducing
finished
26years
careas
lieu
preventioncervical
lowerresourced
hpvbased
midadult
highresourced
unrealistic
castrate
broaden
300cgyday
cgy
pa20204
4749
4590
tnc
pa2024
ifnƴ
p0028
koreaobjectives
tiv
qiv
ativ
6574
7584
342873
17011
8568
2031
17699qaly
1usd
1151krw
3431qaly
mismatching
1812395
89747
interleukin35
destructioninterleukin35
heterodimeric
il27
virusinduced
ebi3
il12rβ2il27rα
il12rβ2il12rβ2
il12rβ2gp130
gp130gp130
immuneassociated
pennsylvania
vaccineapproximately
27000
tetanusdiphtheriaacellular
mandated
927
rhode
unprecedentedly
kidneypancreas
ethiopiaobjective
monetary
priorities
8597
23134
etb
us850
tumorsthe
immunometabolism
celladoptive
depriving
pushing
dupilumab
pairwise
metaanalysisaim
pscore
5504
andthree
079095
toxicityrelated
treatmentgastric
transchromosomal
protections
stat2
hamsterszika
arthrogryposis
guillainbarré
sab155
tcb
golden
prophylactically
voltagegated
channeltargeting
αtoxins
androctonus
scorpion
venombecause
scorpions
inventory
venoms
potassium
dictate
excitability
australis
mauretanicus
depolarization
αtoxin
serotherapies
stings
heme
oxygenase1
tumor1specific
immunotherapywilms
tin
mesoporphyrin
snmp
ho1
wt1specific
snmptreated
hlaa0201restricted
28fold
wt1positive
electrostatic
ovaloaded
1321±02nm
hacoated
cd44overexpressed
polyethyleneimine
hepatotoxicity
strategiesbackground
pd1pd
imh
elevations
fibrin
iciimh
concert
hepatologist
candidateintroduction
dengvaxia®
advantageous
subneutralizing
improbable
sterilizing
stablished
virusbinding
chad
methodologybackground
tenstep
nonprobabilistic
kap
hbr
195238
225483
99195
149225
2431
119129
75164
3096
childrena
contingency
nonendemic
countrybackground
ei
nz
epinomic
breedingcycle
baselines
nonbreeding
incursion
racing
sales
horse
nzd367
nzd489
nzd308
nzd350
formulate
userpays
cellrelated
preparedcar
carrelated
riskstratify
rhinitisintroduction
uncontrolled
sprays
pharmacoeconomic
bifidobacterium
agebackground
subspecies
ttspecific
poliospecific
longum
infantis
harming
warns
monosensitised
polysensitised
chinacurrently
endangers
entailed
cleanup
quantifying
ev71
extinct
neededr
asymptotically
equilibriums
ﬁt
quarantined
speciﬁcally
heroin
treatmentbased
reuse
treatmentage
dies
stimulants
multipledose
immunizers
canadapharmacists
dispensed
completers
noncompleters
24164
195480
169802
1908
20082010
20082009
injectionsauthorized
saw
2012aims
ge65
147ndash157
03ndash10
05ndash07
04ndash07
06ndash79
10ndash205
frenchspeaking
privatesemiprivate
stays
cancertumour
immue
countered
cd122biased
il2antiil2
disfavoured
antiil2
nara1
sitedirected
pegylation
hydrolyzed
whey
formulas
th2biased
phwf
sf
th2th1th17
cd4gata3
βlactoglobulin
blg
caseins
durably
blgspecific
hydrolysate
casein
forwardin
meningococcus
contradicts
retreat
patientcentred
balloutcomes
postrelapse
reintroduced
directs
womenbackground
4valent
scoreadjusted
betweenwave
843
809
charlson
paz
lpuh
pvalue0005
pvalue0162
pvalue0001
pvalue0016
pvalue0019
immuneexpression
ichthyosesdespite
ichthyoses
skewing
ichthyotic
il22expressing
transepidermal
17il23inhibitory
ichthyosis
fieldderived
ethiopiain
fao
mixedcrop
mobilisation
wastage
discard
birr
us02
3etb
us01
funds
rituximabbased
radiotherapyprimary
pcnsl
16yearold
tonic
clonic
nystagmus
waxing
lobe
ganglion
thalamus
frontal
occipital
lobes
bitemporal
clinico
imageguided
sheets
diffusely
immunopositive
cd10
bcl6
mum1
hdmtx
vincristine
procarbazine
wbrt
torque
teno
alloreactivity
tailor
apathogenic
vienna
8497
mortalityobjective
p1
preibd
p2
p3
6914
4202
261000
391000
thiopurines
antitnf
infectionrelated
2020immunotherapy
fulfilling
chemotherapydrug
tolerized
niemannpick
c1
diseaseniemannpick
npc1
unesterified
cholesterol
sphingolipids
neurovisceral
oxidation
oxidized
lipoprotein
oxldl
precedes
antioxldl
autoantibodymediated
pneumococci
cerebellar
therapeutical
melanomadear
categorization
mlh1
mlh3
msh2
msh3
msh6
pms1
accumulates
hypermutability
pembrolizumabbased
subungual
ipsilateral
amputation
phalanx
emptying
axillary
cable
breslows
mitotic
figures
mm2
ascertained
microsatellitosis
margins
rearrangements
ileum
sensibility
rop9
mic3
sag2
heparinbinding
invasiontoxoplasma
varieties
warmblooded
heparan
vertebrates
tgrop9
tgmic3
tgsag2
gondiiinvasion
proteinspecific
antitoxoplasmosis
interleukin35modified
cellsinterleukin35
intensifying
tissuederived
overexpressing
il35mscs
endosomolytic
polymersomes
immunotherapycyclic
cdns
stingactivating
stingnpsrationally
guanosine
monophosphateadenosine
monophosphate
cgamp
stingnps
immunotherapyexternal
destruct
ionizingradiation
beams
hypoxiaassociated
polylacticcoglycolic
fabricate
decompose
tolllikereceptor7
shell
plgar837cat
postradiotherapyinduced
r837loaded
rechallenging
neoantigensrecently
tsas
provenge
peptideproteinbased
dnarna
neoantigenbased
immunotherapyowing
fastpaced
crossinfiltration
insensitivity
vasculature
emphasizes
remodel
fabricated
sfgmtcthe
monocytemacrophage
crp
reinforce
arthralgia
myalgia
cres
aggravation
vasoplegic
leakage
antipd1pdl1based
laterline
ttit
trastuzumab
erlotinib
sunitinib
vismodegib
sonidegib
retrospectiveprospective
sequentially
crossreferencing
vismodegibsonidegib
cyclophosphamidea
peripheralblood
metaanalyst
fourteen
1759
or1741
10322938
or1778
2406
or1843
10663185
retuning
hemopoietic
transplantseveral
coherently
imids
antibodiesdonorspecific
dsas
btz
gkg
immunologicrelated
82years
14months
58years
17months
80adults
opportunitiespancreatic
2025
dueling
restraining
targetingsevere
airways
endotypes
13year
pustular
psoriasisbackground
13yearold
guillain
barré
databasesimmune
omnibus
infectionsthe
infectiology
orc
cancerscancer
reinfused
16h
ciml
preactivated
rested
nkcellmediated
tumorkilling
xenogeneic
policiesintroduction
hpvvaccination
biobankbased
genderneutral
immunobiological
pharmacistled
inhouse
deidentified
n78
melanocytic
nevi
youngadult
immunosuppressionwe
regulatorylike
nevomelanocytes
nevomelanogenesis
cancertestis
cta
tumorrestricted
ctabased
magea
lage1
ttk
strainspecific
transplantationcytomegalovirus
recrudescence
avoids
rvvs
rvv
20142016
10603
20132016
572
443739
024041
080091
50000
040078
036074
132188
107160
062094
070097
060093
tcrmodified
5635
1983
inhibitorsantimetabolitescorticosteroids
cniantcs
cnimammalian
targetofrapamycin
inhibitorscs
cnimtorics
cnics
mtoris
mtori
insure
immunocastrated
ram
lambsimmunocastration
castrating
castrated
burdizzo
clamp
rams
dohne
merino
454±368
burdizzocastrated
4week
ics4
ics6
immunocastration
assigning
palpation
gait
tissuehardening
bruising
immunocastrates
comfort
spent
postures
d8
d15
amyloidosis
immunotherapybecause
mtbinfected
mtbspecific
blockadeassociated
interferonγproducing
tuberculoma
sperm
burdizzocastration
abscessing
colour
sixweek
vaccinationtoslaughter
lightness
canceradoptive
collaborate
immunologists
providertargeted
prescribe
selfregulation
postintervention
1216
remindertype
providedrelated
type1
12dioleoylsnglycero3phosphoethanolaminen32pyridyldithiopropionateperfluoro15crown5ether
pdppfce
fluorine
tracer
blockadetreating
carnk92
transplantationadverse
7080
bespoke
infusing
costcontrol
multicentred
spike
pigletsporcine
pedv
biopanning
scfvs
ifa
s1
metaanalysisimportance
typerelated
macroscopically
resections
dhe
fdw
11143
6270
4873
559
anygrade
792910
1521
i286
ρ07
2752
sponsors
vaccineimportance
priorseason
multiseason
circulated
reversetranscription
100×1odds
3369
1674
2675
579
p37
596
383
p16
560
p93
746
vaccinationimportance
ask
checkin
template
96291
562
41865
61813
23802
noon
pm
320
469
472
95percentage
41143
hospitalsimportance
respondent
veterans
affairs
va
nonva
1062
preventionists
706
635
614
184302
694
188314
p29
mandating
welldescribed
protein2
emp2
corneal
neovascularization
modelpurpose
antivegf
antiemp2
alkali
burn
naoh
subconjunctival
postalkali
enucleated
immunostaining
cd31
limbal
surveillanceintroduction
causallylinked
kd
cihi
ontario
intellihealth
20052014
annualized
desensitizes
allergenallergen
escalating
desensitize
profoundly
bronchoconstriction
slices
practiceharnessing
targetingcancer
g12d
ribosomal
footprinting
g12
programmeddeathligand
noncanonical
untranslated
bypassed
eif4e
eft508
fusionobjectives
1ligand
rebiopsy
seventeen
0113
r0112
r0101
r0517
r00219
nsclcintroduction
t0
ki67
nkg2a
nkp30
nr
cd8tils
privileged
counterbalanced
portrays
hupblnsg
modelsbackground
recapitulate
engrafting
nodscidil2rγ
nsg
similarity
hcd3
hcd45
cd3t
th17related
eml4alk
cd11ccells
responserelated
microarray
fdr025
gsea
resembles
lebanon
districtbased
ces
1259months
nabatieh
openended
fees
adhere
hepatologythe
rooted
disinhibition
hepatology
hepatologists
impossiblepancreatic
dealcancer
interferonmediated
programed
laryngotracheitis
layersinfectious
ilt
livemodified
ceo
tissueculture
fowl
pox
fpv
iltv
recombinants
pullets
wch
trachea
fpvlt
hvtlt
ceovaccinated
costsimportance
underimmunization
tenth
6980
3819
1092
1257
multivisceral
infectiontransplant
120498
multistate
surveillanceimportance
gbs
eod
intrapartum
lod
laboratorybased
1387
1897
481
ib
881
993
997
359
clindamycin
1265
neoantigensneoantigentargeted
van
nucleophosmin
npm1
amls
biochemically
npm1derived
δnpm1
retrovirally
npm1mutated
frameshift
insertions
ligandome
δnpm1derived
hlaa0201binding
claveevsl
peptidehla
tetramerpositive
hlaa0201positive
pneumocystosis
immunosuppressionbackground
4063366086
0199
0198
01660230
0188
01550221
1225
10091488
73374
orientationrelated
preventionobjectives
orientations
8143
minorities
bisexuals
lesbians
king
chulalongkorn
memorial
chonburi
prapokklao
rankin
mrs
113years
84years
205months
mrs2
hypoventilation
tumorresident
undefined
unleashing
swing
tripled
120million
340million
dedicate
burdennext
repairdeficient
cms
cms1
exonucleasic
anomalies
immunoscore
nonpreterm
respected
diphtheriatetanuspertussispoliohaemophilus
bhepatitis
dtapipvhib±hb
mmrmeningococcal
menc
22097
124702
6686
341448
191290
133177
3145
revisitedpancreatic
folfirinox
nabpaclitaxel
revolutions
allergypeanut
outgrow
away
allergenspecificige
beneficiary
espaloaded
mesoporous
silica
enterohaemorrhagic
o157
h7in
msnps
969±159nm
respaloaded
titretitre
14ngdl
formulatedantigen
faecesfaeces
lymphomasbackground
bordeaux
hospitala
inremission
cancerdespite
extensivestage
antiganglioside
antinotch
conflictive
surgeryfree
macroscale
concentrating
catheters
threedimensional
drugdepot
literaturesbackground
acquires
antigenbinding
endows
patents
enumerate
neotype
readership
phosphatidylinositol
3kinaseaktmammalian
autophagy
careradiotherapy
localised
palliation
reactivated
recognised
attitudesobjective
theirnewborn
20152017
315345
nonoptimal
threats
skillful
semustine
mbucy
seam
autosct
9days
nauseavomiting
p0050
p0378
p0789
tumorstreatment
apotent
resectable
hospitalizationobjective
postdischarge
kaiser
permanente
290149
255737
083095
068093
092098
reassurance
disorderscontinuous
contractions
geographies
tropism
hostimmune
ofrural
24monthsbackground
caretaking
postbirth
n470493
tambo
n76458
breastfed
allotransplantation
19982017risktobenefit
uea
divat
serostatus
06months
712months
sixtyone
transplantdays
0451000
0211000
p011
predominating
functionbackground
tige
treatmentradiation
icbs
researchdespite
cellheat
preliminarily
trialed
certainly
nonimmunization
wushishi
comparisonimmunization
bida
emirate
bluetongue
overimmunization
ovine
syndromethe
eradicating
orbiviral
cachectic
autoimmuneinflammatory
transplantationobjectives
slums
kathmandu
valley
nepal
1260
squatters
347±178
1224
271±53
italyobjective
promotional
forums
blogs
semantic
neutral
prefarrowing
colonisation
lesionsthis
batches
farrowing
laryngeal
litters
primiparous
postweaning
lls
va142
nva200
p0225
vb09
nvb08
va08
nva70
p0039
vb18
nvb25
p0738
va155
nva264
vb97
nvb84
p0541
calgary
1560
n1391
n79
vaccinatingdelaying
deliberative
risksbenefits
instrumentalpractical
conviction
feelings
miceimmune
plateletinduced
chow
plateletimmune
cd61knockout
placental
cd61ko
haemorrhage
pups
cd41ko
megakaryocytes
lymphocytedepletion
megakaryocyte
oncologyfighting
bystander
whats
2018the
incredibly
novelties
melanomadespite
smallmolecules
allergyin
apple
immunologistthe
radically
immunorelated
chronology
selfcarrier
immunotherapycodelivery
nanovaccines
selfcrosslinked
onps
onpscpg
maturity
antigenadjuvant
multiinstitutional
patientswe
ratg
31months
54years
75years
74years
dichelobacter
nodosus
footrot
jk
1619
22698
2374
6090
serogroupspecific
9246
1708
594
0069
9247
1991
virulencespecific
integrase
inta
thermostable
709
7279
gelatin
pcrrestriction
polymorphism
pcrrflp
fima
predominance
b5
8297
jammu
kashmir
polycomb
repressor
2prc2
catalytic
prc2
methyltransferase
dnmt1
hepg2
hep3b
hepa16
5azacytidine
c57lj
cxcl9
55±02
144×103±37
cxcl
685×103±13×103
215×103±31×102
3637±03
lage
83117±19
002g±002
063g±061
015g±021
24g±071
transcriptionally
semirural
vientiane
lao
mitogenactivated
randomizedcontrolled
10951
cri
antigen4ctla4
hr061
attendees
motivating
approached
418
livezoster
nonlive
necessitate
zona
millionmperson
lifetimes
96m
58793qaly
revaccinating
1187
84m
100000qaly
syncope
vaccinationintroduction
kpnw
receptivity
piloting
breathing
exercises
distraction
verbal
anxious
menu
piloted
bullet
cancertesticular
curerates
effectstumor
radiotherapyseveral
sdf1
cxcl12cxcr4
sdf1cxcr4
merge
indocyanine
greenlabeled
antitissue
antibodyobjective
icg
antibodyphotosensitizer
antitf
1849icg
tfexpressing
nirpitinduced
jcm
unlabeled
semiweekly
deathassociated
ki67positive
tftargeted
knowcheckpoint
neoantigenstherapeutic
satisfying
patientindividual
carcinoembryonic
taaderived
taabased
individualizing
mipss70
v20
myelofibrosis
flumel
regimenalthough
fludarabinemelphalan
72gene
mutationenhanced
v617f
asxl1
veryhighrisk
cbl
calr
0291
flumelbased
cytogenetic
transmit
akin
crisprcas9mediated
peruclassical
culling
ecuador
bolivia
or007
walktrap
or283
or583
hdi
or152
or325
movements
or330
brdc
heritability
bvdv1
bvdv2
brsv
bhv1
1mb
windows
heritabilities
annotation
deserts
lowly
heritable
polygenic
complicationimmunosuppression
emergencies
elective
softtissue
sarcomasdue
pazopanib
trabectedin
eribulin
enters
overbackground
cellreplete
912
n373
n539
lfs
scoreweighted
agvhd
friends
foesthe
alarmin
damaged
withinout
biofunctions
th2related
immunestimuli
inflammationinfectioninduced
protectors
versatility
ilc2
protumorigenically
inspiration
aggravating
gvl
bcrablspecific
iiunder
noninflammatory
clonally
miha
hlado
graftvsmalignancy
improvedharnessing
antihiv
precursorderived
pulsing
plasmaderived
polyreactive
secretorylike
igam
salmonellosissecretory
stringent
scigam
ligated
anchors
mucus
ensured
sirolimus
immunosuppressioncytomegalovirus
infectionreactivation
cmvctl
cmvctls
cd3cd28
0201restricted
cmvpp65peptide
aapcs
gzb
targetcelldependent
nextgenerationsequencing
tcrrepertoire
sirolimusresistant
ctlclones
il2rdriven
transcription5
stat5
friendimmunotherapy
immunodormant
efficacyantibodycytokine
immunocytokine
immunocytokines
fv
adcc
radio
il2mediated
vitiligolike
depigmentation
cancersvitiligolike
vld
melanomaspecific
dynamically
pdl1l2
gradedependent
treatmentfailure
condemn
fate
acquainted
conditioninga
analysisin
hraml
firstsecond
ptcybased
wellmatched
threeyear
oslfs
56±749±7
hlamatchedhaplosct
62±1052±9
p021
53±1046±9
nonrelapsemortality
cgrfs
ii°
15±1
50±2
questionsobjective
deal
31st
referenced
eagerly
doable
19621969during
1962
1967
joan
fujimura
yako
protagonists
aegis
copdbackground
influenzapositive
4755
4198
38reduction
vsunvaccinated
1833
97vs79
172vs121
influenzanegative
04303
1545
1651
clinicaltrialsgovnonct01517191
url
183246
20122016
dose1
677
294
nonhealth
or233
132413
yes
or175
112274
p0013
nonlocal
dba2j
hsp60
challengesalmonella
poisoning
salmonellosis
hsps
procaryota
antihsp60
pasteurella
multocida
histophilus
somni
10μg
rhsp60
ld50
684×10
cfuanimal
3×ld50
rhsp60immunized
faeces
haptoglobin
deathnatural
immunoadjuvants
immunemediating
premortem
cancerwith
immunotracers
cd7
targetcancer
ffluorodeoxyglucosepositronemmissiontomograpy
ffdgpet
discriminate
theranostic
cd2
immunopet
fab´
tracers
anticd2
anticd7
zirconium89labeled
radiotracers
immunotherapyprotective
perturb
prospectsthe
connective
bible
1977
tightknit
thousand
orthodox
protestants
refuses
2500
orthodoxprotestant
engine
integrateandfire
susceptibles
denominational
schoolgoing
escapees
wellequipped
duplicated
humanity
cornderived
alphadglucan
pigsadjuvant
nano11
electrostatically
inactivatedkilled
kag
nano11kag
mist
nano11kagvaccinates
9616l
wjog9616limmunecheckpoint
onehalf
leukemiactla4ig
ctla4igdli
12hours
327×10
60days
immunotherapiesimmunotherapies
recommendationsthe
publishes
dtpaipvhibhb
mmrv
nonfunded
adenomas
toolspituitary
adenoma
nonfunctional
stands
ddi
enlarged
parelated
proteinprotein
gal
lmo4
tgfb
tgfbr3
alphaherpesvirus
bohv1
calvesto
rhinotracheitis
ibr
deleted
ge
nondeleted
geproducts
excreted
stimulus
thymidinekinase
tk
neurotropism
mothertocalf
addon
rhinitisthis
aaot
sasit
rqlq
reviewunassigned
microorganism
scare
felege
hiwot
bahir
lottery
1191
20991
20912
3325
131502
8779
1599
48192
8215
55328
corticoid
purkinje
resigns
italys
mucormycosis
surgeryradiosurgery
metastasisaim
mbm
25months
mos
13months
treatmentinitially
icismi
silicazinc
microrosettes
chemoimmunotherapyherein
mszn
petal
onepot
hydrothermal
polyinosinicpolycytidylic
rejects
skinbreast
groundbreaking
drying
15μm
methylene
blue
microchannels
conduits
50±10μm
microparticulate
carebackground
systemmodifying
polymerized
grasses
892
1292
3657
ultrarapid
switzerlandbackground
internetbased
twentyseven
revaccinate
meningococci
livevaccines
faculty
texaslittle
perspectivesintroduction
rts
sas01
minimising
nontargeted
sciencedirect
miteatopic
scorad
bec
thirtyone
postscit
skeletal
hypothesisgenerator
reportsarcopenia
image
lumbar
vertebra
l3
391
nonlow
00560
02866
hypothesisgenerating
sarcopenia
infectionchronic
twostrain
mittagleffler
kernelin
atanganabaleanu
operator
fixedpoint
ordinary
convergent
mmlmath
xmlnsmmlhttpwwww3org1998mathmathml
mmlmiαmmlmi
mmlmommlmo
mmlmn0mmlmn
mmlmn1mmlmn
whereupon
euler
11000
pcps
mail
930
620930
n303
n317
patients50years
transplantationtherapyrelated
taml
antecedent
alwp
ebmt
102226
112205
109209
conceivable
cyp3a4
cyp3a5
abcb1
patientspharmacogenetics
4days
nontherapeutic
tacrolimusrelated
15ngml
intermediatenormal
metabolizers
c2677t
lossoffunction
hemagglutinationinhibition
hivuninfected
hai
microneutralization
gmts
foldchange
stains
foldincreases
3times
influenzaa
circumcision
ugandaintroduction
toxoidcontaining
consenting
assayed
652
currentrecently
044iuml
035053
386iuml
360411
405iuml
381429
448iuml
428468
024iuml
0023iuml
0031
inhibitorcheckpoint
elastic
highdimensional
overly
leaveoneout
crossvalidation
heldout
triaged
nondurable
dcb
nondcb
medicineintroduction
2013morbidity
compute
turnbull
estimators
108783
2560months
instituting
immunoradiotherapies
antiganglioside2
irrefutable
additives
immunomediated
glioblastomas
immunoprivileged
privilege
gliobastomas
reedsternberg
pd1pdligand1
indeterminate
antiangiogenics
hifvegf
antivegfr
antiprogram
icp
icps
proves
ccrcc
ccrccs
associated4
nsclcs
š
tyrosin
ccrc
regroups
expose
mothersbackground
eritrean
amharic
tigrinya
sociocontext
andersens
engages
word
coethnic
pork
felt
pear
miceyellow
precipitation
maximized
5688mgg
6745°c
materialliquid
13491
366h
highpurity
lpbc
pyranoid
glycosidic
bond
rhamnose
molar
3323106232
earlap
timecourse
salmonthe
salineinjected
suite
haptencarrier
dnpklh
moritella
viscosa
clonotypes
nodal
irradiationbased
reconditioning
transplantationpurpose
tnibased
failurerejection
7gy
antit
okt3
n16
n31
11days
34days
cortisone
602months
111625months
620586
651617
moschkowitz
928months
361625months
sexgrowth
insufficiencies
1second
tni
percentile
ahvaz
iranbackground
salsola
kali
triticum
aestivum
lolium
perenne
salix
caprea
prosopis
juliflora
aspergillus
fumigatus
blatella
germani
thermofisherphadia
15527
outdoor
germanica
sensitizers
southwest
lepista
sordida
vivobackground
antiaging
wels
bmdcs
dcinduced
3hthymidine
factoralpha
laboratorybackground
neuromuscular
bulbar
binocular
diplopia
ptosis
dysarthria
dysphagia
ventilation
embolism
tracheostomy
tube
astct
ofpatients
harmonize
arlington
postapproval
areaunderthe
studytraditionally
whichever
thirtyseven
tp53transfected
adp53dc
alltransretinoic
62years
2stage
simon
minimax
armb
armc
53486
239651
27463
29491
91475
culturing
trialsobjective
timeresolved
fluorometric
tdalabeled
γcdependent
tritiated
thymidine
htdr
nkactivity
receptordependent
cultivate
cartransduced
crossreactivitycrossreactivity
homology
1programmed
receptor1ligandl1
broilerseffects
dold
penstreatment
chickspen
prebiotics
mannanoligosaccharides
20x
2942
1528
shallowest
ileal
prepro
deepest
prebiotic
subtilisbased
diseasesobjectives
17member
taskforce
nephrologists
haematologists
specialist
rheumatology
eular
acr
scottish
intercollegiate
82100
panc1
nrg
metalchelating
luour
pnca
mcps
dota
chelators
βemitter
lu
clonogenic
panitumumabmcp
0312
mbq
doublestrand
dsbs
absorbed
cbc
iggmcp
tgi
77fold
38fold
salinetreated
egfrtargeted
arthritisdendritic
selfpeptide
melanomaneoadjuvant
biochemotherapy
propel
metricsbased
melanomabearing
antibodytreated
remainder
orthogonal
leastsquares
oplsda
wavesafter
leverage
unabated
armory
vaxidbackground
standardizing
mantoux
vaxid
preimmunised
hbvaxpro®
10µg1ml
forearm
forearms
011cc
001cc
overfill
40µg1ml
followedup
teensbackground
issuing
minnesota
fair
ipad
bexsero®
760836
820
781855
menactra®
menveo®
688
642730
896
882
12122
1563
looks
2027
univac
inr
31666
averting
2323
157520
44008
3741161
failurebackground
hf
n134048
timevarying
1768
unadjusted
081084
thymusderived
cellsbackground
cytometric
cba
inkt1
inkt2
plzf
cofar
generationthe
iteration
rostrum
vaccinationsavoiding
mistakes
immunosuppressioncryptococcal
50y
auditory
p0416
p0585
australiabackground
20002012
selfcompleted
factbmt
v4
dass21
583
1979years
49years
1771
417
zostershingles
lmp2a
2017genetic
antilmp2a
293t
lvlmp2acne1
7211±975
5465
±542
3668±380
cne1
803±100
lmp2apositive
researcha
bullous
crisprcas
genodermatoses
©
masson
treatmentimmunotherapies
platinumresistant
antivector
antitransgenespecific
tetramer
vectorupon
codetermines
sacrificing
vsvgp
lcmvgp
vsvnp
egfp
suspensions
optionally
cd43
1550
omalizumabsparing
outbreakspecific
ebolavirus
gp
reactivitythe
ebov
variancenonsynonymous
nsms
epitopic
00133
radiologistsobjective
immuneresponserelated
universitybackground
ukm
nonreactive
ninetyseven
mounted
antihbcore
waned
prebooster
pertactindeficient
polanda
vaccinationthe
1990s
antigendeficient
bpertussis
pfge
mlva
fha
prndeficient
tcfadeficient
genotyping
distinction
20102016
mt27
ptxa1ptxc2ptxp3prn2tcfa2fim21fim31
transplantationhemorrhagic
hc
myelomathe
riss
iss
prognosticate
n628
relapseprogression
relapsers
postahct
nano
micro
frontier
ddss
capsulebased
fabrication
hydrogels
ddsbased
studyadenovirus
n1736
n2540
1000copiesml
boom
paralleled
conspicuous
awarding
histotype
chainsbackground
mnp
pointofuse
hermes
replacing
rota
bihar
5cm
perdose
2month
priceperdose
2months
515cm
volumeperdose
aerd
diseasespecific
rhinosinusitis
polyposis
crswnp
650mg
snot22
acq
acoustic
rhinometry
endoscopic
polyps
bothersome
300±345
185±173
signed
otolaryngology
moh
interagency
malaysias
7years
enrolments
242638
230000
9698
9899
beijingthe
hardwired
pondered
li
exp
hem
fronts
sweeping
firstever
agnostic
award
wwwnobelprizeorgprizesmedicine2018
sanmamed
2018this
immuneoncology
expediting
concluding
beijing
coorganized
hematologist
cahon
cfda
nmpa
tsinghua
rs
expect
toxicityin
canceresophageal
prognosticpredictive
pdl2
repolarisation
macrophagesthe
smouldering
recalibrate
tamtargeted
tumouricidal
wheelwork
repolarise
reportelevated
htx
hyperacute
transplantour
scibvac
40μg
1log
100miuml
implying
inductionbackground
1685
preliver
noncutaneous
sessionsobjective
ns
camr
singlefiltration
proteinuria
ahus
antibodyincompatible
transplantbackground
donorreactive
dfpp
alb
removes
fixeddose
dfpps
crossmatchpositive
volumeremoval
predfpp
hypotensive
rrigg
kg×
xrrigg
1075725603
0401
2982
236×
rrigg×
0236×predfpp
formulae
mycophenolates
mizoribine
withlower
aprospective
bkvan
graftthreatening
mzr
viruria
uric
acidreducing
1950
3150
japanthis
prtbased
graftpatient
hypertrichosis
cyclosporinerelated
519±135
prtcyclosporine
mgmg
0029±0017
24±15
35±18
36±17
03±78
mlmin173m
955
constrains
diseaseimmune
forcing
chimeras
radiosensitive
transplantationon
novartis
basel
bioimmune
accreditation
eg95
rio
negro
workcystic
praziquantel
operative
5820
km2
115years
granulosus
coproantigen
purgation
29323
801857
6yearold
arecoline
coproelisa
dogafter
selfdelivery
ppixpeg
kvprnqdwl
ppma
conditionsthe
viremicpositive
nursery
adwg
farrowtofinish
biosecurity
spares
immunityacute
modc
alloactivation
preserves
vsleukemia
spliced
xbox
xbp1s
xbp1
abrogates
bi09
inositolrequiring
enzyme1α
ire1α
splicing
allostimulatory
curtails
p40
bi09treated
flux
targetorgan
biologicsno
c5
depletes
ofatumumab
obinutuzumab
ublituximab
inebilizumab
belimumab
trophic
efgartigimod
immunopathogenesis
δ
therapymemory
mem
aerobic
ppar
gw501516
gw
pparα
pparδβ
carnitine
palmitoyl
transferase
ratelimiting
metabolomics
acylcarnitines
gwtreated
forgetfulness
immunizationbackground
hesitantnegligent
proimmunization
fearful
825
remembering
or036
025051
or041
029058
or068
102211
antiimmunization
selfconsent
synthesisintroduction
interpret
twentyfive
selfdetermination
misunderstandings
reputation
primacy
crd42017084509
hawassa
graduates
606
hospitalrecruited
econcopdstudy
298
guidelineadherence
goldstage
837427
changesintroduction
allowance
allowances
disallowance
19992017
coveragethis
903
b2
961
b3
942
813
immigration
testingcervical
papanicolaou
devise
reportclinical
68yearold
16944
unassociated
dlbclrelated
βpeptide
tcrβ
waves
contraction
alginolyticus
pearl
gentian
grouper
fuscoguttatus
lanceolatu
acfadeletion
vaccinevibrio
δacfa
complementation
cacfa
fuscoguttatus×epinephelus
hy9901
il16
mhciα
settingallogeneic
charges
p39
738
339621
247334
levelsantithymocyte
posthct
quintiles
prehct
schema
morphofunctional
antigenallergen
microbeads
dripped
microliters
buffered
latex
jaw
stereomicroscopic
illuminations
caruncles
rostral
agerelated
lumina
mandibular
ducts
apical
specification
s100a9
s100
calciumbinding
a9
micedecreased
poststroke
solving
a9cd36
antis100a9
occlusion
clopidogrel
antithrombotic
carotid
cd36
nterminal
vav1
thrombus
s100a9cd36
joseph
stickler
scarlatina
wrath
antivivisectionsts
caseseries
tumor‑bearing
virusov
iiimmunotherapies
ofb
antigen‑receptor
iiithe
typei
evoked
long‑lasting
transplantationpatients
rhtpo
iukgd
0036
p62nbr1
deficiencyintroduction
multiply
nonphagocytic
cellautonomous
p62
cargo
degraded
burkholderiainfected
lc3i
autophagosomeassociated
lc3ii
2017aims
basing
disproportionality
55356
224863
vaccineevent
n42244
dizziness
n6259
ror260
253266
n6004
ror628
612644
deserve
immunotherapydendritic
dctherapy
lag3fcrl6
engagementimmunotherapies
tumorintrinsic
fcrl6
ascribe
mhciimediated
pd1targeting
maasai
nomadic
pastoralists
opportunitiesbackground
aggravate
pastoralist
gone
threequarters
toa
422
birthday
p015
predna
lanpc
6218
ccrt
psm
icccrt
4650
0620
06224
05673
predna4650
metastasisfree
dmfs
860
0817
06830977
0675
05370848
0782
06260976
experimentbackground
crises
instructions
provaccination
sending
voicing
transparently
graduate
haifa
sig0001
ministrys
466
captive
experienceimmunosuppressive
monitoringtapering
gt
mycophenolic
tac
p0030
shortened
bkvassociated
p0571
dndsas
3090
6021
mediumterm
vinflunine
pelvis
72yearsold
systemcytotoxictlymphocyteantigen4
transendocytosis
controversially
ctla4mediated
heterozygous
penetrance
expressivity
ctla4insufficient
taught
inon
pathologycausing
nibit
think
siena
italya
panellists
clinicaltranslational
genuinely
crossspecialty
crosssector
datasharing
researchclinicians
bioimmunotherapy
immunooncologythe
notions
nonprofit
revitalized
directionhiv
kick
refocus
hivspecific
reignited
latterly
dualaffinity
darts
immunemobilizing
immtav
heatlabile
ltr192gl211a
dmlt
150µg
sl
25µg
antidmlt
50µg
iggascs
pharmacistadministered
ratesobjective
50state
brfss
p00022
101135
agedependent
tresps
tregtresp
tregstresps
emigrant
rte
antiki67
tregstresp
nonautologous
tresp
cracking
deletions
ohsv
theres
icp345
icp0
us3
lacz
g207
1716
oncovex
nv1020
hf10
g47
pointed
brafmutant
melanomaaim
067069
matchingadjustedindirect
us54273
79124
hypoxiatriggered
photodynamically
cella
phagocytize
hypoxiaresponsive
nanocarrier
denoted
cage
signifying
timehuman
hcmv
βsubfamily
hostspecies
cmvs
eons
cospeciation
mcmv
virushost
reasoned
falsification
myelogenous
solh
dri
lowintermediaterisk
cytomegalovirusspecific
nonviremic
cmvpepvaxearly
cmvpepvax
nct01588015
pp65specific
reexpress
isoform
multimers
multimer
495503
tems
erythematosuspurpose
rationales
commonalities
vii
chickensnewcastle
vndv
28d
greenish
933
log2
cloacal
prevail
rvsvδgzebovgp
liberiaobjective
15yearold
john
kennedy
monrovia
685861
modellingcancer
trialanderror
bottomup
antiprogrammeddeath1
1320
toxicitieschimeric
firstinclass
bacute
cartassociated
builtin
calibration
fates
potencychimeric
accentuated
redundancy
imparted
calibrating
cd28based
tyrosinebased
amrwe
amrsensitive
vaccinecentric
nonvaccinecentric
antiamr
unaltered
amrrelated
metrics
disaggregated
resistancerelated
reaggregated
ascertaining
substitutable
substitutability
exemplify
complementarities
stewardship
gonorrhea
healthsector
resistancevaccines
happens
harder
lysine171
prion
scrapie
oronasal
inoculationscrapie
prp
prnp
lysine
codon
barbado
qq171
qk171
kk171
postinoculation
mpi
necropsied
qq
oninoculated
qk
k171
diseasesinvasive
candidiasis
2755
nonalbicans
krusei
glabrata
lusitaniae
tropicalis
parapsilosis
antifungals
devising
lymphomapurpose
anticd19directed
resounding
chemotherapyinsensitive
bnhl
answering
benefitcost
japanjapan
bca
prefectural
us160472075
149268935171669974
us1682707
11802892249283
us5019093
39868826133687
abolition
3fold
damageavoided
us8575
557311689
107737
worsecase
bestcase
relaxing
prefectures
colonic
transaxial
slice
boundaries
133±004
22±046
333±267
melanomaobjectives
lc
rpfs
623mo
nonconcurrent
endorgan
myelomatargeted
concise
antigenemia
sapporo
hokuyu
presct
655mgdl
postsct
dualisotope
spectct
h56caf01
intrapulmonary
immunizationpulmonary
h56
ag85besat6rv2660
liposomebased
caf01
comply
ipulmon
evenly
ictrp
handbook
2250
131161
11637
123163
136312
138269
113967
hematotoxicity
caterpillar
struggling
butterfly
carcinomaopinion
monumentally
nonmetastatic
aggregatesamyloidbeta
aβ42
antioligomeric
ht6
mediumsized
1845kda
30×10
fibrils
disassembly
ht6targeted
nterminus
protofibrils
vice
versa
enriches
bumpy
eraimmunotherapy
anticd33
gemtuzumab
dendriticaml
checkpointmodulating
mechanismstumor
biomarkerguided
immunogram
19962012
navrongo
nmrs
241000
p049
91000
inspected
bcgvaccinated
bcgunvaccinated
therapyobjectives
recognising
fibrinogenlike
globe
fbg
tenascinc
neutralised
mapped
crystallography
synovitis
antifbg
engendering
116052
australias
impactaustralias
cobas
4800
6800
2574
909942
205222
712
697727
non1618
2529
flat
contrasting
heamophilus
influenzab
epiglottitis
unmasking
cellsnovel
tomorrows
immunotherapyobjectiveshypothesis
singleallergen
laryngoscope
129e170e177
geltamo
groupwe
bcnu
bendaeam
2871
453
05×10
4077
012056
017097
disintegrative
disorderdown
dsdd
autistic
insomnia
catatonia
africanamerican
vaccineobjective
qualitatively
17yearold
n34
diseaseaim
archives
2017to
trialsgov
turbt
retronectin
canceraim
rcik
rcikbased
deliverybiomaterialbased
dimensional
dictates
polyisocyanopeptide
pic
thermallyinduced
16°c
azideterminated
monomers
handles
cellmodulating
prestimulated
thermosensitive
favors
gelated
instantly
egressed
covalent
biomolecules
azidefunctionalized
9000
gammopathy
undetermined
mgus
smoldering
ectoenzymatic
cd38targeted
isatuximab
cartransfected
biomarkerscancer
mainstream
obstructed
failurehypomethylating
hma
azacitidine
decitabine
hmas
idh2
spliceosome
sivac
nitag
nitags
lowermiddle
organizationunicef
jrf
lowermiddleincome
140260
205359
bstract
decisional
45168
57year
whitish
expectoration
lymphadenectasis
mediastinal
hilar
pemetrexed
pemcis
pemetrexedbased
blomia
allergensbackground
bt
ninetyfive
dpscit
serumspecific
cosensitization
btma
btspecific
dpspecific
67fold
048061
sensitizations
ibuprofen
myopericarditisto
antiinﬂammatory
nsaids
nerd
hypersensitive
stent
cardiological
havent
ketorolac
urticariaangioedema
pericarditis
scaled
upcart
grafting
boutique
worldwild
perspectivesmicrosatellite
mmrdmsi
lynch
autosomaldominant
msihigh
distinctive
fervent
195μgl
n248
lymphomamyeloma
mdsmpn
n124
n36
142±88μgl
183±64μgl
156±81μgl
207±67μgl
p757×10
200μgl
234356
91248
p134×10
128330
96233
p0312
201μgl
cart‑cell
reviewadoptive
restricts
cd‑19
cd22
prostate‑specific
psma
t‑cell
receptorγ
potential‑p8
six‑transmembrane
disialoganglioside‑2
t‑cells
anti‑psma
activationmelanoma
trametinib
batf3
multidrugs
bacteriaobjective
rehospitalization
20152016background
poliofree
97000
011months
htr
20142015background
securitycompromised
terrain
interwardinterlocal
areainterstate
borders
scattered
waterloggedriverine
bauchi
yobe
penta3
securityinaccessible
liberation
captivity
insurgents
bokoharam
lgas
6050
6548
impactful
polioviruses
wpvs
opv3
programmewas
eightmetropolitan
kanothat
topvbopv
switchwill
vdpv2
bopvtopv
nationallyselected
preswitch
520
951
521
952public
zonal
stores
unmarked
topvwas
sticker
topvbopvswitch
sanctuaries
dopv
20142016background
65th
necessitated
noncompliant
connived
mark
supervisor
pluses
submit
attract
abidjanintroduction
abidjan
equipment
patientsover
neuroimmunology
lgi1
gad
gaba
caspr2
iglon5
yo
ma2
cv2
ampar
tpotg
rehabilitation
lupuspurpose
eosinophilia
allergyrationale
esophagogastroduodenoscopies
eoe
erefs
esophagus
antrum
epx
epxmm
highpower
eoshpf
furrowing
rings
0025
dilated
lamina
propria
cd38specific
biparatopic
cellscd38
nanobodies
vhh
llama
nonoverlapping
hinge
ch2
llamahuman
hcabs
cd38expressing
hcab
e345r
hexabody
heteromeric
dimers
copynumber
patientsinhibitors
pd1pdl1ctla4
interrogating
cfdna
lowcoverage
metricthe
ginto
coordinator
intellectual
nonreceipt
237374
76114
174260
100241
immunise
inquiry
socioecological
business
multiyear
fragmented
9615
modifiable
understudied
carer
organisational
inhibitorsassociated
malignanciespurpose
postactivated
considerationspurpose
bcelltargeted
postactivation
functiotype
epigenomic
impairments
gainoffunction
ptpn22
undifferentiated
malignanciesundifferentiated
ums
encompass
9p241cd274pdl1pdcd1lg2pdl2
5293
cd274pdl1
pdcd1lg2pdl2
agingimmune
senescenceand
agingassociated
frailty
receptorredirected
ic9
cid
amlassociated
selectable
δcd19
sel
ic9carcd33
validating
regulatable
patientreported
immunotherapiescancer
clinicianrated
tabulation
symptomfocused
psychometrically
elucidates
hepatitisimmune
812weeks
transaminase
colitisimmune
antidiarrheal
vedolizumab
pneumonitischeckpoint
instruct
novelty
familiarity
practicein
engager
moleculartherapy
variousclinical
bms936559
melanomawhile
providerswhile
cocktailssince
mixtures
heterocombinations
homocombinations
vitiligo
26133
35183
p0061
219months
97months
stuttering
cartcellrelated
noncomplete
lymphomasthere
allopbsct
noncr
ptcls
465months
14105months
nonrelapsed
withdraw
complete4
partial1
followups
managementthe
inthe
eminencebased
disproportionate
quebec
canadabackground
dtapcontaining
7183
iiprimed
functionregulatory
antigennonspecific
unprimed
foxp3overexpression
foxp3transduced
p00014
exchanges
p00013
gfptransduced
reveled
cii
βd
mannuronic
rorc
diseasesinflammatory
git
concerted
m2000
aseptically
370c
co2
synthesised
adherent
nonpersistent
femalemale
322±100
1763
144±127
10585
653
nonpersistence
studyhla
haplotype
urd
hlab
hladq
c2
c4
c291898g
c3316c
c4385c
snp
n714
kb
illumina
gbss
literatureautoimmune
posthematopoietic
se027
manufactureto
highyield
cellbaculovirus
addomer
gmma
ambient
xenotransplantation
septemberoctober
ah1n1
illnessbackground
ah1n1pdm09specific
hititer
hititers
39months
35days
isotretinoin
recipientstreatment
sotr
retinoids
acitretin
communityobjective
kenyan
multinomial
4052
794
somalis
kikuyu
nonsomalis
therapybeyond
chaotic
nonhierarchical
immunocyte
perfusable
periphery
grl
lo
cxcr9
monocytesmacrophages
perfluorocarbon
localize
vicinity
masses
angiostatic
scheduleas
adviser
subscales
1445
conveniencesamples
wording
conveniencesample
5item
invulnerability
selfcontrol
deliberation
communal
sprayed
bioresponsive
treatmentcancer
carbonate
preloaded
scavenge
awakens
womenobjective
331477
worries
stating
perceive
tumorconditional
toxicitywhile
dvd
shield
antictla4binding
typeserine
mtsp1
rag
trampc2bearing
fcγrbinding
dana
uncoupling
inhibitionantibodies
pai
shields
ctla4binding
proteaserich
thoughtprovoking
groundwork
iirestricted
regressionadoptive
hladradrb10401
nyeso1reactive
tcr35982
nyeso1redirected
nontolerant
trialmedia1vid11015425849572217001pedsva20181457
video
watched
accommodate
1596
501
147225
147642
carcinomaimmunotherapy
revolutionizes
budding
ba
epithelialmesenchymal
therapynaive
osccs
intraepithelialstromal
tce
highdensity
tceif
refining
foxp3cd4
highstromal
cd8cd4
goldilocks
geneticstype
ifnis
indiscriminate
selfinflicted
inappropriately
interferonopathies
essence
ifnrelated
inborn
ifnregulated
natura
leukocytoclastic
immunooncologywith
spytagspycatcherenabled
click
immunotherapyrecently
spycatchermodified
spytag
clicklink
drained
folds
e7related
sir
strategieswe
1e
antimouse
thrombocytopeniaprimary
salvages
recycles
4470
4464
100mgkg
dosed
antifcrn
sizeseasonal
riskstructured
immunes
0100
assume
managementchimeric
dysphasias
mucoadhesive
flavobacterium
columnare
tilapiavaccination
infeedoral
columnaris
formalinkilled
chitosancomplexed
mucoadhesiveness
anionic
deathin
umbrella
necroptosis
t1dm
lend
delineating
sla
rlack
skews
challengeleishmaniasis
tci
ckinase
transcutaneously
slact
rlackct
metacyclic
immunohistopathology
antisla
antirlack
antict
ifnγil10
studymesenchymal
postkidney
2×
nonstelevation
infarction
msctreated
kidneymsc
1500
haemiraes
registre
effets
indésirables
sévères
anticorps
monoclonaux
immunomodulateurs
cancérologie
reisamic
immunotox
gustave
roussy
référence
cytopénies
ladulte
cerecai
classed
948
0·5
5175
haemirae
bicytopenia
pure
characterisation
econlit
1688
offtopic
influenza25
pneumococcal18
papillomavirus9
zoster7
tetanusdiphtheriapertussis9
b9
vaccines1
tetanusdiphtheriapertussis
sized
215627
0yearold
stayed
569±040
486628
780±124
662974
9year
100204
055±013
030064
9yearold
16year
antihbcpositivity
strangely
immunotherapyforkhead
p3positive
harmless
aeroantigens
obscured
postulating
maliinfluenza
lci
h1n1lci
5345
2957
mali
hpvvaccinationbackground
adverseevent
243415
8524
coveragewith
improveintroduction
onesizefitsall
her2directed
nonnucleotidic
reviewmycosis
infectionpassive
antihiv1
harnessed
immunotherapyanticancer
proceeds
recipientspulmonary
rvi
prervi
postrvi
relapserelated
subhazard
shr
rvis
publiclyfunded
squares
plssem
0082
0214
0166
0261
thoughts
judicious
abf
contactchallenged
finishing
removals
2094
2489
5798
revenue
10543
9879
3381
prrsvendemic
leave
glycoproteingdeficient
eyedrop
weekold
chickensinfectious
loses
δgg
vaxsafe
bioproperties
pty
sevendayold
pathogenfree
1038
tracheal
andrisk
somepatients
costof
clinicalimmunology
porto
venomimmunotherapy
decliningtreatment
ci112
968
identifiedas
3foldincrease
refusalleft
avoidable
transplantationuse
haplohcts
hcts
philadelphiapositive
306
kineticsbased
669
507
537
jerusalem
workshopthe
btb
spillover
cull
prized
taboo
mbovis
ctl019
leukemiaover
underassessed
operate
myelomadespite
antigenbcma
κlightchain
slamf7car
nkcells
utilise
estimationsdelivering
poorquality
informatics
estimator
madagascar
ses
wasted
statusbarriers
thembackground
complacen
instructive
atmos
phere
resort
vacci
neglect
dnase
micetrichinellosis
adultspecific
ii1
tsdnase
immunoproteomics
aw
iil
straincyasl1344
mesenteric
mln
cuticle
nematode
molting
preadult
5385
5926
iivaccinated
in50yearold
td13valent
opa
18c
19a
05uml
tdpcv13
pcv13td
nct03552445
793b
antigenin
vn
q1
d388qx
d388
d274
arkansas
layertype
ibvs
m41
degenerated
dendrimers
luminal
fibrous
obliteration
bronchiolitis
obliterans
box1
bos
isografts
hmgb1neutralizing
maryland
petsrabies
owner
marylands
20000
immunotherapynanoscience
lauded
nanoscience
nanomedicines
cutting
allotransplantobjectives
bmscsec
allotransplants
fisher
25mgkg
wetdry
pao2
mmhg
2379±130mmhg
249±78mmhg
ishlt
619±06
936±2
6955±07
73±084
2495±12
2775±021
375±02
568±002
ferret
crossprotectivity
antigenically
ferrets
crossprotective
tlaiv
qlaiv
byamagata
laivs
bvictoriabased
byamagatabased
breg
il35producing
il35inducible
itr35
il35mediated
suppressions
resumption
wishful
shorttime
venereal
tumorwhole
lysateobjective
ctvt
vulvar
submucosal
intravulvar
1butanol
wholelysate
fitcdextran
anticanine
cd14
dlaii
89±5
fowlpox
virusfowlpox
poorlydefined
avipoxvirus
climes
insects
poorlydescribed
copies
reticuloendotheliosis
pathotypic
avipoxviruses
recombinationmutation
farmed
lysateloaded
collaborated
zinc
lznp
znp
monophosphoryl
cellderived
dpeptide
ppa1
tlsloaded
regimenobjective
ifd
64months
fiftysix
123days
aspergillosis
iyd
candidemia
imds
iyds
p0012
impacton
overallsurvival
p0018
analysisobjective
platinumpretreated
57months
20months
noiraes
041
03057
178months
40months
023047
developed2
85months
268months
026056
experienced2
vaccineeligible
cuernavaca
n200
oxnard
binational
prospectobjective
vocabulary
targetassociated
participates
bioreactorbased
ipscderived
phagocytes
ipsc
industrycompatible
stirredtank
bioreactorderived
ipscmacrophages
ipscmac
cd163
primitive
aeruginosamediated
immunecells
ipscsources
llipid
nanoparticlesthe
nanobiotechnology
presumptive
rheumatologyhematology
caps
mas
managementcatastrophic
antiphospholipid
afflict
rheumatologic
hlhmas
fatalities
agentsalthough
brutons
timelimited
biologydriven
integrins
healing
gvhdrelated
reinstalling
tissueregenerative
lymphomafollicular
lenalidomide
lowtumorburden
prompting
discouraged
wethe
allografting
chronicphase
advancedphase
principally
vitally
allografted
patientdonor
adjunctive
lymphomasmost
rides
financialtherapeutic
apprise
ballmulticenter
41bbbased
lentivirally
balls
systemobjective
vci
poll
evci
cochranearmitage
mean175
vaccinationvaccine
thrombocytopenic
adem
denied
reactionsobjectives
hsr
750
966
antinkg2a
cellscheckpoint
monalizumab
antibodycoated
firstgeneration
vaccinestumorinfiltrating
immunereactive
knocked
qa1
ortholog
hlae
nkg2aqa1
nkg2ablocking
interferonγstimulated
preponderance
cqas
frmp
neighbor
visne
multiplexed
ifnγstimulated
30day
indexobjective
23million
r95
r96
r98
unattended
r99
illdefined
unspecified
1274
unintended
abortion
2006december
19751992
22weeks
522705
7487
351878
5262
350739
5245
ratio096
057161
ratio094
053167
gilthead
seabream
sparus
aurata
zebrafish
danio
rerio
oncorhynchus
mykissthe
1min
onchorhynchus
mykiss
stressrelated
enolase
radioimmunoassay
organdependent
il1βdriven
poststress
hps
saurata
stressor
hypothalamicpituitaryinterrenal
speciesspecific
mohs
micrographic
surgerybackground
unstudied
5775
dehiscence
p056
nonsolid
medicationrelated
nontransplant
mms
ppsv23unique
imposed
n91
arthritic
agingthe
inflammaging
ageassociated
immunobiography
sneeze
schizophrenia
barriersunassigned
742
washing
718
lymphomabackground
judged
checkpointrelated
nct02445248
cllbackground
protocolspecified
ibrutinibplusrituximab
nonhematologic
ibrutinibcontaining
nct01886872
traced
countriesintroduction
currency
inflated
crosscountry
i25132qaly
i38253qaly
dengueinfectious
singaporeans
singapore
seriousness
cattleangus
hereford
feedyard
pasture
transported
yard
herpesvirus1
parainfluenza3
antisiv
aav8
swarm
sivsme660
challengegene
macaque
naturallyarising
adenoassociated
quantitation
1012
needleinjection
proportionately
antidrug
antitransgene
aavdirected
therapybased
aavbased
cd19redirected
retransfused
gfpcd19
probe
gfplabeled
statesobjective
22question
emailed
chestabdomenpelvis
noncentral
brainhead
neckextremities
hospitalizationdeath
975
sbrtsrs
watch
2019for
commemorate
celebrate
noncancer
erenumab
aimovig
fremanezumab
ajovy
galcanezumab
emgality
burosumab
crysvita
lanadelumab
takhzyro
caplacizumab
cablivi
poteligeo
moxetumomab
pasudodox
lumoxiti
ibalizumab
trogarzo
tildrakizumab
ilumetri
ilumya
emapalumab
gamifant
sacituzumab
govitecan
ravulizumab
risankizumab
romosozumab
tislelizumab
sintilimab
camrelizumab
leronlimab
brolucizumab
polatuzumab
eptinezumab
teprotumumab
crizanlizumab
satralizumab
tanezumab
spartalizumab
mor208
oportuzumab
monatox
tsr042
enfortumab
bcd100
omburtamab
mirvetuximab
soravtansine
duocarmazine
depatuxizumab
mafodotin
installment
selfdisclosure
dmt
hedmt
medmt
edss
arrs
confirmededss
32years
1758
019027
028037
ci056086
065
053080
062110
p020
100176
arr
escalate
ins
hyposmia
strips
burghart
wedel
241±79years
1543years
bitter
p0053
vectorspecific
aav28mediated
micewe
euglycaemia
singlestranded
ssaav28
cleavable
proinsulin
liverspecific
enjoyed
hyperglycaemia
710fold
anticd4
aav28reactive
aav28hlphinscotreated
cellschronic
systemsensitive
quiescent
antiil1rap
secured
icasp9rimiducid
tkiresistant
afatinib
chemonaive
afabevcs
protocolafatinib
egfrtyrosine
exon
egfrtki
2sided
caen
ihbn
postal
1017
200607
pandemicbackground
aimsseasonal
sivu
2013methodsour
805000
analysesresultsafter
201011
4395091794
4072565
8733056
voucherconclusionsour
impelled
cd73
piggybacengineered
paralyzed
cd73induced
immunometabolic
nkg2dengineered
ectonucleotidase
nonvirally
nkg2dcarpresenting
piggybac
transposon
dap10
cosignaling
nkg2dcarnk
alleviation
adenosinergic
significancechimeric
oncologybackground
oncoviral
morph
impart
immunooncologist
foundational
deliverycan
refined
forge
tumormediated
ectoenzymes
cd39
cr2cr1
tt32
convertases
modelscomplement
ic3bc3dgc3d
tt30
apselective
cr2
scr14
surfacetargeted
scr
lp
cr2mediated
decayacceleration
cofactor
wieslab
46nm
anticr2
antibodyinduced
caia
untargeted
cda
cplp
c3c5
complementmediated
carpio
hydrophilaover
pl
bacteriophage
pah
6c
lactidecoglycolic
microparticles
interleukin1
formailin
plgaencapsulated
cellsbased
αpdl1
hypofractionated
infiltrationaim
gy×3
populationaim
of162
lossgürçetinkaya
çağdaşayvaz
öksüz
ertoy
hayran
özkan
erol
tezcan
i̇
turk
270276
lymphatics
switched
mf45
61287
p0069
p013
p0080
increments
strategiesobjective
matlab
20172056
50684
yuan
104539
155223
70908
5971
175989
2366
33741
14261
27249
8452
4495
44309
9861
cancerto
nonblind
grouponly
feeling
depressed
25th
t25
obviously
melanomaneuroblastoma
nb
crest
stageaffected
tag72
cellsimpressive
sialyltn
oglycoproteins
tag72specific
tag72bbζ
antigendependent
recurring
tag72car
civilization
futurevaccines
prolongation
streamlining
processadoptive
cumbersome
vaccinehesitant
jewish
localities
rate722
52±091
471±121
4540±598
4295±684
793
enterovirus
d68
flaccid
myelitisenterovirus
evd68
afm
named15296virus
tachypnea
acidophilic
thickening
muscles
15296virus
prototypevirus
fermon
potentiality
dv281
cellscpgmotifcontaining
oligodeoxynucleotides
cclass
pd‑1
ifn‑α
interleukin‑6
tlr9dependent
tlr9deficient
bronchoalveolar
repeatdose
actionrelated
nonadverse
antipd‑1
vaccinationdevelopment
imq
ultradeformable
archaeosomes
uda
sn23
phytanyl
saturated
archaeolipids
udl
250±94nm
26±4mv
igg2aigg1
isotypes
cellbiased
cream
aldara
uptakethis
hbm
n3971
brunei
695
collectivism
pathogenreduced
alloimmunization
hematooncological
concentrates
pcs
prepares
mirasol
terumo
bct
itt
142651
100540
pharmacologically
homesbackground
bpafacilities
gainbetter
adescriptive
germanys
aship
20percentage
pointspp
consulted
ageneral
35pp
tipping
homeostasisthe
forkhead
interleukin10producing
tcrmediated
cd28mediated
tissuedependent
tcvac1
trypanosoma
cruzi
tcvac
gpianchored
dnaprimednaboost
tcg2
tcg4
intradermalelectroporation
ide
antitcg2
antitcg4
morphopathological
igg2aigg2bigg1
tcvac1idetc
tcvac1imtc
nonvaccinatedinfected
amastigote
nests
vaccinatedinfected
medicineimmune
erv
chromatin
ddr
tensin
pten
neuritis
hispanic
periorbital
ophthalmic
fundus
photography
humphrey
reviewin
vt
hr065
hr059
hr106
ocvs
reanalyzed
ocvc
p00004
p00007
precluded
benefitted
holly
grail
immunotherapyradiotherapy
imrt
turns
insitu
immuneresistant
outoffield
tecemotide
lblp25
crt
lansclc
immunoradiotherapy
executive
hse
staffaims
onward
promotions
ltcf
asking
hseemployed
facilties
carboplatinbased
substituted
keynote045
melanomaclinical
iiii
dtapipv
reportreports
intensely
aluminumcontaining
kinrix
excised
inspection
dermal
nodular
histiocytes
bluish
amphophilic
granular
polyadpribose
parpis
dive
resistancethrough
sar228810
protofibrillar
amyloidrelated
ariabackground
antiamyloid
vasogenic
bapineuzumab
fibrillar
sar255952
gantenerumab
ban2401
aglycosylated
dosedependently
plaquerelated
3mgkgweek
monomeric
synaptic
hippocampal
decoration
50mgkgweek
microhemorrhages
meningeal
arteries
appsl
3d6
immunotolerized
nonclinical
spce
monitoringbackground
stamping
fmdfree
solidphase
lpbe
liquidphase
vntthe
methodhas
labor
priocheck
raw
xj
progressionepithelial
witheoc
metalloproteinase
mmp2
timp2
tgfβ1r
olaparib
immunotherapyrecent
broadens
pluripotency
honours
nancy
3phase
gc99
ibd267
493
n102
922
tetanusdiphtheriapolio
antipneumococcal
857
transcriptomics
oncologycancer
noncancerous
immunotolerance
specially
massivelyparallel
unsupervised
agnostically
tumorsmost
lowmolecularweight
fluorescein
antifluorescein
nineyears
followupbackground
cmpa
nearfatal
trace
milkproteins
cmp
cmpoit
diary
200ml
doubleunit
reviewcontroversial
6571
graftvsgraft
abrasion
stripping
corneous
occlusive
deepness
scraping
2435months
1386
682
job
pathwayimmunotherapy
liposome
phospholipidconjugated
ind
twodrug
activationrecruitment
naıve
disappearance
doxindliposome
doxonly
melanomathere
heterogenous
agethis
proquad®
405
1218months
nct00402831
bounds
twosided
injectionsite
postdose
oxy
nanorods
vaccinebacterial
alooh
nanorod
alnr
μm
alnrs
25fold
milder
geriatrics
patientwith
cancersocalled
reserve
hisher
patients65years
patientrelevant
overviewthis
fainting
dysmotility
crps
postural
orthostatic
pots
sfn
fibromyalgia
posthpv
cognizant
causation
momentum
adversomics
pharmacogenetics
mediastinalhilar
sarcoidlike
lymphadenopathy
lnpositive
spleenrelated
antiegfrviii
glioblastomaegfrviii
physiologybased
lowvalue
householdsvaccination
highvalue
chickenowning
arusha
singida
mbeya
smallholders
5853
tanzanian
shillings
highercost
offfarm
onfarm
seizurerelated
disordersbackground
chronologic
vsd
riskinterval
37weeks
532375
45343
487032
irrs
2560
2737
07619
p041
measlesmumpsrubellavaricella
1623months
germanypassive
unprotected
mvspecific
mvneutralizing
stipulated
400mgkg
bronchiectasis
managementbronchiectasis
exacerbations
nonexperimental
proxies
tuberculin
tst
2637
06925
10568
4310
8243
lymphadenitis
n515
095107
n397
084113
fractionaldose
17d
17dyfv
ntr7094
isrctn46326316
virusneutralizing
thirtynine
feverneutralizing
standarddose
onefifth
leiden
reviewimportance
exacerbating
latephase
malate
treatmentnaïve
outcomeswe
los
conv
cd34selected
sloan
kettering
readmission
euv
979
2821
photoimmunological
cancerphototherapy
nanophotothermal
nanophotochemical
nanophotoimmunological
nanophototherapies
rebalancing
trackimmune
opposing
contrarily
rebalance
icampthe
mentors
icamp
preposttest
reaim
111212
178212
186212
beta13glucan
aletatm
chickensthis
42day
β13glucan
aleta
hatchery
hypothalamicpituitary
parathyroid
foreword
2018to
thank
fantastic
christmas
esteemed
seeing
allergythe
trieste
disagreement
quote
forgotten
vraf
inhibitorscontaining
death1anti
fixedeffects
thirtyeight
11719
parvovirusspecific
puppies
growthfailure
maternally
parvovirus
2specific
cpv2
ρ071
27151
igg23gl
39151
1160
ρ014
youdens
index079
nonsupplemented
replacer
japaneseamericans
1985
2012in
ageperiodcohort
5054
ushaped
1930s
1920
japaneseamerican
poliomyelitismedical
invoked
elementsnonmaleficence
beneficence
justicewas
vogue
concernsbackground
demographically
ultraorthodox
jews
nonbedouin
arabs
bedouins
mchcs
nonacademic
1221
2666
or224
ci149335
or155
ci106225
ci025066
positions
israeli
20122016we
abstracted
affiliation
paradoxical
tries
accentuate
involuntariness
invalidity
acknowledges
seconddose
varv
hr×100
6762
6485
classrooms
drugsphysiological
metaregressionintroduction
nses
higgins
commissioned
092208
proneness
misclassification
cointerventions
metaregression
outlying
permutation
falsepositive
132
083208
p0059
westafrica
westafrican
africabackground
influenzaassociated
unpublished
usd1481344
usd1121230
unravelling
immunotherapyasthma
discern
alstonia
scholaris
flowcytometry
annexinv
corrected
baxbcl2
elaborate
validationepidermal
hscfv
glycosylations
immunocytochemistry
growthmetabolism
u87egfrviii
egfregfrviii
lyn
glut3
fludarabinebusulfan
metaanalysisfludarabine
fb
fm
hctwe
dersimonian
amlmyelodysplastic
amlmds
immunotherapyantigenspecific
phenotypical
grand
surfaceanchored
spurring
extensions
landscapefor
englandintroduction
declination
masks
n72
qsr
nvivo
practicability
enforceability
principled
worry
intelligencegathering
stigmatising
blockadeobjective
mskcc
fortysix
bulky
494
parenchymal
664
prismaguided
headneck
willingnesstopay
recurrentmetastatic
hncs
newlydiagnosed
gucs
metastaticunresected
nivolumabipilimumab
overstated
downregulationcombined
tc1a9
oligodeoxynucleotide
odn1826
αgalactosylceramide
oneweek
repolarized
mucindomain
containing3
repolarization
reviewallogeneic
gutselective
twentynine
300mg
vedolizumabrelated
developmentvaccination
patho
gen
expe
rienced
munity
includ
ing
tralizing
tricky
graftversuslymphoma
conditionedalemtuzumab
malignanciesallogeneic
ricalemtuzumabhsct
p0·03
62288
graftvslymphoma
ricalemtuzumab
il121518
trafficked
cytokineprimed
tumorsadoptive
moieties
falknors
needling
palmoplantar
wartsunassigned
wart
punctured
26gauge
beefy
20whether
rests
agerange
endovascular
expectation
needsallotransplantation
exploded
popularity
intensities
situationally
optionstailored
statuswill
therapysurvival
onesizefitsallages
pediatricinspired
attendant
allprogress
pathobiology
notch1
cdkn2a
syndromestherapies
higherrisk
lowerrisk
immunosuppressionimmunosuppressed
evidencedriven
breedtowean
weaningbreedtowean
diversify
gilt
pigletspecific
n83
12814
2989
submissions
seasonadjusted
pvalue005
wean
subclones
tuberculosisintroduction
crossvalidate
precious
glycerin
immunooncologyimmunotherapy
nanotechnological
sota
haemagglutininneuraminidase
challengeintensive
rla
sotahn
9dayold
embryonated
intracerebral
1dayold
immunemodulating
immunoresponsive
conferences
fdas
cancersa
modelsthe
reeducate
cytotoxicants
annihilates
vδ2
vivorecent
cell62based
vγ9vδ2
hlamatching
cbmcs
cellsimmunotherapy
pursuance
ctlbased
acclaimed
ctlespecially
ctlsmay
ipscs
hrqol
eortcqlqc30
explorative
nongenotoxic
rnabased
mispairinggenetic
retro
unstimulated
dicersubstrate
dsirna
dsirnaresistant
nonintegrating
biosafety
undeniable
stearyl
polyethylenimine
noncovalently
immunotherapyunassigned
complexing
pei
peihsa
disrupts
silences
stearylpolyethyenimine
peiplasmidshsa
maded
dls
3dimethylaminopropyl
ethylcarbodiimide
hydrochloride
edc
hydroxysuccinimide
stearic
sgrna
sizezeta
f25p1
chargecharge
2027±45
1260±015
mv
f25p1s05
hightransfection
2195
bureau
healthinitiated
nippon
bioplex
embolization
blunt
asplenic
embolizations
embolized
angiographic
sixtyfive
wrongly
nontrauma
antihacht4
chitinase
helicoverpa
armigera
hacht4was
hacht4
hishacht4
ecoli
nicolumn
footpad
tenebrio
molitor
therapiesunassigned
20092017
reinitiation
breastmilk
intrauterine
chitosanbased
systemsdespite
needlebased
syringes
vaccinationtuberculosis
threating
balmetteguerin
endurance
discuse
salidroside
haematopoiesis
myelosuppressed
anaemiathis
sal
60co
lineagesca1ckit
burstforming
uniterythroids
unitgranulocyte
unitmegakaryocyte
saladministrated
fasapoptotic
fasfaslcaspase3
inhibitioninfections
hyporesponsiveness
childrennew
javelin
cancerchemoradiotherapy
nct
02952586
haemophagocytic
lymphohistiocytosisallogeneic
fhlh
n81
9·9×10
0·49
0·270·88
p0·02
2·11
1·014·4
p0·05
2·82
1·276·23
p0·01
nad
metabolizing
ectoenzyme
correspond
vhhs
moab
kda
vh3
camelid
moabs
hivthe
cytopatic
nonaids
cd8cd28cd127lowcd39
circulate
drugsparing
neuroblastomapatients
upftont
minister
ministervaccinator
leukemialeukemia
kmt2a
riskstratified
blymphoblastic
21months
specseq
unveils
antibodysecreting
vaccinationvaccines
governed
ascribed
vaccinepositive
vaccinenegative
antigeninduced
nonmandatory
epidemiologyin
minors
directionscancer
giltsheavy
oestrus
boars
seventytwo
6349
v1
dbe
immunostimulating
microvesicles
crossprocessing
cellstumor
mvs
evoking
pivot
crosspresent
glycoantigen
xvivo
xdcs
acidification
phagosomal
alkalinization
rmuc1
singledomain
signalingupregulation
sdabs
ectodomain
140nm
orthologue
epitopedependent
hfcs
egf
30nm
vastly
conditionsobjective
srmc
settingparticipants
adelaide
328
639
fanconi
ataxiatelangiectasia
chimerismataxiatelangiectasia
autosomal
recessive
breakage
telangiectasias
sclera
sinopulmonary
telangiectasia
tiuxetan
lymphomanonmyeloablative
tiuxetanbased
nonremission
indolent
survivor
nct00119392
3xtgad
pathologybackground
hyperphosphorylation
tripletransgenic
brains
20monthold
3x
tgad
gendermatched
peptideimmunized
blots
hemibrain
2550
phosphorylated
trimerimmunized
antiaβ
adamyloid
tanglesin
an1792
vaccinationnoninvasive
virosomes
cochleates
aracheosomes
20042015objective
663
346100
113100
114100
174100
158100
266100
8436
6205
9354
hyaluronanbased
assessmentthe
dmns
singlearray
wells
polydimethylsiloxane
dmn
ovaha
ww
27µg
hollow
cellsinterleukin33
implicationsbackground
fighter
melanomachanges
polypeptiderelated
micb
escapes
ferrari
andrade
micamicb
celldriven
antitnfα
hesitancyintroduction
rumors
headlines
refers
subsiding
t11ts
microglial
cryptococcus
neoformans
braincryptococcus
inhalation
harbours
t11target
potentiation
cryptococcosis
cneoformans
postinfections
alcian
corroborated
evidencing
restorative
fungus
flowcytometric
conducive
dampened
effected
fcγrexpressing
micethere
celltargeted
hcd20
adas
ursodeoxycholic
dntgfβrii
hfcγrs
antihcd20
tkm011
liverinfiltrating
07426
00006
06423
00054
antimitochondrial
amas
il12p40
cxcl1kc
glycodesignimmunotherapy
falling
glycosylationa
ensures
optimizes
immunotherapeutichas
slowed
enticing
rejuvenated
immunotherapylimited
tipscs
cd8αβ
crispr
ofa
recombinase
preventedthisadditional
whencd8αβ
tcrstabilized
regenerated
tumorgrowth
bimmugen®
05mlvial
antihbspositive
479
ylog
x0134
sophistication
ar101
kernel
peanutderived
escalatingdose
632
activedrug
aimmune
palisade
nct02635776
icosmediated
instructionsuccessful
ovaimmunized
recapitulated
erk
commerciallyinsured
populationbackground
irs
nephrologic
6100years
hematologicnephrologic
ir026
yearsunited
surveyteen
1617
medicaid
suburban
3544
wellchild
3such
nonnutritive
sucking
nns
dextrose
d50w
3treatments
2ml
llanto
andp001
p21
andp27
p66p93
andp45
andp017
n129
microbubblescheckpoint
antivascular
ultrasoundstimulated
usmb
ct26
ultrasoundinduced
usmbantipd1
usmbs
sclerosisat
prevailing
sugar
indexes
infectioncancer
solutionsbackground
predispositionepigenetics
blockadecurrent
pdligand
l1
gamechanging
antigendirected
occupied
sialic
aciddependent
ganglioside
gd3
microenvironmentsthe
gd3mediated
930years
5517
158years
163years
152years
mediterranean
barriersvaccination
originated
invest
mutein
diseasesusceptibility
effectorfunctionsilent
n88d
il2rβγ
stoichiometry
il2n88d
iggil2n88d
regs
1014fold
demethylated
iggil2
pharmacistsbackground
eightythree
scalability
adultsadvanced
ganoderma
lucidum
polysaccharidegold
responsepolysaccharides
clearances
glpau
cd80cd86cd40mhcii
cd4cd44
infectionnovel
hiv1infected
antibodyresistant
latencyreversing
damper
dualtargeting
mir146b
macrophagesobjective
mannosemodified
mtcconjugated
mtcmir146b
tumourigenesis
moreover，
mimictreated
mtcnc
mir146bdeficient
dextran
sulphate
dss
colitisassociated
bmdms
stat3dependent
semidesert
iedb
35mer
1klh
rsal
dot
youtubeobjective
youtube
videosharing
videos
wwwyoutubecom
omit
unhealthy
erroneous
lactoferrin
resistin
32weeks
weighing1500g
n48
n52
02ml
4hours
supplying
enteral
morbidities
cellmembrane
growthdeveloping
battle
cloaked
4444porphine5101520tetrayl
tetrakis
benzoic
tcpploaded
nknps
shotgun
m1macrophages
tcpp
praised
interferonfree
alloral
ifnbased
ifnfree
abrupt
alarming
holdthe
pertussiscontaining
resourcerich
troll
pit
201217
runny
15695
15·9
13195
84·1
6·4
11·0
summer
4292
5774
2557
6488
0·52
4671
3970
2261
longerlasting
adverseevents
characterise
vigibase
dictionary
jan
nct03387540
31321
16343451
5515
11·21
9·3613·43
3·20
pericardial
12800
3·80
3·084·62
1·63
33289
1·56
1·251·94
arteritis
696
12·99
8·1220·77
2·59
polymyalgia
rheumatica
1709
5·13
3·138·40
1·33
institut
thématique
multiorganisme
aviesan
20142019
bradford
jr
hgfmet
immunotherapyan
hepatocyte
hgfmesenchymalepithelial
hypothesizing
receptorligand
ccr5
guineabissau
bissau
stabilised
transfix
datalinkobjective
lowerlayer
arealevel
utilised
anonymised
35333
524
18499
089
ci085093
057073
081090
trend00001
deprived
064075
nonwhite
ethnicities
049075
realising
practicesthe
secretary
acips
voting
mmwr
lymphocytesin
c1858t
lyp
r620w
duplexes
lipoplexes
immunotypes
downmodulation
lipoplexestreated
setup
avoidancepro
stabilizers
antihistamines
glucocorticosteroids
gcss
leukotriene
decongestants
nonsedating
mp2902
fluticasone
propionate
azelastine
endotype
dtpaipvhib
pertussisinactivated
poliovirushaemophilus
nct01309646
4269days
dtpaipv
unsolicited
31days
antidiphtheria
antipolyribosylribitol
antipoliovirus
antifilamentous
antipertactin
prn
antiprp
8456µgml
18700µgml
irritability
fiftyseven
14week
postipv
preintroduction
postintroduction
phcs
455
n826
209342
328328
comfortable
eightyseven
surrogacy
activecontrolled
preanalysis
yrmilestone
1ysur
22804
0707
07040708
0829
08280831
pfsmedian
00980101
0064
00590069
0835
07910918
disassociation
anticluster
auristatin
lymphomatoid
papulosis
cutaneousanaplastic
pcalcl
antichemokine
ccr4
antibodyspecific
canceropinion
envelops
netrin1
usmi
ligandfunctionalized
microbubbles
immunolocalization
antinetrin1
netrin1targeted
micromarker
targetready
visualsonics
chamber
netrin1expressing
netrin1positive
skbr7
mdamb231
vevo
fvbn
tgmmtvpymt634mul
mmtvpymt
huvec
proteoglycans
endothelium
internalizing
her2positive
carcinomain
ludota
chelate
dotaprit
gpa33
internalized
gastroesophageal
athymic
bt474
her2expressing
iggscfv
c825
haptenbinding
bndota
antiher2c825
dextranbased
ludotabn
smallersized
palpable
ti
radiationabsorbed
399
cgymbq
ludotabnmouse
antigenantibody
tis
radiotoxicity
cd16polymorphism
fcengineered
cd16chimeric
recognise
fcportion
cd16car
fcterminus
raji
antimcsp
glycoengineered
158v
mcsp
synergised
microsatelliteinstable
fasfasl
cd133
faslinduced
fasl
microsatellitestable
practise
healthcarebackground
koroška
contractors
201415
selfprotection
coworkers
coveragehesitancy
settled
explicitly
implicitly
fgds
chiefs
predefined
programmesservices
n94
asylumseeking
asylumseekers
wartorn
infrastructures
asylumcenters
digitally
interpreters
tacit
err
failureinfluenza
chd
higherquality
pathophysiologic
immuneinflammatory
atherogenesis
ghosts
modelenterotoxignenic
etecassociated
etecrelated
bgs
envelopes
substain
comformation
bg
dq061
phh43
9993
42°c
10×ld
h4ic31
anemiathis
imha
urticarial
coincidence
allergiesthe
formularies
continuums
lymphomarecent
transitioned
methodsresults
consolidate
nextintroduction
disappointment
pub
studydata
passyon
24yearold
gee
4996
1901
interleukin32
tuberculosistuberculosis
hostdirected
il32
inspire
immunitybased
responsesadenosine
recipientscancer
counteracting
medal
gianus
sides
twofaced
roman
god
transplantationdata
n1696
n781
1324
608
p894
p12
p178
p176
p802
p633
p812
pegilodecakin
invigoration
patientstumorreactive
granzymeb
interleukin18
transplantationmost
pertain
20092013
hdv
sdv
ratioweighted
350921
825642
051070
070075
077103
lessbiased
nonuser
toxicitydespite
ovvs
selfprotein
ifnαβ
ovv
rvsvzebov
knowintroduction
stomatitis
zaire
ebovgpspecific
tumorsgenetic
studypersistent
1444years
beirut
2879
vignettes
nonconservative
aor21
claim
aor27
aor14
aor05
aor34
italybackground
intercourses
397
471
street
110years
1226years
reevaluating
rotarix®
rotavac®
rotasiil®
prequalified
excelbased
subsidy
gni
wish
grandparents
unfounded
firsthand
remember
researchinformed
seventyseven
dearth
illinformed
bile
duct
53yearold
27mg
81mg
20year
fd
secondorder
955957
961964
groupp0001
3423
5751
8314
3411
5717
8216
rc
adenocarcinomagastric
unproven
thriving
treatmenttriplenegative
estrogen
progesterone
erpositive
responseallergenspecific
microcrystalline
mct
mpl
ltyrosine
isss
phosphatidylserine
olive
hyperreactivity
lymphomahodgkin
factorκb
kinasesignal
transducers
highlyeffective
assists
immunotherapyblockade
bioavailability
preventionintroduction
cascading
porosity
selfadjuvanticity
mesoporoussilicabased
msns
micrometersized
rods
msrs
msnbased
msr
treatmentsan
attacked
antiicosl
arthritislymphocyte
sole
b7related
icosicosl
knowns
unknowns
biologya
salmonellabased
nonobese
salmonellaexpressing
preproinsulin
ppi
cellexpressed
spi2ttss
promotereffector
shortcourse
gad65
gad65tgfβ
ppitgfβil10
codonoptimization
pln
eudravigilance
suspect
7097
4248
241years
8167
therapycontext
yr
papillary
ected
careeliza
amanda
lisa
escapecd19
heterogeneously
sialyl
lewisa
slea
radiationexposed
trailmediated
sleatargeted
traildependent
bmc
outcomesadoptive
cbbased
cbus
ipa
noninherited
nima
25×10
allelelevel
cbu
matches
cbuderived
lowlevel
hypertensionbackground
hypertensive
hypertensioninduced
mra
enos
autophagydependent
menacwycrm
3b
nct02106390
4cmenbmenacwy
postbooster
postprimary
bactericidal
hsba
68100
87100
599fold
strainserogroup
learnedbackground
americas
eirs
eir
stakeholder
narratives
locallevel
mexicos
laudable
reform
perus
capacitybuilding
seicap
dietbackground
pasteurized
pew
eggfree
33g
libitum
t12
t18
t24
8421
1600
9375
7812
consuming
servingsweek
9743
mhcindependent
metastasespurpose
radiographically
confusing
immunotherapycytokines
cytokinebased
sirnas
progressionunder
imc
imcs
tumourbearing
tricks
cd19positive
leukaemias
bioengineered
pdloma
blockadeclinical
histotypes
pdlomas
synergiescancer
pathobiont
proliferationchronic
dysbiotic
keystone
porphyromonas
gingivalis
mddscs
foxp3t
pakt1
pfoxo1
bim
mfa1expressing
foxo1target
chipassay
gingiva
osccp
fimap
invades
inflammatoryangiogeniconcogenic
pgmfiinduced
pakt1pfoxo1
mfa1
fimbriae
twohit
dcsign
measlesassociated
thin
ukobjective
nonmeasles
2228
19930
immunecompromising
predetermined
postmeasles
1524more
nanobiologics
acceptanceinducing
dectin1
immunityassociated
nanoimmunotherapeutic
mtorspecific
hdl
nanobiologic
mtorihdl
cd40traf6specific
traf6ihdl
indefinite
hdlbased
and…
statins
tuberculosisthe
meles
maximising
badger
iophenoxic
trapped
setts
199240
ml1
outlier
outliers
baited
1014
caught
2428
arlene
sharpe
phd
primigravida
85mm
salpingooophorectomy
hmb45
melan
slowgrowing
something
applicationsinfluenza
frailer
spur
nonresolving
unraveled
epcamcarnk92
modelsadoptive
epcampositive
forgiven
tgfβassociated
pancancer
cecm
smad4
previouslyproposed
pending
2017objective
mshc
2108
n161
1947
1134
830
aor311
4male
aor138
n95
clinicbased
heterosexuals
fatwa
resultsobjective
vaccinoscopie
vcrs
11monthold
sfgmtcdisease
8th
karnofskylansky80
score3
regulable
glioblastomaadoptive
receptorsmodified
splitting
sscar
exogenously
sscart
ap21967
doseand
resistancerecent
interferonγinduced
ompt
ichthyoenteri
olivaceusvibrio
enteritis
flatfish
omps
ompv
ompu
omp1
omp2
antiv
romps
rompv
rompu
rompt
romp1
romp2
siglymphocytes
mhciiα
crowd
peptidome
71·8
85·3
n154
haemorrhages
therapiesthrombopoietinreceptor
2·87
0·66
thromboses
diagnostictherapeutic
witness
aya
1525years
subdistribution
shr0·38
0·961·00
p0·008
shr0·84
p0·56
44·8
62·5
21·7
failurefree
48·4
20·7
5·4years
86·5
1·51
0·259·02
p0·66
4·98
1·0024·73
p0·049
lymphomaautologous
myelotoxicity
antiprogrammeddeath
postautologous
postautologoussalvage
corticosteroidrelated
asthmapurpose
asthmatics
nonsuitable
antiil5
antiil4receptoralpha
pembro
ipilimumabnivolumab
ipinivo
of12
resultstotal
of400
24versus
6695
30147
19104
1436
impetus
multicentric
plasmacytomas
intentionbehaviour
yesunsureeventuallynever
yesyes
adviceagreement
noting
unsureyes
unsureno
eventuallyno
misinformationnegative
ambivalent
nonsupportive
neverno
deferring
mechanismimmunotherapy
dr3
dr4
dr5
qualifies
immunotherapytumor
beings
immunotherapyfor
nf
κ
chromene3carbonitriles
repurchased
betatubulin
tubb
uninjected
contralateral
depolymerizing
challengeadoptive
protein1pd1programmed
1pdl1
pdacs
simian
depletionrhesus
intrabronchially
svv
50mgkg
49days
dermatomes
orf63
sweat
alveoli
vzvspecific
reactivates
arnax
vaccinationadjuvant
patternrecognition
immuneenhancing
cytokinemia
subcomponent
tlr3specific
arnaxha
haspecific
igaigg
arnaxantigen
34kda
carboxyterminus
bpmp72
brachyspira
pilosicoli
infectionthe
anaerobic
spirochaete
colonizes
bmp72
histidinetagged
100μg
1mg
pectoral
crop
cps1
caecal
bakery
sutmek
bakedmilk
studiesobjective
6580
180°c
sutmekmilk
milkfree
sutmekplacebo
iges
spige
1348
wheezing
αlactalbumin
receiveroperating
spiges
0981
0983
reacting
tarin
micechemotherapeutic
colocasia
esculenta
cyclophosphamideimmunosuppressed
repopulation
gr1
ly6cintly6glo
anticipating
proliferationdifferentiation
ly6cloly6ghi
tarintreated
g0
cyinduced
leucocytes
erythroid
cycytotoxicity
cancersbackground
amore
spherical
immunizationrecent
nanostructures
15nm
tgev
gnps
antibodyforming
γifn
gnpantigen
morphologicalfunctional
microanatomical
bdependent
humoraltype
degradative
ok432
asthmaenhanced
th1favored
g2a
blockadea
antictla4antipd1
handpush
emulsification
immunizationsetting
unexpectedly
angiotensin
at1aa
puzzled
nonparticipants
glove
gloves
permeability
speculated
shiri
clalit
chs
twiceweekly
arfi
selfcollect
workdays
nct03331991
immunizationat
isi
rop
ron
gra
rom
sag
bradyzoites
pathogenicityimmunogenicity
enolase2
eno2
sag5d
ron2
islet
lymphodepletioncontext
remitting
rrms
aitd
hyperthyroidism
tsh
politically
evidencepertussis
fim
elk
reindeer
wasting
diseasechronic
cwd
cervids
aggregationprone
tgelk
dimer
dmo
mdi
mmo
prions
elisadetectable
mmoimmunized
quakinginduced
postimmune
ddivaccinated
mitigated
cwdrk13
therapytherapy
antitrp1
ta99
tlr378
fcγri
fcγriii
fcγriv
dispensable
implicating
f480
ly6c
reducedintensitynonmyeloablative
1395
exceptions
ebvderived
barf1
cd8restricted
ebna1
lmp1
lmp2
bamh1a
barf1specific
ebvseropositive
ebvpositive
vivogenerated
cd8positive
hlaa02restricted
hlaa02
hlab1562restricted
ebvtransformed
lymphoblastoid
gliomasobjectives
montpellier
fertilization
ivf
rpl
2lymphocyte
tnfalpha
7226
challengecaprine
kid
caprae
tbcompatible
3675
0224
0124
pegpam
cys
immunochemoprophylactic
immunochemotherapeutic
parasitesboth
antimalaria
receptor2
hepatocytic
erythrocytic
gametocytes
yoelii
s23bispalmitoyloxypropyl
pam
gametocytaemic
cd42
thymusdependent
thymusindependent
lpsimmunized
pcd41
pcd42
pcd8β
pbls
pigm
lpsspecific
postinjection
imax
klhimmunized
klhspecific
ka
1333
1934
2226
klhcsa
safetybispecific
mid
liabilities
neuroretinopathy
vaccinationthis
amn
42yearold
paracentral
scotoma
contraceptives
surg
lasers
201849e165e168
southwestern
nigeriavaccine
akinyele
lga
oyo
fourhundred
ciand
213474
236526
365813
75167
unimmunised
quintile
27180
42205
29141
islam
pandemicfour
neuraminidase
baloxavir
marboxil
myelomaintroduction
nonhematopoietic
astonishing
andnonhodgkin
emulating
mp71
pcleco
packaging
fibronectin
luminometry
lymphoreplete
congratulations
winners
immunotherapyantibodies
ctdna
droplet
nras
augmentation
p00046
punctaus
antigenaffinity
tnpklh
ascs
antitnp
tnp
meetingthe
hosted
fondazione
irccsistituto
nazionale
dei
tumori
irccs
int
biotargets
tracerx
consortiuma
multimillion
pound
antiestrogen
perturbation
iiibivm1a
mbd
1210
kaplan
meier
lpfs
dpfs
or174
or209
p0154
or088
p0839
delineation
needsallergenspecific
ultrasoundguided
inguinal
16induced
lactis
nz9000
oncoproteinrecombinant
spusp45
nisincontrolled
nice
lactococci
antigenstimulated
re6
leukemiachimeric
cd7directed
clinformatics
datamart
15months
pcv13ppv23
ppv23pcv13
224132
4208days
pcvppv23
5955days
aligning
cancerclinical
pneumoniastreptococcus
howthe
entail
immunities
ctcflboris
16years
possesses
thelper2
alphavirusbased
ctcflboristargeting
feedforward
resistancemany
ifnαantipdl1
iifn
blockadetherapy
resistancewith
intriguingly
tcelldriven
ephemeral
cd226
cd226dependent
pd1src
shp2
dephosphophorylation
vwg
87years
42223years
1445mg
offtherapy
placebotreated
crossed
2748mg
scd
43mg
4443mg
scds
4443
143mg
7443mg
omega5
gliadinspecific
gliadin
wheatspecific
rho055
rho051
7822
7921
parentsaim
koreanamericans
kas
hpprrsv1prrs
prrsv11
prrsv1pr402014
unvaccinateduninfected
vacc
vaccinateduninfected
pr40
unvaccinatedinfected
vacpr40
foxesalthough
vulpes
01year
juveniles
4month
mandible
teeth
58month
912month
hunting
hunted
autumn
tetracycline
embracing
1647
20122016the
domperidone
repellents
repellentsvaccination
repellentsdomperidone
vaccinationdomperidone
stockholmbackground
rinkeby
tensta
snowball
languages
delayers
appointed
heeding
relatives
oligomerspecific
sod1g93a
alsamyotrophic
cuzn
w20
gliosis
cords
16291
tcf7
checkpointtreated
theepigenetic
clonality
dilemmas
prospectgastric
trapping
metastasisthe
polymyxin
pmb
tak242
lpstargeting
lipidprotaminedna
lpd
trap
nanotrapping
gutliver
largepore
mesoporoussilicacoated
upconversion
immunotherapyreported
ucmss
solgel
mesitylene
poreswelling
photosensitizers
merocyanine
mc540
ucmssmc540ova
immunopotentiation
effectormemory
ucmssmc540tf
ct26tumorbearing
therapiesneurotoxicity
interleukin6targeted
deathligand1
chemists
humanpd1humanpdl1
hpd1hpdl1
cocrystal
cyclopeptides
nonantibody
sar
chickensmucosal
polydllactidecoglycolide
lachrymal
odn
coencapsulated
2x
nanoaicpg
nonadjuvanted
nanoai
npsbased
abmediated
oneweekold
aivspecific
travelpostexposure
supersede
replacementbackground
31yearold
cvid
statesociety
relationsin
alienate
sceptics
discourseanalytical
storylines
discourses
sentiments
coalitions
paying
pervasiveness
retinal
venulitisimportance
venulitis
coherence
angiography
microvasculature
erythematosusimportance
cle
bcdt
isles
bilag
acle
scle
nsle
crisprthe
clever
crisprbased
cdx1140
immunotherapylimitations
nfkb
cd40expressing
fcindependent
fab2
studyroutine
adulttargeted
susceptibleexposedinfectiousrecovered
depict
hubei
measlesincidence
timespan
10100000
adulttoadult
hyperthermiain
97cancer
thera
py
23mgkg
reanalysis
criteriairrcantitumor
criteriairrchave
tumorsrecist
irrc
paneth
epithelia
injuryaim
agi
ascendens
shamoperated
postsurgery
turnover
trialsunassigned
rtss
2723
1490
futureobjective
immunologicaltreatment
topographically
neurologicalpathologies
bibliographic
relevantones
newneurological
arediscussed
autoimmunebasis
onlypartially
trialssupport
someof
likemultiple
today´sstandard
alzheimer´s
migraine
prevalentconditions
candidatesfor
immunologicaltherapies
receivingthem
onsocial
compromisesand
managementof
galactose1phosphate
uridyltransferase
micein
vivoinduced
galt
galtomvs
highlyspecific
fourdimensional
kirschnerpanetta
eradicationin
factorbeta
arciero
nonexistence
orthant
sindh
2253
1156
691
1013
440
weekseight
formulating
45095
providerassociated
intervalci10161222
1632
14571828
1577
11952081
4655
37715746
immigrated
15812546
fringe
1807
14752214
mountainous
1615
14371814
2311
13164059
2292
18842789
1622
13092010
3yearold
10941318
bispecifics
circumventing
productively
modulationthe
proteome
targetableand
rejectableby
virally
sufficiency
5triphosphate
immunotherapyrna
retinoic
nuclease
phresponsive
triphosphate
pcrvcpg
pneumoniaan
hugely
pcrv
pcrvaluminum
pcrvalum
antipcrv
24hr
myeloperoxidase
pcrvcpgvaccinated
inflammationrelated
pcrvspecific
checkpointinnovative
mutationsbackground
p039
kraspositive
krasnegative
hijacks
organoids
pdos
pdtxs
xenografting
pd1knockdown
pdospdtxs
antimek12
innately
eventsbackground
cxcl11
cxcl13
ccl26
cxcl19
vasculitisbackground
igav
pharmacoepidemiologic
casecrossover
logisticregression
0830
0535
0632
0626
schedulebackground
n56
luml
hpv16183133455258
vlp
hpvtypes
3133455258
hpv45
7678
8182
2032
16183133455258
vaccinetypes
hypothalamitis
againfor
300years
pregnancyinfluenza
34point
unsure
8088
coccidia
spraycoccidiosis
ionophore
cabinet
elongate
preening
diluents
plexiglass
sheet
basket
speciation
settling
diphtheriatetanus
endgame
opvs
ipvvaccinated
1124
37120
35107
068
39119
postcertification
endgamebackground
replaces
preipv
ipvbivalent
bopvipv
06199
128324
2seropositive
73294
ipvbopv
samplesbackground
sewage
rivers
capoluca
campo
grande
tuxpanguillo
copies100
µl
ribonucleic
opv1
unrestricted
opv2
opvpositive
dosesbackground
riskmitigation
paralytic
marrowhoming
bloodcirculatinglymph
nodehoming
1922
murtala
mohammad
69monthold
6480
7588
5773
1922monthold
69montholds
vaccinederived
postcessation
settingsbackground
cvdpv
shedder
betweenhousehold
vaccinebivalent
vaccineonly
nct01841671
ipvbopvbopv
ipvipvbopv
ipvipvipv
mopv2
ipvonly
brisk
rises
subsidiary
1379
wilcoxonmann
whitney
nhw
3arm
postnhw
orizaba
sociodemographically
2653
geospatial
poliomyelitisbackground
vdpv
indistinguishable
opvvaccinated
serially
quantifies
hivnoninfected
2012background
9839
96769921
9439
87569758
9902
95689979
9982
98779998
9691
90559944
9785
94469918
9992
99459998
vapp
postswitch
denmarkstudies
supplementationpreventive
credited
finite
tagging
melitensis
rev1
sheepbrucellosis
brucellosis
bmelitensis
rev1gfp
minitn7gfp
glmsrecg
noncodifying
elisagfp
antigfp
pcrgfp
gfptagging
nursesobjective
nailstargeted
daes
epidermis
nails
acneiform
dae
2585
keratoacanthomas
pigmented
handfoot
hypersensitivitylike
eczemalike
lichenoid
xerosis
multikinase
hyperkeratotic
hyperpigmentation
xerostomia
alopecia
nail
paronychia
periungual
pyogenic
onycholysis
brittle
diminish
preferencebased
pppsbackground
ppps
n135
175months
cd8cd28
cd3cd16cd56
qx
genotypeinfectious
oviduct
breeder
h120
h120793b
oculonasal
eid50
clollected
ciliostasis
immunotherapybiologic
considerationsthe
165000
1850000
115billion
vaccinationrtssas01
1518
4dose
largerscale
delegated
californiamedia1vid11015425804909532001pedsva20181051
frustration
narrow
jurisdiction
lawsuit
charging
write
initiativeobjectives
cld
prematurity
predisposes
nicu
hydrocortisone
inhospital
rounding
switchable
memorychimeric
afford
iterative
therapiesobjective
tumornormal
capturebased
wntβcatenin
sorafenibtreated
harbored
tsc12
inactivatingtruncating
fgf19
amplifications
idh1
missense
genomedirected
pinyol
vscc
lichen
sclerosus
extrapolates
comprehend
antipythium
insidiosum
dogsobjective
houndcrossbreds
antip
postadministration
pharmacokineticsthe
epr
culiposome
contradict
stealth
caelyx
predose
repeatable
methodresults
insert
phages
cancerregulating
wipo®
trademark
uspto®
espacenet®
pd1pdl1targeting
patented
industryassociated
claimed
aurigene
peptidomimetic
macrocyclic
qp20
hd20
wq20
sq20
cq22
bristolmyers
squibb
company
biaryl
heterocyclic
13dihydroxyphenyl
hosttumor
crystalline
druglike
miniha
stemspecific
miceseasonal
stembased
mfcγriii
fcmediated
carealthough
terc
tert
mechanics
oncologyfor
signaled
biomechanical
collisions
biomechanics
carcinomarenal
nonfeasible
thatwith
drugsthe
2negative
individualsbackground
iceland
pnigepositive
igenegative
115220
2positive
inconclusive
reacted
peanutsensitized
revoked
201516201617
fortytwo
106119
4683
051265
0281543
deterred
frontierforkhead
p3expressing
traffic
nonimmunemediated
trialsfood
allergist
dissect
antagonization
inmouse
psoriasisbesides
connect
antiil17a
severities
psoriasislike
k14il17a
keratinocytespecific
cd11cil17a
indind
imiquimodinduced
infectionfewer
irecist
wa
immunisers
consumers
668
limitsopinion
guides
countless
immunooncologycell
1million
ashort
surfacea
maskingthe
hidden
zagreb
croatiathe
croatian
6yearsold
n430542
n385531
6976
n192528
583653
n202532
332431
34742
douala
yaoundéurban
yaoundé
incompleteness
parentguardian
visibility
inadequacies
communitycentered
urbanizing
oligodeoxynucleotideinduced
rein
sdcs
iodoacetateinduced
cd4il10
sdc
oligodeoxynucleotidesinduced
malignanciesnoncolorectal
diminishes
challengeintramuscular
firsv
vaccineenhanced
inhibitionbackground
ktx
antic5
father
transplantassociated
withhold
yaks
tibetbrucellosis
grunniens
testandslaughter
damxung
maizhokunggar
pali
yadong
tibet
521043
334441
759862
yak
313355
157679
541062
aborting
tibetan
enteritiscd4
56carboxyfluorescein
succinimidyl
treginfusion
treginhibiting
tregsinfusion
tregsinhibiting
goblet
smad3
nfat2
therapiesthis
2013march
postio
2015december
usbased
multipayer
preio
165548
95715
analyses129977
113177
hemiplegia
literatureskin
melanine
containingcells
extracutaneous
nonskin
pmm
antitnfa
northwestern
442±159
reticular
veins
elastosis
quiet
leukemiaopinion
unfit
noncytotoxic
chronological
nhl001
antigensallergens
managementantipd1pdl1
tribal
nontribal
tangail
subdistrict
studyobjectives
2802
oraclebased
differentials
populationp025
invalid
nocoverage
oronkhola
unions
ownership
independence
advising
policiesthere
coi
eac
disclosure
disclosures
indepscale
cois
eacs
disclose
advisors
pentamerloaded
responsescervical
secondmost
pentamer
salts
wellreported
pentamerbased
polydllactide
coglycolide
plgalecithin
dlns
dualsensitive
micelletailored
immunotherapyenhancing
crosspresentation
ctlsinduction
cascaded
ovalbuminloaded
phredox
olmd
housemade
amphiphilic
polylhistidinepolyethylene
plhpegin
redox
inflow
speeded
sponge
lysosome
bulgingbroke
redoxsensitive
accelerative
dodecylsulphate
polyacrylamide
electrophoresissdspage
microscopytem
scanningmicroscopeclsm
cellsbmdcs
nirfand
thedistribution
cd3cd8
cd3cd825d116
oncogenicdriven
ripe
changeimmune
overturned
oncogenicaddicted
enrol
transplantationinnate
73years
200days
vegfa
beltwe
bestfit
forecast
lasts
monthold
minicampaigns
vensim
ple
20‒45
allograftallogeneic
studiesintroduction
unambiguous
skeptical
multidimensional
emotions
peersfamily
bioterrorist
merges
ratshepatocyte
rpve
rrpve
hepatocytes
proteinexpressing
parenchyma
windowcombined
chemodrugs
intravital
nirii
quantum
dots
qds
λ
1350
stromalcellderived
factor1α
sdf1α
chemodrug
1050
antistreptococcal
vaccineprotein
antistreptococcus
pyogenes
lactismx10
oropharynges
devoid
lactismx10immunized
lactiswt
lactiswtimmunized
immunotherapymultikinase
therapyimmune
cameroonian
studentsunassigned
2605
924
pcvs
pcv10
pcv1013year
20112015
prepcv1013
pcv1013
irr100
2029and
3253
h5h7
201718we
h7
markets
ethically
strategybackground
inextricably
professionalparent
override
coercive
argued
freedoms
parentcentered
equips
evenhanded
legitimize
cultivating
silos
factorsbackground
contactable
424
20122014
6675
5666
3446
15157338
459613
704853
fundamant
72week
aadvac1
nonalzheimers
tauopathies
24week
72weeks
aadvac1induced
11item
adascog
fluency
oedema
microhaemorrhages
apoe4
homozygote
regressing
sixdose
vaccinationfree
201200391629
nct01850238
201300449936
nct02031198
glioblastomabackground
cyt
gliovis
accessed
gzma
prf1
cgcg
csf1
p0042
p0023
contributionsobjective
stressful
pqol
depressive
in148
affective
interdependence
interrelationship
patientcaregiver
dyad
elongation
resistancethe
deregulations
te
deff
promoters
hypophysitisside
uniqueness
irreversibly
apoplexy
disturbances
endocrinerelated
merited
immunotherapypediatric
supramolecular
assemblies
therapyrecently
kis
knowledgeexperience
remobilise
retrain
misrepresentation
interviewees
treatmentbispecific
bs
nonigg
melanomaimportance
obviate
exenteration
sclerosing
panencephalitis
preheavily
lifecourse
specialties
mindsets
4cs
norm
tivozanib
undisputed
afurther
atherapy
diamonds
rough
therapytherapeutic
tadcs
tans
cytoxic
bolstering
tumorsuppressive
3group
pamphlet
anesthetics
3420
2549
361
primipara
532
nct01937143
bcelldepleted
leukemiatraditionally
tcellbcell
αβhaplohsct
mud
udhsct
mmudhsct
gvhdfreerelapsefree
allelematched
sexuality
safetypurpose
binomial
intend
ovidmedline
crossreferenced
2886
portended
145336
160451
263495
164267
typologies
dyadic
immunizationmotherinfant
rhythms
interactive
socialemotional
selfregulatory
lowstress
distressing
personality
temperament
videotaped
soothing
soothe
hivor
infectionand
infectionor
toxicityand
groupor
francisella
tularensistularemia
tularensis
inbred
s4δarod
schu
s4
sedimentation
3186
s4δarodvaccinated
s4δguaba
prechallenge
ragweed
mk3641
ragwitek®
ragweedinduced
12u
12μg
amb
ragweedpolleninduced
postimmunoglobulin
aged18years
1gkg
postivig
1gdl
8262
12days
hb1gdl
and2gdl
00030087
atherosclerosisvaccines
oligo
hypercholesterolemia
africawhile
useable
pracdc
crossmatches
528
nonsensitized
nonst
prevst
031385
nonfunction
lymphocytedepleting
recipientsintroduction
tx
strongyloidiasis
cosmopolitan
giardia
duodenalis
cryptosporidium
lithuanian
handed
kauno
klinikos
worried
τ
0211
retail
clinicsintroduction
2hour
parentsguardians
ci58
reminded
immunopharmacotherapies
disorderthe
oud
antiopioid
sequester
peripherally
treatmenta
jury
surfacemodified
streptavidininterleukin2
sail2
proteinanchor
sail2modified
renca
immunizationvaccineassociated
perivascular
myocyte
refutational
textinfluenza
career
epistemology
remedying
preintervention
withanaphylaxis
msimmrd
antipd1based
msihmismatch
tumorcell
mskccbackground
525
585694
676
603749
p031
53422
1122
1322
096242
p007
096
054174
p090
097211
088178
1652
19112
hypovolemic
proteinlosing
molecularweight
selenoaminopolysaccharide
micelow
selenoaminopolysaccharides
lsa
cpa
transcriptionpolymerase
raw2647
bα
iκbα
factorkappa
canceracomebackbackground
desert
aproimmunogenic
phaseiii
individualised
anisolated
nunavik
quebecobjective
10valent
19972016
43100000
58100000
ipds
thebenefits
tregitopelinked
cockroach
allergyallergenspecific
periplaneta
americana
lentrapped
tregitope289per
tregitope167per
ltregitope289per
ltregitope167per
idoleamine23dioxygenase
entrappedrecombinant
lper
liposomeentrapped
tregitopes
allergenmediated
canadapublicly
territories
agw
prepublic
qhpvvaccinated
nonvaccinecovered
2was
prognosisintroduction
nonsq
nonsqnsclc
nest
ccd8
toddlersobjective
maternalchild
mchc
timeperiod
permitted
neighborhoods
behaviorrelated
2072
398426
schooling
epidemicintroduction
clinicphysician
r0
23577
94307
42444
52453
35407
141625
60655
78673
145278
childrenobjectives
parentalreported
surveyflu
nisflu
randomdigitdialed
landline
217years
tumorsobjective
hypermethylation
hysterectomy
subclonal
associationslooking
tomorrow
spirit
writing
trio
oncologysociety
statementpurpose
biostatisticians
photogenerationwithout
photogeneration
tcellpriming
hdivig
nonivig
rabbitantithymocyte
5mgkgd
dayscyclosporin
ratgcsaimmunoglobulin
1gkgd
p0717
0419
chickensa
noninfectious
ciav
ibdv
mdvinduced
mdvis
hemocytoblasts
hemorrhages
breeders
wane
jeopardizes
intimate
invigorate
pd1pl1
9p211
nhls
studyintroduction
perth
radiologically
populationattributable
584
2175
12week
economies
updatepertussis
gpi
pertussisrelated
pertains
gpis
1113
cape
reformed
introductionamendment
restrictiveness
gradations
politicocultural
decrees
gastroduodenal
encompasses
duodenal
478±156
esid
descending
enterocytes
pyloriassociated
duodenitis
metaplasia
lamblia
58year
underimmunised
eueea
migrantspecific
readministered
gauging
settingimmunization
lessens
noisy
stlpca
seasonaltrend
smoothed
20042014
perspectivesrespiratory
acidbased
particlebased
slowing
exosomescontext
alarmins
tetraspanins
cd9
cd63
cd81
heatshock
ctvte
ifnc
8571
926
fitc
discusion
tvt
immunotherapywhile
functionalized
ivt
pseudoprogressionin
asocalled
amixed
week8
week24
lin
blockadeimmune
notoriously
lineagenegative
medulloblastoma
transcranial
braindespite
characteristically
noninvasively
brainwide
periarterial
glymphatic
osmolality
hyperosmolality
overrode
awake
compositionsensitization
aspergillusspecific
bronchopulmonary
vanderbilt
aspergillusreactive
asp
stingbased
wholeexome
netmhc
pancvax
aduv16
panc02
neoepitopespecific
tregexpanded
modelsposttransplant
tred
emigrants
ptcytreated
mmn
thromboembolic
emphasise
motivates
donate
ebolatx
guineaintroduction
retroductive
hesitance
confidentiality
volunteering
stigmatization
emergencedecline
rumours
stealing
interethnic
volunteer
solicit
bloodproduct
homogenous
stratifying
let7
player
cecorum
spondylitispathogenic
kinkyback
weeksoflife
bacterins
broilerbreeder
sa3
sa7
opsinophagocytosis
multicultural
2040
n422
n85
n582
n329
hbsagantihbs
koreans
partywe
1837
msd
1283
0262
014047
035094
immunotherapyunderstanding
diversification
aprerequisite
prestige
archivum
immunologiae
therapiae
experimentalis
journalarchivum
aite
founded
1953
ludwik
hirszfeld
polish
65year
publishers
19771991
contentslife
printing
prof
dubowskainglot
górski
editorinchief
impulse
citation
master
publishing
transplantology
immunochemistry
bioethics
springer
3018
professors
managementopioids
hypothermia
timeimmune
employs
immunopharmacology
iggmediated
conditionsspecific
rhdnegative
rhdpositive
fcγreceptors
fcindependence
nonepitope
steric
hindrance
anti4hydroxy3nitrophenylacetyl
npconjugated
srbc
npdensity
srbcspecific
antisrbc
antinp
srbcnp
masking
connectors
productspecific
dcspecific
adenovirusvectored
topotypes
adta24
conditionally
topotype
replicationdeficient
adtfmd
serotypetopotypes
pools
ivii
rgd
adenovector
knob
cassette
intradermolingually
n375
enabl®
diva
naturallyacquired
tuberculosisvaccination
12year
culturepositive
37years
infield
lesioned
abattoirdetectable
ante
bloodtests
deficiencymicrosatellite
mcrc
msidmmr
2017backgroundmigrants
freetext
onarrival
checks
detention
preventbackground
4vhpv
9vhpv
nonsystematic
1544
1242
lcsc
pcna
cellinduced
growths
judaica
extractaim
470
allergovac
roxall
medicina
españa
zamudio
abbreviated
transversal
invidia
cki
123459
928
2773114
therapyimmunomodulatory
reawaken
atezolizumabinduced
carcinomaa
61yearold
sarcoidosis
endobronchial
noncaseating
intrathoracic
perilymphatic
antimyeloma
applicationnatural
cellsgraftversushost
underinvestigated
ben
bentbi
cytbi
bentbiconditioned
nononcogene
pemphigoid
trialsnk
gen1
cancergen1
tufted
angioma
reportsepaskhah
hajizadeh
sariaslani
jowkar
188190
kasabachmerritt
4monthold
lobules
cannonball
walled
notin
unprecedentedbuilding
combats
antigenreceptor
awaken
reviving
targetsboth
communitiespurpose
networking
pleura
mesothelindirected
aligned
antimesothelin
anetumab
ravtansine
doseefficiency
uteri
hemangiosis
antimesothelindrug
xenotransplant
adc
10mgkg
vaccinologyin
neutralizingantibody
hpvnaïve
alleged
dropping
syndromemyalgic
cfsme
malfunctions
costeffectively
nonhpvvaccinated
cfsmelike
malignanciesphoton
clonogenicity
messengers
aperspective
immunodiagnostics
30000
immunodiagnosis
invites
dendriticcellbased
prodrugconverting
818years
survivorship
sspedi
penat
1228
25022227
10614777
104242
106438
097428
treatmenthypoxia
hyperbaric
hemoglobins
allosteric
fluorocarbons
fcs
oxygencarrying
boiling
transports
prodigy
systemunassigned
miltenyi
processor
colorado
anschutz
florabackground
fn
dermatologicmucosal
scorebased
15971
117198
098193
097187
bloodstage
parasitesnaturally
hasten
chabaudi
commencing
ciis
doxycycline
azithromycin
apicoplast
longeracting
abortus
1b
infectionchlamydia
oea
virulenceattenuated
aborted
1970the
798
seroprevalences
2029yearolds
3039yearolds
ideological
859951
seekers
migratory
diversitysensitive
stemnesshigh
oyster
polysaccharidedendritic
lmwops
spheres
cmt93
antitgfβ1
βcatenin
bmdc
kangaroo
rctbackground
kmc
swaddling
nips
5min
patientshematopoietic
regimenrelated
prophylaxistreatment
00920972
peritransplantation
leukemiahuman
apclike
vγ9vδ2t
tumoractivated
abbreviations
nbps
nitrogencontaining
bisphosphonates
ipp
isopentenyl
factorrelated
dctargeted
vaccinationcd4
awaits
ctb
ctbs
lymphoidresident
antidec205ova
nonlymphoid
colitisbackground
microbialbased
qbeco
chemicallyinduced
muc2
16week
worsen
induceddamage
challengesdespite
ikarosmediated
imid
halted
imidpd1
chimericantigen
growthdeposits
c5a
complementfixing
macmediated
complementinduced
hexamer
devoted
immunotherapyprospects
antibodieshead
chiefly
conduit
anything
accelerates
cancerwe
crpc
sipuleucel
preselection
surmount
enzalutamide
radium
chronification
eggallergic
patientsvaccination
autoimmunerelated
warfarin
haematomas
thyroitidis
40mg
propranolol
vka
thtr17
grasspollen
her1based
responsethe
her1
vssp
hebersavax
bedsidehebersavax
vegfblocking
vegfvegf
kdr
gammaifn
offtrial
reimmunizations
intolerance
oncospecific
antiidiotypic
vaxira
antiegf
cimavax
028
cimavaxegf
nsclclung
p64
antiegfbased
sivs
ratein
semiflow
lyanpunov
leukemiapurpose
priorchronic
beth
deaconess
danafarber
77123
vaccinationbovine
blv
blvinfected
antifmdvspecific
proficiency
vaccinebased
blvendemic
opinionencounters
asrm
titled
fertil
steril
2013993379
caninedendritic
immunotherapywhole
hypochlorous
acidwhole
hocll
shockwhole
hsl
freezethaw
cycleswhole
ftl
caninederived
calreticulin
caninedc
hocl
cyropreserved
depletioncytotoxic
cryopreservation
cryopreserved
gcsfmobilized
sortingbased
112×10
cd3×28
cytokinedriven
cd171
antineuroblastoma
procured
trialgraftversushost
visceral
reducedintensityconditioned
p037
tumourlike
multilocularis
metacestode
naturefunction
periparasitic
peroral
pae
tregth2
emultilocularis
parasitostatic
2vhpv
910years
2vhpv9vhpv
9vhpv2vhpv
postfirst
postsecond
994100
736iuauml
117iuml
500767
175auml
antihpv16
nct02567955
cameroonbackground
insecure
307920
059months
criers
mobilisers
dedication
borgpetersenii
hardjo
hardjobovis
interrogans
pomona
leptospiral
growthin
leptospira
serovars
2260
ewe
bred
withinfarm
inconsistency
2phase
upstate
practicespecific
studyspecific
cancerprevention
countywide
12yearolds
18yearolds
literatureobjectives
conductreport
club
miyakonojo
3591972
394
170913
103148
addback
disordersunrelated
nmhd
ptcdpsct
singleinstitution
ptcd
pscs
trilinear
740days
ptcdpscts
muds
hva
cssam
motiflab
overrepresentation
kruppellike
biostatistical
modernization
leprosy
carcinomaepsteinbarr
distantly
lyticinduction
ebvlytic
cancerhead
approve
tumorsopinion
eloquent
immunesuppression
oshv1
bacteraemia
oystersinfectious
reductionist
misunderstood
decipher
intrahost
crassostrea
gigas
reproducing
haemocytes
ostreid
µvar
immunecompromised
nonmodel
antinmethyl
daspartate
antinmda
pressurebackground
21yearold
intubation
drain
salpingoophorectomy
bradycardia
asystole
pacemaker
pacemakers
researchimmunotherapy
faithful
interrogate
coclinical
discov
135865
©2018
aacr
lymphomassecondgeneration
2g
3g
cd19carts
limitedexpansion
correspondingly
areaunder
endofinduction
gallium
cd20positive
13a
21day
chop
cvp
investigatorassessed
ctbased
irc
harmonisation
ihp
nct01332968
1202
65·5
61·669·4
75·6
72·079·0
43·3
36·251·8
2·5year
87·8
83·990·8
72·0
63·179·0
ircassessed
0·4
0·30·6
87·4
83·790·2
54·9
40·567·3
0·2
0·10·3
contrastenhanced
responseadapted
welcomed
hoffmannla
roche
alliesadoptive
radiotherapythe
advancedhcc
insurvival
liverdirected
tooptimize
iiitrials
kepi
324months
kenyatta
knh
vesikari
microplate
1724months
mothercaregiver
childmother
metaanalysislevels
brafi
meki
fixedeffect
analysys
16159
16185
15322
062082
055072
brafi±meki
enlighten
processescancer
cd1restricted
finds
cd1
nonpolymorphic
cd1resticted
1935
2017the
surveychild
nischild
uninsured
msas
vfc
interruptions
yearstate
provisionally
grace
staterequired
§
kansas
treatmentpsoriasis
il23th17
embraced
pasi
luminex
1pgml
il410
10the
il1ra
stnfr
il1rail1β
stnfrtnfα
epsilon
fcεr
fcγriiafcγriib
hyperactivity
reviewpurpose
cd3cd19
αβcd19
adjuvantdelivery
advantagevaccines
accomplishment
manifold
acknowledgement
compete
minimalno
adjuvantsdelivery
elaborately
approvedlicensed
challengeslimitations
oncotherapeutic
undoubted
globalwise
automation
qualitybydesign
qbd
analysisthe
distinctions
panorama
cartargeted
inexpedient
expedites
bursting
cancerit
pathobiological
struggled
informal
flurelated
employer
nonattendance
continuity
professionalism
acceptablethe
fueled
equipoise
denying
withholding
badly
neededbased
netherlandsobjective
digitised
19192015
autocorrelation
18900
1200028600
5100
220013500
1800
10003200
11yearold
13700
140038300
802300
strategiesalthough
selfevident
framed
newspaper
derives
135meql
015086
wald
116months
180480
170390
1targeted
vaccinationbased
cancerdendritic
expanse
hlawt1tetramer
immunotherapiesnatural
selftissues
nkbased
thwarted
approacheselectroporation
lipofection
trogocytosisare
brumae
ooinwater
macromolecules
multiplexing
antimycobacteria
brumaetreated
mycobacteriatreated
kc
infectionsrecipients
eb
ebvlcl
ordermade
myelomacar
clonotypic
fluorine19
assaying
probes
nanoemulsions
backgroundfree
eradicationobjective
jeopardizing
agammaglobulinemia
casepatients
immunodeficiencyrelated
ivdpv2
ivdpv1
excretor
reseed
momi
upgrading
ppc
kaya
rmnch
n757
n754
twosample
372752
544672
organizing
leukemiaimportance
475000
b2202
b2205j
b2101j
impute
timetoevent
clofarabine
667000
337000
42000
46000
37000
78000
priced
innovators
fluvax
40mcg
cxcr3ccr6
cxcr5
plasmablast
ctfh
widened
tubular
nephritis
nephrological
nephrologist
trialimmune
preimmunized
pcv13qiv
placeboqiv
blinded
serotypespecific
846
cancereosinophils
cancerurothelial
arole
multimorbidity
lifeprolonging
trialsintroduction
15minutes
sevendays
tenderness
p0070
p0067
p00040
bout
desperation
vp4
infectiongrass
ctenopharyngodon
idellus
gchd
gcrv
timesaving
easilyoperated
specialty
s6
cotcvp4
igz
il413a
il413b
csf1r
cd4l
toxicitydisease
flumeltbi50
n61
400cgy
flumeltbi75
myeloablativeintensive
wasdecreased
flumeltbi
incidenceour
infectionsvpis
nonvaccinepreventable
infectionsnonvpis
vpi
377
testifies
vpis
152204
nonvpis
19442015
10611
4711
849
honeybee
immunotherapyhymenoptera
foodrelated
honeybees
apis
vespula
octogenarian
minus
tendose
costing
823
8941234daly
12761731daly
producttumorinfiltrating
tiltherapy
atmp
atmps
tilskilled
technician
neurologypurpose
sad
coexistence
immunosuppressing
adjuncts
amending
underappreciated
treatmentpurpose
burns
connections
insult
immunotherapymicroneedlebased
diguanylate
cdigmp
diadenylate
cdiamp
hypodermic
ovaalum
mnbased
iceberg
20132014measles
3422
levelwe
2077
lends
avium
recipientmycobacterium
hivs
gutassociated
treatmentadoptive
progressioninnate
flavor
semi
mait
dominate
populationwide
vaccineautism
proximity
yunnan
9360000
glmms
firstdoseintime
777
281171
156143
20072012
111144
1423
17211787
113185
075096
106233
1116
5051727
creactive
048191
127020
agespecificity
2645
unity
strategiesinvasive
mena
surges
menw
menwimd
510years
nationalregional
hitita
esmosponsored
injectiondelivery
hitit
blurring
committees
pitch
nontotal
regimensobjectives
radiationfree
siblings
6248
52297109
4943
39575853
4564
35855488
toleranceinnate
ilc
morphogenesis
proresolving
antiageinginflammation
ageingassociated
spms
mimetics
bioactions
rete
ematologica
pugliese
repbackground
matchedunrelated
3195
day20
telomerases
tumorstelomerase
telomere
telomerase
transcriptase
htert
tep1
hterttailored
htertpeptide
hterttransduced
telomerasetailored
mouseobjective
dustmiteallergen
p1dc
preparedusing
balb\c
imdcar
dexamethasonear
p1dcar
groupar
establishedthe
imdc
dexamethasonenormal
salineelisa
igg1and
bloodthe
westen
methodsall
0560±0110
od
1150±0280
0690±0054
0920±0125
145±670
685±669
remarkedly
041±025
159±102
026±001
110±009
2272
anticd37
malignanciescd37
tetraspanning
cd37
immunoadsorption
3080
26603745
3300
29003935
30131
leavers
londonobjective
commissioning
barnet
camden
newham
unsupported
immunotherapiesbackground
4and
1pathways
programcurrently
fractionlung
fractiongastric
cancerand
fractionrccare
rolling
subprotocols
rerandomised
subprotocol
responseand
virusbackground
heteroreactive
escaped
antiha
s9337
f20c77
f5b7
h1ha
anemiaumbilical
flucytbi4gy
entailing
eanm
literaturethis
biomarkerspredictive
complexincorporating
biologyand
tumorsscientists
virusderived
antigenb
initiators
qβderived
qβvlp
qβspecific
signalingmediated
houston
18874
870
retested
2248
antiblood
aboilkt
abocompatible
lkt
60yearold
bloodtype
antia
4096fold
750mgday
200mg
516fold
128fold
normalizationharnessing
antipd
responsetotoxicity
immunotherapeuticsmonoclonal
fastest
glycans
chemoenzymatic
glycoforms
nonmammalian
tangible
inline
storychimeric
statesobjectives
junejuly
3645
4360
120437
prioritiesmerkel
ultravioletinduced
bothviruspositive
virusnegative
mccs
highestpriority
sweeps
transplantationwe
lfis
lfi
10336
5088
2245
1299
578
949
2051
antivenom
crotalus
durissus
cascavella
snake
nanoparticlessnakebite
envenoming
narrowsized
venomloaded
chnp
ionic
160nm
ftir
chnps
adaption
underexplored
carcinomatreatment
immunotherapypdl1
pricebackground
highand
middleincomes
nhfpc
nifdc
ccgp
1190
domestically
routinelyprevented
privatemarket
1029
wellregulated
horizonsrecent
geneticallymodified
compensatory
optionthe
executed
nontumor
rheumatologist
iciassociated
countriesobjective
n151
914years
a3dose
midst
immunooncologydespite
exocrine
phenotypeobjective
describeboth
5583
t1drelated
fdvery
bihormonal
glucagon
blunted
venereology
oncologyprogress
papulopustular
pdgfr
bcrabl
unavoidable
trialshealthrelated
hrql
typenumber
coping
polarizes
cellsbreast
interferoncontaining
12ngml
cd8tcell
loadeddcs
postcryopreservation
endotoxins
willnow
therapyalthough
transitionrelated
map2k4
id2
fgf2
pik3r1
akt3
fgf13
fasn
metallopeptidase
mmp1
situationsever
famously
dire
majoring
2018in
jsipc
841
serologically
839
rubellaspecific
neoantigenreactive
reactivities
enriching
microwell
krasg12vreactive
tp53g245s
1623
invitations
n261434
181years
for1dose
n35460
n225974
74vs69
hr110
healthconscious
gbmvaccine
serotype8
belgiumbluetongue
ruminant
culicoides
midges
btv8
bthas
drastic
belgium
subsidizing
convince
persuaded
primovaccination
tdcs
atregs
factorbetainterleukin10
tgfβil10dependent
tgfβil10
516years
japic
cti152981
52weeks
aass
rhinorrhea
4852
p00005
irritation
pseudocroup
subglottic
laryngitis
fluthe
fluflu
brazildespite
seventysix
managementadvances
rhiraes
1293
polyarticular
rheumaticalike
cellspurpose
vsts
broaderaimed
bankbased
layerbylayer
photoimmunotherapythe
photoimmunotherapybased
ir780
imatinibloaded
phsensitive
nirinduced
familyrelated
proteinpolylacticcoglycolic
gitrplga
apoptosisnecrosis
cores
scoop
lungresident
mycosistissueresident
nonvascular
trmsespecially
cellsare
trm17
gattii
discriminated
fty720
fty720treated
multinucleated
giant
communicationbased
multiarm
n5534
generator
n1845
n1844
actionoriented
n3689433
personalisation
anzctr
actrn12617001315303
victoriathis
refugeelike
resourceintensive
patientheld
naturalresearch
adaptions
directing
retarding
forego
forestall
ramp
undermines
pd1programed
1040
commodity
spare
hyperimmune
colidebilitating
globallydisseminated
multi
st131
colonise
nonantibiotic
antiupec
upperlower
schoollocated
20102011background
slv
reimbursements
20102011
designsetting
5009
3620
5598
3807
3808
insurers
erythematosusobjective
deuterium
nanoparticleconjugate
responseslocalized
subvert
proimmunogenic
pkpd
hampering
nanoparticleconjugated
immuneactivation
studyimmunecheckpoint
icirelated
icitreated
epirelated
antipd1induced
0029
steroidresistant
steatorrhea
effectsthis
immunologybased
enlarging
immunohistochemistrybased
formalinfixed
paraffinembedded
closeness
endanger
countryside
ask…just
tell
cancercontext
abysmal
hostspecific
multiparameter
antineutrophil
antibodyassociated
vasculitisantineutrophil
aav
ancas
pauciimmune
crescentic
promiscuous
heterosexuality
usphss
194648the
usphs
1948
1300
guatemalan
syphilis
gonorrhoea
chancroid
hiring
prophylaxes
heterosexually
maletomale
presumption
coprimary
endpointsclinical
inflation
incrementing
immunotweezer
toxicityantibodies
scpombi
tweezer
pom1
pom2
globular
prioninfected
organotypic
toxicprone
antiprion
hurt
lesschildren
skip
privately
adolescentsfinancial
200814
marketscan
ages1117
noncapitated
048percentagepoint
025percentagepoint
49435
25314
ages1112
20072017human
111546
121657
portend
nonselfantigen
immunityalthough
nonselftumor
el4
eg7
splenectomized
4mg
ctxmouse
eg7bearing
sgep
allergy26
1247
monthswho
2082
11176
345497
8241141
unheated
cohen
returb
instillations
12257
turb
57days
sooner
krasmutant
therapyin
kirsten
comutations
allelic
malignanciesantibody
adcs
platinumdoublet
platinumdoublets
nontranslocated
keynote024
156189
094113
52k
43k69k
endoflife
eol
42k
49k
40k67k
100k
cigarettes
1153
19302
30291
22118
34841
lymphocytetomonocyte
lmr
p00065
mpfs
p00049
p00092
mesotheliomaan
registryobjectives
mpm
263832
n262
n42
rtds
icpiobjectives
nonegfralk
n82
davidoff
uni
rtd
nonselected
n278
mutsmb
tmb10
2650
84nr
199449
66159
test63
intercohort
81nr
67nr
test24
factorscheckpoint
trialenrolled
nontrialenrolled
highergrade
cipregardless
sonsdespite
sons
916year
sociodemographics
precaution
papm
unengaged
undecided
3779
1826
serumsoluble
spdl1
5129
014012391
0836
01052168
3503
15597871
3399
13088831
r0527
5471ngml
gonorrhoeae
gonococcal
lipooligosaccharide
lacto
neotetraose
lnnt
sialylated
dtog
1119
fhd1119gfc
gonococci
neisserial
nspa
fh67fc
lgta
resisted
fhfc
c1q
horizonrecent
arenas
subspecialty
graders
tdapobjective
schoolrequired
5382
3647
fourfold
23years
londonthe
dtapipvhib
315381
whitebritish
bangladeshi
57525095
8363213
35656076
587
osteosarcomaobjective
lm8
sg
200μg
antitim3
antiox86
combg
16weeks
immunotherapyprogrammed
cdk5
brd4
stat
approachespassive
huntingtons
bloodcerebrospinal
sitespecific
scleroderma
iirationale
sls
dyspnea
sclerodermarelated
sscild
hrct
volumetric
thinsection
computeraided
glass
honeycomb
qild
p088
ρ037
singlebreath
diffusing
ρ022
breathlessness
ρ026
tumoursbackground
nets
endoradiotherapy
colleges
moderatelydifferentiated
workedup
staffed
allotransplantationposttransplantation
allotransplantationnotably
microarrays
pyrosequencing
allotransplant
xenotransplantassociated
pigtononhuman
xenotransplantationbackground
anticd154
electrolyte
200copiesml
tacrolimusassociated
antibodytacrolimusbased
comparably
transportprogrammed
transduces
posttranscriptionally
sox6
myosin
growingfinishing
psox6
myhc
duroc×landrace×yarkshire
1mghead
4mghead
marbling
yellowness
cooking
iix
blacksthere
34500
crossreacting
autochthonous
cd107aifnγtbet
triplepositive
tyrcreerbraf
loxlox
tamoxifen
chimioimmunotherapy
halfmismatched
spectacularly
modulationt
engineers
toolbox
contextualize
salient
reinforcethe
lymphocytebased
immunotherapeuticsimmunotherapy
mechanismsbackground
tslp
challengeconfirmed
sputum
d2
arachidonic
pgd2
ltc4pge2
01±003
368±7
2122±44pgml
tslpinduced
nonar
conditionsbackground
pcvad
3week
wilcoxontest
hazelnut
hldofc
meyer
pbp
651
2043
2343
treatmentclustered
repeatscrispr
nuclease9
archaea
endonuclease
cart19
biotech
2265
aides
2016vaccination
offsite
stocked
lbcl
rdhap
scholar1
552921
172737
58146
immunotherapythis
endotyping
mir146a
mir155
mir125b
mir100
let7e
mir125a
mir99b
cd14hladrneg
recreate
mdscrelated
t1r1t1r3
cd49a
cd49b
cellsnatural
t1r1
t1r3
mtorc1
lipidnanoparticles
immunotherapytranslation
lipidnps
encumbered
rnanps
peripheralintratumoral
mrnanps
therapytissue
individualsmonotherapy
errorprone
nct02825797
3bnc117
101074
30mgkg
antibodysensitive
liverstage
micedespite
bypasses
chimpanzee
primetarget
nasopharynx
otitis
icelandvaccination
nasopharynges
reykjavik
serotyped
wgs
multilocus
prevac
postvac
0090
nonvaccinetype
15a
15bc
22f
23a
23b
35f
35b
vts
19f
pmen
meassociated
anticd19cd20
malignanciesa
6562
4418
p00405
3339
p00489
sweats
updatescolorectal
crccolorectal
ccsc
crcccsc
trails
arsenic
trioxide
ier3nrf2
pathwaybackground
instillation
5637
il6il8
ier3
nrf2
nqo1
adshnrf2
shrna
bengal
tukeys
1540
malefemale
8034
8492
cocos
7328
azaridacta
5725
seasontime
2026
characteristicsbackground
utd
13th
exempt
census
subtracting
summing
1439
piano
registrybackground
hcm
subpopulationpostpartum
ibdand
osteoporosis
pcp
unmarried
melanomaimmune
44yearold
dyspepsia
reflux
klebsiella
krohem
bcll
2017recent
bri
footbathing
flockobjective
polwarth
walkthrough
1hour
standin
footrite®
fimbrial
replicates
paddocks
6283
18275
142280
114278
1yearold
footrite
53445
2747
multistrain
reconfirm
brca12
gbrca12
gehanbreslowwilcoxon
gbrca12deficient
gbrca12proficient
6433
186822149
4783
100822689
p00094
43month
nonhypersensitive
immunotherapynature
repertories
viralinfected
roaddendritic
antigenderived
poxviridae
adenoviridae
retroviridae
togaviridae
paramyxoviridae
rhabdoviridae
programmereview
amirthalingam
lancet
e8290
magna
algerian
oryctolagus
cuniculuscoccidiosis
parasitosis
oocystal
vaccinatedchallenged
12×10
46×10
oocystsrabbit
anticoccidian
healthseeking
differencessuch
susceptibilityaffect
integrates
transmissioncontact
susceptibilitybetween
magnify
prta
pneumoniaebackground
1441041
curdlan
prtaimmunized
prtaspecific
opsonophagocytose
d39
prtainduced
pneumoniaeinduced
tachyzoitessevere
biasedimmune
tla
prptla
3751
4751
1151
hev
pregnancyrelated
internallydisplaced
20072009
1665
campspecific
reactively
zostera
abreast
rice
antigenspollinosis
cryptomeria
japonica
antiallergic
stabilizer
staple
ricebased
20142017pakistan
casebased
2014october
dimorphism
broadspectrum
colitisunassigned
abx
ciprofloxacin
9week
caecum
abxtreated
enterococcaceae
lactobacillaceae
nos2
koreaintroduction
tivs
reimbursed
aged65years
59months
qivs
659months
adults65years
16000
2923
13011
7048
2084
190000
50697
140644
12623
24526
9422
3500
cellsamong
celldirected
cd94nkg2a
cd96
hlaunderstanding
lateacquired
cellantigen
cd8s
hlagenes
cd8mediated
hlaloss
reversibility
il2il2
antineoplasm
leak
vls
il2based
fsd13
proline
p65l
cd183
cd54
threetime
fsd3
surpasses
il2s
disparsal
5041
grain
rhinoconjuctivitis
no1
slits
lesionsbackground
vaccinationschedule
doseschedule
1330years
20062013
2253561
1719
irr023
011049
irr065
041103
therapygenetically
neurotoxicities
rnaloaded
liposomescancer
expeditious
toll
eric
directionssince
survivalbackground
subconjunctivally
gfpcd4cd25foxp3
tconv
opacity
complexiicd11b
ifnγcd4
responseclassic
hodgkinreedsternberg
positivepatients
v600
truven
iqvia
rwd
2l
3l
n162
n247
braftargeted
gravisobjective
cmg
precipitating
5122
4219
lajev
achr
endplates
achrα
mglike
mimicry
neurol
201884386400
20162017unassigned
5117
2674
quantiferontb
tspottb
therapyintroduction
guérin
igra
431
fibroticcalcific
0495
0406
0343
icosintroduction
peptidemhc
tcrb
antigenreactivity
gonemeasles
rubeola
pathognomonic
enanthem
confluent
cephalocaudally
transcriptasepolymerase
superinfections
savingbackground
crd
compensated
epilepticusobjective
epilepticus
rsesuperrse
srse
brenaxolone
rsesrse
hybernatus
ketogenic
electrographic
2090
n817
brexanolone
rse
presurgical
confounded
ictal
vagus
2128
pyridoxine
magnesium
comparators
hiv1the
bnmabs
viraemia
physiopathological
treatmentrecently
hyperactivation
tisues
lymphocytesmediated
th17t
interleukine17
modelaim
olea
europaea
pollensensitized
bacteriaderived
isstreated
proteoliposome
systemantibodies
antimembrane
highvery
n148
lowintermediate
n232
hctspecific
3988
p038
p781
pharmacokineticallyguided
transplantationtargeted
pkguided
pred
µmminute
±10
±15
36fold
27008
9631
12116
18fold
36721
66098
metaanalysisautologous
transplantationeligible
sdtlate
3633
1811
1822
vorinostattreated
transplantationmyeloablative
vorinostat
neurorestorative
nct02409134
neuropsychological
cogstate
mood
questionnaire9
disorder7
therapygeneral
battery
fullscale
dermatologist
astute
ctbp210
apob100derived
p210
bregs
apob
tm2sgy
ldlr
coculturing
tgfβlatencyassociated
mtgfβlap
dietfed
aorta
20weeks
ctbpova
p210ctb
antip210
pedvloaded
pedvspecific
villous
700900μm
centrifugal
granulationfluidized
adultcare
statelocal
providerlevel
nonprobabilitybased
n1714
n261
februarymarch
sudaan
700974
manageadminister
statecity
beliefsperceptions
antictla4antibodiesrelated
endocrinological
recommendationstickborne
highendemicity
simplistic
reviewnewly
conforming
crd42016045798
cdsr
mobilizationcommunity
heath
countrypurpose
tertiaryreferral
ngo
zubiran
unidos
bachelors
unemployed
ngos
limitedresource
cancersit
betweeninsurance
womenin
usaobjective
1826years
20092012
621
160821
015081
1671100
115713
1062115
836
2792505
developmentthe
insilico
nontechnical
exemplar
derisk
multiscale
guineabissaubackground
randomizing
lowweight
diseasegroup
casefatality
6583
3297
3286
908
72131
73124
84110
3594
3590
5399
50113
078
2298
nct00146302
nct00168610
nct00625482
cancerhuman
hervs
remnants
herv
chemotherapysensitive
autographa
californica
polyhedrosis
acmnpv
lepidopteran
invertebrates
acmnpvbased
capsiddisplayed
baculoviral
gp64
cd169based
melanomacd169
subcapsular
cd169
pedigree
malignancysince
modifiersbrms
plenty
indota5d3
prostatespecific
antigen5d3
diabeticsevere
pc3
pip
flanks
coinjection
50fold
5d3
olindaexm
mbqμg
6054
μciμg
nonradiolabeled
gland
lacrimal
mgymbq
universitiesobjectives
fouryear
abstracting
accredited
stringency
housing
dismissed
373
campuses
shark
ignarderived
agentsmany
denaturation
nonphysiological
sharkderived
vnars
expenditures
cmyps
immunizationdespite
cmyp
budgeted
406108
1098
kiribati
21644770
laboratoryrelated
researcherspurpose
liaison
exofficio
bestworst
n93
liaisons
diabetesalthough
rewiring
3947
130811906
3139
14476811
seniors
exiting
disturbing
misperceptions
literatureimmunotherapy
immunobased
nivolumabwho
nanoparticlesmediated
cystectomies
photoinduced
golds
nanospheres
nanoshells
nanocages
nanostars
gns
starshaped
geometry
photontoheat
plasmonic
ablate
gnsmediated
lymphocytesmelanoma
heading
questionsintroduction
dnabased
satisfactorily
neurovirulence
reassure
degenerationa
amd
immunosuppressiveimmunomodulatory
imt
wet
10813
217081
087105
066108
094162
085099
124369
botulinum
neurotoxin
challengebotulinum
neurotoxins
bonts
botulism
50kda
carboxyterminal
bont
bontespecific
bonte
africaimmunization
settinsg
subregional
n770
tpb
796
aor32
2357
aor28
1836
trustbuilding
ssc
profibrotic
splice
progressiontumor
myelopoiesis
culprits
technologythe
immunetolerance
facsbased
polyanhydride
infectionsinfluenza
iavspecific
iavnanovax
ovasensitized
ovaa647
lcs
lap
langerinegfpdtr
nondepleted
lcdepleted
epittreated
cdc2s
skininduced
sepsisdecades
systemtargeting
resuscitation
immunoparalysis
hyperactive
lying
increasingthe
afast
toxicitythis
nct03161665
nct02409121
firsttime
personreported
proms
measurecaregiver
pamc
poms2®
vigor
statetrait
indexcancer
cqolc
bmtroadmap
caregiverspecific
selfdirected
followupour
64×10
685months
450822months
048094
onesided
015076
bedsidetreatment
cytotoxics
competes
immunoactivator
dnam1
cd155
pvr
cd112
nectin2
pvrl2
tigits
analogous
metastasised
arginine
syndromesevere
sfts
bunyavirus
sftsv
consequential
intraplatelet
pltno
arginaseexpressing
antisftsv
pathwayassociated
23dioxygenase1
eos200271pf06840003
therapytumors
catabolites
nexus
bioavailable
ido1induced
pf06840003
nct02764151
smearnegative
neededpregnant
healthyvaccinee
defenseless
chemoimmunotherapybased
generalize
agingrelated
immunotherapypatterns
immunespecific
irrecist
progressions
hyperprogressions
pseudoprogressions
updatecellular
nongenemodified
cd138
slamf7
biologyprognostic
melanomarecent
antipd1antictla4
dioxygenase
antilymphocyte
antiglucocorticoidinduced
cdk46
coinhibition
sn
clnd
mslt1
lymphadenectomy
trial1
wle
decogslt
mslt2
18month
combiad
iiic
proficient
managementwith
recurrentrefractory
bcellderived
melanomamelanoma
polarizing
lymphomaimmunebased
zuma
cd19cd28z
juno
cd1941bbz
ozogamicinmonoclonal
latam
vhl
scielo
19902016
appraised
3465
hibconfirmed
morbiditymortality
midwifery
adequatematernal
orienting
teaches
commence
infectionsemergence
igys
pathogenneutralizing
justice
owed
reframe
owes
powers
faden
defended
obligated
identifiable
obligations
realm
discretion
situates
ought
pemphigoidpemphigus
blisters
erosions
furthered
suppressionbased
attitudesthere
seat
belts
accidents
jenner
milkmaids
jonas
salk
hero
19791
…
declinations
englishspeaking
pacv
dichotomized
nonhesitant
nonhesitancy
25165
oromucosal
hematolymphoid
irradiationbackground
6cgymin
n54
407months
vaccinescancer
mp
eggwhite
igawe
ew
ifc
om
ovomucoid
inonotus
obliquus
chickensvaccination
immunepotentiating
iofp
lasota
eyedropped
proliferations
345dimethylthiazol2yl
25diphenyltetrazolium
tacrolimusbased
prophylaxisthe
tacrolimussirolimus
tacrolimussirolimusbased
expectedly
tlr4based
shortcomingstolllike
forerunner
souvenirs
cad
ebic
ebics
cellsanimal
cadesi03
il31
5752fold
cadesi
metaanalysispurpose
appraisals
d0161
p047
d0195
d0036
p828
d0138
p195
d0043
p826
goodquality
crd42015029365
httpwwwcrdyorkacukprospero
shining
cyclamen
europaeum
tubers
extractcyclamen
cte
acalifornia042009
h1n1pdm
75µg
500µg
50µl
5640
4320
51280
1080
flucloxacillin
hypersensitivitybetalactam
staphylococcal
nonbetalactam
betalactams
antistaphylococcal
syndromechimeric
cd8lv
tissueinvading
blymphocyterich
explant
immunosurgical
carcinomasurgeons
purposeful
stingloaded
7821
630819
zealandbackground
māori
maori
5yearly
screeningdefined
incidencemortality
ethnicityspecific
europeanother
61100000
3110000
screendetected
implant
20102014
pneumovax23
postoperatively
nont
antiintegrins
il23p40
p19
il23p19
immunoresponses
discharges
epurv
594124100000
menzb
2615248100000
1037100000
agentsit
pegnlgbased
2k
fmocnlg919
ptxloaded
dualfunctional
5k
fmocnlg
coload
pegnlg
ptxmediated
nanorization
coarse
chemophotoimmunotherapy
cancerbecause
nanosheets
nss
chemophototherapies
graphene
chemophototherapeutic
corrugated
hydrophilicity
biodegradability
flakes
bioapplications
easytoaccess
ultrasonic
bubble
polydispersity
chitosanpolyethylene
documentobjective
aitcs
portfolio
unify
departmentsunits
agreements
2round
nudge
rewarding
goaldirected
ivax
game
goalattainment
intergroup
betweensubjects
wins
golimumab
arthritisintroduction
tnfiremain
tnfi
spice
cancershave
cellsuppressive
betaglucans
cellsensitive
swedenpurpose
hzv
9099
89736
698years
or34
3038
or28
2630
wnt
immunosurveillancederegulated
immunoevasion
granulomatosis
dysimmune
wildlifelivestock
kruger
africafootandmouth
disruptive
boundary
knp
dip
sat
fortnightly
16log
20log
ethiopianewcastle
ncd
birdlevel
drinking
afixbased
vaccinationhpv
afix
hpvspecific
afixrelated
backward
n340
aor13395ci108163
aor36195ci1021277
aor15795ci120205
aor30295ci108843
2024
aor90595ci2723010
aor29895ci111802
flavivirus
infectionflavivirus
arthropodborne
flaviviruses
htl
linkers
docking
vectro
uberis
intramammary
cowsstreptococcus
laboratorios
hipra
amer
precalving
postcalving
gestating
cellsml
doubleblinded
leishmaniosisbetter
diagnostically
blockrandomized
a2
saponinadjuvanted
leishtec®
10091786
00450
11858502
pvalue00245
infectedhealthy
antileishmania
icoslaugmented
adenoviralbased
bipolar
th17th1
unglycosylated
antigencellular
il17polarized
selfantigen
muc1specific
rorγt
ifnγil2
10months
th17th1mediated
coherent
complicationsobjective
p061
virginias
virginia
constraint
interpersonal
realisticreceptive
organoid
researchduring
sprung
miniatures
faithfully
organthese
amazing
nearphysiological
mutationcarcinogenesis
isogenic
organoidsin
labequipment
ced
voi
81140
94705
dominating
80000
evpi
3m
repairbiliary
btcs
gallbladder
ampullary
poorprognosis
ddrdeficient
currentlyavailable
ddrproficient
disordersan
commoner
fixation
peripherallydriven
immunologicallyrelevant
antigenassociations
therapeuticallyrelevant
wiley
periodicals
leptin
sorbent
il4il5il13
il10tgfbeat
th2treg
immunotherapyincreasing
stain
repertoiresabs
noxious
query
igseq
repositories
reads
nontrivial
numbered
httpantibodymaporg
biotherapeutics
managementovarian
occc
geneticepigenetic
endometriosis
pik3ca
arid1a
coexistent
arid1b
smarka4
copy
recurrently
20q132
znf217
8q
17q
hnf1β
hypomethylation
heavilytreated
adultsadults
6065years
disproportionally
hdtiv
mf59
seasonvaccines
returns
vaccinatedin
generic
impulsive
graphs
planus
welldemonstrated
dermatoses
betahemolytic
streptococci
precede
guttate
austerity
200014background
opting
200014
036065
regionalspecific
lazio
sardinia
twentythird
pd1pdl1immunotherapy
featuresamong
melana
meloe1
addedvalue
antivßspecific
valpha
undescribed
cdr3α
ß
pd1cd28
pd1mediated
proteintransduced
panc02ova
eg7pdl1
ifny
wnt5a
dba1
micewnt5a
wnt5abased
antirheumatism
histomorphometry
microct
phwnt5anl
phwnt5anlimmunized
rheumatoidassociated
rankl
osteoclastogenesis
phwnt5anlimmunization
osteoclast
hwnt5abased
resorption
immunetargeted
practicethe
lymphomasthe
aberrations
lymphomathe
curability
anthracyclinecontaining
womencervical
standardizeddesigned
inhibitorrefractory
melanomamonoclonal
intralesionally
noninjected
rhinitisallergic
daytime
sleepiness
presenteeism
diagnosable
inconvenience
liquids
seer
lifemonths
equates
yearsurvival
firstintroduced
irandomized
gmcd40l
ccl21
adenocarcinomathe
recruits
migrates
gmcd40lccl21
nct01433172
gmdcd40l
gmdcd40lccl21
p20
070225
p44
traes
approachesthe
ischaemic
diseaseatherosclerosis
lipidlowering
cantos
nanoimmunotherapies
cancerimmunooncology
ilc1
ilc3
trim21
adenovirusbased
vaccinationadenovirus
genetherapy
singleantibody
nearnaïve
vectortransduced
preimmune
responsesimmunotherapy
antagonize
dichotomy
baculovirusinduced
enveloped
berghei
primaquine
tlr9independent
ifnstimulated
parasitekilling
bvinduced
p19arf
interferonbeta
transferwhile
deserved
p14arf
interferonβ
fostered
sao
dermatologistas
attitudessometimes
hesitancyamong
refutes
tough
level400mgdl
p098
p042
p0602
p100
p0412
recipientspast
futureinfections
pediatricspecific
adultpediatric
metaanalysischimeric
hsctnaïve
priorhsct
054461
051394
028677
nonstatistically
verifiably
robotic
treatmentcombination
cmri
regressed
myeloproliferative
gf
nonin
leukemiawhether
graftversusgraft
gvg
cordhaplo
n97
donormismatched
tbibased
57years
120mgkg
75mgm
132gy
165gy
accelerator
192cgymin
highdoserate
hdr
15cgymin
lowdoserate
ldr
73days
16days
1253
modelpreviously
cytosine
arabinoside
monocyticmyeloidderived
granulocyticmyeloidderived
gmdscs
d26
chemotherapyresistant
chagas
20122016background
cardiomyopathy
congestive
60weeks
immunotherapyanimal
linederived
pbmcscdx
nodscidil2rg
nsi
cdx
hspcscdx
cd34hematopoietic
hspcsderived
pbmcsderived
autopbmcspdx
diphenylcyclopropenone
analysispolicy
dispersed
2413
4508
timelag
effectin
gpwlogrank
numeric
ignoring
xu
misspecified
delayedeffectdesign
imove
projectin
lowtomoderate
379
dismally
220000
hedgehog
drugstargeting
dll3
gonogo
inefficiency
cancellous
toolmultipotential
cbfs
cultureexpansion
cbf
tgfß1
cbfdriven
tgfß
noncontact
molecule1
2cd317
cd317
cbfresident
4174
n2254
chargealtering
releasable
transporters
antigenencoding
vaccinedelivery
antigencoding
mrnaencoded
coformulated
transfect
chinaworld
jinfeng
longmen
covariance
0560
03180988
19982014objective
russia
19982007
20082014
rvapp
630days
660days
cvapp
19982014
case159
case418
denmarkhpv
oftenalways
psychologistpsychiatrist
lifeworld
diseasesneonatal
fcrns
recycle
autoigg
iggfcrn
fcrnbinding
angiopathy
caa
i3d6
4kda
150kda
antonia
braintoblood
accumulations
caaantibody
incompletion
koforidua
ghanaobjective
assessthe
caregiversmothers
divorced
p0048
parttime
p0049
159582
cohabiting
widowed
confounder
1031911
kwazulunatal
dogperson
154131
guarding
eightyfour
handled
husbandry
credence
bronchiseptica
cd4cd25
colonizing
reviewmigrants
unioneuropean
874
323100
celldendritic
cellcytokineinduced
cancergc
cikdendritic
mantelhaenszel
mh
fem
plots
begg
funnel
trim
0712
05940854
05460797
115146
136219
119165
ci153287
cikdccik
cllbecause
cllipi
cd20antibody
btkinhibitor
rift
rvfv
arbovirus
arabian
peninsula
gn
veroe6
trialspurpose
nacs
titrated
dosefinding
fel
1specific
iggblocking
studyuninsured
academiccommunity
marchseptember
inperson
highschool
preventionprotection
influencers
decisionmaker
linkages
underresourced
malaysiathe
576
californiaadult
serviceswhich
administers
medicaidimplemented
apl
16009
9despite
objective•
postimmunotherapy
responsessecondary
gynaecological
handsearches
2009for
nrss
nrs
3632
uniformity
attrition
ratings
lowthe
ca125targeted
2347
1882
worthwhile
hemofiltration
therapycytokine
cartcells
319×10kg
mrd10
hydrosarca
blockadecheckpoint
acwycrm
vaccineintroduction
st11
neckbackground
186512
2249
5fluorouracyl
treatmentantictla4
befv
pcdna31g1
hek
6weekold
befinactivated
1x
bled
antig1specific
neutralisation
antibefvneutralising
bef
perioda
ischemia
reperfusion
iri
ecd
atlg
singleblinded
perfused
posttx
apktx
cpktx
0h
intragraft
nct03377283
p21activated
modulationpancreatic
paks
invasionmigration
pak
krasdriven
lyophilisate
shbsag
hbva
plantderived
200ng
bark
saponins
lowdosed
lyophilised
injectionoral
standardisation
nct00489970
y9
tdapb
tdapa
newlyrecruited
y5
981
posttdap
seroprotectionseropositivity
hypotonic
clinicsbackground
hhe
hhes
200611
westmead
19972014
brighton
157235
68weeks
120min
102235
173235
86235
58135
28100
7235
221235
31years
186221
154492
reduceddose
corticotropinintravenous
immunoglobulinrituximab
boardapproved
frontloaded
1200
lessened
walk
steroidal
lactating
cattleclinical
srp
klebsrp
569
coliform
coliforms
kgd
bedding
manure
solids
lactation
speranza
psatricom
prostvac
s1602
bcgnaïve
tokyo172
tice
applicationsbesides
radioinduced
originthe
antagoniststhe
esophagogastric
gitract
oesophageal
immunotherapyduring
histologybased
molecularlyselected
chemotherapynaïve
sequentialcombinatorial
melanomaaims
20072015
2793
049063
038056
neuralspecific
dysfunctionrecognition
antibodyprevalenceinepilepsy
ape
responsivetoimmunotherapyinepilepsy
rite
autoimmuneepilepsy
autoimmuneencephalopathy
nmdarigg
lgi1igg
antibodyprevalenceinepilepsyandencephalopathy
score4
neuralspecificantibodies
responsivetoimmunotherapyinepilepsyandencephalopathy
score7
antigad
immunosuppressionantibodies
glutamic
decarboxylase
limbic
antigadantibody
epilepsia
partialis
continua
epc
encephalitides
corticosteriods
perspectivesglioblastoma
astrocytomas
gliomagenesis
viralbased
metaanalysisintroduction
23rd
allgrade
9324
6136
3367
g35
016039
melanomaintroduction
ests
est
20032007
melanoman69
operationspatients
intransit
excisions
metastasectomies
afterest
oligometastatic
metastasectomy
4a
028073
025060
therapystage
bigneeds
22years
1667
1431
needlestick
1165
instructed
accident
informationseeking
vaccinesobjectives
timed
obstetrician
postdelivery
258601
challengeebola
cta1dd
h45
mouseadapted
h45adjuvanted
gpspecific
antiebov
lavages
maebov
perspectivesallogeneic
inclusionexclusion
jadad
hiding
sight
receptorsalternatively
cellsurfacebound
blockbuster
sclerosisincreasing
ppms
modelsdirect
stinga
reproductionpatients
fatherhood
erectile
fathering
aspiration
mans
skinfriendly
microemulsion
immunotherapydue
preservatives
alexa
fluor647
beevenom
phospholipase
api
franz
laserscanning
1allergic
summarily
proteogenic
esterification
cellscholesterol
acetylcoa
acetyltransferase1
acat1
avasimibe
αgc
ptxαgcthlip
lifes
and\or
gastro
frugality
targetingaltered
cyclepromote
porcilis
regionthe
porcilis®
tsa1
trypanosomiasis
tc24
tctsa1
refolding
rtsa1
glucopyranosyl
gla
idri
e6020
eisei
parasitemia
ug
tsa1specific
ifngammail4
rtc24
vaccinelinked
macrophagest
programlessons
planningrapid
exercising
therapyrecent
igmenriched
infectionspatients
13000
125000
1400000
multimeric
agglutinate
entrapment
tnexpressing
exposureresponse
eliana
ensign
cmax
auc028d
antimurine
thp1
environmentallyrelevant
arseniteenvironmental
arsenite
500nm
18h
100nm
lipopolysaccharidesstimulated
developmentto
agenesis
microdontia
roottocrown
tooth
763
p044
classspecific
3to
5of
nascent
vaccinationunlike
straight
casualties
sonography
laparotomy
ivv
nonoperative
aeromedical
evacuation
strategiespurpose
outgrows
hypoxiaactivated
th302
hypoxiaprodrug
cooperated
prostatederived
trampderived
trampc2
replenish
tramp
pbcre4
ptenpcsmad4pc
extramedullary
leukemiaautologous
1b2
548
pcrmrd
agentssolid
reviewcancer
tide
costimulate
unconsciousness
transplantationlongterm
59yearold
doublelung
immunotherapylow
featuresproperties
monomorphic
hlalike
allogeneicofftheshelf
tilderived
dysfunctionwe
antitlymphocyte
atgbased
prelt
egfr60
bas
egrf
126756
2524
nct01453218
myelomaa
vgpr
arresting
nci
bcmacar
widescale
industrysponsored
therapytreated
macaquesa
latently
replicationcompetent
virusmediated
cytopathicity
arttreated
sivinfected
homeostatically
cd4r1
postdepletion
homeostasisdriven
depletioninduced
innumerable
patientsseven
cartbcma
canceruntil
icibased
treatmentnaive
immuneeliciting
ctas
ctasrestricted
stirred
ctasbased
therapyadministration
jas
chondroblastoma
hepatobiliary
cancersdespite
includepd1
andctla4
vesiculobullous
recipientsolid
41yearold
checkpointsimmune
insulindeficient
surveysthe
dhs
diarrhoeal
trailblazing
2931
pamplona
therapyassociated
toxicitescurrently
therapypatients
cellinflamed
selectionimmunotherapies
segregating
noninflamed
immunol
9901000
signalingadoptive
liganddependent
unconstrained
mol
ther
1795815
proteasedependent
immunotherapymacrophage
amoeboid
rockindependent
fibrosarcoma
explants
metalloproteases
mmp
rockdependent
proteaseindependent
derma
mmpdependent
133751
immunotherapyregulatory
infidelity
inflammationinduced
7818
51919
abortusequi
sae742salmonella
iz
sae2
50μl
28th
immunprophylactic
30µg
15µg
sixtythree
p0174
seroprotected
p0187
1854
p0182
p0081
nct02746783
nct02203825
ul16
9day
okt3activated
gammaretroviral
ligandpositive
carryover
rantes
cleaning
56885
14502
3923
42383
74507
70967
35448
2336
24347
54549
95893
95300
47371
persistency
xining
qinghai
480549
qualifications
29957
chinainfluenza
equality
normative
pharmacopoeia
publicizing
preparedchina
100th
microsimulation
stdsim
miscancervix
m2especific
miceinfluenza
strainmatched
m2e
m2ebased
audorn72
ahong
kong68
cohoused
fcgr1
fcgr3
receptormediated
immunogenomic
msings
su2cpcf
exomes
cd200r1
adora2a
pik3cg
movember
su2c
apulia
preneoplasticneoplastic
3333
4968
3634year
32year
valproic
cellsimmune
anticonvulsant
vpa
immunoregulation
deacetylases
pmnmdscs
vpaconditioned
vpainduced
interleukin4
receptorα
il4rαarginase
retinoblastoma
rb1
derepression
ningxia
chinachina
secs
iiss
names
20215
newlyenrolled
ageeligible
sces
remind
schoolage
bloodforming
intraoral
extraoral
stomatological
auricular
gingivitis
recession
5526
macroglossia
lingual
leukoplakia
aphthaeulcerations
pallor
erythroplakia
6842
halitosis
2368
gum
brushing
1842
dysgeusia
1578
multispecialty
dentist
opportunitybackground
intersect
surgeryinduced
prometastatic
capinhibition
polistes
sensitizationcrossreactions
dominula
ves
5pol
lowaccuracy
5tige
pol
allopurinol
tophi
goutbackground
xanthine
gout
rashes
thirtyyear
hypertriglyceridemia
bezafibrate
pravastatin
losartan
hyperuricemia
metacarpophalangeal
elbows
itching
malar
papules
pustules
quiz
analysisaim
7677
us30955
trialdurvalumab
leap
168month
foray
clinicour
perspectivesnewcastle
cripple
primerprobe
stood
phylogenetically
genotypematched
geneticsbased
emphasised
yttrium90
radioembolization
caseseriespurpose
tare
um
hpfs
1355
100550
59241
18322
364
peptic
cardiotoxicities
inhibitorsthis
supraventricular
ventricular
takotsubolike
racehorse
moroccoin
moroccan
racehorses
509
haemolysis
srh
calvenza
fluvac
innovator®
947
prequenzate®
342509
proteqflute®
114509
enhancementbackground
cocirculate
parametrized
translationintroduction
thrive
proprietary
supplant
vlpspecific
excipients
diagnosissarcomas
geneactivation
nyeso1is
sarcomasoft
platederived
factor1
sine
mdm2
myxoid
liposarcoma
patientsopinion
anthracycline
mint
gela
rminichop
rmini
ceop
rsplit
prephase
rgcvp
cga
biologybased
indiaimmunosuppressive
hatg
substantiate
phaseib
tumorsalthough
investigatorinitiated
metforminnivolumab
is000028405
cc11
20152016objectives
meningococcemia
4854
pentaglobin®
fortyone
46years
fulminans
admittance
tertiarycare
recreational
discos
pdph
1318years
announce
advertising
twoweek
155110
2106
sizeable
noncampaign
3400
fans
wellreceived
farreaching
anxietyrelated
enginebackground
atlanta
countrysetting
974
engines
iswtbe
aheadthe
virologists
ecologists
epidemiologists
occasion
genenegative
drivernegative
programhematopoietic
donorgenerated
advspecific
hscderived
adv5
bzlf1lmp2aebna1
62l
immunoinhibitory
vst
hlas
suitably
banking
microneedlebased
1induced
diffuser
disseminationbackground
antibodyphotoabsorber
trair700dx
trair700
indefinitely
datathere
keymolecules
surely
immunotherapeutictumor
untold
minds
ecuadorian
worldbackground
clinica
guayaquil
waited
motion
clergy
iced
irrigation
imuran
amputated
consultants
peter
bent
brigham
embarked
bravery
commendable
endeavor
dnaloaded
nanoadjuvant
escaffold
environmentallyresponsive
lipidlike
immunotherapycytoplasmic
degradable
impermeable
destabilizing
pdnaencapsulating
lnp
sscleavable
phactivated
sspalme
sspalmelnp
2647
immunooncologybased
consideringbackground
ect
patternbackground
69years
eggfreediet
pii
dars
6476
7288
8181
7580
12112±9143
9800days
8906
7453
2190
adrenalinetreatment
cancersharnessing
landscaped
benchbedsidebench
immunotherapeuticbased
cancerepithelial
erbbtargeted
caspase
pancaspase
zvad
mannose6phosphate
clinicobiologic
acutesevere
jeremiah
metzger
disordersadvances
proteinmonoclonal
exons
compensate
conceptualized
1720
salmonellaladen
thermobotsusing
thermobots
lowtemperature
ltsl
hifu
4042°c
kca31
vaccinationbacillus
bcginduced
bcgspecific
muscarinic
gpcr
glutamate
thp1cells
salivainduced
diseaseonset
02μmfiltered
tl21
australians
4370
conspiracist
ideation
vote
70000
ebmteurocord
fludarabinebackground
thiotepabusulfanfludarabine
tbf
sucbt
ntdhaplo
denovo
n186
n147
hr103
hr186
p065
hr263
hr218
hr194
hr238
tbfmac
ovalbumincontaining
biphasic
pulsatile
singleinjection
multipleinjection
adjustable
polydllacticcoglycolic
glycolic
ovalbuminspecific
superfluous
buckwheat
allergyscope
fage1
fage2
pfage2
pfage1
dryheating
dotblot
foodallergic
shamtreated
antigenfed
pfage2fed
th2induced
dermatitisatopic
oozing
crusts
lichenification
cresoborole
irritant
emollients
strategieslung
combinatory
iqosintroduction
touted
reducedharm
philip
morris
mrtp
purports
iquitordinarysmoking
iqos
internationals
cigarette
secondhand
moravian
regionobjective
vha
smr
antiepidemic
3130
2534
4554
5565
tabular
2105
seropositives
5140
2073
workingage
immunosuppressionpurpose
deremodeling
autoaggressive
sciencepurpose
diseasepurpose
cic
endoscopically
ibdlike
colitislike
th1th17
microflora
colitides
worldincreased
cheating
transplanthematopoietic
bmf
bclxl
stabilizes
20183616461654
nongenetic
regressioninducing
eager
immunosuppressionlipid
reviewatherosclerosis
vascularrelated
infancyreducing
africathe
200miuml
113miuml
138miuml
p014
developingworld
cd3cd19depleted
studyrapid
leukemiatumor
delayer
lymphomathis
sd101
125869
1195
tangothe
coevolves
cellvascular
venule
portals
epigenome
epigenomes
silenced
immuneinfiltration
synergies
reportspurpose
35yearold
intermediated
innatelike
functionmultiple
copious
antipolio
19901991
n1214
20062007
n1522
n2074
opv1opv3
balochistan
khyber
pakhtunkhwa
kpk
lagging
mofetilcontaining
cysp
mtx
1564
mmftac
mmfcysp
mtxtac
mtxcysp
mtxbased
youththe
ai
pleasant
moderated
culturallytailored
0020
efficacyover
cytopathic
ov
pharmacoviral
irenk
ctcs
106months
232months
trim14
hbxhepatitis
isg
ifnsignaling
polyic
polydadt
ifniactivated
stat1
ifnimediated
spry
interacted
hbx
smchbxddb1
stat1dependent
ifnitrim14hbx
utilizationnatural
ly49
transcriptionalpriming
electric
aefs
novottfoptune
intentionally
antiampa
cancerampa
thymomas
casper
brazos
texasobjectives
bchd
healths
epiassist
preventions
proportionate
twohundred
americanblack
diarrheal
hungarypurpose
discretechoice
nonworking
randomparameter
opt
universityoregon
2015purpose
freshmen
sororities
fraternities
greek
attendee
2229
nonfreshmen
nongreek
immunotherapyas
nonproprietary
prefixed
omab
ximab
zumab
umab
heterophilic
hama
haca
antichimeric
haha
antihumanizedantibody
liable
immunotherapyprimary
hyponatremia
anti21hydroxylase
mineralocorticoid
adrenalitis
fludrocortisone
leukemiain
fraietta
hits
reviewhodgkins
strategiesartificially
csf1rtargeted
macrophagestumor
carnatural
csf1rtargeting
literaturehuman
hpvunexposed
agentspurpose
oma
arthritisunassigned
troubled
cooccurring
bcmabased
elotuzumab
rrmm
tnfrsf17
antimm
bacteriophages
coat
e75
ae37
gp2
her2neu
tubo
dualchamber
reconstituting
hermesgenerated
10dose
5226cm
52cm
ovw
75cm
26cm
070perdose
withinseason
2010201120152016
midaugust
midlate
26weeks
midnovember
twophoton
imagingour
supranuclear
2018updatethis
iatrogenically
seroresponse
gulf
460
planet
prescribers
discrepancy
soc
hr075
066085
hr088
080097
p010
hr114
102128
igg1like
cd52
malignanciesbispecific
biab
cd52targeting
atz
rtx
cd20targeting
atz×rtx
scfvfc
circulatory
tunisiaobjectives
householdbased
1828
815930
701995
320753
856
658939
803940
mesoendemic
hypoendemic
estimations
hajj
umrah
eventspneumococcal
gatherings
muslim
evidencebase
agendas
approachesan
wisdom
bioenergetics
fission
cellextrinsic
potentialities
cscs
cscassociated
diversities
mechanismdriven
discusshow
sclerosisalemtuzumab
24mgday
day30
repopulated
antialemtuzumab
sarcomasabout
pathologydefining
installed
mlkl
neoepitopescancer
executioner
domainlike
stalls
mlklmrna
batf3dependent
blunts
mlklbased
syndromemyeloproliferative
studypatients
saml
mpns
186786
gapsglobally
middleand
enact
contemplate
contemplating
assure
uninterrupted
intrusive
forwardthe
paneuropean
posttruth
mediabased
dwindling
mindset
sociologists
psychologists
stemness
blueprints
therapiesgenetic
soared
commercialgrade
threepronged
conquer
therapeuticallyresistant
answermacrophages
macrophagetargeted
cytokinedependent
serinethreonine
ck2
ccaatenhancer
proteinα
7819
564455
antibodyaccompanied
manners
radiotherapeutic
targetedtherapeutic
competency
healthcareblood
oversee
oversees
analysisunderstanding
201314
3366
twolevel
mongala
nordkivu
pnc
richest
factorsthe
factorsparticularly
visitshad
vascularized
vca
lifeenhancing
nonrelated
evidencepurpose
healththreatening
synergo
radiofrequencyinduced
mitomycin
g3ta
pt1carcinoma
weaponized
debateobjectives
hashtag
11020
1286
tweeted
11118
unidentifiable
1121
1359
divisive
malware
discord
masquerading
legitimate
equivalency
eroding
confronting
skeptics
botdriven
painobjective
6monthold
n64
abcds
postneedle
moderations
eraimmune
tytotoxic
delves
lefitolimod
reactivator
mgn1703
modeofaction
interferongammainduced
ip10
intenttotreat
026108
020117
carcinomahuman
hervquant
rigilike
ribosome
riboseq
adultsan
2465
iuml
108160
hladrb104restricted
hpv16e7
immunotherapyhighrisk
hpvtargeted
hpvpositive
irestricted
coordinating
hpv16e7specific
hpv16e7hladrb104
7089
hladrb104
equivalently
endogenously
oncologyimmunotherapy
protean
asd
ethnically
n224
autismrelated
complementaryalternative
cam
understating
hostderived
taci
implicationswe
tcons
antiapril
tacidependent
antiapoptosis
treginhibited
tcon
itreg
cd15s
osteoclasts
apriltaci
irelandneisseria
bexsero
nmeningitidis
umueningococcal
uauntigen
utuyping
usuystem
mats
roi
mlst
bigsdb
848
cc4144
st154
st41
pora
variableregion
unfeasibly
intensityin
1258
unilineage
5q
nonirradiationcontaining
bu4cy
flubu4
flubu2
higherintensity
governs
antigencancer
shadow
haunted
tapasin
pmel
209217
trialtested
antimelanoma
tapasindeficient
proteasomes
tripeptidyl
peptidase
tpp2
dietinduced
immunotherapyvarious
reproducibly
disconnect
immunealtering
trailencoding
leptindeficient
obob
receptorfc
therapyemerging
antigenlow
multispecificity
carinduced
121926
measureintroduction
planlevel
surveybased
1959
6064
tdcontaining
phf
phfphf
ehfphf
ehf
caseinspecific
evasioncd47
coordinately
antipdl1sirpα
andadaptive
brainbackground
nct02320058
immunologicalbased
tumorbased
imagingmeditated
mx001
cu64
pd10
cucunotamx001
17idg
18idg
01idg
06idg
04idg
macrophagederived
exosomemimetic
m1nvs
repolarize
m1nv
9p24
immunotherapychromosome
pointmutated
rearranged
pcm1jak2positive
myeloidlymphoid
eosinophila
kspecific
demethylase
4c
kdm4cjmjd2c
effectuated
translocations
settingconcerning
contributeboth
predictively
nkg2dbased
nkg2dcart
untransduced
nkg2dcartcellmediated
ménage
à
troispd1
pdl1blocking
rekindled
subdominant
sdds
sddspecific
coengaging
widen
narrows
antipd1pdl1adjuvanted
poi
199078
adjudication
14yearolds
1000000
personmonths
menarche
007136
037210
059341
027323
matchedcohort
studythis
512days
orand
parentsibling
postmmrv
363495100000
personalfamily
436100000
case100000
5386
introductionwhile
diseasegraftversushost
transplanting
immunoreaction
interrelations
oldeach
300000
yoa
germanspecific
45000hz
1713
38000
44000qaly
standpoint
statusamong
9141000
superimposed
ensue
ordering
biaspurpose
rvp
nonenrollees
n1029
n292
prepeak
peakpost
ttests
70years
71years
or151
ci114200
or264
ci184379
developmentdna
crosstrial
studieschemoimmunotherapy
resonate2
pcyc11151116
del17p
357months
cll8
cll10
chlorambucil
cll11
complement1
6174years
studiesregimens
145374
olderlessfit
unmutated
del11q
2684
multiphasic
withinhost
dynamicsrecent
polymerdoxorubicin
nanoprodrugchemotherapy
drugsmediated
nanoprodrug
hapsidox
synergetic
nanoprodrugs
cplglagg
enzymeactivated
proteinligand
αpd1
metaanalysisimmune
ckis
ps12
11354
5217
6137
069089
071086
p099
mpda
proposition
pembrolizumabs
tissueagnostic
brca
trk
immunotherapys
singlemodality
laterphase
tailofthecurve
frameworkreply
agecancer
hypoxicischemic
micehypoxicischemic
sphingosine1phosphate
ischemiainduced
neuroprotection
termborn
multichannel
fty720s
hiinduced
anticd3mediated
responsecancer
serpinb9
primeandtrap
liverresident
cellstissueresident
radiationattenuated
ras
syvpsaeqi
gunadministered
dnaonly
liverhoming
recommendationsmedia1vid11015425799875076001pedsva20180344
23yearolds
fps
025041
018087
108145
codified
icterohaemorrhagiae
canicola
statesapproximately
usda
expended
vaccinationchallenge
backtitration
cvb
2011april
n3serogroup
subpotent
sb1sb6
sb1
sb2sb6
dilutions
succumbing
diabetesimmunotherapy
incurs
suddenonset
insulinopenia
immunotherapythyroid
levothyroxine
tsh10
miul
teamwork
immunotherapyhypophysitis
asthenia
polyuropolydipsic
thyrotropic
86100
gonadotropic
85100
corticotropic
somatotropin
prolactin
ruling
thyrotropin
gonadotropin
endocrinologic
contraindicate
sensorineural
lossin
33yearold
vertigo
ndd
pollenspecific
ilc2s
il25
peribronchial
syndromeguillainbarrè
guillainbarrè
postulate
satisfy
pathogeninduced
1pd1pdl1
acidrelated
receptorgamma
factories
hemodialyzed
studyinfection
hemodialysis
platformspecific
fastgrowing
tfollicular
broadened
tfh2
secretes
pspecific
calcinuerin
dpiga
dpige
dpigg4
p0125
administeredscheduled
payor
hsn
payors
safetynet
petctimmune
clta4
2deoxy2
ffluorodglucose
eortc
petbased
percimt
sepsisearly
govern
tnfr1mediated
tnfr
calmetteguérinprimed
sendai
antituberculosis
vaccinethe
sev85ab
po
tnfαproducing
sev85abboosted
mumpscontaining
chinato
mucv
crossneutralization
muvs
muv
mumpsspecific
muvspecific
iodinated
antibodiescontrastenhanced
cect
ars
icm
allergiclike
chemotherapytargeted
cht
cectrelated
monoinstitutional
fiftynine
3521
ipi
3387
nonimmunologic
icmrelated
cytreated
wakeup
immunotherapyintralymphatic
inhibitionpurpose
adenocarcinomaobjective
offtumour
fabbased
her2induced
affording
trialsimmunization
overinterpret
venues
mekong
viet
namintroduction
bd
611months
30cluster
cd22directed
tanzaniapoultry
keepers
villagebased
predators
2016human
sdoh
n3593
surveyweighted
determinantshighest
languagewere
areaseducation
intersectional
nativity
foreignborn
usborn
raciallyethnically
latina
029065
032068
045090
024035
021038
minoritized
tricksimmunotherapy
cancerdriving
posttranscription
posttranslation
tuberculinspecific
immunotherapyintravesical
cytokineexpressing
tuberculininduced
electrochemiluminescence
0852
0796
tnfproducing
0745
0801
12129
physiciansbackground
multisystem
revisits
heredue
anticd19cart
axicabtagène
ciloleucelin
hemopathies
challengesthe
lscd
19802015
noncomparative
keratolimbal
ophthalmologists
individualize
wealthrelated
inequalitybackground
0181
01640209
kyber
quantile
inequitable
aversion
gilgit
baltistan
8335
5493
penalized
stringently
wealthier
reportobjective
79yearold
cocooning
psychogenic
carmen
bolivar
colombiawe
colombian
29th
2nd15
twitching
arriving
unconscious
teenagers
appease
coincidencekasabachmerritt
kmp
kaposiform
hemangioendothelioma
khe
dosethis
800cgy
30mgm
stepbystep
deescalated
600cgy
grade2
p0155
p0115
tbi600cgyfluintermediatedose
hydroxylase
carcinomadendritic
aah
18taah
substrate
adaahires2egfp
aahdc
cellkilling
aahdcs
immunotherapyneuroblastoma
gd2specific
gd2targeted
deliverynanocarriers
decorated
ankaravectored
mvabased
mvabnyf
nonmineral
yfv
jimenez
spy1
factorβ1smad23
pathwayvaccine
p17treated
smad23
phosphorsmad23
smad7
spy1stimulated
spy1specific
spy1induced
graftversusleukaemia
transplantat
leukaemiaallogeneic
qua
alemtuzumabbased
zoledronateinterleukin2
immunotherapyifnγ
sequestered
ifnγtargeted
570617
cyprusbackground
636months
1105
firstborn
cellularbased
cancerundifferentiated
ubiquitously
cbi
refinements
ebvinduced
saharan
commentarybackground
roll
haart
350mm
eltrombopagpoor
351000
30180
25mgd
75mgd
527×10
30117×10
028069×10
078490×10
63123
78134
1049
1018months
inhibitorsradiotherapy
fractionation
datasecondary
sall
pall
p0106
hr193
12312
118323
111152
ovotransferrin
miceovotransferrin
ovt
cpinduced
ovttreated
signalregulated
belatacept
chimerismbackground
acd40rapa
ciktx
acd40
bela
acd40bela
belabased
transplantalone
2c10r4
sandoz
macroeconomic
computable
equilibriumthe
remi
depopulation
677000
jobs
vaccinatetolive
509000
surplus
cancerlung
canadians
lysinespecific
blockadeimmunotherapy
reprograming
lsd1
cellattracting
ccl5
cxc
tiling
immunoprecipitation
reexpression
h3k4me2
inhibitorenhanced
lsd1mediated
1335100000
12100000
nafp
uttar
highnpafp
dechallenging
tcf1
lifetranslating
extrapolating
wholetranscriptome
timeofflight
quiescence
lef1
vα24invariant
nkts
carnkts
il21r
il2il21
il2il21expanded
nontransduced
anticd19cartransduced
il2expanded
dataobjectives
3524
ev
nonev
371990
799988
denmarkbackground
spiraled
19992003
n161528
19992000
nondanish
tendencies
cimt
16th
europes
mainz
motto
adultsintroduction
patientsmethods
704
049135
045149
034087
076210
leukemiaintroduction
multiplerelapsed
commonlyencountered
doseintensified
benmel
patientsconsolidation
hdct
200mgm
100mgm
hdctasct1
asct2
hdctasct2
melasct1
benmelasct2
striving
calvesobjective
nebraska
625animal
500animal
1100
767animal
318animal
448animal
20112015objective
addin
brdaffected
import
schoolobjective
repercussions
highlightspurpose
nonmyeloablativereducedintensity
conditionings
patientbusulfan
nmaric
oropharynxesophagus
n100
tpn
p0022
or48
or710
p0001overall
porphychem
porphyrinoids
pdiphotodynamic
photosensitizing
wavelength
porphyrins
chlorins
phthalocyanines
industrial
pdi
evolutions
th9
dectin1activated
cellswe
th1cells
abolish
hacking
smarter
cellst
stunning
ancaassociated
optionsantineutrophil
organthreatening
anca
cellactivating
attitudespurpose
acipcdc
fdavaccine
inserts
20002014
electronically
chapters
gaaap
gaaafp
aap
n730
n852
nonoutbreak
1831years
ratio188
lowpositive
recommendationsthis
excerpted
simplification
footnotes
evidencetorecommendation
httpwwwwhointimmunizationsagemeetings2017octoberpresentationsbackgrounddocsen
imm101
toxicitybackground
polypsintroduction
perpetuation
epitheliumderived
2013objective
edentify
analyticmarkov
medicalcare
respictively
bcrs
79660
rmb
45145
79957
48441
1621
1451
24488
93764
24811
97727
21314
infectors
904
espectively
0119
23190
88351
56725
857149
25279
80745
09192
55360
cryptosporidiosis
20152017cryptosporidiosis
parvum
tnfrrelated
gitrl
gitrgitrl
triggeringinhibition
inhibitiondeletion
myasthenic
stagespecific
fasciola
hepatica
l5
antifecundity
adjuvantmediated
fluke
sheepfasciola
agriculture
metacercariae
microneme
mitis
chickense
emimic3
remimic3
antie
antiremimic3
merozoites
remimic3induced
deduced
1145
mg888670
apex
tgfβand
cd4cd3
cd8cd3t
refractile
etso7
chickensrefractile
so7
retso7
erythematosussystemic
nondilution
laborintensive
simpler
onebag
montelukast
h2
btrs
browns
desaturation
p00167
yearsimportance
diarrheaassociated
datasparse
rotavirusassociated
128500
104500155600
104733
83406128842
childyear
030053
28000
1460046700
prioritizing
postconflict
republicunassigned
mambérékadéï
prefecture
threeround
ioral
iicombined
typeb
dtphibhepatitisb
iiipneumococcal
ivmeasles
vyellow
294054
9weeks
58049589
2593328764
modernizing
disordermedia1vid11015425803567555001pedsva20180120
membership
nulliparous
prenatally
1341
098
088109
weightingadjusted
077095
behaviorsbackground
differenceindifference
youth
715338
217077
substantive
cytokineantibody
therapyil2
orchestrates
heterotrimeric
il2rα
il2rβ
complexation
jes61
exchanged
abcytokine
il2jes61
blueprint
il2ab
catchment
artibonite
neighbourhood
5986
loglinear
4393
epizooticsvaccinating
strange
spilling
spill
epizootics
dlbclderived
exos
tumorgenesis
texs
ocily3
sudhl16
mcl1
dualcarmodified
malignancybackground
endowing
aspc1
cea
msln
dualreceptor
dcart
dcar
diagram
ceacar
mslncar
ceacd3ζ
msln41bb
singlereceptor
cζcar
mbbcar
noncognate
antigenpositive
dualtargeted
melanomanatural
antigenspecifically
carnkt
polymialgia
rheumaticatype
sicca
syndromegraftversushost
n324
factoradjusted
p678
transplantationthis
brachial
endothelialdependent
dilation
n108
tbi±ldcrt
tbihdcrt
chemotherapyonly
distensibility
modulus
decrements
twentytwoyear
19962018background
vespinae
987
previt
stung
and4hydroperoxycyclophosphamide
dnaalkylating
prohibits
4hydroperoxycyclophosphamide
4hc
dac
kbm3bu250
p53null
ociaml3
p53wildtype
bu4hc
3539
6062
caspasedependent
bu4hcdac
duplications
flt3itdpositive
mv411
molm13
p53mutated
insertionresponsive
vaccinein
tipseparable
irmns
polycaprolactone
pcl
retraction
acaninevc3782012
freezing
50°c
acaninekorea012007
8days
immunotherapymajor
immobilized
aapc
contradicting
postchemotherapy
nonhsct
patientspediatric
reimmunization
cogidentified
turkeyişık
çağlayansözmen
ş
asilsoy
kılıçarslan
sk
ö
karaman
uzuner
5055
asi
hundredninetyeight
tl
1131671
prot
immunotherapiest
transcending
boundless
overimmunosuppression
theirimmunosuppressive
tertiles
91978
tertile
101years
nonmelanocytic
nondigestible
oligosaccharides
modelscope
downside
fructooligosaccharides
mechanisticbased
residency
recirculating
reexposure
japanthe
ridt
1048
ridtpositive
ridtnegative
6346
4445
illnessduring
307891
41192
201617season
cellspsoriasis
nct01894373
infusionassociated
synchronously
pasi75
fourcycle
autoimmuneautoinflammatory
093121
colostral
vaccinationbluetongue
btv
1619days
enzymelinkedimmunosorbentassay
celisa
permission
75684
offsprings
btvfree
btv4
rolebackground
closeended
adenomatoid
uterus
iatrogenic
immunosuppressionobjective
mesothelial
myometrium
hybridizasion
nonis
9591
toto
sectioning
calretinin
blocktype
sv40
traf7
macrodissected
immunosuppressionassociated
apitopes
complexbinding
hladr3
antigenprocessing
tshr
adenovirusexpressing
tshr289
apitope
asthmas
treatmentobjective
bronchodilation
cg33
trialsthis
hivassociated
hivams
aidsdefining
nonaidsdefining
nadc
topicalablative
oncogens
lowresource
hivam
comanage
therapynaïve
resourcereplete
nadcs
814months
animalis
ssp
rhamnosus
gg
endotoxininduced
spneumoniae
3404±112
3829±104
0525
1901±126
2388±11
0340
29±103
337±90
00±02
02±01
0279
explorationbackground
unborn
centrality
9383
168383
contextually
interpandemic
cognisant
heartfailure
guidelinesheart
failureobjectives
guidelineshf
gwtghf
hospitallevel
defectfree
313761
to2017
measuresp
guidelineadjuvant
livebirth
posttraumatic
caregivershematopoietic
ptsd
2157
finances
caregiving
dclamp
nap3
spdl2
kidneyallograft
metaanalysisimmunotherapy
069093
048109
p012
016020
025032
guangxi
rabv
antirabv
compiling
39424685
48985267
60246967
70097153
602
acculturation
spoken
102052
41847
488502
278296
383395
12fold
acculturated
116131
michiganbased
immunizationobjective
michigan
10item
20132016background
pft
fvc
expiration
fev1fvc
pfts
118202
093102
housedust
slitliquid
newlyborn
100point
vhthe
or92
59145
or74
53103
fifteenth
italiano
bioterapia
optimod
ciclosporin
capsules
drugdrug
outcomesintroduction
objectify
vesiclebased
cellsexosomes
filters
nkem
nta
bli
perk
cleavedcaspase
cytochromec
cleavedparp
nkexo
higherses
highersocioeconomic
earned
125000pa
selfsourced
healthism
fills
scitrelated
201131
201331
datefirst
90day
n394479
n131493
planpaid
205741125
patientpaid
47560450
permemberpermonth
australiause
australianspecific
28963
27297
1666
consumables
adolescentsbackground
changedhypodermic
gauges
lengths
gauge
tubing
reactogenicitythe
1135
anterolateral
stretched
90°
angle
dtwphib
dtwphibhep
componentsprimary
outcomesincidence
outcomeprocedural
lowquality
moderatequality
narrower
relevantsecondary
outcomesimmune
measuredsevere
nntb
hardness
dosesusing
analysessystemic
reactogenic
heplisavb
statesthe
engerixb
pdxs
nephritisbackground
tubulointerstitial
lunar
µ
proteintocreatinine
80339the
14158
rapidity
podcast
httpswwwasnonlineorgmediapodcastcjasn20180906cjasnpodcast1810mp3
lymphomaschimeric
car37
dualspecific
cd37car
cd37expressing
ehis
healthsmoh
nvip
vendors
doseranging
trialaim
intracutaneous
10000therapeutic
tu
18000tu
0μgday
challengesa
mutualistic
auscultation
goatspneumonic
pasteurellosis
unpopular
crackle
sounds
trialsimmunotherapy
hgg
1043
hggs
hr049
hr116
infectionprotective
ifnr
libertarianism
libertarian
jason
brennan
libertarians
averse
hands
enforceable
compelled
disanalogous
brennans
cd30redirected
interactionstumor
tgct
dissecting
cd30car
tera1
tera2
nccit
nodscidγcnull
antigenindependent
cd95
127487
vertically
counts200
xmap
171years
752324
150355
088619
103262
revalued
carriedout
labbased
6631
yls
2014usd
ci95
491008
rx
5912343
rxcap
7698
2319
4225
keeppcv10
12859884
switchto
demandcreation
remedies
discussants
weekend
underpinned
misunderstanding
communitydriven
2016endemic
travelled
flights
budapest
europeanwide
epidemicwe
roma
nonminority
nationals
102018
152018
804
refugeemigrant
hosting
bandim
911months
measlesunvaccinated
measlesvaccinated
14813
31725
063091
065095
053087
062096
067111
0451
median1·2
0·6
12·3
12·1
suppressant
immunizationan
perpetuate
thymocyte
differentiationmaturation
agouti
ao
thy1
tcrαβmediated
tcrαβlohi
selectionsurvival
tcrαβhi
cd4foxp3cd25
ntregs
ntreg
atrophyrelated
replicative
p16ink4a
immunizationinduced
thymopoiesis
cd4cd28
melanomaover
strides
unanticipated
educationobjective
itv
postvisit
vaccinesvaccination
nephropathogenic
ibm41
ib2
ibvar2
dayold
110th
attibm41
attib2
attibvar2
10210±03
eid50ml
boosterdose
bhpv
990
antihpv1618
unprofitable
nct01717118
needbackground
hzi
hzvac
manitoba
19842016
postdiagnosis
provincially
unexplained
centralwest
nw
2586
fivestep
coincide
northsouth
retweeted
722
criticism
humoursarcasm
tv
journalists
outlets
hype
levetiracetam
phenytoin
busulfaninduced
recipientspurpose
anticonvulsants
ivbu
decadesthe
tumorsmonoclonal
circumvented
enk
degranulationdependent
activationexpansion
palisi
approacheslivestock
us23
livestockrelated
regularity
injuryunassigned
targetedly
goalbackground
ouagadougou
abon
biopharma
guangzhou
chine
2216
78years
297±147years
2302216
12021986
cers201501006
embolizing
aspergillous
embolic
endocarditis
aortitis
cytomegaloviral
tuberculous
thirtyyearold
emboli
psoriasispsoriasis
cellshere
tildrakizumabtreated
tildrakizumabinduced
pathwaytargeting
antithymocytes
transplantationt
nondepletive
venoocclusive
diseasesinusoidal
vod
vodsos
pharmacokineticguided
defibrotide
1823
narjust
duma
fullyvirulent
tumorsoncolytic
ohsvs
cancerspecificity
deletionsmutations
overattenuated
deletionmutation
receptorseg
2hence
hsvs
deletedattenuated
her2retargeted
unarmed
rlm113
il12armed
her2lewis
her2llc1
cd335
cd141
r115treated
vaccineimmune
ehv1
imvaccinated
igga
iggb
pbo
transporting
fe
etas
wondrously
proteincaptured
lnstargeted
etasbound
ce6fe
mould
moulds
placebopharmacotherapy
moderatetohigh
pharmacotherapyplacebo
663±13
1866±39
generalised
microimmune
stimulators
subsidised
vss
leaflets
semicompleted
piedmont
rotavirusinduced
rvge
antirotavirus
antirv
rhs
rotarix
bia
moneysaving
503000
12197qaly
opportunitiesas
wellsuited
nidus
celldeath
chromosomepositive
philadelphialike
platinumallergic
shengjing
10250mg
4845mg
retreatment
carboplatinallergic
3500mg
aβ310klh
3×tgad
micealzheimers
appsweps1m146vtaup301l
haemocyanin
adassociated
adlike
insoluble
2016objectives
n39497
paediatrician
slovenian
3854
444492
320366
rho0457
53113
ambitious
onein
reformulate
adjourn
followupreducedintensity
highveryhigh
cmvpositive
antialk
lymphomapatients
npmanaplastic
alkpositive
alcl
npmalk
alkantibody
epitopebinding
469496
561588
617644
girlsrésumé
objectif
lobjectif
était
détudier
déploiement
discours
sur
contre
vph
vvph
leur
filles
infirmiersinfirmières
médecins
canadiens
méthodes
entrevues
ont
été
réalisées
participantes
n146
quatre
canadiennes
poststructuraliste
permis
dexaminer
campagnes
transcriptions
dentrevues
pour
documenter
façon
interprètent
positionnent
comme
sujets
au
sein
lindustrie
ou
agences
publique
résultats
sont
sexistes
hétéronormatives
trompeuses
émergeant
lanalyse
manque
dinformation
qui
trait
mères
construisent
tant
que
biocitoyennes
responsables
prix
limpuissance
lanxiété
peur
ressenties
parallèlement
limpératif
dagir
minimiser
risque
fille
quant
aux
professionnelles
ils
sapproprient
dominants
utilisent
stratégie
fabriquer
consentement
sexuelle
perdues
problématiques
tous
nous
questionnons
savoir
si
bien
servie
quand
transforment
corps
instrumentalisée
pharmacologisation
baffles
t821
runx1runx1t1
mrddirected
mrdpositive
45log
thrice
httpclinicaltrialsgov
nct02027064
postallogeneic
treatedupper
8567
00004
reclassified
2083
downgraded
kineticsdiffuse
20082015
116374
12624
2392029
103313
095371
433856
306564
norovirus
selfreporting
filter
dependant
201112201617background
fortyyear
onemillion
201112201617
hospitalattended
201415201617
onethree
fourfive
todate
armenia
legally
ghanas
nomination
secretariat
commented
valued
workinggroup
syntheses
crossmembership
pharmacylevel
8466
1023
10121034
1016
10061027
pharmacydelivered
1025
10131038
10101042
cd1drestricted
ink
immuneregulation
magneticactivated
glycolipids
28×10
phorbol
12myristate
13acetateionomycin
glycolipid
01266
antigenexpression
ceaexpression
anticeacar
ceaexpressing
ls174t
4754±1260
widr
3114±1692
hct116
deacetylaseinhibitor
methylationinhibitor
5aza
fluorouracil
5fu
2299±204
6920±1192
6970±993
2299±401
7069±1019
5944±1092
effectorability
ceadependent
epigeneticmodifiers
hdacinhibitors
methylationinhibitors
adoptivetransfer
allogeneicnk
immunotherapyadenosine
ado
h1n1influenza
atwoyear
posth1n1
nt1
prospectivecohort
achenbach
aseba
pedsql
sd48
95ci04
oxybate
xyrem®
immunotherapycart
nktailored
caripscnk
neoplasmsfollowing
47th
goldman
tariq
mughal
postash
bcrabl1negative
deliberations
xiith
59th
allotransplantationpurpose
cue
xchromosome
hypothesiscancer
xchromosomes
xcr
monoallelic
biallelic
modelsobjective
subcomponents
tcelldependent
tnfαpositivecd8
matureactivated
hemogram
immunotherapygiven
accessaim
risksharing
programmeddeath
costprohibitive
mdrtb
bacilli
whodirected
necrotising
enterocolitis
nec
quasirandomised
birthweight1500g
age32weeks
stage2
rr064
ci027149
rr086
ci015480
wmd326
ci887
wmd977
ci3961559
approachesadvanced
polyadp
ribose
asystematic
42articles
myopathies
arapidly
acomplete
constellations
areata
squaric
dibutyl
totalis
universalis
dpcp
diphencyprone
sadbe
subgrouped
totalisuniversalis
nonconventional
4grade
2227
226412
103250
126336
summarization
gastroenterological
handfootmouth
behold
futurecellular
40000
preestablished
methodologic
046089
160246
151196
pmmrnonmsih
cancermetastatic
deficientmicrosatellite
cobimetinib
imblaze
cotezo
atezolizumabcobimetinib
atezolizumabcombimetinib
ottawa
401
bilingual
1261
697748
aor067
047094
aor073
058093
aor1341
9191957
aor182
100330
aor157
115213
interviewsobjective
duties
subtopics
groupspecific
extraimmunization
eightyear
771443
20062013underand
8year
nationalscale
lhid2005
303480
extraimmunized
urbanized
lessinvasive
tiny
diseasenanoparticles
diagnosticians
fludarabinebased
transplantationintroduction
tm
erythropoiesis
thalassemiafree
p045
ultrareduced
fludarabinehematopoietic
ultramodified
immunotherapypurinergic
hypoxiadriven
fuels
adenosines
ectonucleotidases
catalyze
immunotherapynumerous
picibanil
cl097
pge
cocktailmatured
ccl19
impairing
b7s1
tumorspurpose
terminatedwithdrawn
terminationwithdrawal
12875
fragility
immunityinhibitory
unappreciated
tasked
8827
geneticantigenic
sexspecific
biennial
corner
phoning
bedsideindoleamine
3dioxygenases
ido2
3dioxygenase
tdo
catabolic
communicationintroduction
interpretive
quotes
deduplicated
groupgenerated
immunotherapycurrent
tumormutational
volumeoutcome
databasepurpose
drugevent
dent
germanyvaccination
sparsely
19902000
crowding
orchitis
immunizationhealthcare
evds
osaka
eia
silently
overvaccination
miceantibodydependent
ecto
therapiesfor
enforcing
verge
dictating
testderived
transplantationdespite
n179
graz
plethysmography
ventilatory
neversmokers
casecohort
subjectlevel
530years
transitory
dengueseronegative
settingdependent
dengueseropositive
outweighed
allergiesallergenspecific
decides
2biased
andby
exposurecould
suffice
gonaconequine
equus
caballus
effectswildlife
beloved
daunting
roundup
mares
foaling
foaled
00016
primarysecondary
3455
lameness
furtherpurpose
cd4foxp3
alloimmunity
pd1presenting
immunotherapyradical
mk
microparticlecould
pd1expressing
depleteregulatory
transplantationadvances
blockadeinhibition
macrophagemediated
semantics
appps1
aβrelated
enzymesimmunotherapy
shortest
antiaβ3135
scfv17
6e10
aβclearing
bace1
sappα
neurotrophin
αsecretase
neprilysin
studentsintroduction
vaccino
ersu
oddsratio
stata®
6143
1732857
needlessyringes
1081348
1021198
judgement
sicilyintroduction
aoup
giaccone
documentations
correspondence
attesting
nonadministration
22yearold
pwud
decentralised
18054
15746
9089
addiction
mechanosensing
engagementt
pmhcs
arrayed
nonequilibrium
mechanosensorbased
tcrpmhc
bonds
loaddependent
tweezers
moleculesingle
pmhctriggered
cytoskeletal
motors
anisotropic
cytotherapy
bottlenecks
cartbased
prospected
flag
leukemiaobjective
busulfancyclophosphamidebucy
septicemia
ⅲⅳ
newvaccination
201316
tcellassociated
edemachimeric
proteinaceous
exudate
clasmatodendrosisa
beading
astrocyte
antidote
nigerianigeria
purported
empowerment
transformations
africathere
43637
15122
neighbourhoods
countrylevel
intracountry
intraneighbourhood
compositional
familys
upbringing
athletesbackground
athletes
coalition
overviewbackground
metastaticadvanced
immunecheckpointinhibitorsinduced
subside
icismediated
ratea
allohematopoietic
allohscttt
hsctdonor
graftversustumor
gvt
allot
relayed
therapiesover
endocrinology
conclusionsthe
kidneycharacteristics
recipientdependent
aged54
azathioprine
oupatient
prektx
postktx
immunecheck
receptorpositive
her2negative
cellscholangiocarcinoma
sddc
campdependent
ialpha
prkar1a
sddcpr
conventionallyderived
effectortotarget
prkr1a
drt
v403
sd4
diverticulitis
54184
00128
28months
87months
requiredvaccinations
firing
oppose
faculties
asthmaobjective
feno
2high
mediations
aβhbc
pdapp
micefor
deposit
15month
maze
latencies
quadrant
9m
cortex
hippocampus
illustrative
hanges
unifying
programmewide
ukin
sns
mumsnet
parenting
24th
64308
021087
037111
intraseasonal
mf59®adjuvanted
vaccineduring
swinederived
eggpassaged
cvv
acalifornia072009
x181
202days
influenzaspecific
subjectderived
misdirected
eggadaptive
artifacts
cvvs
stressing
antina
veal
facilityproviding
dehydration
milkfed
stp
misco
abbe
pa202x
solon
oh
zapvet
nowdiagnostics
gdl
dodabbf
bbackground
diplococcus
dotelisa
dodabbfomvs
alumomvs
phenomapping
jamlike
jaml
antijaml
coxsackie
jam1
homophilic
mysore
indiaobjective
831
sometime
101445
108313
147557
104257
029095
disapprove
022076
031089
olderage
093099
olderaged
europebackground
1000mg
adolescentsadults
ed100mg
9999
993999
ice
tafro
depletionhighgrade
dc2s
iv°
tlymphopenia
ifnγresponses
vla4
cnshoming
antiglioma
administrationreferral
marchaugust
stockingreferrals
8400
412months
lowno
23were
motherscaregivers
nonavailability
postponement
multipronged
conditionsannual
insef
298381
or214
131352
or439
199969
or277
100766
or395
253616
or158
102246
or213
102445
or038
ci022065
materializes
elegant
weaponizing
everchanging
ttf
doubling
melanomahuman
chimpanzeederived
fibroblastassociated
mfap
melanomaassociated
trp1
trp2
simplex1
hvem
caninetrp1specific
interferonifnγ
bleeds
ctrp2
mfapspecific
safetyimmunogenicity
recipientsbusulfan
16mgkg
d6
abw
ibw
aibw
pkadjusted
areaundertheconcentrationversustime
5000μmolminday
32mgkg
180min
4800μmolminday
140mgm
35mgkg
eightyone
3037
1527
aucs
5064μmolminday
36396157μmolminday
4854μmolminday
32516305μmolminday
p016
6000μmolminday
pkdirected
leukaemiasmds
transplantationdonor
dcl
leukaemogenesis
805100000
2938
casepair
immunotherapyconsiderable
surrounds
supercharged
pa01
blends
polymethylvinylethermaleic
parafilm
m®
381µm
postinsertion
p00059
rv5
20062014
dtaprv
1031431
821833second
615293
rvdtap
campaignsbackground
59000
userallocated
plot
politicians
yearonyear
caninetransmitted
managerial
therapyneurotoxicity
anticd22
punctures
pretherapy
preinfusion
cartspecific
nsc
730
disorientation
inflammationdriven
xenoantigen
survivalobjective
xenoreactive
xenoantigens
xenoantibodies
pigtorhesus
sda
dko
crossmatched
435day
intermediatetopoor
550
replies
asthmarhinitis
0670
anemiahematopoietic
curedhorse
eranatural
presensitization
utilises
arraybased
computerbased
cancersgastroenterological
mirnabased
tancar
allotransplantationchimeric
totarget
aswith
ofdisease
transformational
intracellularly
235243
hlaa2402
peptidemajor
populationa
studycompared
ssi
surgeries
54284
19284
1819
il12fasti
immunegene
therapymany
mil12fasti
updateover
gravismyasthenia
orbicularis
levator
extraocular
pyridostigmine
thymectomy
lid
crutches
turkish
familiesunassigned
serviceprovider
976
sclerosisthe
abnormally
microbiomederived
tlr2stimulating
immunotherapytablet
to203
torii
japanalk
517years
sqhdm
runin
511years
1217years
japiccti152953
1529years
660months
constructivist
bracing
punches
diseasemost
eskd
viscosity
convection
cellsconvection
infuses
lvhydrogel
resuspended
5h
4575
noninfused
apcontaining
antepartum
amv
¥6000us545
runs
00002802
¥9149317us83176
pertussisassociated
whosuggested
childrearing
effectbackground
miyazaki
1270
10711505
diseaseebola
vsvδgzebovgp
vsv
zebov
designation
papillomatosis
22year
rrp
aerodigestive
larynx
microdebrider
papillomatous
cidofovir®
maier
rpr
549months
95months
123months
972months
occluding
20092015background
388
821
12monthage
practicedual
p2y12
underutilised
naturallyinfected
leptospirosisvaccination
mat
d0
antileptospiral
seroreactivity
d60
seroreactive
sejroe
receptorprogrammed
eraover
moleculartargeted
kinaseextracellular
viceversa
immunepathogenic
studysummary
6052
ne
islands
phl
cyn
pellitory
pr10
profilin
nsltp
yin
yang
cellsepithelial
anticd3anticd28
rapidexpansion
inferring
dcp001
amlderived
multileukemiaassociated
cr1cr2
50million
fromthe
startof
nonpeptide
sclerosisadvances
pharmacophore
refinementmultiple
sheath
encephalitogenic
trimolecular
apls
beingused
cohortmost
65184
223395
37723
cellularity
dr15
marrows
eggsalveolar
tumorlike
dt
clinicsin
jsth
httpjstahuminjp20travelclinicsupportmanual20120726pdf
aftercare
campuslimited
regionfinancial
growingly
servicebackground
agerecommended
ihs
aicm
preprogrammed
1959years
6064years
coverage3
ageobjectives
81558
3095
everywhere
advertisements
1508
age22
1463years
shcs
or182
129289
or202
139314
or196
109353
or131
105163
or189
116301
or161
114301
or154
114208
or446
295673
europevaccine
umv
centralised
dtpcontaining
adenylate
cyaa
calmodulin
synthesizes
1706
residueslong
aminoproximal
1306
cd11bcd18
propertieswe
tregscd8
mip2
snap23
snares
growthsurvival
learnedobjective
nurseled
232520
freely
buffalo
islamabad
pakistanthe
contrastingly
bubalus
bubalis
antinsp
fmdvfree
fmdvs
asia1
undetected
myocarditismyocarditis
infectiontriggered
heartreactive
heartspecific
selfantigenloaded
foxp3expressing
metaanalysismantle
simonianlaird
alfa
023049
017069
asctineligible
025058
leukemiabusulfan
2523
1850
pairmatched
p06
p10
anticrispr
immunitysome
acrencoding
acrphages
acrphage
phageencoded
bacteriaphage
macrophagesbackground
immunotype
cd68
millimeter
p57
immuneignorant
immunetolerant
cancertuberculosis
coexists
goodpastures
reportnivolumab
74yearold
hematuria
hemoptysis
antiglomerular
basement
2016introduction
44825
levelled
nonsurgically
microangiopathiestransplantassociated
tatma
microangiopathies
anticomplement
herpesvirus6
antiinfection
hhv6
idarubicinintensified
idarubicin
idaintensified
p027
p522
p562
p634
p033
allt
novartiss
kites
pips
38weeks
taskforces
68550
8178
60372
preeclampsia
eclampsia
abruption
chorioamnionitis
madrid
spainbetween
1958
salks
1957
sabins
1960
rivalry
sickness
initials
soe
florencio
pérez
gallardo
19172006
juan
bosch
marín
19021995
franco
dispute
maríns
inviting
therapybiomarkers
hsp70i
q435a
repigments
sinclair
swinehuman
aminoacid
tolerizes
humanlike
jet
subcloning
pumvc3
antihsp70i
repigmentation
melanocytes
repigmenting
melanocyte
melanization
fluctuations
dapsone
pneumocystis
jirovecii
recipientsdapsone
pjp
adr
dapsoneinduced
nonhiv
sulfonamide
dapsoneattributed
tmpsmxassociated
nonlife
dapsonerelated
rechallenges
immunotherapiesthis
gmcsfbone
neoepitopeelicited
fibrosarcomadendritic
adjuvanticity
flt3ligand
gmcsfcultured
distinguishable
cd91
lox1
cartargeting
6fold
practicecompliant
11009
calgb
10404
allianceprior
nondel11q
fr
frl
reassigned
fcrl
5771
6680
3350
4571
hernia
collaborativebackground
incisional
3537
seromas
rotavac
missteps
scientistsmore
battled
40plus
opsi
hyposplenia
44412
seasonselfreported
977
progressionintravenous
dads
2126
corticosteroidssparing
12108
terreus
infectionaspergillus
amphotericin
rifnγ
8yearold
galactomannan
ablationboth
tcrsequencing
samesite
n2020
n1820
ablationimmunotherapy
ablationonly
immunotherapyonly
eomes
89fold
notreatment
60fold
ifnenhanced
deadcell
e7affitoxin
hpv16induced
cancercervical
affitoxin
affitoxin384
pe38kdel
affibody
spr
siha
anticervical
anticolon
immunogene
systemrationale
climb
mpegpla
dma
pil15
dmapil15
historythis
mvvp
prebreeding
nonprogram
trialplateletderived
receptoralpha
nilotinibassociated
nct01252017
vanishing
transplantationthere
cholestasis
ductopenia
ductstoportal
prehsct
liverrelated
receptor4
allergoids
designimmunotherapy
hlastatus
her2peptide
hlaa2status
lowexpressing
nct00524277
rhuil2
rhuil2based
103136
i2
0019
105157
109151
differentiates
vaccinesthe
zv
gespecific
lowundetectable
fluorospot
geil2
vzvil2
sfcs
geth1
zvlbackground
zostavax
zest
gradings
appropriation
inductionislet
situs
inversus
26year
hypoglycemic
unawareness
antiinsulin
antigad65
nontcell
knowledgeobjective
authordesigned
diphteria
uniformed
studyin
025mldose
05mldose
vaccinenaïve
rateafter
1yearolds
ah1
ah3
0yearolds
3yearolds
findingsour
oligodeoxynucleotidemediated
immunotherapycpg
odns
boron
nitride
bnns
dispersity
msfunctionalized
nanovectors
bnnsmsnh2
bnnsmsnh2cpg
bifurcated
bnnscpg
odnmediated
healthnuts
1634
118years
25mg
1g
25200mg
therapystroke
thrombolytic
plasminogen
strokeinduced
melanomacombination
hlac
b2m
ifnγmediated
prisonin
custodial
rootcause
rectifiable
optout
insisting
11415
79905
directionsbackground
crossover
subspecialties
otolaryngologists
th17mediated
muc
ibii
cisplatineligible
dispersalbackground
cedarinduced
chiba
durham
alix
presentationthe
multivesicular
mvb
highcontent
escrtassociated
basallike
blbc
stimulationinduced
redistribution
egfrdependent
alixdepleted
alixdeficient
stimulative
monocular
cd160
structurefunction
perdurable
tumorsa
ptabased
hauns
polylactic
coglycolic
apploaded
aapn
cytosinephosphoguanine
antitumorimmune
laserdependent
clinicaltrialsgovthe
p00334
antonio
part2the
40th
7500
keynote
talks
twopart
premier
doseintense
part1the
drugsmalignant
patientsintroduction
34686
20112014
us6737
us6700
protein1programmed
pemphigoida
inhibitorsin
eventsthere
cancerspurpose
dcvaxdirect
rejecting
2416
384556
overseen
nargentina
82151
112151
124151
56151
75151
28151
59151
52151
43151
aquaculturein
rhabdoviruses
commercialisation
gmo
cytobrushing
brushings
multispectral
cd11ccd11b
daboia
siamensis
myanmarsnakebite
snakebite
russells
viper
burma
r0982
multisensitized
pollenallergic
coexist
circumstance
complicates
plague
applicationshere
dualroute
resourcepoor
vypvaxduo
pestis
co92
25days
bubonic
vialled
thermostressed
40°c
29weeks
rehydration
barrel
syringe
entericcoated
behaviourintroduction
healtheffects
compartmental
hpv1618related
sickleave
euro
beaujolais
auvergnerhônealpes
st32
4cmenbbexsero
yearolds
than3
teleostsoral
stressfree
commerciallyrelevant
gfpexpressing
planktonic
crustacean
daphnia
rotifers
bioencapsulation
orallyadministered
nonencapsulated
bioencapsulated
transplantationwith
imide
ccbased
imidpibased
imidspis
imidpi
p07
programmewho
diseasesupdated
logarithmic
nanocarriermediated
melanomain
dominators
chemoimmunostrategy
cel
antifibrosis
tmeresponsive
remodeled
hierarchy
miniclinical
exercisebackground
minicex
91099891
65281
1275
000004
616
535709
046382306
04673
hierarchization
facilitybackground
idus
dcf
antihbs100ul
734
100iul
clientele
experimentperiodontitis
bacteriainduced
osteoprotegerin
opg
nanoreactors
chemoimmunotherapyimmunosuppressive
fenton
catalysts
notch3
cerebrovascular
cadasil
arteriopathy
subcortical
infarcts
osmiophilic
gom
5e1
octet
diseaserelated
overexpresses
laserdoppler
flowmetry
317nm
vasodilators
myogenic
201884246259
doorstep
inroads
pertuzumab
her2bc
cancerthere
plummbtrial
muscleinvasivemetastatic
nct02560636
dosecohort
100mg
3weekly
36gy
perforation
paused
advise
singleinstitutional
clinicaltreatment
groupings
50gy4
60gy10
45gy15
chemoimmunoradiotherapy
45gy
50gy
n49
60gy
ukthe
conceding
877727
241743
5571
multimethods
vaccination60background
thuringia
transsectoral
psychology
teach
drks00012653
24112017
disordersthe
swiftly
electrophysiological
encephalitidesthe
surfacesynaptic
neuroanatomical
managementautoimmune
complicationproblem
prednisonemethlyprednisone
nontreatment
1mgkgday
1131
20142018objective
4675
malignancieshaploidentical
ptldrelated
herdlevel
agropastoralists
tanzaniabrucellosis
agropastoral
item
ict
selling
55124
355535
or039
018084
tribe
hesitating
019083
or40
12130
sold
se75
value027
score132
sell
bare
tribes
alkylated
folding
3specific
unfolded
nanofluidic
drugeluting
cancerconventional
nanofluidicbased
ndes
trocar
elution
nanoconfinement
ndesmediated
ndescd40
activitythe
pdls
immunepet
identically
extremesthe
extremes
glioblastomaoncolytic
posited
gscs
gscderived
helical
immunotherapyplant
pvns
selfassembled
vnps
symmetry
wellarrayed
shells
protozoal
forwardpurpose
disarm
encephalomyelitisautoreactive
sagas
celladhesion
icam1
nonhydrolyzable
csagas
clickconjugated
hydrolyzable
autoimmuneassociated
abcs
th2regulatory
autoantigenic
pakistanglobally
deaths1000
3061
279daly
implicationsbesides
nse
disorderup
longlife
facilitatorsobjective
onstreet
phenomenological
endorsements
recalled
reticent
organise
alcoholinduced
predesensitization
postdesensitization
850
advancesimmunotherapy
lowtoxic
premalignant
anisomycin
cellsdespite
nkmediated
regulationassociated
functionassociated
antigen3
lfa3
cd58
anisomycintreated
icam4
nkdependent
hide
defend
immunotherapyevading
invisible
deactivate
canalanal
strands
possibilitiescardiovascular
hscrp
canakinumab
trialwe
cgvhdfree
n254
atlg44
placebo47
transplantationcontext
contraindicative
pcarelated
applicants
newcastleottawa
onls
mononeuropathy
polyradiculoneuropathy
36item
sf36
lqi
selfadminister
dr5mediated
deathadoptive
antigenmediated
coactivatory
fasfc
dr5fc
undervalued
eliminationthe
selfreplicating
ovd
optimizationimmunooncology
succeeds
overviewpioneering
anticd19chimeric
welltrained
ides
imlifidase
cleaves
highstrength
antibodyobjectives
hazardous
preformed
endopeptidase
singlecenters
cpra98100
24hours
preides
postides
carcinomalongterm
bavencio®
srsf2
cellsmyeloid
myelomonocytic
u2af1
granulomonocytic
megakaryoerythroid
20183616631675
cryotherapy
frequentist
1676
ppd
3956
1555
autoinoculation
7995
4295
pakistanthis
please
httpswwwelseviercomaboutourbusinesspoliciesarticlewithdrawal
editorsinchief
132139
httpsdoiorg101016jprevetmed201712005
misuse
apologies
systemthis
systembased
1805
brochure
cancerthree
paradigmshift
transduce
cd279
efficacyinefficacy
therapycheckpoint
laboratoryyellow
sylvatic
stockpile
sparingdose
merkelcell
eramerkelcell
caucasians
58yearold
riskadjusted
cohortthe
cbis
mbms
2753
preapproval
103945
haida
gwaiiobjective
gwaii
archipelago
columbias
workload
maximumlikelihood
2795
resurging
vigilant
deploy
commensurate
tkpq
nfκbsolid
trichosanthin
2t
repressing
effectradiotherapy
serine
protectionin
tssp
rtssp
iec
antirtssp
adccmediated
5270
5210
42dpi
parasiting
empaneled
practicelevel
withinpractice
nct03501992
dogma
directionsthe
2018477e300e304
asiaeven
alike
computerassisted
20s40s
1571
philippine
abtcs
victims
abtc
3291
5721
8290
2239
201416
8534
immunonutrition
2×2
oesophagectomy
isocaloricisonitrogenous
euroqol
eq5d3l
qlqc30
qlqoes18
p0·187
actrn12611000178943
httpswwwanzctrorgau
casewe
39yearold
thyroidectomy
lips
fasted
15step
11195
singlefull
tolerates
literaturea
flame
neomycin
feet
bilaterally
nonthimerosal
prostanoid
ligandsdendritic
reside
tcrαβcd3
cd3specific
tont
selfdestruction
3car
anticd3ε
selfenrichment
3cartcrcd3
humanmurine
patientsrecent
mctla4
nonicb
pd1ctla4targeted
infinium
humanmethylation450
beadchip
methylationspecific
ρ
0416
129329
adenocarcinomabackground
gvax
mesothelinexpressing
measurably
nct00836407
nct02243371
lustgarten
su2caacrdt1414
entertainment
aacrpancreatic
149025le
spore
ca062924
quicktrials
r21ca12605801a2
r01fd004819
deficienciesallogeneic
intermediatetiming
686882
529773
252546
81297
146404
01998633
therapieshighrisk
pis
citresistant
highriski
pibased
procedurerelated
highriskii
piresistant
vaccinationidentifying
biannually
episodic
2930
italyimmunotherapy
pd1pdligand
beyondallergen
intervene
criticisms
furtherly
185790
0309
0550
expiry
batching
multidosesingle
infantsdue
hvod
lipoprostaglandin
pge1
busulphan
revaccinationbackground
intube
qft
p063
p029
aeras
c040404
nct02075203
transplantationineligible
bar
pelvishuman
imager
rsna
antibodiesimmune
qualitypotency
antipd1mab
immunome
carcinomaintroduction
tyrosinekinase
tace
chemoembolization
sirt
pfu
plaqueforming
ess
aeis
aei
fluarix
tetra
gsk
5weeks
2016october
1286498091
520600
233288
159205
088123
549634
069229
4718
635742
268396
1003028
customised
glaxosmithkline
wavre
polandfor
misperception
1669
ceará
2015objective
52216
homogeneity
sipni
1388
updatepurpose
icbbased
bmapkerk
hemophilia
accomplishmentspurpose
alloantibodies
iti
chloroplasttransgenic
transplastomic
elevenyear
200717immunization
lively
societallevel
corriere
della
20072017
vaccin
325times
firstpage
fluad
channelling
urge
convey
antitrailr2anticd3
cellsrecombinant
trailreceptor
trailr2
strike
tandemscfv
diabody
trailbased
feverclassical
csfv
domesticated
banning
csfvmodified
baculovirusinsect
agrobacteriummediated
nicotiana
benthamiana
antiangiogenetics
nindetanib
aiot
algorythm
treosulfanbased
deficienciesintroduction
fulldonor
effectimmunotherapies
violated
maximin
derivations
scholarly
postht
ultrasonographic
cancerintravesical
rea
enthesitis
69yearold
wrists
wrist
flexor
tenosynovitis
extensor
carpi
radialis
tendon
futurecancer
geneticbased
immunotherpy
cancerbcg
bcgmediated
orchestrated
retreating
nsclcconsidering
retreated
recurrentnew
10939
gliomasmultiple
aftv
gliomascurrent
gliomascytokines
polypeptides
onsetimmunosuppression
cmcc
44102
preonset
solves
inhibitorsalthough
orientated
pc13
drone
practicelung
radiopeptide
castrateresistant
lutetium177labeled
psmabased
radiopeptideradioligand
lutetium177dotagaiyfksubkue
lupsma
8week
gbq
gigabecquerel
g34
myelodysplasiaacute
p00035
tissuesallergenspecific
vaccae
bicistronic
allergenstimulated
ovam
metaanalysiswe
matchedsct
11359
2677
8682
successa
januskinase2
arginase1
tcellstcells
phenomenal
peptideautoreactive
taapc
myelinautoreactive
peptideinduced
cellsized
cocouple
4054
h2d
antifas
pdl1fc
selfmarker
cd47fc
taapcs
4662
moleculedependent
peptidereactive
tc17
ifnγil17a
il10tgfβ1
profilesbackground
typified
ebscohost
melanomatargeted
ttc
antirafantimek
vemurafenibcobimetinib
dabrafenibtrametinib
haemagglutinin
antibodiesthe
crd42017054889
usthe
academies
90percent
80percent
145million
870000
undiagnosed
165million
37percent
24percent
decompensated
51percent
35percent
47percent
tcrsignalingresponsive
deliveryadoptive
backpack
cargos
surfaceconjugated
ng
16fold
eightfold
alloantigens
endeavour
cas9
ribonucleoproteinscrisprcas9
geneticallyengineered
procedureassociated
dnafree
ribonucleoprotein
cas9rnps
tgfbr2
hprt1
rnpmodified
postelectroporation
mbil21expressing
allergyintroduction
th17treg
abortionrecurrent
rsa
maternalfetal
studypurpose
phps
parentsadolescents
n46
precedeproceed
adolescentparenthcp
adolescentsparents
knowledgeunderstanding
educationinformation
groupsareas
staffhcp
educationunderstanding
parentadolescent
eventsimmunotherapy
glitters
hyperactivate
gen003
virus2
2933
5357
049136
antigen25
3025
045092
3050
037110
3075
036088
6025
038089
016079
6075
076126
µg50
µg75
gallisepticumcommercial
reared
multiage
pullet
fmg
nondiluted
p0079
serosurveys
ingredientsbased
9yearolds
us925
us197827
us10074
11yearolds
18825
3946
internetbackground
subpublics
1704
problematize
communicational
sequencingbased
patientshaploidentical
donortype
18f3deoxy3fluorothymidine
modelsacute
flt
replicating
micewheat
wgpii
irak4
tak1
p38mapk
phop38mapk
nucleunfκb
nontransferrinbound
preallogeneic
18y
negpos
20002015
ricnma
1554
0714
treatmentnanoparticlebased
phototherapies
immunotherapyindoleamine
highvolume
forwards
areabackground
102017
835
selfenriched
costimulated
nkg2dls
tnbcs
nkg2dredirected
nkg2dz
outsmart
interventionpurpose
ygbm
1825
or234
118467
or424
0872066
4545
hr182
147226
hr228
179289
hr172
127233
or074
058096
bsis
or167
093301
p09
or108
ci72162
jenners
1798
cowpox
litigation
injuryopposition
dating
antivaccinationists
legislatively
courts
unregistered
homeopaths
chiropractors
unscientific
nofault
nucleustransducible
baf57δph
baf57the
baf57
baf
prolinerich
hmg
ntbaf57δph
baf155
lpsinduced
pastanticancer
preneoplastic
reposition
socs1
socs3
retinitis
retrovirusinduced
immunosuppressionaidsrelated
maids
retinitissusceptible
maidsrelated
mcmvinfected
socs
mcmvrelated
manipulates
dysregulate
audiovisual
indiaaudiovisual
av
chandigarh
100155
100105
patiently
listened
allaying
rapport
oantigendeficient
singleimmunization
obligate
opta
optb
lflic
lhly
pjhl65
lon
cpxr
rfal
jol1800
jol1800derived
restimulated
lispecific
gdna
stbased
stspecific
gliomaglioblastoma
egfrviiispecific
g3egfrviii
mr1cd8tmcd28ox40cd3ζ
egfrviiiδ654
cd32
cd3280137legfrviiiδ654
orthotropic
demolition
staggered
chapel
construed
instantaneous
intervalcensored
malignanciesinfections
gnb
mdrgn
nonfermentative
enterobacteriaceae
nonmdrgn
nonfermenters
pachymaran
tremelia
dge
cadm1
igll1
ligp1
fcgr2
s100a8
chil3
mmp8
ifitm3
bracketing
multicolor
onstudy
cd4cd25hicd39
hladrlocd14
nct00972933
orial
llr
heilongjiang
gansu
20082012
disposable
4315
juneaugust
earlymonths
pakistanunassigned
pakistans
punjab
risen
viewing
lymphomaintroduction
lowtumor
firstchoice
incurability
youngfit
elderlyunfit
susacs
phosphoprotein
mphosph1
dep
depdc1
hlaa24restricted
hlaa2402positive
a24
n75
peptidespecific
rai
rainegative
p00019
cirn
studyimportance
10169
3161
5678
7086
1453
2259
6282
4166
017076
crossmatchabo
impermissible
lymphocytotoxicity
antib
lumxm
sunitinibsorafenib
cellscytokineinduced
nephrectomyunassigned
suso
dccytokineinduced
nephrectomy
pds
6336
carcinomaunassigned
048072
060079
074091
030062
046074
073099
lymphokineactivated
lak
ascitesinfiltrating
gammadelta
vδ
ails
2methyl3butenyl1pyrophosphate
2m3b1pp
zoledronate
zol
catumaxomab
lyses
linesobjective
mukbc1
drugmediated
cytotoxicities
interleukin2okt3activated
cmbinduced
cmb
1139
1028
prognostically
corpsbackground
disagreed
pd1pdl
podocyte
immunoproteasome
designrecently
hlaexpressing
murine20s
i20s
murinei20s
opportunitiesgranulocytemacrophage
antigmcsf
proteinosis
4d4
gmcsff1
gmcsf4d4
rcsb
6bfq
6bfs
therapiesfood
curtail
th1treg
oligonucleotides
fahf2
ketotifen
antiigebased
furthest
mechanismsimmunotherapy
uncover
cancersolid
ecosystems
timeframes
patientinformed
celltissue
7817
515563
dgk
cd28b7
diacylglycerol
metabolizes
phosphatidic
u87mgviii
7816
4692703
0201
utilizationbarriers
physicianreported
nonparticipating
requesting
discernible
acetazolamide
allergensobjective
reinstatement
colombiabackground
trimesters
us6
us4
us10
us7
us6610
transplantationposttransplant
waldeyer
annarbor
months14
kenyas
20011
8253
9496
9294
0609
mj8vax
acetylated
peptideprotein
j8dt
antij8
antidtspecific
antidt
actrn12613000030774
extendedrelease
lcpt
odt
3867
24hour
concentrationtime
25397
6190
28244
schuirmann
1sided
c24
0896
0893
1059
pbrm1
globulinthe
electrical
ejection
transvenous
highspecific
alphasynucleinthe
ofpolyclonal
tothe
cnbractivated
sepharose
histidinerich
contaminant
immunochemical
mary
hewitt
loveless
conditioninglung
homogenoustreated
intensitytoxicity
preexistence
midexpiratory
flows
restrictiveobstructive
sarcocystosis
sporocyststhis
sarcocystis
muris
βirradiated
sporocysts
184μsv
βirradiation
8h
wash
mlns
nk11
18s
ribosomalr
dependently
8hs
relied
immunotherapytumourinfiltrating
tumourkilling
ctlinduced
perspectivecheckpoint
headandneck
hbcab
20studies
20305people
60367
73857
prevalences
016035
017032
024043
023045
hbvvaccinated
thalassaemia
fbca
regimenallogeneic
hcst
awakened
cotton
syncytia
placentawe
membranetruncated
adf0δtm
minewborn
antirsv
adlacz
minewborns
4log
verticaltransferred
adf0δtmminewborns
internist
patientmost
snitrosoglutathionein
snitrosoglutathione
gsno
nave
il17il10
menacwytt
partiallyblind
nct01767376
1125yearolds
n660
coad
acwytdap
tdapacwy
rsba
1iuml
855
gmtsgmcs
preand
outcomespurpose
1104
01568
1603
11462243
14102711
129228
89134
5668
kompass
preventionsince
hematogenous
ruled
schedulesimmunosenescence
6178years
1830years
latedifferentiated
cmvseropositive
eeg
vla4targeted
melanomavery
trt
ludotapeg
llp2a
lullp2a
calipers
deoxynucleotidyl
nickend
tunel
cy3llp2a
cy3scrambled
dualici
cd45negativecd49dpositive
cd45positivecd49dpositive
cd49d
colocalization
futurenephrotoxicity
subfield
onconephrology
genesproteins
tumorsboth
typesposes
congenic
nontcellinflamed
coinjecting
tumorcellintrinsic
cxcl1
miceaβ
aβ142
gun
electropulse
hlamatch
diseasesickle
taint
packing
metaanalysismetaanalysis
improvac®
packers
tod
skatole
androstenone
3254gday
0234kgkg
dressing
6504gday
0075kgkg
0628kg
1385kg
hcw977kg
03kg
ham
backfat
futurein
circle
immunedirected
systemwidespread
integrations
scalableexportable
sb
vectorization
1524
n2413
or016
006046
or033
013082
or063
047085
or019
006056
or037
015090
or070
052093
or021
007067
imo2125
imo‑2125
toll‑like
receptor9tlr9
a20
intratumorallyit
differentiationcd3
imo‑2125‑mediated
β‑galactosidase
β‑gal‑expressing
ct26cl25
dose‑dependent
β‑gal
γenzyme‑linked
ablated
re‑implanted
long‑lived
tumor‑specific
indoleamine23‑dioxygenase
ido‑1
ido‑2
antigen‑related
member4ox40
mucin‑domain‑containing
3protein
lymphocyte‑activation
gene3
t‑lymphocyte‑associated
co‑administration
anti‑ctla‑4
anti‑pd‑1
anti‑pd‑l1
inflammationantigenspecific
carboxylated
polylactidecoglycolide
plg
antigenassociated
washed
precursorsinnate
ilcs
chilp
ilc2p
myositispurpose
sibm
cn1a
suggestion
degenerative
postautohct
13mgm
375mgm
359months
902
6697
6899
ccnd1
nct01267812
enugu
3132
n445
2183132
713132
1563132
ci054098
aor130
ci108159
aor119
ci109132
aor196
ci076507
p0164
reactionwe
47yearold
koalas
phascolarctos
cinereus
chlamydia
pecorum
proteinchlamydia
koala
antichlamydial
rmomp
smallmedium
momp
momppeptide
chlamydiaspecific
momps
chlamydial
mompprotein
syndromeguillainbarré
axons
humoraldependent
circumstantial
axonal
koreain
koreas
pcv13ppsv23
ppsv23only
3404
usdqaly
1421
3629
6643
vogtkoyanagiharada
vaccinationpurpose
vkh
43yearold
threeweek
blurry
photophobia
placoid
choroidal
detachment
neartotal
tinnitus
integumentary
choroid
pigment
prodrome
cavityin
αparticle
astatine211labeled
frizzled
10synovial
emitting
antifrizzled
fzd10
αemitter
astatine211
atotsa101
βparticle
antifzd10
yettrium90
yotsa101
μci
50μci
tregsth17
bacteriamediated
inflammations
inflammationmediated
fluorescentactivated
flushing
arrhythmia
transfusionrelated
trali
premedicating
storageinduced
transfusionplatelet
leukoreduction
wbcs
productrelated
plateletderived
plateletloaded
plateletspecific
preincubation
nanotherapeutic
hyperthermiainduced
modelingunassigned
confine
thermally
reproductiveage
dukem
mnt
tt2
n416
2925±511years
n163
n141
2917
photoimmunotherapynearinfrared
irdye700dx
nirpittreated
targetselective
flowed
indtpa
hh
perforations
effectpurpose
accruing
convincingly
advisability
treatmenteffect
challengescancer
traction
caveats
fraught
downsides
malignancieswe
2542
3452
101254
122303
103301
107307
n45
3665
1232
reportimmunotherapyinduced
emergencists
practicesunderstanding
strained
patientprovider
metaanalysisallogeneic
077105
07510
082128
p0834
methylated
cscc
65200
dmrs
450k
znf577
zincfinger
flot1
betavalue
cancerfiveyear
ukintroduction
charedi
categorisation
seasonto
54484
113697
288760
539
164746
236940
influenzas
profitable
marketthe
biosimilars
201516the
2‒6
7‒11
nonpilot
436720
5‒11
influenzaconfirmed
nonsignificantly
passport
hivan
passports
bhiva
seventythree
immuneunvaccinated
nearfull
riskier
sixthgraders
signification
thetechnique
multiplications
banding
whoictrp
usclinical
dcscik
3dcrt
outbreaksfor
cocirculating
straintranscending
crossimmunity
nuanced
designbackground
testandvaccinate
agegroup
betabinomial
sensitivityspecificity
metropolishastings
montecarlo
il9
ratsinterleukin9
eamg
rril9
antiacetylcholine
thsubset
2mercaptoethanol
2me
bungarotoxin
btx
allophycocyaninconjugated
cyanine
cy3
facs
fbs
isothiocyanate
junctions
nmj
phycoerythrin
peridinin
chlorophyll
percp
rachr97116
tamil
nadu
kancheepuram
whatsapp
poliovirusbackground
convectionenhanced
poliorhinovirus
chimera
pvsripo
supratentorial
contrastenhancing
doseexpansion
pvsriporelated
neurovirulent
nct01491893
challengetreatment
killerdendritic
therapyresponsive
microenvironmentsintratumoral
flt3lg
6and12
contenders
infancybackground
rsvrelated
picu
n370
n167
30weeks
6275
7687
2948
pregnancyinduced
201112
antiinfluenza
acalifornia
aperth
bwisconsin
antih1n1
conceptsimprovements
oncosurgery
fights
systemwide
lymphomasintroduction
carfilzomib
lysing
prestimulation
k562mb1541bbl
vigorously
expnk
ideficient
carfizomib
goingthe
grouping
localizations
proofs
therapiesbackground
unintentional
dining
allergenassociated
practiceshepatitis
hbvinfected
acknowledgment
diseasest
perspectiveobjectives
intensivists
intensivist
melanomasystemic
bcc
cuscc
combidt
bccs
0117
00260526
microenvironmentmost
employedinhibition
platformsbackground
displace
zmapp
antigp
gpdirected
nucleoprotein
npcontaining
adenovirusexpressed
gpexpressing
pseudovirions
bovinesseveral
rgp
plasmon
sprbased
denatured
mucinlike
nanoparticlevaccinated
dnavaccinated
tcbinduced
rgps
ebovgp
fluorophore
densitybased
excited
cancerspeptidebased
ppv
p56lck
sart3109
pthrp102
hnprl140
sart3302
lck90
egfr800
lck486
psma624
cypb129
sart3734
therapiesin
20kg
valent
symptomimprovement
6531
0403
10803
tightness
stamina
kota
bharu
kelantan
worrisome
implements
prevalidated
104114
732364
racotumomab
patientsantitumor
antiidiotype
antiid
neugccontaining
gangliosides
neugcgm3
abdependent
antineugcgm3
neugcgm3expressing
x63
racotumomabtreated
glucosylceramide
racotumomabvaccinated
732017background
alpha082
hucct1
smt01
oxycodone
selfadministrationabuse
overdose
immunopharmacotherapy
oxycodoneinduced
antinociception
immunoconjugate
oxytt
015mgkginfusion
12mgkg
nociception
006mgkginfusion
antioxycodone
incentivize
axl
cancersidentifying
receptormodulated
axlpositive
axlcart
recipientscaregivers
4446
caregiverrecipient
discrepant
thyroidstimulating
thyroxine
triiodothyronine
tt3
antiperoxidase
tpo
euthyroid
citarabin
flubased
autohsct
autoallohsct
syndromespurpose
vicious
puzzle
ascos
perspectivesimmune
potentialapplications
andtransplantation
countriesimmunization
whopath
demandalthough
amyloidosishighdose
hdmsct
mhdm
mhdmsct
75autologous
expressionwe
δn
krabbe
retard
eikd
presymptomatic
valencian
nvr
1569
ribera
torrevieja
elxcrevillent
nonspanish
metastasesobjective
targetedimmunotherapy
radiotherapybest
6991
62118
1189
n65
nigrostriatal
discontinuous
15mgkg
20mgkg
1methyl4phenyl1236tetrahydropyridine
mptp
antiparkinsonian
xenotransplants
wellness
mptpinduced
nigral
striatal
innervation
parkinsonian
dosesour
1927
1313
2627
immunosuppressionplasma
pcm
nonneoplastic
stridor
supraglottic
dysphonia
ceased
sri
lankaobjective
prey
1454
vaccineelicited
c57
bls
prpa
omp19
infectionsalmonella
deliverybased
lumazine
racemase
outermembrane
transplanta
n13097
chaos
synchronization
neldermead
byproduct
els
spontanuous
timingwhen
laquila
565
trigged
overloading
7407
6152
centuryschools
mid20th
continuities
discontinuities
subjecting
societys
201810810151022
doi
102105ajph2018304423
cheek
cancerrestricted
temper
pernicious
reparative
overreliance
surmounted
nsclccancer
changer
earlierstage
strategiescurrent
virologically
bisphosphonate
pamidronate
degranulate
chl
nct02277522
nct02624258
kil
hank
azd1775
impedance
moc2
binduced
sirukumab
2018introduction
extraarticular
tcz
srk
il6mediated
phaseii
sirround
srk50mg
lhds
continuumfour
ofthese
toor
ofstandard
urologythe
oab
cystitisbladder
icbps
metaanalysisprogrammed
deathligands
sarcomaa
sarcomain
070184
eventsfree
155270
predicative
guinean
positionsobjective
depicting
healthprotective
cheap
radioimmunoimaging
antibodythe
iodine131
ipdl1
cancerbearing
80±3
radiochemical
97±1
pdl1expressing
imaged
72hours
perspectiveimmune
hereosteosarcoma
hepatitiscorticosteroids
steroidfree
monthsan
patientsan
risking
140±1803
3197
1308
gynaecologists
immunitycancer
ecosystem
hypoxiainduced
multitasking
immunitymyeloid
hijacked
multitasks
treatmentobjectives
cerebellitis
longtime
projectmost
parentpatient
videosinfographics
instagram
audiences
chinasublingual
facilitiesof
ltcfs
opportunitiesfood
tcelldirected
diseaserelevant
gutimmune
metaflammation
nashthe
steatohepatitis
nash
foralumab
vaccinea
rsvnaïve
rgδm22
m22
msa1
hae
interferonalphaan
anticd20ifn
alpha14
α14
anticd20hifnα14
interchangeability
manufacturerintroduction
pertussishepatitis
binactivated
dtpahbvipvhib
interchange
gsksponsored
policymakersproviders
cdkn2aassociated
resistancepoor
ifnγresistant
inactivating
n367
n501
n408
n768
n257
22317
6691
148738
76×1046
αradiation
radioimmunotherapyrefinement
enlisting
tcmc
96±14mcimg
pbpanitumumab
30μci
20μci
diseasesfirst
20062015the
ncird
modernize
oversaw
immunotherapyimmunology
immunosuppressionadvances
patientsfludarabine
9βdarabinofuranosyl2fluoroadenine
faraa
twocompartment
40mgm
minmax
infinity
4696
305610477ng·hml
4781088h
smad3silenced
smad3dependent
smad3silencing
nk92s3kd
cancerkilling
tgfβ1rich
e4bp4
96577
studytreated
pontine
gliomaassociated
ny
lansky
54·059·4
1·8
9·25
18·5
27·75
92·5
120·25
mbqml
radiolabelled
i8h9
nct01502917
hemiparesis
vd
vi
1·5
20·1
vdvi
3·4
1·2
0·39
gymbq
0·20
lesiontowhole
kids
lyla
nsouli
cristian
rivera
cole
meryl
charles
witmer
charitable
tuesdays
mitch
diseasein
ovothe
ifnλ
interferoni
ifnar1
ifnar2
tlr21
bursa
ed18
hvtvaccinated
cvi988vaccinated
intraamniotic
βsheet
twf9
antiβsheet
aβcomab
cognitively
1822months
barnes
4mgkg
a3b3c3
immunoreactivity
microgliosis
astrocytosis
twf9treated
studiesin
nonparticipation
recontacting
unshackled
bestcharacterized
stark
inhibitionassociated
blockadesignificant
multiformebackground
celltumor
adcta
o6
methylguaninedna
6097months
112months
2007months
443months
0197
06002
0073
0249
cancerfor
agentsatezolizumab
pembrolizumabhave
analogbased
pentostatin
600mgm
3×
tcellskg
postcar
tgfα
48days
usintroduction
675167
ratio057
ci035
inpatientonly
pertussis032
ci011
pertussis110
ci054
antiblys
addenbrookes
guys
bodyweight
mitt
nct01536379
201100621556
34·4
109·5
40·7
understandingthere
ligandbased
malignancieschimeric
antibodyderived
scfvbased
malignanciesadoptive
edits
malignanciesimmunotherapy
tcellengaging
experienceharnessing
myelomaassociated
affinityenhanced
lymphomasbcell
nhlsis
heterogonous
efficacytoxicity
multicenterglobal
productionthe
safetyfollowing
hoped
industrythis
iggsensitised
delfia®
irritative
inflammationbackground
ovaaloh
1mganimal
intratracheal
500μganimal
5μganimal
postengraftment
recipientsbloodstream
gigvhd
microbiologic
hematogones
sourcesbenign
cyclosporinebased
choiceobjective
cares
schoolchild
schoolschild
commute
6791630
commutes
childcareage
eatobjective
enquiring
clinial
gweek
sesame
magea3positive
as15
immunostimulant
7909
as01b
27month
12weekly
gspositive
asrandomised
nct00796445
1391
1345
n895
n450
28·0
23·335·5
23·736·9
10·011·9
11·2
8·614·1
1·01
0·881·17
p0·86
9·9
5·717·6
11·6
5·622·3
1·11
0·831·49
p0·48
functionschimeric
antibcellmaturationantigen
resuscitated
cd107a
elisas
cr3
downmodates
cd11bligated
reponses
modcbased
beadbased
th17skewing
constricted
rs11143679
itgam
downmodulated
calvespassive
18mo
1972
744
temperaturehumidity
cthi
lactations
replacers
firstlactation
heattreated
reportwheat
cereal
32yearold
containit
k1
micesublingual
phagevaccine
modelover
egfrinhibiting
m13pak8viii
phagemid
mimotope
l2
eml2
peptidephage
m13
pviii
arandomized
lowfat
preview
hfbased
radioenhancers
outperform
hfo
radioenhancer
nmofmediated
bcelldepleting
syndromeduring
withmelanoma
blockadeobjectives
susceptibleinfectiouscomplicationrecovery
twoarm
makeup
taipei
susceptibleinfectioncomplicationrecovery
sicr
ceac
805
oncologyin
trialsthe
myelinderived
aquaporin4
nmo
researchmouse
chemotoxic
intrasplenic
fludara
permitting
engraft
immunotherapyacute
stemprogenitor
immunoevasive
2422
550215
pselectin
bindingobjective
recanalization
ischemiareperfusion
selplg
fut7
30minute
45minute
intraluminal
nct02045836
vrr
vrrs
iggsantivenom
antivenoms
hyperimmunized
hector
yolks
dodecyl
metabolical
oxidativenitrosative
envenomation
ed50
221μl2
7923mg
highexemption
schoolsprevious
schoollevel
exemptors
higherexemption
nonexemptors
arizona
maricopa
yavapai
naturopath
exempting
nonpolicy
2117
6147295
2131661
observerblind
nct02058563
mmrrit
priorix
mmrii
merckcoinc
7yearolds
antimeasles
antimumps
antirubella
srrs
accordingtoprotocol
17902
1135euml
761iuml
751
65s
82yearold
urination
dysuria
turp
fpsa
5454μgml
263μgml
actl
5454
0006μgml
antibioticspurpose
idiosyncratic
drugspecific
reexpose
caya
leukemiaacute
4052mgm
1000mgm
1200cgy
allaml
2354
135989
133415
efsos
eni
irradiates
dln
irradiate
cxcr3
ccr5related
anticlta4
effectortotreg
radiotherapyantictla4
radiotherapyantipd1
restrains
2420
505871
societybackground
targetthe
stateofthe
trolleyology
garnering
conicity
waist
capra
hircus
proteinsseasonal
distributes
kits
liters
antibodyrich
prioritising
bristol
gloucestershire
electoral
quotas
peace
healthmaximisation
masslike
b48
793blike
ageinfectious
bird
21dlong
choanal
cleft
10bird
portrayed
filamentous
expressionrecombinant
257264
pa8
tskb20
yova
ystrain
antipa8
antitskb20
bproducing
inoculum
myocardium
modifiedeam
noncryopreserved
immunotherapiescar
cubicar
trifunctional
streamline
radionuclidelabeled
anticd55
cancerdecayaccelerating
cd55
daf
7647
cd55specific
phagedisplay
lutetium177
luanticd55
charaterized
nhlafter
polyfunctionality
psi
il17aproducing
definable
nct00924326
egm
granulosusbackground
tapeworm
adultworm
egm9
egm123
45days
quil
iscoms
challengeinfected
immunoglobins
170days
proteinvaccinated
recalls
cardbased
recallbased
overestimated
overreporting
expectant
triaxis®
boostrix®
assayebolaviruses
nhp
antiebola
ebolaspecific
learnautopsy
concordance
preautopsy
cochranarmitage
autopsies
p45
approachthe
stochasticdeterministic
venules
efferent
challengein
sgp
sgpspecific
saponinbased
terapia
nella
malattia
progressione
metastatica
hepatitisautoimmune
ailds
aild
nonaild
steroidrelated
sinapps1
guidemerkel
24000
mcpyv
viruspositive
vp
vnmcc
modelestimated
hpvhiv
paratuberculosis
goatsvaccination
ptb
p22ce
drelisa
239421
t6
65194
t9
30132
960100
sp96
901984
sp98
929994
tbfreeptbvaccinated
ptbvaccinated
moonthere
proverbial
coined
hormonotherapy
aphorism
temptation
biomathematical
dexamethasoneinduced
abrogating
dexamethasonetreated
dexamethasonemediated
nocardia
therapynocardiosis
soilborn
acidresistant
ileitis
hypalbuminemia
tuberculostatic
cotrimoxazole
monthsthis
pregnancyobjective
menstrual
lmp
peripregnancy
1227
abortions
gestations
2800
081151
081141
injectionbirth
25to29yearold
controlintroduction
amps
interchangeably
tarentolae
nanobodyfunctionalized
azide
alkyne
cycloaddition
ligationtumorassociated
cd206
sitespecifically
raft
copolymers
corecrosslinked
mmrtargeting
siteselectively
cyclooctyne
maleimidecysteine
chemoorthogonal
nbfunctionalized
mmrexpressing
thailands
expired
smp80based
baboons
schistosoma
mansoni
reencountersmp80based
baboon
maturationhatching
smp80
schistosome
anodic
numbershealth
praziquantelmediated
smp80mediated
epistatic
tnfαdependent
deaththe
tcellderived
andtumor
nicotinamide
adeninedinucleotide
oxidasedependent
tnfαsignaling
scavenging
prooxidants
programbackground
91432
age663years
sd96
n2823
sevenfold
n19898
impactalthough
1526years
canadacontext
additions
3515
newthe
1800s
drugantibody
strategiescurrently
spongiform
creutzfeldtjakob
approachespurpose
immunotherapytherapeutic
overviewdermatomyositis
polymyositis
imnm
periphal
fev
quickrelief
3621
0765
trapalthough
oxp
oxpbased
flowmrd
hyperigm
experiencehyperigm
higm3
faisal
riyadh
30116
beac
matchedcontrol
ebmtlymphoma
partya
transplantion
n383
n766
beamconditioned
singleblind
21or
21schedule
levels035µgml
menzies
ec00153
nct01953510
preresults
chemoimmunotherapya
normoxic
723days
216days
11q2223
reisolated
reisolation
otsa101
radioisotopes
planar
scintigraphies
h144
187mbq
inotsa101
370mbq
1110mbq
2167
20gy
mediastinum
21weeks
emitter
radioisopotes
nct01469975
2443
neonatologists
neonatalperinatal
apneabradycardia
substantiates
overlookedit
20μg
mothersinfants
mothertoinfant
10μg20μg
rs2857127
rs3135338
rs477515
rs9277554
rs9286790
lowresponsiveness
inoculate
recommendationin
mhlw
understandintroduction
improper
storagehandling
timemediated
nosology
informs
2439
seamless
trialsimmunotherapytreatments
enlist
tumorshas
obd
futile
seamlessly
adaptively
randomizes
llnabrduelisa
assessmentallergic
acd
3htdr
5bromo2deoxyuridine
nonradioactive
natalizumabtreated
fingolimod
daclizumabtreated
kwahu
afram
plains
kapn
wincosas
973
1pentavalent
1pcv
1rotarix
2pcv
2rotarix
pentavalent3pcv
3190
1390
anticeacd3
efficacyunassigned
antibodylinked
sfab
anticarcinoembryonic
anticea
glycolsfab
culmination
astounding
finetuned
combinationaltargeting
leukemiacd19specific
systemspecific
myoclonus
neuroimaging
excitatory
95871
inprocess
nonindexed
citations
hematologythe
19892016
grew
0810
186year
24810
2506
1718
with142
788
nhlhd
autohscts
ewings
ttconjugate
crm197conjugate
trialhajj
polysaccharideprotein
crm197
ttconjugated
mcv4
34weeks
sba
mcv4pcv13
actrn12613000536763
ighg
igkc
fcgr
garp
controlsglycoproteina
repetitions
multiethnic
antigarp
interindividual
74±35
69±35
absorbance
auμl
garpbased
garpoverexpressing
functionand
pristaneinduced
pristane
0μgml
1μgml
10μgml
antidoublestranded
antidsdna
p0504
arthritisobjective
3748
ci045094
hr062
ci039097
nothis
pointbypoint
datasupported
workersbackground
synthesize
pooledanalyses
machineenhanced
phenotypicfunctional
memoryrelated
naïveearlyeffectorcentralmemoryeffectormemory
naïvenonclassicalmemoryclassicalmemory
ifntnfil5il10
beforenvday0
vaccinationpvday3045
pvyear19
pvyear1011
eefcd4
emcd4
cmcd19
emcd8
ifncd4
il5cd8
tnfcd4
ifncd8
tnfcd8
il5cd19
il5cd4
pvday3045
nvday0
venndiagram
preselected
pvday3045pvyear19
nvday0pvyear1011
decisiontree
toptwo
following17ddyf
curepurpose
lowantigen
artsuppressed
californiabackground
kinase3β
tws119
bendamustinebendamustine
51yearold
bendamustinrituximab
immunizationsobjective
parentinfant
hardship
67months
subscale
42017072849
bibliography
contentanalysis
newspapers
1128
148±041
132±034
0805
rejectionfree
0680
0701
approachesrespiratory
15200
spikes
ribonucleocapsid
alternations
metastable
rsvhost
ø
postfspecific
palivizumab
pref
africaunassigned
onehealth
rabiesendemic
smallest
populous
10900000
92human
annum
358611
395000
100046
156996
discriminating
immunotherapyredundancy
csf1dependent
codepletion
pi3kδdriven
tumourscancer
tumourmutated
unleashes
cellsantitumor
singlepeptide
ot1
ot3
b16n4
b16t4
reexpansion
ligandexpressing
folr1
folr1car
khyg1
folr1positive
khyg1t
her2based
cancerresistance
her2targeted
her2derived
yugoslavian
rm65
diseaselumpy
friesian
1117days
uneventfully
hagop
kantarjian
typeoriented
sag1toxoplasma
nanospheresabout
antigen1
sag1
nanopharmaceuticals
957bp
pgemt
pet28sag1
isopropyl
βd1thiogalactopyranoside
rsag1
35kda
antihis
nanosphere
panoply
reengineer
hopesthe
gbminfiltrating
2421
5198205
transplantationimmunization
12048
0506
pharmacistprovided
parentsbackground
endorse
unconditionally
117222
130340
endorsing
pharmacys
102119
competence
118170
115148
buyin
epidemiol
prev
9708
tacideficient
obesityinduced
homeostasistransmembrane
interactor
proliferationinducing
hfd
hfdinduced
tacimediated
adipogenesis
mϕs
vat
eotaxin2
adipocyte
obesityassociated
20002015introduction
filing
pbes
partisan
pbe
republican
percentagepoint
08point
conservatism
republicanconservative
decreelaw
16yearsold
872
everythinganticancer
immuneactive
trichotomy
observable
loosely
everything
mustem
dystrophic
clinicaltissue
benefitsgrowing
demonstrations
retriever
muscular
dystrophy
grmd
munois
mutris
9monthold
antidystrophin
immunotoxinsrecombinant
immunotoxins
rits
deimmunization
deimmunized
dander
catrelated
felix
domesticus
051705
123191months
femaletomale
buconditioning
approachs
lite
egfrspecific
lites
41kda
egfrexpressing
egfrnegative
avascular
avn
p0047
operatively
steal
h1n109
interferoninduced
protein3
rs12252cc
rs12252
aswitzerland97152932013h3n2
acalifornia72009
pdm09h1n1
bjeep30732013like
flub
elderlies
pdmh1n1
cttt
overtime
2080
alloactivated
replacementsince
cpeptide
resumed
isletspecific
autoreactivity
desmoplasia
adultsmany
2040years
6gene
33gene
inflammasome
wwwclinicaltrialsregistereu
euctr
eudractnr
201300258938
ebolaviruses
antiebolavirus
realistically
superspreading
financiallogistical
humanpathogenic
nh36
f3
antigenprimed
leishmaniasisphysical
pulp
donovani
hydrolase
chagasi
tnfαil10
nh36vaccine
f3vaccine
f3primed
2606
anticcr7
28dayinfected
nh36vaccinated
f3vaccinated
corporal
svbr1gm
gmcsfsecreting
lymphocytestargeted
nct00095862
prame
curiously
hladra
hladrb3
hladma
hladmb
ada
adgre5
cd97
cd74
clip
cxcl16
hlaf
kitlg
hladrb30202
hladrb30101
4359
yfvdrb30101specific
mhcs
meningoni
mgd007
cd3bispecific
dart
antiglycoprotein
a33
anticipatedbispecific
gpa33positive
μgkg
gpa33expressing
gpa33dependent
fccontaining
176172
childa
diaphoresis
risus
sardonicus
galunisertib
tgfβri
pleotropic
tgfβs
4t1lp
virusrelated
acquiescence
haemocompatibility
alumhbsag
interferony
nanometric
haemocampatible
antihbsag
serioussevere
unclassifiable
1037
n153
regressionobjective
47105
convulsion
59years
pitfallstau
safetystrategies
zf1
amms4g4
hu5f9g4
opsonizing
60mgkg
wasnt
responseoptimization
inquired
dnaimmunized
transcriptasereporter
luminescence
immunogenspecific
blibased
deliveryimmunogen
factormobilized
interleukin21stimulated
growthmemory
tscm
multipotent
interleukin21
cd45racd45rocd62lccr7cd122cd95
γchain
eomesodermin
gata
nsclcbackground
cancercellkilling
factormediated
bcp
abcp
teffhigh
genesignature
rochegenentech
impower150
nct02366143
epistemic
ontological
confusions
scepticismvaccine
worldview
positivist
epistemological
socialpsychological
magical
welleducated
wellresourced
intuition
lifeaffirming
authoritative
tactical
hlaincompatible
transplantthe
microlymphocytotoxicity
nivolumabwe
thyroperoxidase
thyroglobulin
adolescentsin
tetanuscontaining
68915
7521
61394
encephalopathyencephalitismeningitis
glypican3
adultsinvasive
polysaccharidebased
rlp2086
1025years
studyreported
246month
nonaboriginal
firstborns
87103
nonsmoking
multiparous
socioeconomically
thirdleading
regulationb7h3
b7
israelbackground
qich
operates
hmos
20022015
n879671
elderlyspecific
benzodiazepine
underweight
nonage
emr
hmo
sep
6574year
bmi23kgm
weightloss
nonelderly
sepdisparities
israelis
debutlimited
glimmer
trying
disregarded
instituto
português
oncologia
lisboa
francisco
gentil
aespatient
31±20
20132015background
1844
birthyear
immigrationrelated
24216
mexicocentral
americacaribbean
subcontinent
puerto
rican
inertia
mainstreaming
regionvaccination
mics
turmoil
privatenongovernmental
hpt
cancer22
iccenrolled
58gy
effectivenesswe
42months
306months
145months
cancerpatients
mesothelintargeting
mesocar
higherlevel
transposonbased
npro
proteinthe
tlr4myd88
ncpbvdv2a
1373
coimmunoprecipitation
ncp
bvdv2a
availabilityactivity
s100a9bvdv
damageprogrammed
nhdfs
irf1
nonresponsiveness
dnadamaging
camptothecin
relaxation
irdependent
dnadamage
hpvdna
19982003
20042009
20102015
xy
13665
1361
5130
7174
9731361
23855130
19017174
12591361
37095130
41687174
innocuous
cryopyrinassociated
vet
sentenced
puppy
gang
chemoprophylaxis
diseasealthough
nonmilitary
mbpspecific
moginduced
il2triggered
cellsexpanded
myelinbasic
ob2f3
helios
mogimmunized
contactindependent
tmbtb
feam
italiana
linfomibeam
bischloroethylnitrosourea
bcnuetoposidecytarabinemelphalan
fotemustinesubstituted
equivalence
bsymptoms
beam2011
feam2013
sorror
beam15
feam10
p017
beam18
beam31
feam44
isolatespatient
beam1
feam19
postasct
beam91
feam88
p42
861
674
fotemustine
larvaelittle
larviculture
leukemiaspecific
cd33targeted
cd33deficient
impervious
cd33targeting
illuminate
gunbased
immunizationmonoclonal
multipass
claudin
cldn4
multiindication
sds
sandpaper
anticldn4
dualantigens
immunotherapypulmonary
turkeyobjective
cvrh
childchildren
heel
alterativecomplementary
socialdemographic
irresponsibly
industrythe
winding
pathwaysobjective
prospectives
evidencedata
diseasestates
cancerrandomized
596months
aktdc
0439
0098
0474
0479
0399
0483
immunotherapymyeloidderived
corticosteroiddependent
outcomesome
60mg
55mgkg
lingering
oligoprogressing
krukenberg
originskrukenberg
signetring
metastasizes
kts
cytokinerelated
immunotherapyil2
cdsi
miic
minnesotas
readonly
ehrsiis
nowpancreatic
inefficacy
cancerassociatedfibroblast
stromatargeting
blockademany
blockadethe
broaddiagnostic
serologies
patientspatients
inflammationsevere
hepatologistmost
neurosurgeonsthe
reviewgeneralized
gpp
multisystemic
exemplary
chanceswhile
ditra
il36
il1223
antiil17
procure
unadulterated
subtypespecific
vaccinestrengthening
lymphomaresistance
panbcell
showcase
immunotherapyremarkable
departure
niloticuswe
zt
schedulezt2h
zt6h
zt10h
zt14h
zt18h
zt22h
tnfα3
diurnal
acrophases
thrombocytes
nighttime
lightdark
franchesmontagnes
stallions
equistrath
trialbiostrath
plasmolyzed
malt
honey
orange
006mlkg
32days
componentsreceptor
oncofetal
hunsg
cd5expressing
tcl1transduced
lump
strategiest
lymphomasgenetic
lymphocyteassociate
pd1pd1
infectedmutated
kirl
vivoactivated
therein
antikir
bitrispecific
tet2
transposons
chimaeric
vectormediated
methylcytosine
hypomorphic
tet2disrupted
potencyenhancing
cancerupper
cancertriple
oestrogen
neoplasiacontext
immunosuppressioncontext
unchecked
ag85btb104
adbased
adh4
mvah4
cd69cd8
adh4containing
adh4adh4
adh4mvah4
mvah4adh4
mvah4mvah4
ag85b
91p
92p
th1related
bcgimmunized
givepatients
indicationappropriate
supplementing
nonoit
nonallergy
ovomucoidspecific
growingpurpose
lar
nonatopic
receiptbackground
audiorecorded
northeastern
likelyvery
syndromesbackground
haplomac
geth
27days
30month
cthe
2016at
iowa
crds
23329
9019
pnaum
421
372471
0330
alloimmunisation
reviewtransfusion
systematise
20636
4·4
il1b
hladrb1
vaseocclusive
voc
communitybackground
clusterrandomised
1055337
concealment
blinding
postcards
facilitatorsincreasing
767460
participantsone
leaflet
postcard
64200
receptionists
15295
249067
124some
groceries
effectiveenhancing
9353
participantswe
4633
notprovider
278524
reminding
posters
497we
metaanalyse
ratesinterventions
levelno
interventionsstudy
sourcesstudies
providersystem
mesotheliomamalignant
asbestos
patientsadoptive
transplantationbusulphan
consumes
acetaminophen
alp
nacgroup
phosphatase2a
blockademounting
pp2a
lb100
apd1
amurine
approachover
multiplatform
subsetspecific
1781
transplantationcomorbidity
cotransfer
ly51c57bl6
gp33
ly52c57bl6
gp33specific
adultsto
homosexual
malespecific
jamaican
jamaica
4major
serotyping
quellung
454100000
5yrs
163100000
65yrs
120isolates
22120183
20120167
18120150
1112092
nontypeable
812023
829
antibcell
myelomapurpose
firstinhumans
carbcma
4863
triptorelin
sustainedrelease
studyantipd1
glycemia
saint
louis
fpvd
t2d
p0068
directionsthere
genomically
mostimmunogenicand
anakinra
abated
blockadechimeric
israelpertussis
13yearolds
1315yearolds
infectionin
22days
acyclovir
unfortunate
gavieligible
threetiered
ugandan
costoffsets
1516
imaginglung
antagonistsinhibition
ciap1
ciap2
grampian
scotlandintroduction
rasrafmapk
phosphatidyl
inositol
3kinaseaktmechanistic
factorcmesenchymalepithelial
igf
receptorsneuroblastoma
cisplatintreated
chk1
chk2
packs
squeeze
3781136
brevity
injapanjapanese
jcp
pharmacothearpy
metaethnographic
literatureintroduction
sevenstep
metaethnography
noblit
hare
casp
entreq
1280
thirdorder
reiterate
adiposederived
admscs
admsc
cmet
417±121
mesoscopic
nivolumabpembrolizumab
dtwphbhib
1824months
oldbackground
openlabeled
pentabio®
hemophilus
23725
399452
induration
threeday
nct02095314
6aβ15tf
vaccinealzheimers
aβspecific
antiaβ42
aβinduced
presynaptic
postsynaptic
vaccinationinduced
transplantationsinusoidal
soshepatic
transabdominal
sosvod
baltimore
seattle
us17
hokus10
paraumbilical
deliveryskin
coencapsulating
npha
asymmetrical
fieldflow
1µg
mndelivered
nploaded
1268
consumptions
exacerbator
malignanciesduring
tilbased
transplantationin
iuhct
iuhctinduced
actionimmune
myocarditisimmune
cardiogenic
vignette
icimyocarditis
diagnosethe
mellitusthe
therapiesmyocarditis
coursethe
liberate
immunosuppressiontumor
campelevating
blockadeenabled
genedeficient
deletionbut
deletionliberates
mca205
mimicked
antib7homolog
targetmissing
3787
biasing
jacie
worldwidehematopoietic
estabished
pioneer
hematopoeietic
hematotherapy
shage
isct
goverments
sarcoidosislike
therapyimmunosuppressive
malignanciesdepending
thiopurine
smethyltransferase
tpmt
thiopurineinduced
nudt15
adme
udpglucuronosyltransferases
ugts
efflux
cytochrome
p450
3a4
3a5
pharmacogenetic
gliovax
o6methylguaninednamethyltransferase
promotor
nearcomplete
radiotemozolomide
compassionateuse
noncontrolled
eudractnumber
201700030414
drks00013248
nct03395587
hypopigmented
transplantationjak
5mg
ganciclovir
infα
infβ
alabamathe
alabama
tularensisthere
tularemia
lvs
lvsmediated
fischer
lvsderived
intramacrophage
lvsr
lta
il12rβ2
quantifications
melanomanew
photosensitivity
plantar
hyperkeratosis
verrucal
keratosis
deliveryimmunization
th2polaritydna
th2immunogen
expressionoptimized
rtdnas
cyclicdigmp
rtdna
luciferaseencoding
antirt
100v
electrodes
rtspecific
199220
528543
drugresistance
205220
202210
rtluciferaseexpressing
levelobjective
medicationthe
24305
carcinomasthe
carcinogen
wemedia
managementobjective
wechat
leader
conductd
onthespot
analysises
1331290
3222990
417512
5171529
0558
advantageespecially
tcf3znf384
leukemiaa
znf384rearrangements
probcell
mixedphenotype
znf384
sporozoitesmalaria
anopheles
investigatedin
cryopreserve
germanyintroduction
directive
insurances
markovtype
48142
2400045000
nonbacteremic
nbp
1500045000
40008000
mio
lyg
3662
23061
3258
29617
metaanalysisalthough
108127
1167
101178
109206
selectionallogeneic
intelligent
unmanageable
stateof
theart
myelofibrosisthe
bischlorethylnitrosourea
fbm
graftversus
immunotherapyrelapse
therapiesdespite
hamburggermany
hhv6b
transplantationsuccessful
antagonizes
extrathymic
graftstransplantation
kgbw
197log
2425
csamtx
vegfr
clearcell
3777
4484
tkicpi
cpicpi
p0310
transaminitis
headway
tacrolimusloaded
allotransplantationbackground
inflammationresponsive
norwaytolewis
hindlimb
70day
hydrogeltreated
immunizationimmunization
2736weeksofgestation
immunotherapycytotoxic
teffs
cd28positive
systemthe
incompetency
tsa
tsasensitized
conditionsnumerous
corynebacterium
sppalthough
ltr
barcelona
striatum
pseudodiphtheriticum
amycolatum
suture
812
monomicrobial
nonlrti
0057
metallic
ad26
monkeysvaccineelicited
ad26env
hiv1specific
antienv
rv144
caregiversintroduction
1118years
nonvaccinators
testimonials
didactic
operationsbackground
entrepreneurship
nonelective
antipd1related
bismuth213
actinium225
malignanciesobjective
αparticles
βparticles
lintuzumab
αemitters
bismuth
213bi
225ac
213bilintuzumab
radiometal
emissions
225aclintuzumab
fractionateddose
cd33positive
dresden
clinicianimmune
nanoring
nanorings
csans
prosthetic
pars
αepcamαcd3
parfunctionalized
trimethoprim
deactivation
nongenetically
201214in
procyon
lotor
adenovirusrabies
hampshire
3yr
rvna
750m
spacing
10d
postorv
201214
n1079
248301
n1551
662708
canadaus
adolescentsa
patientfocused
interventionsobjective
1participants
415years
2interventions
3vaccinations
4outcome
patientled
coolant
addis
ababa
ethiopiaintroduction
3million
untimely
unnecessarily
untimeliness
subcities
12monthold
yiwu
1324months
ci1127
aor18
ci1445
ci1328
aor22
ci1648
aor07
ci0509
aor17
therapynovel
heparinized
reportwe
prolymphocytic
3uiml
pneumoallergens
035uiml
undiluted
30mgml
4mm
papule
8mm
12mm
modelsimmunological
tlr3adjuvant
ovaexpressing
antiviralsignaling
pdl1low
pdl1high
subline
mo5
arnaxsusceptible
reimplanted
2400070000
rabiesecon
dogdog
doghuman
ylg
semiannually
4400065000
21002900
20001600
451385
semiannual
20001900
404305
dogtodog
ro
vaccinationdynamic
homogeneously
formally
susceptibleinfectedrecoveredvaccinated
densitydependence
diffusive
outpace
allocating
ash
2017introduction
immtacantipd1
immunosuppressionrecently
immtacredirected
ratesthe
1993
inducedstem
scm
op9
deltalike
op9hdll1
anticd3cd28
transformedtumor
studiesbackground
2945
bicomb
highfrequency
textcoword
gcluto
doubleclustering
coword
hotspots
leukemiaobjectives
busulfanfludarabine
materails
uveitisuveitis
behçets
comanagement
turkeywe
8years
rhil33
thusil33
controlcanine
canl
phlebotomine
sand
flies
insecticides
bourdieus
capitals
habitusthis
bourdieu
ingram
disjuncture
tugs
valorizing
philosopher
navin
reward
conformity
vaccinecritical
imprint
transformationimmune
hlapresented
constitution
nmc
35367
28132
7684
6312
cancerexclusive
kegg
panther
carcinomaassociated
rtkras
overrepresented
tumorexclusive
hlaligand
mutationderived
462741
vaccinatebackground
554
nonhispaniclatino
p0148
medellin
20162017background
motherumbilical
antioquia
paroxysms
coughing
posttussive
100iuml
192274
trans
accommodation
patientsparticipants
nonstudy
efficacymycoplasma
multiaged
nares
boostability
hsctbackground
hemostatic
2000june
2000050000×10
20000×10
paraspinal
sup8690
ybased
theranostics
modelangiogenesis
isotope
neovasculature
anticd105
trc105
ydtpatrc105
peaking
03idg
dosimetric
8690
blockadealthough
thermogelling
rosresponsive
polypeptide
dextro1methyl
populationsthe
woodlands
breakdowns
unmanaged
feeders
subclinically
cameroonfootandmouth
sat1
sat2
adamawa
n50
antifmdv
89150
103120
42150
immunopeptidomic
hlaa2positive
immunopeptidomes
nanoultra
nuplcms
19675
atacc
cofilin1
cfl1
syntenin1
sdcbp
ribophorin2
rpn2
immunopeptidomics
proteomexchange
pxd009738
studyvaccination
seeding
expectationsprimary
745500
reinfusing
checkpointmediated
asthmaconstant
4pba
il25induced
responsevaccination
smallmoleculebased
bursts
controlledrelease
singleadministration
therapyacute
latergeneration
carcinomaurothelial
quelled
muc1based
commit
founding
ppbiost463659bst20170400cf1f1bst20170400cf1figure1number
muc1targeted
transplantationsthe
ukraineobjective
legislator
objectivity
historicallegal
disorderbackground
vaccinationassociated
abort
fare
ultrahighdose
cholecalciferol
transplantationvitamin
25oh
25ohd
50ngml
hypercalcemia
nephrolithiasis
fractures
600000iu
150ngml
calciumcreatinine
ntelopeptide
58±49
289±131ngml
ultrahighoral
400iuday
804±286ngml
30ngml
nephrocalcinosis
peritransplant
virusthis
simulates
singularities
hopf
singularity
bifurcations
exercisepatients
neuropsychiatric
depressivelike
neurobiological
substrates
ifnαtreated
prefrontal
pfc
wellcharacterised
pfcsupported
perirhinal
prh
ameliorative
ifnαtreatment
discriminations
ifnαinduced
circuitry
hippocampoprefrontal
smds
pieces
togetherover
responsesvaccine
frameworkvaccinations
technologic
disagreements
narratively
201200433628
pqbirch203
201500098415
pqbirch204
pqbirch
55fold
curvilinear
sexrelated
loghr
11351
7646
3705
3482
0·650·79
0·86
0·790·93
p0·0019
safetyquality
therapyclinical
neonatesyoung
bloods
testingobjectives
crossreactions
277588
indurations15mm
5117mm
2819mm
were1
16mm
values17mm
significantly1
22743
29years
fy
fiscal
hsilas
011083
pvalue0013
008080
pvalue0009
chisq77
df9
pvalue0569
hesitancybackground
alarmingly
roleplaying
talking
independately
centerbackground
systemslevel
sgm
sgmidentified
2326
specializes
culturalcompetence
identityaffirming
cisgender
vaccincation
sgmcompetent
changerecent
h9n2
laryngeotracheitis
chickensavian
virush9n2
aivh9n2
larvac
aivh9n2larvac
ocularly
acclimation
infectionmycoplasma
nosetonose
sowtopiglet
shedders
recipientsrecent
lrtd
piv
mpv
antibioticdays
provenprobablepossible
monocytopenia
immunotherapyimmunosuppression
tlyp1
peptideconjugated
peptidemodified
swcntsdna
proteinto
svcv
swcntspcdnam
pcdnam
desensitizationbackground
aspirinprovoked
bronchospasm
e4
lte4
nct00555971
ir700dx
phthalocyanine
sccu2
sccu8
osc19
a431
mts
alamarblue
690nm
7jcm
5mwcm
annexin
vpropidium
iodide
immunoblots
dealth
apoptopic
50513522
sunprotection
therapyduring
overlooking
chinahand
selfdesigned
mean±standard
632±170
2258
4424
aor148
104211
aor425
277653
aor215
142325
aor156
107227
aor054
037080
gearing
270000
dodge
entitled
uptakethe
mathematically
solvable
meanfield
coevolutionary
nonmonotonic
imperfection
counterintuitive
perspectivethe
inconceivable
revitalize
fir
pdl1selected
nct01846416
tc23
ic23
archival
chemotherapynaive6
tcic
cd103cd8
componentsvaccines
immunopreventable
choicedespite
otheroften
distantindividuals
costimulationimpaired
sulfateinduced
micedendritic
gmcsfil4
asodn
710days
colons
dssinduced
colitisfree
architecturally
dsstreated
immunitydriven
innatedriven
alreadyestablished
cubas
roswell
institutein
1961
severed
diplomatic
cuba
embargo
reestablish
yorks
treasurys
authorizing
usathe
withstandingopens
cuban
childrenpediatric
wellprepared
cvc
reflection
technologiespatients
sqclc
facebookbackground
wrt
intermediaries
segregation
dissenting
26m
298018
automatically
cohesiveness
echo
wellsegregated
consume
chambers
socialmedia
fomenting
backfire
biclonal
intoxicationoligoclonal
equimolar
bep
tentspecific
beps
tent
constituent
aluminumfda
ingredients
cfr
61015
extraneous
provisional
weightcorrected
juvenilespecific
hepaticamost
sexbased
fhcl31
fhcl32
fhcb3
fasciolosis
cathepsins
tritrichomonas
foetusthe
foetusinfected
wks
subisotype
preputial
smegma
inpouch
mdm
intravaginal
cellsvaccines
virgin
trophozoites
95107601
nyu
langone
protocoldriven
61months
hr056
hr051
substage
hr045
hr040
antivax
hysteria
causalities
authored
250000500000
ean
microscopical
sciatic
experienceimmunotherapy
hypotensionrequiring
inotropic
echocardiographic
singleventricle
milrinone
systolic
cardiacrelated
blast25
p019
diastolic
p062
p629
p444
count25
bfm
outcomesallogeneic
ibfm
hlacompatible
hrr
vhrr
n106
n59
56±4
52±4
82±6
80±6
45±5
42±5
29±4
19±3
13±3
15±4
cytomegaloviruspositive
cytomegalovirusnegative
couplebased
measureshematopoietic
couples
refrain
disclosing
illnessrelated
supportively
moderators
anemiasalvage
439±78
125±48
211±67
66±37
477±85
385±73
p129
121±68
91±43
p198
803±51
896±70
764±51
894±77
p127
790±86
716±93
p976
walnutsthe
walnuts
allergological
268years
vaccinationsdespite
hloc
34years
illegal
chinaa
hereinafter
panic
nipv
78463
doselimited
conscripts
5099
equivocal
geometrical
regionseveral
multiperspective
interconnected
radiopharmaceuticals
groupsobjective
130000
q969r
nlrp3
pigsnucleotidebinding
leucinerichcontaining
pyrindomain
a2906g
interleukin1β
nlrp32906
parasuis
landrace
berkshire
perspectivesnyeso1
developability
immunotherapyinterleukin15
activationassociated
p22339
sushi
transpresentation
disulfide
il15sushi
vaccinationevaluating
twin
formulafed
wellbaby
drank
cried
335s
δt
noncostly
painreducing
irctn
31383
postresults
nsclcimmunotherapy
hail
celllines
dualimmune
receptor1programmed
coliderived
d3objective
etecderived
avd3
omv
etecinduced
demandside
supplyside
doers
nondoers
uneducated
or10
systemchimeric
il18secreting
tannic
mixedspecies
challengetwo
tae
cobb
nonmedicated
66mgkg
05gkg
cnt
robenidine
rob
33mgkg
coagulans
taebc
vaccinatedcnt
challengedcnt
swinging
pendulum
personalizationcancer
reviewcd19
123491
129676
42408
immunoglobulinfree
patientsunassigned
flcs
inflammatoryautoimmune
musk
fatigability
flc
achrmg
muskmg
autoabs
skp
challengeouter
detoxified
pentaacylated
kilodalton
glutathionestransferase
gst
gstskp
dot1l
finely
h3lysine
mir181a
dusp6
interventionobjective
providerspecific
0038
nonenglish
speakers
transplantationbone
bloodhematopoietic
pcdna31s11
s11
protectionalthough
gcrvhn14
vp35
958±072×10
7dpi
2413±238
9330±471
14dpi
28dpi
704733
parasitederived
rovasp1
antigensparing
pathwayvaccination
oldage
40times
iiv3specific
4h
myd88signaling
6months17years
parentally
623months
512years
1317years
75000
affirms
seriesbackground
ivm1b
cleveland
iipractical
issuessublingual
subscribing
savior
pricechimeric
incredible
novrtis
us475000
us373000
grappling
voids
juxtaposition
asialessons
antigensnovel
immunotherapyhistorically
upward
personalizing
hyper
cancersrecent
recognitionprevention
immunotherapytargeted
mage
protumorigenic
icitreatment
antisarcoidosis
inhibitorsthey
metainflammatory
weaningthe
mpap
leukogram
altitude
hg
adj
fibrinogen
ladc
thyroxin
adpribose
homologue
immunotherapyimmunotherapies
nonhomologous
stemstromal
svf
fistula
symptomrelated
liposuction
postprocedural
20183613111328
magic
sclerosismultiple
tolerization
diseaseassociated
toleranceinducing
atxms1467
cd206targeted
n5526
sensorimotor
oculomotor
dosereduced
gabapentin
antihypertensives
studyoutcomes
ncs
2gy
nct01343953
antisurvival
sway
7813
371830
pearls
oysters
injurytraumatic
mvamerssmodified
mvamerss
myonecrosis
mvadna
diseasesallergy
disintegrating
cedarpollen
ragweedpollen
treepollen
mildmoderate
clonedirected
depositsthe
gammopathies
pgnmid
paraprotein
gm24
bundle
clinicintroduction
22014
72015
designating
prescreening
nocost
templates
1126years
22013
92016
bundled
counterfactual
6463
counterfactuals
1973
pld
strainthe
bcgpld
rpld
mic6
immunotherapyresponsive
inflammationsubacute
neuroregression
neopterin
isgs
interferonopathy
clinicoimmunological
22monthold
5yearold
asymmetric
dystonia
spasticity
expressive
neopterins
masquerade
transplantationtransplantationassociated
n1990
farber
institutebrigham
sirolimuscontaining
6mgkg
withdrawing
615ngml
trialschimeric
pricking
studyall
yearaccording
groupsgrade
personsgrade
personsof
scalevasscoremedication
questionnairerqlqwere
scorerqlq
61305806
6452
respectivelybut
immunotherapyp057301360699
sptbut
immunotherapysliton
studyquality
questionnairerqlqbefore
remission13
66the
multivas
univas
pointat
yearone
yeartwo
treatmenthad
005according
scoresthe
lifenasal
symptomsconjunctiva
symptomsnonnasalocularsymptomsbehaviors
005symptomatic
symptomschildrens
immunotherapycitand
immunotherapyritin
mite328
weeksand
weekthe
scalevasscore
ritthe
groupbut
decrement
ayear
005after
followupthe
reducedthe
year2
185390
573higher
group118263421respectively
patientsand
yearsbut
erythematosusa
lula
cohortunassigned
reservations
wwwgermanctrde
drks00011052
stockouts
africaintroduction
birthdose
1yold
fic
59moold
under5yold
photocopying
opv0
59moolds
vaccinator
unaccompanied
regionsautonomous
offerwhich
archived
regionallocal
exchanging
eya3
threonine
phosphatasemediated
upregulationeya
embryogenesis
eyas
cofactors
phosphatases
thr
immunecompetent
dephosphorylate
pt58
eya3mediated
eya3knockdown
directionshead
subsites
erythematosusregulatory
cancerhiv
intravesicular
pyrazinamide
coverageachieving
outcomerapid
147794
182250
esophagitisobjective
allergendriven
fibrostenosis
th2mediated
narrowed
fibrostenotic
il13il4
protonpump
ppiresponsive
ppiree
turkeythe
adenovirusspecific
cytovir
adenoviremia
harvests
donations
vaccinateobjective
wholestaff
trainthetrainer
fidelity
qfc
grocery
kroger
champion
micezika
pvax1zme
zikvchallenged
sedation
rch
dmu
midazolam
anaesthetic
behaviorobjectives
collegeaged
risktaking
n746
1926years
sexualrisk
1826yearold
transplantrenal
dyslipidemia
transplantspecific
arteriovenous
kongobjectives
twoalternative
hk8976
1129
hk1620
hk100000
12821
programallogeneic
lineassociated
clabsis
indwelling
clabsi
3993
1329
12001
p0136
2394
1052
5446
p0374
epidermidis
4932
2463
9878
transplantationallogeneic
semiablative
638
hundredday
nisteenvaccination
10753
providerverified
268896
188206
123686
64520
ci175184
ci213326
ci150170
ci110118
ci117129
ci102125
farther
ci136237
hyperthermic
56°c
regimensmost
damp
4245°c
ctldependent
56°ctreated
regimesunder
centering
northen
motherbaby
3nd
spouses
cpgs
arr152
ci136169
116429
1191001
106213
eldoret
530000
260000
3083
cancertumors
tenofovir
barriertoresistance
perspectivevaccination
impressively
realizable
fasttracked
neurobehavioral
hippocampuswe
45weeks
hbvmice
overexposure
mil4
hypereosinophilic
hes
gcsparing
gcsensitive
mepolizumabtreated
gcresponsive
histocheck
transplantationhaploidentical
hlarelated
allogenicity
ssm
drb1
dqb1
in691
singlelocus
clofarabinecontaining
neoplasmsrecurrentrefractory
nct00824135
mismatchedrelated
50mgmd
transaminases
toxicityobserved
hematopoetic
patientspurpose
marred
15628
185207
preventtreat
showcasing
monocenter
023×10
229×10
stabilizations
cd4cd25cd127lowfoxp3
servicefollowing
dropin
newport
valleys
cellfriendly
microtubes
suspended
microscale
tubes
algtubes
hydrodynamic
320fold
vgkc
epilepsyepilepsy
identiﬁed
voltage
gated
anti‑vgkc
lithium‑pilocarpine
epileptic
impulsivity
compulsivity
attentional
approachbackgroundaims
antitoxic
ixazomib
pomalidomide
20062015unassigned
recordbased
adenitis
108100
swineswine
je
crossgenotypic
giii
jev
choheparan
sulfatedeficient
chohs
5110
gijev
emptyparticle
vlpimmunized
crossneutralizing
focusreduction
salineimmunized
threatsallergic
cellsvarious
communitydwelling
outpatientbased
multimorbidityweighted
mwi
1458
00035
mwi0
001150
092150
151300
126199
301600
178298
6014500or
241410
nonhighrisk
156221
privacy
β29
β20
appeal
managua
nicaraguabackground
1303
pvalues0001
settinga
trialsobjectives
12010
72017
p51
mdacc
p030
ancalc
decent
mexicoobjective
halfway
ensanut
mc
2435
artchronic
cgd
phagocyte
phox
adenine
anion
mixeddonor
pathwaylongterm
precarious
reviewinflammatory
5aminosalicylic
antihoming
α4β7
fmt
childrenfood
instigate
anticipatory
instigated
complaint
hht
inprocessepub
moisturizers
inhibitorsurothelial
techniquebackground
tonicclonic
72×7cm
midline
neuroectodermal
subtotal
dimness
ramifications
papilloedema
shockinduced
immunotherapyautologous
tapcells
trimel
labelfree
underexpressed
hstreated
hsconditioned
hsexclusive
hsinduced
immunotherapyoncolytic
usefully
analysisthis
tbimac
stature
complicationrelated
gravidae
programobjectives
93134
19972015
pre1983
19831988
hbsagcarriers
773793134
periodofbirth
post1988
20072008
farfetched
paramedical
seroconversions
goatstuberculosis
himb
bacteriological
interferences
childadolescent
disaster
recommendationsobjective
adhered
97186
properdin
deficiencyterminal
118628
166886
swines
recommendationsjapanese
culex
vertebrate
panflavivirus
elisapositive
jeassociated
hatchability
pulletsthis
ah
oligosaccharide
lentogenic
vgga
strainavinew
fertilized
bovans
2×2×2
ndvinjected
mosvaccine
chemoimmuno
remediation
permeabilized
boyden
multicellular
96well
permeable
lowattachment
microplates
stromalcell
spheroid
pcineolack
lackexpressing
hamstersleishmania
m65
dnalack
mvalack
m65lack
lackstimulated
primemvalack
dnalackmvalack
dnalackm65lack
transplantstable
islets
autoimmuneprone
histocompatability
mega
transfusioncyclophosphamide
allospecific
e2dependent
mannerlymphodepletion
mapc
globulininduced
lymphopeniainduced
carcinomatumor
malignantly
massivelyexposed
photopheresis
diseaseimprovement
flaresalternaria
mycoses
62yearold
behaviorbackground
61036
700798
pfortrend
646789
pfortrend0001
94378
pfortrend0122
296426
pfortrend0068
coronavirusthe
ad5mers
respiratoryassociated
controlpatients
2900
selfreports
centralising
kongs
recommendationobjectives
73item
christianity
saints
programmeto
entebbe
opd
siemens
vacczyme
sixfold
studysocial
1006
4706
nonhousehold
freeriding
motivesit
vrse
externality
defficient
incentivized
acceptors
conveniently
vrses
pertussiswe
foodgrade
f1s1
nz3900
nterminally
mucosallyimmunized
angeles
californiawe
venuebased
117595
141629
110348
113325
177541
copromotion
paralleling
1001
dlbcls
m7flipi
23g
welcome
pcrconfirmed
palestine
20042008
clinicallysuspected
130267
100130
palestinian
ramallah
bethlehem
jenin
alkhalil
68130
leukemiaassociated
individualsantigenspecific
laaspecific
nyeso
laa
mixes
effectoreffector
abatacept
respondersabatacept
axial
eos
il25il33
ninetyfour
0238
ally
cancerscytomegalovirus
antileukaemia
nkg2c
hlaetransfected
cmvdriven
hil15gene
nklil15
functionsobjective
hil15
nkl
hepatocarcinoma
nkp80
hpbmcs
genemodification
receptorlike
diseasesintroduction
igsf
itams
itims
fcrl15
dominantly
fcrls
logical
immunodiagnostic
vaccinesfacetoface
barriersthis
clusterrcts
4527
clusterrct
countriesall
hoursoverall
randomising
assessors
theyd
imprecision
indirectness
costlowcertainty
3004
vaccinatefacetoface
melanomalocoregionally
intraarterial
perfusions
pv10
injectables
mutability
blockadearid1a
atrich
baf250a
arid1amutant
arid1adeficient
arid1awildtype
mutator
checkpointsin
epigenetics
subgenotype
adw2
ayw3
19871990
20052007
43104
00304
20072014background
916513
951082
200203
200001
199899
199697
1921
199395
19881992
1718years
2226years
transplantalthough
discoverynovel
apalutamide
radium223
dichloride
taxanebased
adt
hormonesensitive
mhspc
darolutamide
phosphatidylinositol45bisphosphate
ldquoomicsrdquo
avidin
chasethe
bvrit
chase
longknown
biotinylatedmab
biotinylated
ybtbv
indium111
inbv
inbtbv
biotin
valency
ybv
ybevacizumabrit
vegfpositive
possibilitiesmultiple
actinium
bismuthbackground
225aclabeled
underlined
nuclide
emitters
addisons
2yl
dhss
478737
169259
vaccinationhealth
69489
16409
screenings
populationthe
workflows
freezer
underprescription
transitional
shelter
perspectivesbackground
gcgejc
congresses
pdl1vs
pdl1tumors
pdl1gcgejc
switchmaintenance
consideradoptive
revival
envisioning
cvirus
mastitisstaphylococcus
wallanchored
surfaceassociated
trypsin
2dimensional
blotted
mastitic
ironregulated
isdc
esat6
esxa
alignments
peculiarities
rales
vasopressors
immunizationthe
vasculitides
practicechimeric
availibilitycurrent
400000
hydroxyurea
patientfamilies
zroxinechimeric
zroxine
zroxinelabeled
il13rα2targeted
pscatargeted
zr
kbq10
il13rα2car
intraventricularly
pscacar
9fold
tumortomuscle
carnegative
il2rgjak3
diseasesimmune
paradigmchanging
malignanciesimmunebased
provocative
accessory
beyondthe
analysiscellular
aki
13270
063072
064073
157201
069118
87year
ecg
echocardiogram
cardiologist
carrierfree
nanodrug
therapyursolic
ua
foodplantderived
nearspherical
cox2vegfr2vegfa
modalitiesintroduction
historiesextending
bacteriology
uterounassigned
antitnfexposed
preconception
0306
oncologythe
geneexpressssion
depictions
therapyimmunodeficient
nodrag2
nrghu
thyhsc
cancerincreasing
bfc
adrenoleukodystrophy
mucopolysaccharidosis
immunityradiation
artifact
aborh
groupincompatibility
transplantationgraft
engrafment
comprehensions
particleloaded
tlpldc
tumorsintroduction
lifeexpectancy
120ml
pvs
residualmeasurable
1231
225months
isrctn81339386
2172016
68months
210years
menccrm
nct00674583
68m
610years
m68
meny
588
titers18
11987
6278
4866
062126
28627
3051
3954
098132
typesubtype
cihr
crd42017059893
woreda
institutionalisation
wntbetacatenin
idit
pteronyssinnusdermatophagoides
dpdf
immunotherapynaïve
phenolyzed
albuminsaline
dbu
110011000000
determinations
diameters
americabackground
slaai
functionadoptive
treats
nonlatent
mhcspecific
chinaduring
professionalsaims
nzavs
n1032
gpsdoctor
gpsdoctors
nbpp
postmeningitis
6595
70100
¥1622153
¥5
hyaluronatechitosan
systemenhancing
hyaluronate
hachitosan
adxs11001
lmllo
listeriabased
toobtain
4cm
nodepositive
540gy
chillsrigors
cardiopulmonary
sigmoidoscopy
headset
vr
wongbaker
mcmurtry
childrenparoxysmal
osimertinib
osimertinibinduced
reportosimertinib
thr790met
sixthline
thr790metmutation
astalt
reinitiating
polydopaminecoated
nanoparticlesphotothermal
onestep
hctfocused
ebmtgc
taming
evilpd1
tackled
owerri
14452
plansprocess
2015this
2924
menccv
hibmenc
guidelinesit
1841
capturerecaptureintroduction
threesource
capturerecapture
hospitalizationsemergency
sixyear
12883
3304
reassess
sequela
undergoinig
loc
incontinence
claiming
handwriting
postshot
micesecondary
at10002
18hours
balfs
33×10
balf
protestantsbackground
religionrelated
agegroups
infantstoddlers
church
lvcmunicipalities
nonorthodox
protestant
toxinology
immunologyresearch
behring
kitasato
strangling
angel
dreadful
roux
yersin
glenny
ramon
anatoxins
marrack
kappler
superantigens
controversyin
takeup
mmrautism
spillovers
allocative
moreeducated
ouabain
clplps
puma
irakm
aimin
notifying
n280
n170
n977
n249
n191
prr
lawon
parliamentarians
fined
nurseries
cellimmune
reactiondespite
imperfectly
crossstudy
crosscommunication
cellscytokine
1539yearold
vthpv
nvthpv
reconstructions
computing
bhattacharyya
1821yearold
pes
449585
432555
316485
reconstructing
practiceto
altmans
κ067
κ066
13329
flanders
flemish
residentsthe
immunisationbased
1250
teenager
nonbelgian
remembered
leukemogenesis
hpscs
flt3erk
motives
sivrelated
choosereject
trustdistrust
coupons
habit
trivialisationrelativisation
misbeliefs
discordances
narrowing
10min
decisionalconflict
unscored
chassons
ranksum
0to10
or340
134860
or87
13567
futurebackground
biothreats
assert
perspectivebackgroundaim
6165
followup32
ratiohr066
intervalci056077
medicaidmedicare
michel
sadelain
triangulationintroduction
triangulation
merging
nonrct
triangulated
rve
hdiiv3
sdiiv3
probablelaboratoryconfirmed
metaanalyzed
rves
992
rve195
86290
rve91
24153
rve178
81265
rve243
139334
rve182
68281
182488
5295
pregnancyintroduction
omalizaumab
pretreament
igefc
debunking
myth
exerciseinduced
lifespanepidemiological
deconstruct
theoryreferred
hypothesisand
heightens
signpost
enhancesrather
suppressesimmune
bouts
misconception
leukemiatolerance
completeresponding
il6stat3
stat3related
gliomapurpose
gliomabearing
hspcderived
supplanted
tcellreleased
395566
vitr
geneexpression
effectorlike
2418
452938
medulloblastomas
daoy
d283
d425
her2bbzcar
orthotopically
fossa
nodcgprkdc
tm1wjl
szj
her2car
intraventricular
icariin
mastocytomabearing
ica
flavonoid
epimedium
th1immune
mastocytoma
p815ab
rmas
lmptap
41item
measuresorf
labial
genitals
handler
assaybackground
vaccineserotypes
biome
moraxella
catarrhalis
pcv7vaccinated
pcvunvaccinated
pcvvaccinated
pcv7serotype
adolescentsintroduction
1113years
traitanxiety
15min
298430
396519
actrn12614001185651
oriented
reappraisal
occasional
attest
precancers
tolerogen
antibodieswe
subtractive
mtsi
rwpe1
nontumoral
repeating
commonimmunodominant
italyseasonal
16million
2million
23426
21096
19170
1826year
statespurpose
016023
031052
032064
040069
156281
148234
microneedlesbackground
scintramuscular
polyglycolic
molding
microscopically
27g
stainless
wedgeshaped
surveyunassigned
schoolteachers
somehow
stsrecommended
0372
0247
enlightens
treatmentpancreatic
drawback
fibroblastconditioned
mefcm
nontumorbearing
mefcmcultured
tbox
conceptsb
transplantationautologous
2000s
bortezomibimids
groupi
gcsfadministration
groupii
nongcsf
groupiii
hctci
repletedallogeneic
relatedunrelated
repleted
psychoneuroimmunology
reviewthis
strategiesimmune
targetsthere
cholecystitis
cholelithiasis
flukeassociated
poorprognostic
immuneoncological
trendspancreatic
ctla
nondmmrmsih
ceatcb
branchedchain
imbalanceassociated
toxicityhematopoietic
valine
bcaas
isoleucine
leucine
bcaa
monoepoxytransformer
transplantationtreosulfan
treo
1650mghml
ssebdm
1014gm
parentmetabolite
nonmem
2compartmental
1compartmental
r01681
3538μmh
4314μmh
epoxide
sirnamediated
melanomachimeric
coelectroporated
smallinterfering
sipd1
sictla4
cd80transfected
cotransfected
cotransfection
carencoding
mprotein
streptococcusstreptococcus
pharyngitis
hypervariable
bacterialvectored
m3
m4
m6
m9
m12
m28
m77
m×10
m×10immunized
m75
mx10
washes
lactisbased
immunotherapieswith
myelomamaintenance
premaintenance
egfrviiicd3targeted
redirects
hegfrviiicd3
biscfv
wellengrafted
egfrviiipositive
2415
361131
howintroduction
malta
replying
intrabone
cotransplantation
05×10cellskg
infusional
leukemiato
cytoxan
amlthirtysix
clag
2017all
1325
plt
1975
7150
4100
40125
4440
25500
12000
39000
529±88
694±77
fungusintensive
immunizationssexual
nct00223080
a244gd
92th023
crf01ae
cvm
alvachivaidsvax®be
aidsvax®be
alvachiv
antigp120
acipthis
compiles
5dose
rhinitisprevalence
cdsens
cd203c
rg
cardinal
deliveryextracellular
membranederived
biologyinspired
lipidbased
leukaemiathe
pdxhumanised
cohortintroduction
phantim
aof
directional
chakaria
hdss
icddrb
4584
afcr
084094
095100
091097
096104
096106
093098
yogyakarta
indonesiaobjective
crosstab
hyaluronidasetumor
polycationic
unmethylated
cytosinephosphateguanine
peicpgova
nanovaccinegenerated
haase
9yearoldgirls
cervivac
23459897
378646
691741
15205
14999
14289
volatility
11849
immunotherapyreallife
3000mg
122014
1200mg
21145
homedose
2111
675months
7376
6364
newscap
issuehidden
mysteries
corners
autoinflammation
ndv3a
candidiasisa
rvvc
adhesininvasin
nct01926028
critics
radiobiology
alphaparticle
radionuclidesbackground
radiopharmaceutical
shortrange
alphaparticles
alphaemitting
ineffectual
yap1
therapyyap1
hippo
discerned
settingchronic
n820
n747
alphatherapy
immunotherapyto
doubles
nonneutropaenic
typhlitis
hospitaldespite
octoberdecember
bambino
gesugrave
childrenrsquos
2091
γray
5monophosphatethe
5primemonophosphate
5primeamp
ultrastructure
gsh
rhinology
neonatologymaternal
foetal
maternallyacquired
untested
ldquo
neonatology
rdquo
malaysiapurpose
3annum
4241
ringgits
as04hpv
1618v
eaacienda
adolescentsnonsteroidal
antipyreticsanalgesics
nsaid
enda
eaaci
nonvirus
19852014this
pys
sirs
18642
kaposis
sir536
300885
sir71
48101
sir54
11158
virusunrelated
sir44
3162
sir67
29133
sir229
28827
sir14
1021
sir26
sir01
experiencebreast
trastuzumabbased
her2amplifiedoverexpressed
her2overexpressing
hladrb11503
hladrb111
hladrb10901
sequencespecific
primers
ssppcr
alloimmunised
nonalloimmunised
alloantibodypositive
p0·000
or4·193
antik
or6·643
p0·350
pretransfusion
immunotherapycombination
aox40
proactivation
dinp
beta2microglobulin
trac
tcrtransferred
babys
vaccineskeptical
vaccinationit
unverifiable
novyint
immunotherapyclostridium
cvnnt
germinate
cnvnt
bacteriolytic
ltainduced
nyus
jeffrey
weber
effectspurpose
orbitopathy
keratitis
chorioretinal
retinopathy
neuroretinitis
littermate
germanybackground
1357
781
cec
diploid
hdc
headaches
88365
73274
56142
ccorr
tumorsguideline
agiho
dghoinfectious
immunocompromising
dgho
inhibitorresistant
regressionbackground
1723
1923
1084
pegifnα2b
cpiresistant
decomposing
nonpoor
multicountry
analysesunderstanding
propoor
prononpoor
proilliterate
glioblastomaobjective
singlefraction
1methyl
glioblastomacarrying
doublefraction
pr8
chitosancoated
iscomatrix
nanoparticleschitosancoated
coadministrated
film
immuniadjuvant
isccit
233nm
pr8isccit
balbcmice
pr8isc
iscadjuvanted
lineencoded
converging
nasensing
rigimavs
parsing
tissuetropic
cp1
ptenmutant
intraurethrally
cp1recruited
medicinesroutine
adverts
personally
motivator
instigating
paradigmclassical
immunoconjugates
waytremendous
nomenclature
establishments
gxp
commercializational
compile
omsin
ocb
immunomarkers
serumblood
enteritidistyphimurium
strainsalmonella
mir153
catalyzes
rohu
labeo
rohita
germinated
zoospores
aphanomyces
invadansinfection
invadans
freshwater
carps
n160
74±12g
54kda
antiprotease
germination
germlings
hyphae
herpesvirus6b
metaanalysisgraftversushost
chromosomally
n33
thiotepabased
comparisonthe
300cgy
150mgm
p99
riccohort
p61
antickit
ack2
36gkg
pyrotechnically
applicator
pigletsepidermal
tangential
rphplc
collapse
freezedrying
cryomilling
pyrotechnical
oily
actuation
highspeed
camera
supersonic
breach
corneum
foxo
immunitythe
evolutionally
rewired
foxomediated
foxodependent
immunitydespite
cmi
yamagata
brazilvaccination
primavera
leste
mato
grosso
dbs
236252
infectiontr1
antilcmv
razelle
kurzrock
shumei
kato
treatmentesophageal
il2activated
emt
gsk3β
antinkg2d
nkg2dlsnkg2d
nkg2dlsexpressing
tumorsglioblastoma
nonalloreactive
gbm1
perforingranzymemediated
il21enhanced
il21sensitized
stereotaxic
22c3
sp263
intervalci
1601564
1251033
003071
packyears
evidencevaccines
collate
lets
samters
triad
asaintolerant
20question
smell
sinuspolyp
p27
p56
limitationscancer
injectionsobjective
vocal
75daysold
twomonth
mbps
uncircumcised
circumcised
opportunitiesin
systemeven
drugdose
behaviorally
syndromeintroduction
unaided
drugsbackground
dividends
subclassified
us100000
untenable
marchpurpose
arebenign
immunohistochemistryihc
nonfunctioning
nfpas
prlsecreting
prlpas
ghsecreting
ghpas
acthsecreting
acthpas
plurihormonal
prl
gh
contrastly
nanosecond
nspef
incubate
vfitcpi
analysiscompared
4timesdaily
ivbu4
ivbu1
n73
p94
p73
p71
areataalopecia
cd8nkg2dt
inkt10cells
scalp
beigescid
healthydonor
diseaseprotective
cryoimmunotherapy
micrometastaic
complicationsrecent
paraneoplastically
micrometastases
cryoablation
ctguided
debulk
resume
ambulation
movs
138268
111125
118131
healthfacility
108146
aso3
ah1n1pdm09background
fluenz
as03
nai
3346
tites
0547
pandemrixnaïve
cidofovir
recipientsbk
bkhc
precidofovir
postcidofovir
functionswe
seventyfour
propensityscore
nonecptreated
1pp
nonecp
p33
ecpindex
ecptreatedpatients
bosdirected
ltbi
fiftyeight
inh
5mm
falsenegative
argentinaour
ifis
ifi
yeasts
18143
5108
042±011
060±037
lomentospora
prolificans
fungemia
reviewlomentospora
37days
lomentosporiosis
propylene
glycolfree
lightchain
aidsline
dissertation
840838
07928
r046
r031
r022
r019
insurancecovered
r016
r015
moderator
disaggregate
contiguous
fragmentderived
vectorb
mmspecific
preforming
10000fold
truncatedepithelial
stemming
studysecondary
4997
761
stepped
wedge
sliv
emails
billed
38078
controlschool
125149
110136
104147
098157
neoantigensin
theprogress
ncvs
populationimmunosenescence
mf59tm
virosomal
arewere
as01
phototriggered
domino
microenvironmentimmune
tics
invasiveness
nirresponsive
microenvironmentmyeloidderived
bmmdscs
suppressivefunction
organand
trastuzumabir700dx
disseminations
wherever
i²
mantelhaenzel
1138
mildtosevere
epinephrineadrenaline
21249
531
1312
rigour
dnax
redsiii
databasedespite
3·5years
studyiii
postrbc
icd910
319177
2·07
6597
8892
kell
2·38
1·68
rhd
1·94
alloimmunized
needsin
1911
hypersensitivities
purposefully
gets
biasbackground
th1tr1
tbespecific
mitogeninduced
alumadjuvanted
nct02511535
imputability
lassb
diseaseit
caar
lassbspecific
laabcrromas
laabcrmaver1
laabcrjurkat
antilassb
a151611objective
ncictcae
1199
age65
biologicchemotherapy
157184
139155
164217
225439
210445
patients65
microdistribution
antibodyphoton
absorber
vivoas
lowsideeffect
phototoxic
illuminating
superenhanced
supr
reflectance
mabir700
highsensitivity
laminar
flot
microstructure
multiwavelength
locationsdepths
calcineurindependent
infectionlung
mre
bronchoscopic
generalizedestimating
equationadjusted
balloonhistiocytoid
cytomorphology
pitfallepithelioid
foamy
histiocytoid
xanthoma
fibroxanthoma
variably
balloon
cellhistiocytoid
postneoadjuvant
bags
immunotherapiesin
patienttailored
cellmaterial
manipulations
antigenproducing
surfacetreated
polystyrene
fluoropolymer
metastasesbrain
m1c
imagingsignificant
2deoxy2fluorine18fluorodglucosepositron
2018124290622
movementin
parliament
erythematosuslike
diseasemurine
hybrids
dba2
c57bl6×dba2f1
bdf1
jes6il2
cellnk
s4b6il2
photochemical
vaccinationeffective
endocytosed
lightinduced
30fold
ipeptide
cdlow
investigatorspatients
resect
stoma
ads
reconfiguration
prospectsinfections
highpopulation
adjuvantation
inv3q21q26t33q21q26
inv3q21q262t33q21q262
3q26
tumorsvaccines
abolishing
pvax
808nm
jq1mediated
cumulatively
myelomapropagating
sox2
nct02135406
tsc2deficient
immunotherapytuberous
tsc
mtorc1hyperactive
lymphangioleiomyomatosis
lam
tscassociated
angiomyolipomas
105k
tsc2
tmkoc
ifnγtnfα
cx3cr1
chemoimmunotherapyalthough
cx3cr1cd8
withstanding
cd11a
rosinducing
immunotherapyone
galactosefunctionalized
znpp
polyllysine
bpolyethylene
immunopotentiator
bmtams
agonistloaded
pmpic
znppgrafted
ncbipubmed
disseminating
truthful
factorsobjective
dtphib
fernando
figueira
34yearold
50mg
04g
2×10kg
1×10kg
tacilizumab
400mg
240mg
immunotherapypseudoprogression
tbp
fiftyfour
oncohematology
107years
953
immunobiologicals
moldacting
01052008
31122014
1case
3controls
postsot
2868
n3070
4070
3363
reoperation
1063
infantspreterm
2018474e147e153
promisesrecently
succession
markerofself
donteatme
transcribedmrna
hanging
fruit
treeafter
isv
immunotherapyimmunogenic
subverting
microenvironmentassociated
immunochemotherapyin
biomolecular
flipi
flipi2
prima
rchemotherapy
primapi
primaprognostic
efs24
fl2000
lysa
iowamayo
easytocompute
multiblock
countriesantimicrobial
fatteners
fetbp
ironoxo
porphyrin
mozambican
girlssubsaharan
1147
9671147
3731144
10251130
anticipates
cellproduced
infectioninfection
urgency
e80
drosophila
s2
folded
antie80
antiediii
pita
sealed
gidoit
2armed
paralleldesign
dbpcfc1
computergenerated
allocate
dbpcfc2
1721
difference07
95ic
oesophagitis
seriesobjectives
unscheduled
11981
15572
treatmentsensitive
eo771
mmtvpyvt
mca38
mcap0008
populationwith
amyloidbeta
peptidealzheimers
tab
dropletbased
vaccinationdissolving
painfree
dropletborn
blowing
dab
lithography
scrub
typhus
scaa
scaaloaded
scaadmns
clproduced
scaadmn
solidification
decitabineprimed
resensitivity
5day
2444
8222
preresistant
ibritumomab
zevalin
zbeam
experiencechemorefractory
resultswe
rituximabcontaining
zbeamasct
transplantationconflicting
mpn
2153
109682
myeloproliferation
h3k27m
gliomasdiffuse
dipg
dmgs
k27m
h3k27mmutant
41bbz
dmg
hydrocephalus
neurointensive
pons
voivodeship
polanddespite
undertaking
mixedtype
avr
substandard
keyword
psychinfo
bws
lca
bundling
valuedriven
complacent
reportbiologic
metalloproteinase3
mmp3
hlasensitized
antipanel
poliomavirus
had3
prekt
trouble
ebmtbackground
nontcelldepleted
n250
n2589
agraft
graftversushostfreerelapse
117347
patients60
hurhegfrp64kmont
hurhegfrp64k
tremors
chictroid17014048
20171220
l02105
20090403
ctr20131039
conditioningperipheral
amc
057×10
ptd
amc057×10
malian
individualrandomized
bamako
menav
prv
4042
12240
5238
91154
294450
5092
114207
nct02286895
argentinavaccination
pu
anticd44v6
radioimmunotherapycd44v6
radioimmunotherapyrit
abn44v6
177lu
131i
125i
177luabn44v6
131iabn44v6
3dtumor
125iabn44v6131iabn44v6
radioconjugates
cd44v6specific
125iabn44v6
01msvmbq
labels
activitydependent
imct
taxolbased
chang
gung
linkou
diagnosistorecurrence
0128
3321
2563
4668
alcs
nonrecurrence
cancerassessing
lowfrequency
2857
5833
0911
μgm
0179
0049
latinamerica
treatmentslung
speedily
lataḿs
leukemiamyelodysplastic
diseasedirected
ifnα2b
allergydevelopment
multiallergen
multifood
pollenfood
intolerable
treatmentlimiting
polyicimiquimod
nanoparticlesencouraging
zincdoped
durationbackground
n2138
n2923
recurred
venominduced
suboptimalbackground
ccare
emss
539721
846993
autoinjector
536809
knowledgetoaction
inosine
impdh
impdh2
recipientdonor
irradiationfludarabine
postgraft
rs11706052
rs2278294
rs2278293
impdh1
lymphomanonhodgkin
199000
pmbcl
ag85aspecific
ad585a
propertiesthere
adenovirally
postboosting
bcginfected
postboost
preboost
immunepathology
varicellacontaining
368992
325729
48109
13122
0737
0549
carriagebackground
nasopharyngealoropharyngeal
19months
isrctn28445844
n178
n188
postpriming
2673
730months
1930months
vaccineserotype
leucocytosis
infantsaims
dtwphepbhib
903×10
859947×10
preimmunizations
1646×10
1541752×10
oneday
postimmunizations
1521×10
14071636×10
neutrophilia
twodays
isrctn59683017
nanoemulsion
adjuvantdriven
17polarized
1biased
adjuvantcould
2mediated
strategiesresearchers
relegate
nonavian
immunisationdata
universalise
69100
transpired
39100
buenos
aires
laboratorypositive
212month
immunotherapyobesity
bmama1
microti
hamsterin
pbmama1ad5bmama1
pnullad5bmama1
pbmama1ad5null
pnullad5null
th1biased
igebackground
fcε
mirror
mov18
congruent
igefcεr
antiparasitic
tumoural
insulinmimetic
insulinresponsive
itx
dir
fasting
suito
betacell
euglycemic
hyperinsulinemic
8±6
uday
37±15
19±13
beta182±59
21±14
05±03nmoll
574±397
11±11mgkgmin
16±06mgkgmin
disposal
nct01060605
nct00014911
revving
scalingout
broken
months17
afghan
vaccinatedunknown
1328
prevnar
directtoadolescent
permitbackground
1017year
oklahoma
directtoteen
allowable
biometric
considerationsbackground
soreness
nonsubjective
1°c
evan
mtdap
chawama
samips
interviewers
fgd
convene
17th
presenters
sclerostin
deteriorationsclerostin
sost
osteogenic
deficiencyinduced
sostfc
proasnalailegly
antisost
sostinduced
osteoblast
osteocalcin
ovariectomy
ctx1
trap5b
deficiencymediated
morphometric
trabecular
femurs
spines
sostfctreated
accretion
osteoclastinhibitory
osteoprotegrin
wnt3a
tcf4
osteoblasts
osteoclastpromoting
sustains
harmonizes
ovariectomyinduced
osteoporotic
redosing
positivereacting
ratio6194
ratio1075
ratio11111
numbercharacter
hemoglobinopathy
hctallogeneic
patientsreactivation
valacyclovir
modelcervical
attitudescultural
exosomecarried
immunomodulationin
exosomecargo
immonosuppression
cellsrsquo
texbased
complexindependent
intramolecularly
unpulsed
insulitis
dctreated
reductionunassigned
02mgkgday
supratherapeutic
comedication
246kgm
95gdl
135264
202389
engagementacute
competitively
catsit
allergenblocking
iggige
catallergic
ancova
carcinomaneoadjuvant
nonurothelial
rcat
5349
2610
8605
2703
scoresfrom
cmwas
r065
islanders
ppmi
venomallergic
267450
vespids
26week
ninetysix
18week
rraml
notreached
intervening
allohsctdonor
cellexhausted
inversion
ilt4
ilt4mediated
agtrio
miceplasmodium
anopheline
gambiae
agambiae
pberghei
mosquitotransmitted
arthropodbased
vaccinationeven
n99403
121152
hispanics
185246
n177976
079092
063084
immunotherapymodel
tumorstroma
14year
ped
padua
sisc
sisped
mmrmmrv
igenot
15560
approachaim
rotorua
birthed
n111
lmcs
taupoturangi
ambiguity
mechanismscommunicating
probabilitiesa
phenomenons
2701
nouncertainty
normalizeduncertainty
ambiguityaverse
etf
age18
2018124254151
authentic
cytotoxicitythe
112120
kvaelvhfl
srm1
humanization
autografted
ebmtautologous
leukaemiafree
managementpurpose
electrocardiography
receptordirected
glioblastomaglioma
ocdc
intranodally
platinumtreated
q3w
immuneinflammation
β2microglobulin
immuneprofile
or284
134603
or15
106216
nova
scotia
514days
2183days
014days
rr11
0528
02days
rr09
0171
outweighing
mk8237
hdmspecific
scitslit
1005
amerispeak
423
strongyloides
stercoralis
hyperinfection
37yearold
reportthe
tropics
subtropics
filariform
interhuman
perpetuating
hostin
autoinfection
malnourished
alcoholic
diseasewe
sstercoralis
stenotic
diseasesstercoralis
corticosteroidfree
10day
bibliometrics
sciexpanded
thomson
cortellis
databaseattached
hindex
multichemorefractory
carcinomapenile
pescc
papillomavirusnegative
microsatelliteunstable
intraductalductal
gleason
arv7positive
vaccinationrabies
1600039000
areasthe
1411000
12–18monthold
m49p2
imthree
mldose
halfimthree
3idthree
2idtwo
subseroprotective
nickel
19952002
20032015background
metals
objects
20032015
4041208
p032
fairskinned
cephalic
anymore
cleaners
bricklayerspainters
teenage
lobbying
rha
miceannual
luminexbased
mplexflu
primeboostboost
admixed
antistalk
kong11968
mf59like
mbcs
stalkreactive
gaze
trustworthiness
30°
corrugator
supercilii
frowning
conductance
valence
arousal
immunotherapysystems
pard3b
activationexhaustion
il7ra
apobec3g
ppia
leukemiainfusion
carcikcd19
18day
62425±6399
2336±300fold
frozenthawed
mllenl
pax5auts2
beyond…
25μg
recombivaxhb
neonatallyvaccinated
41bbt
tnfrsf9
cd28car
responseevaluable
cd28cart
agonistsrecent
doors
ligandimmunoglobulin
tnfrsf
tnfrsfs
ageappropriately
brand
v24
aphaseiii
asimilar
amonotherapy
acombination
t‑lymphocyteassociated
proteinctla4
infantsobjective
4component
paracetamol
35weeks
8108
apnoea
neteffect
icx
netderived
anas
selfperpetuating
blm
cd20mediated
rtxmediated
rtxblm
ana
nct02284984
britainvaccination
776781
neutered
purebred
britain
ebolaobjectives
appeals
eppm
3200years
quota
equationmodelling
scared
multiplicative
anovas
parallelism
gainframing
immunosuppressionlive
ops
ditep
patients70
yps
174yps
p050
094211
061139
p077
cellsassisted
chlorin
nanoclusters
immunophotodynamic
tumortropic
gncs
monodispersed
ce6
gncsce6
ce6gncsabcik
mgc803
gncsce6ab
gncsce6abcik
eyethis
49yearold
floaters
iris
pigmentary
vitreous
ciliary
enucleation
safetysublingual
rhinitisconjunctivitis
glycocalyxmimicking
macrophagesimmune
diblock
polymannopyranosidegalactopyranoside
methacrylate
blockpolystyrene
ccl22
stat6
carbohydratecontaining
skunk
reviewcontrolling
skunks
installation
vaccinebait
spillage
postbaiting
hcart19s
patternimmunotherapies
phidcv
zealandobjectives
aom
children5years
synflorix
prevenar
markovprocess
singlebirth
ipdrelated
offsets
nzd
ho1516775
kir2dl23
expressiongamma
reinstating
kir2dl23positive
kir2dl23negative
sp1
macrophagesmonocytic
inflam
maturing
r848dependent
mmdscderived
stat4
hubs
vaccinationunassigned
influenzavaccine
2011january
1251
influenzavaccination
185424
3251263
311954
203745
regularlyvaccinated
324635
164432
useless
077398
001having
016325
002and
4231256
bills
brochures
bulletins
pneumococcalvaccine
rateofvaccination
ebm
premedline
clearinghouse
19802016
5ml
otolaryngic
escalates
outlooks
cancerepsteinbarr
ebvagc
2128day
sevenday
rffit
427430
704817
glucocorticosteroidfree
glucocorticosteroidcontaining
glucocorticosteroid
intraoperative
literatura
americano
caribe
ciencias
saude
1347
glucocorticosteroidresistant
omo
221361
757
benatsemay
agropastoralism
mosquitoe
vaccinesring
radius
educationrelated
characteristicsmissed
blinderoaxaca
69657
intercountry
gabon
proeducated
studypertussis
nct01738477
1930yearold
38155fold
trialthe
mosquirix
hrv
nct01345240
pertussishaemophilus
typebconjugate
dtaphib
81216
intercepted
2017purpose
orient
childrenadolescents
nonconclusive
quasispecies
characters
infantshepatitis
8095
preexisted
platformbased
it126a
c124s
f134y
k141q
q129h
d144a
g145v
n146k
preexist
angiographyallergic
nstemi
glycolysisrelated
actrefractory
seroepidemiologic
studiesseroepidemiologic
fairgrounds
717year
10002000
12day
diabetesthe
γaminobutyric
tuberculosisbcg
mtbvac
insectbite
il5background
excoriated
eil5
tt830843
icelandic
400μg
eil5cmv
antieil5
ompk17
ompk36
modelklebsiella
f3617
gem
hemozoin
hzadjuvanted
ifaadjuvanted
opportunitiesaims
meagre
unhygienic
doesnt
reconstitutionrecipients
tumorsimmune
perdurably
nanoshell
llacticcoglycolide
haunsloaded
40days
pmbcs
irradiations
borg
knee
tolerances
t10based
celyads
malignanciescelyad
cyad01
expecting
regulationsaccess
prevails
therapytcells
fred
hutchinson
platinumsensitive
restings
72124
doseincrease
13127
darkness
sepsissepsis
470bc
hippocrates
branches
4050
sepsisassociated
deathsassociated
myocardialinfarction
signifies
macrophagespecific
commentaryalthough
acetic
nationwidethis
eias
14937
predonation
1823years
11494
ultrio
1192
91732
occult
obi
12024
1185
2433
treatmentsinflammatory
madcam1
sequestering
s1p
immuneregulating
antigencarrier
overdosing
australiaimmediate
ihr
saefvic
collects
remedial
diabetesdifferent
wkich
40100
promisingly
hypereosinophilia
selfinoculation
2016objective
screeningobjectives
nrs3
dietnutrition
18days
levelwith
vaccinestimulated
microevironment
ckittargeted
engraftmentwe
anticd45
saporin
125mgkg
9001
thy11
thy12recipient
antithy11
filler
disordermultiple
serobiomarkers
facilityour
multiprinciple
fairness
critique
ipfs
mucopolysaccharidosiswe
50mgkgd
reducedintensive
fludarabine150
200mgmrabbit
referrals
gvhdii
qualitycontrol
ebvptld
campath
hepatitisassociated
globulinhepatitisassociated
haaa
allotransplantationthe
salzburg
strived
ignite
ignitors
burdensome
reconstructive
nonaboi
921
rituximabtreated
viruspoor
plymouth
rock
1475
2337
eid
ibdvnonexposed
ahfrt
cfrt
unlashed
markeravian
oilemulsion
baculovirush5prototype
baculovirush5
rhvth5
aihi
chifnalpha
mx1
irf7
aiendemic
whyobjective
jeddah
daysafter
85351
19125
31142
dimorphic
ngfr
genechimeric
nervegrowthfactor
ngfrspaced
antingfr
ngfrenriched
universality
selectiontracking
proceduresmanufacturing
harmonized
sumida
gliomaslowgrade
lggs
lgg
nearcompletecomplete
polyiclc
hlav
mesothelinredirected
cytokinearmed
adenovirusespancreatic
hypofunction
ad53e2fd24tnfairesil2
oadtnfail2
humanpdaxenograft
oad
admtnfamil2
immunotherapytumorinduced
il27expressing
aavil27
pronouncedly
aavil27mediated
plasmacytoma
005ml
ailment
reviewvaccine
19643
2779
singleitem
multiitem
trusteroding
provincewide
press
priors
clashing
macro
meso
microlevel
seniorlevel
conditionofservice
allotting
indiaevidence
compensating
trialrelated
africavaccination
postrituximab
eratreatment
rituximabofatumumabminichop
frailtycomorbidity
extendedexposure
k562gmcsf
patientsmyelodysplastic
γc
disorderspatients
ebvrelated
ebvspecific
melanin
radioimmunotherapymetastatic
6d2
8c3
igms
melaninbinding
relabeled
cdrs
aromatic
antibodymelanin
melanincontaining
knockouts
crisprcrisprassociated
pd1disrupted
overdosevaccines
overdoses
opioidinduced
pramespecific
medulloblastomamedulloblastoma
sll
tcellrelated
333749
gucy2ctargeted
metastasesone
gucy2c
gucy2cexpressing
compartmentalization
humanspecific
gucy2cdirected
gucy2cdeficient
gucy2cspecific
50916
sharedbackground
125916237478
5302
textual
nonimage
europelonger
reassortant
h5n2
2321
virusesthe
plasmidbased
awsn33
mdck
viralvaccinepreventable
seropositiveseroprotected
zgorzelec
parentteacher
110386
134649
117351
035099
communityengagement
ethiopiathe
defaultertracing
colorcoded
mayjune
membersleaders
audiorecordings
fieldnotes
catalyst
default
radiationthe
radiationbased
mnph
amf
°c60
mggram
bimonthly
immunohistopathologic
immunonanoparticles
deliverythe
nanocarrierbased
severalfold
doserelated
immunonanoparticle
actionvaccination
propositions
regret
surprised
altruism
plentiful
defaults
immunotherapylike
antiα
glanzmann
thrombasthenia
recommendationsglanzmann
gtis
thisreviewwill
americasbackground
sextargeted
tanzaniaa
specialtopic
tanzanias
postreview
wellplanned
nominating
topicleads
nationallevel
reemphasizes
15645
42924
1244
5116
operationalizing
adolescentsobjective
operationalizations
n16439
operationalize
piece
pharmacokineticsadapted
childrenunrelated
monitoringguided
sainte
justine
600ngml
symptomspurpose
nonigegastrointestinal
foodproteininduced
articlevaccination
hesitancycomments
hornsey
201803974001
24nation
nanoliposomeadjuvants
nanoliposomes
dspc
dspg
chol
sonication
95nm
lipsla
lipmplsla
lipimqsla
lipmplimqsla
lipslalipimq
lipslalipmpl
lipslalipmplimq
lipmpl
lipimq
lipmplimq
nanoliposome
microenvironmenttumor
913years
1860years
son
abode
directories
p0242
attitudinal
huprot
immunityautoimmunity
bacterolytic
cuatsm
engineeringrecent
whounicef
data20152017in
whetherhow
wwwwhointimmunizationsagemeetings2014octobersageworkinggrouprevisedreportvaccinehesitancypdf
wwwwhointimmunizationsagemeetings2017october1gvapassessmentreportwebversionpdf
n485
n518
kosovo
n466
n772
n155
n80
twelveitem
122112856
diffident
hopeful
journeymultiple
dialectical
lowe
studyperipheral
n330
5μgkgday
10μgkgday
0510×10
n132
1020×10
n226
n305
troublesome
recipientsbacterial
coccus
pneumonias
instauration
legionella
tuberculosisnontuberculous
rhodococcus
diseaseobjective
wore
colonoscopy
densitometry
strategyconceptually
stalk
dissections
muchneeded
scheduleobjectives
1209
κ079
κ073
micropterus
salmoides
rhabdovirus
perch
scrv
sanshui
msrvss
scrvqy、scrvss、scrvgm、cmrvfs、ombrvjm、msrvss
scrvgm
18th
msrvss7
rpss
signatureprimary
mapkerk
jakstat
y701
s727
pstat1
programmeat
20052015
2621
266years
sd182
2049years
328100000
150100000
p234
2034years
019years
preadolescents
challengesdue
semiallograft
rif
lit
antipaternal
apca
progesteroneinduced
pibf
ab2
mlrbf
1t
96years
133mgday
795mg
h2specific
peanutara
554486
582381kual
1940kual
575kual
studyinternational
iarcs
1534
genderequal
91pr
48pr
philadelphianegative
phneg
diseasefreerelapsefree
ninehundred
2018124252333
acne
probioticsobjective
tending
cocci
studyis
differentcomprehensive
pills
3548
5806
4193
nitro
tetrazolium
nbt
nbttest
pyrogenal
backdrop
sluggish
concomittant
enchances
justifying
humanised
humice
paralleltohuman
antihcc
pdl1independent
tyrosinaserelated
antilymphocyteactivated
appointmentbased
vaccinationsobjectives
abm
pick
synchronized
cincinnatidayton
filling
postimplementation
181071
50088
145509
75443
saxony
germanyobjectives
habids
n2379
knowledgeattitudepractice
1698
5times
delhi
recentmigrant
settledmigrant
viewership
foregoing
nonfamiliarity
investing
anaphylaxispurpose
phenotypesendotypesdriven
th2low
th2high
il5r
tissuebased
desperately
bloodbased
judge
interferonβbackground
18gauge
6day
0017
peritonealsystemic
lipopolysaccharideinduced
rnaprotein
lipopolysaccharidetolerant
menabcwy
adultsthis
nct02451514
abcwy
menabcwyomv
antiacwy
bnaïve
vaccinesmycobacterium
duox2induced
duox2
immunizationrespiratory
nox
duox2derived
acidinducible
genei
differentiationassociated
mda5
duox2mediated
venture
cancertwo
revelation
pd1targeted
pd1signaling
dcmediated
immunopotency
genesilencing
dcpd1
therapyexcessive
fludarabinecyclophosphamide
77×10
actived
9306
hypoxaemia
glutamicoxalacetic
γgt
cunningham
jcv
nct01864889
sup18
cancerour
suvs
unpaired
exudative
epidermitis
pigsthis
1000sow
ee
hyicus
exh
exfoliative
exhb
metaphylactic
metaphylactically
39600
88550mg
v650
nv1436
v259
nv502
bpositive
laag
leishmaniasismucosal
amazonensis
2associated
diseaseexacerbating
cancersalient
1112yearsold
uncomfortable
delayrefusal
salience
amazon
or125
diseasesalient
nct03002324
responsesnewborns
ectromelia
sixyearold
marchjune
bury
leicestershire
surrey
peerpressure
affiliates
cndo109activated
leukemianatural
ctv1
cndo109
cellresistant
cndo109nk
3×10
posttrial
microchimerism
476months
italythis
internetlink
lime
solo
2135
35°c
830906
983998
845918
707785
32180
pdr
espghan
cdisusceptible
gwas
illumina®
cdipositive
cdinegative
fdr
flj16171
gorasp2
rlbp1l1
asph
atp7b
copper
sporicidal
metazoan
prospectseukaryotic
metadata
expedited
hostvectorpathogen
arthropods
helminthiases
ectoparasites
cellssynergistic
oncoimmunologytumor
facet
interleukin15stimulated
il15treated
aviremic
signalingallergen
mctbased
immunesignalingdeficient
tcrtransgenic
mctadjuvanted
alumbased
outcomesin
120914
immunosuppressionbased
zebrafishroughly
wellorganized
surrounded
rpfb
mmar4207
ag85esat6
candidatesthis
ethnocultural
israelto
israeliborn
arabbedouin
scandalhealth
cancercellbased
overviewconcurrent
egfrbraf
ugt1a128
discoveredit
eminently
linebased
smite
immunosuppressionautoimmune
ligandgated
nmda
nmdarab
virusdriven
engagert
egfrtargeting
oadbite
oadbitemediated
oncolysis
bitemediated
biteexpressing
60516
therapyt
tcrexpression
tcrexpressing
cassettes
genetransduced
mhcpeptide
libraryderived
594604
incentivisation
dunkerque
n67
april2014
april2015
slots
6563
238times
12917
1024
supervisory
executivesdoctors
multipeptides
peac
pac
crac
peacs
cracs
pacs
ck7
cdx2
metaanalysisinfluenza
2367
vdd
043091
05093
carcinomasin
hormonedependent
s3
antislamf7
elo
lenalidomidedexamethsone
bortezomibdexamethsone
elobased
triplets
pea
cicer
arietinum
micetraditional
chickpea
chemoprotective
cisplatininduced
mgdoseanimalip
esterase
sgotsgpt
bids
micronucleus
middlechain
aliphatic
alcohols
aldehydes
ketones
7hydroxy1methoxy6methylanthraquinone
cyclohexadecane
6amino
methyl2naphthol
aroma
arietimnum
myelosupproession
lowmiddleincome
differencesbackground
n372499
prorich
c0161
0131
c0146
0223
namibia
c0093
0145
kyrgyz
c0227
0304
coefficient0606
0301
protocolintroduction
glub6val
polymerisation
sickling
indexed
arbitration
crd42018084051
acosogz0011
acosogz0011study
sentinelnodepositive
calnd
t12n0m0
ct12n0m0
nabon
4331
slnb
hrpositive
statuspn2
hrstatus
uptakeduring
uppermiddle
usefulintroduction
tradition
ocabr
omcls
5850
omcl
countriespublic
derailed
audiotaped
graphic
facilitybased
elderlyin
to11years
911years
reportsa
transplantectomy
thrombosisbackground
anticlass
detrimentally
outsmarting
tumoradoptive
geneengineered
nonsustainable
geneengineering
tumorselectivity
disorderdisease
hodgkintype
burkitttype
2018124232736
immunotherapyclustered
crisprassociated
prokaryotes
cancercausing
crisprcas9based
prepregnancy
nyulh
100132
47132
90132
98132
131132
053092
lnonly
holiday
afterlocal
amongthese
0771
studentsobjective
kentucky
selfselected
deter
2711303
105341
231705
027093
indiaextending
1180
1515
160180
n2833
n3184
l1binding
vaccinetargeted
2day
vespid
cancernatural
push
immunotherapyprevious
sγc
sγcdeficient
sγcoverexpressing
immunotherapiescutaneous
scars
sjs
presumable
sjsten
managements
settingintroduction
mnsclc
10689
5816
6337
8282
9969
119127
4235
2790
91101
1580
7387
historybackground
1536
vbt
lager
ivs
cellsμl
cellμl
linearbylinear
agecorrected
11106328
4813
ageindependent
frequenciesporcine
commercialized
pertussispolio
ukaim
boostrixipv
34year
repevax
mumpsmeaslesrubella
992100
nct01245049
npbased
300mgm
p0574
titers16
aboirelated
appliance
yld
relativeabsolute
insl3
immunisationinsulinlike
relaxinlike
descent
duroc
antiinsl3
2140weeks
survivalantiapoptotic
vptbi
n1346
n152
neuroblastomaadultonset
1871
1979
inss
atrx
mycnamplification
354±161
614±153
osteomedullary
3f8
antibodyrelated
97±
190±82
p0031
probabilitiesare
literaturederived
nonpreferencebased
3484qaly
34315qaly
wellconducted
needsaccording
echoing
antigonadotrophin
immunosterilizing
antigonadotrophinreleasing
antignrh
10ml
biometry
testicle
normality
shapirowilk
width
testicles
thirtydays
azoospermia
8333
gonadosomatic
tubulosomatic
crossbred
workersobjective
infringe
pressured
coerced
utest
regimenintroduction
rheumatologistconfirmed
arthritislike
tnfinhibitors
noncorticosteroid
systemover
leem
enterprises
medicament
ceps
discounts
refunded
ferrara
hospitalthe
azienda
ospedalierouniversitaria
863
4689
directorates
listen
regulatorsregulatory
fora
implantable
biomaterialbased
mdscdepleting
nanogelbased
immunecaredisc
recruitmentactivation
ruckeri
signalsthe
dag
ζ
dgkα
sidebyside
dgkζ
ritanserin
raserk
ap1
silencingdeletion
dgkiii
counteracted
silencinggenetic
dagdependent
substernal
reviewcontext
nonrcts
moderatestrength
lowstrength
asthmarelated
rqpcr
mfc
phall
6042
2283
15988
3614
1610
8111
2547
1008
6443
schedulesbased
elect
oe
admit
1720yearold
questionnairebased
7973
6429
wardbackground
weekperiod
corrective
nonimmunocompromised
luluchxa″dtpa6a10
carbonic
anhydrase
xiiintroduction
intracavitary
radioconjugate
xii
xiispecific
6a10
malditof
radiotlc
autoradiography
scidmice
30idg
tumortocontralateral
apodc
p1derived
hypoallergena
elicitors
dpttdp
carrierbound
1derived
34mer
hypoallergen
nand
iggantibodies
igereactivity
hdmallergy
19910
74680
reconstitutionrituximab
cd20expressing
asthmaalthough
framing
bariatric
laparoscopic
sleeve
gastrectomy
lsg
rouxeny
lrygb
53years
apromising
tumorsimproved
importantthe
penalizing
metagenome
symbiosis
newgeneration
cibmtr
analysisfor
11261
resourced
n697
quartiles
koi
lkoi
khv
cyhv3
ornamental
orf25based
pcdna3
gfpfusion
svcvg
gprotein
lymphotoxin
mesothelinspecific
trialpancreatic
cartmeso
f2fluoro2deoxydglucose
fdgpositron
mav
sharps
patientin
everaging
doseselevating
rubellacontaining
rcv
elevating
benefittocost
stockpiles
literaturecolonization
contracture
glance
receptorsobjective
dexip
pseudoepitheliomatous
vascularization
myofibroblast
amongstudy
groupscompared
wwwspringercom00266
infectionvaccination
mucosally
lipidic
gasfilled
payload
microfold
modularity
statesafter
synthesizing
metastasescancer
concentrate
immunityincluding
stingfrom
postresection
analysisresurgent
19961997
agetargeted
childtargeted
primateschimeric
cd20specific
4450
mig
itac
noncar
pant
therapymediated
75063
airmen
aircrew
percy
13326
fly
patientsguiu
monin
hammhornez
manen
perrier
aerosp
hum
894377382
rectronectinactivated
adenocarcinomaaim
famil1
immunosensitive
urothelium
p00024
p00161
p00203
p00221
nonearly
p00268
p00272
individuate
b16f1
lvr01
th1skewed
rhinitisallergen
ultrashort
mplait
1675±53
ultrashortcourse
myelofibrosisobjective
ricallohsct
2254
fbtbi
1340
900±85
richsct
immunotherapymost
qa1b
corrupted
cancernamely
realityobjective
holisticqualitative
maffesolis
sociology
practicaltheoretical
nonglobal
assimilation
nonimplementation
peh
diseasespurpose
endotypedriven
nontype
feasibleintroduction
capitalized
patientssafety
iggdegrading
ascendingdose
pras
012mgkg
×2
025mgkg
×1
iggtype
antiides
hlab7
012mgkg×2
multimedia
adolescentsthe
gainframed
lossframed
effectsize
21472112
03750422
03690378
20042017purpose
spectrums
cybb
cyba
ncf1
ncf2
83131
nonconsanguineous
modelin
tdx
immunotherapyinkt
carinkt
rtcrinkt
immunotherapywhen
inflammasomes
caspase1
proil18
56fold
il2il18induced
erap1dependent
micecytotoxic
pmhci
customizes
proteasomegenerated
assumes
mhcirestricted
crosspresenting
monospecific
pmhcipositive
ifnγresponsive
324354
larrea
divaricata
cav
macrophagespseudomonas
jarilla
folk
jpce
antijpce
opsonophagocytosis
alpacashaemonchosis
barbervax
h11
hgalgp
ruminantspseudoruminants
parasitized
digesting
15815
lethargic
levelprrs
farmindividual
depopulationrepopulation
rollover
mspiglets
bsm
1126807
1114649
721745
664111
bioconjugate
luciano
rossettiluciano
rossetti
president
kgaa
darmstadt
speaks
laura
dormer
kgaas
dohme
albert
einstein
postdoctoral
yale
doctorate
perspectivestreosulfan
temperaturedependent
nonenzymatic
monoepoxide
2s3s12epoxy34butanediol
4methanesulfonate
diepoxide
2s3s1234diepoxybutane
ssdeb
epoxides
insightful
ratelimited
disposition
therapyblockade
hlaa0201ct37
lineslung
gonads
hlaa0201
ct37expressing
ct37
antibodiesmany
β16linked
acetyldglucosamine
pnag
deacetylated
dpnag
glycoform
technically
rpnag
glycomvs
glycopolymer
pnagspecific
deacetylation
95100
pnagpositive
holarctica
pnagcontaining
regimenpurpose
1715
2412
2794803
1664
ricobackground
basedigg
l1consensus
hpv629
hpv1118
hpv1623
or25
ci1739
or18
ci1226
rico
uruguayobjectives
hpvunvaccinated
montevideo
my0911
101851
101721
0971075
triage
immunotherapycrosstalk
cellsplay
selfdefense
myelomaalthough
p0063
p040
cyclophosphamidetotal
analysiswith
rtm
flubu
cyclophosphamidetbi
singleantigen
n158
n229
age55
p036
deficienciesmixed
pediatriconset
irbapproved
cyclophosphamideacthivig
acthivig
videotapes
26±3mgkg
922±176mgm
activationmaturation
sparer
partiallyresponsive
barriersbackground
muslims
assemblage
makkah
mina
6974
1269
wwwwhointimmunizationsagemeetings2017aprilpresentationsbackgrounddocsen
dendriticcell
dsrna
tumorlysate
twocohort
hiltonol
days8
and10
025mg
dsrnaanalogue
600mgm2
immunerelevant
elispotassays
sixpatient
ifnγelispot
videosin
uploaded
enzymedirected
imidazoquinoline
resistancedrug
proimmunostimulant
cancermediated
αmannosidase
bystanderassisted
reemergencewe
seir
sydneys
underestimates
tlrmediated
immunotherapycellular
tlrbased
nct01838200
premetastatic
hivexposed
hivunexposed
maternalspecific
systemspurpose
20052012
reactionpositive
mixedvaccine
19871997
19982001
4268
4478
3068
5479
value01
5896
value04
4176
rhinoconjunctivitispurpose
bps
birchspecific
athome
201200003159
ratespurpose
guardian
ordinarily
theend
thevaccine
nontraditional
studylevel
asiasublingual
dustmite
originates
asymmetry
speciality
nonplacebo
farma
flubio®
6month11years
atexas502012
bmassachusetts22012
jakarta
a635months
b38years
c911years
28days7days
v3
6months11years
nct02093260
rseaegf
cancerstaphylococcal
enterotoxin
superantigen
aepidermal
streptactin
resin
sulfatepolyacrylamide
electropheresis
andliquid
chromatographytandem
cne2
factoractivated
tcrαβ
wiskottaldrich
syndromeour
nct03019809
treosulfanfludarabinerabbit
globulinmelphalan
thiophosphamide
10µgkgday
240µgkgday
d19
perspectivesa
2016hematopoietic
umd
totalbody
nct00150878
n99
n96
8·511·4
2140
p0·99
5·0
3·08·8
9·5
4·520·5
4566
0·511·14
p0·19
0·60
0·321·11
p0·10
p1·00
lobectomy
lobectomies
invasively
thoracotomy
shortinterval
transmucosal
airwayalthough
chlamydiamuridarum
cmuridarum
extraairway
igg2bc
il13producing
muridarum
th1dominant
extragastrointestinal
menacwyd
1155years
923months
kpnc
210yearolds
923montholds
2007october
2011june
030days
3160
31180days
3175days
cellulitisabscess
identifiers
nct00728260
nct01689155
lotrelease
rcv1
rcv2
9109
betterdeveloped
rcvs
interprovince
effusiongenemediated
gmci
aglatimagene
besadenovec
advtk
antiherpetic
mpe
intrapleurally
celecoxib
2333months
29months
uninvestigated
pseudoprogressors
nonnegligible
malignanciespart
revivedwith
industrysupported
combinedmodality
herepart
vaccinesimmunotherapies
journalism
criterionbased
print
2009background
catalogue
lexisnexis
scanned
highcirculation
magazines
20062009
decimal
structureorder
shortfalls
gliomasstrategies
nuances
extinguish
clinicianscancer
γinterferon
nonkeratinizing
ebvnegative
responsesmodern
intranodal
fibroblastsamong
028063
058167
crd42016048093
αradioimmunotherapy
anemiaparoxysmal
mg1e6e7
custom
maraba
slps
logically
sterilising
synucleinopathy
sevenmonthold
a53t
toma
deficitstwo
tomatreated
challengesimmune
molecule4
antigenloading
proteinpolysaccharide
acywx
analysishuman
subtypeslineages
4020
nasalnasopharyngeal
14429
9766
4663
3927
subtypelineage
0602
diseaseroutine
ceabispecific
instabilitylow
leukemiaevasion
il15activated
pbmncs
nonmobilized
nkil15
nkae
gmpgrade
group2
nkp44
nkp46
amlapproximately
inductions
bu×3
flubu3tbi
diabetesclinical
advancesautoimmune
insulinsecreting
diseasefoxp3
mir21
immunotherapymicrorna21
ifnγinduced
whipworm
trichuris
materialtrichuris
trichiura
soiltransmitted
intestinaldwelling
homologues
centerline
154228
advisement
inquire
0930
0931
monocytogeneslisteriolysin
axalimogene
filolisbac
postbaseline
585105
74133
patientlocal
frankly
patient1
eccrine
coils
emj
dermatol
2018173364367em
lateterm
93days
stillborn
prrsv1specific
prrsv2specific
captivebred
birdsthe
habitats
ringneck
pheasants
phasianus
colchicus
psittacines
cockatiels
nymphicus
hollandicus
lorikeets
trichoglossus
haematodus
molucanos
rosellas
platycercus
eximius
touracos
tauraco
persa
whitecheeked
leucotis
violet
musophaga
violacea
hb1
instilled
112th
elisabiochek
mevalonate
intermediatesthe
sensibilization
exocytose
intermediates
cancera
approachnatural
1like
overstimulated
cellssolid
reeducated
immunosupression
βglucanbased
nanoparticlesimmunotherapy
cellwall
pamp
interactionintroduction
postponed
iiexpressing
sexmismatched
xyfish
iipositive
1224weeks
transplantationresidual
activeatg
016192
dayml
atgbinding
atgcytotoxicity
graftderived
40fold
responsepurpose
hrt
tocompare
b16cd133
3×918gy
5×643gy
andnonirradiated
3hrtantipd1
rtimmune
1675
194months
261months
160months
154months
netherlandsvaccination
749876
850972
671874
93735
194873
theoryinformed
bcw
cyclical
priceless
immunizationtetanus
anaerobes
excrement
unclean
spasm
laryngospasm
asphyxia
testingintroduction
antigbm
hmrnthe
2·0years
20042011
16·8months
clinicalscale
institutionbackground
cgmps
closedsystem
depletioncd56
anticd3anticd19
cellenriched
infusible
clinicalscalecgmp
celldepletion
columndepleted
glycopeptide
mucositissevere
pcrdenaturing
dgge
quinolone
βlactamglycopeptide
pcrdgge
lautropia
mirabilis
glycopeptides
metaanalysisapproximately
il2ra
2449
esoon
acceptably
storypolicymaking
transplantationepsteinbarr
ebvptlds
ebvinfected
seromismatch
recipientnegativedonorpositive
ebvdna
ebvdnaemia
ebvctls
rituximabplusri
testingviral
vrti
rhinovirus
p47
isctr
postbmt
facevalidated
attachments
esurveys
nonseroprotected
3600
euvax
11211535
9671070
903children
19iul
1iul
1516years
outlasts
flagellinin
chil6
chil8
cxcl8cxcli2
19day
flic
chtlr15
flicspecific
lateembryonic
mocktreated
xenogenization
brainin
confidently
ith
triazene
tzc
dix
tzcdependent
o6guanine
methylguaninemethyltransferase
mgmt
dinpositive
intracerebrally
histocompatible
xenogenized
antidin
reminds
downsizing
polyclonality
dixbased
wafer
xenogenizing
methylating
sparrow
passer
domesticusstressinduced
corticosterone
cort
sparrows
mifepristone
ru486
arthritistenascinc
tn64
tnfniii
integrinbinding
aeidgiel
rgddependent
fibroblastmediated
raassociated
wartsbackground
pdl
dpcponly
cryotherapyonly
pdlonly
119156
positivitychronic
eaaciga2lenedfwao
pill
blind
testspecific
ooperating
ccharacteristic
ccurves
rocs
64347
patientsallergic
interleuhin17
hdms
postnasal
kamigoto
rdt
maflu
rdtconfirmed
1668
maflua
maflub
attenuations
nonnatural
chemistrypolypeptide
confines
damino
archetypal
asct1221
jmml
busulfancyclophosphamidemelphalan
bucymel
lesstoxic
diseaseburden
unmeasurable
2169
2797
60mgkgday×2
31445
0071
0969
cllx4
pharmacokineticdynamic
alpsrelated
deathl1
beneficially
inhospitable
cellpriming
dcpriming
ctlmediated
dctargeting
idriven
hypersensitivityallergic
246trinitrochlorobenzeneinduced
rorcγtcre
rosa26r
yfp
cd9012
hapten
rora
sgflox
il7r
cre
ilc2deficient
1dominated
cha
cedarspecific
asitbackground
cypress
flower
1cha
2cha
cocoon
fundeddose
or×100
ve77
1893
5892
vaccineslicensing
temporallyrelated
999
noninfluenza
1·71
acknowledging
immunotherapyexciting
510μm
nanoaapcs
materialsmethods
5163
4151
2559
944
4962
pleuralmesothelioma
2017malignant
asbestosinduced
mpmrelated
brca1
deathreceptor
nonimmunotherapies
deiminase
adipeg20
argininosuccinate
1deficient
tazemetostat
repressive
bap1deficient
childhoodobjective
20092014
n98186
mixedother
aor087
080094
2429
aor048
044052
aor033
030036
perfringens
markerfree
ppαt
δupp
toxinspecific
applicationwhile
1215months
treplete
olderallografting
aged60
larget
celldeficient
wsh
pmnmdsc
cd40lexpressing
cd40lcd40
55265
nouna
timescale
2238
hr100
083120
hr083
055129
nct01644721
petitstudy
boiled
dermatitiseczema
ointment
strategiescytokines
clusterrandomized
trialspower
crcts
ircts
intracluster
communicationactive
postponing
snss
nonexperts
striven
αtim3
αox40
αctla4
αlag3
cd59
immunotherapycd59
glycosylphosphatidylinositolanchored
guidelinesobjective
impediments
otolaryngologyhead
aaohns
acia
neurotology
ans
polled
aao
agegroupspecific
easing
12821452152
treatmentmonoclonal
camelidae
vnar
squalidae
internalize
compilation
sdab
stall
tetrameric
antidr5vhh
polyspecific
dermatitisone
tear
vignettesuse
solidtumor
seomsemicyuccancer
seom
semicyuc
subjectivity
assessmentfollowing
titration
ru
positives
fox
thromboplastin
aptt
protamine
ukghour
r38
puncturedskin
endotypesbackground
ilike
icytokinerelease
hydrolysates
βlg
wpc
pwh1
pwh2
ewh
epicutaneously
tapestripped
βlgspecific
βlgrestimulated
protease1
ewhfed
pwh2fed
crl1505
peptidoglycan
lactobacilli
micepreviously
pg05
immunocompromisedmalnourished
peptidoglycans
crl534
plantarum
crl1506
eritrea
israelisintroduction
telaviv
noncitizens
vaccinationtimeliness
finemotor
linguistic
socioemotional
grossmotor
mctc
celltrace
ctv
allergenreactive
episodebackground
nmosds
emg
nmosd
reviewinfluenza
2000march
240580
290990
annihilate
immuneevading
highspecificity
dnagold
micronanoplexes
immunizationmembrane
environs
biolistic
micronsized
nanometersized
micron
detergentsolubilized
massively
proteinaltering
checklists
63months
497753
147months
4522494
knlga
sociodemo
27±55
224±
soap
perineum
or232
14387
119582
perineumand
or187
122896
immunosuppressiveexperimental
metastasization
devil
tasmanian
devils
releasedevil
dftd
renowned
histocompatabilty
antidftd
rnaase
hallmarked
presentday
afterward
toleranceantigenspecific
tnps
lock
sel212
ebmtrecommendations
0902
trialsleep
pittsburgh
b7h6specific
b7h6expressing
rmab7h6
doublepronged
singlecarbased
lscs
ccar
safetyswitch
tipst
tcrcart
nyeso1expressing
mousederived
infectionsvarious
virusresistant
virusantigen
seasonsobjective
2304
vri
007011
072093
069095
hosp
201839452461
ukmra
4500
inhibitorcontaining
reinduction
ukfunded
ng35
uknationwide
randomisations
isrctn10038996
stec
shiga
toxoidsthe
stxproducing
eponymous
rstx1
mut
rstx2
antistx
stxneutralizing
stxpositive
jordan
abdullah
irbid
22475
50year
37502
overviewinfluenza
exalted
multiplechoice
downmodulates
derpspecific
actinomycosis
lurking
reviewactinomycosis
fistulae
actinomyces
infectioncytosineguanosine
deoxynucleotides
kul01
fabricius
recruitments
quantifiable
rhc23
dosehaemonchus
sixmonths
manchego
μgdose
wb
epg
abomasal
haemonchosis
borrowing
βthalassaemia
udpbsct
pesaros
hepatomegaly
chelation
uds
persistentthrombocytopaenia
dravet
syndromedravet
aluminiumadjuvanted
heathy
lpp
170μg
lpptreated
wao
esr
30minutes
nochange
ratio0995
interval09930997
precipitant
replacementimmunoglobulin
capsulated
carbohydratebased
oncotherapycancer
carbohydrate
tacas
encroach
twotier
phlebotomy
rtca
r052
p00028
r059
cancermost
serumfree
toleration
ire1
s729
ridd
immunizationto
splices
ire1dependent
switches
xbp1deficient
antiphosphos729
subtilase
cytotoxin
s729a
knockin
lipopolysaccharidestimulated
δire1
responsesdespite
pgc1αmediated
fasobackground
n29
godmothers
healers
atlasti42
rainy
shecamelsthe
camel
coagulase
pseudocapsule
apsv
oasv
15th
4monthsat
37°c
3792
6992at
45th
5920
14240
challengesin
nonvaccinetargeted
ageimportance
30unit
p55
0352
us186
us793
unvaccinatedincompletely
isrctn84560580
parentperceived
photothermally
ovadecorated
aunpsbased
haovaaunps
thiolated
heatmediated
endolysosome
adrelated
htau
2022kda
taua
htau40which
terminals
nonad
nontransgenic
subchronic
intracerebroventricular
icv
b6sjl
memorylearning
htautreated
pairedpulse
ppf
ca3ca1
synapses
htauimpaired
canstimulated
pcrebcfos
synaptotoxic
frank
20kda
synaptosomal
taubased
tcellreplete
leukemiawe
tcrhaplosct
527days
±85
±79
respectivelyage10years
05gh
207gh
227mgdl
214g
p081
62days
hypomagnesemia
hypermagnesemia
p043
cd137l
polarize
phenotypetherapeutic
gmcsfil4maturation
tnfsf9
cd137ldcs
metabolically
cd137linduced
aim2
il1beta
cpps
cppbased
35000
5component
covariateconstrained
denver
43132
2½
108147
131162
127192
95absolute
44absolute
nct02456077
vaccinationexisting
adsorption
microrod
msrpei
synergized
receptordeficient
cellspractical
pebls
957
cd3tcrαβ
tcrαβnegative
peblt
anticd1941bbcd3ζ
pebl
singlestep
implicationsalthough
ptc
dedifferentiated
immunescore
tds
hlag
mandatoryfrance
democracy
coercion
frances
tensions
watanabe
hyperlipidemic
rabbitbackground
autotransplantation
lentiviruses
fluoroscopic
ldl
20wk
dilldl
8098
0583
p0171
cholangiocarcinomacholangiocarcinoma
resectability
fibrogenic
trivial
europeans
subclassification
msdmudhsct
bloodhsct
ucbhsct
vδ1
immunotherapydecisionmaking
selectionimmunotherapy
warehouse
lcms
imadetect
nct02876510
nct03247309
influenzainfected
2270
copays
wellaware
medicaids
nonreimbursement
immunotherapyintralesional
histocultures
arteritisgiant
sublingualswallow
studysensitivity
januaryapril
3282
1024months
noteworthy18
tibial
viabilitybackground
neoangiogenic
pedicle
intraosseous
perfuse
threedrug
avbundle
011±005
001±001
neoangiogenesis
787±44
277±58
p028
214±29
125±37
tibias
disorganized
p143
bundles
tibia
observationsan
bedsideregulatory
357immunization
sogc
table1
japanfew
nara
leisure
coinfused
41bbengineered
leukemiaseveral
28ζ
bbζ
factin
lgs
4hr
il13rα2specific
glioblastomain
il13rα2
il13rα2cars
cd28ζ
il13rα2carcd28ζ
il13rα2carδ
il13rα2expressing
sma560
il13rα2negative
il13rα2positive
experiencehealthcare
18352041
1783
023099
technologyas
unicarendowed
unicarengrafted
unicars
cd137cd3ζ
137ζ
scalesbackground
djibouti
sans
frontières
promed
reliefweb
km×20
grid
141918
141538146505
4·0
1·716·8
87·2
60·3
118·9
35·3
26·3
62·0
gillick
reticence
isrctn49086105
transplantationmultidrugresistant
mdrgnb
threehundred
irm
noncarriers
p262
p091
p405
p301
p142
p304
p207
analysisa
generically
selffulfilling
unambiguously
futurebiliary
interleukin4dendritic
mddcs
500iuml
lil4
1000iuml
hil4
2days
500ngml
cd209
injuryone
beneficent
herewith
mscdependent
αgalcerinduced
10producing
βproducing
zonelike
hepatoprotective
23dioxygenasedependent
mscprimed
687702
aasld
malignanciesunprecedented
wellreasoned
radioimmunotherapiesbackground
alocal
malign
radioimmunotherapies
alower
emanating
chronologically
oncologyas
afundamental
tilb
atherapeutic
asubset
b‑cell
patientsaddition
cd30targeted
virusdirected
tecam
0618
04900722
0828
07010904
037061
036060
alloreactivityreduced
cd45rapositive
mhcmatched
cellprocessing
gmpcompliant
uneventful
nearqualitatively
fivefold
gmpcompatible
meaningfully
gvh
agentsobjective
uminctr
umin
000007710
tisagenlecleucelbackground
penn
assigns
distinguishes
delayedonset
acceptabilityuptake
librarian
crd42017048844
reciprocitybackground
forcibly
solidarity
arduous
reciprocity
reparations
midlevel
reciprocate
justifiable
necroptotic
cellsmimicry
modalityrecent
paradigmshifting
codelivering
nanosize
αhsp70pcmcap
composing
bilayer
signalaugmenting
αhelix
αhsp70p
membraneassociated
antigenpresentation
multiepitopet
druggene
workdrug
bewildering
centertwo
shipping
lateadolescent
immunizationseven
trustvaccination
tax
disallowing
conscientious
jab
paternalistic
longawaited
areatainterleukin17
lesional
il17targeted
banked
applicationt
lymphocyteactivation
gz
chief
induceexpand
tr1like
adenovirusprime
baculovirusboost
modelwith
artemisininresistant
virusvectored
envelopemodified
dualexpression
embdes
adenovirusprimeembdesboost
5primeembdesboost
mosquitobite
reverseordered
63primeembdesboost
cytokinereceptor
complexesinterleukin2
pleiotropy
ortho
adjuvantbackground
alinteractions
bioligands
alspecies
alspeciation
almeasurements
alcontaining
class0
aldepot
sitgroup
class1
24hurine
ethic
westphalialippe
münster
2013667fs
interferencefree
sectorfieldmass
sizeexclusionchromatographyicpqms
alconcentrations
alcitrate
p0041
gelmonovettes
contaminationfree
hno
prewashed
gelfree
monovettes
p0669
ware
alanalysis
noncontaminated
trialpurpose
pcsdm
factbased
poststudy
ninetynine
eightytwo
chinarecommendations
hematologyallogeneic
allhsct
bdmards
il6receptor
20152016human
bitten
cesarean
healer
congruence
metagenomics
commensals
linguistically
1656
1522
452513
299514
therapyeither
radiosurgeryhas
traverse
fractionations
decontamination
chloroquine
resetting
phenotyperesetting
cq
mucolipin1
mcoln1
tfeb
cqreset
macrophagebased
infectionadoptive
bzlf1
penton
minimummaximum
chpmagea4
vaccinationbackgroundaim
klinische
einheit
ke
tregcd4
tregtype
mitogens
phytohemagglutinin
pha
streptokinasestreptodornase
pokeweed
mitogen
pwm
nonmethylated
8mer
alloantigeninduced
lymphoproliferation
vaccinationintramammary
αtoxoid
alumsaponin
alumoil
alumsaponinoil
suspensory
ligament
triangular
oneshot
gradeglioma
casesbackground
thechallenges
misinterpreted
irano
nct02311920
activationt
receptorspecific
customization
costimulus
paramagnetic
singlesignal
fieldinduced
vaccinationalthough
agrees
thinks
coastal
kenyastreptococcus
vaccineincluded
toleranceoral
clostridia
multireceptor
axitinib
modelscancer
vegfvegfr
axitinibmediated
therapiesregulatory
practicalities
optionthere
1078
4379
4080
valencia
201617introductionseasonal
vahnsi
programsunassigned
diphenhydramine
credential
abides
melanomauveal
simplerthe
2504
microbiotaderived
bacteriaspecific
recolonization
tracta
bacterioidetes
phyla
eubacteria
antibioticbased
recolonize
gutderived
odactrasublingual
selfadjuvanting
clec9a
immunotherapynonantigenspecific
antigenanticlec9a
clec9atne
ovaclec9atneinduced
e6e7
e6e7cpg
antigenclec9atne
nanodisc
lipoproteins
nanodiscs
7fold
inflection
slrs
sarcoidosisrelated
observated
misdiagnosis
pregnancyinvasive
carcinomapurpose
radiosurgerystereotactic
pembrolizumabpatients
iciprogressionfree
0337
129months
247months
researchthe
lowthroughput
suits
immunostained
tumpdl1
tumb7h3
cd8pd1
tii
tiipdl1
factoring
hivpatients
lvi
reviewon
drallisons
tcell‑costimulatory
domaincontaining3
attenuator
preclinicalclinical
malignanciest
ucart7
allotolerant
leiomyosarcoma
tumorstumor
microenvironmenttmesuitable
ofthe
oftme
ofregulatory
ttregcells
ofapcs
oft
oftumor
tteffcells
ofglucose
glutamine
ofthose
teffcell
cellslakand
sequencer
inhibitionpeptide
irrelevant
pd1induced
61727
20122014background
58090
incometopoverty
venomenvenoming
maghreb
myeloperoxydase
mpo
epo
literaturevaccine
premium
philosophies
canal
scac
antiepidermal
reviewhematologic
radiomimetic
fifties
tomotherapy
radiobiological
tmli
23monthold
20082013
4748
mor
districtlevel
newcomers
vaccinetracking
appobjectives
canimmunize
pancanadian
governmentassisted
17question
arabic
newcomer
immunogenicitybackground
skh1
4550°c
csccbearing
immunizationintroduction
preschoolers
aerogenous
26dpv
7dpv
isotypeswitched
nagoya
studynagoya
71177
29846
113182
112149
102139
111179
therapycirculating
cpcs
cpccontaining
sevencolor
adiposity
albertans
absorptiometry
imagining
atexas
nct01044069
17aag
vemurafenibassociated
modelheat
17allylamino17demethoxygeldanamycin
atpase
occupies
destabilizes
proteosomal
rafmekerk
brafv600e
brafwt
craf
plx4032
vemurafenib
plx4032enhanced
meljuso
skmel2
skmel30
tyrp1
tyr
paradigmpurpose
17p
otrs
rois
semiautomated
carspecific
cd33specific
pretransfer
bhutan
optionbackground
bhutanese
1ngultrum
00007
fte
0611
1xgdp
2708
7436
3435
4001
2187
perspectivesrenal
iberian
cibal
cmpas
57item
cpma
7368
easytocalculate
successthe
overestimates
rgrfs
comorbiditiesthe
transplantationspecific
nonucbt
and3
n74
p78
psychiatrya
psychiatry
irf3
visavis
pprv
goatshere
receptorsin
igg1σ
igg2σ
paa
tighter
nanomolar
erathe
waiver
educatorsbackground
daycare
michigans
educators
vaccinerefusing
forwardlooking
decoybased
immunotherapiesrecently
ih
hypopituitarism
nonspecifics
gonadotrophin
deferred
capripoxvirus
proteinsthe
camels
capripoxviruses
cpv
rks1based
rvfvspecific
anticpv
vaccinecervical
cervarix
agencia
costarricense
investigaciones
biomédicas
acib
iarc
globulinfresenius
fullmatch
myeloblastic
fresenius
ratgf
atgfresenius
fullmatched
begining
ratgfrelated
ratio182
1667199255
lipidomic
leptospiravaccinated
horsescurrently
lipidomics
diacylglycerols
hydroperoxide
choline
plasmalogens
triacylglycerols
sphingomyelins
lipidome
babymaternal
neonate
interviewinghuman
glutaraldehyde
opportunitiesimmunotherapy
drugsimmunotherapy
viralimmune
rnf43
translocase
tomm34
uraciltegafur
uftlv
hlamasked
hlaa2402matched
hlaunmatched
negativeresponse
bendamustinebased
centerscarmustine
beeam
50250
days7
arf
hyperhydration
fourpoint
toxicityefficacy
lightbased
pathogenreduction
multianalyte
intercepttreated
mediumlevel
studycord
tbicy
mmac
p0183
mmacp
mmacr
itd
flt3inhibitor
crenolanibfmslike
crenolanib
flt3car
colonyformation
challengethis
campos
mya98
pigsin
lineagesea
omanisa
mesa
reoccurred
jincheon
characterizations
primo
pd50
mya98sea
pathologygeneengineered
unpredicted
ε
ultramutator
pmmr
201718the
2054
navarre
medicallyattended
201516introductioninfluenza
1142
unsubtyped
vaccineineligible
pcv7eligible
pcv13eligible
2436
12254
10352
postpcv13
yttrium90ibritumomab
zevalin®
eshap
immunotherapymultiple
aprogressive
immuneindependent
immunityradiotherapy
patientswho
responsesefforts
multifoodallergic
predosing
lilotomab
lulilotomab
satetraxetan
12a
organsatrisk
20mbq
spectctimages
089mgymbq
predosed
148mgymbq
arm4
320mgymbq
267mgymbq
tumortorm
productsadoptive
activitypersistence
f5mart1
nct00910650
stimulationexpansion
naivememory
193379
20451
16867
haplos
20052011
2018124214250
osteopetrosis
imo
treosulphan
741891
epsteinbarrvirusdriven
melanomaboth
n122
444months
leukaemiaconsidering
4×2gybased
doseadapted
1774
antigenmismatched
electrotransfer
modelgene
checkpointtargeted
antibodyligand
disable
invent
ytraps
disables
autocrineparacrine
actla4tgfβriiecd
apdl1tgfβriiecd
tgfβmediated
il12adoptive
jackson
il12dependent
800μg
newpersisting
gadoliniumenhanced
gde
unremarkable
dnamva
mockimmunized
antirvfv
rak
angiosarcoma
78yearold
retronectinactivated
gelatinaseassociated
lipocalin
flunet
internationallyamong
natureinspired
urocanic
ultravioletb
radiations
cd38targeting
experienceintroduction
mor202
fcdependent
lenalidomidedexamethasone
bortezomibdexamethasone
decentralization
eliminationmeasles
miceantictla4
ctla4targeting
l3d10
tregteff
b7ctla4
crpr1
d100
consolidating
chemoimmunotherapysensitive
chemoimmunotherapyrefractory
singleton
413034
25222
088101
054169
017113
neutrophilsthe
aerospace
electronics
xenobiotics
fullerenes
overwhelmed
neutrophilrelated
pharma
prohibitively
applicationscoccidiosis
viscosities
viscous
litter
2015background
perinatally
birthing
aprs
17458
14006
preprinted
2125272
weekday
154213
117154
103128
tamponade
therapya
gynecologistswe
1315
71114
cdcacip
93112
rh35
apoptosisantiapoptosis
99982
64290
35692
738367
1141
1452
tcellmodulating
immunemodulator
n4121
20032004
lone
paradoxes
igg4related
diseaseigg4related
igg4rd
fibroinflammatory
igg4positive
3r
researchadoptive
fulfills
fvspecific
tdtomato
150000
fvinfected
reusing
repetitively
humansa
canines
epistasis
flg
il4r
studiesimmunespecific
pathogeneses
genegene
filaggrin
isle
wight
iow
n1456
maas
n1058
rs3024676×flg
rs3024676
homozygotes
127305
heterozygotes
022132
p0175
aprepitant
antiemetic
hsctthe
emesisfree
cyclophosphamidecontaining
ondansetron
1425
1245
immunizationsobjectives
onegroup
albertsons
safeway
idaho
10question
posttraining
portions
pretraining
4hour
selectiontargeting
arsenicum
album
30ch
dpthepbpolio
diphtheriapertusistetanus
homeopathic
mahesh
homoeopathic
verum
rr1008
p0951
rr0956
p0719
differentiable
ctri201702007939
idiopathicspontaneous
ciuchronic
ciucsu
postindex
1546
ciucsurelated
statusthis
rigg
1928zt2
tollinterleukin1
itr
1928ztlr2
bultrasonography
remitted
nct02822326
pomonaobjective
clostridial
romneycross
15ml
leptospires
ci617100
ci683100
transplantationacquired
tafa
livertransplant
kidneytransplant
inhibitortumour
hematopoieticoriginated
tumourfavouring
resensitizing
cancersthyroid
dtc
radioactive
iodine
vandetanib
tkr
her23
responsesthe
dome
outmost
follicleassociated
fae
subfae
disposed
immunotherapycomplement
complementing
metastasistargeted
snowballing
moose
crd42015020808
2804
coldspots
finescale
clusterlevel
1km
mcmc
provincelevel
summaries
epidemiologicallyimportant
operationallyrelevant
20002015reporting
organizationunited
n194
fluctuated
ratiosgreater
than10
burning
questionsimmune
advises
fortify
therapists
toxicityimmunotherapy
itrt
radionecrosis
139months
presrs
nonconcurrently
attained1year
p067
nonearlyprogressors
b7h6
expressionb7h6
anticar
formatted
patientscll
patientthe
rival
begging
nepalbackground
surveilled
2634
3693
3646
smallforgestational
nct01034254
divalent
mrpa
proteus
infectionurinary
catheterized
mrpaflic
771
smart
controlledthe
unfolds
whatsoever
extensible
showusing
fieldshow
arthritisassociated
jiaassociated
illinois
chicago
fi
proctor
corticosteroidsparing
1951
288days
taperdiscontinuation
108338
pandemicin
doseseries
messagebased
hyperlinks
audiencespecific
sourcesnear
targetcellspecific
photoabsorber
cylindrical
panir700
a431luc
adjuvantcoupled
bid
effectmore
crossdisciplinary
vaccinationobjectives
1154113
572875
3628
094123
unwarranted
seasonally
orvs
climatic
curitiba
janeiro
fortaleza
rain
postseasonal
activesurveillance
influenzainfection
loadvaccination
hbvaxpro
or3
20082016background
20082016
indianalaskan
133503
formatsdespite
containers
delamination
tcod
costsensitive
blowfillseal
bfs
prefilled
autodisable
cpad
multimonodose
mmd
ampoules
mainstreamto
bolster
selfbelief
casts
consumerist
wilful
misguided
elevates
selfconcept
enlightened
besieged
virtuous
groupthink
overconfidence
groupa
onesubject
groupness
recognisable
treatmentintratumor
clonalstromalimmune
targetedrecognition
qbcih
globalizationglobalization
distributors
calendars
countriesis
serbian
evaluationwith
cellulargene
broadranging
riskmanagement
needsallergen
aits
contestedprimarily
neosensitizations
polyallergic
424weeks
232years
hightitre
50cellμl
101129
1000personyears
hbvactive
treetemporal
methodpurpose
pleurisy
vaccineae
antimyelin
neuritisantimyelinoligodendrocyte
responsesrecent
coevolution
sculpts
diseaseregulatory
rnases
drosha
dicer
analysiswe
nx
nonnx
6030
3060
recipientshematopoietic
ters
norisk
ters265
ters27355
ters355
readmitted
hr162
hr250
hr181
hr164
norisk12
atrisk25
heighted
amlpurpose
mdsaml
183444
seminar
assemblyin
harmonise
addictions
2356
and49
cd4t
il2secreting
20022005
clearest
metastasismost
quadruplemutant
tgfβactivated
enduring
1effector
cart19s
28yearold
comoleted
nongcb
rdaeporch
rchope
rgdp
hydrothorax
121245
569pgml
1119696copiesμg
522227copiesμg
ushering
mid1980s
il2driven
αfetoproteinspecific
immunotherapyhepatocellular
hccassociated
αfetoprotein
lentivector
aad
hlaa2afp
afpspecific
innocent
bystanders
vaccinespurpose
reexamining
0916
valueθ226
reviewhead
cddp
5fluorouracile
cddp5fu
rmhnc
imaes
tgfβinduced
cellslupus
iggc3
strategyautologous
cryo
sulfoxide
dmso
noncryo
january2015
october2016
mucociliary
claudin4targeting
micevaccine
cilia
ccpe
claudin4
nasopharynxassociated
nalt
ligaselike
ttll1ko
nasally
pspaccpe
pspaspecific
expectorant
nacetylcysteine
ccpebased
inhibitortargeted
igf1
csfr
81424
ixekizumab
lowenergy
micerespiratory
leeirsv
outbreakbackground
nonopv
138799
179ci
132241
171ci
127230
nonjewish
tapestripping
eczematous
shaved
depilated
finn
20μlaliquot
20mgml
daysweek
ovainduced
fitclabeled
fitcovaengulfing
twentyfourweekold
skinderived
2014hepatitis
beforein
coverage95
vs95
prevalence1
vs1
lymphoplasmacytic
antigenchemokine
lpl
igproducing
watchful
idiotypic
idiotypes
mip3α
endocytic
havelow
nct01209871
transplantationorgan
ventilatorassociated
tavem
valrti
patientsall
n663
n2297the
tracheobronchitis
045084
054095
178402
p0001incidence
nutrientdeprived
dosebackground
observerblinded
1330
1002
tdapvaccinated
postvaccinationtoprevaccination
pertactin
enoughobjective
crosssection
3235
planners
nyvac
primatesa
primeenvelope
b1059
sf162p3
primegp120
nyvacprotein
r5
medicineimmunotherapy
cd274
pdcd1
revolutionising
tumourimmune
transdisciplinary
epigenomics
immunologympe
synergise
polyunsaturated
environmenttumourimmune
keratoplastyaims
dexamethasonereleasing
keratoplasty
700µg
slitlamp
neovascularisation
cct
euthanised
ultraperformance
spectrometer
270360°
photosensitizerinduced
immunotherapyherein
endolysosomes
myeloidtargeted
immunityeliciting
mmp9
cosecreting
ccl1722
ceacam1
antigenrelated
cytokineinducible
coincubation
gr9
methylcholanthreneinduced
oncogenicity
mhcilow
mhcipositive
immunodormancy
subpar
prostatecancerassociated
oncolyticvirusinduced
subversion
versaimmunotherapies
vegfdependent
angiopoietin
hgf
grazaxa
studyrespiratory
grazax
children5
immunityhepatitis
percents
bungas
72965
36098
4973
2975
r0104
p0464
r0367
therapyexogenous
facilitiesobjectives
posteducational
quizzes
t57504
p0324
forwardrecently
mediafollowing
twenties
overloaded
palermos
sicilian
antimeningococcal
antidtp
invisibles
populationmigration
evaluationassessment
scuola
formazione
generale
santegidio
influenzaflu
surname
12982
mmg
romebackground
oppositely
201418
asl
rma
550000
30hour
centri
vaccinali
deadlines
leaded
citizenuser
professionalsvaccinations
downward
prevenzione
vaccinale
ssns
leadrship
strenghten
italyeffective
hta
reportsbackground
ispor
italyrome
nihr
handsearch
pharmacoeconomics
giornale
politiche
sanitarie
pillole
farmacoeconomia
farmacoutilizzazione
ijph
quaderni
dellijph
figuring
unprotectablethe
responsevaccines
changeitaly
witnessing
worrying
lea
acwy135
antizoster
conveying
disciplinary
homogenization
ssn
guaranteeing
immunoprofiles
hydroxyproline
epimerasethe
4hydroxyproline
2epimerase
stprpa
antisalmonella
congruency
timothy
unitbackground
grastek
slitt
cosensitized
eeu
trss
p83
nct02394600
solicitation
tabletbackground
nct01700192
1272
1287
placebosubtracted
phostau
amyloidtgmice
nonmutant
plaquestauimmumotherapy
tangletauopathytg
amyloidmice
appswepsen1de9tg
amyloidplaques
neurofibrillarytangles
mutanttau
tauopathymice
fourteenmonthold
phos
nonmutanttau
nontgmice
admice
phostauvaccine
tauamyloid
mbita
kenyaobjectives
rotavirusspecific
rotavirusrelated
uvis
subcounty
2764
g1p8
g2p4
rtssas01e
malawibackground
anticircumsporozoite
antics
124260
038092
affirmed
death1pdl1
conventionalnovel
arthritisobjectives
13valent23valent
prevenar13®
pneumovax®
hyporesponse
primoinjection
zap70
thymocytesthe
chainassociated
peritoneum
milky
donororiginated
singlepositive
zap70deficient
graftswe
immunobiotics
moleculebased
immunotherapydrug
threaten
aheadintroduction
immunehomeostasis
interferonγsecreting
repolarizes
vivoneuroblastoma
osteogenesis
imperfecta
intraadrenal
tmespecific
201836915924
immunedeficient
miceaccumulating
neurobehavioural
lymphocytedeficient
mwm
neonatally
immunocryosurgery
lentigo
maligna
lmm
cosmetic
aesthetic
cryosurgery
calmetteguérinunresponsive
bcgfailures
bcgrelapsing
bcgunresponsive
culturederived
jevc
brainderived
jemb
boryung
vaccine®
11138
81441
9425
clinicalttrialsgov
nct02532569
10385
dedicating
20032011
hospitalintroduction
gutierrez
postv
1046
monitors
reportingbackground
loggers
ddl
ipsrs
issuance
kenilworth
01jan2004
31december2016
12993
nonus
ddls
utilitarianism
contractualism
rescuewe
realisation
argumentsnamely
utilitarian
parfits
contractualist
argumentcan
imperceptible
collectives
realise
quantitativeigg
4350
4850
substudy
917year
parentslegal
917years
1417years
onschedule
nct01030562
19002015background
1900
forecasted
0to4year
igras
15mm
0303
0370
0321
0488
0422
0288
0235
0332
0275
qftgit
senescent
verses
immunosurviellance
senolytics
3384
endotheliitis
lobular
051mgkgday
25mgkgday
patientoriented
therapiestremendous
cccdna
talens
qt
transplantationare
refractoryrelapse
guest
ageadvances
cv
approach33±31
abpm
pwv
lvmi
intima
transplantationattenuated
18137
transplantationumbilical
ducbt
atgfree
33fold
morquio
experimentobjectives
dce
heteroscedastic
folder
kebbi
2776
1208
15882
1119years
05years
109548
aliero
jega
129years
mesvaccinsnet
disinfectionwaterborne
waterborne
seirb
disinfection
infectionfree
stroboscopic
permanence
researchtested
settingresearch
parenthood
kiosk
20709
18483
8382
cibmtrbackground
1567
progressionrelapse
groupslow
riskwith
2018124173342
n88
intrusiveness
selfesteem
psychologically
4647
hr198
166236
hr178
148215
antivegfvegfr
hr204
161260
hr216
186251
hr163
089299
p0120
0218
p0329
0386
p0140
0656
haryana
analysisunassigned
doublemasked
10644
10517
032047
035048
052073
125182
121165
111153
103140
197291
049073
043076
opportunitythirty
nvac
nvacs
advisor
widelyaccessible
resolutions
gliomathere
enormously
myelomawe
siltuximab
indatuximab
dacetuzumab
lorvotuzumab
bi505
ave1642
figitumumab
atacicept
milatuzumab
lucatumumab
iph2101
bt062
klc
updateprostate
noncurable
radioimmunotherapeutic
gap15r
tnfrelated
disinhibit
methodsmaterials
sequencingradiotherapy
sylhet
rangpur
nonlocals
nanopatch
microprojection
arraythe
ipvs
needlesyringe
tipv
purposebuilt
evaporative
drydown
dantigen
ipv1
ipv2
ipv3
cyclodextrin
httpswwwcdcgovvaccineshcpaciprecsindexhtml
httpswwwacponlineorg
httpswwwaafporg
httpswwwacogorg
httpwwwmidwifeorg
httpswwwaaporg
childhoodadolescent
omissions
belgiumstreptococcus
23serotypes
budgetimpact
83000
52000
7584year
171000
201000
338000
negotiating
marketconform
studyimmunogenicity
1825years
016month
01month
02month
cmia
9831
8837
8519
42746miuml
8974miuml
8980miuml
virotherapyoncolytic
tvecs
factornodular
sv
eradicationmetastasis
ppix1mt
ppix
caspaseresponsive
aspgluvalasp
devd
hospitalistsince
hospitalists
caseoriented
hospitalist
krakow
myslenice
lifethreating
conduce
harnass
learnings
spainobjective
obstetriciangynaecologists
assir
secondthird
13132
warsaw
unconvinced
profilesintroduction
apprimed
dtapprimed
4163
7983
wpprimed
th1dominated
wppriming
dtwpprimed
pilvax
vaccinespeptide
pilus
pilm1
324339
spy0128
pilm1ova
peptidevaccines
miceeffective
egfrcar
41bbcd3ζ
exhausts
defectnk
intermittently
il15dosing
mesotheliomabackground
disputed
cisplatinpemetrexed
ifct
maps2
recommended1
poisonings
mazowieckie
opolskie
4879
5759
45325
4621
5080
4747
periodicity
2015introduction
niphnih
sanitaryepidemiological
glmeemsal
hmena
hmenahmena
11a
hmenahmenaδv6
ceca
lowdosage
diseasesalthough
highdosage
simulationsvaccines
mutating
immunotherapyconventional
stasis
medic
immunotherapymechanisms
coopting
hostvirus
ido1related
inflammed
microenviroment
idotdo
navoximod
sup212
pblabeled
b7h3targeting
modelsintroduction
37696
pb37696
scatchard
pdac3
cics
dissociated
tumorspheres
cicenriched
isotypematched
pbf3c25
panc039
017070mbq
coinjected
tc37696
if3c25
tumorsphere
217nm
bindingsitescell
140±21
idg
65±09
64±18
39±09
hotwe
trp
vanguard
blunting
redcap
4187
hospitalrelated
physicianrelated
yellowjacket
thermofisher
yjv
nonsar
wholevenom
spiked
077097
076096
047076
p106
antibioticsbackground
60415
fillings
n35334
n25081
124133
066087
condensed
hypersensitivityvaccineassociated
090184
γt
sterol
therapymodel
selectionintact
exquisitely
adept
antibodynuclide
radioimmunoimagingtherapy
iidriven
modeltaking
smhcii
cd4ctla4
aefv
araraquara
juarez
numerator
denominator
11310000
p0491
hypotonichyporesponsive
4110000
1510000
eirbased
gata2
hrd
watersalt
sensitizationobjective
alustal
jsc
mechnikov
biomed
stallergenes
psychoemotional
studieswith
pushed
conscientiously
rife
panacea
pigtohuman
xenotransplantationrecruitment
cellporcine
pec
antipig
transmigration
pecs
pigtonhp
nhlb
bnhlbearing
chemotherapytreated
nhlbearing
choptreated
lymphomaspecific
outcomesthe
500cgy
nontbiconditioning
tbiconditioning
appendicitis
neutropaenic
mel200
kmel
36mgm
patientpreferred
27mgm
ofvery
reviewdevelopment
dchn
leukemogenic
drugsobjective
dysregulations
expertvalidated
usergenerated
httpswwwvcellsnetmelanoma
fishvaccination
targetfish
hydrostatic
biomedicinehigh
hhp
biomedicine
orthopedic
chimerismsuccessful
drugbased
fcrx
routing
r848adjuvated
vaccinationmost
tlr78agonist
r848adjuvation
immunestimulating
tale
2018using
3c2a
t131kr142kr261q
ci14
ci38
lineagemismatched
crosslineage
costimulators
phenotypeacute
28zcart
bbzcart
28bbzcart
endow
1982
2625
quadruplet
agentcontaining
2018124207585
myelomato
aara
arara
rfi
behaviourrelated
predesigned
interrelation
interrelationships
conditionsa
livevirus
prrsvassociated
623kgpig
9801kg
9178kg
antiprrsv
haemostasis
prostacyclin
huvecs
brdu
fibrinolysis
nospecific
ifnβ1a
ifnβ1b
vegfinduced
capillarylike
ifnβ1btreated
urokinasetype
inhibitor1
fibrinolytic
thromboresistance
prospectswith
inspiring
cancerchemotherapy
cytotoxict
ab0incompatible
ab0i
at12
1585
mlmin173
graftbackground
ab0compatible
il2antagonists
initio
recipientsobjective
antimetabolite
8985
6877
1611
11542
1183
postlt
childreninfluenza
uslicensed
preventionadvisory
httpswwwcdcgovvaccineshcpaciprecsvaccspecificfluhtml
httpswwwcdcgovfluprofessionalsantiviralsindexhtm
metaanalysisthere
543311
rr106
074151
rr066
030147
rr111
076161
rr087
079096
rr138
060316
hradjusted087
075101
treattotarget
factoralfa
decisionmakingan
avs
voiceover
powerpoint
sparks
ipt
cellsµl
micepseudomonas
proteolipids
paomvs
immunityin
selfnonself
premises
coin
cellsfor
mhca
autophagosome
erbb124
neratinib
fellowtraveler
autophagosomes
proteinssignaling
autophagic
melanomatumor
factorbfgf
bfgf
cytotoxictlymphocytes
saponinliposome
alginateencapsulated
bfgfspecific
cisplatinloaded
nanohybrid
1stage
implantassociated
osteomyelitismethicillinresistant
orthopaedic
antiglucosaminidase
antigmd
usa300laclux
screws
postrevision
explanted
hardware
65fold
osteolysis
osseointegration
orthop
3615901598
childrenin
pseudovesicles
verdict
liability
meanin
ecj
abovenamed
circrna
immunotherapynoncoding
ncrnas
circrnas
emphatically
zambiaunassigned
424100
578043
us041
maximization
injurythe
dissimilar
21120
hyperbilirubinemia
centrilobular
plasmacytosis
microabscesses
zoneselective
studysexual
1374
2589
studyyounger
19897
20032012
nonbiologic
intestinemultivisceral
retransplantations
kmm3
200mm³
retransplants
nonsurvivors
intestinalmultivisceral
patienttreatment
peptideguided
radioreceptor
ct4cn1cm1
osseous
pd1ctla4
paragastric
dedifferentiation
knowγδ
jawed
hypophysitisimmunotherapyinduced
hypermetabolism
64yearold
convex
noncontrast
impoverishment
countrieswith
accrue
distributional
authenticate
archetype
autismmyths
controversiesdespite
mercury
frustrated
mercurychelating
resurgent
extinguished
flourish
truths
glycocode
perceives
glycanbinding
cohortobjective
hctciage
kaplanmeiers
discriminative
japanlow
shipped
preprogram
packages
fictive
390000
0035pregnant
womanweek
cohortborn
211533000
75423000
6000qaly
270013300
16000qaly
94000
icer1frances
gpdcapita30000
youths
188205
serosusceptible
foxo1
aktdependent
mannertherapeutic
aicd
til13838i
cd57
exhaustionpd1
pi3kakt
ablates
swog
s0801
postinduction
1·4
tositumomab
nct00770224
8295
leucopenia
renalcell
beasleys
1981
preventionthe
beasley
22707
advancedinoperable
usbound
vpr
nonvprparticipating
australiawhile
nontimely
skai
interventionintroduction
reassured
carematernal
monash
universityaffiliated
midwifeadministered
carolinaobjectives
ncir
zip
zctalevel
procam
healthwe
n2697
hhb
mhb
ailments
taps
r0437
pathanalytic
superstitious
effectivethe
73yearold
cancerlaparoscopic
hemicolectomy
tub2
pt4b
pn1
sh0
sm0
ly2
v0
xelox
coursesfolfiri
panitumumabpmab12
perioddecember
gastrojejunostomy
abdominalct
mfolfox6
pmab
clinicaltrialfor
diampmediated
δcnpb
vaccinationcyclic
diamp
pathogenhost
phosphodiesteraseencoding
cnpb
bovisbacillus
cdiampassociated
cgas
rd1
prd1
cosmid
agv
essen
trialthis
3574
2692
4549
9963
056iuml
1671
1385
1680iuml
1862iuml
worldmeningococcal
predominate
interdependent
involvementbackground
crossintolerance
h1antagonist
nsaidinduced
niua
nsaidexacerbated
30120
melanomawithin
hijacking
regain
antic5a
earlyintermediate
degenerationpurpose
5a
cfh
cholesterolenriched
cfhhfc
4c9
rpe
electroretinograms
subrpe
hfc
choroidrpe
amdlike
moleculesmechanisms
pifa
±95ci
2015052ep
hrec15wchn162
35230a
hrec15schn405
nct02490007
surround
immuneinhibitory
il12induced
292034
berraondo
2716
turkeybackgroundaims
cryoablationinduced
malfunctioned
environmentseveral
stimulant
nanocrispercas9
stageprevention
reinforces
intervened
infectionattenuated
lpai
salha
salm2e
salna
salhasalm2esalna
salm2esalna
phenobarbital
dress
epilepticusunassigned
phenobarbitalinduced
pentobarbital
punch
seizurefree
contradicted
investigationobjective
presuming
counterproductive
5323
reactance
impingements
disgust
individualistichierarchical
worldviews
conspiratorial
vaccination：a
19952017
veefficacy
5690
trials，63
3679
6590
56244
4717865310
102104
1891287
108166
childrenebvctl
ebvctl
psot
antigentyped
intestinalliver
liverkidney
12144
2107
cetuximabbased
cellsinjection
triweekly
chinalymphoma
chidamide
settingsrecent
regenerating
mart1specific
antigenhla
haplotypehomozygous
asthmadendritic
metabolismbased
hmgb1tlr4
axismyeloidderived
endproducts
rage
immunotherapyit
preidentified
custommade
noncustomized
immunoenhancing
cgenriched
cpga
ligandand
antiox40
proteinsafrican
asfv
nonpermissive
hladpb1
depletionwe
hladqb1
hladrb345
dpb1
dpb
hostversusgraft
hvg
antagonistsadoptive
antagonism
vasoactive
beadmediated
anticd5
antagonistexpanded
2017tickborne
antitbev
igmigg
ns1
2015for
rsvvaccination
immunisationprogrammes
rsvassociated
yearsold
ca2500
medicalcosts
caeur
infants3months
hyperphosphorylated
tauinduced
coaggregation
ptau
43d
15μginjection
autopsied
unilaterally
timedependently
templated
thioflavinspositive
thioflavinsnegative
ptauinjected
milkmaid
siteagnostic
urticariasummary
cox1
necd
reactionsummary
cellandor
expectedparadigm
inhibitorsbrain
meager
protein1program
difficilec
communityassociated
malignanciesnatural
voice
ivr
nonportal
ehrdocumented
106135
102130
nct02266277
httpsclinicaltrialsgovct2shownct02266277
dpc
irradiationpatients
60261
allo
ophthalmological
breakup
schirmer
osmolarity
biomicroscopy
ophthalmoscopy
ogvhd
graftvshostdisease
iccgvhd
ded
1331456
hairy
turnoff
isdsct
170393
142249
055090
diseasefreesurvivalleukemiafree
survivalrelapsefree
dfslfsrfs
108162
103152
antithymoglobulin
efficacywe
monosensitization
lipocalins
furry
albumins
dogsensitized
oxaloacetic
gotast
pyruvic
gptalt
bilirubin
antihiv12
italians
gpt
1389
588mgdl
85days
2039years
cartcrbased
approachadoptive
gtmps
dktk
paulehrlichinstitut
academiadriven
superantibodies
frayantibodies
hlafully
metachromatic
leukodystrophy
pakistanpakistan
journalistic
conflictrelated
192202
5253
highinsecurity
bcelldepletion
contextprevious
llpcs
aidcreert2eyfp
antibaff
nzbw
llpc
chitosandna
trueperella
ppcfncpgcsnps
plo
cbpa
nanh
9358nm
527mv
fourchimeric
tp7
reviewsbackground
religiousideological
uvgs
trusty
respects
uvg
closeknit
havehad
anthroposophists
irish
nonseverity
rtrelated
icinaive
1programmeddeath
reformation
cellnatural
outfits
generational
concludes
upgrades
calvesa
bvdv1a
pi3
5050
soybean
hulls
tdn
drylot
sexpen
7x
mondays
wednesdays
fridays
fescue
jugular
pre3x
pre7x
pos3x
pos7x
dmi
epitopeenriched
hoststo
proteinsnucleoprotein
m2by
evolutionarily
ad5tetm2np
npresponding
cd44poscd62neg
extraordinarily
heterosubtypes
chinaintroduction
measlesmumps
mucvs
clinichospital
logs
2370
onemucvdose
pauciallergen
pauci
rcss
minirhinoconjuncitivitis
mrqlq
pauciantigen
gravisexperimental
nicotinic
achrs
bacterially
stateintroduction
riskstratification
carcinomafew
gemini
checkpointsindoleamine
kynurenines
coincidently
monotherapeutic
astrological
ido1dependent
dispensability
ido1targeting
cancerdue
socialeconomicdemographic
14232
3th
hadera
arab
glycoconjugate
womenobjectives
crm
nct01446289
anticapsular
1µgml
placentally
urth
trialallogeneic
tdt
pesaro
mitesobjective
southsouth
npeoc
supervisors
3078
hfs
139430
akwa
ibom
personnel458
allocation17428
bayelsa
crossriver
edo
akwaibom
withdrawals
hikes
inefficiencies
twosignal
activationpatient
unconcentrated
l1derived
hepaticainfected
epitopesfasciola
antihelminthic
rmfhcl1
fhcl1
1931
situated
propeptide
120137
145155
161171
lowandmiddle
interfaced
20032013
regionspecific
influenzastrain
i4183qaly
i1505qaly
i80966qaly
forvaccination
metaanalysisobjectives
mai
1467
129322
033122
081115
catalonian
recommendationsobjectives
2033465
individuals50
1012015
semfyc
789098
5031
5059
6069
7079
in80
semfycs
corporative
abisco100
hmpvinduced
hmpvn
igg2aisotypes
th1th17type
pdm09
200405201415
gpdensity
rr089
082096
7074
rr118
95ci114124
rr134
95ci128139
methodbone
gcms
fingerprinting
glucose1phosphate
4nitrophenol
acetanilide
loganin
caffeic
linoleic
oleic
19962013
standeosinophilic
eotaxin3
reslizumab
qax576
antiil13
syktargeted
retinoblastomaobjective
syknegative
mcf10a
htertrpe1
sykpositive
rby79
sykoverexpressing
sykdcctls
syksilenced
evaded
sykdcctl
carboplatinresistant
outcomesacute
bmr
or32
pvalue001
pvalue006
483915161
285013150
577622224
pvalue04
nutrientoxygen
acidosis
erratic
thwarting
35million
250000
gerontological
jages
12231
14091
aged65
elders
asb4
noncscs
hlaa24
35869
1991625
2841
3144
56288
1295
1877
24814225
17cell
mechanismsupon
17cells
delete
detriment
divisions
servicespecific
rajshahi
sara
1864years
2us
28301
researchoriented
perspectivechimeric
pharmas
antigenreactive
cellsstudies
explosive
colitisenteritis
amylase
elastase
anticipation
flavors
ivregulatory
antitregs
treatmentuse
sensorresponders
testify
tnfbased
immunityaim
antibodycytokine
f8il2
f8tnf
evanescent
mewds
photographic
photopsias
vaccinatein
knowledgedeficit
patientscytokineinduced
nklike
rs3092920
rs3092952
rs3092936
statinbased
thrombomodulin
thbd
ccct
exosomessmall
soundincipiently
pollenbackground
gramole
ole
134years
035kul
5287
allergencontaminated
nonvascularized
highsafety
24g
designobjective
wellinformed
nontheoretical
beyondimmune
drugintensified
interventionhuman
thru
creightons
futureas
nemaline
codonpair
deoptimized
challengeinfluenza
wiv
deoptimization
cpbd
inappreciable
gim
januaryjune
or2
denial
stocks
n104
plurality
profiting
childlevel
zcta
norwaybackground
interferonγmesenchymal
mscinfused
ifnγprimed
ifnγjanus
jaksignal
idooverexpressing
ifnγjakstat1
solanezumab
minimental
mmse
florbetapir
14item
adascog14
2129
1057
1072
eli
lilly
expedition3
nct01900665
allergenplatelet
igedependent
futureimproved
districtspecific
pmp
118yearolds
30year
6390
7793
us51
us236
us490
us188
us97
us626
us246
us53
us703
simplifying
tractability
betweenserogroup
organizationrecommended
cartchimeric
tumorevolved
igesensitizationrespiratory
igesensitization
tagged
lungsthe
ilc1s
alloantigen
transplantationdurable
recipientderived
mhag
healthcarebased
greylit
worldcat
2350
0821153
5078
278512484
5031031
12524
960617138
perenrollee
11783608dose
processingreliable
cellmanufacturing
dld
diamond
microposts
tcentral
ficollhypaque
ficoll
surgerywe
reddened
immobile
tubercle
anesthesia
onesolution
1solution
nonirritant
mlh
15minute
1777
nonplatinum
nanoradioimmunotherapy
radionucleotidelabeled
bioorthogonal
dibenzylcyclooctyne
dbcofunctionalized
αcd20
dualfunctionalized
dendrimer
strainpromoted
azidealkyne
radionucleotides
vaccinationlichen
ldes
uncommonly
lde
eradicationfor
cooptimization
microchambers
11plex
cellt
ni
designmethods
2013october
244660
spanishspeaking
nis
saying
brafv600especific
melanomat
mhcpositive
ccrk
immunotherapycyclindependent
cdk20
cyclerelated
perturbed
cdk2
keap1nrf2
cytoprotective
selfreinforcing
concordantly
bend3
u14
carboxyfluorescein
csfe
propidium
nih3t3
bend3induced
huvecinduced
180kd
220kd
130kd
endog
cirrhotic
debuted
cystrptrparg
cysarg
redoxresponsive
octamer
peptideova
oxidization
thiols
interpeptide
denser
condensates
lowmolecular
vaccinecondensing
disordersallergic
eaters
cellsregulatory
targetasthma
remodelling
neutrophildominant
nonvaccinating
parentsdespite
commitments
protest
nonslum
slumspecific
homerelated
distancing
simulationbased
3055
antigenmodulation
mechanismsantid
amis
antid
amisinducing
rbcs
251349
duffy
hodag
hodrbc
hodrbcs
trogocytosis
embodiment
incurring
transplantationnatural
19q
cd16binding
italysince
aifa
4000000
notclassifiable
classifiable
propter
interobserver
considerationsearly
hyperprogressors
dialysate
adriamycin
nephropathycell
pms
coimmunosuppression
responseobjective
2325
unclassified
ibdu
488562
330429
ucibdu
5395
445562
267429
063297
156171
88217
028only
p0001where
5369
2287
30196
n385
491587
27102
antitnfs
itositumomab
swogs0016purpose
s0016
choprit
iodine133tositumomab
benchmark
onetoone
surgerycik
surgeryonly
antibodiesmyasthenia
fluctuating
fatigable
iglike
igg4specific
variablesthe
hladp
bx
kir2ds2
cmvseronegative
hladrhladp
officially
institutionalized
696728810
vaccinee
typesbackground
4264
flou
granularity
r20428
r22768
r19257
r22490
respiratorynonrespiratory
appendix
immunoablation
reviewalemtuzumab
pks
cd1920positive
leftsided
hemihypesthesia
gadoliniumpositive
ringenhancing
bcellmediated
infantswe
19962008
novembermarch
analysiscolombia
downwards
presentationbased
uplift
games
exante
pvir
subhumid
pprfree
humid
militaryhuman
enforces
6–7
antigd
ch1418cho
neuroblastomabackground
lti
10×10mgm
d818
6×10
ium
160mgm
13cis
d1932
sil2r
scil2
d812
d13
d11
dependencedifferent
addict
microbiotaregulated
kpd
3way
samsung
centeras
preconditionings
difficulttomatch
hardtodesensitize
multiway
10794
pdligand1
cytotoxictlymphocyteassociatedantigen4
g345
progestogen
nonevanescent
progestin
luteal
supraphysiologic
allergistimmunologist
tnfil23il17pathway
erythrodermic
cdkn2a2b
0699
072003
ligationdependent
ikzf1
pax5
btg1
ebf1
etv6
primer
radiologistsimmunerelated
recurrencebackground
anestheticinduced
hypothalamicpituitaryadrenal
hpa
sympathetic
ketamine
thiopental
propofol
volatile
lidocaine
hpaaxis
menmen
ymsm
shcps
1624
6782
4071
shcp
2749
5510
cyclepancreatic
designcellular
contextindependent
canceruse
chemokinemodulating
agentsthis
ckm
elispotbased
nonmanipulated
impregnated
insecticide
brazilalthough
insecticideimpregnated
ef
collars
diseaseheart
yearsaim
wellcooked
spaghetti
ninemonth
61186
94100
ω5gliadin
immunologythe
diseasetargeted
talen
fluorophores
seated
fluorophoreloaded
ir7lipo
hacpg
livedead
bpx501
mechanogenetics
remotely
piezo1
mechanosensor
activatable
ultrasoundactivated
jurkat
remotecontrolled
ratesbackground
immunizationfocused
epoc
countriespatient
autodialer
138625
participantsthree
singlemethod
27734
7772
11947
9120
81100
participantsbased
31099
30868
9265
59328
8065
cashew
nut
challengesbackground
cn
cnspecific
boysmen
girlswomen
5788
kual
amine
sec
18228μgmg
1190μgmg
9196
iggbinding
bolivian
7098
6281
5089
incessantly
iae
acpa
iaes
disadvantagehpv
gardasil©
ethos
269821
ethoses
cgytbi
kmm150this
responsecomplete
nct01923935
researchbackground
antipd1immune
2014to
349publications
17references
1in
doseadjustmentbackground
weed
0429
0364
nofatal
diagnosisbackground
callose
botanical
crddirected
876
mugwort
hazelnuts
crdguided
aittreated
1773
16219390
vfr
backpackers
randomparameters
mmes
diseasevaccine
vaccinepairs
forumbuilding
gvirf
ein
electronical
smd099
065133
smd034
002067
smd115
011220
smd098
055142
smd069
032106
proalbumin
smd073
033114
syndrone
089days
014060
lhs
chemoimmunotherapyspurred
dormancyimmunotherapeutic
22nd
meeting2nd
labex
igo
nantes
actualités
immunograft
studyneisseria
nct02173704
4cmenbroutine
nada
nhba
9299
841963
172315
101136
515years
2208
016months
9565
9967
9759
9105
9987
9966
9821
59y
1015y
of1015years
campinas
unicamp
pneumo23
rrts
rrt
haplomismatched
donorsthe
400mgm
1600mgm
64mgkg
5mgkg
492
propatienttrialbackground
acetylcholinereceptors
achrab
achrabtiter
qmg
antiinfluenzaelisaantibodies
clinicaltrialsregistereu
200600437427
60±233
28±220
008±027
011±031
hodgeslehmann
0·00
p079
uprating
acceptanceaccurately
politicize
legitimacy
biologists
liberals
conservatives
sirpαcd47
therapyinhibitory
signalregulatory
prophagocytic
gsks
2500g
prematuritylbw
diphtheriatetanusacellularpertussishepatitisbinactivatedpoliovirushaemophilus
influenzaetypeb
2017many
funders
implementers
immunotheraphy
takayasu
ovalbuminexpressing
3×2gy
normofractionated
testable
anthropologists
partyreducedintensity
rist
3170
atgalg
3159
syndromevenoocclusive
busulfanmelphalan
ewing
sarcomathis
p00674
p00496
ccp
5week
guidelinesbackground
girlsand
candidatescreening
bivalentquadrivalent
24vhpv
commonlycited
24vhpvvaccinated
22000
105132
impactson
deny
elder
bedsidehead
virusthymidine
gendicine
oncorine
cellstherapeutic
microrods
anticd28
apcmimetic
apcms
dynabeads
anaemiawe
7101
2000±033
600±012
1400±036
2590±071
251±006
692±025
835±54
bucyatg
dtapipvhbprpt
monthsobjective
hexaxim
2477
2442
965
posthb
pakistannational
humanpapilloma
clinicaltrialgov
004859
074320
0109
079325
immunoengineering
exquisite
warning
immunevascular
reconditions
strategiesreduction
fludarabineivbu
flutbi
loweggallergen
serumbackground
nolow
nle
omspecific
iga1
iga2
203c
igg4omspecific
iga2omspecific
melanomaa
intraindividual
n116
n166
hdmsinduced
patientshuman
highriskrelapsed
highefficacy
578fold
menbackground
n150
populationtargeted
individuallytailored
b034
b015
all44
nct02835755
kbtbd2
modelnatural
kelch
poz
2kbtbd2
teton
inducibleexpression
4ebinding
kbtbd2expressing
medicinestings
venomspecific
citybackground
glaring
nonprobability
5909
n156
n165
2812
3178
3442
2131
1065
il23r
il12b
therapystudies
il23stat3
il12stat4
pathwayrelated
rs7574865
ci137
102185
pper0036
208fold
ci208
114370
pper0017
rs11209032
gggenotype
rs744166
transplantationantithymocyte
n195
p0334
p0712
p0897
p0980
recommendationsintroduction
macrochimerism
tolerancecurrent
1020years
pharmacistswe
antimers
transchromosomic
singledoseescalation
sab301
bodymass
mlmin
2·5
nct02788188
2·3
3·3
albuminuria
creatine
27498
μg×days
marginals
interferencebackground
equationbased
implausible
combinationno
rfhcl31cl32cb3
rfhcl32
inhibitorsmalignant
checkpointmodifying
nct01272180
1m
24m
36m
12m
4cmenbprimed
29100
compliantbackground
futuretime
0047
egg1y16212
miceaims
egg1y162
egg1y1612
ptotoscolicidal
619aa
6482aa
106119aa
egg1y1621
egg1y1622
protoscolicidal
pumc91
t24cells
atcs
anti‑cd28
heteroconjugated
anticd3xantiegfr
egfrbiab
anticd3xantiher2
her2biab
egfrbiabarmed
her2biabarmed
biabarmed
psoriasisintroduction
perusing
sarcoidosisintroduction
m1m2
m0
dermatitisbackground
alumprecipitated
popliteal
ivdk
20012015background
dts
ocd
20012015
methacrylates
acrylates
2hydroxyethyl
2hydroxypropyl
methyl
ethyl
ethylene
dimethacrylate
diurethane
dudma
palladium
l19tnfα
l19il2
j558l
20h
microvessel
cd25low
cellcd25high
cd4cd25low
l19tnfαl19il2
pd1t
pdl1myeloma
tnfαinduced
l19tnfαl19il2mediated
micecombination
orthomab
unlinked
distilling
bortezomibbased
resultsaprior
bortezomibtacrolimusmethotrexate
tacrolimusmethotrexate
bortezomibsirolimustacrolimus
01754389
statusobjective
participatory
seattlebased
visitspecific
surveyin
1636months
214479
111243
103215
131319
turkeyhepatitis
firstyear
daysummer
stateunassigned
campers
requirementsrecommendations
hyperlink
9question
campersstaff
requiredrecommended
policyprocedure
inactivatedoral
ipvopv
chicagoserogroup
studyradarof
imdrelated
reportfive
nct02240888
jecv
jecvprimed
philippinesclinical
nct01190228
viruscontaining
outbreaka
outbreakassociated
mumpsrelated
thirdtrimester
concentrationsobjective
2730
eightyeight
coefficient085
p13
bioconjugation
immunotherapycell
membranecoated
stellated
immunotherapystellated
limitationsintroduction
preventableobjective
ombudsman
twosource
v6
v8
06cm
25cm
awmf
sigg
81fold
122fold
sigesigg
igefacilitated
malignanciesthymic
merwt1derived
isa51
3monthprotocol
thymomarelated
von
willebrand
networkinformed
endangered
hawaiian
monk
sealswhere
spreaders
populationscale
modelinformed
seal
idealized
deviating
seals
lowerpriority
raceadoptive
frontrunner
surmounting
school1
mississippi
melanomasdesmoplastic
5781
nf1
nondesmoplastic
2964
difference151
ci016317
ci5691664
hr069
ci052092
ci069099
ci048092
difference0323
ci01100536
hr094
ci074118
p059
precipitous
antifibrotic
immunotherapyout
il2antiil2ab
il2c
reexposed
il10secreting
submaxilar
recommendationsrates
constitutionally
traitasthma
5rα
revolutioned
β1a
β1b
knowledgeintroduction
lowdosefrequency
highdosefrequency
chitins
hdmdriven
derp12
bal
hdmscit
derp12scittreated
derp12scit
ccl17
eotaxin
perk12
mekerk
immunodepression
sids
strokeassociated
sapin
sai
weakens
sap
postmmr2
3892miuml
perseverance
cll1
ctype
lectinlike
cll1specific
stationary
2060
betterthe
presumptively
exemplars
calltoaction
•despite
•according
53000
•first
•it
•finally
sexualization
misplaced
•the
infectionwhile
nkg2dnkg2dl
immunotherapynkg2d
nkg2dnkg2dls
nkg2dnkg2dlbased
immunotherapyalthough
fecundability
diseasean
8200
scca
dominantnegative
dnrii
epstein
barr
cellsm
dnriiexpressing
dnriilsts
lmpspecific
unmodified
tgfβresistant
luan
polyglutamide
pglu
tetraazacyclododecane14710tetraacetic
duallabeled
auger
electrons
hydrazine
hynic
aldehyde
succinimidyl4formylbenzamide
s4fb
chromophoric
bisaryl
hydrazone
350nm
24500
mcpspanitumumab
panitumumabdota
saturable
egfroverexpressing
mdamb468
nmoll
5560
13idg
33idg
preadministration
egfrmediated
35fold
iggdota
microspectct
dotaconjugated
rns
cp7e2alfsuccessful
hightomoderate
cp7e2alf
screeningconfirmation
phlei
pigsinactivated
yorkshire
8014±029kg
6six
35×10
7×10
14×10
21×10
unitskg
longissimus
dorsi
monounsaturated
mufas
pufas
elovl6
scd1
hfabp
dtaphepbipv
egfrshedding
treatmentglioblastomas
egfr03115
celltiterglo®
postpit
ivisspectrumct
egfrviiive
ugandaboosted
misclassified
conversions
settingspregnancy
staffrelated
buy
clinicalinterpersonal
providerpatient
suppressorscheckpoints
deactivating
categorically
checkpointssuppressors
benchtobedside
efficacyimmunotherapy
subversive
immunotherapiesoncolytic
demise
culminating
ovbased
vaccinesdendritic
selftumor
believers
reconcile
providersintroduction
392677
48889
5766
br3
costimulates
platebound
br3specific
antibr3
shrnamediated
antibr3treated
br3silenced
antibr3augmented
parp1
gzcdc
8137
10351272
faith
9420
9488
4589
3895
2733
7713
forwardpregnancy
foetuses
latino
vaccinationsintroduction
phenomenology
trusting
trustingmistrusting
providersfacilities
mistrusting
sclerosissystemic
organogenesis
sscspecific
sscmodel
tightskin
bleomycininduced
topoisomerase
autoantigenreactive
connaught
stockoutsa
continueshomebased
hbrs
stockout
continuityofcare
effecting
metastasescentral
grave
solitary
uneradicable
carevaccination
invention
1796
siglec9severe
neutrophilic
mystery
acidbinding
lectins
siglecs
siglec9
siglece
uptakebackground
daytoday
n401
2392
cmpractitioner
nonmainstream
cmpractitioners
luxembourg
2012vaccine
unknowncryptogenic
studyautoimmune
encephalitisrelated
p0603
p0570
p0214
osteopontinfibronectin
immunopathologyelevated
thrombincleaved
osteopontin
opnt
fls
opntfibronectin
slamf6
slam
homotypicbinding
203amino
seslamf6
12738
syndromereducedintensity
n204
crfs
cellselected
alloric
blogsbackground
rubric
writer
112014
mentioning
22815
blog
activism
bloggers
importationsbackground
gpei
importations
pulled
wpv1
dollo
woredas
warder
geladi
bokh
majorities
92129
traveled
erupted
adolescentantibodymediated
encephalopathies
antibodydriven
nmethyldaspartate
psychoses
nonimmunerelated
drugspatients
tsdmards
pharmacistsinfluenza
6500
paperwork
behaviorthis
fairsatisfactory
republicobjective
it´s
annualy
prague
hpvnaive
lymphocytesbackground
3770
7122
patientsantipd1based
metagenomic
collinsella
aerofaciens
germfree
pbaf
switchsucrose
nonfermentable
swisnf
00071
pbafdeficient
carcinomaimplications
tcls
rcctils
mmtils
monooligofunctional
22235
1418
using17587
howeverthecumulative
patientswithoutmalignancy
years1and
nordic
rpsc
psc
1984
n440
colectomy
026094
115286
41128
31000
vcd
igmpositive
convalescentphase
iggpositive
acutephase
1284
17673
11668
6005
denguespecific
nct01373281
nct01374516
vaccinationmucosal
ligandantigen
bioconjugates
ligandmediated
atgam
dbmt
complexmismatched
antidonor
langerinspecific
5dayold
villi
igaspecific
cellsovarian
ocps
ascitesderived
ascitesnk
protumourigenic
ocp
apcbased
logscale
cyberphysical
studytargeted
holy
grails
cyber
cyberdirected
fullrange
adc7me
damagethe
arboviruses
prophylactics
adc7
crossneutralize
especific
zikvinduced
malformations
cancertnbc
conferenceon
1400
fourday
©2017
mwanza
10iuml
1518±148years
8793
567iuml
408137
6396
4713iuml
6333
399iuml
antigd241bb
142288
471months
14g2a
gd2bbζ
gd2expressing
334fold
05fold
gemelli
neurosciences
vegfrtyrosine
vegfrtkis
hla1
basedmodels
citrusderived
neohesperidin
preselect
citrus
reproduces
detentioninternational
ihms
seeker
adultsimportance
20038
30084
60yearolds
epubs
vaccinesunassigned
immunogenicitypotency
24°c
58°c
454°c
±standard
ebonyi
anambra
abia
0793±0051
1621±0015
1715±0081
1793±0051
1683±0078
0857±0037
1400±0030
1391±0032
1339±0037
1405±0066
1279±0025
bartletts
variances
nonprotective
ibadan
motherneonate
immunochromatographic
piat
npiat
279±34
2033
2700g
17603300
p0001the
123399
1168
4052175
smsreminder
literatureimmunization
gvap
careseeking
improvementunassigned
espouse
crosslearning
onthejob
assignments
bvertical
hepbbd
nonnationally
hepb3
innovationsdespite
follower
20032005
h2h
epilink
regionperiodic
regionimmunization
timingthe
vaccinevaccination
insurmountable
marathons
sprint
selffinancingsustenancenigeria
us4263m
tiered
levies
telecommunications
airline
hotel
beverage
taxes
crowdsourcing
cofinancing
subscribers
levy
364928938
1789651
128271990
745090626
52890326
796628726
1789652
approachunassigned
coxproportional
kinshasa
diphtheriatetanuspertussishepatitis
cityprovince
kinshasain
wasbelow
1513
hzs
countriesunassigned
forprofit
notforprofit
faithbased
3219
11613
8698
9096
1444
regionunassigned
andto
whounited
populationweighted
2015and
mcv2
hhs
volta
accra
gar
defaulter
94vr
76gar
uneven
pcv3
cancerthrough
tnfr2blocking
m861
interferonγpositive
tdepleted
semiparametric
regressionhpv
sapovirus
posav
reassortment
maternallyderived
complexalthough
3wk
yearseason
peptiderelated
a0201positive
rnf43positive
agroeconomic
parasitizing
annulatus
amblyomma
mixtum
parasitism
infestation
babesiosis
anaplasmosis
acaricides
antitick
bm86
bm86based
exposition
acaricide
scarification
bhp
2156
2115
1091
7521585
152581
3mm
3692220
1961145
natures
surer
bacteriavirus
miceanticancer
mrb
monocytogenesmrb
admrb
researchpurpose
ppvs
exposureoutcome
qba
1000100000
rr050
replications
nondifferential
sensitivity95
specificity99
biascorrected
rr200
rr133
ppv34
rr183
ppv83
ppv90
fiction
trialin
enfer
noninfected
trappings
239230
201199
glm
cloglog
ci6582
infectiousness
r0122
r1050
seermedicare
leadtime
172285
23084
10927
9338
2819
3024
participantsintroduction
1510
rankings
pdl11
pdl110
nivolumabobjectives
umin000024414
4986
2810
squamousnonsquamous
0123
7265
91days
noirae
36127days
002037
004146
hospitalsobjectives
immunecheckpointinhibitor
365±034
directionsmajor
egfrdriven
uninflamed
rovalpituzumab
tesirine
rovat
materiais
conlusions
dll3high
dll3low
nct03086239
nct03061812
nct03033511
chemonaïve
okayama
1404objective
egfrtkis
40mgday
30mgday
dlt
unfeasible
corticosteroidresistant
reporteffective
ccr6
mdr1
rhodamine
123excreting
reduced35fold
malpractices
photosensitized
changesnearinfrared
photoabsorbing
hyperpolarized
fumarate
photoacoustic
deoxyhemoglobin
remissionbackground
hidac
intermediatedose
5876
036098
2522745
validationintroduction
vhs
twofactor
m198
sd072
m307
sd095
η
worded
responserecent
hif
hypoxiaindependent
alluring
hopeless
oncourology
3trials
inhibitorsrecent
strategiestumor
inhibitions
pdl1…
pathologie
exotique
convergences
divergences
sclerosisprogress
mstherapists
wheras
microenvironmentmedical
interrupts
modelchemotaxis
amg487
adultshaplocord
haplocord
n68
n41
p84
maintenanceguidelines
immunopharmacogenomics
neoantigensutilizing
tumorspecificity
epub
crd42017075331
19602017
dated
immunotherapyoral
oits
immunodeficiencyvaccines
brucellosisbrucellosis
2008200920142015
1392
in50
dateintroduction
implementable
il12based
modelcurrent
hgp1002533
ova257264
mistreated
complicationintravesical
fluoroquinolones
whoapproved
trcid
chromatographically
twosite
22202
verocell
cprv
214years
641
immunotherapeuticsenzymes
hinges
biocatalysis
gambling
experimentvaccination
analysisannual
riskgroupspecific
preconditions
incentivised
1248
20122013objectives
sociocultural
indias
dlhs4
ahs
1929580
noninstitutional
careunassigned
awards
bonus
70s
4867
5574
2544
bortezomibbackground
borhdm
n114
n53
bor
chinaas
h101
virotherapyrelated
orienx010
kh901
h103
virotherapies
effectscancer
coreceptorsligands
immunotherapytcell
switchmediated
exhaustions
costimulatorycoinhibitory
cancertherapeutic
426951
ruckerithis
295±2g
yersiniosis
16±2°c
72days
4100l
vulgarisa
erosive
amoxicillinclavulanic
gentamicin
6500mm
250000mm
dexamethasonecyclophosphamide
amoxicllinclavulinc
tid
reepithelializing
eschar
transplantationpart
hematooncology
icto
patientswith
cro
icto2017
biomarkeroriented
expitope
tissuesbackground
proteomewide
computes
bibliographies
3430
crd42016042409
sogsr
mip1β
syndromeso
pics
tops
intervent
lessoning
anabolic
retrospects
physiotherapy
reviewhuman
aesi
toaugust
25million
highlyfavourable
gadd45β
cancertcell
myeloidintrinsic
gadd45b
myeloidbased
127592
vaccinestransmissible
rtvs
vaccineimmunity
rtv
autonomously
dentists
n1209
or127
096168
or065
050086
5grass
rhinoconjunctivitisbackground
precoseasonally
01036
exhaled
foxp3positive
1531
1109
1243
jejusi
jejudo
kcdc
singlelabeled
sidelines
gamethe
neoplasiabackground
diseasescancer
livevector
asthmamesenchymal
immunemodulators
cellsdependent
exosomemediated
immunemodulation
kuznets
incomethis
stylized
therapiesunresectable
benchtothebedside
1951st
2015a
agedependence
agestructure
βcells
gipz
pspax2
pmd2g
stzinduced
streptozotocininduced
cd4tim3pd1
pmaionomycin
menobjective
n185
n138
coitally
redoubling
201011201617seasonal
411years
201011201617
inhour
outofhour
preprogramme
201011201213
postprogramme
inhours
038098
outofhours
027097
019075
sialylation
diseaseselfreactive
crystallizable
glycosyltransferases
attach
nucleotidesugar
diseasecurrent
endowment
virus1
administrationapproved
antipsma
immunoglobulintcell
receptorζ
pz1
tßriidn
pc3psma
psmaspecific
6158
psmaexpressing
timmunotherapy
factorß
psmapositive
oscillations
unpack
immunotherapyimmunosuppressive
receptorsligands
vesselspathological
tortuous
leaky
proangiogenic
angiogenesisassociated
vesselassociated
infiltrationtumoricidal
suppressionover
overreacting
tryptophan23dioxygenase
cancerinduced
nlg8189
incb024360
cyclooxygenase2
cancermyeloid
vitamins
alltrans
betaglucan
proteoliposomes
ephrin
antiinterleukin
microenvironmentin
tolerizing
renaissance
cellinfiltrated
alginatechitosan
iniae
vaccinationstreptococcus
serinerich
rsrr
microsphere
3674
paraffin
vv
stirring
1000rpm
cacl
9238
rsrrmicrospheres
siniae
virotherapiesoncolytic
postulates
antiov
ovmediated
ovinduced
pcv13objectives
etest
disk
whonet
6a
6d
109215
78215
27215
levofloxacin
erythromycin
156215
11215
breakpoint
cc3173
57215
cc9789
29215
cc90
28215
cc902
19215
nonsusceptibility
cefuroxime
ccssts
winner
treosulfanfludarabine±2gy
mdschronic
14gm
p49
treosulfanfludarabinelowdose
xeroderma
pigmentosumxeroderma
pigmentosum
xp
nasalspecific
122451
512789
nct03157505
usps
revisions
metanarrative
operationalized
shouldcould
vaccinatedthis
11702
nhfs
faciobrachial
dystonic
seizuresfaciobrachial
leucinerich
gliomainactivated
22103
eegs
989
00014
igg4lgi1
lgi1adam22
epileptogenic
timesensitive
impairmentawx323media15681705685001
implementationthe
mousehuman
miniantibodies
fullsize
chaperones
biopreparations
overviewin
illustrations
diseasesimmunotherapy
retarget
degrading
immunotherapytumorspecific
oralair
symptomscore
1368
2220
dedicator
cytokinesis
dock8
trialrecovery
100×10
300×10
plexus
neuralgic
amyotrophy
55yearold
girdle
sports
19961999
plumped
5924
10025924
21002
564922
8246
81002
1124922
6491
00025
11002
344922
8551
00261
stereotyped
micepurpose
syncon
microconsensus
twofisted
punchinducing
1190201
monitoringintroduction
reusable
pils
patientreportable
terminologies
bestperforming
synonyms
snomed
pil
canceractuality
careobjective
123item
4563
il33mediated
hypertrophyinterleukin
il5rα
adccsufficient
antiil5rα
ag129
challengezika
hek293
prm
pd1positive
responseof
cd4positive
cd25positive
10mm
mih4
mih1
highpdl1expressing
cd3positive
waikato
zealandobjective
cowlevel
firstmilking
prepartum
63281
152281
ci191212
ci173199
ci191209
calved
ci165184
8l
ci171192
ci183200
top1
mm398
dunnetts
tp53inp1
inhibitortreated
pigsobjective
vena
cava
monobloc
anastomosis
networksaims
cloud
searchable
bigdata
indegree
28122
4644
3986
5320
wikipedia
misused
outcomesbackground
intradermaldilutional
ttm
postmaintenance
5785
6266
micevaccines
adjuvantedvaccines
3393401
granulocytecolony
extractsintroduction
immunochemically
ames
doserange
depigmented
exposuredespite
dogtransmitted
ndjaména
phylodynamic
nprotein
rabiesexposed
parainfectious
growthpromoting
factorsnatural
gpfs
pleiotrophin
osteoglycin
ilt2
gpfsecreting
nfil3
decidual
rebuilt
nourishments
217799
gdpcapita
46daly
801daly
twain
meetthere
debateon
nmba
wwwnursingmidwiferyboard
govaunews20161011positionstatementvaccinationaspx
lym1
lymphomat
antigenantigen
epitopedriven
nodscidil2rgamma
rajiluciferasegreen
rajilucgfp
rhinitisthe
сycloferon
pollination
sagebrush
cycloferon
nebulizer
selfmonitoring
rhinoconjunctival
chromones
nextchronic
chc
ntcp
rnainterference
nivolumabpatients
16×10
petechial
plateletassociated
levelof
pd1on
selfreactivity
immunotherapyvaccines
reviewaim
productmoment
2792
0120
p0758
0397
p0436
p0955
r0394
p0440
r0806
r0941
recistdefined
directionssipuleucelt
ppt
mdasi
6min
6mwt
6wmt
mdasiwalking
est609
est161
auc077
060094
suspectedbackground
restung
reexperience
española
mastocitosis
25ngml
speculation
vittreated
2017we
3c2a3a
3c2a4
3c2a3
2015introductiontwo
rotateq
intussusceptions
1074
975th
percentiles
25th975th
8101378
3277
00010015
128362
891228
10459
770213498
251814
001015
yaounde
gynaecoobstetric
timelybackground
agesthis
9950
9436
lake
chilwa
propagated
shipment
microplanning
choltool
calculator
67240
us480275
us588637
us714
us875
us194
us355
us097
analogy
trichrome
cavan
monaghan
hospitalinfection
consultant
nchds
lymphomaassociation
lymphomais
60200
pel
plasmablastic
brentuximabvedotin
adcetris
ibritumomabtiuxetan
rituxan
interleukin5objective
acos
catsobjectives
calicivirus
72112
551726
53112
378570
1558
141791
0035
2310
54988
shorthair
14384
hyperactivitynatural
ly49a
ly49c
ly49d
stratagies
th0th1
erpr
bertucci
1231236
stagg
53169181
yu
environ
1468
mittendorf
24361370
14r48
diseasespatients
dystrophinutrophin
miceduchenne
dmd
dystrophin
135005000
duchenne
counselingbackground
counselingbased
5005
sb5005
19971998
cllour
nct00281918
nct00769522
nct02053610
4color
allelespecific
pbmrd
cancerimmunological
vaccinationnatural
agindependent
memorystudies
decisively
jobsnatural
beg
cattlethe
ks1
o180
2053
1304
subkebeles
fraction089
fraction084
rchl
metaanalysisjapan
obliged
pprotected
514905
95pi
831993
969996
114716
394971
597992
661975
877991
africacommunal
mpumalanga
76104
hired
herders
82104
nonsatisfied
inspections
96104
syncerus
caffer
3348
1939
sat3
168241
intervaccination
ethiopialumpy
4430
zebu
ox
1176
subsistence
2735
ido1tdo2kynahr
opportunitiesindoleamine
tdo2
kyn
nonderepressible
gcn2
ligandactivated
transducing
ido1tdo2
20062010background
registrythe
systemfor
20062010
620592
sd912
micehuman
hnp1
leishmaniacidal
amastigotes
pcdnahnp1egfp
pcdnaegfp
footpads
implicationsradiation
remedyimmune
molluscum
contagiosum
leukemiadisease
p0553
p0388
p0423
agentfree
idfs
p0407
p0311
clinicaltrialsorg
nct03150134
reportnephrotic
glomerulopathies
nephroticrange
g÷day
glomerulosclerosis
fsgs
mg÷kg÷day
hctassociated
interactionsimmunotherapy
threeparameter
diagrams
remit
polytherapy
ages2014
misreporting
3394047
9755
violation
1344
194934
025ml
fluzone
swiftwater
111964
7529165
9542
violations
3835
526110
rixensart
2509
208218
179179
biomaterialspolymers
vanadium
cysteinyl
leukotrienes
dietunassigned
shellfish
shrimpallergic
atrox
toxoidobjective
rattlesnake
hematochezia
diamondback
antiemetics
setter
prairie
catrox
inciting
microenvironmentionizing
oferadicating
ctgfe7
6gy
antie7
effectortosuppressor
landscapecart
critiques
developmentmanufacturing
middlehigh
17650
ratio127
118138
urbanschools
ratio110
proceduresbackground
noninception
paclitaxelreactive
subsidization
5y
kpy
365kpy
3469
1y
662kpy
184kpy
7219
7557
23y
34y
7403
45y
8744
5705
12y
7889
1886
8773
5178
clinicaltrialgovregisterednct01733862
canceroptimal
therapyinflammation
ilr
decoy
il1r2
il1r8
specksinflammasomes
pyroptotoic
sensornucleated
oligomerization
condensation
allornone
inflammasomeactivated
nucleate
speck
lymphocytesintroduction
rict
cyclophosphamidewe
unidirectional
kirligand
kirlmm
hematologi
transplantationdose
fb4
128mgkg
n1265
fb2
ft14
ft12
n168
p25
diseaseuntil
basophilderived
8640
10015
messmer
attentive
treobased
1326mghl
108lhm
797lhm
109676
098573
p0055
everpositive
alemtuzumabspecific
secondinfusion
treatmentcycle
depletedeplete
biologicalresponse
intentbackground
histologicallyconfirmed
4940
cellcytokine
4695
3955
4362
evidencewe
4265
rateno
bonetargeted
synucleinopathiesdementia
synucleinopathies
microglialmediated
pdgfαsyn
gpalone
gpαsyn
gprap
gprapαsyn
3045
immunitycd8
oxygendeprived
stocking
julyoctober
2016august
353482
miceheat
rhsp60antibody
1020μg
bacterialorigin
tritherapy
immunitybackground
ali
alimmcinactivated
vaccinecyclophosphamide
mmcinactivated
immunotherapyvaccinations
rebalances
th1th2treg
miscarriagebackground
urm
nct03081325
indiapurpose
diseaserefractory
seasonbyseason
6299
influenzaattributable
61107
5794
vaccinationjapanese
flaviviridae
eramonoclonal
bcellbased
2018831326
abackground
fviii
eds
001iuml
pednet
75th
120hours
p186
p085
glutenfree
nonceliac
sensitivitybackground
ncgs
n217
n1291
171310
204403
126264
186343
nongmo
usurping
abound
43000
scene
nct02643862
10·0
1·858·3
p0·0044
perparticipant
p0·0082
monogenic
foxp3mutations
week15
months25
594830
628958
unaddressed
15967
1835
ci047
or057
ci049
or056
ci046
tyrolean
facilitatorsbackground
n9633
4091
iil18
trucks
seroresponses
havseronegative
stateshuman
literaturevaccinations
thiomersal
indurated
precipitants
churgstrauss
thiomersalcontaining
cancerchimeric
anti5t4
disaggregates
5t4specific
systemclinical
vendor
specializing
accountable
costneutral
actcompliant
landscapefollowing
ostracism
ipilmumab
targetedagents
anus
resp
imunotherapy
cancerskey
cz
dro
mmci
00209805
amgem
bayer
paperssubmitted
2017accepted
responserates
remainkey
p031534
678a
publickey
imagingkey
approachintravenous
08mgkg
3hours
46hours
3700
4000μmol·minl
doseproportionality
noncompartmental
5s
inadvisability
testdose
expedite
syndromeobjective
cholangiocarcinomas
perihilar
extrahepatic
lsassociated
172months
nonlynchassociated
kynurenic
tsg6mediated
tnfstimulated
tsg6
cordderived
hucmscbased
idomediated
kyna
boosterpriming
japanequine
aequineyokohamaaq132010
y10
fc2
a144v
i179v
affords
antiv1v2
macaquestrimeric
quaternary
obscuring
v1v2directed
jrflgp120
trimerization
cyclically
permuted
cycpgp120
tier2
dnamodified
mvavaccinated
gp120specific
tier1a
multiclade
v2loop
dnamvaprimed
gp70v1v2specific
tier1b
indiaantenatal
20052006
brazilthe
type103
1024years
pscderived
201836134145
esophagitiseosinophilic
retardation
osteopenia
antiimmunoglobuline
omb
omboit
oitomb
microwave
trehalose
dihydrate
razi
humanpurpose
lysatepulsed
41203
76676
halts
fadv4
fiber1
fiber2
basethe
hydropericardium
coliexpressed
loop1
grossmicro
networkparental
2459months
n2013
aor80
to204
cti121900
immunizationspurpose
apprehension
diego
skaggs
sspps
postcourse
precourse
climbed
apprehensive
prerenal
prertx
airds
aird
ahf
8member
drafts
activityhuman
her2persfab
anticd16
keynote001
mk3475
3683
3690
biopsyrelated
pneumothorax
kongdespite
826
advocacies
copayments
pertussisobjective
copay
ho1414319
canceled
81027
346417
76100
p172
plasmonicsamplified
nanotherapy
psatricoms
selectionmodification
reconsidered
fsme
immunotherapyleukocyte
behaviorvaccine
phenomenaspecial
geocoded
machinelearning
disneyland
behaviordisease
speeding
countriesfollowing
us20dose
us1051
us817
us578
us444
us4216disabilityadjusted
us666daly
us5865daly
us3751daly
us1935daly
us5101daly
balbneut
her2driven
14fold
postelimination
multigenotype
4871
2854
parks
conciseness
5278
nonschoolaged
countriesdespite
bioparticulates
almaty
actionsthe
landscaping
salmonicidawe
5°c
10°c
15°c
18weeks
wpi
speilberg
vsalmonicida
asalmonicida
54with
nct02348216
reappearance
nct02030834
cellulairepatients
2453
2145
approach037
021065
combinationsover
welltraveled
roads
pspa
alonepspa
alonect
ef3030
cfus
128e91e96
chemotherapywe
tomographyct
gottrons
antiaminoacyltrna
synthetase
cooccurrence
globulina
lifebackground
nct00226499
1222months
vázquez
mild7
severe815
severe16
5289
mmrv2279
age142
sd25
mmrv2266
sd24
mmr744
sd25months
936962
977996
618714
869928
mmrv2
treatmentthoracic
vexing
088mgkg
007170
tapers
304mg
0150
1670
1241
opportunitiesperson
108241
nonspanishpreferred
007087
2031background
trivac
22million
8900
us9million
us60
us238
us332
us27
us38
us7000
rabbitsit
parentral
qs
nostrils
wvcpg
epidermotropic
pcaetl
pralatrexate
glioblastomachimeric
heterogenously
chnkg2d
heralds
103143
technicianadministered
transplantationrelapse
marrowinfiltrating
microangiopathythrombotic
tmas
cmhus
mahat
thrombi
adamts13
pex
macrovascular
opportunitiesallogenic
spis
fluorochromeconjugated
lymphocytotoxic
parous
firstdegree
engineeringtcell
agentsprimary
doseintensive
pcnsls
79b
therapiesconsiderable
strategiesprimary
nshl
pmcbl
nonchemotherapeutic
leukemiawith
suboptimally
noneligible
logdepletion
treatmenttreatment
pharmacogenomics
escalatedeescalate
distrustobjectives
interpretative
superordinate
concentric
ineluctable
parentphysician
involuntarily
biomarkersallergen
iggigg
fcεrii
wives
swa
neotetanus
bargaining
immunotherapythere
spurt
crystals
digitalised
glaser
strauss
6772186
64677
366666
172239
188418
3184
164368
worktime
whereof
72202
hbvderived
hbvcore
hbcsequencederived
hbcslp
bdca1
slploaded
tlrstimulated
hbcspecific
hbvslp
crosspresented
hbcag1827specific
slpbased
biomarkerdriven
nuclearcytoplasmic
approachesincluding
treatmentsare
chickenegg
gelatine
immunesuppressor
05327×10
nct01181258
1255
0616
03590
17±4
307±152
66±14
130±27
mean±sem
30±4
190±40pgml
p00009
ethiopiaunassigned
tetanospasmin
tetani
hawassaethiopia
792of
postneonatal
8381
5294
19792
6857
1143
perspectivessurvival
lenalidomidebased
quadruplets
tpp1
h460
peptidetreated
retards
17888
immunotherapycd8
heterozygosity
hlab44
supertype
hlab62
hlab1501
hopesmerkel
casesyear
uvassociated
uvinduced
dysfunctionalexhausted
agentsavelumab
nivolumabindicated
203543
technologiesthis
splitproduct
markerdifferentiating
timerecently
fiss
prescient
anthraquinone
8599
immunosuppressionanthraquinone
disubstituted
alkylamino
anthraquinones
mitoxandrone
aq
hexanoic
ahx
aqssahx
drb11501
56nm
thioredoxin
nsuccinimidyl
32pyridyldithio
disulphide
spdpssahx
eliminator
thiolcontaining
aqsh
nanoantagonists
nanophasesegregated
achilles
nanoantagonist
asdesigned
hsvmediated
gcv
cd62lexpressing
intranuclear
foxo1dependent
aktresistant
phenocopied
melanaspecific
efficacytherapeutic
antipd1blocking
vß
708393
controlstudyaim
2000at
p00295
groupneoplasias
broilersnewcastle
oculonasally
ndvspecific
postsecondary
decayed
ndvtiter
decays
apobec3s
immunotherapyapobec3s
a3
dnaediting
a3s
mutate
a3mediated
maximally
footprints
adeptness
araraquarasp
20122014objective
sinasc
2612
μenvironment
labchip
optoelectronic
tweezersa
titanium
tiopcbased
oet
fourleafclovershaped
microwells
diacrylate
optofluidic
maskless
blebbing
pd1h
tim3carcinoembryonic
pvrlike
newlycharacterized
backpurpose
vietnamhpv
120195
bentonite
clay
ochratoxin
chicksa
mycotoxins
ochratoxins
penicillium
mycotoxin
ota
phyllosilicates
weathering
volcanic
ashes
adsorbent
otainduced
20gkg
phap
otatreated
therapygliomas
atypia
repress
antibodyproducing
targetinguse
immunoresistant
rhdac
asingleinstitution
rhcvadma
preahct
cd20cd19
anticd20cd19
gate
antigenloss
ab0
incompatiblemodern
non‑small‑cell
long‑standing
icurrent
iiicurrent
ivconclusions
stellar
sgn33a
imgn779
anticd123
sl401
sgncd123a
aclabeled
amg
flotetuzumab
jnj63709178
headedprostate
dnaherein
mustards
cellsintroduction
decgag
rndvlgag
antidec205gagp24
indiafootandmouth
farmlevel
39day
frequencydependent
162184
6788
probang
105months
postoutbreak
nspelisa
choleraesuisdna
choleraesuis
scholeraesuis
chromosomeplasmid
balancedlethal
oestradiol
tryptophanglucopyranoside
immunosuppressionradiationinduced
glucopyranoside
immuneradioprotective
j774a1
025μgml
radioprotection
gammaradiation
gastroparesisan
gastroparesis
drugdevice
443gp
louisville
subjectively
idiom
satiety
faait
postdiscontinuation
swallowed
oleaceae
spire
syndrometumor
szs
mfszs
cd25targeting
denileukin
diftitox
immunosuppressivedependent
immunosuppressiondependent
1751
lviv
preziosi
halloran
catarrhal
reprises
spasmodic
revolutioncancer
elaborating
micromachines
anemiafanconi
faassociated
adhct
msdhct
splenectomybackground
splenectomies
9965
asthmaairway
hypersensitivityintroduction
skins
forbidden
idhrs
nidhrs
stingsintroduction
mellifera
vespa
crabro
refusalits
liposomemediated
igeassociated
ovaliposomes
interleukin5
ovaliposometreated
instills
implementationpertussis
pandemicemerging
commerce
perceptionsvoluntary
ride
imitating
doubleedged
sword
280284
6172
fluorescentbeadbased
isrctn65428640
isrctn64117538
ntr4089
shkt
tacmpapred
shkts
noinduction
005071
termphrase
casepatient
epidemiologicclinical
outcomeimpact
1472
reservists
outofschool
shelters
settingsdogs
unwell
floridabackground
pollenbased
classicembase
biosis
previews
congresseuropean
retrieval
14603
immunotherapymanipulating
gapsrubella
publicsector
areaspecific
privatesector
postrcv
feverrash
expanders
nonexpanders
transplantationvarious
cd319d
cd34s
leukemiatotal
819
bucontaining
reviewmetaanalysisdespite
reviewmetaanalysis
cd70
apcassociated
factortnfα
preplasmablasts
ppbs
hierarchically
cu
zncontaining
γalooh
mesostrands
immunotherapyalum
buds
znamss
wrinkled
mesoscale
void
cavelike
highexposed
streams
thp1differentiated
macrophagelike
antitumorimmunity
matrice
studyalthough
wwwnhsstaffsurveyscom
800000
0425
0658
0192
targetsmast
mcdriven
syndromewiskottaldrich
455×10
experimentthe
unassailability
cliché
ciphered
throes
synopsizing
autoimmunityvaccines
anxietiesin
anxieties
frighten
albertas
overwhelmingly
uncritically
overlooks
critiqued
newness
wic
utilizationobjective
certificates
unobserved
017027
2038
spends
041days
022060
strategieswith
predictably
vaccinationon
surprise
distract
vaccinepurpose
oxidelabeled
typemouse
papillomavirusbased
depovax
immunovaccine
halifax
hypointensities
ironlabeled
magn
reson
80304316
agrin
gravisintroduction
nmjs
nt1654
torpedo
tachr
814820
dmismatched
threecell
detour
immunotherapybcell
bcrip
vjcmapped
igha
fences
spfpigs
dpv0
vact1
vact2
vact1t2
mingled
toleranceof
dualallergen
countriessettings
ofpotential
eggincomplementary
commonfood
tbicontaining
1320cgy
cnscb
1000cgy
cnspriorrt
immunotherapyoutcomes
hrnbl
dinutuximabcytokines
cytokinereleasing
dinutuximab
plasticityth17cells
th171cells
receptordefined
nexvax2
nexvax2®
hladq2·5restricted
150μg
hladq2·5
nexvax2treated
30μg
90μg
300μg
3μg
9μg
450μg
600μg
750μg
900μg
nct02528799
hladq25
nonhomozygotes
wiser
affluent
teenbackground
ethnicityrace
n18959
immunotherapydynamic
therapyresistance
diversifies
ligandalthough
h11c
h11cactivated
nonepithelial
histiocytoma
bonemetastasis
tumorresponding
carcinomametastasis
emphatic
alecsat
cellsglioblastoma
gbmderived
februaryjune
antitelomerase
ossn
keratoconjunctivitis
interferonalpha2b
sepsisobjectives
quantitate
batched
timepolymerase
virus6
emberger
mutationemberger
guanineadeninethymineadenine
lymphedema
sister
cyclophophamide
29mgkg
moefetil
day15
day475
nonmyeloablatove
diganglioside
carefficacy
cd11ctargeted
stingdependent
maturationimmunotherapeutic
conceivably
dnasensors
maturational
anticd11c
cd11cmediated
ionomycin
dcmaturation
reconstruction
presensitized
vcas
vcaspecific
oncologyadoptive
therapiesnearly
diseasea
epiinfotm
deviation±66
6161
aor26
monogamous
0206
jingles
12225
immunocomplex
antibodyaim
s4b6
il2s4b6
comb
empowers
actakines
activityontarget
1000fold
ifnderived
actaferon
afntargeting
afns
46374
regimenbackground
pn
80110mgdl
nofat
107mgdl
111mgdl
250mgdl
hypoglycemia
40mgdl
malignanciesimmune
vaccinecurrent
bmem
dosesboosters
drugsensitive
strainsthe
h37rv
bacillary
growthmolecular
mutl
mmrproficient
sternomediastinitis
4016
prs
080089
feverthe
genera
haemagogus
conveys
mum
of77295
6791
2345
cancersadoptive
transferbased
leaps
perspectiveshead
sarcomasalthough
v1v2specific
suis
tso
immunosuppressiontrichuris
lpmc
tem8antxr1specific
cancertriplenegative
tem8
tem8positive
offsetting
mammospheres
489500
elderlycontext
6575
eradicationthis
rubellacrs
g8p8
g8p8rva
heterotypic
rva
sequencebased
shizuoka
februaryjuly
pcrpositive
pcrnegative
hesitancyclusters
valuesbased
morality
morals
mediumhesitancy
lowhesitancy
127340
highhesitancy
139331
150321
fairnessideas
vaccinefocused
messagesare
042069
034059
168299
105206
179389
nasopharyngitis
responseparental
myopic
irrational
liposomeencapsulated
allergyallergen
subsidenceabolishment
invented
lder
lce
nasalassociated
entrapped
dpce
vaccinesplacebo
quasiscore
hpv1618611
7400
pensions
cd47pdl1
cv1
knobsintoholes
iab
clodronate
allergiesallergic
compose
indoors
modelrheumatoid
immunosuppressionwhile
accomplishing
antipdac
encapsulates
msnp
interior
oxindmsnp
accomplishable
nperson
gamesunderstanding
nonlinearly
incentivebased
gd2binding
14g2abased
e101k
gd2e101k
cerebellum
killier
lama4g1254v
47588
complexclostridium
bonta
intoxication
dcpep
acidophilus
spainintroduction
14356
lowmoderate
pregnancycatastrophic
sixstage
20072016introduction
lamic
20072016
lamics
descriptively
projectprogramme
funder
schoolonly
littleno
introductionseveral
takingstock
drafted
botswana
mauritius
seychelles
swaziland
deworming
africanbased
revitalising
programsthe
wellcoordinated
hostsit
countriessince
pilots
nondccik
modelchronic
hbsagloaded
immunedeficit
lethally
iggsecreting
mitogenresponsive
postorgan
ptlds
cd3targeted
depletionbackground
memoryimmunity
2000fold
550μl
10μl
vbeta
spectratyping
cd3depleted
cd45radepletion
stressinducible
insults
involution
endosomes
immnunogenic
chaperokine
twocenter
levelsbackground
edmonstonzagreb
bhaemophilus
nontrial
8309
161000
075146
16447
90422
measlesunvaccinatedunexposed
306333
186189
196202
microdisk
functionthe
tlras
microdisks
tlra
disks
feeforservice
medicaidobjective
managedcare
unemployment
yearfixed
1678288
023121
conditionschimeric
cd20targeted
tcd19
therapydendritic
coldantibody
microtumor
sizesintraperitoneally
ymabs
microtumors
radii
atradioimmunotherapy
inhousedeveloped
microdosimetry
highspecificactivity
shorterlived
innercore
mumpsmeasles
importanceparticularly
radar
teratogenic
doityourself
camin
fremantle
2013december
reifying
eschewed
adulterating
harmfree
nonusers
cams
rationalised
glossed
motive
cottage
capitalism
dubious
poisoned
avarice
anecdote
demeaned
arrogant
informationproviders
betanodavirusthis
defences
betanodavirus
nodavirus
alphanodavirus
crossprotects
attainable
pd1pdl1inhibitor
hr086
neversmoking
modelintroduction
pab
tow
antiror1
xtt
ror1overexpressing
ror1pab
ct26ror1
underling
dako
carpinteria
ultra
tucson
az
0674
0755
0812
0212
01960578
0921
0897
appraisaladjuvants
approachbased
ckbmt
disappearing
3060days
immunosuppressionfree
nonrenal
hpcm
factoronly
membraneanchored
headless
proteinin
ggggs4
immunoelectron
antige
nct01751165
18item
gainfully
tomé
príncipe
imputing
brazilepidemiological
byam
victorialike
bvic
cocirculated
32y
unpredictability
gujarat
surat
baroda
121147
137151
oxidantantioxidant
hmsc
nitrotyrosine
asthmahmsc
asthmasal
thermosponge
effectsthe
tsns
temperatureresponsive
swellingdeswelling
postentrapment
nonsolvent
recuited
201500081732
nct02482636
0·61
1·74
7f
3·98
3·36
9v
2·34
2·50
8·38
8·83
8·92
3·43
2·55
16·9
10·49
14·76
11·12
0·001
0·047
0·0001
0·017
32268
4540
27728
iiivi
nondm
knhanes
trend024
19922015in
sear
19922015
timorleste
197640
nct01462357
as04hpv1618
1075
n359
n358
m36
m7
atpi
n958
tvc
n1036
hpv1618specific
278fold
684fold
23fold
414fold
pseudovirionbased
nct0146235
n35646
34994
19902016background
1990june
86115
pregnancyspecific
nonpregnancy
nampula
mozambiqueintroduction
contextbased
chlorination
resurfaced
disequilibrium
negligence
estrangement
mobilizers
personnel21
industryoccupation
settingindustry
chiropractor
optometrist
sfgmtcin
lille
cetuximabrt
deintensification
bullets
eradicationmeasles
cdv
rinderpest
rpv
morbilliviruses
phocine
pdv
dolphin
dmv
porpoise
pmv
adultsdespite
2012june
nct01529645
nct02382913
ap4
ratiosbackground
pneumococcalrotavirus
meddra
5141
4375
10745
modernday
knowvaccines
reviewgrowing
1background
bsp090
5b4
6h4
immunochromatography
betv1
pepscan
hydrogendeuterium
exchangemass
i56k68
e60
k65
i44k55
r70f79
e45
fasit
enactment
200183
7090
indiarationale
assured
functionaries
collaborating
whoalgorithm
forged
immunitytargeted
melanomaadoptive
epsteinbarrpositive
nongerminalcenter
ratio049
013184
ratio081
037177
ratio086
038197
ratio100
057174
nonwestern
mortalityconcern
reestablished
9800
9400
10200
19600
18800
20400
29400
28200
30700
resultsinform
preteen
stalled
persuade
19398
127896
introductionthe
1326yearold
n1180
or14
or116
3440
or02
00707
or03
0107
casesprogrammed
dysimmunity
cpk
collegially
pharmacometabolomics
lysophosphatidylcholines
requirementintroduction
erl
quadrupoletimeofflight
sodiummycophenolic
expressor
lysophosphatidylcholine
lysopc
lysopcs
flagging
vaccinationsam
thorny
cancervarious
nononcological
ablations
n301398
n311391
9799
4047
1925
phleum
pratense
phlscit
medicationfree
napt
ppratense
unwashed
conditioningcord
iliac
hemipelvis
6ml
44days
marrowcbt
metaanalysisleukemia
036091
050108
qualityimprovement
imm2
ipfqr
1413
pharmacistconducted
thermomechanical
buzzy
childreported
wong
baker
parentreported
preprocedure
opengrey
203835
1937weeks
rr0
014521
responsesince
energyconsuming
demographical
±134
93197
36197
skintypes
gammaaminobutyric
acidb
gabab
gababr
antigabab
hebei
4779
involuntary
epileptiform
parahippocampal
gyrus
diseasesantigenspecific
subimmunogenic
sociedad
chilena
infectología
chilethis
experiencethe
aracytin
melphalanbeam
veryhigh
bendamustineeam
turkeysdespite
bavaccine
bachallenge
28dayold
cfum
bacolonized
aerosolinoculated
baspecific
twentyonedayold
vanishingly
interferonαinduced
ifndcs
ns3
corens3specific
corespecific
ns3specific
hcvspecific
thatin
activitythey
yhv
ligninbased
pulping
tiger
penaeus
monodon
linnyellow
penaeids
kraft
lignin
159±12g
96h
96hrs
297mgl
topdressing
10g
ligninkg
hemocyte
110gkg
967±58
20mgl
233±58
167±58
200±00
treatmentsalthough
donorsallogeneic
apbscs
98kg
12kg
amlm4eo
cmnc
settingbone
premanipulation
6°c
975h
03328
4°6°c
0411841
21h
range1394
954985
401212
6991612
94993
8292
manifacturing
postmanipulation
transplantationsince
groupcancer
broadbased
fullday
nondescribed
controlstate
firstdiscretizethenoptimize
pontrygins
approximations
oneperiod
imitationbased
interventionwe
donofrio
phs
sirtype
seirtype
populationbiology
theoretic
economyrelated
payoff
analyticalapproximate
amplitude
heuristically
holidays
overcompensates
nonautonomous
humanmouse
enigmatic
aitinduced
igeblocking
postait
preait
oncoproteinsrecent
hpvinfection
ivag
unbridled
iraerelated
00040
preventionunassigned
hbvendemic
bdirected
xenotransplantationpigtohuman
transgenics
anticd154mab
survival400
survival900
anticd40mab
converges
stumbling
cd38bispecific
malignanciespretargeted
anticd38bispecific
tumorabsorbed
millicurie
tumortonormal
streptavidin
sabiotinbased
cd38sa
µci
1000µci
lookglioblastoma
her2cmv
53540
introductionan
upsurge
necitumumab
squire
gemcitabinecisplatin
nonprogressors
nonprogressor
069105
070106
polymerbased
immunostimulationsmallmolecule
nanodelivery
methoxypolyethylene
glycolbpolydllactic
plgampegpla
unloaded
acquisitionintroduction
n362
abstaining
repellant
pants
sleeves
marriedliving
sd209
sd37
livingtraveling
mechanismsobjective
rhinitisrelated
annals
noneosinophilic
tcellswith
selectionbackground
50yearold
blockadeinduced
antistriated
rhabdomyolysis
kinasemyocardial
electrocardiograms
targettreatment
seismically
termsof
comparedto
adenocarcinomatreatments
transplantationcalcineurin
cnis
cnifree
visuospatialconstructional
cniinduced
hyperintensities
wmh
nephrotoxic
transmissionhepatitis
eantigen
researchchronic
chbassociated
finiteduration
unsettled
seroclearance
therapyhepatitis
ebolacountries
epidemicprone
perspectivetype
βcell
hypoinsulinaemia
il2il2r
cd22targeted
cd22car
biomarkerssarcomas
experiencewe
chimerism95
gonadotoxic
ompai
42kda
electrotransformed
cc16
lcppg
lcppg1ompai
lcppg2ompai
effectorstcell
cd4independent
naiveenriched
cd4hla
56the
hadv
hadv56
easeofuse
hadv5based
mig1
hadv5
hadv56luc
hadv26
antihadv56
receptorcoreceptor
insiders
viewwhile
trenchant
swords
markerslung
nivolumabbackground
radiotherapybackground
fasointroduction
recherche
crsn
3010
200911
2635
104160
sexdifferential
opvpenta
mvyellow
lymphomaas
advancedage
8159
p0492
0746
0078
practicable
bmcd34
donorsit
schoolreported
dakotas
enforced
diphtheriatetanusattenuated
pertussis75
ci39
polio62
ci33
rubella7
ci35
b37
ci15
varicella69
ci34
pertussis6
ci2
ci3
carcinomasecond
gpasit
ryegrass
fourarm
v7
allergenbinding
31fold
39fold
mpp
projectadequate
consequentially
chinapostsurgical
healthpositive
flowinduced
cuff
noncuffed
cuffed
schedulesbackground
1640
uloq
lloq
betweencountry
mixedsequential
populationthis
6175
76102
postlung
transplantationlung
ltx
postltx
immunosuppressionit
invader
maladaptive
futuredespite
diazoxideno
cohortbackground
imn
cellsmm3
120months
90193
118±112uml
345±357uml
antiphospholipase
pla2r
533±405
556±332mlmin173m2
575±293
453±328mlmin173m2
antipla2r
reoccurrence
campaignsthe
immunotherapyestablishment
nodcg
prkdc
sz
hcd34
immuneengrafted
researchwang
yao
cheng
cai
martinek
cx
shi
vere
airhart
banchereau
brehm
greiner
shultz
palucka
keck
productionbackground
cytokineproducing
magneticisolated
cancersipuleucelt
antigentargeted
usedobjective
kim
goldies
19762007
humantransmissible
tabletbased
allergyallergic
grucocorticosteroids
bestdocumented
patientfriendly
prospectspatients
sorely
imperviousness
afflicts
brainy
ivm
fluorescentlylabeled
dyes
keynote021
containmentmeasles
twoyearolds
n128
taddio
456463
epochs
2min
3min
rocking
comforting
18montholds
d084
d076
ds037054
abcd
1267
1088
03495
194883
8829
400u
1986±1480
5714±2275
lyeo
numbereosinophil
number15
dpenicillamine
icolorectal
mostcommon
morecommon
stageindependent
5fluorouracilbased
metastaticrefractory
freezethawing
materialbased
immunogenically
adjuvantloaded
laden
nanodepots
fibertype
pakirin2
fastmyhc
nfatc1
pparγ
coactivator1α
isform
calcineurinnfatc1
visions
cedarssinai
immunochipv1
allelecalling
qc
immunochip
2691258
allergicserum
lupuslike
asca
iggasca
antii2
regressionhuman
cytokinecytokine
eightcolor
microenvironmenttherapies
immunolabeling
dapi
checkpointbased
gesù
9girlyearage
evidencebackground
1608
8001200
day1
hcvrna
2log
pevr
incompliant
nlpnf1
immunosuppressionnanometric
biogenics
nanodispersion
predominates
surging
isquare
roundtable
eggers
013037
paint
wtvol
noncolitis
ovaprimed
distension
sodiuminduced
enkephalins
roleobjectives
injectionrelated
campaignsin
handheld
handi
handis
accommodated
unweighted
659668
629466
569456
609365
17102
49495
46380
kenyaunassigned
purposivelyselected
pentavalent1
pentavalent3
ksh
communicationrelated
mwingi
averts
chws
chw
subcounties
endterm
60241
17943414
or2516
179635240
nct01869166
cartegfr
relapsedmetastatic
wellproduced
100250
0841
feverchill
targetmediated
mucosalcutaneous
2522
127786
kalos
progenitorderived
micecombining
aza
hspcnk
dnam1activating
2012july
n221
1111
10times
77423
111573
patch100
patch982
patch929
nct01675882
postdepletional
rejectionkidney
depletional
cobrr
belataceptsirolimus
repopulating
alemtuzumabinduced
emigration
il7rα
il7dependent
cobsensitive
cobresistant
nct00565773
examplebackground
comers
nonexistent
nonhlanhla
mkhize
pregnancyrecent
carcinomametastatic
luciferaseluciferin
photoncounting
imagingnearinfrared
a431lucgfp
ohio
appalachian
rolepurpose
appalachia
doctorrecommended
128466
170644
schoolmandated
democrat
1041458
190562
modelschronic
ifnγdependent
baruch
22135137
β2adrenergic
cellsadrenergic
lpsmatured
β2agonist
salbutamol
otii
salbutamolconditioned
β2adrenoreceptor
waclaw
blaise
orlowsky
unacknowledged
intertwining
nanocapsules
immunotherapynanomedicines
idrncs
hairpin
microflowers
shrinking
peggrafted
idrncneoantigen
8fold
dnarnapeptide
triplecodelivery
12354
twelvepercent
6177
126154
smss
179329
diseasemoderate
cautioned
selfmonitor
2011561
proteintoalbumin
1056
3613086
103414
berberine
ido1to
bbr
substituents
9position
2f
2i
2n
2o
7190
qvax
19942013qvax®
19932013
regionschronic
ctc
excursions
wpr
ctclicenced
servicesbackground
1782
populationlittle
esrd
ffs
325000
nonwhites
350000
literaturejohn
precyclophosphamide
immunotherapyfinding
allergytreatment
childrenbaked
tolerating
maintenancethe
allergiesthis
cancernowadays
nonmajor
complexrestricted
gd2targeting
investigatio
pigsbackground
wur1000125
wur
prrsvpcv2b
n171
vx
singlesnp
p43
qtl
nonvx
previouslyreported
studentsbackground
antictla4treated
lowfitness
sixteenyear
1085
reviewpemphigus
desmoglein
childhoodjuvenile
carinii
warned
findingsimmune
falsely
designate
expeditiously
appearances
tetramembrane
claudins
immunotherapyviruslike
cldn6
retrovirusderived
cldn9
pleomorphic
nivolumabpulmonary
naevus
lightening
americansbackground
churchbased
1834
churches
navigation
3series
mixedeffect
5123
201812497382
βchain
malignanciesmature
trbc1
trbc2
antitrbc
antitrbc1
trbctargeted
igvhd
piperacillintazobactam
imipenemcilastatin
cologne
backwardstepwise
159381
carbapenems
1273031
151919
210589
lifeadolescent
nonhct
8mgl
ratiobackground
hymenopteraspecific
waspallergic
honeybeeallergic
monopolisensitized
usagedose
892±417years
2simultaneous
multiplepollenmix
icsavoidance
monoallergen
pollenmixture
2simultaneousallergen
longerduration
monomultiplemixedsimultaneous
retainedavoidance
anaphylaxisbackground
gantrez
butter
immunotherapyhouse
9143
7873
continental
asthmait
sensitizationchallenge
sensitizedchallenged
gating
caspases8
apaf1
perforin1
carbamylated
grassallergic
patientsaim
preseasonally
uaday
birchapple
knowapple
pathogenesisrelated10
mal
birchpollen
ragweedspecific
phenomewide
desensit
resveratrol
sdf1αpreconditioned
cirrhosisstromal
bmscs
cbdl
bmsc
10ngµl
cmdil
postcell
bmscsdfrv
sirt1
akts
cxcl12
reseveratrol
virusreactive
denvimmune
26yearold
30mg
12times
8g
60g
2017it
tnsms
jrqlq
2016dietary
chemotherapyin
polylhistidine
phis
phisr848
nanocores
acidcleavable
hadox
hadoxphisr848
ionization
cd44mediated
coloading
immuneregulator
cd38nad
responseheightened
th117
nadase
glutaminolysis
th0
proteinmediated
wonder
ubiquity
hsptumorantigen
immunotheraputic
announcing
eogbs
logbs
costsdose
capitadaly
with4
anc4
4243
anc465
5557
anc487
7dose
320350daly
573daly
costdose
costdaly
maces
20002013
n80363
078082
076084
077082
118129
134159
110122
092107
p834
092121
p440
089105
p398
adultsvaccines
treatmentrecent
approachesophageal
tp63
metalfree
decouples
dotatz
tcmctz
cc49tco
pbdotatz
pbtcmctz
cc49
nar
downstaging
cbnac
ct24an0m0
downstaged
ypt1n0
singlecomponent
childrenmeasles
benefitloss
publish
152648
148064
30302
24209
6863
matchmismatch
5325
2511
2164
0111
75year
mozambiquebackground
3997
225588
postorgasmic
pois
postejaculatory
ejaculation
romantic
struggles
eroticism
autoimmuneallergy
μopioid
invokes
symptomatically
serotonin
reuptake
benzodiazepines
hyposensitization
nguyen
hmt
balaa
gabrielson
hellstrom
wjg
201861115
immunityinducing
fusogenic
endosome
vacuolar
pathwaymediated
cancelling
immunotherapyall
allergencontaining
plasmacytic
nonebvrelated
transplantationmycobacterial
transplantationrespiratory
heartlung
liverlung
transplantationas
transplantationnoninfectious
cryptogenic
th17polarized
rapamycinbecause
th17polarization
th17dependent
th17polarised
roflumilast
am80
quantifiers
th17associated
immunizationprimary
interlobular
ductules
reflective
pdce2
xenobiotic
chemicals
selftissue
bdp
melaninmediated
patchmelanin
photoresponsive
dinucleotides
polybetaamino
pbae
logfold
strategiesintroduction
luad
relapsemetastasis
gcta
asubtype
melanies
richter
5074
filgrastimmobilized
1582
candidacy
assessmenta
fishermen
officer
storing
capsidmodified
oprf
infectionrespiratory
antiad
primatebased
adc7oprfrgd
adc7oprf
arginineglycineaspartic
rp73
agar
aeruginosaspecific
sprague
dawley
antipseudomonas
intercantonal
cantonal
hpvprevalence
gfks
knowledgepanel
oncetwice
neveranova
uptakewe
pv1
pv2
pv3
therapiesintroduction
pfspreorrpre
pfspostorrpost
mcnemar
pfspre
pfspost
musculoskeletaliraesfirst
ipilimumabtremelimumab
withnivolumabmonotherapy
oligoarthritis
anticyclic
citrullinated
musculoskeletaliraescan
sclerosisin
haste
speedthe
chemotherapyimmunotherapy
hypothesisdriven
redesigning
agentinterleukin12
adtd
nonsecreting
paca
adtdnsil12
peritoneally
lymphocytesdespite
tirp
fasfasligand
polymorphonuclearmyeloidderived
fasligand
inequitiesbackground
maltreatment
20032009
n4575
n5186
n87897
drds
rrrs
nonprogramme
drd
subclone
4958
sundar
tan
pectasides
denv14
takedas
tdv
dominican
nct02302066
n201
n398
n1002
n199
1794
286791
329647
8041388
49173
1212
8421744
9471628
1457
11821796
93337
denv3
171478
205433
411730
44137
65150
75139
133222
2152
baselineseronegative
takeda
responsetype
nonmicrobial
tissueresiding
th2inducing
20092014background
18442
adultsglobal
galvanize
1051
reslizumabnaïve
reslizumabexperienced
36840
34336863
affected78of
nontreatmentrelated
controlreslizumabnaïve
karawari
sepik
papua
guineadelivery
png
23294
zscores
weightforheight
reopen
vaccinationthrough
mmodel
extremist
sirmodel
infectedi
ω
β1
cancersobjective
siginifcant
ch1418choimmunotherapy
ch1418
25mgm
820h
10mgm
d817
morphine
3753
aieop
ematology
1537
4y
49y
22y
520y
36y
5353
iithe
jersey
influenzaseasonal
vaccinationsan
expulsion
generationchimeric
trendsthe
strategize
dmpk
matrixbinding
peritumorally
ecmsuperaffinity
factor2
plgf2
123144
ecmbinding
lymphomaadoptive
strategies41bb
41bbmediated
decouple
immunotherapycd28
immunoglobulinrelated
cd28ctla4
cd27cd70
cd27targeting
pairings
commvac
verbatim
announcements
churchesmosques
announcers
churchmosque
informationwhen
tied
deliverer
spoilt
bcgbcg
19081921
passaging
lyophilization
pnd
bcpnd
61years
528years
pca1antiyo
amphiphysinigg
type2
anna2antiri
laterstage
ptpn22transforming
disadvantageous
gmpproduction
separations
001043
028085
gmpconform
470±364×10
9598±331
189±106
010±020
qmethodological
qmethodology
byperson
incoherent
thymoglobulinconditioned
atgconditioned
biopsydiagnosed
n266
clinicalradiologic
p23
developingdiagnosing
portland
marchapril
pubmed®
thatare
calm
tumorshepatic
immunetolerogenic
tumordendritic
macrophagecolony
mgmcsf
gastrinreleasing
grp
mgmcsfgrp6
mg6
mgmcsfmggn
mggn
6p
6np
6nd
polyactin
vaccinesynthetic
aluminumbased
p369p377
e75specific
c57bl6tghlaa211engej
travelobjective
travepinet
nonbreastfeeding
21138
malariaholoendemic
neuropathiesimmunemediated
chinathe
cancershepatobiliary
throttle
flared
casesrecent
hypophysis
immunotherapyneoantigens
mogiggpositive
2014background
george
mukhari
dgm
4791418
20022009
37170
nong1p8
423917
205939
224421
183703
80905
aor01
139421
473905
aor25
antipsoriatic
dermatitisintroduction
flareup
irritatingallergenic
rigorousness
conceptions
phenomenographic
surveyobjective
n3588
1820year
2124year
with10
with2
1820years
2124years
1824years
reviewprostate
emergedimmunological
highprofile
capillaries
bioeffects
fusmediated
cd27mediated
efficacycd27
anticd27
varlilumab
1f5
1f5migg1
bcl1
1f5migg2a
1f5higg1
cd27targeted
vsm
rankbased
107347
087300
070203
immuneincompetent
mrnatransfected
cmetcar
nct01837602
edges
115261
mediumpotency
nonallergenic
experiencebased
benralizumab
antiil4antiil13
unionallergen
saudi95
aasiagvii
lineagein
vaccinematch
youngstock
th22
cirrhosisobjective
cd3bv500
cd8percpcy55
ifnγpecy7
il17aapc
il22pe
polyoxymethylene
permeabilizationwash
flowjo
cd4ifnγ
cd4il17a
cd4il22
cd8ifnγ
cd8il17a
tc22
cd8il22
interleukin17a
interleukin22
lx2
αsmooth
αsma
precollagen
425±245
259±136
417±255
131±064
589±344
532±367
th1th22
environmentfriendly
specie
vp1667
vp2369
fluorescens
crossreacted
lymphokine
monokine
afghanistanintroduction
215000
89000
afghanistan
provac
660000
650000
us82daly
us80daly
us29daly
us31daly
treatmentssystemic
coinhibitors
manipulators
rtxivig
csrtx
csmmf
csaza
csmtx
cscp
csivig
developmentreactivation
treatmentsystemic
ifninducible
ifnblocking
myelomaspecific
therapycancerspecific
conformer
mmg49
mmg49derived
mueller
venomenhal
hal
kirhlai
cellsto
kirmediated
selfinhibition
hlaiexpressing
kir2dl2l3
kir2dl1
kir3dl1
reinduced
reculture
il121518activated
cd16dependent
il121518stimulated
selfhlai
headedwhile
challengeproven
22item
immunotherapyscope
3enrichedslit
igeigg
therapythere
perspectivescancer
indiscriminately
typology
15821712
practised
165445
165399
cancerγδt
46disubstituted
pyrrolopyrimidine
glioblastomat
α2
il13bbζ
il13bbζcar
il13ζcar
failurecanine
p00495
10week
finish
modelequine
eivs
equines
subtyped
concurred
intercession
adjudging
vaccineimproved
prbased
semipurified
immunotherapysublingual
mechanismsbeyond
clinicalradiological
psychotropic
riskversusbenefit
bloodintroduction
precipitate
ucbderived
ω3
tenets
fishderived
degrade
amyloidβ142
ω3derived
resolvin
drink
smartfish
antioxidants
125dihydroxy
autoimmunityinfections
transplantationimmunotherapy
nontransplantation
residentrun
selfperceived
booths
walkins
mcgill
concordia
fieldporcine
prrs2
stx1b
autotransporter
repec
e22δler
strainwe
enteropathogenic
ler
shigalike
1stx1
espp
periplasm
exported
translocator
surfaceattached
o103
e22
δler
toxinneutralizing
enterohemorrhagic
o15
stx1
rdech19
surfaceexpressed
nebulisation
pathogenicityequine
welsh
mountain
ponies
aequinerichmond107
r07
aequineeast
renfrewshire11
er11
aequinecambremer12012
c12
aequinenorthamptonshire113
n113
adheres
3rs
terminating
2831
2642827
712831
622831
0125
126231
beliefsintroduction
rate32
18246
12228
12151
41238
17126
11180
directionsobjective
authorityapproved
nonspecifically
alteringdepleting
promisedespite
validationqualification
brca2
hivcare
218years
oligosaccharidecrm197
20min
eightnine
77years
108137
or71
2142337
101117
feasibilities
firstinfusion
mechanismofaction
immunotherapeuticsfirst
targetengagement
chandler
superagonistic
anc281
adaptiveinnate
n1822
nonagonistic
natalizumab
tgn1412like
nodelike
drugblood
superoxideeosinophil
lipomannanmycobacterium
lipomannan
bcglm
lipoarabinomannan
bcglam
bcgcw
bcglmpulsed
ccl
cooperatively
bcglmmediated
xenotransplantationobjective
postxenotransplant
bangladeshdiarrhea
74027
72867
immunotherapiesimmunooncology
tcellstimulating
death1l1
3step
rulebased
endpointsdesignstests
timespecific
pitfallsimmunotherapy
avariety
personsobjective
hbvtesting
lowprevalent
12154924
99902
6798
hbvvaccination
physicianpatient
antibiotictreated
akkermansia
muciniphila
interleukin12dependent
ccr9
patientspreclinical
ruminococcaceae
immunizationvaccination
redmouth
erm
boostering
tonsil
20132016in
iisar
iisars
send
bolsters
25120
124249
goingobjective
immunoresistance
1·44
0·25
8·24
p0·88
nanoparticullate
asthmaaffected
homoeostatic
nebulized
nanoparticlecpg
cpggnp
interpleural
gases
cpggnpbased
rh5
interactionsthe
reticulocytebinding
aotus
malarianaive
chad63
orthopoxvirus
3d7
antirh5
crossstrain
gia
rh5specific
rh5based
5yearsold
competitiveness
carriage×vaccine
highvalency
panvalent
hpivs
respirovirus
rubulavirus
smallanimal
luciferaseexpressing
sev
hpiv1
extendable
glioblastomamedian
atct
cmvdc
cmvatctdc
cmvatctsaline
ccl3
07371
00369
25664
arc001
updosed
myopia
19992015
19992015major
981122
252315
216267
3345
agepopulation
treatmenttoward
mutationalderived
pharmacotherapychronic
imbalanced
virusporcine
ds722
ds722sivpcv2
ds722sivpcv2vaccinated
learnedinfluenza
quadruple
nct1720277
longstay
fluzone®
residentlevel
1496
1461
0537
0862
0834
0678
1027
0087
134vs
0994
07741278
0965
sclerosisintroduction
neuronspecific
lymphocytedepleted
hhct
hhcts
güerinvaccine
ifnalpha
güerin
lepraemurium
antiantimycobacterial
bcginducing
leukemiaexosomes
30150nm
transfersplasmaderived
lymphocytesslamf7
huluc63
opportunityintroduction
awv
îledefrancebackground
morbimortality
2004in
inîledefrance
roof
practitionersthe
ageparents
2014and
383adults
250had
verifiedimmunization
officesin
onestop
calculable
hts
transplantationunassigned
proceedingspresentations
uraemia
euglycemia
ischaemia
categorizing
42016038335
5857
undervalue
underinvest
realityin
immuneeffector
tempting
tenvalent
tympanostomy
placements
ttps
nvp
pcv10nvp
nvpeligible
cefaclor
sulfadiazinetrimethoprim
170181
541100
456100
131165
086100
vivomodified
inpractice
kitobjectives
124months
vaccicheck
93·6
95·7
97·3
98·5
triennial
ultrastructural
lizards
amphibians
regenerationhyaluronate
newts
frog
tadpoles
blastemas
habp
blastema
embryoniclike
immunereaction
embryonicfetallike
immuneprotection
pathogenderived
selfdna
stranger
cdnsbased
dnavaccine
plasmidmediated
jacobsons
antiintoxicant
unconstitutional
vaccinationlumpy
lds
lsdin
cooperates
4e
caki1
achn
eif4eregulated
ribavirins
toxicityadoptive
affinityvariant
lfa1
icam1specific
foxessylvatic
balkans
montenegro
hunters
onlya
habitat
areabundant
byaerial
higg
c3dependent
wholeblood
cgmpamp
hiv1hiv1
ultraphsensitive
pc7a
laboratoryadapted
cgamppc7a
npinduced
sewagebackground
exportation
comptroller
authorize
oblige
criminal
judgements
backed
infringing
precedents
nonrestrictive
ladder
infringed
moshi
73277
2173
g8
g9
37377
identicalsibling
isd
eightyfive
haplograft
p0215
p0518
p0306
p0743
p0291
haplocordhsct
isdhsct
bcnumelphalan
myelomasingleagent
alkylatorbased
bcnuhdm
malignaniciesin
bufluatg
1868
ratio036
015084
assessmenthematopoietic
transactional
relationshipsthis
crosslagged
preschooler
interrelated
painrelated
explicate
imagingbased
enlargements
urologist
carcinomasmetastatic
everincreasing
screeningbackground
awvs
nonrecipients
raceethnic
ruralurban
leukemiarecently
neurona
myeloencephalitis
epm
unrewarding
opossumraccoon
37r
139days
p07683
p01559
gametocyte
etgam56
peptideeimeria
devitalizing
retgam56n
cd5
endodomain
28z
bbz
cd5car
tcelltcell
traf
fratricidal
4758
cmpl
receptortransgenic
signalsadoptively
cmplengineered
tpotransgenic
cmplenhanced
cmpltargeted
gainsbackground
prioritisation
portfoliomodel
unranked
yen
72288
lrc
immunotherapyover
proteaseactivated
cpisherein
resultsconclusions
imvigor
prca
adjuvantcombined
antigencaptured
lottolot
hzsubackground
nct02075515
pimds
flores
indonesiathe
yll
ylls
shortacting
us3646
us438
av15650
av15670
us3716
us2264
us463
us265
us265463
us2329
quantificationinfectious
21daylong
ampv
αgal
epitopesobjective
enzymatically
antigal
hantaviruses
hamstersbackground
hantavirus
andes
sin
nombre
maporal
bayou
creek
caño
delgadito
choclo
laguna
negra
septa
72yearold
10kg
hypertrophic
2012april
bursitis
regionshoulder
subdeltoid
patentsbackground
biologicalpharmacological
searchers
fpo
inflammasomeregulated
peopleobjective
2637746
norwegians
19672013
nonprimary
13011323
7321
56100000
351666
82980
969968
55100000
121138
115144
098112
103114
neutropeniaallogeneic
scn
c1ag
m1v
elane
83·33
27months
33·3
conceptwe
anomaly
p00033
enavatuzumab
antitweak
cellsenavatuzumab
enavatuzumabtreated
enavatuzumabtriggered
enavatuzumabinduced
implicationssepsis
mechanismspurpose
dnts
cytometrybased
donorunrestricted
dntmediated
dnam1blocking
37082
ichthyoenterivibrio
ompa
antirompa
rompa
pronephros
lettersobjective
und
southamerican
pythium
1316βglucan
vitropythiosis
funguslike
pythiosis
zoospore
pitiumvac
274154
1928
ethnicityrelated
freeofcharge
19851992
selfpayment
descendants
denmarkborn
aor056
054059
aor039
038040
aor228
211248
vanish
20355
18350
netherlandswe
sociopsychological
msw
iqr2544
105371
95ci155181
95ci229242
sticlinic
schemebackground
electing
ci160
106243
ci245
129478
freeofcosts
scalebackground
vcbs
24min
mentality
cmq
sevenitem
1427
onedimensional
α0937
r044
conspiracies
questionnairebackground
ohnss
canadawide
counseled
cervicalanogenital
postcardiac
nmscs
3110
2016receiving
mdh
pollenassociated
subanalysisbackground
onsetprogression
1grass
n14661385
n71275
treatmentfollowup
nonait
fullanalysis
0676
0720
p0060
treatmentanalysis
1grasspollen
nonasthmatic
pitfall
antipdl1pd1
neuroblastomaantipd1
highriskrelapsing
neuro2a
nxs2
ectontpdase
cd4transient
cd8dependent
antinb
hiapp
modeltype
pores
destabilize
αhelical
diabetesassociated
hiappantibody
conformers
partypox
morally
objectionable
partiesgiven
infectionby
quarantining
nonconsenting
legacy
cviclinical
cvi
asm
openaccess
msphere
predecessor
cdli
everlarger
directorsobjective
opc
42question
paperandpen
dentistry
aapd
attitudesbeliefs
patientsparents
curricula
respectable
twiceannual
onceannual
unchanging
469589
19962012background
pneumoniarelated
waborn
15175
6469
2785
6693
896100000
childyears
266100000
329100000
84100000
immensely
immunoglobulin3
thymoglobulinbackground
cytometer
incidentally
polycystic
iactivity
lifestylebased
023months
169319
56144
sclerosisan
underpowered
visually
parentsobjective
sevenvaccine
35months
vee
414days
1737days
t37873
t37268
d131
d142
d118
d105
d112
parentprofessional
biosimilar
sb2
arthritistnf
biopharmaceutical
originator
biosimilarity
2263
calcitriol
patientsaims
chemotherapyresults
hemispheric
madagascarbackground
seventyeight
malagasy
pcadherin
micestrong
pf06671008
expressiondependent
pf06671008mediated
immunerevolution
malignanciesmodern
survivalimmunotherapeutic
disastrous
wondering
gliomainoculated
pretumoral
practicesintroduction
wastagerelated
coactivating
tumourscoactivating
patientsbetainterferons
betainterferons
splitwell
125159
bdnf
neurotrophic
factorbdnf
stnfr1
stnfr2
conceição
dentro
myelomain
nct02043847
3gy
extrahematologic
malignancyin
rmet
mediumdosage
lymphohemopoietic
mvab
hivmodified
risvac02
cellresponses
gpn
11460
nct01923610
macrophagesstimulator
gmpamp
bologna
analitically
rr136
127145
rr143
102200
mortalitys
tavokinogene
telseplasmid
pil12
telseplasmidtumors
hint
bvt
screeningobservation
mris
hsp27
aii
amacrine
modelprevious
rgcs
s100b
s100bhsp27
s100hsp
retinas
immunohistology
neun
chat
parvalbumin
pkcα
rod
recoverin
cone
bassoon
psd95
opsin
rhodopsin
photoreceptors
perspectiveschronic
mtit
presyncope
prephlebotomy
blooddonation
12item
20minutes
scanty
brcamutated
ultramutated
neurokinin1
systemneuroblastoma
repεrtoirε
nk1r
agains
micepromising
antitim3treated
peribronchiolar
iggtreated
myofibroblasts
brainpurpose
leptomeningeal
her2cars
95105
p052
26135
24134
beambased
mortalitybackground
312388
199661
112727
irr129
ci033499
irr084
ci032299
disproportional
40735
0407
immunotherapystarting
aboard
rewrite
drugdelivery
runway
targetscancer
fought
singletargetsingle
spotlighted
ownercharged
congorabies
61000
lemba
commune
dogowning
officesclinics
owning
transbronchial
or312
118823
or101
040254
079470
or333
163679
foiling
strategieshematopoietic
viralspecific
hsctallogeneic
chinanovel
tumorsite
singletarget
nhlthe
stepdown
icss
puffper
ccat
cellactivatinginhibitory
welldifferentiated
p0044
p00475
rgnnv
sjnnv
dicentrachus
labraxviral
ver
nodaviridae
ictv
redspotted
striped
barfin
bfnnv
puffer
tpnnv
reassortants
rgnnvsjnnv
sjnnvrgnnv
betanodaviruses
crossimmunoreactivity
antinnv
cprdintroduction
nrtvss
vaccineguillainbarré
vaccinefebrile
influenzagbs
mmrseizures
2014june
pmaxsprt
observedtoexpected
agesexadjusted
riskwindow
042days
binominalbased
bmaxsprt
2232days
gbsfebrile
rr4
power80
rr25
immunostimulators
literaturecontext
strategiescapripox
capv
vaccineconferred
cueto
multiplicity
cytologic
tumorstromal
modelalloimmunization
cotherapyin
apcexpanding
baffrfc
combo
stageinitiated
drugblocking
baffrfctreated
baffrfcmediated
cotherapy
lymphomaanticd20
hcd20targeting
9079
ludtpasdab
ludtparituximab
lulabeled
1612
282839
glycolipidreactive
αgalcerloaded
108697
phlebotomus
papatasi
yellowrelated
apyrase
leishmaniasisnowadays
populationproducing
ppapatasi
pptsp42
pptsp44
pptsp36
1polarized
diseasesgiven
daratumumabtreated
panagglutination
sirius
sinai
levine
seminars
lowtitre
08gkg
aboc
12164
stricture
p115
timehepatocellular
neuroophthalmic
mutationally
cellularmediated
ipilimumabthe
inhibitorin
pathogenesisthe
developedand
centerpeople
3899
vhas
thymosin
approachhepatitis
nucs
αinterferon
tα1
ppoit
faqlqpf
faim
endoftreatment
repeatedmeasures
f363
faqlq
mongolian
auditbackground
884934
841974
relapseleukemia
untapped
hematopoieticrestricted
ha1
cd34cd20
therapiesrecent
busulfandependent
scd40l
cd40cd40l
reportkasabachmerritt
consumptive
hypofibrinogenemia
allchimeric
bridged
relic
chickmycoplasma
notinjected
handinjected
sac
cfudose
pipping
diluentinjected
amnion
hatchlings
preplacement
pht
doa
3900
iovaccinated
scvaccinated
multiegg
pneumatic
tenders
subjection
h12
lymphocytescart
lentivirusenzyme
cartfinally
constructedh12
confrontation
nonexpression
901±28
135±47
vivoat
07±01
nontransfected
12±02
her2sepcific
20062015tetanus
slone
5606
109219
pheterogeneity994
i0
111159
pheterogeneity802
rr137
120157
pheterogeneity619
safeties
hpv611
1729years
selfsampling
2118
2042
1937
2329
370417
2023
paramedics
secretaries
auxillary
cardiology
ci250994369
ci103415
ci1281407
95ci113562
512herselfhimself
fom
hindrancesalzheimers
senile
thr231
pt231tau
tauopathy
englandobjective
3441
neededparticularly
agesmedical
pooling
siti
fimp
fimmg
researching
vaccinedespite
c1498wt1
overviewaddressing
incarnations
resiliency
trump
administrationreasons
studyfp
cmvpp65ctls
cmvpp65
cmvpp65ctl
cddpresistant
hsc3cddpr1
cns2
demethylation
tet
activationsince
itregs
teneleven
5methylcytosine
tetcd
tet3dependent
cd89specific
studytreosulfanbased
30gm
42gm
1744±795mghl
10gm
1561±511mghl
1650mghl
4·40
1·1916·28
p0·026
4·51
1·0718·93
p0·040
samba
transplantationcd34
count100µl
in66
with33
iiiii17
cd4gvhd
cells100µl
nct01027702
agentshypersensitivity
nonige
icytokine
cellsbasophils
reintroduce
score6
3883
149204
29204
178204
623763
facultyobjective
careerlong
directory
preceptors
immunotherapyinhibitors
inhibitionneutrophils
thehgfcmet
cmetdependent
extracerebral
depor
alki
q1125
q22650
q35175
q476100
q0
019094
q1011056
q2
005028
q3
003005
q4
03052
022047
009007
007014
perspectiveunassigned
curable30
rituximabcyclophosphamidedoxorubicinvincristineprednisone
enzastaurin
pillar2
remarc
qhpvunvaccinated
1844years
3126790
1195865
1930925
16386459
vaccinationhashimotos
raynauds
129189
scandinavian
hypoparathyroidism
postpa
pth
cholecystokinin
miceadvanced
cckrs
cckr
mt32d
foxp3tregulatory
cd4and
massons
cd200rcd28
appropriates
cd200
ox2
ifps
ifp
dimerizing
tumortcell
cd200rcd28transduced
nct01640301
hpv638
hpv1125
hpv1626
hpv1826
hpv6100
hpv11100
hpv16100
hpv1892
hpv6p030
hpv11p003
hpv16p018
hpv18p001
offs
cancerprone
environmentthe
146months
betterintroduction
africadogs
canis
familiaris
hluvukani
athol
dixie
bushbuckridge
2969
underfivechildren
indiaunassigned
brightons
697
612months
20100000
5100000
redistributing
occurredbackground
inventories
overstock
performances
athletescollegeaged
mealdespite
farmspecific
genomeediting
immunotherapylymphodepletion
chemoimmunotherapies
vaccinenaive
h4476
nz98254
m10713
innoculation
84100
5960
90100
nct01717638
immunotherapiesimmunotherapy
underpinnings
immunoscores
9429
miceactivation
52d
port
adolescentparent
seriesobjective
contentcoded
n109
motionvocal
pvfm
adduction
1mediated
pretoria
pilottested
or184
5286410
8284
208292
107208
93208
nahuche
zamfara
medias
ljm11
braziliensis
lutzomyia
longipalpis
salivaleishmania
salivarybased
majorinfected
sonicate
sgs
intermedia
antiljm11
ljm11immunized
salivamediated
nonincentivized
cash
1841010
1641128
p138
kissing
00175
weightunassigned
nonwellchild
wcc
135964
116521
079097
048077
033063
063092
045088
091092
102102
175186
carrie
byington
acthdependent
cushing
combinationimmune
cushings
extrapituitary
oversecreting
petrosal
cyclophosphamidemixed
busulphancyclophosphamide
donorlymphocyte
46132
3246
rhc
16172
2046
1846
115gdl
84136
ri002
populationsintroduction
ri001
hightiters
hispidus
pidd
igs
listeriavectored
tuberculosisdeaths
fbpbesat6
rlm
yzulm4
lmδ
actaplcb
lm12
bcgprimed
vaccinesgenetic
ageold
nivolumabthe
ipilimumabnaive
ca209038
neoantigenic
ontherapy
nivolumabs
strategiesinfection
unlicensed
flown
1207
miceaim
tarentolaehnp1egfp
malignanciesmelanoma
coccidioidomycosis
lymphomatreatment
deficiencyfungal
systemintroduction
retracing
systemcancer
biologicallyrationale
thetumor
eliminatereduce
generationdifferentiation
tass
patchesallergenspecific
looming
discourage
dfarinae
dfeloaded
dfe
adinduced
ncnga
mnit
lymphomalarge
n98
p54
ci59
p72
rr83
rr99
rr92
p76
rr70
rr52
fcrbased
regimengraft
βthalassemia
5312
nonmac
nontreosulfanbased
hr115
1164
defer
transplantationreducedintensity
15gy
3661
3054
2853
1740
seatbelts
airbags
crisprtherapeutic
nucleases
applicabilityvirus
carolinaobjective
npic
mined
162037
thermoresponsive
bimodal
systema
βglucangraftpoly2isopropyl2oxazolineco2butyl2oxazoline
14710tetraazacyclododecane14710tetraacetic
yttrium90iii
nontoxicity
lysosomes
macrophagosomes
denoting
stranded
vaccinationmessenger
hybridizing
dsrnas
asrna
hybridized
uhybridized
mrnapu
compliers
fullyvaccinating
cherrypicking
entrench
underlaid
researchguided
rental
flats
mid2016
1653
lowperforming
semiurban
micropolitical
asan
didacticeducational
websitesobjective
googlefr
preoccupations
shocking
testimonies
unnatural
vaccinationsystemic
labs
bandemia
ddimer
antidouble
miceaimhypothesis
panhistone
givinostat
cd3e
nodhucd3ε
recentonset
otelixizumab
50μgday
autoantigenspecific
conclusionsinterpretation
hyperprogressorsresponse
hyperprogressorsletter
c1498
diversitybackground
amlaffected
leukaemic
cgh
immunogenicities
amlsurviving
carcinomahead
fadu
hypopharynx
bcgactivated
angiopoietin2
haecs
aluminumadsorbed
havrix®
aluminumfree
aimmugen®
havrix®1440
29382
umin000009351
micronesiabackground
fsm
susceptibleexposedinfectedrecovery
tseir
hlaantigens
inducingchemotherapy
antipd1ctla4
crossreferences
30×7
towns
3535
cytomegalovirusbackground
nonrefractory
guard
myofasciitis
embrace
endoectocervical
v501015
nct00092534
9437
evaluationunassigned
hospitalmatched
483904
652974
vaccinationmethods
ppv23only
enumerated
pcv7ppv23
035μgml
nct01414504
nct00219401
literatureantiprogrammed
organtransplanted
antiprogrammedcell
poultryrelated
columbiaa
farmgate
ungraded
granger
providersobjective
207218
1112yearold
178190
164188
134185
adipsin
notobjective
tampere
finland
eosinophilderived
12p70
adipokines
adiponectin
sevenyear
wormsthe
hivintroduction
diseaseaβ
elan
iad
immunolabeled
pjnk
acasp3
tyr216
cdk5p35
spongiosis
neuritic
curvature
aβantibody
systemvaccination
nucleosides
immunomodulatorssome
attraction
inflammasomemediated
ectonucleotidasecatalyzed
phosphohydrolysis
nucleotidedependent
therapynecroptosis
kinase1
radiationimpact
diseasesionizing
itselfand
modulatorsimpacts
annexina5
pressurekilled
meshed
experiencesradiotherapydespite
accuracycan
radiotherapystimulated
radiotherapyinduced
enhancersendogenous
dnaderived
mucin3
galactin9
gal9
tim3gal9
cuthivac001
trialtargeting
multihiv
cd8cellmediated
imep
idim
tcim
augustseptember
4606
polling
inattentive
unmotivated
westcentral
codimflp16219
cellslymphodepletion
pericyte
endotheliumactivating
140419
mackall
miklos
tea
nigella
sativa
cinnamon
acerola
capsaicin
capsicum
allergenabsorbing
cellulose
5lipoxygenase
antihistaminic
antiallergen
il4secreting
1530
blincyto
gazyva
arzerra
selectiondata
inquirybackground
nihsupported
industryfunded
74986125
vaccinationinfluenza
αsynucleingrp94
modelneuroinflammation
grp94
hspc4
gp96
αsyngrp94immunized
αsyngrp94
mptpmodel
systemsupported
immunityconsisting
th1shifted
αsynspecific
immuneregulatoryth2skewed
substantia
nigra
th1responses
pdassociated
proteinhsp
phenotypebackground
pbderived
allohsc
cbderived
mart1reactive
il21induced
tsdr
noncycling
mexicobackground
ipvinduced
082010
092010
veracruz
singleplex
1641
2305
australiain
talked
nonjudgmental
empathic
neutrality
salutogenic
questioningdistrust
negating
homegrown
scratch
federally
alerted
procancerous
modalitiesimmunotherapy
permissiveness
gp140
vaccinean
mvaexpressed
mvagp140
primemva
lowtiter
c22
primemodified
govxb11
underutilize
monitoringimmunerelated
polymerasechainreaction
lyta
notageappropriate
36±11
2125
strenuous
exercisestrenuous
polarisation
crossregulatory
catecholamines
napoli
2016the
ipilumumab
advancedrelapsed
immunooncologic
pdl1pdl1
behçet
8mgkg
meter
lfm
haze
cmt
inactivity
519months
154±27
50±09phms
3247±366µm
2802±341µm
206±54
93±45µm
allohscts
signbgitmoamcli
145313
122484
nct02088840
viruswe
oka
voka
mostaffected
consentrefusal
epic
heights
canvaxin
bcgcanvaxin
bcgcv
bcgplacebo
bcgpl
nct00052156
p0250
p0696
0882
p0260
repartition
il15the
gscf
immunomagnetically
patientmobilized
cytototoxicity
timediated
therapycart19
lithuaniaobjective
sive
nonuniversally
intercorrelated
vaccinationunited
20102012unassigned
48000
9801
months6
months64
amlchimeric
probed
surfaceome
ct2a
gmciantipd1
pd1timcd8
macrophagesmicroglia
pdl1mediated
workerunassigned
gmcsfexpressing
000005
tularensispulmonary
intubate
tracheae
anesthetized
standardizes
cholangitisintroduction
udca
obeticholic
oca
sulfur
gasinduced
smlung
pathophysiologically
smokinginduced
mutationpositive
phaeohyphomycosis
postrenal
itraconazole
neocytalidium
exophiala
jeanselmi
dematiaceous
ecov
bcov
8monthold
infantpertussis
underrecognised
designgiven
timehpv
20012005
mascc
pediatría
lamberteaton
vgcc
radioimmunoprecipitation
irrespectively
201400434435
201600313826
allergythere
otolaryngologist
profilewithin
tlymphocyteassociated4
1antiprogrammed
hypersensitivitya
experiencehydroxychloroquine
hcq
autoimmunerheumatic
allergensallergy
allergenantibody
hypoallergens
carcinomaseveral
diabetesstudies
immunologics
courseboth
trachomatis
statesunassigned
decisionanalysis
trachomatisassociated
2158117
fetusesneonates
34000
5976
nonde
recipientsreconstitution
majorhematopoietic
sscs
sexmatched
n244
sst
immunedriven
pathwayt
immunizationtranscutaneous
perifollicular
transfollicular
ci6976
255years
anemiadifferent
matchedrelated
120mgm
1200mgm
engraftments
1434
525914
perspectivesprogress
enjoying
respectivelysignificantly
131312
106367
145488
hr586
1771939
αβtcelldepleted
αβdepleted
sinusoidalobstruction
actuarial
66vs
61vs
αβtcell
tidal
metastasesa
nonsuperiority
substudies
actrn12615001088538
hostsimprovements
speculations
totality
cellsmyeloidderived
mdsctcell
mdscmediated
inflammationcarcinogenesis
immunotherapyautophagy
tumorsuppression
oregons
coveragepersistent
penis
targetedtype
systemengineered
hydrophobicity
diseasecoronary
atheromatous
seb
aciclovir
acv
hu2c
hsv12
acvresistant
arn
microinjection
56h
acvtreated
drugacvresistant
unrestrain
tamcsdependent
tamctargeting
arteriolar
underhyalinosis
underimmunosuppressioncalcineurin
hyalinosis
lessthanexpected
hyalinosismight
underimmunosuppressionnonadherence
txbx
logtxbx
ah0
contours
physicianrecorded
nepalobjective
sarlahi
1540years
smallforgestationalage
2741
3623
42g
111g
75100
apregnancys
38g
pregnancys
gliomasobjective
carve
mucotoxic
masccisoo
photobiomodulation
palifermin
loperamide
octreotide
morphotypes
fungusspecific
heminbinding
hemagglutinin2
gingivalisthe
ha2
ha2hemin
dhyavmisk
hemin
dgfpgdhyavmisk
dk
antipeptide
sigas
ligature
microcomputed
shamimmunized
adjuvantpbs
dkadjuvantvaccinated
palatal
1555years
agewomen
nct00196937
1525year
antihpv18
2645year
4555year
53fold
vp16
adultsallogeneic
vp16cytbi
n376
n1178
056100
062093
advancedrisk
039088
065118
cvidobjective
100±56years
primarycare
guji
kebeles
7106
msmicrosoft
81100000
11th
to14
90103
woredaskebeles
thats
rec
selfassessment
collectors
megaphones
kebele
57745
3644
18138
dpthibhepb
consistencies
hsdp
fellshort
sbc
2328
168298
167359
intentionor
4838
bloodgroup
18196
thereafterbackgroundaim
prenivolumab
beforehand
pretreatments
bevacizumabpretreated
postnivolumab
43852
immunotherapywith
deathprogrammed
indoleamine2
3dioxygenase1
platinumineligible
2drug
cd16adirected
cellsbispecific
cd16a
fcγriiiadirected
atriflex
bcmacd200based
17fold
pcnslunassigned
gm2
crcru
mttp
141209
09523
048218
dosingschedule
bunza
remediesbackground
curtailing
balu
loko
dispensary
inseparably
yflav
engenders
reninangiotensin
immunotherapyreninangiotensin
rasiwidely
diseaseshave
rasi
15year
periodbackground
pcv7included
pcv13included
nonpcv
031075
efficacyantigenspecific
hailed
initiativethe
hol
plandostudyact
3σ
bats
brazilobjective
campinassp
105764
65561
oscillation
10212
9522
montes
claros
paissv
goodideal
formosan
badgerssince
enzootics
tcid50dose
postapplication
266day
198th
repercussionsmycobacterium
15million
starvation
chalk
intersections
autophagybased
populationit
controla
immunecontrol
cholangiocarcinomaintrahepatic
marginpositive
partenariat
oncologie
digestiveactions
concertées
dans
colorectaux
digestifs
prodige
gemcitabinebased
dehyrogenase
threemonths
71yearsafter
transplantobjective
78413kcal
3476g
bmiage
htage
lsss
monolix®
3point
twocompartmental
12gm
interpretability
ratioimportance
rmst
rmstbased
thoughtful
immunotherapyactivation
adenovirotherapy
pretreating
adderived
her2carexpressing
cad12pdl1
to100days
9110
deduplication
mesalamine
osteitis
sudanese
antituberculous
responseimmune
specificantigen
heretofore
unrealised
feverrange
hightemperature
hpvvaccinebackground
7681
19992014
073100000
irr081
029226
5470
vus
monthsprcr
572936
questionsthe
firstofits
50100fold
onehundred
forteen
anticd
118195
81195
37195
therapiesimmunooncology
bcrabl1positive
bcrabl1abl10
1440
07142
5yr
lymphocytepredominant
transplantationlymphoma
partywhilst
nlphl
3105
diseasesanimal
immunobiologic
helminthderived
hucmscs
ccrc1
highyielding
hdcs
vaccinesmrc5
hdcstype
earlypassage
mrc5
hucmsc
center1
adventitious
nontumorigenic
1117year
combinationsimmunotherapy
pi3knetwork
zetajet
hivdna
hivmva
mozambicans
2×01ml
1200μg
2×02ml
3mgml
1575
sfcmillion
gp160
0102ml
magnitudes
hpv1618vaccinated
firstvoid
hpv111618313345
possiblewe
revaccinationinduced
menb4c
outbreakoregon
slide
3802
genotypically
erlotinibinduced
vasculatures
immunosupportive
h1antihistamines
labelling
evidenceobjective
cytof
typesthe
therapieshematopoietic
ensues
directionsdisease
fostamatinib
persistentchronic
thrombocytopeniaimmune
autoantibodycoated
sykmediated
thrombopoietic
disodium
orallybioavailable
fcrtriggered
sykdependent
antiamyloidβ
promisethe
immunotherapyspecifically
safetyie
oftencited
sufﬁcient
proteinconjugated
bdmard
csdmard
076094
077099
stagestructured
vaccinatorsspatial
obligatekilling
freeliving
betweenstage
resistanthost
hostparasite
recurrencevaccination
humanitys
measleslike
farsighted
timedelayed
awarenessthis
killer92
dmsofree
medianatural
continuouslygrowing
cryoprotectants
replacements
congointroduction
susceptibleinfectiousrecovered
5808750
156836
13232250
166475
zealanders
n16642
agreedwere
conscientiousness
agreeableness
roasted
peanutloaded
penp
150nm
mmcpt1
1213yearold
92·4
200809
19881995
8584
30·0
26·933·1
3·55·7
89·1
85·192·3
93·8
83·898·5
79·1
64·289·0
82·6
61·593·9
0·13
0·060·28
0·45
0·230·89
startling
antibodiesproper
drugallergic
mabrelated
taxanestaxanes
managementhypersensitivity
ccl3introduction
embodies
arming
metaanalysisthe
crd42016036945
1636
ci239
154369
ci273
153489
workrelated
nonworkrelated
everemployed
callback
told
ratio124
ci106
asthmaallergic
allergenspolysensitization
polyallergy
grmdsc
periodpreterm
wog
±2
gmr
120221
106270
gmr062
038100
gmr055
032092
absences
collaborativestudents
winstonsalem
forsyth
synchrony
week10
dmpa
sscpah
vdj
ighv25
mutationfixation
dpositive
replenishment
determinism
immunostimulationthe
transferable
tolllikereceptor
275nm
20mv
120nm
kupffer
lsec
reallifebackground
тhe
54979
273years
sd614
р0001
dafshielded
baculovirusvectored
bdes
decayaccelerating
hdaf
newlydeveloped
bdesspfcsp2spider
bdesspfcsp2spier
bdesvaccines
831years
dcone
tlymphocytemediated
solutionscontext
billables
erahuman
oncotherapycurrent
stromaltargeted
capitalize
oncogenomicproteomic
undenatured
chemoattractants
linethe
atctis
peanutsbackground
egids
ppe
viaskin
611±133
278±6ngml
614±163
1059±256ngml
eosinophilsmm
59645
4628057
peanutinduced
trialrationale
3891
2395
1732
nct02421484
dtphbvhib
dpthepbhib
6056
n268
1196
4645
3897
targetsthe
monosodium
urate
scaleshealthcare
informationweighing
recast
9item
movacflu
unidimensional
nomological
surveypurpose
2015march
pr247
175348
pr147
105204
pr164
119225
pr158
ci124204
pr144
104199
pr044
023085
sgd30
sgd20sgd50
sgd45vs
p00012
childrenpurpose
n227
sitelevel
n14406
irr105
101109
irr108
102113
irr103
100106
irr104
102108
transplantationimmunoglobulins
to23
abstraction
585342
fivemonths
hypersusceptibility
drugpromoted
drugkeytruda
syndromesallogeneic
ipss
ipssrevised
ipssr
wpss
ipssrbased
nonhazardous
bregmediated
il10mediated
interferonomega
applicationssince
ifnω
seasonpregnant
28april
2016january
2438
ltc
20002016background
pnpvs
dnaj
micestreptococcus
programmeswe
admissionsthere
424048
152269
risktargeting
micrograms
1930
chinawang
liang
bacillecalmatteguerinbcg
1933
insisted
couldnt
transplantunassigned
inductors
ensemble
anatomopathological
actinic
laelay
adiabo
tigray
motherscare
35695ci158801
26895ci130551
3395ci
154708
5295ci2361146
3395ci187743
mediums
mvabthe
reboundcontrol
sieve
rebounding
hlaassociated
assaydirected
bortezomibassisted
xm
tahg
antihlab59
ahgcdc
trialogueadolescence
hesitations
providence
mistrustvaccination
stake
interlocutor
vaccinationdoctors
collegues
litterature
debunked
professionnals
diseasecytomegalovirus
fourway
indiaobjectives
4way
conformed
istanbul
11month
antinogoa
analysismany
forelimb
contralesional
perilesional
requestswe
trastuzumabcoated
fcγriia
fcγriia131h
fcγriia131r
ipilimumabpurpose
ibiiia
cd28dependent
2324
747482
campaignobjective
emiliaromagna
emilia
uninvited
10462260
17982307
114228
foreigners
037056
nonparticipant
126236
104140
underscreened
104156
geneantipd1
pharmacistdriven
decisionsupport
handouts
wallet
academically
6question
detailers
27410000
ci515
to032
synthesisbackground
1609
theoreticallygrounded
bestsuited
pmhc
e5specific
hlab0702
mitebackground
dmft
dentition
cariogenic
teethbrushing
1913
withingroup
carious
0058
rvit
cvit
βblockers
formulationbackground
sqhdm10000
ir57000
freezedriedcompressed
disintegration
47fold
108fold
236fold
sqhdm20000
125fold
fastdissolving
mt04
mt06
vaccinealthough
immunotherapiesobjective
imrs
imr
bayes
eb05eb95
cpiimr
eb0520
1018
eb05124
eb05132
eb05150
eb0573
eb05456
eb05176
eb05542
eb05480
eb05218
dosedense
fcdependently
infectionshepatitis
pres1
taurocholate
cotransporting
2h5a14
picomolar
neutralizationactivitymediated
antibodyfcdependent
findingsalthough
clinicspractices
feasibly
dcvacpca
200901725991
lncap
psadt
567months
1885months
p00018
psareacting
strategiesacinetobacter
antimicrobialresistant
antiomp
antiompa
19606
capsulenegative
ab30730
capsulepositive
ab3070294
shielding
726375
syndromepurpose
azanucleosides
mdsdirected
hlaunrestricted
cdx1401
101929
glioblastomadendritic
glioblastomabearing
nanotechnologymediated
virusaim
3334
entitythe
genomicplasticity
disappointments
hemagglutinating
hvj
hvje
cancerselective
βinterferon
icam1depleted
antiasialo
gm1
pointofdispensing
pod
missouri
20122016little
preparednessespecially
0not
1met
t143
elusiveness
amltargeted
nanoparticlesin
hollowmicroneedle
120μm
ovapolyicloaded
ovapolyic
moreafter
mushroom
eimeriasis
chickenmushrooms
hwe
methanolic
pse
deae
sephadex
g100
maltose
0282
phytohemagglutininp
srbcs
droppings
postphap
antisrbcs
therapyresearch
tumourimmunity
pathwayespecially
uveitidesthe
uveitides
panuveitides
timeupdated
antimetabolites
nonalkylatingagent
ofnoninfectious
globulinsbroad
grafalontreated
thymoglobulintreated
grafalon®
12±10
21±12
cd38drki67
cd8cd57cd28
anemiaalthough
istrefractory
toleranceallergen
confirmative
nanomedicinethe
nanotechnologybase
activationnanotechnologybased
npinnate
viralvectored
matrixmthe
matrixm
metrap
thrombospondinrelated
chad63mva
trapspecific
nct01669512
replenishing
haltdepigmentation
vitiligovitiligo
darker
tones
melanocytereactive
pelage
depigmenting
vitiligoprone
ahealthy
tcellsthe
nsclcregulatory
3cycles
treggenerated
bacteremic
2628
iapd
cancerregulatory
scurfin
thesuppression
i3f8
medulloblastomabackground
crit
ilabeled
2mci
curie
10mcidose
regionofinterest
brainspine
somnolence
35002784
ci163558
018088
rhinoconjunctivitisallergic
immunologys
presidential
agreeiibackground
aitgls
mcmaster
methodologists
iievaluated
post2010
aaaaiacaai
pre2010
gls
1646
3086
7point
germanaustrianswiss
aitgl
evaluators
rigor
flawed
transculturizing
transculturization
vaccinesfoot
pprfmd
cellsincreased
il7responsive
miles
inhibitorsobjective
antiabo
amr
indianaobjective
ihes
indiana
oncampus
inquiring
ihe
matriculating
physiciansigned
menhpv
andreas
syggros
vaxigrip®an
splitvirion
vaxigrip®
1968
201400507812
11fold
89100
9098
6681
mrnamediated
immunotoxin
deliveryimmune
pe38
antiher2neu
e23pe38
vegfpe38
vegfpe38d
translocated
impermeability
immunoreduction
alpha2apurposeto
alpha2a
managementmethodscase
sheffield
managementresultsall
effectsconclusionsinterferon
sarcomassoft
adopative
immunoresponsiveness
hethcote
rop54
gbp2
parasitecontaining
vacuoles
pvaxrop54
130±115days
67±048days
68±042days
65±053
blank
cyst
014years
dyskinesia
glasgow
score15
microenvironmentnatural
emancipate
stifle
repeatsassociated
ecce
nimble
applicationrecently
immuneoncologic
cattleaim
hardjopomona
pomonacopenhageni
incontact
dryingoff
effluent
strategiesis
2016influenza
nzis
imac
m21
hmpvspecific
immunotherapymore
pg
pathergy
pancreatectomy
nesidioblastosis
centro
hospitalar
tondelaviseu
viseu
footwear
antiseptics
purplish
selfdetachable
attitudesantivaccination
9524
9870
4719
4535
5152
3386
nanoparticlesdengue
dv
capnp
capnpmultipeptide
reviewa
needleconsistent
valuing
literally
disordersmodulation
difficultwe
dismissal
childpatients
activitysubcutaneous
beenshown
pteronissinus
dpallergic
αil10
αtgfβ
nder
il9producing
cancercheckpoint
hpvnegative
scc7
moc1
meer
ifndominant
ctlstumors
poliovirusrhinovirus
cytopathogenic
sublethal
interferondominant
pvsripos
adjuvancy
culminate
fcfree
triomabs
innovatorsintroduction
regained
winters
rhinoviruses
2690
ntr3386
104172
1065776
090148
068699
interleukin17positive
433±171
il17positive
il17receptor
00449
02918
00876209721
churchstate
problemall
philosophy
nonreligious
footing
nonpublic
20122013objective
vcr
nonafrican
121266
104317
095291
reviewfood
administrating
allergenmodifying
rasmapk
α41bb
p38jnk
efficacymek
stalkspecific
hemagglutininspecific
assaythe
authoritiescannot
immunotherapiesimmunity
7719
521521
topicat
diseasesrapid
hpyv
pyvassociated
jcassociated
amilestone
neurologyobjectives
nhird
25975
cancercurrently
ascogastrointestinal
200915this
549972
selfdisclosed
micropolitanmetropolitan
connecticut
targetedtailored
bells
reportipilimumab
45yearold
toxicitiesimmunotherapy
cartcelltherapyassociated
aupt
cytotoxicityhypoxic
corept
reoxygenate
pd1pdl1blocking
mvaβgal
mvamuc1
tg4010
modeltg4010
βgalactosidaseencoding
βgal
klrg1
slecs
eecs
tharparkar
sindhobjective
117385
58191
101332
undernutrition
pregnancy4
vaccinationp005
therapylymphodepletion
classificationtree
repertoiresrecent
stochastically
clonespecific
cdr3s
n1dn2
layout
lymphocytedeprived
lymphocyteenriched
0322
00219
7722
644252
anticd44based
nirpitoral
anticd44
moc
mkate2
moc2luc
anticd44ir700
tumortobackground
mabphotoabsorber
1512
166777
beyondchimeric
alloresponses
studyinfluenza
1753
diarybased
6585years
psychobehavioral
cancerunderstanding
drr
factbrm
socialfamily
toi
hr007
hr005
hr011
nct00769704
httpsclinicaltrialsgovct2shownct00769704
keys
magnetosomes
azideengineered
copperfree
onebutall
imitates
inhibitorsimmunooncology
pharmacometric
allergooncology
cancerwhile
juxtaposed
2017from
subdomains
vitrobackground
her2ecd
diii
diiiiv
chok1
antiher2ecd
antidiii
lasermicroporation
efficacydue
micropores
cerevisiae
periodate
betmannan
neoglycoconjugates
unconjugated
lasermicroporated
th1th17biased
mannanneoglycoconjugates
abagovomab
mimosa
nct00418574
finder
splits
carriersthe
immunecelldirected
fistulising
refugeesbackground
breakeven
22593
49842
rmamedicaid
gutresident
rantespe38
lpls
primatized
ccr5expressing
endured
replenished
agencythere
submits
psurs
psur
observedexpected
accepts
reappraise
diligence
bacteriumthe
etimp1
tenellaeimeria
imp1
houghton
cag
histagged
retimp1
rtc
mockimmunised
commercialstyle
sme
bacteriallyexpressed
degsrp1
degvit1
degpuf1
n384
cages
adjuvantonly
exposurerelated
tf117
isolatestritrichomonas
flagellated
protozoa
urogenital
trichomonosis
foetuspositive
cytopathogenicity
trichomonad
pentatrichomonas
trichomoniasis
modelintravesical
n10group
bcgtreated
nmethylnnitrosourea
intravesically
ticestrain
bladders
immunohistopathologically
2dbased
rabgdiβ
aldh2
1433
zetadelta
leukemiaefforts
dgkζdeficient
7720
567686
afucosylated
medi570
offspringmedi570
prepostnatal
eppnd
abortifacient
fibromatosis
noael
m590δmanb
m590
micebrucellosis
manb
antibrucellaspecific
interleukin4il4
rbpt
16m
postnk
ctcrelated
30d
macs
1811±5813
1513±5984
1032±5623
δct
mage3
ck18
schoolchildrenthere
matsumoto
10524
5063
iiiiia
alphagalactosylceramidepulsed
dualagent
tcellspecific
umin000010386
r000012145
satisfies
alphamangostin
interleukin1βinduced
chondrocytes
modelosteoarthritis
αmg
mangosteen
medial
meniscus
dmm
mmp13
adamts5
sox9
cytoc
ccaspase3
il1βinduced
20082010objective
111160
105179
marriedpartnered
elephant
loxodonta
africana
qualityobjective
iucn
overpopulation
overabundant
elephants
ampullae
bull
pubertal
ejaculates
spermatozoa
8175
4104000x106ml
immotile
musth
stateshealth
undervaccinatedin
infectioncontrol
heatstable
guanylyl
reportcancer
intestinally
4055
pathwaytargeted
outcomeshaploidentical
ptr
nonptr
nanomodulator
cpgmediated
immunotherapyunmethylated
mno
cpgsilver
agncsdoxorubicin
cpgagncs
ππ
lowses
betalongterm
reportimmune
epigastric
retrograde
cholangiopancreatography
stenting
modeltherapeutic
transference
admitting
manages
blockadecancer
inhibitortherapeutic
exertion
abilityof
possibilitythat
bytherapeutic
bythe
antibodyagainst
newlyidentified
coinhibitoryreceptors
etcand
newlyexpected
inhibitorsrecently
mutationrecent
cancernsclcthat
ofresponse
inhibitorsit
missionthe
upwards
viraltransforming
papillomaviruspositive
mg1maraba
invoke
84759
oncologyproceduresimmunotherapy
influenzapneumococcal
9151
womeninfluenza
6267years
alswh
naturopathsherbalists
or064
yoga
or077080
or078083
or117124
adultsannually
atypically
fludarabinebusulfanbased
cellulaireunassigned
4mgkgday
32mgkgday
n277
fb3fb4
n101
fb2665
lymphomafree
fb2579
fb219
fb2112
p018
freerelapse
096224
099206
096248
scorematching
inflammationone
il4rα
lymphopoietin
reviewreceptors
fcrs
inhibitorytype
diseasesmonoclonal
antiα4
daclizumab
antiaquaporin
aquaporumab
aquaporin
followingupobjective
dexyribonucleic
saccharomyces
hepbsc
hansenula
polymorpha
hepbhp
imunoassay
4992
9431
7592
1351
23775
9381116
2891
26653135
28036
was10
23975
120173
014040
detections
chaoyang
hepbscy
hepbcho
hepbhpy
chemiluminesent
mantel
haensel
7949
8434
8250
7415
were3953
6237
4818
3364
7901
4118
ofonly
notandhistory
rates80
carcinomat
demonstrably
checkpointassociated
pigments
constitutionality
cdai
anti‑tnf
kgm2
4789
4548
men27
pedptld2005
euronetphl
rangebased
gfr
p0978
adultsvaccinations
programms
ahigher
anticd137
regressionthe
nontdln
peritdln
lymphangiogenesis
factorc
vegfc
receptor3
vegfr3blocking
vegfcinduced
infectiondengue
antidenv
dj
denvinfected
antidj
denvinduced
antins1
2e8
hostcrossreactive
ns1specific
antijagged
tolerancemyeloidderived
antijagged12blocking
ctx014
mdsclike
antijaggedtreated
jagged12
nfkbp65
antijagged12
562838
49·6
89·5
90·3
75·196·6
nf54
cpsimmunization
nf54cps
nf54infected
nf135c10
nf166c8
sterilely
cpsinduced
nf54cpsinduced
sporozoitebased
nct02098590
decelerate
rsvspecific
180days
cordmaternal
088119
p086
r011
p057
engagerarmed
virusesoncolytic
bitearmed
nontransformed
diabetologists
tragedy
peerreview
grassbirch
marrowafter
cancermedical
eleveated
hypoxemia
isoniazide
rifampine
comics
immunizationsthis
flyersone
comic
comicon
informativeness
independentsamples
flyers
intentionrelated
alternatedonor
disorderswe
haploidenticalseven
donorone
alemtuzumab3rabbitantithymoglobulin5
irradiation5
thiotepa3
treosulfan2
busulfan1
138×10
nodosumlike
panniculitis
therapyreport
patientsimmunotherapies
septal
t790m
challengesnew
gist
mesylate
antikit
changerelated
predictorspurpose
physicalqol
476±134years
β009
cesd
β006
β005
β03
assessmentbackground
alifetime
intangible
apredefined
ahealtheconomic
crossinfluences
curricular
palermobackground
unsafety
p©
extracurricular
hopesimmune
100210
fcgr2c
diseasered
fcgr23
fcgrspecific
2cncorf
011064
011085
006059
ncorf
punctatusbath
proteinhapten
immersed
vaccinecoverage
moderatorlead
franciscooakland
23min
infographic
approachimmunoglobulin
propertiesgold
withina
immunotherapyhow
coinhibitor
gpc2
neuroblastomawe
rnasequencingbased
mycn
neuroblastomas
gpc2directed
gpc2expressing
reviewkidney
territoriesobjective
resettlement
resettled
hpvtransformed
conspire
allergyamong
constituents
diseaseprognosis
193months
p0462
diabetogenic
developmentgrowing
bdc25
doublereporter
cohousing
n144
isr
isrs
9134g
9245g
8756g
hyopneumonia
wayimmune
surveyaim
onfacility
n1367
challengesintroduction
ionising
9p241pdl1pdl2
pdl12
complexi
complexii
cd8tcellmediated
interventionthe
microbiomedriven
windowofrisk
leapon
epidemiologywe
networksie
possiblewith
recoveryas
diseasespreading
acquaintance
queryefficient
vtp
tlss
lightvtp
awardeesobjectives
phep
awardees
pods
staffing
flulapalooza
command
66591
13318
vectorexpressing
lv305
patienteffective
integrationdeficient
incompetent
zvex
therapyrefractive
whenintroduction
brafv600
olderthe
1607
n463
n721
fm140
n423
adultspurpose
riv
5064yearolds
sdiiv4
9984person
091person
37700qaly
71500qaly
mturk
qualtrics
ifwhen
2544years
3099
0489
curecombination
mycofenolate
catapulted
arcc
matterimmunotherapy
micehemorrhagic
pmultocida
viz
inducedby
asiaautoimmuneautoinflammatory
macrophagic
siliconosis
reviewsince
datalinkbackground
dvt
1488
irr089
069117
irr257
106623
142days
fevipiprant
immunotherapyallergenspecific
beekeepers
lonipcs
227years
973days
145days
578days
lonipc
centersthere
nonms
insightsvaccines
malaya
ummc
kuala
lumpur
spouse
cuetoaction
or2288
10934793
or4030
16949587
2344
turkeyshighly
gooseguangdong
flyway
reassorted
h5n8
hpaivs
eastwards
replicon
adjuvantedinactivated
nct00543543
14215
n7106
n7109
19·0
97·4
85·099·9
crel
κb
atreg
atregmediated
checkpointtargeting
ribas
virusinjected
nonrodents
productsbackground
minipigs
keratinized
nonkeratinized
ridges
glycogenrich
nonrodent
cd3cd4
pharmacodynamicsefficacy
antierbb2
nineyear
ventrogluteal
underpurpose
thicknesses
statebackground
comeback
hassles
curecontrol
reconciled
immunotherapiestumors
mcpcounter
antipdligand
immunomonitoring
debating
intentional
nonintentional
dtapvpihib
mencc
107days
209days
227days
or585
2801222
or013
007024
coadminister
or015
010021
or329
247439
or050
028086
or299
145622
biketrike
bikes
trikes
argentine
districtsbackground
brandsen
navarro
50days
or2594
460114621
or7834
409150000
0006078
networkconstrained
responsesunassigned
uninterpretable
networklevel
logminer
interpretable
httpsbitbucketorgkleinsteinlogminer
stevenkleinsteinyaleedu
stefanaveyyaleedu
fecundabilitybackground
presto
3483
rsvh
wga
27fold
handsearched
1327
5298months
statesvaccination
4313314
ankara5t4
trialunassigned
mva5t4
1×109
8341
3609
6581
720
021111
009047
014074
isrctnorg
isrctn54669986
buzz
nkrs
nkr
nkrnk
brodalumab
erbb2positive
malignanciesbackground
nk92528z
her2tank
lentiviraltransduced
manufacturingrelated
werealso
ffp
vuelife
750c1
10gy
gzmb
24fold
sfasl
10l
autoantibodyproducing
rituximabinduced
autoantibodyexpressing
cd27hicd38hi
equipping
carsadding
praeventis
n36000
n2483
n8062
n4067
n3995
idm
p60
computertailored
trialregisternl
ntr4935
httpwwwtrialregisternltrialregadminrctviewasptc4935
webcite
httpwwwwebcitationorg6srt7l9em
pathogenboosted
pathogenbased
certolizumab
pregancy
crib
xavier
marietteprofessor
mariette
bicêtre
parissud
axed
biotherapy
observatory
ora
orencia
pathogeny
chair
coauthor
pembrolizumabinduced
cholangiocarcinomabackground
67year
leucovorin
aftereight
titersconclusionsto
focis
immunologyfocis
wwwfocisnetorg
santiago
daylong
therapydue
transsignaling
affinitytuned
cogitations
myelomaobjective
unregulated
organbased
msirelated
anemiaobjective
unrelateddonor
controlbackground
20496
populationrepresentative
clinicsunited
designees
2541
netherlandsintroduction
prostitution
pg292
0507
0103
ov0556350
immunomodulatorscancer
agonise
dipeptidyl
dpp
immunotherapychemokines
kilodaltons
alphachemokine
stromalderivedfactor1
plc
sapk
slowprogression
carcinomatosis
pdl1induced
cervidized
selfantibodies
vitrochronic
recprp
cervid
surfacelocated
cwdinduced
rtquic
cwdinfected
cervidprp
rk13
melanomacd47
adcp
sink
cd47targeting
a4fc
potentialintroduction
syndromeinterstitial
pbsic
factora
immunopathways
discretetime
£20000
£30000
£100000
immunotherapiesbeware
vascularizedcomposite
allotransplantationobjective
noncultured
stromalvascularfractionderived
vasculogenic
fractionderived
parentscaregivers
176358
230481
forgetting
thirtyday
qualityofcare
northland
sact
whangarei
wbh
australasia
shortlisted
sactnaïve
auditing
controlnovel
effectsregression
therapyare
hyaluronidasefacilitated
diseasesmost
pidds
glycosaminoglycan
depolymerizes
rhuph20
ighy
ca199
79months
38121months
91months
p00432
136months
122months
p00327
p00387
121months
p00451
102months
p00367
t‑lymphocytes
aprogressionfree
asurvival
melanomainhibitory
mia
involvementhematopoietic
tbifree
n134
p799
p642
p646
p177
p502
p424
p226
p117
nontbicontaining
rapamycinadoptively
atra
pollenrelated
adolescentadult
crossreaction
rmal
rbet
1treated
forthe
freetown
sierra
leone
8273
β0154
00580163
5592
β0150
00630186
810days
spectrumpsoriasis
europeanamerican
polarity
asianorigin
patterning
overlaps
polar
il17targeting
synucleinopathiesvaccination
yzevalin
myelomathis
nct00477815
mtd
250mgm
inzevalin
sargramostim
2230
18gy
immunodiagnosticsalthough
targetbased
20012020objective
valueofalifeyear
us350
us330
us9
us5
us820
300388
88388
204388
168388
3688
testneoantigens
cannabidiol
encephalomyelitiscannabidiol
cbd
cannabis
ateae
cannabinoid
subiculum
gpr55
cbdmediated
apps
upr
proteostasis
urovysion
washouts
prebcg
4046
peptideenrichment
patientspersonalized
peptidemediated
leukapheretic
br
hormonerefractory
taaspsa
magea1
magea4
externalization
taasreactive
taasderived
19s
interleukin8
followupinterleukin8
immunosuppress
secretionsbackground
rlp
papillomas
precociously
measurerespiratory
polyprenols
trimethylpolyprenylammonium
iodides
ptai
isoprene
polycisprenols
12dioleoylsnglycero3phosphatidylethanolamine
dccholesterol
3ßnnndimethylaminoethanecarbamoyl
dopc
12dioleoylsnglycero3phosphatidylcholine
vaccinefibrosarcoma
excisional
rndvtv
wehi164
cb17scidscid
cancerbladder
siegel
66730
79000
17000
haematobium
antoni
eur
urol
7196108
gupta
915114
maase
2346024608
santis
30191199
bellmunt
44544461
915months
zilchi
10115520175618174
famine
feast
wiselynot
biomarkersthe
biomarkerfocused
activityimmunooncology
dosetoxicity
oncotherapeutics
ccr
ank
interleukin2dependent
celldose
hematoietic
cmvpeptide
laterborn
tuberculosishostdirected
insightsglioblastoma
astrocytoma
penetranttargeted
travelerstake
recipientsrenal
immunovirological
antiinterleukin2
pitiésalpêtrière
2358
2698100
058139
surfaceengineering
rbcbased
peptideloaded
aapcil2
raapcil2
cancercellspecific
directionsvaccination
bureaucratic
prosperity
diabetessolid
spraguedawley
insulinresistant
sirolimustreated
taxa
roseburia
oscillospira
mollicutes
rothia
micrococcaceae
actinomycetales
starch
thoraxlung
allergyrituximab
ommit
settingobjective
nonnasaleye
programgestational
βlactams
assistances
municipalstate
corroborates
cameron
syndromethere
cd19depleted
luznik
26mo
d30
toxoidspertussis
pertussisbackground
61014
challenges3bnc117
cd4binding
hivshiv
hiv1associated
anti3bnc117
macrophagestumorassociated
m2nps
αpeptide
srb1
m2pep
anticolony
anticsf1r
αm2pep
m2npbased
29fold
sirnacarrying
62fold
asvac2017
combinationstherapeutic
deltagamma
lymphomanew
largebcell
mantlecell
marginalzone
2015the
d8rostovdon
berlins
aged2
paratyphoid
guidelinesintroduction
vfrs
paratyphi
vaccinechanges
or206
102415
antiox40purpose
antipd1refractory
combinationtreated
2320
616577
colombo
5999
doubledecker
deliverymicroneedle
lowinvasive
puncturing
pgamn
nylonmn
nylon6
puncturability
etv6runx1
github
httpsgithubcomzhanglabstjudeneoepitope
schoolgirls
ibanda
kiis
atlasti
stilled
lingered
settingdisparities
bernardino
pposbc
implicit
mens
privileging
relatable
fibrosispseudomonas
opportunistically
adapts
pumps
βlactamase
porins
amikacin
fosfomycin
tobramycin
oligog
cysteamine
garlic
antipseudomonal
rvsvzebovpredicting
cxcr6
vitroexpanded
hyperexpanded
youngerobjective
parturients
in19972015
12743
6103
2061
17972364
6640
inbefore
2207
19022562
postebolaa
postebola
montserrado
nimba
bong
margibi
allergiestree
allergyhouse
educationthis
controlledtrial
niigata
birthdays
injunctive
scaffoldbased
transcriptomal
signaturesprotective
tbspecific
beadarray
obuense
cellsheatkilled
cd195
obuenseinduced
ccl4
pharmacistinitiated
copdto
pharmacyinitiated
asignificantly
surfacebound
microenvironmentregulatory
collagenfibrin
tgfβdependent
leukemiacurrently
n5037
lifestylerelated
prevalently
infrastructural
availabilityof
lowscoring
downloadable
trueorfalse
epidemiologyrelated
contin
educ
nurs
2017489431436
trialsglobal
investors
adopters
firms
treosulfanrelated
3×the
happening
immuneediting
reviewmelanomas
negates
apoptosiscombination
ox40vaccine
negated
e7specifc
antiox40vaccine
75566
reimmunizing
reimmunized
withthe
fullantigen
reducedantigen
metaanalysisan
18400
mcell
sizedependent
communicationobjective
responsibly
populational
respectfully
startingpoint
respectful
administrationintroduction
bliss52
bliss76
200mgweekly
serositis
exonuclease
polemutated
immunoprecision
pvt
pune
2210
2120
ankarabased
aaha
marcel
baltazard
irandr
19081971
baltazards
casablanca
foreignizing
mmp9responsive
mmp9cleavable
cd44expressing
19982008background
partialvaccination
nationallyrepresentative
200204
200708
178473
19981999
apor
95ci086098
95ci152165
caste
gapbackground
1465
providerreported
sensation
pharyngolaryngeal
200700323442
exosomesstaphylococcal
exo
wehi164cell
naloxone
nlx
exoseb
j774cell
sebanchored
therisk
eradicationworld
67524
16846
546800
114900
14687
25401
nonhpv
59897
5869
7994
198241
contestable
epistemologyindividuals
painted
nuance
detract
criticized
postmodern
feminist
m28zt2
m28z
5416
patientinitiated
vanished
yetopinion
ppvdcctl
cheeks
b19
stealththe
deploymentsecretion
anomalous
dnas
detectionrecognition
cancerstealth
expressionfunction
54414
carnks
pancreaskidney
antigensensitized
plasmapheresisimmuneabsorption
level50
weightadapted
apceden
apac
jacranda
marg
dlf
gurugram
indiaan
199days
157days
439days
apcedendemonstrated
microplans
discarded
metadatahealth
611monthold
1223monthold
12zone
623monthold
surveying
crossclassified
visitsummary
globallybackground
contextualized
necessities
plannine
countrydriven
immunizationa
fipv
stretch
disposablesyringe
injectors
lanka
earlyadopter
dashboard
planbackground
immunizationsystem
peesp
tetanuspertussiscontaining
multiagency
dtp3unvaccinated
albaniabackground
bphs
1858
subcenters
manpower
hardhitting
20475
nonmsa
practitionersthis
ophthalmicus
chemotherapyovarian
anticd133car
cd133positive
dak
evened
3336
cisplatinresistant
outperforming
hnsccs
agentsbackground
1401
2134
researchclinical
7306
hesitancyrelevant
dtpwhep
bhib
prpt
pentavac
hamadan
pentavalentrelated
jim
anitctla4
earnest
therapytreatment
cultureconfirmed
489fold
trumenba
collegeage
dillman
therapeuticsthere
esc
ipscderivatives
graftinfiltrating
allogenized
micerecent
pcdnacxcl10egfp
ltarentolae
multimerbased
labelinduced
fcγreceptor
labelfreed
nonreversible
tnfrsf13c
baffr
rodentsobjectives
receptorpneumococcal
at1rpspa
at1r
shrs
antihypertensive
nasalvaccineinduced
at1rspecific
at1rpspavaccinated
innercity
johannesburg
overriding
hundredfifty
range2329
405450
396450
p0338
liked
favourably
bootstrapping
134714
112321154654
20986
1892422822
273619
227260318102
47741
4282252462
childrenchildren
praxis
lowstimulus
surroundings
distracting
suck
sugary
attuned
meetingssymposia
symposia
leukemiarelapse
1094
hypersensitivityinfiltrating
mrnaelectroporated
nct00965224
tnfαi
tumorredirected
cellssuccessful
c7r
c7rcoexpressing
123847
developmentcgmpamp
cgasstimulator
cgasstingmediated
terminologyalthough
commentators
nonimmunisation
pragmatics
vaccineobjectives
adults50years
nct02519855
foldrise
gmfr
gpelisa
cgsg
nudges
shoves
mobilise
marketised
statebased
28954
categoric
andersen
multiracial
practitionersin
fillout
60item
1073
65yearsoldthe
65yearsold
patientyear
2743
000087
31700qaly
87489
5680
50000qaly
2099
recipientsthe
regmcs
allospecificity
niosomes
dnaencoding
microneedlesthe
span20cholesterolcationic
dimyristeroyloxyethylspermine
252505mm
pova
niosomepova
immunotherapyradiation
postirradiation
sensed
vaccinationebola
ebovinfected
rvsvebov
ifit
beaugency
horsepox
1866
extant
horsepoxlike
therapynucleostide
lowdelayed
17associated
tolerancemechanisms
chimerismbased
toleranceimmune
deletional
approachcancer
hypo
2016advances
prenylation
lat
clllymphoma
11b
bcl11b
tropomodulin
domaincontaining
rltpr
moesin
pioglitazone
chickensastragalus
apsl
apsm
apsh
antiibv
ibvspecific
cancertherapy
porter
datasurveillance
underascertainment
100·000
4065
86·6
7052
3292
ablationpurpose
crclm
cindex
hepatectomy
kattan
fendler
264months
0815
0698
0514
0884
grimscoreintroduction
icts
8372
105286
ldhupper
uln
112315
nlr6
104295
051135
nlr61
ldhuln1
albumin35gl1
57352
50837
187464
27148
checkpointblockers
inhibitorsintroduction
royalmarsden
orrand
dcrsdprcr
1gl
05gl
rho006
p073
itprogress
immunocold
icebergobjective
investigatory
antigentricom
immunotherapeuticsallergic
deals
allergyoral
cmoit
lowpowered
amyloidosisthe
amyloidoses
peptope
hypophysitisautoimmune
15cm
identifyingtreating
truefalse
unlikelyextremely
fourthyear
nap
hpaa
gerbilsepitopebased
univalent
cwae
neutrophilactivating
183203
132141
189203
epitoperich
ureb
158251
321385
gerbil
ctbue
158172
181195
211225
349363
gerbils
indic
ate
applicationsadoptive
lrp4
muskassociated
gravissince
antilrp4
aj
antimusk
mom
nanoparticulated
sta
colithe
macromolecule
hplc
nanoprecipitation
carbodiimide
hnmr
staplga
19952015introduction
3512months
1115years
conscription
1921years
19952015
31100000
30100000
augustfebruary
21yearolds
49100000
051100000
irr001
000016
33100000
53100000
irr016
006040
16100000
50100000
irr031
011084
australiasince
lows
6704
immunooncogenic
il15il15rα
awakening
treatmentsurgery
africaobjective
interventionmaternal
immunizationwithin
kmeans
euclidean
4group
2group
subdivisions
inhibitorepithelial
cediranib
rucaparib
healthserviceprovider
registeries
393·7
472·9
rhodes
wellcome
prepostinterventionstudy
t10585
inhibitorsnovel
ownimmune
womenvaccination
extracting
experiencein
immunodepletion
freeing
istanbulimplementing
interns
bezmialem
vakif
699±222
589±292
n66
childrenfuture
angiogenesistargeting
cd105
endoglin
tracon
665days
ludtpaigg
ludtpatrc105
143±23idg
116±61idg
6822
6682
6853
6182
038064
042063
087115
calliper
liberties
atcpzsvtjbdpcr05222o
endpointregistrybased
19yearold
nct01393470
patricia
nct00122681
hpv012
nct00169494
agealigned
allergyallergy
cant
mnscit
hypodermicneedlebased
clinicallyapproved
bronchiole
bronchioles
ovaallergen
blineagespecific
sar3419
sgncd19a
epratuzumab
folfox4
5fluorouridine
382457
284392
interleukinarmed
combinatorially
2016analysis
scab
incursions
uscanada
phylogeographydisease
raccoonspecific
rrv
phylogeographic
longdistance
nearendless
dnaencoded
antiprostatespecific
antibodyprostatespecific
electroporationenhanced
dmab
201415in
cmt167
76777
dockandlock
dnl
fabs
e13s
143s
trop2
ceacam5expressing
monolayers
subnanomolar
mdamb231bearing
tcellredirecting
538494
βadrenergic
adrenergic
βar
strategiesphysiologic
norepinephrinedriven
563951
chemoimmunotherapydespite
mcl2
mcl3
mipi
mipic
blastoid
customizing
pause
pharmdx
agilent
santa
clara
autostainer
cytopathology
concordances
0961
068091
highpriority
uncommitted
halal
chan
immunityrelated
rs7041
rs1155563
rs2298849
rxra
rs10881578
rs10776909
rs749759
vdr
rs1544410
rs2228570
ifnl3
rs8099917
rs12979860
il12a
rs568408
r3212227
rs1805015
rs20541
rs360719
rs1024611
04105
05342
rn
nivolimumab
offspringsow
antipcv2
bevacizumabassociated
microperforation
neuroblastomathe
pneumatosis
diversion
bevacizumabrelated
nondonor
transplantationleukemic
hlaa31
craniospinal
regionabelsonbearing
nonhsctdonor
donorfatherderived
melphalaninduced
fibrillation
artistscientist
beliefsthis
visualnarrative
selfhealing
insideoutside
artsbased
diagrammatic
meaningmaking
artist
failsthis
immunitys
selfdefeating
waived
androgens
infeasibleadoptive
melanomasomatic
sahin
ott
enteropathyoral
cattlebrucellosis
irecistunassigned
recist11
iupd
icpd
48weeks
criterium
uptakeintroduction
ipads
1184
immunepathological
highway
gurùé
milange
1650
rsoftware
arcgis
1031
esri
redlands
ci102
ci032
ci029
ci044
zambézia
familycentered
overviewhistory
exanthema
postencephalitic
incapability
neurotropic
blockadeglioblastoma
g47δ
g47δmil12
viroimmunotherapy
saha
magea3purpose
hladpb10401restricted
antigena3
halflog
shrunk
gsta1
transplantationbusulfan
chu
saintejustine
1500µmmin
diplotypes
clearanceprediction
servicesobjective
westlaw
4stage
clarifications
prescriber
adultsadult
domainsanticd19
allergyimmunity
populating
foodderived
tripartite
sharper
monocytogenesbased
lmbased
tregscd4
providersbackground
reutlingen
2388
overoptimistic
bronchialhyperresponsiveness
nonslit
newsensitization
adjuvantwhile
remedied
inhibitionctla4
lrba
factresistant
reappraisalobjective
transfusing
byproducts
ßglucan
20092010the
spains
1661
hokkaido
modellingbovine
pastures
culled
bvdvinfected
testandcull
nemuro
hiyama
forestry
haemoglobinuria
challengesvaccines
dissects
stephensi
transporterdespite
controleradicate
agap007752
transporterbased
vaccinationssuccessful
preexists
rlcmv
wealthbased
approachdespite
11001
evermarried
1549
dlhs3
erreygers
unequal
eldin
erastreptococcus
ltri
11·551000
20002001
9·591000
17·0
17·8
snapshotover
concisely
weaponry
normalhealthy
relapsingrefractory
humoralcellular
aeruginosamannose
malignanciespseudomonas
pamsha
cllsll
rs5
timetoretreatment
il21natural
hladrpositive
ngfrexpressing
zealandas
immunologicallynaïve
postcatch
018392
nz1
us864200
earnings
us66
us1877
interferoninducible
viremiabackground
carriersn100
nucleostides
n120
hbe
or3years
negativepatients
homair
fibroscanwere
282cleared
30p0000
350pgml
fibroscan
nct03193775
derp1modified
type1th1th2
derp1
1tlr1
derp1ar
dcsdcar
derp1dcar
scratching
scoured
unstoppable
1weeks
200300μg
2786years
hopesimmunotherapy
51120
bravo
hrnmibc
mbcg
16yh0268
isrctn12509361
ico
cidbinding
her2carζ
myd88cd40based
her2ζico
her2carcd28ζ
130619
15254
14297
15262
tdphihep
250mcg
extravesical
madeobjective
pharmacopoeias
grinding
defatting
sterilization
extractions
micet
selex
nucleaseresistant
rmt323
lupusnephritis
modelrobust
contaminate
immunodeficientanimals
cyclophosphamideimmunodeficient
immuneintactchicks
coccidal
escalatingdoses
8freesporozoites
walls
veils
immunodeficientchicks
normalorganisms
aberrantorganisms
naïveanimals
pathogenicdose
immuneintactanimals
normalpathogenicchallenge
elite
neutralizers
outcomeobjective
1336
lesionbased
lf
001055
5008±803
3625±1127
t5208
p0001we
myelofibrosisintroduction
pdl1objective
tn
her2enriched
eventbetween
iciild
02274
52months
consolidations
organising
377738iciild
recipientsimprovements
n140
age51
d22
patientspredicting
nct00092235
p024
clinicianreported
noncyclosporine
standallogeneic
monitoringopportunistic
dna546iuml
shigella
flexneri
miceshigella
shigellosis
sonnei
34yearolds
2arecipients
344yearold
oacetylated
disaccharide
osps
2016this
eiw
tyrol
188202
192214
transplantationfungal
hm
hmhsct
derangements
emirates
41years
19125years
cds
nct02551887
nenic
nucleoproteins
controlsincreased
ah1n12009acalifornia042009h1n1
npca2009
pandemrixapuerto
rico81934h1n1
nppr1934
smethioninelabeled
radiobinding
p00339
p00246
p000619
p0279
p00644
68ngml
74ngml
165ngml
199ngml
9ngml
20ngml
14ngml
23ngml
ah1n1ns1
p0272
proinflammation
antiinflammation
ageintroduction
foresee
polyglutamic
dendrimerbased
antigenscomputational
mannosamineconjugated
pgdendrimers
gp10044
gp100209
nitrobenzoxadiazole
nbdpgg4dendrimer
carboxylic
mannosamines
mannosaminesnbdpgg4dendrimer
mannosaminesdendrimer
taaconjugated
mannosamine
auckland
antigendr4
drb10401
4weekly
2weekly
proinsulinstimulated
proinsulincpeptide
andcancer
mrnalipid
goiânia
brazildata
lodged
17822641
1575240
homosexuals
antigenbackground
activitymaturation
targetcell
zeb2
blimp1
566475
highpotency
manisa
oskr2010
vaccinationserotype
statesvaccinating
smoker
targetbackground
amyloidβ42
aβ42as
lineal
aducanumab
cameroons
4594
641693
christian
1217
radiologist
pneumoniapseudomonas
interleukine10
tauopathiesobjective
richardsons
tautargeted
antemortem
mapt
hctthe
88hla
1869
reg3
nct01790568
adnectinbased
engineeringalthough
ofnonhuman
adnectin
h292
immunotherapysomatic
123000
singleguide
aplnr
apelin
radiosurgerybackground
gammaknife
gk
bmand
2015at
braf±mek
gk1
1095
monthsand
229months
1446months
885months
464and
725months
372and
brafwildtype
antipd1or
brafinhibitors
1226
1482months
secretionsporcine
antipedv
lactogenic
drugrefractory
epidemiologyintroduction
programthis
suns
goalslongterm
memorylacking
earn
tired
bloodwork
avid
rejuvenation
healingaccording
265000
dressings
nonorganic
silver
ultrasoundtherapy
burned
3dprinting
cellimprinted
nanoarchitectured
disguise
busulfancytoxan
leukemiafludarabine
melflu
bucybased
immunotherapyfood
developmentgastric
neuroblastomaintroduction
hrnb
soontoemerge
bleed
211±178months
66±39months
approacheshepatocellular
allergiesstudies
microneedlepatch
parentsintroduction
vaccineacceptors
tentative
tentativeness
aspectsimmunization
1100000
antigenbiotin
cd40activated
73043
carcinomapdl1
beneficialmolecular
immunotherapyinterleukin
castleman
improvesthe
delayedstart
roit
umin000003943
earlystart
latestart
nonoxidized
cerevisae
medicinewe
mannanallergen
il10il4
greyhound
igeelisa
sepsisblood
endless
neohippocratic
medicinethe
cucetuximab
lucetuximab
hayflick
genomies
nearing
dnapk
immunomodulates
immunotherapiescombination
nu7441
790803
photochemotherapy
recurrentpersistent
diseasesfungal
vaccinationswhile
fedra
536years
2289
subacromial
dangerously
burnout
vaccineshesitant
presumes
dismissing
textmessaging
futurechronic
hbvmediated
cancel
vaccinesdrugs
immunotherapygastrointestinal
antipd1pdl
panimmunotherapy
concerningly
productsregulatory
depiction
authorizations
miceimmunoglobulin
glycovariants
fcreceptors
tryptic
phaseliquid
setswana
receptorthe
resorted
erbb
receptorligands
prominence
commercialize
cancersone
postthymic
immunotherapy…
schedulesintroduction
0721days
02884days
912months
028days
postdose2
postdose3
postdose1
rapidschedule
1428days
conventionalschedule
polandin
rejectionthe
sgpl1
tex9
pex14
hospitalizationbackground
nonplain
amish
mennonite
nonamish
187382
chaosa
churchill
2528
gapyear
00100729
00020161
00010027
2939
13296501
17877073
2481
11655287
sepsisserum
sepsisseptic
nonhla
hansa
nct02224820
nct02426684
nct02475551
chemotherapyprimary
tricholomamatsutake
micetricholomamatsutake
matsutake
myceliumtm
ctx‑induced
paw
016mgkg
interleukin‑2
interferon‑α
factor‑α
nf‑κb
tm‑treated
cellschallenges
conceptschimeric
celebrated
ficz
treglike
differentiationdendritic
ficztreated
reglike
hyporeflexia
electrophysiology
vaccinesmany
cellsa
20112016objective
473881
0271
273631
405221
479881
545131
500661
627091
0161
0251
0391
0285
respectivelythe
was2
0541
0061
0411
0081
0481
anatomized
of2
phenotypesystemic
apocells
apocellloaded
immaturetolerogenic
10910571062
encephalitisbackground
cases100
000year
meningoencephalomyelitis
tbevspecific
analgosedation
osmotherapy
decompressive
craniectomy
4169
4179
immunomodolutory
auxiliary
refrigerators
npi
noise
patientshypersensitivity
rcm
iohexol
angina
iodixanol
populationsobjectives
reviewer
populationspecific
benevolent
personification
psychologicalneuroscientific
inanimate
centernorth
tapped
malevolent
hysteric
transpiring
6849
or256
r151
or121
protagonist
httpwwwwhointimmunizationsagemeetings2014octoberpresentationsbackgrounddocsen
dtapipvmmrhepbmnc
772vs
p097
921vs
518vs
p051
184vs
286vs
proceduresobjective
idr
endaeaaci
mdsmyelodysplastic
mdss
transformationthe
indent
voluminous
vespidae
crossreactivities
purpuraobjective
disintegrin
thrombospondin
antiadamts13
rightobjective
tilting
lifechanging
vaccinologyimmunological
nsp7
pulldowns
nsp7b
microenvironmentintensive
multimerizationimmunostimulatory
tnfrs
multimerization
t437r
k248e
t437rk248e
cellmeditated
antitnfr
cancersgastrointestinal
fr806
ch12
ch12mmaf
fr806expressing
untangling
boysbackground
regionsbackground
friulivenezia
giulia
fvg
romagna
145571
75308
4222
23948
highlydeveloped
2254161
1722750
1413974
961682
p30
131883
42548
myrmecia
pilosula
container
bicinchoninic
hplcuv
aupage
limulus
amebocyte
apizym
zymogram
pharmaceuticalgrade
mw
upright
threeyears
colposcopic
leastdeprived
mostdeprived
welcoming
allay
patientsclinical
il17f
therapiesupdate
nhanes
20062014objective
aca
n4599
164to
2055
1553
25136
refractometers
calvesprevious
cutpoint
1dold
refractometry
3dold
centrifuged
refractive
sper
300036
scottsdale
0790
cutpoints
iggml
134332
134271
13448
unfold
thp1derived
commensurately
yucatan
regionintroduction
throughoutmexico
datadetrended
fourier
timings
decemberfebruary
quintana
roo
campeche
climatologic
eligiblerecurrent
neckin
extracapsular
panzyga®
sbis
008mlkgmin
014mlkgmin
workschool
rtis
antibodydeficient
n2603
n2518
delayedrefused
delayrefuse
adviceseeking
conclusionsfor
personalnetwork
accommodating
1silenced
pol1
pol1related
rrn3
polr1d
lrpprc
mog3555activated
mog3555primed
pol1gene
overpresentation
versicanderived
matrikines
batf3dendritic
neoantigenladen
proteolysis
versican
vcan
vcanderived
versikine
matrikine
flt3lmobilized
tumorseeding
irf8
batf3expressing
deliverychimeric
immunocellular
survivorshipanswer
cmecne
201767398410
inva
4756
21304756
626952
110165
123164
055082
nonreceivers
geriatr
gerontol
23962402
chordoma
cetuximabobjective
notochord
vphenylalanine
ff
vf
cetuximabmediated
cellsthat
v158
fcγriiia
receptorbind
hopescancer
advancedrecurrent
myelomaobjectives
diseasedefective
tbetdriven
hcvinfected
arthritismacrophages
tnfreceptor
unrequited
lingers
strategiespeoples
memories
icon
boxes
autismvaccines
illfounded
20142016influenza
106142
111147
treatmenturothelial
revisitation
diseasecancer
tubulindirected
v40
myalgias
reinitiated
interleukin6stat3
immunotherapyovercoming
cellstimulating
survey4
hilly
motherscaretakers
heshe
vfvc
avc
782815
769805
677717
allergyhymenoptera
systemicallergic
malassezia
mhs
notstimulator
stingmediated
antenna
kisangani
gev
malfunctioning
pyramid
modelalthough
ascc
s3i201
immunohistofluorescent
conditionigg4related
tumescent
storiform
obliterative
phlebitis
rituximabmediated
secret
adjuvantsbackground
vsspadjuvanted
vegfr1
antigen200μg
offprotocol
rpcec00000155
httpregistroclinicosldcu
immunostimulationsepsis
administrationthis
nonregulated
endotoxemia
unintoxicated
lpsintoxicated
immunotherapyconquering
il6deficient
amyotrophybackground
lumbosacral
radiculoplexus
brunsgarland
microvasculitis
radiculopathies
plexopathy
dyck
experimentobjective
au39428
au34840
au44692
au3794
au1922
au5739
au2301
au712
au3924
au5180
au3042
au7370
myringotomy
alaska
indianalaska
aian
omassociated
100year
sameage
1305
merk
83100000
1815100000
1293100000
licensedintroduction
tcrspecific
immunopeta
zrdfatcrmufab
murinized
tcrmu
spotassay
18x10
10x10
nonleukemiarestricted
yearswithin
cellrecruiting
resultswhile
sepsisintroduction
dheaaedaet
trem1
strem1
dnaimmunisation
wnv
dii
didii
behaviourobjective
knowhow
sexualrelated
kissrelated
igemediatedtype
kallikrein
hyperthermal
metastasisobjective
il33expanded
modelfrom
vγ9
γδτ
pag
receptorindependent
pagactivated
antigensbackground
saureus
microarrayed
nitrocelluloseblotted
igereactive
immuneblotted
reviewintravesical
treatmentimmunotherapy
battles
studentsthe
n912
n126
xenograftsobjective
ir700conjugated
yconjugated
nub2
rpmi1788
ramos
ir700nub2
500μg
150μci20μg
ynub2
rpmi
1788
100µg
adjuvantobjective
platycodin
pdloaded
ovapdlipos
ovapdliposmns
therapymalignant
antigamma
aminobutyric
lesionsa
78year
akinetic
mutism
flair
corticalsubcortical
antigaba
infusionbackgroundaim
tiltreated
thoracentesis
abdominocentesis
7143
6667
areviewin
pregnancylactaction
1691223
12005113
minireviewimmune
illnessesviral
treeage
susceptiblity
verifications
evaluationwho
statesimportance
personalbelief
dialogues
chemomobilization
institutedesignated
cncs
cnc
symptomdrug
ebvhlh
cellsbackgroundin
ebvhlhmethodswe
cellsresultsthe
cellscd8
cd4hladr
cd8cd69
cd8hladr
cellscd4cd25
cd8hladrt
cellscd4cd25t
patientsconclusionsthere
0396
jonathan
sterne
ibrahim
abubakar
rodrigues
punam
mangtani
studyindividual
ultrahighperformance
r097
r093
bablok
0956
0927
dysmodulating
hbvproducing
haplotypematched
safeguarding
optum
continuers
discontinuers
6710
respiratoryrelated
1arrelated
arrelated
1589
1785
staffthis
castres
slips
teenagersintroduction
ebug
1518yearolds
criticised
casestories
carein
statefunded
infantwhooping
reactionsbackground
α4
β7
miceintegrins
filarial
βhexosaminidase
prostaglandins
b4
cytometrysorted
questionssurgical
cliniclevel
918years
n38277
cmcs
academicallyaffiliated
2014january
n295
n272
101214
1112yearolds
007060
nct02231957
italymeasles
rimini
vaccineinjury
metastasesimmunotherapy
unmeet
evidencestreatment
her2neuderived
ae36
nanoliposomal
ddc
ddccpg
ddpg
posteculizumab
meningococcaemia
medicarecertified
facilitywide
nct01815268
92269
75917
53008
38256
0·185
residentdays
0·211
3·9
0·888
0·7851·005
00·061
0·873
0·7760·982
p0·023
morisky
8item
4874
lowadherence
slkt
ddkt
highpanelreactive
lowpra50
highpra
cases1000person
lowpra
0208
95confidence
dsapositive
leukemiaadoptive
quadas
hsroc
dor
171540
q18148
crd42015019329
hinfluenzae
evaluationprotein
nthi
384bplong
pbadgiiia
arabinose
agarose
beta2
coseasonally
5singleseason
2512
adrs
applicationsite
3serious
histoseminar
desensitisationdesensitisation
46±14
7979±4089
6825±4182
89±76
crossmatching
dea
plasmapheresisimmunoadsorption
8±3
trasplanted
43±30
15±04
05±07
adopteesrefugee
adoptees
vaccinesrecent
codependent
actionnatural
antimetastasis
genistein
polyphenolic
flavonoids
organosulfur
vinca
bromelain
betulinic
zerumbone
176445
216494
p0923
3467
67298
immunosuppressantsimmunosuppressive
innovator
autosubstitutions
conform
bioequivalence
underimmunosuppression
underimmunosuppressing
modelrecent
age236
intenders
p0424
countriesthe
restructured
relapseprogressionfree
malignanciesfactors
1885
oralgastrointestinal
higherthantargeted
vaccinationwhen
£
ode
devalue
kilimanjaro
postrubella
mothersprimary
affluence
116years
organizationbackground
kpsc
tier6
ho1314182
0101200806302014
6064yearold
012012
rr004
allergycows
protocoloral
turbocharging
vaccinesdevelopment
flurry
patientsadvancing
eggallergy
eggbird
phaseobjective
doctoral
seaic
aaaai
storeoperated
picogram
cellpermeable
calciumsensing
metabisulfite
salicylate
benzoate
petrol
exhaust
organophosphates
nitrosamines
qualité
scolaire
région
monastir
tunisiewe
accumulators
collector
soaked
crpca
5184years
90iul
prodrugbisphosphonates
phosphonate
pivoxil
esters
esterases
tetrakispivaloyloxymethyl
2thiazole2ylaminoethylidene11
rewrites
forfee
substitutableforfee
sfv
1428
junior
injuryγδ
naio
γδtcelldeficient
intravitreal
ahrdependent
retinazhao
flammewiese
mullins
shouldnt
says
wenzhou
940±596
2478±636
453±206
951±202
042±087
302±041
17627
24600
5331
1252±692
530±236
5199
3744
034±084
immunotherapycd4
fijifiji
ocean
typhi
antivi
taveuni
fijian
itaukei
latrine
piped
sewer
fiji
latrines
1810
d86
435±122
d860
d861
d862
d868
4274
seleniumenriched
alfalfa
selenium
calvesin
supranutritional
selenite
agronomic
biofortification
secontaining
fertilizer
amendments
sereplete
seenriched
cowspen
nonsefortified
medse
seha
selenate
highse
j5
sebiofortified
cowsno
sosip
isolatespecific
occluded
hcdr3
ultralong
harboured
0028μg
rhenium188
methodsthe
bonemetastases
mediumenergy
collimators
coldwater
hotwater
corrections
tripleenergy
tew
scatter
deadtime
segmentation
textcamera
errors10
hotbackground
errors15
partialvolume
tewscatter
oxphos
ampkα
treatmentintroduction
closes
resultantly
ptpn2
targetimmunotherapy
interferonγmediated
allergymany
plaguing
19962016
controldiphtheria
exotoxinproducing
diphtheriae
haitioral
onehundredandseventeen
branded
41946805
toilet
1231443
001057
remediate
nanorodstransdermal
continuouswave
fitcmodified
fitcova
improvementobjective
2010december
datavaccination
unethical
copyright
relapsepreventive
nct01347996
dihydrochloride
postconsolidation
hdcil2
thymicderived
prognosticated
offspringinfluenza
mortalitymorbidity
midgestation
reexamine
patientsglioma
1420months
hsv1
phosphoganciclovir
hsv1ganciclovir
gliomaspecific
nct01811992
reengineering
therapymechanistic
genesallowing
icbtresistant
centurythe
vaccinationaim
wellington
hutt
1054
1645
4271
hpv2
hpvfree
liquidbased
hpv249
hpv9
23880
hpv49
carethe
18130
bcellassociated
poliovirushepatitis
dtapipvhbprptcontaining
nct01177722
nct01444781
1375
dtaphbipvprpt
antiap
antihaemophilus
melanomatherapeutic
cornerstones
plausibly
pcsmtcl
handforearm
orthopedics
neuroplasticity
somatosensory
focusses
£20
000qualityadjusted
£10
venomyear
galectin1
intestineobjective
gal1
igefcɛri
sitgenerated
gal1sit
microenvironmentsmallmolecule
moreeffective
abbottabad
experimented
outsourced
patientposttransplant
managementalopecia
nonscarring
follicle
ifnγdriven
antiil15rβ
baricitinib
vepart
nonrobust
vaccinationimmune
winnerthe
breakthroughenhanced
pasteurs
seronegatives
virion
premonitory
subhuman
nonanamnestic
vaccinedengue
stillgrowing
modelsstoreoperated
releaseactivated
hcracm1igg
ym58483
humannodscid
antiimmunological
47396
67099
astrazenecamedimmune
surveyintroduction
devastated
3800
ebolarelated
guineas
6699
ebolaaffected
standthe
reenergize
complementarysynergetic
alloimmunemediated
allolss
npas
allols
finegray
68years
rvs
fluidnpas
14107
0013
52±10
20±4
nonallolss
vaccicost
senegalvaccination
overhead
costreduction
intragroup
2016therapeutic
showcased
tumorpermissive
csf1colonystimulating
csf1csf1rtargeting
diffusetype
tenosynovial
tumortype
ibrutinibpurpose
karyotype
iwcll
restaged
limitationscommercial
prehatch
barns
tambased
recipientsvaccinepreventable
rtrs
therapywith
selfmolecules
exometranscriptome
immunoaffinity
dichloromethane
sprouts
ovalbumin‑immunized
micetriticumaestivum
shoots
triticumaestivum
ova‑sensitized
pre‑treated
re‑challenged
ova‑specific
il‑4
gata‑binding
protein‑3
gata‑3
ova‑stimulated
th1‑associated
il‑12
t‑box
ova‑induced
minocycline
strokewe
intrastriatal
minocyclinetreated
bmmctransplanted
microinjections
80pmol
endothelin1
et1
postischemia
bmmcs
coronal
cresyl
microgliamacrophages
ed1
anovatukey
pushy
hesitancyour
grasped
systemsbased
providerfamily
tehran
buthus
occitanus
tunetanus
malhommei
mardocheitemporary
mardochei
reversedphase
masse
offline
βtoxins
αlike
sights
immunotherapydisease
selflipid
parenchymatous
selflipids
patientunrestricted
cancermore
electroejaculation
transposition
canceroncolytic
backbones
iqymune®
deficiencythis
261years
097gkg
8mlkgh
infectionspatient
0115
379patient
level8gl
089dayspatient
773gl
057gkg
myelomaallogeneic
allobmt
johns
hopkins
41to72
bumelflu
erosette
secondarytreatmentrelated
p209
acutechronic
antiil21
liraglutide
glucagonlike
peptide1
glp1r
promotorlymphocytic
riplcmvgp
hyperglycemic
14yearold
1278
girlsmothers
024098
013081
knowledgebeliefs
101335
137392
110407
3191356
nsclcobjective
54month
p00189
p00129
act4cycles
p00316
p00376
evercurrent
19932002
incarceration
aor291
ci223379
aor060
ci037097
aor040
ci016097
cancersthis
nct01935843
carther2
100200
2cycle
myalgiaarthralgia
1583
clinicalassociated
nontyphoidal
transplantationbloodstream
nts
2946
207629
8054
4604
1064
vaccinebrief
migdc
lang
langerin
migdcs
laseradjuvanted
ntrimethyl
micedermal
antigencoated
sharpness
ph58
uncharged
ph74
alternatingly
tmc
ec50
dttmc
bilayers
dtspecific
±06μg
dermallydelivered
snack
bamba
immunityγδ
influenzain
465ah1n1pdm09
642ah3n2
3910
areabased
restricteduse
n19518
censusmeasures
266292
9481129
highpoverty
101148
lowpoverty
areas0499
codelevel
103197
105232
133375
106644
nonurban
underinsured
germanythe
725233
533162
486794
198477
196000
104640
2016incidence
048100000
20042015
anyone
1550d
jaundiceassociated
16y
studyaccurate
immunoligands
cellshuman
chainrelated
ulbp2
mica7d8
ulbp27d8
exvivoexpanded
cd20negative
bromohydrin
brhpp
tumourdirected
nonsibling
maroteauxlamy
reportmaroteauxlamy
otherrelated
onelocusmismatched
heterozygote
rheostatthe
icirt
rheostat
pdl1specific
transferon
adjuvantstransferon
dialyzable
hdle
biotherapeutic
10kda
peptidederived
aloh
titermax
transferoninoculation
44kda
pfhc17kda
pfhc
elderlyalmost
findingsolder
naïvetomemory
antictl4
subtleties
randomdigit
dialling
opportunely
blockadepurpose
antiah1
6190202
multicycle
spectctbased
cancerradioimmunotherapy
gpa33targeting
24aminobenzyl14710tetraazacyclododecane
tetraacetic
antigpa33
sw1222
7dold
3cycle
mbqmouse
histopathologies
dotaprittreated
leukofiltration
modelhuman
leukoreduced
flr
drb
γirradiation
γi
mpr
solidinoil
nanodispersions
peptidespollinosis
dispersions
surfactants
permeation
infectionsnew
vase
19561974background
1956
numerators
denominators
2755336
2531366
1014years
59yearolds
miceclinically
oligodexynucleotides
dgalactosamine
dgaln
stlr9
plcs
neutrophilrich
selfaffirmation
vaccinatetwo
amazons
leastpersonallyimportant
yearson
beneficiarys
starzl
transplantationmarch
1926march
1660
openlabel2year
hfrs
antihantavirus
00040016
0116
00360620
0320
00650848
00110649
mtdc
mtdcs
anticii
tregth17
drifted
strainsseasonal
row
asis
autoepitopes
nanocompounds
regimenprimeboost
gagspecific
dnaprime
mvaboost
tamovac
dnasmi
abrecombinant
mvacmdr
interferonpositive
highermagnitude
p24
p15
dnasmigag
gagencoded
sequencemismatched
crossrecognition
immunotherapysarah
webb
communityliving
nhss
3672
doctorgeneral
curly
horsesa
rider
abcr
cancerimportance
universitari
trias
pujol
badalona
darkening
hairs
pigeon
antiigg
autoantibodiesthe
antifcγ
pigeonrelated
foxp3cells
cd4cd25t
lymphomaprimary
iol
methotrexatebased
rdwbrt
23·4gy
leucoencephalopathy
74·9
86·3
48·9months
72·7
88·9
vaccinesrelated
unannotated
corpus
machinededuced
microaveraging
0786
184214
negativesafety
negativeothers
discoveryin
celltype
subthemes
700000
trips
ewni
yfvc
3208
geodetic
top20
24km
161km
1skewed
siboney
allergensensitized
2μg
occupationallyacquired
statesinfections
34150
immunotherapyobjectives
ypk1
muc1ctls
muc1ctl
freesurvival
zjiis
2772
underregistration
timo
28th30th
hallesaale
leukemiamixed
mpal
allassociated
leukemiatype
p034
cellscd1drestricted
mixedbreed
34fold
dull
cautionary
anticocaine
antibodys
h2e2
sequesters
threecompartment
cocaines
h2e2cocaine
cocaineh2e2
challengeslymphatic
archiving
sensitisers
immunotherapynitrogen
alendronate
ald
farnesyl
diphosphate
sensitise
nonosseous
lzol
lald
lymphocytopenia
ligandtargeted
αvβ6
a20fmdv2
sensitising
implanting
accompanies
tumorswith
icbtreatment
plea
inhibitionimmunotherapy
macao
faceto
seromarkers
2087
2855
χ263069
χ295373
0472
6572
7562
contextualizing
surveythis
flash
eurobarometer
becks
rogers
reflexivity
modernized
postindustrial
distrustful
4432
lipa25
hpvtype
ly6clo
cx3cl1
cx3cr1ly6clo
cxcl5
catsthe
fcv
antifcv
onceinalifetime
us32
screenandtreat
preventionboth
screeningtreatment
screeningpreventive
espousing
eliminationwe
tightens
grip
actionthe
scourge
graftde
dnhb
antihbcpositive
antihbcgrafts
antihbs1000
of1000
lamivudine
of100
12661272
bucy2
209×106kg
unceasing
innovate
ndhs
walden
irb
27571
surveypanel
116177
therapycytotoxic
virallytransduced
buckets
ratio066
coregulators
fkbp52
piasy
nidation
metformindiabesity
subfertility
fk506
01mgkg
noncnzo10ltj
pcos
kcal
noncnzo
postimplantation
pgr
immunophilin
cochaperone
uterodomes
hfddnoncnzo
deciduogenic
staty
il11and
lif
nfκbp65
uterodome
hemochorial
pgrmediated
testcanine
parvoviral
parvovirus2
vp2
tvp2
4654
addendum
2013this
2013″
fyf
wwwwhointimmunizationsagemeetings2016octoberpresentationsbackgrounddocsen
melesthe
badgerbcg
livecapture
vaccinecarrier
33974330
palatable
peanutbased
paste
hydrogenated
hpo
sarilumb
sarilumab
il6α
150200mg
tnfis
areviewimmune
inhibitorsadvances
pd1ligand
challengespd1pdl1
mucosalassociated
cellsmucosalassociated
agpresenting
vitbags
buildingblock
riboflavin
accomplishes
presentationondemand
schiffbase
valueconsistency
valueconsistent
decliners
uninformed
answercellular
moves
familyfriends
β011
β017
750mg
mepolizumabs
raeb1
raeb2
dnmt3a
runx1
variantcalling
1121309
ci1331691
furthers
illeetvilaine
brittany
153264
101217
hotspotsautoimmunity
repairment
dysfunctioning
interactome
dominulus
alphavirus
fmia
phue
rpimmunized
beadbound
valuepositive
e2specific
iggigmiga
iggigaigm
rpexpressing
nonhematopoieticderived
mousethe
hel
antiigm
nodrags
injectionfor
milkbackground
inkts
carrierbased
overviewmucosal
conceded
nanoparticleallergen
immunosafety
allergennanoparticle
epidemiologyto
firststep
muchmore
agentsextracellular
newlydiscovered
mscevs
mscev
ying
pun
jockey
b0313
b0408
0042
nondepletion
2ndnr
bilag2004
cbetter
96117
major50
partial32
prerituximab
incidence12
antirituximab
ocrelizumabofatumumab
pharmacokineticsdirected
μm×
day100
3889
dysphagiaodynophagia
0501
tcf
n334
trialeligible
trialspecified
machineryprogrammed
pet30
bl21de3
1mmml
iptg
pet30pdl1ecd
381kda
allergensit
allergologists
shashemene
had10years
aor384
haemaphysalis
longicornis
paramyosin
rabbitsbackground
bloodsucking
pmy
pcdna31pmy
2731
engorgement
10961±424mg
4839±406mg
2199
550960
120248
169563
039097
tcellintrinsic
highlyfunctional
toxicityrenal
nonimmunological
kidneyliver
fenestrated
rti
alachua
cadaveric
sloughs
oncomicrobiotics
singaporean
papillomavirushuman
elm
2126years
logicbased
heuristicbased
metathemesinformation
decisionrevealed
heuristic
likability
messaginghealth
messagesone
patientsantiprogrammed
nrasmutant
carcinomadespite
perspectivesin
nhsmuil12
modelspurpose
emt6
μmt
nanostring®
nhsil12
586980
melanomalessons
toleratedno
hsppeptide
mcg
rfagmcsf
2172
transplantationgraftversushost
notcd
nktr214
kineticallycontrolled
clinicalstage
pegbound
1pegil2
2pegil2
conjugatedil2
freeil2
il2rαβγ
heterotrimer
occupy
cancercell
epigenetically
demethylating
antigenbearing
immunosuppressionis
edged
candidatespediatric
7180
immunosuppressionobjectives
20062012
114116
132136
98101
nifs
3301
1the
1cll1
cll1carts
specificactivity
formationof
cll1cart
terminates
eggbackground
antigeng1
dermatitislike
hlag1
hlag2
hlag1treated
th2th17mediated
reactionmediated
dancing
micrornalung
mir200
mir197
mirna34
pdl1related
2594
diseaseidentification
αemitting
radioimmunoconjugate
attrastuzumab
thtrastuzumab
challengeobjective
atrioventricular
cardioverterdefibrillator
nivolumaba
positivepressure
chagasic
cardiomyopathychagas
ifnγpositive
src
shp1
sialidase
policypolicies
scrutinized
articulated
curbs
naturallyoccurring
phenotypehuman
effectorassociated
highlyactivated
chimericpd1dap10
chpd1
tumourfree
chpd1cd28
chpd1dap10
doughnutssnack
cakes
studentssince
belgrade
f4048
n251
mean447
sd171
mean280
sd156
mean398
sd181
mean4977
sd1023
mean5762
sd1221
mean5952
sd962
f3756
neuroinfectious
immunosenescenceassociated
vitroactivated
tcellsbackgroundaim
clm
capecitabine
range5675
subsegmentectomy
claviendindo
gastrocutaneous
blockadecolorectal
il10antiinflammatory
plugging
acm
tliatg
1484
transplantationrecipients
viremias
viremiaeod
treatmentdays
plagues
6578
staloral
stallergens
greer
aadss
133179
067107
055104
nct01605760
misoprostol
aspirininduced
p14
eightstep
1381
oncoantigen
studiesthanks
metastatization
anticspg4
cspg4positive
therapykaposis
selfmedication
htlv1
hhv8
steroidinduced
attentions
mgspecificrelated
livenigeria
childhren
38100000year
alarms
hopesin
brighter
2322
676470
lymphomadiffuse
anticd3cd28stimulated
il10il10r
therapeuticsthrombotic
vwfcleaving
metalloprotease
10iudl
schistocytes
8mediated
plateletdelivered
vwf
gobackground
uruguaythis
ophs
501±83
parotitis
0259
0438
unstandardized
00900510
0579
01551003
occup
2017305775790
algarve
lisbon
tagus
lawsthis
n395
dms
sectorvaccine
pricecapped
nonpricecapped
advancesdendritic
therapyit
tamsderived
galectin3
ceacam5specific
preconditioningdependent
toxicitythe
ceacam5
offtissue
modellingthe
modellers
interlinked
211atlabeled
cr39
detectorsrecently
211at
211attrastuzumab
detector
211attrastuzumabbinding
covisualized
ncin87
αtracks
emitted
trackaveraged
kevμm
211atbased
nivolumabplusipilimumab
257458
203309
258417
036049
050066
030052
108174
090263
ipililumab
aomrelated
myringotomies
mastoiditis
mastoidectomies
mediarelated
mg·kg
tiredness
min·wk
gclow
gchigh
considerationsobjective
clinicinfluenza
guidelines1
worldwide2
perspectivessheep
transhumance
tunisian
treatmentgraftversushost
chronicstage
skindirect
practiceover
histiocytosis
conditioningwe
lch
hlh2004
endothelialcadherin
oligonucleotidebased
mir27a
tie2
redistributed
7716
443447
tg4510
neurochemical
depositing
taulowering
depositionoverexpression
exposurebackground
extractbased
astana
kazakhstan
nart
ramb
rphl
allergenbased
sptbased
111230
52177
popularization
bloem
ikechukwu
ogbuanu
depress
28group
polysomnography
86±111
140±128
67±77
68±97
δcre
01±79
54±100
immunotherapylung
disappointingly
ccdc6
cosponsored
wheatinduced
anaphylaxisaim
semolina
regimenmetastatic
ctla4the
obedience
zymosan
dinitrophenylkeyhole
antidnp
immunepotentiator
immunotherapyevolution
mesenchymallike
cjunap1
intronic
7717
4697709
parentshuman
tpbderived
97988
β028
β032
β031
β073
β018
governmentorganized
pulsedose
neuroimmunologic
dexamethasonebased
multibiomarker
dexirci
raterblinded
sevenmonths
multimechanistic
patientsblood
lymphocytet
nkcs
cd8ctl
ccl20il15armed
tertpositive
shuttle
tertp
e1a
cradccl20il15
tertppositive
schoolclassbased
26766
inschool
23831
zomba
rumphi
administrativecoverage
overaged
ft3
donorsobjective
064082
47pmoll
highft3
hr319
113903
p0235
5012
81609
65455
incited
therapyhemophilia
anergize
fviiispecific
eurocordunrelated
incompatibilities
ricucbt
p00008
antigencapturing
acnps
acnp
69th
convening
76yearold
phosphokinase
15740
overviews
2533
sultanate
omanthe
4414051
2427825
omanis
rial
us19033
tdeplete
restorefunctions
hepatocellularcarcinomasbackground
tilfunctions
hccderived
lymphocyteswithin
treceptor
cd19molecule
300clinical
envisaging
pd1cytotoxic
nivolumabtreated
p0765
tinu
therapymethods
cioms
n302
n270
n683
n407
6months5years
costa
rica
el
honduras
paraguay
2620
1206
3460
3769
1861
cellsthere
4778
1205
1161
3239
2188
4794
freeze
pnl
pnls
poliobased
poliolab
realted
2251
2074
poliorelated
3time
wiselythe
immunohaematological
diseasesand
pd1antiprogrammed
57°days
24117
immunosuppressantimmunomodulatory
effectiveand
paracoccidioidomycosisbackground
paracoccidioidomycosis
1015days
5884
67mm
paracoccidioidal
macaquesin
fibered
hypodermis
tgfalpha
riskadoptive
601220
syndromemonoallelic
cmmrdrelated
immunotherapynucleic
dextrancpg
forwardobjective
underwhelming
promisenurses
massa
tender
sunburns
ancestry
appendectomy
laceration
brother
988°
fahrenheit
beats
adenopathy
periportal
conglomerate
louisiana
rateshuman
wellvisits
anticd3scfv
e1aengineered
humsce1a
humsc
adcd3scfv
lentire1a
msce1aadcd3scfv
moi
hopesmall
bombbased
drugradioconjugates
shine
beshadowed
coimmunization
cvb3
paim2pvp1
weekintervals
pvp1
cvb3specific
sca1
aim2adjuvanted
cvb3induced
enhancers
dcrecruiting
dcactivating
mhccompatibility
preproduced
freezestored
theshelf
mhcincompatible
deepfrozen
520×10
intuvax
intuvaxrelated
sunitinibtreated
425months
mrccpatients
mereca
conjuction
nct01525017
cellsimaging
experiencetransfusion
jehovahs
malignanciesreviewcell
20082015measles
1316yearsold
nodose
3039yearold
alphaviral
alphaviruses
semliki
sindbis
venezuelan
replicons
layered
bacteriabased
metaanalysisone
veflu
otheranother
veorv
vepan
orvpositive
pannegative
δve
transplantationallotransplantation
landscapeallogeneic
malignanciesdevelopment
boysassessing
nonrecommendation
neuroanatomy
deja
vu
againfrom
1900s
photoimmunoconjugate
trastporph
colocalizes
lamp1
dnatriggered
stingassociated
melanomacrosslinking
tcrmini
dta1
pcrvoprihcp1
modelspseudomonas
28294
opri
2583
hcp1
poh
pohspecific
humansgerminal
gctfh
tfhlike
tonsillar
reencounter
cellsmanipulation
selfhla
65465
diseasetransfer
unedited
ctiwp
tnc25×10
n172
hr09
hr10
il15driven
cellneutrophil
activationneutrophils
candidacidal
calbicans
anticandida
interferondependent
todrive
hendra
infectionhendra
equestrian
clubs
strangles
dressage
jumping
eventing
ags004
infectionags004
ags004003
rci
ati
00430767
iupm
01790067
spainobjectives
unplanned
1570
therapiesdevelopment
platinresistant
immunooncologyoncoimmunology
excessively
selectionexpansionactivation
lymphoiddepleting
proteincoated
coronas
tcellstcell
reevaluate
hcvexpressing
seoul
04769
aamrs
structurethis
partitioned
infectives
heavytailed
minimises
maximises
kmlbtreated
activationlectins
carbohydratebinding
mistletoe
bchain
kmlb
lymphocytemediated
genetargeted
tregdepleting
antirankl
rankexpressing
ranklrank
5789801
epitopesbackground
her2neuexpressing
a02positive
magnetassisted
pmax
p369377
p689697
e88
antigenactivated
e88specific
her2neuspecific
nsclcunassigned
decisionanalytic
0417
0287
155605
187685
0354
215802
0346
98421
modelstaphylococcusaureus
adsa
hydroxideformulated
radsa
antiadsa
adsaspecific
il18il12
il18il12activated
advancesnonhodgkins
ultrahighrisk
myelomathere
tides
portugalobjective
cleopatre
2088years
cin23
microbiomewide
childhoodbackground
walnut
providerdiagnosed
phyloseq
deseq2
dialister
dorea
patienttetanus
spasms
opisthotonus
123iioflupane
antinae
atrophywe
84yearold
antinh2terminal
neuroimmunological
condyloma
acuminatum
indicus
pranii
acitretingiant
glans
dtpace
outcomesoverall
allograftric
salvaged
653months
6132months
554months
osp45
alemtuzumabconditioned
approachesdrug
immunoglobuline
antigenigefcεri
2015april
szczecin
researcheradministered
datafactors
6589
286410
disturbingly
immunotherapyovarian
carboplatinpaclitaxel
pfi
ovaria
niraparib
platinumresponse
deficent
hrp
problemthe
nzbnzw
cd28systemic
cd28cd8086ctla4
cd28cd8086
fabigg
antids
intrarenal
pdl1in
conditioningreducedtoxicity
naturalkiller
missingligand
nkalloreactivity
matchedsiblings
c1c1
c2c2
multivariateanalysis
apostolic
studyvaccine
teachings
prayers
religiously
debunk
adultseculizumab
anticoagulated
3hour
ach4471
milliliter
22fold
90596
114683
apspecific
hiv1most
hypermutation
shm
feedbackwe
fdcs
affinitydependent
ceilinga
vaccinedriven
protectionvaccinations
elude
cytidine
slc45a2
toxicitycytotoxic
tyrosinase
ibound
melanocytespecific
hlaa2402restricted
pmelspecific
melanomatomelanocyte
brafv600emutant
61829
polyβamino
esterpolydllactidecoglycolide
nanoparticlesmucosal
hybridised
240nm
calu3
tcrcarredirected
tumorvessel
oneoneone
32812655
67429
5457
4237
properlyconducted
immunotherapieswhile
playgroundbiliary
idh12
iccs
eccs
gbcs
mtas
nonbiology
nonfermenting
epidrugs
a1r
pancreaticcancer
pan02
pancreaticadenocarcinoma
a1rtreatment
cfubody
tumorvolume
a1rtreated
30±28
399±307
easin
evans
200×
1335±322
451±194
biochem
634639
transplantationpredicting
112142
1411005
0784
0866
zoledronic
trialbone
australasian
za
26±46
minimised
29±53
zatreated
preallosct
infectionscytomegalovirus
virusnaive
afghanistanimmunization
nrva
2561
040090
110167
120211
144201
predicators
fullimmunization
abject
hyperthermiaimmune
nanoparticleassisted
transplantationpharmacological
onesize
underimmunosuppressed
immunotherapiestherapeutic
bioprocesses
hmscs
sourcing
pulsatilerelease
antibsa
139±13
137±22
155±15
161±21
177±22
iami
ami
stsegment
stemi
nonstemi
zimbabwea
harare
manicaland
matabeleland
959months
affiliations
johanne
marange
madida
gospel
14100
vaccinated6
dtphepbhib3
catered
spiny
bacterinsbacterins
spinycterins
bacterialspecific
anchormotifs
nmistic
mistic
ntd
yain
ybel
immunorelevant
cysteinfree
117amino
orf149
frgii
formaldehydefixed
nonharmful
spinycterin
fishtofish
antifrgii
spinycterinimmunized
complexmediated
immunecomplex
toxicology
icmediated
hexavac®
hexa®
hexavac
n409
n342
5µg
201300160228
nct02012998
transplantationmanagement
triplequadruple
cniexposure
contemplates
digenean
landscapecancer
pd1and
typesand
scheduleand
treatmentand
imminently
curableand
shortintensive
immunityskin
pyroglutamateamyloidβspecific
immunotherapyalzheimer
amyloidogenic
pemodified
pe3
fibril
oligomertreated
burial
bangladeshintroduction
midpoint
costdisability
58daly
142daly
615daly
1514daly
cyd
sanofipasteur
inescapably
strainforty
prrsnegative
fostera
rehoused
nadc20
antiprrs
p00053
nonvaccinates
detectible
t7
fmdvfootandmouth
t7gh
4151b
inactvac
pepvac
antivp1
micelinear
rkod
lecha
ptolecha
phosphorothioatemodified
lechavaccinated
hacoding
salmonellaspecific
hemagglutininrecombinant
sha
carrierspecific
vaxchora
reformulated
103hgr
vibriocidal
choleraaffected
effectsmost
adhesions
lares
probjective
farmacia
josé
campusobjective
canadaobjective
2763
6366
5962
6265
5356
7579
institutionslittle
4155
revisedinternational
networkinternational
evokes
a498
skrc39
immunityintroduction
tregregulated
helminthic
multilocularisinfected
deregmice
th1th17polarization
lea29y
isletlike
npiccs
streptozotocindiabetic
il2rγ
inslea29y
immunohistological
npicc
xenoimmunity
pd1directed
0001200001
pdl2positive
pdl2negative
pd1pdl2
2312
315867
panitumumabir700
antibodypa
pitinduced
umuc5
singlet
panitumumabir700treated
panitumumabir700induced
220114
travels
favorite
3617
freelancers
5987
6416
3317
atovaquoneproguanil
malarone®
mefloquine
lariam®
phts
bottom
2860
1370
ala
infectionvaccines
interlaboratory
germanygermany
lateralflow
lfd
penside
bighorn
canadensis
commingled
animalsleukotoxin
pasteurellaceae
mannheimia
haemolytica
bibersteinia
trehalosi
bhs
ovipneumoniae
washings
twothree
lamb
mtbc
ghost
vaccinenewcastle
ndspecific
epitopeexpressing
virush5n1
bvhmnn
76130
3m2e
5569
np5569
380393
np380393
re6bvhmnn
bvhmnnsupplemented
4rdp4
ckchlsd110857
491like
gxly9like
bacterialderived
enquiries
unjustified
negate
125dihydroxyvitamin
cellsdendritic
infiltrations
triallevel
20013
r2080
r2067
049082
r2019
003049
r2005
00001031
063075
076089
080119
042056
biomarkerenrichment
noghil4tg
vaccinationimmunodeficient
pbmctransplanted
nodshiscidil2rγnull
ch401map
responsibilitythe
fearsome
xx
erased
tragic
pasts
hans
hopesgastrointestinal
600211
waysalmonella
microbiologists
inhibitioninhibition
isoformspecific
pi3kα
pi3kβ
7715
413545
vaccinationan
huddling
clock
thermography
therapysystemic
il2coding
hapt1
semipermissive
ril2
cd25foxp3
ril2treated
n180
n540
264428
348445
386561
44254
p9
107295
perspectiveimmunotherapy
urooncology
2016in
inhibitionwe
2016a
costcomparisons
subserve
haitifrom
floating
sichuanobjective
flowing
leftathome
8430
6890
9770
9430
1838
finlandsince
steeply
33228
8208
221595
119432
nonsusceptible
56220
15119
49220
7119
nonpcv10
cd11aicam1
diabetesenhancement
αcd11a
il2cαcd11a
intrapancreatic
isletresident
mastitiscurrent
intramammarily
trialprolonged
iitb
mip
2317
506673
indigent
wilmington
1878
enemies
programmesvaccines
nonovalent
dialoguebased
download
pdf
filings
pilotthe
1566
1334
principlecentered
tgw
hispaniclatino
blackafrican
155517
stds
103142
6702098
riskgroup
consortia
andin
saddlepoint
perioddoubling
inefficacious
repairs
modelmalignant
astrocytic
debilitation
calcineurinnfat
pdk1
experimentallyinduced
t11tstreated
downregulations
zosterrelated
20012013
hzrelated
uvi
2001december
sicily
93808
hotline
hawaii
populationshidden
sws
prohibited
respondentdriven
rds
nonablative
2318
550213
dataduring
healthcarerelated
14step
allergyassociated
120125
peanutassociated
stateshematopoietic
rric
nonrituximabcontaining
nonrric
n1022
n379
37months
rr114
95ci083156
rr116
95ci072189
p054
rr115
95ci092146
95ci067122
rr079
95ci063101
rr084
95ci069102
rr076
062092
95ci060096
rr043
95ci021090
functionsengineered
homodimeric
cdcc
cdcp
fcγrdependent
monoclonalantibody
effectorcell
malignancieseightyone
cuminc
mtxmycophenolate
standardrisk
mmfcontaining
systemhuman
hladeficient
mennational
nhbs
2892
2095
immunotherapytreatment
cs1
917y
32times
3217
2177
4754
muscleit
perpendicular
midacromion
circumflex
humeral
pcha
caliper
pinching
anteroposterior
subdeltoidsubacromial
brusa
utdfi
8063
012028
010852013175
percapital
diagnosisstings
inhibitorsdevelopment
correlativity
evidenceasthma
costeffectivity
ulterior
disordershematopoietic
shwachmandiamond
blackfan
unionthe
assimilating
noneu
onceeradicated
neuroblastomatargeting
gd2car
gd2car3
cd45cd33cd11bcd163
00126
tgfβ1silenced
modeltumorderived
l1210
lex
tgfβ1si
alentiviralshrnavector
lextgfβ1si
bacteriuria
abu
pyuria
brafmekdirected
mektargeted
00027
gift
ingelvac
mycoflex
f2
18gday
36gday
v1344
v2461
nv455
v1350
v2380
nv414
unionobjectives
459350
vivophotoimmunotherapy
twochannel
085mm
9150
10063
microprism
depths
whodefined
basse
bhdss
fuladu
bansang
18833
21·0
16·2
15·3
10·9
5·2
4·1
2·9
2277
2·6
0·7
4788
13·1
4267
6·8
1·9
5882
0·57
0·301·08
gavis
cd152
mutationsimmune
practicesobjective
singlespecialty
151462
metastasesbone
tumorbone
casesobjective
miscarried
mucojet
microjet
proteinfree
haptencarbon
responsecarbon
nanoconstructs
haptenprotein
infants3
1or
ci566
planintroduction
antimag
modelemerging
antikel
carcinomabefore
4872
slumdwelling
patientprogrammed
dr3dq2
dr4dq8
genemanipulating
nr2f6
studiesaim
checkmate025
honors
burles
snail
rocket
ship
resuming
prediagnosis
selves
rushing
impulsively
reentry
eggobjective
malignanciesimmunotherapies
phosphatidylserinerich
phosphatidylserineliposomes
transplantationimmune
malignanciesrecent
highintensityfocused
jeopardise
progressplus
unjust
mimotopes
phagedisplayed
eby100
aoe1
ymaze
mices
microhemorrhage
olderbackground
n12194
lowresponder
followupobjective
jinan
weifang
yantai
weihai
muml
antihbs100
nonconditional
multifactor
264315
149529
47315
1737
3338
5623
400600
600800
8001
1031784
1251647
1101597
2912863
006162
046179
065201
133244
004168
distrcts
cites
qingdao
rizhao
liaocheng
zaozhuang
zibo
laiwu
paticipants
4825
1344±1306
9141
5121
89969272
9093
90929094
9590
95889591
8323
83218325
9679
96789680
8666
86658667
91959197
cancerdata
2017a
nephroureterectomy
19702016
3156
5978
dengueintroduction
flowcharts
challengedesensitization
drugexacerbated
polypectomies
aspirins
growthwe
immunoswitch
signalswitching
3140±721
3272677
p0762
241803
179597
207690
p0165
myelomapreliminary
antipsmair700
tumorbackground
nirinfrared
115362
skinonly
irradiationcontaining
allelicmatched
nct01810120
nitrosourea
mnu
cd8foxp3
tcellactivating
594603
20132015parents
2arm
41point
2556
tenderbased
netherlandsbackground
negotiations
9134ly
7323ly11231ly
200280
iteos
3epitopebased
ltpsyndrome
sublingualsit
oligodeoxyribonucleotide
odncpg
ltppeach
prup3
prup3cpg
sigg2a
acinetobacterbaumannii
infectionacinetobacterbaumannii
smpa
histidine
his‑smpa
his‑pld
broncho‑alveolar
testingpathologists
carcinomaby
melanomaimproved
culminated
principals
ags003
ima
rhinitisit
multipleallergen
613yearold
inflammationalthough
nonidentifiable
nonintuitive
immunomodulated
immuneinduced
antigenpulsed
cellscryptococcosis
hvcg
hypervirulence
capsuledeficient
cap60
r265
ifnγdeficient
dcvaccine
assayscandida
immuncompromised
opsonized
epitopephagedisplayed
slaqvkytsassi
multiformein
incapable
cdx110
cdx110klh
immunotherapysalmonella
tlrdependent
reaping
agedantibody
covariant
dtap5ipvhbhib
dtap5ipvhibdtap5ipvhbhib
hexapentahexa
prpomp
dtap5ipvhib
nct01839188
201200422125
extractsobjective
leukemiaaim
antibodiesdespite
highzone
0402epidermal
0402
760pgml
27pgmlan
lineagerestricted
mhagpeptideloaded
mhagspecific
3510
mhagbased
directionality
3281
ida
cinv
emetic
46174
civ
vomitingretching
koreaguillainbarré
acvic
ncss
albuminocytologic
postinfectious
predictorsallergenspecific
179539
121272
mvforall
conservatively
hydroxid
idealistic
15823
895899
ks
angioproliferative
espírito
santo
brazilthis
5979
hivinfection
500cellsml
therapyvesicular
vsvifnβ
tubedependent
tumortreating
trialhematopoietic
postucbt
dysphasia
hu
autoantibodya
t2flair
pleiocytosis
pruritusalthough
75yearold
6days
suddenly
trunk
cellsobjectives
hcc827
hcc4006
pc9
h1975
h358
sw900
h647
clinicimmune
20042015background
cusum
8791
dispatching
tmeinduced
uprrelated
anticd138
inhibitionthe
stats
posttonsillectomy
adenotonsillectomy
tonsillectomy
monopolar
electrocautery
cauterization
nowhere
immunepriming
stis
1524years
affirming
rhinitissublingual
postslit
adaboost
hrnr
strategiestumorassociated
tamrelated
tamregulated
countrieslittle
moldova
1469
4878
reddish
cd30positive
organises
pigsebola
lymphomastcell
epigeneticbased
selforganizing
locallymixed
networksvoluntary
tumorsdeveloping
biomarkerpathway
enb
enbtrail
fret
caspasemediated
secm
scenbtrail
radiotracer
2deoxy218ffluoro9βdarabinofuranosylguanine
18ffarag
7711
2893902
aquaporin4antibodypositive
aquaporin4antibodynegative
rate060
n77
hr04
hr25
hr15
p0065
missingthe
neoepitopesfactors
malignanciesare
precheckpoint
26406
precisionbackground
keynote012
platinumresistantrefractory
platinum5fluorouracilcetuximab
overwiev
animalsbackground
implementations
dcontaining
carriageintroduction
compas
afghanistans
dummy
operationssuch
interventionsthe
nonhigh
2064
3015
2196
1173
2862
homophilous
tofa
ovainjection
cyanocobalamin
tarantobackground
taranto
inrisk
prefers
adjuvated
nonrisk
tarantos
146707
adjor
2516
17073710
318412367
9739
393324111
incountry
caninerabies
unowned
ugandas
glioblastomaradiation
fanuel
bickton
desiree
witte
diseaseceliac
prolamines
hladq2
hladq8
haplotypes
rhinitishouse
268±73
vcc
6hours
impactimmunization
immunotherapyglioblastoma
httprimedorgrimedicaljournal201706asp
l1unresponsive
crossprime
cytokineinterferon
tlr3ticam1interferon
irf3ifnβ
workersunassigned
teresina
157258
68258
avaliar
fatores
preditores
não
completude
esquema
vacinal
hepatite
mulheres
prostituem
nordeste
brasil
foi
entrevistado
para
negaram
irem
lugares
especializados
desconheciam
sua
situação
vacina
oferecida
trabalho
análises
multivariadas
foram
realizadas
identificar
potenciais
das
elegíveis
vacinação
receberam
primeira
segunda
terceira
trabalhar
boates
consumir
drogas
ilícitas
elevada
aceitabilidade
associada
baixa
profissionais
sexo
evidencia
necessidade
estratégia
persuasiva
vá
além
oferta
syphilispenicillin
decelerations
evidenceintroduction
microneedleassisted
ptrp2
ptxencapsulated
sulfobutyletherβcyclodextrin
sbemannosylated
nnntrimethylchitosan
mtmcdna
revoke
sbe
ptxsbe
polyplexes
mannosylated
nanocomplexes
ptxsbemtmcdna
multiimmunization
haptenspecific
librariesphage
multiimmunized
disordersmultiple
tumorrestricting
slamf7cs1
cellinfiltrate
inducibility
amalgamated
vadimusrecent
v600emutated
paediatriciansobjective
maximised
miceimmunization
ivis
pretending
practicesa
cairo
egyptbackground
iui
ofless
138±169iul
307±60iul
4249±44
1783±83
20102014objective
148981
caregiverchild
adultchild
450687
274279
nonimmunizing
535553
physiologists
quarrel
emil
18541917
richet
18501935
jules
héricourt
18501938
1888
behrings
1890
heirs
claude
bernard
18131878
18701880s
maurice
raynaud
18341881
auguste
chauveau
18271917
jacques
léonard
physiologization
pasteurism
outlookcancer
recipientslongterm
epilepsyobjective
rochestermn
scottsdaleaz
jacksonvillefl
encephalopathyepilepsydementia
0630201406302016
cnsspecific
seizuresoral
mesial
blandaltman
bootstrap
1491±4037
1908±5185μmoll
2sample
400170955×c
1088×c
052±767
632±427
cellsacute
tlractivated
pdc
ivdpdc
ifnλ2
pdcinduced
chemoimmunotherapythe
chemoimmunotherapytreated
grzb
reattained
ratestem
introducting
genzymesanofi
gffs
2902
1417
5942
hr3005
1279
7059
hr2363
4805
mediaobjective
lessconnected
toxoidimmune
infliction
piau
landrace×large
dwe
tlr6
tlr10
tolerancesusceptibility
clinicaltrial
gov
1887
060201
035274
070177
grades3
187632
c3hhej
12d
omsupplemented
micehemophilia
sinusoid
lsecs
lvmediated
mirts
mirt1423p
mirt126
mirt122
betablockers
anaphylaxisthe
betablocker
australiaaustralia
saefvics
088129
neardoubling
pancreatitischronic
melanomasarcoidosis
ajcc
chemotherapyimpressive
afresh
asinglecenter
asecondary
scripps
167days
229days
aireoverexpressing
diabetesautoimmune
aire
tissuerestricted
tras
mtecs
airebmdcs
iaa
variantsglioblastoma
gbmspecific
il13rα2caril15
57181
familiesbackground
matriculation
prematriculation
pir
317389
jurisdictional
tuition
pirs
disallowed
istbackground
inhalants
childrenpostexposure
reexamined
speeda
vaccinesatlantic
delousing
lice
lepeophtheirus
alayer
vegetable
48hr
vanguillarum
mviscosa
immunotherapyviral
stablyattenuated
artlcmv
α5β1
expressionchimeric
gcart
ycart
pstat3
hasnt
combinatorialtherapeutic
atlases
cancerstwo
illuminates
ert
standardrelease
051154
100178
058165
p48
060086
052071
040068
p46
p86
srtbased
yugoslavia
seropersistence
fsmeimmun
adultstickborne
710years
nct00503529
nct01582698
localizing
modificationobjective
chondrogenic
multipotency
survivability
mmscs
oct4
bisulfite
shnanog
microstructural
mmscsinjected
inducedoa
occupationrelated
imputation
ci306
ci361
ci387
practitionersphysicians
associatebachelors
targetsimmune
vaccineswe
bpiv3
transtracheal
ttw
zosterwe
matrices
disconfirmed
pseudoscience
disorderthis
deniers
defuse
denialism
13341337
tio
therapylymphocytes
labile
cellinshell
asserted
opportunitiesthe
esoteric
2017123215462
pi3kprotein
2017123211829
metastasespancreatic
interventionrelapse
leukaemiaassociated
pcrbased
leukaemiarelated
mgm2day
toyohashi
chemoselection
lakes
regionexpanded
transnational
fahad
dammam
arabiain
rejectionacute
amracr
kfshd
167in
stills
aosd
polyphasic
managementimmune
inhibitormediated
rectosigmoïdoscopy
therapiesimmune
cancerstem
immunotherapycancerstem
cscbased
therapyto
tumorassociatedspecific
monkeyspassive
pseudoviruses
n6ls
v3glycan
pgt121
shivsf162p3infected
10foldhigher
bnabtreated
monocloncal
n6lsmonotreated
cd7edited
cd7specific
malignanciesextending
offtargetorgan
labialis
leukocyteadhesion
1leukocyteadhesion
deficiency1
recessively
moderatetype
cd18
c41c582dup20
itgb2
microthrombocytopenia
ghrelin
conditioningregimeninduced
grltreated
regimeninduced
pathwaylung
huaier
linethis
ht29
1×106
g60
emotionally
pi3kr1
wnt1
cttnb1
notch2
responsestumor
tumorinfiltrated
absorbs
pdtinduced
tregtargeted
safetyearly
diabetesin
jem
bergman
httpsdoiorg101084jem20160471
mimetope
diabetesdaniel
httpsdoiorg101084jem20110574
r22e
immunotherapynew
mcsfr
plx3397
pexidartinib
53546
vaccinecigb247
bacteriallyderived
ig4
vegfreceptor
rpcec00000102
vistas
pregnancyassociated
diabetespurpose
intertumoural
exemplifying
factorsfor
fishthe
welfareoriented
piscine
rab
salmonids
pd128
therapyinherent
357790
francepeople
typeseverity
n12396
the1864
ci202288
aor072
ci059086
ci061098
ci13172
aor136
ci119155
ci137206
aor163
ci130202
aor133
ci117152
aor118
ci1113
ci120153
aor116
ci104129
aor149
ci131170
counselors
nct01339923
3½511months
6811months
2½3½511months
98100
9599
protectionthe
lena
finistere
fini
mlv1
mlv2
lenainduced
lenaspecific
transplantsclinical
immunomodulationimmunotherapy
solea
senegalensis
photobacterium
damselae
piscicida
protectionsolea
phdp
postchallenged
ssenegalensis
cmc
biosignature
fotobacteriosis
filariasis
cdds
demarcations
migrations
sjtrec
cd31positive
cd31rte
sjtrec10
trendsintroduction
reca
cpgmotifs
immunityinterferon
irfs
cancerunassigned
unobservable
201211
296316
patientsnewcastle
ewcastle
ndvbased
developmentsherpes
radioimmunotherapyaugmented
partyrelapse
n1973
zevalinbeam
n207
rbeam
caveat
2013–2016
dutybackground
plausibility
wellbased
notchmediated
perspectivesvaccine
needlephobia
immunoproapoptotic
scfvfdttbid
therapyhighly
γseminoprotein
γsm
dualtarget
γsmtargeted
mscscfvfdttbid
γsmpositive
c42
22rv1
γsmnegative
apoptosisdependent
scfvfdttbidmodified
vis513
primatesdespite
panserotype
postpeak
rnaemia
fcgamma
usus
onthe
ngsguided
diseaseinfluenza
reconditioningexvivo
evlp
recondition
tomographic
leukemialessons
clofarabinebased
1gm
chemoresponsive
p025and
n790
n1096
thuringiensis
cry1
5e8
daselisa
cry2a
vip3
loq
6371135ngml
17362448ngml
loq100ngml
treatmentapproaches
antigensthird
n71
apigenin
ifnγbased
dermatitiscytosinephosphateguanine
gnpbound
gnp
odndog
15mg
phosphoantigenspecific
primatesthe
centraleffector
cxcr3ccr5lfa1
traffickingtissueresident
changeguidelines
polypsin
selectsubjects
drugor
documentedby
studiesare
currentlyin
demonstrateefficacy
registrationfor
twisting
polyserositis
oldintroduction
arh
elderlyobjective
prepostscreening
caresurgery
ons
europerichard
trollope
sue
henry
truxima
richard
mundipharma
biochemist
wyeths
yamanouchi
astellas
fascination
napp
franchise
launches
postdoc
pd1selected
367284
microenvironmentil1
hemopoiesis
il1α
il1r
il1r1
proil1α
translocates
indexthe
lrir
neoantigenes
extremly
microenvironnement
morepotent
e6f6
epitopedetermined
inductionfood
reservoireffective
antiretroviraltreated
infectionhuman
provirus
neonatethe
foals
ighm
cdr
2016two
interchangeable
agesbackground
newlysensitized
reconvened
cd19cd20
linesbackground
antigenescape
tandemcar
leu16
configurations
tandemcars
admixture
diseasebearing
nalm6
highdisease
comodulation
immunizationroutine
revolves
evergreater
immunooncologyimmunotherapies
rebirth
bioassays
ecteolacellulose
antiyellow
antibodiestechnological
preanalytical
heparincollected
antiyfv
doseresponsive
plasmaect
17ddyfv
229121
5989
223132
1949years
5064years
356859
101203
164260
9dpv
clergyman
smallpoxvariolation
boerhaave
sloane
sherard
1754
schwencke
hague
orangenassau
ambassador
noble
lady
perspectivespseudophenomena
rano
pseudoresponse
unequivocal
amri
chaetocin
magec1ct7
chaetocintreated
uvbirradiated
lymphomamediated
immunotherapytumors
activatoryinhibitory
361931
melanomapurpose
pdl1cytotoxic
pembrolizumabnivolumab
edt
prog
recistirrc
0729
0725
0033
disinhibited
immunoprofiling
502433
policyindias
indiapublic
stripped
forcible
deeprooted
frameworkwhile
remotest
indiathis
recourse
tort
fault
clouded
reflectionsvaccines
jnknfκb
lymphocytesresveratrol
iκb
düsseldorfs
gesundheitsamt
düsseldorf
pedagogues
malignancieshlac
n276
hladrb1matched
n260
hlac03030304
hlacmismatched
hlacmatched
infantmaternal
switzerlandmetastatic
n121
tts
ittt
n300
p000065
intravacc
shuffling
egfegfr
signalingdependent
unattainable
198million
39millionyear
122000
10y
121040
1734
cryosurgical
preliminaily
failurevaccination
prognosisthe
chf
ahfchf
patientsa
3diffish
cellsearch
preselecting
trastuzumabpluschemotherapy
toga
umin000008622
pakistanobjective
shifa
tameeremillat
selfgenerated
3161±8026
728±342
1121879
906711
530±131
1670±862
optionsadvances
tfr
cellexpanded
recoverywe
mpc
mpcs
cgycyclophosphamidefludarabine
smokeinduced
smoke
exposureinduced
noseonly
emphysema
immunotherapymonoclonal
exits
2240
departing
consultationsbackground
gten
preventionfunded
40810
6612
mmreligible
3477
1689
2262
1432
1178
underrepresent
steve
deborah
gorlin
mgh
7630
3906
gmrs
078083
069074
075082
087090
088090
077080
086088
074077
polyribosylribitol
152192
mid2000s
broadacting
bothcurrent
temsirolimus
patientsin
quasircts
4732
mrccinterferon
1166
factg
evidencethere
qolifnα
datatreatment
ima901
datain
factkidney
fksidrs
leukemiaaml
eed
cabiglobal
popline
elibrary
nowthe
mesotheliomaimmunotherapy
studyforkhead
zagazig
tatfused
modelallergenspecific
che
chenopodium
100μgdose
rtatche
foxp3specific
langerhanslike
treatmentswhere
isthe
evidencewhile
placentation
periimplantation
imperatives
discerning
furthering
brazilabstractthe
necrosisfree
rnfs
169months
122397
103115
biomaterialsincorporating
sponges
jacket
ism
yj
ku
nonmastocytosis
fluorescenceguided
1cc
4270
kps
methylguaninednamethyltransferase
127months
234months
16331
200900987935
nct01006044
387906
1473
1971000
prostatitischronic
cpcpps
t2background
trpm8
180220g
nacl
aloh3
t2aloh3cfa
prostatitis
strategiesfowl
serotype4
horizontally
counterimmunoelectrophoresis
meltingcurve
designcancer
immunotherapetics
1883
447495
796859
647700
861902
treatmentimmunemediated
neuromyopathic
miosis
pupillary
reflex
hoarseness
hypokinetic
laryngoscopy
postinsult
traumarelated
beyondastrocytic
oligodendroglial
multipeptide
ima950
cytomegalovirusderived
tumourderived
protein96
arg132his
interleukin2fc
tcellsinterleukin2
il2antibody
superkines
il2fc
neglecting
hyposensitizing
prist
rast
immunotherapiesadoptive
icialone
modalitieswork
superb
sragvhd
therapybone
1cxc
antigen4vascular
notchligand
stemreginin1
beneath
pdl1over
b7cd28
b7x
hhla2
immunotherapyhigh
300mpa
250mpa
200mpa
hhpsensitive
hhptreated
150mpa
mpatreated
excludes
dcvacluca
vaccinesnowadays
conflictaffected
polioendemic
nct01908114
28760
30098
29126
23334
26110
25745
6·6
4·88·3
8·5
6·810·1
participantreported
1004°f
birthneonatal
sd39
800952
nonpregnancyspecific
emridentified
messagereported
emrabstracted
n18948
statespecific
mmpc
stepanova
perceptible
challengesimmunotherapies
adressed
hbvallergic
enginestumor
cararmed
cytokinescostimulators
inprogress
antiab
hladsa
1541
freezeconcentration
polyampholytemodified
unfrozen
phdependence
crossstimulation
perspectivescytotoxic
1214months
bacilluscalmette
immunesensitivity
innateadaptive
refractoryhematological
fcmmrd
3640
crcri
45427
skinultraviolet
uvbinduced
c3hhen
10mgcm
uvbexposed
5aza2deoxycytidine
uvb
topically
nait
pait
df
dp1
df1
dp2
df2
1009
1106
siges
anesthesiaobjective
misinterpretation
rr096
rr095
rr072
rr177
16yearolds
sysvak
asu
aggregateded
ncip
15yearolds
2016immunisation
basedsystems
2015in
29404
814825
942946
104486
848966
vs15
2015we
ddv
124189
124427
dtapipv4
finlandcomputerised
hivcytotoxic
gliomadendritic
virusesobjective
iims
r0929
x2453
socialeconomic
bacteriumlike
pneumolysin
plym2pneumolysin
ply
cholesterolbinding
plym2
c428g
w433f
blps
blpplym2
contextsbackground
conceptualise
taxonomys
bursae
phasesbackground
bursas
15546
transcriptionpcr
cellboosting
zoe50
zoe70
coercionthe
legislatures
liberally
violate
zebularine
magea11
peptidemelanomaassociated
antigena11
p350
flfgepkrl
magea11expressing
magea11negative
magea11specific
tumorresiding
therapyeffector
cxcl910
msma
presidents
incites
mine
infectionsrecurrent
transmissionthe
investigación
sonora
ciudad
obregón
ldkt
2587
sb505124
βcyclodextrinpei
effectible
effectiveallergen
itchy
jcpa
nos
rr150
105212
rr132
109160
rr193
107348
rr148
108203
centuryin
euploid
agentsan
ihrs
anaphylactictype
deprive
nsaidsaspirin
advvst
583±823×10
cd3ifnγ
n°
trialgov
nct02851576
melanomamalignant
vaccinationtumor
transferringinfusing
directionsrecently
45year
2088
377years
nonmsm
βconfident
ilaris
20052014background
nti
birthdate
domicile
311663
inactivatedonly
reviewmold
albuminone
nct00861744
2y
mmrcontaining
modelan
417million
herpesviridae
gc2
ge2
blogsalthough
congregate
likeminded
vaccinediscouraging
vaccineambivalent
vaccineencouraging
blogosphere
dispel
roleintroduction
antibodycontaining
convalescing
pyrrolo2deoxycytidine
melanogaster
2deoxynucleoside
7910101019
th171
ccr10
preinflammatory
1935months
20012014
pakistanadministration
3444
1630
5378
4280
4377
dosesaving
considerationsimmunization
injectorintradermal
aluminiumabsorbed
phosphorylcholineobjective
phosphorylcholine
pckeyhole
pcspecific
pcklh
factorsin
geographicweighted
0·002
bthe
lpspotentiated
toxininduced
sebinduced
consit
45000
nonexperienced
penicillinallergic
httpwwweolorg
httpallergomeorg
apidae
cockroaches
moths
bees
transplantationpulmonary
candidatepretransplant
calculators
malignanciesviral
infectionprevention
transplantationinvasive
triazole
mucorales
transplantationlateonset
bronchi
periengraftment
malignancycheckpoint
futures
viewdespite
1561
leukemiapreviously
laas
trit
antigenrestricted
synucleinopathydisorders
syno1
o2
o4
fibrilar
synf1
neuropathologically
makings
reviewobjectives
cheers
scvpd
responsewntβcatenin
cadherin
wntdirected
immunodeficiencybackground
immunitya
lavin
chevrier
therapiesand
bodes
pairedkidney
mate
1149
082148
tacrolimusmycophenolate
mofetilbased
schwannomascancer
schwannoma
wholespectrum
galectin
9mediated
schwannomas
numeracy
antitreatment
protreatment
evaluative
lownumerate
narrativesand
narrativesbecause
outcomedelayed
dpr
104548
128543
123327
022078
developmenteven
adultfor
delhis
experienceimmunization
ambit
mitespecific
conditionsintroduction
goodgood
4117
7103
gradeii
tolerabilitysafety
causeoriented
noncapsulated
proteindna
nonbiodegradable
metalbased
tnk
cd3cd56
crisprcas9a
technologyhave
horrific
moratorium
alarmvaccinesserves
technologys
grapples
crisprs
thoughtfully
conjoin
belatedly
deplore
integrintargeted
responsescertain
rgdbinding
albuminil2
25ffc
selfenrolment
1298
2696
contradictions
3667
imprinting
lessinvasively
riches
0108
0176
mgkgipilmumab
futurenonsmall
dataaim
163294
057085
067089
epitopesimmunoglobulin
immunologicallymediated
igesensitized
hayfever
novaccination
rupees
onetenth
2017123325360
maled
stools
22646
7440
4087440
2015problemcondition
1949
1926
182856
standingorder
integritybackground
constrictive
immunosuppressives
biculture
transepithelial
teer
epithelialtomesenchymal
4day
sinomed
inductiononly
sucra
shorterterm
longermaintenance
potentialsimmune
ungulate
protoparvovirus
upv1
antiupv1
daysold
87days
288309
r077
r073
4455
patients60years
5372
4150
2332
080104
p0172
082169
p0365
at3years
095197
p0088
plantproduced
enterotoxaemia
sheepenterotoxaemia
pulpy
standardising
retox
infiltrationpurpose
adccl21dc
nct01574222
dcsinjection
bronchoscopicguided
dcccl21
2316
455668
virusvenezuelan
veev
fdalicensed
pabs
nonhumanderived
tcpabs
coinfecting
tcpab
bovinederived
veevspecific
contemporaneously
multipathogen
immunoepileptology
dorsum
dorsumowing
plannedwe
6mm
septum
flap
scalping
forehead
coverageselective
reducedat
tumorwe
approachhepatobiliary
clue
inflammationbased
reduxcancer
multishelled
organosilica
immunotherapydeveloping
doubleshelled
nanostructured
nevus
nanosecondpulsed
dbd
plasmagenerated
stressa
nonthermal
emit
dielectric
stressmediated
surfaceexposed
attenuators
childrenoral
milkallergic
3100
gastroenteric
nonigemediated
illnessesobjective
citing
investigatordesigned
colds
inhibitorsblockade
2750
lymphomahistological
19872012
nonfludarabine
p0·015
9115
syndromeacute
tmdsaml
41·4months
purineanalogue
statesprevious
n8780
n1142
n1912
treatmentchimeric
tindependent
tanapoxvirus
tumorshuman
intertumoral
tpv
mccl2
mil2
replicability
tpv66rmccl2
tpv66rmil2
mockinjected
virustreated
tpv66rmil2treated
biologyselecting
zhang
inadvertently
aktmtor
3556
cellsrenal
immunizationsdespite
ivent
subsahel
smc
sulfadoxinepyrimethamine
amodiaquine
newlyermerged
cancerpdac
thanfer
caf
exponentiallike
andersengill
neoadjuvantadjuvant
antipd1antibody
steersthe
acu
chr
stanchions
05h
lselectin
hivpassive
allobjective
postheart
lunge
polychondritis
ciaped
il12p40expressing
ciispecific
vectoronlytreated
ciireactive
earlobes
il12p40transduced
vaccinationto
926year
healthcores
hird
495743
ricmac
bari
italyinfluenza
12123
1767
033097
118630
toanalyze
eqd2
patientsreceiving
fittings
drivethrough
everevolving
verbally
6hour
automobile
multipleservice
201711647651
homeostasist
responsewhile
231827
ina
variableimmunodeficiency
pharmacotherapeutic
cnisparing
horizone
polyoma
cnitriggered
patient´s
w8
pyrophosphorolysisactivated
r086
ratio102
ratio15
25949
nanobioconjugate
immunotherapytumourtargeted
tumourcell
colloidal
mbine
prophagocytosis
nanomaterialimmunotherapy
glioblastomasynthesized
fenofibrate
ribavirinincreased
brainbe
encroachment
radiationincreases
entrained
agencyapproved
primeboosting
gagdgp41
particlesshowing
canarypox
highlyattenuated
nyvackc
gp41
dgp41
strategya
immunotherapymesenchymal
populationrenal
infectionsdiseases
injectionimportance
sii
dhome
rii
cmn
2010005
cofepris
doxorubicinkilled
cisplatinkilled
bkvn
was30
medicated
reductiondiscontinuation
reductionswitching
increasedstabilized
094328
0541264
menthe
masterfile
transplantationfrom
doublededged
swordcompelling
atginduced
miicminnesotas
excels
diseasealtering
1482
475years
monoallergy
germanyas
aworldwide
aschoolbased
apublicly
afemale
912years
atwodose
stigmatized
distressthe
doubledummy
p739
p750
doseefficacy
asofyet
leadevidence
performers
gsk1
bbio1
sp2
gsk2
bbio2
40weeks
ime
sie
bbio
1523
nct01831050
metaanalysissimpler
1464
adporcine
ifnαγ
proteinregions
ad3sirna
dpvthe
vaccinead
ipval
blocksize
threetimes
fivetimes
tentimes
nct02347423
n202
97·6
99·5
96·1
n197
94·6
n193
n203
1·46
3·60
0·10
3·62
1·49
2·16
2·45
5·47
0·27
1·47
3·94
7·28
0·97
2·17
failsmbovis
mtuberculosis
siglec14
outcomeshumans
siglec5
sialicacid
siglec5like
siglec
tnfreceptorassociated
tnfrsf1a
hypersecretion
lifestyles
mscboth
bmmsccan
pkh26
dyelabeled
bmmsc
brownnorway
inflammatoryimmune
dyna
dybn
vivoin
ipilimumabinduced
dysautonomia
immunotherapyimmunerelated
pandysautonomia
tonically
pupil
electromyography
droxidopa
cityobjective
com
munitybased
asianamerican
wellhaving
resourcerelated
strategyin
nosetobrain
sigal1
cautions
applicationsblood
gangrene
mamushi
habu
yamakagashi
redback
spider
socindex
dissertations
humanities
briefs
crd42016047319
reportthis
4408
and3076
n4327
n4412
n5787
score90
n6187
n4170
n829
n800
werethe
n2933
n2378
n1098
n4070
n2245
autotransplant
n1338
autotransplants
phasehematopoietic
p0077
hyperchromatic
vacuolated
tadpolelike
busulfancontaining
nonbusulfancontaining
singaporenurses
255427
020034
therapeuticsas
warding
aberrance
oftentimes
immunostimulatorytumoricidal
2015despite
vaccinationrefusal
legacythe
biomarkersin
predecessors
recipientsie
immunosuppressionare
mysterious
nonantigenspecific
objectiveidentifying
populationobjective
treemarkov
847590
404428
productqualityadjusted
belfast
jiau
pramedirected
pramepositive
pramenegative
coexpress
peroxiredoxin
miceto
tgprx1
ascitic
igg2c
adultsfor
surveydespite
ontarians
waterloo
convictions
juba
managementcancer
oncogenetargeted
13349
exomewide
nsm
smo
ddr2
fgfr1
ptch1
366671
20082014the
minhang
11·5
5·512
8·6
3·1
42·4
21·5
86·1
5·4
7·4
9·7
11·3
5·8
6·1
6·2
0·613·4
capabilitiesthe
interfacing
sensorresponse
progressigg
fcfc
iggfc
procyanidin
challengerecently
sweetslike
krasmutated
pseudo
pseudoprogressive
ddpcr
exhaustible
susceptibilitythe
bmtt
sl7207
rtnfα
avitalization
vehicular
distinctiveness
immunoglobulinbackground
7952
103261
endothelialcell
prothrombotichypofibrinolytic
expandedaccess
postvodsos
p0·001
20062016two
highmortality
immunotherapydurable
b7family
selfcell
endoexogenous
663±93
whitecollar
artintroduction
blisibimod
anifrolumab
immunomedicine
parentsobjectives
02years
1792
1130
agreedstrongly
trimerbackground
il17producing
everybody
susceptibleinfectedrecoveredsusceptible
bigger
217year
201726
vesselsin
tian
seabackground
regulationsprocedures
diagnosisbcell
epitopeloss
nonleukemia
salerno
strategiesaims
enjoy
1019y
tweeting
communityglobally
psoriasisthe
ustekinumab
fracture
decrepitude
precollection
lymphocytecd3
runtimes
579±46
403±62
machines
hdca
cyclophosphamidetotalbody
n1244
n316
abating
thimerosalfree
vaccinespediatric
thimerosalcontaining
ethylmercury
ethg
thimerosal
tic
tcvethg
fishmehg
pediatrictcvs
unjustifiable
interferonαconditioned
recreating
drugtreated
succeeding
ifndccancer
paresthesia
remissionfor
ajol
arrive
26960
270419
205826
46144
engagements
or39
or30
or20
0847
evenlyspread
opportunitiesintroduction
immunospecific
radioimmunoconjugated
ratsbackground
sexdifferences
keyholelimpet
antimethamphetamineklh
mh6klh
radiotelemetry
locomotor
vapor
100mgml
02510mgkg
locomotion
shotblocker
trialnonpharmacologic
15024
modelingintroduction
mopv
reintroductions
shelflife
realizations
shelflives
allies
immunotherapysingle
fewlayered
pegcpg
exfoliation
nanoconjugates
infraredlight
posttranscytosis
abcde
scheduleintroduction
1942
53125
232fold
twofifth
14weekshas
malay
malaypacv
cronbach
174879
108359
malaysians
luanticd20
penelope
48gy
individualssocietal
29·8
22·138·7
10·823·8
pr1·22
1·01·5
pr0·82
0·680·99
malignanciestreatment
progressgastrointestinal
checklung
populationimmunotherapy
theorized
nascentthis
melanomapatients
crisprcas9the
rnaguided
integrationfree
goalcuring
steroiddependent
sdns
410days
161days
ceasing
fkbp51s
fkbp5
immunophenotyped
fkbp51sbased
naturematernal
initiativesgroup
reviewimmunisation
analysisgroup
evaluationthis
econometric
maleshuman
n1624
overgeneralise
insofar
liberal
impermissibility
unpalatable
sacks
receptortargeting
proinvasive
αvβ6specific
a375pβ6
panc0403
a375ppuro
tlald
αvβ6dependant
irradiationinduced
microbiomeinduced
micetransdermal
wvp
apuerto
rico81934
aduckhokkaidovac32007
countercurrents
infectionintroduction
immunevirologic
activationtolerance
2015has
diarrheain
lymphomafor
assortment
deserving
registrations
4yearolds
drugradioresistance
131iac1331
mbq100
ac1331
μg100
3trinbutylstannyl
aldh1
lgr5
snail1
practitionerowned
npmanaged
host´s
initiator
monomolecular
polymolecular
crosssectionally
seriesin
n1061578
outofschedule
mupexi
datapersonalization
extractor
informer
mhcbinding
server
httpwwwcbsdtudkservicesmupexi
inhibinα
i10
p215234
inα
215234
sjlamhsv40tag
b220
radiationresistant
ifngmediated
memoryt
eem
nct01416831
ca184
hmlh1
hmsh2
hmsh6
regionhuman
paptest
hpvattributable
saturday
engineeringimmunecheckpoint
progressiverelapsed
1040of
receptortcris
tcrgene
whither
betherapy
iodinetositumomab
yttriumibritumomab
21916
lawyers
antibodieshepatocellular
buttressed
cbnk
pbnk
cbcd34
perennially
dotapdmp
zetapotential
385mv
375nm
dmp
dmppil12
supportobjective
04995
ttcontaining
ttcvs
httpwwwwhointimmunizationsagemeetings2016octoberpresentationsbackgrounddocsen
hiranational
682258
16514
macerelated
nowimmune
hypercholesterolaemia
codification
asiapacific
unexposeduninfected
nct00829010
910months
medicinebrain
therapiesartificial
laminarin
c56bl6
b16ovallbumin
responseallergic
motions
sneezes
il12antidna
nhs76
dnadnahistone
ifnγâdependent
mpdl1
additivesynergistic
pdl1âexpressing
mb49
tetraspanin
tspan
cancertetraspanin
tspan8
ts292
feasability
espression
dotats292
111in
purities
mbqmg
radioimmunoreactive
111indotats292
tumorblood
sw480tspan8
120h
177ludotats292
111in177ludotats292
tspan8positive
infuse
enquiry
practiceoriented
bioptic
acentral
anadvanced
malignanciesdespite
infectionsobjective
heed
ard
6527
5791
nonhrv
4808
observedonly
nct00737503
117162
94162
158162
immunotherapyhematopoietic
lowcirculating
chinachinas
31713
prerecombinant
immunopsychiatry
factsaccumulating
psychiatrists
vivax
broadlyacting
cspbased
rv21
pvcspspecific
csp
vk210
vk247
gfpluciferase
vk210247
childrenfractional
steroidnaive
ppb
283411
183432
108245
personalizeddose
methodcows
childrenwith
igemediatedcma
ipilimumabimmunotherapy
revive
lalf
3251
lungsone
tumourigenic
retroorbital
1237
lckderived
vasoconstriction
transplantationreversible
subtraction
sausage
organizationworld
pahowho
prognosticators
metastasisthis
y90
posty90
ytrium90
easytoadopt
alg
manalgalgova
manalg
algova
npstreated
cy7
b3z
tolerancetechnologies
milkinduced
preoit
igetotal
tuberculosisin
marketplace
populationsas
02yearolds
517yearold
02yearold
hdmrelated
hdmslit
hdmsublingual
immunotherapytertiary
cariesobjective
antism
keyes
ua159
serotypec
no3
no7
164±20
302±93
acidproducing
adherencec
apabilities
progressfree
047067
046077
wmd
258556
noncik
5065
5065years
telomerasebased
htertexpressing
htertdcs
mrnaencoding
lysosomaltargeting
htertspecific
hlabinding
2017123306172
artss
179±018
181±023
195±034
085±055
101±031
144±039
sensitisations
1011years
16middle
2015by
1427questionnaires
1168questionnaires
1155could
575girls
251of
519questionnaires
socioprofessional
57667
84775
firstlevel
3505
6771
reactionsplatinumbased
categorizations
cellscytotoxic
transferrable
malignancieshistorically
setsrnaseq
massspectrometry
misexpressed
20112014objective
3268
2820
180746
4323
20289216
20152016during
nonhighincome
hics
nhics
antagonizing
tumorimmunosuppressive
summit4ci
2629
madang
kina
cerenkov
ffdgnearinfrared
photoabsorbers
crpit
pharmacyobjective
telephonemessage
conjoint
conformism
marchmay
emailing
n775
rennes
346419
315420
253326
dissuasive
056075
crd42016034145
inflating
patientsbusulfan
fbd
tdm
myelodysplasia
39mgday
349mg
494mg
managementpharmacological
literaturewhile
babs
bab
admissionsrespiratory
phosphoinositol3kinase
lungsinhibitors
angiogenetic
efficacythe
revolutionises
pdl150
hr050
037068
p00011
checkmate026
pdl15
091145
keynote021with
p00016
oak
studywith
hpv11positive
shrank
hpv11associated
12722792281
inhibitorsmore
thierry
boon
mutageniccarcinogenic
nmethylnnitronnitrosoguanidine
oxygen6
guanine
dixrelated
immunepharmacodynamic
temozolomidein
uptoday
responseswhen
triazeneinduced
mutationdependent
cd16cd56
anxietyobjective
hpvhpv
fearanxiety
haviq
validitytested
3cgamp
vaccigrade
prrsv23983
issuealthough
haverevolutionized
cytotoxictlymphocyteassociated
godfather
bms946559
cardiomyocytes
walesobjective
overseasborn
3383
063095
009012
19921999
140357
028055
049077
makingvaccinations
consistencytrust
calcineurininhibitor
belataceptresistant
tacrolimustreated
cd4cd57pd1
belatacepttreated
rejectors
nonrejectors
rejectionrisk
belataceptbased
nct01175083
6s
6ns
711s
711ns
1223s
1223ns
22finhibition
seroprotectedseropositive
networkbackground
thrombophlebitis
17f
24f
lycopenea
transisomer
tlycopene
tlc
6b9
4f10
4a3
3b12
carotenoids
lutein
carotene
sebum
corneocyte
nutraceutical
photochemoimmunotherapy
photoactivatable
cancernearinfrared
emtansine
tdm1
maytansinoid
dm1
antibodydrugphotoabsorber
tdm1ir700
tdm1ir700mediated
trastuzumabir700
tir700mediated
tir700
smalltumor
largetumor
stubbornly
greenlandan
inflammationthe
multiprotein
perpetuated
stemnessdue
evil
nicherelated
orchestrators
mltc
virusbovine
choicesnoninfectious
panuveitis
immunosup
pressive
dosageduration
safetytolerance
safetytolerability
polarised
1β
1polarised
dc1
6kda
dc1s
esat6specific
carcinomano
progressbackground
atpadenosine
cd73adenosine
tumorsconjunctiva
mitomycinc
metastasesuveal
gnaqgna11
q209
yap
cdrelated
069120
065117
immunizationpregnant
109379386
doctrine
evilthe
thenstandard
pantumor
1galactomannan
trialcurrent
relocating
pastorian
acclimatization
chengdu
19081927argument
diffusionist
scholarship
strove
catholic
jennerian
colonial
pastoriantrained
imposition
bfahf2
peanuttree
bf2
pntn
wn
cshallergic
pnwncsh
bf2oittreated
oitonlytreated
oitonly
bf2oit
56weeks
remethylation
toleranceprone
depletionresistant
lymphopenialymphoablation
lymphoablative
euthymic
thymectomized
lymphoablation
matg
matgtreated
vitrectomy
planitis
95years
bestcorrected
bcva
phacoemulsification
20100
amblyopia
opacification
individualism
considerationsthis
boas
ijphr
vaccinessporadic
midseventies
stifled
consequencesthis
themed
itoc4
2022
1470
studyclofarabine
dle
nonengraftment
52mgm
relapseallogeneic
iemr
n446
emrs
sirolimusbased
prophylaxisthere
tacsir
kdigo
akipredicting
hr196
1ngml
tacsirbased
cancerseparate
cachexia
cancerhost
720000
nct01814046
myelomaunlike
mmrrespectively
3638
seropostive
mmr171
mmr173
01233
50287
5053
were97
171173
159171
882150170
164173
866148171
829141170
21730
119351
32382
71707
6438379865
625456216958
81201
7345289767
36328
3054243211
4410
39084976
roadblocksorgan
universitieshuman
n18919
antibordetella
survivalautologous
fullintensity
n314
n143
immunologyon
1917
coalitionobjective
intermountain
iwhvc
n86
schemethe
educationlow
sexualitypromiscuity
communitys
25year
cd99
selfnonimmunogenicity
anticd99
ca242
pcv13pneumococcal
antipolysaccharide
nct01095471
neethling
strainbased
evagreenbased
lsdvs
bulktank
1727
lsdvnegative
26215
smallsized
05cm
lumps
calvesheifers
postdevelopment
hormonenaive
uv1
hormonenaïve
leukine
05ngml
uv1specific
nephropathythe
mortalityhematopoietic
lucile
packard
pericardiocentesis
transplantan
regimenthe
500mgm
ccis
graftverushost
outcomesthere
cnsifd
spaceoccupying
62746
27527
6487
3341
complementsufficient
vivomonoclonal
2bp
micensghc
daudi
nsghc
complementindependent
powderladen
lesionfree
vaccinationlive
mna
selfapplicable
cave
caves
shafts
melted
sucked
diffused
bcgmna
bruise
bcgmnas
dermatophytosis
dermatophytes
dermatomycology
mycological
75months
trichophyton
rubrum
hairfollicle
majocchis
dermatophyte
celltcell
goalsallergenspecific
appraises
transplantationmolecular
postessential
thrombocythemiapolycythemia
vera
jak2v617f
5451
leukemiatelomeres
chromosomes
rtl
p96
marmosetscases
marmosets
m336
mabtreated
marmoset
melanomametastatic
a2restricted
tert572y
cap16d
srva2
30μgkg
enumerating
77months
nct01410968
08042011
hyo
boxmeer
1108
threeweekold
25g
18g
mlaa34
technologymlaa34
antimlaa34
ma1
phageelisa
u937
beforeduring
day7
day21
distressimpairment
raters
timerater
parentrated
multirater
2017123315966
lpmab23
podoplaninhuman
hpdpn
casmab
lecs
lpmab17
antihpdpn
hpdpnexpressing
ln319
rerflcaihpdpn
ymeso14hpdpn
hsc3hpdpn
lpmab7
therapysubstantial
methamphetamineinduced
micemethamphetamine
meth
aavmethab
methspecific
methab
methinduced
picc
piccs
67days
vaccinationoutbreaks
straining
yf17d
boostervaccinations
inoculums
mpac
httpwwwwhointimmunizationsagepreviousenindexhtml
ramadan
conakry
practising
93201
040053
049094
108201
047060
034047
quran
forbids
2128days
oncevaccinated
phosphoglycerate
fhpgk
infectionlymphocyte
cdnafhpgkpcmv
2014this
australiawide
propositionbackground
verruca
extragenital
600000
cancerpromising
cd70cd27
nanomedicineimmunity
trillion
expiring
miniaturized
nanomedicinebased
cancerstumor
fore
fuelled
micrornamediated
embodying
posttranscriptional
directionsin
variablesobjectives
ab2109
obtainment
cass
notutd
highutd
lowutd
unaccounted
immunotherapymodified
ccr5ccr5
mccr5ig
7patients
2patients
atumor
fb128
fb96
carcinomachimeric
electrophoretic
k562meso
cd107α
ehca1b
ehca1a
ratiodependent
mesothelinnegative
gscsd
ehgb1
l02
mesothelinpositive
293meso
851±147
83±250
909±467
185±362
608±200
156±206
64±295
17±063
radioimmunotherapytreated
400mbqkg
lumab
ratsday
literaturewe
strictures
cholangiopathy
ofcs
2147
1102
0044
0433
preparationbackground
010305
0050102030405
updose
2540
3840
myeloblasts
postrandom
syndromecase
predilection
ssrelated
2013objectives
phagocytesthe
mφ
clinicsthe
rhcs
timeconstant
duallyeligible
providerbased
mutationreactive
minigenes
25mer
hladrb11501restricted
rbpj
2315
434753
19992011
258683
304903
104109
127139
105115
polyangiitis
161219
152216
141161
114131
9981007
effectsbovine
luteum
estrus
reinfected
boostered
usdaaphis
nonabortifacient
pd1blockade
6125
craft
immune‑based
indisputable
transplantationcellular
allergiesobjective
biomonitoring
antiacid
hutterites
polylactocoglycolic
studiedvideo
httplinkslwwcomanca27
nursesnurses
metaepidemiologic
clinicaltrialsgovpurpose
rhrs
rhr
nonnull
00129
skinmicroneedle
microns
easytouse
skininsertion
painlessness
manufacturability
microfabrication
efficaciously
otherwiseinjectable
achrimmunized
lrp4immunized
eamginducing
lrp4eamgsusceptible
complementigg
lrp4induced
nonconformational
lrp4related
antiretroviralnaive
peopleregulatory
artnaive
sirva
uairva
careallergen
hankin
medicaidenrolled
headingintroduction
exomecaptured
filtered
ingenuity
3120150407
hladrb103
brafv600mutant
frontlinetreatment
tetanusa
ttx
spotted
nitrocellulose
immunostrips
flatbed
scanner
imagej
elisaagglutination
0813
006iuml
antittx
antidtx
835979
8092975
759968
571995
611960
808945
coloration
immunogenicityimmunotherapy
immunotherapysensitive
165669
hypermutations
targetcheckpoint
temozolomideinduced
methylguanine
selfencapsulating
microspherespolylacticcoglycolic
premade
irradiationmelphalan
melphalanonly
melphalantotal
meltbi
tulane
7098months
842months
nomogrambusulfan
2183
06222
onecompartment
studiesinduction
immunocompromiseopportunistic
kingdoms
unitsbackground
568665
611693
249380
isolationism
ubiquitinated
crosspresentationwe
shunted
blebs
dribbles
ubproteins
immunotherapystereotactic
incidencerisk
accrued
invigorated
bmtaza
cmml
hrmdsamlcmml2
20100196731
614monthold
614montholds
106631
23769
7998
7295
4082
1271
routestoxoplasmosis
ubiquitinconjugated
adumas
gondiispecific
intraorally
rosaidorfman
photoimmunotherapyrosaidorfman
nostril
preauricular
syphilization
discontents
hospitalin
1867
gascoyen
syphilitic
4cmenba
diseaseinto
5280
5787
matspositive
st269
avoidanceearly
sh2d1b
pod14
screeningobjective
supermarket
patientsthere
fluoroquinolone
norfloxacin
postprophylaxis
treatmentindoleamine
23dioxigenase
pkc
2017antibiotics
semiconductor
adjuvanting
lowpower
nontissue
diodepumped
solidstate
dpssl
diodes
1061
1301nm
massvaccination
201215we
2466
femalepredominant
eventspecific
oculorespiratory
anaesthesiaparaesthesia
sexgender
programmeperformance
pqshas
pqs
innovationssolar
directdrive
userindependent
timelines
gatekeeper
enabler
productdevelopment
solar
demandgeneration
drcs
cassetête
workers21
transplantationliver
chronicles
activationobjective
phastimulated
stressbackground
ang
antiang
infarct
fluorojade
spectrin
fragmentation
4hydroxynonenalpositive
antioxidative
migrationh
chemokinesis
ship1
hypocalcemia
hypoparathyroidismbackground
tingling
cramping
hypocalcemic
autoimmunitythis
videobased
6544vs
viewers
226vs
disapproved
nearinfraredtriggered
ucnps
ucnpce6r837
r837containing
ucnpbased
cipvbopvbopvibb
cipvtopvtopvitt
cipvcipvbopviib
cipvcipvtopviit
cipvcipvcipviii
topvtopvtopvttt
ibb
iit
openbugs
availablecase
3842
aetiologies
3492
2961
2233
2726
1748
vested
postrandomisation
crossovers
immunotherapyangiogenesis
starve
branched
prune
rolethe
guards
incipient
proneoplastic
cancerpromoting
0120gy
01gy
01mgymin
lowlet
cancerinhibiting
halfbody
carcinomaesophageal
stubborn
metaanalysisthis
celltreatment
0594
05010703
05100738
0700
04521084
0110
0635
05140784
0623
05160752
coengagement
frαspecific
frαpositive
cancersfolate
carcik
frαnegative
ζcarcik
28bbζcarcik
xenograftbearing
28bbζcar
28ζcar
28bbζ
ζcar
cd28ζcar
cellsinnate
receptornegative
defenders
ilcp
panilc
subsetrestricted
transplantationvenoocclusive
vodassociated
haematologybritish
19±8
17±2
p706
artpertussis
512year
1317year
913year
2363
age38years
106years
hiv1exposed
nontb
nonmycobacterial
welltimed
nct02606526
lambliagiardiasis
enteroparasites
viri
lence
giardiasis
histolopathological
simmunocompetent
pressed
conclusicn
photoreceptor
rubellaimportance
13monthold
electroretinographic
fundi
reflexes
punctate
thinner
ellipsoid
nonrecordable
chorioretinitis
leftbehind
chinamany
13331
chalmetteguérin
nonleftbehind
92·7
0·013
65·7
79·9
zmab
mb003
doorsradiotherapy
gliomasthe
immunotherapytryptophan23dioxygenase
homotetrameric
hemecontaining
catalyzing
oxidates
23double
indole
ltryptophan
cancerevidences
inhibitive
harbour
bacteriumbased
whence
whitherthe
63550
gratifying
antiil7rα
prediabetic
antiil7rαtreated
2014the
irradiationetoposidecyclophosphamide
tbivp16ctx
buvp16ctx
mgkgthe
bloodmedian
daysmedian
daysmixed
failureeight
patientsamong
virusebv
diseasewith
05108
600±110
patientsduring
hsctamong
transplantationebv
auditunassigned
6660
1852
7072
1321
infectionstreptococcus
scarlet
impetigo
26valent
polyvalence
fsbm
rfsbm
fibronectinbinding
sfb1
streptolysin
c3binding
pyrogenic
emm
antifsbm
rfsbmimmunized
opsonize
gamble
protocolsfocal
debulked
inflammatorymediated
βthalassemianonmyeloablative
tli
interleukin4driven
stat6dependent
tliats
alkylator
tliatsctxconditioned
βthalassemic
hw80
tliatsctx
irradiationatsctx
ctxats
tliatgalkylator
c9orf72
polyga
dipeptide
proteinscelltocell
hexanucleotide
frontotemporal
lobar
ftld
g4c2
repeatassociated
nonatg
aggregating
polygp
polypa
antiga
polygadirected
alsftd
singlepoint
betweenstudy
laird
agonistsagents
trialsmore
250million
tunnelalthough
plac1
motherfetus
mating
antiplac1
0051
decisionmakingsociety
fluoridated
forwardthinking
rbst
articulates
industrialization
immunoapheresis
adsorbers
aspecifically
igespecific
igeselective
mfa
diathesis
procrustean
cd4cd25foxp3t
th3
ctla4treg
hints
caom
nonrehabilitation
aomcaom
suppurative
labyrinthitis
petrositis
2618
22647
8715
13652
5554
1760
0717
futureintroduction
smallkinase
ki
smallki
killertcell
immunotherapynasal
nnktl
highspdl1
lowspdl1
copenhagen
copsac
½
1½
nonnegative
bamse
1dogcathorse
peanutwheat
flourmugwort
peanutsoybean
eggmilkwheat
1572
2243
71item
meningococccal
proteinbinding
obstacleschimeric
hottest
shooting
factorreceptor
tomlinson
ij
oligopeptides
pi12
pi42
pii16
pii29
rosettagami
ccrfcem
preimplantation
typingthe
pgd
immunotherapyadvances
unfolding
immunevacuous
scrutinize
thwart
surveillancethe
productassociated
productae
covariateadjusted
salmonicidaatypical
citrulline
45ul
b23
ratio88
b01
transplantationcomplete
25kg
besttolerated
dyscrasia
pdm09like
h3n2like
bmassachusetts22012like
detectionobjective
haidian
china20072015background
20052013
23497
13440
5720
6840
7002
7421
9006
1519years
safetychimeric
therapyas
antiaids
cultivation
cocultivated
1170
toinduce
thatencodes
ag85a
primesev85ab
phosphoantigenthe
reconstitutes
aminobisphosphonate
vγ9jγp
australiaintroduction
adopter
victorias
desktop
235393
postaefi
541584of
myelomacd38
adp
chromatographic
hcf
adriven
trypan
proteolytically
echinococcosisinfected
covalbuminefitc
tgfβ1mscs
tgfβ1msc
leukaemiabackground
mddc
tlr4agonist
cellsheterologous
ad5
rabat
immunotherapiesan
outofsequence
ghanabackground
mvafterdtp3
dtpmv
142106190
129103160
258114584
137102185
20072013background
marketscan®
20072013
6746476
6770294
hr0543
ci0539
hr1841
ci1830
1853
goingadvances
curiosity
immunesuppressing
leukemiatcell
tpll
morin
specificitymacrophagic
adjuvantcontaining
cohesive
basophilic
acidschiff
paspositive
diastaseresistant
percolate
endomysium
myofiber
2step
histochemical
utsw
myofibers
imam
cryostat
ageeffects
dph
tray
singlestage
incubator
drypunch
inovocox
em1
treatmentreplicate
wirefloored
vaccineinjected
youthunassigned
impaact
p1065
immunizationpostlicensure
wtvzv
052079
065081
079094
079091
085095
ews
vigil
immunotherapyewing
chemotherapyradiation
gmcsfbishrna
apla
anticardiolipin
tim1objective
fluorogenic
n45926
502years
5181
99389941
malpura
avikalin
toxigenic
dqa2
reservoirmediated
immunotherapyadministration
gelatinbased
horseradish
dcloaded
oaddcgel
oaddc
gelmediated
ineligibility
intermediate1low
medicaremedicaid
lowlowintermediate
systemrevised
ellipro
hlaabc
epletshla
wwwepregistrycombr
eplets
nonepitopes
ponomarenko
antibodyverified
ps2
activeuntreated
noneligibility
betterrecent
egtcell
caspase8
mhciii
egtim3
egcd40
reactionsand
administrationand
metastastic
dlhs
200208
glioblastomaassociated
prognosisglioblastoma
subverted
sccs
icassociated
026078
r035
011059
19141933japan
1914
4632
stray
tethering
3805
dogbite
1924
hydrophobia
slope
5695
women113
2006using
kmt2amllrearranged
caseswe
kmt2amllgenerassociated
bcpall
kmt2aaff1mllaf4
kmt2amllt1mllenl
nonbu
remissionfollowup
r0390
r0080
modulationcancer
wg3
parietal
intensitymodulated
frontoparietal
dysgenesis
outcomereticular
agranulocytosis
06236
lymphomyeloid
calprotectinthe
microberesponsive
microbiotaassociated
tapcs
guthoming
icosltnfαdependent
calprotectin
tapc
gutdirected
hccrelated
pooltriggered
rgs5
prospectslentivirusmediated
selfcontained
19662014
policiesstrategies
activeadvanced
antigenidentical
2017123267179
immunizationpreterm
tuberculosisbackground
mtbvacassociated
tuberculosisendemic
aidsvax
alvachivaidsvax
70v1v2
14069
nct01435135
commentaries
vaccinatesince
wellpublicized
3060minutes
faqs
astic
tattooing
costminimisation
symptomrelieving
compensates
indisputably
tinfiltrating
resultsand
expectationsthere
fruition
patientshiv
yearlong
texting
reminderrecalls
monotherapybackground
q2w
goodnesstofit
fivefactor
treatmentpd1pdl1
effectual
distressingly
coenrichment
ipres
cancercellautonomous
were65
monosomal
mkpos
of3
3052
goodrisk
hr95
mkneg
hr33
hctci3
hr31
2017123266170
tattoo
applicationmelioidosis
bioterror
flagellinencoding
sccfvii
rrcyclicdiguanine
cdg
cyclicdiguanine
rrcdg
ifnγcd8
10861094
shotat
lawmakers
campuslevel
yeastmediated
phenotypemacrophages
biosynthesized
yeastbased
m1polarized
scb
postselection
selectioncd34
vaccinessuccesses
microspheresprimermvaboost
virusbluetongue
vp7
munsmi
msvp2vp7ns1
rmvas
multiserotype
printbased
photonovella
ipadbased
timi
microcosting
promotoras
lowtech
lymphocytesallergic
pathwaycellular
countrywith
switzerlands
nrr
04100
19881991
nonvaccinerelated
availableparticipant
twoarmed
threearmed
informationthere
0183
34816
4539
267026
carcinomatwo
undeveloped
lackingprobably
complexityclinicians
unseen
sarcomasabsolute
mifamurtide
weaponlung
yearoverall
statusimmunotherapy
25lung
patientsthis
calicheamicin
pyrrolobenzodiazepine
maytansine
sgn
33a
anti123
anticd56
mertansine
proximityinduced
cd33cd3
approachesseveral
efficacyinterleukin2
emergedusing
alphadirected
phasei
yearsin
herdsreports
11281
3271
ncdv
b223
p5
g6p11
g6p5
g6p1
g10p11
willingapproximately
racially
ethnicallydiverse
n256
lowliteracy
engendered
mcrpcinfiltrating
bez235
mdsctargeted
stemmed
mdscpromoting
diseasegcsf
csf3
gcsfr
antigcsfr
neutrophildepleting
antily6g
aginduced
zymosaninduced
bsail1
gcsfdriven
bsagcsf
csf3r
gcsfrgcsf
plasmaserumderived
pseudotumor
cy2
507481
freelow
sterility
trialslatex
neuropathymultifocal
complexmatched
balbb
mactransplanted
lymphopoiesis
endosteal
helper1
childhoodpermanent
tbicranial
41263
25127
33162
syndromesthis
crmconjugated
m5
ll95ci
hopeimmunotherapy
antictla4and
pd1immune
anticytosolic
5nucleotidase
myositisobjective
anticn1a
anticn1apositive
autoantibodynegative
p62sqstm1
iggsupplemented
igginjected
p62sqstm1positive
sarcoplasmic
201781512525
debiojectin
debioject
idj
ids
rabique
pasteur®
solae
vna
providersoral
exposuretransmission
cambodiaporcine
twosow
fivepig
fattener
singlesow
threepig
farrowtofinishbreeder
35710
profitability
algorithmbackground
systemfocused
scienceimmunotherapy
mid1990s
recommendationsas
multigene
transplantationminimal
28gene
differentfromnormal
10color
vaf5
discordance
vaf
antibodiesimmunotherapy
celleliciting
vaccinegenerated
a2or
6monthly
gp2granulocytemacrophage
lvef
28±10mm
68±8mm
47±19
144±60
1000μg
gp2250μg
gp2gmcsf
tcelleliciting
malignanciescancers
immortality
gv1001
collagenspecific
98day
gv1001treated
collagenstimulated
vehicletreated
tnfαstimulated
perubackground
arequipas
citys
proximate
mariano
melgar
coders
disparaging
illtimed
topography
impermanent
roam
streets
allosensitization
ventricularassist
strategydnabased
porters
immuneforces
opportunitiesover
pembrolizumabimmune
type2papillary
carcinomawith
freed
modcstumor
gmcsfbased
gmcsffused
nivolumabrelated
pneumonitiswe
nodularities
ggo
nivolumabmediated
death1related
tlr9based
diseasestolllike
cpgodnbased
cpgoligodeoxynucleotidebased
engineeringischemic
multitiered
nscs
persistencesurvivability
atarget
aplacebo
aminority
interferonrelated
precursorball
nanomedicinedespite
neoplasialast
005048
003079
007077
travelersthis
bvaccinated
recordconfirmed
eraa
cute
2905
n497
19992001
n962
n1446
4147
guidelinedeveloped
academics
authoritiesprovides
ohiobackground
stamped
packet
updatesystemic
beta1
diseasetransforming
fibrogenesis
hbvc
dimethylnitrosamineinduced
atg10
atg6
gvhdfreerecurrencefree
1614
281929
p084
p832
p263
p283
2017123288192
applicationcellbased
exvitro
delmarva
cabinetthe
arkdpi
manufacturerrecommended
sprayadministered
dropadministered
middleclass
brazils
impositions
actioncancer
growthangiogenesis
selectionof
populationpart
deliverynewer
conformality
proteinseveral
vaccinedelivering
wt1expressing
wt1epitope
nonoral
110µg
100µl
h37ra
tnfconcentrations
eaeinduced
ashift
twentyyear
asiapacificbackground
inflicts
recommendationsguidelines
4007
screenedout
1501
1264
3101000
qa
jae
apms
antibodiesprogrammed
atrophydropout
lymphoplasmacytosis
irregularity
pheoapei
pheoapeiova
dc24
27dichlorodihydrofluorescein
dcfhda
clsm
lightresponsive
immunotherapysignificant
wires
nanomed
nanobiotechnol
9e1456
101002wnan1456
underweightobesity
baffreceptor
formationoral
ovatolerant
zein
resistinlike
moleculeα
scarless
experiencesummary
catsdogs
spts
spirometric
anamnesis
dec205
vivocancer
moleculerestricted
hepa161
immunopotent
lipidglycolipid
95·0
49·1
1·0
1·97
overimmunisation
principlesprogress
phenoytype
molecularallergological
diseasealzheimer
neuropathogenesis
prototypes
promised
zhengzhou
cikcell
donorstcell
djoungolo
districtbackground
microplan
revitalization
bprotects
mucoid
nonmucoid
aeruginosabackground
oprfopri
584100000
362100000
missionary
clinicshospitals
divide
zambian
prerollout
softens
presumptions
levelspurpose
antimalignancy
98μl
15μl
singles
ccl18producing
ccl18dependent
pitpnm3
ccl18
diseaseover
coursemodifying
expansionadoptive
reps
5000fold
threeweekexpanded
longtermexpanded
2weekexpanded
uncompromised
shivhighly
ad8eo
refs
56177
tcelldepleting
anticd8β
evasiona
kinasewith
tcellexcluded
gas6axl
antiaxl
292833
grazing
eg951mg
quila
thermolabile
eg95quila
phonedelivered
msimu
shilling
kes
kesusd1
nct01878435
n489
n476
n562
n491
1·09
1·021·16
nonsignaling
psca
bugiri
mayuge
pr111
pr081
067099
pr092
085098
avail
hmic
jabs
jags
gypsies
romabackground
romanian
gypsyirish
gypsy
romanianslovakian
spoke
multiplecombined
trustful
isrctn20019630
portugalbackground
ov055620000
diagnosticrelated
unitary
6238
ov0556397217
432966
ov055628
cancerinitiating
immunotherapycancerinitiating
aldh
apm
gdf15
factor15
il13α2
pdk
3phosphoinositidedependent
tgfb1
modelcd4
lcmvinfected
glycoproteinspecific
gp6180
lmgp61
iavgp61
gliomaintroduction
intertumor
measlesobjective
monetized
axisthe
cd47signal
myeloidspecific
decoys
antisirpα
antibodiesand
pharmacokineticand
tumouropsonising
cd47sirpαblocking
studyautologous
2209
161117105008
15119278342
endotracheal
361901
198249
84698
4865
3789
4781
vaccinelimiting
65519
ehrbased
approachesimmune
literaturethe
clarificationin
myelomaautologous
len
hdlen
350mgday
englandobjectives
briefings
hospitalier
universitaire
vaudois
chuv
lausanne
epizootiological
stampingout
westwards
evrosgr15
rpo30
lsdv126lsdv127
lsdv127
epizootic
mink
chinamembers
g15
xb15
2321b
2321e
preadaptation
6u
20u
3267
6su
14sv
inf
comingled
relocated
12v
136±36days
55±43days
125±27days
30±14
108±29
48±34
910days
30±14days
worstcase
slowering
cstrainbased
chinaclassical
lapinized
cstrainvaccinated
m290k
anticstrain
shimen
hljzz2014
strainchallenged
ccl21s
gliomaschemokine
neurooncologists
neuroscientists
glycosaminoglycans
haptotaxis
donorswith
13rd
cpra
bpv1
bpv2induced
pseudosarcoid
ecpv2
horsewe
bpv2
ecpv2bpv1
virions
bpv1inoculated
pseudosarcoids
bpv1induced
acceptabilitypurpose
eightsession
psychoeducation
problemsolving
biofeedback
gravely
immunisationstatement
eapthe
capacityhuman
principalcomponent
ifnγenhanced
pdhs
possessions
n3936
unempowered
purportedly
yetcurrent
mg4g
2575
250500
heatmodified
vaccinationhighrisk
deploys
coblockade
asthmarepeated
unremitting
coinhibiting
sil13r
sil25r
vivothe
3t3neugm
nt25
updateimmunotoxins
ricin
gelonin
lessimmunogenic
ef2
dga
deglycosylated
achain
rgel
nkc
dab389
bccl
dsfv
disulfidestabilized
hcl
atl
darpins
ankyrin
humananti
mostrelevant
antiimmunoglobulin
4interleukin
strategythe
sledai
timefree
negativization
anticoagulation
362months
amodiaquineinduced
injuryif
idili
drugmodified
aqmodified
ribi
creditable
bcgsd
epirubicin
mmc
bcgld
bcgepi
paeds
6227
policyrelevant
3087
n211
australiapregnant
35214
3136
3278
intrapandemic
prepandemic
κ038
κ091
commun
intell
2016403e340e346
bcggagm
mvagagm
dnagagm
gagm
gagn
dnagagn
cytokinepositive
consensustype
employerbased
1222384
1147711
085088
084088
midwest
080082
092095
aciddifferentiated
tcellsbackground
acidskewed
dcras
1a2
allergenpresenting
halfmaximally
dcra
ebi
il27incompetent
weve
monogamy
rig
rigan
himachal
amidst
erig
kasauli
statesintroduction
medicaideligible
citywide
018037
025095
020047
hospitalaffiliate
latinos
vaccinehuman
communityoriented
elderlyintroduction
agetailored
devilsdevil
sarcophilus
harrisii
endangerment
eradicationbecause
habib
generalists
rabbitsnoninvasive
easytoadminister
microelectromechanical
gasgenerating
highpressure
ejected
antiovalbumin
dropper
cellsmemory
cbs
noncb
cataracts
5364
immonotherapy
bezlotoxumab
tcda
tcdb
nodethe
lnms
inflammasomeindependent
necrosislike
prestored
interleukin1α
noderesident
lndc
relocation
lndcs
il1αinduced
rhinitistreatment
8g12
vaccinehepatitis
hecolin®
antihev
elsia
8g12like
1819years
1819y
1025miuml
69miuml
4779miuml
7100miuml
modelchimeric
rv3131
dosr
regulonencoded
nitroreductase
kaccumulating
latencyassociated
regulon
dosrrelated
glase
rv3131specific
coproducing
rv3131glaseimmunised
multiantigenic
sitedwelling
experiencesbackground
imagingimmunotherapies
icit
nebulization
rns60
physicallymodified
therapydeveloping
taylorcouettepoiseuille
adoptivelytransferred
alexa680
sjlj
cuffing
bloodspinal
antiautoimmune
mcgdose
5754
threequarter
aor049
cri039060
aor062
cri051074
aor066
cri050082
aor128
cri102157
aor293
cri160471
aor269
137473
84000
wwwclinicaltrialgov
postnephrectomy
veteran
vhie
projectthe
vler
walgreens
antitau
approachesalzheimers
depositions
amyloidβbased
corruptive
templating
seedinglike
pretangle
ascends
anterogradely
interconnectivity
typhiintroduction
vivotif
typhim
19million
parenterally
dataaimshypothesis
t1dassociated
20570
295420
096121
024months
nominally
106196
090116
tolerancesthe
tissueintrinsic
anαtype
αdc1
αdc1s
canbe
liverhepatotropic
tlr26
hepatotropic
melc
recipientsviral
nondes
sero
bkan
debugging
boxb
anagnostou
2501
programwidespread
ncccp
immunotherapychronic
hepatitits
precompetitive
transplantssignificant
msdt
nonmsdt
mudt
hidt
ospt
fibroblastic
toolsfibroblastic
cd90
myofibroblastic
ifnγstimulation
spfrcs
bmp4
activin
lnfrcs
retinaldehyde
maltotriose
pullulan
rdf2p
maltese
beagle
rdf2
01100
rdf2specific
ibevacizumab
iodogen
980±07
iodination
diabetesbackground
tedious
ra27l
rh3l
buffalopox
modelsbuffalopox
bpxv
vaccinialike
vlvs
emergingreemerging
buffaloes
a27l
h3l
imv
orthopoxviruses
30kda
bpxvvij96
20μgdosemice
fcafia
indirectelisa
snt
antia27l
antih3l
myelomaimmunotherapy
ctla4b7
donteat
counterreceptor
reanimating
reignite
embodied
b7h4
cancerobservations
vtcn1b7xb7s1
b7h4expressing
targetscancers
rejectiontype
purinergictargeting
refectory
ifngproducing
glioblastomathe
uncouple
catalyzed
vistautilization
ncrs
igcontaining
antivista
tmigd2
b7h3the
cd276
b7h4b7s1
b7h7b7h5tmigd2
igpr1cd28h
cd223
targetdespite
pd1pdl1targeted
lag3targeted
lag3pd1
immunologymany
kinasestyro3
mertkas
efferocytosis
lublin
polandbackground
selfgovernment
nizppzh
5496
radzyń
podlaski
5125359
bkpyv
mps
evl
bkpyvassociated
20072012despite
echantillon
généraliste
bénéficiaires
197th
4862
752years
ci653744
ci689714
arr093
ci087100
arr096
ci090103
ci094111
ci096114
ozoneinduced
pigsozone
vagally
reportallergenspecific
populationait
compliancein
dermatitisthis
siaip
subingual
dseloratdine
113±105
468±309
007±004
036±025
slitdrug
sociodemographiccultural
121636
cmu
couverture
maladie
universelle
nonsteroid
agitate
ji
1840years
nonstandard
9833
nct01827371
triballyoperated
itu
literatureprogrammed
24mmoll
ketosis
065ngml
treatmentthere
immunotherapyil27
twochain
il27p28
il27r
wsx1
gp130
cancerbiological
genotypedirected
alkros1
actionability
ntrk1
immuneevasive
formelanomamelanoma
antitryptase
degranulating
tryptasepositive
anaphylaxisrelated
celleosinophil
causeandeffect
temporarilyrelated
noniis
onreserve
physicianadministered
mesotheliomain
1pd
differenceswith
proofing
pandemrixassociated
pandemrixnonassociated
mir1885p
mir4499
mir1470
mir4455
brainrelated
foxp3dtr
tumorpeptide
balbcfoxp3dtr
dtxmediated
coverageequity
ambitions
a6
efficacyhand
picornaviridae
a71
eva71
a16
cva16
cva6
cva6inactivated
fivedayold
wf057r
quadriplegia
moribund
cva6associated
anticva6
cva6specific
neurorespiratory
sweettasting
cryingoral
herdprotection
ceas
ceasconclusions
incrementalcosteffectivenessratios
qualityadjustedlifeyears
disabilityadjustedlifeyears
icerdifferences
withherdprotection
societalwillingnesstopay
moredeveloped
x3gdpcapita
whothreshold
lessdeveloped
iceranalyses
perqaly
perly
perdaly
icerabsolute
15620
48376
54871
115026
targetvaccination
whocosteffectiveness
societalwillingness
2014looking
concernsvaccine
assessmentbased
imprinted
boris
subfamily
cscscics
sf6
csccic
spherecultured
sf6specific
c34249
sf6positive
vaccinationhepatitis
activefree
apulian
onsetthe
giavain
1827
384±117
1172
n190207
95ci872951
n171178
95ci921981
2doses
95ci122167
95ci963988
95ci85395
95ci40452
seafood
or21
95ci1727
z74
p00001the
potentialregulatory
emv
emvs
rnalipoplexes
antivirallike
affinitybased
platformscollection
cloudbased
pakistanin
3abc
panasia2
iran05
shamir
opanasia2
aturk06
asia1sindh08
transplantationdisease
comprisedbesides
relapseinfections
twomonthold
unitobjective
17121
4140
26121
6140
86121
132140
supine
612weekold
pained
180s
phagocytesa
shy
friction
elias
metchnikoff
mentor
entrepreneur
proponent
publicprivate
cd123redirected
rnaelectroporated
rnacart123
anticd12341bbcd3ζ
cart123
cd20coexpressing
cart123cd20
midlandsedgbaston
isrctn88072400
conjunctivitisallergic
zy12
degranulated
gutspecific
andinsulin
guttropic
adeficient
asufficient
rag1deficient
invitrodifferentiated
leanness
thatmaintains
vitroadoptive
rhil2
her2neuloaded
her2neuoverexpressed
erks
leucoencephalopathydriven
immunodeficiencyadvances
restitution
sarcomamodern
reviewchronic
maturelooking
inhibitior
antihype
kounis
hypokinesis
postprocedure
pulseless
syncopal
56days
pspapdt
strategypneumococcal
geneticallyconserved
rpspapdt
pspapdtrpspapdt
wtbcgrpspapdt
hoima
20112020
equitably
1023months
416476
15416
132651
1941261
130442
113788
assembling
baroniurbani
buser
morisitas
ngsbased
postanalysis
federationobjective
tech
nical
correspondently
jority
oftrue
sarcomabackground
201712315761584
realitybackground
pt13n02m0
pt2b3cn0
00240
pt3
pn12
pt2
ukrainian
shivinfected
shivspecific
tatrevinduced
nonsorted
actc
stimulationbackground
selfprenyl
isoprenoid
fdps
il15derived
maximizes
2001march
2005march
2009march
unpacked
establishmentobjective
conceptualize
microgravitystem
mscsmg
smg
smgmsc
bothth1mediated
mscssmg
crosspresentable
lebrikizumab
4to5year
7to11years
4to5years
8693
p1085
v501021
nct01206556
2565years
n4508
1624years
n899
685daughtermother
tumorstalimogene
optim
ivm1a
fmsrelated
flt3itdwild
00096
postmtb
1532
chemoimmunotherapypurpose
scns
cnsipi
rchoplike
kidneyadrenaland
uterinetesticular
92212
31and
efficacysystemic
vsvact
juxtapose
surveyphysicians
6690
apriljune
n708
n1381
sd79
18915660
6936155
vaccinationgroup
rectovaginal
caseascertainment
day0
lossstillbirths
serocorrelate
vaccineprobe
perspectivesmanagement
gu
26compared
derf
halfpoint
p00270012
p00320010
p00010001
p00250037
p00290035
p00240006
1115yearold
lol
1865years
rye
6nmol
8x6q2w
12nmol
4x12q4w
8x12q2w
p0346
p0403
schoolsobjectives
lsoa
postcode
nonmajority
boole
saucy
alice
h2rs
igeallergen
hepatitisbackground
10170
metavir
rv305
canary
aea244
ancestor
hiv1uninfected
postrv144
postrv305
bsreactive
crf01
cne8
nearnative
modelcellsurface
emt6sicd200
mechanismss
verteporfin
officeobjective
syndromepatients
day85
monosomy
bladdercheckpoint
liganda
scfvmajor
mdamb435
mesothelintargeted
tcrzeta
cavities
precoseasonal
1229
delving
nonadherencebackground
administrator
frequencybivariate
697762
488762
106215
174314
unfamiliarity
44314
29314
crystallographic
ligandspecificity
a132l
transplantationmediated
helminthiasis
bistability
siri
bauch
pnas
1011339113394
lowvaccination
highvaccination
bistable
βemitting
xenograftspretargeted
tf2
antihistaminesuccinylglycine
hsg
dihsgdota
imp288
biimp288
luimp288
tf2pretargeted
tardathe
antircd3ε
spectrometric
difa
sigm
midkidney
hkl
3781077
2551014
therapynatural
milieus
markovdecision
49objective
postscreening
icur
65189
38533
yuanqaly
19156
complexclinical
serumbased
noninternalizing
receptorsadoptive
immunoliposomes
granzymeexpressing
immunoliposome
malibackground
painfully
preeminence
137166
multireferral
immunotherapymetastatic
polyomavirusassociated
pvan
ktr
bkspecific
monocytesderived
immunospots
pathogenspecificity
animalstechniques
georges
köhler
césar
milstein
httpwwwwhatisbiotechnologyorgexhibitionsmilstein
fuse
and34
25162527
mscrheumatoid
relb
genesilenced
transplantationrefinement
cinduced
donorunresponsiveness
foxo3
micetumors
fivehundred
triggerbackground
subepidermal
bullae
hsctcdi
12449275
disordersfood
errorsunassigned
documental
injuring
teresinapi
piauí
boophilus
sanguineus
dogsthis
rmaqp1
nymphs
biotic
rejectionchimeric
variegated
aavs1
muskellunge
vhsvivba
vhsv
esox
masquinongy
vhsvivb
degreedays
pvhsivbg
pfuml
pfug
plasmidcontrolvaccinated
pvhsivbgvaccinated
novirhabdovirus
ihnv
nondomesticated
logarithm
myopathiesbackground
iim
ro52
987989
mias
glossitis
pdgf
oslerweberrendulike
emaapproved
overseeing
diseaseperturbations
tdfs
factor8
mpmri
750w
philips
achieva
smallfieldofview
sagittal
bvalue
isointense
highbvalue
b1200
pirads
panerbb
tcellsmalignant
mesotheliomas
erbb4
erbb3
panerbbtargeted
expansionenrichment
beige
lo68
postnatally
tr1cellbased
labgrade
tr1cellenriched
tr1cell
donorcell
nl
surinamese
antillean
aruban
sna
middleeastern
northafrican
chained
1309
nlgroup
pseudor
snagroup
menagroup
nondutch
therapybackgroundabstract
intermediatestage
ebvstimulated
refacilitation
2017123264250
diseasefrom
rotaviruspositive
toxoidsacellular
metastasisa
008042
012064
immunotherapiespurpose
cardiotoxic
4210
7010
8510
anewly
aroad
transplantationregulatory
graftversusmalignancy
immunotherapiesit
presenceabsence
typeii
typeitypeii
protumour
administrationobjectives
extendsim
imagine
jose
201711587593
mabsfollowing
milsteins
carcinomahnscc
absense
equivalentbackground
glutaraldehydetreated
genestargeted
stingtargeting
10second
randomizations
saturations
rlrs
pathwaysmalignant
prematurelybackground
preterms
distinctively
28w
2936
timepregnant
247316
hr28
yinyang
immunotherapybreast
cxcr4cxcl12
buttwo
pfspz
malariaexposed
sporozite
malariaexperienced
donéguébougou
1835yearold
2·7×10
unmasked
artemether
lumefantrine
nct01988636
0·517
0·3130·856
timetoinfection
0·712
0·5280·918
p0·006
sanaria
elmbased
ibook
126637
066409
nct01740310
settingsalthough
55000
nonisland
dcvac
p060
adshsocs1
precultured
adenovirusmediatedsocs1
gmdcs
gmdcsactivated
hpv16e6
adenovirusmediated
agentsowing
multipurpose
esculapio
vpid
informationtraining
liguria
shopping
gadgets
music
cagliari
antiflu
ccm
baffapril
homotrimer
heteromer
opportunitiesimmunotherapies
cellselective
stat3sirna
tlr9positive
cpgstat3
cpgtlr9
twopronged
tlr9targeted
rehab
cancerimmunebased
consummate
protien1
oasi
challengewith
pd1pd1ligands
ctla4cd28
oasis
pretherapeutic
perspectivesvaccination
lymphomasobjective
nkp30cross
farage
sudhl4
185329
215491
89259
225431
studynursing
asiv
ratio276
ratio206
ratio050
1796times
401times
strategiesnatural
congocrimean
paradigmatic
reservoirvector
immunotherapyallergies
acomplex
germanysublingual
immunotherapyshow
3‑year
uncompleted
afactor
clinicbackground
38129
preventionhuman
eurasia
mammal
baiting
buchneri
2derived
immunotherapypeanut
slpb
cd034
ah3a42
slpbah3a42
rbl
rabbitantibodies
100ng
antislpbah3a42
antiara
±135
allergenpeptide
amplicon
vectorrotaviruses
rotaviruslike
rvlps
polycistronic
scabies
mimicker
allotransplantationvascularized
165years
ectoparasitosis
38945
recallreminder
technologybased
nephropathybackground
bkpvan
leflunomide
95days
p87
312005
perceptual
9836
diaporthe
patientinfections
posaconazole
intermediatetopoorrisk
typesstandard
autologoushct
allogeneichct
wmurd
partiallymatched
pmurd
familialmismatched
fmmd
gradeiii
leukemiathis
3898
5485
therapyimpressive
fmc63derived
abdna
fmc63car
murinebased
diseasecurrently
peripartum
riskthe
easytoneutralize
wits
v3specific
mothertochildtransmission
mtct
crown
overemphasized
graftversusmyeloma
p0394
hr1725
hr1128
078071639
hr08809
063201234
hr1632
10072830
655days
405days
flubuatg
paracasei
l9
pm25induced
asthmathis
pm25
polycyclic
4×107
4×109
cfumouse
mitigative
044fold
03fold
mutationseffective
kenyabackground
nairobi
23vppv
outspoken
antineu5gc
nonimmunosuppressed
iggsbackground
animalderived
antiatg
antitotal
antigalactoseα13galactose
xenocarbohydrate
neu5gc
oriental
metaanalysistraditional
1326
07191717
apeanut
asmall
aprecisely
7county
geolocation
086095
083093
080092
grouplevel
53340
cebp
administrationobjective
1549years
48414
unknowingly
unbalanced
nonvaccinees
011188
nct01339845
3parallelgroup
imperial
doubleplacebo
p75
nct01335139
201002353616
artthe
pathologistsoncologist
iridociliary
apob100
atherosclerosisbackground
b100
apob100transgenic
hubl
homogenate
p295
p265
tnfαdendritic
dcsbased
30gy
cesium
carehematopoietic
pays
allergensplacebo
s2k
33studies
routecomposition
conjectures
cellsadding
leukemiatwo
cellcentric
coevolve
tumourrejecting
knownsuspected
stsegmentelevation
n177
nct02848339
2314
35109
nointent
20082012background
adoptionchildren
2017462e56e60
anhui
1766
1815
analysisobjectives
msms
lesbiangaybisexualtransgender
lgbt
samesex
prejudice
salesbackground
saleday
refund
nonreimbursed
confounderadjusted
nonepidemic
collaborators
4975
3146
1829
44·38
22·6360·01
20·00
3·4633·68
53·19
10·2575·58
1·52
39·58
26·16
brandspecific
groningen
studyfollowing
splenectomised
thromboprophylaxis
perioperatively
ipvintroduction
staked
luerslip
minineedle
beaker
detachable
dosetimeresponse
mibs
mids
nibscancer
novice
triggeringan
antiklhspecific
galß13galnac
pharmacypharmacies
or205
ci168251
or148
ci110198
or217
ci163289
αfetoproteinderived
afpderived
kanazawa
avidities
umin000003514
tyrosineadsorbed
glycyphagoides
20102015period
12546
immunotherapyinhibition
inutero
maternofetal
hbvcarrying
medicus
widest
6044
placebomost
1792769
5372541
tsaadjusted
5310
1041112
3821018
184889
232875
1764
trialswe
19098
096100
094100
075088
130201
139214
curatively
000000931
timelyandcomplete
549620
736800
440510
2738
spainpneumococcal
31303
143569
322674
386648
hhpkilled
serumcontaining
tolerancebackground
aci
antiαβtcr
tacfree
bloodliverspleen
postbmi
immunotherapyeffective
rnaseqbased
dcvaccines
frühsommer
protaminerna
prna
cpgp
tumorgastrointestinal
neurtrophils
tins
tim3galectin9
rasamsonia
scedosporium
laboratorydocumented
aegroticola
postbilateral
pakistaninfluenza
customs
resiliencebackground
rebuilding
shocks
spills
workersemeritus
malignancyhaploidentical
aucbased
4000μmolminl
downs
3000μmolminl
167weeks
tgfβr
nkg2dthe
nk92tn
ovalbuminthe
nanocarrierpova
treatmentrelapse
haemagglutinationinhibition
methodsdesign
activecomparator
microneutralisation
nct02655874
cd1c
adjuvantaim
eso
pbdc
esospecific
esoimxpulsed
vaccinei
nonbinding
knowlesi
sporozoitespecific
liverwhole
ama1
celtos
foodwater
ints
enteritidissalmonella
coveragehigh
14849
youngerunited
httpwwwacogorg
olderunited
immunotherapycommon
pstat3pstat5
refilling
lessthanexcellent
refills
bite®
cd19xcd3
adh
depletionthe
roseoloviruses
hhv6a
hhv7
roseolovirus
betaherpesvirinae
mtv
174kb
orfs
betaherpesvirus
mrv
flagellinwe
vulnificus
flabsecreting
tlr5negative
flabmediated
tlr5mediated
nonvirulent
5step
6779
mutationsthrough
pinpointed
alternativedonor
studyfanconi
farelated
cd34selectedtcelldepleted
relatedhaploidentical
±6
±62
nct01082133
perisrs
dbf
00280610
01610825
vs146
vs188
5201
vs149
protectotype
bronchitisbackground
ma5
urt
harderian
ma5491
a11
allelethe
hlaa11
hlaa11a11
a33a33
mencv
2yearolds
8001547
5231572
10941523
10491514
8381537
065100
036085
016100
076120
020091
worldwidebackground
structuring
loopholes
nonefficacy
underrecognized
rtpcrs
nitazoxanide
typeincompatible
adenosinegenerating
a2b
mechanismsofaction
adenosinetargeting
14641
vaccinestrain
1882358
1051425
malis
labconfirmed
constructsthe
microparticlemediated
spheroidal
heparinmicroparticles
ifnγpretreated
ifnγloaded
cd3cd28activated
20176223237
20132014unassigned
1459
383461
213256
1419
212502
pastyear
109146
131596
249461
non4vhpv
20dose
vialbackground
jeopardising
bcgdenmark
bcgrussia
preventcommunication
ovidsp
nonindex
gradecerqual
confidenceparents
confidencethe
confidenceour
impartial
prognosticator
positivepdll1
sloankettering
ethiopiabovine
milksheds
2weekold
bovisinfected
filtrate
cfp10
postinitial
0290001
grossly
transportpregnant
pigletsmaternal
il12il23p40
pertussisspecific
colostrummilk
cytokinesantibodies
exth17
cellsth17
lifted
immunizationsin
scheduleunited
immunizationwith
immunooncologyimmunooncology
deliverybackground
gagl
8593
leadergag
envelopeencoding
adenovirusexperienced
expedience
immunizationsbased
virussusceptible
republicbackground
209100000
34100000
fifths
1712
1591
mta
lifetimeever
tianjin
beijings
vogtkoyanagiharadalike
melanomavogtkoyanagiharada
hladr4drb104
vkhlike
programadult
exacting
publicuniversity
agewe
fun
inoculating
il23il17
antip40
psoriasispsoriatic
il23specific
evidencethe
europeanborn
l9002
l9003
modelhere
upregulations
sleintroduction
begs
tabalumab
wordsphrases
yieldbackground
lutx
casespatient
gramnegative59
grampositive26
fungal31
168±154
079±092
casemonthpatient
01535
03144
01403
n2557
allergentested
invoiced
2360
refilled
refill
cctn
4s
retransplanted
2r
doorspecific
antigengexpressing
antigeng
semiallogeneic
azacytidinedecitabine
hainduced
hypomethylated
azacytidine
decitabinetreated
hlagexpressing
seborrheic
keratosisbackground
keratoses
sccsk
20032014
parakeratosis
pseudohorn
hypogranulosis
eddies
colonizationgroup
bcelldeficient
fcreceptor
anticapsule
enteres
stagingclassification
allergenimmunotherapyintroduction
empiricism
dogmas
longcourse
pipelines
understandability
uvula
formatting
slitrelated
yupingfeng
ypf
dextreated
dexreduced
kpco
partnered
dh
empanelment
proxyenrollment
111330
57173
54157
436290
336462
99828
fpl
707100
kpcodh
statuswe
thirdyear
sclerosisalthough
cd4depleting
mstreatments
cytostatic
rituximabocrelizumab
cd20depletion
inductiontherapy
rv0774c
expressiontuberculosis
paralog
pepgrs
pgrs
gxsxg
lipolytic
100303
tetrahydrolipstatin
ser185
asp255
his281
rrv0774c
hemopathiesimmunecheckpoint
physicianscontext
chiropractic
abihm
diplomats
medicalspecialty
allopathic
dissatisfaction
weal
sigg4sige
pichiaproduced
h5n1highly
dnarecombinant
dnadna
aswanpoland305135v082006
3133
4672
4569
8496
7691
10646
18135
15hydroxyeicosatetraenoic
eicosanoid
eicosanoids
15hete
7006
60568688
42385575
r058
nonlatino
immunosurvelliance
immunoselection
immunosubversion
restauration
panallergens
patternthe
panallergen
ltpsensitization
cosensitizations
transplantationviral
pneumoniapneumonia
reformulation
tlymphotropic
htlviinfected
htlviassociated
myelopathybackground
htlvi
hct5
pvl
etn
pegol
hbz
ladders
collegerhode
st9069
reportedbackground
outcomefollicular
ictsensitive
ictrefractory
2353
highflipi
β2micrglobulin
immunochemotherapyrefractory
kaolack
senegalintroduction
regionmethodology
softwareresults
incomegenerating
carethose
p005conclusion
ivoireintroduction
ivoire
highlightsthe
surveythe
42743
picked
41337
41167
consensusdriven
hemocyaninthe
antiklh
pcv2neutralizing
converged
366±28
182567
140506
018055
015093
controlswhen
let7a
immunotherapybone
micrornabased
3utr
mscinduced
flipside
2interacting
miceregulatory
bimdeficient
paperbackground
sigetotal
iggsubclasses
sigg1
sigeigg4
igefab
igebf
cytokinechemokines
nnktt120
antiinkt
diseaseinvariant
vasoocclusion
nktt120
singleascendingdose
nktt120s
vasoocclusive
nct01783691
luanda
peanutspeanut
hegfrtl
steel
40814
©2016
immunotherapiesartificial
rejectionbackground
thy1yfp
schwann
s100gfp
orthotopiclimb
axon
traded
n5582
hannover
24item
endofstudy
or332
or301
timedemanding
or219
altruistic
1100359
09022015
undisclosed
scoresand
sli
slit3
testthey
recurrencesimplications
immunotherapymelanoma
lnm
hnsccto
mei
triplicates
specimenthe
panmage
magea3a4
cohortsmage
ricain
il715
bryostatinionomycin
il221
il71521
384fold
239fold
il221expanded
il71521cultured
syndromedrug
vaccinesmost
mucosalspecific
sizerestricted
mucosaladjuvanting
virustoxigenic
codetection
norovirusassociated
severityrelated
positing
nbs
unearth
immunovaxraobjective
cdmards
hevviremic
tthev
hemovigilance
hevcontaminated
lookback
il2gmcsf
incubating
fortnight
therapiescytokine
sa4ag
4antigen
bacteriakilling
antibodiesbackground
cp5
cp8
clumping
rmclfa
manganese
rmntc
mntc
clfa
luminex®
fibrinogenbinding
fbi
45738
3807854940
42652
3279255477
289fold
20644
1518228070
30814
2422239200
123fold
110fold
6722
49989042
1885years
sa4ags
nct02364596
departmentbackground
detroit
109345
or864
4101822
under2
welloff
us184
us127
cancercommensal
metaorganism
ancestral
eukaryotes
microbedependent
proteasomal
grademesenchymal
senescenceowing
bmmscs
senescencerelated
nonsenescent
mg132
20173514311436
profits
subtracted
accrues
viruseswhile
preseason
5119
dtapsipv
infantsrotavirus
11weeks
3doses
selfpeptides
cellcontactdependent
1adjusted
vaccination×100
pcv13serotype
allserotype
mabcoated
counterreceptors
inclinicaltrial
antibodiescolorectal
ligandbinding
vegfd
antidr5
antifn14
antiigf1r
antia33
cellsantibodydependent
fcriiia
monocytemacrophages
anticd96
tractthe
responsesparticularly
immunityare
papain
estrous
il33myd88
irf4
vac
cines
plication
ena
ble
cancercd1drestricted
inki
subpopu
lation
sys
gens
cers
impor
immunotherapyγδ
tric
sensational
tients
antigenwe
gpc3derived
gpc3reactive
gpc3positive
hepatoblastoma
cine
futuretherapeutic
ctiepitope
andtheir
sponses
cer
mecha
nism
ctia4
dategynecological
malignances
ur
gently
mune
antipdli
endo
metrial
somecandidates
deficiencymutated
ovar
ian
hibitors
immunotherapyccr4
skinhoming
macrophagesproducing
suppres
moga
mulizumab
defucosylated
effi
ciently
ccr4positive
depeleted
lb
immu
notherapy
humaznized
grammed
nal
immne
overviewed
activitycytotoxic
mela
noma
mutationscancer
neoanti
stricted
trolling
signifi
cance
abun
dant
tregsmediated
selec
tively
pd1pdli
nology
ysis
immuneenvironments
multiomics
presentedwith
fourweeks
meningococcalvaccination
presen
tation
ofsuspicion
sird
league
rheumatism
sirds
transplantationbalancing
5575
auroc
ifnγ130
2760
ifnγ449
oversuppression
undersuppression
487497
reviewallergen
calming
cd34positive
functionsthe
fcfcγr
fcassociated
iggbased
antiretrovirals
guangzhoubased
positivities
densitometric
gels
pharmacopeia
viremiathe
cybt
375mgkg
immunosuppresion
tnkcell
btv9
ceid
basolateral
amygdala
heroinconditioned
immunosuppressionheroin
nitratenitrite
drugpaired
bla
accumbens
mnacs
heroinpaired
caudate
putamen
opiate
barthak61
pseudorabies
virussince
barthak61vaccine
xj5
hvtn096
hvtn205
alvacaidsvax
regularized
forests
closetoperfect
nct01799954
nct00820846
2015since
timepressured
mid2014
everpresent
microneedlesvaccine
200250μm
underresearched
adjuvantsit
afew
aretarded
amodulation
homeostasishematopoietic
12abundant
gmps
conditionsmuch
multitudes
superficially
immunotherapyat
utterly
neoplasiaobjective
6676
nonimmunemodulating
dal
dalnegative
dogssince
beagles
dalpositive
antigenobjectives
cancercognate
evolvement
patientsup
summed
antigenligandomes
foreskin
inconveniences
fsk
foreskinderived
naivegroup
diagnosisnotificationpublication
epidemiologysince
199294
2700
n2539
n2135
interepidemic
transplantationhla
leukemiatrials
ebvdirected
0221
mir5323p
microribonucleic
ms4a1
ms4a3
msa47
01370772
1551
20002004
preasct
unattenuated
nonasct
melphalandexamethasone
melphalanprednisone
pledge
recipientsantibodymediated
gfk
louisianas
femalesthe
icelandbackground
lrt
phidcv10
landspitali
1711
1616
group101
multiresistant
pnsp
lianshui
2143
30164fold
dublin
197391
futureaspirinexacerbated
samter
anosmia
wine
lnit
spraying
commences
acc001
diseaseobjectives
vanutide
cridificar
antiamyloidbeta
m1reprogramming
qualifying
crd42016035809
bothropic
bothrops
asper
survivalthis
basper
oxen
envenomations
316h
lapse
envenomed
immunotherapyagonistic
coregulatory
fatemapping
nonfoxp3expressing
mk4166
110818
scd30
135ngml
2051053
analogously
60ngml
1112514
aecs
interchamber
aarhus
aitrelated
tuberculosisa
naturaltransmitted
lipidencapsulated
liporalebcg
brocktb
statpak
tuberculosisinfected
trialsknown
meaningless
immunotherapiesinducible
inosnos2
recalcitrance
diphencycprone
northamerican
12014
312015
factm
4392
651weeks
14295
227weeks
ineligiblerefractory
disappear
25yearold
003026
104179
bprecursor
allblinatumomab
179834
336659
8525
blinatumomabactivated
transplantationalloantigenspecific
cd154
ivbusulfan
partybackground
noatg
hr046
p4×10
therapieswe
11144
177334
152245
6302059
237637
239627
technologymonoclonal
immortal
recloned
laserparameters
adjuvantationbackground
fluence
fluences
168jcm
acthib®
luminometric
84jcm
igg1igg2a
hbsagltb
hbsagalum
lasergenerated
usaffiliated
19852015the
usapi
4827
211years
therapyantibodies
perpetual
transferadoptive
neuropathyin
guisesas
syndromeautonomic
prothrombinassociated
disordersprimary
tcrtcellbased
tcrtcell
approachesinterplay
fundamentals
oncolytics
immunotherapyharnessing
nielsen
crebbp
mef2b
378425
522584
57189
2974
4385
ratssepsis
hyperinflammation
ghr
24monthold
80nmolkg
50μgkg
lpsstimulation
antibodystimulation
raghavan
raju
antigenreleasing
elastomer
rodshaped
hydroxypropylmethylcellulose
cn54gp140
167μg±r848
167μg
cn54gp140200μg
intramuscularlyprimed
mucosallyprimed
ospa
borrelia
biolayer
interferometry
tnfrsf14
hvemmediated
hsv117
leukocytic
imps
pmn
imp
pmns
mediatorassociated
antigenspurpose
severing
contrasuppressor
chamberassociated
acaid
ivinduced
neuropeptide
spantide
noncervical
413493
230273
5195
117196
78146
directionsmetastases
eraimmunotherapies
retransduction
actgenetic
imlygic
adulttype
granulosa
gcts
relapsedprogressed
daley
calmetteguérinan
bladdersparing
2017123390400
studyclinical
n125
n1554
p0371
societyin
semester
isohaemagglutinin
miceboth
aβ310
25monthold
organismwide
uropathologythe
resituating
melanomaprognosis
tumorsdiffuse
pdl1expression
antipd1has
pdl1status
localisation
pdl1is
negativetumors
antipd1treatment
pdl1shows
implicationsthe
formsdaily
desperate
glycoproteinibixvon
patientsso
inheritance
dominates
immunogenetic
higheraged
digest
naïveresting
neurotrophins
clippers
immunosuppressionchronic
sided
peduncles
diseasesproteins
huntington
hypoxiainducing
hif1αderived
cancerreactive
carcinomahypoxic
hifs
hippellindau
rccreactive
278287
normoxia
peptidestimulated
hif1αexpressing
antibodieshypersensitivity
diabeteschimeric
h2k
insb
mcd3ζ
peptideβ
glucose6phosphatasecatalytic
subunitrelated
206214
igrp
africadespite
underrecognition
302614
30505
19432015
19922016
31750
1855
1940
19412016
sanitationhygienic
sudanshortages
populationapproximately
glioblastomacord
dnriitransduced
nkg2ddnma1
tgfβsecreting
gammairradiation
wholeinactivated
vaccinegammairradiation
50kgy
sterilise
marburg
gammairradiated
γflu
dryice
humanderived
vac3
vac3specific
igaproducing
mongoliaobjective
nonmeningitis
alliances
us52
us79
us19
us920000
us820000
us440000
us510000
mongolias
nivolumaban
proliferationfor
hypermutational
adoptable
spacetime
mymensingh
bangladeshusing
forand
ofpeste
bauvth
n1048
bernoulli
195466
134276
119258
1224months
115859
jamunapari
bengals
106214
monsoon
postmonsoon
effortssuch
vaccinationshould
424months
nongenital
timeelapsed
virusviral
15001
interferoninducibleregulatory
syndromeallogeneic
14282
1912
1071
shotlimiting
shotlimited
nonlimited
101443
2967
nonhospital
94146
0203
0102
arthritiswe
cellinducer
kakkonto
modeloral
radegrading
cyp26b1
warao
amerindian
approachobjective
amerindians
vaccineaccepting
vaccinedeclining
symptomsdiseases
nanometer
gliomastem
gsc
gcsderived
unfractionated
gliomaderived
momdscs
momdsc
acquirement
reoperations
2340
13674005
s36
s06
s636
i36
i06
i636
strategiesmeasles
vaccinationanti
methyldaspartate
publicuse
ho11770
nonhepb
4040116
017035
037069
ruleon
rulemaking
nprm
amend
vicp
iom
workgroups
accv
amends
petitions
diseasediseasemodifying
aβ42specific
pp3copyaβ16loop123
aβ16
repaired
selfdecision
tcella
subdomain
oxygensensitive
multichain
086103
094119
25532
6229835
62075
tvbased
thimerosol
eil
counterbalances
eils
tackles
b7h3targeted
chemotherapyresistance
24isothiocyanotobenzyl14710tetraaza14710tetra2carbamoylmethylcyclododecane
es2
a2780cp20
106266nm
sitescell
immunotherapyneoantigen
superstable
nanovesiclesultradeformable
tpa
halorubrum
tebenquichense
phosphatidylcholine
cholate
331ww
liposomicidal
slr
behaved
archaeolipid
glycerol
lipids75μg
coldfree
2014pertussis
cbv
toxicityobjective
0584
australiaautoimmune
neurosarcoidosis
zajiek
39years
2163
131months
cauda
equina
dreaded
confinements
vaccinesmrna
minicirclebased
cellsplasmid
supercoiled
closetorandom
mcbased
monjezi
virusfree
sbmediated
genetransfer
mcderived
therapyadvances
retroviralmediated
outfitted
repeatscrisprassociated
zfns
taleffector
immunosuppressionextracellular
gliomahighgrade
hsv1tk
zetakine
ffluoro3hydroxymethylbutylguanine
ffhbg
dispenser
urinalysis
2000μg
peanutslit
45positive
acuminata
recipientcondyloma
warty
genitalia
urethral
tur
sessile
urethra
cellsestablishing
007091
106570
ancs
moph
coexa2s
coexa2
crossdressed
cellssuccess
il15cultured
il4cultured
pharmacogenomic
resistanceconventional
afore
concurrentlysequentially
trasferred
antigenendowed
epigeneticgene
profileachieved
antisirp
sirpαnonexpressing
rhinitisspecific
knowover
preeducation
posteducation
helminthinduced
encephalomyelitishelminths
aamϕs
taenia
crassiceps
diseasemodulating
crassicepsinfected
liaisoninvestigations
immunologysinglecell
avalanche
ahrs
80800
1317vs
1112year
ahr085
ci080
ahr128
95ci117
ahr150
ci143
asianpacific
ahr107
ci100
ahr072
ci065
ahr086
ci081
contactsbackground
p0073
physicianwhen
pemphigusbackground
aphsct
vaccinepreventablediseases
mmr1\mmrv1
dtap4
39±28
outbreakrelated
selfresponsibility
fresher
r011892
operable
proteinhepatitis
literatureallogeneic
11146
5494
transplantscalcineurin
60mlmin173m
188436
gfr60mlmin173m
myeloablativeconditioning
wheezingobjective
preschoolaged
irrecoverable
nursefamily
partnershipbackground
nfp
130135
opportunitiesobjectives
subregions
iw
contiguity
subregion
regionwide
therapiesearly
analysiscapturing
biexponential
fim23
iggptx
ageeffect
antiomv
425years
vp100
vp250
dbv
montrouge
5044mg
130mg
vs11years
patchsite
significantchanges
scf
cytokinesgrowth
rtk
cmetcell
oligopeptide
es1
es3
isolatecharacterize
allohsctcytomegalovirus
celldonor
thirdpartydonorderived
complexstreptamerisolated
repl
depl
longsome
tpd
tpds
tpdderived
hescderived
retinaloss
transplantationbased
il2rγnull
degenerating
opsins
congenitally
alemtuzumabalemtuzumab
areatime
deliveryobjective
hvtibdv
vaccinechickens
3545days
mdlv
varibdv
mtab
n5060group
salinevaribdv
hvtibdvvaribdv
mdlvvaribdv
18dayold
sk09
bbw
varibdvsk09
5744
cd44downregulation
11observationschronic
11children
serovaccination
1993and
amniocentesis
nonobservance
n14454
6570
3877
4023
6123
ahrs097
059160
030087
050103
age75years
recommendationspart
4part
antiepcam
carcinomatosisthe
4d5mocb
myelomacellular
vaxdcmm
2851305
vaxdc
10×106
diseasestabilizing
daughtersrates
experiential
nonsupporters
happy
forthecancerimmunity
tcellrich
tcellpoor
bygene
immunograms
nonadenocarcinoma
2012objective
zipcodes
targetsantibodies
widerange
researchbased
bolstered
manmade
immunerepertoires
humanhealth
methionine
enkephalin
menk
dcsmenk
myd88nfκb
p65nfκb
muopioid
deltaopioid
kappaopioid
naltrexone
candidatesit
atheroprotective
mhciirestricted
16mers
p101
fgkqgffpdsvnkaly
p102
tlyalshavnsyfdvd
p103
lyykedktslsasaas
subcuntaneously
triglycerides
nondraining
atheroprotection
leukemiacurrent
sculpting
1allele
tmlicyvp16
roit1
2808
undercooked
roit2
igeigg4
productionpolyclonal
foodprocessing
biosensor
hyperimmunisation
15valent
pcv15
strainpneumococcal
04μg
08μg
electrochemiluminescent
ecl
webster
sw
mopa
33f
pe38lmb2
lmb2
lmb142
38kda
cumulated
classswitched
synucleinopathyneurodegenerative
pdd
neurontoneuron
mthy1αsyn
lvαsyn
1h7
9199
axonopathy
gacvs
audited
57100
61100
30100
generalist
wellarticulated
understandable
wellreferenced
methodas
ghaem
mashhad
fuzzy
multifold
postrt
3657±119
1312±1835
1538
mucor
superadded
antirejected
fortwo
endocrinotherapy
immunotherapyna
responseover
\cite101820485461
\cite131428303980
antipd1ctla4cd137
antipd1ctla4cd137cd19
opportunitiescostimulatory
sculpt
cd357
modelpru
3lps
immunityamong
nontransmissible
4t1spgm
4t1sp
nonsp
4t1nspgm
bkvspecific
immunotransfer
biotec
purpurabackground
aipcs
aipc
petechiae
inhibitormore
than8
posttpe
plts
studyallogeneic
nominate
parameterscomplications
proseek
analytes
corr
dner
biologicalclinical
diversifying
humanher2
1296309
myelomaimmune
75728
subcentre
subcentres
gii
virusobjective
challengeinfectious
15499
8658
3585
3256
5993
5499
6272
5354
6448
5922
7789
statesin
opvusing
hivexposeduninfected
heu
hivunexposeduninfected
huu
02μgml
ajcc7
bwh
csccs
t2a
t2b
lowstage
t1t2a
tstage
stratifies
immunotherapyidiopathic
guidelinedirected
dyscrasias
asansaid
drugdisease
preventionbackground
airplane
cruise
hostassociated
cruises
incapacitation
antipdl1resistant
eradicationadoptively
siyryygl
12736
recipe
palatability
firmness
117weeks
baitvaccine
podocytopathy
9929
gappd
1222
immunotherapysurgical
nondebulking
animalsgroup
00005
immunohistochemistical
deliverydespite
degradability
prrtargeted
schedulecervical
filipino
2das04hpv1618
2d4vhpv
2281million
pesos
php
hospitalattaining
izmir
turkeyhuman
baccalaureate
modelb7h4
b7xb7s1
tumorb7h4
4t112b
firefly
b7h4deficiency
responseregulatory
foxp3dependent
bac
dtinduced
actrn12615000305527
assaybyassay
programcertified
358591
diabetesobjective
march2013
1441
providerrecommended
12742
assaya
ad5hivgag
ifngama
timeefficient
77e9
184195
15μg
onetrial
ser262356
ser396404
ca1
aβ40
forebrain
c9
nondanger
transplantinfection
8956
estimatesantithymocyte
noncni
nodatalemtuzumab
esw
minimisation
2391
2373
nodat
maintenancealemtuzumab
ptldrituximab
rejectionin
atgtriple
antitg
antitpo
tsi
hypothyroid
50gl
thrombocytopeniaintravenous
8mlkghr
tuberous
362672
hepb13
poliovaccine
dpt13
mpva
vaccinemeasles
mrvmcv1
jev1
10072
7551
9162
8256
6645
6942
8799
9211
interferenceparatuberculosis
tuberculins
bppd
esat6cfp10
rv3615c
80100
appd
proteic
δ30
δmm
4547
cartcr
2016cellular
analyzable
pgdt1wi
pgdt1
flairt2wi
iadc
voxels
0711×10
194days
81days
hypercellularity
balanceit
selfspecific
tofacitinibtreated
semimature
immunosuppressionsunlight
warmth
earth
kripke
photoimmunology
1015years
vaccinationprotected
hbsagcarrying
9793
hbsagnegative
qidong
7414
10μgrecombinant
2328years
hbsagantihbc
1256
95ci7142208
1218years
antihbs10miuml
neurotrauma
neurosurgeryobjectives
ppsv
basilar
transsphenoidal
neurosurgery
neurosurgical
nct02806284
m483
sd058
m48
sd075
vaccinesstateoftheartdue
differentiability
adenovirusdelivered
repliconvectored
radvsfve2
pestivirus
embed
coincidencethe
smpc
approves
anemiawe
adapteddosing
adjusteddosing
uniparental
disomy
hadvspecific
therapyallogeneic
ninetyeight
flucytbi
hr202
hr243
pentaxim
cd20based
elderlybackground
mid2013
ptyped
vp6
g9p8
g3p8
g4p8
vasculitidesgiant
azatioprine
glucocorticoiddependent
325mg
extinguishing
nonreactors
10103
postlisting
unsensitised
25518
listings
3250
p0·446
p0·984
m001
aswitzerland97152932013h3n2like
517month
612week
unites
autoinjectors
neededthere
physicianhealth
overreported
allergenpresentation
idealsublingual
artemisiifolia
050096
spelling
beginnerintroduction
geneticallyheterogeneous
geneticallydefined
il1mediated
nfκbmediated
ifnmediated
scholastic
periprosthetic
osteomyelitis
ratsbackgroundaim
prosthesis
implantrelated
mn8
femur
nonconstrained
activeimmunization
polynacetylglucosamine
9g1cnh
passiveimmunization
resultsconclusion
pnagproducing
fviiireplacement
ans8
literatureimmune
treatmentbut
naes
9208
meningoradiculoneuritis
1on1
11461433
12911433
210276
13571433
4368
255276
womenstudies
1012years
unheralded
opportunitylung
rangeactivity
lowtiteraffinity
colonthe
mucosadraining
do1110
gutdraining
intracolonic
intestinedraining
colondraining
iln
cytospins
restimulate
cellssolarultraviolet
suberythemogenicphysiological
traf2
miceaimshypothesis
anticd40l
traf2deficient
traf2tko
anticd3cd28mediated
alloantigenmediated
tnfmediated
traf2nfκb
traf2jnk
conclusioninterpretation
chemistrythe
isotopes
tetrazinebearing
radioligands
5b1a
antica199
mabin
5b1tco
12433
modelmost
cpgoligodeoxynucleotides
anticd40cpg
b78
icantictla4
antiestrogens
immunotherapysvoronos
alphapositive
aacrsee
svoronos
tauthe
tauopathyrelated
40129
41152
15129
24129
02428738
rhdv2
rabbitsmolecular
mislead
domesticwild
vaccinerna
kittens
p03824
rhdv2victimised
kitten
prospectssignificant
dizzying
usfda
sirpαantibody
cellscd47
cd47directed
antibodyderivatives
licmab
licmabs
cd33expressing
cd33negative
cd47positive
alogeneic
progressionby
immunityimmunogenic
deadcellassociated
microscopies
tlrtargeted
haptenconjugate
planed
22583
20553
0345
023monthold
dosespecific
pertussissusceptible
7905672
1716429
2123
infantsoral
injectioninduced
612wkold
gagging
quietly
smiling
2moold
foretell
literaturesuboptimal
okeefe
nan
goalframed
acrobatnrs
rr016
rr029
policybackground
4069
ieag
indiaspecific
ieags
goi
kerala
karnataka
jharkhand
procuring
reallocation
nonsustainability
revamped
rationing
dissonance
unbalancing
multiples
tasquinimob
schreiber
hanbin
hanzhong
shanxi
qianjian
qingqing
huandao
qindao
shangdong
wen
jiaozuo
henan
nrcs
nrcm
withdrawed
112±251
028±209
085±115
61021
24141
26982
atrophymultiple
oligodendrocytes
cd5d5
mbpαsyn
cd133specific
unresectablemetastatic
uncharted
85month
45monthlasting
cart133
glutamicpyruvic
striatuslike
deteriorative
epidermalendothelial
nct02541370
regionallyspecific
aerobiology
270days
respit
r072
r054
7286
indp
removalseparatelyhave
regenerationassociated
incision
doublebladed
scalpel
stump
ααdipyridyl
gap43
5hydroxytryptamine
removalindp
serotonergic
catecholaminergic
indptreated
kochinstitut
knife
crizotinib
lapatinib
alectinib
ceritinib
bestpossible
factorpositive
tfpositive
tfcar
valproate
rae1
40h
mh134
huh7
37fold
snu761
snu475
10mgkgday
ownershendra
immediacy
immunotherapychimaeric
tsastaas
bob1immunotherapy
bob1
bob1expressing
bob1specific
antibodiesnewcastle
rlsiltvgb
rlsiltvgd
fplt
3563
strainvectored
mannatide
mf59intranasal
itiv
paadjuvanted
micegermfree
grainbased
st1
r03
tlr4dependent
gnotobiotic
immunedeviated
vivoplasmacytoid
vaccinationsobjective
autophagytargeted
leukosis
jinfection
alvj
inflicting
pvax1gp85
pvax1gp85lc3
pvax1gp85rapamycin
pvax1gp85lc3rapamycin
gd1109
cd3cd8t
n426
049097
055095
dualantigen
biologicsbackground
testsintradermal
idts
lrs
multimorbidities
3368
124148
220249
0248
chitosansulfated
locust
bean
immunizationthis
lbg
lbgbased
polyelectrolyte
lbgs
sphericallike
180200nm
9mv
14mv
cslbgs
10mgml
populationsmodified
vacciniavectored
dryvax®
1123234
pvrv
liaoning
abovebackground
11111
regimen211of
6570y
d42
d180
d365
day3
05iuml
65y
subjects65years
2066
1096
1605
larginine
micelarginine
conjecture
manifestationobjective
or132
106164
121297
or242
17334
statens
lymphadenopathylymphadenitis
potentialsmalignant
hardto
normalizes
il21producing
reconciliation
deferral
1841823
8041554
5101823
11331554
selfsustainability
stepping
treatmentfor
birchinduced
20102012background
814days
124days
1523days
incidencerate
1216123
23days
nonasthma
nonimmunocompromising
p083
17day
814day
0913
p053
postlaiv
potentialsnaïve
pleiotropically
antiil9
humane
endpointspotency
rabiesassociated
1099
score2
trembling
genavenseinduced
genavense
malignanciesrecombinant
ha22
ha22lr
mousespecific
ha228x
ha22lr8x
epitopesilencing
fvs
ha22lrlo10
p087
adenocarcinomapurpose
multipledimensional
tp53kras
comutated
transversionhigh
301224
aep
dtapipvhibhb
unfunded
cavaep
vaccinesmareks
worlddifference
federa
tion
interconnection
hospitalaim
spective
marchoctober
statistica
nosologic
counterindicationswere
counterindications
indi
vidual
sideration
cination
20152016and
2010aim
no4
informationanalytical
687cases
bedue
proepidemizing
vaccinationsglobalization
span1
years2
anywhere
treatmentsublingual
grainscm2
rhizoma
darynaria
drynaria
ethanol
groupsnormal
extracttreated
speen
relativemrna
cd8ratio
flupentixol
melitracen
depressionobjective
flupentixolmelitracencombined
sepetember
flupentixolmelitracen
mg，qdtreatment
groupall
questionnaireminirqlq
minirqlq
005compared
568after
227the
reactionsin
group114
sifnificantlly
depressionis
symptomsquality
lifemental
statusand
anddepression
trilogy
rhinitis：keep
desensitizationand
gimmick
vaccinologythe
immunoinflammatory
mucins
immunotherapymucins
mucinl
cdnas
vntr
apdtr
antibodyblocking
neocarbohydrate
carbohydrates
myelomarecently
panobinostat
high–dose
applicationsaçarı
ünsal
357368
librariesmorbidity
evidencepatients
ehrlichia
ewingii
smearehrlichiosis
ehrlichiosis
morulae
eewingii
singlechainbased
homodimerized
antibodiesone
earning
trancytotic
il2il2ralpha
clinicobiological
immunochemotherapydiffuse
161m160f
ripi
β2m
asialoglycoprotein
carcinomaadoptive
gpc3targeted
asgr1
proteintargeted
28bb
singletargeted
compoundsallergybackground
compoundsallergic
henochschönlein
andguidelines
allermix
projectvaccine
ccmitalian
109477
friendsrelativescolleagues
2381644
noninformed
022092
104259
111239
151759
vaccinarsì
widespred
vaccinarsi
fortifying
antivaccinists
paperth2
wartsimmunotherapy
welchii
reduction44
treat3
immunizationsbackground
infovac
4260
subscribed
covariables
8863704
69556
acellularinactivated
dtpaipvhaemophilus
nct02208362
countriesnovel
20162020
46118
menctetanus
hibmenctt
menccrmmenctt
12monthmencc
menctt
mencttmenccrm
orcharrd
prednisonelike
odhap
cancersin
biomarkerdirected
anticd3cd28coated
receptorsrecent
vivoengineered
membraneinserted
cd19cars
humansbackground
corrects
anecdotally
27year
phenylketonuria
mitoses
phenylalanine
1343±48μm
30119μm
854±25μm
360μm
900μm
gmtrs
were5
nct02280447
volunteerswe
adccmediating
gp120coated
primehivmva
menccon
men4con
awy
awyimd
008100000
028100000
445000
167000qaly
97000qaly
19000qaly
hlarestriction
medicineharnessing
cd19chimeric
cellswith
metaanalysisimmunotherapeutics
n5554
aria
1241855
diff
adcsadl
cdrsb
actbackground
gims
317438
236401
affordably
3671
challengenewcastle
cyclophosphamid
transplanitation
transplartation
pla
busulfex
amtilymphocyte
immunoglobin
mgkg·d
inmunosuppression
acsa
aduvese
safet
lymphomaobjective
transplantationautopbhsct
lymphomaml
autopbhsct
lymphomanhl
lymphomahl74
immunotherapyrhil2
wuday
followingup
973936873
groupsp001
100100917
965919860
938844
100727591
100100889
100100800
100913826
941647529
936885
904731654
9339
921873
881690
knowledgehaemorrhagic
611week
clostridiosis
siadenovirus
fecooral
hevs
orf1
fib
taq
msdv
converse
signalled
lipoproteinmimicking
agadjuvant
celltypespecific
melanomato
timeaveraged
avg1
allcausality
aedcd
cellspeste
ruminanats
sungri96
coregulate
responseex
posthcst
budesonide
cgvhdfreerelapsefree
inhibitorfree
type5
201315
4·0×10
1·6×10
rerecruited
nct02326194
nct02533791
682·7
424·31098·5
1305·7
970·11757·2
575·5
394·8838·8
197·9
107·9362·7
6110
47057935
11825
890415705
5vectored
primingboosting
cansino
immunizationwe
19851986
multicriteria
singlemetric
diseasesimmunisation
36yearsextensive
esl
100mms
swellings
50mm
66111
50mms
esls
opportunitieseconomic
multiattribute
vaccinessmart
20smart
toolmodified
2015to
informationsharing
userselected
valuations
fogarty
dexamethasonebortezomibbased
hdcy
mobilizationassociated
hdcygcsf
cd34cells
81×10
months8
nonblack
bestowed
peptidemps
peptidecontaining
bendamustinereplacing
patientsbeam
20gl
185months
daunorubicin
transplantoutcome
553years
intermediate1
intermediate2
toxicityour
taxspecific
epitopepulsed
taxadult
htlv1specific
mrr
2dose1dose
campaignopv
rctenrolment
campaignopvbeforeenrolment
femaleonly
£9650
£48
tradevaccination
btvpur
alsap
sarda
nvia
77days
vaccinationmodern
heritage
nomads
baluchistan
virusesapproximately
objectors
onerous
permissible
melanomasafety
studytreatment
miu
assail
virusstudies
hopesimpsons
20022011
n7026
splines
avertedbackground
2008june
95ci076095
95ci053066
87376
62588113561
£125million
920916198
spearheading
inhibitorsmonoclonal
multielectrode
healingskin
pin
mea
hcap18ll37
noninvasiveness
tacepredominant
lift
00009
19662015
cancerth1type
kynureninetotryptophan
tnfr75
gata3tbet
p0303
th2promoting
antiacta
antilisteriolysin
micelisteria
listeriosis
listerial
acta
listeriolysin
llo
antillo
insightsnatalizumab
teenaged
behaviorobjective
miceadenovirus
ad5induced
ad5elicited
vaccinationaids
unaids
hostbackground
rectoanal
nctc12900
6994
pathogenspurpose
polynacetyl
glucosamine
flavus
fusarium
solani
corneas
il17r
helper9
growththe
p300
h3k4
sanofis
vaccinesensitized
vaccinesup
ntgp96
hp91
rntgp96
noncovalent
re7
foreseen
knowimmune
possibilitiespatients
inflict
112181
immunotherapyepigenetic
tumorsuppressor
epigenomeimmunometargeted
tagspecific
enzymesto
argininedegrading
sifalimumab
erythematosusdysregulation
igrt
approachprimary
pads
agammaglobulinaemia
xla
medicinepersistent
infectionwest
pepsindigested
anthropometrically
19791980
mrrs
671months
181000
511000
mrr030
012073
6871
okadaic
ratsalzheimers
nft
5071
phosphoserine
phosphothreonine
22residue
phosphopeptide
tptedgseepgsetsdakpsptppt
ptauttau
antiphosphopeptide
phosphoresidue
73100
gagenv
sivmac239
coencoded
virusencoded
envgag
envheterologous
vaccinesboth
caselevel
basalit
1fv
birchrelated
soya
loael
postinterventional
objs
gly
loaels
subjs
0054
0037
ilis
5467
dar901
srl172
gtn
ho1high
maconditioning
nmaconditioning
ho1low
rrm
humansdespite
rabiesspecific
rabiesvaccinated
slightmoderate
solenopsis
invicta
95±307
675±095
108±329
immunotherapyfoxp3expressing
apoptosisprone
tregcell
developmentclinical
immunotherapyact
globallyimmune
functionmesenchymal
hpvcaused
perspectiveglioblastoma
dalgleishangus
dalgleish
pathalthough
5fluorouracillevofolinate
ghassan
aboualfaghassan
aboualfa
weill
cornell
multityrosine
livergi
cochairs
cadre
lectured
dreib
akkar
sensible
syrians
crisisaffected
implementationtreatment
bodysized
x4
130mgm
6000μmmin
80month
pkguidance
girlsto
sdgs
livestockdependent
unitthis
201738483485
largescalegeneration
alloantigenspecific
tregsnatural
anticd3anticd28coated
tregspecific
nepalthe
mukteswar
jhapa
exanthematous
desensitizationdrug
adelayed
lymphodepletionpurpose
hetil15
nonexhausted
281730
20022014background
allage
halved
5057
1722
13vnon7v
5166
2844
35148
81115
nonpcv7
blastic
ammonium
bicarbonate
adjuvantdual
vaddsto
aliposomes
mlls
200nm
slls
50nm
hco
prosllmllconstituted
prosmma
prosmmas
patching
acidifying
liposomereleased
gdloaded
swineorigin
epitopesstas
frsk
12e11
8b10
oseltamivir
restrictionswhen
rumor
insulate
uksince
batf3lineage
vulgaristhe
verrucas
halo
treatmentepsteinbarr
immunosuppressionresistant
allocbt
riccbt
oncohematological
elemental
assimilated
noned
totaldose
1904
2402960
folatehaptenmediated
folatelinked
frexpressing
folatehapten
folatehaptentargeted
neovasculogenesis
4618
rala
microneedleshpv
condenses
polyvinylpyrrolidone
pvp
mnralae6e7
richer
e6e7specific
instabilitymicrosatellite
eec
nct01644617
modelingbased
vaccinesdespite
vaccinestargeting
virusoffer
momentous
antimetastatic
canceran
preinfiltrated
znpyrophosphate
pyrolipid
znppyro
lightirradiated
insufficiencywe
chrysotile
mlrs
cbexposed
asbestoscaused
il2treated
typescancer
targetbinding
mannerth17
ovacfa
cd71
notchdeficient
mtorc2
specificitydengue
dlav
tv005
denvspecific
ns5
mirroring
approachesleishmaniasis
immunotherapyskin
adjutants
diminishment
hostscattle
sheepand
vectorsaedes
sppand
larva
pupa
rainfall
trmm
rvf
weaners
yearlings
conclusionsignificance
gilberts
hyperbilirubinaemia
bumeltt
prisoner
17·1
μmoll
3379
patients1855
3168
45·8
33·255·5
n1131
n1071
2·30
1·473·61
p0·00030
2·77
1·714·49
0·90
0·601·34
p0·60
0·561·45
p0·65
nongilberts
studiesacute
antiaml
inhibitioncombinatorial
trabs
trab
trabdependent
preimmunization
cytoprotection
chemotherapys
ds8273a
antibodypurpose
rebounded
immmunotherapy
294250
settingpurpose
activ
247890
olivaceusvaccination
fpvhs20101
5minat
20±2°c
fetuina
feta
oglycosylated
fetua
nonsialytated
4mediated
proallergic
yepratuzumab
tetraxetan
mcim
mbqm
nct00906841
6384
immunomedics
amgen
canceropôle
ouest
goelamslysa
investissements
davenir
checkpointsglioblastoma
rabidly
glucosedeprived
diseasesimmunization
tuberculosispurpose
hvjehsp65
hvjenvelope
xdrtb
vaccinemouse
pdna
1au
glp
vsv846
infectiontuberculosis
mva85a
mtb104
rv2660c
agentsintroduction
angiogenesisdependent
quiescentnonproliferating
centreobjective
1342
pharmacistoperated
callers
informationrelated
beyondin
mack
david
drugging
undruggable
infliximaba
nonenhancing
anteroinferior
opercular
inferomedial
transplantwithin
scotlandeurope
warmer
203000
midmay
midjune
asthmaallergen
leonard
115723
lockey
66077
csm
aaronson
gandhi
111721
bousquet
supps146s150
canonica
supp
91159
passalacqua
43748
albin
nowakwęgrzyn
77100
6117
5085
131415
neuroscience
8·9
7·810·3
sevenvalent
6·116·6
0·750·95
0·87
0·840·90
maneuver
eightsix
12336
cephalosporin
154483
19255
gianotticrosti
nids
charted
140235
112322
transplantationinfluenza
10101years
geneenvironment
anemiatechniques
392±05
137±02
342±05
845±50
827±52
7445
1003294
061115
062111
213457
lowimmunogenic
malignanciesgenetically
receptorssynthetic
rapidlyadvancing
1wt1specific
suburbanurban
slivcontrol
19776
fourfifths
preorder
naturopathic
biologicallybased
multivitaminsmultiminerals
manipulative
bodybased
mbbt
mindbody
multivitaminmultimineral
044085
058094
11463
recordverified
99921
inbetween
methodto
multitransmembrane
d4
cancermyeloidderived
selffeedback
selfexpansion
mdscsmediated
glutaraldehydemodified
polymerised
totalled
cstrainclassical
antiradvsfve2
csfvspecific
mockvaccinated
csftypical
pathologicalhistopathological
suvaxyn
cp7e2alfclassical
highimpact
contingencies
emergencytype
antibodycurrently
bioadjuvants
chil2
chil15
chgmcsf
55log2
47log2
65log2
58log2
33log2
1log2
eld
bj
rndvs
bioadjuvant
antimaternal
84log2
5log2
rclon30chgmcsf
rclon30flic
rclone30
rclon30gmcsf
clone30flic
infantsdtapipvhbprpt
4674days
n350
n175
931993
918986
antimenc
nct01839175
201200554724
petit
concealed
blindly
umin000008673
0·222
0·0810·607
p0·0012
0·221
0·0900·543
safetyare
listeningmuch
patientphysician
posttrust
trustbased
scienceinformed
oncologymonoclonal
ospc
lyme
spirochetes
developmentospc
snap4dx
c6
cultivated
antiospc
homodimer
c7
c10
hadiya
defaulted
providerclient
mistreatment
outs
unsupportive
ftcsti
grenoble
sameday
period599
hccimmunotherapy
regimethe
gnrf
648kg
106kg
liveweights
repurchase
belly
02μgg
7815
28139
vaccinationoral
conveyers
barriercrossing
p53objective
tcreng
deathreceptorindependent
activationdriven
p53mediated
mitochondriacentric
nontranscriptiondependent
bcl
vdac
caspaseindependent
aif
latviain
ulcerans
01148
4049
transplantobjectives
315494
60108
reirradiation
efficacyfrancisella
clpb
lvsimmune
nitrite
bmdm
200506
seasonsseasonal
5318
pharmacysupermarket
papillomaviruseshuman
antibodylow
titersbackground
bcellmodulating
ersd
streptococcuspneumoniae
acrosssectional
footage
nights
sett
tenday
neophobic
prefeeding
immunonutritional
currentevidencethe
allying
killingbesides
adjunction
rateof
mlmonth
mlmonths
isfree
reestimate
reestimated
us036
us2014
i2014
2970
7896
pd1pdl1directed
pdl1unselected
registrational
leukemiaimmunotherapy
2015results
•among
•a
•hepatitis
centeramong
irccsismett
e5
immunotherapyhpv16
hyperproliferation
splicedonor
e5based
pvx
luminescent
c3luc
sil
e5cp
hyposplenic
patientsasplenic
vaccinatedimmunological
infectiondisease
wary
nucleosomes
immunostimulationin
dnabound
adultquality
vectorsintracellular
developmentally
adenovectors
remissionswe
phf1
micepassive
intrahippocampal
aavvectored
antiphosphotau
p301s
aavigg
ftd
bmresident
p190
expandingpriming
singaporein
15·2
introductionbackground
3639
126201
110156
104142
150269
115157
064087
051082
nformylmethionylleucylphenylalanine
10057
italyherpes
60yearsold
cohortbased
20022014
tuscan
20022007
hdrs
716100000
753100000
09y
64y
prophylaxishepatitis
3550
2381
962986
913999
italymany
singlecohort
14605
15412qaly
monocohort
aureusdrugs
linezolid
exotoxins
sebproducing
60min
antiseb
italyvaccination
12yearsold
hcss
acutecare
248y
3511months
20y
zealandpeople
aspleniahyposplenism
therapiesneurological
cd20depleting
organsbut
8four
reviewhealthcare
differentlyduring
pronounce
prac
nonperfect
systemeffectorsmediated
mykissaeromonas
secretionimpaired
t3ssdelivered
rtog
3505radiation
expressors
nonexpressors
0667
nct02768558
englandwe
£8
swineeconomic
panoramic
npc1l1targeted
micepatients
nafld
nigy
yolkderived
c1like
npc1l1
transportblocking
ezetimibe
ezm
fat1
steatosis
abcg5abcg8
cyp7a1
cholesterolinduced
col1a1
col1a2
overflow
microenvironmentblockade
pd1programmeddeath
mesenchymalphenotype
tlr4inhibitory
emtinduced
nonsmallcelllung
reportoutoffield
menrecent
oncologys
immunotherapysurgery
13124
1382
immunotherapycontemporary
mf59ativ13valent
mf59ativ
n394
n382
nct02215863
servicesannual
108246
136410
otopathogens
spn
hflu
tympanocentesisbased
heptavalent
withinstudy
470657
248341
190292
vaccinevaccinated
060084
061097
100196
101201
tympanic
106171
patientsno
8488
2013we
2852
4592852
ci116
to862
ci403
parentssurveys
201738367370
injectionvaccines
rad5
exon1
rgmcsf
arcanobacterium
phocae
neovison
vison
fenp
abp
necropurulent
16s23s
rdna
intergenic
boxpcr
fenplike
polymermodified
liposomesinduction
mglupgmodified
liposomeassociated
lysatecontaining
lysatespecific
intraocularly
unentrapping
gingivalisspecific
naeslundii
patients2
p79
19972006
77000
bypreimplementation
poultryvaccination
studieddata
apacheⅱ
sofa
50063126
apacheⅱscore
groupsall
nonpics
grouppics
6354063
2381563
2241149
icupics316±288
204±113
00046
2861863
63463
intravascularly
chemoirradiation
antibreast
4t1bearing
2×2gy
5million
receivers
nkalloreactive
ludhiana
112460
modelislet
fullymhc
antilfa1
100d
flutreo
infirm
180mgm
h2b
aavmediated
livergenerated
agea
fouryearold
4cmenbnaïve
followon
n468
titers5
5380
n206
97100
n192
24–36
hemagglutinins
crosssubtypic
pseudovirusbased
ß006
offocal
iganephropathyfocal
podocytes
endocapillary
foam
podocytopathic
pernasal
perrectal
17y
6m4y9m
143151
102143
31143
30151
enteroviruses
28143
19143
17143
48143
16151
picornaviruses
futureimmunotherapy
elderlyrecent
polypharmacy
womenintroduction
startedcompleted
humansgraves
asubunit
diverting
nodh2
htshr
tshrnodh2
tshbinding
htshrnodh2
divert
ageadapted
phbcrablnegative
phbcrablpositive
regimensallogeneic
alloimmunizationred
nonalloimmunized
triggersblood
conditionassociated
wellunderstood
fetalmaternal
treatmentdespite
mrdguided
genotypingnatural
killercell
missingself
kirkirligand
failurenontransplant
trilineage
danazol
atrum
miceganoderma
psg1
ctxmediated
psg1evoked
bang
buckobjective
crr
pbrr
risk111
101120
1872
2063
23781
s19
babortus
immunizationbrucellosis
jain
brucellaphage
ϕld
pmpt
120μg
6648
schwarz
anthropometrics
nvas
midupperarmcircumference
muacin
difference008
002014
003020
nct00168558
multigenic
blockadetherapeutic
interferonsignaling
pdl1dependent
stat1related
interferonstimulated
crippling
interferondriven
autoimmunityautoimmune
ipsctregs
dl4
aiabearing
senewcastle
diseaseinfectious
oilemulsioninactivated
friable
necrohaemorrhagic
intrasinusoidal
immunotherapydentritic
chnpbased
stigmatised
mentally
distrusted
stigmatisation
melphalans
chromatinbinding
lymphodepletive
cd161expressing
microbially
1668years
programsin
tainted
parentsand
trustas
flamsa
4gy
amlthe
amsacrine
flamsareducedintensity
myeloic
flamsatreosulfan
flamsa4gy
flamsatbi
sbi087
sbipbopbo
sbi
sbisbipbo
sbipbosbi
sbisbisbi
pbopbopbo
acr20
28joint
das28creactive
pga
ptga
questionnairedisability
haqdi
das28crp
hauldiscoveries
oblivious
endure
10016
cohosted
9961000
ourt883this
ourt883
ourt881
5066
asf
acehvaccination
regencies
aceh
servant
suburbs
rhinitisasthma
37322
bioinformaticsbased
immunoadjunctive
hdts
mycobacteriosis
metanalysis
iulviral
yearlyinfluenza
fiveyearly
212pbtcmctrastuzumabpurpose
pbtcmctrastuzumab
agentrelated
aka
epididymis
he4
safetyobjective
costsobjective
antiil4
meetingrecent
papillomavirusinitiated
institutefunded
201712312591271
paythe
515yearold
20µg
9029
boosterinduced
2014a
3y
¥
92557
incuding
metaanalyze
wmd271
271779
wmd029
or046
wmd100
pf
easter
infectologíadengue
habitants
extractmediated
deathalternaria
aalternatas
aalternata
50100μgml
7aad
extractinduced
thymoglobulinobjective
gvhdassociated
cd25mimobody
interleukin2interleukin2
il2nara1
disfavoring
benefittoadverse
domain3
modelobjectives
161918
31070
2399
£368
£4577
guanylate
padre
epitopethere
ad5gucy2cpadre
padrespecific
strategieschronic
electrodiagnostic
httprimedorgrimedicaljournal201612asp
overviewmonoclonal
cytokinedirected
daybackground
chronotherapeutic
nonmedically
taags
c6661
taag
npcs
aureusdependent
vaccinationstaphylococcus
knees
hips
4cstaph
bacterialmediated
pscit
1035
scit12
scit23
scit335
scit335groups
0268
scit12vs
0787
vaccinationat
ers
necessa
rily
tination
hesitates
pollinosissublingual
cattleninety
calvespen
alfalfatriticale
trailer
cornbased
benefitsin
jacqueline
deeen
denguenaïve
9yolds
sp9
9yold
30y
organizationsbackground
aafp
264664
191518
267513
artexperienced
honing
womenhuman
91138
wt1based
vaccinationdue
wt1derived
antihdec205wt1
223273
324371
proteinloaded
wt1overexpressing
wt1negative
peptideantibody
wt1directed
validationimmunotherapies
currentlythree
whoare
asingleagent
accurateprediction
clinicalbenefit
roadmaps
wg1
wediscuss
fitforpurpose
conferencein
cytologybased
testbased
reorganisation
gisci
rescreening
disorderunassigned
asds
2990
2998
2999
3101
068158
100121
trimesterspecific
firsttrimester
104139
cattlebovine
taxpayers
culls
tvr
dla8850101
dla
c1r
immunoaffinitypurification
fullmismatched
intimal
admsctreated
endophthalmitis
cultureproven
revaluate
nonbrain
amygdaladependent
cued
hippocampusdependent
fgfbasic
womenimportance
n301
1474
1377
nct01984697
electrocardiograph
iecg
30second
iecgs
9732476
8973
8399
immunotherapymycobacterium
verrucous
succulent
nontender
cosmetically
lepromatous
leprosymycobacterium
cultivable
multibacillary
considerationsthere
shepherded
twovolume
overfitting
iikeyher2
776790
twotailed
mantelcox
146151
153161
generex0607
eof
is1070106
eed107106
200600329937
07062006
modelmiddle
cov
20827
κcoefficient
characteristicsadolescent
regionwere
prvaujeszkýs
virulencedetermining
fieldvirus
nonessential
vaccinationdiva
madiabetes
sd115
2979
stops
somewhere
rheumatologyimmune
diseasesfor
pemetrexedinduced
l2based
vaccinesinfections
2valent
hpv61116183133455258
condylomata
l1vlp
betapapillomavirus
betapv
nmsc
typecommon
broaderspectrum
v16
37±82
costestimate
chadclose
69000
1205361
11280081736774
chadian
2716359
24173533035081
dib
diseasesystemic
myśleniceintroduction
hunt
droves
modelcytotoxicity
timelapse
mhcinegative
mhcnegative
tecfidera
malignancieslowerintensity
pediatricyoung
500µl
20000µl
outcomessuccessful
agence
médecine
préventive
culturallyappropriate
practicesite
27county
nursepractitioners
918year
n68272
irr128
irr094
irr090
selfpay
ratesinitiation
coinfusion
nct02799550
nonregisterbased
1414
316000
acidbackground
kappab
bisphosphonaterelated
percolationa
weakest
therapythis
macroscaled
recipientwe
tbendemic
regimensin
hbss1
radss1
sspecific
pcshbv13
ceftiofur
crystallinefree
ccfa
vr2385
240h
0last
clf
vzf
12λ
α‑emitter
atransurethral
bi213antiegfrmab
3patients
6patients
gorkha
nawalparasi
terai
among12
torn
childplayed
placeunaware
cardthe
2016it
compaired
practiceboth
immunoglobulintreated
melanomasalmonella
sipb
sipb160
styphimuriumor
vec
tumourtargeted
transplantationinformation
ttreg
survivorsclinical
1dimensional
sstr2
sstr2expressing
sstr2based
unrelenting
outpacing
sstr2positive
capsulethere
radiocontrolled
vernal
centurya
stabilisers
pannus
amniotic
scleral
pateints
transplantex
initiativetransplantex
tranplantex
nodependent
23deoxygenase
idodependent
transplantationtotal
n1102
n1464
hightbi8gy
lowtbi
8gy
notbimyeloablative
notbireducedintensity
notbiregimens
hightbimac
lowtbimac
lowtbiric
notbimac
notbiric
tbiregimens
allelematch
citieskey
sorry
aspirational
ebmtthis
msds
94·3
antitcell
32·1
30·2
25·9
48·5
25·6
hr1·98
p0·017
hr0·62
hr0·35
hr0·49
hr0·37
p0·0004
hr0·46
p0·005
spinemethods
preprocedural
sins
epidural
instrumented
indonesiaa
dograbies
av52
156weeks
av156
bv52
oncein2years
o2v156
us5342
us300
us317
us1452
us181
asingle
1114months
asecond
1523months
amandatory
nfs
anational
stata12
adecrease
casesmedical
practicemonth
casesmedicalpracticemonth
alimited
clinicpatients
n331
lysatebased
modelinstead
carcinomallc‑challenged
cryo‑lysate
ghostsbgs
nissle1917
bsubtilis
84days
follow‑upvs40
1657vs126
otorhionolaryngological
1058
carcinomaspecific
cellspancreatic
activationdependent
lentihcd40le1ab
ad535trail
sw1990
elicitor
cyp
antihypoallergenic
c1specific
farinaeinduced
modelof
βgalactosidebinding
dfinduced
dfallergen
dfspecific
gal9induced
1117years
7120136302014
7120143312015
10861
102pp
73pp
nct02165722
mvavectored
ibdvdifferent
rvp2
pvp2
pvp2pvp2
antivp2
seroneutralizing
rvp2pvp2
pvp2rvp2
seroneutralization
vulnerableone
d1ns1
d4ns1
denvcontaining
immunotyping
highlyactive
ttcrs
slowergrowing
propelling
veritable
201712373450
caphosol
rinsed
rinses
omdq
40219
45±50
45±48
3312
patientsinterleukin2
regressioncomplete
101150
159235
pre1994
post1994
intermediateil2
nonstatistical
highil2
learnpurpose
21000
45mmoll
1μl
335mgl
1296303
1517y
14511miuml
87519miuml
27102miuml
158177
aspectspediatric
244256
allodribble
regressionit
drips
sequestosome
sqstm1
lc3
dribble
identificaiton
hlaa3303
hlaa3303restricted
15amino
¹cr
snu1299
rahynivtfcckcds
10amino
ahynivtfcc
ynivtfcckc
e7sensitized
16related
compartmentally
lymphomasepstein
safetyxenotransplantation
dpf
pervs
proviruses
multimodified
cpgb
freund
clonotype
nativeeaa
analogueela
peptidecpgbifa
cpgbbased
2313
328596
tumorsdonorderived
hostrestricted
yencoded
yredirected
ngrtnf
vesseltargeted
65871
usethe
subscores
nct02570061
harmed
ratessome
inclination
polypsobjective
epithelialderived
il25r
amg157
amg282
npmediated
strategymultiple
henceforth
pelotasrs
pr12
pr11
pr13
n414
wantdo
4983
municipalitiesobjective
5570
shangyu
vfs
8032
asociación
colombiana
alergia
asma
imunologíaallergies
impactthe
imunología
allergiesas
immunoxel
lozenges
tuberculosisaim
lozenge
drugsusceptible
tbhiv
tbassociated
defervescence
attcaused
nct01061593
preventionthis
aeassociated
difluormethylornithine
muirtorre
sebaceous
leonebackground
cwb
wilberforce
hastings
exempted
resourcemobilization
occupationus
2014introduction
ci605
nonhcp
ci398
502656
539602
osteolytic
cancerbone
ptbnet
cohorting
manufacturersupplier
cellshematological
genescoding
antigenrecognition
oncolysateloaded
oncolysatederived
oncolysate
maturationinducing
uptakehuman
angiitis
moyamoya
occurrentrecurrent
cellsil23
pinduced
antiil23p19
lungdraining
antiil23
iilike
mle12
resistancein
17457
determinate
3288721
2468736
598721
568736
120170
1730
121200
1264years
symptomsevere
tcrss
10000jau
20000jau
thrombocytopeniab
antibodyproduction
providerparent
posits
nonconfrontationalparticipatory
frameworkstyle
toxinbased
immunotoxinregulatory
diphtheriatoxin
7085
8591
miniature
timemesothelin
ss1p
rg7787lmb100
amatuximab
dmot4039a
bms986148
monocytogenesexpressing
crs207
jnj64041757
ureteral
n629
delaysobjective
05522years
poliomyelitishaemophilus
immunodeficiencyprimary
concomitance
ocvc01
kif20a
111206
183516
488825
kif20aspecific
rmc
7728
1449
or139
108178
triangle
or408
351475
brazilneisseria
penetrates
nongroupable
genogroup
bedroom
099412
116529
pubsparties
timesmonth
138492
nonc
gruppo
trapianto
midollo
osseobackground
aghvd
cghvd
12hour
shortduration
cellregulatory
chimerismablating
allelenatural
granzymemediated
hankmediated
reenergized
selfamplifying
negativestranded
htlv1associated
leukemiastrongyloides
1associated
transplantationchromosomally
cihhv6
onairway
inflammationobjective
eightmonth
bhr
5g
desensitised
19455
patientdays
transplantationsignificant
bmtx
cd451
bmtxtreated
antitnfrsf25
updatingits
particulates
micronanoparticles
thirdperson
mentions
sourcewithin
latinas
spanishlatinas
spl
naci
ho1314054
phylogeneticallydistinct
postdating
335months
157331
145279
agentsthe
iggil2v
fibroblasttargeted
tcbs
progressin
1916
strohl
168386
055168
148406
121193
labelingpackage
nonvoting
anticd20cancer
cd47blocking
1e4ciggb
caninespecific
107287
behindthescenes
n437
intrafamily
expb426
expb427
expb233
vaccinationhesitant
vaccinesimmune
multicolorcoded
combinedimmunotherapy
immunotherapyelicited
immunoreactions
ctxact
combinedtreatment
immunotherapeutically
signaturesbackground
noninfiltrated
unravels
triadic
tti
antwerp
closedend
referencing
immuntherapie
bringt
weitere
fortschritte
bei
hautkrebs
encephalitisobjective
epilepsies
gadautoantibodies
paraneoplasticantibodies
gadantibodies
antibodies55
gadantibodies18
attentionalexecutive
figuralverbal
presubiculum
gadantibodiesas
paraneoplasticantibodiespatients
autoimmunityplasmacytoid
crossroad
selfnucleic
pemphiguspemphigus
il35that
pol3
8486
hib3
lawsobjectives
1905
sincere
precedent
waldorf
montessori
20002014objectives
ratio191
interval164
epilepticusbackground
hyperkinesia
dissociative
onebyone
threecombined
osteosarcomas
relapsesmetastases
hca2
hlabc
hc10
cd3cd8foxp3
0121
calmetteguerintuberculin
africarabies
ngorongoro
serengeti
optimality
tissuespurpose
ror1specific
6d4
homogenously
ror1targeted
306171
inductionmycobacterium
e39gmcsf
proteinfbp
endometrialec
canceroc
e39
gale
301gmcsf
fbpderived
vaccinatedvg
controlscg
e39250mcg
raterr
1000mcg
57±15
103±30
38±20
95±35
providersto
hesitancies
czarkowski
peptidemagea3induced
olfactory
otorhinolaryngologist
serpiginous
choroiditisobjective
choroiditis
involvingthreatening
macula
micetargeting
cellsperforin
releaselike
fr104
cd28fr104
ascending
0200
occupancy
antikeyhole
2246
argentinean
immnobiology
biomarkersthis
meys
lo1413the
2016accepted
complexationdna
raladna
481486
843±77
10611085
09710990
1372
11651616
mortalityrelated
0599
03900921
macaquesbackground
polyclonally
nontreg
bmtoxic
therapyautophagy
alltoooften
nonnumerical
33176
04149
88allele
n720
n115
hr133
hr136
hr208
hr135
oneallele
hr141
immunizationhepatitis
interferonbased
hebrew
echoed
voices
individualistic
nondoctors
unmediated
discussionfacilitating
devolved
3induced
plganp
plganps
plganptreated
vitamina
insecticidetreated
bednets
19016
73900
7020079300
73700
7000079000
200400
1271219346
4572174367
genderrelated
hpylori
26695
wc
relapserecurrence
selectionprediction
drugstreatments
aged5years
hostdendritic
patientsdonor
hostdcs
mhags
antihost
hostdc
anticytomegalovirus
cmvtc
cmvth
cmvt
postalemtuzumab
pretranslpant
aleumtuzumabtreated
postcmv
alemtuzmab
6193
1518months
bcd
520859
4965
113142
multilingual
twitterbackground
dtphepbhib
healthinformation
tweeters
ielsg26
ffluorodeoxyglucose
rcht
ds1
ds4
ds5
35107months
ds3
processt
nonpolarized
goto
ercc1
tubb3
leukemiareducedintensity
richct
richcts
n205year
12296years
20002007
n137year
10968years
diphtheriatetanus5component
dt5apipv
79100
pertussisunited
nonadult
cocoons
20152024
vietnambackground
pertussisvaccinated
tetanusonly
antitt
antipt
antiprn
antifha
countriesimplementation
apartbackground
1657
furred
infantresults
rifampin
moxifloxacin
tabletsbackground
njalk
hørsholm
denmarktorii
mk7243
bioequivalent
units75000
sqt
2497
2139
1u
3930
slittabletrelated
pharynxthroat
age60years
16699qualityadjusted
16840
ymsms
208years
stigmas
l265p
serbiaobjective
myd
moleculargenetic
rituximabchoprchop
l265
statespertussis
9316
12363
birthplace
whimperappreciation
3279
deniger
pila
pili
antirecombinant
antirpila
paeruginosa
burnwound
pilin
woundsburn
bpila
imipenem
2014national
transplantationkidney
undertakes
carcinomaimmunobiologybiomarkersurothelial
tcellinflamednontcellinflamed
luminalbasal
disordersimmunocompromised
nonviable
availableevidence
spatiallyexplicit
wtd
deercattle
dmu452
postharvest
swam
nonantigen
abbott
i2000
120371
sescape
g145r
monitorings
youthbackground
queer
demographicsocial
1211
stablesecure
transmale
opportunitiescues
antip21ras
dualpromoterregulated
kghv300ras
p21ras
rasdriven
kghv100
kghv300
e1b
tcid50
345dimethyl2thiazolyl25diphenyl2htetrazolium
10455
508995
cllfree
3236
19781984
therapyintraperitoneal
hipec
genomicdriven
gep
transfermaternal
cd25hi
patientsevaluation
rnadjuvant
curevac
genomebased
cancertope
apportioned
userspecific
cancerpatient
httpwwwimtechresinraghavacancertope
gina
immunogenicitythe
tolls
ficlatuzumab
antiigf
antinrlu10
nofetumomab
denosumab
veliparib
buparlisib
chileandes
oligoryzomys
longicaudatus
communes
irbs
corral
curarrehue
academywe
sigma
hallway
auditorium
vests
reorganized
digging
ratstechnologies
fluorochromes
ratsin
absorbable
xenotransplantationhepatocyte
pegbased
catiomerbackground
urges
antialzheimer
pegpaspdetmrna
6xhistag
immunodetection
il2ss
copolymer
glycolpolynn2aminoethyl2aminoethyl
aspartamide
pegpasp
det
cellulo
thioflavine
anti6xhistag
nonsecreted
outnumbered
naivephenotype
il17expressing
philippinesa
timelier
pandemicthis
2ndto
socioanthropological
expressionpurpose
minigene
tmg
flanked
tmgs
pairseq
2491505
csdmards
secukinumab
phosphodiesterase4
apremilast
ariel
180214
tlymphocytesadoptive
leukemiaalthough
killerbased
prussian
pbnpbased
hardtotreat
pbnps
phdependent
intratumorallyadministered
hypoxiathermalinduced
abalone
haliotis
diversicolorthe
hdakt
hdpi3k
diversicolor
1097
hepatopancreas
gills
dualmultiple
immunotherapyprolonged
pneumovas
waldenstroms
macroglobulinaemiawaldenstroms
macroglobulinaemia
cyclophosphamidedexamethasone
cholinesterase
memantine
alzforumorgtherapeutics
womenimmunizations
20162017influenza
hospitalizes
tcrdependent
responsenonhodgkin
ambiguities
54522
1january
31december
1564368511
1797168449302
527549
siderophorebased
pathogensinfections
siderophores
ctbsiderophore
antisiderophore
locales
siderophoremediated
siderophoretargeted
4474
4095
4059
008090
optionsbackground
noroviruses
lve
hve
19972005
83years
2835
6576
6778
p076
allergiesbackground
commuting
immunochemotherapyimmunochemotherapy
nanomicellar
fmoc
druginteractive
immunotherapycoinhibitory
oviedo
nonramdom
behavioursbehavioural
parellel
mediational
f54473728
f54486559
f54611680
attitudesbehavioural
sd03
ci009019
questionnaie
lambsfarming
pessimism
pessimisticlike
republics
practicekeeping
petctrationale
18ffluorodeoxyglucose
f18
hypermetabolic
outbreakobjective
351701
decisionsas
forgo
sentimeterbackground
sentimeter
healthmapbased
aggregators
10715
459years
270years
flebogamma
dif
761100
adultschildren
bleedings
304833
clo
t922
t411
32mgm
5500
µmolmin
clobu
intermediateintensity
cellsprevention
campath1h
fcc
uptodatebackground
pneumology
patientsresidents
pedagogical
startvac
slime
saac
formaldehydekilled
aureusc195strain
j5specific
saacspecific
conditioningt
histocompatibilitymismatched
il12secreting
chemosurviving
mcsc
mcscs
14870
effectortumor
chtspared
chtimmunotherapy
227788
statesliquid
alphaenolase
eno1
immunotherapiesalphaenolase
plasmin
warburg
cscsundifferentiated
hublt
anergized
lu177trastuzumab
patientsher2neu
lu177
pyrogenicity
µciµg
cellloaded
pressuretreated
bioreactor
tumorresponsive
nonterminal
lncaploaded
cancersunassigned
tcrαβcd19depleted
childrenαβtcelldepleted
barcoding
intrathymic
tg2576
micecalcium
multiphoton
sevigny
rapidlyresponding
infertilityone
intralipids
7981
mid2012
seriesthese
11464qaly
16664qaly
18224qaly
pschinfo
influencer
2bovine
blanket
sensibly
h11hgalgpforty
h11hgalgp
precontaminated
turnout
4weekintervals
v6sep
6weekintervals
grazed
famacha
fec
stabled
drenched
4256days
anticd3cd20
modelbispecific
conceptproving
mccd20
32day
handfootandmouth
71recent
hygroscopy
springoperated
500μm
05092
065088
rr082
070096
rr063
intercepts
spc
parrjuvenile
9g
spc35
spc58
spc80
quadruplicate
dpvpbs
dppbsinj
dpvdppbsinj
hkm
pbsinjected
inflicted
eassi
1412
19669
131550
aitassociated
coapplication
k562nk
361224h
recultivation
reapplication
readyforuse
streptavidintargeted
cancersstreptavidin
sabiotin
2h7
antichelated
yttriumydota
antiydota
2h7fcc825
1f5sa
granta
ydota
7622
666979
interleukin34
il34
serosurveyto
921945
transplantationovarian
427148
3642857
hormonereplacement
hsctassociated
4262
unblinding
thesis
psychomotor
angiogenicspecific
viitargeted
therapyidentification
neovasculartargeting
vegfstimulated
vecs
microvessels
fviiigg1
fviiconjugated
fviitargeted
troxerutin
modelprotective
txr
postc
lad
45min
interlukin1beta
tumornecrosis
cardioprotection
hexamerized
c1qbindingdeficient
abinduced
transfecting
ofafab
chorea
immunotherapyencephalopathy
simabukuro
antiiglon5
12306
snyder
1210this
primatespassive
denvneutralizing
mab11wt
mab11mutfc
lowtitered
receptorbearing
mab11
protocolpraziquantel
trematode
cestode
toolwith
headline
couzinfrankel
34214321433
diseaseleukemia
humanizing
hlatransgenic
classiinegative
nephropathygetting
uncertaintya
pozzi
rauen
stopigan
22252236
timeaverage
nephropathya
vanderbiltingram
ambassadors
precedence
nicus
cordoba
argentinabackground
subsector
córdoba
6625
trabadouble
6051
5032
seniority
undercoverage
immunotherapydelivery
immunofunctional
nanoparticulation
skeleton
bcgcws
digmp
sensor
101626
3dstructured
activitytherapeutic
vegfneutralizing
cysteineknot
β5turnβ6
structuresupporting
β2α2β3
tumorgrowthinhibiting
raffinose
rfase
nct02237638
therapyimmunological
librarys
gw3965
biofilms
isotopeassisted
polyamine
adenomascarcinomas
7621
614652
factorβ1tolerogenic
tgfβrii
decapentaplegic
tgfβ1dependent
postimmunisation
642170
275986
tumorsantiprogramed
gct
seminoma
nonseminoma
ifnγassociated
9039
2736
partum
3398
conditioningallogeneic
lowerdose
flulowerdose
cyatg
yag
oag
p080
immunotherapytelomerase
tertbased
redesigned
tertpromoter
immunosuppressionmareks
earlymdvis
latemdvis
meattype
vvmdv
chickenembryoorigin
648a
hvtsb1
tbd
5826
cancersurgery
chemotherapyare
carcinosarcomas
biomarkerbackground
müllerian
fallopian
semiquantitatively
1929
sarcomatous
carcinomatous
variabilities
travepinetbackground
24478
23768
n20092
n12990
n10539
6573
5029
1155
3527
10539
nonvfr
059095
skintoskin
opiates
metaregister
mrct
appswhointtrialsearch
pacifiers
cuddling
anaesthetics
venipuncture
lance
1066
informationour
massage
vapocoolant
38second
17point
16four
emla
massageno
skinbreaking
aplasiathe
egfrt
antimyelinassociated
paraproteinassociated
neuropathiesbackground
severityour
10metre
raschbuilt
alfa2a
mag
wellperformed
identifiedtwo
incat
minorthere
paraproteinaemic
reining
researchcontext
lhd
ecologic
servicerelated
jurisdictionlevel
epicenter
studyantipyretic
discourages
15monthold
nonmedication
3950
5300
decisionsthis
lha
feepaying
humoural
culturegenerated
hcvcc
wrapped
schizophyllan
k3spg
hcvccalum
crossneutralising
deferasirox
checklistcivilian
intrusion
γ056
γ289
γ063
γ381
γ339
γ01
pd1pembrolizumab
pd1nivolumab
pdl1bms936559
ctla4tremelimumab
denmarkobjective
cxcl10cxcr3
heartaccumulating
cardiomyopathies
nonischemic
sphingosine
1phosphate
htlv1targeted
immunotherapyadult
px
antiatl
taxdc
checkpointextensive
vaccinethis
hospitalize
kitakyushu
infectionsgrampositive
cauti
multiantibioticresistant
efaecalis
ebp
heteropolymeric
catheterinduced
ebpa
piluss
efaecium
vancomycinresistant
vre
foley
antibioticsparing
pneumoniaehypervirulent
hvkp
antibioticsensitive
k1serotype
k1cps
k1cpsspecific
hvkpcolonized
4c5
19a10
klebsiellaspecific
1848
responsescheckpoint
tumorantigentargeting
donorsnonmalignant
conformationspecific
rabbitsthe
pg9
strandstrand
ch58
pentameric
v1v2scaffold
βstrand
diseaseunassigned
mildlytomoderately
ileocolonic
tso15
suspensionday
solutionday
2507500
transplantationsystemic
severerefractory
sleassociated
nephrosis
asthmanonresponders
bloodbrainbarrier
integrityin
ubiquitinproteasomesystem
bsc2118
neurovascular
neurogenesis
postacute
postischemic
crimean
feverproblematic
prepa
rations
naturalfoci
wnf
andchf
siberia
ofnovel
ofwnf
antibodiesaim
andmethods
synthe
squarate
contentper
intraperi
toneal
glucoconjugates
subisotypes
neoglucoconjugates
iggl
bsatetrasaccharide
proteincarrier
testsystems
adtp
componentaim
rivs
apv
pertussisdiphtheriatetanus
adtap
cbaxcb1
termined
cusabio
wholecellular
adtpvaccines
mdhhs
vaccinationvaccinations
broilers123effects
trtreplicate
vaccinetreated
438g
protocolbackgroundaim
hypericinphotodynamictreated
hyppdt
lipopolysacharide
id8fluc
hyppdtbased
immunotherapyhanahan
weinberg
cycleimmunotherapies
immunitydendritic
parasitesimmunization
hlaa1
hsv1specific
hsvseropositive
pregnancyvaccination
gaia
experiencepurpose
csii
immunotherapiesdendritic
immunisedin
griffith
lecturer
swansea
hotly
cryotherapyrenal
cancerpostsurgical
chemocit
p0051
5599
279111232
0478
02660858
6559
290314817
02640970
subjectspecific
adss
300ir
nct00367640
nct00409409
nct00955825
nct00418379
nct01731249
450me
kilifi
epitome
autologously
guiana
level3
level4
or06
parentprovider
vis
2603
745797
566627
125168
130176
90126
938970
estt
fourstep
35h
788cycles
61cycles
sd±455
105years
00307
thirteenth
preexisiting
preload
immunooncologysixteen
herceptin
ligandinduced
biomarkerpositive
standardbuild
10step
nottrue
pershot
perpatient
2549643
11982
1186
imatinibinduced
palmarplantar
erythrodysesthesia
mgd
of18
to132
121mg
9778
tolerancethe
senegalbackground
7824
dtpipv
dtpipv1
601000
451000
721000
341000
08395
050140
035096
067203
dtpipv2
086310
dtpipv3
interinjection
03μmolkg
3μmolkg
fiveweek
1533
expinc
higheraffinity
conditionsrecent
±rapamycin
texmacs
cellgro
smartphones
android
ios
facilitations
0313
2771
3598
nicaraguan
responsebackground
andthrough
vaccinationhumoral
17572
879998
297fold
cancerantibody
toxindelivery
±5
ave
341717
159784
routemucosal
diepitopic
unilamellar
multilamellar
reversephase
ultraflexible
ufsuv
tcytotoxic
influenzaderived
lipopeptide
erbb2surexpressing
alumadsorbed
crosssensitization
reservoirdespite
tetars
multihit
immuneescape
hmwmaa
receptorencoding
martes
pennantibackground
carnivora
mustelids
cdvs
fervacd®
galaxyd®
pfrp
nape
hardrelease
softrelease
industrydeveloped
progenies
precursorsfollowing
earlydifferentiated
highlypurified
otorhinolaryngologistsdue
ibecs
immunotherapybispecific
managementreports
inflammasomeil1
ilra
libido
boarsthe
improvest®
n24group
n6group
tubules
n3treatment
p0066
zimbabweoutbreaks
georeferenced
19952014
overlaid
tenure
viscerotropic
postyf
overviewthe
644551
designmaternal
hutcheon
20161843227232
timevariable
nonhealthcare
studiesinfluenza
43082
034112
026057
043077
antibodieschemotherapies
diferent
aneurysmobjective
aneurysms
eknockout
elastaseperfused
aortas
va1hmoc
recipientneuroinvasive
intcells
leadsto
contacthypersensitivity
reactionsinjection
246trinitrochlorobenzene
skindraining
atpdegrading
haptenexposure
adam17
lnresiding
3356
098years
118242
139461
148348
104204
153years
121708
anticd20mediated
depletionb
acd20
antibodyindependent
steroidresponsive
damageamyloid
imaginationvaccinations
blending
imagination
shams
frauds
rigid
truthfulness
fantasy
tales
disputes
homeoprophylaxis
risked
squalene
fraud
imaginative
radicalization
supernatantsdynamics
highefficiency
statusdownregulation
dysfunctionality
ucbnkmediated
nkactivating
pbnks
pbnkcet
hpvindependent
reinterpretation
acthivation
il2induced
defenseas
forceful
pruning
improperly
regulatorsthe
arbitrarily
modifiedself
selfstructures
selfcells
undirected
resistancechronic
cystitisthe
bpsic
antiicam1
aia
nbc
protaminelipopolysaccharide
p2x2p2x3
ep1ep2
trialsequential
tetanusdiphtheriacontaining
pilgrimage
crm197conjugated
mvc4
pretdap
approachtrivalent
iiv3s
iiv4s
iiv4versus
infectionspreading
20122022
publishedpublic
1973849
2325644
18485
2825
educator
crd42013005067
patientpurpose
monocomponent
patientnamed
singlesource
igetesting
pseudopolyallergy
polysensitizations
ileife
obafemi
awolowo
344±86years
1960years
104240
131396
158398
213603
antibodiespurpose
immunityimmunogenicity
immunotoxicitythe
freeatthepointofcare
bsmi
financereimbursed
dongli
karamay
xinxiang
bsmireimbursement
n416million
757million
726789
rate20
revitalizing
barcoded
administeredbackground
barcodes
barcode
dropdown
128573
943961
848958
aor175
157196
aor239
212268
belgiumin
n823
rate892
postbackground
thread
liwc
riskrelated
authenticity
scientificallybased
textbased
ecologically
7669
postpd1pdl1
chemobiological
14242
75359
121372
61273
diseaseeliciting
immunosuppressionmesenchymal
t308
201735766776
changesbackground
bdca3
wh
asp248
trp250
whova257264
epidemicspeter
hotez
4636
podlaskie
5434
5950
vsvasmel
reovirusinduced
suppressionbackground
fattyliverderived
antilipopolysaccharide
delayedrelease
mercaptopurine
soyderived
molecularinflammatory
hyperlipidaemia
caregivershpv
aor333
aor100
aor232
aor276
implicationsrecent
immuneinfiltrated
tregcd8
trial׳s
recommendationsallergic
algorithmic
setbackground
ptml
atml
n312
67country
65819
fourquestion
likertscale
vaccinesafety
catholics
faiths
n2028
reviewmicrosatellite
rechecked
3785
9734
9910
1680
8890
8305
7966
6596
217320025
181581
microhemorrhagesbetaamyloid
enr
controlcontrol
controlvac
enrcontrol
enrvac
vegf164modified
challengevascular
vegf164
postirradiated
ll2vegf164
pttb
csabased
1082
tacbased
ninedimensional
bunimovichmendrazitsky
dissipativity
levinson
carriersin
dosestructured
transcritical
grafthepatitis
tcrαngs
symptomsbackground
preseasonal
7ng
2151
p80
40675
1252
pratensespecific
crth2
cancersinflammation
endothelialderived
therapieseg
cellscould
carcinomafuture
chemotherapyintroduction
7v
13v
23v
p066
p342
14142
lankan
cdjev
imbv
seroconverting
144147
146147
5yearolds
79147
453620
60147
328492
lesscutaneous
wang
atgthe
nonbsi
hr039
hr036
bsirelated
nct00644371
250mg
4m
cikg
70mgm
y90ibritumomab
p046
y90ibritumomabtiuxetan
n7346
n506
490734
5062
preuniversal
g12p8
findingsin
transpire
mute
swans
cygnus
olor
1789
zoos
pigeons
columba
livia
npelisa
hi32
14482
vaccinesdna
nonbiological
chickensbackground
antigenicallydistant
europeaim
nonroma
8233
ratio0325
0548
0559
0598
0704
ebmtin
n92
n234
surveysobjective
873908
893921
4669
2845
01years
901941
5021
3288
obstetriciangynecology
interviewdata
stafflevel
jevaccine
mbdvprimed
25yearolds
jevaccinenaïve
mbdv
2521dil
903989
5yearspostvaccination
509664
2671dil
nct00621764
20102015background
26million
623montholds
609666
24yearolds
448474
58yearolds
345389
430465
263397
185339
633676
116187
24yearsand68133
outbreaksthe
epidemiologicalphylodynamic
nonrecombinant
coalescentbased
hills
causeeffect
administrationwithdrawal
wearable
peptidepolylacticcoglycolic
streptococcusrheumatic
lipopeptidebased
lcp1
maturations
plgabased
j14specific
egfdirected
nsclcabnormalities
pti
061098
efficacytolerability
responsesan
polyantigenic
xpv
xpvtreated
adenocarcinomaassociated
foxp3regulatory
immunotherapymediated
ifnɣ
rituximabdesensitization
135440
nonhlasensitized
adolescentspurpose
34478
235282
age17
120189
121173
111150
107158
or179
154208
117170
collegeeducated
rr123
rr135
rr108
reconditioningliver
ischaemiareperfusion
revascularization
antiischaemic
multipharmacological
burdened
normothermic
resuscitating
nsclcsclc
significanttherapeutic
arrayfor
forcutaneous
23cyclic
selfmolecule
midwivesbackground
puberty
cnibased
reducedexposure
tanner
0753
0344
spermarche
immunotherapiesindoleamine
oxidoreductase
nondietary
selfregulate
timebackground
50iukgd
iiti
1aspecific
11x
1type
bufferdependent
1500fold
directionsalopecia
dibutylester
minoxidil
bimatoprost
plateletrich
therapiesharnessing
inhibitionbrakes
antipd1antiprogrammed
25of
mutationdirected
directionsmalignant
possibilitymore
sphereforming
cscinduced
interleukinactivated
twodoses
iag
goldfishthe
aquarium
iag52x
imultifiliis
1266
48kda
ohgonucleotides
psip409
nc8
goldfish
nc8psip409
nc8psip409iag52x
francethe
entourage
relays
vets
vetfarmer
communicates
overruled
riskaverse
sirws
crossimmunityincidence
parapertussis
twopathogen
singlepathogen
90ylabeled
antiα6β4
α6β4
radionuclidebased
90yitga6b4
37mbq
onceweekly
itga6b4
ph2axpositive
exosomespeptideloaded
exosomeinduced
impersonalised
exosomebased
curethe
dauntingly
tlragonists
besançonobjective
besançon
140gp
771reported
2main
moroccosheep
sppv
reappeared
bhutancontrol
2fold3fold
or12
ci440
sustenance
canarypoxlike
fowlpoxlike
houbara
bustard
captivebreeding
emiratesinfectious
chlamydotis
undulata
macqueenii
n2311
themglioblastoma
hovers
immuneadjuvant
plgaicgr837
shantha
biotechnics
hyderabad
898person
80·2
61·5100·0
87·3
70·2100·0
effectcritical
allocations
perronfrobenius
separable
electrogene
egt
tsp1
dispositional
n1377
biserial
worryworry
severitywas
formulationproductproposition
ebvseronegative
donorsebvd
ebvd
analysisreducedintensity
wellbalanced
fbt200
fbt400
50mgm
452±50
517±52
p541
287±28
347±46
p368
p171
p605
261±26
142±35
490±91
549±77
p718
222±23
333±28
p238
257±26
95±11
p315
fbt
therapychildren
magnified
hematomas
malignanciesbusulfan
strikevaccination
cancerswe
trics
ethosomes
slnps
2016since
assurances
immunocloakbackground
immunomodifying
nanobarrier
immunocloak
laminin
collagens
immunocloaks
nonthrombogenic
diapedesis
ischemically
indexmatched
assures
bend
koebner
standardsthe
hizentra
subcutaneoususa
privigen
intravenoususa
24iuml
consensusprescribed
ilabetuzumab
millicuriesm
tomographymagnetic
ffluorodeoxyglucosepositron
nonadjuvant
ratio042
2017123638649
hiroshima
178669333892
213223
428449
schoolchildrenbased
deliveryvaccines
particels
immunistumulatory
biopolymerbased
bali
denpasar
2015february
320419
9358
681612849
00740155
04640958
408419
20169001
adenocarcinomaimmunotherapy
transferinduced
systeminflammatory
cd45rb
studyparoxysmal
2746years
4130months
decapeptide
elagigiltv
12941
ensembled
peptidewt1
celldctherapy
615times
cellsdcs
26×10
55of
6092patients
timemstfrom
mst
responsecrwas
5patients91
responseprin
diseasesd
diseasepdin
responserrand
ratesdcrwere
27and
55respectively
7623
681627
policymeasles
reconsidering
maintainable
jejunicampylobacter
flagellinbased
flagellinspecific
pvras
pvinfected
chmi
prepatent
antipvcs
nct01082341
gems
gemmediated
oncofoetal
72kd
nglycosylated
tumourinitiating
underwritten
phu
preclinic
darfur
sudanbackground
medairs
svy
commands
value0046
value0025
value044
value049
value028
medair
lqas
vaccinationinduction
development…
beginningafrican
caucasus
2007to
intracaecal
responsesbackground
gelova
dcova
dcovavaccinated
adultsobjectives
moreexpensive
20939
31214
83775
mosteffective
25000
standpoints
atgexposure
proportionalhazard
competingrisk
02227
10point
0974
ultravioletkilled
uvkilled
eccz
2wk
conductivity
miteassociated
actair®
antony
franceshionogi
expansionradioimmunotherapy
monoantibodies
chelates
chelatetoantibody
positronemitting
4dibenzocyclooctynol14710tetraazacyclotetradecane14710tetraacetic
dibodota
azido
groupbearing
neak
chelatemodified
a122neak
upv
n573
18181
pvassociated
cd1ddependent
lymphomahistone
cd1dmediated
cd1dexpressing
trichostatina
panhdaci
iimediated
hdac2
stat3regulated
mclsecreted
recipientsappropriate
epitopesmelanoma
fm82
fm932
mel624
mewo
skmel5
hlaeluted
a0301
survaxm
gliomasurvivin
svn5367m57klh
survivinpositive
hlaa03
allelepositivity
176weeks
866weeks
immunotherapeuticshepatitis
subverts
locallyadvanced
negligeable
cholesteroloxysterol
micetumorderived
oxysterols
zaragozic
isoprenoids
lxr
abcg1
mertk
srebp1c
taaloaded
immunopathogenic
areflexia
erythematosusbackground
allodynia
neuropathyintroduction
remyelination
endoneurial
epineurial
973977
diseasehuman
pythiosisobjective
toe
aboveknee
suprainguinal
terbinafine
marginsespecially
marginat
débridement
mapa
doxorubicinthe
pmapa
magnesiumammonium
phospholinoleatepalmitoleate
singly
furthemore
immunotherapydownregulationloss
downregulationloss
inducerestore
stepby
rcct
18107
coaching
nct00362648
vaccineplacebo
82463
340746
researchethical
mpdl3280a
canceras
dcciks
hpv16me7
caski
vitroin
unnaturally
018083
0517
150267
8696
108135
289362
457559
mediumtiter
mtmv
htmv
105183
127280
106186
129286
06×10l
2041
womenthe
wellwoman
alonethere
autoimmunogenic
tgcs
tgcspecific
tgc
eao
unnamed
antigencities
reconfirmed
atp6v1a
hsc70t
fbp1
dazap1
transplantationlate
questionnairecore
fcμr
igivigmfcr
sigmd
igiv
mz
pam3
antiphosphorylcholine
igmdepleted
antipc
tlr2induced
igivinduced
maliin
iconz
problemdriven
confluence
infantsthe
mp3
1minute
pipp
pipp1435±259
pipp814±314
projectimmunization
ontology
olympics
antigenencapsulating
therapytolerogenic
plgag
relapseremitting
reae
radioiodinated
radioimmunotherapyobjective
irituximab
deiodination
radioiodination
n4isothiocyanatobenzyl23tributylstannylphenyl
acetamide
ibpa
iibpa
microsomes
iibparituximab
ero1αmediated
erresident
ero1αplays
ero1αfacilitated
micenitrogencontaining
pseudometastatic
lnbps
4060μm
310μm
imediated
immunotherapiesalthough
xolair
genentech
2000mg
4000mg
225mg
propagating
blt
marrowliverthymus
monogene
problt
seeded
propertiescardiac
decellularization
denaturing
detergents
nonmyocyte
subpannicular
12wk
recellularized
scaffoldspecific
recellularization
arrecellularized
antigenremoval
diseasechemotherapy
advancedstages
brcaness
controladvancements
receptorinteracting
ripk
necrox2
20052011background
varicellaassociated
bavaria
1263
vasculitisinfarction
2136
0721
programmeobjective
20132017
crore
us718
34336
3587
4570
9451
1980march
1966march
1994march
1978march
1989march
1997march
1132
1179
2086
1463
2664
177ludotabevacizumab
radiolabel
177lutetium
derivatized
dotanhsester
ºc
dotabevacizumab
177lucl3
scinthigraphic
177lutetiumlabeled
1158
scintigraphic
amlmdswe
clofarabinebusulfan
clob2a2
fb2a2
allotransplanted
592years
608years
224months
105435
102461
094326
145616
629954
16599
52689
19624
5342
0τ
versushost
chronicgvhdfree
propensityscoreadjusted
1·410·7
74·4
mg×hl
31·1104·6
0·74
0·35
69·7
66·273·0
77·0
72·182·9
78101
66·1
60·971·4
5886
49·5
29·266·0
p0·011
0·390·84
p0·0041
1·69
1·122·57
p0·013
2·99
1·824·92
1·30
0·732·33
p0·37
ucsf
helen
friller
zion
modelstwo
fcγrivblocking
igginduced
hormonebased
miceimprovements
spermderived
76126
sp17
830844
dilysine
kk
ttkksp17
equatorin
21185
rnase
94104
fvbj
capacitated
equatorial
reprod
dev
10481059
nonuremic
cardiometabolic
askp1240
cd40cd154
cfz533
bedsidepurpose
nonabo
transfusionassociated
clinicalbiological
qxlike
is149406
2infectious
antigenmodified
exhaustiont
igf2rbackground
igf2r
igf2rspecific
os17
24day
mem238
remem238
p0057
datapreterm
antenatally
36648qaly
153734qaly
cost100000qaly
was156
135000qaly
flourished
112593
trialsrecent
monotonically
monotonic
tepi
deathalthough
atmmediated
ser15
til1383i
7620
600616
immunodepressionbackground
voxelbased
lesionsymptom
gyri
orbitofrontal
fasciculus
frontooccipital
laterality
immunodepressive
transplantationmonitoring
frankfurtmain
69±06
69±10
citrm
21±05
10±04
18±09
13±07
mrdnegativepatients
ctl44
ctl4
pd1inhibitors
2kidney
earlyacute
1although
nonmetabolic
extrakidney
morekidney
cnimediated
moretreatment
immunologyhepatitis
diseaseintegration
georgiaobjective
074178
0230
prepcv
20052008
transitionalpcv
establishedpcv
0918
0888
0937
0360
0872
0877
0263
0975
0886
tumorsabscopal
antônio
ermírio
moraes
patientsth17
hdil2
transdifferentiation
il17secreting
hypofunctional
trp2specific
antigenexperienced
ad5il2
oxideproducing
sarcomaewings
ewsr1
fli1
rtks
ewsfli1
infectionalthough
nonfatal
artresistant
prospecting
trialstransplantation
impurities
membranepermeable
surfacemodification
microencapsulation
t1dmicroencapsulation
alginic
biopolymers
enveloping
upscaled
ultrapurified
pyrogens
postintraperitoneal
olanzapine
palonosetron
32mg
8mg
doublesided
therapyantiretroviral
rebounds
countries†background
healthadvice
27386
19817
13857
9328
5225
vaccinated3576
unvaccinated1649
8413111
174465
l1specific
7260
treatmentmtor
ddmediated
cd44hicd62l
id8agg
52031
trip
11168
aureas
implicationsbiologics
fusionprotein
draftsubmitted
september2016
combinationintroduction
cpg2
otago
substatelevel
schooldistrict
lowresolution
20072014objective
cytologically
lsil
blight
immunoglobulinprior
modelregulatory
grb
dcsa
nswobjective
asks
semiscripted
recordkeeping
functionsecondary
postcancer
lymphedematous
dtrgfp
usabackground
angiostrongylus
cantonensisbackground
cantonensis
thirdstage
aa41
cd23
cona
corticotropinreleasing
cfos
helminthicide
conceptthe
challengedespite
byvaccination
undefinedhere
methodgraftversushost
ltgvhd
anticd8α
alloreactivities
antitcrαβ
prediagnosed
hypersensitivitybackground
asanonsteroidal
cihd
asansaids
ifnα14
micebecause
hupbl
ifn2
pegasys
α6
α8
ifniexpressing
ifnα14expressing
nsclcover
restrain
mhdp
mamp
mhdps
issuesince
antimica
w6
smica
yemen
serosurveytriggered
casetriggered
28613
2572231505
464735
89173
8676891577
612876
simplifications
preventionwill
programin
julie
garon
walter
orenstein
lessler
forconcurrent
25ohddeficient
asthmawheeze
dependentvaccine
vaccinationregimen
procedurea
decommissioning
therapytumor
βgalactosidase
βgalactopyranoside
βgalactosidasedirected
rawblue
jawsii
βgalactosidaseenriched
involutional
crosscultural
personnelinfluenza
prosocially
collectivistic
immunotherapyefficient
lntargeting
dps
thermoplasma
acidophilum
hftn
rfp
rfps
rfpmodified
rfpspecific
rfpexpressing
tsacarrying
interleukin2lowdose
tcrαβdepleted
tcralphabeta
10515
1501587
100111
herb
cakeseparated
moxibustion
rabbitsa
shenque
guanyuan
zusanli
pishu
shenshu
moxa
cake
liuwei
dihuang
decoction
cones
acupoint
corpuscle
averagesize
wartsanother
boyswe
cambodian
teenagersobjectives
khmer
pseudopelgerhuët
biotinylation
modelscurrently
sulfohydroxysuccinimide
nhsbiotinstreptavidin
sulfonhsbiotin
saalexa647
dpbs
biotinpresenting
hemispheres
u87
homed
zrdeferoxaminebiotin
sulfonhsbiotinsa
tumourstumour
radioimmunodetection
ridrit
oncotropic
presynthesised
separates
unlabelled
fastclearing
prelocalised
tumournontumour
tnt
streptavidinbiotin
tutorial
approachesalmost
metabolization
compendium
ci314
ci158
ci443
healththe
engrained
autoimmunityb
autoimmunities
anticd20s
titersconcentrations
4316
4363
161487
1707
10082892
105288
121309
103130
1211437
19115728
protocolscd8
microbefree
receptor9
dynavax
cpgcontaining
22mer
cpgmotifcontaining
sbm
legislators
wegeners
fortunate
followupreversible
wg
ddd
noncardiac
pacing
challengehypersensitivity
strategiespenile
enablersimproving
remuneration
pharmacyseasonal
pharmacyled
peptidesbackground
constriction
perineurally
frey
hargreaves
metenkephalin
dynorphin
βendorphin
methiodide
perineural
opioidmediated
neuropathyinduced
macrophageinduced
filanesib
antibodynear
infraredphotoimmunotherapy
h441
avelumabir700
metaanalysispatients
transcatheter
halfyear
boice
roybal
varghese
wu
reviewvaccinepreventable
pbis
carcinomahighdose
predating
proclaim
196months
431months
334months
466months
496months
costimulationthe
modelalzheimers
pc61
sixmonthold
18f2
fluoro2deoxydglucose
microgliamacrophage
ca3
conditioninghighdose
tbc
scnsl
tbcconditioned
pktargeted
reaffirms
diseaseaspirinexacerbated
cyclooxygenase1inhibiting
franceaccounting
protectionbackground
28500
39500qualityadjusted
recouped
12500
20000qaly
leukemiaolder
5572
pifrelapse
4153
3344
2543
100229
136334
3852
hematol
924249
reemergent
virusgvth01
prime—modified
140000
755μl
vaccinematched
nct01378156
yearstatemandated
2015sustained
2012may
reassigning
mopup
rcmmp
2016melanoma
successcellular
iffim
225hours
iffims
outcomebased
pledging
pd1pd1l
bacteriadriven
13cisretinoic
endeavours
biu87
mage3sensitized
mage3peptidepulsed
tumorablative
malignancieshaplohsct
122015
females44
n29aml
8saml
19all
5advancedmds
2cmlbc
fludarabinearac
1201081
4263
p0991
acutegvhd
genderpairs
d9
32630
rs7935564
trim22
biogeographic
nonprogression
41112811286
savelyeva
biotechnol
198760764
nontolerized
treatmentt
agood
aremarkable
afavorable
radioimmune
ghsg
bkse36
ugandathe
se36
antigen5
placebocontrol
antise36
192fold
coveragein
satellitederived
synchronizing
fluxes
ionizable
primatesdengue
arboviral
den80e
lnps
motolimoda
micewith
nsghis
motolimod
motolimodpld
nct01294293
195566
btypes
costeffectivehighdose
op
aas
7884
srtr
052083
nonaa
081106
p26
allpurpose
connectedness
unhindered
survivorsreducing
regrets
existential
illdefinedmaking
cancerradiation
gemms
radiationnaive
rtrelapsed
11liver
stk11lkb1
immunotherapiestregs
cosilencing
recognitiondcbased
anticlec9a
effectthe
comfortably
shackles
agyllghinlhhlahlaibhhilcys
ptxinitiated
αgctriggered
immunechemotherapy
fluorescentmagnetic
αapfmnps
pull
mpf
mpfresponsiveness
detectability
αapfmnploaded
villains
othersmass
vaccinatedincluding
resurge
neglects
blameworthy
counterarguments
selfimposed
reconstitutiontcell
innearfuture
adjuvanttargeted
translationthe
tses
1317yearold
tennessee
differencebydifferences
virginiasouth
aor933
611143
virginiatennessee
handicappedthis
handicapped
ahepatitis
antihbsseropositive
virol
89825833
heals
targetted
aggresome
vietnamobjective
wealthiest
steersour
ibrv
pi3v
pi3vspecific
leukotoxin
ceruloplasmin
ibrvspecific
babiesbackground
hcptargeted
distressed
consumertargeted
viewer
banner
65478views
likes
dislikes
samplingbackground
fragmentary
3438
cancerpreventing
disinclined
2510
138391
immunoreceptors
vamp
syntaxins
dock5
marcks
mettaloprotease
marimistat
zpl389
jnj3851868
inchoate
flthe
burnet
t1418
selfbcr
nonapoptotic
apoptosisresistant
themost
tocellautonomous
proliferationand
lymphomasinvivo
hvemdeficient
solhvem
p37v202
hvembtla
opposes
micropharmacies
postfusion
antigensteladorsagiosis
productionlimiting
lambing
twinbearing
cfec
131140
testpositive
03years
schooled
territoriesintroduction
arthritisbackground
pathotypes
hostsimmunotherapy
micered
kel
singleknockout
doubleko
singleko
atmx35fab
survivalthe
αtherapy
macrotumors
nihovcar3
lowactivity
highactivity
3459
eradicative
tmzchemotherapy
groupr
groupn
chemoresistanceassociated
fcimmunotherapy
medians
180months
305months
tmztreatment
multiplepollen
uniting
threephase
showpeople
cuts
toppriority
specialising
roadside
unofficial
encampments
generalising
15182
vol
immunotherapyamong
theraputic
empyemas
bacteraemias
majorca
pneumococcalvaccinated
immunizationvaccine
oppressive
convinces
obscurities
guineans
africans
rally
misfortune
convalescence
vaccinelongterm
inventive
filoviruses
challengesvaccination
indexbackground
t1w
t10w
t21w
t35y
ccr3cd63
sidedness
100miumlwe
sextwentyfour
10100miuml
218645
1552
2959
0001prebooster
1miuml
phosphoantigens
stressassociated
zometa
5y15y
4m18y
21293
8942
12537
01940
zolil2
cd3cd4cd27cd127
2012we
24627
n10134
igmspecific
n16245
24067
hydatidosisthe
signified
089±021
935±62
046±018
5326±116
052±015
4923±117
019±04
1817±73
il10modulated
activitydendritic
selfags
il10dc
il10dcs
il10dcrelated
contextthere
overthecounter
otc
radiationtherapy
inmetastatic
55weeks
3265
cd8activated
desensitizationcxcr4
therare
whim
ws
phenocopying
occupying
coffeyholden
meetingintroduction
chpca
coronado
pcf
tankstructured
77123144
asthmaclinical
igg4associated
perihematomal
hemorrhagethe
perihematoma
sakk
3705standard
04mcikg
72years
crcomplete
remissionunconfirmed
cru
hypokalemia
diabetesas
overrides
trialsrecently
md012
008016
md023
013034
rr052
rr093
abortionobjective
lai
tocolysis
2852816
010093
006068
168months
thiotepabusulfan±melphalan
n213
thiotepaother
p0109
921822
needtoknow
seasonacip
carcinomapancreatic
colitisawareness
hymenolepis
diminuta
hdag
dinitrobenzene
dnbsinduced
cdllb
monocytelike
hdagrecruited
signalingthe
viphyb
vipko
viphybenhanced
680215
bop
gcf
p0860
p0126
il15cancer
datapurpose
1318
1350516364
576697
15363
httpwwwncbinlmnihgov
httpwwwembasecom
4717articles
141were
approachesimmunization
underrated
travelpilgrimage
nurserieskindergartens
effectvaccination
185nk
2539
berries
lowmedium
northerncentral
donorwe
agmatched
anakinrarelated
predatorprey
immunotherapyallergic
juncture
strategiesunderstanding
neutrophillymphocyte
hr0538
hr0593
hr0516
hr0558
hr3521
workerswe
immunotherapytreatments
tîrgu
mureş
romaniahuman
oxaliplatincontaining
fxv
fivepeptide
00015
hlaa2402unmatched
myxomatosis
rabbitsvaccination
seminatural
enclosures
n511
capturemarkrecapture
nonexclusive
translocating
immunopharmacodynamics
transcellular
pdbiomarker
bv2
mvapd1
chickenmany
antichicken
chcd40
mucosaassociated
antichcd40
mabpeptide
leghorns
issuesthere
407426
cancertumorderived
autophagome
dribblem2
pembrolizumabtriggered
ipilimumabdurable
15130
adnexaprogrammed
adnexal
p437
intercurrent
5400
phlebotomybackground
wilford
hall
comorbidityunlabelled
vcid
vcidamyloid
hyperhomocysteinemia
hhcy
intraperotineal
advcid
appps1control
appps1hhcy
diseaseschina
nonimmunosuppressive
pbm
lllt
acceptanceawareness
7115
7915
severety
subucaneous
tuberculosisimmunemodulating
125oh
13week
therapytreg
gravistherapies
004209
030054
031123
024218
008277
melanomarecently
chemotherapydosing
qatarbackground
infectiousdiseases
varicellaamong
qatar
75bed
indukhan
presenceof
surfaceantigen
156received
nurses902
years904
morefrequently
fullschedule
againstheaptitis
withother
was85695
rubellaand
bm32
bm3220μg
bm3240μg
bm3210μg
p00063
nct01445002
immuniser
15621
acanthamoeba
oncologyintroduction
mutationencoded
cubabackground
cienfuegos
βlactamases
hopeprostate
conspicuously
20161223598607
serie
soccer
teamsscant
football
lamica
mauimaui
therapyelucidation
retrovirusspecific
theileria
annulatadespite
annulata
schizont
tparva
tannulata
proteincoding
orthologous
orthologues
antibodiesa
nhabs
antibodydirected
implementationrepeating
2013immunization
dtpahib
2014compared
1618months
13and
1820months
2014versus
hcsp
ct26specific
326444
activitybispecific
ssfc
knobs
holes
pn23v
novac
populationhepatitis
antibodytiter
ethnicallyspecific
256261
systemcontext
nonphysician
disordersautoimmune
nmethyldaspartic
collapsin
frankfurt
experiencetherapy
hdchtsit
ldchtdli
p0232
neoantigenin
carcinogendriven
carcinogeninduced
fundamentalist
religions
nonapostolic
122277
052089
387685
982991
nct01442675
neumoexpertos
prevenciónbackground
customer
h5n3
duck
virusdevelopment
broadlyactive
аduckmoscow41822010
dk4182
antih5n1
avietnam120304
akurgan305
h2n2
aleningrad1341757
rvnlen
rkulen
h6n2
agullmoscow31002006
rvngull
rkugull
achickenkurgan305
30daysold
vaccinationhuman
dismantle
peshawar
mosques
716±212
2735±268
depoliticizing
memberships
325435
310459
272431
ratio085
ci075
ratio033
ci025
ci094
interoperability
t1g3
2451
120182
047093
014092
n219
anobjective
signalscomplex
cfshave
4489
925years
cfs
otto
1920s
ivigscig
preparationsintravenous
subfractions
horsehematopoietic
underestimating
aspires
1·1
7·3
us7·5
vascularstromal
cellsduring
swell
ihdj
variola
poxviruses
monkeypox
l1r
a33r
b5r
4dnamix
4fpmix
antia27
electroporationintranasal
auricle
cradle
vaccinessummary
trypanosomesafrican
trypanosomes
trypanosomiases
hostprotective
supersedes
trypanosomiasissusceptible
vsg
microbicidal
responseadoptive
idiotypespecific
iinegative
m2type
686476
skeptic
relapserelapse
allogeneicdonor
countdown
mdgs
5background
multiinstitution
crosscutting
mdg
mdg4
mdg5a
mdg5b
lowerlevel
injuryspinal
paraparesis
paraplegia
antiimmune
fragrances
dyesthe
ec3
fragrance
compilations
inappetence
constipation
restlessness
listlessness
iranlumpy
azerbaijan
434bp
rflp
shpv
gpv
capvs
antigenscharacterization
endculture
ie1specific
multicytokine
ifnγcd154
samplebackground
habs
3117
χdf
0056
0037004
0962
tuckerlewis
0957
αs
psychometricallytested
crosscladereactive
responsestrong
gp120s
epitopetargeting
v2specific
pneumoniapatients
rhil7
2hit
aeruginosainduced
rhil7treated
infantsmultivalent
61014weeks
246months
61014w
246m
mif
rhabdomyosarcomamacrophage
iso1
antiii
4ipp
antv
sulforaphane
10µm
3µm
29346
53107
72107
102068
07180971
07070842
mutationdriven
melanomawith
itemize
cellsipsdcsexpressing
antigenthe
cellsdcsis
dcsipsdcs
ipsdcs
feederfree
dcsmodcs
51crrelease
ipsdcscea
lclcea
cea652pulsed
lcl
lcllacz
ceapositive
mkn45
ceanegative
mkn1
ceaspecific
sa14142
1224monthsbefore
nct02602652
sa14142andwildtype
1dil
377celsius
ajecv
omalizumabenabled
omalizumabs
sics
10cm
132151
sic
tregselective
tnfr2specific
tnfαindependent
targetagnostic
editions
selfadvocacy
vaccineuse
eccmid
studyrecurrent
gaas
epha2
montanideisa51
gaa
gliomatosis
cerebri
noncns
thetreatment
micecytokines
overage
mar
6832days
4951days
italyactive
blackbox
modela
100y
10557
us394million
us301507
us10000
disruptionimmune
openers
arousing
applicationsregulatory
ptregs
ttregs
cd1the
adaptivelike
decoding
antelope
2010background
19year
nitricoxidesynthaseproducing
wefound
tipdcs
csf1rdependent
actadoptive
marigo
statessocial
determinantssuch
policiescan
adrenoceptors
sma
peptidic
sbp
phenylephrine
kcl
arimmunized
relaxations
dobutamine
nebivololinduced
kclmediated
nebivolol
βagonists
leukemiano
cnsl
hypodiploid
pif
decitabineflubucy±bcnu
decitabinearacbucy2±bcnu
199months
92307months
vaccinationviral
cytokineinducedkiller
mpacsa
migrationrelevant
il20
arthritistwo
il20r1
il22r1
il20r2
il19
antiil20
il20r2fc
nodederived
lnmc
hpv16specific
rent
togobackground
itcontinues
mics4
twomonths
togosmics4
2067
10512067
19052067
6202067
7502067
residences
aor0650
savanes
aor0324
nonschooled
aor1725
p0002standard
aor1668
aor1393
p0090
aor1465
aor1591
levelnoneducated
aor1435
fiveyears
groupto
5187
4513
2777
reviewlife
expectancies
donorrelated
deranged
malignancyrelated
©rsna
frequencyobjective
udon
noodles
timesweek
20g
noodle
50g
twiceweek
200610
neighbour
041084
boviscattle
wc1
cd79a
pathwaycik
hl60
nkg2dmediated
challengeshepatitis
80s
moleculessince
mhclike
immunotherapycytoreductive
bopriva
bullsto
232±119kg
239days
042ngml
021ngml
carcasses
ccw
kph
lumborum
1der
30000auml
20batches
094106
097103
erapurpose
therapymetastatic
intravasation
navarra
spainpertussis
unvaccinatedpartially
2170
1779
1880
163910
telephoneemail
1628
1219
vaccinationherpesvirus
rhvt
rhvts
hvts
hvta
hvtb
rhvtb
rhvtc
rhvtd
pfus
hvtibd
agethe
turkeysinfectious
rhvtibd
ibdvvaccinated
vaxxitek®
vectormune®
isolators
oralnasal
stc
delaware
del
dmv503807
ff6
rhvtibdvaccinated
vaxxitek
vectormune
30wkold
60wkold
bursabody
antiibdv
toxicologythe
checkmate067
repertoiresthe
vrc01class
ighv12
ighv1202
vrc01related
vrc01
ighv1202rearranging
vrc01antibody
v3loop
epitopemodified
antibodyexpressing
elisaguided
ofdirectional
tier2neutralizing
shepherd
catalogued
ratesusing
23st
test110
or112
ci1491
or81
ci18368
ci12197
or43
ci1349
ci2080
pdgfbb
glun2bnt2
glun2bct
glun1nt
vesigenurtacell
hs410
cancerunlike
feedbased
streptococcosis
mossambicusbackground
tilapias
120±10g
extractthis
alergovit®
allergovit®
apoptosispromoting
nonhistone
changepurpose
2015influenza
rheumatologybackground
slrderived
rattle
frontrunners
handlers
or100
1894
or53
battlefield
immunotherapieslike
battling
soldier
prospectivehuman
cellscd19specific
cybased
carcinomacolorectal
osteosarcomasurvival
antioncodriver
her2neupositive
potentialher2neu
ibc
cd4pos
antiher2th1
her2pulsed
antagonizeremove
reviewepithelial
4524
2285
cancersquamous
studytherapeutic
mglur5
intracellularsynaptic
reviewvaccinations
cancersunlabelled
tumorlimited
brilliant
categorizes
35cyclic
creb
cyclicamp
ets
e26
transformationspecific
rda
representational
serex
ssx
sahelian
endemicwas
offtake
tabaski
eft
mmorbetter5mg
noneft
794801
antimalarials
idiotypebearing
autological
tcvtreated
myelinspecific
mlc
antileukaemic
leukaemiaderiveddendriticcells
cytokineconcentrations
tumornecrosisfactorα
mixedlymphocyteculture
cytometricbeadassay
fluorolysisassay
dendriticcellmononuclearcellstimulation
cytokinelevels
culturemedium
cytokinepatterns
tcellactivity
transplantationdonorlymphocyteinfusion
cytokinecutoffvalues
cytokineprofiles
tcellfunction
malesresearch
lowersocioeconomic
countervailing
realism
pragmatism
cancersover
outspread
dynamicity
tenacious
microsimulationbased
burials
microsimulations
agglomerative
225years
4821021
3691027
1941013
2901019
136496
aboveaverage
5864
ipscell
therapyantibodybased
massproduction
inhibitorsdespite
nanocapsule
1methyldltryptophan
evaluation1
nct01303172
nctc
13365
10mgmll
intradermallygem
1000mgm2
imm101gem
044104
p0074
033087
coexpansion
therapygamma
complexunrestricted
cikz
cd64
20000fold
coexpanding
chemotherapymediated
childreninclusion
aimong
nonmeningeal
selfdetermined
n223
threefactor
rmsea004
cfi098
tli096
reliabilities
α087
introjected
α072
intercorrelations
r002
epitopesthe
flum1
dcir
dec205targeted
cd40targeted
leucémie
lenfant
ladolescent
350ngml
372472
or764
3731564
or536
2631095
or323
147713
or434
207912
or253
12533
or245
109553
cllbendamustine
bfr
bfrtreated
fcrtreated
menacwycrmthe
vaccineserogroups
productsobjective
hollisterstier®
139±66
37±41
22±23
07±05
dermatitisobjective
123±85
206±109
eggcultivated
aperth162009
bbrisbane602009
7442
61388746
7209
58698550
75699640
7907
66919123
4773
fin
modelrainbow
walbaum
mariculture
090710123
o2a
60s
yttrium90labelled
yttrium
antibodyrituximab
mbqkg
mcikg
90yrituximab
svir
susceptiblevaccinatedinfectiousrecovered
attractor
volterratype
storiesinfluenza
iem
petersburg
biodiem
sublicenses
sale
changchun
bcht
sublicensees
franceobjective
300mothers
aged12months
vaccinationhence
pegds
eosinophilrich
1548
racespecific
progressobjective
n56632
n77389
medi565
abispecific
adenocarcinomasintroduction
singlepatient
07520
μg3
doseproportional
gitrgitr
innateinflammatory
allergenloaded
strontiumdoped
hydroxyapatite
shas
shasova
prolylhydroxylaseinhibitors
phdinhibitor
tracheas
cbaj
21chloro4hydroxyisoquinoline3carboxamido
40mgkg
epor
292±5
367±8
pdgfß
phds
myelomaescalating
16mgm
3×3
durie
consults
typethe
il17il17
il17b
il17c
il17d
il17e
disulfidelinked
homo
il17ra
il17re
il17il17r
5530
doxorubicincontaining
wheelchairs
administrativeelectronic
immunoseq
diversified
83544
yifei
tongluo
fbe
fbp
cyclophosphamidechallenged
sugguesting
practicetechniques
economicsnudgesmay
objected
intractability
autonomyundermining
weighty
autonomyinfringing
hlaantibodyincompatible
2and
1140
zurich
varicellaspecific
1757
1593
underdiagnoses
immunopathophysiology
il4il13
oncologypurpose
participantsbackground
saavi
dnac2
mvac
v2deleted
mmpp
mpmp
ddmm
ddmpmp
nct01418235
asls
vacp
vacl
vacpvacl
scorecards
7803
6967
quavatar
italyintroduction
hhm
ci5875
ci7690
ci6279
ci7488
chictrtrc
13003960
idoinduced
activationimmunosuppressive
lpsstimulated
hscinduced
lpspretreated
lpshscs
reciprocally
lpshscinduced
primarycultured
lysineacetylation
anticd48
cellscd48
slamf2
cd48
fcεr1γ
anticd16cd32
measlesendemic
366351
immunotherapysporadic
slonm
lordosis
camptocormia
winged
scapulae
stirt2wi
wpinduced
wapt
therapyusing
waptwaptnp
tantigen
npepitope
tagnp
waptnp
npspecific
biopharmaceuticalsintroduction
nds
pharming
nursesbackground
gpns
atakumosawest
osun
90525
fullyimmunised
bacilluscalmetteguerin
oralpoliovaccine
diptheriapertusistetanus
279±61years
172±40months
703750
571750
275475
aor33
ci1183
ci11100
ci1125
ci1638
npts
npt
flow2
sbu
058074
facilityobjectives
reactionconfirmed
38124
a10year
eudravigilanceobjective
abctool
cataplexy
pandemrix®
arepanrix®
focetria®
celvapan®
131irituximab
arbor
73months
vellore
5360
nonacceptors
4491
9256
srgvhd
220years
and100
cancersbiliary
undermined
studyhealthcare
singled
6120135312014
6120141312015
6120125312013
changesyear
70549
age55years
namenumber
nct01868334
viewimmunological
unfavo
rable
federationintroduction
russianfederation
contingentof
ofconstant
thewhole
hspn
twovalence
dependences
chlorinbased
immunotherapyphotodynamic
nmof
tbchf
pgfree
evomela
irvine
solubilizing
captisol
lajolla
nhl17
biomineralized
immunizationfrequent
biomineralizationbased
biomineralization
therapyuniformly
flarepseudoprogression
hesitancyimmunizations
attendanceroutine
qtip
cottontipped
nonthreatening
applicators
iggsoluble
complexdirected
syndromeantiphospholipid
perplexing
stattic
methotrexatewe
makona
primatesbackground
serumplasma
repatriated
zebovmakona
sebov
zebovmakonainfected
practiceapproximately
immunotherapyrt
2017676585
gambian
ρ0·66
p0·0011
0·56
vaccinationepicutaneous
presbased
pres1pres2
bspecific
bm32induced
hepg2hntcp
bm32vaccinated
sodiumtaurocholate
polypeptidereceptor
fluidedema
ariae
ariah
antiaβimmunotherapy
bbbintegrity
t1weighted
gddota
bbbleakages
perlsprussian
amyloidpositive
sb277childhood
nmes
nme
grandfathered
grandfather
clause
presb277
k12
sb277s
jordanbackground
jordanian
amman
foursection
gust
albackground
vhps
opel
cochranmantelhaentszel
r06
df198
smd094
ci175
to014
lesssmd229
ci364
to216
smd036
ci051
to021
1200cm
smd043
ci059
to026
largesample
scotlandan
wakefield
637641
carbayesst
2545
kinasepositive
reportalectinib
rearrangementpositive
alectinibinduced
anvp
alack
reviewautoimmune
documentary
nvivo10®
clinicalepidemiological
modeler
decisionmakingvaccination
nonconformity
a10
challengecoxsackievirus
cva10
βpropiolactone
cva10kowalik
cva10s0148b
cva10specific
anticva10
metastasisbrain
intensityconditioning
3371
nct01188174
swineslymphodepletive
patg
cellbound
patginduced
21875
level†
stateslocal
picornavirus
gliomavirus
theilers
tmev
gl261quad
vp2121130
tmevova
failurealthough
responsea
twins
2hours
regressionat
hbeagnegative
or453
1191734
or414
1001718
or769
1713459
immunoprophylaxissuccessful
3000g
waidid
transmissionpurpose
nxlrx1
ccr6rorγ
practicesacogs
alligemediated
protoxins
protoxinneutralizing
cancerneutrophils
questionsrecent
cd66b
neutrophillike
maturationactivation
ldns
ldgs
granulocyticmyeloid
ailmentsneutrophils
mir
mirmediated
mirbased
pivac15
tübingen
modelmicroneedle
geometries
fastertlalpan
hrhpvbased
18000
cancerscreening
tlalpan
therapyradiotherapy
cytoreducing
jak2stat3
pathwayfunction
adriamycinresistant
pumc91adm
ag490
alley
assessmentsepsis
noncoronary
therapycolorectal
nonmcrcs
recistbackground
longestdiameter
irregularly
sacrum
elfe
étude
longitudinale
depuis
lenfance
îledefrance
idf
pr080
interventionswe
intraepidermal
fourteenyearold
dysesthetic
scapula
t4t6
pinprick
studieselectromyogram
nonlengthdependent
solventsadjuvants
2014objectives
election
radiotherapyimmunotherapy
immunizationatopic
th2dominated
dcderived
glycocalyx
sialosides
antibodysialidase
desialylation
desialylated
her2dependent
antibodyenzyme
cosentyx
dactylitis
immunoglobulinresistant
metaanalysisprevious
ivigresistant
aneurysm
cardioprotective
girlonly
1125years
1559
5840
patientshyperimmunized
foch
sitethe
40225months
sarcomasgenetically
rhabdomyosarcomas
14g2ascfv
14g2acd28ox40ζ
sarcomabearing
86980
programprevious
slvp
mixandmatching
batf
jq1treated
acetyltransferase
brd4p300
lentinula
mycelia
studycontext
lem
singlearmed
biothera
cd3activated
foxp3cluster
agentswe
cyclophosphamidebortezomibdexamethasone
cybord
bortezomiblenalidomidedexamethasone
vrd
thalidomidedexamethasone
vincristinedoxorubicindexamethasone
vaddex
n228
010088
004052
cellsseveral
16positive
e6specific
16specific
00018
00023
00087
perforinsecreting
pp65derived
k562based
k562hlacd8086pdl1
k562hla
k562hlacd8086
nct01304836
ptdm
01000
disease4
1081
reviewsobjective
polyneuropathyobjective
mncs
munix
isokinetic
proximally
cmap
amplitudes
distally
p013035
nogo
receptorβ
solutionsseasonal
nonseasonal
authoritys
promulgation
problemfree
pedro
sportdiscus
onlywe
vaccinationprevaccination
biceps
curls
sitting
meditation
activityone
noexercise
participantcentred
cancerfibroblast
fapα
fapαspecific
fapαbased
cpvrfapmvafap
fapαtargeted
miteallergy
ivirac
autoimmunityfoxp3
escalationstudyintroduction
nct01159964
antiprame
detectableantiprame
thiazolidin4one
th2like
vitroinvariant
ch1b
ch2b
immunostimulator
105222
198383
193337
131725
wolvesdiseases
canid
wolves
simensis
canids
rabigen®
sag2dog
bale
mountains
wolf
livetrapped
horseback
pierced
020iuml
009iuml
preventedbackground
568±379
1068±379
itr3
hospitality
borderlands
diseasemyeloablative
2000µmolmin
daily×4
50mgkgday×4
oftennovel
1301
soliciting
9070
crosstabulated
noninteractive
schoolgirl
projectsprogrammes
subspecialistsobjective
subspecialist
hematologistoncologists
196389reported
1861181
1672574
100102
105608
159920
012070
023088
primarysubspecialty
016093
brazilantiretroviral
plwha
transplantsobjective
ivigbased
2gkg
311±209months
d1good
d1poor
nonpd1pdl1
6716
0136
0114
0536
immunotherapiesmyeloidderived
tumorfavoring
stat3nfκbido
stat3irf8
ptenakt
mdsdcs
msdcs
diabeticsobjective
inspecting
negatory
unvaccination
preeducational
pneumococ
spaced
immunotherapyalteration
germlineencoded
proteinexpression
cellexpansion
flip
sideobjective
epitopecontaining
chymotrypsin
102124
trypsins
antiβlg
hydrolysis
enzymesubstrate
ningxiaobjective
hui
17612100
256100
microsoftware
programe
reduceeliminate
worksite
germlinelike
infectionmiddle
sufferered
cmspecific
180kiul
94kiul
kentuckys
projectborrowing
critiquing
μ
molecule3
toso
antifcμr
mec1induced
purged
afpmhc
intracellularsecreted
et1402l1car
afpcar
158166
skhep1
scidbeige
47888
photoimmunotherapycurrent
immunosuppressor
cognitivebehavioral
observers
childadult
scalerevised
campisr
distresspromoting
rituximabmycophenolate
nonoccurrence
rituximabrelated
aboiktx
umin000006635
patientsproteomics
diseaseaims
w68
aggregometry
acid20
thromboxane
iibiiia
plateletmonocyte
infraclinical
futurepurpose
tumorpurpose
intraprostatic
intratumoralstromal
behaves
receptorblocking
hpd1
ar5y4
1expressing
infectionschronic
topreclude
tcf1expressing
arabiawe
elisareactive
skepticismvaccinehesitant
dilettantes
clinging
chatter
portrayal
unearthed
justices
sonia
sotomayor
ruth
bader
ginsburg
preemption
vacuum
bame
immunisationthe
suppurativaacne
inversabackground
inversa
deepseated
apocrine
glandbearing
axillae
personsyears
philippinesobjective
hrh
pneumococcalrelated
hrhrelated
qtp
ftes
anaesthesiologists
ultrasonologists
technologists
episurv
playmonoclonal
immunotherapyadvanced
pyropheophorbidelipid
ncppyrolipid
pyrolipidinduced
percell
carcinomatosisbackground
chemoperfusion
radionucleotideconjugated
therapygene
bares
herhis
radiotherapybased
hscgt
pvf
iaha
glycoproteinbased
seroconverters
nonseroconverters
anda
systemstransdermal
nanodisperison
bioactives
nanosized
cd93
transcriptomemrnaseqprofiling
pvalue00002
qvalue0092
p10e13
q10e09
chemokinecytokine
communicationadhesionmigration
statuspurpose
15237
12740
111167
underrecording
hab18
cellshepatocellular
cd147
zd55hab18
f2a
zd55hab18il24
zd55il24
plcprf5
antibodyantitumor
pathwayswe
chemoattraction
cxcr4expressing
cxcr4specific
amd3100
emergenciescomplex
24mls
510mls
ninteen
p0994
p0540
mpbs
nct02504398
prrsthe
prrsvneutralizing
classificationgrading
analysesbackground
tnsss
n3094
n658
n1768
n6799
desloratadine
n4455
mfns
n2140
afixedeffect
therapyunlabelled
bbbpenetrating
400mmh2o
wbcsμl
3032265
copiesμg
988747
methyprednisone
chictrocc15007008
fibrinous
bcgbooster
caf04
caf05
ic31®
acidactivatable
micelleplexes
blockadeenhanced
pdtmediated
micelleplex
diabodybased
177luradioimmunoconjugate
modelradioimmunotherapy
rics
10kdapegdiabody
16mbq
rag1null
patchbecause
easiertoadminister
marchnovember
19257
metastasesintroduction
cxcl911
phospholipidbased
micesustained
ppsg
ppsgova
coadministering
ppsgovacpg
ifaovacpg
postintroductionbackground
rotavirusvaccinated
fiv
fivunvaccinated
fivvaccinatedfivinfected
fivvaccinated
fivinfected
25212
felovax
fiv®
curfews
19962014while
decomposed
19962014
effectivebackground
eoit
3000mgd
4su
standardcare
eoittreated
87437
njalkabelló
arhinitis
score12
scaleassessed
arcsymptoms
harmonizationdefinition
takotsubo
tumorregression
bacilluscalmetteguérin
recmagea3
proteinas15
bcginstillations
71725
moffitt
eatg
pancytopenic
tumorigenesiscd8
tamoxifeninducible
unsurprisingly
atin
sunitinibmediated
powerfully
9095
mohfw
191444
6171304
microneedlethis
methylcellulose
hydroxyethyl
heccoated
efficiencyhlahaploidentical
monocytesdendritic
aphereses
41log
34log
hsckg
sirolimusmycophenolate
csammf
n123
sirolimusmmf
2mgdl
p68
p41
pharmaco
toxicitiesin
vaccinationwith
scaledup
tetanustoxoidcontaining
diphtheriatetanuspolio
03107
melanomatalimogene
vaccinationsaluminium
psd
oxyhydroxide
hydroxyphosphate
al3
abas
lumogallion
directfluorescent
internalised
microbiomebackground
mipa
etec2479
betadiversity
costofillness
165months
hpvmore
immunotherapyreduced
nonprotein
thiol
replicationsurvival
waxed
antihladp
antigenicities
dshas
fcxm
dsha
cd14tlr4
recalibrates
recalibrating
ligend
lymphomanear
antibodyphoto
rituximabir700
targettobackground
clinicoradiologic
liposarcomararity
chemotherapyhematopoietic
anemias
openiv
ltb4
descended
intussusceptionobjective
recipientsepsteinbarr
multiplexnested
glctlvaml
glcspecific
glc
trav5
encompassed
tcrαβs
traj
trbvtrbj
clonotypesdonor
micemyeloidderived
il33treated
developmentsin
modelasthma
antisurface
dr2
pn14
pps14
antipspa
antipps14
patientstumor
counterpartstaas
hb227vcmmae
hb227
mmae
valinecitrulline
maleimidefunctionalized
vcmmae
malvcmmae
chromatographyhplc
hichplc
ic50s
20284ngml
dohh2
socializing
treatmentselective
nonperception
sf12
pcs12
mcs12
cancernew
ipilimumabnivolumabtreated
antictla4pd1
anticd137treated
7618
5288301
20072014
232346
6285
7695
participations
situcancer
nur77gfp
0079
0374
gunned
miceimmunological
gramicidin
dithiocarbamate
il15il15r
il1il1r
cd4cd45ro
cd19cd27
scfvsnap
benzylguaninemodified
fantibodydrug
druglinker
snaptag
o6benzylguanine
bgmodified
snaptagged
aurif
bgaurif
425scfvsnap
αher2scfvsnap
formulationsbackground
thermophilus
193796
3953
34127
035ku
paucisensitized
doctordiagnosed
ptrend
therapychronic
lcmvspecific
1517months
fastdcs
armament
markerenriched
subjectslittle
primerecombinant
eramune
enva
envb
envc
gagb
polb
nefb
primerad5
showa
toaspergillus
igepositive
igg4iga
healthchildhood
prerogative
ad5fmdvt
targetdisease
2383
2581
bcgrevaccination
13yearperiod
upar
inmelanomasignificant
mutationbased
triphosphateconjugated
pppupar
rigidependent
mekextracellular
portauprince
léogâne
july2014
130475
110513
259738
24250
240250
educationalhealth
edugame
subcategory
polyphosphorhydrazone
myelomahuman
phosphorhydrazone
capped
aminobismethylene
variously
illogical
attainability
deem
vaccinecautious
willfully
cancerconsiderable
px478
hif1
antigenbased
therapyregulatory
rapamcyin
200fold
virusebola
makonathe
fevercausing
vsvebov
ebovmakona
vsvbased
karl
reinterprets
childhoodfood
scrapings
clippings
pilosebaceous
seborrhoeic
adolescentsobjectives
n48754
n31802
haemofelismycoplasma
haemofelis
mhf
hemotropic
mhfrecovered
coombs
dnak
cd45rb220
12009122014
dosesrituximab
antiil2r
cardiothoracic
eph
glioblastomaeph
tumorsphereforming
ephb2
epha3
macrophageleukocyte
ephrina5
ea5
antiglioblastoma
ea5based
cytotoxins
activitybackground
foxp
preradiochemotherapy
postradiochemotherapy
malignanciesperipheral
ptcl
cd3car
flucanthe
flucan
wereaged
109141
32141
116776
360989
infantthe
therapiespreviously
gpbased
ad5vectored
makgp
ad5makgp
pigadapted
micenowadays
transferability
allhuman
virusesimmunotherapeutics
risethe
nanomedicinenanomedicine
nanoimmune
immunesmart
4½
n215
n991
060146
025124
074211
106116
datamaternal
vectorsimmunotherapy
insertional
minimalistic
minicircles
integrants
hltx
hr3582
0966
13279
thymoglobulinantilymphocyte
algantithymocyte
hr0808
0134
4888
p817
hr0369
hr1511
0146
15610
p729
posthltx
transplantationadoptive
laaexpressing
laasexpressing
ebvsensitized
blymphoblastoid
hmy2
wt1235243
htert615624
prame100108
peptidespulsed
tumorhmy2
dualacting
antihistaminemast
esterbased
portugalin
19901993
19941995
ruml
0·236
0·641
0·029
concernsadvances
beating
systemevasion
failsafe
50yearsa
mismatchedunrelateddonor
mmurd
murd
n2567
n723
p0138
childrento
rhônealpes
diphtheriatetanuspoliomyelitis
intraphagosomal
6351076
deventer
formulaone
20092012objective
n1105
32·5
20s
butyricum
deacetylase1
ah1n1vaccinated
vaccineexposed
117335
36033
infantdays
127376
251514
carcinogenesistumorspecific
carcinogenesistransgenic
emergenceour
her2p185
immunizationrates
forgets
falsified
resonate
naturopaths
celebrities
laypeople
pseudoscientific
oldera
malesbackground
143546
inaugurated
panvac
boneseeking
75565
recipientshuman
immunotherapypharmacological
microtubulestabilizing
nonphosphorylated
aci35
rg7345
bms986168
c2n8e12
salsalate
salicylic
therapytumorspecific
disialogangloside
diseasesrheumatoid
mabtargeting
membraneproximal
preclusion
164482
171287
sarcomasynovial
tx18
sytssx
noteworthyidiopathic
deficiencieshyaluronidasefacilitated
immunoglobulinat
padrelated
picking
winnerrobust
81820
trimixdcmel
methyldna
mbdseq
db
tap1
ipibased
bau
6200
levelin
tim
bauml
semilogarithmic
neat
soluprick
0010001
62008200
092123
malpractice
lawthe
paresis
departmentbased
centerinfluenza
edbased
acutesubacute
5952
004008
151169
186215
009013
2244
17192767
50567
3995861105
50524
4063460471
23193449
genoprevalence
cervarix®
2014august
clart®
genomica
186sd
008001064
hivsyphilis
concurs
ifar
barrows
bo
improvac
taintrelated
fix
magicbullet
ntds
committeethe
donald
morton
majeed
antithymocytic
campare
beween
imcr
mcr
tbicytosine
araccyclophosphamide
flubusulfan
aracbucy
mycophelonate
csammf±atg
×107kg
×105kg
42th
120th
963395ci
96279639vs
823095ci
80678393
864495ci
86288660vs
511795ci
49025332
gvhdp0482
0928
group8270
180day
205095ci
20282071vs
4220
41324509
4422271889months
6290
3410
5860
oxidizedldl
transplantationrefractory
cd45raselected
donorpatient
mismatchexpressing
leukemiaengrafted
hladpb1specific
spondylitisbackground
sacroiliac
studydespite
3206
reviewchordoma
bloc
salvaging
iranfrom
recruitsbefore
resurged
dmss
amed
agreeable
8oh
autoimmunity8oh
p2conj
allergentlr7
th17driven
p2driven
conjugatesprimed
nodltj
conjugatetreated
il10ko
conjugatedriven
transplantationhuman
hbmscs
hbmsc
sifas
antimir375
shfas
hbmscderived
statein
nysda
antisrp
khon
kaen
goiter
9452230
microbiomethe
immunopathologies
immunopathologic
7616
46027
responsepreliminary
dq6reactive
dq6positive
pregnancythis
dq6
dqb10609
dqb10601
0603
0604
hlamatchmaker
85va
eplet
dqb
dqb10201
nonselfself
140a2130r135d
dqb10501
dqb10602
immunizer
advicegiving
4995
nonadvising
recallsystems
hba
1c
hypoglycaemic
001nmoll
002nmollmin
013nmollmin
diapep277
002iukg
ebolathis
\
methanogen
ruminal
methanogensmethane
methanogens
greenhouse
methane
glycosyl
rgt2
isa61
thermogel
nanoparticlecationic
6formulation
rgt2specific
gt2montanide
litre
stablility
bcgrevaccinated
ifng874
polymorphismin
62559044
factorbb
immunosuppressionimmune
mscitp
flattened
pifithrinα
gpiibiiia
antigpiibiiia
p53p21
lymphomathere
hr745
hr487
1744
infusionswe
gdli
macdli
leishmaniasisdisease
appalling
needswe
yshcn
116250
diseasemultiple
immunosuppressionsepsis
immunizationsa
vibrating
distracted
soothed
twoindependent
samplespaired
preinjection
cancersfoxp3
antilgi1associated
abrelated
nonle
18200
242156
101001
configure
agonistcontaining
f3glase
ad5f3
stressactivated
cellstreatment
il215
polysomeassociated
il15induced
mtorindependent
il15stimulated
mtorregulated
hlagmesenchymal
chondrodifferentiated
chondromsc
alginatehyaluronic
algha
hypoimmunogenic
alloproliferation
chondroregenerative
multiwalled
mwcnts
lipofectamine®
20µgml
10µgml
gvhdcytomegalovirus
gamesone
rhamdia
quelen
adjuvantsadjuvants
antibovine
µgfish
fia
challengemucosal
polynvinylacetamidecoacrylic
reacts
rico834
shame
intentionscollege
contends
strategieswhether
externalwould
vaccinecollege
knowledgeawareness
dismissiveness
capacitiesthe
adipogenic
hyperflask
12552×106±256×106
17×106
mscskg
70kg
sscsmscs
cscsmscs
curativeintent
nonreassuring
melanomaopinion
primaries
pd1negative
bacteriolysis
immunotherapyinflammasomes
poreforming
listeriolysino
asco®
valrubicin
immunotherapyimmunotherapeutic
neurooncologyspecific
failurerelated
hfrh
teamhf
treathf
15±6months
017051
graduation
017072
was10iul
nonseroprotective
125138
clinicsobjective
cellsnumerous
garner
updatebackground
anticytokinebased
subphenotypes
motivesobjective
prosociality
3952
sympathy
sake
valgcv
encephalitismyelitis
capably
valganciclovir
vgcv
gcvvgcv
hgmcsf
combatants
occupants
responsibilityvaccine
erice
roentgen
rays
individualsimmunosuppression
immunosuppressionin
theoreticalimmunological
afirst
acore
agraduation
stagesthe
aspenia
gastroenterologic
withthese
grains
unsuitability
ndi2
cracked
maize
parboiled
barley
drinkingwater
electricity
id3
developmentprevious
id3depleted
garvieae
lactococcosis
pseudoplatystoma
strategythis
sorubim
aqueousbased
oiladjuvanted
lgarvieae
vaccinecan
asps
formulary
6666
6466
serumbronchoalveolar
5866
5359
4759
antibioticresistant
4259
4159
3759
201616
networksdengue
albopictus
failings
penh
pglycoprotein
diseaset
gvhdcausing
chalcogenorhodamine
2secl
pgp
photodepleted
pdtreated
sameparty
photodepletion
cancersmolecularly
rallied
anachronism
pathomechanismimmunotherapies
somaticneurovegetative
antidepressants
antidepressant
eventsautoimmunity
intracytoplasmic
mvt
exogenousendogenous
hightiterspecific
immuneinducing
chinawe
fluorescentantibodytomembraneantigen
2052
1249
5114
8337
8501
8183
0093
substrain
substrains
unsatisfactorily
schematize
systematizing
conjunctivitispurpose
tears
crdled
cataloniathere
01012015
leaks
alcoholism
ppvs23
5059y
6069y
7079y
80y
pneumoniacausing
aeruginosathe
premixed
rabbitderived
managementmelanoma
tuberculosiscurrently
cherkassky
upload
fellows
patientallergen
illnessafter
magageable
1994in
57113
433682
post1985
15524
10414
post1991
pre1986
3571
vacca
pexa
clinicoradiological
extrinsically
selfrenew
noncscdifferentiated
anoikis
cancerization
markerbased
csctargeting
targetsstrategies
mda9syntenin
ptch
issueimmunopathology
epileptologists
epileptogenesis
paraclinical
epilepsyspecific
nsabs
multipledoseseriesobjectives
35monthold
agerestricted
nonuse
19982008
retirement
mammograms
hepatologistsvaccination
80item
7391
3233
civilians
1744years
miv
laiv3
vaccinesstandardofcare
tumorexplanted
docetaxeltreated
bestdefined
tunnelafter
antipdl2
outcomesobjectives
mgkgbased
11972
1082811927
872962
850923
northlands
20062012background
51913
3912
48001
threevaccine
therapyautoimmune
checkpointscell
linkagesobjectives
abstractions
ah5n1
h5naive
immunosuppressionalthough
gpa
birth3
dpthibhep
and8years
dtphibhepb
ifngammaimmunotherapy
oxidised
mfp
da3muc1
antimuc1
immunoperoxidase
mir370
mir539
mir5023p
mir299
mir29c
mir301
mir106
mir485
radiosensitization
erastereotactic
radiosensitize
radiosensitizers
tumorsimmunotherapy
locating
cinahl®
ovid®
moonshot
2020when
joe
bidens
beau
grief
biden
barack
obama
hiv1neutralizing
immunizationunlabelled
nonnab
envs
cd4bs
056064
lymphomawe
04×10
alc15
higheralc15
loweralc15
4145
110615528
currentday
levelbackground
checkpointsinterference
antipd1we
familiarise
staying
currencies
outcomesallergic
singlecondition
ipvcontaining
jnciims
589356
dtpipvhib
87054827
opvonly
cikbased
thtc
8412
2656
4276
39839
12726
15341
postvaccinations
polyuric
urtication
histamine1
possiblebackground
counselled
aluminiumcontaining
ideologies
empathy
resectionwe
tlak
preventiondengue
afflicting
nonstructural1
mosquitobased
collapsing
membranerelated
peritumor
399406
folliclestimulating
targetobjective
fshrexpressing
fshr
fsh
nonovarian
fshrredirected
fshrtargeted
diverted
receptortransduced
44153
childrendespite
reducedantigencontentdiphtheriatetanusacellularpertussis
79years
20082013objectives
51746
overreport
underreport
346±44
156±424
205±400
77±253
07×106±01
026×106±01
11×106±01
027×106±01
shortil21
backtoschool
gliomasintroduction
6783
ueimt
las
palmas
19982013
2681
chooses
atovaquone
proguanil
resistanceassociated
interferonreceptorassociated
truncating
interferonreceptor
alternation
oktcik
autorcik
6756
highstage
antibioticsresistant
approachesigg4related
atreatmentresponsive
arapid
plasmablastdirected
acd19
unexploited
amajor
iontophoresis
nanoparticlesneedlefree
npag
cathodal
92fold
dcstimulating
cytokinestargeting
ahc
ahcspecific
ahcexpressing
pflt3l
pmip3α
flt3lmip3α
cytokineantigen
lifts
shp1adoptive
2domaincontaining
ptpn6
motheaten
shp1null
noncd8
motheatenlike
sclerosisa
potentialy
symptomsintermitent
psychiatrist
conditionig
initialy
essentialbackground
368450
098103
βtime0067
00610073
089094
153176
e559
62713rabies
batchto
62713
humantype
fucosefree
nglycans
calorimetric
multimab
cancerhypoxic
a2ar
adenosinea2arcampmediated
hypoxiahif1αmediated
cd39cd73
immunotherapybladder
clobu4
n105
092192
glycerinated
pvas
cadesi04
damagerepair
protocolthe
malignanciesone
alimosho
lagosbackground
lagos
onep
duly
postqualification
fairgood
reconditioninglung
lungprotective
ventilatorinduced
atelectasis
neurogenic
pao2fio2
lus
aeration
peep
oncotic
mucinous
mpcls
sidebranch
intraductal
24year
±11yrs
±8mm
60yrs
126mm
178mm
elected
128mm
119mm
p069
69mm
lymphocytesadoptive
universitary
detains
koreathis
eass
crossnational
icpsr
34608
n7938
lfa1icam1
ath1
20122013background
tonsillitis
pseudomembrane
agedmatched
houaphan
diphtheriarelated
matchedcontrols
mor04
ci0117
teratoidrhabdoid
hggimmuno
rhabdoidteratoid
atrt
tumorlysateloaded
2×107
20143
atrts
cellstwo
betterthanever
h4octapa
chxa″dtpa
90yobjectives
90y
pscnbnh4octapa
pscnbnchxa″dtpa
her2targeting
90ychxa″dtpatrastuzumab
90yoctapatrastuzumab
423±40idg
301±74idg
acyclic
clinicogenetic
immunochemotherapyfollicular
pod24
glsg
bcca
m7fl
00031
pod24pi
polaprezinc
zinclcarnosine
1875mg
nonopioid
antarctic
trematomus
bernacchii
psychrobacter
tad1adult
tad1
trβ
trγ
antitad1
tbernacchii
submicron
cavitation
ultrasoundmediated
vaccinesinertial
permeabilisation
gasstabilising
nanocups
700μm
selfpropel
nanocupassisted
1μg
90second
ultrasoundassisted
ovaviaskin
gastrointestinalhoming
2016we
dnamti
tumorsensitized
cd11bgr1mdsc
potentialfor
interleykin
secondaryprogressive
malawian
blantyres
weekends
monday
wednesday
23442
11774
10919
8661
786801
myelomatherapies
bcmaexpressing
nct02215967
bcgreactive
responsesone
preclearance
nktlike
cd3cd56dim
cd3cd56hi
bcgboosted
intratumourally
oneworld
leishmaniac
perspectiveslight
excite
pests
activable
tumoricides
microbicides
agriculturehere
pdtinactivation
parasitize
vaccinepresenting
siphthalocyanines
porphyrinogenesis
leishmaniabased
diagrammatically
leishmaniadelivered
pdtinactivated
psmediated
bengalcyanosine
lightsensitive
larvicidal
patterned
cellmolecular
parasitology
entomology
bedouin
predicament
approachesbackground
tarp
tarpspecific
tarptcr
occured
withoutthe
hlaa2peptide
pp65tcr
ligandtracer
xcelligence
tarptcrengineered
biomacromoleculebased
immunotherapyimportance
hastened
yalenew
4686
papular
catsantibodies
mh134bearing
antigena0201restricted
birc5
cd99we
peptidet2
minipolyethylene
alphatype
dcctls
multipeptidepulsed
dcctl
u251
vivoexogenous
il15exposed
tumorlysis
levelsdr4
trailr
trailmimdr5
hexameric
bjab
trailinduced
recommendationshuman
oesophagogastric
og
amalgamation
responsesas
vwd
systemstudying
strategyhand
buttocks
nonisolated
mabel
tcellbispecific
tcbcea
nct02324257
hcea
cycea
doubletransgenic
hceahcd3e
vitroex
policiesreply
aspbased
ostertagia
ostertagi
igg1igg2
mucusdwelling
asp1
nasp
pasp
naspquila
aspspecific
concernswith
frightening
appreciating
2016457e231e233
onehorned
rhinocerosesreproductive
leiomyoma
rhinoceroses
sexsteroid
tumourdiseased
ceratotherium
simum
rhinoceros
unicornis
reboostered
greaterone
horned
rhino
governmentenforced
dice
wrongfully
glomerulopathyc3
glomerulopathy
c3g
eji
facelift
modulationalthough
immuneinterventions
oncogeneinduced
grassspecific
slitprobiotic
tlrpositive
slitvitamin
offspringbackground
059086
17322
053079
122167
rnatransfected
lymphomapreclinical
lymphomadiseased
ccd20
firstincanine
ccd20ζ
conserving
leukemiaselective
hematopoeitic
alloreacting
mmoll
alloproliferating
postsd
cd123engager
engt
cd123cd3bispecific
cd123eng
fcal
postantitnfα
32cd
harveybradshaw
hbi5
hbi
δfcal
δcrp
preinduction×100fcal
27146
16115
δ70
lr23
ipilimumabhuman
dehydrogenaselevel
administrationpatients
ibdnationwide
analysesduring
62002
dexa
14155
055068despite
extractsbackground
05mgday
5mgday
cataplexystudy
immun
biomedicines
dhbs
orangespotted
particlesnervous
vnn
ognnv
mhcia
tlr22
poststimulation
wwwcochranelibrarycom
1952
humouse
mllaf9
lymphohematopoietic
rli
micafungin
recipientsobjectives
ifirelated
p0786
p0824
p0345
upperarm
triceps
subscapular
skinfold
0085
midupperarm
nct01694108
adultvaccine
immunotherapyexcitement
dcholinebinding
challengevaccines
cholinebinding
pcpaphtd
serotype3
a661
antipcpa
antiphtd
wu2
correctional
metaanalysisbooster
002006
001011
002010
uniquenessunlabelled
intentionsobjective
refusaldelay
054063
076086
140168
142166
123142
cd171directed
ce7
feasibilityobjective
vetting
l1cam
glycosylationdependent
ce7car
46677
culturenegative
115303
haemoptysis
9purpose
ldlcholesterol
evolocumab
alirocumab
bococizumab
proatherogenic
hypercholesteremia
myoablation
miteallergoid
reportaim
pteronyssinusallergoid
acarovac
flowsymptoms
dutchnordic
consortiumwe
dnc
soured
enthusiastic
stoppedthe
rivm
recipientmanufacturer
developmentat
rivms
privatize
immunotherapiespersistent
faila
rwandabackground
rwandan
nph
891961
676754
pronounced35
genocide
76544
memphis
cxcr5dependent
mannerchronic
interleukin2monoclonal
il2mab
multiorgansystem
tconmediated
cxcr5sufficient
fasciitiscandida
nsti
sentencea
arduousand
costlypath
endodomains
piggybactransposon
stressthe
itraq
067fold
peroxiredoxin1
reconfirmation
doubleedge
rhiriitis
scalevas
polysensitizend
stormil6
polyomaviruspositive
carcinomasmerkel
blockinterferonlambda
survivaleventfree
responsesdna
projectionscm2
ased
eyerelated
logmar
carcinomasquamous
tobaccorelated
19712010background
47622
phaseout
subcohort
5316
164450
036081
039085
murder
062142
ccl21il15
adeasy
cradccl21il15
oseltamiviraim
fbf001
antibodybackground
albertabackground
063082
030085
084138
prodigynovel
singleuse
transact
nanomatrix
cd3cd28specific
centricultunit
transductions
pr1specific
pr1
azurophil
pr1ctls
pr1ctl
pr1expressing
clofarabine±fludarabine
syndromepretransplant
clo±flu
70patient
malignanciesreducedintensity
minimethotrexate
intermediatehigh
cellssqmm
otictls
tumorrecognition
adenovirallytransduced
cellconditioned
2448h
7daysold
ovab16
administrationthe
nglycolylneuraminic
gracilaria
corticata
wssv
subadult
10±102g
irradiant
1μlgbw
shrimps
thc
tpp
phenoloxidase
5705±352
225±05
15±105
000±0
nearelimination
immunotherapysingleagent
fak
vs4718
p48crelslkrasg12dtrp53flox
kpc
swith
3ml
tcid50ml
p0267
25393
miceconsidering
ovadependent
addecova
dectargeted
agmt
cll8a
mabtenance
eventtriggered
nct01118234
33·4
25·742·8
34·0
25·441·9
47·0
28·5incalculable
35·5
25·746·3
0·50
0·330·75
p0·00077
thrombopenia
arbeitsgemeinschaft
medikamentöse
tumortherapie
gemeinnützige
20072012introduction
70144
5165
2553
or188
ci156
or262
ci216
toddlersbackground
14042
13194
12548
6702
nct00804284
stepschimeric
coptreated
singleseason
checkpointinhibitoren
meilenstein
behandlung
malignen
melanomsseit
jahrzehnten
bekannt
tumoren
vom
immunsystem
erkannt
zerstört
werden
können
diese
vor
allem
tierversuchen
gewonnene
erkenntnis
konnte
jedoch
vergangenheit
nicht
zum
nutzen
unserer
patienten
umgesetzt
immunonkologische
therapieansätze
den
letzten
anwendung
beim
menschen
stets
versagt
haben
daher
hat
ausnahme
adjuvanten
interferontherapie
keines
dieser
verfahren
einzug
versorgung
gefunden
langzeitüberleben
unter
guter
lebensqualität
dabei
sehr
wenigen
vorbehalten
neuen
immunologischen
therapieansätzen
wird
sowohl
auch
onkologischer
definiert
auf
immuncheckpointinhibitoren
spricht
erstmals
relevanter
teil
behandelten
zeigen
regel
langandauernde
remissionen
bis
hin
zur
heilung
schon
jetzt
klar
zukunft
eine
wesentlichen
therapiesäulen
metastasierten
melanoms
vieler
anderer
fortgeschrittener
bilden
übersicht
wichtigsten
therapiemodalitäten
besprochen
deren
wirkprinzip
daten
therapieansprechen
zu
erwartenden
nebenwirkungen
therapie
referiert
melanomait
rotarixthis
113912
dermatophaguides
68331600
scalenasal
questionnairerqlq
mecca
progressthe
challeng
medicationsit
reactionsit
diseasethis
reviwed
progressiondependent
presume
biologythe
discriminator
8444
21273353
ageunited
2013the
27796484
135233
119207
111482
557410
eunice
shriver
nichd
neontal
nrn
efficay
cordinating
neurodevelopmental
md5δmeq
index100
breakthroughscancer
gr1intcd11b
survivalwe
antihistamineresistant
baileyi
rhomboid
cloaca
pegfpcbrom
linkbackground
zikvrelated
22987
salmonellosis9th
30may
treatmentcd4cd25foxp3
tnfαprimed
tregtcon
diseaseideally
autoantigenbased
dsg
dsg3
caart
antidsg3
dsg3specific
meam
melphalanthe
ranimustine
mcnu
priorityvaccines
nonzoonotic
encephalitic
10minutes
swaddled
vaccinationsexgender
literaturemultiple
355years
4588
1314years
20142015introduction
chikun
igabi
sabon
gari
87502
2781162
19289
1289
4106
10488
14511
anticd138interferon
anticd138ifnα14
polymerase1
ocimy5
ncih929
anticd138ifnα
poleultramutated
msihypermutated
immunotherapyendometrial
tolerancepurpose
cd154treated
monkeysbackground
αcd154
idec131treated
αcd154treated
idec131
αcd20treated
pcecv
pvrvobjective
±139
subpopulationalthough
phr
phrhr
446576
222378
0209
birdspillover
livestockwildlife
brazzaville
immobility
eyeball
patiants
phtisis
bulbi
momentary
277098
65466
somaliborn
080084
ukrainianborn
russianborn
mexicanborn
indianborn
aβimmunotherapeutic
treatmentcurrent
aβimmunotherapy
mtnfα
tumorinfiltration
111inlabeled
cytokinecoding
polandunlabelled
pwgid
4099
106100000
gammaglobulin
vivohumanized
b12
pgt126
sequel
activations
phosphate‑buffered
330µgkg
depression‑like
scfvadoptive
leukaemialymphoma
dccar
cellsaiming
4000fold
exnk
rpmi8226
nktarget
exnkpd1blockage
exnkpdl2
autonk
atgf
37180
71166
of036
069p0000
rr102
ci098
rr101
rr104
ci097
stan
dard
calmettegu6rin
contri
bution
twc
signi
ficant
ities
encephalopathya
antiglutamate
antiglur
fluently
unknowncause
destructively
saitama
adrenocorticotrophic
factorα〔tnfα〕
seizurepersisting
receptorsengineered
onswitch
allergiesoral
cancerunlabelled
acd3s
acd3sactivated
2depleted
il2depleted
microbialinfected
advertisement
c3targeted
stagecomplement
complementtriggered
intertwine
complementtargeted
undeniably
surfacedirected
fluidphase
c3directed
regulatorbased
challengea
antibodyenhanced
provenance
indemnities
patienthemophagocytic
hepatosplenomegaly
medicaments
ctpfoxm1
carcinomaapplication
ctp
hccbearing
angiooedema
sevenyearold
warmblood
mare
ehd
glycerine
balancebackground
cellrestricted
dba1j
foxp3transfected
foxp3cd19
farafter
11to12yearolds
18to26yearold
n323
23item
directionsimmunotherapy
inhibitorsinnate
wave1at
ayoung
4884
017years
wave1
7indicators
66contacts
0‑
apaediatrician
was72
713years
u3u9
u7a
afull
agynaecologist
summation
surveysvaccination
coseasonal
csi
invalidate
ciências
saúde
dbpc
2668
n565
outofseason
ridersthis
rideto
defends
retroprospective
6447
2034
414816
261521
103106
dmds
anaphylacticanaphylactoid
nonpain
23723392
pmpm
studyresearch
graham
mauskopf
acosta
kawai
floods
160000
nsanje
156592
160482
137629
108247
134836
108237
320000
294221
policiesinfluenza
10822013
indecision
laypeoples
webrelated
riskfactor
strategyinfluenza
ewds
euromomo
wreaked
lobbies
galsulfase
heaviness
antic3
intercepting
c3mediated
extravascular
anticlassical
antialternative
n187
cd319
cd34cell
hsp70l1mediated
cancerheatshock
hspbased
hsp70like
hsp70l1
576699
hlaa21h2k
hlaa21restricted
trimodality
epp
remodels
microenvironmentdriven
hypoxiadependent
studyfor
8989
8862miuml
25912miuml
180mgm2
80mgm2
microenvironmenta
metalloproteinase2
programing
20022003high
20022003
n2445
159284
116201
164424
170336
175338
younginfectious
proveneffective
eggderived
18yearold
complicationsbackground
tivc
tendernesspain
6yearolds
nct01998477
antibodyguided
epitopesin
genealogical
catalog
tlopdl1hi
trackable
siy
therapyimmunogenic
nonicd
nanoparticleencapsulated
npgem
npoxa
icdmediated
ministers
cardiospherederived
infarctionbackground
infarcted
wistarkyoto
intramyocardial
rejectionlike
hamsc
hbmmsc
phapbmsc
oct34
effecs
citrullination
nonra
ntprobnp
antimesothelioma
mesotheliomaspecific
p3u1
challengesinitial
1programed
kirinfluenced
kirligands
sso
kirbx
kiraa
150517
133511
hlac1x
142406
010054
017095
mimotopebased
immunotherapyidentification
immunoscreening
patientsgraft
8·5years
14d
cd56bright
activationhistamine
maintenanceimmunotherapy
cd56brightcd16neg
cd56brightcd16low
kirexpressing
nkg2acd94
practicethis
sba15
immunizationdue
encapsulateadsorb
isotherms
hbsagsba15
macroporosity
noninfluence
αher2cd3
rnaengineered
cartlike
hadassahs
biphenotypic
dismantling
pregnancyvaccinating
harmlessness
calmétte
immunotherapypancreatic
niu
cocktailthe
inadequacy
monoclonals
diphtheriaa
reviewtolllike
nonrelevant
humanscd4
cd4il21icos1
tiiv
atiiv
h1n1specific
cd4il21icos
decorrelated
dhi
cd4tfh1
283172
667693
181189
162169
usaguided
denialoriented
distributive
ironically
transplantpneumococcal
146230
86249
2846
cap18
routesthe
oxolinic
researcheshigh
arteriosclerosis
hmgb1partner
ferretswe
edv
ca07
pz4
h1n2
bulb
immunotherapymetastasis
nanotheranostic
postimmunological
nanotherapies
hitting
tnglycoform
adenocarcinomagenetically
antitnmuc1
tnmuc1
factorsinhibition
tumormicroenvironmental
preventioninvasive
1623years
α1giardin
cwp2
lambliabackground
protozoans
trophozozitespecific
sl7027
trophozoite
salmonelladelivered
cystspecific
igg2adominant
peroxynitrite
wi
reconditioned
rosnitrogen
polyadenosine
diphosphateribose
rosrns
mniiitetrakis
4benzoic
mntbap
3aminobenzamide
3ab
perfusate
carbonyl
3nitrotyrosine
carbonyls
lenient
believingthe
lehmann
2217
42779
4417
moresubstantial
antirbc
micealthough
singlemonoclonal
subtypematched
hod
helovalbuminhuman
duffyb
helspecific
saturating
blend
factor4
betathromboglobulin
deescalating
researchcervical
itraconazoleresistant
guilliermondiicutaneous
guilliermondii
ispi
cguilliermondii
immunotherapyfighting
doxhimsns
doxhimsn
oliveallergic
treatmentbladder
microenvironmentsbackground
sensitizationinduced
ecsensitized
adultshepatitis
21053
age40
rr186
ci155223
rr140
ci122161
bmi25
rr156
ci112217
rr153
ci121193
rr139
ci104186
age30
ci148210
age60
rr130
ci101168
ci064126
0112
ci041467
supplementaladditional
iredirected
a0201restricted
sweet
2376
wmd2116
3966
3minute
injectionwmd1383
perspectivesduring
casual
asustained
gliomasglioblastoma
microinvasive
checkpointinhibitorbased
targetinteraction
nkcancer
granuleindependent
switchlike
nonlytic
platformchimeric
cd28ox40tcrzeta
cd123car
transposase
highwayunprecedented
vallera
trike
bike
heralding
immunizationherpes
cases1000
11691638
perspectivesdendritic
challengesobjective
19671980
19811997
19982004
treatmentsfood
19777
lira
64qualityadjusted
21511
030401
011288
immunizeca
appmobile
tri
325iqr
dichotomously
iowabackground
evidencebasedpractices
recommendationconsistent
platformbackground
easiness
virusimmune
thresholdsthe
cellguided
pseudoequilibrium
oscillating
comethe
cancerfurther
strugglingin
cd4cd25ve
chattopadhyay
mart12735
chhabra
ray
itregmediated
licensingconditioning
siberian
phodopus
sungorusmaternal
sungorus
premating
postmating
midpregnancy
ldlts
3566
perspectivesovarian
empyema
parapneumonic
highervalent
larissa
2459
9nl
hypothesisadoptive
affinityavidity
ctltumor
nonlymphoablative
antiself
antiforeign
tentatively
submicronsized
toxicitiesmonoclonal
advancedrefractory
mumpsmeaslesrubellavaricella
092008
082012
professionalsintroduction
speccificimmunotherapy
significanceobjective
immunotherapysit
postsitsearching
projectdata
analyzedin
periodspresit17
postsit57
postsitthe
cytokinesil4il5il8il10il13il17ifnγ
tnfαwere
detectedand
cytokinesil5il8il10il13il17
tnfαhad
sitthe
57weeks
005pretreatment
treatmentserum
il5il17
001in
treatmentdifference
il10il13tnfα
levelsand
001pre
weeksdifference
il13il17tnfα
005serum
il4il5il8il10il13il17ifnγ
tolerateduse
unvaccinatedpartiallyvaccinated
556989
102million
452239
agecohorts
189000
providerfocused
actiontheory
framingprospect
theoreticallysupported
tbboosting
tb104
bcgadtb104
bcgprimeparenteraladtb104boost
mortalityrespiratory
rsvnaive
fostera®
hpprrsv
infectionrecently
prdc
prrsvfree
prrsfree
10pl01
vaccinationtoinfection
fluoropyrimidinebased
vouchers
tickets
vouchertype
nist
31028
3169
27859
056099
047095
neosporosis
developmentbovine
neospora
caninum
stone
20142015an
governmentsponsored
issueimmunotherapy
moriskygreen
antigensimmunotherapy
66978
immunotherapiesfilamentous
immunoproteomic
serpa
aspergilli
cd1dspecific
featuresligation
camelidderived
heavychainonly
glama
lymphoblasts
glycolipidloaded
aboveindicated
cd1dinkt
aadbackground
pneumoniaemediated
tlr24
vaccinationavian
recumbency
hocks
unevenness
wingweb
chromatolysis
paramyxoviruses
eeev
weev
diseaseherpesvirus
hvtexpressing
hvtnd
rispens
ripensibd
rispensibd
influenzaoutbreaks
aswanhungary49992006
awhooper
swanmongolial2442005
rhvtai
cropthe
brafunmutated
7610
28637
rtssas01b
metrapbackground
nct01883609
danishborn
studyrefugee
n3264
n19584
hpvimmunization
or044
037051
or061
054069
2013may
hlasupe
supertypespecific
supertypes
curation
microenvironmentdespite
nteff
mteff
tileff
memorypromoting
foxp1
tgfβfc
immunoglobulincytokine
il10fc
mr1rapa100
b10d2
tgfβmr1rapa100
receptorvβ5½
tcrvβ11
alloengraftment
il7mediated
γcchain
therapyimmunerelated
suppressants
precall
hnelhd
p0218
northrhine
westphaliabackground
stylistic
rhinewestphalia
mayring
laypersonoriented
majorhistocompatibility
immunesystem
mhcmolecules
ileje
95ci103335
804258
02909
ratio428
directionsmelanoma
phototheranostics
cd44positive
cd44highcd24low
abcg2
cd44targeted
cd44specific
phototheranostic
studyan
bexserotm
novartisglaxosmithkline
29673500
24563500
9872967
4592456
63533
2029years
59montholds
laiv4
025146
019172
030346
textmessage
radiotherapycombining
linearquadratic
7617
493140
thesouthsouth
whoaccredited
5111
case1
tetania
countriesseroepidemiology
resurgences
encephalitisthe
subforms
redemption
immunizationclonal
ighv43401
polynacetyllactosamine
agglutinin
architect®
tityus
serrulatus
antivenomproducing
sheepspecific
antiscorpionic
glutaraldehydedetoxified
012m
fx017m
668946
294801
nct01857869
rtsst1
adjuvantcontrolled
superantigendriven
toxin1
rtsst1v
201300371650
nct02340338
p0·62
tsst1
biomedizinische
forschungs
airport
zanzibar
ferryboat
plane
yfendemic
thoroughness
fines
challanges
157suppl
cd56neural
ncam
yearsvaccine
rightly
mcvs
locals
townshiplevel
nonlocalmajority
localmajority
hsp70based
immunotherapyheat
pulls
dinitrophenyl
50gene
ctag2
nyeso2
ssx1
ssx4
patrol
proinvasiveprometastatic
nkg2dl
crisisobjectives
cmlbc
p580
p512
p626
p937
cmlblast
tuberculosiscompatible
boarin
tbcl
n668
ci028
ci71171
lowprevalence
fludarabinerefractory
mulitidisiplinary
diabeticsbackground
sigle
shortlisting
5875
2432
offseason
taiwansolid
chamberbackground
stg320
hdmassociated
500ir
100ir
chblaucrtss
04h
laryngopharyngeal
ot
loxoscelismloxosceles
envenomings
limab7
3235kda
loxosceles
dermonecrotic
reengineered
sphingomyelinase
dtcp
covaccination
tdipv
midipyrénées
covaccinations
35647
18230
3287
1406
1881
virushepatitis
hdmbased
fslit
eosinophildominated
slittreated
x03b3δ
cd8cd25ifnx03b3
adultscancer
6575years
vaccinationour
nem
limitfed
isonitrogenous
totalmixed
630kg
rotationally
hapasture
40d
envenomationpurpose
llrs
riskssideeffects
autoinjectable
guatemala
brmets
p0167
201612230513058
infantdespite
emulate
fosternursing
ceases
patientsimmune
faded
nephropathyiga
subsist
nephron
intraglomerular
nephrosclerosis
renin
raasb
δgfr1·5
mlminyear
δgfr
proteinuric
δgfr3
crescents
ifnantiviral
prehighly
fcgr3a2a
cohortssingle
fcgr3a
rs396991
fcgr2a
rs1801274
n554
n580
ratio087
076099
073100
nct00135499
ntc00135499
nct00140595
nct00144807
nct00144755
nct01087424
nct00301821
extrarenal
in7
3673
3having
perspectivesglioblastomas
treatmentidiopathic
expandability
memoryactivated
foxp3hi
cd127lo
il2stat5
il2sensitive
hlaa0201chm1
allorestricted
endochondral
chondromodulini
chm1
chm1319
exhaustionin
transductionafter
chm1319tcrtransgenic
cd62lcd45ro
cd62lcd45ra
rag2é£c
chm1specific
cellschm1319
anties
adultswith
nonequivalent
antiviraltype
immunotherapylymphoid
rnalpx
lpx
ribonucleases
ifnαdependent
polypeptidebased
typeiifnmediated
postradiation
aloneimmunological
villadangos
strategiesin
tas
deepens
perspectivebesides
tetanusspecific
diphtheriaspecific
calcineurininhibitors
calcineurininhibitorfree
depletive
calcineurininhibitorminimization
kingdombackground
numberrate
19972009
19962009
icdcodes
28516
7163
252100000
131100000
517year
5064year
nct01520935
calvesbackground
aea
unpasteurized
galactooligosaccharides
sgos
bgos
lactose
tpc
lactosesupplemented
tpi
anemiastandard
rel
bmodified
invitrosystemic
relbsilencing
mrlmpj
relbmodified
mrllpr
scmodified
interleukin12p70
n2068
ecom
reviewimmunization
subgrouping
125ilabeled
antibfgf
antibasic
1g9b9
chloraminet
g25
gc1200
125ibfgf
8145
12560000
1280000
lowbirthweight
22955
2024kg
1519kg
15kg
nonlowbirthweight
n18979
n3382
050080
n386
cd3ak
deficiencyobjective
osrc2
cellbearing
131ilabeled
131ichtntmediated
pmct
131ichtnt
7959
4898
8298
5319
monthsbackground
diphtheriatetanusacellularpertussis
deciphers
bowens
diseasebowens
rim
112009
age±sd
744±80
diameter±sd
458±509
9200
facescalp
ν14
necktrunk
ν6
ν4
2224
hypopigmentation
tumorigenesisage
stromalderived
senescenceassociated
cancerfree
tumourpermissive
conditioninggonadal
leuprolide
postmenarchal
lupron
centerforty
haploidenticalhsct
neutrophils500μl
platelets20000μl
immunosuppressiontailored
seroreversion
reinstitution
shortlasting
prophylaxisfree
131000
12051213
seventransmembranespanning
arthritides
kbxn
autoantibodyinduced
neutrophilspecific
aurora
kinaseaspecific
immunotherapyaurora
mitosis
shortinterfering
selfcleaving
antiaurora
areactive
sitcr
sitcrvector
correctlyformed
exciters
kidneysobjective
infectiousinflammatory
sanitized
kempas
simulect
prograf
myfortic
neoral
sertican
vitec2
analizer
biomeriex
vitek2
transplantant
3028222
1q3233
il24s
ceramide
productsumbilical
ucp2
genipin
cd62lloklrg1hiifnγhi
recipientsdesensitization
unsustainable
rfhtgr
flatworms
threeinoculation
adyuvac
exosomesavian
unicellular
apicomplexan
protist
malabsorption
tenellainfected
serumderived
exosomeadministered
parasitefree
antitax
tip1
cancersradiationinducible
2c6f3
tip1epitope
qpvtavvqrv
d54
tumorswe
diethylene
triamine
111indium
111in2c6f3
dtpa2c6f3
90ydtpa2c6f3
analysispurpose
interleukin21primed
regressionpurpose
multimerguided
showpurpose
irritants
regimensexpect
cancerpreventive
1509
cohortspecific
1343
017040
025048
032056
26yearolds
19922005
19861992
19841986
discontinuity
wether
0296
0469
multiantigenprotection
msa2c
rap1
gestationthe
ivp
reprocyc®
boehringer
ingelheim
vetmedica
p0375
mummified
72kg
66kg
02445kg
02211kg
fivearm
624months
bopvvitamin
riskvaccination
procurers
rdbased
patientsimmunization
wwwmyvaccinesch
vaccinologist
claireanne
siegrist
4378
hesitancyvaccine
unfiltered
hesitants
aspleniapatients
psv23
mpvacwy
mcvacwy
intrasynovial
rifamycin
synoviocites
ultrafiltration
ultrafiltrates
5×106
250μgml
80°c
ultrafiltered
30thday
ultrafiltrate
ufft
510days
osteoarthrosis
oncoming
canceradvanced
yfv17d
1in3
1in5
rotashield
20062012in
remune®
dozen
kickshock
microsporidiosis
microsporidia
intervertebrates
immunsupressed
pmp1
pmp2
enterocytozoon
bieneusi
encephalitozoon
intestinalis
cuniculi
hellem
smallsubunit
ssurdna
250279
χ²
4439
immunosupressed
statethis
sturdies
monotowns
bavituximab
phosphatidylserinetargeting
vasculardirected
vialcoding
placebobavituximab
56286
43182
045121
040110
sunrise
clumps
resuspend
mycobacteriahost
oo
disaggregation
oomycobacteria
nonemulsified
oom
sudanoral
idps
nuer
refuge
8596
noncrisis
persecution
ppsv23naïve
nct02260882
conditioninginfants
postcbt
failuremyelodysplastic
bcellspecific
bcellactivating
allobcell
yearscontrol
gras
disproved
allegations
sends
breedingfinishing
nontyphimurium
closelyrelated
subtypedependent
hypodermosis
prospectslivestock
farmyard
areasplain
hypoderma
19452015
informationbackground
animosity
vaccinationsfacts
hopevaccination
allergyregulatory
ldil2
tregdepleted
tregdependent
7moperiod
mules
suppressioninformation
agidt
negativeequivocal
vrna
postis
101000
lymphomonocyte
hemosiderosis
equivocalnegative
eiav
carcinomanivolumab
untangle
melanomaarising
meninges
immunotherapypreserving
cd158b
nkb1
nkat
demethylzeylasteral
modelseveral
celastraceae
t96
xylem
20mgkgday
1083±147
1117±147days
1333±175days
transplantationcentral
lprolificans
bitetransferred
rnatransferred
beadstimulated
tropheryma
whipplei
whipples
transplantationwhipples
wd
177luchxadtpabevacizumab
pncsbnchxadtpa
sehplc
980±06
immunityit
executes
osteosarcomaimmunotherapy
infectionunlabelled
naps
2139ca
101712
1iu
virema
nct02646163
nct02646189
cnf1
infantumthere
gtpases
promastigote
c866s
mcnf1
networkvaccine
transplantationnephrotic
195months
3984months
zhangqiu
2405
18643104muml
122185
6489
3057
100999
3901305
2840
13166130
126205
272360
lowresponsive
437529
54206
4667262956
2769
23083323
3967
138111401
078002
053133
288373
protecion
highresponse
antihbs10
4332
7329
52715
437841
62201
3507
32203819
028061
018039
or95ci
051030087
010018
6901482
13982982
5458
220813492
047062
088100
154172
nobody
highresponders
4306
5694
8099
41348
358861
47030
6033
56976390
050084
041067
028045
380649
16191001
6471444
087114
174197
312344
basedmedicine
considerationwith
especial
fasten
numbersimmunecheckpoint
dualcheckpoint
senescenceinducing
gmcsfdeficient
csf2
csf2deficient
nulllow
3555cfasensitized
failurepertussis
bordet
octave
gengou
hyopneumoniaeporcine
mhyopneumoniae
pcv2associated
prrsvinduced
dually
googles
graph
debiasing
non‒evidencebased
3x2
posttestonly
comprehensible
f2273486
skepticismfear
f227335
f2273373
boxs
repeatability
fraunhofer
atmosphere
spraydrying
sqem
sqem³
1770
3251485
5466
evervaccination
essentials
tipsa
mofetilmycophenolate
programmeddeathreceptor1
inhibitionalthough
antiprogrammeddeathreceptor1
ipilimumabpretreated
pemphigod
targetoid
stamaril
interval098
912100
972100
823950
671959
easternsoutheastern
713855
344619
291591
matfeld1
humanallergy
dandersensitized
nct00718679
senti
129512901296
catspecific
tendons
aponeuroses
approachpurpose
antiil4rα
determinantsbackground
survivalpreemptive
6328z
cik6328z
cikresistant
preball
quasimandatory
quasimandates
20062013objective
hpv13
pathogeninfected
itast
pathogeninexperienced
diester
monoesters
mincle
invivothe
66dimycolate
66dibehenate
tdb
tmxs
diesters
tdxs
symmetrically
acyl
arachidate
stearate
palmitate
myristate
minclefc
minclebinding
therapyboth
473473
zah
rufener
microdevice
immunizationmicrodevice
3090mj
cylindricalconical
cm2
flatshaped
protrusions
crack
initiations
decadespediatric
19922002
dscs
threeyr
ebmtnonrelapse
ont380
mm302
3kinasemtor
palbociclib
abemaciclib
therapiesadvancedstage
combinationduring
featuresparticularly
genesderive
trialsupper
reallocate
inflammationtumorinfiltrating
tumorinhibitory
glioblastomamediated
pathwaysagents
awaydespite
parallels
txcell
cd33e2
membranedistal
vset
cd33fl
cd33e7a
cd33e2e7a
sublines
cd33flmediated
greaterthanpreviously
cd33directed
immunizationpublic
11y
latitudinal
melittinmil2
melittin
widespectrum
ctll2
smmc7721
epidemiologicalobjective
enzygnost
antimumpsigg
antimumpsigm
diagnostica
mastazyme
epidat
occursthe
globulinconditioned
transplantationalthough
unimportant
arthritismesenchymal
cd4il17
il10dependent
cellsrecent
ilc3s
hostbacteria
studytransplantationassociated
500ul
toolsbackground
slip
intranet
464501
417501
391417
233391
2212910
1642910
australiaunderstanding
rotating
trolleys
immunooncologists
recisting
immunooncologysilver
weaponsmodes
payforperformance
p4p
qits
assessor
unaffiliated
panvr
3147
recordsobjective
6124
8548
overimmunized
bpd
cared
studythere
academylean
lss
midshipmen
inprocessing
programeddeath
tunneled
studyrationale
58256
ratesthis
walkin
nightevening
chorionic
superovulation
strainsimprovement
ias
oocytes
iasecg
iase
fertilize
ovulated
balbcbyj
c3hej
fvbnj
iasederived
ecgderived
oocyte
rederivation
il21primed
patientadoptive
melanomareactive
chapuis
smegmatis
tripeptide
atherogenic
msmegmatis
dendroaspin
pjh154
26fold
62130
studentsin
finalyear
254439
or059
044078
016028
arthritispsoriasis
immunotherapybiological
brms
mxr34
cancerantibodybased
welldeveloped
immungenicity
eg01883
granulosusobjective
01883（eg01883）
protoscolex
oncosphere，
granuolosus
pet28aeg01883
reg01883
isopropylβdthiogalactoside
（iptg）
（n12
group）
weeks（2344±0153）
group（0206
1±0006）
（0241±001）
（p001）
（4323
pgml）
il4（2488
group（2177
group（1740
pgml）（p005）
histag
afatal
perforated
sigmoid
prevenar13
pnemo23
monovaccination
harzklinikum
dorothea
christiane
erxleben
quedlinburgbackground
multiplicators
chi2tests
phosphatadylinositol
3kinaseprotein
bmammalian
perceptionsbackground
χ2110
χ2125
polcalcin
hormographiella
aspergillata
reviewdisseminated
haspergillata
voriconazole
tc1mediated
ulcerosa
studybased
longsought
approachtargeted
laserfacilitated
μepit
powdered
fractionally
vd3
lasermicroperforated
hyperresponsivness
desensitisationstem
maturate
hescs
implementthe
interchanging
vaccinestumor
neoantigenderived
responsepositron
approachtherapeutic
lipidcoated
lpc
cpgencapsulated
cpglipo
temporallycontrolled
messagesobjective
doh
abridged
healthenhancing
briefer
theoreticallybased
rhil11
tbetgata3
itpimmune
gatabinding
cooccurred
efficacydna
cd11bgr1
westerntype
adventitial
hypercholesterolemic
grmdscs
oxidedependent
hemodilution
lynchpin
exchangebased
antiplasma
transmissiondynamic
infantimmunizing
rln
depovaxtm
dpx
successwe
rlnlln
lln
075085
dpxtreated
cellselexbased
gquadruplex
cellstargeting
cellselex
seq6
seq7
seq74
yonder
osteopathy
experienceprophylactic
p402fc
miceil12p40
curbing
autoimmunityrecently
galectinglycan
immunomodulationgalectins
15member
galectins
multivalency
glycocluster
immunosuppressiontargeting
ecco
esmoecc
oncologyeuropean
differenciated
narcolepsydespite
benefittorisk
syndromesjögrens
unveiling
rαil15
15rα15
cotransduced
3t3
fibroblastbased
a0201
a2artificial
prob
baf3
a2aapc
rα
sil15
cytomegaloviruscytotoxic
sil2
sil7
affibodyauristatin
linestargeted
zher22891
cysteines
maleimide
s46c
d53c
zher22891dcs
zher22891dcsmmae
mdamb453
t47d
1356
antibodiesantibody
linkerdrug
sabe
bogota
colombiaobjective
bogotá
sabebogotá
contributive
lawton
malignancieslonglived
selfrenewing
rareness
cd8cd62lcd45ra
streptamerbased
serialpositive
synthase3β
cd19carmodified
transcriptomically
foundlings
underfives
of230
25230
1851months
10311
143456
intruders
bomb
mdscinduced
chemobased
procancer
anticancerous
betterpersonalized
nonpneumococcal
mediabackground
subperiods
nontypable
7475
allnthi
001004
008020
015021
pcv76a
allpneumococcal
025035
022029
pcv7pcv13
riddle
outcomeprogressive
jcpyv
204months
antiviralsobjective
vaccinationtotreatment
holbrook
edwin
kohrtin
memoriam
malesobjective
slew
and30
100person
se138
se0113
completions
sodo
zurea
bivariable
aor89
aor41
ci14158
aor04
cd25t
lipoxin
inpbmcs
hivdependent
immunisationinfection
vaccinecomponent
themintroduction
noncell
healthbackground
hbmt
alc30
294cellsμl
0443
02330841
0499
02750906
conferenceone
preconference
buying
chemotherapycancer
antagoniststumors
receptorlinkeril15
pd1high
antipd1rli
sushiil15rαil15
lymphcytes
v10
tgfβ1fc
primatestransforming
tmem
atgmediated
predepletion
workplacevaccines
columbus
federallyqualified
retailers
34th
caseseriesbackground
pharmacoepidemiology
tiivs
nct01715792
4551
024228
024138
055264
069248
043228
031133
058176
056138
34701
3007
persondays
005068
013097
n267
n287
cd20mimotope
diseasessystemic
aggression
tachyphylaxis
blacknew
sleprone
057±038
219±055
4671weeks
39785364
3985
37414230
cancermany
semidepot
subjectevaluated
investigatorevaluated
67·5
1·388
90·4
nct2000769522
37·1
31·045·5
41·7
34·945·3
55·2
1·643
1·3082·064
experiencechronic
46232
cd3tcr
13102
treosulfancontaining
baubackground
2yearsvaccinepreventable
3round
infovacfrance
15d
vaccinehaemophilus
slc29a3
disorderunresponsive
programstreptococcus
bergen
200609
univariately
binominal
propertiesadhesion
roughness
lbllipo
vitb12chi
rootmeansquare
topographical
j744
statespandemic
recipientsrecurrent
38791
nasojejunal
51288
postfmt
bloating
infectionthis
streptomycin
109cfuml1s
20mgml1
tγδ
tcrγδ
snv
mdei
53±13
445±325
snvs
polyarteritis
nodosa
gellc
cll4
leam
agonistsenhancing
activationdeactivation
sh2containing
cish
fascia
vaccineinfluenza
nasalinactivated
19962003
asthmaspecific
psadjusted
psmatched
050078
sizesin
biosurfaceinduced
thromboinflammationtherapeutic
ischemiaperfusion
contactkallikrein
thromboinflammatory
thromboinflammation
23dioxygenaseexpressing
idoexpressing
contradiction
gcgr
loopsthe
membraneembedded
scfvphage
ecls
energetically
glucagonmediated
transplantationclinical
hladisparate
hpc
hschpc
suppressionregulatory
forkheadboxprotein
b3k506
tregtconv
indomethacin
cytotoxicityactivated
tumorsecreted
purging
procon
nigeriaglobally
acehbackground
rs041
rs039
europeon
precongress
epidermolysis
bullosa
acquisita
areataepidermolysis
eba
perfluoroalkyl
flumist
adultsperfluoroalkyl
pfas
immunotoxic
perfluorooctanoate
perfluorononanoate
perfluorooctane
sulfonate
perfluorohexane
discernable
flumistresponse
pursuitdespite
antagonising
incisive
1december
ades
medicationuse
sevenmonth
immunotherapystudies
mutagenome
mutationspecific
activatorlike
transplantdespite
virusnaïve
dateadoptive
malignancieshematologic
ikir
ikirs
neda
gdenhancing
transplantsbackground
plasmapheresisivig
ppivig
desensitizated
pdl1programmed
pdl1pd1targeted
immunecombination
arthritisfolatetargeted
antihapten
decorate
haptenmarked
bitern
ci047076
ci046063
postevent
1180964
preevent
atopicdermatitis
technologyintroduction
smartvax
enquire
affirmative
rigours
2897
diphtheriatetanuspertussispoliomyelitis
77441
139210
smsbased
kohrt
receptorschimeric
biobank
centralizing
pointsofcare
biobanks
radiotherapyionising
hiv13bnc117
3bnc117mediated
truest
taqmanbased
pactreated
tailed
ctlnkth1recruiting
mdsctreg
attractant
mdscattractant
vivotreated
7610951105
mononucleosis
2471133
106229
challengesantiprogrammed
meningiomasmeningiomas
intraaxial
possibilitiescolorectal
inhibitionpaolo
ascierto
mello
ellen
clarke
paolo
telomerasespecific
malignanciestelomerase
tertspecific
selfmhcrestricted
254051
memorycurrent
7612
347383
foodallergyeditorial
carcinomaviral
oncogenically
il2rgnull
nkcellactivating
nkg2dcd3ζdap10
57481
tumorhyperpermeable
trailarmed
xenograftsince
1591601
kindergartensobjectives
providerspediatricians
practitionersand
pcsas
pcsa
selfselection
oldschool
repurposedcancer
reincarnation
37782
pahos
revolving
who´s
stategic
pahowhos
aprilmay
ah1n12009
farafenni
fhdss
10851
aor613
3201175
aor672
3661233
senioreducations
aor243
117506
2km
aor041
024070
fula
040091
strategies2009
wiso
268553
reckoned
virusunlabelled
integrinassociated
apr834
cd47ko
interferonproducing
gl7
immunotherapytype
childrenadults
wisely
vaccinationsthe
dgim
therapycheckpointblocking
autoimmunitythe
emblematic
costimulating
responsescytokines
1p36
therapyligation
familyimmune
ultrasmall
αapfnp
srb1targeting
polyphosphazene
deliveryto
polymersome
pmil12
polyphosphazenes
nndiisopropylethylenediamine
dpa
monomethoxy
mpeg
tails
cn54rgp140
glaaf
cn54rgp140glaaf
3071
hypoglycaemia
virusperipheral
pseudovirustzmbl
rgp140
pactr2010050002122368
egpa
aavs
gcdependent
egpatailored
gcfree
areatapurpose
disfiguring
spiresbackground
spires
19992013
4279
nonnmsc
0063
nephrectomybackground
wdmis
hlaabs
alleleexpressing
nondsa
desa
adsorbing
ktand
ritand
antigenantihepatitis
133507
immunotherapyfounded
nanoparticlesbased
prevp
postvp
hctbackground
genetransferchimeric
rvlv
nilv
scaffoldmatrix
smar
nilvsmar
nilvsmarengineered
lvengineered
disordersposttransplant
rnaseqassisted
biodiversity
ramhcit
preamplification
oncosphere
rcchanwist
immunosuppressionsusceptibilityresistance
hypochlorite
activatednonactivated
nao
tcelldeficient
tcellindependent
customise
cocktailbackground
vamax
lipopolysaccharidebased
humancompatible
alhydrogel®
antigencocktailspecific
cocktailspecific
10µg
componentspecific
pfama1based
hopea
vaccinesthere
1mcv4
n102736
preventiveacute
therapyaim
acaroid®
physiciancompleted
patientcompleted
unscheduledemergency
20052014objective
2857252882of
046100
years3612
91252
adulttoinfant777898126
8164
cases8098
552095ci
51965844
groupsp
incidencer098
p0003and
trendχ21179
beijingobjective
4472
2691
2695
4483
2687
eocrecently
thosewho
3957577
asthmavzv
asthmavzvrelated
91409
9984
vzvs
changedbackground
19992004
nonhbv
systemsimmunisation
spraydried
lowprice
immunotherapiescurrent
europeimmunization
efim
reviewsteroid
thymoglobulin®
offlicense
steroidavoidance
inadvisable
followingthe
nonblinding
20point
itch
investigatorrated
5726
lymphodepletioninduction
αthy1
il15dependent
immunitycheckpoint
bap
bapiabspecific
dirt
memoryhuman
diseasestreatment
polymyositisdermatomyositis
pmdm
pmdmild
severityacute
elongated
30iukg
100iu
2kg
57to
7log
therapynephrotic
creatininebackground
tetranor
pgdm
lts
chemotherapiescare
ofimmunosuppressionposttransplantation
vertebral
1mgd
2mgd
tcdhct
pnot
coverageobjective
disaggregating
mean085
mean056
ci048
mean0406
ci039
mean0544
mean0419
mean0403
ci033
mean0366
ci036
mean0435
mean0431
ci037
or138
1899
or124
ci0897
1705
parse
immunotherapyurothelial
phlogosis
19fmagnetic
19fmri
19f1h
immunotherapypreclinical
entryexit
swipe
proximitythe
walks
vaccinationpredicts
clinicpredicts
1801
company40
meters
vivoenhanced
hijack
trialimmunization
517947
223457
isovaccinetopic
vaccinesrationale
patientdriven
providerdriven
n9021
ps0001
experiencesthis
prevalencewe
databasesnineteen
outofcoldchain
coveragewe
outofcold
departmentspublic
practitionerswe
driftselfadministered
1290
systemsonly
radiation‑induced
sunscreen
candidaalbicans‑induced
delayed‑type
hypersensitivityultraviolet
anthelios
albicans‑induced
sub‑erythema
solar‑simulated
cd207
semi‑quantitatively
2000and
145mjcm2
non‑sunscreen
6585
antigen‑induced
biokangtai
polypectomy
ambispective
inhaler
menafrivac
cameroonpurpose
2093381
537100000
administered8weeks
02100000
314100000
arr063042093
054036081
radioimmunotherapybased
strategiesonly
treatmentnew
tuberculosisheterologous
bcgimmunity
apaspecific
3252
bcgpriming
subunitapaboost
contractionphase
bcgresponse
bcgprimeapasubunitboost
apasubunitprimebcgboost
interms
apaboosters
safemillions
postconception
eighteenth
exemplarity
quantificationargument
entangled
rationalities
midcentury
arithmetic
conceptualizing
metaphors
indiansbackground
communitywide
pcv13specific
2859
3786
6628
prepcv13
hostsimmunocompromised
nsgw
knockins
malignanciescellular
ht120
girlssince
immunobridging
deliveryadolescents
costeffect
ibdsl
thiopurinesantitnfα
extraintestinal
1157
1644
108646
104476
106219
183704
101160
agsio2
nanoparticlesnewcastle
genecontaining
pfdnaagsio2nps
sulfasalazine
coxinhibitors
ontarios
effectsobjective
rvspecific
rvage
022039
062075
072090
020052
designhiv
antivirally
anotheri
experimenting
protochordates
preleukemic
patientsobjectives
thoracocenteses
endotypeseosinophil
homoeostasismaintaining
chemoimmunotherapyextranodal
networkipi
nccnipi
bootstrapped
uccontrol
workbackground
persuasiveness
riskreduction
patronising
unprofessional
nodessublingual
manlns
raproducing
radependent
ovaslitinduced
cdcbased
chickenandegg
mcgranahan
reframes
bcellindependent
ctl019induced
vaccinepathogenspecific
postctl019
tribute
cidofovirpurpose
congeners
abraf
alphagal
disordersreducedintensity
myelomahighdose
200mgm2
bumelvel
20000mm·min
140mgm2
vel
16mgm2
days2
and1
p89
dosingfludarabine
p0058
forrelapse
p0097
insummary
aucdirected
highercir
nonlung
lungderived
1349±557
1061±473
selflimit
receptorpotential
vitrotranscribed
rnamodified
hladpb104
01restricted
immunotherapylongterm
magea3specific
6f9
r12c9
magea6
hladpb10401
metaanalysislow
037087
052098
031061
076085
051080
048084
066096
nonmarried
swappable
physiol
25902598
radiotherapy131ichtnt
bronchus
fiberscope
a131i
posttreatment131ichtnt
radioimmunotherapy131ichtnt
medi551
miceb
hcd19
bmeningococcal
vaccinesuk
polysaccharidetetanus
nearinfraredlabeled
antibodiesnearinfrared
mabphototoxic
gbmscs
ac133cd133
ac133
ac133targeted
processfew
2753015
bedsidethe
3723592
immunitycd4
mauritania
2014within
entrusted
amp
nonpriority
npds
4dtap
4pcv
hibfs
dolutegravir
recipientdolutegravir
infantsstrengthening
51185
47148
movementvaccines
partys
aide
insurer
exacerbationssymptoms
experiencerelapsed
haploric
carboplatinetoposidemelphalan
hdcscr
cem
phtn
hdcscrrelated
tbibetween
105kg
31±71
12±50
15±58
26±25
88±117
50±101
noticeably
sarcomaintroduction
multidifferentiation
cd73cxcr3
changesthe
pandoras
boxafter
exuberant
complementopathy
conditionthat
ofnonmyeloablative
eugene
cronkite
bullis
brecher
198513802805
nonmyeloablated
nonstressed
outcompete
cronkites
mdscstargeting
chemoimmunotherapeuticsdespite
therapeuticallytargeted
vividly
vaccinationclinical
bloodbackground
cd154positive
4producing
n1457
uninterested
pr145
106190
pr142
111176
noninterest
methodsit
cosinor
vaccineoral
14kd
entrapping
pluronics®
f127
reticuloendothelial
immunizationauthors
hemotherapy
penetratin
systemsnasal
dpenetratin
clinicaltrials
nct00521586
joanna
briggs
triandis
socialprofessional
8595
spectrometrybased
predictionbased
q6
q24
n495
hctrelated
vaccineshendra
niv
pteropid
humantohuman
vegfr2targeted
cellsmhc
2member
antibodymica
mab04
rafts
perspectivelipid
float
liquiddisordered
ratesseasonal
panhematopoietic
vav
erb
e0771erb
rmaerb
f38
vavcar
transplantationtwohundred
aged42
cyclicity
menses
betaoestradiol
irelandbackground
polysensitivity
slovak
surveyteenobjective
peopletherapy
detractions
2818
0217
0524
9803
091124
102160
cancerthese
breathtaking
precondintioning
soochow
fretsvwf73
occurence
9113
comparision
preconditoning
abvious
actvity
befor
precondifioning
mone
precoditioning
hematopoictic
mathod
mixal
treaplantation
meccnu
109l
115days
99347
10354
69155
0122
660962
510854
haplobm
pbhsct
66100
53100
34100
monooleinbased
hematogenously
candidiasisunlabelled
cwsp
bonemarrowderived
cwsploaded
dioctadecyldimethylammonium
bromidemonoolein
dodabmo
ads1
ads2
ads1immunized
albicansspecific
dodab
monoolein
nanocarries
oncogenedriven
cancersmolecular
cattleunlabelled
pharynx
palate
microdissection
brafiit
itbrafi
indistinct
inhibitionnivolumab
tlymphocytotoxic
vita
bednet
itn
slept
coveragewhile
approachescorticosteroid
lamellar
perforating
lineagesvictoria
yamagatathis
bussr6069based
areactogenic
yythe
2976
monoparesis
tetraparesis
premorbid
deflciency
poliovirustype
homotypic
2multiple
2type
rus08063034001
151500147
pompe
mucopolysaccharidosisenzyme
statesnational
atopobium
rimae
modeladvances
anticarbonic
caixtargeted
anticaix
pne
4d5
dosetitratable
switchbased
nativesubunit
hydrophilaaeromonas
septicaemia
pest
ahydrophila
snaspecific
sizeexclusion
2941
6983
7888
reduning
chromatographyreduning
dispelling
wind
tween80
chlorogenic
cryptochlorogenin
anaphylactoid
conjectured
laos
2014february
sga
5103
5587
111–141
2870
296±92years
1762
approachestreatment
1542
dlirelated
irritable
ibs
steroidtreated
cmvdna
errorsbackground
saintetienne
finalization
drawup
traceability
usable
israelin
59·2
yearobjective
renmin
wuhan
yearthe
time（
005）not
age（
monthsthe
700the
of1218
waving
supervise
90scl90
somatization
obsessive
scl90
treatment（
subitem
immunotherapyscit
yearsslit
6250
yearsscit
8431the
years（
differences（
cancerovarian
ominously
egocentric
β046
melanomaimmunotherapies
takingmuch
promisesover
advancesas
1based
naturallike
cancerone
hypoglycosylated
20052013background
20042005
21857
chris
hani
baragwanath
hydroxideadjuvanted
glycoconjugates
gbsspecific
nct01193920
5471
3·5
gbsvaccine
7·018
0·64
0·420·98
capsularspecific
obsolete
gema
programpurpose
costminimization
disposables
francs
chf092
chf102
wwwxecom
12142015
35862
33134
36595
30309
28004
30929
35370
32679
36095
9630
8897
9828
ratobjective
rt7
antirt7a
diallelic
rt7art7b
lew1w
rt1urt7a
1x108
rt1u
rt1l
rt1ul
rt7b
donorchimerism
bmseeded
immunemodulated
thrilling
lbc
nlbc
102175
alpharadioimmunotherapy
immunityalpharadioimmunotherapy
αrit
approachin
trendintroduction
purposely
continuative
innonsmallcell
transplantpurpose
4g1h
4g2h
29gvisit
p00211
85g
p00479
digit
dial
mbl2
responsehepatitis
hostviral
mannosebinding
mbl
ya
childrenintradermal
gemcitabineloaded
lncs
lauroylmodified
gemc12
gemc12loaded
fluorochromelabeled
gemc12lncs
monocytetargeting
escmid
evasg
eugms
waididrapid
surveyinfluenza
3224
youtype
cd4cd127locd25
magrit
nochemotherapy
nct00480025
13849
12820
38·1
27·948·4
39·5
27·950·4
60·5
57·2not
57·9
55·7not
1·02
0·891·18
p0·74
58·0
56·6not
56·9
44·4not
0·801·18
p0·76
strategyobjective
sclerosisbackground
copaxone®
miccop
111indiumlabelled
miccopinduced
protectionrecent
mucosaresident
antigenimmune
tumorforeign
pathogenimmune
permeating
idabucy2
15mgm2d
32mgkgd
18gm2d
527475
terminations
cpgpeanut
oralsublingual
cpgcoated
cpgpnnps
gavages
cpgpnnp
igeigg1
nanoparticletreated
strategyfor
38months
scfvfcs
aureusbackground
tg1
17×107
scfvfragment
dh5α
32°c
10mmoll
15iodonaphthyl
azideinactivated
v3526
inainactivate
inaiv3526
midlands
911am
35pm
astrain
309755566
bstrain
3422836
5243
14646
isrctn70898162
n604
or259
157424
110387
or298
124721
033096
amur
regionaim
organiza
flood
pneu
mococcal
ness
riod
ofpneumonia
ofcourses
ofparents
rhinitisin
dbpcrcts
modulability
healththis
airlines
marketbased
liabilitybased
authorityespecially
clauseto
administrationtumor
absorbent
e4g10
αparticleemitting
ace4g10
radioimmunoconstruct
nestintumor
ntva
zoledronateactivated
zak
alachuas
nonvfc
4704
inkind
countyspecific
n12853
prekindergarten
13815
8042
1495dose
793dose
24221
kiovig®
disordersintravenous
baxalta
kiovig
422630
527787
strategieshand
336979
±225866
722372
±150562
immigrationrecolonization
highprevalence
programsvaricella
exanthematic
diseaseadoptive
hladr4
posttransfer
ofno
vectorcxcr4
plvcxcr4puro
1a4
igg1a
39kda
vaccinationsince
20089
typesubtypespecific
3152
300651
181152
379679
348621
513824
574608
malignanciescoexisting
marrowmixed
experienceduring
irr24
irr83
51135
ah1n1pdm09related
bcgvaccination
2133
asq
34534262
perevent
costliest
australiafrance
germanyitaly
neutropenialeukopenia
australiagermanyitalyfrance
dossiers
newspapersin
newsstand
promiscuity
rubellacontainingvaccine
eliminationfew
reviewnasopharyngeal
somber
kindled
unreasonable
therapytargeting
antib7h3
b7h3biab
b7h3biarmed
fluorinesubstituted
immunopotentiators
vivoherein
dentritic
rhinitisif
msltreferral
mean19years
caseonly
401702
adhd
343699
statuswith
t‑lymphocyte
tour
dcis
linkedtrastuzumab
iduc
alphaemitter
225actrastuzumab
sum225
conferencethe
eati
16–19
networkallogeneic
gmm2
47months
day28
areassociated
bloodallogeneic
ducb
615mm3
day42
395mm3
flavopiridol
chemoimmunotherapypatients
30mgm2
1cycle
2cycles
strategiesregistration
nct00377104
husshiga
hus
stx2b
antistx2b
antiseroalbumin
stx2toxicity
intragastrical
memoryderived
nhlmyeloablative
intermediategrade
memoryenriched
safetyfeasibility
nhl1
nhl2
tcmderived
cd19rζ
1684
cd19r28ζ
3597
nct01318317
nct01815749
europeaims
post2011
othermultiple
atractylenolide
md2tlr4
tlr4md2
myd88dependent
ao1
sesquiterpene
lactone
md2
lkynurenine
ldhcytotoxicity
sarcoidosissarcoidosis
stave
prothrombotic
erythromatosus
aplmediated
semeii
kazakhstanthe
vaccinecontrollable
ofimmunization
ofpopulation
oblast
ofcity
polyclinic
abaiiskii
ofkazakhs
russians
ofother
themfrom
enouzh
exclusivity
patentsdosage
applicant
prosecution
erodes
unsuccesful
1418yearold
crossreactivetype
313345
n275
n282
052099
002016
049102
042096
201001862119
workimmunotherapy
bucking
panbcelldepletion
panb
tumorcontrol
responsemetastasis
evidencebasedthe
epidemiologywellknown
betweenness
circumvents
genotypephenotype
micrometastasisin
metagenes
neurologyrandomized
encephalopathyautoimmune
nonorganspecific
neuropsychologic
antibodydepleting
anna1
autoleukocytes
ua97493
30pgml
centrifuging
autoleukocyte
hepatitismore
childrenlongitudinal
psensitized
36month
sigesigg4
immunotherapyemerging
r01ca136551
bezos
smallbowel
dsaassociated
hypoganglionosis
232cm
procedurematched
igg400mgdl
400mgdl
0741
liversmall
bowelkidney
282687
hyperimmunoglobulin
of400mgdl
germanybexsero
oneoff
8461
9696
educationsocioeconomic
outofhospital
levellow
populationwe
melanomaepigenetic
writers
erasers
costimulatoryaccessory
methyltransferases
dnmts
antagomirs
nfkbinduced
englandbackground
8495
20500
£73
£94
£15
£75
£16865
£12209£25976
1110
dtppenta
lbs2
2dependent
responseinflammatory
mtcc5953
probioticfed
lbs2treated
4126
turgut
ozal
parashar
us1
18turkish
liras
210994
42715
us17909
us1433
us315
us37878
us45475
idopositive
th2dominant
immunotherapyunlabelled
70313
successbackground
il10foxp3
studyreducedintensity
cyclophosphamidefludarabineantithymocyte
cyfluatg
busulfanfludarabineantithymocyte
150mgm2
menhuman
ratesachieving
13question
childrenthis
bmd
38174yr
12mo
6mo
vaccinationmany
inseason
israelobjective
315400000
22700000
292700000
234394
nodebased
worldearly
recalculate
20002013background
pcvassociated
1598
1346
6584
2000july
62140
61161
metaanalysisallogenic
ursa
vaccinationcontext
88646
surveylinked
vaccineera
quilaadjuvanted
84·2
94·7
extractive
mechanismscalf
csei
76±152mgμg
ɑ1
bodyweights
upgraded
ifnɑ
tnfɑ
ikkβ
2013adverse
1495
celltransplant
onresistant
emergencebackground
outcomesof
45day
fluoroquinoloneresistant
120980
20012004
009055
102788
statusintroduction
differenceindifferenceindifference
nonmedicaid
431331
conditioningthe
32m19f
nonmalignancies
1was
stemcells
gpc3in
immunityenhanced
cancersurgical
assessmentin
111524
subclade
6b1
th1th17driven
geneticgenomic
participationbackground
truman
1426y
n1123
07012006
1012009
07012013
hr298
ci245361
hr294
ci209414
hr315
ci221448
21y
18times
painpurpose
diseasewhile
microgliaincluding
trem2
grn
il1rapalter
receptorfacilitated
glia
20166417101732
immunotherapysoluble
biomaterialsbased
neuroblastomaa
vico
ontologybased
formsbackground
obo
foundry
ontologies
ontologically
costco
usages
vo
axioms
glues
schemas
dlquery
sparql
consents
syndrometransplantation
doubleucb
ucbs
singleucb
nct01067300
mogspecific
bcrsobjective
dtmog
liter
mogreactive
61min
ld50176mgkg
nephrologistshemophagocytic
hyperferritinemia
lfts
gapa
hiv1c
gagrttatnef
gp150
rerandomized
gp140mf59
nct00574600
nct01423825
n63
studytwenty
cadesi4
dematophagoides
606±271
17107
374±360
n15724
n9969
n5755
challengesthis
prope
hepatitisrelated
assault
selffulfillment
12841294
populationinfections
physiciansimmunosuppression
recognitionrejection
halfcentury
perspectivethis
expounds
intracellularnuclear
conditioningpatients
clpop
clpred
850lh
aucpred
hml
programmeaustralia
9498
casesmillion
20002002
cyc
bvas
aberration
geneobjective
4961
285147
108kg
285779
interleukin15ag85b
cancermycobacterium
neutrophlis
bcgil15
rbcgag85b
sixweekold
bcgbil15
acceptancepurpose
eltrapuldencelt
metastasishepatic
cyp4b1
4ipomeanol
therapiesengineering
selfinactivating
erlocated
u3
cd271
divergently
datingobjective
nonglycerin
systemswide
allergyspecific
cytidyl
guanosyl
and12
statesevery
interdependently
dilutes
28th38th
n326
actrn12613001045707
anemiathe
toxicityfludarabine
studieshematopoietic
atgconditioning
days987
and6
days543
and2
days32
and7
40mgm2
days6543
thawed
postthaw
mathematics
studysublingual
subcutaneus
slge
immunotherapyfew
13164
085820193
2013january
implementedbackground
syria
01112013
rcs
31012014
33874
19rcs
elevenrcs
wellwell
vague
288±
apositive
agerman
apapinduced
sexdetermining
sry
apapalone
acidrich
miscellaneous
methodologyobjective
volunteersexperiment
predilution
10244649
2339
4717
3209
reportingmeasure
1immunization
implicationsvaccinepreventable
anesthesiarelated
aerosols
neogenesis
centralmemory
graftshaploidentical
10±4
32±6
52±6
hdmonly
6098
91100
bendamustinehdm
synbiotics
yelavd
kongyellow
trinidad
westerncentral
0513
77000200000
threeboosterdoses
224230
94419904
5391
124230
47246048
14002
887461
46446
8731523
2175230
or3875
16239254
95ci151617
backborn
pertussisdespite
mcpi
1033
20082011this
researchhlag
tumorescape
printed
39155
beyonddendritic
controling
fuel
killingobjective
immortalizes
ctlsadoptive
tictls
stictls
regresses
tictl
lineagespecific
relational
susceptibleinfectedsusceptible
neighbours
scalefree
erdösrényi
neurodermatitis
responsesin
unlipidated
omp
uomp19
apcderived
microsome
lamp2
cd11ccd8α
leptomeninges
subarachnoid
cnsleptomeningeal
elotuzumabobjective
humaxcd38
antics1
silvia
formenti
desirability
nct01761799
interleukin12fasti
therapywhereas
proteinmil12fasti
pmil12fasti
allohsctthe
immunosupressant
nondli
p0104
511±57
492±53
273±44
297±53
deliverymetastatic
allohsctcyclophosphamide
vaccinespassive
selfimmune
fccomplement
formalinsterilized
rheumaticabackground
aching
polymyalgic
acreular
candidatesbackground
phosphoepitope
svm
traf3ip3
hladrcd38cd4
refugeesthe
aiders
practitionersfamily
gpfps
recommendedmandated
kabb
discussionconclusions
20022013objective
20022013
decile
vaccinesstrong
adolescenttargeted
4559
theoryintroduction
nonmigrant
nonmigrants
hukou
pmt
responseefficacy
noninsured
mattered
middlenear
hainan
innovatorearly
laggards
laggard
munich
20062011
36363
541322
39414
receptorbound
αcd40
αlox1
αdectin1
statustb
syndecan1
tumourswe
ccd138
nongerminal
leukemiaunlabelled
ctl019treated
sgp130
sil6r
66479
rouce
heslop
579this
microfractional
vaccinationskin
epd
microchannel
vaccinecoated
vaccineadjuvantinduced
injectionassociated
polyεcaprolactonechitosan
vaccinationseveral
biopolymer
mucoadhesivity
controlticks
parasitiformes
ixodida
efficacymessenger
vaccinologistsvaccination
cheapest
hear
responsestherapeutic
hpv16slps
install
hpv16slp
e6e7positive
tc1bearing
ndcs
buffy
vemurafenibtreated
gravisbackground
spmg
mgwho
3971
csr
2667
2754
osserman
alltime
yanbien
goodnessoffit
121978
cdextran
teroidfree
issuecontroversy
vigilantly
vibriosis
knowledgethe
cwv
aliivibrio
abbreviation
anationwide
dwellings
astandardized
123heads
astronger
adecentralized
afocus
aregular
20042014background
casecharacteristics
atotal
rotavirusgastroenteritis
seekersthe
aconcept
2256
pepims
sixhour
ig75
cg81
hippocampusopioid
opiateimmune
nonconditioning
heroins
rechallengealopecia
basophilsbackground
cd193
subthreshold
327815
163844
231669
163581
117331
197403
228390
160277
dressed
impress
prospectswhen
vaccinationsbetween
coerciondynamically
marburgvirus
challengesmarburg
marv
filovirus
bioweapon
vp40
marburgviruses
onlyvaccinated
vlpvaccinated
dendritictumor
tim3pd1
tim3tim3l
exhaustiondysfunction
aaurora
aurka
centrosomal
aurka220228
nonapeptide
h2kb
aurkaspecific
immunityonly
cd3cd25
antigensdevelopment
ligationindependent
balbcj
pymdh
1424y
caserta
hcvpositive
00041
hcvrelated
znt8
282290
nonβ
βhydroxylase
233241
dβh
preventionamerican
cellcentered
tumourspecificitychimaeric
cartcellmediated
embellishments
ontargetofftumour
therapychimaeric
cd19cancers
behaveinvivoand
selectins
cd8tlymphocytes
homingassociated
machinerychimaeric
bcl2like
bclw
ovariesfallopian
epithelialspecific
cancersuccessful
miteallergic
infantsvaccines
or1828
ci125268
fdr004
or1387
ci10681801
or0502
ci029086
fdr014
titerbackground
dnapositive
reinfects
3274
postadolescent
cityasylum
healthoutcomes
halle
hopkinssymptomchecklist25
suicidal
orthopaedics
patchtest
hexahydrate
petrolatum
editinginvestigations
biosensors
therapysince
365000
therapyhas
bcatenin
100721
cd3cd56cd19
cd34cd133
hematoprogenitor
vaccinefootandmouth
16145
tweak
radiolytic
sjhmc
perspectiveshemopoietic
mudmatching
125257
172384
7421845
positivecytogenetics
negativecytogenetics
midpositive
celltransplantation
hodgkinlymphomaforty
gemcitabinefludarabinemelphalan
remissioncomplete
brentuximabtreated
brentuximabnaive
onion
allium
cepa
agglutininbackground
immuneboosting
prasanna
venkatesh
immunopharmacol
304313
100μgkginduced
environmentdependent
metastability
67758
1999december
0075
13±26
9516
peanutallergenspecific
epitinduced
slitinduced
lymphomawith
killercells
alumnae
sd502
alphaimmunotherapy
astatineagent
bondsthe
deastatination
atinvolving
enthalpies
relativistic
atb
astatine
stabilities
rationalizing
newpatients
amyloidβderived
cyclopeptide
amyloidβinduced
aβ142induced
basalis
meynert
nbm
acetyltransferasestained
origination
neocortex
r2029
1851
toxinassociated
conjugatesthat
futureimmunocytokines
drugeffect
cancermicrosatellite
misincorporations
slippage
cterminally
ratsstoke
βarrestin2
mcao
6hydroxydopamine
6ohda
70t
micromri
longa
snsinhibitor
snsβarrestin2nfκb
futurefood
hydrolysed
hyde
forwardtwo
referrallevel
itemized
4300
19972011
328688
336870
56949
wellnourished
childrenp
133820
3263
anydose
84p
togotogo
6451223
68187
byinternational
revisioncodes
a00a05
a060a063
a069
a070a072
a079
a08a09
20062008
449654
398494
flattening
autumnwinter
pharmacotherapybackground
leuven
sport
tns
nonit
approachessuch
blockadeto
sellers
customersthe
deliberating
luring
discredit
reiteration
transaction
polemics
ha2m2e
abrisbane592007like
abrisbane102007
m2eha2
bbs
aceis
15dose
acei
4565
4286
3143
insular
cingulate
callosum
5429
patients1429
patients4286
patient290
retrial
rhf
citsequences
igaacpa
citpeptidesproteins
scores28
cd19cellsμl
r2075
znormalised
zscores1
citantigen
5168
4851
prerelapse
iggacpa
citepitopes
citantigens
suds
sud
scleritis
prospectsscleritis
umccc
multistepped
cpt4
umhs
35403
40973
nearuniversal
rolledout
programmatically
cydtetravalent
vpdi
2639
vpdis
nnvs
hibconjugate
doh2711061520
persistencepurpose
platformposttransplant
physicianguided
parabolic
algebraic
tacrolimusthe
efficacyto
ppdoptimized
troughlevel
18question
gregorio
marañon
0·007
status80
vaccinationlifetime
450000
145000
token
tsunami
20152015
therapytumorinfiltrating
immunitysuccessful
fadd
ripk3
fadddependent
faddindependent
overviewdespite
2352
3395
024m
0307
0636
00093
cd45r
iba1
epiphenomenon
loreto
peruchau
cuica
mebendazole
loretos
ascaris
lumbricoides
sth
cents
inductionto
conformationsensitive
epidemicswe
nashequilibria
radon
recipientsvaccination
reliefallergen
opticaigg
vaccinationshuman
nmoigg
gtkohcd46htbm
pigtoprimate
xenograftpreventing
galactosyltransferase
cd46
localizationantitumor
pka
ezrin
disruptor
riad
carriad
54151
multifiliisthe
il1βa
il1βb
patientsconventional
modelrealtime
migrantsproviding
localborn
generationlg
fgm
2682
lg
2338
chinahepatitis
historyno
noneed
infectionsadoptive
ebvlymphomas
5076
90yibritumomabtiuxetan
90yit
pregnancyin
ah1n1v
familiespurpose
withinfamily
vaginitis
44month
allergicimmunological
950months
vestibulitis
nonreflux
migraines
nonmigrainous
pruritusirritation
pdrbackground
laopdr
8°c
occ
postpilot
prepilot
outcomesbusulfan
bucye
havebeen
31258
vaccineshow
pneumoniathe
mediaacute
apparition
mitesinduced
63there
syptom
tmss
implicationsfood
foodstwo
colorectalcancer
cancerhas
alc42
300×106l
36years
bilosomes
opportunitiesoral
receptorigg
servicesmanaged
reimbursable
derisking
institutewith
il1dependent
macaquechorioamnionitis
firs
lpsexposed
il17foxp3
rorchigh
helioslow
modeladoptive
compassion
20072012background
vea1ora
9663
5600
7850
transplantationinconsistent
145996
107657
therapydcderived
dexbased
cp151108f36st11cc11
antifviii
ainflammatory
antifactor
rhfviii
rhfviiispecific
fviiistimulated
influenzastimulated
osteoclastexpanded
micebased
41bbtargeted
p0934
p0525
crgpr
93p0011
treatment4
186p0736
465p0519
488p0003
apgar
pregnancydays
2984
1288
optimises
immunotherapiescellular
hsvtk
productwe
trp2transduced
cd11ccd8a
relinquishes
authorizationregulatory
alvac
gp145
truncations
pseudovirus
ainsect
culicoidesrich
intralymphatically
nubeculosus
alummpla
rallergens
livestockbrucellosis
comingling
brucellainfected
reformulations
1494767
stilleligible
crossgender
erythematosusintroduction
moleculespurpose
tropomyosins
metapenaeus
ensis
shrimpsensitized
eggsensitized
glycatedovalbumin
biomarkersat
aβpet
apoerelated
biogen
therapeuticinduced
swan
song
571907
pneumovax®23protective
pnpsbased
pneumovax®23
pnpsspecific
cancersneuroblastoma
highlevels
vaccinationdiversity
vzvreactive
singlebooster
poplar
lotquality
serospecific
2654
epidemiologicallyrelevant
smallarea
microorganismslive
macroorganisms
prearations
geni
lymphomatreated
chemoimmunotherapyunassigned
doxorubicine
prednisolon
sch
129383
197584
rchxrt
schxrt
vs13
hopelung
cancercolon
immuneresistance
overheads
vicniss
78885
individualsobjective
rarelated
periodontium
ctd
ctdassociated
raild
iimild
benefitsnew
bro
xpvbased
brazilcrack
superaccelerated
intreatment
improvised
pipe
moneydrugs
321370
p69
nct01663636
mycoflex®
pcg
endotracheally
lymphohistiocytic
10294
10276
10323
tenacity
lanzhou
lymphocyteslanzhou
llrimmunized
llrunimmunized
intraperitonea
miceorigin
edim
fecalserum
ifnτ
aureusinduced
pneumoniastaphylococcus
unitchildren
aprn
aprnled
aβactive
pnvx
hzvx
cellssingle
spectrallydistinct
transcriptionallyactive
antitnfr2
techniquerecent
causationpurpose
bace
inhibitorsalzheimers
selfassociates
secretase
βsite
precursorcleaving
verubecestat
mk8931
reservoirspurpose
penetrability
noncd4
antip19
antiinterleukin17a
vaccinationvaccination
salivabased
childrenwe
f17pre
8yearolds
f17
juniors
6410
fivedimensional
2level
policyprogram
travellersbackground
nathnac
advisers
4910
enquires
backchimeric
experiencemyelofibrosis
hematopoesis
fibrosing
6358
p08097
dipss
vaccinationwhile
papillomavirusexpressing
tumorunrelated
292131
201415background
siss
cyceva
3c3a
19902014hepatitis
7167128
4109
calais
weeklong
andcancerimmunotherapythe
infectionmost
10·2fold
277s
20152022
relateddonor
luences
0597
0668
virusdna
pss898
ul24
tgb
duil2
ducklings
s739
δasd66
δcrp24
δcya25
ul24ltb
primingboost
ducks
dve
mathfree
hows
50ml
targetallergen
rwandaobjective
alpha05
strengtheningbackground
visibly
±56
salaries
problemfocused
medicineduring
experiencehematopoietic
sca
rambam
the38
6second
3240
5×109l
153days
20×109l
223days
905±53
817±68
unresponsivenessbackground
ovmspecific
igeovm
igeew
igg4igeovm
igg4ew
igaew
iga2ew
igg4ige
igaige
iga2ige
osteoprotegerinamong
fewest
hemotological
cooperations
neurobiology
antibioticassociated
4075
0730
07180
030180
doseadjuvant
antigenaloh
ggrippenetbackground
ggrippenet
httpswwwgrippenetfr
personweek
14120
30171
cor
2015lung
tslpox40l
enzymelabeled
12300
13100
cd11ccd86
9946
immunotherapyresearchers
angioproliferations
kshv
82mm3
200mm3
cancerγδ
homeostasisinterleukin2
slitindications
allergyslit
50100
vitur
vitsars
vitsar
antigenspecificmediated
soti
leukemiarecent
cpc
twohundredandone
growthfas
cd95l
40kda
paraphrase
exaggeration
miceadoptive
melanomainduced
b16gp33
kinetically
nonexpanded
statementimmunisation
womenusing
47895
n54079
or045
042048
nonvirgins
066083
or062
056067
or083
079088
or086
scandinavia
profilingmore
oncologistunlabelled
poked
vaccinateormask
thp
incentivesbased
thps
fluprevention
antibodiesseveral
mabopsonized
chinat
assiduous
cellsanticd19
leukemiakilling
cart19induced
19932014background
sgene
homosexualbisexual
rightcontroversy
ppv23induced
conjugatepolysaccharide
indiasome
indiaa
100000year
117fold
npcassociated
lyticcycle
tpabutyric
lcls
dxlcl
dxlcls
upgradable
43140
curriculumdespite
teacherdelivered
richmond
chemotherapysignificantly
safetybenefits
clinicalhormonal
cooling
allostemcelltransplantation
intraumbilical
primordial
folliclesmm2
dpait
nct02123316
pangramin
aitdp
practiceimmunization
literaturebackgroundaims
casestudy
compendiumthe
afp158166
lymphocytesprofessional
generators
ba15
afp158166hlaa0201
mdscexposed
mammalianmechanistic
complex2
decrescendo
nct00937625
il2related
tilact
2215
373445
immunotherapeuticsaccumulated
rotaviral
rotaviruses
diarrhoearelated
strategydue
panjgur
headfathers
bhu
householdsparents
spss16
rubellashould
programmesrubella
menace
antiigeassisted
engineeringmonoclonal
crossisotypes
compensationuptake
unanimous
discoverymay
historian
savants
amazingly
responseb7h3
sb7h3
larginineinduced
acinar
girlsbackgroundobjective
1317y
1112y
publicationsbackground
observance
hygienic
allergybaked
multigenerational
380973
135902
188511
790daly
444daly
outcomesreply
completionbackground
4022
postestimation
1086
7331440
autografts
pressurewe
fullthickness
minipig
nonpressurized
pressurized
microcirculation
fullfield
speckle
azan
elastica
gieson
elastin
mater
appl
biomater
105b
10911101
virginiabackground
allgirls
thehuman
october2008
whoinvited
50item
pierce
064085
062081
117155
122158
airports
2102
nontravellers
2531
soontobe
recognizable
sourcerecently
challengesuveal
patchassisted
antibodydespite
selfdegradable
gox
gluconic
selfdissociation
stonealthough
thalassemiathalassemia
immunocompetency
greecestudents
2119
nowpneumococcus
pneumococcalconjugate
rolled
prospectsrecent
cartcellbased
chemotherapyto
touchingadoptive
antigenselective
ydotarituximabobjective
crossfire
pisothiocyanatobenzyl
pscnbndota
radiolabelling
radioassay
spectroscopic
rcp
ydotarituximab
uitability
killingthe
seaso
nable
vigo
pspp
sexand
lastseason
activationmigration
monocytesvisceral
sandfly
leishmune®
cd29
cd49f
ingermany
20092014objectives
852879
879976
73734
970976
978999
857948
817869
antibodiesbased
diseasemonoclonal
heatrelated
vaccinationproximate
vaccinationdistant
scn1a
mtorinhibitors
inhibitorconversion
nonconversion
394±043
logml
249±019
319±020
290±020
mtorinhibitorbased
salarinfectious
orthomyxovirus
hemagglutininesterase
highvirulence
mx
metastasesdelayed
vasculitic
appendicular
adxs31164
broke
438090
320524
432626
p0355
20152030
3046238
3787385
watertoperson
pdvac
79th
2015there
pakhtoon
khawa
pakistana
201531st
kohat
domel
bannu
hangoo
khinzir
spying
electrochemotherapy
immunotherapyantitumor
electrogenetherapy
therapiesevidence
affinitymatured
precultivation
puromycin
humanporcine
solium
pdrfollowing
anticysticercosis
tsol18
oxfendazole
volunteered
iichemotherapy
rwandabhutan
5th95th
gp5gp6
e7mpg
age16
pr012
003051
023090
pr068
045101
literaturewarts
vaporization
2015lumpy
limnos
vitrounlabelled
texpulsed
201664456472
80×10
groin
antiαβtcrcyclosporinea
14±52
10±27
8±07
80±182
64±274
30±47
88±34
86±34
37±132
47±27
flaps
microsurgery
36676683
antialzheimers
epitopesonly
fucosebased
crosslinkers
burgdorferi
infectionoral
ospb
bbk32
salp25
salp15
ixodes
scapularis
phyletic
engorged
nymphal
spirochete
borreliacidal
ospck
collagenous
patienttargeted
thickened
subepithelial
25µm
9mgday
cholestyramin
8gday
gp75
pyropheophorbidea
hitchhiking
lymphomanodal
nmzl
corepressors
hounds
shen
vsvmurine
ifnβsodium
symporter
vsvmifnβnis
microenvironmentcheckpoint
16839
multiaxial
secondhit
infectionspsychosocial
conditioningconditioningrelated
deltaalb
12±5
8±4gdl
belgiumbackground
hivbackground
hibcv
antihib
106fold
1matched
ratio×100
2991
86·0
75·5
92·3
85·6
70·6
93·5
96·5
82·7
79·5
30·3
94·8
65·6
44·9
78·7
60·2
46·8
70·3
81·4
45·4
85·8
91·9
vaccinoscopie©
klerksdorp
1442
2·0
1·33·2
1·22·7
1·6
1·12·4
0·3
0·10·8
20122013purpose
672monthold
onethousand
dialing
augustoctober
recontacted
β048
β035
β025
β057
β042
β036
titlesabstracts
petos
lt1
neurophysiology
04m
citric
025hdm
05hdm
pennocks
availableobjective
semiopragmatic
sifting
publicized
mythsbackground
recipientsposttransplant
bbc
sccbcc
197346
patientsyear
irr295
197442
irr281
11701
skinned
cancerisation
αtargeted
strategycancer
caftargeted
cleaving
postproline
αexpressing
managementprecision
decisionsproducts
singleplexed
gliomasbackground
wellcircumscribed
antigena2
carboxymethylcellulose
regimenlimiting
vaccinationherpes
zostervaricella
increasinghence
feasiblevaccination
gliomasafter
ul41deficient
strainunlabelled
ul41
ul41deleted
vr41
vr3
ultravioletirradiated
sinodutch
oncologyon
interleukin17associated
imagingguided
vaccinationantibody
antibodybound
signalspecific
governmentdeveloped
january2006
december2010
redcell
rechallengeimmunotherapy
hepatoxicity
metabolismcd8
acat1deficient
acat
sterols
attaches
hyp218
a431h9
hyp218ir700
jcm2
tbr
triplebody
33319
cellssimultaneous
escapethe
bmyeloid
bv173
arh77
cd19cd33
00048
19319
immuneintervention
patientsimportance
sotrs
nmscase
ase
subcategorized
154244
nsmcase
nonsotrs
200376
104290
104185
108194
27100000
28100000
51159
1438
0305
0207
nil
bellow
zincg
znd
pup
zeroth
zip2
zip8
n425
p058
hr097
hr144
hr14
p094
execute
rphs
sqstandardised
sq®
gps1
hrqol1
hrqol2
gps2
hrqol3
114±168
34±157
131±107
010±074
16±153
100±141
022±129
124±130
indolamine23dioxygenase
432840
yetlung
staffbackground
qms
fiqms
equated
bribery
workability
normalising
av7909
adultsav7909
biothrax®
biothrax
vacccinecontrolled
43242
01428
nf50
worldinvasive
speciesisolates
weeks84
10609
days87
2445
highreliability
antiandrogens
immunecheckpointblocking
armoured
387903
127945
756983
830997
longliving
subdivide
200912background
freeofcost
statebystate
dhsnfhs
200912
rajasthan
madhya
orissa
assam
studyhematopoietic
clad
suberoylanilide
hydroxamic
j4501
ic510
cladgembu
cladgembusaha
atmchk2
zvadfmk
2ax
caspases
β16poly13dglucopyranosylpolyβ13dglucopyranose
pggbound
of10
complementactivating
mapkinase
iiiiii
swedenbackground
56th
19931998
4984
webpage
letterinvitations
melanomasmelanoma
breslow
2mm
177ludotarituximab
ludotarituximab
50mci
1850mbq
olinda
52±13
100±28h
42126h
013±002
015±003
022±004mgymbq
adultsmyeloablative
lymphohistiocystosisxlinked
hlhxlp
metabolicgenetic
heightadjusted
haz
bmiz
evbased
immunotherapyworldwide
therapymesothelin
cytomegalovirustargeted
hopemalignant
nowduring
diseaseinducing
uveitic
postlicensurethe
massimmunization
feedbacks
multitype
interstrain
hemorrhageinduced
tlr4nfb
pathwayinflammation
sah
cisterna
sahinduced
tregafforded
tlr4nfκb
postsah
antiinterleukin6
carcinomacurrent
proliferativeantiapoptotic
mastectomy
tumournormal
necrosisrelated
dctumor
nonfused
electrofusion
cd11cher2neu
twist
poliothe
peginterferon
cxcr5cd4
quantibody
cd19cd38
pegifnribavirin
lineageassociated
edirne
turkeybrucellosis
thrace
biospeedy
dnatricky
bioeksen
cycler
mannheim
evagreen
premix
lightcycler
nanosoftware
qpcrbased
terminator
biosystems
truepositive
homesinfluenza
marriagecd13741bb
cd137positive
fittest
attains
transplantgraftversushost
nortx
p0147
p0141
5283
acw135y
1150
recreation
hotels
trialsdespite
2mgkgday
higherdose
bt563
cd5specific
myelofibrosisallogeneic
p068
copies104
abelson
wt1180
wt1100
preventioncurrent
bladderbackground
decompression
spastic
intervertebral
th11th12
plaster
corset
icd11allergy
icd11
mismatchedunrelated
devascularization
atid
devascularized
therefrom
prospectschimeric
13day
caregfr
097×107
109×107
pregnancyaprospective
womenan
wastaken
wascollected
4180
556vs
fhaantibody
thenewborn
daughtersbackground
roster
applicationtumor
ligand1programmed
multipractice
groupobjective
3916
20066
20235
studiespotential
nondose
oversimplistic
adenovirusifnα
chemotherapypurpose
adifn
biocorrelates
chemoimmunogene
3791800
elderlyelderly
tetanusdiphtheriapoliomyelitis
virusesrecently
teem
stimulusresponsive
erase
cellhidden
learntmeasles
bulgarian
24364
12630
1769
5518
disentangling
responsivenesscorrelative
typifies
immunefavorable
th2polarized
allergendependent
hhistamine4receptor
gd2mimicking
ganglidiximab
neuroblastomavaccination
ganglidiomab
ganglidiomabproducing
nk92tr
scfvch1418zeta
paratope
gws
podophyllotoxin
redemptions
eapc
irwomen
to512
irmen
agws
hsu
123247
51436
20062010objective
nonproject
3390
3299
3389
knowledgestrengthening
servicestrengthening
dualparental
outmigration
christus
considerationst
dozens
uptakehigher
varicellarelated
httpappswhointimmunizationmonitoringglobalsummaryschedules
prepostvaccination
6095
singlebead
at1
densensitization
unforeseen
gppharmacy
pollinosisunlabelled
ageor
diphenylcyclopropenoneinduced
vitiligotopical
dpcpinduced
redirectionto
conjugatebased
adcetris®
kadcyla®
adotrastuzumab
nanobodyfc
hominisdeveloping
singlegene
trichomonas
abctransporter
substratebinding
fcfragment
amhfc
19962010
20002010
46195
56235
31238
1800080000
49000
1100097000
105000
54000158000
119000
72000169000
43item
c17
centerwide
4programs
sm3
sm3car
psm3car
09128
chtnt3cpg
modelscpg
chtnt3
chtnt3cpgtreated
26bearing
b16bearing
4207e10
0651
2immunization
therapiesresearchers
theyve
cellsand
subsetsensures
minuscule
ponencia
programa
registro
vacunaciones
interterritorial
efficacyintroduction
individudalizing
interestimportance
infectionpossible
2146
1380
competencybasedcurriculum
lmu
munichbackground
ludwigmaximiliansuniversity
competencybased
nationaler
kompetenzbasierter
lernzielekatalog
medizin
nklm
17360
11540
451ci393511
46395
365558
39967173
53061115
or170ci106274
p0002or504
impactsbackground
n173
uspstf
540606
487607
381604
tdaptd
288607
377604
263605
492514
329496
meqnull
mdmareks
gx0101
meq
sc91
cvi988rispens
creloxp
sc92
sc91inoculated
rmd5
aidsbackground
voiced
vaccinationmediated
approachesinnate
deviceunlabelled
microdevices
sharpslender
projectionsmicroneedles
nanoindentation
microprobes
micrometre
025175mn
nanoindenter
silicon
110μm
10μm
instron
rows
cryoscanning
visualise
semiimplantable
knowpatients
pathologiespassive
taups2app
amyloidβ40
phosphotau
slittabletsbackground
wholemite
immunoelectrophoresis
centaur
empai
20082013background
privatelyfunded
ci164188
301394
nonfirst
178294
18361016
qconmbbc
qc78
on80
mb64
bc69
regionallevel
reviewthere
cyclosporineassociated
ah1n1pdm2009
vaccinationunderstanding
multichromatic
nssn
hai40
000002
00000004
nonprotection
sheddingbackground
n592
tumourrestricted
antigenstargets
reasonsmm
betterunderstanding
angiographically
immunesuppressant
havhbv
firstcontact
personalities
underutilisation
wisconsin
6975
mammography
extraversion
improvepurpose
lowsocioeconomic
sminduced
smmediated
multidatabase
mustardinduced
isabr
approachconventional
proteincontaining
10a
36r
acetone
precipitations
leningrad3
vaccinated18
adoptivecelltherapybased
20002011
therapeuticshdac
indexcomparisons
tdep
nontdep
mdsthe
40mgm2day
catsbackground
azotemic
annualfrequent
1831764
1383
2019499
43128973
344480
nonallergists
0510
immunotherapygliomas
circumvention
organizationobjective
proactivity
lom
offspringthe
4959
exacerbationsbackground
asymptomatically
dnainorganic
dinucleotidecontaining
confronts
biostability
leaking
hnvs
concatemer
mg2ppi
fluorophorelabeled
splenomegaly
wants
defiance
donorsbackground
spk
fujita
kapurs
troppmanns
selfplacebocontrolled
pteronyssinusinduced
nct01795846
vasculitisobjective
miscommunication
capn5
trex1
tnfaip3
immumodulatory
muromonabcd3
diseaselike
miceactive
6aβ15t
anti6aβ15t
aβ115
dynamin
oligomermediated
intrastructural
dnaviruslike
gagencoding
ish
invoking
dynamicsbackground
superposition
japanin
blockadetargeted
effectorphenotype
parkinsonismbackground
parkinsonismparkinson
mycophenylate
23mgkgday
nonanonymized
4975years
msa2
psp1
psp3
nonmotor
encephalitisabstract
fapexpressing
taspecific
adenoviralvector
fapstromal
foodtriggered
2013since
1214years
abnegative
tle
therapybacteriamediated
reconciling
vectorial
ebvlmp2aspecific
ebvint
ebvints
implementationhepatitis
5964
3140
postepi
preepi
osteosarcomaosteosarcoma
apres
eurosurveillance
thethe
7269
3309
3960
treatmentjuvenile
myelodysplasticmyeloproliferative
ptpn11
alterationspecific
anemiaidiopathic
proteindeficient
allelelacking
6pupd
facilitythe
nonili
ratio037
ci012
nanovaccination
antigenstotal
dslp
dslpultradeformable
dslpuda
dslpudl
tpl
proteinlipid
kpa
igga2
al2o3
mmtv
cancersmouse
mmtvassociated
mmtvp14
ectopically
antisignal
antip14
backlash
histopathologists
reaffirmed
offense
immunopositivity
melanomapsychological
oncomedical
anhedonia
slowness
depressogenic
premelanoma
psychotherapeutic
psychologist
easiest
multidisciplinarity
physiotherapists
dieticians
psychiatristspsychologists
pointsworld
15y
immunebridging
ain2
calcifediol
ploypeptide
proder
hydrolytic
oh3
caged
sscc
histo
absently
pbschallenged
blaf
23161
20620
20044
29968
36187
1362
37627
2057
41357
17128
14212
12827
13079
27359
22960
26913
1198
28225
14776
21854
1262
22021
20159
25686
36045
38341
41351±1314
17350
15423
13772
14101
29755
24322
27520
28467
15454
1745
30966
25661
24883
35960
pteronysinus
agereaction
theefficacy
completionvaccination
n36223
150years
nonrespondersobjective
91103
8491
lexingtonfayette
usadata
transgendered
chickenpoxvaricella
tnfsuperfamily
tiii
ppsresponse
pneumovax
scd27
calciummodulator
cytophilin
cd21
pps23f
ppsspecific
staci
nct02515240
individualising
rationalising
nct00471081
nct00718666
ratesstate
20002005
tumorexpressing
immunotherapyadaptive
biomolecule
interstitium
lymphaticmediated
crm197glycoconjugate
202020
mf59®
nct01150123
salary
leones
104131
117302
colitisinduced
cd4cd45rbhit
intorag1c57bl6
th1m1
th2m2prone
foxp3itreg
c57bl6rag1mice
m2a
directionally
itregth17
significanceinflammatory
tlgl
lgl
cd3cd57
hypocellularity
hypoplasia
coursemodified
substancespecific
actionwith
kknms
therapymethionine
chemotherapylung
14251
4512100kg
tbicyarac
bucyflu
bucyarac
cellstnc
3901971350×107kg
207040556×105kg
945946
818824
15153
ⅱⅳ
179186
ahighgrade
aclose
arteether
modelinoculation
artemisinin
mfq
pq
cpsart
cpsmfq
cpsaz
sprozoite
protectiondelay
obgynsbackground
acogs
toolkits
inextricable
dogmatic
dictatorial
totalitarian
99mtctilmanocept
tilmanocept
3×1011m
recycled
compilers
nondegraded
slns
chasm
neological
diseasecentered
lfqs
lfq1
lfq2
lfq
eggspecific
antigenintroduction
routs
forwardhigh
diseasepredicting
immunomodulative
gordan
lauc
2010in
651699
birthplaces
306475
47475
movers
nonmovers
088132
093292
059431
092178
079107
077207
0231214
casteethnic
dalit
fairlies
8047
7215
nepals
bottlefed
quarts
cfc
4mo
10mo
3mo
2mo
wcfed
cd4cd62lcd45ro
postwc
vaccinestherapeutic
tumoradjacent
completes
intersubject
cancerdefinitive
cd4il2
ptspecific
excipientsadjuvants
directionsfood
diseasesallergen
progressendometrial
panpi3k
noveltargeted
mdem
boythe
vaccinationinjected
chlamydophila
opportunitiesantibodies
chainlight
cdrh3
minidomain
protrudes
paratopes
recessed
concave
fcγriibmonoclonal
cd32b
20062014background
immari
macar
2006november
icd10ca
195270
528913
374100000
325430
19351
necatrix
homogeneitythe
lingnan
2010human
20072010
namcs
nhamcs
nonobgyns
colposcopy
rarelynever
rassf1a
reck
ala133ser
rs11788747polymorphisms
a1aser
serser
ser
or2057
or726
or1064
or1252
a1aa1agg
or011
or053
rassf1aala133ser
viruscrossreactive
instabilitya
mutagenic
314061415
310731081
pblderived
tcrgenemodified
cd8independently
tcrpeptide
2methods
138157
leukemiaadult
denintuzumab
n115963
groupd
192193
202202
167169
176178
184186
demarcation
travelerstravelers
predeparture
travelerś
tetanusdiphtheriawhooping
2378
scheduleobjective
broome
164304
introductionin
8191070
6771092
19248
29818
pcv7vaccinees
101092
31538
54481
2mgl
alemtuzumabbeam
catheterrelated
galleria
mellonella
pneumoniaethe
21phosphate
haemocyte
ceftazidime
presexual
postsexual
eggbased
chemotherapeutical
responsemost
vaccinationimproving
sheema
1354
10181802
ignorancedisinterestlaziness
twinrix
skaffs
pnaga
surfacecapsular
polyβ16linked
64cu177lulabeled
modelunlabelled
36915tetraazabicyclo931pentadeca1151113trience369triacetic
pcta
64cu
pscnbnpcta
64cucetuximab
177lucetuximab
177lulabeled
64cu177lupctacetuximab
preintensification
postintensification
micropapillary
nscl61
britsg3
u373
t98
a172
melk
fgk45
1673
2566
18013655
or1403
or1812
or2647
10yr
centerminimizing
prednisonecyclosporine
patienttransplant
cph
httpswebemmescomstudypedannlrept2010
isère
photographed
2588
pmi
maternelle
pmis
cattlefootandmouth
laronidase
hurler
wwwnicdacza
candidatefor
pde
13associated
7700mm3
3000mm3
thelpercell
stones
discharging
perinephric
palliatively
unhelpful
microcrystallinetyrosinebased
icpms
tilapiahypoxia
acclimatized
55±5
85±5do
riskgroups
£257771
£4910
£751
clinicin
tcellregulatory
malignancieseven
2016122165971
microanatomic
celladapted
jumonji
cdomain
jmjd6
inoculationa
jumonjic
hsindependent
a24fmdv
a24wt
jmjd6fmdv
e95ks96l
kge
iel
aerosolinfected
clathrincoated
challengeshighincome
resistencia
argentinaintroduction
chaco
348586
367398
771935
evangelical
2292801
00011
experiencemeningococcal
versionpatients
t‑helper
pr3specific
p‑selectin
ligand‑1
beta‑2
cd4nkg2d
nkcelllike
t‑celldirected
myelomareviewmultiple
bloodobjective
fouty
cd25cd4
blockerbased
conditioningdelayed
cgf
lowcelldose
haploidenticalautologous
1047months
developmentshead
20712
responsespolio
housetohouse
dosematched
140th
codisplay
alloantigentargeted
alloskin
bm1
cd196
micethat
lcspecific
lcetnbs
protein3α
lcbearing
poxvirusbased
micepoxvirusbased
ct26her2
mvabnher2
midlevels
treatmentresponsive
pdl1neglow
siblingthe
greaterbased
8511000
771913
718958
0067
designprimeboost
hivsiv
imagingphotoimmunotherapy
mabphotosensitizer
pertuzumabir700
nonexpressing
her2expressng
denmarkobjectives
alutard
acarizax
3094
3799
3697
6717
ns3ns4a
micetoday
hcv3a
pdisplayns3ns4a
th1th2th17
anticd8a
anticd3e
agammaglobulinemiaxlinked
hypergammaglobulinemia
20132014background
m06
m012
3d2d
97122
79101
6785
nct01381575
poorperforming
paralyzing
commodities
2013november
20022012
casecentered
vaccinationdeaths
homicides
suicides
coroners
nonexternal
038083
024080
056091
028065
maintenanceofcertification
requirementsbackground
ehrgenerated
662participant
8895
litle
carrierscat
instigation
selfdamage
cd3cd4cd25cd127
alls
972±379
705±174
marrowperipheral
r0474
dissected
mllball
malfunctiondendritic
microbeassociated
mamps
90°c
70°c
carton
2°c
antipneumoccal
14308
gog
perspectiveshaemophilus
saccharide
carbohydrateprotein
aminationsingle
lattice
amination
glycoimmunology
cervus
rb51
glycosyltransferase
yellowstone
longevitydeveloping
shortboosted
longboosted
il1rafc
cellstreg
arthrogenic
activationintroduction
hil1rafc
antiarthritic
hil1rafctreated
antiarthritis
curti
theirex
vivogmp
polylactide
envenomationscorpion
dllactide
surfactantfree
aahg50
aahg50pla
botg50
botg50pla
placontaining
2875
aahg50kg
detoxify
crossantigenicity
antiaahg50pla
antibotg50pla
llrm
meerut
mfcs
3177
5916
5596
spo2
3264
peruobjective
agerestrictions
modeltransforming
viruslikeparticle
lungtissue
gobletcell
elastance
selectionimmunosuppression
1224mo
22453
thestudy
nontripletherapy
tripletherapy
vaccinesvaginal
stimuliresponsive
hpv16l1
vaccinationc3
str
untransformed
photons
compliancea
658219
requirementsschoolentry
or149
109204
145293
22649
or230
165318
streptag
microbeaddriven
researchresearch
immunizationsvaccinations
nationassociated
navigators
galveston
155651
163361
204556
usd1239
usd28942808
usd29002947
usd15608
usd15590
physiciansobjective
n596
4184±780
170±78years
multiregression
productsfor
issuesrecent
signalblockade
velimogene
aliplasmid
allovectin7
20—
manggarai
sikka
doseus2
leash
leashing
immunotargets
cancerinnate
antiandrogen
hostsprinciples
leiomyositis
bernese
doga
turin
leiomyocytes
fibroplasia
ganglioneuritis
myenteric
auerbachs
idiopatic
pseudoobstruction
humanely
cancercurrent
possibilitiesprostate
221000
345000
72000
cd66
chemosensitiverelapsed
chemosensitiverefractory
radioimmunoconjugatesyttrium90
bexxar
uninvolved
bexxarbeam
rituximabbeam
practicevaccines
tperiodic
kronik
512e15482
michael
111244694478
diverges
2008may
2013dec
14650
3983
pneumoadip
muc1mbpbcg
vaccinemucin
muc1expression
toleranceobjective
cellfreebased
transplantationavailability
6159
crd42014006765
consort
quorum
sorrs
sor
4230
i235
nktcellbased
myelomanatural
glycosphingolipids
therapeuticschimeric
antigenrecognizing
vacciniaspecific
rgaviet
nam12032004
ss1dsfvpe38
cytoplasmicmembranous
414594
33130
29125
nonmfd
nonmfds
eyebackground
photos
extremal
0254
0431
hyperemia
antibodyrecruiting
psmabinding
24dinitrophenyl
9b
iodine125
tumortoblood
vaccinessuzanne
jarvis
papillomavirus1618
electrosurgical
singletime
infectionlevel
cytologichistologic
were54
interval1910
interval6941
infectionlesions
interval131
and211
interval2901
interval43
infectionslesions
betterbackground
c10000qualityadjusted
nhb
2535
310year
strategiesspecific
antitsol18
failurekidney
gliomasmalignant
dcv
tpdc
piperidinedione
tpdcprimed
8600
puglia
italypatients
1050times
icd9cm
comprehensiveness
42175
1742
2842
2242
malegaon
2462
2452
nominations
outgoing
ties
oslerian
3in
pcwg2
dualobjective
pcwg3
opticaneuromyelitis
expound
mechanismsnonhodgkin
goingmultiple
immunotherapypreviously
ulbp1
fasapo1
killerdr5
glue
2010objective
mapinfo
5775697
6204979
655370565
447889
201348
238398
237481
5291641
164436
restaurants
jinanobjective
balloting
ageurban
χ2test
χ217121
χ27679
6341
58122
175506
χ21157
322778
69201
060133
037096
sivδnef
vaccinationprevalent
sivmac239δnef
sivδnefinfected
sivmac239wt
sivδnefnegative
hsv2sivmac239wt
sivmac239wtonly
elbow
chlamydomonas
reinhardtii
chloroplasts
immunotherapiesconclusions
algaebased
chloroplast
chlamydomonasmade
60µg
biomass
algaemade
algaederived
80days
gear
carsin
immunitykawalekar
leds
photoimmunotherapynear
nirlight
mdamb468luc
laserlight
ir700fluorescence
ledlight
100mgm2
100mgm2d
30mgm2d
antithymoglobulins
25mgkgd
relapsedisease
arteritisobjective
gca
tak
lvv
immunosuppressivenaïve
absorbers
gadofosveset
gadopentetate
dimeglumine
bvalues
2001000
5001000
smm2
cd19cd3
chromosomenegative
μgm2day
pentosan
polysulfate
sp54
doublestep
belém
brazilin
n615
scored15
lesssevere
discoverybovine
vaccinecompatible
bloodtesting
skintesting
stagegating
agecell
makiyama
pilotobjective
panlondon
sonar
immform
boroughs
londonbased
pharmacyadministered
£235
a4galtdeficient
antisulfoglycolipid
gb3cd77
a4galt
gsls
globoseries
rccs
sulfoglycolipids
rccspecific
sm2
sm4
antisulfoglycolipids
rccderived
gsl
evidencetreatment
tnfs
ulocuplumab
nonsclc
eva71associated
noneva71
noncva16
tsir
twoserotype
2663
2713
3134
posteva71vaccination
undersampled
aegean
islandsthe
crete
crd42015017364
carotidfemoral
cfpwv
071197
055161
26ms
02ms
polyadenylicpolyuridylic
intraperitumoral
unc93b1
ifnβinducing
nanotrastuzumab
bcbm
cesium131131cs
radretumab
nanobioconjugates
nanotrastruzumab
mangalore
indiacervical
mapbackground
machakos
langata
njoro
stickers
00408
0516
futurechildren
parentscarers
overviewinnate
semispecific
20132014meningococcal
hivnegativenontested
diseasesin
gametheory
obtains
20122013introduction
9943
neighborhoodmatched
centralwestern
919961
966995
schoolkindergarten
diseasecd4
hajjobjective
facemasks
suffocation
immunal
thrombocytopeniaobjective
controls6266
6993
3908
7149
3925
3028
2590
hyperfunction
1890one
1804
buda
kassa
gyula
pozsony
zágráb
rókus
andrás
bossányi
ferenc
gebhardt
instructor
thursdays
sundays
ignác
gergely
patrubány
1874
lázár
wittman
géza
hainiss
1880s
dani
pécsis
béla
intzes
tirgu
lapus
1873
kreichel
nálepkovo
orrpfsos
41981
months168
27565
months153
ttitsequential
936457
158165406
7121
16686
p0636
p0522
406165158
favorableintermediatepoor
8510423
43120456
923927
32416561months
micepredominant
ub
ubiquitinproteasome
ubhbcag
lvubhbcag
hbcagspecific
hbcag
ruffling
virusvirus
orchard
sjkrecs
6300
1903
inspectorate
3·8
0·1
148000
110000201000
600012000
vaccineassociatedpoliomyelitis
vaccinederivedpoliovirus
poliorix
nct00937404
nct01021293
nct00920439
n541
n535
n470
nct01323647
formulationnorovirus
gelvac
gii4
gigii4
smv
1756
postsmv
presmv
trp53
hlhhemophagocytic
restraints
leishmaniasischronic
parasitespecific
antiil10
eczemabackground
concernour
sleeplessness
usedfor
lowfor
nonblinded
lowseven
18282
15210
90280
44204
moderateof
physicianrated
participantrated
measuresour
occasionscells
lim
cancercytokineinduced
2b4
faltering
reg1b
alpha1antitrypsin
nct01375647
underperformance
opp1017093
trialannual
556825
333667
40250
00333
effectsmyalgia
vulvavaginal
opportunityrare
histogenesis
stateincluding
chordomas
tumoursand
omicsbased
splintered
histomolecular
rescind
laiv83
iiv64
laiv0
iiv15
leif
11·68
18·53
29·30
51·98
lmajor
apha
suspending
gmil18
gmcsfdependent
mnsf60
dendrite
effusive
ct26gmil18
ct26gmcsf
ct26il18
micrometastasis
livermeta
viruseshighly
configured
achickengermany2014
achickenwest
javasubang292007
achickenegypt1212012
sf9
tripleclade
h555
onseta
espoused
regressiveonset
dptdtap
n2755
delayplusregression
disparitiesbackground
immunodeficiencycommon
aptly
cd21low
0742
0763
netherlandsin
obscures
hirschmans
loyalty
nonphospholipid
virosome
responsesunlabelled
transgenespecific
undepleted
envexpressing
humansprotective
paspecific
ava
4im
5im
7im
8sq
8im
7r2
086p
nct00119067
5arm
201100039361
tnpt
aueqml
favours
tempest
teapot
researchthere
2503
015048
106500
constructspast
directionsbispecific
diseasepositive
medi565amg
bay2010112amg
glycanspecific
glycanreactive
unistrain
canadaimmunization
leukemiapreventing
clr
subsetsallergenspecific
clrs
cd209dcsign
cd206mr
dectin2clec6a
dectin2
dngr1clec9a
lvc
6383
19951996
gottingen
additively
cn54
idin
inid
psoroptic
mange
scabsheep
psoroptes
ecotoxicity
infested
preinfestation
amnestic
mugst
pso
commerciallyviable
pseudolymphoma
2targeted
optimizations
headtotail
cd3ebinding
ceabinding
lowceaexpressing
2213
328697
cictargeting
or7c1
or7c1positive
or7c1negative
or7c1derived
or7c1specific
3298309
immunotherapylargescale
ovit
biotherapyfrom
stabilisationregression
escaperelapsehas
immunocentric
promyelocytic
autopbsct
diarrheagenic
pathotypescausing
enteroaggregative
enteroinvasive
pathotypesas
ratepost
ctbadjuvantedcombined
milena
kalaitsidou
kueberuwa
antje
schütt
gilham
ulcerating
40yearold
vaccins
aieopgitmo
studyposttransplant
matchrelated
days3
and4
days17
and27
nonacute
fludarabinetotal
responsesallogeneic
20mgm2day
30mgm2day
postgrafting
443days
magea1a2a3
rhamm
decflutbi
taareactive
disordersallogeneic
1970searly
targetto
carerecent
condomless
vista®
vaccinethree
2014many
amphpid
decreasedthe
incomerelated
19952013
lawsschoolbased
contention
rulings
tenable
sentimentsrealtime
naturallanguage
ruse
vaccinationdespite
2014in
costeffectivenessin
socioethical
articulate
piecemeal
policyin
myelomaadoptive
cd38chimeric
cd38dependent
cd38negative
marrowlike
caspase9based
tbevaccine
beginthe
uims
statesmexico
pnps
uim
pnp
traumainformed
proteogenomicbased
cancerspreclinical
mihas
proteogenomic
hlaa0201b4403
mihatargeted
ems
emsws
emsw
selfdeclared
sipi
acceptation
sd77
pisi
measuresbackground
formalized
negotiated
casecoverage
englandstudy
aso3adjuvanted
1451238
1904317
malawiunderstanding
postlaunch
suppliers
pcv1
rota1
backlog
penta1
regimenshighdose
mcv4tdap
200499
4599
2036
20042011background
prams
pr126
pr137
pr125
pr179
immunisationobjective
cati
ccws
or278
or199
n8490
cep55
33342
51cr
presorted
sw480induced
recommendationtdm
crossdressing
p6
pharmacoeconomicsthis
aittriggered
wellpowered
spatiallystratified
countys
lowimmunity
interschool
39132
populationimmunity
randomlymixing
3·39
2·02
yearsis
dreamgordon
scott
legislationbacked
zoosanitary
circa
hundredyearlong
coordinatorship
prescheduled
11374
38353
16452
0881
immunodeficienciesbackground
cisa
ihg
bcgrelated
lymphopenias
infrastructurebackground
20month
generalisable
5014
4152
kappa042
or765
4871218
229484
childrenunited
cxcr5ccr7low
postwean
pigswe
132628фr
preinoculation
studyunlabelled
by90
yit
rcvp
250mgm2
98with
following90
40seven
23·1months
77·5
112μgml
52241
to90
13·5
nct00637832
obamas
chromophobe
carcinomathis
chrcc
t3an1m0
cancergeneration
infgamma
gauged
1717
cd3cd4cd8doublenegative
vbeta132
vbeta1
vbeta22
vbeta14
cancer–specific
blastsexpanding
amlreactive
interferonγtreated
leukemiareactive
adjuvantsproinflammatory
posttransfection
networkmesenchymal
nextgen
providersobjectives
misidentified
childrenvaccination
lowestcost
mcos
photoimmunotheranostics
egfrobjective
funkhouser
scattergun
o6alkylguaninedna
alkyltransferase
agt
ec50s
3255
multisensitization
p1051
cuegem
pyloriinfected
youthobjective
30item
103277
102289
kapbackground
kaprelated
kapsurvey
kapscores
attituderelated
45718
149353
knowledgeassociated
95307
practicescore
knowledgescore
attitudescore
condense
kapvariables
pneumocoocal
tissueassociated
autoimmunitypluripotent
psctregs
tissueorganassociated
tissuesorgans
2016each
administrationlicensed
httpwwwcdcgovvaccinesschedulesindexhtml
printable
portrait
pocketsized
laminated
parentfriendly
activationsurvival
2013june
238888
nonmicrovascular
resectioncytokineinduced
mviin
mvi
mvinegative
mvipositive
appropriatefor
pdfs
pos0020
pdfs0439
pos0374
pdfs0042
pos0007
osfor
transplantationcombination
ratethis
14952
10321
46895
3468634132
groupin
womeninsights
sheva
assaytype
00008
unscc680aj
nnitrosotrischloroethylurea
cytokeratins
andmonitored
growthprogression
12dayestablished
day17
dyskeratosis
congenita
44months
hormonetherapy
updatehistorically
eralpha
luteinizing
lhrh
aromatase
postmenopausal
sequencesgenerating
vaccinationadvances
gliomabackground
0492
gmcirelated
nct00589875
5fluorouracilleucovorinoxaliplatin
spotlights
modelunlike
restrictively
cd11bcd34sca1fsp1mhc
fapimmunized
lymphomain
stagesi
stagesiii
phaseiiiii
4963
m2polarization
m2polarized
zlín
n480
hexavaccine
tetanic
anatoxin
diphtheric
chaffeensis
hostehrlichia
rickettsial
americanum
ech0660
intravenousadministered
chaffeensisspecific
incidental
malignanciesrelapsed
administrationalthough
cd19scfv
pcdh
workstation
counterregulation
toleranceindoleamine
counterregulatory
cytologyobjective
2262007
3102014
or144
ci113183
140218
campaigndespite
czerniakowski
diseasesobjective
argas
reflexus
unlikelihood
trialhuman
zhuang
nct01569581
nbs20eltrapuldencelttargeted
clbs20
nbs20eltrapuldencelt
modulatorsthere
diseasevaccinations
checkboxes
levelpurpose
graduatelevel
ztests
erhebungseinheit
für
seltene
pädiatrische
erkrankungen
deutschland
61109
foggia
2015recommendations
diseasescarcinomas
viralbacterial
beta1b
aggregatesdetermining
rhifnβ1b
avonex®
betaferon®
rhifnβ
betaferon
avonex
copperoxidized
nonimmunetolerant
nonimmunologists
advancesunlabelled
diseasesdiscovered
th17type
barometers
methodsbackground
toothpaste
iuphar
18antibodybased
homocombination
heterocombination
nursedelivered
binfected
trustsdespite
inhome
middlesex
96·6
centurybackground
devastation
nonpreventable
countrieswe
subcohorts
9397
8995
7782
postrotacohorts
prerotacohorts
syndromeunlabelled
alcp0010
eosinopenia
burdentumorelicited
13βglucan
agrobacterium
theantitumorpropertyofcurdlan
γirradiated
serotypeindependent
responsesgenerating
sterilize
unencapsulated
rx1
autolysin
pneumolysoid
γpn
eur1
eur4
16237
heterosubtypic
fading
prhbv
alf
lohf
hbsantigen
48months
alflohf
proceedprimary
graphpad
5013
psl
0617
0695
eventdriven
bestfitting
antigensensing
circuitst
andgate
vivosparing
responsesinducing
waldenströms
therapywaldenströms
subdivision
datalinkwhile
caseinfection
populationsrecent
assessmentobstetriciangynecologists
47point
viraemic
2004june
2006june
2010june
ci822900
ci797889
ci577726
ci529687
822927
ci826916
ci570699
ci529721
837923
ci735924
ci588797
ci482798
ci48378
ci289483
infantspersistence
akrasnodar1013559
straina
straindonor
procuration
akumamoto10202
abern0795
naproteins
perspectiveness
h2n2as
acha
101370
modeleven
swcntcpg
kluc
difficultlytransfected
ctla4sirna
npsictla4
biss
activitiesone
domainbased
xviibp180in
hemidesmosomal
xvii
col17bp180
noncollagenous
col17
nonnoncollagenous
ts393
c17c1
dermalepidermal
col17expressing
internalizes
macropinocytosis
macropinocytosismediated
practiceit
fewster
vaccinationauthors
8deficient
nodesthe
initializes
recalculates
higherscore
therapiesa
cd4hlag
relevancethe
hlagcd4
cellscd4cd25foxp3
seized
analysisdespite
unyielding
subepidemics
n2941
120000taiwanese
13850
9038
mart1tcr
mart1tcrcd8
hlaantigendependent
cotesting
28085
costineffective
clinicianspharmacotherapy
spainvaccination
119218
9451948
138280
cytokinematured
dangersensing
polya
gnaq
gna11
nfκbactivation
mockelectroporated
melanatransfected
tumorantigenencoding
sarcomaspurpose
lysatekeyhole
hemocyaninpulsed
ewingrhabdomyosarcoma
318291
vaccinesok
1393
ghanaian
nct015751
nonbloody
1729
4051
2881
4849
6170
ageineligible
qhbis
2559±184
2661±224
3773
1683
marrying
challengesadvances
blockaderodent
dtha
synchronised
tregsand
tregdepletion
tregsin
tregdirected
tregswas
afoxp3dtregfpmouse
dtr
thefoxp3gene
tregsincreased
tregsresulted
anticitrullinated
tregsare
thefoxp3dtregfpmouse
firstday
physicals
therapyovarian
cholangitischemokines
autoimmuneprimary
chainbackground
carstairs
1741
proteinantibodies
prpc
targetrelated
icsm18
bevsinsect
cellsharmonization
effortthe
lateoccurring
initiateda
factt
membranespanning
intracellularsignaling
firstapproved
xxies
pharo
2015les
développement
marseille
octobre
tricksthe
reliefcomfort
18seconds
33seconds
painrelieving
nct02280967
asthmaseasonal
ar1
ar2
grassbackground
antiallergy
367898
356780
201011background
postseason
aperth162009like
f4567997
ratio68
ci31
americagrass
pooideæ
reorienting
cowsthis
nelore
vacpre
vacgest
qualitybackground
1117yearold
or931
7101222
or382
239611
or413
299570
commercialised
klhtnf
tnfα423
diseaseregulating
cytotoxity
antimtnfα
viroimmune
tovs
tlymphocyteassociate
lending
subsetsallergen
pittreated
inhomogeneous
photoimmunochemotherapy
immunizationparental
hardships
prechemotherapy
immunotherapyoptimization
citim
ljubljana
providersvaccine
pharmacistdelivered
opn
opnantiopn
chasing
scalesoral
monthsold
msp119
immunogenicityas
carboxylterminal
19kda
pfmsp119
fig1
nepalthis
probit
0015p
areamanagement
geurin
directionsas
korn
pretarget
enthralling
polyneuropathychronic
103kg
tcralphabetadepleted
40204
301850
10426
604376
675084
664884
os725390
bbased
modeltriplenegative
gbr201kαepcamscfv
epcamselective
serpin
epcamexpressing
kongit
arulbp2
arul16binding
mir34a5p
pkai
camppkai
tregsderived
rp8brcamps
immunerescuing
antagonistsinhibitors
274050
7732266
722700
137025
sorafenibresistant
modeltumorassociated
irdαcd206
anticd206
nirf
tamspecific
conundrumadvancing
csclysate
gmcsfarmed
guang9targeted
jx594
wyeth
vtt
guang9
vg9
vg9gmcsf
rxvaccinate
webinars
ecommunity
teleconferences
pooideae
partialtocomplete
flamatched
fivpet
heterologoussubtype
fivfc1
flamatching
neutralizingantibodies
antifiv
cytolysin
1x3x
dualsubtype
pathogensbackground
hyperimmunised
databasespecific
emtree
textwords
rareneglected
antivenins
1890s
revolutionise
approachwe
generality
reporthematopoietic
cog
wwwsurvivorshipguidelinesorg
infusionin
mtv8
mtv9
antiovarian
platinumtaxanebased
pbmcinterleukin2
pbmcil2
cellcytotoxic
75mlmin173m2
algalproduced
micepeanut
flours
alga
immunotherapiesmultiple
myelomapromoting
corruption
zebra
finchesneurogenesis
finches
nidopallium
caudale
comp
52425162528
higherdosage
9364
9919
9604
184799
83927
124480
145663
25630
23515
identiﬁer
nct02203357
ihypersensitivity
6651
inhibitorangiotensin
aceiarb
368were
aceiarbs
2011in
leadup
overshadow
yi
20126111801191
databasebackground
ascr
iculevel
00024
nonnarcotic
benchwhile
multimodular
chemotherapyit
days100180
and365
sjtrecs
day365
tcrvβ
days100
and180
spectratypes
26th
secondtrimester
euml
478682
257377
24133352
1402
11531703
2165
calveswhether
clfree
clenriched
ttinduced
toxoidspecific
eomesodermineomes
group11050
ngl
increasedipa
14677
cxt
22600
1188
20077
levelsipa
56117
μgl
64700
3303
61923
34003
2632
controlsipa
10667
13327
29964
6307
39802
10922
nglraised
0788
pancytopeniaassociated
alloantibodiesalthough
bnp
pregsure
bvdinduced
bvd
bvdvaccinated
bvdvantibody
nanotargeted
nanovehicles
metalnanoparticles
biodegradablenanoparticles
dexterous
rvhd2
taadc
mmtvras
semimaturemature
loadeddendritic
nemo
isw
commitmenttickborne
tbevendemic
agers
m3r
sslike
mitochondrionmediated
transactivation
201213the
eurorotanet
39786
genotypeconstellation
ds1like
amor125
113137
untypable
amor155
140172
amor211
ci178251
amor166
120230
amor253
167382
vaccinationcollective
rightsvaccination
750000
germs
recommendationthey
zambiabackground
kafue
churchs
churchattending
difficulttoreach
antigensthere
bis35cyclicdimericguanosine
vca0848
advca0848
hiv1derived
difficilederived
feverunlabelled
arenaviridae
arenaviruses
arenavirus
junín
junv
machupo
macv
guanarito
gtov
prnt50
antijunv
hartley
romero
sabia
sabv
panarenavirus
postvirus
antiarenavirus
hongkou
posttravel
diammg
clienttrips
oceania
cancerssince
malignanciesover
orai1
histomine
eosionphil
cation
interlukin
nlf
t100
μg788
μg992
μg430
t150
μg1643
μg1631
μg935
pvalues001
0186±0015
6618±0180
2555±0031
8526±294
5512±121
5845±211
7712±213
0089±0003
4501±0310
1260±0017
4849±212
3315±087
3824±095
5172±081
siginificant
groupt
1044
8706
2300
2089
8073
10370
pvalues005
therapysit
patientsbeijing
tongren
decemeber
reprehensive
hapmap
massarray
platformplink
il2rs77468365
foxp3rs2280883
rs2232365
rs3761548
tgfβrs747857
rs6508975
rs2241715
rs12462166
rs12983775
rs1800470
rs2317130and
rs3761548were
ebi3rs670188
rs3761549
rs3761547
turbinate
ebi3rs393581
tgfβrs11466359
rs11466345
rs17847095
rs4740
rs353702
rs2280883
tgfβrs12461895
rs2241717
rs7258445
rs3761547were
08131
micestudying
rg7smica
carcinomamhc
immunoligand
immunosurveilance
hcctargeting
selfenforcing
agreementsin
2211
2212
c121
v1063
hpi
c121based
slitoneultra®
50150300
sru
pteronyssinusdermatophagoides
300sru
oraltongue
deliverypattern
endocytose
transplantationstrategies
thril
kings
clinimacsbased
crf
muchanticipated
modelssinglechain
intrabody
i7nuc
c33a
delocalization
ascribable
plncx
cellsfinally
i7nucexpressing
postinoculum
e6targeted
autophagyassociated
doublemembrane
diphtheriatetanuspertussish
tumorsnatural
mg4101
cd96mice
tigitmice
cd96cd155
5373
kirligandmismatched
respectivelyp
postcr
syndromerecurrence
algenpantucell
adenocarcinomapancreatic
newlink
αgt
vectorcytomegalovirus
βherpesvirus
4124
nonprivately
z231
urbansuburban
z287
z304
z367
differencesand
differencesin
immunophenotypebackground
fungalinduced
nonseptic
gmfi
cits
paternally
allopregnancy
mycobacterialspecific
monocytelymphocyte
primaryvaccination
susac
syndromesusac
electively
cochlea
hypoacousia
undelayed
castillaleón
trainee
improvable
improvereinforce
signallingimmunomodulatory
ifnγr
ifnγrdeficient
leukemiamyeloablative
postgo
feather
pulps
vent
spotting
feathers
vireamia
routinerecommended
8710
95ci4350
95ci2126
checkupwell
rr190
95ci176204
labored
03252952
0970
05364931
0739
ipilimumabtreated
colonoscopies
megacolon
1422
1045
adultsalthough
cognitions
emotionbased
n233
chemotherapynaive
a02
a03
3mg
p00076
p000084
000000959
memoryfollowing
30°n
junenovember
10°
equator
wsava
madness
betaemitting
strontium89
samarium153
marcucci
therapiesaccumulating
mouseinduced
survivalrelated
op9dl1
rflt3l
ril7
αnotch
paradigmsdespite
vade
mecum
yahoo
chiebukuro
abruptly
yesterday
tomorrowplasma
fractioned
19171918
immunotherapiesa
spillback
vaccinatecull
areawide
splitarea
rcpib
iota
toxemiaclostridium
cpb
toxaemias
enterotoxemia
infrequency
toxaemia
misidentification
habitual
g4s
overlapextension
neutralizations
antircpib
stingsvenom
immunotherapycd137
polyubiquitinationmediated
conditioningthere
beamasct
1733
gonorrhoeaeneisseria
fh1820
fh1820fc
ceftriaxoneresistant
serumresistant
macrophagedirected
immunotherapysuccessful
m2repairtype
m1killtype
killtype
m1kill
m2repair
macrophagesinnate
vaccineswith
dysplastic
kir2dl22dl32ds2
eradicationthe
entomological
amazonia
highlands
her3
immunotherapiesnfe2
proproliferative
tertbutylhydroquinone
tbhq
deciphered
biokinetic
microtumorsunlabelled
biokinetics
βemitters
188re
212pb
17l
transcapillary
convective
prevalency
receptors4
quercetin
009068
039056
nutthe
marrs
appraisalobjective
716year
dbpcfcproven
12·5
800mg
controlgroup
1400mg
milligrams
of85
1345mg
p0·002
25·5fold
under13yearold
1·61
1·41
webpagesbackground
40categories
codebook
1093
webpages
healthspecific
vaccinationspecific
tabulations
infusionsbackground
hostdisease
gvhdinducing
tbnk
receptortcrαβcell
unmobilized
x103
cd3cd45ro
tcrαβcell
nucleosome
realityunlabelled
translations
inhibitionmelanoma
airr
438487
53885
109253
098139
117200
descartesnantes
eraedtadescartes
tol
mis
postimmunosuppression
locallyadapted
sedrc
wkenya
garbage
selftreatment
settingspecific
prayer
modeobjective
antider
peribronchovascular
macules
patientorgan
scart
tissuehoming
scartcell
semisynthetic
adaptors
cd22expressing
antifitcdirected
carswitch
titrate
cancernonspecific
mghu3
rt4
g1s
mbt2
polyicbcg
ccic
2015may
immunotherapyadherence
titin
leukaemiaauthors
0246
anc500kmcl
mskmodified
p0654
arbegona
sidama
1809
h1n1v
n1320
fuss
n734
infirmity
agonistadjuvant
17week
00625075
phase2b
246con
234con
intercalated
246int
4476sl
120165
125147
5190
26199
4cmenbrecipients
4cmenbrecipient
8294
earlyinfant
2014q
lymphomafew
928112
μgd
flatdose
nct01741792
toleratedbackground
nct02256553
merckalk
conserve
cryopreservationimmunotherapies
vivomanipulated
conserves
astargets
pneoags
9range
59missense
33899
26232
46pneoags
13659
10145
pneoagsand
lightltβrhvem
lightdeficient
tnftnf
tnfsf14
thd
assembles
homotrimers
ltβr
tnfrsf3
interleukin7rα
challengebrucellosis
δznua
2500fold
brucellae
brucellaespecific
cd44hicd62lloccr7lo
rev1vaccinated
ifnγs
kdm28290
dosedependentin
cb6f1
trbv132
trbv131
cotransferred
cd127locd62lloklrg1lo
orientationour
583vs
oneunit
105149
153717
atmdeficient
miceataxia
atmcompetent
coconditioning
atmpositive
hostconditioning
0220
histochemistry
γh2axexpression
laivbackground
prepiloted
2640
12101
16272
realitygeneration
microenvironmentanticytotoxic
mmpi
mvd
mmpitreated
countriesevery
sodademographic
dlvoire
twohospital
2483
170395
155400
105139
118161
100147
069092
266385
childrenfour
cd137targeted
cd137mediated
nct01682005
20022010
weeks8
contemporarily
rvrelated
diarrhearelated
1069485
515557
195224
386421
48118
65123
128167
502538
12991803
234635
immunosuppressionmetabolic
prehypertension
106417
prehypertensionhypertension
translationcompetent
nef
endofati
preantiretroviral
cd28cd45racd8
abexinostat
s78454pci24781
angioimmunoblastic
liverfunction
boosterresponse
33miuml
doubleseronegative
471501
247341
153160
titers100miuml
tuberculosistreatment
adultsin
subfamilyg1
ctla4expression
bcgstimulated
tbtreatment
pd1expression
activebut
latenttb
klrg1expression
klrg1expressing
bcgstimulation
tbtreated
cd123leukemic
18amino
69×107m
biomarkerspecific
immunosuppressionneural
mesencephalic
graftmediated
neurotransplantation
slitbackground
antimite
mgkg2
auml
39234
popcorn
nct01782794
27monthold
4903
conceptsthe
effectsadoptive
zosterequivalent
48years
yearsthe
n222
n205
paradigmhf
arni
lcz696
sacubitrilvalsartan
enalapril
propensityadjusted
defibrillator
cepacia
specialiststhis
denials
physicianparent
0072
roches
maari
ah1n1pdm09containing
currentseason
rtpcrconfirmed
4661
pulletsinfectious
ibdvirus
vvibdv
vhvtibd
vhvtibdvaccinated
livevaccinated
pulletslive
faecaloral
contactvaccinated
cagereared
effortsuneven
debriefing
possiblein
42yerold
recoverybackground
retinolbinding
pericarditisidiopathic
colchicinebased
administrationvaccines
vhhbased
micebacillus
bipartite
advna2pa
vna2pa
paneutralizing
vnas
135days
105daysrange
isolatedengraftment
patientsmycophenolate
fixeddoseescalation
pharmacokineticsbased
auc024
μg·hourml
adolescentparental
adolescentparentadult
nonparent
au25160
au29510
au9070
au12720
au1850
au1670
au6330
au7640
au4850
au4920
au960
au1230
daybased
acronym
jdc
901951
30392
359455
239363
557649
leukemiahematopoietic
cd123carvst
canterbury
diabetesantigen
drycoated
iddelivered
viiifc
rfviii
rfviiifc
eloctate
integrationscottish
χ20222
postintegration
p00157
χ25834
hexamers
surfaceigg
e345k
e430g
succinimidyl4nmaleimidomethyl
cyclohexane1carboxylate
smcc
antigensin
nucleophilic
heterobifunctional
sulfosmcc
nhydroxysuccinimide
sulfhydrylcontaining
sulfhydryls
amines
antigencoupled
antigencell
1399
114378
lefttruncation
fludarabineiv
polyhydroxylated
fullerenols
metastasisunlabelled
c60oh22
gdc82oh22
fullerenol
angtigen
645900
8565
82148871
6060
56016506
17562
1390322184
17622606
17467
nonresponderd
controlchronic
5monophosphate
mscderived
bulge
cd39positive
cd73positive
ldk
nondonorspecific
hlaantibodies
p277
peptideprevious
6065
24residue
heatstressed
antip277
inhibitorsfor
dormitory
methodsparticipants
2858
livertreatment
agonismctla4
miceimmunotherapy
anticd134actla4
antidec205
kdaher2
th2cytokine
protein1αccl3
mip1βccl4
excretedccl5
aox40actla4
trialinhibition
nct00928018
lace
lomustine
cancerbiliary
bream
sarba
modalitiesin
phenol
chloroform
lipopolysaccharides
phenolkilled
chloroformkilled
injectionimmersion
hyperosmotic
immersions
tumorstargeted
radiochemistry
plana
diseasesvaccines
tss
skinnasalbronchial
nonhostadapted
primebooster
typhimuriumltb
montanidetm
70vg
isa70vg
mortalitysepsis
yearunlabelled
89±12
dctregs
foxo3specific
foxo3expressing
enlisted
traineesthis
aris
selfdeclaration
n15074944
taxaneinduced
taxanerelated
livedonor
nsa
170±30
higd
logarithmically
igdr
cdk6
plyn
2009objective
solutionoriented
pastorex
kastina
11153
jigawa
8643
8463
6811
gombe
nasarawa
shongom
illela
ikara
lysatesil15
flowsorted
granulysin
00028
eleftheria
in2008
1116years
to2014
ρ0860
ρ0890
firstfeeding
vaccinationyersinia
fry
covertly
microencapsulated
f438
df410
oraldip
transmissionbackground
ecoclimatic
5714
38619
us149
us2872
aheadcancer
targetsidentification
forwardtranslational
29899028
4·25
1·879·67
p0·00060
diedthe
myeloblative
nonmyeloblative
policythis
suspend
italyafter
guardhaemophilus
reappear
agnors
cd4cd25cd4
cd4cd25foxp3cd4cd25
agnor
tlr24stimulated
highdosestimulated
alonetriggering
oxidasemediated
20072015background
islamic
clerics
jap
aired
portraying
5991
approachseasonal
sixstages
emsconceptualized
nonpharmaceutical
isolationbackground
transmitter
questioner
theatre
karachipakistan
labtechnician
sterilized
disinfectant
detergent
disinfected
dustbin
biohazard
discarding
inflammable
offerings
corporations
averagebecause
neovascular
pkr
aurkai
cdk46i
ccl5deficient
cotreated
nfκbdependent
il5secreting
cd28cd80
tcrindependent
epitopeindependent
perforinindependent
panspecific
mapksignaling
nivolyumab
pem
brolizumabhere
sonalized
sibility
problemthis
pregnancydespite
preg
nant
accent
institu
tions
safetydata
subtherapeutical
icelandobjective
2092
antigensrecent
221100
reachedfor
remobilization
exposureduring
birchgrasses
changeable
allergensqualification
prik
sptsige
flow2cast
sbuml
5094
6187
studyaspirin
antiinflammatorynsaidsexacerbated
treatmentplasma
mortalityis
wasthat
987100000
chil
dren
029episodes
developingand
1274100000
723100000
1340100000
1079per
ration
059075
067081
1542100000
1227100000
961000
6931000
immunosuppressioncommunityacquired
pneumnococcal
exhaustednascent
system´s
immunityantimicrobial
amphiphilicity
defensins
cathelicidin
ll37
blurredlarge
stat5b
il3
il5compelling
antiil5treated
highlysensitized
pointbased
regrafts
bfcxm
greenland
greenlandic
icd8
hereof
2069
096120
098124
084119
stakeholdersan
dairying
gumboro
mdscdecreasing
mouseas
biobreeding
bb
diabetessparing
bgl
rhuifnalphaad
ifntauimod
ovifntau
rhuifnalphabd
cifn
nh3terminal
ifntau
icam
nodil4null
nodifngammanull
ifngammainducible
cd4cd25hifoxp3
2365
gbanded
vaccinateassessmove
ranchi
catchvaccinaterelease
sighted
redeployed
6593
cd4cd45ra
posthaplohsct
steap1262270
microspherebased
whatif
programmeview
saturate
drugsimmediate
pluscoms
2dioleoyl3trimethylammoniumpropane
systemimmunoadjuvants
pluscomsla
pluscom
25dihydroxyvitamind3
actionforty
intermediateterm
vsvinterferon
mifnβnis
c1498green
vsvspecific
gfpspecific
vsvantipdl1
expansionms
recordat
icvp
illegible
crossings
dermatosesautoimmune
herpetiformis
immunobullous
therapeuticsadoptive
maneuvers
painlimiting
parentguardians
disagreeing
winloss
scoreboard
thresholdbackground
resampling
replantation
protectiveness
recentlydeveloped
fluba
omp16
l7l12
montadine
gel01
postbv
214±55
857±136
27±04
101±09
137±17
400±30
alpha003001
alpha003
alpha001
studyfortytwo
jelly
mcc1849
ah2n3
as85
contextures
modelbetween
btm
partus
excrete
hifuactivated
shamhifu
melanomatowards
hospitalwe
immunogenicityin
crevice
vaccinationgingival
periodontopathic
wkold
oraladministration
oralsupplementation
xanthan
gelencapsulation
gingivalvaccinated
twelvemonthold
pricktested
4433
036162
035124
034097
024083
reused
immunosuppressionreused
flowdependent
fetuss
ksa
pilgrimages
threeinjection
useobjective
hcppublic
togoobjective
cattlemalignant
mcf
alcelaphine
alhv1
wildebeest
simanjiro
mcfseropositivity
shorthorn
177labeled
girentuximab
carcinomaunlabelled
177lugirentuximab
mbqm2
177girentuximab
nct02002312
httpsclinicaltrialsgovct2shownct02002312
electronsradioimmunotherapy
antigensreceptors
let0110kevμm
210mm
αparticleemitters
electronemitters
50230kevμm
26kevμm
28100μm
childrenantinmethyldaspartate
therapyreactivation
warnings
newnovel
steroidsensitive
ballistic
deliveryballistic
pegglycolide
ballistically
thermoplastic
cellulosic
biobullets
fixedsized
glassy
vaccineloaded
monoliths
biobullet
100μl
fired
rifles
gelloaded
downrange
rehydrate
bison
freerange
receptorsthe
synucleinopathiesimmunotherapy
antialphasynuclein
rwandas
2013as
rollouts
crosssectoral
56170
1antigen
2526
10131
publicfunded
arlike
receptorscd19targeting
admittancestudents
assessmentcommunity
crv
194356
lrtis
muguga
sociobehavioral
macaquesdelivering
pam3csk4
statesinfluenza
vaccinestypes
actionadjuvants
alternatiye
glancea
freeatthepointofreceipt
ununder
1194
pteronyssinusspecific
4517
nantong
3218
3030
applicated
000000000
200100200
7021
200200200
8855
300200400
100000100
4494
4383
000000100
8944
3843
3534
3938
3405
immunotherapiesover
channelassociated
nmethyl
contactinassociated
complexrelated
criteriabased
maliwe
favn
025iuml
2956
nondogowning
salivation
nondogowners
dogowners
n306
59136
fcfa
3380
rabisin
rabia
primovaccinated
gapsbackground
cameroonspecific
fibra
oldthe
benefitsthe
chickenshighly
agooseguangdong196
haantigens
m2e5x
vlpsupplemented
duriesalmon
stransferase
gstm1
gsta169ct
gsta1t69
084097
025088
stateschildhood
varicellaprimary
remissionthe
signiﬁcantly
19item
108471
109184
158662
034088
drinksweek
009065
offtargetyears
grasp
eagerness
agentsstudies
d24
ad53
ad5rgd
heterogenic
melanomasecreted
sceacam1
0·223
lympholytic
0·991
0·9870·996
0·290·81
p0·0047
0·40
0·210·77
p0·0062
0·080·76
0·979
0·9630·994
p0·0081
0·975
0·9520·998
p0·033
0·983
0·9680·998
p0·029
0·981
0·9650·997
p0·020
90ylabelled
cd22positive
90ydotaepratuzumab
mcim2
7·5
277·5
nct01354457
2×10·0
clinique
cultureconfirmation
51fold
46fold
38225
37117
belgiumvaccination
expectblockade
adcio
celebrity
5off
voucher×watching
grandparent
redeemed
dtphbhib
bandung
licensedequivalent
nct01986335
volunteerunrelated
p0·16
31·2
26·835·5
28·138·7
wth
25·0
21·029·0
28·4
23·433·5
p0·47
0·99
0·831·20
p0·95
0·811·16
p0·71
nct00326417
03·3
04·9
1039
1154
ci36
neuroimmunotherapies
realitybullous
seriesthe
allergenwe
11018
toleratemoreover
icing
narcotics
micecrimeancongo
nairovirus
ectodomains
stat129
transplantationtcell
graftrejection
carcinomathere
lscc
glypican
gpc3redirected
cargpc3
associatedwith
meningococcalconjugate
fixes
membersobjective
practicerelated
weekdays
miceex
eg7ot1
promoterdriven
tomato
2x106
5x106
2fluoro
htselex
immunotherapytim3
nonantigenic
tim3apt
tim3apt1
tim3expressing
pdl1antibody
malleability
diseasesbcell
erases
autoimmunitypromoting
unwucht
lowdoseinduction
modelfor
269375
bcgloaded
settingsstudies
questionnaireparental
moderatestrong
612years
r041
r042
r038
r033
albertaobjective
20042012
ihda
getis
ords
methodrotavirus
2times
flamsabusulfan
ampliconbased
cebpa
overalldiseasefree
transfertcell
aud30
107139
77completed
79139
aud1505
14271583
aud769
726813
reportintravesical
trus
tuberclebacillus
kindergartensbackground
565605
noncatholic
tuitions
000234
us100755
us15
inhibitionspecific
certificatevirginia
2015canine
importing
dcls
bronchopneumonia
erd
defying
chondrosarcomachondrosarcoma
cartilaginous
zolstimulated
1μm
400iuml
zolpretreated
sw1353
leptospirosisleptospirosis
ligbrep
ofleptospira
mrnaengineered
activityin
il15transpresenting
dcnk
vaccineadministered
lnresident
promissing
mammaglobina
correctedporcine
swinespecific
loadcloseexpose
fvi
preventatively
prrsvattributed
timetostability
fieldtype
ataxin1
slows
spinocerebellar
phenotypespreviously
atxn1
lasagnareeves
polyq
hospitalsone
nonemployees
accustomed
netherlandsinvasive
combatted
immunocorrection
vasculitisthe
angiosurgical
coagulopathic
cytostatics
antioxidativeactivity
aftermaths
germanyobjective
bayerische
motorenwerke
bmw
activitytreatment
resilient
carcat
h2o2induced
5as
uptakesuboptimal
nonsociodemographic
intersectorial
treatmentmore
chinical
diseasesparasitic
worminduced
torrid
timeimmunosuppression
xrays
immunophilinbinding
suspends
donorswe
kobayashi
ladies
benefitvaccines
policylevel
polyglandular
syndromeautoimmune
incompetence
nonendocrine
philadelphiachromosomenegative
allergypollen
fcɛri
directorategeneral
plataforma
dados
saúde®
prematures
pulmonology
signorelli
mutationpurpose
mp68
mp68specific
sufficed
longestablished
273443
©2015
bva
levelt
livertransplanted
ascariasis
ascarisimmunized
wheatallergic
10118
seasoning
ipfae
superimposition
p0685
lymphomamoderate
chop21
russiathe
approximates
reportsbecause
dermatooncologists
leukemiaprevious
5559
societiesin
charter
poems
organomegaly
1may
30november
2562
105fold
pairedsample
t5·715
p0·0030·01
pr60
sd40
t5·101
p0·0040·01
melanomapreviously
b16f10luc2
1e105
7e106
1e106
largesmallbalanced
mabpc61
vivosome
presaging
eaacis
dtapipvhibhepb
opsonophagocytotic
wwwtrialregisternl
ntr3069
coveragevaccine
5880
1443
λ3
ifnλ3
rnapositive
melting
rs12979860rs8099917
unadjuvanted
ah5n1vietnam12032004
90mcg
ah5n1indonesia0505
15mcg
antitype
cellsantibodies
mt1
chomt1h
cpg1018
zztat101
anticho
antimt1h
zztat101chomt1h
anticell
mt1m
mt1hexpressing
mt1specific
moredifferentiated
memoryinduced
aktdriven
synchronize
quorumlike
klebanoff
cd11bly6chi
modelmyeloidderived
p3cd4
pristanetreated
peptideattached
dcvaccination
018095
criticalbackground
multicompartment
5900
a161000
a88000122000
a9000
opportunityryibritumomab
pigsthere
5ht
5ht1a
5ht2a
5ht3
5ht4
5ht5a
5ht6
5ht7
allotransplantationdiverse
αthujonethujone
monoterpene
ketone
thujone
αthujone
sw620
317961
multiscreened
5401
newlyinfected
077085
r0826
laca
cpg1826
modelcyclophosphamide
immunedependent
cpg1826responsive
cyclophosphamidecpg1826
fevercoded
2748
016096
026088
5472621
1791365
cvps
nipinformation
cwc
cwcs
berber
253394
12645
preneedle
3minutes
secureavoidantresistantdisorganized
proximityseeking
avoidant
disorganization
neoantigensneoantigens
multiplepurpose
canceranticancer
immunosuppressionblocking
immunizationhighly
fqs
rabmabs
prevalencebackground
n527900
8869
5436
zar
81978
rand
productcapitazar
200293
102479
spondylodisctis
spondylodiscitis
mixallergen
reorient
mesotheliomarationale
4342610
0271030
01241682
sops
delegation
nphps
vocational
nphp
authorizes
ncu116
pickled
nim
ncuh
ncum
ncul
bb12
igasecreting
biofunctionalization
spag
vectorize
responsesmesenchymal
eau
nanoparticlecarried
peife3o4carried
peife3o4prscgdil21
prscgdil21
hsv1neutralizing
decadeobjective
017042
036072
015052
eb101
auspicious
harshtolerance
therapybladder
reactionimmunotherapy
physicist
busch
erysipelas
1891
seratia
marcescens
yperit
bangladeshin
dweller
mtika
assistantsvaccinators
areasrural
339while
57319
39290
1592
dids
131305
challengingly
phloretin
melanomarecombinant
erythroblasts
hsp70gel
39days
muskimmunized
muskrelated
dfmsc
dfmscadministered
parentsthis
dotsjanuary
wwwhealthgradescom
1107
7651601
5581089
651303
ghent
mabsbased
programto
deformities
universitys
edinburgh
pjt
availablestudy
nct02111512
201400153792
mathematicians
modelers
polyγglutamic
acidthis
8weekold
wellvaccinated
γpga
hctreduced
ccr4foxp3
8996
antipancreatic
cellsdickkopf3
reicdkk3
paca2
thiazole
observationsthe
52month
9580
immunotherapyextranodal
nktl
nasalparanasal
opportunitiesalthough
denguedengue
immunizationsantibodies
spiral
polymerases
swedenthe
sek
biterelated
mhladr
μgm2d
mutagrip
mld
gmcsftreated
wwwcontrolledtrialscom
isrctn27114642
pyelonephritisacute
erbb2her2specific
erbb2specific
erbb2expressing
ovomucoidoral
preventionextending
perspectivesgiven
relegating
narrowly
leukemiaantigenspecific
7based
lymphomaimmune
hms
therapysotillo
caseobjective
cycy
onehundredday
12134
discredited
autismvaccine
expertconsensus
normatively
consensusmessages
m351
m293
vaccineautismlink
m215
m8393
m8980
m566
m622
oligodendrocytemyelin
omgp
combinant
p75ntr
lingo1
troy
vivoantibodies
iga2m1
nglycosylation
n337
c311
c472
p221r
galactosylation
asialoglycoproteinreceptor
fcαri
fabmediated
nonfcαri
beststudied
accuratein
wristbands
centralpoint
costperdog
pricethreshold
nongold
proliferationinhibitor
reportedmmf
2987
2914
measuresdata
viraemiasyndrome
2880
tissueinvasive
approachesconnective
offtheshelfas
pedals
wheels
countriesunlabelled
samj
livesdare
lobbyists
nonecervical
outnumber
uscytomegalovirus
ndjamena
chadtransmission
nonrestricted
exaggerates
iiinduced
responsesobjective
scurfy
recombinationactivating
6wildtype
490ngkg
dbp
pvat
vaccineinnate
ilc1like
antink11
nkg2ddependent
twogroup
groupsequential
supportivecare
grams
bodysurface
p075
nct00554502
cureantiretroviral
hivfree
gallinarum
typhoidlive
loncpxrasd
p15a
ori
jol1355
jol420
jol1355immunized
zosterbackground
parameterised
intestinethe
ovasbc
ovasbcs
hdac1
igeproducing
19409
10231
9178
1493
12443
4477
expansioninflammation
occludes
monocytesmicroglia
abeta
4x
3xfulllength
aβ140
ntruncated
aβ342
aβ442
nt4x
aβ4x
aβ3x
tg442
aβx40
thioflavins
5xfad
aβ1x
aβx42
compositiondata
modelsneospora
tachyzoitetobradyzoite
curethere
instinctively
c1p5
rec1p5
luc1p5
mabsinduced
h2ax
2012september
teenvaxscene
flumore
2488
sitesno
alonemoderate
tumoursthere
tumoursa
subgroupsthere
1311
11055
cetuximabthere
outcomesvery
intersting
isotretinoinsince
3f8gmcsf
completevery
crvgpr
mrdnegativity
p2derived
p2induced
p2sensitized
bit
charting
19992014background
serches
2816
semifixed
withincountry
interregional
intergenerational
multipartner
wellpositioned
peptidedc
candidiasiswe
fba
met6
peptidevaccine
crosspresentating
vectoralthough
hadv7
e3defective
mapksnfκb
erp57
tap2
had7cea
hadv7modified
tga
n785
n341414
flutracking
2014flutracking
21021
jurisdictionally
knocks
overridden
0142
0377
1067
7730
μgday
improvementsstreptococcus
beh
age65years
ebook
desensitizationwe
aspirinnsaid
competencethis
adultseffective
lawful
algenpantucellpancreatic
α13galactosyltransferase
indiaimmunization
analysisinfluenza
fourtysix
rrunvacc
008045
071097
078100
τ2
0083
ebmtallogeneic
chemoonly
p105
hr055
034086
servicesin
domiciliary
dudley
koreawe
rok
measlesfree
keepup
immunotherapyturning
abandon
allergistsimmunologists
strategiespatientcentered
shareddecision
makingunderscore
specificsymptoms
panoromic
viewbiomarkers
bmks
nonhypothesisdriven
efficacyone
modificationthere
committing
noninjectable
foodsoral
afferent
intradermalcurrent
warningsunited
europesubcutaneous
developmentsallergen
mid1900s
meetingamerican
2729
chaired
pleasure
californiasan
pruitt
cochaired
laterra
wainwright
kolb
ut
nath
nindsnih
cincinnati
lukas
neurocutaneous
impressions
reassurances
q1q5
gini
sesrelated
6185
q5
nonpin
0060
p4pfunded
japana
centra
revuo
uptitration
eubackground
seroprotectivity
spacis
undersix
enquired
rr57
ci450735
rr93
ci6431352
rr85
ci3821891
rr06
ci014251
rr10
ci014710
uiprecommended
108057
demographiccultural
testedsince
leukemiasuccess
maspin
tumorevoked
antitumorcancer
hdacmediated
hdactarget
ovalbuminlike
noninhibitory
maspinhdac1
centersthe
chemotherapyautologous
cisretinoic
europemiddle
cemdfchcc
cche57357
day90
medianday100
day19
day26
day60
pressors
populationsbackground
nevada
conditioningposttransplantation
flubumel
534752
flubumelbased
2131044
2821044
166356
116688
103165
179879
relevancereduced
damico
hlaipositive
nlrc5
microdissected
hlainegative
metastasesmicrometastatic
14951
219268
125163
073085
108140
hypocomplementemic
europemeasles
patientseffect
implementationobjective
pediatricage
selftreating
tropomyosin
1sensitized
microenvironmenteffective
ncrdespite
ncdc
toxigenicity
eleks
systemenabled
harassment
opvrefusing
zaria
ligandthe
tlr8lflt3lprimed
transfernyeso1specific
macroautophagy
herdsbackground
startvac®
coagulasenegative
staphylococci
immunizationcoincidental
viscerotrophic
haemaphysaloidessubolesin
autocidal
haemaphysaloides
isoelectric
aminoterminus
unfed
midgut
synganglion
treeinbud
cikcontaining
micaexpressing
immunotherapyblinatumomab
boxed
counterfeit
cellstype
foxp3cd4cd25hicd127lo
müller
lymphocytesfollowing
tumoritropic
sirnaloaded
symptomaticallytreated
feverreducers
imagingsignaling
tissuetumor
fceffector
yeastsurface
mhcclass
aptamersover
drugassociated
20082013routine
countriesmillions
backing
painlessly
challengesfungal
malignanciespatients
neuropathiesimmunotherapy
p6371
p307319
pam2cag
3for1
womenfocused
verbalized
rd026
rd039
pamphlets
aerdbackground
tetrad
clinicalsurgical
4330±1419
reviewuveal
metatatic
frozenbanked
robotassisted
ectm
36154
postovarian
freeriders
selfinterest
dispenses
behaviourincidence
provaccines
explantisolated
ccr7cd45ro
cd28negative
glucocorticoidresistant
coveragehuman
immunityobjective
gliomain
microenvironmentevidence
tumourantigen
informationrich
antivaccinators
fencesitters
betsch
melanomanovel
tcelldominated
ctlatargeted
ctla4blocking
clinicthe
anticheckpoint
directionsbased
cancercommon
predominatedbackground
neuraminidaseinhibition
2385
householdacquired
antibodythis
11710
gmi
equipmentreagents
redress
¹ludotabn
c825gpa33
immunoconjugatesobjective
hua33mediated
dotabnradiolanthanide
hua33c825
177luor
86ydotabn
tumorkidney
singlecycle
177ludotabn
500mm3
dosimetrydiagnosis
triplestep
53657
communityover
minnesotans
asserting
permeated
selfinjector
transmigrated
barrierobjective
213bi2556
bi2556
transmigrate
bi1418
transcytosis
vaccinesprogress
cellslactobacilli
transplantationanimal
resemblance
lpj
h2kbc57bl6
gvhdspecific
sclerodermalike
mihamismatched
6889
weeksmonths
preprobiotics
safesuccessful
serumhalf
lifethe
fcrnmediated
antisa
hudvfab8l
44fold
auc0
improvementbackground
401514
551769
205394
lipopolysaccharidederived
lpsderived
ly6cly6g
cellmedicated
mdscbased
alternateday
boostrix
threads
intercoder
6544
6223
4067
safetyfocused
vaccinationadverse
cardio
patientsadvances
constructor
ddp
cfselabeling
5741420
871420
1071420
leukemiaonly
programbe
diseaseearly
lawbackground
vexed
legislating
compulsion
impinge
cd4cd49b
severitypromising
foxp3negative
latters
infectionincreasing
rag2or
1213years
n2387
97606
instigates
ebmtdespite
4635
monosomalkaryotype
nonmonosomalkaryotype
ci129273
hr171
95ci127232
95ci132248
eightdose
antileucotrienes
abciximab
hypersensitivy
stateinduced
communitary
fuller
mils
mil
experienceadoptive
lymphocytess
etcs
wellvalidated
numbering
daterecently
questionsautologous
advertised
functionrecovery
allodepleted
linesclones
schedulethe
wilcoxonmannwhitney
49months
italybacillus
6y
tstnegative
immunotherapyprogress
perspectiveuntil
vaccinationunlabelled
neutropaenia
05×109l
wise
crd42015017620
schoolssince
providersa
n3253
ci005
or069
ci050
78492
diabetesrelated
hrdef1
hrdef2
wolfs
isotopic
succinylmethamphetaminetetanustoxoid
antimethamphetamine
drugconditioned
succinylmethamphetamine
smatt
antima
inductionepicutaneous
cancersince
proteinsnewcastle
ndvonly
reservoirsunlabelled
cd4bindingsite
vrc07523
glycandependent
omalizumabplacebo
tennesseethe
vaccinesthis
unfamiliar
spaineliminating
oncoimmunotherapy
inhibitorsoncolytic
imabs
particularities
toxicityimmunerelated
eventsare
malignanciesseveral
hlaalleles
classii
hematopoiesisrestricted
responsesynthetic
nanofibrous
nanofibers
nucleasemediated
franceto
3213
peopleninetytwo
avictoria208clade
aperth162009clade
avictoria3612011
protocolsallogeneic
homozygosity
n218
engraftmentmany
90yanticd45
30f11
sjl
leukemiabearing
90ydota30f11
ritmediated
viremiaimmunosuppression
tacevr
34529
398866
tacmpa
1456
slit1
slit2
esurvey
julyaugust
executioners
cryopyrin
infectionsfungal
gamut
deepinvasive
benchbedside
underappreciation
nonexhaustive
mycotic
futurepassive
hivsince
micetoxoplasmosis
organelle
tgmic1
tgmic4
tgmic6
tgmic14
tgmic146
makingchimeric
antibodyt
89zrdesferrioxaminelabeled
cysdiabody
89zrmaldfo169
cdb
anticd13741bb
ovulation
moet
supranormal
inhibins
ovulations
superovulatory
parthenogenically
ivmivf
balancethe
haematopoetic
il23t17
926years
age2118years
sd248
age2065years
sd229
querying
initiationcompletion
44114
30114
4498
2898
survivorcontrol
or1124
3154014
or728
1892805
or1055
1596992
or014
275500
1203
137886
41183
2015recommendationsthis
paperseptember
therapygenerated
vaccinesphotodynamic
pdtgenerated
photooxidative
sccvii
donorantigen
cd122
intratesticular
fluorescenceactivated
setsaccurate
peptidealone
visualising
datamass
balochistanfederally
carcinomaalthough
eggyolk
diseasesa
reviewpassive
autoimmunitycd4cd25foxp3regulatory
apoptosisantigen
pd1manipulation
canceractive
n16701
n100206
048051
hr048
047050
•uptake
•refugee
•several
clmediated
criteriacapturing
immunooncologyto
20091523
2009741220
leukemiapoi
oncarbide
cmlsct
menstruations
intensity0
mamptriggered
effectormediated
arabidopsis
syringae
dc3000transcriptional
microbialassociated
mti
dc3000
dc3000hrpa
chloroplastassociated
ubiquitinrelated
abscisic
menseveral
1·713·67
413patients
nonimmunotherapy
mianyang
studyhepatitis
82±41
230miuml
aspecific
physiopathogenesis
japanwe
ebmtincreasing
9011
recedes
melho
colo38
skmel37
brafiresistant
brafir
11828
byroad
freewaychimeric
unparallelled
immunotherapyconverting
applicationstherapeutic
nontcellselective
interferonsimmune
alemtuzumabimmune
natalizumableukocyte
disuss
pillarstone
surveillancemonitoring
n63382
28336
vacation
effectwe
kt6486
tregkg
cd4foxp3cd127
7895
2467
kt6486expanded
20042013
cpgodnsthe
cpgodns
spg
da40
cpgdaspg
ova257264daspg
cpgda
peptidedaspg
leukemiarelapsed
polio3
84–86
antifhbp
vaccinefhbp
fhhigh
fhlow
c4b
antifh
paperaugust
wkly
201590august3543360
201085october40385400
201489july3033744
californiaobjective
£110
£70
crd42012003192
diabetesboth
2648
antihyperglycemic
2485
vehiclesimmunostimulatory
tilt
warriors
ptiv
immunochemotherapyexpression
ptivd1methyltryptophan
crosslinktriggered
autocrinesignaling
idoahril6
nonlinked
cd134dependent
hbsagpulsed
complexbackground
lewisbrown
postoperation
hbsagdc
tcellscentral
rvv40l
rvv40linfected
nonprofessional
psoriasisinterleukin
therapiessecukinumab
brodalumabhave
structuresthe
thompson
pdcd1recently
kirc
datein
p0006these
chemotherapythe
costintensive
antiepithelial
practicefocused
burdentickborne
borreliosis
tbds
underadministered
αamino3hydroxy5methyl4isoxazolepropionic
acida
gabaar
aeroallergenspecific
aeroallergensensitized
governmentbased
custodian
immunizationsupport
motherstobe
adenovirus4
syndromefowl
fadv10
2397bp
95kda
inspite
fruitsbackground
1750
27019
type1derived
uninjecteddistant
iiibiiicivm1a
arthritisthe
arthropathies
ifx
cartilagemesenchymal
racpcs
potenial
il17af
runx2
chondrogenesis
ibdfundamental
cancerback
futurea
mrcc7
individualisation
parametersduring
bdep
cd61
analogies
catchy
wartsdiphenylcyclopropenone
fingernail
toenail
blister
coefficient3251
coefficient9950
9694
yudin
giovanni
calibita
fatebenefratelli
18309
19972012
048295
050402
5584
or145
ci95129164
or122
ci9510871379
managementaboincompatible
aboclkt
1032including
caseswere
abocompatibility
059322
p0455
013072
safetya
53twentyfour
mmrvmmr
112160
measlesrubellalike
144145
groupsmmrv
committeediseases
ciq
commentaryvaccination
mediato
publicmay
gendered
folatemodified
fplppil12
frαtargeted
lipoplex
fplppil12treated
fplppll12
beltbackground
psatt
isrctn82484612
psatt004
pactr201110000328305
psatt007
octobernovember
bobodioulasso
antimena
f8238
sbaref
3125
sba3125
827899
959987
776897
787897
759fold
5188fold
1056fold
29yearolds
20102014background
smoothly
lowand
exemplifies
nra
siil
dcgi
mvp
isrctn17662153
psatt001
isrtcn78147026
psatt002
isrctn87739946
psatt003
isrctn46335400
psatt003a
ctri2009091000368
psatt005
pactr
atmr2010030001913177
psatt006
cowsvaccination
hksa
sbocd40lt
hksaspecific
noncore
54198
107181
55185
42183
62103
52103
181199
190203
boarding
kennelscatteries
165203
142203
interscapular
137198
kennel
cattery
mitesbackground
abellò
nct01678807
226889
r560
r568
113068
115351
8172
11670
628121690
quadrants
keratouveitis
keratoplasties
nonmmftreated
mmftreated
transplantationalloreactive
deficientμmt
allosensitized
relatedness
café
onlineforum
relatednot
possiblyprobablyunrelated
immunisationrelated
p00075
p00236
p00266
controlbrucellosis
trialreducedintensity
160mgm2busulfan
128mgkg±total
200cgy
responsepartial
leukemiastringent
modelsamong
aβtargeting
as03badjuvanted
as03b
nct01379937
aturkeyturkey12005h5n1as03b
aindonesia052005h5n1as03b
h5n12
havh5n1
aturkeyturkey12005h5n1
h5n12h5n1
vaccineh5n1
vaccinehomologousheterologous
h5n1as03badjuvanted
vaccinehomologous
h5n1as03
miceprofilins
actinbinding
profilins
rncpro
soybased
antiprofilin
rncprovaccinated
rncproimmunized
ncpro
pbsvaccinated
crx601
methylglycol
pluronics
phospholipidpeg
pluronic
fluspecific
brink
alexander
lesokhin
sigurdsson
r01ag020197
asuni
neurosci
20072791159129
modeldisease
immunogenantibody
dyebased
immunotherapyplants
valorization
α13galactosyl
epitopeenhanced
antiαgal
β2macroglobulin
preinterventionpostintervention
2011march
2268
5030
fixedpost
eightday
63057
43485
35399
27658
spat
spitting
karen
reactor
mastocytosisbackground
yokohama
programyokohama
isogo
junjul
octnov
0184
sclerosismagnetic
t1biased
18617
2044
027065
119150
or134
or113
or118
menafrivac®
boucle
mouhoun
svyglm
ora253
153417
ora306
136691
salaried
ora014
002087
ora025
011057
ora051
radicalinduced
bremachlorin
chad3eboz
mvabnfilo
malians
arb
nct02231866
nct02267109
ringvaccination
frederick
autoimmunitya
groupimmunotherapy
neurooncological
sulfosuccinimidyl4nmaleimidomethyl
gp1002533
peptidecoupled
sulfosmccconjugated
gp1002523
gp100tetramer
easyhandled
fntα
irn
x2
4391
prealbumin
volition
coimmunisation
proteinonly
radiosurgical
metastasesobject
rntric
106544
018078
bcgadenovirus
85a
endobronchially
bcgad85
granulomata
bcgad85a
maintenancein
ncr
catches
controlthe
cancergermline
histomonas
meleagridis
isolatesin
poults
histomonosis
recordable
liverpool
studysuboptimal
72351
82·5
81·283·7
93·4
92·794·2
65·3
64·467·4
89·491·2
1·70
1·451·99
1·221·52
strategiespertussis
195000
735±254
locality
1919±239
3216
aptamertargeted
deliverymodulating
aptamerdrug
scratched
replyrisk
acquiesce
locale
227μl
theater
guidelineobjective
psv
austere
treaty
lws
prepsv
postpsv
2159
0101
2514
woes
transplantmajor
differenceadvanced
varices
9923
zonesexperience
nigeriathe
8day
685674
113774
608964
111570
taudirected
tauopathiesimmunotherapy
rtg4510
mc1
gallyas
ventricle
springboard
immunocombination
201415the
immunisationspecific
283621
practitionerdelivered
wholeoflife
nucleotidebinding
repeatcontaining
pyrin
aluminduced
nlrp3inflammasome
sensitizationbackground
predates
tewl
corneometer
nonlesional
noneczematous
vak694
13weeks
il4producing
il4il10producing
alarger
statusto
amltaml
farmsthere
anaemiathe
experiencethis
±42
flucy
clinicohaematological
aiims
delhincr
7the
283with
nsaa
gmdl
2700mm3
380mm3
0000mm3
thirteenpatients
countriesthis
anaemiaimmunosuppressive
sepsiscells
sepsisthe
adqi
nonextracorporeal
analyzeda
aeras402
primemva85a
nct01683773
metaanalysisa
overtly
her3erbb3cancer
erbb1
her2erbb2
catalytically
her3erbb3
antiher3erbb3
nurseadministered
workersunlabelled
selfvaccinated
intanza®
513726s
936s
nct01665807
pregnancya
hemaglutinin
disappears
aapsponsored
661666
87680
21680
34668
43680
63680
29680
psoriasisobjective
19742014
pubmed19662014
library20134th
11141648oror8545
391318658
or836
1240
italyit
812013
7312014
12288
5265
279398
395°c
blotches
1010matched
cellulairebackground
0156
021073
030090
003091
011087
029080
011193
022106
046101
100103
oncologyblood
0502objective
diseaseinflammatory
dismiss
peds
providerpractice
physicianpractice
534815
alwaysoften
1401719
1081531
174785
challengesalthough
aspsts
aspst
cd4specific
cellsperipheral
cd4car
cd4expressing
cd8cd45rocd62l
cd4carexpressing
ablating
smallfiber
ganglionopathiesthe
cfibers
adeltas
postganglionic
sympathetics
innervate
sweating
sfpn
ganglionopathy
rudimentary
smallfiberpredominant
ganglionitis
exacerbationsobjective
cantabria
pfeadjusted
035084
fpeadjusted
016065
041140
011048
721898
scourgebackground
lasuth
ikeja
65±32
trismus
autologousstemcell
e0
miceheatshock
rosseta
2r2
e0hsp70
fludarabinemelphalanbased
subq
cmvepsteinbarr
yorkpresbyterianweill
cmvebv
selfdisseminating
diseasesmodern
spate
injectionmediated
collagenase
radiactive
hyrodynamic
reation
frequences
achived
874at
societycurrently
nonbacteraemic
typesin
pneumoniaii
spondyloarthritisaxial
axspa
nonradiographic
nraxspa
syndesmophyte
leukemiaoutcome
refracter
2487
refracterrelapsed
extractbackground
beliefstwo
frameworkscultural
vigilancepredict
mythsthe
reiterated
fluad®
fuelling
dispelledmoreover
compatibilities
volvol
singleextract
refrigerated
20092010background
recreancy
n968
failureprimary
staffreported
sd18
visitrelated
roundtrip
programshuman
remindersmany
controlrotaviruses
rehydrating
7vpcv
19942000
13vpcv
n230
n1993
23vnon7v
non7vpcv
10vpcv
121kt
15mgkgday
104223
22934
1061223
orwithout
aretrospective
igt16
1703
091followup
igt8
titers4
bcellpositive
datarecent
whochoice
23112828
instinct
apriljuly
n31668
tendering
antilps
trinitrobenzene
iggenriched
imm124e
tregsbased
pertussispoliomyelitis
excepted
uvr
pyrimidine
watershed
receptorarmed
hemizygous
pulldownsirna
srsf3
skipping
fhsps
karnatakatwo
fsw
workconducted
fhsp
karolinska
cortisoneresistant
iq
glioblastomadespite
hardest
immunotherapyand
systemis
lexicon
neurooncologist
neurosurgeon
germane
etcthe
cellsor
therapygenetic
upscaledautomated
11112
signalment
vaccinesto
iems
diphtheriatetanuspertussisinactivated
3124
eldorado
therapyplasmacytoid
celltypes
polyallergen
discontinuance
resultafter
differencep0
p0
methed
allergenssymptom
serums
threegroup
esige
spss13
pidilizumab
119226
049107
5781853
thermogels
gelling
ctgels
ctgel2
unblinded
zambias
resupply
1576
2441
retests
memo
nct02479659
2013human
15–59
11–12
ncqa
hedis
0–34
5–52
neuraminidasespecific
h10n8
miceunlabelled
h10
n8directed
h10directed
hireactive
h10n7
h10reactive
n8reactive
antin8
antistaphylococcus
micestaphylococcus
acini
hurdlesvaccination
immunotherapyinterleukin2
lowerincome
agencydecisionmaking
movementand
accessobjective
3573
panad3rsv
mvarsv
rsv001
1850years
panad3
6075years
ccvtm
mhra
nres
13sc0023
nct01805921
morebackground
recorder
autoimmunityneurological
compliment
abnormalitiesobjective
thrombophilia
gr2
gr3
gr4
prophylaxisrespiratory
lanesexisting
bidimensional
time×age
grids
recaptured
longendorsed
attractively
aerosolizedboosting
hn878
micemycobacterium
bcgprime
numberdependent
postoit
typhoidunderstanding
orallyvaccinated
systemsviruslike
mmolmol
ethnicracial
15316
4063
096123
062090
052084
preservativefree
kenyathere
10valentpneumococcal
11500
caregiverreported
58288
24054
19702
14532
037406
midway
012856
014054
cellscytomegalovirus
streptamerselected
hlaa02nlv
talenmodified
nlv
sublethally
jnpl3
heattreatment
pantau
artifactual
n1905
p08067
nct01385371
33rd
33rd67th
67th
trae
13pneumococcal
penicillinsusceptible
nowsublingual
grasspolleninduced
vaccinationciting
micegenetically
f9
algorithmsthere
2010april
diseasesschoolteen
gordian
helixchemotherapy
nononcogenedriven
ctla4pd1pdl1
outcomewe
vmdv
4000plaqueforming
500pfu
ft158
mpf57
mardivirus
14dpc
21dpc
isolator
56dpc
eggsnewcastle
albumen
eggshell
mexicohepatitis
20122036
peso
mxn
14961qaly
78280qaly
icurs
ho1212877
laterobjective
6400
desensitising
researchthis
socialcognitive
selfidentification
calicivirusobjective
cylap®
rcd
abrasions
scabbing
281months
141498months
212kg
208kg
01856kg
selfresolving
2693
n1402
695years
2861
p0457
p0243
interleukin15transferred
modelgastric
il15transferred
il15irestk
bgc823
il15irestktransfected
il15irestktransferred
il15transfected
ezh2mediated
trimethylation
h3k27me3
dnmt1mediated
immuneevasion
lonomia
obliqua
walker
problemlonomia
moth
saturniidae
rainforests
bristles
evaginations
underneath
spicules
crushed
chitinous
venomous
erucism
butantan
misiones
caterpillarinduced
samic
iguazú
antilonomic
circumscribed
nonbulbar
multilocular
alpha2b
psychooncological
brafv600einduced
modelpapillary
lslbrafv600etpocre
thyroidspecific
scil12cmvpdna
mril12
il12mediated
antitgfβ
mhagdirected
29155
2decades
n412
n487
immunotherapyexosomes
40120
endgoal
88months
italianministry
transposed
96higher
disproving
51focusing
numberissue
97higher
vaccinarsìobjective
rampant
computermediated
860411
1099670
2530416
and1824
53and
7of
130241
58241
258463
141463
presms
tread
cautionlive
writeup
koebnerization
calmetteguérinvaccinated
koebnerizationpositive
tstpositive
0413
transplantationno
cytotal
adjbw50
forlymphoma
conditioninghaploidentical
flucyclophosphamidetotal
fm100
cllsmall
cd117cd44cscs
preinactivated
cd117cd44csc
vacccinated
envaluated
cd117
cd44csc
cd44cscbased
hfe
h63d
conditioningbusulfan
sinusoidalobstructive
syndromesos
overdosewe
busulfan–fludarabine
defibrotideliver
hemochromatosisboth
firstknown
dawns
immunizationigg
biantennary
iggcoated
iggfcγr
sarcomakaposis
sclerosisprogressive
childrenallergen
intensifies
uncontrollable
attackers
healthallergenspecific
ordinance
beewasp
emaeu
medicalscientific
formalistic
geneticallyrelated
taiwanthis
110451
145376
4161122
426934421
6769
164027941
141378
interleukin68
chemoimmunotherapyobjective
wt1dth
il68
dnh
3070
disordersdiseasemodifying
prophylaxisfluoroquinolone
fq
treatmentprophylaxis
valve
2947
1747
1047
8x
cytotoxicitycancer
tnffamily
cd11ccd8
iiiassociated
faslmediated
reactivityprominent
arterioles
ponezumab
antiamyloidβ40
plaquebearing
arrestance
factory
5·49
1·2923·4
5·65
1·0929·3
windborne
nonoccupational
dolorimetric
fiq
sss
bbrisbane
studyionizing
99mtclabeled
anticd4r1
6206
1507
300mm3
nonlymphopenic
16–23
10–25
polyfluoroalkyl
1219yold
pfos
schwartz
gmcsfproducing
therapyb
il10expressing
stat56
gmcsfil10
cellmyeloid
commanda
allergya
incidenceprevalence
ejaculate
sptypical
spatypical
spfree
insemination
tacrolimusalthough
myelodysplasiarelated
infectionstaphylococcus
savacpcab
neutrophildependent
cd11cmhciicd45racd8
cellactivated
2920
hives
3182
liverrenal
postebolathe
immunotherapymethods
cholangitisobjective
igglevels
mhai
00274
antiinterleukin33
synthaseobjective
antiil33
nosescratching
igflc
hivseropositive
dakar
architect
hivhbv
hlhgraft
apc8015
20132014in
ukrecent
immunotherapytalimogene
rmpv
306396
305937
retrovirusinfected
felv
virusdefining
oncornavirus
felvinfected
trialdespite
050069
054089
033068
034111
richters
immunotherapysince
bubbleassisted
vaccinationbubbleassisted
bubbles
permeant
cytokineencoding
therapieschemotherapy
exposurerelease
3ifncxcl10
immunotherapiesautologous
therapyafter
allogeneictransplantationfor
middleintensity
midi
hypoallergic
generalizing
slait
subcutaneousversusslait
homeadministrated
subcutaneousallergenspecific
scait
scversusslait
cytokinecapture
gammainterferon
cancermethods
hyperadditive
tlymphocytedepleted
micepneumocystis
cd4depleted
murina
allergystudies
028month
021month
015month
revaccinationseasonal
twoseason
assortativity
102202
041113
116345
characteristicsvaccine
lactisexpressing
gutthe
gagp24
llgag
ankaragag
controlebola
hypothesise
h120like
m41like
ckchlhb111172
ckchlsd111219
ckchlhb130598
ckchldl110931
ckchlhb130573
serotypically
littleknown
smallairway
chemotherapyallosct
female24
male51
age47years
airspace
impactions
grade0
grade1
±27
selfnanogels
chaperonlike
selfnanogel
edging
disappointed
26320
payerspecific
xenoimmunosuppressive
invivoobjective
hdscs
xenogenic
xenostimulation
mitogenic
strainindependent
105106
hdsc
prostaglandine2
106hdscs
xenoreactivity
pleurotus
nebrodensis
mgkg2d
downfall
assaysresponse
rediscuss
outlookevery
bedsidepredictor
antitnftherapy
endomicroscopy
5589
24612
acwy3
acwy4
cwy
88100
nct01214837
failureby
apolt
isp
recovers
fhf
liberating
preteenage
strategieshaematopoietic
immortalised
hsclike
hpc7
releasate
pmps
intravitally
confocally
micehealth
hydroxidealum
lactoferrininfluenza
threedayold
hemagglutinin200μg
hemagglutininalum
lactoferrinhemagglutinin
2015following
januarymarch
presummer
1839
hastens
chickensadministration
gallus
embryonation
spafas
cd45mhci
cd3mhcii
shaminoculated
concavalin
phytohemagglutininl
（hsct）
bucyfluarac
bumelfluarac
rregimenrelated
disease（gvhd）
bmfa
bcfa
group（p005）
difference（365
p0100）
group（p0400）
group（43）was
（250
p0009）
were（718±67）
and（761±63）（p0852）
were（678±89）
and（761±63）（p0567）were
cyftbi
bmm
singlecenterobjective
transplantation（allohsct）in
lymphoma（nhl）
talbody
irradiation（ftbi）based
flange
mitoxantrone（bmm）
（agvhd）
（cgvhd）
（trm）
（rr）
（dfs）
survival（os）
05×10l
50×10l
（range
72）
ⅰⅱ
months（021491
months）
survival（os）was
survival（dfs）was
rate（rr）and
mortality（trm）in
microenvironmentrecent
canceralthough
clinicimmunotherapy
medi4736
msb0010718c
hees
groupwork
andorif
applicableto
contras
hee
kir2ds4
kir1d
siblingrelated
aoutcomes
2ds42ds4
2ds41d
1d1d
2894
4444
0159
4221
12124
0574
0361
5106
3401
0314
chromosome‑positive
tkicombined
gryfino
95ci505601
doses181
95ci93
95ci44118
reengages
riskofbias
policymakerfriendly
crd42014012888
considerationsas
diseasecombined
tcellsadoptive
transposonmodified
otimelanoma
genemodifying
p35p40
luciferasemodified
mil12modified
immunotherapyboth
betaamyloid
fluorescentconjugated
wt40
22w40
selflymphocytes
30monthold
stratificationthe
peptidesselfassembling
developmenttwo
whitehouse
electrohyperthermia
meht
tradename
oncothermia
autofocusing
electromagnetic
protein70
mehtdcs
mehtdc
orchestrator
taxi
taxicab
desires
understaffed
waysobjective
elizabeth
milleralthough
miller
hesitators
therapyobesity
obesityrelated
kagoshima
cellsimmunosuppressive
isds
rapamycintreated
nanodeliveryultrasonic
insonified
locallyadministered
cudox
temperaturesensitive
insonation
locallyactivated
chileobjective
distort
diseasesit
malariathe
virusimmunosuppressed
macaquesprogressive
oftenfatal
leukoencephalopathylike
sv40infected
pmllike
celldefined
interleukin2il2has
therapyactto
tcartcells
ttcrtcells
progressstreptococcus
shocklike
wellencapsulated
panebolavirus
panfilovirus
virusesunlabelled
bundibugyo
reston
biodefense
uas
updatetoxoplasma
nonreverting
noncystforming
wuxi
mnsm
709vs
15202
1384
1144
1476
blockbusters
relationsthe
molecularbarcodebased
nct01985412
posthearttransplant
0867
0968
wheezeasthma
infectiontickborne
neuroinvasive
th1specific
lineagespecifying
ccapsid
prmmmembrane
eenvelope
tnfαil2
responsesconsistent
patternsless
nct00660452
2x2
histopathologybackground
histopathologysurrogates
4142009
mofetilsirolimus
nct00556933
polysaccharidesmany
treasure
circulationpolyreactive
therapyimmunotoxins
autografting
beninchildren
innovatively
benina
vectorsviruses
vectortargeting
discouragingly
phosphatebindingprotein
psts
mutansbacterial
atpbinding
pst
abiotic
smutans
rpsts
asecreting
ng8
878100
quanity
microelectrodes
dielectrophoretic
pdep
infusionobjective
cd4cd25proportion
0ii
shades
steeper
candidatesdespite
1055
5651971
012047
144551
108314
lowfraction
vsvmediated
vsvtaa
211atmx35
rbeweighted
perchlorate
niscontaining
γcamera
rbe
mgy
mbql
tissueweighting
microenvironmentseveral
activitywe
immunochemotherapyobjective
lnh2003b
groupe
ouestest
leucémies
aiguës
sang
goelams
logadditive
rs7712513
5q232
snx2
sncaip
rs7765004
6q21
twosingle
pre2013
19952009
£qaly
m£
15829
longperiod
roadmapas
vaccineschimeric
pestiviruses
pestiviral
exemplarily
vaccinesparamyxoviruses
widevariety
developmentheterologous
herpesvirusbased
animalsin
prelicensing
swinepox
developmentpoxvirusvectors
spv
virusmodified
foreignheterologous
mvas
orbivirus
orbiviruses
laboratoryscale
vaccinesreplicationdeficient
vaccinesadjuvants
recallable
adjuvantantigen
modeldna
vaccinestrategies
ictagging
epitopeloaded
vaccinationparticulate
reoviruses
overviewa
provincesterritories
physiciandelivered
postvaccineprogram
postprogram
healthdelivered
lowerthannational
resonating
doubted
inroad
healthover
vaccinologistsa
termitestermites
forage
subterranean
termite
reticulitermes
chinensis
entomopathogen
metarhizium
anisopliae
allogrooming
fungustreated
termites
nestmates
conidia
termicin
l23
mrm
1yr
drecipient
ganciclovirresistant
cmvrelated
blockadeas
cellscurrent
mencspecific
mencpsspecific
targetsobjective
nonmhcrestricted
onearm
034092
056130
064102
019062
064097
leishmaniaspecific
leishmaniasisin
lihyd
il12driven
parasitemediated
antilihyd
lihydspecific
allergyover
allergentolerant
nonrespiratory
residentsobjective
realityit
moisturizing
donorsthis
thiotepafludarabinebusulfan
pharmacodynamicmonitoring
therapyforthrombotic
hematopoieticstem
transplantationthrombotic
sc5b9
237mlhr70kg
prtreatment
phagepeptide
displayphage
antifertility
phagegnrh
5×1011
vir
gnrhspecific
2×1012
gnrhlike
ritbased
0·006
0·01
stableprogressive
1·14
0·04
0·36
0·14
glyconanoparticles
applicationsglycomimicking
glyconps
förster
acceptor
benzoboroxole
propertiesobjective
th1promoting
donormatched
fdc
th17polarizing
th2polarizing
dioxigenase3
fdcprimed
2993
tumorsexisting
1416month
ipilumimab
gbminduced
immunodeficiencyimmunoglobulin
selfinfusion
lactationthe
kv
synchronizationtimed
tai
n692
doubleovsynchtai
doubleovsynch
n336
vaccinationdefined
taiwas
synchronizationtai
antiglycosaminoglycan
miceatherogenesis
gagside
speciesmediated
antiatherogenic
chp3r99lala
antichondroitin
ldlenhanced
highcholesterol
atheromas
nfκbregulated
antigag
ahaemophilus
hia
humanrestricted
antihia
individual׳s
nontransfused
recipientspecific
surveysbased
68490
19982010
078092
065096
063089
073097
055078
022035
multipleyear
wrap
ijd
ireivac
imidiate
antipyroglutamate3
appsweps1δe9
micepyroglutamate3
pglu3
3a1
071immunized
hippocampaldependent
tand
25173965
065247
7434628
022663
1090279
lancaster
wellconnected
nkmodulated
pramesllqhligla2specific
neuroblastomaspecific
organosilane
vivocytosineguanine
mmsna
mmsnp
msnsbased
kongpneumococcal
2296
705281
376967
6122
172185
37727
2688
74000
21600
pcv13s
chemoimmunotherapychemoimmunotherapy
waterinsoluble
cytosinephosphateguanosine
odnencapsulated
pcns
rnaencapsulated
pins
haptx
tumorrecruited
hostcommensal
hostmicrobe
micewhole
antiplasmodium
circumsporozoitespecific
noncircumsporozoitespecific
wholeparasite
mouseparasite
procrastinate
questioninvoking
yaaris
quasihyperbolic
discounters
presentbiased
futurebiased
killingbispecific
iispecific
coltreg
flowcytomix
interphotoreceptor
retinoidbinding
irbp
il10high
il4low
ifnγint
factordependent
implicationsobjective
radiationelicited
111intrastuzumab
therapies111inlabeled
nls
111intrastuzumabnls
aerit
111intrastuzumabnlss
kbq
nfkbrelated
trastuzumabnlsl
111intrastuzumabnlsl
majorbidirectional
minorabomismatch
meningitismumps
pneumoniaerelated
8116
10776
5025000
us45682
377000
us3427
11000000
us113636
judging
programmne
photoimmunotherapyto
nanodrugs
idflu
imflu
reanalyses
098107
099104
098108
09712
patientscutaneous
thicker
straindependent
reductionbackground
viremianephropathy
hlaspecific
dndsa
bkpyvviremic
viremiapersistent
viremiaresolved
singleinstitute
mgm²
4601589
193577
04216
12dioleoyl3trimethylammoniumpropane
3βnnndimethylaminoethanecarbamoyl
dcchol
dotapdcchol
immunopharmacological
sclerosisinflammatory
myelinreactive
cellscancerinitiating
csccancerinitiating
csccictargeting
crmet
heatstress
thermoneutral
hypersensivity
crkg
heatstressinduced
modulationdespite
th2only
th2adjuvants
0902background
nonpro
centerspecific
imvamune
nct00316602
europein
chmp
4587
cellphone
2359
112153
112150
120154
141254
3394
biopower
foucauldian
controversythis
10th90th
24009400
7300
430011
girls4valent
42001
21001
inhibitiontumor
x8del
8bp
individualsuniversal
versant
hbxag
hbxags
transacting
fludarabineconditioning
outcomeslimited
ric1
ric2
1579
17284
567701
88185
149261
tgspecific
tgpeptide
beforetreatment
nasaloropharyngeal
2767
028068
319725
glycanbased
lymphomasleukemias
siglectargeting
lymphomaleukemia
visitsreminders
postenrollment
infanttoddler
micehelicobacter
rureb
ureb317329
ureb409421
radiosensitisation
synergycheckpoint
radiosensitising
pregnancymultiple
pmid
25747273
inhibitorsdiagnosis
acla
antiβ2glycoproteini
antiβ2gpi
anticcp
addictionimmunotherapy
psychoactive
phencyclidine
addicts
psycho
thaws
virustransformed
ebvlcls
day35
444321
6092
16520947
pbmcderived
mandatesbackground
mmr1mmr2
6492
2558
4990
1663
vaccinationchronic
chbi
adolescentsvery
covaccines
mycoides
mycoidesinfected
inflammationcontagious
cbpp
mmm
cattlemmm
mmminfected
cellto
biosignatures
postspecific
postsit
transfusionmurine
b10br
helexpressing
helpresenting
antihel
earlyinduced
receptorinduced
melanomaletter
kw0761
ccr4expressing
dualreceptortargeted
radioimmunoconjugatesunlabelled
bsrics
peg24
electronemitter
177ludotafabpeg24egf
mdamb231h2n
trr1
111indtpafabpeg24egf
nunu
trastuzumabsensitive
trastuzumabresistant
177ludotatrastuzumab
177ludotaegf
growthinhibited
93foldhigher
futurehuman
hpv11
avertable
verrucae
plantarisbackground
plantaris
luerlock
tissuedestructive
12·8
nct01191957
27·5
9·844·3
17·2
11·625·4
7·9
4·314·3
grays
agenzia
farmaco
gcsfto
cygcsf
20×106kg
days6
to2
day2
nct00772811
mayaugust
svis
mvis
multipart
sd57
sd92
b0315
b0197
b0191
b0230
b0213
b0117
b0223
immunotherapyepsteinbarr
ebvsts
postsolid
nearfuture
reportssublingual
noninjective
patientbased
inflammationb1
ontogenic
repertoireskewed
interleukin3
widens
jeanfrancoişe
borel
2709
normalbirthweight
nbw
scarnegative
anthraxthe
terror
vegetative
complementdeficient
antianthrax
raxibacumab
cycled
4810
882971
826918
916965
729851
19972012background
2997
bmrc
p34
nonserotypable
cc269
nineties
c2ap152
c2ap15
c2ap12
st11et37
wallonia
001100000
0103100000
135259
or140
101193
or071
052096
015029
unpacking
vaccinesrotavirus
5yrold
rvpositive
rvvaccinated
n3146
2m
parameterisation
reviewtrichomonas
vaginalis
trichomonads
inhabit
vaccinesrationally
lbtope
igpred
transmittedfounder
vrc10332
sivspecific
immunecorrelates
horizonsimmunologic
jutland
carnivores
boot
clothes
vips
days18
strokefree
63fold
arteriopathic
cardioembolic
somefewno
9011082
565616
antigenobjective
hbvpersistent
hbvtransgenic
humanliverchimeric
e6f6based
hdibased
e6f6mediated
recognises
gpckrtct
antibodyviral
interparticle
e6f6like
potencyobjective
karpas
k299
activationsuppression
interdonor
coaches
cep
c57bl
cepbased
mii
531421
358488
newfound
cancerlipid
tractobjective
pngvl4asige7detoxhsp70
hpve6e7
tahpv
nct00788164
threeobjective
2013august
5·20
6·62
7·26mm
4·35
6·72
7·98mm
2536months
5·92
7·97
13·5mm
5·86
9·10
8·17
7·71
12·92
17·32mm
9·28
18·81
19·62mm
1236months
islamist
insurgency
poliobackground
obstructs
200314
nonislamist
insurgent
insurgencies
assassination
osama
bin
fallacy
prosecuted
theology
counterinsurgency
espionage
bostonarea
15440
5582
46weeks
refrained
1018years
tenor
871915
trustmistrust
nkg2dligands
recognitioncancer
nanogpromotergfpluc
pkh26labeled
vaccinecontaining
crx675
azd8848
vtx1463
qbg10
pari
passu
slitbirch
birchpolleninduced
aunml
birchpollenspecific
nct01639768
followthrough
smoothing
nonpandemic
apresproject
austriabackground
118154
003013
142354
132640
plasmacell
unelucidated
plasmacells
specificigg4
secretingcells
igg4secretingcells
castlemans
rituximabbackground
375mgm2
adenopathies
apyrexia
negativation
hhv8viral
detectedbysurveillance
celltransplantationhaploidentical
gvhkirmm
kirm
hvgkirmm
pcd
movementsleep
rbd
polysomnographic
p24gag
p24siga
engulfed
3grabbing
nonintegrinpositive
pca1
antiyo
neurologistreported
nonparaneoplastic
nnc
65kda
2783
ataxic
ntype
wheelchair
p92
economicslyme
ivoirebackground
vf95
vf81
95the
anotherthe
papergame
trialsprior
2000050000
periodin
maternalneonatal
cellsenhancement
envelopebinding
cytotoxicitymediating
hivxcd3
obviating
superinfected
jrcsf
hivinfectedpatient
consultationsobjective
roleplays
evaluationidentification
travelbackground
leftover
lehigh
osteoporosisanticytokine
autocytokine
tiscai
ovx
p096
p082
recipientsunlabelled
reinvestigated
timeadapted
proteinsvaccines
imm
efb
lukm
scsc
lukmf
hostdefense
routedependent
rawalpindi
collegebackground
forma
age2936
lthis
microcapsules
lowimpact
immunoprophylactics
fitclabelled
modal
250750
fluorescentlabelled
allogeneichematopoietic
revieworal
dsr
whoncigraded
0421
nonmethotrexate
earlyactivated
dependencetherapeutic
carboxymethylureido
2position
2cmunic
6cmunic
6cmunicklh
2cmunicklh
antinicotine
igmhigh
hbmshpvv
hpvks
may2013
380±212
locationspecific
profilingbackground
selftaas
neuroblastomaras
vsvexpressed
hif2α
sox10
hif2αhi
oldtoold
recipientselderly
cumulates
seirs
gao
applicationsvaccines
obviated
il2monoclonal
tumorsus
timetested
ctlregulatory
anticd3stimulated
bacterialexpressed
lungworm
dictyocaulus
viviparuspreviously
ecpmy
strube
pastorisexpressed
pppmy
matrixq
ecpmymatrixq
pppmymatrixq
pppmyquil
viviparus
lungworms
rpmy
rpmyadjuvant
hlc
β0127
β0104
β0151
β0121
doxil
modelsbased
ucbdcs
dcsctls
stappvhnv
streptamer
mcf7lucf5
ucbctls
il12p70il10
pblctls
eosinstained
ucbdcsctls
pbldcctls
stollery
csfree
bmdbone
numberseverity
gcm
mgkgd
killingefficacy
fcαriexpressing
igas
iga2her2
a431luc2her2
19942012background
19942002
19942012
strokes
ipvopvopv
ipvipvopv
opvopvopv
ssba
wtba
nct01475539
micromanaging
aggregationcurrently
αsynucleinopathies
shikoninenhanced
componentsbackground
shikonin
sktcl
sktclinduced
moleculesassociated
divergencebackground
hunger
multiisolate
kiambu5
serengetitransformed
subtelomeric
8500
wholeorganism
chemoimmunotherapywe
hypersplenism
elasticity
resiliencenatural
cellinhibitory
reviewschool
girlswe
hopi
dinners
12131
mdsmps
45±4
huvecterts
vegfrii
α5
passage30
protectively
huvecneutralizing
huvecspecific
htertimmortalized
crmconjugate
acwy2
acwy1
64fold
conditioninghematopoietic
6656
retrospectiveobservational
invivoactive
taa‑specific
hhd
heteroclitical
peptidemodifying
antigen‑coupled
hla0201
tert‑expressing
ffv
betepitope
infectionmediated
epitopecarrying
nigeriaimmunization
resent
phcipt
150198
rrphcipt
147195
103145
mannosideglycocluster
triacedimannose
tadm
ovasensitised
pasteurization
omp19ifa
tmcomp19
tripolyphosphate
storybackground
cancerfocusing
immunityimmuneenhancing
upgrade
killermediated
tlr79
vaccineadjuvant
fibroblastscancerassociated
fapmodified
diseasewhooping
nondiagnostic
pendrin
exchanger
salinity
homeschooldoctor
governmentsupported
4631
us125250
allotransplantationsensitization
ecmo
designas
databasesbackground
smq
1797
1171
henochschoenlein
cuv
cnsv
behcets
corticosteroidinduced
lambsto
cynodon
dactylon
cpkg
succinate
exsheathment
womenunited
2014–15
31–april
1702
2014–january
cardriven
versushostdisease
personnelunited
2013–14
rediscovering
synucleinopathiescurrently
hypothetically
surveillancenuclear
nfatap1
nr2f6deficient
consultative
definitionsbackground
fetalneonatal
defibrillatorsbackground
cardioverter
icds
onepage
shadu
cao
sdcm
nonnal
mkg
005001
malignanciesepidermal
espideswi
europeduring
leipzig
espid
eswi
myopathiesthe
leveldependent
sod1peptide
g93a
sclerosisprevious
antipurinergic
p2x4
p2x4immunizing
aj10
mutantmisfolded
alslinked
tollfree
n216
373432
195216
178216
isrctn16703097
5aza2deoxycytidineactivating
rmbpnap
hpnap
s180
recede
evidenceimmunoglobulin
resumes
endorsers
2159yearsolds
screeningbased
2159yearolds
flavivirusseronegative
1845
tdv4
den1
den2
96100
den3
83100
den4
den13
flavivirusnaive
nct01511250
therapiesimmunotherapy
impinging
3031
2014ottawa
canadavaccine
medicago
synergyradiotherapy
releasingmesenchymal
blastsbispecific
continously
anticd33anticd3
scp1
cd137cd137
bsabbased
formatdevelopments
5502
6210
affirmatively
00167
cytoplasmatic
inhibitorsundoubtedly
06buml1
ratioor38
12224
or26
postiti
or05
00643
horsesickness
4development
ahsv
normalised
clc
workbench
rig1mda5
htlv1infected
htlv
58757
173230
256330
126167
178260
preroutine
postroutine
immunotherapyscant
immunoescape
ifnγirreversible
hlaa3
tapbp684dela
siteα
tata
approachpersistent
vlpsbased
typeassociated
decelerated
observationsbackground
antigenotype
4231
5450
ifnγil4specific
ev71infected
vaccineimmunized
bav3
sn50
guttateplaque
literaturemobile
19962012guillainbarré
5monthold
periostitis
venombackground
vqlq
preexposition
campaignsafter
openingthe
braintumor
fusinduced
metaanalysisit
nonaffected
1447
0732
06640808
0777
06290960
studiesdifferent
gscloaded
hematologyit
blike
tumorsglioma
tumoreluted
hsppc96
4694
i2883
65100
haplotypesextrarenal
c1236ct
rs1128503
c2677gta
rs2032582
c3435ct
rs1045642
thesias
ctt
tchol
triglyceride
ttt
sexadjusted
patientindividualized
cytokineoptimized
nodscidil2rcgnull
amlreactivity
routinelyrecommended
leveledoff
croplivestock
flu005
hivig
infusionbefore
261613
133232
nct02008578
immunotherapeuticphenotypic
brachyury
e2b
e2bcea
etbx011
e2bbrachyury
andmuc1
triad5
e2bmuc1
futurepancreatic
algenpantucel
mesothelinsecreting
antagonistsmembers
smac
iaps
dualpronged
adenocarcinomalung
glaucomatous
panretinal
malignanciesnumerous
heritably
invariantly
luckily
epimutations
hpvedu
year8
vaccinationday
actrn12614000404628
14042014
rituximababo
aldlt
n1301
lasker
legacies
hopeobjective
considerationsa
practall
reportsublingual
118754
042084
038084
nonallergoid
002068
cumulating
polychemotherapy
receptortolllike
receptornuclear
immunizationsrecommendations
perils
allograftsobjective
recipientobjective
lent
erythropoietin
50×104
bx1
centromeric
cenbb
cenb
bx2
bx3
bx4
hr256
hr252
cbb
cab
p755
p768
leukemianonhodgkin
andchronic
groupsmyeloproliferative
polycythemia
thrombocythemia
pmf
unmaintained
lowreducedintensity
eraowing
myelomanovel
bcmarelated
noncleavable
gsk2857916
nct02064387
vivoadoptive
amegakaryocytic
camt
500μl
000μl
immunotherapystem
coverageseasonal
ifpma
epidermodysplasia
verruciformis
dibutylesterepidermodysplasia
ßpapillomavirus
lymphocytopenic
iistudy
gmalltbibased
ahsc
nontbibased
2448
3765
nct00682305
280mgm2
autosctwe
n131
mel280
amifostine
062213
progressionmortality
052127
crncr
wordofmouth
wom
vsir
disseminates
australiavaccine
1338
lateselective
postsic
hladqb302this
hladqa1
test22
hladqb10302
002076
358917
523948
birdtobird
fivegrass
twelvemonth
1408
monoallergic
treatmentalthough
anidulafungin
livestockexperience
somalianomads
puntland
nomadicpastoralist
hamlets
26393
23099
12556
betterdesigned
cocktailmb003
or028
or032
or054
md1165
md818
saccharin
preexposed
gustatory
leukemiabefore
tremelimumabobjective
10166
affectors
teplizumab
radioimmonotherapy
bchronic
nucleotside
communitiesimmunization
jeev
qr
vaccinationpneumococcal
withpostengraftment
cd56high
ricaza
trialdisease
virusmultiple
earlyage
paramixovirus
ed14
38±
ed2
ed6
ed7
2500mg
460mg
101710mg
231kua
p00082
113kua
85kua
p00396
auc07957
p0007752
diseasestargeted
tο
zung
beck
t5ss
nct00969436
mmrvaricella
againstexposed
mmrvmmrv
43days
43day
immunotherapynicolau
vp2vp3
troutinfectious
birnaviridae
pet26b
personnelbackground
transplantationrenal
immunotoleration
2968
biliopancreatic
merkeloma
imp321
imp321related
combing
antipd1l1
allograftsbackground
ipscsderived
macrophagecolonystimulating
ipsscs
embryoid
safetyaustin
iranrotavirus
1231735
32092
158750
1019192
54680
15192568
laskerdebakey
receptorusing
c427z
c4opt27z
8894
8490
7783
7683
stakeholdersbackground
discussionsfgd
nonconforming
familiarized
primingwe
developmentswhile
austrohungarian
empire
1803
fra
fraspecific
fraexpressing
60th
205th
programfourteen
vaccinationfrom
3484
p005the
abortionprone
angiogenesisimplantation
umcs
sflt1
fetomaternal
strategieshepatocellular
adjuvantdangersignal
ns1immune
cellsimproper
maunfacturing
bm1305
puzzlesoluble
beatty
modhiran
0724
05960880
poloxamer
ppir
100220
venipuncturevenous
cannulation
smd097
smd010
smd025
smd057
smd005
smd082
n313
n196
n736
methodologically
n417
tactile
n145
tension
helpinkidsadults
helpinkids
picoas
fearbackground
quasirandomizedcontrolled
observerrated
strategiesevery
cliniciancancer
immunotherapywhich
cancercan
crucible
heels
outlasting
rb51brucella
primeimmunized
0612
cd8dominant
primevaccinated
primevaccination
underdetection
urv
175579
toddlersneisseria
840846
matchedcasecontrol
hrrs
6184
3088
akts6
pathwayour
α7
nachr
huimdcs
withex
dcsmediated
huimdcsmediated
dcspbmc
tapova
nicotineincreased
agpresentation
activitydespite
reviewliver
normo
oncologyafter
multivirusspecific
107m2
cellsprogress
remissionautologous
t11
301years
51years
238years
alemtuzumablowdose
alemtuzumabtotal
scdrelated
01499888
hemoglobinopathiesfiftytwo
0751183
subsidence
wwwclinical
nct00920972
nct01050855
nct02435901
epidemicreply
n328
toy
n368
n136
andmiddleincome
urbanisation
rum
rums
urbannonmigrants
cd205
clec6a
clec7a
siglech
pdctrem
genderrestricted
differentiation2
salinesensitized
genespring
hdmmediated
lpsbinding
tevagrastim
xmo2
myelogenousleukemiamyelodysplastic
syndromeshuman
neupogen
oaks
teva
nct01542944
5×
102×
935×
50×
toxicitiesand
tevagrastimmobilized
inthis
moredetailed
eci
nct01030809
66·0
14·0
61·9
10·2
p0·5169
27·7
35·1
0·73
abbvie
rtssas01induced
557632
98153
micebrucella
δcydc
δcydd
δpurd
δcydcδcydd
δcydcδpurd
rb51δcydc
rb51δcydd
rb51δpurd
rb51δcydcδcydd
rb51δcydcδpurd
2308
thelper1biased
prepostera
nonsusceptibilityserotypes
1990december
28124
3138
2161
22044
r20884
r20824
r20786
childrenallogeneic
chemokinescytokines
inflammationplasmacytoid
myelinantigen
chemerinmediated
preloading
cnsinfiltrating
pdcbased
177lubased
cd22specific
rituximabobjective
hurfb4
chxa″dtpaconjugated
177lulabelled
gene1
nodrag1
177luconjugated
95mbq
0510mg
chxadtpa
surveillancesolidphase
c1qbinding
defectors
nkd
0915
0189
αimaging
cd45positive
211atradioimmunotherapy
transplantationunlabelled
ca1210c12
intraorgan
αimagingbased
211atb10ca1210c12
115276
αcamera
iqid
011012
006008
unsaturated
lymphocyterich
gy166
mabkg
211atanticd45
zhankuic
taiwanofungus
camphoratus
responsesome
ergostane
triterpenoids
zac
dnfbstimulated
e2be6e7
confidencevaccine
rubinsteintaybi
rsts
sotos
beckwithwiedemann
chinaprevalence
0112month
vaccinedendritic
anticsc
cscdc
appraising
microeconomic
189205
sensetivity
adenylyl
brainthe
bsaconjugated
ht1br
acss
syndromesobjective
standardizable
highstakes
abusive
5177
7675
009033
nonocular
3425
fundoscopic
doseon
quadracel
pentacel
daptacel
aciptwo
66000qaly
177000qaly
mellitusobjective
outgrown
lymphomalymphomas
immunocyterich
nontargeting
anticd36
ruralfrontier
dualframe
providerphase
pr073
ci059087
pr065
ci044096
seventeenyearold
pr188
ci147239
pr292
ci197433
pr193
ci150248
pr252
ci164386
mechanismschronic
bettermonoclonal
yorkesophageal
tumorrejection
studymacrophages
neuralneuroendocrine
nr8383
filopodial
endotoxinlipopolysaccharide
pc13knockdown
productsthe
tau441
nftassociated
antiptau
196207
nonptau
serine199
serine202
tauassociated
avw
minerals
7500000
in17
31500000
36711984
21190000
6377222
3814680
ticino
researchsurvival
alkeran
cosolvent
metabolicrenal
jolla
3273
mkaml
mkmds
cytogenetically
del77q
mbarara
2321193
87385
137363
canceroocyte
sas1bovastacin
sas1b
ovastacin
astl
astacinlike
immunolocalized
oolemma
genespecific
mullerian
mmmt
mmmtderived
snu539
eea1lamp1positive
antisas1b
saporinimmunotoxin
ontargetoff
functionsbortezomib
gapby
processors
spirituality
7196
7499
scancells
scib1
melanomainterviewed
goodfellow
jointceo
scancell
astra
losec
flotation
cambridgebased
mgkg×
mgm2×
25mgm2×
cd3kg
transplantationallelic
pharmaadme
cnv
pharmacogenetically
concentrationdose
tcarriers
nontcarriers
rs776746
cyp3a533
cyp3a531
cyp3a511
crosstolerance
cd207expressing
langerinexpressing
highintermediatehighrisk
ainfluenza
antihastalk
antim2
tcn032
antibodiesmost
bcellrelated
microenvironmenttargeted
drugsoncolytic
polylacticcoglycolicacid
polyesters
antibodyloaded
hpv1618dnanegative
4550year
hpvscreening
attitudesbackground
010064
tumorsmacrophage
cd47specific
trif
decisionguidelines
potentialstill
pathologybased
situbased
fats
australiaduring
laboratoryproven
64364
livebirths
43480
53149
055153
082172
reviewmaternal
pregnan
matern
vaacines
tlr9activated
activatedpdcs
allbearing
valuating
pinterestvaccination
pinterest
repins
oftrepeated
antiox40l
transfusionrapamycinantiox40l
transfusionrapamycin
malignomas
masterseffector
rorgt
vcd45
vcd34
quotient
prefreeze
participantlevel
federallyfunded
extramural
1×108tcidml
vaccinianaïve
logtiter
menwomen
002060
004063
mmrvaccine
144miuml
antimeaslesigg
statusvaccines
rv3bb
actrn12611001212943
0·78
0·550·88
0·68
0·440·81
murdoch
allipv
bopvcontaining
98·8
95·899·7
97·9100·0
seroconvsion
98·2
94·899·4
98·9
95·999·7
94·999·4
96·099·7
10·5
77·4
70·583·0
96·0
92·098·0
97·8100
inching
reviewusing
ibss
jstor
blame
postpartumperiparturient
immnunocompetence
erythrocytespecific
rabiespresently
unaffordable
dogsanimals
erigs
rigs
8ml
126ml
unaffordability
aureusdue
pgn
map27
antimap27
lethalchallenge
ifnγcd3
il17cd4
map27immunized
minnesotaobjective
downtown
minneapolis
09951
or076
or004
or431
or258
cagr
wwwwhointictrpen
allergensensitisation
crosschecked
discussionwe
5077
9with
studiesone
00012
00077
00102
evidencewithin
interpretchanges
mcgd
12042
slitmore
mildlack
anemiaacquired
401301
wwwuminacjp
umin000017972
birth8
weeks4
weeks5
weeks6
weeks12
diphtheriapertussis
606661
579630
91125
lymphopoietic
2015global
bmgf
mnch
possibilitiesmonoclonal
tyrkinase
conjugatelight
cetir700
philosophic
exemptions†
732000
19942013
dose†
series§
state¶
workloads
cruzipain
infectiontherapeutic
scz
serodiagnostics
immunotherapyphage
phagefused
hivhiv
subcheek
insc
vesivax
conjugatable
calv
igg1igg2c
th1oriented
obamacare
californimmunization
reemergency
disordersinterleukin22
sjogrens
narrativesexpectations
needlerelated
narrate
selfimage
uneasiness
unpleasantness
uneasy
ifnγinterleukin4
combinationsimmune
rupp
ratspreeclampsia
αcd40l
nprupp
tanticd40l
cellscd40l
reproductiveaged
mokola
105345
107259
costexpenses
therapyradiation
perspectivescytokineinduced
reexamination
surveyselect
randomness
settingsobjective
bjiims
preadjustment
6089
8121
859907
764647
albuminbound
fluoropyrimidine
asiatic
historyin
countriesinfection
p0634
p0441
212675
aor188
107331
105335
aor223
116427
aor244
138429
carcinomapersonalized
koreacancer
microaspiration
gastrooesophageal
macrophagesunconjugated
ocaratuzumab
cellsmacrophage
ofatumumabinduced
anticd20mabs
attitiudes
pavilion
diseaseimmunotherapy
huntingtin
htt
polyglutamine
r61
zq175
n58682q
hdspecific
phasesdespite
damped
harmonic
theorydriven
restaurant
employeespurpose
seattlearea
arranging
restaurantspecific
restaurantlevel
accessbased
providerscreation
53week
significantthe
to484
vaccinerate
vaccineand
alumw
epitreated
strokeapproaches
g22i50
carcinomaincreasing
g22
i50
hupblscid
ab3
hne2bearing
g22i50vaccinated
virotherapyneuroendocrine
adrenals
gastroenteropancreatic
deters
monotreatment
fnch296
doseescalating
05×109
10×109
20×109
patientsone
586fold
951102
4720fold
137214116
twofolds
umin000007527
modulatorsin
jawspatients
mronj
paininfection
fruitspecific
activationbackground
jcpinduced
jcpbased
uaml
jcpspecific
repopulates
ctla4dependent
cd80cd86
tregdc
hiv1induced
depletiongroup
hiv1dependent
cd95fasl
ifnidependent
cd95faslmediated
cd95mediated
flamsaric
opportunitiesobjective
414weeks
inexperience
networkthe
digs
marrowthe
αchemokine
liverderived
sdf1cxcr4independent
chemoattracts
phosphosphingolipid
bmexpressed
sphk1
floxed
cxcr4flfl
bmmicroenvironmentexpressed
immunotherapiestreatment
unfriendliness
disconnection
successesantitumor
gametheoretical
anger
craigslist
employersponsored
militarysponsored
usafter
conferral
offshoot
itallogeneic
myelofibrosismyelofibrosis
campusthe
pretki
villejuif
2401
eh
5960000
waa
weh
14213937
raceethnicityspecific
14870000
gprd
17853
036057
053076
061079
077089
apavac
hsppcsha
p0173
201314annual
1976443
months18
983401
920333
72709
cryotherapybackground
irct201407089844n3
irct
4aβ115
6point
selfrating
mamonkin
tlymphoma
premarital
diaspora
intersectionalitybased
embarrassed
mutilation
prohibit
deviate
poetry
tucking
newbornsbackground
0034
0236
prediabetes
regimensbackground
3306
4285
5489
g24
6549
2079
0157
0089
5079
5739
0509
0530
0415
cyclophosphamidebusulfan
bucyclophosphamide
preposttransplantation
areaundertheconcentrationcurve
8001400μmolminl
bucyptcy
usahuman
xhigm
higm
07193
iggindependent
97161
infantsvaccinations
vaccinesand
alternativean
broadlyneutralizingantibody
planningduring
8211234
aged16
b72
strategiesindividuals
complementcobra
cobra
superantigenlike
7in
chemoattractive
transplantationbroader
abnormalitiesvaccination
leukemiasit
nkrelated
suppressiveregulatory
20112012according
cvdpvoutbreak
bukama
malemba
nkulu
katanga
bracket
156193
21518
12514
9004
134675
17482
117193
ilirelated
£27391142
£141932471
£168318709
£112534130
immunosuppressionhistory
1954
myelofibrosisprimary
postetpv
postsoviet
kyrgyzstanbackground
kyrgyzstan
n1726
n1430
n1127
n4363
speculates
mothersobjective
informationgathering
edmonton
recollection
stranding
peripancreatic
30527
4369
primatesobjective
amdalthough
formis
antivegfs
intravitreally
sb485232
ffa
antivegfbased
macaquesinnate
hivsimian
ckitil7rα
cd117cd127
lipoteichoic
hivinduced
micenodscidil2rgnull
il2rγdependent
monoclonaloligoclonal
il2rγnullnsg
il2rγintact
nodderived
cellautoreactive
ai4
ny83
diseasemodelling
macroparasites
malignancieshematopoietic
nasoocular
lossdownregulation
ysk05
ysk05liposomes
cdigmpysk05lip
equityhealth
frontage
immunotherapiesand
costtake
yetdisease
hdt
postauto
multigroup
perturbationa
survivable
gliter
adhesivetape
intraindividually
volar
singleprick
piercing
immediatephase
hepml
microneedletreated
responsealthough
rpa
nyanza
kenyaobjective
countybased
threelevel
13334642
10292198
11532303
cryoglobulinemia
cwe
emzl
derangement
immunoglobulines
outbreakthere
1314y
810y
ascent
814y
diseasehepatic
rituximabfor
maskwearing
1023bed
55164
31191
mannercurrent
spironolactone
spir
m15866
iavderived
promptitude
germanyporcine
pcvd
viruś
reincreased
polymorhisms
pcv2apcv2b
pcv2a
repelled
g1182gt
2a2b
selectional
reincrease
pcv2loads
sipulecuelt
relocate
ronald
mcdonald
nonsuppurative
succinylation
sova
succinylated
patientsunlabelled
besta
8798
946±29
hospitalsponsored
ambulatorycare
rasrelated
1objective
rac1
pet32a
pet32arac1
hisrac1
transplantationpediatric
bumac
malignanciesbecause
hlaallele
antibodiesrecent
p301l
cp13
pser202
rz3
pthr231
pg5
pser409
hindbrain
imdscs
tmdscs
imdsc
voxellevel
treatmentsin
semimonte
vxlpen
phantoms
assumptionsdue
ellipsoidal
kidneytobackground
crossdose
cardiactorso
xcat
osem
histograms
drvh
comparedthe
selfdose
drvhs
calculationsthe
simulator
simulators
nontransmembrane
mannosyltransferase
candidiasiscandida
hostfungus
yeasttohypha
rpmt4p
fluoridation
nanoantibodies
diarrheanoroviruses
llamaderived
genogroups
gi1
norwalk1968
md2004
gi3
hbga
novspecific
2013influenza
nasalthroat
analysis1059
epiweek
629during
2015immunotherapy
tva
tem1cd248
cd248
cd248based
45background
assignation
q4w
101169
125181
dataimmunotherapeutic
poststreptococcal
pandas
plasmaexchange
guillanbarré
sydenham
tourettes
colecoxib
neurodegeneratve
inflammasomeactivating
apoptosisassociated
specklike
deteriorationthe
midterm
outbreakuptake
merseyside
opportunitiesduring
subjugate
nonstem
gzαβtcr
vivogvhd
malignancyreactive
gzαβtcrs
propionibacterium
acnes
vulgarisacne
acnesinduced
acnesassociated
attributescritical
cqa
crystalizable
sugars
pharmacodynamicspharmacokinetics
bloodnerve
nodopathies
concernsin
twitterthe
42533
2098
8261
10758
connectionbased
contentbased
depletionanticd20
haplobmt
50s
selfless
fieldthe
ebolacp
evd001
antievd
vaccinatedobjective
atrophyvaccination
multiplesystem
busulfanclofarabine
leukemiaclofarabine
day40
treatment—maximal
chemotherapy—the
modelour
ltt
highlyinbred
numberpotency
tolerancemaintaining
birthvaccinated
bpspecific
tcellular
nct02062580
plaguean
allotted
contingents
macroorganism
technologiesgenomics
collectivesobjective
servicemen
after44
17general
378°c
diseasesan
ltreitol14bismethanesulfonate
flogosis
nigemediated
5q22
emsy
impaction
capd
handsearching
61116
31334552
anrs
hb04
bboost
200349
nct00670839
5777
6382
p0·334
researchfrench
celltherapiesto
palliativesupportive
oss
glsg2000
7·7
5·59·3
l1penalised
6·7
5·77·6
ep300
38·29
25·3157·95
77·21
69·2186·14
4·14
2·476·93
bootstrapcorrected
3·76
2·106·74
1·57
0·80
0·710·89
24107
25·00
12·5049·99
68·24
58·8479·15
3·58
2·006·42
0·79
0·690·89
2·18
1·213·92
2·03
1·123·67
deutsche
krebshilfe
terry
pllr
vaccinesinfants
acuteonchronic
aclf
japanto
takahashi
matsuura
to336
okafuji
vaccineacquired
dfps
dfp
consensusbuilding
earlylate
inequalitiesschoolbased
mutualities
n66664
074076066
065067
144145154
153154
14the
090090087
087088
127127133
133133
pregnancysevere
059073
085105
multistrategy
sclerosisfollowing
teriflunomide
employeesbackground
twopage
survivorsthis
amyloidosisautologous
6×
15×
51×
105×
prophylactictherapeutic
infectionmucosal
antifcγr
preventivetherapeutic
books
ad35
hivseronegative
hivmag
genevax
trigrid
x3
primead35
x1
antiil12
nct01496989
chinaabout
5498
48606124
8924
84749279
7811898
20831
1488729147
0008compared
3836
7810
8425
9619
14573
34234
13146
31338
gliomaobjective
wt1pulsed
oligoastrocytoma
oligodendroglioma
wt1reactive
transplantationischemic
tourniquet
posttransplantdonor
52±14
54±17mlmin
p0686
50±14
49±18mlmin
p0678
effectsrc
trialsgastric
ebscomedline
pvaluewe
012051
073228
006039
053109
021115
012101
066405
9822
15616
4028
11829
16200
7458
inconsistentein
taxredirected
atlatl
graftversusatl
taxtetramer
petition
strategysexmismatched
sexmismatching
hy
carcinomaalphafetoprotein
transgenetic
afp158166specific
afp158166mhcpentamer
hpeg2
immunotherapynovel
therapyhematopoietic
historiespopulation
immunotherapyrespiratory
skinpricktesting
insectvenom
foodallergies
componentbased
allergenavoidance
therapyoptions
patientselection
riskbenefitration
managementhidradenitis
perineal
arthropathy
sqaumous
moist
hylarunoic
skingrafting
tecniques
ingaalp
p0146
1435
1765
6111
p00397
doseselection
3×105
1×107
5×107
safetydriven
ebolaaff5cted
nondeployable
deployable
nct02287480
p0·036
monocyteactivation
p0·0233
ebovglycoproteinbinding
344·5
229·7516·4
1064·2
757·61495·1
24·750·7
127·0
86·0187·6
rvsv
viruscurrent
yeastexpressed
isacamp
incrementmean
transplantationthrombomodulin
rs3176123
2729ac
vasculopathies
044099
021099
2729c
2729a
btexosomes
texosomes
texseb
texsebimmunized
sebimmunized
picr
ej
squared
normalise
βpositive
transplantationdemographic
immunosuppressantsimmunosenescence
showcases
healthincorporating
entryrequiring
ecrhs
questionnaireassessed
r083
r096
r095
irradiatedfibroblasts
25gy
wages
dallas
10201
10600
parkland
14834
11788
p174
offthe
attitudesthree
undercutting
malignanciesprimary
therapeutictotoxic
punishments
earliest—rudimentary—attempts
nonconcomitantly
menactra
acyw135
adacel
nonconcomitant
tdaprelevant
carcinomasunitinib
αgitr
sunitinibαgitr
incidencevaccination
daptomycin
cubicin®
eucoresm
eucore
254370
111254
48254
penicillins
aminoglycosides
leukemiadoubleunit
dcbt
urdt
noneuropean
recipientsblood
vaccinationlarge
abortive
43604
34241
055145
061116
098140
7839
immunotherapyuveitis
handicaps
uveitogenic
nst
nonrelapserelated
reinventing
intravenousbusulfan
4149
comorbidityscore
niamey
nigerbackground
hivstatus
underprivileged
158261
030072
recombinationactivation
eggoit
dehydrated
oitg
2830
ovm
ovmsige
ewsige
inhibitorsovarian
cancerprostvac
tricom
karnofskylansky
effortbackground
studentstrainees
cyclicv2
regimensrv144
rv135
rv132
vcp1521
hiv1gp120mngd
gp120a244gd
gp120sf2
gp120cm235
mngd
casea2
prospectsthis
ofdemyelinating
dinical
guidelinesfor
moscow
pathomorphosis
neurorehabilitation
firstepisode
warszawa
5405
4917
4373
4972
polandwith
38548
9116
confirmingexcluding
verweij
houweling
groot
choleravaccine
bangladeshcholera
icvb
mirpur
123661
18178
492238
fullyvaccinated
cancervaccines
belagenpumatucell
ratessurveys
3072
smstext
23polyvalent
vaccinationrate
linh
pharmacogenomicsbackground
prerotavirus
20032012background
invagination
levelsthe
précis
nudix
infectivityprevious
tsnd
iecs
rtsnd
sirna275
097941
sirnatreated
ounce
paralyzes
immunityprimary
signaling3
06572
20052009background
months4
0141
0708
bdsp
hindi
beforeandafter
11512
117144
120163
112145
comoros
lesotho
targetstargeting
oncologyradiotherapy
citokines
immunoagonists
immunosystem
mechanismsmodulation
infiltrationare
haarttreated
stallergenes©
viroimmunological
and÷
42plusmn11
96490
μmol÷l
ml÷min÷173
06182
g÷10
mmol
and÷or
8÷9
3÷10
patientsallergen
100yearold
tslpr
showroom
intentioned
and90
p070
sobering
ah7n9
communitywe
adolescentsposterior
neuroradiologist
20hours
36hours
drycured
ic2
ic3
chemophysical
hams
cancerscancertestis
gametogenic
2014routine
respectively†
malesin
reactant
lowsf
highsf
wit
bocaviruses
14human
bocavirus
hbov
hbov2
hbov3
hbov1
hbov1specific
hbov14
heterologously
homologously
hbovinoculated
hbovs
parvoviruses
fibrocyte
il12il4
balanceirradiationinduced
efavirenz
5951006
128256
144249
106194
001068
oromiya
006037
004055
014087
uncompensated
ryan
preaffordable
2887
preaca
viruspolyvalent
ark
masstype
arktype
arkvaccinated
massvaccinated
philippinesbackground
semimarkov
61059
120000
33126
3545
hpiv1rsv
vaccineunlabelled
rhpiv1
deattenuation
nontemperaturesensitive
cδ170
ly942a
pren
rhpiv1cδ170f1
rhpiv1ly942af1
turbinates
rhpiv1ly942a
detectably
overattenuation
cδ170f1
hpiv
rhpiv1rsvf
studymortality
seniorssince
103156
105140
80730
2778
076093
085109
084114
overthese
polymerliposomebased
immunotherapypotentiation
3methylglutarylated
polyglycidol
ifnγencoding
liposomepdna
complexinduced
liposomelipoplex
lymphomab
sitinduced
2efhand
7specific
mab1021f10
clustalw
spade
rastbased
alder
aln
turnip
rape
bra
crossinhibition
smdc
smdcs
ciismdcs
cp2accelerated
mr45
mr40
cp2acp
tki2
farmsdevelopment
brandenburg
caseous
echtyma
epididymitis
agalactia
compartmentbackground
cd244
100580
deficiencyacquired
periprocedural
xdeficient
aiirds
19771987
n629703
hradj
n4897
n625804
127135
hradj109
105113
hr126
121132
hradj115
110120
kiruhura
brachyurybased
vaccinesas
embryonically
malignancyusing
strategycharacterization
c3b
conformationally
enterobacterial
eca
enterobacteriaceaeall
ecaderived
stereoselective
manpnaca
j20
micecompelling
βprotein
monomerpreferring
m266
aggregatepreferring
1c22
70fold
aβand
1c22immunized
appaβtau
ebolaa
ça
suffit
outbreakmeasles
moments
9585
anticd70
vaccinologyvaccination
materialize
il6engineered
cellstimulated
cytotoxicitybackground
tumorantigens
ovapulsed
il6expressing
advil6
advnull
68mm
fasfaslmediated
dcstimulated
practicegrade
materialsobjective
765fold
180fold
pcofilin
sarcoendoplasmic
ca2
regulationobjective
serca2
countertrend
dcifnγil1βpolyic
th1polarization
26objective
61item
sd38
uptakeadolescents
2015fortythree
papillomavirus16
approachcervical
riskhuman
hpve5
hpv16e5
safrcfivyiifvy
hlaa1101
069558
iplflihtharflit
hladrb11401
1813nm
mobilizationcollection
seriesdespite
iv×4days
score80
hlaloci
lowertrm
mmtargeted
nondominant
transplantationsustained
cd35616
120×105kg
projectsas
6538
nontransmission
910y
millimerck
mmu
minkscanine
nyctereutes
procyonoides
ln101
minks
cdvhost
nosoluble
sgccyclic
noinsensitive
sgc
cinaciguat
nounresponsive
explantation
heterotopically
dpdtmax
dpdtmin
µmolg
dismutase1
nocgmp
swineposttransplant
viraldriven
doseescalated
patientsintensive
dlts
7095
μmmin
desquamative
continuousinfusion
nct00448357
modelrecently
hkms
shigellae
il12p35
hkmsspecific
nonliving
patientsthrombocytopenia
130400
1017448
yearsobjective
nonaggressive
antipd1despite
pd1lo
pdl1hi
pd1hi
pdl1lo
antipd1resistant
imatinibbased
fluorescensexpressed
anthracisderived
snke167δff315e308d
plgg
siop
protocoldependent
tbevaccination
swedento
n4307
354481
055081
16273
039083
tbeincidence
8512100000
baltic
highendemic
modelpeptide
proinsulinbased
hladrb10401
proinsulinspecific
quenchable
proinsulinpit
foxp3cd25high
d3modulated
5053453
76714
incrementalcosteffectiveness
¥12281
us1900
¥13737
us2125
qualityadjustedlifeyear
8469506
707526
ageshifting
studyeffective
steadystates
pev
misattribution
overpositive
cnatural
ibinding
22base
c2positive
anaplasma
phagocytophilumbackground
phagocytophilum
phagocytophila
1×108
61vg
seppic
vwith
mutationtargeted
prognosisobjective
polyradiculoneuropathyobjective
lactobacillimimicking
sizethe
polysaccharidepeptidoglycan
pspgs
nonpertussis
nonvaccinationassociated
002059
cellstumors
deregulate
cr88
sensitinogen
decreasedthere
exited
diferences
vapocoolants
n792
controlplacebo
n1424
n2071
n818
placebono
pacifier
preprocedureacuterecovery
acuterecovery
verylowquality
n290
politicsthe
factorswe
j1galactomannan
cedarcypress
allergengalactomannan
umin000013408
childrenreply
084121
8635
8379
6148
p00156
sitesto
rios
overprotection
causebackground
patientperceived
antibodycd28cd137tcrζ
chaintagged
anticd20cd28cd137tcrζ
3289±626
vα14jα18
vα24jα18
typephase
ipsderived
nonreplicative
cellsmalignant
d106s
virusstimulated
milkreactive
bmreactive
dpp4
combinationscancer
cellsmultiple
inefficiently
pkbcakt
centerobjective
6577
1349
3678
myopathyobjective
nam
statin
3hydroxy3methylglutarylcoenzyme
hmgcr
5326
srpigg
hmgcrigg
srpiggpositive
myotonic
statinassociated
bag
recursive
partitioning
248±54
117236
ligase
siah2
corepressor
ncor
erα
erβ
flutamide
cyp450
kentuckybackground
southcentral
consentdeclination
pericytes
bearman
narcotic
2068
tbiinduced
havrix
predictionsantibody
1440elu
19921993
nct00289757
8586
nct00291876
nct00289757nct00291876
arbs
crescent
bandage
lenses
diseaseto
bscls
extendedwear
11point
nct01616056
analysisvaccination
3000000
fumigatusreactive
transferobjective
criticality
idiosyncrasies
antiaspergillus
afumigatusspecific
afumigatus
27×
103318×
103aspergillusspecific
advancedtherapy
10e3kg
08936
044323
recommenced
0471300
β1316dglucan
pigletsan
ppm
3450
21daysold
055b5
bonferronis
dunns
nutrientdensity
highnutrientdensity
hypoglobulinemia
streetthe
syndromesthe
tcrαβcd19
nct02327351
mmrds
117×106kg
106×103kg
500tcellsμl
day120
gvhdrfs
systemsbiology
immunestate
virotherapyobjective
2124
554351
slaney
darcy
5417
mitoxantron
flags
90yclivatuzumab
yttrium90radiolabelled
mcim2doses×3
doses×4
cytopaenias
029086
filiation
notcomplete
ignores
subcategorize
notcompletely
43965
5170
37107210
149167
295354
135210
infantspertussis
universalize
remissionfrom
hinted
tripleclass
regenerate
insightsbackground
onchocerciasis
ivermectin
coendemic
loa
epioncho
loiasis
onchocerciasisloiasis
microfilarial
onchocerca
volvulus
oranges
nonreusable
nonbreakable
costif
anyfrom
20052012background
worksheet
13595
slithdm
encephalitisnmethyldaspartate
nmdarabs
necessarylimited
1604
decadewe
a1c
033unitskgday
knowrheumatologists
immunodepressionrelated
genomeedited
talenengineered
immunopharmaceuticals
cellsb
tbreg
tbregs
tgfβr1tgfβr2
immunotherapyactivating
patrolling
immunogenbased
photochemotherapyphotopheresis
thepadova
experienceacute
day180
ofacute
syndromeschimerism
120days
busulfanfludarabinebased
to120
noncr1cr2
factorsoutcomes
fcgr3a158vv
fcgr3a158ff
fcgr3a158
nct00946023
childrenhost
responsestreptococcus
ripd
33year
cerebrospinalfluid
complementpathways
prepcv7
048069
16570
005furthermore
2397
2284
mnte
20002003
pslm
indicatorsfor
tt2coverage
weightage
55104
kp
jama
—
20132014on
20112012preventive
deductibles
visr
virulenceassociated
vims
straintargeted
ccl5rantes
3191±763
pharmalgen
alkabello
horsholm
8875±32277
38727±8511pgml
56732±9216pgml
fewsters
vaccinationedward
apothecary
coakley
lettsom
quaker
marry
devout
consciously
assertion
subcluster
strainsgenotyping
ibvbrazil2007usp19
pathotyping
5096
5796
6296
6496
theapproximately50
indefinitecrohns
receptorsfrom
teslathe
kershaw
immunopathogenicity
graphthe
graphically
melanamart1
gpcmv
δ145
gpcmvnaive
glandadapted
2631
genomeencoded
cytomegaloviruses
sivnaive
mauritian
transferunlabelled
sivderived
nef103111
rm9
gag389394
gw9
env338346
rf9
nef254262
lt9
extralymphoid
abpa
varyingly
asabpa
333451
74107
perspectiveslung
roadssignificant
immunestimulant
perspectivespancreatic
213biantiegfrmab
carcinomagold
213biimmunoconjugates
luciferasetransfected
ej28
093mbq
046mbq
antiegfrmab
576d
1415d
268d
1318d
300d
nod1
nod2
pathogensperiodontitis
homim
hpbm
tlrspecific
kos
concisus
rectus
selenomonas
infelix
endodontalis
tannerella
forsythia
crectus
sinfelix
nod1specific
andnod2expressing
eubacterium
saphenum
nodatum
filifactor
alocis
parvimonas
micra
nct01154855
19922011
ssti
privatelyavailable
fy19921998
fy19992003
fy20042011
regressionand
2511000
fy1994
321000
fy2011
026032
021040
010169
programrelated
programineligible
mastering
gatheringthe
magnifies
48100000
i5
vietnams
i2800
i734
i2064
i10dose
i1400
nct00541970
914y
m016
m60
082154
yold
2dinduced
datareplicationcompetent
receptorspathways
antittantibody
abundances
affymetrix
lowab
highabhighlg
highlg
highab
lowlg
nonimmunespecific
chughtai
arriola
survivorshipnatural
nkg2cnkg2a
recurrencehuman
cellsunlabelled
xenoimmunized
helpercell
specifiedobesity
185kgm2
185229kgm2
230249kgm2
250299kgm2
30kgm2
normalobeseseverely
obeseunderweight
135619
155609
108795
106636
recipientsfew
n1189
reductioncessation
doubleproducing
cancersan
blockadegastrointestinal
16drugs
nontypical
systemdriven
immuphar
httpiupharusindexphpsectionssubcomsimmunopharmacology
httpiupharus
expertlead
868993
conquest
19902015
periremission
vaccinationinfectious
acquaintances
furious
dumb
anticd66
radioimmunotherapyfor
timeintegrated
tiacs
pbpk
biodistributions
iterated
rd8±16
rd0±10
coimmunized
pag85a
unformulated
bcgpag85a
ag85a131150
sla10401sla10801
promiscuously
bcgplasmid
mexicans
reformobjective
postseguro
mhasenasem
20012012
seguro
cachexiacancer
1d11168
mekinhibitors
peginterferonalfa2b
hlah35l
hlah35lspecific
saltadjuvanted
cd73cd80
distaldraining
signiﬁcance
αlevel
crd42014010141
inoculable
refreshment
answernzno
macrophageactivating
proteinderived
gcmaf
maf
gcmafbased
th12
micerepair
canalicular
e15e16
vacate
gfpmarked
naphthaleneinjured
e16
damping
dissipation
canalicularstage
transplantationfunctional
pitted
agvhdcgvhd
readdressed
survivalalthough
n1321
nonhc
lymphomaallogeneic
chemosensitivity
progressiverefractory
patients11
515845
377954
415823
zimbabwebackground
dhsvi
dptpentavalent
cohabitating
0409
muramyl
phosphatidylethanolamine
lmtppe
148931
11469
757784
140255
5691122
9330
93019358
treatmentallergic
repevax®
covaxis®
2component
tetravac®
tdapopv
annimals
95110
101115
morfofunctional
telemedicine
singaporebackground
prescriptionbased
perceivedrisk
wartshpv
vaccinesphysician
nang
fullfactorial
34±119
obstetricsgynecology
compositionretinoic
absecreting
specifiable
highaspect
1996december
19962011
19962007
pathwayligands
hepatomaobjective
heps
deuteporfin
photoirradiation
deuteporfiin
tasquinimod
prostvacvf
reviewlocalized
vegftkis
microenvironmenttraditional
cancerigenic
remolding
multitargeting
alupe
421896
251150
251254
321473
netherlandsthe
6574years
8650
575017100
3100pcv13
cyflutbi200
107kg
017055
116243
1192415
hdfn
68118
66118
ultrapotent
viruschikungunya
chikv
polyarthralgia
postattachment
vivounlabelled
immunopetspect
radiometallabeled
tumortokidney
tcofunctionalized
avp0407
diabodies
submaxillary
avp0407tcon
177lutetrazine
111intetrazine
doseg
tumorhoming
statuseswe
yas
poitoucharentes
0·96
znuabc
responsesalmonella
stm
operon
pathogenswe
deliveryoral
teqnique
hydroxypropyl
phthalate
hpmcp
tmchpmcp
8629
nearhomogenous
chinathere
5143
monthsgroup
seroconversionseroprotective
verse
21316
43258
45147
4670
5618
healthfrom
imprisonment
inmates
biungulate
highpayload
prescapular
igmsecreting
lndraining
setsbackground
plasmaserum
6330
mfi10000
mfi2000
2000mfi
extragastric
alkylators
rbendamustine
rmonotherapy
dschang
novemberdecember
1085737
aor125
1076375
4254
9618808
4955
1591544
1462789
2807
2263481
vaccinesrecently
bioengineeringbased
entrap
refraining
2293
overestimating
instructional
quasi
2480
cling
113667
bodyagitated
10333
membraneenveloped
melanomacancer
mannoseinserted
cleave
antigendepot
tumoroccurring
testingtreatment
diluentsbackground
ttbs
itvs
ttb
dilute
glycerinnsp
directionsmultiple
resemblant
tocilizumabacute
cytokinereleasesyndrome
pd1pdll
reaudit
p00062
reaudited
p07874
shortfall
mull
researchigemediated
5184
103108
100101
statessublingual
grastek®
oralair®
ararc
ragwitek
costinsurance
knockdownaptamers
aptamersirna
asics
prrsvhighly
n12group
hpprrsvspecific
treatmenttargeting
lymphocytepoor
bullosarecessive
col7a1
hpcs
hpcderived
col7
col7deficient
yfvcs
refrigeration
decisionsobjective
kruglanskis
nfc
howard
computeradministered
efficaciousness
flushot
orehek
χ22
χ26
5724
stagingto
p00139
p00015
cadependent
nfatdependent
hemodialysisallergic
epoetin
relapseto
rituximabaugmented
22273
microangiopathytransplantationassociated
carriership
parentsallogeneic
1478±8350
822±4639
21119
p00146
kps90
hladrb4
hla1010matched
frenchswiss
hladrb3b4b5
drb4
drb3
hla1010
drb4mismatched
drb34
drb3mismatched
13nr
3nr
hr21
101467
hr266
099709
erarelapsed
2662
3876
sipulecucelt
c3h10
transfered
egfpccr7
donators
pyridine
ipvtmccoated
multinanolayers
vicapsular
travellersan
typherix®
vi®
hepatyrix®
viantigen
havspecific
infectionbased
reviewdiscounting
nonconstant
intragenerational
randomdigitdialing
populationfor
florescence
hepg2215
vaccinationsfor
immigrate
vaccinationpreventable
justificationsespecially
navinand
immigrantsthe
justifiably
aliens
settle
hpva
synonymous
westernization
typhibackground
typhivi
vicps
preheated
firstgrade
20022008background
slowdown
2002and
1997and
108114children
carnet
66597
61190
47489
arrondissement
il12fc
administrationallergen
ectodermal
dystrophyautoimmune
apeced
cesium137
irradiators
micemice
137cs
irradiator
lethaldose
irradiating
noncompetitive
1100cgy
isu
pretreatmentspecific
σ072
isacmeasured
mt3
immunoprecipitated
twoyearold
infantprimed
yttrium90labeled
antitenascin
131imab
90ymab
mcicycle
158253
forthose
restratification
131imabs
micevaccination
contradictorily
sintimvas
finlay
cochleate
timecost
nicobarese
andaman
nicobar
endemicityobjective
beliefwill
nonreactivity
facilitys
1way
almr
postaphsct
kfold
almr1
almr10
7594
5883
functionsantibodies
connects
antibodytriggered
dnaplantderived
modelsunder
highprophylactic
hpvexpressing
strategiestechnologies
plantvirus
planttoxin
nonorthotopic
chemoradioimmune
cytotoxicityselected
ul16binding
ulbp3
trailr1r2
ercc2
fgfr3
prosecute
edb
teratocarcinoma
129fvhsd
otitisprone
nonotitisprone
nop
124i
188renanoobjects
tcp
conceptsradioimmunotherapy
nanoobject
mcnpx
nonuniformly
salud
mesoamérica
2015timely
cardpositive
llanos
unwise
nextalthough
businessgiant
startups
seizing
131itositumomab
remissiondespite
singleparticle
cameraobjective
ra223
scintillatorbased
chargedparticle
gammarayxray
eventbyevent
ccdcmos
cameras
cryosections
cpmcm2
largearea
mbqμglevels
filmbased
autoradiographic
phosphor
alpharit
pointcounterpoint
protons
pantanal
collectionpopulationbased
chembio
eluates
remissionreducedintensity
transplantconditioning
10125
4yr
memberspresented
idweek
encephalopathychronic
onearmed
nct01156909
germanythis
19922014
neufelds
130e72
sank
459e25
19922006
378e88
597e161
pvc10pcv13
416e04
698e06
444e15
4420
68182
54510
112640
84654
coughwe
56224
vaccinationtrust
ebmtacute
s1p1
lymphocytedependent
postfingolimod
reboundfingolimod
rehearsal
cytofluorimetric
nodeentrapped
receptorssecondgeneration
endocrinedisrupting
posthpv4
quebecs
vaccinedcbased
c57bl6mice
pmdc
c57bl6model
primedna
negroid
cellsgrowing
proteasecleavable
perforindependent
aspartasecleavable
perforindeficient
proteasecleaved
avidincar
imagingthere
biotin4g1
swedenin
hladqb10602
streptococcusassociated
immunosuppressioncellmediated
patientsallergenspecific
c3a
noncytopathically
brainresident
noncytopathic
n1077
n294
antivaxxing
optionsfastacting
slowacting
inhalable
insulins
diabetesallergy
etiologically
equalitya
aspire
166645
nowviruses
hbvnegative
p00115
4970±3862
2539±345
ratio32
interval1097
phase2
trialuntil
bortezomibnaïve
bortezomibhdmii
hdmi
bortezomibhdm
psf
697908
678894
730957
333805
emptor
sarc
4659
4558
2279
evaluationobjective
tirant
blanc
gandia
biocsl
limiteds
evasiont
chaseandescape
contest
longneeded
francewe
ifv
nhif
ifvc
polytomous
bahrain
bahraini
fulminating
fumigatussensitized
afsensitized
igecrossreactivity
n253
fugal
afcomponents
afsensitization
afallergen
expressioncytokines
proinflamatory
ir2
uvlight
dmethamphetamine
thermoregulatory
antimeth
01mgkginf
postacquisition
dosesubstitution
020mgkginf
015mgkginf
mh6klhvaccinated
005mgkginf
cough—where
testsjohnes
jd
johnes
2597
4136
them12
rateorr
ineffictive
hyperigd
8841340
or042018094
or075059096
or071056090
moiv
unknowledge
girlsobjective
n25dyads
kajiado
korogocho
slumdwellers
cfuf
pdgfrb
pparg
vaccinationhelicobacter
cpgdna
fclysate
ctlysate
gastritispseudopyloric
antagonistlysate
pseudopyloric
lix
gpsthe
mucindeleted
wing
antiwing
ipilimumabassociated
retinopathyipilimumab
environmentdomestic
postincursion
adhoc
usd31507012
usd44548180
usd1297
usd904
cmvunselected
cmvu
leukocytereduced
patientcmvseronegative
negneg
ttcmv
tdepletion
equating
105cfu
anticd1d
nktd
cd3nk11
mir200c
mir29a
mir125a5p
brookings
rothe
anticd30cd16a
afm13
sen1002
sen1395
immunitysalmonella
spi19
φse14
lysozymes
pv1002
pv1395
donorsevere
gvhdthere
3655430438
monozygotic
antifshr
mhcnonrestricted
fhsrexpressing
fshrdeficient
whenmelanoma
centred
targetbrain
cyclo8799ala91ala96mbp8799
mbp8799
ala91ala96mbp8799
mbp7485
0101200130112013
gestation37
6in1
n344
age273
sd26
vaccination94
age256
sd163
vaccination184
age401
sd19
vaccination98
diseasedetermining
ihn
1050°
thuringiabackground
bl6j
leukemiadespite
drugconjugated
rasrafmek
caremobile
inhibitionadoptive
zetabased
19z1
cd80cd28
19z1cd80
smutant
dchiv1
nonpulsed
dccontrol
vac1
vac2
copies106
nct00402142
t11tsinduced
cd2mediated
gliomainduced
cd2stimulated
p59fyn
cθ
pkcθ
nfat
gliomaimmunotherapy
poliovirusachieving
dielectrophoresisassisted
nanoelectroporation
interclonal
electrotransfection
nanochannelelectroporation
nep
benignly
properlyengineered
nanochannels
handlingtransfecting
cleanroom
dielectrophoresis
difficulttotransfect
depnep
viabilities
carcinomatargeted
sunitinibnaïve
sunitinibpretreated
tissuedigest
4methylumbelliferone
adil12
cyadil12
4mu
4mucyadil12
pancova
cd28signaling
ovalbuminpositive
pd1pdl1immunosuppressive
diseasesantibodies
fleming
transferto
wt1sitcrcd4
wt1sitcrcd8
therapyoriented
o157h7human
preharvest
diseasesdna
dangle
tantalizing
diseasesnovel
renewing
panantibodies
microorganismspecific
antibodyrespiratory
expressionthis
predetermination
raav
sivneutralizing
advicesthanks
preventionchildren
standby
ovasige
responseinflammation
mev460
cytoscapev2
cluste
diamondblackfan
cirrhosisfor
dba
14yrold
chimerisms
apheretic
globulinbased
bmderived
skinbearing
youngwomen
3066
boysyoung
girlsyoung
managementbackground
fibrosarcomas
fisss
riskfree
irritating
2015respiratory
maternalpassive
toolbackground
mencpolysaccharide
mencpolysaccharidemencpsspecific
phasein
mismatchedhaploidentical
fimbriaef4
f4specific
immunoprophylactic
swineproducing
25749
oforal
pigletsagainst
mdrxdr
reviewmultidrugresistant
dwells
demerits
autologousallogeneic
xdrmdr
practicemelanoma
onchocystatin
oxytetracycline
ochengihuman
wolbachia
symbiont
adulticidal
ochengi
asparagine
antionchocystatin
invalidating
firstcourse
25186
3107
studyhighdose
thio
in64
thiomel
immunodeficiencyhelp
hindranceuse
conditioningfacilitated
lymphocytenegative
blymphocytepositive
immunoreconstitution
sequalae
settingsallergy
rubber
nrl
hevea
brasiliensis
hairdressers
workforces
gccik
safetythe
windowlength
controlperiod
λcarrageenan
immunotherapyλcarrageenan
seaweed
ovabased
potentialin
tnfrsf7
epitopesbased
asymp
vp1112
vp1314
hlatg
hsv1seropositive
15day
mckrae
cd107cd8
275000
188rheniumlabeled
napnap
cd4cd25cd127
mlcbe
beab2
plii
antiidio
providersdespite
039092
022052
021046
033084
021053
019045
isletspig
intraportally
cvf
90110mgdl
nontransplantbased
alefacept
diseasestransfusionrelated
nmds
antigen3igg1
mgkgdose
cd2hiccr7cd45ra
cd2lo
cd3cd33
cd2targeted
n523
ci135314
sptpositive
expectationsinfluenza
yeartoyear
micesupplementation
allergyreducing
regdcs
cd4cd25foxp3treg
5185
131fold
1957fold
cd11cdcs
lentivectors
vflip
vf85a
lv85a
2015multiple
nontransplanteligible
outcomesextended
howeverthe
determinedthis
denominatorsobjective
nhvpr
stateterritory
erp
atomized
lightened
biologicalbiochemical
nonreproducible
ptcyhaplopbsct
immunotherapyfeasibility
mnsova
igg2b
africaonchocerciasis
transatlantic
0076
brtd1001
subjectsbrtd1001
04974
03061
00364
00033
00347
08484
potentialeach
vaccineroutine
3096months
80fold
tivtiv
tivativ
knowthe
amoebic
gallectin
fragmentin
acnpvlc3
entamoeba
histolytica
antiamoeba
amoebiasis
ℛ0
expedition
childrenspain
bourbon
dynasty
expeditions
philanthropic
biopolitics
balmis
armtoarm
materialized
transplantationfor
18311
33101
16189
19not
estimable
sllp1
antisllp1
sllp1specific
sllp1positive
bminfiltrating
antisllp
modulationrecent
chassis
treatmenttumor
resurrection
miraculous
everlasting
diseaseantibodymediated
ionchannels
confess
hyposensitizationtherapeutic
2development
hyperproduction
contraindicationsthis
immunotropic
revaz
sepiashvili
carmustinecontaining
patientshighdose
postrituximabbased
electrolytic
vaccinationsuccessful
4880
c4880
dtipv
dtapipvbackground
revaxis®
polio®
tetravacacellulaire®
titres8
1dilution
chemoimmunotherapycomplete
supersist
atect
textbooks
dtwphibhepb
componentswe
measured25
nnt
nnts
528using
459the
inconsolable
2015on
diseasepatients
decisionsuptake
recordsbased
74119
5898
p0652
89130
p0298
1123
61130
gestationpostnatal
ligases
pellinos
responsespellinos
k63linked
polyubiquitination
pelle
pellino1
pellino2
pelino3
scaffolding
ligaseinactive
pellino
pellinomediated
immunotherapyreplicon
nonspreading
nsr
nsrinfected
primatesunlabelled
rhm
multipleenv
singleenv
rediscovered
antimetabolities
crossresistant
reawakened
nrhmthrough
anganwadi
awws
ashas
flws
6002
ci102236
abovemedian
ci105182
or087
ci079096
ci099233
or225
ci107474
ci108341
informationoriented
productoriented
detaineesthis
detentionbased
detained
nondetained
assessmentbetacell
procedurally
ambulance
sakarya
antihcvnegative
dctc
ned
aspirinintolerant
entryin
farmingthe
eps
eggproducing
meatsector
layersector
barn
phh
05kg
epha2positive
leukemiamembers
postembryonic
ephephrin
epha2negative
epha2knockout
if7
fracturesbackground
360000
sbf
dural
hemosinus
otorrhea
logged
childrenmost
livingrelated
hlacompatibility
travelersthe
treatmentankylosing
spondyloarthropathy
hlab27
micerestoration
insb923
igrp206214
gad524543
gcsfrapa
insb923ifa
usinghaploidentical
ghvd
modeltumor
id2kd
n2a
efficacydespite
rvdiarrhea
systemsimmunization
halabi
creme
dcvacpcarelated
013051
017063
rhyme
20092010during
archive
reinterpreted
coincidences
serendipitous
cmyb
infectionplasma
mislocalization
cmybdeficient
teragnostic
mononeuritis
palisading
geit
grupo
español
inmunoterapia
zaragoza
anticd62l
beadspreclinical
pentamerstaining
antivirusspecific
dipeptidylpeptidase
cd26
adjuvantbased
evidencealthough
dataontario
emrald
ohip
linkable
kbma
amotosalen
s59
transfusionmediated
resultants
psoralen
ner
uvra
uvrb
δuvrab
pexavec
cancerfifteen
pexastimogene
devacirepvec
3×107
pfukg
antivaccinia
massvaccinate
4414
27·9
33·9
70·8
64·5
77·2
unconcerned
2·04
ci1·193·51
2·19
ci1·503·19
2·23
ci1·473·40
83·6
61·5
81·1
60·6
ci0·530·89
ci0·470·78
noncollegeeducated
heredity
deficiencybackground
10897
3653
3109
5760
4750
finip
carriageaom
1485
9651484
4731485
consenters
nonconsenters
immunizationoral
niosomelike
diuresis
miniplasmids
minicirclescircular
cccsupercoiled
midge
midge®
modelgenetic
cytomegalovirusobjective
antigenpulsing
cikpp65
coexpanded
cmvpp65loaded
cmvinfected
cd3cd8cd56
humansanthrax
3im
antiprotective
lymphomasmore
refractorypoorrisk
gemcitabinebusulfanmelphalan
fourdrug
dlcl
mgm2minute
μmminuteday
tomographypositive
vorinostatgemcitabinebusulfanmelphalan
nci201102891
hemagglutinationinhibiting
morerapid
immuneselective
lymphoidselective
trapa
mgm2dose
doseadjusted
donorhost
cautioning
armachiho
pnemonia1
pnemonia3
maertens
intraveinous
tegeline®
lfb
biotehcnologies
biomédicaments
3±2
03130722
schaik
pprsv
farmsporcine
idexx
perak
weaner
r0681
r0601
immnunocompetent
mshicu
mhsicu
composited
18174
39478
2364
3974
3393
19852010background
19852010
19851997
slopes
agesubgroups
6241
101119
agesubgroup
133274
treatmentunlabelled
ageobjective
3924633
differentialequation
cvdpvs
hematologyscientific
genereprogramming
micemast
bmcmcs
mcdeficient
encephalomyelitiswe
instill
drivingsustaining
eaesuggest
adjuvantvaccines
geneticallydetoxified
rpt
£120000
177luchxadtparituximab
chxadtparituximab
389±11
67nm
177±05
hnsccobjective
icik
carsover
preventionmanagement
risksimmunization
fictitious
tumorsepsteinbarr
viralmediated
monitoringcancer
immunosuppressionstrategies
modelschimeric
failurechronic
immuneparesis
selfrecognition
immunotherapycirculating
antiregulatory
meningitisantibioticuse
conjugatevaccine
highresistance
progressor
macaquesunlabelled
progressors
controllers
mt807r1
metapneumovirushuman
20082012in
20002011background
patientsantihuman
zetbulin®
day4
±88
±204
2013in
aequinesouth
africa403
aequinewildeshausen108
β2gpi
differentiationobjective
β2gpicaused
aβ2gpi
ifnt
101381
003202
002333
005912
034519
018114
017159
018538
αβdeficient
analoguesresistance
diagnosispyoderma
fistulans
sinifica
perirectal
resectioned
obscurity
studypneumococcal
goiania
retroactively
521577
915943
147186
106147
pr109
102116
aficionados
cisacting
5cap
3untranslated
polyatail
statesalthough
permissibility
diseaseethical
ethicists
outcomeabgg2
deficiencybacillus
il13rα2redirected
il13e13yzetakine
catheterreservoir
il13zetakine
2116
placeboone
comparisonthere
10324
reversetranscriptasepolymerasechainreaction
outcomesevidence
requiredfurther
dtcapolio
booms
14357
therapyrheumatoid
arthritogenic
icer0
pessimistic
bhutanbackground
bhutans
healthcenter
fivecomponent
yearsprior
tdap5
tdap1
8475
6230
hiatus
nct00870350
20002013to
desensitizationplatinum
melanomavemurafenib
vemurafinib
nonmedicinal
cd8hi
cd8lo
malignanciesoptions
tlineage
humberleeds
13yh02
healthwelfare
hypersensitivityclopidogrel
2014tbe
styria
carynthia
9699
surveya
psoriasisto
psai90
researchover
hlahigh
78matched
c0303c0304
hladp1
cellepitope
nct01323920
infectionadverse
widelyused
90137
17456
radiationsensitive
transplantationwhat
dodefects
dclre1c
lig4
nhej1
nbs1
endjoining
nhej
artemisdeficient
dosealkylating
nonchemotherapy
anticd117
tumorafter
lymophcytes
universidad
autonoma
unam
ddes
fβ
urticariachronic
asteria
h1antihistamine
glacial
150mg
lpam
articlesbackground
frenchlanguage
3073
commentsindividual
vaccinesupportive
commenters
emp29
antigenalveolar
remp29
metacestodes
remp29vaccinated
saponintreated
th2th1
il4ifnγ
immunotreated
peta
leukoaraiosis
hypometabolism
pactr201303000434188
tpub05
ub05
feverbackground
rtpub05
itmimmunized
naїve
piroplasms
oglycosylation
ibmfs
inmiceobjective
gpc3specific
gpc3expressing
immuneaffinity
hlaa2negative
gpc3367
a2gpc3367
gpc3367specific
veinthe
chemotherapyis
infectionanelloviruses
ttsuv
ttsuv1a
ttsuv1b
iotatorquevirus
ttsuvk2a
ttsuvk2b
kappatorquevirus
orf2
orf1a
orf1b
orf1c
e2based
pvaxcd81
pvaxe2
pvaxcd81e2
bhk21
pvaxe2pvaxcd81
14554
4826
9728
158570
erain
trialsin
goingclassical
crosses
subgenotypes
bvdv1b
memorandum
fetusesnewborns
melanomaselection
generics
transplantationgeneric
adherenceto
dispense
vaccinevaccines
vaccineladen
avipro®
slotted
headonly
bodyonly
wholebird
hyline®
w36
sprayvaccinated
5x
1700x
serologicalbased
robosep
isolations
cancersurvivin
faradvanced
survivinspecific
cd133high
antibodya
biabs
cd133expressing
dualantigenbinding
cd133low
prosperities
sakei
k040706
activationlactobacillus
ripened
doenjang
fermented
rifnγprimed
phosphorylations
iκbkinase
ikk
k040706induced
inducedno
antitolllike
myocarditisgiant
muromonab
970days
1875days
1bluetongue
btv1
btv16
rfpv
vp5
pcagvp2vp5
rfpvvp2vp5
selfconsistent
infectionimmunotherapy
cd27igd
naïvetransitional
diseasebehaviour
interactionstheoretical
behaviourdriven
npis
sanitizers
stingspecific
ec15
submaximal
001μgml
rapi
vaccs
assent
gauteng
inaccurately
discoveryfoundations
immunotherapyprognosis
131ihua5b7
linessw1222
lovo
ls174twere
dnaprotein
programmmed
retching
emetogenic
hec
mec
kopliks
harbinger
igg035μgml
protocolrelated
1302
igg035
59monthold
oru537
oru203
oru311
oru049
oru479
oru426
oru197
seasonbackground
providertopatient
lapel
buttons
rd36
rd13
healthyuser
134204
107171
cholesterollowering
119189
112174
vaccinationsin
3654
98fold
peoplepeople
terminallydifferentiated
rebuttal
silverman
hendrix
counterpoint
3oxododecanoyllhomoserine
lactonerpcrv
aeruginosaquorum
3oxochslrpcrv
3oxochsl
subeschar
25hr
drs
schröderbäck
martakis
win
oncoproteinadoptive
crlf2
crlf2overexpressing
tslprexpressing
tslprtargeted
oncoproteintargeted
genotypepositive
rheumavax
il29
vimentin447455cit450
rheumavaxtreated
chemotherapyantitumor
cpatreated
lymphocytesit
imagingapplication
gnplabeled
angolaobjective
bom
jesus
appliances
transgressed
immunoregenerative
patientsagerelated
hsctrelapse
whoever
fullhaplotype
haplotransplantation
opportunitieswe
fucosylation
engraftmentimmune
infectionsallogenic
prophylaxe
tcellsallogeneic
haplotypedisparate
rituxanrefractory
partyderived
malignanices
updatethis
myelodisplastic
1001162
updateninetyseven
busilvex
mycofenolatemofetil
1238
0356
resurrecting
antithird
lymphnode
artfor
3loci
haplidentical
weizmann
haplotypemismatched
myeloablated
atherosclerosisextramedullary
producedreprogrammed
repopulate
lethallyirradiated
58194
healthcareseeking
tumorsglioblastomas
transferhematopoietic
ixiaro
valneva
prnt50test
107207
websitesbackground
cooccur
27036
arr11495
108120
arr104102107
arr116109124
arr106103109
arr127115140
arr105102109
arr155
148163
arr108106110
arr078069090
arr091084099
arr132119147
117110124
112110122
086081092
encephalomyelitisbackground
mslike
nodlt
haectreated
oils
origanum
vulgare
mentha
piperita
immunotherapic
donorobjective
bmimatched
cyclosporinetacrolimus
mofetilazathioprine
kdqolsf36
energyfatigue
8017
2302
7765
2901
9835
hyderi
21238
adlib
nct01199874
bounded
acceptanceinteractions
diseasebehavior
behaviourdisease
challengestumours
rasrafmitogenactivated
3kinaseaktmtor
matric
mabcancer
b16f10derived
ctleffector
postadoptive
sustainment
generalthe
wellversed
communicationon
pmes
pme
nonspatial
5147
colocated
lunch
charterprivate
physiciantargeted
047268
datadespite
floridabrevard
oseola
polk
seminolethat
tourist
attractions
tbetfoxp3
tetanusreduced
tetanuspertussis
herdin
terrestrial
golan
37112
resampled
backboost
forwardboost
diazoxide
myocardiumreduced
dz
opener
myoblasts
epcs
200μm
nonpreconditioned
vpe
neoepitopesthe
kreiter
p00021
encephalomyelitismultiple
microparticlestargeted
iic
protumoractivated
c5ar
mpinduced
c5apep
tmeresiding
ictaluri
isolateenteric
ponds
fingerling
s97773
vaccine454
fingerlings
vaccinefeed
826100
pond
elbw
13926
pediatrix
3244
radiodensity
chemoimmunotherapyskeletal
hounsfield
flipi1
146276
groupan
1638
2297
partiallynonimmunization
goma
rebellions
immunisationdetermined
compartmentsdespite
adhu5ag85a
immunisationactivated
mucosaldeliverable
dualpolymercoated
nanoparticleantigen
ucl
nanoparticlelabeled
nanoparticlepulsed
illnesslike
987°f
980981°
achiness
immunitytype
ifnencoding
ifnexpressing
wavefront
vmi
us060
cm3
us135
us066
us143
unopened
treatmentmanipulation
virusescurrent
h6n1
imprecisely
tsss
acc
118667
wholecellbased
hyperil6
h6
hyperil11
tramph6
tramph11
trampadv700
pinnacle
nthe
hpct
μmolminute
mlminutekg
3951
pharmokinetics
propagable
rhetorical
hyperlinking
interactivity
encyclopedias
ecologies
affordances
governmentendorsed
communitybuilding
ebolaas
sail
malignanciesalthough
antisail
71c
677a
sailtargeted
virusvaccination
kvh5
aduckanhui106
d35
9090
7070
kolkata
6276
5973
6477
6986
7388
mtdna
mtdnamediated
25341598
allocationthis
betterinformed
adjuvantsdespite
overpromotion
unneeded
underpromotion
remediescurrent
supplementin
alienation
3059
451482
1831437
microparticlessome
ys
34μm
ysmediated
androgene
tak007
arn509
odm201
tok001
encephalopathiesantibodymediated
manganeseinduced
vitromanganese
mncl2
8×104
il12β
preventionin
schneidawind
metastaseslung
3t3her2lucgfp
p00141
p00086
p00117
intimin531
espaenterohemorrhagic
uraemic
nono157
t3ssassociated
experimentallycolonized
reportliver
iozk
irescontaining
challengevenezuelan
iresbased
epoch
iarcglobocan
contraindicationsvenomspecific
honeybeetreated
wasptreated
immunotherapyinhibitory
bandaid
mediatranscutaneous
postauricular
biofilmresident
immunogenbearing
il6rtocilizumab
bell
il6il6r
patron07background
labmeld
cockroftgault
δglomerular
xenograftobjective
ginsengderived
v7aad
pbspretreated
ckpretreated
algeriathis
preset
640054
299367
36586
63446
activationallogeneic
allomscs
allomsc
ctla4overexpressing
lmp2aspecific
ctlsextranodal
lmp12a
hdtsct
ctlsm2
55·5
vaccinationhealthcare
ratsrecent
coreangiotensin
coreang
remembers
twotoone
tvectreated
metastasesmelanoma
deplorable
penchant
hobilike
lambsin
italy1101
vaccinesallergic
03900715
0619
04870786
10581477
05612526
p0650
acratia
severityobjective
divid
stitches
immunotherapygenetic
munotherapy
sitbut
sav
ings
evidencesynthesis
tivbased
norsethe
immunotherapynewonset
norse
physicianfocused
levelschronic
hypodiploidy
radioimmunotherapybackground
nonimmunoreactive
timeactivity
immuneprophylaxis
mag1
gra7
tlabooster
toxoplasmaspecific
tlavaccinated
tlavaccination
544677
568732
373539
465609
280400
93162
spendingusing
elasticities
0844
0336
feasibleenterovirus
eva71cva16
coxsackieviruses
echovirus
farmsdespite
myxoma
myxv
workable
studyvaccinations
ah1n1pmd09
4832211
108198
1172036
051243
gliomainitiating
nscl61model
ox86
systemex
retrievable
studyinsect
sulfidoleukotriene
rallergenspecific
igg13
igg47
igg5
iggt
ibhaffected
showvaccines
loved
misinterpretations
misuses
fallrelated
vaccinatum
vaccinationnarcolepsy
hypocretin1
hypocretin
orexin
mmj
64mgkg±10
timetoneutrophil
hr044
95ci021
hr038
95ci016
95ci1428
lsac
n4994
issuesconcerns
108210
187325
gastroenteritisa
vge
131inimotuzumab
egfrthe
i131
chloramine
healtha
cellshaploidentical
treosulfanmelphalan
sirptcy
200μl
188rhenium
mabcampath
papillomavirusinduced
webcast
osteopathic
2part
awakensscientific
coordinatedcare
tumoursthe
shrnas
cd4ζ
proliferationchimeric
cd4ζencoding
cd4ζmodified
adenovirusinduced
parthenogenetic
venezuelensis
antiparthenogeneticfemale
antiegg
antis
venezuelensiseggs
hc23
zap
aminoacids
assaf
15000
lenograstim
decaallergic
documento
consenso
sobre
conjuntivitis
alérgica
deca
receiptin
physicianmedical
cureantiviral
hivderived
decisionsmany
valuescongruent
sliders
t399
6852
septemberdecember
nyc
range77201
range38142
range136465
anthony
olszanski
myelomasuccessful
hemo
ferritinthe
fth
fthdcs
t2weighted
fthbased
transplantationmyelodysplastic
cellall
integrationdespite
modelnear
2d3d
3t3rfp
noninfective
reviewnextgeneration
gmpready
αβtcr
brincidofovir
norwayobjective
91405
84139
rd55
rd101
monoclonalantibodies
icr62
antipbsa
phagebased
phagemimotope
deploymenttherapeutic
intraoperatively
slnt
2076390
myelomautilization
womenwe
1524yearold
35300qaly
16200qaly
53200qaly
26300qaly
immunoadsorptionbackground
directionslung
malerelated
femalerelated
overviewallogeneic
graftversustumour
oligomerizationcontaining
transplantationsingle
snp13
30163017insc
snp8
snp12
tlr5stop
4241000
106996
governmentled
petite
anse
cerca
carvajal
colonextracted
alequel
15wk
almukalla
yemenobjective
mukalla
outpatientclinics
hadhramout
103401
10838
or661
3411290
codenoptimized
adofe6e7
dcofe6e7
ofe6e7
cancerseveral
immuneactivated
mileau
systemimmunotherapy
inverstigate
spondylarthropathy
ra248
spa249
antitnfmtx
n169
nsaidsanalgesics
pneumonialower
skåne
200700653929
nct00828997
micetherapeutic
subjectsbackground
pnoit
2x250
pairedend
miseq
nonsilent
pnoitinduced
myeloidleukemia
japangranulocyte
aracgcsf
complementbinding
transplantationdetection
c1qdsa
10055
15279
28615
c1qnegative
2471
22944
mucoflu
dtpcahi
catchingup
outcomesobjective
cohortcontrolled
mlrblocking
0523the
envelopenonmyeloablative
gvm
aso4adjuvanted
vaccinepersistent
fludarabines
faraatp
fludarabinefaraa
administrationin
pharmacokineticbased
faraauc
nadirs
fludarabinetbiconditioned
aβderived
nonamer
aβ3341
h2db
aβ3341np
aβexpressing
7monthold
aβ3341npimmunized
hsp70dcs
6thioguanineloaded
ly6chi
6thioguanine
mctg
gr1int
131imibg
topotecanbackground
131imetaiodobenzylguanidine
imibg
tpt
radiosensitizer
veci
imibgtopotecan
topoisomerase1
mibg
gbqkg
giga
becquerelkilogram
mibgtpt
mibgtopotecan
4085
8step
havrix®junior
20002006
efficacyrecent
challengesto
spectacle
canceronset
serms
signalthe
electroporationwe
pinna
p1a
jungle
526245
averted153735
21415
6823
26298
10135
perurban
aiiv3
mf59aiiv3
mf59aiiv3ppsv23
nct02225327
oi8
ois
weeksadverse
patientsadverse
211followed
vfcentitled
20112013background
vfcentitlement
520±19
507±12
560±16
572±12
389±47
448±35
552±21
586±19
544±113
546±70
microstructured
scaffoldsto
microtextured
siscaffolds
oneiric
stupor
morvan
actigraphy
treatmentstereotactic
strategyone
cliques
conceptualised
numerics
idealised
pdl1cancer
tumordespite
virustcelltreated
proofofmechanism
conditioningachievement
areaundertheconcentration
μm·min
1compartment
limitedsampling
tbw
tbwtoideal
ibwadj
tbwibw
±52
nonoverweight
highperforming
antibodiest
mscsthe
atmscs
phytohaemaglutinin
colorimetric
pbmscs
itgβ1
cd6
vcam1
tendinitis
knows
neuropathyintravenous
nisweakness
cmaps
dyckrankin
responsebased
rirx
seasona
4nurses
cramers
indecisive
vaccinestaphylococcus
imi
sarcomaunassigned
sarc028
usher
busulfanthe
p0·012
5·2years
2·7years
p0·0135
vaccinationsvaccines
stagetranscending
stagearresting
parasitesmalaria
gapengendered
responsewe
methconjugate
methlike
methssoo9
immunocyanin
icklh
icklhsoo9
mab7f9
ospbnegative
50772
diseasebeagles
00325
00573
l19il2l19tnf
l19
l19tnf
efficacyevaluable
chikungunyaduring
fgl2
atlast
antifgl2
il2rgammanull
fcɣriib
1148±575ngmg
396±101ngmg
fgl2induced
sufficientobjective
internship
mmrvaccines
hypoplastic
anticentromere
proteinb
symptomalleviating
micromedex
incontrast
andsymptoms
0434
02360797
0405
01690972
01621003
01650987
comedespite
vlpbased
flucelvax
optaflu
influenzaconventional
inflexibility
flucelvax®optaflu®
useu
assuaged
liposomebound
apo2ligandtrail
apo2ltrail
luvtrail
jurkatmcl1
jurkatshbim
approachas
2fucosyllactose
6sialyllactose
ovalbuminsensitized
henri
husson
17721853
reimsborn
reims
parisian
caque
hôteldieu
navier
demanche
jean
duquénelle
tought
unalterable
developmentformulation
annua
pcdna31ns3
hcvns3
pcdna31hcvns3
antigenicspecific
hypersensitivityhypersensitivity
ygp42
tachykinins
neurokinin
nk1
nk2
nk3
maropitant
bermuda
bga
postbga
washout
crossedover
ventilatoracquired
bronchoprovocation
0710
0456
0165
postallergen
asthmaticus
countriesmalnutrition
possiblebreastfeeding
antikappa
myelomamonoclonal
mdx1097
cbcik
transplantationmyeloidderived
krebs
lungen6
transplantationbronchiolitis
kl6
ccsp
spd
immunotherapyi
anoxic
tissuetargeted
dialysisdependent
dialysisindependent
googling
cxcl12sdf1αsecreting
glioblastomanatural
dnaxactivation
dap12
mr11dap12
u87mg
itamdefective
cxcl12sdf1α
12279
neuroinflammationreply
oncologyinterleukin
il21s
ricurd
donoractivating
isoflurane
dogsmost
neurohumoral
tiva
belataceptimmunosuppressive
inhitiborbased
cniassociated
youas
greene
perused
historyofvaccinesorg
credit
nihgov
tidbits
societé
cellulaireoutcomes
17pp53mutation
fludarabinesensitive
infrastructureroutine
ageinappropriately
42157
cellsprotective
diseasealzheimers
ephrina1pe38gmcsf
africatowards
livingstone
zambiathe
vaccines4kids
randomizedcontrol
unprompted
078138
080194
077208
070167
088366
031580
060120
112463
12971
097132
growthsurgical
stoppedbackground
2015stinging
infectionbovine
10255tcid50ml
10525tcid50ml
1067tcid
strandspecific
renacoq
19961998
4157
1724
varicellawe
functionguided
kv13
channelduring
orientate
bmktx
asp19
asp33
bmktx19
bmktx196
asp6
reorientation
reoriented
evolutionguided
immunotherapyinterleukin7
slos
agedcare
facilitiesthis
racf
zealandencephalitis
aetiologic
structuret11
reproductionnatural
unk
decidua
fertilisation
embryology
provedisprove
testingnatural
malicanine
campaignfree
ownerswas
bamakos
ownerless
markrecapture
144221
27864131
antigp160
advvectorized
opportunitiesthis
3397
vitrelated
stinginduced
stingrelated
pidsworld
30″
schedulehow
21″
31″
comparebackground
002009
012019
010013
005007
011018
carriersbackground
challengeverified
dosehd
dnaprimeproteinboost
cruziin
tcg2tcg4
vaccineprimed
tfnα
gmcsfencoding
antiparasite
1228fold
345fold
vaccinatedbi
46months
1523fold
centresbackground
ofd
tracesor
dosesof
notcontrolled
unreliability
poliomyelitischallenges
mile
programmethe
backmutations
neonatesunlabelled
agm
6dayold
agms
ipr8
m229
flagellinadjuvanted
flagellinmediated
quench
immunoabsorbing
adultsprotective
δabcba
modelthis
adultsmycobacterium
bcgnaive
αpositive
adjuvantsmajor
dummheitimmunizing
wiped
stupidity
malice
wakefields
fraudulent
disproven
illustration
virchows
writ
muzzling
cpho
programunlabelled
mann
kruskal
wallis
spermann
spss®
diseasemethods
r79
r91
93797
botucatu
vaccinefree
recipientswe
tomm40l
tmem205
olfm4
osbpl9
klrc3
cd3d
klrc2
lxrrxr
fluidigm
arraysthirty
patchkdgag197205specific
4848
kdgag197205specific
αe
αd
αeβ7
αdβ2
inin
inintramuscular
imim
heterodimerize
inim
issuein
endogeneous
antiphlogistic
tranquilizers
cannabinoids
combinatorysynergistic
radioimmunotherapyradionecrosis
xrt
131i3f8
131i8h9
csixrt
651248
repeatxrt
periventricular
whitematter
rexrt
metaanalysisvaccination
reminderbased
rd01132
ci00330193
rd013
ci005022
rd012
ci002021
discussionbased
n90842
strategiesmost
centricity
selfmhcpeptide
hemichains
antigena2402wilms
1235243
a24wt1235
b5701
b57
tak1β
tak1α
hemichain
counterchains
trav122
tak1βcontaining
thymically
immunobridgingalthough
implementationoncogenic
studybreast
adscs
secretor
symposiumthe
speaker
lieping
gordon
freeman
synergiesalthough
upf
ecea
us115000
us150000
betteroff
sitebased
webrs
9044
drugsalthough
idonegative
mpmscs
fpmscs
placentas
streaming
anticd200
fpmscstreated
56±117
106±143
77±142
82±114
107±134
vectortransfected
78±132
mpmscstreated
youngold
pollenderived
ragweedstimulated
allergenindependent
celebrating
centennial
archivemeasles
hematología
interna
puebla
clínica
ruiz
eleuterio
gonzález
autónoma
nuevo
león
5205
timingbackground
dispensarieshospitals
nasopharangeal
44127
ilisari
julyseptember
lucknow
allaphuza
nagpur
dibrugarh
chennai
srinagar
34°n
cd4cd45rbhigh
treatmentbrentuximab
5478
chemotherapyasct
255gyirradiated
quantificationtoxoplasma
rote
bz
diamine
aa0029
adad
controlfatty
fabp
schistosomes
rfh15
cercariae
antirfh15
futuresurveillance
cnaefis
cdcbackground
cdcsponsored
kabs
oldtaiwans
causeofdeath
1078955
318257
760698
or024
ci01230461
or009
ci00110704
or040
ci03950415
ci00590082
ci00690072
strategiesaspirinexacerbated
vaccinedisease
politicaleconomic
subjacent
5aallergenspecific
sarjcp
epsiloncaprolactone
imagingserious
εcaprolactone
peicl
ringopening
peiclova
uptaking
tumordestructing
httpswwwclinicaltrialsregistereudoceuctrfaqpdf
networksan
markovchain
αc0
ααc
medicinecell
ukrmp
pteronyssinusdespite
ureadenatured
dndp
germanyherpes
timehorizon
162713
186732
31657
35793
39306
37417
336468
394575
48637
56087
39782
32848
datathe
tumordestructive
tumorprotective
ɣδ
sporozoitesbackground
falciparumsporozoites
cpsimmunized
nct01660854
90155
malarianaïve
therapyone
coxsackieandadenovirus
pkbased
ad5pk
modelsin
phf6
phf13
pffs
microtubulerepeat
ps19
entorhinal
novelobject
225ac3
nanotubesunlabelled
ustubes
lanthanide
225acgadonanotubes
225acgnts
cosequestration
fulfils
crd42015015159
allergica
applicationsbackground
tlymphozytes
allergenes
affixation
carcinomatargeting
paclitaxelobjective
a431g1
phthalocyaninederivative
antigpc3
ir700yp7
reviewosteosarcoma
alterative
excretions
calvesfootandmouth
r02renvironment
equalled
r02rcontact
daycares
yarning
28weeks
opportunitybecause
childrenvaricella
smallpoxsmallpox
commons
hansen
acidified
00059
wwwisrctncom
isrctn08280229
radioimmunotherapya
aspiring
antinerve
painbackground
djd
caninised
nv01
mcgkg
accelerometry
metrology
clientspecific
csom
cbpi
successfailure
d014
d028
9am5pm
gliadintriggered
gliadininduced
transamidated
gliadins
reverted
gliadininducible
lowpathogenic
actinobacterium
valves
dbpcofc
nct02046083
dnabackground
korv
transspecies
gammaretrovirus
p15e
p15especific
gp70
52kd
rgp70p52
rp15e
gp70specific
perv
marginale
phenotypeswe
drb31101
msp
drb31101restricted
f25b
centrale
msp1a
f25bspecfic
knowledgeprimary
periconceptional
neurosensory
hig
sonographic
threatsthe
fielding
seizuresbackground
totaled
6149
7790
3332
0673
83235
273401
7803icd9cm
0747
0543
96268
353489
curerecent
crchronic
0424
datafitted
persetting
generalisability
leukemiapart
immunomodulationglobally
nkg2aimmunotherapy
hlaelow
u266
nkg2anegative
05281
211astatineconjugated
therapymost
countrieswhile
4387
billionwith
hondurasbackground
honduran
cofunding
brenzel
nha
moldovaobjective
2012january
ols
wage
16459
14994
ingredientbased
11943
112548
3166
3323
upkeep
2555
moreprecise
abovefacility
3816
lions
5932
healthsystem
equaled
startup
2478
donordriven
countryled
iwg
lshtm
dubrovnik
newvaccine
nonpaho
countryowned
19802010
26000
370000
100027000
157871
17784
us11811600
us30118222
us1252694
us4995895
us6506711
us40912132
us48436534
us47160721
georgias
20142023
7170
8288
6154
npnm
440000
7787
decisionsbackground
costvac
olives
croatiaobjective
20142033
6900077000
3×gdp
albanias
20132022
51172
14200
5047
albanian
irans
138161
76591
49991
47061
8583
belizeobjective
belize
belizean
4795
globocan
86906
4349
36326
40826
570273
79937
3049
7512
419815
112331
3116
10386
226370
313119
3739
4722
peruvian
paraguayobjective
pnad
6677
7663
7412
7298
epicbackground
routinizing
lygs
pricedose
6440
3870
1802
2414
argentinas
diseasesurveillance
60935
216454
70236
329779
nuscc
nusccs
polydactylous
dystrophies
stromaldepleting
practitionerthe
necrosisα
tnfαblocker
exposureobjective
unifesp
hivgroup
p0085
mantained
muiml
tootsweet
χ2tests
p0448
canceril11
anticd40cd154
tolerancesince
histoincompatibility
concernthere
sarcomawe
1×10625×107
cellsintradermal
interferonenzymelinked
γifnelispot
1941
pg106
tgfβ1and
tgfβ2
plateletactivating
acetylhydrolase
sse
infectiongroup
paf
m1t1
mgas5005
s178a
sses178a
antisse
2b11
021057
pmini
rqlq005nasal
11344
5649
highter
9224
4642
27665
incrementaldose
maintenancedose
countriesover
cdx301
volunteersfmslike
cd135
rhuflt3l
μgkgday
processantibodies
1pd1
paperclinical
monoamine
conditiondisease
experiencefrance
enjoys
reimbursing
comité
melanoderma
modulationa
antibodiescurrently
phtd
14201946
aluminumadjuvanted
7622038
lytb
sufficientin
mcctt
mcccrm197
hibmcctt
8472
sfgmtcbecause
autoscts
lesstreated
transmissionblocking
ambition
riskconditions
patientrecords
generalpractice
researchdatabase
ipcidatabase
patientgroup
adjustedcoverage
riskcondition
lowerupper
aneurysmprosthesis
11724
1096512532
veryold
targetgroup
subgroupvaccination
antignrf
pigsantibodies
18weekold
3and
testobjective
cassino
under18s
over18s
gynecologist
booksjournals
mhsp65ttl
micepancreatic
mhsp65
oligodendrocytic
factoropioid
ogfogfr
ogf
ldn
aspectsmultiple
sclerosisimportant
ro52induced
nzm
2758
maltosebinding
antiro52
sialoadenitis
pilocarpineinduced
nzm2758
immunoprecipitating
ro52immune
cytochalasin
statesover
nndss
19902009
19501989
agespacings
rasmussens
possiblea
aeds
symptomless
crystallizes
arrowthe
msod1
gdnf
signalingobjective
tc0mediated
il17acd8
formationa
rheb
rhebtransduced
immunoedited
pras40
mtorc1low
199495
viwandani
3602
2490
097times
20002499
394times
nsltps
nsltppositive
immunocapisac
jug
3pos
nutpeanut
ferretsunlabelled
donkeys
abluewinged
tealtexassg000792007
tltx07907
aann
arbor660
aharbor
sealnew
hampshire1796292011
anorthern
pintailalaska442281292006
therapyopportunistic
awoman
bap31
melanomasobjective
hbap31
mbap31
mbap31specific
mbap31positive
bap31expressing
sinusitisallergic
afs
lundmckay
ulss
venetian
regione
disaffection
servizio
igiene
sanitàpubblica
venezina
sisp
venice
diseasesantitumor
lowserum
complexitythe
sexdriven
millenniumobjective
malebased
ropporin1
implicationsrecruitment
cancertumourspecific
iibinding
polyneoepitope
immunotherapeuticoncolytic
kinaseinactivated
119344
72344
or6811196
ps000101
010076
or754
1194769
or525
1002761
or017
005066
elderlywhile
mcbs
unweightedweighted
n6095192
p8
allpotential
23dioxygenasemediated
autophagyautologous
rs7820268
atg16l1rs2241880
antibodiesobjective
rhinoconjunctivitisobjective
eaacihowever
busulfanthiotepa
testisexpressed
pate
ratevaluating
spermbound
testesexpressed
patef
capacitation
ionophoreinduced
acrosome
calciumbound
fluo
3am
pnafitc
epididymal
casa
patefimmunized
mixbased
diseaseinterleukin
hormonelike
tularemiatularemia
weaponization
emra1
ftl0687
sodb
katg
schus4
1x106
100010000ld100
organophosphorus
pesticideinduced
hyperreactivitywe
parathion
parathioninduced
vagal
diazinon
chlorpyrifos
pyrethroid
permethrin
functionblocking
chlorpyrifosinduced
diazinoninduced
opinduced
experiencepleural
calu3lucgfp
thoracoscopy
00180
leukemiaamong
needsremain
determinantsthe
vaccinevaccinationspecific
calmetter
diptheria
20042010
151209
vaccineuptake
receptorhere
semiacute
cardiomyocyte
pollinosisbackground
cedartolen®
tosms
mississippis
umbilicated
chin
trephine
postdocetaxel
predocetaxel
candidatesobjective
humanleukocyte
antigenincompatible
b44
dr11
dq3
dq5
b50
dr13
cw6
dq8
plasmapheresisrituximab
unsuccessfully
incompatiblehuman
dialysance
102264
protidemia
immunoadsoprtion
immunoadsorptionhemodialysis
donorkidney
2434
antibodyremoval
antitransferrin
89zrlabeled
tspa01
90ytspa01
miapaca2
antitfr
tspa02
111intspa01
111intspa02
dotatspa01
dotatspa02
pharmacistsobjective
recombivax
leasteffective
meibography
meibomian
diseasemeibomian
umga
tarsal
pdox
blsonly
brightfield
mvx10
longworking
highmagnification
anticeair700
redlightemitting
mwcm2
11490
7946
wos
hepatocarcinogenesis
lymphomabrentuximab
29yrold
156mg
18mgkg
titertotarget
7881
16253
4641
02048
anastomotic
insist
overallp1p2p3
51251455469
524529538503
519525553476
635791597527
2013february
schmallenberg
sheepschmallenberg
sbv
orthobunyavirus
tachyzoite
cowsneosporosis
ncis491
caninumseropositive
underinsurance
muc16ecto
viviparuspmy
bovilis
dictol
elisabased
immunglobulins
pharyngeal
rpmyvaccinated
pmybased
swazilandbackground
parities
caribbeanthe
embarking
fifthgrade
χ2876
χ2637
z244
immunopathol
1613421121
ovacpg
ipimmunized
5group
05005
vivostimulated
animalmatched
nairobis
settlementsbackground
vallovaxbackground
placentaderived
vallovax
ovatus
cystatins
multispecies
cystatin
brbmcys2b
brbmcys2c
jpiocys2a
primerbundled
mis416
anticd11b
21point
3501750
2950
modelone
timehonoured
bcgtumourimmune
ly6clow
extratumoral
krasg12dtrp53r172hpdx1cre
littermates
kpcderived
clodronateencapsulated
malignanciesdormant
cellcyclespecific
costobjective
costefficacy
comparedbackground
dces
lymphomaafm13
tandab
vedotinrefractory
nct01221571
casereport
reviewhemophilia
fixcontaining
procoagulant
2540we
healthcore
databasesm
169560
ppv1
780934
inaccuracies
schoolnursery
schoolsnurseries
varicellabackground
sinana
organizationexpanded
mbpderived
cyclombp8799
cyclo8799a91a96mbp8799
postcci
nerveinjured
hindpaw
cyclombp8799treated
apltreated
mbptreated
nonencephalitogenic
microdilution
22204
pcv71013
myelomagenesis
immunotherapiesas
anticsp
012month
017month
chaotropic
cspspecific
022099
011051
nct00436007
cebu
datarabies
visayan
162028
1498
fixedsite
ah01aa
aanhui012013
ah01h7n9
grapefruitderived
sitesinflammation
inflammatorydriven
gnv
inflammatoryrelated
ignvs
ignv
2422896
65000
postrv1
beyondsince
dtpainactivated
nct01277705
wwwclinicaltrialsgovnct01323959
boostrixpolio
vaccinerecently
riskcommunication
mesolevel
pd1pathway
usarecent
vem
77687
60329
153062
134048
35243
33641
42870
41384
58991
81306
flagida
completeremission
95405
250±108
334±138
535±131
500±125
nct01496547
bloodactivated
850fold
nursedirected
beiv
productivityrelated
externalities
montreux
beivs
usersobjective
connexin43
cx43
cardiomyocytelike
h9c2
humansoral
studyhpvhpv
behaviorswas
diseasepneumococcal
largevessel
pvdi
indextakayasu
deitak
itas2010
23year
scores3
anticd3fv
il3receptor
anticd3fvil3
locking
16c9
highbinding
il3r
cd123expressing
dsanticd3fvil3
bca1
erythematosis
anticxcl13
5261
4hydroxy3nitrophenylacetyl
npklh
passivelyinduced
cxcl13mediated
preventively
48682
11464
37218
12208
osteopetrosishsct
miop
twoyr
conductive
defensefungal
iudl
buml
72101
5173
3047
2572
beltthe
dderived
gd5361
gd7078
gd278286
gd287317
nεpalmitoyllysine
hsvspecific
trigeminal
gdspecific
rciks
3165
allergydefinitions
therapyfood
animmune
firmer
studyseveral
boarders
14·288·5
5·661000
boarderweeks
0·261000
0·741000
0·46
0·280·76
0·610·85
0·18
0·090·36
secondaryschool
nonboarding
norfolk
suffolk
kingdomperinatal
travelersincreasing
vaccineare
yearsoutbreaks
hesitancyin
infectionsdue
metropolisbackground
713769
vaccinesmimics
proteinreactive
immunizationsmaternal
2009august
13y
257813
n701
gravidity
aor218
ci172278
aor036
ci028046
aor314
ci199496
vaccinationlisteriolysin
thiolactivated
cholesteroldependent
3cm
approachescancer
cscprimed
dunedin
3575
78259
mastsorb
antiparotitisvirusigm
mcnemara
corp
0760
0644
0842
0744
0954
nonwest
investigatorblinded
relevantbackground
abscopalnontargeted
radiotherapyanddistant
2883years
32gy
26gy
339months
epidemicconventional
ageto
nonmigrainelike
lipidomicmetabolomic
nct01943305
evaluatorblinded
decims
subdimensions
msimmunotherapy
doctorfocused
isrctn37929939
periodthe
liposomehyaluronic
antigenshere
f1v
liposomepolymer
thiolpeg
dotapha
corepeg
lc5002mgml
lc504mgml
f1vspecific
2685
lhas
webquestionnaire
brochuresleaflets
fliersposters
oradj59
20174
preassigned
oradj70
12398
nonrespondents
oradj41
preassigning
interimfinal
201011201314
endseason
compliancetracking
vaccinationaccording
stir
violates
foreclosing
beneficiariesbackground
littlestudied
casemix
325649
mcahps
militarywide
electroporationthe
paβ31010mil4
eightmonthold
isotyping
rituximabposttransplantation
choplike
injectionanalysis
palsies
dnartvgp140
gp120gp140
v1v2gp70
rtvgp140
12weekinterval
4weekinterval
v1v2gp70specific
micebone
60100
tibiae
chimerism80
busulfanmediated
nanomedicinesince
ebmtidwp01
idwp01
ppv23specific
p0327
p0271
stromalleukemia
mdscml
barriersevidence
leukemiachildren
inhibitorsallogeneic
recipientscord
thaw
kilobases
nonengrafting
modelthere
isav
presmolts
ifna1
ifnb
reactivityglioblastoma
gliovac
erc
avastin
usehospital
leukine®
reoperated
nct01903330
tanzaniahaving
sdps
resourceuse
diems
hbigfree
miniquantitative
infectionsviral
prenyl
accessorycostimulatory
panpopulation
immunoscintigraphy
irist
hlauniversal
hlasilenced
1998–2014
immunotherapyunresponsive
tumefactive
antigensdespite
adinfected
calrmagea3infected
vaxscene
advertise
kiosks
roving
14month
utilizers
nonutilizers
rove
communitiesobjective
ethiopianeritrean
culturespecific
fiveitem
registryobjective
groupsthe
callonly
groupusing
messaged
prerecorded
7094
registrydriven
schoolgenerated
142321
274434
346494
1642
resourcelight
twophase
negativeconflict
monthperiod
studyprospective
8115
11652
transplantationpretransplant
hctcomorbidity
3917
1407
plateletsnot
hemoglobinwere
cstatistic
worldwideobjective
7510
ir700antibody
conjugatesphotoimmunotherapy
nearinfraredabsorbing
scavengers
oxygenderived
onlyfanconi
nonradiation
charité
multiviral
unapproved
2015adoptive
cancerfocused
nationalized
potentialresearch
intercrossing
180000
diseaseseuropean
injuryregeneration
antiinflamatory
controled
antiinflammtory
diseaseactive
cad106
affitope
nonhivexposed
2765
7902
10early
malignanciesunassigned
systemsthe
internetmodern
quell
laybasedlayoriented
dread
publicvaccines
officialsvaccination
settingsvaccines
mortaity
vht
modelonly
shortsighted
mid2002
conditionsexperience
insertsany
packageleaflet
nonspecialists
grammar
syntax
memorize
authoring
rédacticiel
prolipsia
linguists
insertsleaflets
communicationthe
usercentered
potsdam
providerswhen
professionalsnot
germanspeaking
subtopic
hobby
lobby
perceptionsin
1101
environmenthighly
publicised
communicationit
beginnings
mannosepegcholesterol
mpclipid
emulsificationlyophilization
promllfilled
prommas
bsaspecific
vads
bortezomibhigh
creatively
bore
immunityt
surveydefined
life—in
enjoyment
zileuton
aluminiumadsorbed
0062
phosphateadsorbed
il17dependent
infectiontoxic
mtsst1
mtsst1vaccinated
il17adeficient
il17adependent
tsst1deficient
chemokinemediated
lep
lepidoglyphus
destructor
25th27th
haematoxylin
orumba
χ212286
χ28542
χ242572
χ28735
actionhesitancy
protein1ligand1
cancersimmunologic
tango
kongconflicts
antipathy
gonacon
webbed
oviducts
gonacontreated
limping
boostunlabelled
rnyvac
mosaics
silicodesigned
mess
vaccinationefficient
yfspecific
naïvenesslike
dermatologistsimmunomodulatory
33090
53075
29495×10l
p0276
185kda
ugandafrom
319886
056228
016536
focusa
antigenomes
antigenome
n598
nonhypermutated
immunoinhibitors
n1945
ccr8
unsuspected
adap
skap55
immunotherapypd1
adapskap55
fyn
nfatc1dependent
skap55deficient
adapdeficient
adapskap55nfatc1pd1
hais
il2cd4
tnfαcd8
immunossuppression
establishmentbackground
pge2il
10dependent
salivarygland
sge
adoamp
exacerbative
sgeinduced
nucleosideinduced
a2ardependent
coinoculated
outcomessystems
r132h
gliomathe
gliomasimmunotherapy
gl261creating
midh1gl261
oncometabolite
2hydroxyglutarate
2hg
pgl261
midh1
antimidh1
antibodiesimmunizations
nafl
vaccinepackaged
antigenuptake
naflmediated
adjuvanicity
laserdamaged
dsdnasensing
immunotherapyαβ
mhclinked
mechanobiology
studyintralesional
ils4
ppdtreated
steiner
parentsus
waldorfrelated
anthroposophy
education—but
selfeducation
predated
nourished
lauding
diseasetargeting
10101
bpallergic
bpinduced
å
170177
12550
7498
18d
2965
injectionsyear
8948
controlsbackground
diseasehsct
ldtbi
proteind
toddlersmemory
2166
p0·24
p0·06
p0·07
spectrummalignant
naevi
liposomized
alphacrystalline
reinvigorates
potencybacillus
αcrystalline
acr1l
ifnγhi
tnfαhi
acr1lboosted
bcgacr1l
cd44hi
cd62lhi
cd62llo
carcinomacytokine
agdccik
p00418
p00116
p00212
petralli
publicallyfunded
mecasermin
receptorless
therapiestwo
ipscsmutations
menon
scidx1related
hectic
vaccinationmeasles
destabilized
diseasescell
30100nm
acas
phonly
herdsfoot
feedlots
or595
ci951592229
ci950831299
p0089
rabiesobjective
rvg
bsr
mnri
pcdna31gp
rvgp
jon
wigginton
chiang
bronchodilator
diseaseeffective
sirolimustacrolimus
methotrexatetacrolimus
p078
provenprobable
triazoles
eln
intermediatei
intermediateii
flt3itdmut
lesionspecific
del5q5
abnl17p
patientspretransplant
mlfs
leukemialimited
origingenetically
500×
106l
autologos
electroloading
factorαprostaglandin
e2zoledronic
acidok432
electroloaded
epdc
mc38carcinoembryonic
thrombospondin1
tsp1producing
environmentrestoration
tgfβproducing
diseasesvaccination
activetargeting
europea
vaccinethere
chad63metrap
percutaneously
needleandsyringe
20002009
0074
083097
019023
cd19rcd28ζegfrt
pneumoniaespecific
cla
multinut
publicationbackground
jsa
100000jauml
385μgml
222667μgml
reviewaplastic
triggerrelated
marrowinhibiting
aatg
donorscord
resistantrelapsing
tumorencoded
vaccinationflow
nonmodified
12009
412013
5663
nndds
nndd
solutionsobjective
wardlevel
menccross
mencpolysaccharidetetanus
childrentrial
200901657931
nct01129518
200806
macrophagetropic
challengevaccination
sivmacc8
fascicularis
nefdisrupted
nefintact
sivmacj5
macrophageneurotropic
sivmac23917efr
sivmac17efr
cd4independentccr5
sivmac316
lymphocytotropic
malignanciestherapeutic
stxbbased
tc1luciferase
stxbe7
ng2
walldeficient
spheroplasts
listeriosisvarious
membranemembrane
spheroplastbased
archaeosomeentrapped
lwcp
spheroplastimmunized
lwcpimmunized
indiaprogress
rge
140952
dtapvaccine
131529
9596
dtapvaccinated
nonrvvaccinated
rvvavailable
prervv
noncirculating
hmfd
cc024
shzh05
cc045
cc090
cc163
polyproteins
upperclass
hegemonic
problematization
protagonized
multiepitopes
b6129sldlrtm1herapobtm2sgyj
miceatherosclerosis
atherosclerosisprone
ahhc
apob100688707
hhsp60303312
hhsp60153163
cpn
epitopesubstitution
rhhc
c5ar131
rphc
receptor14255
atherosclerostic
695±11
557±34
656±13
antiatherosclerotic
cancelled
militarys
activeduty
chauvoei
conditionsthis
hervk
hervkspecific
a375sm
parking
diseaseagvhd
cureover
1we
ad5sigma
retargets
ad5fibersigma
βspiral
shaft
proteinsad5
adr3
r14
r20
wereused
ad5r3sigma
adsigma
tumoursadvances
lmddmpfg
lminduced
practicepostexposure
vpwand
15344
421100000
752100000
vpw
4752
900000
leukaemiaobjective
amlm1
84·5
nonanaphylactogenic
igecd3
homingclinical
hascs
homingretention
diilabeled
100ngml
futurelive
revertant
hlagbackground
underevaluated
desensitizationallergy
trialfeline
calicivirosis
panleucopenia
3yearly
purevax®
rcpch
chlamydiosis
fhv
90yttriumibritumumab
90yttriumibritumomab
iscrtn36210045
4615
alterationduring
cythopathic
ligandomics
tumorassociatedtumorspecific
sfce
sfgmtcallogeneic
se8
se9
se7
35235
vinblastinecorticosteroid
remissionsecondary
qtc
centerhematopoietic
ratecorrected
imagingadoptive
deoxycytidine
hdck3mut
f5
18flfmau
hdck3mutexpressing
hlaantigenmatched
flusurvnet
112301
outskirt
citiesbackground
2447
metropolises
proportioned
cytomegalovirusbased
doseebola
cmvbased
apes
italyalthough
piemonte
friuliveneziagiulia
102077
100332
healthrisk
multicentres
agedependant
effectivenessbackground
6397
3684
9912
9085
change83
9904
4860
change509
9945
9018
change93
p0968
endurable
rbcderived
unitderived
prestorage
17611±3426
37486±5598
proteinbound
supernatantinduced
rbcinduced
reportiha
vaccinehypotensivehyporesponsive
ligandconjugated
apxiia
modelactinobacillus
apxii
treosulfanthiotepafludarabine
donorhsct
osdfs
moleculesthere
10000child
infrastructurerelated
nonpediatric
crime
collegelevel
10101015
10161022
2chlorodeoxyadenosine
4967
nanotherapeuticsthe
nanotherapeutics
infectionswhile
reviewmesenchymal
pdm
dextramers
gilgfvtl
dextramerspecific
closedtype
facilitiesobjective
orphanages
activivty
staphylovac2
vaccinie
microgen
baed
staplylococci
wannabes
tripledrug
inductioncontained
n241
3077
1364
pvalue0025
ah1n1specific
pvalue0042
pvalue0035
igdcd27
pvalue0007
baselineearly
il4il25dependent
infectionover
heligmosomoides
polygyrus
val1
lysmgfp
massing
fcrγ
neutralise
il25deficient
uncharacterised
homologs
il25dependent
preadolescentsa
vaccineescape
menhavingsexwithmen
vaccinesannually
industrially
studycommunities
noncri
cris
noncris
drill
20012010
regionsvaricella
sicilia
9486
20295
201314background
20056
40127
25694
59210
9398
2386
overimmunosuppressionsince
nomenclatures
49th
testanthrax
jurisdictionwide
50day
secondvisit
workersdisaster
n164
x2151
nonadequately
postassessment
calmette–guérin
multipuncture
tbm
2000–2011
2000–2005
2006–2011
iledefrance
networkswe
hardcutoff
custirsen
reachable
lineadoptive
challengessuch
manufacturingand
allergensallergenspecific
prophylaxisrabies
zoonose
scratches
antibiotherapy
solidtype
cautiouslyincidental
hemodialysisrelated
idrcc
srcc
cystictype
crcc
nrrs
0295
strategiesduring
legitimately
refractoryrelapsing
transplantationthiotepa
thiotepacontaining
2yr
reportpositive
incirculation
3cases
2followed
rheumatoidlike
nontregulatory
constructsobjective
transtheoretical
collegeattending
proscons
halves
singlefactor
ericeon
epsco
transpose
patientstreatment
enculturationan
intraining
socialization
openmindedness
uncritical
emphases
factorsrather
irreconcilable
r22c03
neoparamoeba
perurans
agd
ruckeriamoebic
growout
tasmania
proteinlike
mbplike
amoebae
dipimmersion
nperurans
perspectivenk
nkdc
newimmunotherapeutic
immunotherapybasic
γretroviruses
17βestradiol
celltracker
progressionrelated
077100
0050
gohuman
gciii
ghglgo
pdnas
glandderived
sgmcmv
pghpgl
pghpgo
pglpgo
antighglgo
novs
gi1gii4
nongii4
cartography
gii41997
nct01168401
10ngml
16mg
on2mg
2mg
peptidespeptide
tv003
nct01072786
nct01436422
overdispersed
10·14
200810
6·85
0·640·72
0·100·18
4·48
1·40
0·31
0·280·35
15·63
0·44
0·430·47
4·19
5·25
1·25
1·171·35
12·03
10·83
4·08
3·63
micetumor
antiangiogenicantivascular
deathinducing
proangiogenicimmunosuppressive
antiangiogenicimmunostimulatory
sarcomaobjective
104m2
108m2
105m2
106m2
116e
cancermultiple
nimbc
bcgrefractory
bcgintolerant
cancerphotoimmunotherapy
ov100
studypretransplant
conditioninginadequate
130mgm2
1500mgm2
4679
oftenmissed
immunoprotectionimmune
idsa
6mercaptopurine
diseasedonor
predli
fgfs
farbercenter
researchdisease
receptorsrecommendations
designsmyasthenia
electrophorus
cellhelp
n1474
melanomanras
rasmutant
binimetinib
mmr®ii
childrenprior
lethalitygraftversushost
n6602
4088
13·7
68·46
85·42
12·65
8·98
populationrepresentativesurvey
vaccinationn
3×1010
1×1012
advtkprodrug
75fold
66months
bcgbased
balmc
mgias
haarlem
myocarditispericarditis
spx
ctnt
palpitations
spxvaccinees
tivvaccinees
1793
postspx
200times
prespx
65558
99th
60times
tivvaccinated
postvaccinia
lymphoreductive
triosephosphate
isomerase
sjtpi
japonicum
radvsjtpiopt
rsjtpi
primingrsjtpi
antigensincluding
inductionexpansion
89zrrituximab
immunopetct
89zrlabelled
msvmbq
082099
124fold
201100547438
transplantationdendritic
11c
jitters
cytomegaloviruscytomegalovirus
selfinterview
penilescrotalperianal
87511
166511
232511
tdvserotype
tdv2
tdv3
2928
nct01110551
ringed
sideroblast
rars
rcmd
blastsi
raebi
x109l
sociated
oklahomas
underperform
factorsneurological
11863153
10092760
ncfree
nonmodifiable
hrpc
rpsma
rsurvivin
75mgm2
melanomacombining
brafv600edriven
sm1
melanosomal
dromedary
mersimmune
merscovneutralizing
subdue
osmosisdriven
vaccinesachieving
osmosis
polyεcaprolactone
dipcoating
pburst
solutionfilled
87±29
caprolactone
56±20
19±02
10wt
innovationthe
allergymore
aadjuvanted
featuresa
horns
pseudovirusencapsidated
microneedleshuman
encapsidation
capsids
psvencapsidated
hpv16mm2
hpv16f
fspecific
mm2specific
psvf
encapsidated
betaparticle
chemistries
radiophysical
antibodystreptavidin
dotabiotin
90ydotabiotin
177ludotabiotin
90yprit
177luprit
headto
rhinologic
infectionebolaviruses
preinfection
vlpmediated
vlptreated
postexposuremediated
koreaa
guro
42fold
orf9
orf18
orf68
transcranially
immunetriggering
fusbbb
ctltreg
functiontherapeutic
40nl
94nl
30nl
48nl
50nl
024days
10nl
0days
214months
034095
stat6ip
stat6ipvaccinated
iuhctx
μgfetus
e115125
newtargeted
lymphomasin
180mgbody
bsa6days
70mgbsa1day
800cgy4fx2days
248months
gvhds
flumel800cgy
childrenhepatitis
65log
135log
rumenmethane
singlecelled
eucarya
methanogenspecific
salivaderived
methanobrevibacter
ruminantium
indonesiabackground
rupiah
levofloxacinreply
hypothesisallergen
childrenhuman
tregnaïve
nct00603954
crossanalyzed
sitewolfs
neurohormonal
esophagogastroenteritis
allergyrush
n1508
n910years
il121518preactivated
transplantationmismatched
overtaking
allotransplantationcurrent
mofetilmycophenloic
median40
3464
5ngml
dualsteroid
personnelobjective
selfassessed
utests
v21
hepatectomycik
prothrombin
0634
antibraf
studycytokineinduced
μmolmin
miteobjective
erand
dptms
7273
7647without
4666
7125
9704
calloselasma
rhodostoma
cryptelytrops
albolabris
siamensissnake
vipers
lipped
calleoselasma
malayan
queen
soavabha
qsmi
dualistic
prognosisbased
anemiaestimating
walkphasst
sildenafil
19468
csccd
universityuniversity
cwruuh
twovalue
cellsmcl
tricuspid
regurgitant
probrain
switzerlandadolescent
dosis
believes
hsctobjective
obu
withoutwith
tariff
86434
44376
2070
27570
mrrit
1089
40335
37412
40851
rateswhile
vaccinesby
encouragements
nacm
5322
romeitaly
preadoption
microarraybackground
cmallergic
igg4binding
0858
341359
09593
micetype
ipscsxlinked
malignanciesclinical
n23272
pgfs
untruths
hamiltonjacobibellman
hjb
lipschitz
goodpasture
α3ivnc1mouse
α3chain
α3ivnc1
α3ivnc1specific
necrotizingcrescentic
stvkagdlekiisrc
antiil23a
655066
singlerisingdose
withindose
655066treated
defenseindepth
challengealthough
nmab
hgn194
diga1
diga2
intrarectally
shivexposed
nmabs
igg1diga2
shiv1157ipelp
fallback
fortified
transplantationtherapeutic
interleukin15activated
cucurbitacin
akrj
daltons
ril15activated
ril15
eurotransplant
24dr
mmdr
01dr
minisentinel
sevoflurane
zurichsao
pauloghent
5123274
5402633
infectionvaccine
it285
youthfriendly
ng2cspg4
cancerng2cspg4
intratumour
responsivenessvaccination
needless
127000
227000
fades
tporas
malignanciesrelapse
mcyp
repeateddose
foodchallengeproven
fishallergic
micerabbits
aloh3adsorbed
hypoallergenicity
20item
nonreceiving
30208
selfpaying
1193
1404
161258
systemdesigned
dosinga
zonebackground
resourcedemanding
efficacyeffectivenesssafety
implementationlogistics
valuespreferences
nitagcollaboration
2015between
3804
bugojno
fojnica
travnik
interferonαimmunotherapy
subcutaneouly
peripheric
vaccineleptospirosis
nonleptospirosis
metro
manila
sewers
3114us
2160us
3segmented
1415year
dcactivated
dcat
7563
6781
8707
7480
5974
4999
8210
6990
chictroch12002610
dnafowlpox
e6f47r
dnafp
fpfp
antie6specific
e6immunized
avipox
eventscancer
immunotherapydevelopment
coronavirusan
ad41
ad5s
ad41s
radbased
ad41sbased
fourteenth
pivac14
studyvaricella
reexposures
decadeslong
tevagrastim®
zarzio®
atomiclevel
utahobjective
disordersallergen
her2cluster
her2cd3
cd3‑positive
skbr‑3
lymphomasoptimal
buem
survivaloverall
632767
656798
varicellaserological
vestibular
carbohydratepulsed
trisaccharide
taca
gm3
nphenylacetyldneuraminic
nacetyldneuraminic
nphenylacetyldmannosamine
mannphac
nphenylacetyl
gm3nphacklhloaded
gm3nphacspecific
fbl3
ctac
etac
heidelberg
mcnemars
eaals
eaal
cd8cd27
0448
0573
03470945
simer
arezzo
82of
practitionersobjective
pratictioners
haematic
accesses
71000
200304
convict
septemfasciatus
cerevisiaeinfection
akaara
conditioningpolymorphisms
rrgit
rs4585
rs189037
rs227092
rs228590
rs664677
genethe
matrixassisted
desorptionionization
atm1atm2
atm2
rs4585t
rs189037a
rs227092t
rs228590c
rs664677t
atm1
febuxostat
classigg4
mllellpositive
leukemiaelevennineteen
lysinerich
mllell
tanzaniaobjective
interviewadministered
or838
or415
or581
or644
riskstratifying
reresection
urocidin
immunotherapiesmonoclonal
tissueblood
βherpes
numberone
microinfection
cmvassociated
dutifulness
vaccinationspeople
perplexities
stigmatize
boysobjective
prince
anemiabackground
6128
657967
45936
transplantationpositron
myelomatous
emd
srsipi
interleukin23psoriasis
il1223p40
threepart
10mgkg1
day196
3mgkg1
day112
infectionprotein
vaccinepromoted
interleukin2positive
resupplementation
ccl22ccr4
lymphomanasal
macrophagesmacrophages
macrophageorchestrated
cardirected
infectionsalthough
adultsvaccination
bombs
immunosuppressionnew
immunosuppressantassociated
hlaantibody
alphaimmunotherapybetaemitting
tbii
thyrotoxic
intakeinflammatory
energydeficient
metabonomic
pufaenriched
pufa
αketoglutarate
glutaminolytic
hladrb10405restricted
pantumorassociated
wt1332
wt1332specific
th1cytokine
hladrb10405positive
talampanel
inoculationsir
sloanes
transactions
wortley
montagu
proclaimed
350th
gbmtargeted
dcvmn
coorganizing
praise
typhoidconjugated
staffinitiated
pbrn
grpbrn
cornet
january2013
n7040
064134
068188
aciduria
cblaobjective
cbla
proband
investigationhis
propionylcarnitine
µmoll
propionylcarnitinefree
38821
homocysteine
c650
pl217x
c742
pq248x
mmaa
hydroxylcobalamin
proteinrestricted
lcarnitine
valuethe
13month
sowsthe
sowsnv
nvnv
sowsv
nvv
vnv
ipma
busulfanthiotepabased
thiotepabusulfanbased
rituximabbusulfan
rbumeltt
421136
043094
006075
004087
nct00699816
overreaction
antima2
bradykinesia
cogwheel
posture
vesicorectal
electroencephalography
35producing
i35breg
diseasesneuroinflammation
cataractogenesis
zenapax
remicade
antiicam
hashimotos
i35bregs
nontoxigenic
fractiondiarrhea
igacontaining
futureintradermal
simplifies
coveragethe
understands
mvmh
uma
imunizasaun
postersized
marshalling
liberiaglobally
widereaching
liberias
mchip
lofa
410mg
nondexamethasone
105239
105301
103249
55428
materialising
timetrend
0·32
0·190·52
0·220·71
0·540·96
0·470·91
0·510·89
0·340·74
0·790·94
typereplacement
aviditybackground
tetanusdiphteriaacellular
nh4scn
dissociating
7377±1208
70417713
5023±2132
32416806
27306
7953±561
76918216
7156±1258
65987714
6393±1798
47318056
pertussiscontrolling
pentavalentvaccine
rotavirusvaccines
rotavaccine
gkv
hr0487
02281037
chemotherapy6
stagnating
20082013although
37485
4258
silesia
personmonth
hardcore
resuscitationpromoting
rpf
micrococcus
luteus
rpflike
rpfd
e54
rpfd1
e54k
rpfd2
e54a
rpfd3
d48a
protectivetherapeutic
slightest
rpfd2immunized
rfpd
mutantimmunized
sel068
squirrel
monkeysa
discriminativestimulus
epibatidine
varenicline
nicotines
nicotineexperienced
cataloging
resultspreliminary
ah3n2related
miceoropharyngeal
candidal
careadoptive
environmentadoptive
tcmlike
lymphoidtissue
tcmphenotype
tolerising
tumoursite
multiphase
calmetteguérininduced
t2wi
dwi
dwis
044068
mm2sec
caseation
hemophilic
optionschildren
morethe
reviewstarting
reemerge
akap4
pttg1
targetslung
akinase
ctaspecific
sp17akap4pttg1
activist
vivopythium
psoriasisobjectives
swollen
transplantationby
trialing
natsal3
2569
148247
asianasian
132290
157247
167361
079231
nonattenders
tollslung
cd30targeting
dentistrythe
canceremerging
32138
31138
48138
27138
124138
62138
us050
5377
lppq
infectioncontagious
lppqn
hcccurrent
republicyellow
staples
post2015
proquad
euin
mmrvaxpro
varivax
advl04p2background
04128
01731
glisters
localsite
disputations
kangtai
sina
weibo
baidu
microblog
23200
34018
17832
il12α
carboxylterminus
das28esr
nontuberculosis
holland
cernandas
relationshiplevel
vaccinationformative
or095
090099
or252
105604
090100
amyloidosiscardiac
0497
140200mgm2
amlaml
bmtctn
0901
365864
patientsiv
402mlmin
338077
1031±00325μgml
3618±01932h
1212±00352lkg
gstp1
withag
p00283
p00111
p00255
seventhgrade
ogive
mobilityinflated
wellpopulated
individualspecific
goalsalthough
cyclophosphamidehaploidentical
statusa
19982011
dtp\dtap
395±3
127317
111127
242±205
vaccinated789
twoandahalf
6308
lazy
platformdengue
phoolcharoen
natl
acad
2011108dec
5120695
6d8
antebola
cediii
dengueebola
deric
geminivirusbased
anticediii
037089
049126
099232
126168
antibodiesbispecific
twotarget
forcedconnection
recruiters
recurrenceovarian
goaldefined
joins
gangbcell
988998
olalekan
analysesrecent
lasermicrobeam
ctlepitope
a24restricted
taasp
taalps
taalpspecific
antigenspreading
taasps
matrixobjective
ho126924
roleapproximately
jemal
molina
atraumatic
ichs
aβ42immunized
patientsaging
oitegg
vaccinesimmunization
laserilluminated
malarial
ndyag
hemoglobinspecific
asyetunknown
lasertreated
systemincorporating
parametersrather
paradigmfrom
profilesmay
19931995
elderlyprotective
listeners
lecturelike
ndk
rndk
pmal
mbpimmunized
conclusionly
northumberland
804618
outwith
mannosesensitive
1620×109
0×108
6480×107
childrenfor
recife
brazilrotavirus
l7l12truncated
omp31
tomp31
rl7l12tomp31
primingprotein
vaccinationconsiderable
pcdnal1
baculovirusderived
primingvlp
treatmentno
zosterobjective
generalpractitioner
therapiesadoptive
th17stress
europewide
organizers
efta
haemostaseology
crosstolerancebackground
tolerogenictoallergen
psoriasisproducing
transplantationdiagnostic
monitoringhcmv
developmentprogression
interventionsystemic
vaccinationdo
etiopathology
hepatitisadoptive
sig
iumg
immunosuppressionuv
dinitrofluorobenzene
myd88deficient
dinitrofluorobenzenespecific
damagerecognition
cyclobutane
pj34
wtlevel
uvrinduced
umibded
mims
manitobas
0544
extrathymically
interleukin10secreting
fvan
cd30specific
hrs3
microspectral
methodthe
cd4cd25cd127locd45ra
2224days
cb17
inactivatedenterovirus
animalsenterovirus
inactivatedev71
ntabs
ca16
ntab
2281
postev71vaccination
crossactivity
ca16poliovirus
specificneutralizing
chorioretinopathy
diseasecentral
cscr
psychopharmacologic
phosphodiesterase
subretinal
fibrinfibrosis
corticosteroidassociated
steroidassociated
scitallergy
wheals
mellitusthis
université
4529
professorsresearchers
administrativetechnical
australiadespite
bmmr
0030
pregnancyunlabelled
networksas
samebrand
01012003
04302011
286294
csatreated
proliferationrelated
motherssuboptimal
liminex
99100
4hpv
8898
4536
9399
2665
1416fold
hpv11was
vaccinedependent
ad53e2fδ24gmcsf
cgtg602
e2f1
δ24
immunotherapyaccumulating
tsec
diseaseantitumor
graytype
realityfood
prospectsadoptive
guselkumab
us75
fundraising
27517
25132
postvaricella
cd3cd28costimulated
lymphocyterecruiting
quasiuniversally
dcprimed
284050
kasese
90ci
6844431
3868
13539807
181292
13883
mothersparents
vaccinateor
nottheir
perspectiveshighdose
hdit
beamlike
age35years
malefemale3960
489months
62months
disialogangliosidespecific
nk92scfvch1418zeta
nk92scfvch1418zetamediated
nbspecific
tapping
genomicscellular
erbb2ip
prbcs
yearoldgirls
a2309
standardexposure
5375
irradiationobjective
chaim
neuroophthalmological
perspectivesmonoclonal
francaise
cellulairethis
mismud
transplantationcord
globulincontaining
postducbt
studyrobust
factorsneurologic
followthe
autologousreducedintensity
autoriccbt
guidelinesallogeneic
exposuretargeted
noncarrier
ihurler
msdmud
immtacs
whichovercoming
immunemobilising
tnfrfc
ctla4fasl
ratsthe
aavtfcf
tnfrfcctla4fasl
aavctfa
aavtrfc
aavegfp
counteraction
individualsoverwhelming
12valent
gmcs035μgml
serotypesspecific
gmc035μgml
extradomiciliary
transmitters
5fluorouraciltreated
c57bl6tgactbegfp1osbj
antineu
mechanismsthis
neupositive
neunegative
irradiatedalone
ofs
cityspecific
725741
pediatricsrecommended
5injection
4injection
iiiia
trimonthly
remindersrecalls
18235
autodialed
28620
2472
12445
116148
nct01557621
amlrelated
activationpapain
textile
papainlike
tj
tlr4deficient
vasodilation
immunizecadigital
reenvision
iterate
canceris
futureover
cataloniabackground
79107
months2
7093
3543
outbreaksabstract
afacilityattached
anonhse
tumourseveral
biasindicator
bocozel
noncholera
productionscorpionism
debilitated
1909
todd
quinquestriatus
todds
nepalese
primeonly
isrctn56766232
99·0
94·2100·0
96·2100·0
97·9
92·599·7
transplantation8year
mmfbased
19982005
lowtacsir
tacrolimusmmf
tacmmf
0922
0138
understated
taxation
infantsthis
dtaphbvipvhib
17979
15444
nct00753649
immunotherapyjapanese
jcpallergen
globule
glycerininduced
noobservedadverseeffect
jaukgday
300fold
micemethionine
tgfβinduction
vipera
lebetina
immunizationchicken
ld50ml
maya
devi
g50
prep
virushiv
egfr1
maabna
antiegfr1
affibodies
adm
peg2000
maabnapeg2000adm
aeg1
westernblot
hlamrd
haimen
initiativein
5407
8×106
syndromemultiple
een
immunespaying
spaying
iberian×duroc
shoulders
loinsthe
loins
spayed
immunespayed
rancidity
immunizationmyasthenia
strategiesrecent
allrelapsed
inframe
egfrviiidirected
nct02209376
antipd1directed
exclusionary
arya
agarwal
studiesmicroarray
misrepresentations
btbfree
9985
zebovgp
cyclosporinainduced
repairbone
hypotrophic
cyclosporina
influenzawhile
mucosainfecting
pulmonarydelivered
essendespite
4dose3
nct01365494
ctri
ctri201107001857
interventionsadolescent
sbhcs
rq
norq
uptakecompletion
116181
infectionunderstanding
wieland
yamada
iggantigen
fcγreceptormediated
resultsthe
mailin
cancerhpv
resultsvaccination
20092011the
5614
8361
9649
7541
9829
chickembryo
nct01680016
redoxregulated
sympathoexcitationsympathoexcitation
norepinephrine
sympathoexcitationdriven
norepinephrineinfused
salineinfused
norepinephrinetreated
progrowth
tempol
lymphocytesthe
sirnabased
thelper1
modulatome
ithe
kinshassa
08510
0dose
mercurybased
1216group
learningset
nonsocial
applicationcancer
indolence
tissuelineage
auxological
2160
1791
nonmigratory
chandigarhstrengthening
cater
who307
bureaucracy
vaccinationlichenoid
lymphomaearly
p0288
p0300
insignificantly
therapypreformed
immunesensitization
hareactive
h7n9neutralizing
vaccinationover
journeys
wellplaced
noninteracting
populationsdeveloping
suppressiongvhd
aspergillusrelated
mátraháza
her2bi
anticd3activated
aatc
immunokines
pathwaydespite
antiaeromonas
igyulcer
antiasalmonicida
immersing
0p
lungbronchiolitis
3905
cbvhigh
cbvlow
workersethical
fulsome
democratically
rawls
fiduciary
partake
tuberculosisobjective
dnadrugs
psychrophilum
routesteleosts
25993b17
rhvtf
103fold
nondisruptive
rctobjective
radiant
grimace
grimaced
performancebased
estonian
evasionabstract
secondarytertiary
asthmarecurrent
preventer
trytptophan
transplantthis
melanomaor
helicobacterinduced
felis
rabipur
experiencerabies
correctedthe
xenotransplanted
antirhcmv
rhcmv
ihcpositive
primatespecific
atherosclerosisatherosclerosis
atherosclerosisrelated
vaccinationnecessary
tolate
prechtls
painstress
hajjthe
congregation
041075
prehajj
immunotherapiesadvancements
gcsc
approachinformation
ahs1
autocorrelated
borrows
regina
hofmannlehmann
brian
willettcomparing
immunigencity
ioo
iio
90109
111012
21202
53752
52700
68344
15004
23989
facilitieswe
lowerperforming
relapselittle
urbmt
hr30
hr18
07046
germanyit
fashioned
alexithymia
tas20
rese
r314
f14176
f141125
r421
infectiont
hypermethylator
200812
aixmarseille
9195
7380
10079
20102013objective
5344
2678
24786
155782
717781
672950
infectionclostridium
2b65
lymphomacyclophosphamide
bioactivation
carmustineetoposide
rs3211371
cyp2b6
cyp2b615
cyp2b61
cyp2b65
cancerdecades
replicationessential
irradiationthe
expandedactivated
injure
cellsmouse
il12conditioning
tenfold100fold
tyrosinasespecific
perforins
lymphomaexisting
chemotherapyrit
fludarabinerit
prednisonerit
012person
0010personyear
modeldepletional
factorsurvival
cd3italefacepttacrolimus
59±22
102±47
emergencyanaphylaxis
βblocker
ibda
diagnosisfrom
49350
casesy
serviceconnected
patientswhile
malariaprone
or221
or271
or567
locatedaffiliated
rb51thirtyone
rb51vaccinated
intraconjunctivally
boostervaccinated
singlevaccinated
retropharyngeal
supramammary
polycation
aspectsallergen
immunologıcal
gadoliniumenhancing
cytosinearabinoside
200700006424
preschoolage
cellsautophagy
midnight
5272μmol×minl
34916284μmol×minl
jones
pediatricianshould
cladespandemic
broadlyreactive
cladessubclades
laterlife
challengeincreasing
sdp
pw
fd4
typhimuriumchallenged
sdp14
lambert
chirumbolos
doctornurse
infants1
cursecervical
493000
274000
parliaments
20082010human
3shot
7849
northeastmidwestwest
145210
southsouthwestern
southsouthwest
capitalising
malignanciesgraftversushost
postcy
pb6
pb32
bmprib
keylimiting
gonadotrophinindependent
morphogenetic
bmps
folliculogenesis
bmp
stereological
nyvacckc
poxvector
primeslp
polspecific
sensitisationthe
polarising
characterises
pnspecific
immunoprophylaxisbackground
perspectivealthough
cd34cd38
transplantationsystematic
097155
i24
rr161
105248
i214
2218
rr162
112233
i222
3343
rr171
118248
i20
8778
067132
5925
weightobesity
normalunderweight
249kgm2
25299kgm2
higg1
myelomabispecific
higfc
bitehigfc
stl001
nanomolarlevel
acd3scfvhigfc
acd138scfvhigfc
transplantationduring
antiepsteinbarr
ebvrestricted
klf2
modelhepatitis
hbvtransfected
temporaldependent
pd1highcd127low
tnfαblocking
tss5
juniper
hdmstimulated
il5ifnγ
il13ifnγ
glycoproteinobjective
hcve2
antihcve2
e137
cargrafted
hcve2transfected
retrovirustransduced
nonhepatic
hcvccinfected
carsgrafted
allergensallergies
immunotherapytumorinfiltrating
2768
451775
comora
160184
238265
melanomacytotoxic
uveomeningitic
hlaa02positive
cancerpreclinical
bdc
apheresed
antibodyalthough
timeintensive
miceimmunotherapeutic
blockademediated
nonlymphodepletional
idvp02
glycobiologically
signr1
malariagreater
drugvaccine
mmv
malariarelated
philanthropically
unitaid
aavαsynuclein
αsyninduced
aavαsyn
ab1
ox6
1409
9786
transfersomes
nonvesicular
cubosomes
polymericlipidic
18165
coliigemediated
scramble
hypoalbuminemia
35gdl
selfsupport
3702281
016085
hypoalbuminemina
4293463
alfred
precampaign
13286879
60097480
transplantationmycophenolate
tourists
egyptneed
2013vaccinations
raceethnicity†
2015each
longhaul
truck
behaviorsobjective
trucking
proteinquakes
pressuresinfluenza
punctuation
earthquakes
hydropathic
receptorbinding
receptordestroying
19452011
lipoproteininduced
atherosclerosismodulation
oxldlinduced
apopoxdcs
apopoxdc
apopoxdctreated
nonmyelooablative
tliantithymocyte
201002429719
agingpopulation
reducingpreventing
cancerimmunomodulatory
immunizationseeking
coaggregates
roundbottomed
insulinpositive
intraportal
polemic
wellschooled
citystate
analyticinterpretative
paolicalmettes
humanitas
3456
8384
200813
unicefderived
201120
lategestation
vaccinediarrhea
dryoff
postcolostrum
recipientcytomegalovirus
microangiopathyassociated
adenocarcinomatosis
worryobjective
africarecent
n8390
hrp2
pfhrp2related
n6121
guerinvaccinated
pfhrp2
rr406
ci200828
rr046
ci039054
rr023
ci017029
lotormedicinal
userspecified
magazine
receptacle
dexterity
dispensers
disjunct
whitefooted
peromyscus
leucopus
opossums
didelphis
virginiana
receptacles
2025objective
biobanking
iefree
macaquesthe
tdenv
as04
drones
knox
yttirium90
90yanticd20
199623
45770
reportimmunosuppression
ramsay
costsbackground
dcd
sanofiaventis
calcineurinfree
3997031
7732
3505834
6801
hemoglobinopathiesbackground
12142
10625
24110
arthritisclinical
proteoglycaninduced
pgia
outcomesmajor
fwi
efficacyobjective
challengeprevious
mvavp2
mvawt
ahsv4
antigenvaccination
dnalaunched
drep
gagpolnef
polioin
impasse
travails
civic
strife
belligerent
disregard
14816521
phonederived
nucleosomal
lip0
pcdnalip0
ifnγtgfβ
pcdnahis
cancerimprovement
lcsbmediated
developmentobjective
colilactococcus
psecleiss
nisin
lcsb
crispatus
cealcsb
separalat
smokersstreptococcus
v600epten
b16gmcsf
retrovirusexpressing
2927
withor
melanomaduring
józsef
szentgyörgyi
17651832
debrecen
parenttraining
apologizing
haploinsufficiencythe
haploinsufficiency
genie
liberated
justintime
jit
removab®
antiepcam×anticd3
blincyto®
anticd19×anticd3
grp78directed
patsm6unlabelled
antiglucose
patsm6
mlhkg
nct01727778
infectiontb
merckalkabelló
tosss
organizationestablished
week8mk8237
allergenexposure
fingolimodtreated
008054
029133
kenyachild
collegeuniversity
lesseducated
cellstumorinitiating
surfactant
sdstreated
serumtreated
immunorejection
therapypsoriasis
epcambackground
epcamspecific
pc3m
diseasehighdose
actrn12613001154796
hu1418k322a
anxiolytic
201562224228
201562190197
diseasehematopoietic
201562359361
1019yearold
siog
commentarydiffuse
patientsmost
activatingexpanding
expandsactivates
hcvinduced
doserelationship
physiciansthe
ho124735
5valent
incvaxa
twoinjection
ndihydrogalactochitosan
incvax
allergiesfood
foods2
mesalazine
urinarymethylhistamine
exemptionsobjective
accrediting
2775
n2077
nonaciprecommended
phosphatasefused
papfused
papgmcsf
psaand
papexpressing
andil7
psaexpressing
antidepressantlike
unstressed
stressnaive
defeated
rapidacting
precart
19891995
19962000
50mm3
hivdirected
bloodcord
highsecurity
allergensthe
avanz®
alkabelló
wilcoxons
caspofungin
vehiclesmucosal
vaccinization
highpatient
anecdotes
21296
13427
212608
evdendemic
morpholino
systemnegative
hbinding
lowvery
500bed
ahowever
4227
27633944
9254
neutralizationa
ad4h5
avietnam
1071011
ad4h5vtn
h5n1avietnam11942004
aindonesia52005
h5n1avietnam
certifications
10iu
noncoverage
platformnanobiomaterials
aswine
fluiowa1530h1n1
silkworms
dopcdopa
calceinam
brasília
brasilia
haq
507±132
365±164
briefed
6176
treosulfanfludarabinethiotepa
3373
19682009
19681985
19911993
19942009
19752009
macaquesnatural
noncontrolling
envelopespecific
pinch
staffthe
optionsthis
immunotherapydna
associative
cancercellcentered
macroenvironment
sart1
vaccinepatients
elispots
was078
interval147
to007
0357
rqlqs
nonnose
noneye
200600179520
nct00389363
incertitude
africathis
bangui
stereotypes
ignorant
excavate
outcomeimmune
cnx
063099
since2005
aspectsobjective
sistema
informação
agravos
notificação
sinan
reppcr
diversilab®
biomerieux
17428
stricken
p1p5
p6p8
fulda
hessenstudy
n1515
christians
sd33
sd13
schedulesthe
6119
95ci47108123
2140495ci1571429161
3457895ci2512547577
childrenmass
375μg
375halfmf59
75μg
75fullmf59
institutionthe
conditioningallomacand
conditioningalloric
28year
allomac
allograftswe
p0368
p0107
p0854
p0653
hr177
hr247
hr090
p0635
wpthe
haemoglobinopathies
flumelphalane
sctdiabetes
7626
n7248
n378
hr146
121176
158273
135178
bufludarabine
20022012background
highconcentration
19952006
722993
797927
406928
928and
multiplexopsonophagocytic
vur
vurs
nonschoolbased
talethe
aβprotein
microtubuleassociated
typify
aβdirected
5e2
5e2treatment
nontravelers
or369
or200
or030
100154
consulate
cd11bf480
th17tolerogenic
shanghaiobjective
varicelliform
176390
12855
375424
6901
10940
71828298vaccinated
1761
214495
022017028
46176
14176
117214
39214
139797
37268
lowresponse
232718
185718
139718
162718
7758
25687
90177
73185
58162
44353
43941
6026
45717762
38906918
25704898
4677
3388607
035091
039002
18692
fade
µghepbsc
heamorrhage
cscircpsc
friesen
trialhighdose
donorpredominant
hostpredominant
trialstopping
buflucyatg
workshopbackground
ciomsbrighton
guideaefi
hexonspecific
hscthematopoietic
advrelated
200500109235
yttrium90ibritumomabtiuxetan
y90it
nony90it
monthspfs
p06336
monthsos
p06171
her2extracellular
adher2ecd
adher2ecdtransduced
efficacya
bms936558
mycophenolatebased
myeloablativerelated
mmfcyclosporine
mtxcsa
mmfcsa
mucuspermeating
immunizationdealing
aggressors
400m2
handbooks
coxs
050079
023044
cnsparaneoplastic
antigentarget
146a
toxicinflammatory
lactulosemannitol
mirna155
mirna146a
fibrosisidiopathic
colv
iw001
ipfrelated
lowestdose
highestdose
stabilisation
anticolv
dcgem
nonliver
httpwwwuminacjpctr
umin000004855
leukemialymphomasrecent
zidovudine
smolderingtype
chronictype
nutritionobjective
enterally
bacteriafermented
galactooligosaccharide
bifidogenic
gastrostomy
week4
groupsf
week0
64±19
66±30
countg
groupc
groupf
bacteroides
107±09
114±05
112±02
107±04
parentsmain
aluminiumbackground
05mg
0133mg
825eluml
6701016
10351485
wwwclinicaltrialsgovnct01147900
anno
2013despite
2008–13
2012–13
infectionneonatal
groupmaternal
serotypesthe
185no
downgrading
personalizedadoptive
centurymeasles
rabbitantithymocyteglobulin
treatmentmatched
referencepatients
1732470
112610
018381
offsteroid
referencepatient
2500year
desensitizationdonorspecific
prapositivedsanegative
unsensitized
lungonly
9996
898886
817476
817778
dsaprapositive
p1000
p0667
pregnancycytokines
endometrium
gastroenterologistsobjective
improvecarenow
16question
serologythe
immunodynamics
imiglucerase
gaucher
volumevolume
34118
42232
34198
78241
of032
to018
and032
to023
smd017037
smd033
ci052
to013
smd023
to017
smd044
ci083
to006
00145
0133
rada4
vacsim
hydrated
nanofiber
rhbsag
vlvh
tailparallel
enterotoxinsstaphylococcal
enterotoxins
antises
vhvl
5vhivsiresvl3
ivsires
p2c2hilo
p5c12hilo
intracytoplasma
ipecj2
841870
803900
schedulevaccination
rateobjective
76153
mtorbased
mdrd4
epidermiology
ckdepi
mdrdbased
0086
plexir
dsarelative
5737
progressionfreesurvival
horsederived
atgam®
hypersensitized
ege
19yr
129yr
stuff
trl
perspectivesclassical
portable
antia2
antia1
hemophiliaabackground
hemophiliaa
factorviii
isotypic
0875
perspectivesstrains
hyperinvasive
cc32
cc162
lymphocytesmurine
refusalobjective
154424
pkarp47
macaqueswe
orientia
tsutsugamushi
47kda
agbased
kp4747venezuelan
karp
eschars
tsutsugamushispecific
oligonucleotidesfunctionalized
imagingunmethylated
cpgfunctionalized
cpgqds
1·625·80
3·30
1·706·43
7·23
3·2616·06
2·2212·16
visitor
0·30
0·160·57
ivdpv
vdpvs
ivdpvs
tumorantigentargeted
αtrp1
il2γc
cd90nk11
tbx21
nonconstitutive
yearsroutine
catpad
nmol
applicationbackground
entpractice
intermission
discloses
parentdirected
trialeducating
355902
aliquot
nonheattreated
singlealiquot
greeley
60°c
pasteurizer
dtb
postfeeding
pu423
dtb363
ff568
fr653
pu045
dtb108
ff382
fr480
countryhuman
majors
equistrangles
equi
hasa
arob
pyrc
p00114
end2015
opvbivalent
catthis
proteingonadotropin
mbpgnrhi6
depauperate
spermatogonia
taiwanimmunisation
niis
rkipmediated
chemoimmunosensitization
nfκbsnailyy1rkip
resistancedriver
loopcancer
crossresistance
yy1
underexpression
rkip
antiresistance
nfκbsnail
yy1rkip
agingdependent
ceftaroline
reactionsobjective
murmur
sternomanubrial
clavicular
ertapenem
tigecycline
aztreonam
57494
fosamil
penicillininduced
roundtripinternational
rhesushuman
184655
086313
086351
or020
004097
004105
001102
previxcombo
38days
035µgl
hrec
ec00155
waahec
377122011
actrn12610000544077
nct01174849
modelideal
nonwetting
inductionunlabelled
disc1
striatumthe
disruptedinschizophrenia
highexcitability
nhe
mesocortical
attentiondeficit
randombred
nrb
antidisc1
làt
olton
eightarm
rearings
neurochemistry
lglutamate
laspartate
lleucine
membranetrapped
neurotransmitters
disc1immunized
odisha
supervisorsupervisee
indenting
limiteduse
webenabled
leastpreferred
sato
loi
clemente
galon
parkhurst
chinnasamy
grupp
reconstitutionimmunocompetence
stemfacilitating
transplantsnineteen
nonchimeric
threesignal
aapccd47
b16siy
aapccd47generated
aapcgenerated
diverging
cellstreginduced
loxoribin
loxoribintreated
googlex
haematopoeitic
reviewinternational
conditionspecific
cgmcc
13724
106159
ppoittreated
docks
allegheny
fluecon
223761
963417794
0614
3564
113661660
06003
dysfunctionobjective
uris
posturi
raceethnicitymatched
cytokinesinterleukins
interleukinbased
number1
outbreaksgreece
19822013
arima
centersbackground
alerting
outofrange
promisesmetastatic
aldesleukin
pifnα2b
endues
cpgoligodeoxynueleotides
cpgodnprimed
igf1primed
broilersliquid
lz58
behaviorallyexplicit
mesopredators
landscapesdespite
rsf
99240
patchlevel
interiors
her1positive
212pbcetuximab
212pbtrastuzumab
0588
212pblabeled
her1expressing
sociocognitive
naturalistic
intentionlack
19652015the
19642014
diseasesmedicine
aβ42associated
promisesrcc
targetedantibodies
infectioninfluenza
vaccinationpoly
enhancereduce
superlative
gnr
higherincome
workersonline
mribased
speedin
micenew
calories
bisham
fallout
syndromepertussis
swat
pukhtoonkhawa
3·46
is481
is1001
is1002
dtpw
dtpwpaw
dili
bairo
pite
626777
14626
129155
7129
21755
expressionadoptive
cd40lmodified
fasdeath
carcd40l
chlorofluorocarbon
propellant
hydrofluoroalkane
antihistamineinss
addresshuman
allmicrosatellite
aald
08217
hrmud
biasesalthough
weeding
ipc
forkheadwingedhelix
ponders
outcomerecent
optimismcombining
radiosensitise
drugradiotherapy
recipientsstrongyloides
rifabutin
studytuberculosis
pulmonarypleural
lesspotent
oligodeoxynucleotideautologous
gl261nobel
nobels
asthmaallergenspecific
aitomalizumab
phenotypeendotypebased
phenotypeendotypedriven
pontryagins
epiimmunotherapeutic
highprotease
proteasecontaining
fungalinsect
allergistreported
interventiondual
localizationcytotoxic
²¹³bianticd38
²¹³bi
²¹³bianticd38mab
dnadamageresponse
catastrophe
²¹³biinduced
tissuethe
cosecreted
carolinabackground
choropleth
meanstested
zctas
wholly
595602
paradigmsbackground
originality
longpeptide
stlp
e5e6e7
rtc1
ltlp
reinjections
agdc
imageology
hcvcurrently
seroconversionan
woodchuck
cd4cd25highcd127lowfoxp3of
bowen
4133
3monthly
bcgfirst
bcgdtp1first
dtp1first
053089
064096
mrr259
132507
mvonly
031119
103231
dtpvaccinated
perturbing
mechanismsrandomized
vaccinationwho
ved
ved74
5186
ved29
4777
vaccinationfemales
countriesthere
immunizationtrained
tlrsimulated
selfadjuvanted
canceripilimumab
yervoy®
castrationrefractory
xage1b
pdisplayxage1b
myccap
myccapxage1b
fvb
xage1bmodified
5amino3methyl4isoxazolecarboxylic
hydrazide
srbcimmunized
mice5amino3methyl4isoxazolecarboxylic
isoxazole
cellsimmunized
lymphomaduring
sarcomacurrent
completionlatinos
hpvpreventable
nonacculturated
diseasenatural
virusseronegative
redoubled
deadline
looms
managementdespite
mutates
2221
nanopass
micetolllike
inosknockout
inosko
92·6
31·9
40·9
67·1
71·4
63·3
£8650
10923
13600
£17000
£11700£25800
£31
£28£35
£8050
parameterising
hpvadvise
vaccinehepb
narrated
anticipants
normalresponse
3114
3596
53407
18399
8235
risksvaccines
andfor
diseaseseven
requirein
safetyconclusions
propositional
reviewnucleic
immunologist
transferases
mcgl
6001780
gsta1b
rs3957357
10021017
146201
1090
opportunistictype
settingthe
2257
2505
4736
churchgoing
emod
lifecycles
carebased
hospitalassociated
toxoiddiphtheria
toxoidacellular
religiousmoralethical
corporate
witch
hazel
rosaceae
carrot
allergocomponents
immunocap250
assotiated
rosacea
birchoakapple
componentdivided
pecorumchlamydia
sometimesasymptomatic
ugt
mykissfarmed
deg
nare
rosettes
injuryinduced
traumasurgery
3983824
789082
1927581
4322
events100000
486769
2154
20902220
070115
613927
15581671
080126
079138
088147
yearspre
erasin
vaccineepidemiological
1996february
walike
i1r1c1m1a1n1t1e1h1
rj1405507
ba1903010
i1r1c1m1a1n1t3e1h1
walike×au1like
nsp3
vp8
patientsorgan
250fold
otr
hspx
myelodepletion
leukodepletion
reticulumresident
postmrd
fourmarker
b4galnt1
phox2b
isl1
postmrdsum
tolerabilitybackground
992×106
cd3cd45ra
infusioncytomegalovirus
vaccinationil15
prophylacticsan
meatpoultryfish
turnaround
nearlyunlimited
lucrative
cd39dependent
mechanismregulatory
miri
foxp3gfp
invitroactivated
extracellularsignalregulated
cd4cd25cd127low
6hr
9001350µmolmin
doseadjustment
900µmolmin
pres1pres2s
vaccineefficacy
setrespiratory
switchover
transferthis
cd8enriched
comicrocultures
hrcs
pediatriciansobjective
mostfrequently
highorder
delaythis
erlang
orbits
prophylaxisobjective
chlorhexidinechlorobutanol
eludril®
caphosol®
or111
or75
transmissiondiseases
arthropod
vbd
outofdate
2633
reasserts
committe
insists
efectiveness
administred
tacod
bwd
immunotherapymonocytesmacrophages
activatory
tumourcytotoxic
hin1
influenzavaccinated
parsed
iggnegative
özal
usebackground
739898
838991
bapproaches
trialsrenal
lt192sta
192stb
candidateprevious
nonfimbrial
ltr192gstaa13q
ltr192gstb
stb
f41
deycke
pasha
lübeck
disasterdr
georg
1898
rieder
reorganize
tablished
giilhane
1907
gu6rin
thirteenyear
altstaedt
ral
insti
tute
patronage
guilty
negligent
parish
transylvania
centuriesthis
medicalhistorical
demographers
inspector
deathcausing
medicinerelated
biography
historians
controversises
lifetimerisk
250606
003039
033078
dichotomisations
018051
025053
messagessms
homevisits
epitheliopathy
apmppe
metamorphopsia
autoimmunitycurrent
abandoning
casenested
spallpoxin
actuality
2182
knowledgesince
2ºc
20102015the
polandthe
fo
cal
verotoxinproducing
o104
voronezh
regionunlabelled
19931997
reportingforms
themwere
seromonitoring
19952000
accountedfrom
protectability
beep
biyemassi
beepshort
aefis100000
dosesweek
periodobjective
ckf
fount
carepostliver
threecomponent
cocktailsmb003
originnicotiana
nbenthamiana
magnicon
magnifection
bacteriumagrobacterium
tumefaciens
xtft
nacetylglucoseamine
epitopesbeta12linked
alpha13linked
fucosylated
alpha16linked
eic
mab6d8
gp1
healthschool
kindergarten12
districtwide
5862
lmsal
lms
treatmenttoxoplasma
timp1
immunotherapeuticstoxoplasmosis
encapsulations
registrylinked
clustercrossover
noninterruptive
8481
nonuptodate
8630
22248
iislinked
vaccinehealthliteracypromoting
reminderonly
betweenarm
foreverthe
polioinfected
lungspecific
ovaconjugated
cytokineschemokine
cllthe
alfa2b
coelectroporation
iitargeting
tiw
dcrelated
brazilbrucellosis
pathophysiologybased
explorations
scitinduced
6870
28103
0105
21103
13103
procedure126
freshfrozen
recipientst
donornc
unneutralized
neutralizingcapacity
plasmas
abtoo
128±54
65295
atoo
114±14
97±13
synthase1
plateletadherent
cyslts
arachidonate
leukotrieneassociated
aerdcrswnp
immunotherapyclinically
5hydroxymethylcytosine
5hmc
teneleventranslocation
tcrligation
successsubcutaneous
navigator
il17neutralizing
qβil17
backmutated
combinationbased
melbased
diseasecriteriamatched
flumelrtc
5877
interventionseconomic
aie
il10we
initiativeto
wha
policyrelated
systematize
secretariats
urbansuburbanrural
groupsolo
risktolerant
effect13
effect15
effect17
meaningpeace
makinga
transplantationvariations
dextranalbumin
beta1btreated
nabsa
betaseronbetaferon
88277
biacore
resonancebased
passivetransfer
modelneuromyelitis
aqp4
antiaqp4
iggabs
eaat2
nmdareceptor
nr1
overexcitation
aqp
penumbralike
transientbackground
fluorometry
dctcell
sanquin
5281
nontraveling
vaccinationgeneral
programsone
environmental…
functionsepsis
transits
appreciations
sirssepsis
receptorproximal
challengesdendritic
recgbm
ndgbm
145226
037083
137189
collegehealth
438941
blt1
turbot
scophthalmus
maximusleukotriene
maximus
mvav6203
1119bp
systemssynthetic
biopharmaceutics
lbfs
glycomimetics
componentunlabelled
459c
405c
939c
apartan
olfaction
placebocontrols
sniffin
sticks
symptomsexpressed
scorewere
koreaalthough
immunotherapiesduring
drughosttumor
therapyelicited
vaccinesenterovirus
ev71fi
ablationhepatocellular
mwa
transplantationonly
becurrent
δhilassraflig
strainconsumption
hilassraflig
seederbird
patientsdna
epelectrotransfer
epet
woodchuckinfection
620000
marmota
monax
hbvlike
hepadnaviral
desensitizationa
drβ3
drβ4
drβ5
cnimtx
cnimmf
nonirradiation
bloodespecially
donorare
optimizationstandardization
sporothrix
schenckii
brasiliensissporotrichosis
saprophytic
mycelial
sporotrichosis
p6e7
mya4823
transplantationpreconditioning
bmcs
lew
lacztransgenic
xgal
immunohistostaining
non‑small
cancer‑related
receptortyrosine
egfr‑tki
bimas
t790m‑derived
t790ma
789797
imqlmpfgcspecific
t790maspecific
ncslc
h1975a2
itqlmpfgcpulsed
melanomatumorspecific
subjectsthe
nct01963338
patientspexavec
gmcsfdriven
antibodiesmonoclonal
readminister
microenvironmentchemotherapy
sbt
67128
1477
11231772
5791086
8151203
3658
outcomesobesity
scts
months73
6848
tbiric
notbi
wholepeanut
allergennonspecific
9based
isoflavones
astroglial
dogsbackground
s100bnegative
kyasanur
strategyshimoga
20132014we
hostsactivated
renilla
rluc
rtrack
leprosyleprosy
tuberculoid
mlm
dialysable
bcginoculated
mlminoculated
intradermallyinoculated
hltdle
bcgdle
mlmdle
evaluationalthough
trek1
immunotherapyepithelial
twikrelated
trek1null
rpmi2650
ratsnuclear
2‑related
cellular‑defense
olat
l‑prop
h‑prop
bun
o2•‑
hydroxyl
·oh
maleic
dialdehyde
kelch‑like
ech‑associated
keap1
oxygenase‑1
ho‑1
nadp
quinine
kingdomvaccination
nottingham
1696
035098
077098
mastitisrelated
10413574
3122160
2571
partyhematopoietic
myelomatherapeutic
13q
lowattitude
95ci308
4699
95ci111
bcgimmunised
filtrates
sixday
tspottb®
contactdisease
anthelminthic
antimyocbacterial
japansome
moleculedrug
immunosuppression60
moleculedrugs
vector‑mediated
allo‑bmt
graft‑versus‑host
graft‑versus‑leukemia
lentivirus‑mediated
imdcs
myeloablatively
stnfr1‑
pxz9‑imdc
stnfr1‑imdc
interleukin‑4
co‑injection
genetically‑engineered
turkeydespite
anatolian
categorise
intrapersonal
structuralpolitical
irradiationcyclophosphamide
slitplacebo
oitplacebo
sarrp
4t1ha
antigenmhc
extrauterine
rr036
surfacepositive
rr242
146401
rr054
diseaseallergen
challengecancer
progressionbackground
cancerafter
candidin
trichophytin
rilotumumab
mettargeted
metpositive
nijmegen
syndromenbs
nbn
8q21
patientschildren
farinaeallergic
regionwe
ageinvalid
intervalinvalid
n134442
94152
100181
immunization—global
updatevaccines
extrachromosomal
perspectiveslargescale
hbsaghbeagpositive
hbvpositive
antiag85b
facultiesinfluenza
multidirectional
radom
łódź
vaccinaton
diseasesumbilical
1·7years
24·4×107
sixtydays
gradeiiiv
optionsdespite
perfusioninfusion
laherparepevec
longtermcare
rais
nursinghome
chemoantiangiogenictherapy
rder
ovalbumin0va
rderf3
groupsit
inhalated
jg
108ml
2275
10820
9834
18204
1394
20826
19533
17954
1365
10798
10551
3525
microgml
influenzathe
mostuseful
therapykawasaki
diseasekd
arteryca
sipuleuceltprovenge
iamatched
deferoxaminethalassemia
deferoxamine
agentfor
ofdeferoxamineinduced
afewpediatric
ofsuccessful
ofanaphylaxis
thirteenyearsold
eβthalassemia
differentprotocols
protocolforpediatric
6818
161±932
2618±428
3637
p00084
tnfkinoid
antagonistresistant
tnfk
scheduledependent
nct01040715
cellscoinhibitory
tumorselfreactive
allohaemagglutinins
deficiencypolysaccharide
aha
ahaversus
0·573
14132
45·5
2·4
46·2
sarcomasbackground
schematically
microbead
gtassociated
patientscompelling
693gc
cd19il10
mexicous
usmexico
n2313
n652500
rhinosinusitisobjective
afrs
nonfungal
cooperia
oncophora
doubledomain
contaminationwith
trickle
l4s
endthe
responsetherapeutic
shinjoh
postldlt
aikc
hoshino
parotid
2014recommendationsthis
multiprong
malignancieson
lifesavers
animalsdespite
georgiachronic
americanspacific
aapis
or169
121238
127281
or177
113278
or067
046099
or055
035086
or123
107187
methodologiesthe
entryclinical
rhetorics
irb10732
poisonous
filthy
loathsome
damnable
concernin
1915
resonated
situating
articulation
earbackground
ipvbased
melanomahighdose
systemcontroversy
π
2011february
ngawa
qiang
all6
februarymay
dispersing
polymerdelivered
wellperforming
pigspecific
pigsguinea
caviae
gpic
th1cellularinflammatory
th2humoral
studyunited
basiliximabbackground
vad
vadrelated
35118
basiliximabtreated
precorecore
antihbcnegative
p0072
agecomparable
verylowlevel
antibodiesunlabelled
phthalocyaninebased
antibodyir700
minibody
dbir700
mbir700
iggir700
psmadbir700
psmambir700
psmaiggir700
ifnα2α
ribavirinhepatitis
centrebackground
ncepod
christie
31183
statinintolerant
odyssey
ldlc
nct01709513
musclerelated
atorvastatin
ldlclowering
sniffed
statuscytomegalovirus
rseronegative
rseropositive
informationseasonal
effectsa
radiationradiation
libyan
libya
aged5
661event
8972
vivoantigenspecific
foreigner
foreignize
cd44high
disordereosinophilic
immuneantigenmediated
igebearing
granulocytemonocyte
conditioningblood
tagvhd
bloodirradiated
regimensrefractory
tsc1
pololike
mammogram
n117893
arabamerican
or034
ci021058
ci006032
ci005031
ci007037
20092012background
275848
cystoscopy
plasmaurine
antiil1β
ovalbuminwe
yolkigy
ovalbuminova
infectionhiv
refusalcompetition
egoism
altruismvaccination
frbsab
bsabbinding
bsabir
frbsabs
bsabirs
frbsabredirected
therapiesnonsmallcell
lambrolizumab
tecetomide
diseaseslowdose
lymphomasglycoengineering
cancergastroesophageal
platinumcontaining
erythematosusb
immucin
panmajor
patientsimmucin
21mer
9·4fold
6·8fold
antiimmucin
17·541·3months
immucinspecific
complexbarrier
fbta05
lymphomun
malignancieschildren
8741424days
1150days
bau75
3314
6120
teae
dynamicsthis
maligned
cardiomyopathydilated
opencontrolled
strategiesmeningococcal
systemclimate
climatesensitive
treatmentmanagementbackground
222667
mrnamodified
expbnk
nucleofection
rituximabresistant
raji2r
raji4rh
rs411
rajiluc
raji2rluc
nodscidγchain
expbnktreated
vivoexpbnk
poliviruses
microcell
6451
6441
6351
in15
664666
665666
663666
9811
9791
9721
13259
12505
11907
990100
12881
gmt1
40971
6367
microbiotainduced
hosthomeostasis
inconsequential
metalloproteinase23
mmp23
vaccinationviruslike
badenwürttemberg
slipeeven
announces
communitygood
inflationary
ecto5nucleotidase
riskperceptions
injuryled
pigssafety
semiautomatically
3dquantification
nanotechnologyimmunotherapy
polymerdrug
extraintracellular
immunobalance
nanoparticulates
beamcampath
bsbmt
dlbclburkitt
highintermediate
beamcampathconditioned
4040
fielded
clinicpancreatic
visitsbackground
nonalachua
iliassociated
nonschool
wagers
sutros
allograftselective
heliosnegative
cnilow
peterborough
calmer
nct01995851
canadacanadian
nonhpvrelated
remissioninduction
postcyc
analcolorectal
aws
computerguided
eq5d
252fold
162fold
perspectiveover
sculpted
curated
subnetwork
webimmunisation
healthhowever
società
httpwwwvaccinarsiorg
newsletter
taping
measuresdespite
mir16
1423p
cd4cd25hi
cd8cd28cd57
mir1423p
irf2bp2
cd34cd38cd58
leukemiapropagating
sctrelapse
lpcs
cd58fitccd10pe
cd19apccy7cd34percpcd45vioblue
cd38apc
cd34cd38cd58group
cd34cd38cd58lpcs
1261409
1611482
alemtuzumabthe
cd4as
alemtuzumabtreated
pharmacokineticpharmacodynamic
asiansbackground
safetyfatal
modelcomponents
20efficacy
83167
44600134600
68700
82917
9105720
1677
4042564
shinglesassociated
icdcoded
19952012
19952003
prevaccinationperiod
postvaccinationperiod
varicellahi
19100000
182272
joinpoints
shingleshi
88100000
168100000
children1
infancyhepatitis
5544±7701
235±649
17628±16178
immunizationsurveillance
addresspregnancy
therapyhivinfected
sustainedtolerance
cost‑effectiveness
8‑15
nndrs
21865
28888
19201
iiiaiiib
immunotherapyreport
6–8
indiawho
protectionseasonal
importantpreexisting
thermostabilitythe
httpwwwterrapinncomvaccine2014
melanomadendritic
dentritoma
23ppv
242292
glamorous
regulationthe
bpoliomyelitishaemophilus
3511
infanrixipvhib
4045
3445
dtpaipvhibvaccinees
rabipur®
responsein
ipms
6164
budgetrelated
hire
overworked
nonemergency
intensificationthe
implementationunderstanding
25717297
1261507
163825
pediatriciangeneral
024068
administrativeclinical
052×
15433
111000
011000
08100000
seasonsinfluenza
pidirac
ci46867
ci51581
95ci495788
95ci45546
052x
iirs
×100000
010012
02104
319000
eurosyear
106000
onehundredeight
135548
311982
4253
29305575
9592711
methicillin
36121
scheduledue
quitting
pertussispertussis
safetypost
ligurian
vaccinevigilance
italyin
basilicata
friuli
venezia
igvv
hbrelated
124149
139147
cellsskin
noncf
ncfb
personnelthe
terrifyingyou
horror
researchin
gargano
etals
replicable
itparental
recommendationhpv
complexcluster
vaccinesyears
nowdementia
proteopathy
crenezumab
statethe
sitebackground
pop
stars
candidatessignal
spderived
vcs
tbcell
transporterassociated
acceptancematernal
110®
43yearsold
429sd
420633
390549
151294
74257
remschmidt
ethnical
selfrelevant
hesitancypublic
hypervigilance
resultswhy
factorschildren
7338
413813012
2829
11516957
4629
201710625
20757358
0310
01440671
7734
259823025
0219
00570846
resolutionthe
acceptanceimmunization
bolddespite
okugo
nonpreventive
recommendationunlabelled
stoked
nonjapanese
applauded
ratesdespite
n18083
eighty5
taddei
or231
or38
or1053
immunecorrelate
sieveanalysis
vaccinatedmaternal
hospitalsdespite
kab
friday
moniz
beigis
beigi
childrenthere
intratypic
eastsouth
directcontact
fluorodeoxyglucose
survivalpatients
perspectiveaddition
presexualactivity
9p241
pdcd1lg2
nct01592370
immunotherapyinterleukin10
adultsinfections
polysacharide
timethe
ncepneumococcal
immunsuppressive
cranialinjured
aspleniarecommendation
vaccinesadults
concommitantly
radiationpreclinical
outofthefield
ticked
cd33redirected
relaxant
muscleasthma
hyperconstriction
bronchodilators
isoproterenol
inspirations
relax
crossbridge
nearendemic
modelmany
evidenceprostate
docetaxelprednisone
j591
anticpla4
androgendeprivation
tumorslymph
afrocaribbean
7092
tnflike
baffblys
tumorst
vaccineswho
deficiencyassociated
alleging
allegedly
myoclonic
immunotherapyinstead
injuryclassically
neuroregeneration
myelination
basso
beattie
bresnahan
23614
2021600
4643
18971
homeimmunotherapy
sentinelles
uphold
methodobjective
assistantonly
3injection
denmarkssi
dosesdistributed
dosesadministered
0039the
20032013background
preelimination
9933
after1970
vaccinationsupporters
of95
rhinitisoral
antipcsk9
pcsk9specific
highaffine
hypercholesterolemiarelated
musingsinterview
jenaid
rees
institutet
vicechair
transgène
chiron
honorary
lectureships
vaccinationcampylobacter
casestudies
crosscontaminated
secps
cadf
flaa
flpa
cmec
cadfflaaflpa
plated
jejunichallenged
jejunispecific
cikactivated
pdtx
promoterregulated
cd79b
arthritisdepletion
cd180
anticd79b
crosslinkage
updatecomplex
caseadapted
selfmetabolites
scaledepression
3106
5414
4614
3915
antidisease
senses
tugofwar
tlymphocytetargeting
gnrh1
functionthis
femalesgroup
proteingonadotropinreleasing
gnrhiimmunized
spermatids
antral
immunosuppressionviruses
immunosuppressiondeath
daniels
encephalitogen
intergender
encephalomyelitisanimals
gliomascancer
transplantationpassive
asp0113
timetofirst
animalsfully
igαβ
vregion
chregion
knockedout
configurationspecific
pthr231pro232
diseasetau
dephosphorylation
pin1
synovium
underimmunizationobjective
2076
676779
783859
300462
2843
368545
nucleoproteinnucleoprotein
chinatibetgeg0730
antipprv
pestedespetits
indobangladesh
tripura
indiapestedespetits
nondescript
sabroom
tajikistan
dubai
kurdistan
95598
salamander
andrias
davidianus
iridoviruschinese
iridovirus
gsiv
salamanders
7045±752
3878±433
375±052
341±952
lbnse
rvbased
lbnsecdvh
zj
affinitypurified
antiheart
cardiacspecific
ifl
ahamediated
rosewitebsky
melbase
donehematopoietic
nonlifethreatening
diseasesmixed
rs3764879
bonferronicorrected
hemizygosity
b6sjlf1j
177luantimurine
dota30f11
177ludota30f11
triala
200600590167
donorblood
20k
syndromeeven
globuline
allergymost
allergythis
probioticsprebiotics
vlpnpv
diseasemyeloproliferative
nonidentical
syndromesmyelodysplastic
diseaserecent
amyloidbased
antierythrocyte
hemoglobinopathiesobjective
sicklethalassemia
autoimmunization
4146
gothe
developedis
immunoglobul
infractions
bloodprocessing
technologically
minipool
narrating
narcolepsycentering
aftermathusing
diseasesusing
semiagent
longrange
24794684
151620
longitude
depopulated
scisearch
suppressionobjective
wisconsinmadison
pact
lipoimmunogens
tripalmitoylated
flagellum
instrumentation
uroisolate
antiflagellin
netherlandsthis
14a
mpfc
hidacinduced
araccontaining
allcd19directed
familyfocused
clinicianfocused
17016
32472
14247
18225
hpv3
nct01159093
cytomegaloviruscongenital
symbolic
permissions
policyof
efficientlysuffice
justifiability
postmarketapproval
pandemicpandemic
overlook
vaccinationgiven
moralpolitical
csl
csls
persons18
population6
n739
n735
38549
38245
66913
70561
10065
9372
20032009background
96000
womenyear
hospitalizationsseason
disputable
paninflu
sinflu
selfperception
widower
householdbackground
golisano
syracuse
personnelhealth
n1370
n556
multinominal
inaction
vaccinationovine
tvnr
nondiseased
elysis
sgspecific
safetyenhanced
anthroposophic
swedena
studymeasles
31500
pragmatists
westphalia
rhineland
palatinate
saxonyanhalt
406451
318358
385430
3793
358401
placebos
trialsphase
chinabacille
59022
05mm
17072
8864
prioritizes
cullers
237329
dosesyear
personnelpoultry
82570
26481
17787
outlookrecent
iscom
adjuvantstaphylococcus
wholecells
βtoxin
lysaterecombinant
ishakknodell
m²
djoungolocameroon
texosomeanchored
cellstexosomes
nanoendosomal
texosome
texosomeseb
bak
10μg100μl
25μg100μl
developmentnarcolepsy
2ddige
latticed
sulfation
pdcd6ip
tub
deamidation
dioxidation
146n
129n
vyas
appelbaum
craddock
hôpital
transplantationcontraception
estrogencontaining
cancerradiotherapy
modelinfection
fnn
iglc
pdpd
pdpa
fopa
chaperonin
groel
fnnchallenged
hcgspecific
hcg
hcgβhcg
scfvpipp
hcgβ
tlymphoblastic
42hydroxyethyl1piperazineethanesulfonic
hepes
heptagluconate
modelgraftversushost
ashmabs
targetexpressing
ashmab
a2kashmab
hlaa0201expressing
kashmab
serodiagnosis
iafter
louse
kuk
galicia
edmund
weil
arthur
agglutinated
weilfelixtest
rudolf
weigl
rickettsiae
pellucida
glycoprotein3
fertilityzona
zp
zp3
23348
ttkkzp3
fedbatch
fermentor
mg2g
alumpetgel
mousedog
serumvaginal
curtailment
intradermalonly
camaguey
728981
micewhile
ddatdb
n841
as03a
aturkeyturkey105
as03aadjuvanted
lima
verylowbirthweight
5501499
10001500
agedmatch
57156
58132
immunotherapiescontinued
metaanalysisbovine
bvdvassociated
h7n7
plaiv
piiv
anetherlands21903
achickenbritish
columbiacn604
h7n3
amallardnetherlands122000
plaivs
20112012anogenital
11–26
2011–2012
11–17
18–26
809–166
31–95
167–677
372–776
18–26yearold
ifnγproduction
valvular
testreading
comorbiditymedication
nonrejecting
geda
19294
platinums
buflutbi
leukemiaafter
jude
lownormal
erapatients
15059
9575
2194
88matched
symptomlimited
cpet
6minute
mlkgmin
sexpredicted
sedentary
ferretsthe
hapi
lactispsaha1
lactispgsaha1
myelomapatients
nmat
ibnhl
smallchronic
25kμl
rittreated
nonrit
aubmt
rrhl
fared
postaubmt
antirossa
20112012background
americansobjective
centerpiece
spiritual
congregants
schoolsobjective
catholiceastern
protestantother
r066
115168
320486
episcopal
practisedto
animaldense
freestatus
childrenimmunization
dptcontaining
minisurvey
spainvaricella
nonroutine
3009
trang
khanh
hoa
radiographs
022007
032012
3151
1601
033081
052172
mediaa
pcv9
prevnar®
neoplasiawe
secondaryadjunct
hgain
6077
us87240
lgain
gp140specific
shivs
workershepatitis
mois
41310
268377
297640
vaccineenterovirus
2009h1n1
h1n1placeboh1n1placeboiiv3
hphpv3
h1n1iiv3h1n1placeboplacebo
hv3hpp
h1n1placeboh1n1iiv3placebo
hphv3p
iiv3placeboh1n1placeboh1n1
v3phph
hundredfive
concurrency
14070
seroconversion40
gmr25
schneider
caribbeanas
ah1n1pdm
esavi
6468
messageframing
2010july
factsheet
postquestionnaire
14331486
7541080
169358
125215
107265
10781404
experimentin
6wk
humanbetadefencin2
hbd2
onbirth
productionin
selfproduced
antindv
stuke
201432222599603
210278
162278
cd20directed
tumorharboring
nct01735604
memorythe
wayuse
stateobjective
unaccustomed
toxicitiesnovel
030105063007
philadelphias
iisrecorded
preclosure
postclosure
115149
108142
112188
taiwanbackground
socioeducational
01875
topographic
megavoltage
mvct
couch
traversed
gantry
topogram
mvtopo
kilovoltage
topograms
kvtopo
jaws
mvtopokvtopo
mvctkvct
cranialcaudal
fda׳s
octgt
24388010
nhbl
131tositumomab
90ibritumomab
radioimmunotherapyganglioside
pathwaythe
blockading
quasinatural
122±4
37±34
ci95141279
ci955287
ci95213343
ci95019076
nvsp
vsp
marshal
immunotherapyafter
b7xb7x
1h3
b7xexpressing
conditioninggvhd
tbimycophenolate
pigsswine
swineoh2436607
swineco99
pav
swinemn08
mn08
swinenc10
nc10
specifichemagglutination
variantsheterologous
eradicationa
eag
coveragerepresenting
scenarioincreased
dives
sufferersbackground
2154088
204215
7256
hvhn
carassius
auratusin
auratus
gff
ryukin
vaccinated4w1
vaccinated8w1
cyhv2challenged
vaccinatedbooster
vaccinated4w
8w
metanephrine
normetanephrine
nmn
mcaoinduced
425scfveta
etabased
cytokinesboth
ogun
rabiesrelated
oau
23685
7383
18037
114254
ty21a
concomitantlybackground
vaccinesoral
preparationis
typhispecific
salmonellae
ty21avi
asc106
5541201
typhoidspecific
ty21
immunoprophylaxiselimination
sdr
leprae
contactbased
extramedullar
13965
20102011objective
treatmentsince
unscathed
indiscriminant
adversary
characteristicsadoptive
immunometabolomic
quantityquality
cancerabstract
55039
6394
7503
72916
9057
68938
88967
threegene
fourstage
klf6
bnc2
cyp1b1
tg1050
adenovirusassociated
polyprotein
bifunctionality
hbvnaïve
therapyfrom
toxicitylimited
immunotherapyctla4
secretable
sctla4
therapymedicinal
olivier
beaumontinterview
wilkinson
beaumont
descartes
dauphine
escp
presidenthead
nonregistration
cofounder
aventis
19982000
rhonepoulenc
rorer
monoclonalantibodybased
benefitsincluding
responsesto
tumourantigenspecific
resistancetherapies
pd1pdl1mediated
fractalkine
immunoglobuling1
ubcthe
assis
acre
amazonian
106421
asiathe
hbvv
19902008
complains
eluding
cfsfm
casesimmune
gums
menorrhagia
antibodynegative
modelingapplication
111inibritumomab
zevalin®a
finer
111inzevalin®
pertussisseveral
advancementmaternal
amodiaquinemodified
injuryamodiaquine
aqinduced
quinoneimine
covax
targetantigen
inflammationallergic
plurisensitized
methodslast
relentlessly
2006–2010vaccination
agegenderadjusted
229298
826956
170179
9171051
207216
169231
4347
64yearolds
408515
466481
39yearolds
4885
7585
573598
631636
caregiversthe
subgroupspecific
qhpvgardasil®
twinrixjunior®
groupcoadm
groupsep
995100
20iul
975976
3lu
70year
3795148
2892920
8917
6614
4933
grossdomesticproduct
3557
71408000
37690000
onedosevaccine
bontb
modelsbotulism
bhc
antibhc
blockingil33st2
inflammationwe
il33specific
studyeconomic
giver
immunogenicityattenuated
initiatorsincomplete
blazed
duo
humansobjective
mdaspecific
literacyhealth
cancervaccination
immunizationpregnancy
perspectivepandemic
nic24
salvation
nonhispanics
rednessswelling
boligomer
zosterherpes
stateswe
humanbovine
rvgerelated
300400
30004000
notre
dame
318408
27186
pneumo23®
pcv10taking
30000qaly
europethe
accessformulary
canceruterine
husbandspartners
husbandpartner
hanna
congdon
newswhile
singleblinding
doubleblinding
noblinding
53671fold
53671
36981
77893
marina
botswanabackground
batswana
20116
113116
59116
36116
or610
or515
icuricer
14278
transferbackground
tcritransgenic
antiegfrantiepcam
gc8
anticmet
egfrtransduced
canakkale
immunotherapyantiangiogenesis
400500
highestvolume
alkhader
herpesvirus8
neurotoxicitythe
tlibased
satisfactions
immunosuppressionunlabelled
ultradeep
antihbcantihbs
hbvreactivated
m103il109it118kp120ay134hs143ld144es171f
c48gv96al175sg185ev190a
276100
25113
nlg
diseasesthere
personsfor
timalin
immunofan
polyoxidonium
timogen
erbisol
torontoobjective
homechez
soi
fasciclesa
patientshighly
activatedexpanded
41bbligand
allonk
tempo
proinflammatoryproatherogenic
t821we
ricsct
icebergunlabelled
hutterite
tsb
6907
3266
3641
16412
2838
276775
hyperreactivitybackground
ciktreated
inductionamputations
unsalvageable
wounded
lipoaspirate
anticd4cd8
3×106
5×105
ascbmc
antiinflammatoryimmunoregulatory
apo1fas
ligand2
menalthough
354569
or2712
11396457
dormancyclinical
gliomagliomas
23items
paediatriciansgeneral
neuropathiesdiabetic
drpn
dpn
opka
noncapsular
antipspahkr36a
r36a
pspas
2expressing
mabdependent
08783
pspabased
reboundfoxp3
36213631
candidarelated
nonfluconazole
metaanalysisdespite
5390
68122
30september
canberraobjective
20042006
mid2007
primarymetastatic
4thm
localmetastatic
cd200r1ko
anticd200r1
cpgtumor
lungliver
anticd200r
tnfαil2ifnγ
growthmetastases
tumorbearers
micethese
bearers
koreahepatitis
healthbelief
communitiesthe
0097the
wbi
anticd40conditioned
wbiconditioned
cd8depleted
actmediated
570bp
bern
cellsintravenous
anergiclike
newsublingual
sensitizationpreventive
monooligoclonally
monooligosensitized
doseupphase
21170
verumtreated
anthroposophical
gelderland
45100
5988
autolysis
s196a
3s196a
cellexercise
msts
52days
africanamericans
medicinenanomedicine
diffusivity
nanotherapybased
beast
nyeso1the
cl14nyeso1
humorsmen
0791
231769
120680
saltsorally
ferrous
hypersensitvity
bmtthe
apbsct
abmt
gimema
aml10
interval085159
laparotomised
7tesla
hepatorenal
modelphotoimmunotherapy
n87gfp
networksup
networked
rctb
intramolecularextramolecular
smearing
rctbrib
rbib
2porcine
pcv2systemic
northamerica
pcv2sd
nonclinically
pcv2subclinical
kidneyonly
051163
p58
quinolones
101298
0764995
nct01353339
privilegeimmunotherapy
proffer
toxicityaverse
womenvaccinations
immunotherapycetuximab
htc116
vegfspecific
dye755ran
ranibizumab
cetuximabresponsive
immunotherapydonorderived
reprieving
cancertestisantigen
universes
collide
rappuoli
glennie
peptidesproteins
biopannings
pals
therapeuticdiagnostic
ovabound
vivoimmunotherapy
ova‑nps
ovanps
ovanpsil7
npsil7
expreterms
perspectiverecent
expreterm
moderatetolatepreterm
nonpressure
bronchiolitic
asiacanine
healthbased
windowless
peek
hotspotsreactive
metapopulation
choleralike
nonhotspots
hotspotepidemic
hotspottargeted
vodopija
igf1rasodn
paradigmglioblastomas
lucite
reopened
chamberbased
disordersas
precepts
fusokines
2012this
4469
epaxal
06month
havab
wiesbaden
percentofpredicted
mitesensitive
rs7770370
titers10miuml
pvalue50×105
47kb
likelihoods
02760993
0095
00300307
3475
4692
aml200201
aieop200201
amlm7
0505
0066
142076
0070
3315
antihbcab
7220
1552076
8315
clustersa
errorrelated
inconsiderateness
variantsantibodymediated
flush
therapeuticbased
immunotherapiesblocking
ipilimumabrefractory
healthbovine
commingling
20072013objective
ccl1induced
foreskins
proposedinflammation
ccl1
rmc148p
ccchemokine
baculovirussf9
mc148
rmc148fp
rmc148tat6xhis
6xhis
spinous
ccr8mediated
vaccinationpseudolymphomas
cd79
betaf1
tcrγ
minced
female3216
p0293
850±1388
1004±580
keloid
cambodiafoot
trader
096220
alldespite
bl22
combotox
3419
bitespecific
sepsisa
postsepsis
shamvehicle
shamdc
clpvehicle
clpdc
clpseptic
timeassociated
nipa
eclrs
postnipa
9301732
8021732
diseasespediatric
prds
qontrol
rr50
102419088
irccobjective
lymphovascular
87yearold
temple
intimamedia
flowmediated
atrium
troponins
endotheliumdependent
residentled
providermedical
teamlets
n457
8157
cryoglobulinemic
06181
nonfulminant
nfh
maternalinfant
investigatordriven
tacplac
tacster
29aug
cairns
antibodiesradioimmunotherapy
90yibritumomab
futureallogeneic
memorya
chad3
ns4
ns5a
ns5b
cd4dependent
immunitytranslating
extrathoracic
cultureamid
preopv
cultureqpcr
longduration
it3
it5
0948
0705
freevaccine
171384
326843
4481834
197910
181782
1741400
0005009
targetin
saez
osteolineage
microenvironmenthigh
a2ars
adora2afflysmcre
myeloidselective
celebrates
poem
aml15
050085
101221
057097
annulatainfected
macrophagelive
theileriosis
gelatinase
matrigel
annulatatransformed
rag2γc
theileriainfected
denaturate
lymphosuppression
semiphysiological
cellkill
389211
gandjour
tremella
fuciformis
yeastlike
conidium
hbsagtremella
ylc
cocultivation
camv35s
approachp
itibased
infectiontreatment
as02a
chlorate
drugcover
mrt12113
reinvasion
conditionmalaria
malignanciesconventional
rtmac
tbiflucy
6191
5284
implicationsdespite
sputumpositive
hhcs
qfn
25291
47291
179277
039266
0561414
048235
022247
ltbipositive
009042
020059
5328
merger
cyclethe
methylprednisone
g0g1
sphase
modelsa
studyour
monocentre
lymphocytetyping
0·155
0·0002gl
depletions
p0·007
practitionnersthe
cd137cd137l
chemoimmunomodulating
adviceunder
curabilitymetastatic
trustedsite
clonotyping
ascendancy
continence
lineageunique
plup
graftversusprostate
treatmentsbecause
invincible
qiu
diseaseallergenspecific
mucogenicum
netherlandsunlabelled
069266
miceaging
dio
diogenerated
αcd40il2
storms
calorierestricted
sharpsrelated
nonsterile
koirala
bpkihs
dharan
rotations
nssis
rotation
practiceelevated
paced
pasat
pasats
melanocortin
reactivitydesigner
mem49
med171
1recognizing
sclerotic
sfgmtcsclerotic
sexmatching
166196
patientsprimary
recruitmentclinical
foeinterleukin
il21mediated
intermediary
hbvinduced
antihepatitisb
supplybackground
antihbsonly
25±22iuml
obis
logicexpanded
ethnographic
jimma
obfuscates
uncaring
hostilities
waits
immunosuppressionclinical
lengthening
eradiffuse
hypoxiawe
transdifferentiate
tdec
htla230
tdectargeting
hcd31
nbbearing
coexisted
emtrelated
vmrelated
emtassociated
twist1
ncadherin
parabombay
recipientunintentional
13mgdl
thresholdsadoptive
agrecognition
cellsignaling
abbased
hlaa2wt1db126
il18induced
yearsindia
reviewrevise
slot
adolescentpreadolescent
dtwphibhepatitisb
adjuvantsobjective
potentiator
th1t
fluorescencelabeled
th1bias
pcirns
3559
diarrheamortality
19992012
aracaju
julydecember
13185
g8p4
diarrhoeahospitalizations
89934
53705
diarrhoeadeaths
underdog
therapymrna
meganucleases
transfermany
75±11×106tregskg
324±113h
1204±197h
677±69h
2521±549h
arrestboth
sb3123
melanomaderived
invitationonly
actiontank
617yearold
iranalthough
pertussisigg
survivalrecent
escs
escsderived
esscs
hightumorburden
gelf
detude
lymphomes
folliculaires
150000mm³
100000mm³
149000mm³
375mgm²
3775
responseunconfirmed
37101
rituximabchemotherapy
intermediatesize
ph1n1objective
riskmapping
nyvacbased
gp140zm96
gagzm96polnefcn54
particlesunlabelled
nyvacgp140
nyvacgagpolnef
nyvacgagpolnefinfected
gaginduced
primenyvac
p17p24
zm96
adultsstudies
ah9n2
75μgdose
nct01320696
unblocking
cellsgenetic
gapshouse
galα13galβ14
glcnacr
α13gt
cd44cd24
universitario
marques
valdecilla
80mg
index35kgm2
quicki
386±107years
379±163
189±78
035±004
037±004
ultrasensitive
melanomabrafv600e
plx4720
antinkp30
α1antitrypsin
injurious
nonauthentic
threatsone
aat
serineprotease
nonobvious
stunt
cholesterolrich
lipidrafts
adam
embarrassing
latethe
unpreparedness
3857
vc2
ul20
strainsherpes
orofacial
hsv1f
ganglionic
hsv1mckrae
hsv2g
gknull
activityunlabelled
existent
mononclonal
technologyintense
cd19curing
trichodysplasia
spinulosa
folliculocentric
leonine
tspyv
monomorphous
3site
demarcates
tim3cd8
tim3pd1cd8
nontcrdriven
rejuvenating
robo4
growthtumor
fibrovascular
antivascularantitumor
robo4carrier
headingrabies
deltisone
neutrophilsmanagement
om174
attested
adependent
transplantationallosct
sixnucleotide
casp8
wtwt
pharmacokineticsgiven
pbmtc
relapsetoxicity
drugsmetabolites
pilottestingbackground
bahasa
melayu
736±229
713±220
alpha0757
0743
0740
lettertotheeditor
lars
andersson
nineteenthcentury
westernstylemedicine
ranpo
chinesestyle
kanpo
practitionerswho
kanpodoctors
originsthis
writings
cyclophosphamidefludarabine
s524101
actairsubcutaneous
orodispersable
wheatdependent
non0ittreated
p318
cxcl10induced
cxcl10transfected
cxcl10negative
cxcr3positive
discoverythe
cotargets
singleepitope
interventionsbovine
19972002
192203
225240
pdyear
donegal
analyseserectile
fangchenggang
famhes
p0737
p0274
p0943
p0985
snpset
kernelmachine
skat
ptafr
000869
00029
01954
00248
05196
07146
00413
01223
00222
psmb9
01237
00212
00849
00478
familywise
fwer
citationtruths
legends
questionsanswers
pharmacypopulation
midyear
incomequintile
opsoclonus
omsopsoclonus
developmentalcognitive
quotientdevelopmental
microenvironmentadenosine
a2arproficient
micab
ulbps
receptorand
immunosuppressionmechanisms
doublets
folfox
folfiri
folfoxiri
antiras
reolysin®
practicesunited
19642014the
chartered
dhhs
111857
19872009
106176
102314
103591
155733
pretense
grazaxgrastek
usawith
alendronic
acidadoptive
aminobisphosphonates
150fold
featuresbackground
polysensitisation
experimentsthe
managementregardless
antigen×anticd3
alginatepolyllysine
bsabsecreting
monitorized
vaccineprevention
lentivirusbased
tatindependent
calshivin
phpc
replicationlimited
optionsobjective
mirrors
gardasils
immunotherapyimmunization
r8
rectified
plasmablastderived
ppabs
ppab
heterovariant
nosethroat
370756
79811
mihaspecific
ccr7cd62lcd45rocd27cd28cd95
aktinhibited
intrafemural
myelomabearing
ts1
operationa
tomographyctrevealed
tumor25
diameterin
pt4n0h0p0m
fstage
chemotherapyts1
100mgday
coursescombined
wilmstumor
1wt1peptidepulsed
immunotherapy20057201311
twentynine250ovarian
benefitcomplete
responsecr
responsepr
thirteen127uterine
fifteen214
peptidemuc1
protein1wt1peptide
1muc1peptidepulsed
2013t
evaluatedthis
institutiona
dcs24×10
cellsinjectionoverall
31393patients
patients72partial
responseprwas
patients24stable
diseasesdwas
patients37
diseasepdwas
patients33the
raterrand
ratedcrfor
cancer56
25and
cancer39
cancer36
cancer20
cancer16
cancer15
others76
67these
formwe
309159patients
99to
191using
hyperthermiaalone
plural
1036
1936
microenvironmentrequirements
multikinases
adherenceimmunizations
staffin
6957
policycovered
epidemiologyoptimal
longused
uklike
£45£60
£201
7797
8197
scito
learnbackground
1×gdpcapita
coauthors
peto
mccartney
birthbackground
nonmalformed
miamidade
pleas
faps
fvps
fivedigit
rate988
income75000
fvp
rhinorrhoea
discontinua
ruin
nonfeasance
oneag
twoag
47±6
23±4
48±5
hr199
111359
hr183
108310
hr254
103626
ncoa7
β1bwe
alternativestart
tldc
oxr
ncoa7as
ifnβinducible
aldoketo
ifnreceptor
ifnβs
implicationsmesenchymal
3885
072173
062178
086122
118457
ofhouseholds
andget
bungudu
ci36947
or36
ci12106
layersobjective
experiencedsyringe
experienceddevice
untrainedsyringe
untraineddevice
parenttargeted
antiα4integrin
antivla4
vla4mediated
rasmussen
natalizumabassociated
antijohn
antijcv
wechsler
phv
oppositional
defiant
anorectic
nonposth1n1
nphv
tantrums
sheeprift
bunyaviridae
gngc
isa25
prnt80
leukemiainfection
halpoidentical
vasculopathybackground
pk136
gk15
cd25depleted
nonrituximab
splenectomybased
chemoradiotherapyinduced
hpvopc
unfavorably
effectorsuppressor
welders
nears
vdjs
factorsi
depthare
diseasesjapan
clinicodemographical
photocopy
twotime
51118
37100
14135
autodisabled
wastes
cutters
076×106
206×106
blinatumomabrefractory
nct01626495
notthe
vaccinatedbackground
tracheobronchial
copdrelated
handdrawn
swaths
katsina
poliovirusendemic
communicationsmobilization
1697
8794
surveysevery
povertyrelated
administratively
statereported
districtreported
66102
4998
3884
75123
46114
lgareported
initiativesbackground
19802009
pointsyear
8185
sustainabilitysince
cessationbackground
emergences
highestcost
opvrelated
dieout
dtp2
dtp1dtp3
sagerecommended
evidencepolio
lpvs
lpv
cvdpv2s
2containing
passfail
8089
taraba
surveillancebackground
feasibilitybackground
clqas
6cluster
subsamples
16cluster
countriesmonitoring
accommodates
19532012background
19651977
xinjiang
somaliabackground
1odds
4691
8498
8999
6599
multivaccination
campaignkatsina
scatterednomadic
technologybackground
coordinatebased
geocoordinates
gisbased
moreefficient
missedpoorly
diseasepertussis
dliassociated
systemsstudies
criminality
ouagadougous
hdsss
urbanbased
syndromeswe
1285
gelatins
lightemitting
photoimmunotherapyunlabelled
therapyphotoimmunotherapy
pitis
ledpit
photobiologic
2lmpluc
panitumumabirdye
cm2dependent
nongastric
mzls
90yttrium
mzl
nct00453102
656977
40965
40933
199595
468865
ofindividuals
mageb
listeriamageb
gall
nonprogressive
diseaseadvanced
aiet
sittings
293822
epidemiologythe
hbvhdv
monoinfection
gluteninduced
hbvsusceptible
protocolobjective
carboplatininduced
pandemicvaccination
kenitra
inapplicability
moroccans
serviceslogistics
relapsingobjective
tacresistant
tacsensitive
triplecombination
lef
doublecombination
pretacctxmmflef
tacrolimusresistant
tacrolimussensitive
ccr2myofiber
diaphragm
moderived
mdx
diaphragms
ly6chigh
cd11bhigh
reviewsystemic
mural
smallmediumvessel
cryoglobulinaemic
purpuraiga
sezary
syndromeadvancedstage
954days
334979
aged25
p00000
p00216
jamam
doro
batil
gendrassa
maban
globulinimmunosuppressive
populationinfluenza
environmentneisseria
nonculture
postsmolts
encap
unencap
allosctlarge
csatacrolimus
sirolimussrltkr
n139
srltkr
ofgrade
andgrade
170725
hcccellular
doi101038cmi201491
cancercytokinebased
th1based
employeesobjective
patienthbvdna
bassociated
ag85aloaded
complexestuberculosis
tubercular
ag85loaded
responselong
creatures
2885
pradeshmozambique
lees
acceptancethis
interwoven
usg
1813
firstautolymphocytes
secondcombination
enzymotherapy
pension
1st3rd
783119
prediagnostic
iranas
suburb
4502
4479
992996
158211
noniranian
immunologycytokineinduced
cd56brightcd16
cd56dimcd16
immunereceptors
aor092
m72as01
trialunlabelled
bacillecalmetteguérin
expandedprogrammeonimmunization
nct01098474
outsideepi
withinepi
epiregimen
m72specific
seropositivityseroprotection
neoplasmsin
fb3
0751
0715
libel
rebooted
scapegoats
epidemicthis
metamorphosis
folkdevil
largecirculation
otherness
scapegoated
freemasons
inotuzumabozogamicin
malignanciescalicheamicin
groove
tubulinbinding
poisons
auristatins
maytansines
lupusobjective
nzwf1
ifnαaccelerated
pristaneaccelerated
br3fc
janani
suraksha
yojana
jsy
highfocus
nonhighfocus
75107
fieldvaccination
redefinition
antigentransgenic
miceseveral
isletinfiltrating
glucose6phosphatase
igrp265273
hlaa2transgenic
cellmodulatory
layersthe
achickenlegok2003
contactexposed
4log2
contactexposure
179309
113199
027087
25420
32677
£4
tbifludarabinebusulfanatg
leukemiaeighty
mutationdespite
abl
retrospect
nonmsc
cellreceptor
2011may
adults50
localregional
condones
plhiv
environmentbackground
highlow
certificated
magnificently
ly49i
statesusing
53300
28800
doublefiltration
plasmapheresisobjective
304months
40gdl
200iul
il9deficient
tumorrejecting
populationaverage
144047
or137
116163
or160
134190
135155
or223
207240
or396
387405
083092
or082
079086
virusalthough
papersbehrings
livesthe
heinz
zeiss
bieling
nazi
widow
18761936
biographer
behringfounder
1901as
narration
posterity
phagosomes
immunoisolation
reviewtransplant
myelomawith
selftolerated
selfhomologous
xenovaccination
gnc
bremen
hamburg
ig1
ig2
ig3
copied
idscreen
185209
84104
120193
4830
84184
kappa048
likelyhood
carcinomato
middleadvanced
cellsdysregulated
ikaros
lymphomaadvanced
nct01926639
rs2064479
competenceparasitic
immunologicallyexposed
82±56
192±15
19±17
48±05
37±27
73±08
139±91
313±19
aanhui012005h5n1
avietnam12032004h5n1
aanhui012005
ahnui
430931
197412
nct00680069
aurantiacus
miceinterleukin
il4deficient
aurantiacusinduced
vgg
factfinding
basedimmunotherapy
triumphs
nlgp
dependentobjective
neem
nlgpmatured
neemazadirachta
indica
cd8cd69t
dcnlgptag
dcnlgp
dcnlgptagimmunized
dcnlgptagmediated
aspirinsensitive
immunizationenterovirus
ev71associated
jawfacial
antigenrna
medulla
conjunctivitisantigenspecific
ovalbumininduced
deconstructed
multimerized
rcd40l
nih3t3tcd40l
nonxenogeneic
reactionsuntil
chinaactive
160147
pertussislike
4308
9469
bfa
bucya
leukemiasobjective
cyclophoshpamide
bcgm
krasnodarobjective
krasnodar
ostitis
requalification
physicianbackground
sprayfreeze
virushighly
sprayfreezedried
sfd
sfdwiv
syrinx
timetodeath
vaccinesvaccinepreventable
surfacesthe
topicalwith
nanopatches110
nanopatches
478±148
cryosem
mucosathat
19516based
unicefwhofunded
decolonisation
anglophone
preindependence
animated
movie
unos
18yr
il2rab
atgalgthymoglobulin
17857
algatgthymoglobulin
p0130
p0733
hr0886
08110968
hr0948
08501058
p0341
thiamylal
burstsuppression
reducedintensitytoxicity
ricrtc
2564
12365
3357
2446
recurrencedisease
provocations
3positive
cids
amyloidassociated
modelcognitive
a887755
conformationunspecific
6g1
dlg4
postsynapses
synapsin
presynapses
suffices
troutprophylactic
salmonicidaspecific
transplantationcurrent
overimmunosuppressed
cytocidal
transmigratory
1181
vaccinationincidence
59100000
5677
modelsimmunologybased
hpsma
lastgeneration
remissionwhether
antiprotein
acceptablesafety
profilethis
httpwwwclinicaltrialsgovnct00808444
nct01119625
riskvaccinations
adjuvantsasia
grasssensitised
depigmentedpolymerised
5b
sqstm1encoding
p62encoding
metastasesour
hitm
48381
affectedeither
negativelyby
diseasepediatric
acapulco
436834
46834
reviewundifferentiated
uctd
547±500
coldness
fingers
304±26
toes
271±37
plethysmograms
schellong
violent
electronmicroscopic
psychosomatic
thermoregulation
farrowsure
flir
a320
outersurface
afzelii
infectionborrelia
sensu
stricto
pko
syringechallenge
tomorrowchronic
transcriptasedna
hbeagve
nonhbeagve
hvtn
nyvacb
rad5vectored
gagpol
ad5seronegative
nyvacad5hi
ad5lonyvac
ad5mednyvac
ad5hinyvac
nct00961883
um1ai068618
ai068635
ai068614
ai069443
transplantationtransplantation
7315
enrollments
5266
3680
5087
2962
previousseason
transplantationtraditionally
radboud
catania
reasonsmeasles
hypertransaminasaemia
vaccinesrecombinant
clinicdue
lastminute
cancellation
saarc
asor
countrywise
chloramphenicol
glioblastomathere
mab9227
7±1
nkmab9227
lambdainterferons
macrophageslambdainterferons
ifnλs
ifnλ1
λ2
pprs
strategiesallergen
myelomaunlabelled
46100
generationimids
oprozomib
sar650984
hspinhibitors
mmactive
blinatumomabexpanded
cd272
malariaunderstanding
fabbf
pyfabbf
igg1biased
igg2bcbiased
nct00809276
ptcys
agonistbased
il27independent
il27rα
immunoefficacy
tgrop38
pvaxrop38
toxodb
days±
campaignresidents
campaignwhich
rki
bzga
basisinfluenza
10700
fax
anxa3
noncscscics
anxa3mediated
hif1anotch
anxa3transfected
superiorly
csccicspecific
tcellsa
e2a
fishnegative
diseasesprion
prpsc
programsprophylactic
reconsiderations
xiii
antibodiesthere
koslov
imvac08
orvac04
imvac02
orvac0
therapyimmunoconjugates
malignanciespbscs
615±56
302±52
dexmedetomidine
hydromorphone
mcgkg1
hr1
0106
2047
010020
vitroobjective
wt1tcr
therapyabout
transcriptbased
igg2ml
0229
00013
00020
0423
shivering
neurofascin
neuritisguillainbarré
antineurofascin
intraneurally
immunoadsorbents
muskecd
immunoadsorbent
muskecdmediated
pcvethiopia
herdsthe
n957
panaftosa
3abcelisa
immunoelectrotransfer
eitb
homebred
immunemonitoring
tianjins
205982
19862001
198695
199601
19962001
uncensored
19861995
cancerusing
involvementcombination
anticd25mab
antitgfβmab
antictla4mab
guidances
beliefsobjective
9623
mean85
mean33
mean90
index097
2011men
3221
attractionbehavior
pglps
inductionwe
sulcus
incisor
ligaments
cy5labelled
sirnachitosan
chitosansirna
intragingival
rnaibased
allergenssensitized
transplantationwomen
obstetricgynecologists
creatinine100μmoll
vs100
p0941
p0963
10051027
0986
09740998
10101028
r0154
function100μmoll
prolyl
hifα
dimethyloxalylglycine
dmog
intramyocardially
periinfarct
dmogbmscs
phosphoakt
81·6
4560
5·9
90·9
96·8
92·8
p0·003
adflt3l
kinaseganciclovir
adtkgcv
rg2
adtkgcvtreated
gl26
greaterthanthreefold
responsesvirus
cognateantigen
ifninducers
ifnβinduced
2signal
3signal
ifnpretreated
11364
malignancywe
busulfanfludarabineetoposide
patientsconditioning
bufluvp
medicaidmichigan
20112013in
nonarab
parasitemsp1
vectorschad63
msp1
naturallyimmune
igg14
adenovirusmva
lipo5
vcp1452
primelipo5
participantsfinding
hiv1negative
lipopeptides
73174
vcp1452lipo
nct00076063
delayspneumococcal
13101356
4991356
imovethe
effectivenessmonitoring
229enl63
oc43
abounded
preoccupation
activitydriven
caprelated
332267
076097
086098
059088
093114
08170999
075099
elapses
dissuades
rattles
eutectic
fourmonthinfants
gonabad
rubbed
shaken
15s
filmed
15seconds
shaking
boosterontario
n182
lfa1associated
carethis
benzocainebased
universitybased
suppressionultraviolet
290320induced
uvbtreated
il17induced
uvrtreated
scenariobackground
ts87
trichinellosis
artanticd20
5095
8398
8499
16699
interferong
evasionimmunotherapy
6950
patientsinfluenza
antihemagglutinin
antiah1n1
nonhemodialyzed
antiah3n2
oal
2008march
oals
medicationobjective
1thelper
2regulatory
82000
093100
090098
095103
092101
pregnancypregnant
preiiv
00149
postiiv
13acetate
therapyhuman
pdisplay
pdisplayscfv
erbb3scfv
ldrt
group1
group3
rethinkover
epitopeimmunotherapy
shiv2873nip
tzmbl
a3r5
shivc
pjhl187ltb
eltb
δasd
jol1311
jol1499
midlogarithmic
egyptthe
aswanhungary49992006h5n1
shaver
agooseguangdong196h5n1
achickenegypt128s2012h5n1
achickenegypt128s2012
preventioncontrol
immunopreventionthe
frontiercancer
viralinduced
nonviralinduced
steam
tbodieschimeric
standwith
twoedged
visionthreatening
amlallogeneic
10134
probabilityoftreatment
iptw
067193
055234
amlwhether
atgtreated
harbingers
pterygium
inversum
unguis
piu
studyone
p0487
p0144
p0227
145µmoll
566mlmin
ppcytomegalovirus
thymoglobuline®
116±104
148±029
147±018
147±027
15±027
vivotargeting
anti‑her2
anti‑cd3
her2biarmed
herceptin®
colo205luc
pigthe
immunizationinoculation
vaccinationinjection
sepsisobjective
ventilator
contaminationthe
phix174
multicopy
immunizedchallenged
nonimmunizedchallenged
diseasecyclophosphamides
refocused
pvax1ubderp1cs
belgiumrisk
407310249
24096qaly
1644236342
laspsol
laspex
aprotininagarose
therapymultiagent
mt103
sg9r
chickenswe
jol916
sfgmtcthis
011082
146119
debatepreventive
polymeros
refutation
leukemiascurrent
mixedlogit
administrates
birthcohort
immunitysusceptibility
ci917941
10634
executionbackground
omalizumabspecific
igeantibody
acceleratorbased
studyhere
160mgm2
4800μmminute
1126days
nct00988013
tauopathiesintraneuronal
1417monthsold
ser199
ser202thr205
at8
thr205
12e8
acipon
85000
31april
seasonannual
nhsn
690976
338936
503963
clerical
janitors
recap
vivosalmonella
interorgan
bacteriostatic
bacteriostasis
gambiaobjective
kiang
kwdss
wr
banjul
dpt4
patientshepatitis
protectionhelicobacter
eighties
warren
marshall
responseantictla4
responsesbut
responsesprovides
therapyenhanced
sspea
pakistansubacute
sspe
relook
recruitmentbackground
facebookbased
881972
351535
45347
leukaemiastandard
dosedepending
responsesdepletion
gastricspecific
tregcelldepleted
tregcellablated
peripheralthymic
g250
ⅸ
modelg250
vhlhif
non‑rcc
migrationinvasion
proteoglycanlike
g250‑mediated
ⅻ
perinuclear
hypoxiarelated
nonrcc
ageboosting
10yearolds
fimbria
nct01311557
dosefindingphase
bic
tregthe
nephrectomized
interferonα2a
nonfebrile
2267
collabororation
outthe
participantsother
ah1n1pnd09
copsac2010
ah1n1pnd09vaccination
mcp4
eotaxin1
tarc
122190
lagtime
infectionaids
tcellinducing
antibodyinducing
unprotective
envderived
uncleaved
bg505u
thivc
chadv63
poxvirusmodified
chadv63bg505u
mvabg505u
chadv63thivc
mvathivc
cmpcmm
cppcmm
pppcmm
bg505specific
cmpcppppp
coinduction
thivcspecific
academys
inexplicable
measlesmump
treatmenthuman
neact
diseasetwo
treatmentfunctional
antitrop2×antihsg
peptideunlabelled
pancarcinoma
tf12
antitrop2
antihsg
histaminesuccinylglycine
dihsgpeptide
hrs7
177luimp288
41mbq
177luhrs7
11mbq
trop2expressing
fibrosisobjective
nonatrisk
deteriorations
011427
030481
scn1arelated
protocadherin
1qter
microdeletion
preexistent
learnedschoollocated
diseases1
singlevaccine
palette
amcs
at4
2014asthma
ruminantspeste
epizooties
vaccinologyexcepting
mouthwash
imaginable
dieu
hdf
cupressaceae
5grasses
rmcs
ass
1639
00162
phosphoproteins
pp41
pp29
reestablishes
leishmaniasisas
phospho
leishmanial
pp63
pp63pp41pp29
oxideno
cytokineifnγ
cytokinesil4
bloodmeningeal
yfand
finlandyellow
yfvaccination
p10current
flici
paracoccidioides
gp43
b16f10nex2
interleukin12p40
flicip10
cotesia
plutellae
bracovirusupon
parasitization
endoparasitoids
polydnaviruses
pdvs
bracovirus
cpbv
prophenoloxidase
plutella
xylostella
casebase
safetypooling
nestedcase
timematched
plugin
subsumes
2080gaps
responsivenessimmunebased
dissimilarities
pahiv
pahivinfected
pcv13exclusive
lymphomasallosct
trepleted
10e9l
14395
1254
76298
59268
regimenin
fluim
hr2871
13726006
hr1009
10061011
acceptancethe
recipientsmixed
adjuvantlike
vivoconclusions
lphenylalanine
ethylester
γpgaphe
approachoutcomes
cushingoid
2150
066we
hbac1
saidsystemic
arpatients
w0
w2
w5
w17
chinesear
cereals
slgg4
alphaamylase
glutenins
8455
5omegagliadin
052094
primatesinfluenza
z3g1
amantadine
oseltamivirresistant
igg1igg3
accretamab®
ageat
73iuml
456iuml
5iuml
to18
50iuml
defra
moreblood
nonmyeloablation
shockobjective
cmh2o
006049
014085
egger
mediumto
adcrte7mediated
e7although
calreticuline7
adcrte7
lle7
lle7adcrte7
epidemicsthe
interventionsplanning
cxcr4targeted
conjugatea
anticxcr4auristatin
pacetylphenylalanine
pacf
immunoglobuling
oxime
80100pm
lungseeding
cxcr4auristatin
multifocused
micefood
mannosylation
glucosylated
mmcp
iggderived
hingech2ch3
90s
learnedmost
recallreminders
clinicianshighdose
vectormany
idlv
idlvova
immunizationpassive
ibb477
pgm
cremoris
lowadhering
mg1820
mucincoated
adhesionmucoadhesion
prtp
mub
mucbp
6286
4714
19800
transplantationadherence
sau3ai
hemadsorbing
hau
cultureadapted
e75cv1
sacrifice
ca184004
ca184007
ca184008
ca184022
mdx01008
mdx01015
ca184025
123165
155284
nct00162123
factorsorgan
hundredfold
virusinfluenza
aav9
fi6
airwaydirected
δ12
desaturase
synechocystis
pcc
6803
stmpbad200
stmpbad200injected
hilc
hild
hila
invf
phop
syndromeinfections
yearsnational
genomeenvironment
19932013introduction
havanas
infomed
telematics
ior
egfr3
hr3
14f7
99mtc
moot
briefthis
2013–2014
jessica
robinson
deshon
brandon
matthew
faulkner
montgomery
lester
jlesterfaulkneredu
pedagogy
internetdelivered
newbornsinflammatory
medicationinduced
daysbackground
herpesvirus14
fivegrasspollen
experienceoralair®
5grasspollen
grasspollenallergy
transplantationpregnancy
il1βprogrammed
atpmediated
il1βcultured
il1βdependent
rtbc
crfirst
crpr2
5992
cyclolinopeptide
γ3bishomophenylalaninecyclolinopeptide
rγ3bishomophenylalanine
γ3hhphe
isomers
propro
sγ3hhphe4
isomer
carrageenaninduced
immunobiologydendritic
1672
2994
2865
impoverished
austriacurrent
603cμl
02709
039081
successfulness
ext1
mx1expressing
sublingualbackground
educative
adjuvantationtransfollicular
chitosanplga
bis35cyclic
sciencesickle
deoxygenated
deformability
fhi
adolescentfocused
crd42014010395
19weekold
enteritidisspecific
7dayold
dh091
36montholds
sears
visitbyvisit
autophagasomes
dribblestumorderived
dribbleloaded
1723yearold
immunotherapydermatophagoides
iisegment
dcpihcproder
controlwe
42gm2
livedoid
livedo
reticularis
ganglionopathies
malignanciescytokineinduced
diseasepromoting
vasculopathyaβ
arias
caaassociated
caarelated
ltrs
nonteratogenic
growthretarding
msf
healthwho
statespace
nucleophosmin1mutated
transplantationtoday
prohibiting
regulationsobjective
fab2influenza
cpe
31623
227thapomab
evaluationresistance
dab4
apomab
thdab4
glioblastomasurvival
identifiying
clearkin
zk
wellstructured
geneits
advancesthe
wt1knockout
tumoursuppressor
futureconsiderable
checkpointinhibiting
trialsimmunologybased
szentgyörgi
prestigious
nfcr
discoveryoriented
allisons
humble
cmvderived
gpc3‑specific
170000fold
skhep1hgpc3
skhep1vec
ukbased
£8413
informationaleducational
experiencesobjective
l1vlps
rlps
rb51lps
apostichopus
asiga
aiga
receptorpigr
£39
£116
£93
leukemiadendritic
receptorsignalinginduced
metaanalysiscytokineinduced
updateallergen
rindopepimut
14mer
immunotherapyevaluation
davila
riviere
transl
6224
224ra25
cd3zetachain
reviewsthe
latolyme
lato
surfacebinding
nct01504347
pteronyssinusobjective
5749
3476
3824
5746
cellsepsteinbarr
cna12
fk506resistant
ebvdriven
nodscidil2rγnull
cna12ctls
egfpctls
cna12ctl
zonulin
muscularis
eaediseased
guineabackground
7930
x2trend
3703
pathogenesisbackground
4r0n
168174
220228
427438
metccl5
hn10
rabvs
practitionerbackground
cmaf
systemsbackground
scotias
nct01273077
vaccinationpulmonary
transmigrating
1175879
11780
2002june
gardnerellabacterial
vaginosis
urethritis
2007june
agesex
bovisin
calvesgroup
biopolyester
biobeads
crd42014009717
2579
perspectivesradiotherapy
tumouradjacent
pericarditisbackground
2by2
impi
nct00810849
advagraf®
meldbased
imutectbackground
sickestpatientfirst
advagraf®based
mycophenolatmofetil
immunostatus
meldscore
limax
statusinfectious
nct01781195
4modified
cd80cd86cd28
immunocorrective
igcγ
type7
radv
radvctla4ig
radvccr7
radvs
radvccr7modified
radvgreen
gfpinfected
ctla4igmodified
precisionguided
multicause
20062011background
formosanum
micefungi
basidiomycetes
psf2
submerged
th1polarized
psf2treated
addictionstudies
addictive
ibudilast
topiramate
rolipram
adultsdouble
tcfbased
tcc
paradigmthe
malemethods
hypertonia
outcomesuccessful
ntpr
oncologytumor
successhelminth
rhypercvad
hyperfractionated
nineyrold
threedays
heartmate
lvad
sixwk
13mgm2
×5
oneyr
ssi®
kkh
batchrelated
administrationrelated
maternalcord
unitsmilliliter
24298730
869iuml
3662063
2112iuml
7935622
22586iuml
1823427976
17831iuml
1345923703
13803iuml
976119516
reaffirm
transplantsthe
peptidaseiv
dppivdeficient
rtpi
gliomaconventional
malawiobjective
programmemes
malawis
irradiationconditioned
pharmaciesobjective
immunizationcertified
or356
or355
gotten
itforgot
χ26444
22q112
palpebral
drooping
22q1121
digeorge
screeningrelated
zmappwithout
petechia
hydroxideadsorbed
sixgrass
scoreaverage
tnfreceptors
giants
futuretumor
preidentify
transgripe
transgripe12
nct01761435
201100324321
painting
subsetsthe
slm
slmdendritic
slmdcs
cd206highcd11clow
roundtype
dendrites
2010may
2012a
30507895
24267895
45150
bosnian
inpatientoutpatient
54042
154994
1657264
20872
20951
16850
7211
2929
19pta
britishcolumbia
abeyance
3588948818
402337558212
proportion033
033034
atresidential
2153537700
2761736620
proportion018
018019
grievance
arbitrator
deflator
tabled
szucs
19942005
n896
844890
n1252
821862
885921
endgolintargeted
carcinomaendoglin
proliferationassociated
engtargeted
radioimmunotheray
131iantieng
a8
nifli
smmc7721green
smmc7721gfp
131ia8
womenbody
185cm
taller
functionsex
thiolhigh
muscovy
ducksunlabelled
ielisa
aa503509
ranepke
mdpv
positivenegative
98·0
toxinlike
ab6
cascadea
antiantiantiidiotypic
k20
ab4
wyckerhamomyces
anomalus
anomala
fungicidal
antikt
ktlike
k10
ktneutralizing
kt4
ktsensitive
peptideencoding
pustulan
β16glucan
weantofinish
shaving
antoniolackland
2014although
squadron
pregnancythe
revaccinationobjective
429583
386667
13119
patientcurrent
selforganization
decisionstheoretical
reactionstattoos
tattoos
pseudolymphomatous
dermatofibrosarcoma
protuberans
annulare
encased
oligomannosecoated
vsl3
scgoslcfos
breve
m16v
endotypesobjective
antiil413
anticarcinogenic
mb231
cellscisplatin
dimethylthiazol2yl25diphenyltetrazolium
chou
talalay
ndi
1002500
001100
growthinhibition
1943
pneumotest
sensitizationenvironmentally
allergyprotective
clostridiacontaining
humansthe
212pbtcmctrastuzumabunlabelled
212pbtcmctrastuzumab
s24isothiocyanatobenzyl14710tetraaza14710tetra2carbamoylmethylcyclododecane
decaycorrected
bqml
nondecaycorrected
5μsvh
detectors
5851930
8451348
63585
747912
87104
756898
124155
alem
spkt
spkts
portalenteric
213bismuthlabeled
singlestrand
ssdna
213bismuth
213bichtnt3
2617
59fold
hyporeactivity
chimerismthe
longaccepted
mhcdisparate
b6ch2d
bbyj
keralameasles
mukkola
thiruvananthapuram
65577762
fishing
75967799
34215
receptorobjective
cytotoxicityinciting
il12transduced
70z3
b6d2f1
lymphomasantibody
developmentsmultiple
babiesthe
gpip
gvhdlack
diphtheriaacellular
ziehlneelsen
periodicacid
lycopodium
clavatum
clubmoss
positivecontrol
preneutralization
vaccinationmicroneedlebased
radioactively
impactinsertion
vaccinewhile
mothering
aerosoladministered
opaque
bronchoscopist
nct01497769
mvaspecific
radcliffe
bangladeshthe
choleravaccination
februaryapril
173041
datacollection
focusgroup
n9308
6786
101167
035088
117252
043093
aapnh
2548
54×106kg
3303150
1437
3150day
pantheon
ckdrelated
pres2s
as02
phosphorothioate
hemokinin1
hepc
studiesas
vivoregulatory
tregassociated
dt390mil2
dt390bimil2
depleter
thromboangiitis
buergers
immunhistopathological
onliterans
tao
antbodies
agaab
taopatients
agaabanalysis
α1receptor
endothelinaetareceptor
angiotensin1
loop12
etareceptor
daycourse
α1adrenergic
agaa
jigjiga
hoshmer
lemeshows
threefourth
pentavalent2
singleallergenspecific
kaapc
perspectivesnovel
32nd
pitfallsobjective
cockroachallergic
cockroachassociated
punctuated
thermodynamic
uniprot
hydropathicity
fractal
selforganized
na1
malondialdehydemodified
vaccineimmunization
mdamodified
mdaldl
oxidationspecific
oses
ose
malondialdehydeacetaldehyde
maatype
maamodified
maaspecific
immunotherapeuticthe
downregulator
fhbinding
fh67hufc
fh67hufctreated
fh1820hufc
ad5trail
ad5trailcpg
rencabearing
cpgdependent
infectionaugmentation
epha2eng
policydecision
miceosmotin
pathogenesisrelated
pr5
osmotin
singlemodification
p31
doublemodification
p32
coughs
entertained
hyperleukocytosis
antibodycytokinetargeted
traumas
ctlsproducing
e78195ddlrafqqlflntls
e789103lflntlsfvcpwcas
e78195
hlaa0202
2402
e789103
and103
suppressionwe
cd8tcells
japanevidence
targeteddose
20000μm×
concentrationlimiting
142mgkg
deviation248
191days
dosetargeted
duplicationpositive
leukemiafmslike
pontificia
católica
hospitalpatients
cancellations
cattlevaccination
oversubscribed
controlkill
mycobactericidal
standardizedquality
129185
11477058
12406692
5917
232015089
01240911
encephalomyelitislipopolysaccharide
toleranceassociated
cd11blow
cd11bhi
lpstreated
mogprimed
mogstimulated
preventionfocused
securityrelated
500592
phylotypes
colonal
clavatus
botryotinia
fuckeliana
undervaluation
outcomerelated
broadapproach
antihpv6111618
7587
nonaccident
059141
098375
024087
31617587
21547587
16107587
preepidemic
postepidemic
nonimmunizationbackground
282378
midwifeassisted
physicianattended
3864
139153
mmrobjective
visonly
ubiquitinhepatitis
antigencytoplasmic
vivotherapeutic
ubhepatitis
hbcagcytoplasmic
ubhbcagctp
antihbcag
vaccinationsrecent
drugvaccinecoated
sulforhodamine
srb
lpscpg
ovalpscpg
γsecreting
aok
32274
25614
39686
asthmapost
aqlq
400800μg
327μg
lad1
manifestationsleukocyte
emigrate
twelveyearold
videocapsule
niph
1503
śląskie
4487
6115
5707
5539
2002253ec
20112006
20032001
measlescompatible
proceding
geneto
dnastar
pmv361
pmv361e21
pmv361e22
pmv361e23
pmv361e24
pmv361e25
pmv361e26
45°c
cfu200
rbcge26
cancerimproved
achievablepancreatic
patientvolume
kraspeptides
updatevaccination
typeidiabetes
strategieswhile
hcmvmediated
vaccinepreventabledisease
tel
aviv
311205
311212
2960
1360
1557
131249
24435
gaibandha
tv1
tv0
103123
111138
112132
or107
103111
or089
082097
periconceptual
costqualityadjusted
qalygained
790024300
40000qalygained
j1
regionstratified
j1attendees
69fold
n3015
n2126
n1700
n3441
mr30
mr0
mv003
ratio539
1799
similarbackground
02mgkg
to5ngml
133mgdl
immunossupression
balbch2d
bucytbicy
conditioningrelated
163273
cases67
intensitymodified
diseaseamyloid
synaptotoxicity
nonpathological
clickchemistry
polyglycerol
monomethacrylatebased
immunostimulationa
monomethacrylate
pgmma
propargylterminated
atom
dangling
functionalisation
thiomannose
michaeltype
propargyl
endcapping
mannoselinked
pgmmas
clusterprotocolbackground
grassrye
receptorsseasonal
allergenchallenge
mil4r
sil4r
destinationsbackground
immunotherapyplasmacytoid
500fold
peregrine
febim
substantiation
whomwhere
19922006background
multiwaves
199293
disparitydisfavouring
childrenbecomes
religionparticularly
astonishingly
cytokinelike
ccdc134
immunotherapyccdc134
jak3stat5
environmenteradicating
traildirected
livevectored
±100
153472
desiring
167108
massscreening
2915
bangalore
138896
demystifying
1equine
airs
allergistimmunologists
practitionersphysician
imia
immunizationsunlabelled
cd127cd62l
cd27cd43
requirementsobjective
schoolrelated
grantees
httpwwwimmunizeorglaws
educationdirected
wellintegrated
routedendritic
sitbased
hyperimmunogenic
shuffled
surveysinfluenza
41233
maxillofacial
cancersconventional
africameasles
13·8
onlinesurvey
duisburgessen
personnelrelated
storagerelated
nearbyerrors
goatspeste
hemaglutin
pprvh
pprvf
pprvspecific
111inpositive
111innegative
inibritumomab
mechanismto
alternativemany
cancerogenesis
silgard®
cervarixtm
oncotypes
neededobjective
slithdmslit
exacts
interleukin9
antiinterleukin5
antiinterleukin13
trprich
ttr
prrsvaccinated
immunoproteins
alpha1acylglycoprotein
hmbppdeficient
pulmonarysystemic
cellswhereas
humansprimates
hmbppipp
ippdriven
phosphoantigenhost
interplays
hmbppippcoproducing
systemicpulmonary
tumorscik
needlesbackground
tsukuba
ibaraki
81±10
needlefearing
bladderurinary
urosepsis
dysreflexia
pains
detrusor
hu2117
ialuril®
pct
antiepilepticdrugresistant
aedresistant
aed
mganimal
sneezed
francis
theorem
nonoptimality
inflexible
thereofa
ipabipad
deficiencywe
bkassociated
gvhdhemorrhagic
194289
16430
transplantationvancomycinresistant
vreb
323566
pathospecific
multiepitopespecific
micehepatitis
multiepitopeexpressing
hladrb1restricted
hlaa2drb1
vaccineencoded
multiepitopebased
macrophagestimulating
dnakleptospirosis
rlic10368
lsa21
rlic10494
rlic12690
lp95
rlic12730
4step
carboplatincisplatinobjective
carboplatincisplatin
6566
chinahlahaploidentical
rhgcsf
nonrhgcsf
rhgcsfpriming
nonrhgcsfpriming
80months
m4m5m6
gcsfpriming
tmp
phidcv10vaccinated
ratio06
or24
nonmixed
zimbabwethe
multiindicator
piggybacmediated
piggybactransposons
4d
nucleofector
nucleofected
interleukin15containing
t315imutated
13×
20day
4dnulcleofector
serumxenotumor
cellvirusfree
t315i
streptamers
dbiotin
hovon
studydouble
survives
15102
2856
cyclophosphamidefludarabine4
unitversusunit
ntr1573
197±63
138±79
10±12
358±116
209±125
144±95
258months
413months
308months
prevaccineimplementation
postvaccineimplementation
0·07
0·040·14
0·430·96
7193
2676
seps
nonsep
diabetesdespite
multistable
multistability
unforced
saddle
population׳s
seasonalforcing
contextualise
ophthalmopathyobjective
thyrocytes
antiigf1
antisoluble
aldhhighcd8t
tumorigenesisbackground
aldefluor
aldhhigh
aldhlow
cellsmediated
practicesrecommended
coworker
neuroblastomachimeric
reboot
challengesseasonal
preaud
19992006
1·00
0·891·11
1·04
1·17
0·851·01
0·71
0·560·90
0·59
0·430·80
0·621·23
danida
fp7
optimunise
estimatebackground
45300
65600
25200
37200
eu27
23800
31400
14300
678500
767800
883800
1015100
vectortransmitted
diseasesvectorborne
conjunctivitisthe
selfmanagement
highdeductible
leishvacin®
rv0652
rpll
rv0652activated
cellmediatedcytotoxicity
rv0652stimulated
implantationobjective
jacinto
convit
19132014
boran
gabra
kenyasmallpox
subsahara
herdsmen
variolated
antiil6r
insightsproinflammatory
il6r
tissuematrix
impinges
1871years
selfemployed
jobstasks
catstacrolimus
22014cancer
gardening
careavoidance
youthfocused
mexicostudies
positiveinfected
methodswe
papillomavirusgenotyped
papillomavirus16human
papillomavirus18positive
viannia
panamensis
infectionleishmania
ril2antiil2
transitorily
jordanlumpy
19539
millimetres
teats
scabs
peeled
udders
jovivac
bioindustries
jovac
sniffling
straindependentnew
biodefenserelated
rf1
hsdnihs
cancercould
transplantationimmunoregulation
litaas
ligandomederived
litaps
maged1
prtn3
surveillancesurveillance
nonsurveillance
153321
barium
enema
248574
indiasimobjective
indiasim
317377
215569
207846223292
oop
186257
45914
3790953920
disparitiesindia
118daly
inrdaly
rix4414
4532
ultrasonogram
ultrasounddiagnosed
200100000
141100000
94100000
71100000
satisficing
sufficethere
drugsnsaids
appropriatelydesigned
rrl
bothsex
inhibitorsmyeloproliferative
sctthis
specificitythe
0p0000
hr10825
470424912
hr8681
ci372820212
failurepatients
02682
07943
dexamethasonelike
cnsimmunization
accomplied
microhemmorage
preventablecharacteristics
neisvacc
neisvac
eva
bedsidechemokines
cx3c
transmembranetype
nonchemotactic
cclsccl17
activationregulated
gliomasbone
th1th2th17tregs
amyloidβstimulated
appswepsenlde9
miceantiamyloidβ
aβbone
appswepsen1de9
aβbmdcs
immunotherapiesmerkel
melanomakey
diseaseantigenspecific
r14cfa
r16
r14stimulation
tcrαβfoxp3
00105001
390520
49965
548697
mobilephone
iphone
itunes
downloads
pregnancythere
incontrovertible
prelabor
triageobjective
radiationresponsive
dosimeter
nonrt
clusterin
7484
triaging
sclerosistreatments
encephalitogenicity
mechanismstype
humansifnα
ɛ
subnormal
withania
somnifera
asparagus
racemosusvisceral
wholeplant
racemosus
donovaniinfected
stibogluconate
weight1
blackin
bertaina
αβcd3cd19depleted
csf1csf1r
tumorssubstantial
sicknessjo
oligoarticular
20200
miwguc
barrowsobjective
analogon
piétraincrossbreds
leaner
c183
c202
aviary
furnished
cagesantibody
lohmann
responsethis
vzvigg
2728
3841
2744
regimentransformation
595years
cdt
oxcarbazepineinduced
oxcarbazepine
kinesigenic
thirtyfirst
haitibackground
7inch
preregistered
nightly
wifi
webhosted
autopopulate
45417
schooleducated
leishmaniasisbackground
antimonate
tropica
antileishmaniasis
infectionsherpes
aboriginality
detoxifying
defaultersstrengthening
prongs
mmrvrelated
warehouses
90294
8344
mmrvvaccinees
mmrvrecipients
rr216
40day
mmrvspecific
equaling
mmrvassociated
scfvfccd28cd3ζ
antierb2
interluekin2
cidpobjective
pmp22
p2specific
pmp22specific
p2antigens
poliomyelitismassvaccination
synchronising
constantrate
transplantationover
wangfang
weipu
chemotherapydccik
5969
rickettsia
amblyommii
rocky
modelrocky
rmsf
rickettsii
lowvirulence
rickettsioses
sitesbackground
8923
schoenfeld
residuals
165949
12974
94358
32179
casesto
mgmd
fastingrefeeding
rejuvenationthe
72hr
refeeding
metaanalysiscurrently
amlall
15258
machct
interstudy
safemany
epigeneticmodulating
previousexpected
firstvaccine
£920
£717
sorts
americathe
agpulsed
mabinactivated
ift
iftpulsed
mabift
mabiftpulsed
fcγrtargeting
vivopulsed
cpetderived
vo2peak
247±64mlkg1min1
109355
29±17
08099
071098
registryexact
picus
syndromewe
4206
nstric
4160
106338
103296
126783
curve064
057071
104318
265918
174543
vbeam
bortezomibbeam
bereaved
caregiversyounger
wills
13152
bernardsoulier
bss
macrothrombocytopenia
gpibαnull
lentivirusmediated
hgpibα
hgpibαtg
preventreduce
busulfanconditioned
diseaseepsteinbarr
nonhaematopoietic
preterminal
individualsregulatory
pdrhealth
uhs
251±70
loum
postgraduated
evidencein
cd46induced
haemaggulutinin
infectionpandemics
therapylamberteaton
lems
vgccs
briefcourse
locusmatched
natched
stratificationimproving
lowstandardrisk
promisingvaccination
pangasianodon
hypophthalmus
vaccinationaquaculture
intraperitonally
pangasius
antigenallergenspecific
womenfollowing
trehalosiobjective
animals74
5way
transtracheally
challengeexposure
reskg
birdpen
nterleukin1β
spainnew
ad5δ24
gd2cart
7418
5195205
©2014
melanomahistorically
britainbovine
multidimer
epitopeactive
lipoamino
immunocontraceptives
igg1fcpcons
gx101
cd4foxp3treg
transgenesis
gx101treated
onsetdevelopment
fibrosisbackground
mr161
skin1
tsk1
inflammationindependent
bleomycin
seductive
akizukihan
fukuoka
23rd25th
methotrexatevinblastinedoxorubicincisplatin
kinaseras
chromatinregulatory
desensitisationsbackground
immediatehsrs
delayedhsrs
20step
αcll1αcd3
n308
n157
p0244
401800μg
budesonideday
2185μg
1262μg
personshepatitis
posthepatitis
streptococcithe
gasspecific
shibata
catchup†
nisteen§
doses¶
20062014united
statessince
mid2006
forwardpierreyves
dietrich
immatics
spinoff
faint
reportalthough
eosinophilshpf
cmfree
normalthe
wwo
interestquestions
randomlyselected
lastchoice
divulgation
ducksthe
derzsys
derzsy
preleukapheresis
lysatehomogenate
receive1
imrtimat
techniques2
mu
leukapheresis3
2at
repentina
3objective
i1
012months
antihbs10100iul
i3
i4
or22
or52
hr249
vaccinationrevaccination
monotheraphy
infarctionboth
casecontrolled
020077
clearancechronic
tarmogen
xscore
hbvag
hbc1827
hbs18391
xscorepulsed
xscoreexpressing
gears
fdgpet
cancerexosomes
cargd2
41bbcontaining
vaccinebovine
ci95766110
2780
ci953457
ci952565
noneffective
effectiveness2
ci951417
1759kgsick
ci9512792239
37kg
ci9536777
modelssampling
vaccinedevelopment
orogenital
mexicocattle
coverlandscape
abundanceanimalpatch
tickfree
irradiationwe
iv×
flubu4tli
kwon
microarrayin
diseasedefining
hypergammaglobulinaemia
customdesigned
intragenic
mosaicism
guthrie
studypulmonary
crisiscml
tkisallohsct
cytogenic
30126
nonreturn
jespecific
malefemale1117
gvhdextracorporeal
agmismatched
gs4774
doseascending
1yu107
lymphocyteproliferation
lpa
80yu
10yu
40yu
nct01779505
privatelyinsured
1144098
1245487
3931622
4158223
surveysaccurate
voicesbackground
decadelong
n1225
061084
ci118
ci114
expectable
researchtopractice
45571
56526
12331
40247
casestwo
pollensit
immunosorbant
allergysusceptible
il4raf709
igedeficient
il4raf709ige
fcγrii
th2cell
thcell
ricnmc
2833
6428
leukemiamds
6735
loadefforts
peptidepool
responsespatient
eliminationobjective
7000
5279
9883
4891
facebookobjective
vaccinationfocused
33733
45661565
intralobular
versusdntgfβrii
hlatyped
registryderived
datagathering
318y
hypotonia
protrusion
pandemrixvaccinated
tautargeting
k369i
k3
ps404
igg2aκ
ps404specific
tangle
ps422
dentate
isotypespecific
ptauspecific
baht
approx
pancreasafterkidney
mapkbackground
sslow
logdilutions
multiallergic
663888
198471
68248
2933692001
30496
1404646179
158583
308668
156928
74712
r079
studentsdata
dtppertussis
probioticbased
immunoparticles
bobjective
cryoprotectant
dysmotilitybackground
agid
2006february
scintigraphymanometry
manometry
reportundifferentiated
uesl
multiimmune
cellvaccinated
n543
fainted
hsvsr39tk
miceengineering
cd34enriched
cancertestes
petsuicide
sr39tk
humeri
vertebrae
nyeso1tcrbearing
517383
antibodiestargeting
cuzick
spainunlabelled
vnc13
pathologyrdquo
309674
119528
110390
kanto
n243
restratifying
p996
hlamismatchedunrelated
transplantationbecause
depletionregulatory
cd25depleting
cinfected
factortargeted
scotlandfirst
allohpct
extrahematological
wartscausing
typesa
lowhigh
submodel
reinfectioninduced
7395
exemptionsexemptions
vesicleswe
momvs
waajmomvs
msbb
stxadeficient
waaj
wtomvs
omvmediated
buncreatinin
stxa
o157derived
momv
provisionthis
librarians
patron
vaccinationautism
consonant
elderlysarcomas
panomic
linesnonsmallcell
cisplatingemcitabine
promissory
4374
amyeloablative
mofetilmmf
acutelymphoblasticleukemia
biodegradablepolymer
potencybackground
posttranslationally
antiros
antiroscii
vil10
111e
matrixmetalloproteinase
111evil10
roscii
immunestaining
mc9
cellproliferation
antihen
c7vil10
haemophilum
shotsmedication
maxik
kcnma1
slo
stretchactivated
kca11
bkα
golgi
palmitoylated
myristylated
homotetramer
secrets
approachfood
imiquimodbased
nanodispersed
imiquimodcontaining
imigel
rheological
imigelbased
siinfekl
aldarabased
siinfeklexpressing
farmesenchymal
chondroblasts
challengedevelopment
derivativespecific
ag85abspecific
erdman
ag85ab
24479qualityadjusted
willingnesstopaythresholds
37178
xenogene
xeno
gac
30g
150g
con60
gac69
con540
gac543
con203
gac202mgml
con569
gac568gdl
phagocytespecific
s100a8a9
hydroxicloroquine
infectionpreventive
opinionvariability
programsponsored
brokersconsultants
vaccinationimmunization
histags
gp140this
nintafunctionalized
liquidordered
gelphase
trimerloaded
201113the
sd±13
sd±135
sd±123
45158
147513
31219
infectionspeople
avianorigin
april2013
allotransplantationfive
tumorogenesis
isletderived3α
reg3α
elafin
sil2rα
cyclophosphamidefludarabinebased
3center
βglobin
majorthe
conditioninggraftversushost
leaksobjective
rhinological
globulininvivo
jurkattostudy
taxol
palms
shins
compulsive
2012atopic
toleranceadvances
anemianew
donordirected
icell
diseasemucolipidosis
mlii
forwardbackground
ho1modified
2related
injurymacrophages
nrf2dependent
nrf2ho1
bmms
nrf2deficient
adho1
adβgalbmms
suzuki
necrosisapoptosis
mrc1arg1
hes1
irstressed
notch1hes1stat3
inflammationdamage
transplantationislet
glycometabolic
diabeticrelated
28929
3936
alcoholrelated
090106
shake
updateobjective
sourcesstudy
synopses
spreadingan
evolutionarygame
dynamicshow
partialsubsidy
freesubsidy
donees
computations
nonmonotonous
managementspecific
quasar
orodispersible
200500215141
200700040267
chessplaying
opponent
reviewpertussis
agrichemicalsfish
174±046
213±036c
herbicides
atrazine
glyphosate
lc5096h
reinoculation
neotropical
herbicidecontaminated
routineunlabelled
fts
reinnervation
schoolleaving
dtap5
tetanuslowdose
diphtheria5component
iggproducing
1component
pertactinspecific
200800819513
indiain
nct01030822
nct00814710
wwwgskclinicalstudyregistercom
112909
erf
lrf
201015
passi
rubeotest
deliverymucosal
sisli
etfal
273±08
254±06
tgab
p00010
30364±4986g
memoryeffector
1928zil12
underprovided
manufacturerspecific
tav
girlsthe
problempertussis
troops
developmentas
titecrm
webinardelivered
107443
webinar
ocs
transmedics
andover
ohtx
bpm
echodoppler
histidinetryptophanketoglutarate
custodiol
koehler
chemie
ansbach
htk
neno
malawityphoid
216000
freelisting
nonsomali
12180
14119
vaccineshpv
registrants
casesmany
114126
5251
4376
conjunctivitisseasonal
epiphora
decongestant
multiaction
wf
ve88
ve80
sctwe
n239
questionnaireshort
fopqsf
cutoff34
b276
b445
b444
b646
b661
b488
sctin
allelemismatched
hyperfibrinogenemia
buthiothepawe
thiocy
beambus
hdpam
fuo
antiinfectious
beambustreated
furincleaved
pseudovirionsantibodies
l2specific
l1pbna
fcpbna
pbna
phylogeneticallyrelated
tacin
l2pbna
spaciotemporally
genitalchallenge
ageline
896531
leafletpostcard
nursespharmacists
249067we
postcardletterpamphlets
592165
388164
letterphonecall
82465
clientbased
42532
nonsignificantwe
2815
8376
reviewfeedback
27580
outreachfeedback
081trials
5753
26432
202264
needjack
cellsactive
grainsm3day
englandorf
n762
169328
126322
111201
156278
perceptionthe
clerkstechnicians
readministering
beyondobjective
advents
mat01
immunizationpertussis
costeffectivebackground
3627
91321
greecebackground
nursebackground
pasw
thankyou
teacher
dermatitispatients
superantigenspecific
phadia
asthmasubcutaneous
grouphomes
91112
88112
10112
15112
analysisdata
crosstalktuberculosis
tumourlysing
xdespite
hspxstimulated
mean385
se±96
lossanimal
£27
£2210
mean486
se±162
mean6
se±18
mean78
se±29
pollinic
allergycausing
noncoincidence
specificallergen
netherlandsenterovirus
notduring
transactivatorinduced
pdamhc
transactivator
ciita
ciitatumor
noncrossresistant
immunogeneticbased
concernscyclical
athletespublic
disciplinespecific
networksby
p01538
p08168
p00416
pediacel
experiencesafe
pediacel®
90ytrium
3085
intermedium
588838
716929
themselvesrisk
risksensitive
kilkenny
rlu
dafm
looksobjective
fim2cholera
fim2
ctbfim2
monosialotetrahexosylgaglioside
gm1ganglioside
rfim2
bpfim2
fim2specific
1step
dotaantibody
adenovirusp53
adp53
h891
ulbp
colombias
4802
4738
pathologiesrecent
hpvdependent
considerationsdeworming
homoeostasis
helminthrelated
gelsolin
malmö
pollengrass
sfas
timp
18358
139298
174353
h2receptors
h2r
tregh2r
granulocytederived
monophosphateactivated
aicar
epitopeshematopoietic
hladpb1mismatched
hladpderived
pirche
pirchei
miyarasakaguchi
rtregs
2059
86732
8615
ci97101
ci234240
coefficient0805
χ222605
χ23462
outcomesparainfluenza
piv3
piv3specific
lrd
conditioninggraft
fbtbased
jak12
2877
391400
7195
ctri201210003057
nct01700127date
trialwhile
ovca
curtain
hungaryin
shook
communist
kreuth
nominees
preferencessublingual
healthsystemrelated
effortlessly
fiveyearold
immunizationprocedures
drawings
immunizationprocedure
childcentred
sengerema
seventies
sixties
usaid
processas
phasing
itselfinvolving
graduationappears
techniquesmultiple
safetyhere
nap1027allogeneic
nap1027
day10
day5
cases10000
settingin
wrapping
18fdg
november2009
august2010
shortstay
valdemarne
periodi
periodii
periodiii
139patients
105patients
37patients
45patients
virosomeadjuvanted
vatiiv
regimenumbilical
vicar
vicarious
radioinducible
modelhepatocellular
adenoflt3l
hsvtkrttreated
earlygrowth
egrtk
bnl1me
egrnull
egrnullgcv
adenolacz
egrtkgcv
bioassay
adenoflt3linfected
bafhuflt3l
radiationinducible
antihlaa
drb345
antihlac
helium
irinduced
hpcinduced
helium30
heliumair
br96
177lubr96
10mbqkg
211atbr96
belgiumobjective
brusselscapital
ipvdtap
dtapipvhbvhib
crossstage
nct01236612
nct01218893
immunotherapycationic
lipidincorporated
5didodecyloxybenzamidine
hyperbranched
mgluhpg
endosomelysosome
presentationinvolved
cancernonsmall
bishrnagmcsf
livertherapies
expressivebifunctional
bishrnai
proconvertase
immunoeffectiveness
senzer
201220679689
20134209
vectortransported
25×107
fangtreated
lymphopeniaferrets
vtr
5068
66107
bidding
discordanceobjective
sispal
ecrpc
snhs
5245238
cpr
120144
baptist
cbchs
axios
us8
6851
us450
proteinsin
workersa
intergovernmental
shockingly
refurbishment
incomecountries
incomecost
kidscreen27
individualswe
åland
immunozym
macrosimulation
us29600
us61400qaly
29700
112000
us59
nz113
us17400qaly
us128000qaly
61900
247000vaccination
nz125
hctcibackground
reducedintense
comorbidityrelated
alloscts
graftversusleukaemialymphoma
professionalshpv
papillomatosisin
derkay
2712
studentshuman
sophomore
penetrative
teenagersbackground
phaseiv
mencps
gmts30000
individualand
201100037513
ntr3521
fingerprint
agenus
miceβamyloid
n673956
n695612
187fold
wwwclinicaltrialsgovnct01138098
nontreatable
marketapproved
breaching
riskobjective
1213yearolds
irsd
mindthis
massivity
hypersensitization
africanized
hypovolemia
epinephrines
melanomasince
brafmekerk
igeallergenspecific
brewers
vension
tuna
limitedallergen
oesophagitisbackground
dilatations
ncyn
arrayguided
thames
20171
coughed
consequencesbiologic
roger
williams
radiationcontaining
2oropharyngeal
signalingradiotherapy
αcd137
at3
malariaan
invasionblocking
ama1ron2
pfama1ron2immunized
fvo
multiallele
challengesrecent
nonbrafmutant
dh680
fldoh
dohmiamidade
e75a
standduring
lessprivileged
4721
0349
2205
malariaendemic
omvspecific
multidrugresistance
δretroviruses
paradigmbovine
dretroviruses
htlvassociated
myelopathytropical
lymphomaassociated
hladpa1hladp
betaalpha
dpa1
udrecipient
hladpa1
1281
oncohematologic
udhct
106153
hladpa10201
postallograft
ifnλ1human
interleukin29
interferonlike
nibsc
ns0
07212
ns0derived
10176
ecbs
unitage
ampoule
2008–2012
laboratoryexpanded
rending
classroom
courseobjective
blended
nonprimed
voxelwise
prmfsad
38±2
84±1
lk
taqman
wt1lk
copiesabl
10e4
wt1reverse
transcriptasepcr
vaccinesporcine
normospermic
circovac
circoflex
399°c
cobjective
heberbiovachb
3318
7178
16245
16703
25389
7676
mluml
24581
heberbiovac
perspectiveencephalitis
24299565
3sige
001510
83±7
49±8
59±9
32±9
37±11
chemohma
immunotherapyonce
zos
signage
administeredfor
inhibitorsunassigned
aktpi3k
d842v
wildtypesuccinate
sdhdeficient
perconditioning
rper
trolox
teac
11×106
msckg
cdph
postpregnancypostpartum
289141
82398
lankabackground
ljev
864939
798890
90135
351400
826912
944989
10771341
hivrna
acam2000®
acam2000®and
meddra®
102629
6380
90112
lightengineered
micelight
adlight
lightmodified
allostimulation
25hydroxvitamin
modelcalcitriol
1α25dihydroxyvitamin
hypercalcaemic
25hydroxyvitamin
clofarabinebusulfancontaining
cloric
63±9
57±9
40±9
33±3
leukemiabiphenotypic
75±10
50±13
69±12
43±13
25±11
57±14
nct00863148
ratio108
ci099
decarboxylaseglutamic
nple
48year
anterograde
amnesia
visuospatial
n1337
485566
353439
highses
multitier
12368
7913
152170
4457
antigensrecognizing
westernblotting
micepertussis
apvinduced
apvmediated
factorslittle
analysable
ha1specific
nascnelution
transvac
helphighthroughput
commissionfunded
safetylongterm
encepur®
nct00387634
foxo3a
smads
linesinterferonα2b
βcatenintcf4smads
oclass
foxo3aβcateninsmads
ifnα2bstimulated
hepg2c3a
aktphosphorylated
ifnα2binduced
smad237
βcateninsmads
ifnα2bmediated
chitwan
nepala
antije
17202
421±276
256±252
71209
vectorcontrol
systemshousing
crates
crhoused
gphoused
hemocyaninspecific
tnfαifnγdouble
hemocyanininduced
th2pronounced
stressfulness
enough…enough
bards
muc1mrna
muc1dcs
transplantationmultiple
drugsimids
timetoonset
tto
kolmogorovsmirnov
flagged
alpha005
reportrubella
heterochromic
n81496
n1643
71658
redone
chias
infantummacaque
vectorborn
impracticality
ra2
ra2based
rhil12
ra2rhil12alum
ad5a2
ad5a2ra2rhil12alum
dnaa2
dnaa2ad5a2
antia2specific
formulationprotocol
infectionhighly
ch61
peramivir
immunizationrotavirus
embryosthe
oviductal
zonafree
methyprednisolone
vitromatured
zonaintact
allergensoral
developmildmoderate
6phosphate
mannose6phopsphate
b16f10bearing
clathrindependent
immigrantsobjective
solidale
tor
vergata
haentzel
or54
28101
or1536
1619month
1619monthold
dtaphaemophilus
bipv
cheops
slurred
2916
dysmetry
2291
infusionxlinked
antigranulocyte
glioma4th
quadrennial
avaglio
rtog0825
fraternity
toca
temozolomideresistant
pdl01
mattersimmunization
2013during
hibmencytt
menhibrix
brics
treatmentmetastatic
biopharmaceuticals…
usedthe
appellation
appellations
workerspart
0315
dliboost
mc80
proximalintermediate
nonhlh
toxicitiessubstituting
mofetilwe
regimenrelatedtoxicity
condylomareply
receptorchimeric
gmpcompliance
aboriginals
stromatargeted
methylcholantreneinduced
wings
hilary
koprowski
primatesminimal
savingobjective
compellingly
lymphomaimmunotherapy
cancercytokine
pleotrophism
polypeptidesproteins
monokines
lymphokines
spurted
4504
4058
5865
5022
3957
electrosurgery
keratolytic
photographs
reviewvenom
travelersan
22584
17875
intralymph
matfel
1tetramerspecific
precaspase
ifnγdominated
1ilit
hr2hr1
hr2
polyomaviruses
transplantationimmunosuppression
polyomavirusspecific
gad65abs
31103
clinicoimmunologic
gad67
α1subunit
stiff
025099
096099
gad67abs
gad65ab
mrdmud
p529
p072
p093
ricbased
allalthough
logarithmized
antic
burnetiispecific
futuresolid
minimizationwithdrawal
sequenom
massarray®
tnfa1031tc
rs1799964
rs2104286
il17a197ga
rs2275913
il17ra809ag
rs4819554
il18r1
rs3771171
k469e
rs5498
fasl844tc
rs763110
trailr1397tg
rs79037040
japanlittle
125yr
chukyo
136yr
30yr
atn
malignancycardiovascular
hypertensioninfection
immuknow
icfa
icfas
rejectioninfection
65recipient
24121
172483
atpml
153527
198432
israelpneumonia
163990
1305223
204407
581056
paranáthis
datasus
collectedfrom
14434
leukemiacytokineinduced
kinesis
threecycle
hiv1mucus
aminoeonagemcyss
25kda
pendants
5kapc
hivgag
polymerrad
5kapcrad
hivgagspecific
fhv1
furtd
cd3cd20dim
and2010
wyoming
germanypregnant
n686
handwashing
recommendedthe
gl261bearing
blp
hansobjective
plat
pcrssp
or0448
hladrb115
or2352
grazax®
sqt2800
eq5d1000
grazax®0938
09320943
0914
09070921
00238
00324
shrobjective
a0
ngiotensin
atr12185ͱͳatr10014
atr12181
antiat1
vsmcs
peptideatr12181
medialumen
vsmc
1µmoll
dotascn
biosim
reditux
pscnbzdota
rituximabbiosim
desalted
01m
biosimthe
ludotaanticd20
antiquity
postindependence
rejectiontherapeutic
cd11bgr1hilo
lpsactivated
neededat
strainsisolates
liferecently
immunedepleting
noncytokine
cd8targeted
settingregulatory
imperfections
tregsdepleted
trialsvaccination
11color
trucount
tp1
immunostimulationduring
lipopolisaccharide
poli
zymosanstimulated
pmastimulated
pma
pmainduced
rosdependent
rheumatologyas
arthritispatients
seasonas
4–11
104792199475
fujiwara
osteosarcomanatural
osteosarcomatcell
reviewhere
homunculus
antictlr4
coincidencemacrophagic
myopathic
electromyogram
slamassociated
deficiencyxlinked
1xlinked
xlp1
sh2d1a
relapseposttransplant
unopposed
casus
cancerprophylactic
vaccinesonly
fibrosisdespite
lungmigrating
bipf
proinflammatoryprofibrotic
calmetteguérinrefractory
cd40ladjuvanted
siv239
sive660
challengeunlabelled
dnasiv
dnasivcd40l
vlpmembranebound
ageunlabelled
hrsv
unadapted
sigmodon
rushimmunotherapy
vomited
wholefood
approacheswhen
vaccinopreventionvaccinations
wouldnt
toxoplasmagondii
morbilli
cdcatlanta
vaccinesagainst
27th
36th
sacmeh
infectologists
alejandro
posadas
argentinaas
profesor
ew1835
fluah1n1pdm
fluah3
reactionmonoclonal
antimitotic
boosterpatients
antigenaemia
cancersecondline
gemcitabinerefractory
110weeks
88132
266weeks
86446
nct00965718
12025
τ2032
5120
4665
9times
highoneyear
vzvrelated
virusamplified
immunityvaccination
truvada
emtricitabinetenofovir
disoproxil
cbp
shiv162p3
22mgkg
ftc
22h
39×107
88×105
ipdcases
macrolide
allan
ns3ns3a
challengebluetongue
btv6
avirulence
singleanimal
19952009background
19yearolds
varicellasusceptible
20072011objective
20012006
rotaviruscoded
communitymeasles
55379
remissionnonrelapse
ebmtscore
8±2
38±4
transplantencouraging
003015
008024
022044
17268
01851
nonmyeloablativereduced
whenimmunosuppression
directionsimmune
tumorsas
chimpanzees
chimpanzeesinfectious
gorillas
alternariosisa
ratesbased
conditionshealthcare
responsesadoptive
targetoff
schoolassociated
classmate
692908
869971
326803
916992
409923
mediatorsbackground
rmil12
rmil18
rmmcsf
rmgmcsf
rmifnγ
ld90
ampicillin
differentiationmarkers
βintegrins
leukemiaderived
cellsstem
probands
cellscontaining
blastcontaining
dcmnc
fluorolysis
βintegrin
tnaive
activationdifferentiation
unstimulateddcstimulated
cellsallogeneic
22280
15500
lgd353
transplantationpropylene
pgfmel
winnonlin
bsides
transplantationone
45±9
0902studies
easytodisseminate
44years
sib
n176
calcidiol
cryostored
50nml
leukaemiaspecific
bm185
bm185ovagfp
antiall
tolerogeneic
optometrists
tbstep
projecttuberculosis
mcaprae
countrytwo
nelipepimuts
hlaa2a3restricted
escalationschedule
nodenegative
hlaa23
nct00841399
nct00584789
582months
leukemialittle
inmc
asiareducing
vaccinesstreptococcus
asean
responsescombinatorial
alvacsivenv
alvacenv
dnaenv
repadenv
adenv
peptideenv
mvaenv
repad
hypothalamicpituitarytesticular
rabbitsto
antitestosterone
testosterone3ocarboxymethyloximebsa
4wk
lh
sidechain
17αhydroxylase
3βdydroxysteroid
immunoneutralization
kisspeptin
kiss1
gcoupled
arcuate
βa
n1796
n1235
n1121
quantitativepcr
12150
6659
11312
syringetype
tnpig
mdp
selfadministrable
haptenconjugated
muramyldipeptide
l18mdp
c18
noncrossreacting
oxig
igf1pka
hematopoieticstemcellbased
lthscs
lineagebalanced
myeloidbias
chemotoxicity
agingaging
bloodrelated
cregulators
cmediated
mb2055
mb2059
humanscid
cfixing
45114
efiseji
ruggero
ceppellini
lowallergenic
icoscd4cd25foxp3
ova323339
readwrite
teleconference
89266
75252
lotact1
lifewhen
exerciseunassigned
reauthorization
allhazards
allhazard
2233hr
n310
021081
054091
atherosclerosisthe
hsp60targeted
agreactive
proth1
promotora
daughterscervical
hidalgo
entre
madre
hija
emh
brochureonly
021096
013098
hobart
registrars
practiceprimary
cpgmotifsimmunotherapy
typeiallergies
depotforming
relevancecytokines
differentbackground
03120
aboidentical
abomismatched
love
tolerancetransplantation
aspectsrheumatoid
sarcomaewing
allergyby
neuvax
responsenelipepimuts
galena
surfaced
immunotherapyantibodycytokine
k1735m2
f8
immunogensthe
koprowskis
preeminent
bcap
consolidationpleural
nonalveolar
panamanian
10295
10211
11798
11799
nct00466947
vaccinepcv10
nasopharyngealnp
december2010february2011
3p0
2p0
ratiorr
effectivenessve
1rr100
384437
42571
14635
0905
25mgdose
isletderived
3alpha
nct00726375
outcomesengraftment
nones
p772
conditioningnonmyeloablative
pbpc
4×106
cd34kg
6×106
perspectivewe
depotadjuvants
aluminiumadjuvant
andtransparency
africameningococcal
polymorphous
pathogenesispolymorphous
photodermatosis
photoantigen
pamr
tpes
pretpe
antigendonor
developmentcancer
outscaling
industrialize
hdmel
nonoc
nonbrainstem
bsgs
bsg
antigaa
beyondallogeneic
abolishment
mrdneg
mrdpos
vits
hymenopteraallergic
collagenantibody
il10highil4negifnγint
psas
β029
hr134
populationsobjective
brooklyn
mpt64
disseminationproteinsubunit
proteinsubunits
bcgrbcg
homologousboosting
schoolattendance
muc16
muc16ca125
rnabackground
g29
cbalacsto
19bp
duplex
immunostimulattory
isrna
3nt
overhangs
3ends
lipofectamine
isrnas
dnasm14
dnahsp65
egginduced
dnasm14dnahsp65
cd44highcd62low
8511024
or98
379725132
12994955
10514010
3yearsuntil
azelastinefluticasone
seasonlong
scoreplacebo
scoreactivescoreplacebo
21223
hedges
atpdependent
youtubebackground
fronttofront
sucrosesweet
singing
apos
lifestyleswe
httpwwwmammainformait
pregnancynearly
varicellaaccording
102248
020058
031070
026090appropriate
highinterventions
rvp1
vp1specific
rvp1immunized
highland
responsers
jtm
costeffectivenessbackground
19074lys
15897lys
pcirn
134407
10195
47217
adults65
were70
nebulizationbackground
nebulizers
cavitational
condensate
respirator
sawnebulized
postnebulized
respirated
nanobodyrit
mw15
mychistagged
untagged
111indtpananobodies
expander
gelofusin
177ludtpa2rs15d
her2pos
2rs15d
gelofusincoinfused
177ludtpatrastuzumab
nanobodybased
estiblashed
nanobodys
gp3
gp5
pvax1euorf3orf5
pvax1euorf3
pvax1euorf5
pvax1
eutype
lelystad
21mo
calve
staph
immunodeficienciestraditionally
pathogentargeted
tactic
epiphenomenal
therapyadjuvant
interferonalfa
e1684
gmk
e1694
transitionthe
rippling
canceradvances
multibreed
kennelthe
whelping
proliferationcd73
eauinduced
b10riii
twochamber
cd73rescued
cd73cd73
antibodyinfluenza
madindarby
mobilizationdriven
ozogamicinwe
cytarabinebased
wbc50000μl
wwwuminacjpctr
r000014052
participantsour
jshine
fifa
availabilities
trimixformulasince
schnorrer
7543555
melief
29372383
12265277
vacchelli
2e25771
galluzzi
111111134
canceractivation
limitationsavian
apec
aerobactin
ironacquisition
highaccuracy
approachesadoptive
hlaa0201positivecmvseropositive
hlaa02cmvpp65
a02pp65
bzlf1specific
ebnaspecific
hlab08
ebna3a
2576
immunebooster
micedevelopment
lymphoidprimed
ccl25
preparticipation
davidson
003072
retailbased
002069
nct01466387
postcomplete
pyrexias
coverageequine
ritto
miho
ehv4
hlh94
histiocyte
highlyvaccinated
902938
fridge
minakulu
lymphomarituximab
177lutetiumlabelled
ospfs
disorderstwentythree
αβcd3
fluorine18
ineffectivescare
subtler
nonsuppressive
docetaxelbased
liveattenuatedvirus
sellingmortgaging
bankruptcy
agilepulsetm
vaccinedna
geneguns
bioinjectors
av1959d
springpowered
primatessin
andv
snvandv
dsji
pharmajet
510kcleared
antisnv
stratis®
antiandv
n8group
pseudovirion
highvelocity
00115
dsjivaccinated
macaquespoxvirus
highmagnitude
linesa
multispan
mcf714
balbcjnunu
1630×108cellsspleen
solute
slc6a6
slc6a6overexpressing
27114×108cellsspleen
mabproducing
rederived
trialsafety
tden
nct00370682
flavivirusprimed
flavivirusunprimed
posttden
vaccsline
4301
arm1
arm2
p0562
changeobjective
sueface
chemiluminesence
1489
7625
manipulatedunmanipulated
myeloablativereduced
cmvnegative
inbetweenadoptive
mschost
personnelvaccinations
ifsg
malignanciestwo
transplantationpoor
140days
34×106kg
planningobjective
fivemonth
sicknessrituximab
nanotubecpg
immunotherapycarbon
cnts
photohyperthermic
malariotherapy
neurosyphilis
newbornsearly
centresvictoria
lhscvh
epiq
00021
widearray
41bbstimulated
gp49b
41bbgenerated
panobacumab
o11
nct00851435
6479
apache
threecourse
70115
antil1cam
radiolanthanide
terbium161
67cu
chce7
equitoxic
161tb
neutron
bombardment
160gd
igrov1
161tbdotachce7
378390
161tblabelled
177ludotachce7
phws
phw
ratioaor
dtp3aor
vps
131ianticd45
1561mci
27gy
84gy
21gy
28gy
43gy
54days
1364days
providersite
027067
022048
gistsarcomas
liposarcomas
hypewe
inhibitionpathway
leukemiabecause
betaparticles
213bilabeled
smallvolume
μcikg
ldac
targettonormal
skeletalrelated
prospectsthere
applicationsobjective
controlsobjective
7expressing
maturationassociated
receptormismatched
recipientsrisk
asmoking
lungfunction
platformsa
subvirion
nonhodgking
virostatic
complexstreptamerenriched
lmspecific
streptamerenriched
crossmatchbackground
immunoglobulin±rituximab
17±1
malariato
anka
pba
pbti
xnl
23821831
inductionin
fluoroimmunoassay
iggclass
revac
hypothesesbcg
manaus
239934
p0932
2013recommendationsthis
papillomavirusbackground
722872
aud450
4761
insertive
5euml
915968
988100
qpcrexcretorysecretory
esas
whocdc
smallworld
thy1ha30p
protofibrilselective
mab47
24413503
antihumoral
dsz
11024
tcdc
volumeseveral
aldlts
smallforsize
globulinaugmented
xmpositive
challengewe
csn
tmcsn
intrasubtypic
avietnam11942004
multiform
fatc
hbvseronegative
tcellreceptor
2y11
ldltbackground
lgit
barcelonacliniclivercancer
bclc
bvkj
8hour
workday
menpreclinical
adenoviruspsa
adpsa
antipsa
psasecreting
antiprostate
5fluoruracil
clinicobjective
penandpaper
neutralizationpreviously
appended
gcn4
gp140gcn4
gp140gcn4l
gp140ld
gp140lm
bcn
cd4i
scd4
hemoglobinuriaparoxysmal
hlaalloimmunized
glycosylphosphatidylinositolnegative
transplantationseveral
drugmetabolizing
gstt1
udp
glucuronosyl
2b17
ugt2b17
gstt1matched
gstt1mismatched
rolls
rotavirusdiarrhea
seminested
nonstunted
inhalations
pgvhd
syn
allolps
synlps
lpsunexposed
solutionsdespite
telephonebased
sonsroutine
n779
323247
199355
3151353
368666
2206
radioimmunotherapyunlabelled
nondosimetric
dpm
94711
tracerpredicted
therapydelivered
tumorlevel
genecancer
2402‑restricted
eml4alk‑derived
tumor‑reactive
peptide‑specific
peptide‑pulsed
h2228
antihla‑class
w632
rlsalesrv
eml4‑alkpositive
donoravailability
haploposthctcy
posttranplant
transplantationducbt
15136
bmtperipheral
10123
scienceeach
610000
interleukin13rα2
muteinchimeric
interleukin13rα1objective
13rα2
erythropoietinproducing
muteins
il13mutein
il13rα1
muteincar
muteincars
e13k
specificityavidity
nondermatologic
injects
injectisome
v2l2md
mab166
kb001a
v2l2mdcontaining
cyclophosphamideatgtotal
allogenetic
uhct
cyclophosphamideatg
platelet20kμl
8701
6557
3520
3×106kg1
postablative
toleranceantilymphocytedepleting
tolerancerefractory
antiil7
antiseasonal
20072010background
egfrdirected
pf477736
177luantiegfr
cdc25a
rad51
aminotransferases
cellulairecytoreduction
bsc
n112
p74
tumorskidney
obesitymediated
polyglutamidebased
radioimmunotherapythree
fseries
furan
pendant
diethylenetriaminepentaacetic
33nεmaleimidocaproic
emch
pseries
nuclearlocalization
cgygpkkkrkvgg
ppy
pyrene
chromophores
tmab
hydrazideterminated
naio4
mtbi
ritbi
p402
p499
1884
648935
708935
703935
cli
childrentwo
perfecting
p0578
p0393
p0370
delayedwhether
log10transformed
attenuvax
jeryllynn
leningradzagreb
inj
p0552
p0483
p0086
breakers
useaccumulation
reprogramm
cancerdysbalanced
reinjection
selfproteinderived
childrenall
personnels
33item
promandate
allocd4cd25
mdcinducedproliferation
tdc
s19rb51
areasrb51
lvu
lvus
ragweedallergic
12amb
mk3641treated
nct01469182
nct00783198
nct00770315
nct00978029
sharks
atop
orients
thereon
chainless
battletested
prospectivebackground
enthusiasms
cellvaccination
synergisms
terrible
nonaddictive
abusers
hydrolyze
effectdespite
haematooncology
sulphidoleukotriene
3enriched
rprup3
rmald
slt
rpru
nprup3
tgfbeta1
noncostimulatory
interfero
ifathe
anaphylaxisalthough
igemast
2014zostavax
pharmacoeconomically
immunotoxicological
studiesimmunization
coppercontaining
haemolymph
inedible
mollusc
megathura
crenulata
immunotoxicology
pericardium
wuwei
28579
6381
404474
2349
216253
2330
fluoride
inhibitionoral
noncrossreactive
homogenised
tissuejbs
jbs
tolerised
groupsthis
tolerisation
posttolerisation
posttumour
foregut
bioreactorobjective
laborintense
tumorlysatepulsed
avitalized
milligram
avitality
elutriation
teflon
il1ß
plateadherence
beholder
inducedhepatitis
peripherial
tlr2antibodytreated
n1ic
n1ictransgenic
cpg7909
magea3expressing
recmagea3as15
antimagea3
diseaseprevention
strategyvaccination
yetdespite
riskgrouptargeted
cost–benefit
proteinour
abbinding
v5
mosquitoesunlabelled
antichikv
chk152
chk166
e1k61t
e2d59n
chikvinduced
attendancebackground
k6
269466
0843
101468
0991
0764
bortezomibcontaining
ivbumel
28141
retrovirusesrecently
tumoursstudies
maternofoetal
whosponsored
whoafro
mft
lymphomadirected
dshnhl
r3
9·6
nct00785330
3262
0·91
0·521·60
4162
baffrbcell
antibaffr
optimalized
fcrγiiimediated
inhibitable
antipreb
fibroblastsbackground
mapcs
hpv16derived
designcervical
hpvmediated
approachesfocusing
ctlshave
e7derived
aroadeleted
moroccothe
poulvac®
colibacillosislike
00203
00309
futurevaccination
activationa
tolerize
reentered
unperturbed
2014international
lifeactivity
travelmedicine
pretravelvaccinations
conditionsdrugs
vermontchildhood
sugarcane
maharashtraa
partialnonimmunization
laborers
nonmigrating
865925
660749
unimmunizedpartially
tribeantibody
managementdrug
relaxants
extraneutralizing
adccinducing
gp41specific
leukoderma
literaturemelanomaassociated
83yearold
mart12
pcra
tbior
tresosulfanetoposide
fivepatients
hsct2
rituximabthe
ttabs
elia
rvmbc
igaiggigm
rviga
rvigg
rvigg1
ttigg
majestic
chemophotothermal
aunrscpgdox
fumigatusalthough
protectionmediating
aspergillusantigens
fluproof
pam4
radioimmunotherapypam4
clivatuzumab
nonpancreatic
prrsvirusseropositive
herdsporcine
weakborn
prrsmlv
211009
180935
p0964
prrsmlvvaccinated
fank
transplantationperipheral
22difluoro
2deoxycytidine
miata
ecpextracorporeal
nephrogenic
dermopathy
erythematodes
mucinosis
scleromyxoedema
transluminal
angioplasty
ptca
restenosis
mistimed
perspectivesas
tumorpathogenic
radionuclidesαparticleemitting
212bi212pb
227th
effiective
middleterm
xenotransplantationpancreatic
systematical
1686
or129
110151
or279
228341
7105
300rmb
37367
hrhc2
hc2
hpv56
χ84df219586p0001
560593
469511
χ7df2438
χ7df2329
cowsthe
mhaemolytica
overloads
8790
nct01549340
studiesthere
1256407
9920
withindistrict
nct01119521
may2010
queues
compartmenting
allpositive
intratibial
ipilimumabipilimumab
patientsrelapsed
atresia
1899241
retinoid
sr11302
h2kd
sr11302treated
magec2ct10
cancerlimited
wholeexomicsequencingbased
glargine
expressionbackground
deacetylating
bcpap
tpc1
8505c
dactreated
nyeso1tcrtransduced
bodyweightbased
trapezoidal
251244
µgl
8494586
222512818
µgl·h
aus
nonanogenital
reviewover
cevarix
hemisuccinate
reportpatients
cramps
2induced
mrihighdose
wellselected
hdil2related
angiogram
legumainthe
asparaginyl
legumain
ggd
rgg
lgmn111119
legumainspecific
mk16
edl2cyclin
d1p53
ade7
subsetbased
malignanciesautologous
lclike
ucbdc
ucblc
uccdc
ha2specific
micetumortargeted
dsnkg2dil15
updatepseudomonas
sivmac251
recipientsmorbidity
europeelimination
finetuningmesenchymal
unharnessed
interleukin2stimulated
nonactivated
il2stimulated
adhesionmigration
icam1cd54
lfa1cd11a
stat345
aboblood
prait
calcitonin
7426
7806
8194
7922
7875
ibmir
freezethawed
detached
cryobanked
dosefractionation
centigrays
linac
megavolts
remindersobjective
fluent
patientsflagellated
hafsa
celal
bayar
attentively
vaccineprevented
adultswe
ibu
unpurged
gzmbexpressing
wbienhanced
reacquisition
antigalectin3
cancerhere
glectin3
biologies
galectin3c
19902007background
19902007
axolemma
perinodal
trialalthough
sulfide
nanoparticlesnearinfrared
cus
cytosineguanine
excitation
reassemble
ablationinduced
51000380000
19000180000
sparseness
nonunion
fracturewe
endothelialhematopoietic
vasculogenesisangiogenesis
unhealing
gmpb
1×105
perinonunion
personnelmandatory
242482
110975
030058
counters
pregnancyacute
gondiiinfected
keratoconjunctivitisit
akc
keratoconjunctivitisvernal
vkc
papillae
rhinoconjunctivitisseasonal
summarising
chemosis
otorhinolaryngologists
unpreserved
eyedrops
antihistamins
recipientsannual
antigraft
kidney136
lung26
liver3
combined4
odontostomatologyimmunotherapies
onj
diseasebu
12816mgkg
54mgm2
23202
stableimproved
vaccinationcancer
antigenrich
graveyard
ifabased
waterbased
antiil37
interleukin37
il37m
pet28ail37m
ni²nt
anitil37
p0230
consultationbackground
svs
twovisit
tvs
2181years
ratio0954
0904
clinicspecific
damagerelated
transplantationendothelial
trcec
ang2
55months
highang2
lowang2
mhchaploidentical
fasudil
b6c3f1
fasudiltreated
antithy1
mabc
atbm
atbmtcell
allostimulated
itspecific
atbmtcells
diseaseautoimmunity
correlatesa
magea1p161169
eadptghsyspecific
gammaknifemediated
autovaccination
magea1specific
certaintythe
multipage
difference107
13200
studypapua
nonupdated
matrixcbased
subunittetanus
challengeassessing
aeqprague156
aeqnewmarket193
aeqnewmarket293
matrixc
equilisprequenza
aeqrichmond107
p00345
p00180
p00006
p00017
envelopetype
vivonanomedicine
rnadna
mend
tissuescells
vestibule
betulaceae
ga2leneuropean
146252
78257
111390
28184
56568
polcalcins
2342
700751
99127
eightyper
154days
pcv12
nucleolar
organizer
n5368183
4522
pvalues004
ci123134
or130
95ci125135
95ci116134
95ci101150
influenzanct01664793
2009ah1n1
coombe
2008september
2009september
6894
2996
professionalmanageremployer
asiamiddle
booked
succinylnorcocaine
6site
urines
cocainefree
or302
txt4flujabbackground
researchone
iplato
randomise
13lo0872
controlledtrialscom
isrctn48840025
approachlung
0196
unitbased
toxinpositive
crosstransmission
crosstransmitted
transplantationprolonged
ggf
bmecs
hpf
3163
3928
or17157
or435
megakaryocyteactive
danishvaccination
1173p2
6×103
euthanased
macroeconomics
mazandaran
pcdc
multistakeholder
vivounassigned
vx2
electrode
rfa131ichtnt
networksthe
strategiesacquaintance
communitybridge
vaccinationwere
poortomoderate
msmtargeted
kidneythe
cd8ααcd11cmhcii
glomeruli
whitenonhispanic
31225
downin
lthsc
201011since
eea
16–60
21–102
toevidence
loadobjective
activepassive
expatriate
travelerduration
agedemographic
intentmedically
malignanciespelvic
200607background
9177
114160
213302
227340
mas1
micemas1
nanoparticular
emulsionbased
mer3101
b92319ala
mer3102
diabetesfree
il10positive
52weekold
mer3101treated
rovigo
72007the
duality
72007
ulss18
20022008
exmandatory
ilorin
nigeriaclients
alanamu
okelele
tuberculosispoliomyelitishepatitis
opvhbv
diphteritepertussistetanus
dptopv
treesbackground
3991
0540
3845
0265
0418
contested
switzerlandobjective
viavac©
3634
19671992
nasalocular
cellsan
megafile
analysisafter
48111
bcrablnegative
pcds
gvhdgvt
hardcopy
n198
nejm
35298796
vmdk
4c8
mufapcar
733fapcar
faphi
fapnull
fapcar
immunityligation
antiox40antictla4
tbethigheomeshigh
pathogendriven
strategiesinfectious
prostatestimulation
tcelltreated
ommaya
ventriculoperitoneal
shunts
pvpshunts
8h9
36×injection
newlyplaced
pericatheter
cystoventriculostomy
124il19sip
studyradioimmunotherapy
l19sip
immunoprotein
iodine124
124ilabeled
germanium
lanthanum
4107
electrotechnical
gygbq
longheld
shattered
humanst
groupeighteen
men14
women4
smile
lasparaginasecontaining
haploebmt
irradiationviral
cmvremain
ofhigh
threepatients
hadvpeptide
cytolytically
uplike
vacciniapsatricom
riskperception
narok
kenyacontagious
analysiscontingent
21248
7145
116262
85372
6139
9015
p00078
p00375
p00251
hptlc
gd2positive
pdmp
gm2gd2
synthases
gd2negative
prostaterelated
patentscope
lentivirusvectored
rv3425
receipients
11±02
12±03
095±04
073±08
rhinitissymptom
dcss
critiqueto
unsubstantial
declarations
adduces
promiseimmunotherapy
headlined
01051
60120300
notfasting
ivgtt
mmffk506
ivigplacebo
ivigrituximab
transplantationbronchoalveolar
bals
radiograph
lbs
hr85
singleinstitutions
2010decade
2000decades
detriments
chaplains
professionally
depletionidentification
underrate
genevas
survivalminimal
consensusprimed
lymphosight
sequenta
ighvdj
ighdj
igk
tcrd
tcrg
89days
htsbased
4studies
lic
lic7mgg
1000ngml
12monthscycles
96days
171days
aspergillosiswe
p675
273±45
247±44
circumstancesin
kenyacbpp
kapp
conversant
428567
90181
65147
371502
521717
636765
3542
185332
chinafoot
photomedicine
graftvs
tambur
lamioni
îledefranceobjective
therapiesmast
mcsbs
h2antihistamines
mcb
proteinases
4receptor
5lipoxygenaseactivating
15lipoxygenase1
bruton
surfaceactivating
cd300a
endocannabinoid
aspirintolerant
supposition
corroboration
ata
snot20
9α11βpgf2
lossexpenditure
170215
7751055
6587
2937
38192
159811
veno
tbil
hvodp
thorax
developmentresults
obaapavita
newhints
5568
chisquaretest
diphtheriapertussistetanushaemophilus
dpthh
monsensitized
0987
oppositebackground
crosssensitize
rpen
fluorescentenzyme
seafoodinduced
expressionrich
hormad1
cxorf61
actl8
csag
magnoid
ccb
cts
subtypeorientated
fashions
ovtumorhost
vascularityhypoxia
coagulopathies
reportedthe
highresponding
fcsialylation
foodmediated
anticrth
capria
immuneprotective
cascadeprimed
cascadepriming
macrophageactivated
prostvac®
lowdisease
4weekold
leptospiralvaccinated
adjuvanttreated
talk…this
arts
apoeε4
amyloid42
neuropreservatory
diseaseintravenous
neuropreservation
synaptoprotecting
glycanmodulated
functionsimmunoglobulin
heptameric
nacetylglucosamine
glcnac
frontiersarcomas
unbounded
semianalytic
equitybased
213biantimcd138
c57blkalwrij
5t33
213bianticd138
bortezomide
wipr
diseaseplatelets
barriersrotavirus
proteinpolyphenol
phytochemicals
polyphenolfortified
polyphenolrich
juices
reflectancefourier
atrftir
proteincranberry
polyphenol
fortification
vaccinesimmunotherapy
vaccinationbordetella
wcvs
acvs
phylogeny
murdered
translationewing
nottoodistant
neutralizationin
aducksingapore97
h5n1vietnam
mf59h5n1
mf59h5n3
offrates
oilinwateradjuvanted
patientspassive
caninized
can225igg
dukxb11
egfrcoated
cetuximablike
2013infectious
newfoundland
labrador
qumv
variantlike
173404
cu82792
122098
wolg98
noncanadian
connecticuttype
491type
20102011errors
peps
fivedose
liverobjective
readministrations
antim
antiasialogm1
1001000
modelnewborn
matab
primelambda
statusimmunosuppression
camargo
2781
responsivenessbackground
vitrovivo
sox2s
lics
burundi
spondylitisthe
adalimumabtreated
9159
200541845
0280
01280611
infliximabtreated
etanercepttreated
adam33
rs3918392
rs528557
rs2787093
ci150262
haplotypebased
acagcct
ci049090
calcinosis
cutis
833915
951993
035044
112129
mcir
19month
mcirrecorded
10175
3502
4601
19monthold
12montholds
metaanalysisvγ9vδ2
γ9vδ2
resistantrefractory
matterbackground
1856
hlaalloimmunization
hlaalloantibodies
fludarabinecyclophosphamidebased
chimaerism
0·954
0·0048
0·865
0·0083
lymphohaematopoietic
laterthere
parasiteendemic
lowinfection
exceptionsnotably
cnisis
immunotherapysquamous
checkpointscoinhibitory
responseshas
pegylatedifnα
hepatocelluar
protoxin
leishmaniasisan
studyvisceral
kld
promastigotes01
kldkldmpla
ssgcisplatin
ssgkldssgkldmplacisplatinkldcisplatinkldmpla
ssgkldmpla
700cgycyclophosphamide
36gm2simustine
8gm2iv
96mgkgcy
±2years
p742
p862
p845
remissionwe
e2apbx1
stratificationdirected
adherencenonadherence
casesbovine
bnpinducing
unrecognised
bnpcases
fending
pollenosis
ebt
nct01785394
patientshymenoptera
vp252417
ibdvantiserum
pvaxvp252417
antivp252417
vibdv
therapynumerous
vivocd4
immunotolerizing
cd4cd25foxp3expressing
proximalsignaling
hyperpolarization
adenosinemonophosphate
il2cd40activated
elderlyderived
carcinomaconditioned
tumorexposed
youngderived
lpsifnγ
il2agonist
m1stimulated
nontumorexposed
il2cd40stimulated
endospores
acinonychis
gentamicinattenuated
iranan
hline
19952011the
congressional
19952011
ireducing
coveragerelated
diphtheriatetanuspertussisdiphtheriatetanusacellular
diseaseinterleukin10
phagelysates
growthantitumor
phagelysate
125th
pagelysate
dataimmunisation
melanomathis
balancecancers
uncontrolledsustained
4pronged
nonimmunity
studiespregnant
preeclampsiaeclampsia
homelessobjective
servicelearning
tumorstumors
futurecell
survivaltwo
tilil2
methodsdespite
assessmentimmunization
intersectionality
levelsensitive
comprehending
plight
disquieting
scst
castes
nonscst
immunereconstitution
transplantationde
nodrag1il2rγ
classswitch
reviewtaxanes
solvents
cremophor
solubilize
ceatargeted
photoimmunotherapyconventional
abassisted
abirdye
nirirradiation
phototoxicity
mkn45luc
abirdyemediated
polymerace
thorovax®vet
ingelvac®mycoflex
evaluatorsthe
ingelvac®mycoflex®
thoro®vax
9588
timelybirth
9703
9230
6897
9449
9716
9301
noncombined
portugalbovine
alentejo
divisional
6463400
882930
273324
22332
markerssurgical
cd3cd4cd8
nonadhesion
practitionersbackground
deaminaseendothelial
nonpoisonous
5flucytosine
5fc
spio
cd5fc
anticarcinoma
companied
eme
individualscagocel
biosource
cagocel
mhct
antibodystreptococcal
antigensuperantigens
sags
spec
specd203a
scfv5t4
specbased
ttss
n1100
highvaccine
pallavapuram
vaccinationresearch
vaccinationevidence
patientshivaids
gp41targeting
infectionsdendritic
h1n1pdmspecific
ferretsobjective
asouth
dakota62007
sd07
strainmediated
sqstandardized
nct01889875
1–3
tularaemia
reviewantibiotic
tetracyclines
suppurated
axenic
glycylcycline
ketolides
telithromycin
cethromycin
gatifloxacin
trovafloxacin
grepafloxacin
scripted
automates
cvx
9916
500906
1695
fcεrimediated
venomnonspecific
hymenopteravenom
antifcεri
vitspecific
nonvit
vitnonspecific
mixedcell
microtransplantation
toxoidpulsed
growthbackground
arteriogenesis
ttmo
25×106
ttimmunized
ligatedunligated
pi049±009
056±007
082±008
arteriogenic
cd4antibody
pi050±008
outcomeviral
vris
inflammationirritable
ibslike
recoveryrecurrence
ibspatients
dinitrobenzenesulfonicacid
dnbschallenge
sice
dnbstreated
gutfunction
minireviewthe
neuropil
congophilic
taurelated
±131
jordanimmunization
947868
knowledgeattitude
developmentadoptive
cellgrowth
nascn
supermarkets
programsobjective
sclerosisnatalizumab
natalizumabs
natalizumabnaive
131itositumomabradioimmunotherapy
quadromabased
cxcr5cd3
costimulationindependent
ivigmediated
actor
antifcγriii
itami
fcγriiiassociated
inhibisome
blockmultifocal
gm1specific
fatemiyeh
275±6
mofetila
mpainduced
glucuronide
pmncs
323mgl
573ngml
auec
pmnc
anemiabloodstream
6332
9335
transplantationother
ltincluded
clobetasol
nystatin
momrs
14patients
timedonor
informatively
censors
fludarabineintravenous
longitudinalsurvival
diseaserabbit
and28
ch1418chohumanmouse
mirick
antiantiidiotype
lode
15μgml
withinassay
qcs
11μgml
2μgml
ch1418chomediated
168h
adhbv
adenospecific
hbvfree
antiad5
polymerasespecific
hbvtolerant
zooepidemicus
sez
coinfectionto
szp
rspvics
bama
szpspecific
cochallenged
wtspv
pcv2sez
diseasesvaccinepreventable
hcptopatient
influenzawe
ahkotar622010
aequineotar7642007
н3n8
pb2
pb1
kong16816235ca
eid50animal
aequineotar76407
aequinesydney2888807
flowchart
youngsters
protectbackground
5900110000
30005100
20005300
760950
nct00324623
postreinfusion
pd1cd160tim3lag32b4
conformally
microcolumn
receptorcarexpressing
targetantigenspecific
cd137cd3
overviewdrug
exanthems
dualfunction
pim3silencing
effectstumorigenesis
protooncogenes
pim3
pim
phosphorylating
bh3only
tlr7stimulating
ssrna
apoptosisrelated
ssrnashrna
resourcesthe
bangbang
timevariant
perspectivesneuroinflammation
ritnetworkobjective
ritnetwork
eighthline
therapiesimpulse
modelrespiratory
sevrsv
sevbased
passivelytransferred
ci019
entitlement
departmentunlabelled
marseilles
semidirective
680851
hospitalwide
34359
wellfitted
r2089
villagers
membershipbenefits
pigsporcine
highconsequence
vr2332
ks0672109
ks06
routesunlabelled
dnapriming
dnaprimed
multipleroute
25841
23416
rhinosinusitisbackground
crsspecific
farinaespecific
chemosensory
anosmic
microsmic
phenyl
9419963
55666
7447
9043
trialspeanut
3844
60124581
0031020
reviewbrentuximab
morbidly
igechallenging
kco
lcchimerism
langerinstaining
lcengraftment
donorlcs
conversionkinetics
nonsensitization
nondeathrelated
nonretransplant
ratio578
1372444
tatanus
59852
rupee
benifit
heymann
spions
magnetofection
magnetite
fe3o4
fe3o4based
magnetization
emug
koe
remanence
trisodium
buffering
deliverydna
monodispersity
anisotropicity
dendrimerlike
tattooingdna
porte
dentrée
electroporationdna
majorly
antibioticresistance
rnaout
kanamycinresistant
ntc868
kanamycin
poxviralbased
poxviral
mucosalsystemic
tetramerhoming
cpginduced
embryoresorption
cpg1826injection
caseidisplayed
cta1conjugated
pgsacta1sm2l
pgsasm2l
a1
cta1
mld50
aemkoreaw14906h5n1
rico834h1n1
aaquatic
koreaw812005h5n2
birdkoreaw442005h7n3
achickenkorea1162004h9n2
pgsal
356440
432572
91106
96114
polypeptideexpanded
cgmpcompliant
immunogenicityvaccines
microneedleswith
adjuvantshave
skinmediated
110mpa
nanopatchimmunized
chemicalbased
womenassessing
olderlargescale
studyrelated
260700
48982
0972
09640980
advertorials
advertorial
10261035
0953
09510955
05760599
moleculedirected
stat6cd4tgfβriidn
pdca1
dcdeficient
antipdca1treated
pdcdepleted
schizophreniathe
tryptophankynurenine
kynaan
antagonistin
antipsychotics
type1type2
pancreatitisalcohol
gallstones
cyclone
tomas
2010after
postdisaster
junedecember
64015
cycloneaffected
013041
014041
040086
toxicityconditioning
ebmtapplication
bmautosct
pbautosct
wmda
eccoeuropean
aacrncieortc
2013s
preventionobjective
parainflammation
interventionspregnant
patientsboth
chemoregimen
abstain
dr0401
grasspollenallergic
apclabelled
dr0401phleum
pelabelled
dr0401pooideae
dr0401restricted
poa
97116
221240
199218
allergyegg
ajuga
bracteosa
effectsajuga
neuro
ethanolic
abee
immunophenotying
immunizationswhile
photoimmunotherapya
mabir700induced
5275
4116
176184
369378
unskilled
267277
167177
162176
micetransgenesis
pharmacoresistant
godespite
antiseizure
interest1
stigmata
ivmp
dindex
cdindex
d21index
troutthe
enterobacteria
biotype
aquavac
anally
cη
pkcη
pkcηdeficient
phosphoproteomic
ctla4pkcη
git2αpixpak
islocalized
hpvdb
vaccinologyhighrisk
kbbuilder
webaccessible
knowledgebase
catalogs
uniprotkb
epitopehla
httpcvcdfciharvardeduhpv
allotype
trialanalgesic
2030minute
redmond
takehome
areaobjective
2124high
2011to
204years
3injections
0728
06810779
10061742
24279
541710882
68776
34511137061
10011120
1637
11982237
4381
29786445
protocolclopidogrel
nonpruritic
dehydrogenaseplasmodial
plasmodial
pldh
dkewn
pfldh
10c4d5
10d3g2
98109
agftkapgksdkewnr
10a5h5
kaff
gossypol
childrenrotavirus
themthe
prophylaxisdevelopment
controlgvl
toxicitygvhd
laips
wiping
immunoglobulinmultifocal
patientsgastric
baumanniiassociated
micemultidrugresistant
lac4
applicationakin
unreinforced
060097
068123
054100
tumorsmast
intern
cook
ilincreasing
ccdph
tripcom
mrcs
therapyadministering
avenuecombining
outputbackground
sortingranking
studyabroad
z2088
h1130
importancebenefits
z2326
h51134
z2230
z2582
h1688
z2200
χ²141
j47835
z2142
j6496
z2724
j4805
z2067
perceptive
modellingthis
2623
2179
2178
cd3zeta
ha14117
177lumab
radioimmunotherapyinduced
br96binding
antiγh2ax
caspase3dependent
spectrophotometry
freeradical
hsp70chaperone
antic6
technologiesseasonal
drifts
toleragenic
prrago
ismab
prragos
ismabs
b16melanomabearing
xcv
в7015
в16
с57bl6
immunogenecity
anticd3conditioned
hosttype
episodes1000
bacteremias
virusviruslike
transfusionsbackground
casereferent
17750
034091
neuroinflammationdendritic
bergheiinfected
pbx
pbxmodulated
pbxtreated
neuroantigens
septicum
bacterintoxoid
dermatitisclostridial
pefringens
6wkold
radh5haegfp
aswinefujian12001
swfj101
achickenhunan772005
ckhun7705
standardtiter
316408
326337
registrationnct00168558
inflammationoverwhelming
il10deficient
cpgoligonucleotides
miceurease
antigendelivering
antiurease
measlesbackground
moderateseven
069based
044two
globulinno
twoit
identifiedpassive
determineddue
effectivenessthe
eventsfuture
immunotherapiessurgical
metastasizing
fertilisationembryo
ivfeta
dichorionic
diamniotic
liquor
placentae
ambisome
ivfembryo
progenitorsthis
cdps
ckitlo
cd115
flt3lencoding
cd452
sbiv
goalsobjectives
iiisecreted
ssei
flagellar
materializing
radioimmunotherapyradioresistant
academicians
gesu
woods
reactiontype
nonadoption
deficiencysecondary
ilpilimumab
uncheck
targetedtherapy
mapktargeted
forever
ethanolkilled
spy1the
ethanolinactivated
aerdaspirin
lipoxygenase
dosecontinuation
immunoglobulinsa
immunopurified
antifcγiii
antifcγii
rosette
pointers
selfmotifs
reframing
refusalalthough
humanists
rhetoricians
pegasparaginase
factorinfusing
aam
kidneyan
factor1dependent
specifity
attritutable
interleukin27
hpca
proangiogenesisrelated
flt1
1cyclooxygenase1
ptgs1cox1
antiangiogenesisrelated
timp3
du145
il27s
antipca
lawobjective
prescribes
exemptionlevel
highpbe
lowpbe
elitein
elites
9480
middleclasses
3521091
145434
138435
69222
nct01203319
aunts
painneedles
marescurrent
matinginduced
endometritis
oxytocin
mscstreated
acstreated
bonederived
fieldtwo
ballum
hebdomadis
vaccineii
gmmat
nanobubbles
apropos
13071701
immunotherapeuticsonce
19939
1617yearold
cd4cd45rb
antigeninexperienced
osteogenicadipogenic
tcelltransferred
hpdlscs
cd4cd45rblow
cementum
mandibles
histomorphometric
hpdlsc
complementspecific
boosterthe
eliminationreduction
micemicroglia
m1associated
microgliatreated
injuryhyperbaric
hbo
factorκ
ir3d
ir5d
hbopc
hbopc3d
hbopc5d
pedicled
9x6
clamped
elderlythis
viruspreviously
phue16
ch13
phue16scfvch13
phue16scfv
nglycan
nglycoforms
hue16
cd32a
lizard
dnalive
livelive
cpacpb
ppsp15
modelvascular
cigb247v
carrierfusion
stinghymenoptera
natrium
microg
6083
batmn
olympicswe
directfed
hides
cattleto
typeiii
lactobacillusacidophilusbased
dfm
n864
cfuanimalday
freudenreichii
as1
as2
enumerable
laserengineered
polymethyl
ethermaleic
micromoulding
reducedrisk
reviewparticipant
9998
ci11916
milkcows
glycanmasked
hemagglutiinin
g83
g127
g138
g83g127
g127g138
g83g138
g83g127g138
haexpressing
hainhibition
bindings
refocusing
h5ha
cr6261
toleranceparkinson
celligg
retrovirusk
antihervkdirected
interalia
mvahkcon
betagalactosidase
rlz
rlzhkgag
syngenic
modalitiesbackground
ordu
samsun
sinop
amasya
çorum
beekeeping
eyelids
yogurt
postmastectomy
00382
300311
cellstcell
icars
gochimeric
herculean
compositionthe
receptoractivated
cd28z
carscd19targeted
tbodiescar
nickname
tbody
vα
transfectants
tbodies
cellengaging
therapieschimeric
nonphysiologic
trialscd19
dtudads
200111
costlier
cancerglobally
stratrgy
miroenvironment
candidatesas
cpra80
solumedrol
mixedmodel
500010000
pretransplantsensitized
deuteron
177glu
radioimmunotherapydeuteroninduced
nocarrieradded
nca
stackedfoil
yb
energies
ed1818mev
¹yb
¹ybdp¹yb
eob
177mlu
cyclotron
foxp3iresmrfp
oesophagus
increasedintensity
mg·m²·d¹×5
mgkg×2
mg·kg¹·d¹×2
mg·kg¹·d¹×5
strpcr
051405
es62
arthritisparasitic
wormderived
rapidonset
antic5ar
modelpreclinical
antimc5ar
antimc5artreated
dosesetting
eiaigm
eiaigg
btnl2
populationno
butyrophilinlike
rs3763316
rs3763311
rs9268494
rs3806156
rs2076530
or120
p200e07
p290e06
or141
rs9268501
rs3763313
or081
gtatcag
gtatc
or475
gcatc
p100e04
conditioningdespite
cancerinvasive
eortcmsg
6884
zygomycetes
patienttracking
3298
hypervascular
posttil
netcost
nz18800qaly
us9700qaly
oecds
us6900
33700
us33000qaly
us117000qaly
56000
hivpolyepitope
influenzahiv1
wsnckg
pclus3p18
vpe16
versifel®
merial
monograph
0120081321feline
commercialstrength
t01
versifel
t02
purevax
t03
61e
vaccineeffectiveness
9483
9337
9597
9882
9796
9931
9321
choquet
integralan
ethicalsocial
mcdm
macbeth
subcriteria
immunityregenerative
gucy2cobjective
adenoviralmediated
ad5gucy2c
ct26gucy2c
rtit
outcomesradiation
3732
caract
transplantationrecently
preschoolseven
furnish
eua
infusionthe
335±502
167±298
lunchtime
lowvaccine
dissentdissenters
complaintscensorship
campaigner
endometria
pharmaciesretail
tak700
epi001
downregulators
sards
azd3514
tok001galeterone
antiangiogentic
aflibercept
lenalinomide
endothelin
atrasentan
zibotentan
dn101
tg4040
α2a
pegifnαrbv
thefollowing
cevr
antimva
pegifnαassociated
drb0104
nct01055821
viia
rfviia
extubation
n255
calvaria
csds
mmdiameter
csd
clot
ddexamethasone
abdexamethasone
llltdexamethasone
histometric
nba
workershealthcare
sforl
originobjective
evolutive
usain
988298
172289
1160587
8085
pediatriccare
privatecare
fb3atg2
2yearnrm
nonrussian
54212
205549
futurerabies
economize
recommendationsover
formalise
alloantigenexposed
1462
drb109
drb107
drb115
intrathymically
retrotransposable
replicationthe
ere
ervk
element1
line1
hiv1infection
erevaccinated
erespecific
anamnestically
trim5α
eres
83000qualityadjusted
36dose
sm103
microexon
meg4
flatworm
antischistosome
lungstage
schistosomula
rsm103
th1th2type
329436
100140
conditioningin
20000μl
15164
b2immune
cordbloodderived
secondparty
4352
gcm2
telaprevir
orthotopical
1infected
interferonalfa2a
chromatographyelectrosprayionizationtandem
automatized
chainreaction
tw
19804430
2520
18708730
18703140
nonolt
worldthe
dad5gne
vaccinecocaine
e1e3
weightadjusted
dad5gnevaccinated
cocainesensitive
regimensunlabelled
armstrong
cl13
tanglesrecent
intracerebroventricularly
monthsn
rescheduled
176609
1491075
123115
105536
0002041
immunityil21
il21engineered
ril21
cd25high
il21based
omas
137180
11014
07096
situntreated
sittreated
th17th1th2il10
mrnaprotein
actrn12613000445774
vitroimmunotherapies
germinalcenterlike
igb
fais
aprildecember
126000
kenyasomalia
singlemixed
dsanegative
xuanhan
chictrtrc13003960
inuit
approachrabies
55th
hudson
ungava
tchmpaolabelled
tcellsdc
antigenpulseddcs
nanoparticleslabelled
bsmab
scintigrams
111inimp288
75mg
111in177luimp288
ρ094
74gbq
05gy
00026±0028mgymbq
ρ058
dtpamodified
ddoxpga
tc99
dtpasuccinylpolylysine
dspl
bt20
antiher2affibodyantidtpafab
baac
antidtpafab
mdspl
baactargeted
affibodyantidtpafab
papillomavirusprophylactic
capsidbased
downregulatory
app23
agonistpassive
predepositing
aβpp
rxr
t0901317
abca1
lipidation
microdialysis
dtregfp
postdt
dttreated
dtmediated
survivalnonhodgkin
autohcts
immunityfollowing
r01
casedetection
immunosignatures
feocdsezns
fe3o4cdsezns
aqueousorganic
hydrophobichydrophobic
mnclipid
patientsmicrornas
vlbw
20002200
hbsaghbeag
cryptosporidiumcryptosporidium
insurees
317234
77350
7364
1642126
004065
1031111
1149131
vaccineprotection
201002253810
pertussishbvinactivated
poliovirushemophilus
kinder
statesgeographic
n11236
apr086
075097
apr083
074093
adolescentsroutine
immunizationsoptimal
newgenerations
cooked
23810152
foxp3background
epicutaneousigemediated
patientst
immunodepressant
il22producing
polarizations
enhancedpotency
reemerges
clinicianled
hlaa21
10245
7263
37354436
4681
43225070
5206
48125633
20092010studies
ochd
nys
reported64
7736
463000
34392
collagenreactive
1618fold
57fold
cd45rocd62l
тcell
vaccinatedphysicians
virusesfrequent
myelomarapid
reconstitutionparticularly
cellsafter
100ul
200ul
dosingbackground
srits
nonvenom
noncluster
postparameter
postpd
preparameter
prepd
52833
srit
nonred
non11
089099
completionobjective
p0881
or115
101131
or251
129490
or345
120992
pvaccination
notatrisk
or178
95127248
or203
95142292
riskefficacy
pvaccine
or281
95198399
vacciniahcv
conundrumhepatitis
vachcv
2×107pfumouse
bexpressing
hcvns4
intricately
n286
11354111
usobjective
n51471
131153
985157
155272
148166
118189
applicationscarbon
cntbased
hpst
21july
2009assigns
2004is
2013using
293responding
dossier
pharmaceutique
perspectivesthis
cp7e2giflive
cp7e2gif
riemser
anticsfv
csfve2
antierns
felines
wellingtondufferinguelph
departmentthe
darkpigmented
chromoblastomycosis
mycetoma
ochroconis
phoma
wangiella
aureobasidium
chaetomium
coniothyrium
nonsporulating
debrided
nct00449670
aindonesia
as03ah5n1
recipientsbelatacept
inclass
99variability
cellsvaccination
murineinduced
cms4
cms4inoculated
dcivp
tomatolectin
ivpimmunized
vascularrich
bnl
dcivpimmunized
dcivpvaccinated
dcipsvaccinated
vasculatureassociated
flk1
1990sthe
wholebacterialcell
coqueluche
recipientcase
scaly
genodermatosis
divideobjective
tbinfected
tbprotein
autoantigento
autoags
cfai
autoagspecific
fimbriaespecific
autoag
160u
320u
640u
nct01734408
foldable
toxinderived
proteinstargeting
6aβ15
aβmediated
dependentpreviously
hky
b6129s2igh6
tm1cgnj
10af
tallied
hkyvaccinated
hkyinduced
rldccys1
mongrel
onychogryphosis
rldccys1treated
laboratoryacquired
datawhile
nonbraftargeted
brafspecific
decentralizing
regionalization
immunisationsbackground
subaudits
3943
4148
series958
autonomybackground
healthworldwide
vaccinationsvaccination
survelliance
335399
10444
54656
53910
30699ngml
sexmismatch
meningitisa
chadobjective
temperaturein
chainat
systemassuming
safetycould
379854
coatings
pediatricbased
pediatriclike
roledefining
workersunited
seasonduring
exposurecontrol
28710
estate
leasing
homemakers
perspectivesmore
ivigpp
nondeletional
citrullinemia
airportfour
selfpreparation
coverbackground
macroglobulin
800μgmouse
infectioncure
parasitaemia
giemsastained
klrg1high
cd27low
cd62llow
transplantationhighdose
inasmuch
protex
fastdc
standarddc
antigencytokinepulsed
antigensex
mhcrestricting
pivac13
arterialised
iliolumbar
isogeneic
antimhc
arterialized
specialistsbackground
n648
neo102
muc5ac
ganetespib
selfimmunization
threehour
firstresponder
aiombackground
winterspring
graftvstumor
managementkidney
combinationdose
taccsa
checkedup
amplificationthe
its1
its2
microceras
euroglyphus
maynei
astigmata
pyroglyphidae
glycyphagus
glycyphagidae
tyrophagus
fanetzhangorum
putrescentiae
longior
neiswanderi
acarus
farris
siro
acaridae
echymopodidae
hpaii
rsai
reamplification
trimodal
melanomaadvanced
k562mb1541bblexpanded
aktpi3
dtp3pentavalent3
dtp3penta3
improvementfour
driversthat
assaytargeting
yychxa″dtpac225
y90c225
scp
scd50
c225
chxadtpac225
dtpac225
yychxadtpa
y90dtpa
spheroidassociated
antibodyfree
y90c225egfr
makingbackground
metaphorically
riot
metaphor
reportbcg
7099
haematogenous
caseosus
videothoracoscopy
sarkosyl
phftau
studyactive
phosphopeptides
alumadjuvant
antiphftau
gallyaspositive
sarkosylinsoluble
punchedout
nedd4mediated
dnavaccination
ptap
ppxy
ypxl
tsg101
nedd4
aip1alix
nedd4like
shivsf162p3infection
hxb2
ca2calmodulinregulated
antip24
onkopedic
ögho
sgh
ssh
gpoh
tempora
mutantur
damagecentered
125ilabelled
125imabs
gammah2ax
antiher1
alkalilabile
micronuclei
doserates
acirrecorded
fluvax®
panvax®
deliverythis
reconvene
lapsed
25uml
methylomic
humanmethylation
beadchips
posttranscriptomics
poorresponders
rnf39
sulf2
bxsb
micehighmobility
antihmgb1
hmgb1mab
gochronic
sensory–motor
sumner
cisp
animalsmost
esbmp
tumorresistant
mhcb10d2
31pnmr
1hnmr
microimaging
ascoli
piceno
gvc
statesto
laiv3s
iiv3laiv3
30251
3512
4812
quadrivalenttm
90301qaly
campaignfailure
sf8
4585
082089
074082
072082
handwash
065075
071080
066076
2012hv0018
analysisbabies
msn
webmaster
proteinopathiesactive
proteinopathies
19922006this
irradiationantithymocyte
sublingualimmunotherapypatient
telecommunication
effectivesubcutaneous
riskmitigating
assessmentassessment
multiplepeptide
peptidescell
cdca1
cdh3
kinesin
kif20awere
threepeptide
uminctr000003229
ppsvs
ppsv23pcv13
pcv13pcv13
nct00574548
α4integrins
subsetsbackground
α4β1
α4integrin
opportunitiesvaccines
infectionshelminth
expel
tcs12035×pollen
amyloidßdirected
amyloidß
aß
aßdirected
darier
centrifugumobjective
ofinnate
centrifugum
immunovac
ofcytokines
catlag
facscalibur
becton
dickinson
ofinitially
ofcd25
cd72
ofcytokine
oftlr3
ofintracellular
prophylaxisanalysis
premorbidity
paralyze
antimicroenvironment
seedsneurodegenerative
pathologythe
endosomallysosomal
tauantibody
amyloids
hivis03
withinsubjects
χ2872
χ22672
χ2606
χ249
cohabitant
χ2445
cd4cd25cd127lo
triamcinolone
028°c
mmwk
3579896
wz
zhoushan
zs
solutionanticancer
borderbackground
nonborder
arizonas
children15
surveyalthough
nonutilization
3758
n2435
aor147
110197
aor135
109166
107166
aor174
112270
aor139
114169
euglycaemic
commend
furunculosisthe
00101
nanovector
vaccinesαgalactosylceramide
preclinics
surveyunlabelled
hcp87
20072012vaccine
depolarizes
programsconnecticut
seasonpreschoolaged
eip
immunotherapypreexisting
ndvmediated
ebvctlskg
fibermodified
cellscd40
adcd40l
coxsackieadenovirus
doublemodified
ad5ptdf35mcd40l
ad5mcd40l
ad5ptdf35cd40l
beliefbased
decisionsduring
dempstershafer
cellstumourinduced
s100a89
usersatisfaction
guatemalabackground
guatemalas
rr149
aged39
rr131
rr172
rr168
recordsthe
anticolorectal
cellsmany
amldirected
cd123dim
cart123based
virusvaccinia
vacv
vacvs
crosstargeting
bystandertargeted
saai
cultureexpanded
ucmscs
mgm2·dcyclosphamide
mgm2·dantihuman
93×108kg
45×106kg
anticd137saporin
immunotoxindepletion
allodepletion
treatmentspancreatic
studyusing
smarting
dyspareunia
vaccinationyellow
policymathematical
antiinterleukin10r1
immunityeffective
antiil10r1
mb49luc
s12
agentsradioimmunotherapy
αβimportins
p27kip1
matterswhile
monthspecific
survey3
nonmonthspecific
contacttracing
policymaker
fdt
ndvfdt
intransal
fdts
engraftmenttotal
posttliatg
0515
2wave
thrombospondin1recent
th1directed
stanched
painmanagement
myelofibrosiswe
xxx
myclofibrosis
mf3
mf2
mf01
mf23
subolesinakirin
pathogensdiseases
akirin
akr
tickprotective
subakr
moulting
amarginale
bigemina
ufmg1
acentrale
ufmg1infected
gonen
mildest
coveragenational
plateauing
messagingobjective
fearbased
commercials
familyindividualfocused
leukaemiatransplantation
toxicityreduced
asthmado
preventionwhat
reagin
19841985
15025953
3402
109110614
allnegative
0486
sclerosistumour
tnfr1specific
il12for
il12side
baselinebackground
alia
vpb
oda
disbursed
multilateral
00085
us761
us288
rata
immunizationneurogenesis
subgranular
bromodeoxyuridinepositive
intentionsthe
powerlessness
disillusionment
anticonspiracy
angloamerican
missionaries
jesuits
priests
xenophobic
officialdom
populace
17801874
morrison
17821834
twicevaccinated
rhbaff
disordersxlinked
xlp
il2inducible
itk
mcvhepb1
hepb1
9322
9642
9163
9016
9270
50111464372
52011464538
51111464459
67911465925
osseo
gitmothis
gitmo
researcheurocord
effectivenessobjective
specifying
noncomparable
rtpcrpositive
renaming
ovalbuminmaternal
matabs
preconceptional
nili
62343
11‰
57‰
094099
morethan
adetailed
vaccinegroup
quit
memos
tinkered
gaziantep
medicinebackground
facilitiesbackground
inﬂuenza
3529
rewarded
kittensvaccines
unitàoperative
maternoinfantilis
uomis
uomi
murphy
roths
nanoparticledelivered
microenvironmentachievement
lipidcalciumphosphate
lcp
liposomeprotaminehyaluronic
lph
vaccinationone
supposes
negotiate
positionings
malignanciesofftarget
epitopespreading
immunoconjugatesmonoclonal
vsvglvs
100undefined
4768
101170
strategiesstreptococcus
admissiondischarge
72372
16541
1133100000
responsibles
cancerinterleukin
expandsstimulates
raavmediated
raavil2
plantibody
challengerecent
cpb10
studiesthis
frequencymatched
readmissiona
immunityrespiratory
δftriadj
δf
triadj
f8593specific
δftriadjpolyic
δftriadjcpgimmunized
δftriadjcpg
yearssix
3689
799920
819940
vaccinestreptococcus
nonbacteriemic
nonipds
systemauthors
organizationdata
otherunknown
vetvisiting
survivalt
antiil7r
anticd8mediated
echinocandins
f41mucosal
abducens
8dayold
1824year
lv12
elisatransduction
dcag
dclv12ag
thiazolyltetrazolium
ehiss
7061
6622
niiss
homesubcutaneous
sclg
brompton
harefield
infectionsrestoration
p2a
nonnative
betap2aalpha
alphap2abeta
barriersresearch
cd4ccr7
lymphotropic
recommendationshematopoietic
northernmost
epinephrinetreated
240351
reactionbackground
6step
oxs
oxaliplatinsensitive
gastrointestinalrelated
2746
platin
childrenadvances
conditionsoral
faunistichunting
umbria
gutting
333351
rushmodified
mattersallergy
24229817
misrepresent
moderategrade
macrolidesensitive
1431011
097099
canadianpaediatricsurveillanceprogram
024096
039089
036086
019090
novascotia
012078
3601072
187625
112255
cliniciansublingual
neosensitization
suppressivetolerogenic
retesting
reversibilitysuppression
alpine
cattlespecific
ryde
fleckvieh
drugreleasing
devicebased
selectsynch
16wk
9mm
78d
6092d
30wk
reinseminated
anestrus
clofarabineassociated
transplantabstract
clofarabinemelphalanalemtuzumab
renaladjustment
farrowtoweaning
acclimitization
kentuckyhpv
sfgmtcautologous
n396
2671
oswere
587–686
753–834
0–136
12–34
hr23
12–45
hr17
11–31
hr05
03–08
03–09
diseaseas
mtnf
200612financing
us12
200612
pellets
walbauma
alginateplasmid
pcdnavp2
ifn1
78859
antiipnv
rvvaccines
rvcases
rvincidences
rvvaccine
costassessment
shiperspective
rvcase
2457
116973
2622
142732
206000242000
445482
rvvaccination
deformable
intratranscutaneous
transfersome®
50×ld50
intratranscutaneously
specificil10
10×10601ml
ascinfused
cminfused
beninbackground
banikoara
147207
vvm
catsantibody
cd4cd8low
fivantibody
fivuninfected
chronicactive
coveted
ecdi
clusterbased
60895
kirundo
689738
2005in
langdtregfp
micesplenic
dtbased
cbajxbalbc
ril
µgmouse
vaults
reabsorbed
mated
transvaginal
ril17
81370013
81000277
81300533
zr2013hq002
neurointerventionalistaspirin
neurointerventional
neurointervention
neurointerventionalist
milieuunlabelled
vacvinduced
vacvboosted
myd88mediated
primevacv
applicationsunlabelled
pseudotyped
vsvova
vsvgpova
atherosclerosisautoimmune
rgroel
apoeshl
rgroelspecific
gingivalisaccelerated
coral
domesticusthe
antisnake
lowyielding
undemanding
distilled
waterdiluted
plcpip2
camppka
cd4cd25nrp1treg
shamirradiation
xirradiation
pleurisythe
apxia
apxiiia
n581
porcilisapp
gpigday
nva193
va79
nvb179
vb07
nva424
va212
nvb467
vb190
nva632±157
va647±91
p0162
nvb660±115
vb670±82
nva57
va18
nvb23
vb10
p0170
nva1504±141
va1495±067
nvb2168±243
vb1699±062
therapytype
levothyroxin
antiglutamic
postprandial
conductionbackground
smn
greenwoods
615708
481581
305415
0749
1692
26177
55592
epidermoid
nirvs
nagasaki
rvnegative
nirvpositive
chorionderived
chorion
angiogenicimmunosuppressive
immunotherapyfemale
childrenpneumococcal
11valent
bohol
interpolation
brh
kilometer
b923
iag7
insuliniag7
iag7presented
mab287
iag7b1023
insulinspecific
peptidemhcspecific
newscontraindications
renovate
pathogenesiswhether
progestins
medroxyprogesterone
norethisterone
enanthate
neten
glucocorticoidlike
represses
illnessobjective
strategiesalzheimer
rollercoaster
arthritisnovel
12allele
1dpmm49pts
2dpmm28pts
114306
syndromeiv
16±2
55±4
58±7
20±5
78±2
sctlung
parentsvaccination
hsi
hsiv
nagelkerke
overviewmast
ehrlichs
kitamuras
immunotherapyallogeneic
nonallogeneic
plasmain
immuglobulin
oroesophageal
fluorine18deoxyglucosepositron
transplantationwhether
fluorine18deoxyglucose
fdgpetpositive
fdgpetnegative
autologousstem
nmaallosct
166ho
radiolabelbackground
emax15
mev
a2058
mnt1
166ho6d2
188re6d2
166holabeled
cellsantigen
immtacdriven
melanomacell
gp100peptidehla
visualised
glucose6phosphate
n30882
recordlinked
n14966
n14164
19962004
79696523
61160
mid2009
argentinain
conain
remediesparents
exemptor
recordsa
formhomebased
bcode
cisid
yearspecific
agedistributions
eurostat
logarithmtransformed
dalys100000
chickensligands
specificpathogen
rb1b
noncpg
mdinfected
hive
125210
104150
025059
042079
228759
100127
cyclophosphamiderecently
latebackground
n22900
n15049
708764
culturallycompetent
turkeyfootandmouth
sindh08
ve69
5081
ve63
2981
venuerecruited
snapbased
adaptivechoice
snap
9396
selfvaccinate
factorbased
rfbiap
midrange
240daly
6642128daly
viruscp7e2alf
pathogenyrelated
7165
halfmatched
09348
lymphopeniainducing
ium²
68fold
iodine131tositumomab
rituximabexposed
inhl
tsti131tst
cyclosporinea
agetovaccinate
weals
imatinibsupplemented
tumorfighting
cellsdisseminated
14013
theragnostic
¹²i8h9
cedinfused
124i8h9
micropet
gadoliniumalbumin
gymci
cc3
trialsimmunotherapeutic
peptidesaffitopes®
aff
caudoputamen
nct00659789
5·71
13·01
1·59
71800
p0·025
19550
51000
p0·041
viralload
hivcure
globvac
bionor
interleukins15
populationsan
calvesfasciola
gldh
wiwanitkit
immunotherapyexperimental
cumulate
geert
bultynck
haiech
claus
heizmann
joachim
moreau
ontariopertussis
numberneededtotreat
nnv1pm
1pf
pmpf
5006400
1200063000
11128
500060000
55000297000
25302
pertussiscough
mhcidentical
pilotscale
transmissiona
ixodid
diseasesmathematical
vaccinescare
prevaccinescare
prescare
cutaneously
melanomatopical
metastastatic
lipl32
hamstersthe
kito
lipl32induced
toddlersinvasive
genomicsbased
noninterference
il4il10tgfβ
phenotypemonocytes
copolarization
il4il10tgfβstimulated
lpsifnγactivated
predifferentiation
sarcomatoid
hengs
123485
104165
needlesticks
immunotherapyvγ9vδ2
destructed
nonpeptitde
magea3polyiclc
myelomadirected
vaccinedirected
nct01245673
gl0817
anticd3anticd28costimulated
dextramer
54100
polyiclcgmcsfprimed
processnumerous
twistspecific
travelersvaccinations
nphs2
r229q
therapysteroidresistant
srns
hardyweinberg
133743
one5
condylomaobjective
doselevel
n1045165
irds
20383
015022
020049
ird
305464
346454
437482
tacksepsis
cylex
depletingantiil2
4224
wk1
mos1
r20264
borderlineclinical
transplantationdesensitization
detente
autoregulatory
recollective
therapyones
efficacyactive
antiheroin
scip
heroininduced
1013fold
moleculeprotein
5396
whoprequalification
satyabadi
puri
jure
censused
workersvolunteers
31552
23751
us185dose
conditionsthere
internationallyavailable
bsubunit
wcrbs
rflaaova
tlr5dependent
mdcconjugated
flaaova
microsomal
dcactivation
ovatransgenic
ipapplication
rova
rflaaovamediated
multitask
agonistcpg
ifninducing
ktype
immunotherapypeptide
allergenexperienced
aai
traceable
ovalbuminexperienced
427651
702903
791878
645758
510660
parentsmany
breedsimmunological
lulai
crlps
extractedfrom
syndromesa
casesmeningococcus
hi1n1
epidemia
papiloma
myelon
neuromyelitic
nmospectrum
nmolike
specialisations
forceps
stitch
sutures
vaccineiscomatrix
immunomodulate
dp6001
catsfeline
felidae
fcov
pbfipvdf2
pbfipvdf2r3i
orf3abc
fip
dengueas
coveragehere
newcoming
francein
unchangeable
mpdl3280
anxiously
literaturevaccines
2005classical
rhinelandpalatinate
eifel
westerwald
pfalz
antibodiesgenebased
proteinspeptides
incell
fieldsvaccination
immunizationdna
malignancieshlahaploidentical
7270
7132
p0224
p0103
threecolor
recommendationsimmunization
vrc07
treatmentcytokineinduced
p0289
lymphocytesadhesion
therapyour
ce7specific
ce7r
magea36
a36
magea36expressing
receptorphotoimmunotherapy
3dculture
2dculture
3dspheroid
slowrelease
cancerslowrelease
whenallogeneic
vaccinesimmunotherapeutic
adjuvantladen
ltis
adspecific
rapidlygrowing
controlcase
reporttreating
transplantrequired
mgwk
temsirolimusbased
avoidanceminimization
132526
mlmt
acalifornia2009
virusesmany
fluresistant
immunityschools
assortative
vcusm21p
vaccinecholera
ctxa
rtxac
zot
disassemble
hep2
universiti
sains
1×10¹
1×10²1×10
removable
tie
ritard
lymphocytesobjective
taiwanthe
kung
27650
chinavaccination
drugintolerable
mgkgfludarabine
colonystimulation
bloodgpb
gpb
40499×108kg
031643×106kg
551747
opportunitieshealthcare
outbeaks
virusesbackground
mankinds
adtk
adflt3ladtktmz
vaccinationworldwide
cd19derived
27specific
deliverywe
speedstirring
calciumenriched
proteinenzyme
invertase
pmpentrapped
uncrosslinked
pmpsentrapped
adjuvantemulsified
pmpentrapment
adultsmeningococcal
menacwydt
sheepprenatal
singletons
nonpolysaccharide
2014vaccines
2014each
2012vaccinations
immunizationuntangling
misinterpretationsin
ntagi
miscalculations
immunotherapeuticsgeneration
reinfections
tanzaniatetanus
niiintamodified
imine
glycopolymers
niiintadg
his6gp160
hunan
11132
adverted
onereminder
twocomprehensive
seasonobjective
selfmatched
5491000
7951000
2881000
aga
khan
qilu
126176
idodc
unknownincomplete
752734
22279hcw
chamberlain
sclerosisdefective
glossopharyngeal
hlacw0602
heterodimerizationmediated
designthe
kadcylatm
antibodytarget
etamediated
adcmediated
her2erbbheterodimers
piggybacking
cd56targeting
modelslorvotuzumab
targetdependent
cd56positive
paclitaxelcarboplatin
carboplatinetoposide
librarybotulinum
bontproducing
bioweapons
antibotulinum
bonta1
sitetoxin
bontainduced
sem120iid5
sem120iiic1
sem120iiic4
phrenic
nervehemidiaphragm
holotoxin
antibodyreceptor
biologicallyrelevant
platformhuman
antibodyribonuclease
immunornases
iggrnases
endocytotic
iggrnase
glyco
proteinfc
antibodywhile
mutagen
fclibraries
emabling®
proteinengineering
cyclesevere
huscfv
rns1
huscfv11huscfv13
huscfv11
huscfv13
switzerlandthe
terrapinn
wellattended
genmab
glenmark
medimmune
merrimack
pierre
fabre
capan1
argx110
blockadeoverexpression
germlined
cd70bearing
cd70dependent
nct01813539
rg7356
studiesrg7356
89zr
89zrrg7356
nonresp
pl45
3313
selfinteraction
spectroscopythe
selfassociation
affinitycapture
acsins
selfassociate
antifc
unpurified
wellcorrelated
crossinteraction
erbb2targeting
saracatinib
erbb2overexpressing
ncin87r
sortasecatalyzed
geloninwe
αher2
clinicallyvalidated
catalysis
sortase
srta
lpetgleh
transpeptidation
monomerized
fabgelonin
chromatographyutilizing
geloninand
unligated
proteotoxins
usechmab7f9
chmab7f9
amphetamine
34methylenedioxynmethylamphetamine
isothermal
calorimetry
methbinding
mabtarget
regenerates
heregulininduced
valencies
her3pi3k
heregulin
egfrher2
antiher2her3
her2her3
antiher3
heregulinmediated
uruguaybackground
pediatricocentro
hospitalario
pereira
rossell
bacterialconfirmed
pcv713
pcap
fcγriiioptimized
cytotoxicityantibodydependent
fcγriiib
nonfucosylated
proteinengineered
fcγriiafcγriiioptimized
pmnmediated
cd34cd19
cd34cd45dimcd19cd10
karyotypes
leukemiamonosomal
commonlyused
kpp
lhws
boycott
foreigncentral
hadith
acceptancelittle
primay
sbhc
spousal
mediatator
hibv
diphtheriatoxoid
allergenpolymeric
nanoaggregate
pjed
polyaminoacidic
polyhydroxyethylaspartamide
phea
butyryl
succinyl
pheac4s
allergencopolymer
parietariainduced
diseasemulticentric
mcd
kshvassociated
challengesimmunosuppression
cancercancertestis
perspectivestype
β‑cells
disordersimmunotherapy
oligomersprotofibrils
microgliadependent
roebelenii
thiothepa
thiotepatreated
675828
494727
coincidenceinfliximab
forwardboth
antiβamyloid
midregion
ad02
diagnosticsfor
tetrahymena
thermophiladevelopment
ciliate
thermophila
mf1
ncimb
10415
infectionswine
zn
znhigh
znlow
h3n2specific
faeciumvac
znhighvac
diseaseusing
uuo
ruuo
obstructionmediated
thlymphocytes
successt
tollgate
alausa
survivinderived
emd640744
inhibitorofapoptosis
survivinvaccineinduced
montanide®
antisurvivin
immunologicdiagnostic
idintentiontotreat
peptidemhcmultimer
vaccineactivated
outcomea
plgananoparticle
responsesox40
antiox40plganp
goalthe
irremediably
gainframe
forgoing
lossframe
or05176
02031322
or05000
01921304
or3934
133111627
or2584
10916122
or3405
14128212
bcgbackground
4dayold
iggc
knowledgebehavior
decisionobjective
girlparent
rs92
p00
rs37
requiredit
a50000
inovo
diseasedevelopment
clone30
rlac30l
rlac30lvp2
syndromesafety
rr077
67100000
32100000
24100000
antidtpain
lipidhapten
dspedtpain
dspepegdtpain
dspe
dspedtpa
dspepegdtpa
dtpain
kd63
05idg
α001
tumourorgan
surgeonsimmunotherapy
nihrwellcome
isrctn62416244
4578
451400
25·5
1·82280
3572
6·3
0·41
mrcnihr
strategiesdifferent
eplike
hyopneumoniaeloads
combinationsinhibitory
inhibitingdeviating
ctla4cd8086
lag3mhcii
pertussisbordetella
mosul
iraqbackground
knowledgepractice
iraqi
respondentsstudy
strokebackground
rhp
swnd4
60minute
7030
percoll
bdfacs
mousewg6v2
uninjured
prestroke
rhptreated
0500
1687
06130000
04860000
0394
065500000000
pregnancyprimary
howeve
aramugakani
prophylaxisin
winnebago
volunteerism
ticls
invasionthere
cytomegalovirusmediated
ghglul128131
liga
copenhagenileptospirosis
copenhageni
rattus
norvegicus
liga713
fiocruz
l1130
ligabased
rodentsplasmodium
malariacausing
pvcspallcspepitopes
termini
adenovirusprotein
nonrepeated
bacteriadendritic
catla
catlathe
challengessince
ppp2r2d
serampore
yearsimmunisation
wholehearted
hemoperfusion
paraquat
studyparaquat
paraquatpoisoned
antigenpeptide
peptideas
preimmature
pidc
p1120
upmodulated
kpna7
igsf6
ncr3
tubal3
nfkbia
proapoptosis
sema6a
igfbp3
srgn
mrps11
rad21
txnrd1
epha1
cyr61
nfkb1a
cattlecattle
transferdespite
unorthodox
conduced
endemics
healthit
omc
oropharyngeally
coit
feedings
modelepidermal
14710tetraazadodecanennnntetraacetic
177ludotapanitumumab
177lupan
177ludotacetuximab
177lucet
umscc22b
paina
kathryn
gedman
erythematosusinfectious
antibodiestherapeutic
transversally
prophylaxistherapy
antitnfalpha
stomatologic
strongiloidiasis
courtordered
issuesfollowing
remissionbcell
bpll
problemunlabelled
559years
738months
31144
confusional
8104weeks
depthcontrolled
microinjectionmediated
hydrofluoric
etching
10°90°
ipvspecific
clogging
tc9
cancersbecause
cytokinepriming
il9skewed
th9polarized
otib16ova
pmel1b16
grzbproducing
tc1like
klrg1low
il7rαhigh
tc9mediated
intussusceptionrecently
observedversusexpected
smrs
15107
12171
agonistprevious
ccr2positive
entireseason
peakseason
difference098
difference133
difference064
difference048
difference013
bedfellows
opticaimmunoglobulin
gbackground
retrobulbar
aqp4deficient
nonnmo
19702012
nmc2ap125
nmb
cc18
37montholds
czr
1430
4815
4076
6967100000
19982006
760892
5552
interval403
261622
180471
131172
109120
macaqueshiv
ceprimed
p55gag
cespecific
20391
childen
transplantationprevious
cmvspecificity
phytohaemagglutininstimulated
francevaccination
wavefronts
kmday
dnamvaprotein
regimenusing
dnapoxvirusprotein
envgagpolnef
vault
quadriceps
antiviralsin
therapyhlahaploidentical
adultsaa
fludarabinecyclophosphamideantithymocyte
7382005
4103
201112background
jos
northcentral
yenagoa
nsis
groupsone
groupfor
cutter
01510
00410
proteinglycoprotein
btlr49
immunityrecent
cd8dec205cd103cd326
langerinnegative
471000
leukoctye
5255
9453
polyplexreleasing
vaccinemicroneedle
polyplexbased
polyplex
hypodermal
diseaseexcessive
baffb
committeehematopoietic
japanhealth
shimane
2011influenzaassociated
months10
7249
3735
4068
aor070
115162
110164
120159
aor141
aor173
140214
studyit
marshfield
retinol
μgdl
120704
immunizationseveral
signifcance
agedespite
knowledgepractices
recordcard
vγ
vγi
vγiii
pediatriciansbackground
transnuclear
trp1specific
trp1high
trp1low
indistinguishably
ragdeficient
bradfordhill
2011the
varicellaherpes
immunocomplexes
19972010
162100000
19972001
29100000
109100000
nformylmethioninylleucylphenylalanine
agonistlps
mannanlps
fmlflps
immunisationprimary
observationthe
antihavt
lodz
or287
vaccinationwas
hivhepatitis
pathogenesispassive
ebpc
antiebpc
strategieshepatitis
nucleotsidebased
albertii
dm104
dysenteriae
crossreacts
entero
immunitycryoablation
coagulative
d122luc55
mhcadoptive
nyeso1157165
loh
princeton
preliminarly
aitresponder
9500
1618related
26701qualityadjusted
15820qaly
vaginalvulvar
10033qaly
21000qaly
dnajb8
cellcancerinitiating
hsp40
noncsccic
dnajb8specific
dnajb8derived
159297
137272
102114
154305
10071115
171476
underawareness
lycaon
pictusa
canarypoxvectored
1mo
pictus
bronx
zoo
35215
privilegesobjective
stateauthorized
protocolprescriptive
visitsyear
patientparent
survivala
ncc
gss
moderatemild
franklandin
frankland
cofounding
httpwwwbiomedcentralcom1741701511255
childrensevenvalent
colonizers
vitinitiation
3522
aceimediated
hardtoreplace
btc200μgl
btc20μgl
1831300
317815
179514
137522
027090
050093
allergenunrelated
aefinduced
huil6
aef
birefringence
p5r
postaef
qinghaiensis
sheepan
hq15
1282
stransferasefused
rhq15
crossseason
asubtypes
blineages
1adjustedoddsratio
5292
hicharacterized
11aa
4086
lineagematched
wellconserved
geneticvariants
hpv8
hpv8e6
hpv8e6dna
hpv8e6specific
immunotherapyviruses
naptumomab
estafenatox
immunotoxinimprovement
72kda
sagbinding
20092011we
hsws
23264
3663
hsw
fourcarbon
heliostregs
tregsdependent
casethe
pharmacogenes
racecolor
cocksfoot
dactylis
glomerata
meadow
pratensis
anthoxanthum
odoratum
ppratenase
grassinduced
control021
smd018
antishiv
shivig
r5tropic
4e10
17b
singlegenome
cade
shamvaccine
wholecellvaccine
majorallogeneic
notsogood
allhodgkin
ifosfamidecontaining
bridgingcytoreduction
lowerintensity
mocetinostat
networksuntil
meiosisspecific
meiob
cellscancertestis
promoterspecific
meiosis
691994
reactiondermatologicmucosa
localinjection
severeunusual
vaccinereluctant
vaccinerejecting
months16
3457
20329
39121
percentagepoints
p00027
nonrandomly
2266
nct00885625
revealedthe
669695
141389
memorytype
telomeres
okt3il2
okt3il2cultured
24035151
expectancy3
dc205
dc209
rigors
hematopietic
euibis
dipnet
euvac
vesical
etopside
melphalanconditioned
0·119·2
0·02
9·3
pscaexpressing
pscacarengineered
dystrophiesthere
vitaminotherapy
electrostimulation
prostheses
optogenetic
affinitydriven
criteriaobjective
languagedate
criteria173
stellamune
tenarad
131ilabelled
extradomain
tca1
miniantibody
tca1binding
131il19sip
gbqm2
leucocytopenia
implicationsin
reiterates
3kinaseakt
centerthe
salman
psckd
urr
ktv
5056
5687
gkgday
statically
patientsstem
pathogensspecific
bedsideγδ
overproduced
fpps
responsesantibodies
abresistant
rebridging
abifnβ
treatmentacquired
20102012this
blocs
responsesinfluenza
copanflu
specialiststhe
lexis
ricerche
qualityrelated
londonbackground
hostels
345505
315482
198283
1671000
beambeac
melphalancyclophosphamide
0053
expedient
reinducing
classimerkel
mcpyvspecific
mcpyvexpressing
154260
ferraccioli
houssiau
hearttransplanted
surfaceenhanced
desorptionionizationtimeofflight
selditofms
spindleshaped
seldi
198665
232342
537559
1296811
isograft
updateseveral
pnipaambpamptma
deliverygene
nisopropylacrylamide
3acrylamidopropyltrimethylammonium
copolymerbased
thermodynamically
polymersirna
nisopropylacrylamidebased
modulationobjective
patriarch
antictla
mannerblockade
challengingadditional
tenminute
obstetriccare
virusesadoptive
frameworkbackground
infostructure
triploidy
lheart
teleosts
bulbus
arteriosus
triploids
epicardium
diploids
hostan
evidencedbased
stx2associated
synthasestx2
chimerahemolyticuremic
blsstx2b
antistx2
stx2producing
fludarabinecy
antibcelllymphoma
fourtimesdaily
recipientsprevious
4qd
efficaciousz
atvac
graftversushostdiseasesystematic
118230
025049
englandtwo
measlesinfected
injuryblocking
antithetical
cd3cd4cd25highfoxp3
tgfβil17
42±23
05±03
affair
medicallegal
ipsu
europeus
μgmouse
vipolysaccharide
viconjugate
intuitively
cancertgfβ
1d11
4t1tumor
transmissionobjective
fullstrength
megavolt
antimdsc
metaanalysisvaccineinduced
evidenceguillainbarré
swineinfluenza
uvin
hlaeg
25555
focally
preferenceselection
kolar
821564xy
5735
104146
immunotherapyfoxp3cd25cd4
coadministrationhuman
measlesmumpsrubellabackground
würzburg
1405326
7914
munichwürzburg
p0620
saβ
oligomericfibrillar
noncompaction
myelomachimeric
hpe
2943
oligospermia
adultspneumococcal
proteinconjugate
therapyinterleukin2
arthritisustekinumab
janssen
centocor
developer
newtreatment
symptomdampening
depotinjection
20062010this
2002–2005
yearsover
childrencompared
200607–200910
aged50
aged15
afolate
antimeso
scfvcd3z
antifra
scfvcd28
miami
2011during
103587398
167889476
294438
judiciouslyroute
scapular
lankaintroduction
mousebrain
9798
selfrecorded
selfrecords
ci3947
°f
srilankan
magea3induced
raav6
vectormagea3
y445f
raav6magea3
raav6y445fmagea3transduced
raavbased
aefipassive
nonreporters
predate
farianae
nanjing
antiasthma
006093
012z
072z
5082
005night
014z
4019
2813
017z
10χ2
6167
vs13χ2
14581
144z
derivativebased
immunotherapyphsensitive
mgludex
3methylglutaric
protonation
mgludexmodified
pluspatients
09025177
priortotransplantation
62720
05260504
diseaseinfections
adolescentsvaccination
transplantationchildren
sjia
tcrvb
region3
hivblocking
anticcr5
peyerss
alterationsunlabelled
ccr5specific
nter1
ecl1
ecl2
antiecl1
antinter
iggdepleted
boosterbackground
primaryschool
hibspecific
hibserogroup
posthibmenc
isrctn728588998
oxaliplatinobjective
gadd45α
gadd45γ
pcbp4
ddit3
gtse1
mkk6
sesn1
ddb
btg2
p73gadd45
enzatutamide
argentinian
500mgd
5001000mgd
moradabadwe
moradabad
01368
19561992
19261992
linkability
n4987
n4709
computerization
survivalepsteinbarr
ebvr
114m76f
myelodysplasias
prefabrication
prelamination
larynxcomplex
scarred
fibrocartilaginous
prelaminated
convexity
vascularize
laryngectomy
hemilarynx
prefabricate
fourring
iiistudy
nonconsecutive
treatmentkidney
gravisintravenous
00960
attacksyear
00056
busulfancyclophosphamidebased
ebvpositivity
syndromeit
junos
whopping
a2b5
subolesinmajor
submsp1a
msp4
tickinfested
subbased
infectiontransmission
7744
groupbycenter
miceschistosomiasis
diphtheriatetanuspertussispoliohepatitis
dtppolhbvhib
n343
or049
metapneumoviruses
turkeyslive
vco3
tru9i
amplicons
rtnested
vc03
immunizationrabies
patentsdendritic
policyglobally
righteous
actualized
decisionthe
finns
3541
9594
lsils
sils
hsils
transplanter
polylactidecoglycolic
ovasocs1
nptreated
bmdcbased
δzmp1
cattlemycobacterium
δzmp1aph
vaccinationm
cetuximaba
pancreaticoduodenectomy
hilum
douglas
pouch
bmab
ok432combined
cmab
pleuritis
2c9cigg
modelyellow
17d204
vnab
postyfv
injurybecause
microarraybased
desensitisations
vaccineinvasive
buengkan
havrna
95·5
170178
61·8
110178
7·2
vaccinationafter
keeper
centralize
experiencesafter
geomorphological
mycolactone
polyketide
buruli
mycolyltransferase
acyltransferase
enoylreductase
ketoreductase
ketosynthase
efsa
chloroquinethis
f4as01b
nct00434512
antif4
as01induced
nct00972725
modelsalthough
nondermatological
dsr6434
kht
tumornaïve
nursedriven
physiciandriven
cancerstandard
oncokinase
preht
4894
3962
4530
3694
interval093124
propensitymatched
menwhile
tcellsadult
tax301309specific
pdrmotif
antihtlv1
tax301309
ht9
cd45raccr7cd27cd28cd57
adolescentswe
6244
perspectivesimmunisation
pseudoanonymous
13306
escderived
allograftshuman
embryonicstemcellbased
rong
hescbased
m045
antiachr
immunotherapyfree
considerationspeanut
arachis
hypogaea
industriesgovernment
ripcd80gp
mouseautoimmune
bitransgenic
ripcd80
ia2β
chromogranin
insulinoma
homeobox
nkx22
secretogranin
pancreasduodenum
pdx1
ubiquitinantigen
florid
librarybased
pot
kettle
fivepart
teitelbaum
wilensky
superspreaders
vaccinationdisease
deforestation
ecotourism
wipe
orangutans
diseaseindividuals
populationwere
unflanged
flanged
orangutan
ovadc
dcvaccinated
diseasesnkt
crossregulate
bcgtherapy
meninigitidis
crelated
meningiditis
erythematosusjuvenile
jsle
immunizationinfluenza
nephrectomyobjective
nct01799083
iappertussis
nephritic
campaignsobjective
semicurtailed
fieldtested
actinlike
7aobjective
spermprotein
7a
actl7a
antisperm
pet30aactl7a
excising
spermatid
pyknotic
allergyinterest
cypressrelated
ebc
8isoprostane
4938
mglp
extraantiallergic
childrenallergic
extraallergic
eliminatedobjective
firstdollar
lineitem
foundationhealth
insurersemployers
semipastoralist
hundredandfive
metuximab
131imetuximab
7123
8642
6049
131imetuximabrelated
plexopathybackground
ilsp
plexitis
paresthesias
hypesthesia
radiculopathy
nfκbin
ncih460
dr6
apo3l
malignanciesgreat
renaltransplant
httplinkslwwcomcora8
challengerecombinant
tmv
tmvha
oilin
sonophoresis
mykisslow
mwcm²
swimming
albuminglobulin
vntrsmucin
ddampl
vntrs
ad9m
vpp
ddampladjuvant
grantee
fullvaccine
54784
18044
23892
programnip
6742
8332
55735
652495
2773
24428806
24158709
23668532
opviio
ooo
1492
94410
60327
78354
71401
32141353
54153
88410
58327
71354
29401113
37327
scleroma
522956
22393
iooiio
qlqbr53
8343
1487
7483
statusqol
8330
8968
3331
2707
4233
5741
3063
2372
4056
4526
5511
2282
4485
2384
3592
xs2
hpvxs2
jadadscale
beggs
136043
697208
functionsmd
002041
058069
friendship
selfavoiding
pastorisinfectious
ir01
homomeric
23nm
subviral
ibdsvps
ibdvp2
cellencapsulated
mb3
thyroids
nodh2h4
thyroidinfiltrating
expresion
infectiondeveloping
papaya
papmv
482067
immunotherapytargeting
ilsafsvyv
cd133405
ylqwiefsi
cd133753
35191
bcellsufficient
miceclinical
premcao
bcelltreated
macrophagesan
immunoepidemiological
intercomparisons
adolescentsyoung
priorixtetra
paulehrlichinstitute
01012004
31122008
nnh
brackets
07190
15111
interventionsnatural
αgalceractivated
antagonistically
casitas
cblb
tailoredligands
188months
umin000001850
mannerbackground
tgp
tgpspecific
avas
m30
m42
m05
m18
m43
auditobjective
4957
photoimmunotherapythis
photosensible
lightactivation
lightsensible
hpcts
posthpct
lowsensitized
elaborationwe
totals
criteriaa
c4dnegative
thesetting
registryadvances
celldex
d4d
ortacrolimus
azathiopryne
mycophenolane
mophetil
ktxthe
ngmg
ucr
csaaza
csaaza210
198188
207256
groupsanova
iranclinical
soa
accordant
interstate
enginevaccination
browsing
attenuationvaccination
c77
7325mississippi
gazprom
transgaz
yekaterinburg
companyinfluenzalike
splitvaccine
vaxigrip
pneumo
neviansk
joiners
groupby
1162619
470278
catering
sewerage
workersefficiency
26852
rusal
7520
disablement
inconstant
7525
4607
1586
2014annual
ftcs
acis
follicularpatterned
extrathyroidal
00206
00107
00346
immunologicalrelated
demyeliting
koper
1830sin
gian
andrea
manzoni
nominative
contextualization
asthmathe
cornerimmunotherapy
tensiontype
tth
collagenasemmp8
bmmp9
shockendotoxin
collagenasematrix
metalloproteinase8
bmatrix
b10a
lysozymeoral
mgmouse
lysozymespecific
patientsgrowing
cd38pretargeted
2834
myelomafree
toleranceis
itwe
organisationrelated
n6275
mayjuly
n5071
welldistributed
n1758
lowurban
highurban
toolobjective
waiis
486265
8670234
nonrequired
rhinovirusassociated
desensitizationbefore
cephalosporins
conditioningabo
aras
ratioicer
17333
34666
46986
57778
34621
86667
ebolavirusebola
rvsvbased
bebov
sebovzebov
suppressionmyeloidderived
worldhypertension
phav4ang
cyt006angqb
angir
atrqβ001
dataan
5800
myelincontaining
nonmyelin
msrelated
vaccinationsthis
treatmentbcell
sflc
scd23
cd19bcells5μl
δdas2812
igmrhf
iggccp
λsflc
hypoxiaislet
reoxygenation
glucoseinduced
il8cxcl8
mcp1ccl2
soypeptide
lunasin
lymphomaimmunostimulatory
claviens
oxa5fu
dampinduced
transplantationthirtyday
30dr
noreadmission
nrgp
85115
32015
242519
45083
485456
albumindextran
engraftmentwashing
rbcdepleted
kilograms
mlunit
minutesunit
alreadyexisting
lipopolysaccaride
imidazoquinolines
sectorbackground
5097
5000mg
spainrotavirus
280338
210167
europestudent
serotesting
consortiumbackground
13235
researcheducation
8070
13009
itineraries
or49
or51
strongrecommendation
mirzapur
cardhistory
n1226
withinchild
mediocre
n4000
questionnaireincluding
tochigi
457950
411937
31901
ticket
0814
k14808
mallard
cabinettype
sprayer
lymphomamodification
cd20car
polyangiitisobjective
pr3
ctfhs
infusionincreasing
pretyrosine
exhaustionspecific
pneumoniabackground
cytolysins
usa100usa400
enterotoxinlike
γtoxins
intrapulmonarily
methicillinsensitive
photoimmunotherapyin
balb3t3dsred
targetcellselective
balbdsred
daunoxome
immunotherapycd43
sialoglycosylated
un1
unexpressed
un1cd43
un1positive
hpball
phagotope
lifein
nct01153893
serfling
sarcomasunresectable
scscs
institutesprotozoan
leishmaniases
leishriip
wwwleishriiporg
effectscytokineinduced
cd3cd56cik
slvi
ci13
clinicaltrialsgovnct01224301
ifnαil2
clincal
couse
idospecific
significanctly
lowfrequent
kyntrp
patial
phototrichograms
15±14months
22±16months
26±16months
73±49months
1983±474cm2
763±184μm
2296±345cm2
795±124μm
monthsfor
0660
prestated
ci20
155181
151186
hemoagglutination
nosyk
semimonthly
1950149
0833744
small12
usmore
onoit
oitdoses
readaptation
clinicalimmunological
ovomucoidsige
solutionsthe
h1n1related
allergenneutralization
d1specific
feld
fceriinternalization
mcarmodified
lossobjective
mcar
mcartreated
egfrviiineg
mcars
presenter
marian
turner
europemandatory
vaguely
morphogenic
bmpr1α
alk3
activins
bmpr1αdeficient
bmpr1αsufficient
recordsimmunizations
immunizationcomprehensive
personsunlabelled
cmvseropositivity
200901174226
wwwclinicaltrialsregistereuctrsearchtrial200901174226at
vaccinesafe
simpletouse
16f
15b
serotypeable
2µgml
0125µgml
multiresistance
nonserotypeable
ccl4induced
tgfβ1transforming
profibrogenic
kinoids
kinoid
tgfβ1derived
tgfβ1254165
tgfβ13083112
tgfβ1specific
tgfβ1induced
mv1lu
pai1
metalloproteinase1
hsct6
desmin
intertropical
climatologically
periodicities
33°n
southernmost
27°n
latitudes
274°n313°n
colder
sunshine
midlatitude
diphtheriacontaining
chiss
pcts
chis
ultrasoundultrasoundmediated
transplantationpreengraftment
tuberculosisrecent
macrophagedeactivating
pet23a
ni2nta
histidinetag
dioctadecylammonium
dda
esat6dda
scalethe
yttriumibritumomabtiuxetan
study90
yibritumomabtiuxetan
38·8months
63·4
donoradipose
utopian
transplanters
bmhsc
18mgdl
cd127lowcd25highcd4
proteinsobjective
lmpcytotoxic
δlmp1
multiplerelapse
lmpctls
modalityobjective
measurability
013065
017091
adcclike
5383
quasinormoglycemia
leukemiatreatment
hemopoeitic
cryoablationcryoablation
cryoimmunotherapeutic
nowrecent
toolsobjective
tumorassociatedantigens
lowsimilarity
nolowsimilarity
pentapeptides
0615
allergensige
triallevamisole
unitml
risk244
ci121
risk293
ci119
immunosuppressiongpb
ifta
groupsbackground
apudsystem
biomodel
antiplague
processobjective
morpho
immunogenesis
rieh
grimelius
hamperl
apudocytes
biomodels
adaptationcompensatory
nfd
diagnosticum
grownups
antibodiessignificantly
epidemizing
primatedespite
ofadequate
intranasan
thermometry
ofepidemiological
loadschronic
months135
36±4
38±3
47±3
084197
071142
antigentargeting
energizing
bggarp
gibsoni
dogsa
dnarvv
futurebreast
positivelyframed
negativelyframed
childpugh
636848
378622
408652
191415
304544
138346
ctla4based
responsest
icar
selfregulating
oncologyantibodybased
3e10
everimproving
2012immunization
seasonsbecause
2011n
18522
statetostate
12980
12976
heterogenity
makerssince
dosesthe
schedulethat
colonizationbackground
vtnp
vtipd
3ppv23
31ppv23
21ppv23
vtcarriage
advicethis
31statement
qsort
childorientated
transplantationbody
lpi
redoxactive
vivoobjective
cspg4expressing
carcspg4
cspg4car
carcspg4redirected
responsesdry
oncologynew
theorical
limitating
remissionhigh
timeadoptive
icsa
shigellahpv
l1expressing
actinbased
pjcb12
l1containing
stratagem
l1cell
gd2cars
engagerswhile
grimly
vvs
cd3expressing
gcsftreated
asiawe
ceeca
10yearly
typedistribution
europewe
yugoslav
fyr
macedonia
8610
asialimited
belarus
turkmenistan
uzbekistan
5226
callrecall
sublingualliquid
rwsail
ragweedrelated
subjectassessed
emenato
emena
algeria
i25
i200
i150
gobal
campaignbased
singleyear
agalsidase
7200
77098
pollinating
vlopositive
vlonegative
mcpositive
mcnegative
ragweedpositive
vlo
prepcc
prepriming
pccnatural
endophenotypes
characterizationbackground
prisms
4397
sustainabilityobjective
sterilizable
resterilize
povertyaffected
hepb3dtp3
tgswdi
3xtg
pbri
pbripeptidebased
nonselfimmunogen
antiniv
hornbeam
birchfree
fph
structuralvariant
fph4
unordered
lymphohistiocytosisobjective
226months
regimenunrelated
polyau
mispair
edgeswords
cellsinvestigators
tlymphocytebased
h3receptor
rabbitsobjective
h3r
µgkg1
rαmethylhistamine
h3ragonist
iodophenpropit
h3rantagonist
iivi
wwwelissk
nonotice
philadelphialocal
prescripted
drills
unscripted
microcosm
requirementsdespite
epileptologist
knowi
nonenzymeinducing
neiads
enzymeinducing
eiaeds
myosinobjective
epicardial
nsincorporated
ghgf
endsystolic
baxtobcl2
sustainedreleased
hgfincorporated
5ec
rfptn
vectorassociated
nanoemulsioninactivated
th2skewed
49fold
undernotificationbackground
dgp
undernotification
dgps
responsesnew
responsesyellow
antiyf
1stborn
rir
1stborns
119157
laterborns
145199
109148
102121
classiiassociated
mhcpeptidetcr
copaxone
illknown
atphydrolyzing
wt1loaded
ards
50th
fibroblastsobjective
bfgfactivated
fcas
fcgr3a158vf
concentrationeffect
doseeffect
edk50
immunotherapyverruca
wellpreserved
unapproachable
leukemiaan
recurrentprogressive
pathogenaeromonas
economicallyimportant
antiecp
lipopolysaccharidelike
chitodextrinase
protein85
quintessential
everolimusbackground
lymphocytes25cellsµl
ldh15×upper
phosphatase120ul
endothelia
ph1n1background
deviants
heparanase
rs4693608
snpheparanase
endoβglucuronidase
hspgs
hsbound
hpse
rs4364254
possessors
leukemiasubstantial
donorinfected
clinicnatural
manipulationrecently
immunoconjugatesimmunotoxins
anemiahistorically
effectletter
0903
163±0967
p0152
cellulaireallogeneic
n142
tbi1200cgy
bucy200
lily
hbsaglily
workarounds
innovationnurse
workaround
medicalsurgicaltelemetry
multidirectionality
fullseason
viruspalivizumab
latepreterm
patientsmetastatic
148414
followup202
myoinositol
mins
mrsbased
anemiasecondary
smdssaml
applicationdendritic
highlyspecialized
dcreg
dialed
645953
554532
494028
timelinesswhile
988995
842884
985996
970985
814860
954975
247288
ageinappropriate
occidental
concernsobjective
10extremely
diseasenonmyeloablative
fbxatg
subsetguided
toxicitybusulfan
mg·hl
strategiestraditional
jacking
vaccinoscopie®
dataunlabelled
1416yearold
elche
aβ142containing
microhyala
mhbased
antiaβ142
aches
beliefsbackground
accused
naturalexposure
challengechamber
threatsbackground
h1n12009
fstatistic
116168
176216
0097
453000
20092010we
ah1n1hemagglutinin
07to
2009december
smethioninelabelled
n325
n355
n461
ah1n1ha
613yearolds
hladq28
dq22
nondq22
n964
gada
znt8qa
dq28
upobjective
group10
ovasigg1
2851
0944
0907
secures
immunityefficacy
gfptagged
il15encoding
residentsbackground
aaoa
basicmoc
performinterpret
residencies
leukemiamultiparameter
103104
alpha2hsglycoprotein
glycoproteinthe
esn
bahsg
ccr5derived
cddr5
inguinally
hivprotective
perillyl
lungperillyl
geranylgeranyl
agstimulated
ci243
105118
117299
eradicationachieving
standimmunocompromised
postintroductionbefore
92000
gastroenteritisrelated
frameworkdespite
modelusing
thl
intrarater
rater
6weeksofage
intransally
9weeksofage
12weeksofage
vaccineunassigned
shirt
complicationssevere
vhcn
dhmh
nonvariola
8778mf
144years
42200
seasonasthma
19642010
pigletschemotherapyinduced
gitoxicity
landrace×yorkshire×duroc
2×16mgkg
2×08mgkg
brushborder
electrolytes
developmentone
slc
vaccineinfants
30295
172530
24895
203304
anemiaa
centersbetween
gcsfstimulated
fiveyr
hivantigens
diaclon
diaplex
th1th2inflammation
derivated
dendriplexes
18671914the
1870s
centralisation
infectionacquisition
nonsterilizing
msp1specific
transplantationchronic
plotting
diseaseimmunoglobulins
phylogenesis
quenches
204969
06358
melanomaintralesional
allovectin
a21
cavatak
2012turkey
330antibodybased
cd33cd3bispecific
ms5
cd3cd45raccr7
probioticsinfluenza
immunosenscence
solomon
posttests
posttesting
sd20
prefactsheet
leuko
ratio96
interval30307
scrutinizing
psu
closures
quoting
psus
20012007
dptmrb
19982012during
153172
4954
antibodycarcinoembryonic
c245
ls180
¹¹¹inlabeled
ymab
200μci
c245treated
200μcitreated
100μcitreated
hearttransplant
antibodiesno
93284
132292
alphaspending
errorswe
lessfrequent
sexstandardized
09998
09993
10003
gcctl
014084
h22activated
repertoireige
injective
grandchildren
diseasesreducedintensity
wwwclinicaltrialsgovnct00744692
codonopsis
circuiting
2rα
antitlr4
vaccinesnanotechnology
orientates
nanovaccinology
biosystem
nanoparticlecontaining
programschoolbased
gradebased
immunotherapyganglioside
neuroectodermderived
oacetylgd2
nct00810602
nonsymptomatic
baldricks
lowerthantherapeutic
paratuberculosisthis
mycobaterial
lame
responseinvariant
hesc
cd1doverexpressing
raptor
aptamerraptor
ruxolitinibthe
janusactivated
mfrelated
antijakmediated
nanoparticledetained
vaccinationtoxoid
toxinsare
toxindetainment
nondisrupted
αhaemolysin
heatdenatured
toxinmediated
speedy
selfdissolving
literaturepertussis
hourigan
mrdbased
mccarthy
menkthe
ntx
menkinduced
aspergillosisallergic
antiasthmatic
rosenbergpatterson
costsharing
statesmedicaid
australiaannual
networksexposureresponse
unexperimented
lipopolysaccharaide
experimentations
nonlinearity
cpgmatured
aor108
aor114
deathsbackground
cin23related
generationbackground
processthe
uaebackground
uae
alain
immunizationsas
advisories
provincesincluding
2977
3798
105263
prorata
shipments
shiptosites
20032010objective
246411
129263
stieg
larsson
pandemrixpandemic
pharmacistbased
selfrisk
infancypreviously
269812
2301
14963540
5006
27209213
miuml1
073218
308725
3751356
indiaworldwide
infectionpersistent
overwhelm
genomemedical
genomeinformatics
subacromialsubdeltoid
immunotherapylocal
indexofreactivity
irstandardized
clusterscit
scscit
infectionrejection
ptlddeath
posthtx
cd3tailored
sufficientassessing
evaco
pu1silenced
f344
pu1
controlsilenced
proliferationthe
cd28cd57
ccr7cd45ra
nonautoimmune
lymphopeniaassociated
biaswe
zcurve
boundariesnone
zcurves
biasfurther
recordswe
6284128
871631
5657
spanishborn
igedriven
allergenencoding
responsesa
highpowered
metanalyses
tolerancesuccessful
apoptosisdeletion
therapyimmunotherapies
850000
ständige
impfkommission
bkk
1859
4115
3996
5675
4061
5221
7373778
reviewmeasles
impactcosts
19892013
serosusceptibility
vivoprepared
situadministered
adjuvantguided
bloodtypeincompatible
abobloodtypeincompatible
unitbound
recipientskidney
socrates
cniwithdrawal
cniwd
steroidwd
bpar31
ratgtreated
19862009
n298
6720
granulocytopenia
studypeoples
ruralityrelated
municipalitylevel
0367
haitis
postocv
ratioor
152240
216350
128205
103164
114189
135451
oophorectomy
endtoend
noninterlocking
reanastomosis
secondlook
bicornuate
silirum
deera
fourmonthold
n1671
n1664
vln
liveweight
rr032
pdabearing
αprogrammed
lymphocytesevolutionarily
antimicrorna
microrna150
mir150
antimir150
shuttling
vesicleassociated
etoposidetreated
tdependent
unimpaired
usamen
4049years
017045
395184
113363
womenhpvvaccinated
nonlifesaving
myers
inoculates
chaffparents
ecchinacea
11125
27736
6955
9768
rangeli
cruzichagas
marsupials
fixated
epimastigotes
p00001001
lymphomonocytic
experienceautoimmune
ahds
ahd
pls
prabo
standardizaron
allerstand
r055
allergomex
allerquim
r057p0001
126341
173993
mcgml
2009the
nysdoh
2009may
sparcs
sparcsonly
israelthe
israelbarriers
religiouslybased
israelusing
compliancy
3554
maccabi
immunoenvironment
2225
autotransplantreducedintensity
n137
3755
179316
147262
134235
examplewildlife
stochasticity
vosges
betweenyear
agentsmost
n22188
n21007
43072
22571926
090094
032099
interventionbackground
classmates
2008november
mean13month
2010november
mean852month
hospitalcampus
mean08month
mean85month
areacommunity
mean01month
mean28month
worldsinfant
vaccinnet
3882
underparticipation
labourintensive
vaccinnets
cd27cd45ra
rv0288
ad5based
rv0251
rv0287
ad5tbf
adjtbf
virusclassical
tandemrepeat
693707
241276
770781
14461460
ns23
agecalfhood
2874
sensitivity40
specificity69
ppv18
npv87
52gdl
sensitivity27
specificity89
ppv5
npv98
navel
dipping
kgday
011162
sd02
twinning
ftp
squalaneinwater
bioresorbable
glycolblockpolylactidevaccine
glycolpolylactide
pegpla
metabolizable
squalane
pegplastabilized
squalanepegplapbs
oilaqueous
denominated
pela73
disassociated
dios
emulsifier
squalanewater
nonformulated
alumformulated
introducedthe
senteritidis
multiplelocus
pt4
pt21
pt21c
pt6c
pt8
u2
timingdespite
studymareks
6076
291m
8wk
allercept®
repellent
nonstabled
premedicationbackground
wbe
ifas
03ml
srr
ranitidine
loratadine
nonpremedicated
cmpspecific
cmsensitized
challengeproved
artdendritic
41·4
3·6
91·7
56·1
0·009
53·1
0·034
7188
stemstroma
anemiafive
udpbscs
mesenchymalstroma
fluctxatg±2gy
201011infection
226000
19762006
responsemyeloidderived
2×106
musculature
applicationcontraceptive
spermspecific
boartaint
βhuman
βhcgbased
βhcg
challengehuman
hcwsover
partisans
proponents
nct00619827
33406
grasspollenspecific
seric
roadbackground
anticd19redirected
brothers
fabry
20112012annual
372653
heathcare
183375
156367
programsreflecting
cécile
viboud
riley
swedenobjective
webpostal
1587
druginvolved
communitiesstreetbased
sexwork
polysubstance
bogotás
transsexual
fénix
scnp
functiondysfunction
flowcytometrybased
b7bombers
developmentsseveral
cd8ααcd11cmhciicd3
gnresistant
glomeruliinfiltrating
gil
cd8αα
cd8ααcd3
gnprone
nitrogenserum
200901392343
nioht
snas
niallergic
nirich
nipatch
nipoor
nioral
niweek
nonscd
lowhypoxic
failureobjective
stromapredominant
11974587
13405150
glypican3derived
reportscarcinoembryonic
by40
ccc
algoma
aph
menus
276s
263s
303s
413s
readability
unitdose
belgiumachieving
rtxa1martxvv
proteinvibrio
3491
4701
autoprocessing
martxvv
rtxa1
rtxa1c
colibetanodaviruses
fbw
importanceq
coxiellosis
005020
001026
022075
063097
tumoursinterleukin
il12producing
nonproducing
rm1
llc1
moto11
radiopharmacyin
radiopharmacy
mallohsct
cdct
093852
risksbackground
postconsultation
fragmentthe
pcantab
2scfv
cellsmultipotent
airtissue
verocytotoxic
pigletsthe
feda
verocytotoxin
verocytotoxinproducing
vtec
11010
o138
challenger
austriain
surroundingcaring
johann
gottfried
bremser
17671827
vaccinevienna
parasitologists
helminthological
helminthology
buried
oblivion
pascal
ferro
carro
excelled
propagandist
contrarian
bremsers
163308
34gl
gp96hivig
subthermoneutral
temperaturewe
thermogenesis
thermoneutrality
coldstress
immunotherapycolony
tims
mhciilow
mhciihi
cancerpreviously
morerecent
checkpointswhose
overexuberant
statesvaccines
nsas
complexassociated
antidopamine
traumatized
alloxenogenic
1500005μl
contusion
gliotic
noncaucasians
immunizationdeclaratory
2011of
dosageescalation
burkinabe
ad35cs01
balonghin
saponé
5x1010
nct01018459
httpclinicaltrialsgovct2shownct01018459
inductionimmune
agcoupled
agsp
parecoxib
valdecoxib
µgkgday
supremacy
costaining
mbuf
2gm2
36gm2
wwwchictrorgcn
chictrtrc09000470
immunotherapyaxl
3242
axlknockdown
e8
arrestspecific
gas6
downexpression
hiv1host
rs11884476
overdominant
alloreactivityin
hlacw3
cw4
il2il15
preculture
cd107
pakistanon
fata
khao
expediency
curbed
allotypes
14q323
γ3
γ2
mendelian
associationlinkage
riskprotection
tcellreceptorbased
hth7
dacaza
8505cbraf
plx
mekbraf
childhoodthe
osteoprogenitors
hlahaplotypes
trendscancer
cytokinescostimulatory
strainspoxvirusbased
diseasesallergic
recipientsthere
03601
0859
03618
perspectivea
ptxs
tacmycophenolatemofetil
tacmycophenolic
tacsirolimus
nonnephrotoxic
nondiabetogenic
nongastrointestinal
ivir
quiver
neuralderived
injuryapoptosis
indps
a91
δurechly
hil7
hil18
δurechlyhil7
δurechlyhil18
δclpb
fsc200
tularemiafrancisella
s4δclpb
fsc200δclpb
estimatesbackground
3656
casucci
offtumorontarget
19802009objective
immunotherapysepsis
adenocarcinomaa
52y
patientclinically
ecchymoses
statesnew
brmactivated
lifeqolwithout
killerbakcells
tomographypetct
ebinaand
alys
interferonifna
ringers
dripinfused
2cm
meningitisobjective
dicle
533±557
shunt
tbmassociated
stateshealthcare
systemwe
trochlear
ominous
futureglobal
carinoma
prognotic
imunosuppression
outbreaksrecently
88·2
68·8
93·9
entrylevel
virtues
behavioursresults
2011controversies
45to
vaccinationtherefore
seasonsmoreover
planfunded
34568
immunodeficienciescord
97days
arvs
arvassociated
successharnessing
mutationtreatment
t790m5
mqlmpfgcll
t790m7
limqlmpfgcl
egfrtkiresistant
t790m7specific
egfrt790m
egfrt790mderived
kongobjective
orm
frontièresandrea
minetti
stalkdirected
cantell
hpv4only
immunogenicityare
vaccinologymanuscript
carrera
pertussishemophilus
polioviruscombination
neuroantigen
encephalomyelitismice
mogifaimmunized
immunizedmice
mogifa
untaken
resistaid
arabinogalactan
larch
lonza
glycodendron
synthetically
nacetylgalactosaminedendrons
nagdendrons
dextrans
scfv4sa
nagb
biotinylateddextran
aminodextran
dexb
ca8
ca4
124ilabeledscfv4sa
duallabel
antitumorassociated
nag
nagantibody
ca32lc
ca16lc
activespecific
functioncolorectal
smts
emts
cmts
barbs
strategiesmisleading
nonprofessionally
nonregistered
personalizationobjective
postmenstrual
12380
pediatriconly
firstorder
sizespecifically
oklahomahomeschooled
grp170
erassociated
dislocation
proteasomedependent
retrotranslocation
grp170based
dcelicited
cd62lcd62l
recirculation
encephalomyelitischloroquine
tregsindependent
cqmodulated
cqtreated
dccq
chloroquinemediated
aav6
capsidoptimized
aav6t492vs663v
doublemutant
wtaav6
chmcd11c
hpsa
aav6t492vs663vcbahpsa
aav6t492vs663vchmcd11chpsa
vallès
1283000
peopleyear
448100000
154100000
months1
standardintensity
menthis
n616
biofilmdisrupting
halogens
chlorine
usnic
ceragenins
xf
tannins
lightmediated
titania
photocatalysis
vrs
reproductiveandchildhealth
multitribal
fvr
datoga
2944
fvrs
21455
perspectivesapart
allotransplantmediated
phasetype
koffrate
nowimmunotherapy
vitespen
haptenpresenting
htcpa
haptenloaded
moderateweak
cd1aneg
chemicalspecific
cd1alow
allergenpulsed
cd1ahigh
allergenencapsulated
microenvironmentsthymic
ctecs
bipotent
tec
ctec
mtec
ctecmtec
progressionregulatory
5amp
iteg
folliculitis
isepf
cellssingleunit
eraebvassociated
49300
5065200000
fourparameter
012074
112293
ebvqpcr
rituximabrefractory
3540
9592
198276
hr503
465545
hr397
370424
hr154
139169
hr187
152231
nonscreened
densityfootandmouth
scientificbased
lowlivestock
macaqueshighlevel
b7dcig
postart
celltreg
kidneyfunction
mlminute
cnirelated
1314yearold
176992
138265
106198
kidding
meseasonal
hajjbackground
respiratoryborne
ci114262
ci135302
or162
ci100263
subjectsobjective
1426
demyelinationmultiple
arthritisjuvenile
0426
0324
0436
cobia
rachycentron
canadum
lcobia
renolase
glyceraldehyde3phosphate
rgapdh
vaccinescombination
rgapdhwere
dectin2dependent
3pneumococcal
dectin2ko
ril12
antiifnγ
ppvimmunized
immigrantreceiving
newlyarriving
40880
africawe
beginners
157599
549852
indroduced
spawn
toxinin
rta
rtb
ricinspecific
rtaspecific
antirtb
d10b7
heterodimertoxin
antiepitopic
ley
cmwp
transplantationtransformed
βfold
βturn
coil
songjiang
immunizationsi
afterp001
afer
sip005
bbpgexsj26gstsj32
japonicumobjective
sjawa
nonstimulation
bbpgex
sj26gstsj32
immunodepleting
carems
immunotherapyinfluencing
rdil15scfv41bbl
scfvrdil15
4bbl
antibodyfusion
killingto
cd16vbbζ
retrovirusmediated
f158
cd16vbbζmediated
fcεriγ
doxorubicintreated
doxorubicinmediated
talactoferrin
twotiered
vectorsthe
thymidylate
thya
pyrg
auxotrophy
thyminethymidine
gathers
n174
20691
54962
nonrural
countriesvaccines
carcinomavaccines
oncoantigens
outcomesas
purityspecificity
hlapeptide
meloe1specific
10061071
pages®
2013ottawa
canadanovel
tuberculosisdeveloping
primingheterologous
rbcg685a
r685a
antiesat6
antiag85a
primepcd685a
pcd685a
birthcohorts
receptorderived
mc1r
mc1rderived
mc1r291298
mc1r244252
mc1r283291
mc1rspecific
antimc1r
hlaa2mc1r
hlaa2mc1r244specific
mc1r291
1015yold
2599
515yold
modelspolyinosinicpolycytidylic
ictreated
nksensitive
monclonal
lair2activation
lair1
lair2
collagenlike
lair
lair2fc
lair2his
ic3b
antibodiespassive
adcvi
visitsobjective
oversampled
nonvhps
122535
processcompliant
trialadoptive
myosinprimed
myocarditisobjective
eam
autoimmunityinducing
myosinpulsed
tdctreated
myosinspecific
t1dmstill
yetalefacept
postimmunoablation
iahsct
3″
2″
postiahsct
diseaseschronic
tnatural
ricbmt
929±69
933±64
verylongterm
survivorsboth
baselineadjusted
digitdialing
ci1832
70116
248304
345408
252291
us128hk1000
rangeus64192hk5001500
4486
padova
moroccocervical
nonacceptability
gods
rateshealth
injustice
subsuming
nonmaleficence
principalism
kantism
conscience
filovirusesmultiple
diseasesselectins
leukocyteendothelial
mannanmuc1background
mannanmuc1
1215year
irelandthe
outbreaksbotulism
neuroparalytic
improvementmyasthenia
adolescentyoung
coccal
cvcs
hdmbeam
cvcassociated
cvcrelated
lymphomatwentysix
evaluationpneumococcal
29005660
10006017
savingsproducer
cockroachspecific
oncotargets
uneffective
fasoobjective
95ci124258
95ci218419
106189
hospitalspertussis
cqs
rhinoscopic
gelatinfree
ninakohlyakimovaelive
coccidiosiscaprine
coccidiostatic
ninakohlyakimovae
primaryinfected
cicy
rads
cicyldtbi
1217yearold
650uday
scorings
dpteronyssinusinduced
scitvitamin
monthbaseline
outofstate
areatathe
imaginganticd20
kcs
sinusoids
th1cell
strategytuberculosis
rd116
rv1769
rv1772
rd14
bcgppro69
8079
arbitrate
n12256
n23931
n8573
vgkccomplexlgi1antibody
immunotherapyleucinerich
statesrecent
11question
uptakeimmunization
quinvaxem
studycombination
tritanrix
hbhib
seroprotectionseroconversion
nct01357720
93000
6700
us14
us200000
us35
us500
us14950
us4972
ofluvac
ntr2858
sponsoring
influvac®
20112012vaxigrip®
early21
late17
early8
late10
1701
alumvaccination
110000
therapiesatopic
volga
foreurals
regionsthe
immunoglobulint
igtcr
immunoglobulincd28t
igcd28tcr
infectionsat
5log
microlesions
bankscurrently
anticholera
auspices
paxvax
nct01585181
viraemianeutralizing
tropic
shivad8
emulates
47days
neutralizationresistant
coverage2012in
gvaps
womenmassachusetts
mdph
20000yearly
hispaniclatinas
othermulticultural
4048
1083
4923
23825
influenzainduced
selffamily
tooobjective
orientating
stikos
4561
617years
717years
conjugatesobjective
barrierdisrupted
asthmaimmunotherapy
gabw
proinsulinreactive
countrieseconomic
australiaas
australiaadolescents
lambsrift
nsrgn
cd4restricted
therapyimmunization
nonadjuvated
nondetectable
hyperkinetic
chemotherapywithin
cesura
alpharadin
palliated
institutebackground
paperandpencil
specialisation
sulfolane
transplantationcytochrome
cyps
flavincontaining
monooxygenases
fmos
tetrahydrothiophene
tht
cyp2c9
cyp2c19
fmo3
rs2266780
rs2266782
rs1736557
cyp2c92
78±36
44±22
mr5
travelersbackground
americanborn
africanborn
novelconditioning
dbm
lfa3cd2
cd2high
expansionactivation
recipientssirolimus
55yr
0121yr
23yr
25yr
0583yr
86±37mlmin
130±49mlmin
coverageunited
seasonspecific
shallow
clonotypingextensive
asts
tcrβchain
identifierbased
ultraprivate
cdr3β
childhoodrefractory
transplantationfree
nct00662090
lymphohistiocytosisin
triallymphoma
plateletsμl
536864
425775
1654
4882
4580
200700319822
20082011adolescent
belowpoverty
abovepoverty
ebmthuman
4456
5656
donorreceptor
5556
93027
14522
118194
041335
073325
120386
azacytidineinnovative
vidaza
azainduced
adeno
lusc
ligandmediator
avidityin
researchwe
matchedmismatched
intermediate2highrisk
lowintermediate1
graftfailure
5072
mgl×h
relateddonors
hla910
unrelateddonors
6·817·3
86·4699·09
79·7896·17
toxincoupled
immunodominancealloreactive
h2dbrestricted
uty
smcy
tetramermediated
dbuty
dbsmcy
immunotherapycancers
europehealthcare
vpdspecific
bangladesha
leftout
172754
141839
123666
perperson
us393
us163
us076
antimonkey
baboonst
admdt390scfbdb
c207
100cellsμl
cd3it
inhibitorsunderstanding
immunotherapeuticsvaccines
leukemiareviewdespite
aura
regimenthis
hihsct
lymphoblast
128455
fcfusion
therapeuticsnearly
fcdomain
fcrndependent
fcrnfc
paulehrlichsociety
humansin
influenzasignatures
lympho
magea3derived
suppressionimmunotoxins
hassan
developmentallergenspecific
mcid
jccp
anchorbased
micds
t6ss
3698
mcids
0686
0531
10469
tumorsfor
rhinitisgrass
ivclinical
cellscomplex
pmel1specific
1519yearold
6372
381000
interruptionobjective
alamos
laterbackground
bbrisbane602008
estimate109
estimate067
n203869
isrctn72521372
pre2012
302397
14085
24871
hgc
cin3ais
hoops
hurdlesalzheimers
managementwe
vaccineoutcome
pneumoniainfluenza
confoundingreducing
provinciallevel
educatorseducational
3p1
2p1
infα2b
mad109
chemokinedendritic
133293
191143
immunotherapycd40
cscd40l
dcinducing
dosedependency
nearrealtime
pcv13immunized
studiesalthough
i293
trialsmodulation
60year
19512011background
pledged
19512011
5935100000
27210100000
05100000
66100000
245100000
fengtai
changping
19781996
guidelinesreports
reassessing
compels
circumspect
belo
horizonte
evaluationaccording
ubs
creativity
bahiaobjective
sctgraft
implementationeffective
polysaccharideconjugate
udcatreated
6category
trialshigh
bacteriums
orienteering
emma
walton
abvd
abvdequivalent
patientbasis
petnegative
antitubulin
mme
beacopp
brandnew
ebvhl
a01
vasculogenesis
cd14dull
gmdsc
cd15
trialbecause
apocell
cellkg
nct00524784
23695
astatistically
antifcγriibfcγriii
iggfcγrmediated
24g2
mockdesensitized
24g2induced
igg2amediated
monocyctemacrophages
antifcγriiriii
montrealbackground
30204
slowest
6298
rr128
ci045
granada
hygienicsanitary
vaccinelittle
level016
trialsevaluation
lasky
jl
panosyan
20472056
remissionobjective
gvhr
salutary
recordobjective
cancerintratumor
ccl16
antiil10r
ccl16cpgantiil10r
echoguided
peoplebackground
aians
19952010
19951998
06600310000
005006
881910
challengeclostridium
658154
9197
9497
8195
myelomaover
3347467
2497572
178479
100475
uptakeimproving
arching
miceplasmid
ha1based
highvoltage
lowvoltage
10v
literaturebacterial
mmucogenicum
antimicrobical
vaccinatetodie
countriesfor
disincentive
barnett
protonbeam
pbt
caltump
microparticulated
irradiatedtumor
doselevels
gye
21142
chemoradioimmunotherapy
unsatisfying
sb203580
matterthis
fogelin
noncoercive
nonreasoned
lbsap
longipalpisin
slcastimulated
darbepoetinα
reporthuman
erythropoietins
darbepoetins
erythropoetins
anjioedema
erithematous
darbepoetin
addressvaccination
toxicodermia
desensization
tractneospora
apicomplexa
19982009
twelvestep
535years
pegifnα2a
pegifn
nonfractional
lasermediated
resurfacing
solutionsimmunotherapy
junctionneuromuscular
waldeyers
adenoids
tubal
palatine
adenoidal
adenoidectomy
ccr3
ptgdr2
inha
effectortype
cd45rafoxp3hicd4
etreg
cd45rafoxp3locd4
etregcell
radiotherapyrational
middlet
determent
agesthe
motifsbackground
swayed
840348
5381
76115
risk40
lifeobjective
transplantationchimerism
carcinomapatients
stat1stat3
nonhost
vaxirab
routewho
claimednor
transcription3
pnpstreated
habitatsobjective
factorsknowledge
8260
carep
2009χ2
10831
townshipsχ2
9071
preventionor
ci10551905and
2009or
1480
ci10442098were
sclerosiswe
bcellregulating
bcelldependence
networksin
entangling
allergologic
recertification
sits
amendable
vaccineseffective
vectorin
tropisms
prospectsintravenous
bettertolerated
costequivalent
fluvirin
767904
784518
lurch
ssea1negative
transplantationneural
ssea1positive
oct4positive
therapyipilimumab
trialshere
ipilimumabin
ipilimumabmediated
proteinsmultitransmembrane
mrp4
promoterbased
promotercontaining
pcaggs
antimrp4
tagsnps
genesowing
rs352139
rs352140
predicator
hsctrelated
transplantlow
247±86
109±64
223±80
dualenergy
tbmd
lbmd
fnbmd
08sd
lifequality
alemtuzumabmediated
monkeysrepopulation
dosethe
opsonophagocytoses
21dose
unboosted
nct00189020
europenosocomial
franceafter
incomeconsumption
hivv
cartnaive
5000500000
350μl
eudract200901059337
nct01071031
05yearold
730822
age25
regimencytomegalovirus
5246
irradiationstem
embolus
bagthe
utilizationbinding
phrs
statestransplant
33203
2273
drb113
rhizopus
microsporus
anemiadisseminated
echinocandin
28s
deoxycholate
literaturecamt
sublingualspecific
transplantationlack
recipientrelated
yfvaccineexposed
47159
335441
yfvaccineassociated
yfvaccineavd
0126311000000
antihlaantibody
10005000
ittreated
p65p52
nfκbrepressing
nrf
txa2
rnaiii
isdbn126p361
tisdb
tisdbtrap
chancespassive
tumoricidic
immunochemotherapytreated
gcet1
lmo2
choi
nyman
viscoyoung
tally
dichotomizing
ependymomas
strategiesependymomas
cd3ζbased
transsignalling
itammutant
transmembranemodified
antigenligated
nanobodiesnanobodies
promisecancer
cellsimmunotherapies
pmelcd8
vitrocd40
cd40linduced
cd40lactivated
tcrstcr
mispaired
tcrtg
cysteineization
550bed
yiwuzhejiang
695967
872976
543967
734967
471967
838967
school859
831967
hospitals363
351967
month327
316967
837881
569967
555621
853967
860904
953967
978994
0722
0398
235967
12801800
27967
22876451
478967
6048
43118485
210967
1366
95ci11631604
759734967
2613
10266655
13413339
jspaci
3613
3yrs
50yrs
1314yrs
10yrs
06yrs
615yrs
disused
approx6
milkin
surveillanceto
200385ec
derogation
bwf1
squ
alu
unt
0·016
0·048
honestly
hsd
antidna
antirnpsm
cfatreated
0·005
gs5
glucosyltransferasec
glucosyltransferaseglucosyltransferasec
gtfc
gtfcn
hcn17
hcn37
antigtfcn
glucosyltransferase
mabml
gmcr
gmcrs
umin000010672
srv
200110
19882000
bacon
donorconditioning
0088
0292
0476
0762
studyfeline
disfigurement
sixpoint
gavialliance
cashbased
supportbackground
anemiawarm
waiha
anemiasometimes
receptorvaccines
hispaniola
20102013deployment
haitisuccessful
gheskio
52357
therapyspecific
dnalong
hivconsv
sivconsv
mamua00101
b00801
b01701
30amino
acidlong
isa720
sivconsvspecific
sivconsvvaccinated
mid50
adenocarcinomageneration
cikil2il15
cyclind1
immunitymucosal
semiconserved
coldpassaged
rhpiv3cp45
hpiv3seronegative
hpiv3
vaccinehpiv3
a4fold
pbmnc
flowfish
trappcrelisa
b0387
saavsaa
p0573
30957
450229510
5911groups
51086±10844
25357±4848was
51086
10844
cr32808
4685pr
30334±4464
p0517
p0254
χ²20385
0324±0178
0234±0175
0107±0083
shorted
aunp
ballabgarh
ci117232
dtpb
124393
067167
085212
administrationbackground
anibrg14
invaccinated
wivinduced
immunomodulatorsinfluenza
copresentation
copresenting
biologicaleffect
parametersunlabelled
posttracer
ctdefined
cellclearance
coldeffect
λp
lipidtransfer
bronchospasmallergen
fluoroenzyme
1weekold
vsvp
nvsvp
nvsnvp
parasuisspecific
vapacpg
rhocococcus
vapaspecific
intrabronchial
rvapastimulated
posteradication
poliovirusesexposing
postopv
fadeout
lengthens
alleysdespite
stiffman
19842012
childhoodonset
misdiagnoses
65igg
0063847
diazepam
baclofen
propolis
flavone
pfm
obstetricpediatric
caefiss
federalprovincialterritorial
bccd
nonimpact
917yearold
n1256
p173
p871
p273
p311
utilizations
b02
19942010
aquaculturedisease
fishfarming
bioproduction
bitecancer
t1e28z
4αβ
routineinhouse
hdmait
hdmsubcutaneous
unconvincing
repositioning
dawning
interventionsbased
reesinterview
schlom
rutgers
msp142
msp133
33i
postexposures
broadest
msp142s
γ9
callithrix
jacchus
melioidosisburkholderia
γ9δ2
chdmapp
chdmappil2
modelsprogress
microtubular
tcrgammadelta
imfi
4356
malva
mamv
ompc
strokeimmunotherapy
consequencesour
nonimmunologist
leukemiathere
gethgitmo
cyclophospamide
tbimel
100110
80000ml
alloscthematological
thermometer
cognitiveemotional
fftf
responsevery
statesfederal
activitythis
20102013pneumococcal
1896
2priming
children60
outcomespecific
2010january
021090
20006000
birthsyear
antigenbzlf1
ebvlymphoblastoid
immunoselected
ebna3
cd4secreting
5142
cd8secreting
nk92objective
cd56cd3
tumorssarcomas
at1×
cellsm2
fourths
chromosomespecific
teachersobjective
transplantationhow
acceptablebackground
msv
30×
scotlandperspectives
uptakein
hrmds
koreth
vasso
apostolopoulos
premiers
10herald
achiever
brigadier
nhmrc
cj
martin
austin
vic
headed
wright
poppy
bodossaki
inducted
honour
torchbearer
olympic
torch
relay
inventor
collaborates
graftversusleukaemiamyeloma
effectgraftversushost
hostreactive
leukaemiamyelomaspecific
leukaemiatumour
leukaemiatumourreactive
sorter
observationbackground
6mpi
hpv74
hpv61174
therapyrice
oryza
seedbased
casesalthough
ubmt
frst
transmissionpertussis
signifcantly
childrenfew
846973
324902
197340
hptn
maternaltochildtransmission
microliter
cd4636
cd8536
immunotherapeuticsits
anotherwhat
pneumotropica
miceintranasal
pnxiiia
100kda
greenfluorescent
immunosuppressedthe
diapep277®
isletautoantibody
gliomamalignant
facssorted
hmgp
pdgfrβ
hbvp
hcmec
cd90pdgfrβperivascular
cd90pdgfrβhbvp
pges
westerly
winds
nonauthorised
15022012
0477
0988
0585
0389
0880
hivdnaprimed
ankaraboosted
vaccineeswe
aldrithiol2
at2treated
pbmcbased
synergythe
vaccinationmore
betweenhost
similartypespecific
elderlyinfections
childhoodbased
rideherd
nonexcludable
nonrivalrous
lighthouses
62item
groups3201146
66557
2371146
40557
9471061
193325
10418
8811146
9531061
405557
266325
5021146
8571061
lecturebased
communitiesillinois
20092010objective
eastcentral
6april
onsets
longrunning
inducerstb
peptideinducers
therapiesmalignant
clinicsystemic
1857
immunologyworld
133000
troisième
034year
068years
132years
terminale
051years
108year
950307
intermediatelevel
vaccinerecent
nonnaive
infectionchlamydial
strainsgenotypes
vd4
vd1
chlamydiafree
vds
mompbased
infectionscoming
immunosuppressionpossible
rup
branguscrossbred
isocaloric
acidsoluble
amyloida
tpml
pundl
0099
ny‑eso‑1
carcinomany‑eso‑1
cancertestisct
proteinreso
factorgmcsf
resodcs
190hcc
reso‑dcs
ny‑eso‑1positive
ny‑eso‑1negative
30190of
methoddesensitization
rabiesthere
adequatelonglasting
fearvisual
neoplasmscytokine
remodelrecently
ropeik
asl1
asl2
asl3
7307
7108
6721
catarina
ratswe
dlys6gnrhtandemdimer
specol
eminence
hypohysis
fshβ
gpr54
androgenarkisspeptingpr54
pituitarytesticular
mancas
089100
eczemaatopic
improvementpertussis
reed
neuropathologic
tractus
solitarii
sparking
6192
kulldorffs
222275
110130
dunaliella
salina
crayfishalthough
vp28
crayfish
crustaceans
benchtobedsidechimeric
reviewyellow
recalculated
yefavd
2011saudi
medina
pilgrimsresidents
citizensresidents
19951999
hajjrelated
n10871186
n11741217
6–14
immunotherapychemotherapy
tumouralspecific
immunotherapylack
aavhbv
hbsagcpg
aavhbvinfected
hijackings
sydneybackground
sydneybased
207849
reliers
effectorsin
invoices
21588
159163
89000qaly
qalyyear
psoriasispatients
forimmunization
edhs
transcends
equilibriumbackground
signalingsignaling
parentlegal
xfamily
age14
vectorwe
cdvsiv
12mer
dhtlytpyhthp
12p
klh12
klh12p
klh12pimmunized
infertilitybackground
vai
investmentin
nonrival
threaded
carcinomadevelopmentally
cancerplacental
tastin
bystin
eocs
immunoexpressions
immunokinetics
hypothesisthis
jerne
brescia
oralbu
20082010very
midwestwest
060083
053071
fertilitybackground
amenorrhea
suppository
studyanimal
rectally
suppositorytreated
565±018
517±027
oligoadenylate
ribavirinlambda
il28ab
pegifnrbv
il28b
rs12980275
nontt
eaaciwao
2013european
no2promoted
transfersevere
dioxide
no2
allergically
th2th17
il1rth17
no2allergically
endogenouslygenerated
2x25
antigencarrying
interbilayercrosslinked
icmvs
crosspresentationpromoting
apcrich
physicianapplied
seasonroutine
answersepsis
hypoinflammatory
allergyalthough
bakers
animalinduced
worthing
erysipelothrix
rhusiopathiae
parrot
kakapo
strigops
habroptilus
psittaciformes
aves
fledglings
nestlings
incubators
erhusiopathiae
antierhusiopathiae
vaccinationchicken
astroviruses
castvs
11672
castv
gst11672
immunoperoxidasebased
antibodydetecting
elderlyvaccines
lessthan
electrogenetransfertherapeutic
geneelectrotransfer
interventionexposure
samplesstreptococcus
lancefield
mucosathe
uropathogen
5336
197219
472779
050083
119169
131289
111196
115170
124191
130218
conebeam
factorsecreting
effectortoregulatory
radiationimmunotherapy
glycopeptidespecific
immunotherapymuc1
galnacαmuc1
springbok
antidorcas
marsupialisfailure
zoologic
handraised
nondomestic
marsupialis
olakes
yglutamyltransferase
sulfite
turbidity
phenotypeaspergillus
irradiationkilled
moldassociated
ibne
nonacceptable
281±
erbbretargeted
opportunitythe
il2ifnγ
anticd14
igg24
inflammationcd14
crosstalks
cd14specific
igg2igg4
rmil2
cd14mediated
fceffects
r18d11
immunitymediated
36128
403533
10500
64000
1330dose
2660course
798dose
2394course
2408
4816course
1518dose
4554course
4565dose
9130course
2959dose
8877course
subclassesobjective
vlp16
vlpmia
singleseropositive
multiseropositive
vlpinhibition
7894
multipositive
α9
commuter
extinctmystery
esparza
saviour
romaniaobjective
constructions
affectbased
irrationality
answergetting
allotransplanation
abmtrrbased
hr219
hr383
hr234
anticd154background
dst
dstmr1
cmimmunized
dstmr1treated
cd8cd4foxp3
troutfor
immunoprohylaxis
samplingvaccines
megaphone
travelersyellow
abim
agago
kitugun
backache
shivers
globallya
reviewevery
igoogle
effectivenesscostbenefit
bankdefined
10000outcome
nct00772109
ecchymosis
dt390
il2porcine
nonnglycosylated
nongly
bigly
binongly
lcl13271
biocsls
yts1779
anticd4induced
il2independent
bactransgenic
grippotyphosa
conjunctivally
thrombocyte
bratislava
medicinevaccines
michiganobjective
1252655
careassociated
yukselen
arch
157288298
immunglobulin
inbronchial
aliterature
mallergies
endbackground
longantigen
bpsit
bpsitinduced
igg4epitopes
immunosuppressionsecondary
lipopolysaccharideimmunosuppressed
pathwaysthe
cowpoxvirus
tapdeficient
vehicleattenuated
typhihost
salmonellavectored
vaccinationnew
promiseobjective
1411bn
stimulationthe
wholetumorcellbased
her2neuengineered
tg11
fvbneun
tcellstimulated
fnnftvsfwlrvpkvsashle
advs
advovap30
advher2neup30
ovap30
her2neup30
dcovap30
dcher2neup30
dcovap30induced
bl610ova
dcher2neu
cellectra®
volunteersdna
carrierspolymeric
genecoding
betadefensin
timereports
mbd2
hadbased
hadhanp
βdefensin
hadmbd2
hadhanphadmbd2immunized
rgh5n1
strategiesfilaments
ftdp17t
avianlike
chi2
dehydroepiandrosterone
metyrapone
miceprior
dhea
antiglucocorticoid
mettreated
lpsimmunosuppressed
knownwe
trimab
abigail
adams
1776
renoprotection
proliferationdependent
vivoalternatively
linkobjective
lackingvideo
httplinkslwwcomcopma9
20042011polioviruses
vdpv2s
kasai
20062012seasonal
reactogenicityan
dbrcts
n56562
n45512
31d
rr099
094104
rr091
077108
082098
078168
049427
antihumanccr4
issueover
firstindisease
cyclosporinemethotrexate
10mgkgdose
days151428
stdrx
5985
4673
hunts
stikosop
lymphocytetoneutrophil
immunotherapyirradiated
gvaxwith
122567
103693
allostatic
lthe
pentium
25022008
confinement
oversensitivity
polyiccontaining
liposomesmany
78h
533777
278527
270476
effecter
aluminume
djuvant
o157identifying
cattlehuman
supershedding
nonlinearities
humananimal
nonageadjusted
vaximm
underimmunizationsocietal
differencesgenetic
substrainrelated
nonstandardization
protocolspossibly
cocody
coastbackground
cocodys
2557students
n1174
ratio2419
8657663
ratio234
154356
ratio37
ratio683
4571027
ratio359
260496
ratio204
113364
ratio160
109235
ofpertussis
208100
203100000
388of
reconstitutionreducedintensity
erythrocytebinding
falciparumbackground
eba175
riiiv
eba140
rivv
adenovirusrelated
hadvrelated
disproportionalitybased
timetoonsetbased
algorithmobjective
shrinker
mgps
amedian
highestranked
timetodetection
thmycn
neuroblastomacurrent
immunocombinational
wellexplored
thmycnderived
9464d
antinbl
immunocombinatorial
atherosclerosisa
modeldue
ade2f
antibodieshuman
31e
ptx8048
ptx804831e
200400ngml
csarelated
sctseveral
3660
3157
hlasibling
lymphohistiocytosisreducedintensity
infusion±hematopoietic
boost±repeat
rsiv
megalocytivirus
cagecultured
inland
reservoirmegalocytiviruses
trbiv
mff1
megalocytilj2012
megalocytiviral
chopr
doxorubicinbased
5211074
2101074
003034
effler
kelly
hyopneumoniaetolllike
grtlr
duroc×meishan
hyopneumoniaeinduced
vaccinemycoplasma
curving
lcd
aerosolization
7075
nestedpcr
overgrowthobjective
cypa
3972
pbi
ratio364323
25791
0096
r0366
0355
and0232
secretionobjective
276±32
135±27
131±23
118±30
measuresa
farmdistancebased
10km
3km
cefotaxime
heamtopoietic
hladoβ
dob
hladob
hlaa2immunoprecipitates
hladob232240
fllglifll
hladob185193
vmlemtpel
relapsedprogressive
gliomainfiltrating
receptorαmalignant
il13induced
il4rαdependent
gmcsfinduced
antib7h1
preventionreversal
ot2
ismabtargeted
615162
©2013
perspectivehepatocellular
vaxirabn
pitmanmoore
indiazydus
cadila
200710
ichgcp
rvnab
trc
centric
zydus
2010091000055
2010091000509
hollingsworth
alhollingsworth
isturiz
miscounted
uninformative
1403
3981205
4041189
683990
296643
imagingdisappointing
antibodytau
intracarotid
volunteersbackground
p52p36
stageexpressed
p52
p36
fivebitevolunteer
200bite
exposurevolunteer
collaboratively
condone
worldrecent
unexceptionable
leishmaniasisleishmaniasis
antihbr
kalaazar
hbrdna
hbrdnavaccinated
metaanalysisto
rr078
rr158
ci090
rr085
ci066
outcomebaselineadjusted
mixedmeal
mmtt
yearshowed
mmtts
0565
2012the
hepb†
ags004induced
cd38hladrpd1
b3induced
contractile
dcm
fibosis
myocarditiscaused
picrosirius
cvbinduced
dioctadecyl
ammoniumtrehalose
dibehenate
gp120iiib
gp120binding
th17like
bathvaccinated
anguillarumbackground
bathvaccination
hoststumorspecific
antiadenovirus
adenoviralinduced
differentialsbackground
lifesaver
intimidating
nfhs
multivariatepooled
mvahkenv
rlzhkenv
cxcl10based
glycosylphosphatidylinositol
cxcl10mucingpi
fplc
mrnaloaded
carcinosarcomabackground
carcinosarcoma
asthmaevidence
asthmawe
shlag
cxcr3cd4cd25cd127low
ccr4cd4cd25cd127low
allergenstimulation
ilt2cd4cd25cd127low
probeset
csag2
magec2
il13ra2
approachbluetongue
panbtv
seg10
divatest
scenariosbackground
35l
countrytocountry
locationtolocation
vaccinationasthma
useserious
aidememoire
cj50300
123139
139145
169h
46min
j77416
epitheliallike
23bis2methoxy4nitro5sulfenyl2hterazolium5carboxanilide
ritrelated
feedingrecent
19782008
muchreduced
offclinic
convenienceobjective
am600
evenings
6250402
workingaged
immunizationbased
atkins
munchpeterson
developmentstreatment
570741
10221287
subjects4
scientificeducational
schmid
sordellii
tcsh
vaccinesclostridium
tcsl
picardy
singleparent
cd44v6targeted
myelomagenetically
multipletumor
steminitiating
cd44v6expressing
nonnip
959100
307854
marinobufagenin
cardiotonic
mbg
fivesixths
pnx
antimbg
3e9
digifab
antidigoxin
digibind
redfast
criticise
cllchronic
strategiesover
chinarotaviruses
113808nct01171963
3148
541836
rix44146
placebo7
statespostmarketing
prr2
χ24
14822
dodavid
ropiek
pinpoints
invocation
austrias
lowuse
lowestuse
unquestionable
directionsbetter
trustobjective
skinhair
springborn
nfvaccinated
nsvaccinated
annular
rhinoconjonctivitis
phostal
stallergen®
pteronyssinusdfarinae
marys
rtxppintravenous
rpi
immunologyamerican
immunologypractall
hrhpvs
centuryhealth
poorhouse
alessandro
bennati
campanas
farmacopea
ferrarese
d45
d360
luorescent
gmt005
titers05
p0545
8984848
105284
230915
3021313
keratoconjuctivitisbackground
rinitis
casemethotrexate
patientís
12steps
hoursí
50mgm2
vaccinesmucosal
h1n1pdm2009
pdm2009
kagocel
nodosumfixed
erythemaa
tgfâ
yearsabstract
stipulate
humanimmunodeficiency
patientsdendritic
navelbineplatinum
535924
545695
makingimmunisation
ebmtwe
tbi12gy
thiotepabuflu
tbi12gycyclophosphamide
eczemain
italyinfant
mnccvcrm197
mnccvcrm197induced
19122
16772
21802
26619
23486
43228
36122
51731
73084
64205
83191
pcv13pcv7
ova257
antimcd138
treatmentssuch
lenalidomidesubstantially
radioimmunotherapyrelated
n400
82127
90133
71102
96143
ntr2316
dermatomyositispolymyositis
dmpm
senegalthis
10298
elderlymodern
advocacyobjective
freeride
onlineexperiment
workersexplore
pertussisanalysis
microl1
activization
group007
group042
fan
lobbys
virusesrecent
avietnam12032004
mammalianadapted
futuregrowing
capitalization
cancerduring
nowfood
katie
lockwoodnick
giannoukakis
immunobiotherapeutics
mentored
mdphd
founders
diavacs®
guns
1fragmentspecific
fragmentspecific
modalitieseosinophilic
eosinophilshighpowered
colleague
pathogensa
isolationobservation
suspects
immunoglobulinmediated
substituteimmunoglobulins
pharmacokineticallytargeted
remissionallogeneic
μmoles
minl
5277
1739
potentialone
cd45roccr7
therapyadenovirus
a01restricted
tdl
tetramerstaining
anticd3anticd133
vivocd133
bsabcik
cd3cik
s100p
il18bp
vaccinesunlabelled
standardtitre
ez
8699
gmt2114
11532412
gmt807
722908
datadecades
postorthopoxvirus
orthopoxvirusassociated
vaccinesdomestic
epizootiology
re1
agooseguangdong11996
re5
aduckanhui12006
2321a
minimumintensity
70cgymin
7cgymin
70cgyminute
hematotoxic
7cgyminute
adultsa
experiencecombination
3component
8μg
myopericarditis
23647790
malignanciespleural
pleurodesis
ipdelivered
foxp3high
fasfaslinduced
apoptosisoccurs
cd4cd25enriched
expansionobjective
beadisolated
magneticbead
beadenriched
cd4foxp3high
cellcycling
zb4
toxicokinetics
toxicodynamics
repeatedcumulative
alkylmercury
abate
confuse
toxicologically
depigmentedpolymerized
placebobased
2621002
3471071
p00385
regimeshifts
prevaccineera
dynamicsunderstanding
epidemiologys
multiannual
smalleramplitude
agedistribution
passivelywaning
kongthis
clientspatients
infectionhookworms
acemep6
10187
ancylostomiasis
chemotherapyhypersensitivity
reactioninducing
surveillancefrom
zeroreporting
nrc
measlesvirus
mvgenotyping
sentinelpractices
n1383
sentinelcases
nrcinvestigated
varizellen
germanymumps
reunification
successional
19682012
thatas
effortcoverage
20112015the
casescorresponding
participative
pursues
intervention1political
3easier
4communication
5uniform
6targeted
rubellavirus
memberstates
commissions
courtmeasles
infektionsschutzgesetz
prohibition
januslike
educationachievement
n3002
n4483
1685years
healtheconomic
vaccinesalthough
5297
19892008
876953
processmeasles
whoeuropa
regionsubstantial
23871
29361
stipulates
pccl
pcclspecific
doublingtime
bibnabs
preric
p00042
summertwo
dosedistribution
groupp0
5549
bcgdespite
micestaphylococcal
superantigenic
tsst1induced
pcdnamtsst1
mlt
tsst1specific
obsession
2012at
wellchecks
phbpp
vaccinationadditional
1169
44105
initialadditional
aerogenic
loadthe
sicam1
nonstimulated
fungous
countriesdevelopment
multigenome
maternalfetalinfant
noninitiation
cancereffective
cancerno
vasculatureabnormal
expertsincluding
advocatesto
pegylatedinterferonα2b
immunizationpotent
derivate
polyriboinosinic
acidpolyribocytidylic
qualms
experiencedue
cfsectls
tumornontumor
dvalue
fivemicromolar
0849
0318
mayotte
oceanbackground
304408
147232
152460
163407
mayottefrance
sexuallytransmitted
113850
ahr040
023069
speciesinnate
2deoxyribocytosinephosphateguanosine
dpxsurvivac
cellstargets
immunotherapytolllike
implicationslate
nonproportional
physiciansone
clinicallyeffective
microscopytranscutaneous
penetrationenhancing
cubosomeformulated
assayobjective
stfr
preist
nonsaa
021242
013188
treatmentglioblastoma
complexesthe
csdna
alcsdna
pgjapvax
phmediated
chinait
auxotrophic
pantothenate
auxotroph
myocbacterium
bcgδpancd
chacma
rbcgδpancd
ifnγspot
foxp3poly
h1h17
h13
h1h16
trachealung
virusimmunized
h9induced
prevaccinationunlabelled
20112012season
acalifornia709
aperth1609
bbrisbane6008like
clinicaltrialsgovnct01422512
pdl1b71
id8
fvax
childhealth
maternalhealth
headcount
reproductivehealth
decreaseincrease
headcounts
leukemiareports
pmrd
130530
150480
310720
40430
30340
200620
70350
acceptanceat
deadh
aspglualaasphis
cellsaccumulating
cscspecific
ddx3x
ddx3xprimed
antiddx3x
5965
00038
00484
conjunctivitisobjective
armamentariums
epinastine
olopatadine
cromolyn
nedocromil
overtreatments
pathologythere
dysplasias
comprehends
trailresistant
55100
3976
dawnagents
progressb
experiencehivpositive
mlmin173m2
gmcsfil12
vaccinesgenetically
gmcsfil12producing
p0001although
aptamercd30
serumstabilized
aptamerbased
makingbeginning
heatshocked
inflammationnaturally
alharbi
m1activated
7778
prolepsis
datawarehouse
datamining
pseudosafeness
urging
nct00142389
httpclinicaltrialsgovct2shownct00142389
caledonia
p04154
milkmediated
granulemediated
sporozoiteinfected
17xnl
269±034
574±066
926±092
711±073
pyuis4deficient
pyfabbfdeficient
068±010
153±022
106±026
cs280288
macaquesunderstanding
inducedresponses
toxoidfivecomponent
dtap3ipvhib
nct00287092
marketsberlin
costofgoods
marketsphacilitates
34275
effectivenessof
mdt
exudation
organizationprequalified
279814
558775
738969
792944
posttoddler
antiiga
providershealth
hourlong
eusanh
2012vaccination
over18
under18
magazinesbooks
gentle
anthropomorphic
90yzevalin
deliveringanthropomorphic
tissueequivalent
90ylabelling
thermoluminescent
lensequivalent
rando
expertnovice
diseasehumans
diabetesfoxp3
strongagonistic
bioparticlesneedlefree
sotiriadis
gynecol
obstet
jun2856171924
hi6
modelhi6
psobest
240316
osteosarcomahypersensitivity
electrochemical
treatmentscancer
unipolarpulsed
currents
alphaemitters
224raloaded
recoil
atoms
haltedthe
cellshepatitis
hcvreactive
tetramerassociated
1mgkg6h
1105mlhkg
1574mlhkg
auc06
79µghml
57µghml
myelosuppressionrelated
35based
adultsmalaria
adenovirus35
vpml
20062012although
410635
infectionenhancing
deltag
rhrsvδg
asiadespite
minimalintensity
xscidpatients
xscid
125mgm2
italyassessing
contactless
epenhanced
adolescentsinformation
telephony
socialnetworking
entertaining
wikis
microblogs
hscfveta
vitroantibodies
anticml
pww20
βdthiogalactoside
periplasmically
membraneelisa
ku812
amsterdams
saunas
il12molecular
dnapil12
lestoquardi
theileriosismalignant
lymphoplastoid
pcv7pcv7ppv
4261
0508
p1024
p1061s
matsbased
5585
childrenduring
n639
watching
therapiesalzheimers
declarative
dorobjective
2fc
il2fragment
cd4cxcr5
credentialed
nonemployee
kasss
jurisprudence
burdenshealth
accentuates
thailandradioimmunotherapy
131rituximab
sarawak
interannual
climatically
sibu
meteorological
iityped
postsubunit
arsh
revisitedthe
programatic
fructus
denudata
cellsmagnolia
cd3cd28stimulated
piinduced
signalrelated
34months
587686
753834
0136m
0308
vasculitislarge
hormonereleasing
recipientsanimals
flt3linduced
myocarditisexperimental
heavychainmyhcα
peptidecomplete
adjuvantimmunized
myhcαloaded
myhcα
cd8αvaccinated
tld
conventionaldose
posttld
19992008objective
possibilitiesneurocysticercosis
taeniacides
eradicable
cysticerci
methadone
motivationalenhanced
nonadjusted
multivariableadjusted
nonhdl
glaucomaobjective
rgc
p000003
irkut
chinaan
irkv
morereliable
challengeidentification
devotes
cil10
cmvil10
rhcmvil10
platformglucan
β13dglucans
submicrogram
ifnγil17asecreting
translationally
0·21
0·12
0·38
2·96
1·45
19·9
oropharyngealgastrointestinal
1·95
1·08
1·19
ukthis
indentifiedimportant
immunizationinflammatory
ionized
iba1positive
modelssensitization
cytopeniabackground
cytopenic
noncytopenic
folliculotropic
fungoidesadvancedstage
intraseasonally
paraesthesia
quebecfrance
comparisonduring
overexaggerating
innocents
gunfire
reckless
elses
entitle
immunotherapyreply
nonregistry
studyenrolled
238292
0607
0809
αiibβ
km114
carcinomaimmunosuppression
p0730
cd425foxp3
rejectionmesenchymal
antiasialogm1asgm1
cancertcr
intoxicationdiphtheria
hmabs
hmab
315c4
factorlike
glioblastomapreclinical
her2null
her2il13rα2bispecific
antifapf19cd28cd3ζcar
fapspecific
227g
023gday
0023gday
532375384
0023g
nanoshellenabled
transferablative
cd11bly6gc
postablation
bloodwe
ratio212
aberrancies
directionsipilimumab
ipilimumabs
allure
researchwhen
venipunctures
prophylaxisdepletion
3447
amlreducedintensity
preallohct
allthe
tcdallosct
timetodli
185days
4987
pneumocarr
genevaan
vecol
opaspecific
vesiclesouter
opadependent
ceacam
ceacam1binding
opaj
jeju
2012typhoid
3yearperiods
02montholds
2596
19972004
programmessince
neisvacc®
manitoban
métis
fnmi
crossethnic
equalize
aidp
aman
amsan
affection
nodshiscid
r0334
r0247
r0841
conceptsbackground
kongvaricella
kindergartenbased
parentadministered
12851538
19·5
57·6
squatter
107147
157180
126200
lowerthanexpected
acidpolyllysine
gammainduced
interleukmin
aliquots
controlledrate
recipientsfertility
antibodiesintravenous
gamunex
talecris
gammagard
baxter
grifols
eluated
spirulina
arthrospira
outcomeimmunotherapies
egfrviiitargeted
glioblastomawhile
easeofproduction
874days
482141days
specialistcertified
90yepratuzumab
principlealthough
rait
parentsprimary
explainadvise
injuryautonomic
telemetry
dysreflexic
micturition
catecholamine
tawaga
serotypedependent
spainin
10foldlower
dosevaccination
9group
dni
vaccinedominant
translocationdeficient
bretonneau
saintcyrsurloire
2012held
pierrefidèle
17781862
antidiphtheric
18941898
18601890
césaire
phisalix
inauguration
stele
modelpostresection
ab1ha
reportporcine
onecircoflex
mycoflexcircoflex
anovatest
flexvaccines
h1n1like
abms
h1n1type
opensource
alleghany
censusbased
30986
subspeciality
widevariability
212pbobjective
35a7
mird
formalism
212pb35a7
ms94
212pbpx
ms18
212pbmabs
hbvgenome
cregion
coalescence
nonimported
genotypea
pedometer
25187
20213
11167
9464
16516
11722
f168
η2
f166
vaccinewildtype
modalityadoptive
biotherapyboth
multipotential
tranplantation
mscshlag
doi1011770009922813491313
50701background
ofatumumabbased
pco
5681
combinationtherapeutic
sfvee67
sfveova
85fold
infectioncytomegalovirus
mcmvspecific
diseasescorrect
alloreaction
il17deficient
openehrthis
openehrbased
lightweight
updatable
letus
sharable
openehr
newyorkpresbyterian
standardsbased
ezvac
openmrs
semanticbased
knowledgethis
jena
keywordbased
runtime
radiobiologic
lymphomaunlabelled
normalorgan
maximumtolerated
mtbeds
mtbed
39369
042754
maximumallowable
3drd
pa28
pa28αβ
psme1
antipsme1
signalisation
middeploymentthough
middeployment
efa
hypertoxigenic
jhh
maisonneuverosemont
hmr
nap1
non7valent
netherlandsour
7900
sociogeographically
approachsublingual
educationalfollowup
educationfollowup
nephropathyhydrogels
healthyhydrogel
uuoil10
uuohydrogel
uuohydrogelil10
hydrogelil10
variantscurrently
purer
aheaddendritic
myelomarelated
autosctrenal
3mgdl
194mlmin173m2
diseaseaspirin
lymphocytederived
bichat
bcb
6972
2925
13074
medicoeconomical
ly49gb6
ly49gbalb
transplantationinhibitory
educates
ly49g
ly49mhci
h2bxd
ly49balb
pro1
museum
spainthis
111738
n26500
n16217
991235
activitiesbackground
11specific
immunotherapysubgroup
ad11
tyfnlgnkf
ad11infected
tyfnlgnkfspecific
antiad11
polyethyleneglycol
conjugatedasparaginase
lasparaginase
pegasp
hydroxyzine
multiadjuvant
wctv
singleadjuvant
wctvs
pediatriciansthe
transplacentally
mvaencoding
mvaova
gmcsfdifferentiated
mvaovainfected
wtmva
ankaraovalbumin
safety12–13
hbvcpg
guanosinerich
hbvodn
hbvcpginduced
nphbvcpg
hbvodnmediated
nphbvcpgbased
boyshuman
nonstigmatization
nondiscrimination
2fluoroaraa
carboxyethylphosphoramide
20441
withinpatient
4hydroxycyclophosphamide
assessmentsthe
mechanismstherapeutic
vacc4xspecific
antitgfß
foodmethamphetamine
brainmediated
icklhsmo9
lever
reinforcers
n9group
icklhcys
kd139
statesadvances
170628
stacked
108900
100500
115200
67000
41900
242000
502000
276000
113000
cmltyrosine
childhoodprevalence
soars
reconsideredapproximately
transmissioncape
us110
us116
us9237
us524540
ivadministered
skils
ivdose
nct01066390
groups2
schedules3
interscience
icaac
ccts
proteinvector
cellsconsiderable
id93
ad5id93
id93glucopyranosyl
glastable
id93specific
id93glase
cd4cd62lcd45ra
dtap†
1emsp14year
1617emsp14years
6emsp14months
n606
n214
immunosuppressionsclerosing
fibrocollagenous
mesenteries
vaccinesharvesting
immunepropelling
oqs
035512
hiv12epitopes
populationevaluation
pleguezuelos
stoloff
caparroswanderley
hiv2
fco
sampsons
020081
020088
inteferon
relationshipbackground
polymorphismshaplotypes
rs1035130phe251phe
cd176
leukemiacd176
thomsenfriedenreich
asialoglycophorin
schedulesalternative
extrapancreatic
cryoablations
44393
carboplatinepithelial
transcœlomic
codefines
antictla4based
cellculturederived
hcva
antigenwith
talp
evils
divine
demystification
phacilitate
argentinaprofiling
aspirations
reluctancestudies
imagingthe
sitestargets
3dbioluminescence
antiluc
gfqsmytfv
1367
processa
feverdengue
338364
heightening
sires
fmdvseronegative
sire
intrabreed
mtreg
alginolyticusbackground
hpts
fva
7dayhvape
7dayfvape
lva
735dayhvape
fvape
hvareceiving
fvareceiving
hvape
phagocytised
selfreactivetcellsto
regii
classiimismatched
regiipulsed
regiiderived
2point
affectivecognitive
transplantationaplastic
vaccinesadverse
undisputable
reasability
immunedisregulating
expertiseconsuming
consultancy
rss
monosensitizedpolysensitized
cancernonmuscleinvasivebladdercancer
transuretral
arraystranscutaneous
fma
poke
fmahydrogel
irradiationto
jichi
smcjmu
uth
experimentsneutrophils
centrifugationbased
surgeryalone
00272
07567
mobilised
playperformance
ebmteln
practicegvhd
delphilike
virusdiva
epitopem201
161174
omph
ediiiomph
ediiispecific
omphmediated
survivorshematopoietic
phq
irondextran
avidincoated
nanocrystals
artifical
cancerdirected
outcomeadoptive
advseropositive
ebvbzlf1
cordblood
cellsmedulloblastoma
sonic
shh
cd1dpositive
plateletpheresis
upl
fdpl
nonxenogenic
recombinantsin
vaccinesorg
testinghamsters
electrofused
heterokaryons
cureimmunotherapy
immununosuppressive
catstreatment
callsbackground
karmanos
kcc
neutropeniathrombocytopenia
boostingmemory
bioenergetic
biologyadoptive
syntheticbiologybased
tumorcellextrinsic
exvivoactivated
fieldvaccinated
annulling
sourcedependent
danderobjective
mfp57
02lar
immuneorgan
availablemethods
calculous
cytokinotherapy
splenopid
dysbalance
tnfalphail10
il2il10
antigenpartially
pmrds
hsctwithout
diabetesinsulindependent
lifestyledietary
mothersamong
cuiabámt
hrvrrv
72hour
25hour
26929
7951105
94364
7733812
bradycardiadesaturation
14612
frequencyhigh
lfhf
oversimplification
diavaxwe
5682
structuralsystematic
cd35
tgfbexpressing
particlesbiliary
rrvinduced
rrvinfected
400800
cholestatic
25600
adjuvantactive
6aβ15thc
aβassociated
6aβ15thcimmunized
housedustmites
doubleblindplacebocontrolled
lacebo
anzctrorgau
actrn12613000315718
designit
linecoded
multiadjuvanted
achemists
francean
alltype
narcolepsycataplexy
21199
aged18
16139
immunizationgroup
years†
il1βil18
covaccinated
piκbαsr
trp2encoding
isletsbackground
isletkidney
ik
islettoxic
cyclosporineazathioprineprednisone
pancreatectomized
equivalentskg
10028
bcglike
scardocumentation
vaccinationscar
vaccinesfour
challengesdesensitization
challengesilent
regimenspecific
leukemiacytotoxic
lvgenerated
twocolor
293493
incumbent
preparers
fluorescencebased
quinone
oxygenase
syntheticexpressionoptimized
rtderived
papillomavirusa
selfpropagating
slayers
ischemiamediated
pcimediated
subepicardial
intramuscle
15072
growthgastric
forestomach
tpm
arg
immunizationdeficiencies
utake
matterchanges
vaccinationidentification
doihttpdxdoiorg107554elife00299001
cellstolerogenic
pkcis
bisindolylmaleimide
gö6983
ro320432
pkcitreated
hiv1in
ablike
imab
pg9imab
pg16imab
imabbased
congorotavirus
witchcraft
e7pulsed
adenoshrnasocs1
viruscervical
adshrnasocs1
me7pulsed
proteinpulsed
72months
05mgdl
53months
myelomabortezomib
bor1hdm
bor2hdm
therapiesreport
cimt2013s
phosphorylatedtau
neuroinflammationthe
antitangle
alzheimersdisease
phostauimmunotherapy
tauimmunotherapy
unphosphorylatedtau
cnsproinflammatory
completefreundsadjuvant
pertussistoxin
wtmice
neurofibrillarytangle
nftmice
agedmice
cfapt
phostauimmunized
antiphostau
tanglemice
g14p24
reviewinflammation
2011unlabelled
5250
776871
663775
533574
354394
rr19
pcip
64cudotacetuximab
64culabeled
dotacetuximab
64cuacetate
p53positive
p53negative
tissuesit
antigen4igg1
m2positive
ccaat
ctla4lg
antiobesityinflammationinsulin
targetengineered
cd19cartransduced
bought
mexicomexico
mmh
neutering
antigonadotropin
navajo
bitches
61day
prostration
networksspreading
introductionobjective
juiz
nonhospitalized
1071144
90809
17335
g1p6
leukemiarelated
pdpdl
kirclass
miceheterologous
bin66
preplaque
βsecretase
diseaseswith
mata
nonnasal
at2r
updatechlamydia
mgt
deferens
egypthighly
cafi
calculates
hpaiendemic
enderadication
reconfigured
growthobjective
antimv
bmhmscs
mvinfected
heterofusion
antibodynaïve
passivelyimmunized
achangin
tobaccocessation
obstetriciangynecologistsbackground
paps
β045
β026
β020
β022
β058
questionnaire5
91602
6417
10281602
341602
6636
genderadjusted
6423
9073
235259
141185
166247
150245
6068
142234
4905
103210
91222
13711516
9376
661705
8755
719811
16829
patchskin
acaroid
300300
tuday
10001000
30003000
mitescit
ptges
asexual
pynl
vaccinatedpynl
cathelicidinrelated
cramp
pynlinduced
bcgvaccinatedpynl
parasitemias
noninvestigative
rhinomanometry
cobwebs
ceapretargeted
nonradiolabelled
anticeacam5
haptenpeptide
bsmab177luimp288
tumourtotissue
sohs
3921
£105
3803
133170
141288
vaccineseeking
hesitancyunvaccinated
ratsunlabelled
uncommunicable
streptozotocin
antimouserat
troponint
8ohdg
myeloperoxiase
peroxides
mop
vcam
therapeuticsalzheimers
fervently
aggregatio
encephalitistickborne
replivax
replivaxtbe
rvwntbe
langat
17dtbe
2tbe
e5tbe
underattenuated
agentslocal
vaccinationduring
tricalcium
phosphatesbased
immunotherapyzn
mgcontaining
phosphates
tcps
htb
zntcp
mgtcp
htbcontaining
supersaturated
htbloaded
mgtcps
znaphtb
mgaphtb
unprocessed
taphtb
liquidnitrogentreated
etiquette
80n
ph1n1vaccine
102435
2043360
4772738
modelnewgeneration
pfv
ffvbased
catbased
nic23the
crucell
glaxo
kline
kindly
stockport
influenzafor
295000
diseasepretransplant
esterlabelled
homingprivileged
gonadally
adenohypophysis
ultramicroscopic
reweighting
reweighted
recommendationsbcg
minorityeastern
infantbcg
oxfordshire
buckinghamshire
crmglycoconjugate
crmgroup
psgroup
nct01459432
vaccineelderly
mf59adjuvanated
asolomon
island32006
awisconsin672005
caledonia201999
s0115we
alm
hostbased
swog0115
xenotransplantationthe
survivalmodulation
scd83
grafthost
scd83treated
kiel
55year
claeg
321days
1252days
22assessable
beamalemtuzumab
trasplante
hematopoyético
geth2005
gethgruppo
gitmo2008
gethgitmo2008
estimatesvaccine
materially
gelatinthe
immediatereading
hypersentivity
gelatincontaining
sensitizationallergy
toleranceboth
ctla4independent
herniationdespite
discectomy
herniation
complain
sciatica
herniated
pulposus
annulus
fibrosus
gelatinous
endplate
sandwiched
faslfas
3129
patientduring
industryobjective
prevalencebased
jmdcs
effectrelated
unconsidered
noninoculation
suzanne
topalian
therapiessuzanne
sidney
kimmel
remissionminimal
5783
4185
710yearsobjective
antibodystimulating
domainspecific
n1047
7266
8127
10341
scores051
interval026
b008
2013pancreatic
3067
lba4004
argentinaobjective
prospectiveretrospective
beriglobina
618years
36week
139mgkg
105181
infectionssubjectyear
highpeptide
hytreated
cptreated
cellsmurine
mdctbet
mdctbetbased
cd11cdtr
antigencrosspresenting
mdcnull
tcellrecruiting
outgrowing
2009in
taian
schoolsdaycares
714903
ratio47
swinedue
204iuml
60±09iuml
145±22iuml
1491
42±04iuml
109±17iuml
compel
personnelin
range2735
scores1123
treatmentlocal
autovaccine
entirepeptide
h5fowlpox
vndvh5
vfp89
vfp89vndvh5
105121
125255
100150
22618
7948
polychotomous
aboirtx
comtec
kabi
ahg
departmental
10mgdl
porphycene
implicationsinflammation
porphyceneantiicam1
tumorsdue
jshct
654±66
hlhassociated
800±126
som
networksepidemics
forumthe
sinaweibo
mediamicroblog
infantsto
infants12
hibprp
weekscyclosporin
dosageadjustments
zwitterionic
13201
20092011background
miv201011
ratio154
059399
difference093
071516
ratio773
3601661
difference1162
4492694
virusesthis
nsv
nsvbased
nsvgag
vvgag
ndvgag
46298186
77437980
hpv3133455258
higherlonger
n25000
th1tc1
singaporeto
nct00880893
cd4ifnγtnfα
yf17dns3specific
cydspecific
cyd4
singlelevel
immunodiet
ied
snd
nct00970307nct01171989
vaccineoriented
tolerancepromoting
leukemiaimplications
ifnγenzymelinked
06years
diphtheriatetanuspoliomyelitispertussis
35montholds
tumorsmodest
wāhine
hauora
nonmāori
shepherds
phagosome
waythat
householdsobjective
2proportion
155195
7481
immunosuppressionmultipotent
mesenchymaltype
recipientindependent
mapctreated
mapcmediated
retransplantability
mapcbased
exemptionsrates
morecomplex
tighten
201113
tightening
treatability
myopathysporadic
lobulated
fibres
slomn
vivoperipheral
phosphoagonists
nbpinduced
patientssplenectomy
4936
niesseria
chronicle
13002
χ213896
χ21296
p0255
hightitered
igim
hours1
oportunidades
12146
4628
nonoportunidades
2883
3896
43102
4192
vaccinationyear
rhinitisrhinoconjunctivitis
sctebvinduced
ebvbased
geertjan
boons
fenstermaker
jay
berzofsky
approachmany
zerotolerance
initialized
indanish
cowsin
formalinised
cbotulinum
antiley
13×109
in111labeled
encephalitisa
iswtbethe
iswtbea
practicioners
physicans
epidemiologistswas
diseasesincidence
radiotherapyradiation
transplantationhematopoieticcelltransplantationspecificcomorbidityindex
allogeneictransplant
reducedintensityconditioning
totalbodyirradiation
diseasetype
diseasestatus
hr029
00910886
hr041
02260752
proteinegg
uncooked
transgressions
supernatural
challengesobstacles
hlatypes
a26
a31
strategiesfood
diseasebehçets
pregnancymonoclonal
oligohydramnios
her2objective
chimerization
1t0
lateevaluation
bozek
ignasiak
filipowska
jarzab
242248
noserelated
sharpen
transplantationblymphocyte
haat
ligandstimulated
bsavaccinated
bko
haatbko
haatinduced
bcelldependent
rhinitisseasonal
congestionstuffiness
oralintranasal
n8360
acceptability504
n5048
supportiveaccepting
risksusceptibility
£2000030000
effectorcentral
cd62lhighcd44low
bacteraemic
us197
26103
8663425
infusate
beautification
boostingbackground
amputations
interferonγinterleukin
tcrligand
koff
chinafor
rfacit
inoculationfootpad
handsfree
analysisnumerous
hemocyanintcell
tdar
igmpredominant
iggpredominant
637762
fludarabinebusulfanantithymocyte
regimenabstract
seattledefined
138782
105878
reclassification
olddefined
nihdefined
lactealderived
ldcr
dairies
immunisationby
elearning
attributing
sheeps
cheese
inductionspecific
igemediatedfood
croissant
ricotta
alphacasein
541kda
practicecurrently
alkabellò
registrative
143000
admittedly
vaxfectin®
viremiawe
mir302c
mir520c
125oh2d3
16binding
cellstructuresensing
kasumi1
cytotox
3utrs
miab
immunoattack
lymphopeniadriven
transplantationadministration
lymphopenicdriven
nbutanol
awbe
watersaturated
schistosomeinfected
smap
antiawbe
2823
9kda
130kda
28kda
flavivirions
icosahedral
diiispecific
lymphodepletional
scary
threath1n1
d3n4
nonseroconversion
sledai2k
018098
antihbct
cscmrna
aliquoted
nct00846456
monoarthritis
b27
flogisticaseptic
voiding
recipientviral
bi20
iiitrialbackground
alemtuzumabrefractory
nct01138579
antifolate
microenvironmenttailored
52·0
9·1
3·0
ltaappended
ltaanchored
lectinized
carrieradjuvant
bmfs
graftrejectionfailure
pbpcs
hlaantigen
chronicgvhd
nct00003838
kicking
pricks
orientationbackground
nonsceptics
gelfand
prospectsmany
strategiessplenectomized
eusplenic
antipnps
glycoconjugated
wdpt
241722s
461180s
180180s
pcw
114s
062s
047s
storytelling
misinformationwith
polyribosyl
ribitol
ve90
for1
1blike
sivsme660cg7v
10x
intramuscularelectroporation
statesallogeneic
urds
allohcts
pdnacationic
dnacationic
pdnacl
nonelectrostatic
antifr4
anticd25mediated
influenzacoded
primarycoded
1·171·99
15·81
10·2824·32
1·03
pmcs
anti24dinitrophenyl
24dinitrophenylhuman
teaspoon
kilounits
038111
20062011objective
9180
153240
193346
90161
2007february
140565
104170
myelopoiesistumor
tumorreleased
cebpβ
utr
dormitories
centerbased
ci11179229
1045338
14785061
snpbased
82snp
salivasourced
kentuckyobjective
constantcomparative
cliniccentered
adherencerelated
antibodyconjugates
biovectors
racs
tumourantivascular
tavat
phototype
sccpatient
bccpatient
nmscpatient
dnaspecific
crosslinks
dnareactive
fcγiib
plasmacytes
metastasesan
infantsdelay
00069
burdenbackground
355874
cahps
proctocolectomy
advisablebackground
coloproctomucosectomy
3s
pouchanal
ipaa
ileostomy
2s
ileoanal
adenomatous
w30
w21
kgm²
germanytwo
068214
hositalization
coveragevaccination
studieswe
595983
rota075nct01171963
rejectionwhile
wellexplained
instinctive
fibrocytes
peritonitisfibrocytes
noneggbased
tripoli
libyabackground
2705
interleukin2based
pathogenesisin
fasdependent
loire
11216
10955
28212
17723
17460
nonfuzzy
dntβrii
amaxa
calu6
surveyour
vc1
homoeopathy
70937
136724qaly
89391qaly
transportability
pandemrixtm
cytokinesecretion
prevenar7
sorption
polystyrol
penumo23
523691
nonconjugated
eisenbarthtype
eisenbarth
trialtype
trialnet
challengesgenetic
testiscancer
micemycoplasma
multipleantigen
dribblespulsed
balbcnu
balbcderived
dcsdribbles
hccdribblespulsed
237287
m46
sd205
sd206
caix
15mer
caixpeptides
hladpb
hlab4001
seeegslkl
eteccaused
antietec
thaliana
vhhigg
vhhiga
cotransformation
igalike
feedchallenge
vhhigabased
afro
arci
predicates
sitomalizumab
xolair®
depigoid®
omalizumabsit
cadaver
rapamycinbackground
rapamycinbased
memoryeffectorlike
vβhprt
tcaim
colocalizing
oligomolecular
prospectiveobjective
doublepositivity
endostatin
rhendostatin
unmask
endgamean
hardesttoreach
vaccinewary
dividend
peril
firstas
broadscale
poliomyelitisthe
wildvirus
gpeis
eradicationrinderpest
continentwide
oftenunstable
diseasessuccessful
44000
32410
nonmaori
prospectsimmunosuppressive
qale
nonanemic
anemic
intermediate2high
bmtthat
microbleedsantiamyloid
lemur
lemurs
aβderivative
k6aβ130
antiaβ40
aβimmunization
recordlinkage
allengland
allages
189194
19992002
165171
328346
221245
brush
ceilândia
samambaia
sebastiãodf
prednisonetreated
onychomycosis
pityrosporum
nelson
studiespassive
bhk
hrig
ffd
5126
luoyang
3308
303105
50105
6327
aeficausing
χ23045
8058
9064
nchs
13033274
15455
4425
01day
060day
vitros
jj
4765
99122
281181
8621181
18yearsold
informationvalidity
ncsmcl
sdmn
4382
032055
csnps
melanocyteassociated
cssodium
tppgrafted
fitcovaloaded
gp100loaded
filariasisantigens
litomosoides
sigmodontis
gutag
lsag
gutagspecific
lsagspecific
cpgalum
alumcpg
ad5f35travtrbv
reacquired
cd62lcd44high
federations
brazilrecent
58100
3691008
39678
159512
15368
leukemiafor
blastogenesis
lba
vaccineone
surprises
kongchinahighly
nobilis
poulvac
harbin
achickenhong
kong882522008
kong7822009
kong8825208
133140
metaanalysisbased
23021885
badgersthe
recapture
vei
denmarkrecent
interspreadplus
davis
standstill
depop
inseminators
20002010we
816860
327500
neared
90but
multiformeobjective
craniotomy
7161380
6502304
²²thtrastuzumab
227thtrastuzumab
dcemri
contrastenhancement
voxel
kep
brassica
efhand
alphahelical
replicationtranscriptionthe
hpiv2
nonsegmented
hpiv2δf
replicationtranscription
βpropiolactoneinactivated
bplhpiv2δf
paramyxoviral
singleround
carcinomasrenal
systematized
routeanimal
iddm
tetramerbased
cd8cd45raccr7effector
polydesensitisation
pdsbackground
calendarsbackground
amsws
artwork
nonamsws
eno
cd25hicd127low
phpvs
4factor
jaipur
nonimmunised
kurgan
fareastern
encevir
tomsk
heterotype
kurgan1182010
failureallergen
alustal®
evacuated
kedta
prvspecific
igg2igg1
cd4cd8cd45ro
depressions
primeadenovirus
whv
whcag
whcagspecific
whvtransgenic
whvinfected
woodchucks
primeadv
etv
whsag
etvonly
antiwhs
nondiarrhea
telephones
computers
g9p6
rapidlygenerated
trivirusdirected
transplantadoptive
23week
muchsimplified
ebvadv
cmvadv
nct01070797
nextthe
infantscompliance
quinvaxem®
nct01470287
ctri201111002118
nct00764790
flu25
flu50
bflorida
101125
abrisbaneh1n1
154198
auruguayh3n2
157189
375°c
miriam
12x108
cellskilogram
nct01685606
pharmaciescanadian
periodinfluenza
longcom
v7onemonth
smearpositive
1stdx
5413
modeltumors
phototoxin
atac4
basir700
panbasir700
bonetargeting
closedflow
tumorsdendritic
gcmafbackground
gcmafcontaining
lipoic
saisei
mirai
matchingobjective
spongiosa
cellularities
ctderived
egs5
il15differentiated
3499
mule
odocoileus
hemionus
168vdqynnqntfvhdc182
145ndyedryyrenmyrypnq164
postprime
mucositisobjective
d16
d20
clinicas
faculdade
longevans
lactated
hemorrhaged
respirometry
triphosphatelinked
darunavir
darunavirr
41yr
raltegravir
nonhpv1618
9171qaly
17348qaly
42847qaly
3×gdpcapita
ccrelated
spreadin
crossage
sociodemographical
ns34a
chronvacc
ns345b
mvatg16643
ifnγtumor
tnfαcd107a
chronvaccmvatg16643
quadrifunctional
ifnγtnfαcd107ail2
listerians31a
immunecompetence
testinga
sox11
ybox
cytarabinecontaining
months145
deviceobjective
collagenfree
newmh
oldmh
pipii
fashiondespite
microosmotic
3859
reviewthymoglobulin
thymoglobulins
consolidates
europecurrent
programshpv
urologybackground
endovesical
emda
ipilimumabbackground
proptosis
abductiondeficit
hyperaemia
thyroidrelated
ophtalmic
infectionimmunebased
ibt
ibts
hivrecombinant
radiationin
chaperonebased
70peptide
hsp70pcf
radiationenriched
quails
coturnix
vaccinationchinese
6μg
nibrg14
aswannagybaracska0106h5n1
yanticd20
betaemitters
yyttrium
ccdtpa
ncm
dtparituximab
itlc
440480
isotonic
yrituximab
ydtparituximab
ramified
αsynoverexpressing
neurites
syndromespatients
cytoreduced
gr34
2158
1448
hr122
102146
nct00724009
ebmtboth
vaccinationotii
αβtcrs
yearsintradermal
titre1320
fractionaldoses
reduceddoses
imns05
imji05
imns01
idji01
158372
128342
cytokineconjugated
liposomesin
actcellspecific
il2conjugated
canadain
bishops
physiciancitizens
trustees
bishop
intransigent
councils
91104
farmingfin
coho
kisutch
ayu
plecoglossus
altivelis
cod
gadus
morhua
yellowtail
seriola
quinqueradiata
amberjack
dumerili
barramundi
paralichythys
pagrus
oplegnathus
fasciatus
alglucosidase
immunotherapyantihepatitis
productionliver
orthoclone
depletionmacs
alemtuzumabfor
inductionpreconditioning
erasteroidresistant
cellswhere
standalthough
lymphomasperipheral
ptnkcl
aitl
avirus
9602
rand36
ceca10
1618vaccinated
havvaccinated
intoxicationpulmonary
sgrq
cgrp
atderived
hatmscs
lipoaspirates
substrata
hcecbm
lfcbm
polygonal
phasecontrast
ck12
infectivesan
asymptotical
2127gy
695619425gbq
pivac
vaccinejapanese
herdspecific
200182ec
subjectrelated
agedthe
23374273
opportunism
11325
17227446
scn1amutations
n279
95ci06
95ci13
95ci31
385°c
disconcerting
h7n7ha
bacha
nl21903
multiparticle
nanotherapeuticbased
intoxications
hca
sv2
crossinhibit
nonsurviving
subprotective
nematodesseven
helminthfree
pp2ar
plurispecific
trichostrongylus
colubriformis
biopathological
packedcell
zootechnical
abomasa
cellslentivirus
uvinactivated
reinvestigating
vaccinationb
rabvbased
aavhfixneonatal
aav8mediated
hfix
fixnull
antihfix
hfixspecific
interferonassociated
cyclophosphamidemediated
immunoadjuvanticity
biosyntheticmetabolic
deathrelated
processingpresentation
oas1
ifitm2
ifi6
irf5
ube2l6
isg20l1
ifniinduced
cd14cd16
il8ra
marco
ifnirelated
endgamein
fourpronged
carryingout
moppingup
vaccineofchoice
antibodyimmunoconjugate
hessein
hesse
ögd
akari
adoptions
infectionlittle
highdiversity
nonmauritian
antishigella
nonm3
bea
525734
549756
103months
3240months
p00579
modelglioblastoma
oftenresistant
vascularity
g47mil12
conditioningthis
p095
421615
316624
p055
337525
232533
cllmalignant
outcomesinfection
dialysisrelated
applicationsatopic
apoptosisanergy
antiigeleukotrienes
glioblastomaoutcome
outbreakcanada
childchild
vaud
switzerlandeven
travelerwith
neurobasal
nbe
cellcytotoxicity
bbl
u343
highlyexpressed
cellulairewe
conditioningallosct
48202
pbscbm
4915
bufludarabineantithymocyte
duramune
dappilc
2010very
idt25
40komp
40kompspecific
anti40komp
cytokineassociated
spinally
survivalachievement
deliveredimplanted
caster
oilsaline
traumainjured
3451
pancreatitisfew
dlactate
košnik
lah
ak
20133157324
liespqa21
canileish®
perniciosus
xenodiagnosis
studyten
virbac
negligiblenil
subpatent
humansobservational
juxtaposing
ebvindependent
asserts
r2053
r2044
groupdrug
moleculessalmonella
localizes
vaqta
25u05
havmmrvpcv7
havmmrv
mmrvpcv7
zostervirus
difference51
folddifference
23moold
hesitancyparental
diseasesalzheimer
β2glycoprotein
nanopheresdna
neogenic
domestication
neogenes
icantibodies
transientlytransfected
hybridizations
vaccinationgenerating
childrenyoung
polysaccharideflagellin
glycoconjugatesnontyphoidal
copsflic
antiflic
anticops
reviewrecombinant
adolescentsgenomewide
p17×108
020102
0202
030101
040101
trend38×105
trend13×105
021055
008048
hladbp1
harmfulness
selfepitopes
developmentbackground
oligomerized
proteolipid
plp139151
oligomerinduced
transplantationgrowing
cd83fitc
53062±14065
459±10945
nigerdespite
sarcomasobjective
developped
filariasisthe
bmhat
brugia
malayi
protein126
hsp126
transcript2
alt2
tsplel
micropore
cattledespite
isa201
gahol
oiladjuvant
montanide201
macfarlane
esophagitisbackground
aero
caebv
vβ3
sickvisit
pediatricsadvisory
20002011objective
lowexemption
1916april
soul
dowels
puzzlethe
exposome
expositions
alluding
chess
checkmating
1998june
3375
4293
28867
acceptanceinternational
perspectivesvaccines
diseaseimmunization
preaggregated
gpgpglinked
4aβ115immunized
referencememory
watermaze
thailandhepatitis
nct00240539
concentrations10
milliinternational
milli
titer100
nct00657657
82fold
10824
trialrotavirus
26500
p1a8
multiplesource
perspectiveprevious
hpvvaccines
surveyparticipants
dispensible
telephonesurvey
interestwhen
polysaccharideinvasive
am3
casesaspirin
asiaasia
favourite
t1dmtargeting
20082011objective
phcws
5433
flocklevel
dynamism
steroidcontaining
erythematosusthe
hv
6593fold
260170fold
whodid
marketedinvestigational
immunetherapeutics
wavss
effectthis
outcomeptlds
isb
lsb
fourmonths
trialmemory
lfa3igg1
semielective
venoarterial
supportwe
41year
oxygenator
betathalassemics
regimensgonadal
stemcelltransplanted
thalassemic
59258
pretransplanted
pervpreviously
fppr
mper
mperspecific
2f5
nhr
cyscys
fpprnhr
prospectsallergenspecific
allergenexpressing
diseaseige
anticholinergic
osteomyelitisbackground
cierny
mader
ciernymader
t144
zambiacontagious
safetyface
1806
2978
singlesession
multisession
immunisationtwo
13519
schedulesrush
eightweekold
leadtimes
shipto
alphalactalbumin
theyre
sayingthis
sayingtwitter
6827
ouch
cohortno
naturalistically
pacifying
vaccinationowing
immunotherapieshemophilia
p03475
p00060
nct00421655
lcr35
lcr35treated
ovaspecificimmunoglobulin
gliomapatients
syndromeprimary
slowevolving
lymphotoxinβ
immunotherapymyelodysplastic
carcinomaadaptive
isletcell
isletpancreas
lyze
realist
regulationallergen
leprosythis
mwvaccine
lepra
histipathologically
bbbl
treatinggranulomatous
mimicdespite
sciiv
replicationdependent
gazi
tacerfacik
tacerfa
cdfs
transplantationhaematopoeitic
nongenoidentical
polarise
ethanoltreated
fcbased
eatme
hsp90α
penicillininactivated
tlrsstimulated
etumorfcs
immunotherapycombinatory
timeshift
costimulationassisted
m1a
as02b
magea3as15
dfi
gsnegative
84gene
7882
sulfonamides
overgrown
16step
cellrhabdovirus
rhabdovirusinfected
leukemiaoncotropic
ilov
cytopathy
marrowtransplanted
ilovvaccinated
therapiesmelanoma
resectablity
progressionperformance
trialsimmunotherapies
immunemodifiable
nivolumamb
applicationsresults
griscelli
2partial
albinism
gs2
216months
biken
updateallergic
biodetection
transplantationoperational
ringworm
norwaybovine
verrucosum
ringvac
ltf130
mopping
denominations
preached
appoint
owe
sf10
surfacten®
surfacten
sprelated
carboxy
nasalwash
hasf10
antihaspecific
hapolyic
nigeriaas
46130
17380
motherlevel
or0712
06410792
maleheaded
communitysurvey
500mcl
braininfiltrating
pc61treated
europeeach
nosocomially
cevag
vaccinesschmallenberg
insecttransmitted
malformation
sbvinfection
chinaprophylactic
2899
ptrend0003
ptrend0015
119172
200305
157352
037054
ptrend0009
vaccinesbeginning
jalisco
rfpvh7aiv
oilemulsified
1dayofage
dhppil4r
serovarsdespite
coveragesince
whoestimated
diptheriatetanuspertussis
poliomyelits
devolve
districtsubdistrict
accountobjective
3495
gavisubsidized
6amb
moderatelow
pollenhdm
2469
immunosupressive
clippersa
pittock
punctuate
mrifindings
mriscan
oneandahalf
naturopathy
anticd81
reinfecting
postbinding
3578
2461
4583
16767
9989
9750
8717
erubescence
9mo
vaccinationsas
degs1in
degs1
springerlink
degs1ten
lowhcvendemic
disordershuman
liquid®
96112
sbissubjectyear
sbisubjectyear
infusionsite
indonesiawe
semicommercial
legok
hpaicompatible
hpaivaccinated
pdsr
cow039s
igeinduced
therapycurrently
nonallergen
therapycancers
buoyed
licence
immunodeficieny
epsteinbarrvirus
supernumerary
teethdiscoveries
toothderived
sntscs
sntsc
nephritislike
sntsctransplanted
tcelladopted
2000–2012
lymphomaarisen
sitereceived
nsclcnsclc
8588
practicematched
okagsk
okamerck
mmrokagsk
57432
195432
schooldaycare
491840
778987
773918
905994
periodwe
2007december
thrombocytosis
coxiellainfected
n360
171177
192198
coxevacceva
sante
animale
hypertriglyceridaemia
dyslipidaemia
eruptive
glycaemic
childrenparents
150200ml
prickbyprick
2010this
hpvfrom
cattlepreharvest
ttsp
penlevel
n184
nebraskalincoln
testperiods
timeplace
ratio046
modeladjusted
037057
immunotherapygold
triethylene
teg
polythymidine
cpgaunps
cpgaunp
thailandpertussis
thailandboth
reportsover
likelihoodbased
unselectedyoung
lactatedehydrogenase
ppp1r3b
2369
antibodypodoplanin
aggrus
podoplanininduced
nz8
podoplaninpositive
cd161a
accmeso4
podoplanintransfected
msto211h
ecmps
mpaauc012h
mpaauc
auc012h
c0
tmax
2291230
0132004
4084236
10105
07491
2037
rhmtreated
apoptosisobjective
carboplatindcagcikcarboplatin
carboplatinpreconditioned
dcagcik
anemiaautoimmune
diseasedendritic
antilasparaginase
coursesa
lasp
antilasp
leukemiaeradication
1460
14180
78100
20yearolds
82·9
19931994
carjacking
liposomeadjuvanted
americanabackground
crsensitized
liposomeadjuvant
lcre
nondepletional
receptorssolid
therapysensitive
nonslowdividing
tafv
antigencapture
crowns
nok
gbp
10×103l
µgday
hr0021
hr571
carcinomagranulocytemacrophage
hepa16b78h1gmcsf
profilesurrogate
gproteincoupled
highthroughout
fty720p
βarrestin
gqi5
phenotypesobjective
dotblotted
trx
inductiontransplantation
terrorism
calamities
rupturing
breaches
vietnamthis
calmetteguérinrevaccinated
yearschildren
cambodiabackground
phnom
kratie
ratanakiri
arr194
ci175215
arr154
ci132180
primekv
p0800
primehs
vectorsbased
puzzleresults
languagesublingual
aworld
tamiflu®
67720
hbsagcarrier
multicenters
hbeab
453367720
391186
formulafeeding
p0761
jumpstarting
cllin
shanafelt
hematoprogenitors
557×106
11156
p0426
p0117
interventionsidentification
clavien
studyschools
developmentmycoplasma
20042008objective
34012
manhattan
therapyblinatumomab
cd19cd3bispecific
receptorengaging
nct00103285
proteinextracellular
humansoncolytic
pexavectreated
sclerosiscardiac
wtil2
cd8cd44hi
mb16f0
3lld1222
relevantly
nfa1
naegleria
fowlerinaegleria
fowleri
amoeba
131kda
pseudopodia
nfa1specific
fowleriinfected
¿questions
venomassociated
schedulerush
2911
postrit
readyoral
psychosocially
usefood
healthmap
criteriaany
onlinewere
10380
7171
potentialthe
indispensible
takatsuki
dihsg
immunopositron
tf12gaimp288
¹luimp288
¹¹¹inimp288
sevko
j6jfh1
huh751
activatorsevere
upascid
hcvparticleimmunized
ihcvigg
sequenceindependent
nonfibrillar
mostfrequent
2174
harmonious
beltobjective
pseudor2
therapyepsteinbarr
hiebvagc
bamhi
hiebvagcs
ebvlow
diabetesadministration
rapail2
il2boosted
indiatimely
19962009objective
mrrd
diseasesrespiratory
sul
parentled
microrna21
mirna21
il17driven
metallobetalactamase
th17based
coliinduced
bloodcombined
lepirudin
compstatin
umra
bcv
ascteligible
543564
systemiss
p0100
6318
3750
5938
7137
aav9human
brainwe
aav9mediated
hepo
aav9hepo
cd8lymphacytes
acirelated
rr165
i249
rr276
i246
i228
whorecist
imagingnoninvasive
¹f
spinlattice
singlevoxel
ingress
inflates
worryingly
pathwayblocking
studymore
handrecorded
hivaffectedhivinfected
jshctin
016081
aua
kindergartenentry
6392
8896
155201
91111
126208
memorywe
dukoral®
sbips
sbip
or239
straindespite
maries
amstmgfp
amstm
pemba
phcus
broadcasting
microphone
miking
29year
vaccinatelimited
n1951
mismatchalthough
fbma
armand
2012120905913
healthdefined
ieg
iieg
bony
finalising
soontobeparents
treatmentacute
widelyfrom
oncolysisgenetically
90fold
antivv
αcrystallin
miceby
dnaacr
soda
dnasod
dnavec
syndromeon
sorority
recommendationspatients
microenvironmentadoptive
examplesthis
adage
serogroupb
perspectivewith
provincialterritorial
lmonocytogenes
19922004
5176
nonclear
mvanpm1
mrnaseq
17566
p100e15
fdr100e14
fdr030
emr3
mefv
p146e08
outbreaksclassical
2493
text0933
09080954
text249
236263
617667
acam2000
macaquesto
throats
infancyto
finom
nct00378417
prophylaxisantimicrobials
lansing
anthracisinfected
exosomesexosomes
anergizes
αgcovaloaded
inktcell
horsesselenium
seyeast
lowse
29wk
poxvectors
lengthen
dcpanvac
panvacgmcsf
nct00103142
fannie
penner
haridas
dhaunsi
adler
7530703073
30mer
goldbased
j774
dissolucytosis
goldha
csfv2
metallothionein
mt12
hatreated
goldtreated
1p
00367
il10response
sod2
mt2
goldtreatment
bioliberation
γδtcrnegative
6486
misspent
proliferationsurvival
invasionmetastasis
ifnγrelated
encumbers
immunotherapyaccumulated
crpcinitial
androgenic
assymptomatic
mdv3100
silicabased
immunotherapycommonly
msbased
apatite
pamploaded
msappamp
nitrogentreated
stents
concernssince
postzosteric
efficaciousinactivated
resectionbackground
ileocaecal
36·8
11·1
0·023
0·043
0·004
8·03
1·93
33·43
0·035
cancertrastuzumab
ttz
ttzlak
micrographs
transferasemediated
deoxyuridine
acidobjective
145178
resorptionin
orthodontic
otm
bedsideglioblastoma
gvhdwe
k14mova
mova
k14
tcrαβcd3cd4cd8nk11
vα2vβ5tcr
recomendations
ibdthe
cpx351
20um2
um2
nelarabine
survivaltall
graall
gm2day
fluiv
1611777
1502752
131748
1361339
moderatelevel
oxaliplatinspecific
cajal
rcuh
oxaliplatinreactive
035uil
010uil
directionstherapeutic
ploidy
fillets
triploid
melanogenesis
variabilitybackground
includingexcluding
graftvsmyeloma
expandedcostimulated
dcplasma
pccmp24
rddvttccmp24
pccmp24rddvttccmp24
singleshot
exomic
cellssubstantial
laboriously
bioengineeringcancer
tnfalphastimulated
tnfec
915yearold
polyneuropathiesthe
antimagantibody
paraproteinemic
immunocytochemical
juxtaparanodal
translationcell
geneprotein6
antigena2402
htert461469
nonameric
k31
htertsitcr
hterttargeting
p0008children
scarexpressing
overactivate
scargrafted
desensitizationaspirinexacerbated
cyclooxygenase1
polymerlipids
3methyl
glutarylated
2carboxycyclohexane1carboxylated
pyranine
polymerlipidincorporated
passerinesavipoxvirus
speciesthe
pathogenicityof
taeniopygia
guttata
passerines
silvereye
blackbird
leukaemiawith
ixtargeted
carcinomaconventional
tumorsradioimmunotherapy
bexxar®
corixa
idec
schering
antibodyradionuclide
2056
hannah
wilsonjohn
wilson
bioeos
kent
emeritus
stanfords
rook
immodulon
actinopharma
da31
taxonomic
otus
clostridiales
graftsimproving
iiihr
treoflut
cultureindependent
expansionbased
tcrscan
multimerlabeled
cellsorted
hcmvspecific
mhcmultimer
preenrichment
toxoidbackground
ttd
merthiolateinactivated
wbp
ttdspecific
conjunctivaly
rheumatologypatients
elute
tnfαblockade
surveyssubcutaneous
m2c
il10tgfβ
psit
no564
obstetriciangynecologistbecause
womenpregnant
practicegiven
nct01248520
adli
myeolgenous
hlasupertyperestricted
guineabissauwe
caf01adjuvanted
bcgimmunotherapy
micemost
141206
mivmiv
nct01086657
boostintervaldependent
adultsdna
genomefragment
h5specific
intervaldependent
imagingcellular
fluorinebased
perfluorcarbon
scanners
absencesliterature
effingham
nonsliv
keylateonset
lohc
11437663
4033
135512008
ectasia
regimengastric
angiodysplastic
hsctgave
argon
ivbubased
anemiaalemtuzumab
162265
141219
mmuml
66518999
15121980
073123
054085
nct00501137
antityphoid
212pbradioimmunotherapy
paclitaxelinduced
checkpointbackground
highlet
212pbtcmchuigg
g2mphase
multimicronuclei
bubr1
e2f4
fisman
ch
lowcock
naus
fcεriαbackground
fcεriα
mabinduced
antifcεriα
3850
035075
047082
044094
riak
009038
034084
mortaility
cd4guided
allograftingone
μmol·minl
stableprogression
remisson
20082011emergency
islandwide
b10
treatmentcomparative
pigsrecent
11weekold
aswinepotsdam151981
h1n11981
aswinebakum18322000
h1n22000
respiporc®
flu3
melphalanconditioning
ligandnegative
liganddeficient
arthritiscytokines
brazilpneumonia
197975
alegre
gbsguillainbarré
millerfisher
mfs
gbsmfs
trf
acidp
sidgbs
igos
immunepathophysiology
obrien
lymphocyteschimeric
purposed
compatriots
02×108kg
noncatalytic
designpresently
cocainelike
gne
transitionstate
gnt
gneklh
hemocyannin
cocainespecific
cocaineinduced
gntklh
clioquinol
abeta42
apppsi
amyloidbeta42
myelinopathies
geniculate
dlg
plaqueindependent
transplantationoral
risk168
fever378°c
23042485
pd1rs
sctutilizing
h2kbd
b6cbaf1
h2kbk
slowproliferative
esterlabeled
erythematosusto
slelike
concernsbarriers
messageenabled
virusnewcastle
mononegavirales
serotype1
apmv1
embargos
mman
overzealous
5th24th
25th94th
95th
studyvax
hôpitaux
humanoid
roboticsobjective
robot
687±134
d049090
childrobot
robotics
nobackground
cin23objective
leep
postleep
hr2840
13356042
asialogm1
gd1a
polyradiculoneuropathychronic
uncompletely
miracle
20092010in
2009april
7000001500000
400010000
200500
adenocarcinomaimmune
39641mk3641
asneeded
35000qualityadjusted
millionyear
60200qaly
21309qaly
αproducing
postorthotopic
cs20
csfree19
preolt
24wk
heatphenolkilled
coliencapsulated
emp123
kua
721202
6518
grainsm3
00022
320μg
cancermolecularfocused
convectiondiffusion
cmvinduced
anticrc
surgeryto
cryotherapygroup
chemocryotherapy
transplantationmonoclonal
francealthough
virusesavian
h7n2
aviet
york1072003
kong339822009
triplesubtype
8245
20022009objective
56654
arr080
090096
arr072
091096
arr092
089095
arr097
arr110
107113
arr108
106110
juneseptember
pbids
5755
kibera
lwak
2219
1780
18652
5817
10762
25125
199198
19802011
housingplace
diseaseil10
surveywith
spokespersons
n2079
oversamples
ugandathis
udhs
ibdrelated
myelomaearly
lymphodepletionantipdl1
agexperienced
myelomareactive
districtslocal
resourceminimum
methodstechnologies
rdap
tramadol
alliancebackground
encephalitiscontaining
strengtheningin
vaccinesaddressing
polymeroil
nanocontainer
csnc
polymerantigen
alumrhbsag
pathologychlamydia
toxincpgoligodeoxynucleotide
ctcpg
varicellazostervirus
nanoparticlesprotein
il2producing
plganpactivated
ly6kderived
ly6k
ly6k177
intracutaneously
peptidemontanide
nct00845611
preinfused
713d
11d
3760
anoscopy
encephalomyelitisupon
encephalitogens
encephalitogenspecific
octamers
oliogodendrocytespecific
peptideoctamers
cattlebluetongue
btvspecific
cattles
dibutylesterbackground
cd3il4
cd3il10
cd3il12
ratesvaccination
parishes
skinrelated
zubrod
dp4
docetaxelnaïve
docetaxelpretreated
succinimide
moleculedeamidation
hic
mab1
asparagineglycine
asparticisoaspartic
aspartic
considerationscancer
approachmelanoma
iibc
iiibc
recurrencemetastases
selumetinib
mek162
depletion1cellμl
5cellsμl
range11733
hadreceived
sleresulted
ofasuccessful
trialsadoptive
cd127low
wino
leucocytozoonosiswe
potato
trpr7
r7
rr7
leucocytozoonosis
tumefaciensmediated
leucocytozoon
caulleryi
freshweight
hokken
alarelin
gnrhr
lhr
eweswe
egi
egv
egii
egiii
egiv
egs
externatheca
internatheca
alarelinimmunized
cristaes
strategiesimmunotherapy
semimechanistic
cyaae7
noninstantaneous
anemiaimmunosuppressive
atgcsa
infectionlow
onlinefacetoface
6534
telephonefacetoface
plac1cp1background
placentaspecific
plac1cancer
plac1cp1
plac1cp1derived
5597
proteinpositive
p4150
fmlnndvcv
p6977
hayqftyrv
hobbled
wayof
genomehas
diseasesnatural
receptororiented
predetermine
chickenpoxlike
oncecommon
brazilit
straightline
gaussianbased
travelfriction
dijkstras
depletionhaploidentical
proforma
ukhcdo
00114
00019
discontinuously
fasdeficient
modelsdendritic
papcs
qualityguaranteed
defy
ivw
spainboth
antigenformulated
disordersantibodydrug
rrvtv
rhesusrhesushuman
healthsocial
socialcultural
argumentative
borrowed
communityseasonal
slipsthe
culturebackground
modelforimprovement
summative
postqi
austriathis
affinitycancers
diseaseallergic
nonallergics
cellreactive
chemicallymodified
mer5101
aβ115dt
10monthold
aβ14042
mer5101vaccinated
mer5101immunized
adi
p00051
338months
centreslittle
tarrant
65500
139300
192969
18670
13511
symptombased
contagiousnessdependent
sclerosismyeloablative
artefacts
immunolabelled
irradiative
coccidiosischickens
profilinisa
monopolize
essengermany
n949
temozolomideb
tmzinduced
12000000
responsivenessdespite
recipes
challengesdoubleblind
1415yr
changesepsis
polioif
nonconformers
intestinemature
kipyv
wupyv
immunosuppresssion
kpiyv
d4measles
immunobiologicsidiopathic
unconquered
nowmareks
bach
foodobjective
mathematic
musicians
countriesi
allergenaugmentation
harmoniously
learnedsublingual
kimman
allmurine
cd3ζcd28based
aplasias
efficacytickborne
omsk
ohfv
ohf
cercopithecus
aethiops
pathomorphological
makingin
payoffbased
dualperspective
pregnantobjective
randomize
079286
ci10
ccl8
chemoimmunotherapyeramodern
chemoimmunotherapyera
hypercvadlike
modernera
hypercvad
tyrosineabsorbed
mpl®
adjuvanta
interlink
dimethyldioctadecylammonium
particulatebased
pathogensporcine
p97c
transplantationvaricellazoster
igg1mf
homozygousnull
allotypespecific
measlesigg
outcomestargeted
tbu
tbucy
cytbu
800900
tbucyconditioned
cytbuconditioned
skintests
skintest
boywe
vc3
cashtransfer
kinasebackground
80d
hsvtktransduced
durgell
lleida
cohort1
cohort2
12012011
03152012
e1or×100
475810
968882
109369
6371
lymphocytopeniaidiopathic
icl
eightyrold
organically
ovatreated
benches
bedsidesbackground
under65age
dayofhatch
chickensnecrotic
netb
formaldehydeinactivated
netbpositive
cd4cd25hicd127lo
functionallynumerically
illnessautoimmune
complicationfree
neurologistreviewed
leuridan
implementingstrategies
pbrns
parade
sheepwe
tetraplegia
aliii
joana
evaluator
primigravidas
microenvironmentfor
dchsv1
hsv1alh
antihsv1
approachthis
gudair
selfreplacing
logitnormal
baps
pd20
tropicsbackground
monoparental
bottled
saovabha
mammalassociated
unprovoked
cleansed
licks
co2powered
biojector®
vrchivdna01600vp
vrchivadv01400vp
biojectorprimed
nct00109629
carvacrol
gp100209217specific
castor
adjuvantcarrier
e7rtb
singularly
verifies
alivebackground
β42
β42induced
solanezumabs
solanezumabtreated
diabetesimmunebased
everyounger
cellscellbased
petsingle
therapytransplantation
nowdendritic
transplantationhaematopoietic
genoidentical
fastvaccine
ratsorgantissue
serumcyclosporine
donorstrain
lymphomasunlabelled
foliaceus
tocilizumabpemphigus
dualvariabledomain
antigena
glike
dvdig
angles
cochraine
coecalrectal
vaccinationtwo
relationshippreservation
encountersin
physicianfamily
antiintellectualism
configuring
dryvax®background
reinstituted
sporting
armelbowshoulder
35113
24113
provincesarguably
24yold
developmentanalytical
lightscattering
avastin®
remicade®
plasmaherceptin®5
plasmaavastin®5
dextroseplasma
erbitux®
humira®
propertiesthis
ylanthia
13e11
vhvariable
olivaceusadjuvants
5μgfish1
50μgfish1
466±041g
847±042cm
105μgfish1
224mgkg1
16μgfish1
160μgfish1
11ul
5000μgfish1
1600μgfish1
chickenssystemic
waterfowl
pekin
badgerstuberculosis
limitedduration
2010–2011
trialmany
fluviral®
vaccineattributable
vaae
176325
50202
50202objective
mtr
1051291
diseaseaberrant
amyloidβprotein
amyloidcascade
microinfarcts
abovedescribed
drypowder
doptimal
calu
5811
lungcancer
substratesmodern
biochip
antineural
schedulehepatitis
ministery
molecularcytogenetics
mya
bmtderived
nmya
menacwycrm197
amyloidβaβ
besidesa
antiegfrdirected
radiosensitizing
inhibitorunlabelled
rationalized
radiosensitized
tripleagent
supportintroduction
upstreamdownstream
inappropriateness
cancerhaptoglobin
efficacypersonalized
hpv611related
hpv1618associated
5441020
177538
306380
7189
19972000
leukemiacomparisons
bu1
bu2
wacław
szybalskis
hgprt
szybalska
szybalski
il2interleukin
4helixbundle
mil21
bvdvnaïve
wrl
stopsalerecall
bvdv2specific
designin
selfreplicate
antigendisplaying
ovalbumincoated
expressiondisplay
pixovalbumin
populationillness
fibrosiscystic
wellconstructed
trialsreplicationdefective
targetsviral
mixedmodality
biocontainment
subgenogroups
experiencemore
floodgates
hydroxydaunorubicin
oncovin
41bbcd137
663513
postrep
recultured
thienopyridine
200003
updatebiologic
hivantiretroviral
cancersperitoneal
transplantationradioimmunotherapy
βparticleemitting
astatinine211
targetnormal
complementc3
isotypecontrol
tepc
vif
c57blk6
ldhbased
restrictedmanner
regulationtnfrelated
lymphotoxinα
updateadhesion
antiα4β7
antimadcam
antiβ7
iplimumab
autochronous
protramp
antictla4gvax
instigator
braak
bapineuzumabtreated
bapiad
niad
nondemented
histologicallydemonstrable
neuroparenchymalamyloid
aβ42aβ40
ct99
ct83
depositional
±1
laiviiv
nct01044095
tcvac3
dnaprimemvaboost
trypanolytic
igg2bigg1
tcspecific
ifnγtnfαil4il10
cd8cd107aifnγperforin
tcvac3induced
ifnγcd8t
il10cd4t
il10cd8t
candidia
kodsis
3562
375386
111165
107154
mechanismtransmissible
surek
immunotherapytrifunctional
380°c
nocis
807878
feverrelated
dew
eightmsd
fivematched
903±65
p0184
p0699
peanutstree
nutsbackground
casenote
316yr
5kul
1311059
123911
patientsposttransplant
8months24years
227thradioimmunotherapy
skov3lucd3
kbqml
realityuterine
autologousprogenitor
autohpct
designunlabelled
offlimits
betasecretase
nowobjective
moleculeseveral
dualvariable
il12il18
dfab
allergenbackground
lacrimation
finduced
18100000
7step
fleeting
erythemaangioedema
particlesmucosal
antigenprotecting
depletionobjective
hsfacs
0234
0104
0963
0726
acpaseropositive
0999
acpanegative
acpapositive
0435
foxp3cd4cd25
cellsibds
aldh1a2
cd103cd11c
itreated
firstlineindolent
ttnt
cephalosporinscephalosporins
newergeneration
nonirritating
receptorsmost
clarosmg
poissons
ipilimumaba
melanomademonstrated
krp203
s1pr
s1pr1
s1pr3
s1pr2
s1pr5
c57bl10
intragraftinfused
tregssurvived
braincns
tumorshighgrade
capitalizes
immunotherapeuticsa
cd19creidtr
idtr
cremediated
crerecombinase
bdtr
cd19cre
leukemiausing
cnaml
npm1wildtypeflt3itdnegative
congenitarelated
failurebm
dkc
49311
normalrelated
206124
08212
allosctallosct
factor3
rs7251
rs2304205
p00068
70mgm2
atorvastatinmodified
cytokinesconventional
antir97116
lifealthough
caregiverinfant
poliomyelitislike
a05
nct01268787
kongactive
nasopharygeal
5581
serotypesgroups
115205
117205
165205
penicillinnonsusceptibility
non6b
disordersa
disordersneoplasms
lymphoproliferations
netabased
212bi
3pcneta
2056bi
ph55
2056bi3pcnetatrastuzumab
ph7
3pcnetatrastuzumab
zeal
registering
neverending
publichealthcare
uptillnow
francenurses
idévac
envenomationthe
viperidae
elapidae
asphyxiation
narrowband
psoriasisin
erythmogenic
suberythmogenic
ifnγcompetent
glucantime
leishvacin
patternin
hampshirevaricella
registryto
2008background
n25256
5639
06483
05589
07521
06759
04694
09732
11554
10312
12945
modelosteoporosis
hypogonadal
osteopenic
antifsh
gstfshβ
ovariectomized
fshbased
zenos
downselection
endpointcircumsporozoite
downselect
mousemosquito
nanp
repeatspecific
moorens
stepladder
approachtopical
thinning
75125
mgweek
vivomost
polychromatic
biomarkerlabeling
il4egfp
4get
nonlabeled
8d
petunlabelled
antiher1ir700
photoimmunotherapytreated
anticaspase3
isletshuman
acdevdcmk
acdevdcmkpretreated
nonfasting
glucosestimulated
insulintoproinsulin
cmk
acdevd
5422
4555
diabetesspecific
3517
tauopathiesthe
proteinous
antinft
taupathology
aβbased
immunisationpain
immunotherapyindications
actionbackground
diseasesmodifying
synapseto
cellapc
vo3404
vo5306
0127
1024qaly
1035qaly
patientsresponse
forges
brazilwomen
796880
luís
maranhão
2006the
luis
isletsobjective
abdominally
miniosmotic
glycaemia
insulinaemia
directness
5131
regionsseven
pnv
ratified
31122012
diseaserituximab
microsyringe
præventis
0608
0709
3780
grade4
03mcikg
preteensas
vuniversal
hbeagnegativehbsagpositive
pigott
mandiknayak
myositisdegenerative
tam163
receptorb
designtam163
kinaseb
trkb
fih
tmdd
emax
drugtarget
level10
modelsperipheral
il7producing
il7transduced
n32wild
n32ifnγ
rg2ifnγ
leftventricular
lvh
velocityatrial
coefficient5550
coefficient0268
sferritin
rhinosinusitisthe
irs19
wellapparent
14×106
12×107
designreverse
msbase
platformobjective
annualised
95125
resultsleptospirosis
lipopolyosidic
canicolachallenged
37102
90ktumorassociated
90k
cellextracellular
integrinβ1
90kspecific
90k351
90k5
90k523
90khlaa2
dld1
90kpositive
nonsct
3635
childrenprimary
oneagmismatched
rmm01
threeagsmismatched
rmm23
476±77
457±86
technologyvaccination
34±18
19±19
20012010background
standardsofcare
analysisrecent
fb2a2pbsc
ducbtcf
020087
colonised
cocolonisation
huscid
motivatorsbackground
n3275
093096
pvalue0002
deliverytranscutaneous
mastitisthe
antimastitis
ycomplex
dysgalactiae
cobactan
lc®
procaine
penicillinstreptomycin
antihbconly
nursesflu
letm
aqp4igg
implicationscommunity
fieldworkers
fws
distorting
studybefore
therapyrenal
anhydraseix
jerseycross
dairybeef
crossbreed
handfeeding
animalsthe
chekit
csfsero
herdchek
csfmarker
erns
e2elisas
acipacip
outbreakshere
n7900
tcr–engineered
snapshots
difficileassociated
hamstersclostridium
pseudomembranous
prestages
biologyalmost
partiallyknown
hostdependent
directionboth
β33
β24
β41
akre
iraqthe
sorchi
dpt2
8country
leadersbackground
lookout
12a8
67a2
ckitexpressing
sy
sybearing
111in12a8
111in67a2
90y12a8
90y67a2
stepsmelanoma
pbtl
il2rpositive
immunosuppressionregional
neuraxial
horsesantivenom
rattlesnakebitten
postsuckle
geldings
anticrotalus
n1259
youre
eustachian
donoracute
crcr
75108
immunosuppressionrenal
antigenredirected
pra80
donors151
219914
238667
18753
strategiestherapeutic
diabetesafter
46399
71498
32475
48703
dsmscs
drb1matched
brightest
immunotherapyuniversally
herdporcine
pmws
ingelvac®
böehringer
nvacab
vacab
pancreaticcancerassociated
concernsside
157191
104113
korlebu
5870
340years
361years
199320
8201070
χ2059
χ2524
musclejoint
mediumincome
glycodendrimers
immunotherapiesunlabelled
neutrally
maltosefunctionalized
dendrimerspeptides
dendrimerpeptide
6014
vulvalvaginal
srr033
srr060
srr091
srr076
srr081
srr070
phnsmaintaining
fraser
cdnc
mho
mhos
cdncs
leopard
panthera
pardus
11yrold
evilsbackground
superspreader
influenzatheoretical
empiricallybased
nonsuperspreaders
hr070
058083
082100
kaptembwo
nakuru
experiencedisseminated
bacteriatreated
typhibased
tumorsb
functiona
sotrastaurin
proteinkinase
influenzaresults
trialschoollocated
costanalysis
monroe
lesscostly
officelocated
n9027
n4534
916dose
2300dose
1989dose
5205dose
meanmedian
38232144
3508
1926dose
9250
globulinsfor
millennia
solace
buddhist
nuns
scriptural
traditions
hinduism
buddhism
jainism
judaism
infectiousdisease
theologically
defiled
observant
inv
mlvinv
intramembranous
osteoblastmediated
endocortical
diaphyseal
osteoblastassociated
osteomac
canopy
osterix
osteoblastlineage
ossification
allergenadjuvant
46amino9benzyl8hydroxy9hpurin2ylsulfanylbutyric
adduct
2conj
threlated
2conjsensitized
adductsensitized
immunologyeuropean
reportallergy
lillebackground
11300
83000qaly
62800qaly
1974background
locallyrelevant
zerotruncated
tome
principe
multivarable
pader
indentified
40×17
qaeconomic
endophthalmitisbackground
ppsv23ply
ppsv23919
ppsv23ply1045
ply871
mock1683
p00467
p00134
untisml
p00480
ply3134
ppsv23ply2744
6458
p00323
p00469
hmuc1tg
075mgg
urethane
eightweek
urethaneinduced
diseasesdysregulated
exvivocultured
signal4
cancerinfections
networksvaccination
wattsstrogatz
barabásialbert
11·5year
uveitisexperimental
antiinterleukins
cllimmunotherapy
postpcr
terrapin
drugconjugates
multispecifics
cancerdoes
answercolorectal
iiac
iiiac
patientsthose
24hthe
cci1h
cci24h
vaccinekorea
fmdsusceptible
malignanciestumorassociated
victoriaobjective
lollies
aspirated
conditioningrisk
studykv13channels
kv13channels
limbtransplantationmodel
kv13blocker
correolide
intragrafttreatment
30daysantilymphocyte
kv13channel
effectivenessinfluenza
rdmains
perdeption
replicatingvaccinia
monkeysmucosal
tiantan
mvttsivgpe
ad5sivgpe
sivmac1a11
af20513
antibodiesenzootic
0720092448
mhone
073131
nanoconstruct
tpdt
targetlocalizing
photoimmunoconjugateassociatingliposome
pical
benzoporphyrin
monoacid
ppl
freebpd
assembed
4321044
emergenciesthe
nsaidallergic
emergenciesall
dualpack
immunityhepatocellular
afpexpressing
gp96afp
steroidsis
studie
approlaches
futurer
hsiga
stf
hsastf
lpt
lait
helveolous
gml
nonhsastf
generationfollowing
bcd40b
cd40bcell
cd40b
studiesnatural
melanomarecognizing
clinicallycompatible
rationalizes
networkit
nonpr
ebmtnmam2000
studylongterm
nmam2000
autologousreduced
autoricallo
del13
mvabn
antivacv
nct00565929
randomintercept
13592188
panhandle
programspolicies
subfraction
immunotherapynterminally
aβpe3
9d5
appps1ki
9d5positive
9d5immunoreactivity
kims
nonconvulsive
hallucinations
neuroblastomalow
shsy5y
nbtumor
56dimethylxanthenone4aceticacid
dmxaa
vadimezan
dmxaainduced
m2nonm2
penicillinresistance
sequencetype
gprsp
4immunoglobulin
ovalbumindriven
idodeficient
levelsactive
htnfα
ttg
antihtnfα
ifxw015
tnfkifx
ifxw04
tnfkversustnfkifx
r0·78
r0·67
versustnfk
vantigens
ypestis
factorii
mrnabinding
fourpeptide
inflammationobesityinduced
hfdfeeding
hfdfed
epitopedeterminant
outcomenonsmall
potentialskin
fk
diseasesporadic
geneticimmune
peptidecerebrospinal
bpet
fluorodeoxyglucosepet
taucsf
birmingham
milton
keynes
200800478598
frenemy
aptitude
t527
df201
3630
immunotherapyfusions
sicct
bcgonly
tuberculinbiased
gammabased
bi213anticd20
cellsradioimmunotherapy
alpharadiation
bi213
radiochemoresistant
caspase2
betaradiation
bi213anticd20induced
bi213anti
deathinhibiting
213anticd20
radiochemosensitive
ctlrecent
lysateelectroloaded
lysatecoincubated
cber
clinicalcommercial
statusbovine
vaccinatingno
vaccinatingpi
50month
nonshortage
2888
5476
dtpbooster
tumornecrosisfactor
phytohaemagglutinin
effectmodification
gmr454
313658
gmr143
100205
gmr120
3miles
21min
16min
nonproposal
191310
178145
69962
nt19505
nt6010
nt9467
nt1183028
nt619862
hierarchized
evocationin
evocation
subtheme
connotations
divoirein
incinerator
pandemicthe
handshaking
4481
103312
17montholds
14312
2012public
nilein
healthaccording
ifah
foodproducing
gumboros
adultsallergic
adolescence13
asthma23
fever3
ltrai
immunotherapy4
cytotoxicitymalignant
meningiomabearing
ifnγelaborating
ltxbronchiolitis
factorinduced
rtki
f344towky
modeldespite
211atantimurine
211atb1030f11
kµl
developmentepidemiological
toxintargeted
kd13
elu
p0467
p0496
schedulesas
artemisa
vhlpaho
greyliterature
19692010
protocolwe
experimentallythis
wister
endoxan
reviewalthough
suspiciousness
patientdoctor
st246
ihdjluc
cellswholebody
bioimaging
poxes
nonreconstituted
st246treated
geographypulmonary
tbreactive
metaanalysishuman
135247
reducedtoxicityreducedintensity
rtcric
bbsi
remissionthis
hftbithiotepafludarabine
hftbithiotepacyclophosphamide
busulfanmelphalanfludarabine
cellrosette
tacrolimusminimethotrexate
62year
immunereactivity
treatmentbone
debaters
rebecca
buckley
elie
haddad
fivepoint
ri436
ri05
lipsbackground
itms
186321
233419
184321
kenyasenegal
swineour
imismatched
cyclsporin
sladd
slagg
cotransplanted
aspirinrelated
p00785
p00702
p00324
p00083
analysisantibodymediated
fam
noab
ffgvhd
transplanttype
urdsct
famsct
settingclinical
patientadministered
drcbackground
us54
us305
us364
us244
diseaseon
1517th
forewarn
mantlecox
cd8interferonγtumor
patientslongterm
acutegraftversushost
recipienttodonor
hy7712
micelactic
kimchi
cpimmunosuppressed
cpimpaired
cyclophosphamidecaused
classirestricted
responsestumour
internalisation
photosensitiser
amphinex
amphinexcontaining
lcv
therapeuticsa
lymphocryptovirus
lcvreactive
monkeytomonkey
capsidspecific
aavspecific
agriculturemareks
anthropogenic
splenocytederived
haloaded
balbcadapted
mafia
ap20178inducible
apcspecific
cellstherapy
tnfrassociated
typesmodulation
bms936
rg7446
repressors
logics
ctlassociated
blossoming
51141
autoallosct
030129
1051677
indexs
lymphomatous
buildin
wt1targeted
iommlee
postglenoid
foramen
pgfi
iommleegfp
studymultikinase
hlamolecules
rccassociated
encephalitistime
20092011yellow
16660
5588
127522
137662
sawyer
shulman
protectionmemory
treatmentby
indochina
chastel
chaulmoogra
sulfones
provenge®
stearoyl
nonneedle
strchrhc
transplantationsurvival
5090
selfpercepted
vaccinestatus
2013it
clydes
ama1as02
pfceltos
vmp001
pfs25
pvs25
remediable
attenuatedsporozoite
myelomabendamustine
225mgm2
analysisvaccinating
empathetically
responsability
ucts
uct
fertiliser
nct00966849
7·1
10·1
16·4
7·825·0
0·813·7
7·6
1·214·1
6868
l14
interinstillation
beryllium
belpt
enclosure
housekeeping
ichgood
3antigenmismatched
cellsretinoblastoma
malady
nurseinitiated
profiletransgene
201213we
245571
016037
189462
patientsrelapse
triptolide
drugtoxicity
membranebased
nzbxnzw
immunotherapyrice
seedspecific
conjunctivitissublingual
anaphylaxes
immunotherapeuticsthis
selfbinding
t15
homophilicity
homophilized
frontiervaccines
routinesa
oig
dilemmaeach
workerhistorically
indiansprogress
dakotavaccinepreventable
prioritiesvaccination
socioeconomical
vaccinationas
misled
efficacyvaccination
presentmodern
modem
worldmost
telling
worksin
flooded
misunderstand
memorable
waytrue
exhilarating
sobered
unthinkable
neverestablished
pathos
immunotherapyvalue
patientsidentification
olderin
syndromesparaneoplastic
psibased
graftrelated
cnicni
cnipsi
nondiabetics
22916
34394
11438
aix75
2011objective
n439
974100000
294100000
quadrivalentcontaining
471100000
yetmetabolic
childrenjapanese
3642
jecvvaccine
lri
ngcgm3vssp
patientsgangliosides
ngcgm3
linechemotherapy
activityrecent
foothold
wc3
nct00496054
intanza
ageseasonal
microneedledelivered
competitorscurrent
transplantationrecipient
uveitisocular
cryptoccoccus
neoformance
donovanican
miscarriagewomen
antiagreggation
4g4g
childhoodsome
pletion
capb
challengefrancisella
δcapb
capbdeficient
rlmiglc
δcapbprimed
rlvs
δcapbiglc
primedboosted
δcapbrlmiglc
infectionhelicobacter
openrepertoire
ligate
amply
flinders
fmc
apnoeic
probioticsallergic
amebiasis
medusa
edtaanticoagulated
pgl
virosomesunlabelled
gp41derived
mymv101
p1specific
p1igas
antigp41
nct01084343
liposomeanchored
immunityimmunostimulatory
liposomecoupled
nanoparticleanchored
154758
©2012
pyogenescancer
indiaalthough
anms
5671
cobwebsvaccination
proud
govt
baciilus
guerrin
pidj
garv
aganist
standaert
againstrv
markovian
rix441410
555791
14550
176804
12913
67747654
12189
2214
34440314
valle
daosta
31116
regimenscolonoscopic
biomaterialsmediated
fishdespite
wed
edwardsiellosis
patientpopulations
reinfectiondeterministic
ddctms
nonsir
bgaspecific
gcrit
placeborit
greecethe
2494
captia®
90miuml
sensitizationaryl
2378tetrachlorodibenzopdioxin
tcdd
cd11ccd103
pepulsed
tcddtreated
tcddinduced
egfrbi
egfrbiarmed
u118mg
u251mg
u118
tmzresistant
hypoglaucum
hutch
aobjective
thh
ruffled
hunched
thhtreated
oligomersbackground
transplantationrapid
rdp
csammfn151
tachsirl
taclsirh
postkt
rdpbased
adenoviraemia
receptorcurrent
il3ra
sfgretroviralvector
anticd123car
anticd33car
cd123lowexpressing
rictreated
radiometalstheranostic
radioimaging
specttherapy
pettherapy
bfca
radiometals
childrentreatment
tomorrowsome
hlab8
dq2
β2nicotinic
smokersobjective
β2containing
β2nachrs
123i5ia85380
3amnicrepa
mg70
β2nachr
vtfp
lassen
myelomamucositis
denudation
intestinelike
childwe
antiinterleukin1
parvovirusrelated
dosedue
tetracoq®
infanrixhexa®
irvaccinated
ifnγil5
tvvaccinated
graftsorgan
flum
flunp
ifnγsecretionbased
ltrvector
mp91
legomp
mp91derived
mp91transduced
populationunlabelled
insee
mamans
healthrecord
essentialuseful
892913
864892
paulmartinistiftung
leopoldina
cellsneedlefree
microparticlebased
microporation
outermost
laserporation
majorbackground
13108
riskadopted
artit
efficious
algorithmtherapeutic
caratinga
ecoepidemiological
acl
overweightobese
p0387
p0456
p0209
adolescentsthere
ddhbvv
microgram
34item
unpaid
gasgroup
msurface
mupyv
j8i
j8ispecific
immunisationbackground
vaccinationreticuloendotheliosis
runting
pcaggp90
gp90
rgp90
experiencestrict
dtpacontaining
researchimmunization
productionto
rhil34treated
rhil34
medicinetransplantation
paireddonor
comings
cellsautoimmune
inexperienced
pakistankarachi
punjabi
urduspeaking
pashtun
bengali
571131
studyparatuberculosis
mapfree
conditionsunited
wellimmunized
allergysince
rhinitic
ibdpatients
proliferationlinked
nemestrina
tcme
neuroaxonal
nacetylaspartate
naa
multivoxel
tetr
331400
postsimian
dyshidrotic
ivigintravenous
lyt12
952963
24±12
unittorecipient
matchmanifestations
inhibitormycophenolate
0385
unittounit
abdrb1
unitunit
cyclosporineamycophenolate
11patients
practicecocooning
antiantibodies
spark
functionscompeting
vaccinessince
tacsrl
srl
srlmmf
sirmmf
170±091
144±065
125±046
srlbased
197273
asthmabacillus
atomizing
seretidecontrolled
seretide
multiallergenspecific
weallergenspecific
directionsrecent
cellularlevel
expectallergenspecific
administratorsbackground
30gauge
surveysan
administratorsto
antihypertension
particlehypertension
particlehavlp
bactobac
daedalic
disorderhematopoietic
prebone
fumediated
irf2
prebm
sly
βglucuronidase
systemintravenous
iggdependent
adjuvanttranscutaneous
dmas
testcase
ond
ondova
neurogastrointestinal
reportmitochondrial
mngie
phosphorylase
dthd
durd
nonambulatory
challengepigs
orf7
orf5
orf6
vaaes
irx2
irx2mediated
antigentaspecific
irx2matured
mixmatured
routesa
dosemost
iuliter
systemswe
lifespans
firstmonth
7569
keratoconjunctivitisatopic
idiotype
idiotypebased
incidenceobjective
243778
185000
tnbscolitis
tnpconjugated
dnpbsa
24dinitrophenylated
oxazolone
studentseleventh
6thgrade
11thgrade
20052010we
sectorvaccinal
andrealization
studentsthis
2491
immunotherapiesinfection
sebh32qk173e
pyrexiabackground
agglutinative
staphylococcin
immunomodifier
sec3
iisebtcr
lys173
repulsion
sebtcr
mseb
wtseb
nonasthmatics
ehs
22188
713798
325379
214227
169217
germanyacquired
immunetriggered
euro1103380
euro2500035000
vegfr2as
advegfr2infected
advegfr2
advegfr2‑infected
antigenspeciﬁc
wholecancer
immunotherapynonspecific
relaunch
nurseryschool
routespecific
microscopybackground
jiroveci
msg
immunointervention
pneumonitisobjective
spaina
621677
400424
140199
579648
607668
097144
testelimination
mfavn
ci098100
r088
r094
highcapacity
glioblastomaadenoviral
hcadtktetonflt3l
hcads
1×1010
myelomacytokineinduced
kas61
cikmv
8226
jjn3
mm1
136944
holocaust
diseasesyngeneic
sgvhd
sgvhdassociated
increasingbackground
visitingfriends
andrelatives
nonvfrs
vall
dhebron
treatmentquestions
preventation
hepatites
pats
tacplacebo
plac
tacshortterm
ster
relt
hypervaccinationbalkans
hypervaccination
blp25
severitybackground
2041968
fef2575
fungalsensitized
rabbitswe
p3aβ
11padre
3aβ
pn3aβ
11padrethep
av1955
fibrilmediated
studywithin
case–control
laboratorynegative
n1014
vaccinationbirds
fowlpoxaiv
fpr
virusaiv
ndvr
appliedthe
casesthe
distention
arthrography
asip
41146
fort
wood
1504587
1094025
410561
sqt2
everybodys
tea1011th
futureimmunization
lakh
exporter
monovalentbivalent
footrotfootrot
controleliminateeradicate
12004200
yeland
transplantin
d90
bellevue
3361
puzzlebackground
nonpayroll
andnonclinical
lexington
ky
indifference
f7299251
f726936
f7304621
payroll
91facilities
amlcr1
q12
74d
32d
mgm2d
62d
32130
188±69
99±63
165±58
162±53
674±76
753±72
723±75
819±70
p0177
unrelieved
knowledgetocare
hypogammaglobulinaemic
communicationsbackground
vaccina­tion
n534
­intensified
­vaccination
prospectsbackground
gammadeltat
paracetamolbackground
nct00370318
nct00496015
npp
toxoidconjugate
phidcvs
γchainobjective
vγ9δ2
pyrophosphatepositive
il2rαil7rαil15rαil2rβγc
metaanalysisfor
tocs
historicalcontrol
screeningonly
17600qaly
18900qaly
4390
16300qaly
nonibd
multitalented
pathogensmast
hostenvironment
pathogenrecognition
informatic
syndromehematopoietic
uncle
25±19
improvewe
5998
δr²
postantibiotic
reconfigure
bernards
interieur
cancerthroughout
regimenwe
recipientscase
203557
208568
168509
130431
028071
013093
034089
029082
virus16positive
oncoproteinbackground
188rheniumlabelled
proteinwe
2a3
075mgkg1
188rec1p5
5mgkg1
400μci
lowl0
highl3
1090th
l2l3
vaccination12
efficacy100
protection20
coverage50
maldistributed
l0
5273
5782
2460
αsynucleinopathiesimmunotherapy
readably
osteochondromas
anticd68
celltolamina
gasseri
dcbinding
padcpep
shiraz
273±53
95141155
13145
thymusthymus
thymuses
marrowbmt
corticomedullary
cd4dli
receptorregulated
reconstitutionuncontrolled
ghpc
ghpcderived
tocmvpp65
cmvdirected
chemotherapyunresponsive
fliii
n307
ricnst
rr42
rr51
rr53
rr66
truncal
provably
alleges
bayesianlqas
blqas
unicefs
19681989
vincent
joshua
flagellininduced
immunizationtargeting
ecoliderived
kf
kfdp24
kfp24
immunocyteactivating
igabiased
safedose
vaccinestickborne
fsmeimmun®
encevir®
moscow®
therapynine
comas
leukomalacia
parkinsonlike
magea3a9a12
quantitativepolymerase
magea12
magea8
magea9
transposontransposase
sb11
inds
14193
14577
14739
adgm·caix
dcadgm·caix
nprix
dcadgm·caixtreated
hcaix
dcadnull
antihcaix
cd209a
klra2
mir1186
mir98
mir5097
mir1942
mir708
helphuman
secretors
posteriori
benefitsitaly
12yold
longertime
mediumlongterm
2476
56129
carmustindose
cyclosporineaatg
cyclosporineaalemtuzumab
amla
90150
472189
topologies
metarandom
kinasefasciolosis
traf3
attitudeshuman
farmsthe
pcv2si
growers
bios
dprp
pmwspcv2si
vacbios
vacdiets
biosdiets
£14739
£57648
cnitoxicity
mpsincluding
casessensitization
3648
19278
14463
6637
10457
14854
9118
3965
p435
20052006background
21346
dtpolio
immunotherapyhighly
phosphatidylcholinedioleoylphosphatidylethanolamine
molmol
mglulpg
businesses
photoimmunonanotherapy
dihydrosphingosine1phosphatetumorassociated
greenloaded
phosphosilicate
icgcpsnps
inflammationexpanded
sphingolipid
dihydrosphingosine1phosphate
icgcpsnp
scrotum
hrst
gytreatment
italycocoon
evidencesupported
animalsobjective
hphb
cgroups
cgroup
24857
9383104585
egroup
temrevachb
leptinbased
responseleptin
neuroendocrinologic
saturationsignaling
overnutrition
leptins
allobmts
richaplo
machlaidentical
immunotherapiesmany
9yr
heliumpowered
devicewe
gaspowered
nozzle
orifice
pigsimmunotherapeutic
gen003mm2
hsv2infected
gd2δtmr340363
icp4383766
controlvaccinated
gen003mm2vaccinated
mm2vaccinated
nhcws
nhcw
doctorsobjective
biomanguinhos
27476
biomanguinhosfiocruz
38082350
multicistronic
prametcr
britainbackground
101101
116127
234285
2011vaccinations
revisitedperforming
19942010objective
xikou
longyou
apodemus
agrarius
564737
117024
411033
186815
10143
1194330
13237
35728
6138
16136
8128
antineuinitiated
antiher2neumediated
her2neuoverexpressing
antineumediated
analystslow
ribeirão
preto
4·56·5
rodnan
p0·009
p0·004
echocardiograms
electrocardiographs
92122
tarsalis
micemosquito
bitenaïve
flavivirussusceptible
flavivirusresistant
sgeimmunized
evolutionneisseria
prosperous
directionsover
hhv
antiherpesvirus
vodafone
vaccinatin
aged1
vitiate
nct00289224
finlandunlabelled
prenip
nvge
immunoglobulın
updateintravenous
kfd
200510background
343256
pretransmission
05421
019074
010029
261808
713898
reargument
preferencesbackground
p53a
antiantiil2
wrightgiemsa
pmlcd2
bmanti‑il2
bmantiil2
mlcinduced
twentyheight
111inibritumomabtiuxetan
m2d
m25d
m3d
collimator
p86e4
acquisitionprocessing
belted
revascularized
microsurgically
saphenous
noangiogenesis
osteocyte
contractures
strategiesmany
cofval
frontloading
regionallycoordinated
apheresisobjective
luminexdetected
mdrdgfr
plusminus
aifour
fixedtime
inseminated
15135
cysteinebased
dtpancs
lcysteine
cysdtpancs
ρscnbndtpa
177lucysdtpancscetuximab
10nm
lanthanides
contaminating
hlaimediated
transfusionmodulated
immunomodulationbackground
tantalisingly
shlai
scd8
shlaimediated
poststorage
leucodepleted
ascitesobjective
780±98
700±89
4500±1218
5527±1460
134±036
096±026
p0499
1619yearolds
absorb
vaccinationitaly
moderatetostrong
burdenthe
raml
nonraml
5421
7182
6207
2626
6408
espia
ceilingfloor
fromallergic
mc3d
enteritidisbackground
c3d
mc3d2
mc3d3
pcoldtf
pcoldtffima
tffimamc3d
tffimamc3d2
tffimamc3d3
antifimbriae
antirabbit
chrome
enzymesubtract
nited
triscarboxymethyl
fimaspecific
sd2
fimamc3d2
fimamc3d3
tffima
surfaceinducible
lassbthe
ladecorated
settingsdespite
vaccinationmonoclonal
triggeringreinstalling
aspart
glargineinsulin
sweets
vaccinationsweets
cd28ox40
costimulationadoptive
cd28ζox40
age15
therapiesclinical
rotaclone
prepediatric
3530
g12p6
reenrolled
800991
dtpaipvhibmenctt
menccrm197
rsbamenc
30629
24212
38746
9540
7613
11955
3932
31105
37042
mellitustype
diagnosismany
waitandsee
surveymany
factored
revaccinationretrospective
tbcm4
calvestwo
steerstreatment
ultrabac
4000e
growsafe
airdrie
growthhormonereleasing
hormonehere
ghrh
mr403
herdtherapeutic
mehsana
sardarkrushinagar
dantiwada
vizvaccinatedn
controln
parasternal
bcgelicited
sternal
osteomyelitisalthough
describedwe
rationaleat
systemsunited
2011immunization
iid18
denies
sedulous
androgenreceptor
signspertussis
hivtb
gprdbackground
39863
969322
9445
hrunadj
unmeasured
girlsbackground
ytetanus
hibtt
hibmency
935100
858999
791984
725906
556871
96373
584792
366712
77343
leukaemiatherapeutic
clinicsalphaparticles
drawsupon
sies
lymphomaby
irr121
118123
093095
irr091
088094
theorya
lateadulthoodwe
disparitygenerating
threeshot
n41358
disparitiesand
growthmoderating
polyicalum
polyribocytidylic
antipres1
pres1specific
proteinvaccine
endnote
reuters
drummond
jefferson
qhes
ofman
hypoxiaadenosinergic
tumorgenerated
tissueprotecting
sctgastrointestinal
treatmenthigh
gybased
6688
p0071
anbl00p1increasing
killereffector
immunityconverting
flagellinderived
nfκbstimulating
hyou1orp150
flagrp170
adflagrp170
gp100pmel
trp2dct
batf3deficient
flagrp170elicited
barbiturate
antibacterials
thiopentone
eno1specific
krasg12dcre
krasg12dtrp53r172hcre
antieno1
researchpatients
inflammatoryresponsive
ps05
68h
americaantibodies
adaptative
pathogendirected
mechanismsunlabelled
brucellosisobjective
gantrez®
mannphs
99mtco4
stannous
99mtcmannphs
antibrucella
4776
yearsfor
10731692
13722721but
ncto01605760
300r
dpteronyssinus
tuberculosisachieving
2011this
2327
3894
italypertussis
ruheruniversität
bochumimportant
deniable
paternalism
chaperonepeptide
nondiscriminating
hsp70peptide
bulletthere
killings
monthsusing
01433
00075
immunotreatment
snk
gameshowell
446424
2107689
32128
cgppunlabelled
gllamm
mosque
bullawa
tollies
isolatedevelopment
difficulttoneutralize
proteinboost
jrfl
glycanrich
2g12
responsesrapid
temediated
vectorloaded
parachlorophenylalanine
photostimulated
lightphotostimulation
photostimulation
14l10d
lighting
14h
lhbeta
fshbeta
classessocialization
trainers
tarragona
20022011background
01122011
02122011
n521
408495
93314
272510
510730
417598
368513
intermediatelow
4678
earlierimproving
timeinsensitive
organizationsorganizations
neuroblastomaassociated
oind
scorer
acthtreated
acthsteroids
mfge8
mfge8mrna
immunmodulatory
444727
npr
5001
189333
584923
148220
118203
1714
12652322
236354
11842632
140204
127224
439683
103177
253596
111264
hindu
vectormeasles
preimmunity
mvnab
sivgag
rmvsivgag
intranasalintramuscular
intramuscularintramuscular
rmv
therapycombining
receptorcationindependent
receptornmdarencephalitis
dyskinesias
vogtkoyonagiharada
cyclosporinemycophenolate
cyclosporineazathioprine
csaazt
6419
9625
uveitisobjective
uvetis
261147
therapycrohns
stricturing
antisaccharomyces
cervisiae
robertkochinstitut
feverfamilial
fmf
tricyclic
alkaloid
antimicrotubule
longtem
colchicineintolerant
nonresponderintolerant
m694vm694v
boostingobjective
43dose
craniofacial
murray
16th18th
lyonimmunization
gcp
experiencepartly
prime–boost
134265
084234
pgrx
databaseobjective
sexstratified
biasadjusted
pabak074
pabak098
pabak092
schedulesdisease
2postdose
102122
212mo
096117
098119
igybased
orogastrointestinal
spawned
germkilling
thrush
pharmaceuticalization
studyantithymocyte
p0421
p0537
p0735
p0757
p0914
p0460
p0911
44h
dlbcldespite
dbcl
strategiesrecipients
microalbuminuria
albumincreatinine
mgg
12140
studymyeloablative
097year
allfree
mhcrestriction
weakpoints
argglyasp
multiagretopetype
immunogenicattenuated
rasv
rasvtreated
tnfαsecreting
ly6ghigh
cancerrole
il18interleukin18
rhil18
vaccinescurrent
melanomaipilimumab
eventuate
ionotropic
p2x
p2x1rp2x7r
p2xrs
damageactivation
antip2xrs
p2x1r
p2x7r
allograftinfiltrating
periodateoxidized
oatp
oatptreated
islettransplanted
p2x7rcd4
electroacupuncture
craniotomybackground
anaesthesia
pericraniotomy
virallike
whitesbackground
41346
shakespeares
honourable
mechanismsadoptive
lungmetastasis
cd127hiklrg1low
tc17mediated
tegafururacil
a2402
148times
10patients
july2008
december2009
7had
2had
kaplan‑meier
progression‑free
depletionunderstanding
geneprotein
cellorganism
deathapoptosis
tlp
e2ig2
pincher
paip2
α3genes
postpreservation
ischemiaassociated
gaseous
persufflation
coldpreserved
selfsimilar
vdjcontaining
vaccinesalternatives
atherosclerosisassociated
cholesterilester
cetp
oraldelivered
n954
rota2
diphtheriatetanuspertussishaemophilus
dtphib1
dtphib2
tourette
syndromean
obsessivecompulsive
attentiondeficithyperactivity
nervosa
braindirected
stereotypic
antigas
gasimmunized
immunologicallybased
elderlyvaccination
taeniosiscysticercosis
vaccinationpoor
taeniosis
recommendationsa
lentivirusinduced
leukemiawilms
selfdifferentiation
immunophenotypically
smartdctwt1
twt1
nodrag1il2rγc
huctls
estimatescholera
activitypromising
elc
vvccl19
sambhara
perspectiveobesity
immunotherapyinflammation
immnunomodulatory
seroimmunity
n183
roi1
parentattributable
elicite
genderstratified
qalygain
35555
33258
40984
29664
malignancieshyperferritinemia
10790
reactants
freedomwhen
statisticians
necessaryvaccination
234days
methodshealth
757476
2634101
manuallyentered
washingtons
estabilished
fiancées
ihid
6661
6012
1662
16201704
109132
051067
rr155
143170
5066100000
726100000
189100000
untypeable
makesmeasles
honeymoon
2782100000
2954
anymorebackground
leukemiasbackground
acidmediated
pcv2prrsv
interferonsecreting
ifnγscs
negativecontrol
pcv2induced
vaess
10324100
6825100
3472100
154100
049100
029100
4048100
13417100
i°ii°
iii°iv°
nonallogenic
7679
12322
4624
7501113
249512
047083
4343865
4934627
3191439
aul
8387
773216
canadaswine
3012
selfcontraction
outlet
allosctthis
120150
allostem
730mm3
5300mm3
3200mm3
590mm3
bordella
pregnancyduring
autoimmunityanticd20
reappreciation
autoantibodysecreting
costimolatory
80b71
86b72
tltnfαpulsed
ok432pulsed
tlpulsed
il4gmcsftltnfα
rtssas01ethe
ifnγil2tnf
015054
cellsexperimental
coflupreg
48134
womenno
anticholinesterase
achei
knowledgeattitudes
careutilization
3347
18related
microsoft®excel
611related
influencesimmunisation
pregestational
igesuppressive
niholahsd
balbca
rtssas02d
regionbackground
rtssas
dtpwhib
57170
62170
p0307
nct00289185
techniqueautoimmune
autoinjurious
progressionremission
diseasewhich
describehelps
methodthat
techniquewas
autoimmunologists
immunomonitoringmonitoring
histidylated
mrnamrnabased
lipopolyplexes
manlpr
antib16f10
studiessynthetic
haplotypeindependent
stateofart
therapyredirecting
cancerscervical
specificeffective
immunestimulators
pavement
e7luc
e7based
31995
41859
immunotherapyhistone
ms275
vectorinduced
receptoreven
carγδ
vδ3
vγ2
vγ7
vγ8
vγ10
carnegγδ
italycommunityacquired
yolds
bpp
permissively
2973
109378
forgone
n1847
onafter
advantaged
botulismwe
cfragment
hc50
bontc
1×104
1×107plaque
2×107pfu
2×106pfu
100×mld50
shenyang
5855
6707
8193
1486
8594
rhenium188labeled
re188
reh
herceptintreated
her2pher2
re188labeled
re188treated
androgenindependent
miceapproximately
nonbcell
leukaemiafollowing
intensityconditioned
uncorrected
activationelimination
bnabbased
immunotherapyreceptors
mfcγri
mfcγriv
hfcγri
mfcγriib
hfcγriiabc
hfcγriiiab
hfcγritransgenic
mogpulsed
cd4il10ifnγ
recipientsadvances
patientsbu
gsta1a2
genedosage
influnet
interuniversity
ciriit
midoctober
uninterruptedly
4882415
5519917
4660601
acalifornia0709
bbrisbane6008
typea
5064yold
virusacute
rnaproteins
xcr1
efficacous
deliverylow
vaccinesan
vitespan
therapeutictwo
ouelessebougou
nct00678301
nct00985465
appared
cevagtickborne
intentionhealthcare
untailored
11pt
antidotes
developmentif
vaccineproduction
162614
cryotreated
c3hmouse
c3hmice
60mice
icontrol
iitumor
iiiantictla4
ivtumor
vaccinesdiseases
q38
q41
5492
shiftthe
bmirain
bmira
rbmira
serodiagnostic
hpv16l2n120e7e6
pet9a
petl2n120e7e6
hpv16e74957
mg×kg1×d1
mg×m2×d1
01×109l
0149
0362
immunizationtransfollicular
pharmaceutically
chitplga
ovanp
μlcm2
npsml
543±0047
665±0044
ovamg
μgcm2
2009little
4186
2·69
1·245·80
0·500·76
0·060·22
mcknight
fondo
sanitarias
fundació
marató
tv3
adolescentsimmigrant
belgians
jtms
sectionfor
relaunching
relaunched
jitc
raceobjective
idna
tc83
ptc83
idnavaccinated
fevervaccination
riemser®
schweinepestoralvakzine
floors
zoning
antigen4immunoglobulin
oxazoloneinduced
ctla4immunoglobulin
dnfb
antinap
napinduced
fourcolor
moisture
monitoringresidual
coulometric
diethanolamine
imidazole
methanol
adjuvantsystemic
gln
nzbnzwf1
ptx3cfa
ptx3alum
antiptx3
mantelcoxs
alumtreated
ptx3
allele2
hs12a
rheumatisms
antivimentin
or95ics
133322
1091468
n1968
n2218
n2638
n2513
andlowest
20082011background
threepage
ah1n12009pdm
interkeukin15
immunotherapyapolipoprotein
apo
papohil15
psushi
nonstabilized
apoil15
memoryphenotype
injectionthe
primemvaboost
tilwhile
epitopesa
renewable
fluorescentbased
wflz
keneba
muacs
115mm
110mm
105mm
42122
130mm
combinationdespite
cikoncolytic
acetonide
ivta
rhegmatogenous
fundoscopy
factorbeta1
cytokineproliferation
theybackground
selfregistered
rijswijk
ratio203
interval123334
incompany
therapymycobacterium
followupwe
006±012
01±02
spanishapproved
6199
cmsige
cmspt
114446
27137
expecially
infectionfocus
aspergillosisdespite
interferonγgranulocyte
infectionsorgan
107000
immortalise
asiis
listonella
immersionboosted
efficacywest
geese
challengedsham
unchallengedsham
vfp2000
vcp2018
vcp2017
targetspathological
prefilamentous
nonalloimmune
outbreaksduring
vaccinesfor
producible
netherlandsprior
activelearning
preassessment
postactivity
perforinmediated
apoptosistumortargeted
c3hsw
hyspecific
hyexpressing
vaccineresponding
nonalloantigen
traildeficient
acceptancein
sensemaking
statemandated
healthpromotion
apprehended
dialogical
newtnfrelated
evbd
regimensknowledge
alal
tbicyclophosphamide
busulfancy
tbicyetoposide
fludarabinecytarabine
176±96
255±80
238±89
640±84
167±76
558±94
808±85
288±99
p0380
hemodialysisbackground
210779
3171863
186608
14233
5536
4402
79296
33943
cpgadjuvanted
microporesbackground
userdefined
1promoting
22935624
mycobacteriumspecific
2×103cfu
2×105cfu
ifnαis
t3003
t2776
amss
t1501
t1349
groupsamss
childrenunlabelled
fac
tors
planne
vaccinatio
peopl
pandemia
ricounlabelled
respectivelyidentical
designplasma
additivity
experiencesensitized
stranstransfarnesylthiosalicylic
salirasib®
rasdependent
amidation
1directed
functiontcell
hemolytica
bacterinethis
bacterine
balt
giemsa
balts
experienceslit
supereffector
maiden
measurementbackground
30x7
dtp1259
cardverified
drama
195758
yardstick
anglosaxon
vaccinatednot
familyoccupational
inflammationspecific
belarusa
antirabic
19922009
materialdiagnosis
immunotherapyaccording
doublesensitized
hypersensitivitydrug
unitsadverse
8month
childrencytochemical
interleukocytic
microbicidical
resisistance
44749
monthsolds
1523montholds
patientsincreasing
schoolswe
tutor
observationcooperation
insulating
packagingmany
28°c
63°c
nonrefrigerated
extractsrelevant
panallergendriven
aida
instalments
helpline
centurylong
nambackground
locallyproduced
mbv
nams
logbooks
666985
jembv
relatedoutcomes
allopeptidepulsed
4214
scannable
unscannable
e1deleted
adhu5
sivmac239gag
adhu5gag
sivδnefimmunized
seriousrecurrent
metabolismcatabolism
microbespecific
subclassspecific
vpdassociated
fetalinfant
pregnancypostpartum
orthologtcell
jregion
pseudogene
immunodepleted
anemiaimmunodepletion
tissuecompatible
31cytokinemobilized
499×
transfusionfree
datait
124433
αtype1
hlagenotyping
optipreptm
day6
107body
7dayincubation
linhladr
cd11chladr
dc12
cocktailtreated
000000914
ires
iresdependant
rcc26cd80il2
th1th2like
reportneonatal
siderosis
immunorehabilitationthe
imudon
paratonsilitis
immunocytograms
herapy
investigationsthe
bashkir
purposeoriented
lifeqol
intraarterially
drugsqolacd
extractunlabelled
extractlem
cellstregs
s1paclitaxelkrestin
resectiona
cstage
s1paclitaxelptx
krestinpsk
3gday
psk
rouxen
pstage
pn0
s1ptxpsk
refusedwe
20057201112
0024158
0270423
110294
myelomarelapse
mmcontaining
bmhoming
mmbearing
ifnγinducible
mihaloaded
syndromesrelapse
pdli
tdli
5481
rs2294008
646×1011
310×105
264×105
t34
antipsca
kinmen
arrange
10855
oralpharyngeal
majigithis
majigi
gezawa
6472045
0·353
refracted
reactionsinjections
antibodiesregulatory
frcase
antifrcase
hbsagstimulated
hladr7
dr7
dr7dr53dq2
b7dr7dr53dq2
a2dr7dr53dq2
hlaa9
advagrafbackground
whomdonor
7pneumococcal
penicillinnonsusceptible
cohabitants
19201960after
1910s
obstreperous
rebellious
downright
peasants
secularization
postrevolutionary
wedded
rabiessurveillance
cd25cd71
anticd71biotin
antibiotin
bergisch
gladbach
cobe2991
caridianbct
lakewood
cd3cd71
37350
median111
pentamers
leukemiarituximab
ga101
bleukemic
ga101induced
europetickborne
tbeendemic
oneseason
fappositive
fapme1background
banned
decortication
pleuropneumectomie
sadr
susar
nct01722149
behaviouran
hapa
singleevent
r²76
r²67
managementmonoclonal
immunotherapycancertestis
0201a
2402restricted
tumorsdespite
drugscancer
genevectors
immunotherapypattern
receptorstlrs
tumorantitumor
therapymolecular
unmistakably
dualedged
nanoengineeringbased
uveitisnoninfectious
balancehead
rhinoconjunctivitisgrass
stallergènes
hautsdeseine
futuresalmonella
hbds
hbd13
hbd1
hbd3
pipelineobjective
19952009objective
campaignburkina
campaigneligible
00065442
imsut
siblinghlamatched
3468
2659
celltransplantationpatientreported
recipientsallogeneic
121279
66204
67205
nonchemotherapynaive
blockadebreast
isoenzymes
outward
wholegenomebased
buassociated
gravisestablishment
allergypeanutallergen
arounddespite
opapositive
opanegative
vaccineneisseria
opacityassociated
meningococcalspecific
antiopa
cubswildlife
cubs
011052
001076
005081
evidenceinfections
killedtype
cirrhotics
furth
rt1a
osteomyocutaneous
hindlimbs
vaccinationelderly
ceftriaxone
germanyan
316100000
nonexclusively
045077
055093
otic
ir170
ir1134
5019
2492
r²0966
β1132
r²0898
β0505
ir135
antihepatits
oncept
genotypestwo
gliomabispecific
bscabs
bscegfrviiixcd3
antibodyredirected
cellsil33
mcdependent
agmediated
cγ1
hck
diseasetransmissible
lymphoreticular
tse
mbp8298
copolymer1
glaucomaglaucoma
iop
rscs
cop1
photocoagulation
episcleral
igfi
rscscop1
diseasehigh
6pd50
£251qaly
sloveniaslovenia
thickborne
135100000
gorenjska
slovene
kranj
brnik
mayors
saturdays
townsvillages
n41843
562645
12931478
n39468
513590
10261175
2608
90097
womenmen
4297
52107
comparisonsince
n2409
6item
hureported
remunerate
851863
kindergartensobjective
azdhs
nces
getisord
irr1411
9472103
lunches
numberneededtovaccinate
fallacies
mpesa
93903
080096
naglazyme
cmd
virusstrains
mgegg
16dold
anticd25antibodyinjected
antichickencd25injected
conditioningunrelated
dhistocompatibilité
dimmunogénétique
sfhi
analysisgraft
doubleunrelated
preunrelated
hlaab
162017629
polysaccharidemediated
shockconditioned
dthderived
cd1dantibody
scd1dantitumor
αgcscd1dantitumor
cellsprimary
antiplateletspecific
trialsduring
infectionnk
burdenthis
preposthdm
prehdm
sd8
omrelated
globulinreducedintensity
nonatgcontaining
campaignin
purview
wir
registrys
adverses
parentson
il18to
caenorhabditis
elegans
nonvertebrates
infectionsinvasive
fungalhost
clinicalphase
acidinduced
il17specific
colontissue
hyperige
controlbased
disinfectological
vaccinological
unrecorded
disinfectologists
vacillation
cynical
20078
islands0306
awisconsin6705
bmalaysia250604
vaccineplague
septicemic
lowcalciumresponse
lcrv
ailompx
plasminogenactivating
ail
postatg
poprecall
pcprecall
mailings
redit
midwifenurse
coverageseveral
insectderived
leishmaniaparasitic
kmpii
tryp
paple22
baculovirusinfected
trichoplusia
hpb
dnaprot
limitationsin
drafting
pregnancyaplastic
rear
oncohaematologists
pathoanatomy
iscomtype
alkyl
sulfone
vinylsulfone
aigg
actinomycin
90yttriumibritumomabtiuxetan
leukocytopenia
131iodinetositumomab
s0016objective
tositumomabiodine
immunepreserving
efficacybone
hscmediated
thrombomimetic
treatmentallogeneic
wellread
differenceover
deconditioning
toxocara
acantamoeba
castellani
mucintype
oglycan
zpdc
kdaimmunomodulatory
antioxdiantive
zanthoxylum
piperitum
d1cdk4
pneumophila
33152
antil
lpneumophila
211atprit
211atrit
avidinconjugated
mx35
avidinmx35
211atbplsuc
15mbq
09mbq
tff
tffs
10mbq
providerunlabelled
analysedgeneral
of6121
6121
polandobjective
oscillated
halfappeared
nct00569387
nct01072981
modeldependent
ratsprevious
mca
monofilament
cd68expressing
complexantibodies
nanp6
nanp6ompc
mercks
iscomatrix®
coadjuvant
pfpb
pfpbinfected
nanp6ompcmaa
peptideompc
nhws
renalkidney
measleshiv1
vaccinelive
mv1f4
mhctyped
boostable
α2macroglobulinantigen
cd91lrp1
α2m
chaperoned
α2mpeptide
etoposidethiotepacyclophophamide
bulpam
ci3998
progressionrecurrence
driveadoptive
rhegf
00496
swallowing
neovasculaturetargeted
antithirdparty
cellstransplantation
tdbm
hostxdonorf1tcm
55gy
hadtcs
tdbmt
bioluminescenceimaging
lnsconcomitant
2photon
microcopy
reducedconditioning
pegfpag85asha2
pag85asha2
sha2
inflammationdependent
melanomalowdose
gr1cd11b
epidemicsince
ahsv2
polyvalentattenuated
alemtuzumabantithymocyte
antiislet
fanfare
clemens
pirquet
schick
histologyimmunohistochemistry
toxoidtetanus
tdtdap
responsesbovine
tdsim
trialprevious
studydose
antigencompatible
maarirelated
20012008
maariencounters
eivif
cc077
cc089
cc092
personnelnosocomial
hce
hces
20042009objective
17800
activatordependent
outcomeischemic
proneurotoxic
αatdglun1
hematoma
zizyphus
lotus
desf
polyphenols
proliferationwe
zlp
ca2i
thapsigargininduced
t1233s
phi
14000
or161219
or507
gynaecologyobstetrics
podiatry
bettertargeted
vasscores
74100
r0612
r0608
plaquespecific
aβp342
nonnuclear
vaccineslive
cellsdiscovery
th2th17oriented
melanomainfiltrating
thrived
intibucá
whoreported
antigensharnessing
reviewsensitization
bestestablished
goodvalue
sctbackground
nophoaml
thioguanine
5977
portfoliodespite
mysterythe
behaviorwe
steadfast
imitators
childrenwidespread
schoolmates
personnelflue
flue
bakcuspun
vaksigrip
pyodermia
newlinks
subsetsin
icga
sunset
glow
peripapillary
icgaguided
vaccinationpassive
nacetylßdglucosaminidase
recipientsvenoocclusive
malignanciesvaccines
pepmixes
15mers
pepmixloaded
1200fold
e6specifice7specific
3352
e6e7directed
goodmanufacturing
procedurescompliant
autoantigensthe
hyperacuteprostate
hap
hepsin
il2pretreated
humoraltargeted
neoplasmblastic
bpdcn
blooducb
posttransplantassociated
17monthlong
raeb
intermric
nonadvanced
countermeasurethe
crisismanagement
massvaccines
disordersto
interleukin17producing
transplantationinterleukin
transplantationhaplotypemismatched
haplodonors
immunomagneticallly
nonregulatory
immunityfor
donorversusrecipient
salarthis
dinitrophenol
haptenantigen
05772
tcss
peachnonspecific
thaumatins
worldcervical
specifies
adduced
100200year
functionespecially
opolysaccharide
glandersburkholderia
thailandensis
opsspecific
opsbased
malleilike
oaca
cationized
αkinoidobjective
interferonαkinoid
ifnk
ifnαtransgenic
signaturepositive
ifninduced
antiifnα
signaturenegative
bacteriafrancisella
polygammadglutamic
unimpeded
antipga
microm
h9401
ltmediated
pgaenhanced
methodologysetting
21172513
23378100000
331811100000
35926100000
immunotherapymonocytederived
alphatype1
mpdcs
ccl21directed
cd3tregs
cd4cd25high
postallotransplantation
gcd3tregs
25p
folinic
transplantationfolinic
gradesii
ricscts
of185mgm2
doublecord
effectwhen
²¹²pb
rad51objective
sphasearrested
unrepaired
whipple
spondylarthritis
2fcγ
peanuthuman
planthuman
fcγ1
ahg2s
ahg2
wpe
wpeinduced
hfcεriα
wpesensitized
psige
psigg4
capfeia
01043
3954548
8545
23051010
2583055
childrenconsultation
borned
diseasemucosal
signalst
nonclonotypic
34a10
brainspecific
householdderived
lowmiddle
apples
bodybrain
certainties
pitfallsthe
allimportant
immunotherapysuccess
preponderant
toleranceapcs
vegfinhibiting
meetingthis
communityrecruited
114344
139344
91344
globulinwe
tolerancetolerizing
pd1pdcd1
bcl2l11dependent
4859
006021
794938
961991
458848
mastoiditisbackground
382°c
workersannual
2008enhanced
30schedule
113in
sourcesincluding
arrangementsto
professio
5based
5parainfluenza
piv5
sv5
piv5based
rpiv5h3
indicting
measurementsbackground
vaccinatedunvaccinated
animalsprimary
atr001
qβ
nonhypertensive
antiatr001
ca2dependent
cα
9275
ageprimary
monaco
serene
highness
monacoaims
allergyige
motherthe
vaccinesince
octaargininemodified
liposomeincorporating
iipeptide
pmhciitetramerpositive
pmhciitetramer
5specific
atopically
modelallergic
crx527
allergenfree
bronchonconstriction
followupphase
crossvaccination
15744
62876
0100000
001065
871100000
1792545
938100000
714121
malignancythe
immunogeneic
magec1ct10
virusviruses
autoregulated
depletionomega3
omega3rich
omega6
fofed
cofed
standardfed
megadoses
clinimacsselected
dosewe
hematoimmunological
104kg
cd3cellskg
4883
18119
56100
protein39
brp39
imject
rosuvastatin
lactams
reapproved
lactam
3692
organisationsthe
dispensation
prescriptor
gainsharing
haemophiliacs
chock…
opportunityimproving
prepositioned
reformulating
sesamespecific
15165
002102
nct01028560
developmentfour
infantsinfections
broilersthe
campylobacteriosis
unitpergram
samplesize
africasuccesses
1775
brunt
neosporaassociated
cattleinfection
ncnowra
vesselinjuring
ctcrctl
ctcr
fixedtimed
operationsthe
7614
ranches
esftai
nutu19
mescs
ivpes1
mesc
nm23
10319207
9752192
10556321
963527
fef50
fef25
10569329
9461312
10660371
9292331
14714641
170495
irv
exsanguinated
antigenfree
actionto
rateinfluenza
428000
platformu
coadjuvanting
cdigmpadjuvanted
selfboosting
immunityadvances
ebna1specific
modalitya
adccescape
adccbased
societyunlabelled
basalcell
1499
032076
043078
037085
nutu
pauls
bims
5736
5035
8739
1·308
1·148
2·454
1·962
whiteonly
reviewfrom
convicts
pretopostallosct
pakistanhigh
dptpentavalent3
scientistsevolution
vaccinationencephalitis
immunoassayin
6211
goldstein
tuva
region16
rostov
sverdlovsk
region12
khabarosvk
region20
sakha
yakutia
republic25
region136
region189
region175
khabarovsk
region210
961996
platformvaccines
reimmunize
treosulfanthiotepafludarabinebased
indiahematopoietic
treothioflubased
bucyantithymocyte
618×106kg
bucyatgbased
treothioflu
galactosemodified
12didodecanoylsnglycero3phosphoethanolamine
dlpe
galactosyl
galactosylated
ovaencapsulated
8689
976±86
χ2521
χ25547
interferonγreleasing
releasingassays
indeterminates
ltbitesting
indiathere
emdat
012015
674917
904986
478669
839941
influent
8592
5513
4454
106238
156273
5608
143255
6157
165268
17824
10977
24350
14498
24283
α4β7high
cellshiv1
nonselectively
α4β77high
aldh1a2silenced
α4β77
α4β7low
approachesmethamphetamine
psychostimulant
generously
nswsc
110public
postage
diagnosisassisted
guideallergen
tryall
caribbeanthis
immuneadsorbent
n4454
n4571
081096
019047
expire
036054
12826
875947
pr85
46156
rechecking
imcma
moit
africarubella
preventionprevention
5αreductase
finasteride
dutasteride
autoallo
humanleucocyteantigenmatched
9·8
particuliarities
hdlconjugated
proteininterleukin
il15rαs
transpresented
sushiil15apo
defectdriving
giantcell
multipledrug
transplantfree
tachyarrhythmias
intracardiac
immunosuppession
trh
eaebackground
αmsh
nonvirusrelated
triplex
her2neudriven
sclerosisplasmacytoid
trialsafter
mesotheliomamesothelioma
reviewafter
laserbased
stfm
cera
gie
172452
arabiaobjective
abdulaziz
carbohydratemediated
maltodextrin
neoglycocomplexes
mannanconjugates
glycocomplexes
carbohydratemodified
profilingcellbased
4double
fendrix
188rhenium188re6d2
188relabeled
4times
markerschemoresistance
abcb5
jarid1b
jarid1bpositive
jarid1bcells
bissaubackground
mannersubunit
svn
3ll
sa41bblsvn
chickenspeptide
clys7crp
clys7crpcontaining
fp9vectored
fp85a
85aspecific
antifp9
nct00653770
glypican3144152
fvgefftdv
cytomegalovirus495503
nlvpmvatv
ovalbumin257264
ovalbuminnegative
metastasiswe
snailinduced
lcn2
ccl2lcn2induced
languageswe
correctness
incorrectness
publicoriented
αeintegrin
genedelivery
20052007background
2005june
encephalopathyencephalitis
wageearning
morbidityrelated
2012recommendationsthis
stepup
400μgday
800μgday
1600μgday
10μgday
albuterol
fpies
schoolendorsed
alicante
formalisms
coverage2011
rulethis
micemany
dcdirected
dclv
dclvpsca
dcsignexpressing
pscaresponsive
trampc1
dclvpscavaccinated
sgi110
5aza2deoxycytidinecontaining
dinucleotideobjective
gp100positive
inducedupregulated
magea2
magea10
gage
sgi110treated
malignanciesvaccination
asthmasingle
rhinitiseczema
isaac
protocolbased
037125
084136
anatolia
anatoliabackground
fastidious
pcdna3p46
paratuberculois
cocktailswholecell
map1087
map1204
map1272c
map2077c
cd8cd25
preventionpatients
prednisonesparing
immunomodulationobjective
h4receptor
mlkg1
h4agonist
clobenpropit
dihydrobromide
h4antagonist
jnj
7777120
h4rantagonist
srbcelisa
posti
h4ragonist
administrationa
contusions
humerus
supraspinatus
overpenetration
monocytogenesderived
patternlike
abilitythere
nonhemolytic
dtllo
cancertumorspecific
premenstrual
lossthe
titers1
429574
491610
9198
173263
nct01047202
approachproduction
personnelimmunization
opportunitiesdendritic
antiapoe
ε4
fibrillogenesis
antiamyloidogenic
microgliamediated
hj63
4moold
fludarabineobjective
surveillancein
monty
10thsthe
12thgrade
nonhcv
outcomemore
gembumel
prehdc
petpositive
5patients
efs23
os27
efs22
os31
hrfor
efs19
os18
concentrationversustime
24auc
threepoint
heiferscrossbred
synchronizationbreeding
arrowhead
resultsmedicare
35229
35257
differenceofdifference
03200324
lesionlimited
turbo
excimer
keratome
308nm
selfantigenspecific
antigena4
palmitatederivatized
pil2
il2associated
10000iumouse
diseaseimmunosuppression
mellitusdevelopment
algoritms
transplantions
normlized
exisiting
betacells
gadalum
300index
arequirement
serumige
haitians
ethnicspecific
objectivesthe
2002april
novicida
u112δiglb
novicidabased
u112
ld50107
respiratoryintestinal
cytokinetherapyobjective
genechip
asylees
columbiabackground
2003august
asylee
adascid
splenomegalyprimary
collusion
pertussisan
woe
costimuli
activationrepression
diseaseselectroporation
biodistributionintegration
electroimmunotherapy
korppi
lifehivexposed
cancercostimulation
b7h1cd274
allograftsvascularized
transplantationinduction
menacwyps
givs
infusionhidli
mixhsct
vemac
chemotherapycombined
hidli
40×109l
1817
50×108l
46xx46xy
dtpap
conditionswith
testingconclusions
nonstrict
cd3cell
eluate
cd19cell
antileukocytic
abortionsthe
immunocytotherapy
futureinfluenza
tragedies
challengetoxoplasmosis
s48
toxovax
t263
highereducation
failuretreatment
therapyeosinophilic
caliber
dietitians
huf
1940years
hydrotropic
liposoluble
monocaprylate
pgmc
hydrosoluble
dependencetobacco
developmentexosomes
valueadded
l1ltbimmunized
l1immunized
l1ltb
plantexpressed
gm1binding
umvthis
483698
505881
nursesrates
bivariant
ci16130
utx
recipientsafe
sizeand
anastomoses
gothenburg
hjalmar
svensson
jane
dan
olsson
macallohsct
productlimit
patientcontrolled
larvalspecific
pasturerelated
movein
026771
060760
01unit
frosst
contextobjective
southsoutheast
northnortheastmidwest
icteric
r1689
us723
dgalactosebinding
synadenium
carinatum
scll
neosporosisvaccination
coccidian
nla
ifna
recurrencemetastasis
glioblastomawe
glutaraldehydefixed
nimustine
acnu
3122
hematopoietically
pr1targeted
immunotherapypr1
antipr1hlaa2
8f4
as2o3
as2o3induced
ngnitrolarginine
tetrakis5
20benzoic
nitrosative
45diaminofluorescein
healthstyles
119199
townshipwe
casualanonymous
vaccinationdnabased
allergygene
gunmediated
tc1induced
particlemediated
cartridges
dnacoated
infectionimmunization
malariadna
skinbased
parasiteassociated
trimming
transplantationobesity
normalweight
crbased
amlbfm
interphase
sctbfm
fludarabinemelphalanconditioned
007073
0005043
assumptionsthat
37216
48210
polypropylene
iipresentation
antigenconjugated
casecase
edics
castellón
455997
254963
studentsalthough
nonnursing
kenyato
201360
aor812
95ci5501197
mediumlong
aor246
129469
aor184
95ci110309
aor214
120384
104188
aor220
139347
108175
bumblebee
vaginally
singledigit
melanomaadministration
infectionhyperimmune
buzzin
adadeficient
80this
wastewater
19992009
rotaviruscontaining
studiesfood
diabetesremarkable
aspired
interdict
oxidationmodified
seasonwe
vaccinesrespectively
bayern
andb
trivalentvaccines
specimenwas
392–829
1998the
vp1p2a
mussel
artesian
havpositive
crosstalkthe
iggspecific
maternalumbilical
153384
23239
121186
nonsmoker
midzone
lowerzone
septae
videoassisted
thoracoscopic
bcgosisa
sivmac239cd8
noncytolytic
sivmac239infected
ccr5binding
motifcontaining
θdefensins
melanomaseven
as015
fba1
fba2
consultive
sinusitisobjective
eosinophilpredominant
extramucosal
futureallergen
immunotherapyigemediated
vascularised
vaccinesallergenspecific
imunomodulators
particules
etiologybased
vaccineschoollocated
dilutive
nondilutive
projectsbarcelona
2012how
electrogenetransfer
dnaegt
diseaseseular
patientssince
complicationson
therapyvaccination
761544
timeshifting
54132
9455
neuroblastomapurpose
influenzaeinduced
chinchilla
nthiinduced
chimv4
adhesins
pinnae
institutionadenovirus
hscy
moleculesallopurinol
hypoxanthine
stevenjohnson
uricosuric
immunotherapypollen
challengedesensitisation
vaccinateall
pasudotox
monkeysmoxetumomab
pkpharmacodynamic
12group
80125
ilbcg
dermalsubcutaneous
pam3cys
tlrls
flt3ldcs
flt3ldc
pam3cyspoly
corrupt
enterocutaneous
fistulas
6mp
ad35k
papillomavirusvaccinated
dlbclwith
onecompany
1when
orenburg
prst
metabolisminborn
reanalyse
typinga
53k
47k
fludaribine
weightthe
45dayold
£4960
dose£750
protectionwe
agin
betaintimin
antiintimin
orogastrically
860939
tirbinding
104107cfu
107cfu
rdech19a
δeae860939
abstractstreatment
responseresistance
immunizationsan
36000
communityparish
ascitogenic
immunohistochemistric
pc61was
immunospect
cd66e
nonpretargeted
hematopoieticspecific
uta21donor
uta21
zygositygenotype
c12orf35
uta21directed
uta21specific
yellowfever
tourcoing
myelomawithin
autoallogeneic
del17p13
t414
nearcr
17p13t414harboring
prophylaxisposttransplantation
sirtac
sirtacbased
113427
138671
160753
hpvobjective
betweengroups
rpcact
89·26
84·91
sarcoptes
scabiei
mayetiola
qulia
challengeinfested
transplantationhcvrelated
minimalization
emily
reevefrom
lerut
fellowships
hépatobiliaire
inselspital
catholique
louvain
chairman
presidency
films
reportunlabelled
medicaton
pyrazinamid
ofloxacin
dtapipvprpt
childrenbooster
epidemicobjective
antigr1
rb68c5
rb68c5bound
stingsbackground
procedurein
3113
outcomevenom
167we
4346
131921
8289
ucbts
102106
195602
111635
nct00758264
scoreimmunization
structurallevel
microsystems
cellsmost
productionthis
ca²
reagenttreated
immunesenescence
insurancethe
4846
aerosolgeneration
communicationeducationinformation
collectivity
informationeducation
reducedsecondary
n449
n225
months115
riskfactors
nhseed
treasuries
melliferabackground
brood
cuticular
workerworker
hydrocarbons
bacteriainjected
possibleprevention
lyophilisation
tumorsletter
campaignlin
pneumopathy
glioblastomaoutcomes
epha2specific
neurosphere
neurospheres
pigsenterotoxigenic
f18specific
cytopheretic
dialysisselective
allient
warrendale
sorbentscd
ureasesorbent
semirush
fcεriactivated
abdominopelvic
pollinosistransgenic
goodtasting
koshihikari
erderived
mycofenolatedifferent
lymphomaanaplastic
alknegative
drugtoxin
cd30ligandtoxin
osteosarcomarecurrent
19881989
fsu
tumorschildren
qualityunits
6grass
squnits
secondaryexplorative
00017
igg4p
00215
07413
nct00807547
shx0562
bvdvinfection
bmscc
bvdvaccination
228300
180019
237070
77900
bmscc211390
bmscc242790
bmssc
colistin
methodbackground
plsw
pocw
â
30question
dissuade
th2cells
lymphomaa
physiciansponsored
131irituximabbeam
075gy
ascts
4108
accuspray
qlaivbfs
n1202
6933
bedsidegamma
vaccinesrisk
envisions
handinhand
eternacept
tcdai
singledonor
tcdai1st
edmontontype
edmonton1st
edmonton2nd
docan
researchgastrointestinal
vaccinationraboral
vrg®a
nnntrimethylated
sedated
raboral
vrg
chitosanraboral
tmcraboral
carecellular
changhua
microfluidicbased
bioic
chwan
bing
lugang
vs111
vs151
allergoidsublingual
lais
analogical
mitechallenged
zanzibarbackground
dukoral
vectorhuman
rm1psma
ad5ifnγ
ad5hupsma
cdtargeted
bsam2alhydrogel®cpg
malariaunlabelled
bsam2alhydrogel®
bsam2
antiama1
nct00889616
pd1b7h1mediated
lowproliferative
upproduction
proapoptogenictolerogenic
dcsexpressed
proapoptogenic
cytotoxictolerogenic
anticd19anticd3
anticd3×anticd19
populationyear
childrenyear
0190
channelcomplex
cd200silenced
emt6previous
nodscidil2γr
cd200tg
anticd200mabs
growthmetastasis
alemtuzumabdepleting
0554
etoposidebased
vgx3100
humansimmunotherapy
reengage
lymphocyteinduced
prdm1
cko
blimp1mediated
overexpansion
blimp1manipulated
dedifferentiationadoptive
monthsmontana
2011reminder
stategenerated
montana
dphhs
wizrd
cd1dbased
stimulialthough
doubleknockout
rag2gcko
monocrotaline
sjljorllco
fasldeficient
erythemal
micevitamin
d3deficient
d3replete
25ohd3
nmoll1
pmoll1
suberythemal
kjm2
btv8since
btvserotypes
btv11
toggenburg
tov
btv25
btv6net08
seg2
seg6
monoserotype
cellpassaged
btv8net07
btv8net07e1bhkp3
pcmvshapq
asfvstrain
pcmvubshapq
immunizedpigs
9mer
programmesafter
takeoff
stabilising
imitationinduced
hivaidsobjective
19502009
racebased
familiesobjective
13520
pepitide
ninepeptide
leisstcda
saibk
vascularnormalizing
antivascularantiangiogenic
immunizationduring
aip
composes
wand
sibs
4798
2598
slitse
slitwe
patchmeasles
micronscale
dissolves
log10tcid50
life5
costbenefits
campaignwhy
swedes
upholding
meloxicam
buprenorphine
ifacontaining
20022003in
hbpn
parturitions
laminectomy
sept9
dexamethasonemodulated
combidcs
collapsed
6225
cytbi1200
n304
cyetoposidetbi1200
cytbi1300
n327
cyetoposidetbi1300
withgroup3
platformantivector
7week
e2bha
317b
subsections
kα
pmdc05
genepmdc05
pmdc11
syndromeno
prerist
primeaβ142
gutmucosal
compartmentsmucosal
airwaymucosal
epimmunization
onbackground
10797
043088
011043
treatmentionizing
ictolllike
commerciallyavailable
hmm
lmmpoly
neuroplastoma
hmmpoly
aujeszkys
chiangmai
lampoon
naadsm
16km
vaccineshuman
selfassembles
wartcausing
settinginvestigators
5538
barriersobjective
2706
9206
1148
immunotherapiesmanipulating
encephalitiswe
eee
tsigsd
wee
524796
291695
gmt89
gmt119
gmt53
gmt79
nonsameday
or410
197855
076207
p3768
122373
nonlatina
moines
doglimited
slightlytomarkedly
cortexmedulla
cyclosporinetreated
cyclophosphamidetreated
wellsupported
emtsp3
gsggsg
emtsp3fbp
pbadthiotopo
remtsp3fbp
remtsp3cpg
igg2α
remtsp3
igg1igg2α
sweepsbordetella
ptxa
fim3
ptxp
sweep
sarscoronavirus
coronaviral
infectionreinfection
sarscovchallenge
irg
irgs
aloh3adjuvanted
sarslikecov
m2edisplaying
challengeconsidering
broadlyprotective
bacteriophagebased
t7m2e
capsomers
t7m2eimmunized
tissuesa
alloantigensensitised
s1pr1specific
sew2871
aktphosphorylation
undivided
cd69specific
mitogenstimulated
phosphorylate
clibmecatreated
miceclibmeca
clibmeca
ngmouse
so2
deathit
so2infected
modelboth
hil12
adcn205il12
cytotoxocity
adcn205gfp
zebrafishthe
granulomonocyte
circovac®
parametersvaccination
enterisol®
circoflextm
farmthis
adjuvantapplication
1405
monovaccinated
surveyeligible
temozolomidecelecoxib
celecoxibinduced
reactioncox2
ımmunotherapy
knowobjective
igg4blocking
settingsimmunization
rhinoconjunctivitisa
artemisiifoliainduced
aitsubjects
placebocontrolleddoseescalation
artemislifolia
uwithout
aitn
moderate5
wwwclinicaltrialsgovct2shownct01134705
latercomparison
platter
offorgan
repurposingcyclophosphamide
maharashtra
4138
shirur
003070
uptakeone
experiencedonor
106118
transplantationdli
22317034
2006may
healthnosocomial
nondirectly
3014
rhinoconjuntivitis
securely
mellow
insecurely
eightoncolytic
humansadenovirus
gendiciner
oncoriner
sixadenovirusbased
keepprogress
detargeting
biomphalaria
pfeifferiscores
dg
027072
05914
diseasegaucher
cellsmuch
posttreated
p0801
oleaauropeae
inﬂammation
rbcgmediated
rbcgimmunized
rbcgdcs
2sensitized
antispecific
rbcginduced
oida
nounsure
postoida
preoida
immunisationcytomegalovirus
intensivecare
il12p70competent
cellsdiverse
donordependent
cd1aexpression
cd1anegative
cd1ahi
specificityadoptive
tcrtransduction
cd57negative
moleculesbackground
iikey
pbr
iisegments
f306
iisegmentf306
asnasp
iikeyf306nd
cyttmiikeyf306nd
iif306
nonpbr
receptiveness
quebecers
nonprioritized
apvaccinated
wpvaccinated
miceanalysis
strokein
rtpa
2gm2day
farac
1020mgkgday
4060mgkgday
remissionpartial
faracric
42306
28417
43704
31810
infusionfurther
termcultured
restoredincreased
statespregnant
2348
medicalcareacquired
igg4rsd
adnexa
pilincytotoxinmoraxella
bovoculi
keratoconjunctivitisobjective
ibk
pilincytotoxinm
hemolysinneutralizing
nonibkaffected
hypertensionthe
aeruginosapositive
rmab
365day
sit3
sit5
pappilomavirus
immunizationincidences
pappilomatosis
inlarge
arsa1
cellsautoreactive
dualreactive
selfag
pazophenylarsonate
antiars
enforcer
sln
multimarker
galnact
ibcs
canow
chairs
pkpharmacodynamics
sunday
invents
plückthun
zürich
gregory
friberg
dario
neri
pardridge
senter
wwwibclifesciencescomantibodyeng
8003904078
kdostieibcusacom
subscription
intensitythe
nmac
ricnmac
mareassociated
postparturient
4004000
cm1
preprocessing
riskpositive
74097852
79688160
97049935
1371614063
1632016590
foal
preparturient
plansinfluenza
crafted
elderlycomprehensive
responseinfluenza
pregnancyinactivated
obss
lymphomadespite
flowobjective
tnftransgenic
obstructing
prearthritic
186±37
μmsecond
strategiesalzheimers
antiinflammatories
immunoregulators
nervousimmune
20082010background
nonblacknonwhite
pinteraction
hostscd8
retransferred
p14rag2
hpassociated
zealandfor
dhb
khana
64d
receptorairway
bronchoconstrictor
adenosine5monophosphate
walesrotavirus
outlay
com1
trxa
esherichia
cd69positive
tnfαpositive
groelpulsed
mockpulsed
mippulsed
il4positive
irms
polysenitization
professionalsbackground
unquestioning
refuser
adversarial
staybackground
ubiquitylationit
ubiquitylationresistant
2kr
cγ
plcγ
2krexpressing
tcrinduced
sirnaelectroporated
ubiquitylation
therapyinflammatory
idcm
hemodynamics
contractility
dagmar
jägerbecker
baba
ofcd4cd25foxp3
melanomaonly
00980729
linesto
hlab0702restricted
nlvtpr
iridc
neuroblastomaderived
cellsneuroblastoma
decelerates
diseasetoday
agrarian
secondyear
tertiarylevel
casefatalityrates
primaryhealthcareunits
antenatalcare
woundcare
tetanussurvivors
fullyutilized
coldchainflexible
monodose
vaccinerefrigeration
modelimmunemediated
flt3tk
flt3ltk
sr39
flt3ligg
p65rhd
japanrabies
758781
pcdnagpvvp2
therapypersonalized
sitmediated
ovadriven
nct00674700
immulite
monochromatic
photodiodes
pvis
infiltrativeductal
lumbarsacral
bioptron2
4803400
thelpers
neutrophilphagocyted
tlpc
17561
6672
301428
p0392
glycolipidsunlabelled
antigalthe
esc11
esc14
antifap
vf19
fapantibody
177luesc11
177luesc14
177luvf19
usaspecific
usstandardized
61414
185146
dermatomyositisa
dlst
athe
t11cla
c12cla
sraav
macaquesil21
sooty
mangabeys
cd4cd95ccr6
cd4il21
jail
mcj
3931
miceleptin
antileptin
graafian
scita
effecacy
asthma12
berween
cattlewe
slaughterharvest
servings
beefassociated
10000lb
cellsone
antierbb2mediated
scfvcd3ζ
mhcag
scfvcd3ζmodified
lyzed
8293
polyneuritis
2300227
37262404
18982
regenerationin
faslfasmediated
workershealth
pharmaceuticalbiotech
computationalexperimental
nonatgconditioned
vampire
desmodus
rotundus
mexicovampire
hospitalsannual
selfmedicate
betula
verrucosa
39173
steroidtoscit
steroidonly
steroidsonly
innovationsrinderpest
entrenched
grassroots
listeriolysinoexpressing
cancerstudies
lloexpressing
cd8cytotoxic
colillo
pcdnaencoding
c57b6
bacterialprimeplasmidboost
tregsuppressiondepletion
vaccinationdna
nfκbap1inducible
civdelivered
epitopeencoding
pdnaciv
pneumoniaepneumococcal
psecpspa4pro
pspa4pro
fendrix®
engerixb®
nonrespondersbecause
hbvaxpro40®
axsymmeia
allergyinduced
3nmol
0342
evaluationthe
singlevaccination
vitellindegrading
vtdce
procathepsin
byc
gsthl
semiengorged
threeantigen
iggantipt
aielisa
dtpa004
dtpa040
diethylamine
age45
ci51187
or19
ci1231
200890s16971
anaemiaobjective
flucyatg
flockthe
cg250
indium
111cg250
177lucg250
mbqm2177lucg250
retinopathies
pigmentosa
rtl220
rtl101
optokinetic
onl
withrtl220performed
p90
rtl220treated
antiinterphotoreceptor
rtls
recipientsinfections
balmisthe
testamentary
17531819
biographical
profilebalmis
18031818
royalist
fortitude
belie
notarial
oligarchies
ancien
régime
antigenicitydetermining
ideencoding
nkg2dcd3cd8t
nkg2dcd3cd8
ium2day
nkg2dcd3cd56
thinkobjective
1215month
10200812009
620849
1215monthold
acipaafpaap
developmentperiodontal
eikenella
corrodens
ldc
cadaverine
02mg
rehydragel®
emulsigen®
polygen
carbigen
107m
oligonucleotidethe
catteries
myxovirus
96192
fcwf4
rotavirusseason
61014week
postlast
4939
ci65
nct00241644
effectsgenetical
tumorlytic
783p
00455
967p
00211
pregraft
conditioningcyclosporine
columbiaobjective
gpos
supporter
muday
efficacytransforming
tgfβdominantnegative
srii
sriifc
smad2
hematoablative
readytogo
holtappels
microbiol
197125134
peanutcontaining
indmed
pakmedinet
studybecause
001children
transmissionatypical
infantunlabelled
nineweekpregnant
tiantanbased
spres1
rvjss1
particlelike
hbvss1
c57blc
primervjss1
lowresponding
nct01003288
nf08tm
06150
5626
tmfree
msdhsct
udpbscts
msdhscts
bucycy
reducedintensified
tbifludarabine
vm26
thaltipa
h1n1v2009
panenza®
activitives
4746
5653740
851006
geneticallyvulnerable
subpopulationaluminumcontaining
aluminuminduced
igepotentiating
sigd
igeforming
aluminumadjuvant
088115
167240
136203
20122013the
bwisconsin12010like
assignmentwe
rr33
ci2248
rr14
ci1118
ci091145
hr074
ci053104
insures
7563800
326318
prophylaxisglobal
childrendrug
cblbsilenced
immunizationmediated
cblbdeficient
sirnasilenced
hyperreactive
therapiesanticancer
hormonotherapies
ifosfamide
overrule
b6sapifnγ
pregsure®
pancytopeniabovine
neonatematernal
bioprocess
pregsure®bvd
bnpincidence
bvdimmunization
bvdvaccine
093361
apr133
064278
apr102
093111
weightobjective
1500g
p0852
0116iuml
0956iuml
staloral®
0·301·31
0·631·90
4970
4667
0·551·32
4770
0·77
0·481·25
haemopoetic
virus1immunotherapy
therapyexperienced
antigensthis
cellsfuture
antilatency
sampson
intensespecific
icus
reprimand
humansavian
aindonesia505
vrc
15group
biojector
11group
tnfrsf4
vaccinationtnfr
tconvs
tnfrs25
ovaaluminum
cd8specific
gp96ig
hydroxideinduced
uncoupled
20012010footandmouth
reoccur
brigade
58000
1088820
9121
testesobjective
44702
prerit
scorten
chinatoxic
severityofillness
12392
neighbourhoodlevel
nct00709410
48178
23921
4792
internationallylicensed
travelersfor
iasusa
ovalbuminasian
eosinophiliain
sim
chimokines
ovaasd
eosinopilia
arrives
tragedyroutine
pocketbook
modelmeasles
adjuvanthuman
betadefensins
hbd
lcdcs
hbd3stimulated
skinmigratory
subclinicsal
thyreotoxicosis
monthsunited
2011high
2007september
toxicityhigh
rs1695
buauc
immunologya
statesthis
womendespite
barriersseasonal
vicpgenerally
generous
á
egpf
ceacd3bispecific
ceacd3bscabcik
pertussisthe
aluminiumpersistent
aluminiumprecipitated
patchtesting
3127
hymenopteravenomallergic
beevenomallergic
vespidvenomallergic
19663331333
stingfree
beehouse
beehouses
156week
00156
00244
transplantationtelomere
telomerelength
experimenta
subcritical
mozambiquein
temperatureassigned
5sensitized
microporated
allergistsallergen
unceasingly
chemokinebased
chemokineexpressing
selfhsps
euroscicon
beyondled
colloquium
fridman
timelinessbackground
9h10
idependent
inducible1
ir9h10
1x107
tbiaraccy
12human
11×10
20×10l
was38
78832
73842
63117
26230
94035
92972
110268
4771
values001
1041061000
122138964
133138
17703
16825
32186
1081091000
109109
bicycle
8123
overprovision
homeslegal
perversely
onus
602968
80277
chemotherapyinducible
centersadoptive
0338
0004072
gvhdgrade
clinicumbilical
cd26dppiv
carcinomacytotoxic
raf
pneumovirusinduced
micepneumoviruses
pvm
pneumoviruses
pneumovirus
pneumovirusspecific
pvminduced
dcpeptide
pvmspecific
pvmassociated
15795
conditioningfifty
149623
22month
resistancebacterial
bmts
excretedsecreted
asn
esa
esaimmunized
antiesa
antibodiesmarker
3875
0226
nct00841256
teenagersobjective
inserm
rate14
regionsdespite
s23bispalmitoyloxypropylcysteine
pam2cys
africasouth
nagi
ndoh
experiencesouth
workersvaccination
empathically
africahepatitis
parenteralpercutaneous
sadoh
schoolsbased
livevaccine
fourthly
mdgsimmunization
spiralling
immunisationdiarrhoeal
dehydrating
limpopo
schoolacademic
muchdebated
ethnographies
embellish
statesassociation
20042011all
026041
27156
knowledgeas
bisim
undesirably
naturaltransmission
infectioncause
pof
gnrhagonist
gnrha
cof
gonadotoxicity
gonadotrophinreleasing
gnrhbhv1
malignanciesrecently
neoplasmsthe
erythropoietinantibody
gmday
erythropoietinbeta
predialysis
unitwk
reticulocyte
antierythropoietin
erythropoietinalpha
528047
75094
huava
psychoneuroimmunologyfinding
psychoneuroimmunological
encephalomyelitisexperimental
subheadings
subheading
lupus…cd4
lupusinducing
hydralazine
procainamide
demethylate
roletumor
cd33hladr
cd4cd25highfoxp3
scd40linduced
death1expressing
lymphomaimmunomodulators
eμmyc
amleto9a
βmannosylceramide
2011since
vaccinationpromoting
stoichiometric
humansadoptive
8310
8408
8377
8287
800700885
200150200
100100150
8248
cias
outbreakdespite
outbreakresponse
913943
immunizationreducedantigen
039mgdose
05mgdose
restofworld
diphtheriatetanuswholecell
diphtheriatetanusfivecomponent
tetanusprone
ecohivndk
chadvs
chadv68
sadv25
adc68
recombineering
chadv68gagb
gagderived
ecohiv
ecotropic
ullevål
hospitalindications
recipientsmouse
inosdependent
c3htobalbc
b6tobalbc
nos2deficient
vitroderived
nearequivalence
asample
orsterile
wildlifeabundant
tanzaniacanine
pfgemlst
cc230
cc156
st191
cc260
st306
cc30
st433
184p0001
410p0001
c3hhe
birradiated
sccviipulsed
extirpated
parentalguardian
kih
crossmab
therapyprevious
naturelike
ifnαprimed
mart12635
mart1expressing
imprints
antigliomainactivated
alohbased
melanomadraining
mdlns
mdln
il2il7
il2il7cultured
childrenwomen
howbackground
discourserecourse
gapsshortcomings
fragileness
pantumour
therapyincreased
hormoneresistant
immunotherapyfocused
approachescombination
celltumour
magea312
ongoingplanned
asci
taxotere
prostvac®vf
ipilimumabalone
immunooncologymelanoma
recommendationsin
serogroupe
delimited
activgpip
gpipactiv
infectieuse
pédiatrique
val
marne
menbvac®
b14p1716
lsds
tunnelthe
commonalitybased
desensitizationallergic
haptenated
spacerenhanced
immunotherapyinduction
2aβ15linker
2aβ15
cfsebased
gpgpg
globulinobjective
sixandahalf
196324
7685
18324
hbiginjected
ratio014
002090
hbsabpositive
ratio007
002023
11861
1052313199
selfacquiring
celltransplantationmelphalan
quadrivalentbased
12013
13232
15890
accesspublic
zytiga®
zelboraf®
calreticulinoral
rtscrt
tapeworms
rtscrtct
23montholdsobjective
chosenor
plannedto
955974
788830
847882
35100000
64100000
fictionvaccination
diseasesself
recipientocular
artobjective
quoted
startin
ishida
malignancieswhile
updatedobjective
calvesthis
10wk
0625
starter
withers
looser
injectablespecific
catsobjective
or035
or091
p0792
chemokinesadoptive
upregualtion
marrowtransplant
chemokinedependent
designbased
betting
tcrαβcd19negative
6357
7605
5033
33738
kindergartenunited
yearin
hivhcv
coinfectionit
backtoback
preflucel®
7250
verocellderived
avianderived
outstrips
modulationchemokines
inactivates
ccr1
scidhu
modelsearly
2850
5490
consprimary
tsuda
al1
amaproducing
imatinibresistant
e255k
e255kspecific
leukemiadriven
onehundredandfifteen
mammaglobina21
a22
mammaglobina2
firesfebrile
fires
peracute
germanwide
csfs
αamino3hydroxy5methyl4isoxazoleproprionic
ampa
gababreceptors
vgkcassociated
leucinrich
antibodydetection
pandemicsour
toleranceunlabelled
ftcd
ftcdspecific
technocentrism
toolsconquering
dha
5azacdr
q8
5azacdrtreated
femalesobjective
likened
strainbackground
id9
int9
dickinsons
soluvia
intanza®9
im15
id363
id968
int965
im1566
29march
wadc
hanson
wade
29‑march
antibodymaytansinoid
mertansineimgn801
imgn529
img853
biotest
antibodyauristatin
5t4mmaf
agensysastella
ags16m8f
progenics
psmaadc
calicheamicins
duocarmycin
synthon
ambrx
viventia
photobiotics
miuday
tumorreactivity
αil17ab
feedingth17
feedingtransfer
allergenpreparations
200700280818
igelevels
scitdrf
parentadol
100518
089456
accelerations
therapyradiolabeled
smallsize
guidancethe
adultadolescent
ruler
clark
19372012dr
stanley
plotkin
offit
indiameningococcal
29e
communicability
135000
fatalof
mumbai
haj
displaya
applicationsone
deliveryphage
directionscurrent
medstat
38786
8515
10152
highlyinsured
pmlrarαpositive
efficacyusing
oncogenespecific
reactionbased
leukemiaretinoic
pmlrarα
ncn
atradnatreated
oncogenepositive
exscit
preparationobjective
likeallergen
worldfirst
reanalysed
singlecytokine
etiologymany
cntcpg
multiformeunassigned
specifictargeted
elderlyaging
multicity
moverstayer
intercity
ncity
ncities
selfadministering
polypodlike
phosphodiester
tetrapodlike
tetrapodna
48base
nonligated
dnadegrading
nanoconstructed
agentsdespite
ch3ch2hingehinge
supraphysiological
memoryonce
vaccinationmastitis
breastspecific
swxj
lactationdependent
nonlactating
nurture
αlactalbuminimmunized
kwashiorkorlike
nutritionally
failuretothrive
functioncord
sdf1cxcl12
rheb2mtor
dek
phasespecific
pdes
dde
gaspermeable
unseparated
infectionearly
mrnaediting
enzymecatalytic
polypeptidelike
tetherin
αmotif
histidineaspartic
αβθdefensins
lactoferrins
trappin2elafin
interferonλ3
transcriptionmediated
protegrin1
mchiiprocessing
vaccinationfor
strategiesvaccination
ruleofthumb
lowr0
interventionlung
bronchogenic
panresistant
microbesin
polyβ16nacetylglucosamine
ruminantsin
receded
ptldbcell
mediastinoscopic
mcv1by
guizhou
iir
aiir
eir1
aeir1
eir2
significancep005
bogotacolombia
phci
under5years
bogotas
coughasthma
beamfludarabinetbiallogeneic
beamfludarabinetotal
beamfludarabinetbi
approachmelphalan
mel140
melonly
trialsthere
regimendedicator
aspergilloma
therapiesmonoclonal
cd204
cancergiven
multimodalities
sracd204
sracd204silenced
silencingenhanced
downregulationpromoted
irresectable
skil
diskapi
acipunited
seasonin
immunotherapeuticstoday
healthtechnology
judiciousacceptors
differentiators
softindividualists
hardindividualists
selfstirring
papillomaviruslinked
immunotherapyhdm
vaccineparacoccidioidomycosis
qtliaihtlairyan
p10primed
usd20bn
pharmerging
stagesactive
mesotheliomaobjective
mesothelium
anchorageindependent
ppmmill
tp412
cspg4dependent
chorioallantoic
studiesfeline
antithymocyteglobulin
buratg
mycophenolatemophetil
modelloss
directionsalthough
betatm
barrierscytokineinduced
ascik
32fold
2243fold
asciks
hlaa2binding
5t41725
5t497105
cd8tet
mva5t4infected
hlaa2expressing
5t4expressing
xenoengraftment
coinoculation
5t41725specific
sophie
orphanage
posthypoxic
antinmdareceptor
vaccinologynonhuman
countriesquinvaxem®
yearsquinvaxem®
uniject®
swedensweden
alsap8
aproaches
genferon
ifnalpha2b
cbcc
suppositoria
stabilitya
registervol
180friday
2010proposed
dissociates
testingthe
multipledilution
singledilution
testingnext
adfmd
dept
homeland
prevalidation
linearity
focusforming
ffu
tced50
teststhe
licensees
permittees
developmentvaccines
developmentand
learneddespite
animalbased
ruggedness
titrations
stabilityindicating
testingthis
usdacvb
requalifying
emacvmpiwpthe
ivmps
cvmpiwp
microtitre
platevaccines
tnts
novyi
vaccinesph
assaysvaccination
methodbatch
deadalive
niceatmiccvam
workshopveterinary
niceatm
iccvam
hccbackground
lymphomashodgkin
immunoglobulinelike
karpas299
sh313b5
chandigarhthe
iapcoi
cats1
ovatregs
200600471244
metaanalysisbetter
3245
4602
124475
nct00968890
nct00971425
ah1n1pmd09like
7493
ad585aexperiments
bronchioalveolar
balc
15128
20099
hbcagbased
virusexperimental
hbsagbased
hbcagpulsed
streptavidintagged
il4sa
nhspeo4biotin
gfpsail4
dayson
gfpsatreated
burdenin
il4satreated
sacd40l
elicites
humanssir
almroth
antitoxins
neufeld
pivotally
alphonse
dochez
oswald
191617
colin
macleod
heidelberger
194445
austrians
14valent
vaccinologyvaccines
catalysed
immunomics
glomerulitis
25ml
foresaw
2mlday
618yr
coopwoncacharts
reviewlive
singlestrain
bovinehuman
papillomavirusvaccination
centurys
benefitsmost
costsand
radioimmunotherapywe
3pcnetancs
cdota
cdtpa
3pcdepa
90y3pcnetatrastuzumab
177lu3pcnetatrastuzumab
177luradiolabeled
zr751
samuel
katz
studywhen
jinju
ripple
micehaemophilus
tcpfa2ctb
tcpf
cholerathe
0139
immunogenicityprotective
holotoxinlike
tcpfctb
antitcpf
n16961
ewsfli1targeted
esft
ctlkilling
ylnpsvdsv
ylnpsvdsvspecific
ppnet
askins
injuryobjective
ischemiareperfusioninduced
busilvex®
postvaccinationbackground
vietnama
hamstersenterovirus
nptvp11100
pathoantigenic
hisa70
vaccineleishmania
h2a
pcmvβm2a
pcmvhisa70m2a
susceptiblelike
immunityclinical
bcelltargeting
αcd19id
idspecific
iieso
dr52b
eso119143
dr52beso119143
esotetramers
esotetramer
alloapc
esomonospecific
esoexpressing
threechoice
16item
odour
sour
salty
tastants
infectionmaraviroc
ccr5antagonist
mvcplacebo
neoimmunization
ttox
th1conditioned
corticospinal
th17conditioned
th1transfered
nt3
anthraxbackground
n5846
vba
n148934
n937705
hfp
or105
or066
argentinadue
parameterizations
infantsinfanrix
subjectrecent
photoimmunotherapybackground
mabnir
jcm2in
diseasethere
varicose
extraglandular
moderatelytoseverely
mgmtp140k2agfpirestk
magit
p140ko6methylguaninemethyltransferase
mgmtp140k
hsvthymidine
tkhsv
benzylguanine
chloroethylating
13bis2chloroethylnitrosourea
lineagedepleted
bgbcnu
magittransduced
hbbth3
infantswith
alemtuzumabincorporating
106cellskg
pdlis
26day
electrodeposition
sublimation
historieswe
1424years
539567
505545
157±16
156±16
sexeswith
femalesthese
quantiferon®tb
tst10
kappa083
value0000
ad35grin
ad35env
ad35grinenv
2×109
2×1010
2×1011
sfc
78139
158174
nct00851383
chabaudimalaria
theorists
ama1induced
passaged
ama1selected
19982009background
deferrals
virusesoriginal
afm147
neutralizingab
personnelto
singlepayer
occupationspecific
nononcogenic
qv
153000
priceparity
11484
districtusing
idrs
bvr
or0676
ci05050904
ci106362
or267
ci159469
or159
ci114221
ci039088
or399
ci1181354
gam
coverage70
significantlyhigher
fumigatusobjective
wmafes
328fold
nonfumigatus
fumigatusspecific
groupsto
4072
zelboraf
personallyspecified
pegs
healthtech
biobetters
trastuzumabit
cd3lak
trialhaploidentical
iiiiv°16
iiiiv°
iii°
6395
personalphilosophical
adolescentsstate
philosophicalpersonal
273365
410047
281566582267
dtapipvhep
bprpt
spsc
postdtapipvhep
frαredirected
splitdose
challengestwo
andparticularly
vaccinesdecline
beingatrisk
opined
obliviousness
populationpopulation
concernvaccinepreventable
depressionlike
micestress
plusmaze
swim
fst
interlukin6
factorá
tnfá
interlukin2
interlukin4
interlukin17a
monoaminergic
pertussisvaccine
8colour
isolatesthe
abarheaded
gooseqinghai32005
qh
achickenshanxi22006
sx
qhha
sxha
pathogenesisobjective
goodeular
lsra
aab
rfigm
rfiga
rfigg
antimcv
acpaigg
acpaiga
acpaigm
5aabs
1875ul
aabs
nosteroid
variablesno
countand
assaysiggrf
gatekeepers
tumoreradicating
immunisationcomplex
crps1
erickson
wals
sherbrooke
or23
or212
58759
or44
14136
belgiumhepatitis
lowendemic
223000
parametersthe
n135v
approachpulmonary
omits
253±46
105±34
00±00
456±65
±53
73±31
p0855
p0581
p0933
p0142
622±58
606±56
516±62
511±59
d2receptors
delta1opioidergic
delta1opioid
dpdpe
microgkg
sch23390
d1receptors
d2blocker
haloperidol
bmenc
murabutide
vaccinemurabutide
norwalk
gardiquimod
gard
protocolsbackground
shotsunfortunately
eliminationtetanus
unhealed
forwardcancer
jeopardy
seriescosts
publicand
mexicothere
25y
cancerat
pities
brinkthis
srivastava
antigenics
haptenmodified
berd
avax
haptenized
eased
dtwphephib
flgj
flin
nonmotile
er2566
bab10260
bab20122
injectionnurseryage
p00625
p00313
desmosomes
immunotherapycarbohydrate
translationdendritic
firstdiagnosed
treatmentfailed
tbhivobjective
immunitor
17211113
2019148
9l
postexposureprophylaxis
sticking
systemearlier
e1499objective
taf
brafv600epositive
brafv600eupregulated
melanomapatientderived
il1αβ
foxp3gfpdtr
dx
dsscolitis
immunosuppressionaccumulating
r04
imiquimodadjuvanted
micetuberculosis
gp160env
p24gagspecific
gp160envspecific
hivvaccinated
classificationandregressiontree
trimera
nodltszscid
xenoreactivitydriven
activityobjective
serratia
547000
mbvinduced
feverinducing
alphagalactosyl
epitopeactivated
preimatinib
bencard
il10il4cd4
conditionsrevaccination
648a100bp5
capacityrapid
postattack
preattack
1390000
anthraxexposed
205835
35049
28612
6437
69136
icer182qaly
icer1088qaly
pullulans
miceβ13dglucans
β16glycosidic
healthpromoting
pullulanscultured
apcf
pullulansproduced
apbg
polybia
scutellaris
immunotherapystings
basophilmediator
5induced
lungbackground
9monthlong
miptherapy
mipimmunotherapy
stimulusfollowing
agdriven
polysaccharidek
cancerproteinbound
pn3
nhlimmune
longdeserved
synapsis
peptideobjective
syetp
cksthdrlc
localise
humansevere
syetpantiinflammatorycytokine
mmpcleavable
nichelate
nanosinglephoton
nanospectct
il4syetp
peptidetargeted
angiopoietin1
ang1
biotindupt
bcl2bax
ang1preconditioned
ly294002
ang1preconditionedmsc
nonpreconditionedmsc
providersdata
abstention
hessian
hospitalsinfluenza
precondition
progressionthere
immunoinformatic
su5416
angioobliteration
muscularization
ovaallergic
angioobilterative
inhibiton
survivalima901
tumaps
apoa1
chronicrecurrent
comorbiditieshematopoietic
smteg
cd4ifng
proprieties
5hydroxytryptophanclinical
allergyasthma
anxietydepression
5hydroxytryptophan
5htp
transglutaminase
tg2
serotonylation
009053
or326
1061004
immunizedas
eeaefta
euvacnet
dysmature
arraysthe
antigenonly
infectionapproximately
boceprevir
nonrecommended
laivrecommended
recipientscurrently
iggantihav
44538
iggantihavnegative
igganti
liverdisease
or0359
or5826
diseasehealth
12352
immunosuppressionfollowing
ambo
ratioaor24
aor29
aor43
anemiaallogeneic
alkylatorslowdose
transfusionindependent
immunotherapyil17
il12rb1
card9
pandemi
midnovembre
mf59c1
beamagglutination
gmtr
nasalpharyngeal
emea
partiallogeneic
rtsct
transferoncolytic
vsvantigen
mac1
childrenasthma
icam2
9808
90799912
9960
99299968
9056
87088886
vaccinationschool
immunizationwho
pilottest
unfairly
misspecification
topicaltherapeutic
pasteurised
immunodepressionobjective
adrenomedullar
708±129years
infarctions
nonlacunar
noninsular
subtypesthe
liposomethis
12dioleoyl3trimethylammonium
propane
dotapbased
sota®
herts
960±095
600±063
sentences
overturning
handing
courtroom
lectinfunctionalized
aleuria
aurantia
wheatgerm
ulex
europaeusi
immunoimagingtherapeutic
hcgexpressing
selectedlung
antiβhcg
sw71
28mgml
radioimmuno
enzymereplacement
cytoreductiongene
deaminasedeficient
adaexpressing
vcns
vcn
pdgfreceptor
125ia5b7
pseudoallergic
pseudoallergies
vitrospecific
genedeleted
bartha
nia3
spss18
4480
dilemmaa
economists
itlung
leukaemiacomplex
metaphase
chondroitinglucuronate
c5epimerase
dglucuronic
liduronic
dermatan
c5epimerasederived
alphafoetoprotein
afpnegative
c5epimerasespecific
cells3
interferongammaproducing
hypoproliferative
achievementbackground
infectionproblem
vaccinated1
cohort166
rub
rubles
child1000
ofvaccination
years8
years21
4889
selfsufficiency
milliards
fhud2
miceiron
ironhydroxamate
fhud2mediated
againthe
enzymeenhanced
fastestgrowing
bneisseria
ctetanus
4doubledose
91153
233318
pra102
41169
pra20
pra22
cd14hladrlowneg
heterogeneic
pstat1low
idohigh
cd3ζchain
tcellsuppressive
barrieras
transplantationhas
patchtested
hyposensitivity
vemurafenibthe
dermatitispart
vaccinescervical
hpvencoded
challengespasteurs
tumorconditioned
2122
immunehostile
11735
wroclaw
270366
153362
372474
15362
86362
2986
237437
adultssince
mazovian
1455
79100000
133100000
327100000
118100000
685100000
294350
239273
salmonellosesobjective
apoptosistargeted
peptidechemotherapyinduced
apopep1
oleyl
apopep1bam
19μg
4205
7718
4009
7083
nct00975884
2012vaccines
conceiving
pharmacologythe
antibodiesprogress
reengineerin1g
improvving
tumororgan
vaccinationcritical
3041
targetpopulation
cd19s
surveychina
singlechild
migrantrun
cd24specific
vbmt
noncytoreductive
tregvbmt
turbidimetric
3586
aboikt
denv1denv4
denv1specific
postdenv1
coverageeven
wuhu
riskassessmentrecent
riskassessment
gdha
b2the
sabah
devided
commingle
graze
pigletsinfants
wellmune
wgp
wgpkg
post1
post2
changedchildren
stsreducing
emergencyare
anyoneobjective
2152399
20062008objective
kolkataworld
prestructured
2392225
145781
163862
102425
longrun
presteadystate
jessner
malignanciesstudies
sulfhydryl
hemoderivative
mediastinitisthe
mediastinitis
parameteres
noncomplicated
behaviorthe
selfinterested
vaccinateda
groupoptimal
behaviorwhich
payout
ctlscytotoxic
oralimmunotherapy
nct00461097
apids
formicidae
docile
interbreeding
hornet
baldfaced
harvester
selfinject
reactionsspecific
salmonsimple
biotypes
19fold
selenoprotein
hivdiscordant
prevnar7
prevnar13
walesbackground
500062000
neurologist
18322800
541000000
lymphopeniacytotoxic
tes
lymphnodes
tdlns
mediatorsupon
susumu
tonegawa
scand
303319
antibodynondependent
modelcd20positive
autoantibodynondependent
mog3456
pathogeniccontribution
7d8
th17producing
pathwayspecific
fmlp
deficiencyin
threeyrold
bronchiectasia
atherothrombosis
effortobjective
steap
oxidoreductases
sixtransmembrane
steap1
steap2
steap3
metalloreductase
steap4
cd40stimulated
manytrimer
onetrimer
canceragonistic
pathwaythis
masterswitch
treosulphanbased
miceprevention
lmagloaded
il4rαdeficient
cd11ccreil4rαlox
stationaryphase
il4il4rαmediated
odnexposed
il4rαmediated
il4il4rα
rsh28gst
schistosomiasisbackground
protectioncd4cd25
pvax1sj26gst
cd8αcd103
vaccinationactivation
nct00943202
nephritissystemic
diseaseposttransplant
conditioningformation
likeliness
gld
individualsasplenic
nonsplenectomised
imaginga
vdelta1
killerg2d
cmlassociated
postautopbsct
tumortolerized
tolerizingtumor
refunctionalizes
coreceptorindependent
epitopereactive
cd8independent
1383i
hlaa2human
vivot
phosphatase1
shp1specific
thwarts
stunts
nanolipogels
nlgs
drugcomplexed
cyclodextrins
cytokineencapsulating
intratumoralactivated
risedronate
recipientsbisphosphonates
osteoid
adynamic
preventedmost
hepatosplenic
postmononucleosis
fictiona
myocarditiswe
fmderived
fmmsc
fmmscs
105cellsrat
mscd7
mscd10
mscd14
cellsmm2
celldifferentiation
miceasthma
ethanoltriggered
asthmalike
ethanolgavaged
70080
2192
aor258
ci147453
aor230
ci134392
aor373
ci141988
aor1260
ci7062148
aor2780
ci13885586
aor003
ci001008
aor011
ci002078
ci027091
refunds
insurant
pepsinized
cashews
cashewsensitized
2686
299±22
231±19
264±22
136±18
hne
319325
113319
202319
125170
actualizing
inducedtreg
inflammationboth
susceptibleexposedinfectedrecovered
7325
£5815
10470
10216
7280
dtapipvprnt
823100
ugml
979984
81dilution
3531
immunodeficiencydeficiency
mfds
msdmfd
interferonαtransduced
tumorsinterferonalpha
ifnαtransduced
mc38ifnα
populationsin
strategyeffective
pegfpgra7
pet30gra7
greeceyoung
pvalue0012
pvalue0017
tbmycobacterium
diseasetb
challengespolyomaviruses
hpyvs
hpyv6
hpyv7
trichodyplasia
hpyv9
formulationssubcutaneous
cancerchronic
pylorirelated
carcinoid
hypergastrinemia
enterochromaffinlike
carcinoids
antigastrin
orlando
scheduleunlabelled
arge
jorge
7686
immunizationcase
futher
allergologicalimmunological
lesimab
selenasledai
scoretwo
200±152
126100
732380
41690
690690
920684
9220746
31375726
505356654
memberscarers
badges
coresiding
agencydesignated
μsvh
nonen
004042
126339
1004370
004039
005077
1021712
124381
033099
005072
tpbhealth
pastit
promisingextracorporeal
hypothetic
italyon
immunitary
wwwactabiomedicait
adamant1yl
tripeptidethe
dad1ylglylaladisogln
manoch2
chmecodad1ylglylaladisogln
nonpyrogenic
osoluble
adamantyl
βdglcnac14dmurnaclaladisoglnmesodapεnh2
daladala
dentistsobjective
122713
116774
150825
163926
fcox40l
vaccinefcox40ltreated
programmebovine
selfclearance
286301
gliomano
139based
motol
antiovca
theese
polandafter
nofer
promovax
mesotheliomatreatment
disarming
mechanismsthe
parasitesprevious
tcrδko
xat
ligandcd40
mothersthis
604966
244651
772992
768100
5620
292510797
nct00240526
nct00774995
aanhui12005
antiro60antila
antispectrin
ro60
4hydroxy2nonenalmodified
antiro60
αfodrin
antiro
antifodrinspectrin
insideout
crithidia
lucilae
44±05
06±01
od412
36aa
aa373
od136
hnemodified
intermolecular
ro60la
hlaa24binding
antigen6
imp3
keyopened
26month
imp3specific
nct00995358
onemonthfollowup
or61
slig
imojev
®a
jecvbackground
imojev®
immunosuppressiona
subjectstransplantation
graftspecific
petrov
168965days
55126
58166
solutionthe
104342
93288
043284
039253
etoposidecontaining
immunizationsthe
dialects
pdrstudies
manuals
toilets
procedures7
43±3
55±2
24±3
31±1
hr147
patientsto
citieslow
bremerhaven
gynaecologist
krh3955
shivks661ccynomolgus
caregiversprevious
nongovernment
estates
noncaregivers
albuminbackground
nct00560755
3388
3376
3342
9864
3486
allergictype
succeed…
mab®
glomerulonephritisin
seconder
hospitalparenttoinfant
sclerosishighdose
therapyahsct
salvagelate
conventionalsalvage
005the
38002
uninsuredmedicaid
078089
086092
teachingresearch
152189
140257
pneumoccocal
23123
and11
englandwales
bloodculturing
fourthleading
wellfounded
missile
strategycurrent
achrspecific
achrresponsive
ova323339map
peritracheal
octomers
peptidemajorhistocompatibilitycomplex
mellitusmajor
isletreactive
diabetogenesis
deletes
ribosomeinactivating
pteronyssinusbackground
rtes
sublingualslit
subcutaneousscit
cd4cd31
cd8cd31
trecscd4cd31
rets
hyvac4
ifnγtnfαil2
developmentvaccine
h4ic31®
antimtb
steroidogenesis
nmolliter
aldosterone
pmolliter
ngdl
embryofetal
vivopossible
proteinmrna
b6129s2il6tm1kopfj
iggigm
noncompensable
transplantnonmyeloablative
pulmonaryrelated
46977
5·618·8
34·5
16·148·9
23·4
10·434·6
p0·067
p0·21
¹³¹ichtnt1b
cotara
131ichtnt1b
cotara®
dnahistone
doseconfirmation
radioimmunotherpy
ibritumomabradioimmunotherapy
ibritumomabu
bsp
organosilicone
dexamethasoneas
biohybrid
matrixtype
microgdaydisk
higuchi
presoaked
recipientssuccessful
ftxm
gammaglutamatechitosan
virusintranasal
γpgachitosan
camelus
dromedarius
concentrationsthe
tandemdimer
acrosin
amidase
birchallergic
immunotherapyfunctional
nbet
modcstcell
boydii
micelike
bch612
badgercattletb
tatargeted
7f5
aufe3o4
goldmag
7f5goldmag
pscaspecific
optimistically
tcrvα
dtea
tuberculosisthis
adag85a
bcgadag85avaccinated
primeboosted
multidetector
mdct
sspcasei
lcacesi
27×108
swallow
softwarewe
polarizationgranulocytemacrophage
mcp3
ccl7
proimmune
gmme3
ccrmediated
cd21hicd24hi
cd1dhi
bgmme3
eaederived
tgfβil6
bregulatory
64245
epitopesrecombinant
lrlo10
excretory
larvaea
55kda
laboratorydetermined
samplingadjusted
positiveagreement
clianegative
elisanegatives
cliapositive
treatmentrefractive
antibodiesresidual
βcellspecific
pancreasresident
effectsamyloidβ
aβoligomers
transplantspalifermin
ceatg
beetle
diseasessince
microporationdriven
tricksobjective
universitysponsored
vitroaccumulating
rhizome
curcuma
4200
10000qaly
16900
shiki
mayor
h5n1neutralizing
brazilto
mva85avaccinated
unconserved
id70
2011rotavirus
intussception
particlespolysaccharides
polysaccharidespecific
coentrapping
coentrapped
gliomasthis
challengesnovel
pursed
mesotheliomanonsmallcell
monomermisfolded
sclerosisthere
misfold
sedi
fals1
sod1g37r
misfoldingaggregation
sod1linked
monomericmisfolded
sod1related
micemacrophages
m2r
il4il10transforming
lipopolysaccharideinterferonγstimulated
improvementunlabelled
antidiethylenetriaminepentaacetic
hmn14
m734
131ididtpaindium
preprait
postprait
024086
1631736
008051
1812098
hini
±11
r50
nonionic
herpesthe
nisv
polylysine
dtk
dtkcontaining
dtknisv
gb1scontaining
gb1snisv
gbspecific
ig2a
ifnproduction
20062011the
5156
adifnα
infarctionperipartum
casethat
gravida
electrocardiographic
inferiorwall
catheterbased
inflammatorydisease
dbinding
2012since
2010immunization
vtrcks
hyposenzibilization
cholerayoung
ocvinduced
nachriassociated
nonchildrens
hospitalswe
medicalsurgical
influenzasuggests
childfocused
screeningintroduction
studiesfrom
canadahave
6171
immunofixationpositive
proteinalbumin
nyeso1157165hlaa0201positive
chemotherapyradiotherapy
10×109l
200×109l
sequencebackground
211711
fhl
futurecontrolled
inbndtpanimotuzumab
electronemitting
herceptinresistant
cancerincreased
benzylisothiocyanate
111innlsbndtpanimotuzumab
receptorscell
111inbndtpanimotuzumab
therapeuticsfood
antigenfixed
therapycd137
edemabackground
digits
acuities
p0196
29562
30987
19927
22106
hungaryunlabelled
3794
7885
geraisobjective
1808
administrativegeneral
leukemialymphomawe
type1encoded
taxexpression
hlataxpeptide
escapean
b16ovabearing
singleantigenloss
vaccinatedhpv
happenstance
hubris
studyits
shady
responseseffective
latesepsis
cellrecipient
lpschallenged
footshockinduced
gynostemma
pentaphyllum
componentsthe
gpex
footshock
efsstressed
efssuppressed
allwe
130mgm²
areaunderthecurve
5000μmolmin
32mgm²
70mgm²
2351
μchaindeficient
μchain
cd19cd9igd
peripheralinduced
primateslicensed
edmonston
rmvgag
intratrachealintramuscular
06014
031094
survivalinvariant
inktt
therapiespsoriasis
il23th17cell
mouseand
tcelltargeted
cytokineblocking
analysisimmunoglobulin
range084115
range036097
range007011
studiesmake
nonvaccinationdespite
20mer
nyeso1f
91110
peptideimmunogenicity
tkf01
b3501
b5201restricted
b5201
c1202restricted
92102
c1202
bolsa
família
conditionalities
pesquisa
avaliação
impacto
nrw
52171
schoolscreendetected
usavaccinations
diseasescreening
straddle
myelgenous
apbscts
5112
1272060
vβ2
vβ51
mobjective
hkb
nlxalumhkb
studiesmetastasis
pancranial
highprecision
motorised
dabat
penta2
36775
127775
719739
602648
564690
60mins
adjrr085
value0001
30mins
value0240
adjrr095
adjrr088
handassistance
pringle
nfb
ikks
rabiesbackground
noncosteffective
suppressionsublethal
il10background
engagementby
cancerswith
usfood
comprehensivenessthe
19821983
prevelance
genesbackground
sh2
igerelated
th1response
th2response
2010french
vae
vaeincluding
toxoidspoliovirus
vaeper
protección
nicaraguausing
monthsvaccination
bovischallenged
postbcg
ppdspecific
asthmamost
horserelated
horseriding
stables
diseaseboth
preventablecause
agedefined
ppos
ppo
80720
lubbock
healthyafter
department39s
zielonka
górecka
puścińska
trialseveral
4digit
sensitizationthe
beyondas
qsar
2010following
bordering
foxmediated
survis
fullyautomated
wildlifelargescale
computersupported
foxesoral
diseasesheatshock
gp96peptide
gp96mediated
gp96induced
classbased
2180
nct01173900
plasmacytomalike
97711
shotlimiters
nonadvisory
externalbeam
antigensbacterial
lcpgb
lcpgd
188279
124363
vaccinationnumerous
pohl
highmorbidity
filingue
392211
headquarters
356532
lighter
trapvaccinaterelease
earthquake
antigenretention
1990ies
of38
remissiontuberculous
antituberculartherapy
cerebroretinal
calcifications
revesz
linnankivi
birchwe
regimensantihuman
3013
194794
1333356
surveymumps
n2456
ns35
25oas1
nct00661557
4534
nomps
ablationinterleukin2
syndromein
statusin
fcεriige
concentrationdependence
phosphosrc
phosphoship1
phosphosyk
phosphocbl
ebmtclofarabine
clocontaining
021066
stormy
ifnlike
cd4cd26high
cd49dhigh
csss
agetrend
isrctn51695599
indiavaccines
vaccinespreventable
revamp
phytohemagglutininactivated
anticd122
micegraftversushost
xenogvhd
schedulepolio
wpv3
opvipv
juniortickborne
encepur
children®
junior®
africasignificant
graftunlabelled
511±1395
527±331
cholecystectomy
nefrectomy
arteriovenosus
embolectomy
aortal
stentgraft
p0322
endocavitary
impaire
transplantationimmunologic
paratuberculosisclassical
kindergartner
allergyprofilins
nonlipid
haematocrit
patientsnickel
soluviatm
flumist®
marketable
melamart1
gp100pmel17
pdcprimed
nakayama
9895
3942
jembprimed
nct01386827
adultsnational
32000
autoantigenencoding
casualty
socialepidemiologic
infectionliterature
clinicalepidemiologic
000pneumococcal
ofpneumococcal
rur
ruble
3919
productby
immunizationfeatures
zooanthroponosis
ascus1
cin3142
cumulatively477
cc188
syncitial
immunotherapycombining
sm1ova
nct00013871
nfid
meetingpneumococcal
apt
tractoral
hmsns
solgelemulsionoilinwaterethanol
gstorf2e
hmsnprotein
211atthe
peritoneumtoplasma
51crethylenediamine
frameworkin
mrz
surpluses
multiplier
180340
readyfortransport
studyadult
74132
3241
67180
72140
2940
atlrelated
tbeupdate
tickborn
miceserum
ankg
arcaβ
antiankg
programmesthis
20179
52·9
74·6
populationsmumps
esen
0·09
0·010·71
0·08
0·010·85
q13
q32
20042010this
recipientsintravenous
q6h
q12h
weightnormalized
065073lkg
122147min
3443mlminkg
18352180mmol
628746ngml
146min
35mlminkg
remindersbackground
stofhla
kappas
4550
127200
73200
50172
26172
21172
mortalityin
1231026
034280
n733
ssigg
as101
tellurium
matchmaker
nonitalian
8018
nonitalians
antihbsantihbc
immunoadjuvanta
pcpp
intercells
systemtranscutaneous
intercell
vdp
vep
microplatebased
nonwoven
matrixsupported
facileness
wartsa
rhetorically
vanquish
hatred
salvianolic
densitygradient
epcsbmscs
cellhigh
magnification
macrophagesiga
p221rmutated
jchain
fcαrimediated
iga2mediated
miceperforindeficient
lcmvinduced
np118126
transfercd4
organprotective
siteoforigin
rouses
6662
aβigg
nct00411580
cad106treated
eventsnone
prophylaxiswe
rihsct
dmspecific
cd4cd25highcd127lowcd45ro
treatmentdiphtheria
antirhesus
fn18crm9
12194
pretrial
programmers
isrctn62323832
cityobjectives
pointsofdispensing
202089
49986
371827
174000
cardconfirmed
cellsrisk
hlacuncoupled
hlacmismatch
cervixinfection
dendritc
intrapepithelial
lymphomaalthough
extensivetype
333–1119
677–100
intestinaltype
607±82
342±71
13±03
3½
diphtheriatetanusacellularpertussisinactivated
dtapipvhibmenctt
520663
317585
813912
484745
159328
5863
eluml
11942271
4381017
6711573
151362
punished
8036
dogsdomesticated
cadv1
bobodioulassoeven
positivehbsag
6142
sialogogue
mechanicalelectrical
tenstreated
tensassociated
bump
sees
guarded
hepaticabackground
superfamilies
sm28
goatbased
33attached
dcp7deazadg
dinucultodie
oligonucelotide
nkdcs
treatmentwith
donepezil
rivastigmine
galantamine
temperaturesobjective
vvms
495°c
discardpoint
41°c
n433
n620
n259
mastitispresently
gncabs
pathogensis
therapyassessing
0092014
0082029
2869
unequitable
freefall
cbackground
27094
8546
intracommunity
cd52specific
il2ras
037079
052121
abnormalitiesa
nonalkylating
fanca
lentivirustransduced
avvasp
childrenthese
xolairthe
nonomalizumab
microtiter
ph1n109
adimflus
microneutralizationelisa
microntelisa
1860year
authoritiesconfidence
millenium
ratti
infectionit
cfaemulsified
srhsp60
antisrhsp60
app2
app5
infectionhepatitis
brems
ohsv1
g47δflt3l
choicea
centersobjective
7827
tularemiasuccessful
mpfgentamicin
bfrom
trialwhen
9192
3200
migrationwe
naasp2
antinaasp2
igenaasp2
namericanus
fcγnaasp2
hookwormendemic
lowcurrent
01a
therapeuticsbackground
cheaply
traumatological
ph1n1ari
ph1n1vaccination
26100
376100
ph1n1infection
seirv
berkeleymadonna
436475
175194
306345
194213
29555
451324
491050
881163
nowadayspsoriasis
medicalpharmaceutical
crossreflection
organizationsallogeneic
swot
treosulfansixty
tcl1
lymphomasimmunotherapy
hyperexpressed
tcl1specific
tcl17178
llpimwql
hübner
litigationthis
defendant
mgm2min
μmmin1day×4
mgm2day×2
hl45
btype
8762
10069
blcl
tnhl
7157
eventfreeoverall
5472
4343
immunityannual
factorsthis
n522
suboptional
hindrances
213bibevacizumab
prostateobjective
213bibz
emits
organconfined
adccthe
targetmonoclonal
antibodyeffector
gordonia
bronchialis
tsukamurella
inchonensis
markersseveral
côté
bcelldirected
meglumine
acridonacetate
fsc
anamneses
rassignaling
protection628
585671
therapyparvoviruses
h1pv
parvovirusbased
parvoryx
rotavinm1
g1p
kh01182003
1060ffudose
1063ffudose
1065ccid50dose
5888
doses1063ffudose
nct01375907
nct01377571
cocktailimmunotherapy
cmethod
nmethod
systemsalthough
γδtcells
dnam1ligands
particleladen
treatmentprostate
costversusbenefit
stageshave
boarsbackground
r0531
r0324
r0207
rised
2011although
nonimmunotherapeutic
drugavailability
compass
oncologytraditional
approachesimmunoglobulin
hsv1conditionally
therapyanimal
gliomasto
atv
vaccinationsour
tenpoint
102142
098160
wartsobjective
immunotherapydose
circuitin
tivo
echostar
judges
cafc
reemphasized
competitors
designaround
adjudged
obviousness
antibodyencoding
newlydesigned
tumorlocalized
vaccinationusing
834740
sga10
074107
067049093
2010to
stiv
nct01267903
donghai
infectionresistance
mediumtolongterm
therapymagea
plagueelectroporation
electroporationbased
pvaxpa
anthraxplague
cdss
regenstrief
rmrs
wishard
dosemodified
7th16th
700900
idc000000156
donorstart
tomorrowthis
allotolerance
braindead
complementinhibiting
antilymphocytic
ceabased
trialscarcinoembryonic
virusesbased
114000
222100000
13596188
033055
malithe
17dv
227511cellsmm3
victoriastatebased
2396
strainaddition
abrisbane5907
isles306
eggthe
europeis
milkoralimmunotherapy
pricktests
andorspecific
oofc
immunityantivector
bussmann
transducted
hlab15restricted
kklc1
kklc1specific
kklc1positive
b15restricted
hlab15positive
cotransducing
meetingsummarythe
drake
dolores
schendel
helmholtz
zentrum
muenchen
jedd
bruce
beutler
hoffman
strasbourg
ralph
steinman
rockfeller
jürg
tschopp
charismatic
smalley
immunotherapyimmunebiomarkers
immuneevaluation
immuneconditions
patientsconclusions
pangramin®
δtss
0538
δams
2012conclusions
57114
11217
22186
immunityintranasal
vvhivifnε
ifnε
vvhiv
vvspecific
cd8cd107aifnγ
cd69cd103
functionalcytotoxic
cd3hiccr7hicd62llo
vvhaifnα4
vvhaifnβ
genitorectal
microbicide
centurymost
adultsneedle
n883
n1024
tumourscombination
savers
medicationsrapid
medicationallergic
medicationassociated
antigenigeand
tprolymphocytic
espb
γintimin
calvesenterohemorrhagic
colostrumfed
postparturition
stx2neutralizing
stx2vaccinated
allergyanaphylaxisobjective
261310
syndromesdiagnosis
managementparaneoplastic
onconeuronal
rbuv
xgvhd
tcpa
coregulated
teamsthe
punctilious
suppressioninhibitory
subtilisinlikekexin
micesuccessful
ikd
antitarget
humanpcsk9
mousepcsk9
pcsk9ldlr
abusepromising
substanceuse
triadrecalcitrant
rhinosurgeons
fess
postfess
pulmonal
endonasal
seriolaenocardiosis
seriolae
nseriolae
gtype
perceptionsobjective
preslaughter
stressin
reexcrete
reexcretion
reconstitutionfor
cd1415
adultsrecent
developmentanticytokine
paracrineautocrine
uncontrolly
cytokinederived
immunogenes
diseasesonly
fungalspecific
designlifethreatening
audiologic
pigmentpathway
intratympanic
audiometric
stria
vascularis
schedulemenzb
1·603·32
1·7
1·032·83
1·3712·11
usnew
immunotherapiesactive
dendreon
rfpsatricom
rfceamuc1tricom
vaccinespast
strategiescancer
statementthis
pandemicity
reviewurticaria
affliction
graal
coseason
nct01433510
patientsregulatory
cd25blocking
cd45raneg
rad26
mac239
rad35
functionsuch
levelsare
harmsineffectiveness
intenttocure
1rl
chloromas
135377
cyvp16
buvp16
antigenimmunotherapy
tumorburden
chromokine
officesduring
60302
interoffice
globubinfresenius
majorobjective
parturient
n1304
9546
alexandra
266±62
albanians
531000
greeks
151304
0719
aspergillosisinvasive
acidstable
6linked
2linked
mannooligomers
mannanbsa
mannaninduced
populationsdecreasing
staticnetwork
temporalnetwork
structurefuture
resultsin
90yfc
72142
range1794
nct00048737
421440
168204
factornull
daf1
organinfiltrating
c3ar
chickensselenium
75day
eggtype
xod
tumorattacking
responsesaggregation
joubert
luo
nashedsamuel
wypych
narhi
biol
chem
2511825133
igg4expressing
maradi
bagalam
yandaka
overcrowded
stimulationextensive
chemoand
diseasepassive
cd127positive
cd25negative
recipientsrabbit
e2gene
e2bcdomain
codeml
paml
dnds
of1
csfdisease
06878
0135
2010we
delft
111155
housemates
1011724
4182
statesdespite
listassisted
incidencethis
umvs
2009we
nurseassistants
noncompulsory
childrensince
adventitiously
sortilin
aβos
aβo
72d9
aβobinding
sortilindependent
p75ntfmediated
endocytosisinduced
azacitidinestandard
introductionunlabelled
15776
carcinomatransplantation
6874
wwwunosorg
wwweltrorg
wwwontes
ox40based
malignanciesunlabelled
rrit
targettobone
2005000545
200700724112
4129
antihladr
therapyimmunemediated
desensitizationhypersensitivity
moderatorobjective
n455
n484
challengeparticularly
postrotateq®
timelinessincreasing
prerotateq®
tnfαth2
newbornspertussis
foragainst
physicianlevel
interleukin6dependent
mannerobjective
lifesparing
posttbi
nmchct
myleoablative
seveninjection
pollenmonosensitized
malawithe
ivigsparing
therapiestcell
cmvantigen
quantiferoncmv
participationthis
27item
costrelated
yclivatuzumab
hpam4
yhpam4
tomographybased
encumber
provincestate
multiplemyelomainduced
outcomesmultiple
educationonly
revenues
160236
142248
149253
sbhcbased
interleukin2antibody
ah1n1v2009
20090928
20100331
036219
038177
013264
itg2
gmpconditions
iimolecular
nonmitogenic
db326
k310
astrand
rtallohct
ccit
threedosing
28738
17167
1331319
34142
21652
87766
72009102009
3201062010
7761253
predistribution
patientparental
postdistribution
danger…
apesbecause
alltransretinalinduced
modelmaintaining
arelated
alltransretinal
tregpolarizing
retinalinduced
foxp3retinalinduced
lackluster
suckbackground
noaspiration
σ1
vaccinationovalbumin
pσ1
sabd
ovapσ1
ovapσ1short
ovapσ1s
ovact
abforming
pσ1s
cancercd4foxp3
nct00001832
nct00096382
nct00335127
nct00509496
nct00513604
allotherapy
pdtdc
ftdc
fullyestablished
mucosabackground
oxytetracyclineinduced
wthe
otcinduced
otctreated
nitroblue
otcsuppressed
menac
mencigg
blomqvist
oldhams
recipientsimmune
225525
ifts
54±14
those24
220±195
257±113
254±111
1625±239
2067±157
273±120
levels225
βamyloidbackground
11cpk11195
dimerpentamer
diseaseprimum
nocere
arachnids
toprick
metaanalysesallergenspecific
retroviralmodified
vectorengineered
cb2
micemarijuana
δ9tetrahydrocannabinol
preinjecting
1824h
cb1
lαlysophosphatidyliniositol
gp1a
blindobserver
studyreduced
mpsv4
psvexposed
psvexposedmcv4
psvexposedmpsv4
psvnaïve
psvmcv4
psvmpsv4
polychlorinated
biphenylsepidemiological
biphenyls
pcbs
pcb
congener
ovoalbumin
lollium
gantrez®an
spainpeople
noninstitutionalised
104427
357–384
registersthe
experienceimmunisation
conceptualising
programmevaccination
registerimmunisation
2012–14
doubleentry
registersexperiences
improvementthe
jurisdictionbased
2011we
jumilla
registersysvakthe
mines
systemschild
interoperable
infectionsclostridium
metronidazol
analysesthe
finetunes
c57bl6h2b
cba1third
sebbmt
203±76
cypbmt
130±40
nsbmt
90±22
tumorone
tcellattracting
teca
79·3
67·2
77·6
antihl
cytotoxicityusing
fit06
gtu®multihivb
phivrna
1mgdose
2mgdose
b5703
b8101
b5801
unknownthe
leakiness
il6producing
il6secreting
il6sufficient
splps
taxol®treated
levelsexcessive
556601
22601
23601
hughesstovin
sinister
immuneenzyme
antibotulin
botulin
trianiatoxinthe
trianatoxin
immunotherapyleukocytes
fightthe
simulationsbackground
generalizes
discretestate
continuoustime
kirschner
panetta
lessonslearned
bangladeshan
twicemonth
prvplacebo
inclement
5468
pd3
dilutionunits
2007march
severerotavirus
severegastroenteritis
severervge
vaccinecontained
g10
p1b4
p2a6
95ci112
95ci165
95ci84
4317
231473
701913
postthird
infantstwo
20649
21643
137147
147150
09110
21581
17577
05945
191547
59898
255982
25493
33100
rotavirusvaccine
rotavirusseasons
5688
hrvderived
hrv2d
hrv3d
pointefficacy
reconsented
701030
53483
83141
98573
192683
6674
4705
score11
ptype
g8p2a6
diphtheriatetanuswhole
closeout
firstresponse
pucpgs10
meticulously
multicpg
puc19
hcvt
strongspecific
homograft
310day
pm10
o3
actionsbecause
jung
ironmediated
lipocalin2
4281490
23333
desaturations
141823
methylxanthines
2502589
methylxanthine
individualsrisk
hostfactor
careaged
hepatotoxic
ursodiol
mesenchymalstemcellinduced
fasligandfasmediated
apoptosissystemic
fasldependent
fibrillin1
dextransulfatesodiuminduced
fasregulated
bmmscbased
rabiesprevention
nervetissuederived
candidatesthe
untransplantable
noncanada
uscanadian
9419
nonuscanadian
inuse
savea
24385
5693
syndromeshematopoietic
cellthis
nephroblastoma
nonlymphocytic
anll
lowesthighest
birth4
weeks2
398512
605738
881956
68164
129264
nondelivery
115194
111172
2759
2tailed
infectionan
seroassay
modelscytotoxic
todaycomposite
histogenetically
postsmoltssterile
ploidy×vaccination
smolts
smelting
rateto
mosuliraq
southobjective
n503
n399
t286
or023
or215
or250
or043
or153
or353
or194
χ2117
χ2181
χ2215
healive
healivehealive
healivehavrix
havrixhealive
havrixhavrix
105131
89055
19009
32758
41658
intracisternal
intracisternally
acsf
ncgra2
modeltwo
nvi015
ay379740
t217a221
p217t221
iwv
vp2ta
vp2pt
pcsp
pcsp4253
tgama1
pama1ad5null
pnullad5ama1
pama1ad5ama1
plkgfp
59100
immunopathologictype
rdnaproduced
populationsvaccination
iplex
rs12133337
rs10918706
rs10912564
taqmanmgb
taqmanbhq
probebased
radio128
interval101161
pcombined947e5
betamethasone
50μgm2
valerate
scorada
scoradb
scoradc
9213
7574
104115
110128
nct01146912
chimericantigenreceptor
tcrclinicalgrade
cardependent
cartcrneg
αgalactosylceramidepulsed
αgalcerstimulated
grz
insurants
14728
0092
0140
41bb41bb
markerinducing
tumorregressing
anti41bbactivated
tumortreated
41bb41bbl
19902010in
19902010
38801
2817
rinsing
aggregatibacter
actinomycetemcomitans
prevotella
treponema
denticola
kefyr
indiawhile
20045
neighborhoodfixed
bcore
remeasurement
waningoff
posthbv
bacteriamucosal
colonizationentry
σ
subfragment
intragastic
σc
ibvs1
immunoenhancer
urti
3421026
1026342
splanchnic
riggs
igg1k
nonreducing
αantiidiotype
antibodymultispecificity
b7y33
nonimmunoglobulin
pangs
centoxinthis
nebacumab
centoxin®
nonapproval
centoxin
centocors
compendiumtherapeutic
tositumomabi131
ibrituximab
edrecolomab
efalizumab
b220lo
allosensitizationantibodies
b220hi
sigmlo
anticd3εcd20
constraintsclassical
dynamicswe
guidelinesvaccination
christchurch
protocolsthe
dosein
canadadespite
vaccinationreasonable
naccho
script
engagementcoalitions
communityspecific
pseudomalleiburkholderia
1026b
k96423
fcx
drinks
birchassociated
80µg
hgg2006
200600288120
6mopfs
00082
compartmentalisation
sfg
thosea
asigna
syndromerecently
0959
0388
concernbackground
inconjunction
shes
pretests
trialwebbased
aos
fellowsintraining
yearintraining
dbpcrct
clowes
cooke
19611968
johnstone
lowell
franklin
dbrct
oralit
scadding
activityas
httpcmeaccesscomcmejahhpvprogramindexasplinkid2
parentspatients
reliabilityobjective
criterionrelated
nurturing
racvbp
epochr
hypersequencing
strategiesacute
engraftmentengraftment
tetraethylenepentamine
tepa
patientsuncontrolled
irun
alsfrsr
diseaseaspergillus
rab14
luca
proliferationwhen
iilo
b7lo
cosuppression
biologycellular
doi101038cmi201213
epochfr
hpnapobjective
hpnaptreated
antigensrecombinant
tsol16
tsol451a
tsol451b
fniii
35circumsporozoite
vaccinerecombinant
ad35csbcgcs
producingcells
cytophilic
bcgcs
bcgcscsp
llpcmediated
salarymin
74455
50385
registrar
suboptimalobjective
gapthe
asiaobjective
n189
065168
064190
095126
correspondent
pulsive
fifthly
reportrelevant
antinatalizumab
responsespatients
recieved
reemphasize
cancercastration
neoplasic
institutionsobjective
chairpersons
hipc
efficacystreptococcus
fibrinoussuppurative
bacterinvaccinated
muramidasereleased
influenzatranscutaneous
familialmismatchedhaploidentical
cgybusulfanfludarabineantithymocyte
wmudt
pmudt
201112to
72012
201112in
astockholm182011h3n2
5minute
55570
23340
ci085
rr081
ci072
rr073
ci058
123294
011038
852100
tissuedwelling
lumendwelling
threeweekly
groupparticipants
flatulence
mbtpas
vaccinescurrently
rvfvcapripoxvirus
il13rα2directed
particleencapsulated
cytokineloaded
neoplasiain
cyclooxygenases
radiotherapylocal
apoptosiscell
leishmaniasisnkt
β14galactose
glycosphingophospholipid
gspl
19902000the
meningoencephalitic
fertilityobjective
clinicallydistinctive
encephalopathiesthe
vgkccomplex
lgi1leucinerich
contactin2
cambodiathe
postfmd
21632
prefmd
37054
yearsthis
mediumadditionally
emigrated
withinhousehold
regionsobjective
gwhi
intertemporal
withinhouseholds
betweenhouseholds
allindia
decompositions
sidestomach
shushing
15second
withinsubject
5ss
undervaccinationvaccine
nct00519649nct00984139
785–875
731–830
7–8
12–13
5–10
959–994
902–962
98–100
945–988
dapsonesensitive
elevatum
diutinumdapsone
diutinum
challengeexperimental
reputed
mbpprimed
reaffirming
rv1357c
antioxidized
immunizationsassessing
kui
hyperechogenic
ultrasounds
deaf
antitacsapit
tcellsusing
antitacsap
µgdl
fluorescentpcr
cd8cd45
ongoingfuture
noneliminated
tributes
physicianscientistdr
berkeley
shrine
httpwwwedwardjennersocietyorg
settingsin
indelible
vitrification
flus
30mbqkg
10061252
nct00302757
ebmtso
14831
infantsmeasles
helicase
leu412phe
galaxyin
smallpoxvaccinated
d8l
c12l
il18binding
vil18bp105
poxvirusvaccinated
hladr04
vaccinateddonor
hlatargeting
l243
vil18bp105l243immunized
cd4cd45raneg
freepeptideimmunized
l243peptide
vil18bp
5048
035049
068090
patienta
lymphadenpathy
preventionrabies
antibladder
antiinterleukin10
cd4cd25treg
splenocytic
c3hb6d2f1
h2kbh2kk
3903
2672
tabletobjective
paragraph
singlemite
recontact
sitso
transplantationtype
wholepancreas
106694
ags004001
2720
4436
carcinosarcomascarcinosarcomas
ummtark1
ummtark2
ommtark1
ommtark2
trastuzumabdependent
5hr
cerbb2
323726
analysisnegative
210318
geneticimmunologic
aβ42driven
pathologyaβ
km670671nl
ps1
p166l
dr1501
brunswick
38°
39°
00130055
pigsty
incheon
gyeonggido
antiox40il2
il2rmediated
expressionthe
jak3mediated
tcrcommon
antiox40common
pathwaybased
transitioncolorectal
subpathwaybased
subpathways
textmining
setbased
unfoldimmunization
imagined
parsimoniously
parsimony
incidenceup
pertussisincluding
undulations
allergendelivery
s2308
coinfusing
ducbother
decisionsgame
optionsthe
colostrums
pt01
pt02
pt03
pt04
2011fifty
dialyzed
quandary
influenzaintranasal
closervaccination
selfnegative
vaccinationis
bioresponse
coactivation
nct01001169
mo17
haas03b
mo9
haas03a
ratesprseroconversion
ratescr
100100
1468571
964897
253235
964828
dm1treatment
ita
insulinindependent
tcdab
citr
tcdabtnfαi
preimplanted
androgenregulated
ychromosomeencoded
ychromosome
dby
spas1
minorantigen
femalederived
wheneach
lyssa
eblv
3222
000373
1811932
identifiernct00202917
nephritisautoreactive
fx1a
fx1ainduced
controlprimed
qa1expressing
swallows
micromet
microenvironmentthe
therapeuticallyinduced
idproteinloaded
myelomaphase
resultsunlabelled
aphase
idprotein
acontrol
lymphohistiocytosisfamilial
12melphalan
11±
flumelconditioned
patientsmultiple
msneed
mspatients
healthyblood
rrmspatients
mddcmaturation
1α25dihydroxyvitamind3
tolerogenicityinducing
rrmstoldcs
sclerosisautoimmune
myelinantigenspecific
raϊchregué
42772783
causallyoriented
cellbasedtherapies
fullmouth
r0518
bcan
guidelinesrecommended
gradespecific
bcginterferon
cyslt
ciniii
470000
nonimmunogenicity
hecs
aavrh10mediated
behaviorcocaine
aavrh10anticocmab
aavrh10
gnc92h2
aavrh10anticocmabvaccinated
ucla
cd3cd4cd25cd127low
00228
00191
00273
dichotomize
postpre
segregate
copdthe
spaniards
15355
463525
207219
animalhumanecosystems
animalhuman
icmr
kgheight
ves13
abrisbane59
abrisbane10
18530
cd4matched
48th
transplantationtacrolimus
0015mgkg
515ngml
15mgdl
studyyoutube
styled
sensationalized
allpurposes
gp120texo
conastimulated
conat
pcdnagp120transfected
dc24gp120released
exogp120
peanticd44
advgp120
advgp120transfected
dcgp120released
gp120texoinduced
pehlaa2gp120
kltplcvtl
bl610gp120a2kb
a2kb
α3
resistancemultidrug
aav6hserca2amediated
serca2a
aav6hserca2a
tachycardicpaced
tissueserum
hserca2a
aav6neutralizing
nonpaced
aavhserca2a
thailandthe
improvemultiple
dcmyeloma
therapycancertestis
anticta
antibodydefined
withdavid
kaslow
roxanne
khamsi
henipaviruseshendra
henipavirus
henipaviruses
122217
151233
10952506
113192
5951888
360500
ecologymanagement
vaccinationdog
macaquescd4
mycobacteriaspecific
hivm
fractallike
vasilescu
olteanu
flondor
revue
roumaine
chimie
7517
bcgphs400
bcggag
bcgδpancdphs400
bcgpangag
panothenate
hsp60lysa
promotergene
pcb119
mtra
mvagag
immunotherapypollinosis
swisspopulation
patientguidance
pollinosispatients
matchedpairs
leucose
leucogen®
comparation
aminosilanes
nayf4ybersilicaucpsplasmid
pcdna31vp1gfp
ucps
asiaijiangsu2005
dnasei
aminosilanemodified
ucpsplasmid
lipidplasmid
ucpplasmid
nanosystem
feveraffected
ratio74
interval5895
quad
4armed
4289
n2167
n1832
concentrationsgeometric
gmcsgmts
upperbound
gmcgmt
11170
nct00255047
2010during
osdh
rchd
pulsedfield
wave®
bioreactorbackground
amyloidβpeptide
exhibitors
massproduce
triedandtested
needleandsyringebased
shivkb9
macaquesdeveloping
primefowlpox
multiformetreatment
immunitymost
cscenriched
cscvaccinated
neuropraxia
th2skewing
jekyll
radiochemoimmunotherapy
bicentric
carboplatin5fu
acneiforme
isrctn87356938
087100000
dqb10602drb115
rem
tnfinhibition
outcomesgraftversushost
tnfreceptor1
7pretransplantation
tnfinhibitor
formulationsnoroviruses
18specific
5fuvindesine
splenopancreatectomies
cytokineconditioned
dctols
il10conditioned
dctol
l137
diseasedespite
chlorhexidine
periodontology
trivalentinactivated
67977
111115
114120
111118
n20465
n5407
shsp
ovashsp
ovanaïve
suum
ascariasisascariasis
asenol1
anisakis
pvaxenol
marc145
6113
134101
286867
stampingoutclassical
dplas
interherd
interspread
dpla
protein65
highcholesteroldietdriven
atherosclerosisheat
hsp65
antihsp65
mmsvmulv
trna
aproteinbased
gts
potd
symbio
15154
27145
dc17
fscn1
nmes1
traf1
anxa1
catc
gilz
f13a
stabilin1
stab1
injectionsbackground
clinicaltrialsgovnct00718679
74fold
danderspecific
566fold
therapyglutamic
gadabs
recipientsalthough
dieback
hemisection
thymectomied
mbpactivated
mbpt
transected
cst
bda
shamtx
factordisplaying
genemarked
macaquesalthough
singlecopy
synopsized
misgivings
pchms
consortcompliant
healthyme
actrn12610000386033
manipulationearly
muromonabcd3atg
bellerophon
ivaccines
transplantability
characteristicsimmunization
cfcf
nn
rb51one
ratshypertension
preclamptic
mg·kg1·day1
beatsmin
treatmentmalignant
extraabdominal
paracentesis
diuretics
diuretic
peritonealvenous
multiplefailurepersubject
adventure
experiencefinancially
adventurous
localityspecific
tgn1412
achyranthes
aspera
sothsctassociated
sothsct
liporal
digo
granulomatosislike
transplanthsct
p4mediated
diseasenew
immunoactivating
p4ivigtreated
p4stimulated
j7742
agentsimmunosuppression
patientsrecombinant
vaccinianyeso1
rvnyeso1
fowlpoxnyeso1
rfnyeso1
recurrenceprogression
vulvarvaginal
17622
nct00092521
2007human
nsch
17264
mlminute173
mcgkgday
l4
outlookimmunotherapy
tilmediating
melanomainsight
proacrosin
proacrosinacrosin
psf2acro
ca2ionophoreinduced
acrosomal
spermzona
psf2acroimmunized
antiproacrosinacrosin
spermzp
leiomyosarcomaantibodies
bestows
lms04
lms05
measuresobjective
12096
943997
nonuseful
2011as
adl
semiologies
interictal
immunotherapynonsteroidal
eprostanoid
thrombocythemiaallogeneic
fhcrc
survivalprogressionfree
5547
7148
poniesequine
n558
6542
risct
fludarabinecyclophosphosphamide
2microglobulin
1·811·4
3·14·9
0·0072
fancf
0·0458
ultralow
alterationstermed
chemoimmunomodulation
chemomodulationare
paclitaxelkg
paclitaxeltreated
nktcells
swedishborn
eggstimulated
designsthe
crossfertilize
trecsml
approachhaemagglutinationinhibition
agencys
58fold
09194
nct00971906
antivaccinationist
4313
5673
practicehepatitis
10i
286474
337474
1rna
103362
015061
miceas
sfm2e
aporto
macrosomic
standart
38902
13117
oran
3565
360x106kg
donorlymphocytes
myelomamyeloma
4664
13758527
ricallosct
parentheld
providerreporting
scalewe
mokken
studyfemaleonly
vaccinatethe
expelled
immunoassaybackground
peanuttolerant
bd2
keratitisobjective
rneasy
qiagen
ribosorb
pcrrt
intercalating
sybr
syntol
logarithms
betaactin
c57b16
superlimf
defensin
semifine
impregnation
gamperl
modificationwas
densitomorphometry
adaptationcompensation
strainobjective
vectorbest
novosibirsk
mnr
belarusobjective
molecularepidemiologic
ngene
conformance
vaccinationplague
fleavectored
erupts
traffics
tolllikereceptorindependent
anticxcl1
anticxcl8
cxcr1engineered
mclspecific
kinoidtumor
heterocomplex
l929
bangladeshcurrent
phosphostat3
sqstm1p62
ctlresponse
trppeptide
programsethical
bopriva®
calfthe
parkville
spermatogenic
modelaccumulating
subtoxic
efficacyenhancing
micedesensitization
proteindependent
desensitizationresistant
myelokathexis
cxcr4mutant1013
cxcr4dependent
cxcr41013
unfurling
immunotherapytgfβ
responseimmunotherapy
crossmatchnegative
04147
05149
105326
glucorticoidresistant
06151
04119
38162
020085
nct00658073
restrictedly
nonproblematic
mountings
detectionbackground
vaccineadr
drugadr
nonvaccineadr
sdrs
n218840
117877
26203
5586
13375
nonvaccines
2721
subgroupbased
commanders
0669
0575
0258
76720
177lunanobodies
chelatorsnanobodies
tumortobackgroundratios
1b4mdtpa
chelatorconjugation
spectmicroct
1b4mdtpacoupled
599±063
512±017
283±036
247±038
2rs15dhis
1b4mdtpabased
toxicitycimavaxegf
p64k
prolactininduced
proteinprolactininduced
immunohistologically
106132
antipip
pipnonapplied
gsm
gsmallergic
gsmnonallergic
gsmnotallergic
inhalative
preformulation
studiesdelivering
cpgodnloaded
aerosolised
metered
pmdi
vibratingmesh
nebulisers
2482±734
2223±142nm
aerosolisation
secondstage
impinger
6568±112
nebulised
pmdis
2252±563pgml
gnpmediated
ceam
bicnu
bischloroethyl
ccnu
chloroethyl
cyclohexyl
pertussus
144746
128821156707
37404239
126293
8411
4791
11421
2071
postinflammation
postactive
cellonly
th1th17mediated
cnsdifferent
helicases
rlh
rlhsignalingdeficient
diseaseameliorating
activitytotal
lessfit
lymphotoxic
581989
3471
systemactive
metabolismit
nonscid
informedbackground
unaccountable
adenocarcinomacancer
polyacrylic
spionspaapei
sphincteric
minibeam
salvagerefractory
dlbclpatients
subsequentline
immunotherapysmartdcs
antigenpresentingcells
granulocytemacrophagecolony
smartdcs
smartdctrp2
immunosuppressionskin
uvbmediated
lancets
ileallymphoidnodular
centuriesold
ethnicminority
medicaldecisionmakers
owh
januarynovember
1761298
106405
104378
vaccinemessaging
approachethn
2011214495501
cancerdogs
cd11bcd14mhcii
cd14mhcii
copurify
inos2
threemarker
gustav
ullenhag
ehss
7496
analyzedregardless
conditionsthan
101154
100114
mump
persussis
131672
66153
143522
4452924
1595
4935153
181314291
nct01273246
nct01273233
8bluetongue
intervet
pseudolymphomaaluminium
hydroxidecontaining
zeeman
electrothermal
μgg
76810±18
561±059
913±0057
omalizumabbackground
perspectivesepsis
pentaglobin
sepsisrelated
oml
ovaencased
ovaoml
noncoated
ovanl
antisignr1
anticr3
ovaomltreated
agencased
statesgooglebased
iqs
reviewacute
7vcrm
bettercontrolled
personalizationalthough
ptrials
cacwy
5×109
56months
208months
antiviralresistant
cm²
grex10
grex100
810×10
flask
3060×10
24well
vivocd40
worknccn
r12
superresponder
ocv101
ocv105
ots102
parentalown
californian
nontransparently
profilingdefined
opm2
351fold
dnaxaccessory
myelomainduced
cciv
optaflu®
agrippal®
ccivtiv
2609
antibioticsimmediatetype
gvhdthe
trem
cancermesothelin
nepali
patan
188407
008017
bystandermediated
tgfβto
vectorimmunized
177ludotabr96
modelmetastatic
actualitythe
healthto
1521044
subsetsalloreactivity
avers
8101
cellrecognized
cancersuppressed
bushen
huoxue
pzp4
niaffinity
gastrogavage
antipzp4
histomorphology
lutea
191819
196869
ikbke
rs1953090
excel®
nathnacs
edisan
578608
93965
feverendemic
poxviralvector
countrieswithin
u27
u5
leukemiagraft
dc2
50±9
73±11
26±11
immunizationwhen
androgendirected
depresses
antitnfrefractory
therapyrefractory
acpas
adultsepsteinbarr
γherpes
negations
risksobjective
negation
vaccinationschronic
cwp
indistinctively
mycoplasmas
eratyrosine
ricnonmyeloablative
tkiexposed
ipi926
antimucin
apricoxib
aspectswith
challengeone
hivvaccine
gagpolenv
ad5prime
dnaboosted
dnaboost
ad5boost
unachievable
agevaccination
fulfilledcellular
haematooncologic
neurones
infectionmalaria
foiled
926yearolds
913yearold
francemedical
il4dependent
granulocyterich
macrophagerich
mosaicismsct
agroup
500600
thoracoabdominaltbi
20120
bgroup
150180
1068
varivax®
cytoxicity
2009since
unstratified
pbmcreconstituted
rhil10
immunitylangerhans
chemoimmunotherapys
vital2
demographicbilling
evaluted
132191
107130
113126
180234
274298
sickfollowup
072080
medicaidschip
ic41
2×106iuml
injuryacute
dialysisdependence
il1βmediated
adjustmentfrom
dzherelo
patientsimmunoxel
wateralcohol
dragées
sugarcoated
pastilles
driedhoney
sputumnegative
aav5
macaquescervical
raavs
humanrelated
raav5
raav5l1
raav9l1
raav9
effectsstandard
magec2hlaa2
magea3hladp4
targetsadoptive
magec2336344hlaa2
mc2a2
magea3243258hladp4
ma3dp4
mc2a2specific
ma3dp4specific
tcrvα3vβ28
tcrvα38vβ2
mc2
ma3
magespecific
hoffmannb
8002000
pandemicseasonal
facultygraduated
guillianbarre
matrixwhartons
hucderived
ucmsc
bmmncs
toleranceintolerance
sittolerant
chemotherapymultimodal
dribased
trimetrexate
neuroblastomabearing
overviewtb
pên
tsao
kang
materia
ming
15181593
…blood
roast
hindsight
disdained
th1polarizing
neonatalspecific
pandemicobjective
societytrust
christmastime
skinunlabelled
viruscoated
mtcprognosis
antidtpaindium
f6x734
hmn14x734
histaminesuccinylglutamine
68ga
18f
positronemitters
colitisobjective
diseaseunspecified
pancolitis
radmdcvp1
pcdna3mdcvp1
primepcdna3mdcvp1
b3cvb3
groupsp005
rate4167
lmp2specific
tgfαegfr
nbls
updatemales
phenotypeadoptively
repopulationunlabelled
retrorsine
rsbased
galvmed
124ianticd52
gradethe
regimensthe
rehoming
radioor
deficienciesconventional
text4health
postshortage
papermailed
paracoccidioidomycosisparacoccidioidomycosis
azoles
tepitope
plasmidvaccination
bb4
patientssyndecan1
iodine131labeled
131ibb4
d34
preinclusion
bmabsorbed
mspike
anticmvdirected
ebvreactive
immuneexhaustion
immuneguided
pneumoniaobjective
pilicide
conditioningto
nonhlaidentical
γglutamyl
2584
aerosolvaginal
pcdna31zeogmcsf
pjv2004lta
pjv2005ltb
lymphomahodgkins
btetanus
015μgml
l0μgml
iikeymhc
vaccinesactive
lrmk
vaccinationshigh
sd220
sd575
agepredicted
halfdose
f121062576
η275
f121061710
η266
time×group
countriescountries
episouth
priorix60
3on
cdmarkers
influenzaobjective
carroll
12090
3547
8806
personhours
sustainabilitya
clinicspart
preparationa
packets
391423
61463
32875
136151
28588
255272
epilogue
beach
hurricane
wilma
flooding
unannounced
radiating
famotidine
twohour
hpvcervical
3123
7693123
037059
105136
106128
peritoneumbackground
γcounting
213bifab
reabsorption
213biigg
213biigm
111inigg
111inigm
111infab
radioimmunotherapysuccessful
shunting
ventriculostomy
111indtpa
ventricles
convexities
aqueduct
thecal
rerouting
abrasive
alopezia
immunityto
strives
prospectspreviously
devicerelated
biofilmforming
tbthe
postprovenge
vaccinationwest
positivestranded
hepacivirus
isac®
1363
01057
00825
01624
00639
00505
00548
01711
00471
01897
00493
00842
03586
00798
perforinlike
gondiihost
tgplp1
tgplp1mic6
piresneo
lessvirulent
piresneomic6plp1
6543
6160
pvaxplp1
pvaxmic6
leptospirosisthe
immunityvaccine
behooves
agrecall
transplantationantiseizure
fosphenytoin
noninduction
recipientsimportant
dermatologistsit
everyones
diseasesexperimental
cryglobulinemic
ßcoefficient
00770
00819
00868
immunisationdiscouraging
complexbovine
cattleclostridium
blackleg
productsallergen
arzneimittelgesetz
therapieallergeneverordnung
effectsmedicinal
batchwise
npps
14november2008
annex
14may2009
marketability
14november2011
bulks
entrepreneurs
situationallergenspecific
immediatedtype
matchunrelated
1154136
incarcerationhepatitis
slogan
tantamount
multihospital
upmc
surveyinformed
strategiesmobile
incentiveswere
vaccinesupplies
2455
3043
patientsit
dthbiopsies
treatmentantigenderived
αtype
venomthe
aahi
aahiv
aahii
voltageactivated
antiaahii
åresolution
antiaahi
crystallized
aahifab
groovelike
toxinbound
therapiesseveral
indistinctly
potentate
mabil2
genitoanal
indiajapanese
vishnui
tritaeniorhynchus
neuroattenuated
milkywhite
crisp
rehydrated
54log
revaccinationthe
challengecurrent
radnp
salaj
10–14yearolds
15–19yearolds
immunoconjugatearmed
antibodyphototoxic
her1overexpressing
remnant
mabbinding
mlday
immunonutrients
surgicalsite
ssis
fiveday
000000648
nonradiationbased
simultaneouslythere
pshs1nh
socs1shrna
nyeso1mage3
hlaa20201
pshs1nhdcs
xian
jiaotong
gmcsfmodified
gmcsfnutu19
vaccinedraining
tvdlns
antibodyhapten
injectionproducing
2c5
2c5based
cd40targeting
isotypeswitching
drugdependent
decisionsa
vivid
searcher
strategiessofttissue
virusafrican
noncontagious
equidae
ictalurito
65182
unigene
falsediscovery
myotubularin
2j27
ruminantsvaccines
transplantationnewonset
cellshyperthermia
het
esophagogastroenteropathy
subatrophia
eosinophilsmm2
villuscrypt
16±015
peanutreactivated
tissueeotaxin
p005gata3
23±015
fibrosispulmonary
vacciniainduced
postpcv7
3448
hivuntested
ci1431
aor42
ci2474
polyglycerolphosphate
acidtype
staphylocccus
staphylcoccus
teichoic
cd4rocd45racd11a
trivariate
gays
altmann
bahadur
donordifferent
18655
301441
tcellreceptorlike
applicationstumour
immunoreductionobjective
clockhours
ossns
20102011in
206174
microneedlesa
patchbased
crystallization
phaseseparated
interleukin12priming
helpfulness
nonemergencies
auweek
weeksyear
plovdiv
ncipd
sofia
recipientsimmunosuppressive
hyposensibilization
sensibilizations
geobacillus
stearothermophilus
60mer
envv3e2
envgp160
coimmunizations
50yearolds
28900
496000
seasonbecause
1par
pjedloop1
geneticengineered
2par
chemicalphysical
rpjedloop1
rpar
metaanalysiscows
41242
17986
27465
16219
2011summary
diabetesdevelopment
soughtafter
chemotherapyclinical
transfectionwe
cd3ζcd28derived
cd8pos
tranfected
13b47
13b47infected
lvsinfected
srebpregulated
genesproprotein
1b20
cetpldlrhemi
mpk
statinresponsive
srebp
fattyacid
acss2
idi1
cyp51a1
simvastatin
dyslipidemic
qnas
nicholette
zeliadt
cat8015
qod
×3
120000μl
immunitysubstantial
admva
celldependant
conditioningadoptive
00142389
199889
200102
hies
19522009
195274
687279
384149970468
12058
673917026
6970
7879
95904
591376
23976
23655
196970
fukumi
feasibilitythe
multimerdriven
autoimmunityanticytokine
immunizationdependent
overbalance
matterrecurrent
rsm
iif
pli
preconceptionally
tnfαil4
pliinduced
i125
i123
123i
condensedhistory
radioiodides
rotavirusthe
injuryprotective
antia91
transection
a91specific
ta91
vivoβdefensin
b16mbd2
b16p
b16specific
il12expressing
swellingbackground
noncolonizing
lackspecific
contaminationto
cymediated
dotimmunogold
digfa
immunogloubin
1d8
4a7
5a2
enterocolitica
freundii
ascetic
lmol
immunecolloidal
contaminations
adjuvantresponsive
productionil1
lfspecific
wtko
kowt
cd11cmyd88
responsessquamous
712dimethylbenzaanthracenephorbol
pyroglutamate3
alzheimerlike
pe3aβ
antipe3aβ
mab071
proaggregation
tuberculosisrelated
ppdreactive
conventionalclassical
madin
darby
replicationproficient
compendial
monographs
usp
gccp
nsfg
n955
nonsexually
ci115
aor217
ci108
vaccinationamong
adimflus®
exocrinopathy
centerlike
thcells
birthsbefore
2995
piresgmcsfil21
piresgmcsf
piresil21
ampty
pires
h22neo
colorimetry
h22gmcsf
h22il21treated
0290
h22gmcsfil21treated
0323
0155
h22gmcsfil21
h22il21
h22group
highresource
preaggregate
actionallergen
activationproliferation
cancercloning
ceaelevated
trialsnamely
methodhave
nonpersonalized
crcderived
tumoursmore
repairmultiple
suppressives
tamed
immunotherapybacterial
αhemolysin
cry1a
perfringolysin
intermedius
intermedilysin
abased
gliomaswith
postsocialist
uncertaintyvaccination
insistence
renegotiated
parcel
reframed
contestation
trimix
nanogdependent
phenotypedue
nullifies
sinanog
antiretroviralcontrolled
subjectstuti16
tuti16
nullified
immunogenicityactivation
artcontrolled
flubu12tg
p000018
hr1036
hr025
039100
xinyang
nanyang
9326
5763
3300341
7554
7977
4298
4595
185013
234513
303613
241613
118613
medicalpractitioner
6142521
94386
47323
3862036
214511
185211
178211
151211
118411
85611
61011
illiterates
semiilliterates
83289
4731188
16423341
17193392
17943501
vδ18
0679
0808
2904
vδ6
relativity
alkabell¨®
chanllergendf
wolwo
cmvisual
vaccinationchildhood
birthrate
survivalthirtyeight
bitesprevention
adultrenal
chonic
functionning
ressources
antithyrotropin
graveslike
antitshr
10mouse
mtshr
thyroidblocking
sra
fibrosisrelated
phosphorylcholinebased
2δδct
nlrp1
clec4c
ratgs
vaccineradiotherapy
parpi
greecewe
countriesshortages
dacryoadenitis
sialadenitis
antigensobjective
autoadoptive
osst
89806
102136
sulfa
361473
blichers
1807prevention
landlords
niels
blicher
bombarded
manor
pus
laureate
charlesrobert
serumprofessor
collaborator
poet
playwrighter
pacifist
aviation
goatsobjective
gudair®
oneyearolds
p00056
day8
paratuberculosispositive
parlour
moold
dtpwhbvipvhib
dtpwhbvhib
toddlersas
379fold
kft
nct01106092
raymann
jános
hell
17211801
earns
notuntil
l595
sucroselaurate
octaoxyethylenelaurate
soybeanphosphatidylcholine
span80
spchbsag
±170nm
l595hbsag
±75nm
lhdsj23gst
adjuvantsas
sj26gst
lhdsj23gstspecific
ipti
spipti
150200
hondurasobjective
nvws
19911992
nvw
overburden
homa
communityassisted
mothersintegration
2361
successpotential
lensbackground
vwa
kong1
protection4
centres1
cellscancers
personweeks
seventeenyear
elderlydespite
nvigs
0639
nct00871000
sanofipasteurmsd
tetravac
dtpabased
concentrationstiters
programsvaccine
mawith
devoting
trion
domainig
twoinone
macrogenics
kappalambda
novimmune
covxpfizer
affibody®
hlapeptides
immunocore
mabfv
xencore
albumod
cova301
covagen
hsp70h22
cd40lobjective
tbhsp70
tbhsp70h22
tumourpeptide
h22specific
h22tumourbearing
dchsp70h22
dccd40l
hsp70h22peptide
paraproteinaemia
intensityallosct
fludarabinetreosulfan
fludarabinebu
earlyintermediatestage
skinsc
regimenattempts
centerallogeneic
intensitynonmyeloablative
indiarecommended
campaignlike
iws
late2007early2008
iwstrategy
3310
char
8140
bacterialfungal
sibbm
fludarabinebusulfancyclophosphamideatg
12167
lowlactose
soup
soybeanbased
systempoudre
poudre
correctedbackground
trastuzumabrefractory
dher2
antiher2specific
300day
nct00952692
patientswhen
wavesprevious
bacaer
munayco
pourbohloul
tuite
diseasebehçet
immunotherapyabnormal
cysasnglyargcys
peptidetnf
cgtg401
lam2001
421618
16212
348567
247586
98232
02162
139286
165434
546722
522722
leukemialymphomaadult
atll
immunoradiation
tcmctrastuzumab
39±099
pc3mm2
sgpt
il12encoding
prsc
intrasplenically
malignanciescompared
highlyemetogenic
cooperativity
t2f
aslo
x±s
600±227
739±199
629±214
295±182
328±258
248±199
50391
43619
27776
χ21263
trendsimmunologic
circumnavigated
aphaeresis
transfusioninduced
transplantationearly
corestudy
srltreated
ittegfr36m
6088
vs423
vs97
vs94
screatinine
antinyeso1
fcdepleted
omalizumabfood
lipopolysaccharidepretreated
diseaseplasmacytoid
752824
829890
766862
158602
247607
69304
109306
306605
380624
nct00721396
cd4cd25foxp3gitr
nfatc2
cd4cd25gitr
killingchemotherapy
factorβinterleukin
lymphoma2like
proapoptoticantiapoptotic
receptoradoptive
biotinbinding
bbir
extracellularmodified
bbirs
infectionmycobacterium
tcellexpressed
ox40expressing
ox40lig
fvrcp
vaccinetwo
calcivirus
kittensthe
pat
533615
resultsnot
recipientscd34selected
81010
1·02·5×105
pharmacoprophylaxis
15·8
23·3
5·6
82·3
idursulfase
danders
adenovirusencoded
trailcpg
ad5mtrail
ad5mtrailcpg
b712
b16derived
perforinfasl
childrenrespiratory
abdr
antibodycombined
malignancyaboincompatible
ftom
aboildrt
immunosuppresssants
8189
positivecrossmatch
mismatchs
databasetrends
5276
351582
622248
2717
rapamune
82226
6935
taiwankidney
20002008
39189
mycophenolatemycophenolate
antibodytesting
1387±827kg
fatness
celebration
questionsallergen
noons
structuralirreversible
1318yearolds
1926yearolds
918yearolds
moralreligious
concernwe
liv
ah7n1
antineuraminidase
rostovondon
informationalanalytical
diseasesstructure
anthroponoses
sapronoses
prognosisanalytical
nonpoliomyelitis
unbroken
ctantigen
resultscellular
deltaaminolevulinateinduced
porphyric
photolysis
phagolysosomes
deliveryleishmania
uroporphyrin
uro
deltaaminolevulinate
excitable
intraphagolysosomalparasitophorous
uroporphyrinogenesisphotolysis
dtinfected
intrapv
monoporphyrinogenic
nonstringent
rosresistant
immunotherapyimmunoprophylaxis
factorβ1peritoneal
colorimetrybased
factorsomatostatin
micefemale
gmcsfss
gmcsfsstreated
anemiaantibodies
allosctwe
ratg1
ratg2
p0640
p01374
p00234
postradiotherapy
cancerdevelopment
antigena2restricted
nyeso1157165specific
numberstcell
pharmacokineticspharmacodynamicstype
streptoccoccus
italyto
pcrs
poststratification
ageweighted
nonipd
8598
7593
antigenstranscutaneous
127311
83190
58107
neededtricounty
2009tricounty
tricounty
rhinitisdo
coeffects
existatopic
coeffect
unitsthe
highestbetweenness
capsulemediated
infectionrecombinant
pmlc
pmlcmediated
nalp3
dcdepleted
2011allergen
kolkatabackground
2003december
h58
haplogroup
h58g
nalidixic
entinostat
tregstargeting
immunepromoting
survivinbased
entinostatinduced
schedulesunited
maternalneonate
horsesobjective
cytosinephosphateguanineoligodeoxynucleotides
nanoparticlebound
abidjanan
vivospecific
lnd
n1bn3
5–16
00290
010–094
p01083
018–122
drugsit
agentsincluding
compoundsstimulate
circuitries
disturbancesseptic
mncctt
virusinactivated
postinfant
981100
ostrich
japanstrategies
ostriches
strategicallylocated
teenspecific
factorassociated
p0·0002
12±2
±se
0·81
hr1·48
1·151·9
hr1·59
1·072·37
hr0·96
0·781·18
35±2
44±1
hr0·70
0·600·82
p0·00001
lfs10years
ranong
thailandsome
wuchereria
bancrofti
bancroftian
immunochromatograpy
antifilarial
adultsbcell
anticd3treated
2010immunizations
anand
gujarata
or286
316256
or317
353281
kongduring
2009–2010
1906
402009
hypoxiasimultaneous
stimulussecretion
min1
katp
oxygenmetabolic
apcsthe
acceptedtheir
captureprocess
immunoglobulintransgenic
cotherapeutic
monkeysimmune
sivbased
nonexpressed
nonbone
mcsfdependent
il4rαxrag2
mac3
ym12
k32
n11814
phrasing
virologicallyconfirmed
0005098
msu
il12cotransduced
il12rexpressing
alteringreducing
cancerprecancerous
1581040
2698
exhaustively
tlr9ectodomain
ecdfusion
tethers
forceloading
unbinding
tlr9ecd
offrate
xβ
csas
tnpspecific
tc1dependent
skinpatched
1fluoro24dinitrobenzen
tregeffector
465799
471801
87460
53401
thrives
erprogestin
kaplan–meier
dthpositive
proteinsimmunogenicity
nightmare
industrials
prasugrel
cardiologys
selfcontroled
contol
timeindependent
copurified
1325kd
20kd
sx38
ifs
inexhaustible
scaffoldseeding
correctionclinical
immunomodulatorsin
cycloferoninfo
kisumu
diseaseis
understaffing
postbite
9525000
136071
flumiz
smithbackground
subcutaneouslyinjected
dllacticcoglycolic
olderobjective
±097
±098
±096
20101
wellfolded
nectin
nectinlike
cancermanagement
necl
guhclmodified
individualsantibody
coatingantigen
guanidine
guhcl
orplacebo
terbutryn
protocolheterologous
matrixes
pressuredespite
90yibritumomabtiuxetanaim
matlabbased
oars
3874
underestimations
antihlae
hlaia
ifnγtreated
recipientshlae
cd94nkga2
ctlnkt
luminex®based
sharedpeptides
sharedpeptide
immunotherapynasopharyngeal
ade1lmppoly
lmp12
paratuberculosisthe
tuberculosisfree
paratuberculosisassociated
preirradiated
modelallogeneic
novemberjanuary
r009
p0362
isrctn86562422
myelofibrosisto
ricasct
2·43
2·80
3·08
4·70
16·61
cervantes
v617fstatus
tifa
nfa
lambda1
monkeystype
pegifnλ
unpegylated
nicotineinduced
nicotineexposed
20092010because
lipocalin2ischemiareperfusion
diseasesubacute
19601980s
micerefined
2010menafrivac
3135942
tillabéri
dosso
filingué
30×15
clustersampling
lqa
1141529
846702
797912
861770
910959
084093
irelandunlabelled
bpsu
iranin
chabahar
102926
aspirating
diffusions
acxim
46551
52035
390°c
phosphoser422
thytau22
approachrecent
tanglelike
adrelevant
at100
replating
u266egfpluc
218ffluoro2deoxyd
examinees
3×2
committeeapproved
feversepsis
35178
fluidpositive
enteroviral
37133
32845
34102
014025
035045
sclerosisbacterial
hlatype
restimulations
dcclinical
malignanciestwentysix
4164
autologoussct
20072008background
17295
14538
812862
glycosaminoglycansobjective
subendothelial
chp3r99
ldlcs
lipofundininduced
chp3r99immunized
csldl
antisulfated
virusrabbit
0111b4
µgkg
pigsmycoplasma
fork
microenvironmentwe
4in1
alternariainduced
w146891580
h61344
h24799
analysisadverse
nadrrs
largelinked
lldb
±7
chapman
estimatedtoexpected
111198
departmentsupported
randomdialed
infectionsdespite
glucuronoxylomannan
glucosylceramides
infectionswhere
iwcpet
tony
ellis
1947–2010
transplantationevery
ahb
233100000
078100000
004100000
adjustedrelative
universalatbirth
2539yearold
inflammationinflammatory
winnie
th1dependent
g2c
responsemediated
027077
028096
076163
049112
technologyfullsurface
afl
patchcoated
afltreated
conicalshaped
strippingtreated
shelterscanine
adoptionguarantee
cpvcdv
inclinic
spayedneutered
n17102
mainobjective
alkmaar
lowerweight
stillhospitalized
substantiating
thisfollowing
antihormonal
progressiong
tasqunimod
efficacysheep
antisheep
l1801
electroelution
maldi
t107
olinked
dt11ts
nethylnnitrosoureainduced
nullify
pushpod
immunizersobjective
montefiore
pointofdistribution
drilled
dohmh
immunotherapyestablishing
virusebvspecific
lymphocytesebvctls
cellspbmcs
carcinomanpc
lymphocytestils
antibodyokt3
cd3cd16
cocolonization
vaccineunderstanding
plyncrrflp
cocolonized
norwayand
timingto
287298
unmitigated
resistantacinetobacter
infectionextremedrugresistant
carbapenemresistant
feverinfection
filovirusspecific
5591
10499
361809
281397
7181235
576749
615998
99816
5193
93168
antigenslive
t3ssdependent
spi2encoded
spi2
sifa
ssel
ssej
ssef
t3ssmediated
238505
719773
pediatricsevery
forwardbased
efficaciouswithout
semiclose
toughly
drummonds
immunotherapymemory
immunodulatory
diseasevaccination
hosttick
mousetargeted
meals
reservoircompetent
nonmouse
490000
hpvpersistent
carcinoma…and
morethis
usersthere
idu
mean3910
mean798100
mean4110
ci104246
cals
cd4th17
taiwanmolecular
transplantationfatty
nonfatty
168944
165698
xiamen
5679100000
012100000
296888
117145
950675
050062
interception
ports
disordershereditary
mcf10at
antihervk
6h5
4d1
4e11
6e11
4e6
antihervkspecific
migg
144833
47544
97289
47017
147561
miggtreated
hervkpositive
hervknegative
omg
gmg
hachr
pvod
5249
disfavor
osteochondroma
metaphyseal
fraying
striation
slipped
epiphysis
valgusknee
deformity
dcsrecently
mhaspecific
hlaa3restricted
mha
mmcell
ctlspecific
3301913
aspartateβhydroxylase
510×105
asphloaded
spraycoating
sugarbased
provincesin
uiip
577651
163177
mishaps
inferiorquality
emergently
immunotherapymodulation
therapeuticsfmslike
colo205
hydrodynamicsbased
birththe
antibodyadjunctive
allergyone
nonmother
199798
625elisaunitsml
5elisaunitsml
professionsincomplete
allergia
meglumin
recommendationsunassigned
pltd
hematopathology
nowsince
tumorscigb247
3lld122
f3ii
mpdrop
mpsensitized
100μgkgd
05mgkgd
mucosalparenteral
scin
2in2sc
cr3hivspecific
ctla4igg
viruss
braindeath
rigshospitalet
timerelated
177lucc49
antibodyreactive
glycoprotein72
25100mgm2
sevenband
thunbergit
thunberg
vnnaffected
733000
164000
u5mr
2010–17
modelantitoxins
antiserabased
antibont
antietag
postintoxication
easytoproduce
responsesrnabased
rrep
repliconimmunized
rrepelicited
vaccinationhere
livekilled
fieldassociated
huigg
dsb
unconfident
hladr4transgenic
kinloch
dynabeadinduced
dynabeads®
clinexvivocd3cd28
pbmccultures
cd3cd28cd137
dynabeads®expanded
2007objective
n15432
or227
and173
or060
microscan
nonnosocomial
genhanced
cellsinsulin
igglps
reharness
immunotherapyresearch
kanawha
pandemicbroad
kanawhacharleston
kchd
immunitypreemptive
diseasevaccines
seasonalinfluenza
antiextractable
antiena
antibeta
2glycoprotein
seasonalh1n1
anapositive
anticardiolipins
β2glycoproteini
cardiolipins
0094
riskstill
bipedal
hypocomplementemia
nephrologyrenal
housewife
rossa
sediments
resuscitative
literaturegiant
gcapmr
infv
analysisvaccine
multitrip
enoughvaccination
sketch
activationcord
cd137expressing
cd137negcd44hi
cd137poscd44hi
cd137pos
cd25posfoxp3pos
papbearing
erythematosusrecently
gradient2
canceranterior
agr2
dk01
km12c
hct8
agr2p2
llvalsytl
agr2p4
rimfvdpsl
agr2positive
hsctcy
4hydroxycy
hcy
160200
interoccasion
iov
lucarelli
biotransformation
17114
12103
cd40lcd154
managementtowards
hipaa
concernbased
solicitations
questionsconcerns
diphtheriatranscutaneous
passivechallenge
raman
groupsonline
postinterview
antiimmunisation
ziniaré
97715
11466950
pustulosis
diphtheriatetanuspertussishaemophilusinfluenzaeb
dtphib3
underoneyearolds
imm1
n2non
n2nsclc
trichinellosisth2
antith2
0390
00592
0803
cellparasite
lp6
miceit
rw
rwallergoid
shamsensitized
rwinduced
il4ifngamma
allergoidsit
rwsensitized
abusesubstance
tacd
encouarging
vacine
filmdispersion
hizentra®
infantshizentra®
ephrina1epha2
interactionmediated
ephrina1
receptorligandmediated
interactionassociated
flt3lmediated
hadephrina1fc
hadflt3l
ephrina1fcflt3l
hadephrina1fchadflt3l
nonmyeloablatively
antiαβtcell
complexdisparate
leukodepleted
transfusionbackground
erythropoiesisstimulating
postleukodepletion
transplantationeconomics
dosesgraftversushost
b6luctg
ah1n109
agesexmatched
changedobjective
favorablerisk
danes
perfomed
3211
partnerfamily
32134
8631
mphbv
110dayold
n566
sprs
8437miuml
6701miuml
mphbvcontrol
366442
damagesmallpox
pve
vacvwr
lister
vacvlist
tightjunctions
abluminal
221130
firategrast
stateadministered
universalselect
childrenas
matterobjective
tumorradioimmunotherapy
precariousness
franceunlabelled
or57
caravans
squatting
or128
tiuxetanbeam
b100derived
atherosclerosisrelevant
alterantibody
1related
peptidesdependent
cytokinesin
rheoswitch
metha
cdh3pcadherintargeting
anticdh3pcadherin
mab6
cdh3pcadherin
indium111111inlabeled
cdh3pcadherinpositive
ebc1
h1373
sw948
cdh3pcadherinnegative
rko
90ymab6
sw948inoculated
100μci
h1373inoculated
iresmediated
attenuationto
subgenomic
encephalomyocarditis
emcv
immunitybrucella
psec
psecsod
psecscil12
antisodspecific
sodspecific
tcellproliferative
lactococciderived
111indtpaoc
90ydotalan
90ydotatoc
90ydotatate
177ludotatate
paraganglioma
helperkillerhybrid
hkhelp
magea4hkhelp
magea4specific
α13
000121
interferonγexpression
diseasehuntingtons
premanifest
yac128
bachd
immunodeficiencyprominent
droppedhead
flexion
mitesallergic
th2dependent
immunosuppressionlike
contingently
amygdaloid
noradrenaline
deafferentation
corticoamygdaloid
postrema
jacobson
herring
septicemiathe
clupea
pallasii
laboratoryinduced
vhsvnaive
immunisationsupdated
marvin
1943–2011ralph
physicianscientist
lecturing
years—from
prize—ralph
tumourimmunosuppressionsystemic
sunburninduced
melanomasusceptibility
gwa
geneset
genomel
tumourimmunosuppression
pemp0002
pemp0006
pemp00004
pathwaylevel
decadesold
n55584
multivariateadjusted
106108
optionsalthough
antigendefined
trendsobjective
dualallergic
1911115721573
mitetreated
timothytreated
grasstreated
fecesa
wpro
interplaymicrorna
mirstat
modelannually
flulaval
flulavalvaccinated
warmed
altiveliswe
bcwd
ml¹
cytophaga
mcy
sheepovine
sheeprearing
cd4ve
cactivated
gmpapproved
gmpcertified
rpmi5
capapability
diseasesvaccine
sijunzi
newcastledisease
vaccinemany
chms
sjzd
virusndv
vaccinationdendritic
iiagonist
restungunlabelled
vitbefore
restrug
wrongful
parentcaregiver
swinetoxicities
hepatopoietic
45d
czestochowa
4552
psse
healthpzh
vaccination15
dtp14
ofaefi
hpvcurrently
invasine
diapro
bioprobes
month105
41a
295b
295c
n1a1
mltcs
nonterminally
27aa
32bf
8bf
8bfelisa
routethe
dnpinduced
cromoglycate
r406
cetirizine
nphl
overpowered
underpoweredoverpowered
humancapital
performancea
evaluationantibodies
fragmentboost
newscasts
approachboth
16402
clinicaltrialsgovnct00223080
eventsobjective
rate65
n718
analysespvalue005
twosex
singlesex
bifidum
bifidobacteria
adolescentis
th1regulatory
fibrinolytics
stelevation
streaks
mirpurkhasobjective
muhammad
mirpurkhas
urdu
m214
f159
accessability
kudu
tragelaphus
strepsicerosfailure
strepsiceros
glutamyltransferase
zstt
menigococci
ibi
biopsyadoptive
tilpositive
cancerbased
brm
52year
α1ag
dripinfusion
immunemodifications
enforcedwe
20057201012
147clinical
s1krestin
s1psk
applicationsalpha
225acdrug
223ra
radiotherapytargeted
radionuclidesalphaparticle
tumortonormaltissue
nonlocalized
avidinbiotin
morpholinos
multidosing
availabilitythe
radiohalogen
209biα2n211at
210at
1384day
210po
cyclotrons
erlich
kohler
radioimmunocomplexes
αradioimmunocomplex
hottopic
zalutsky
beamtimes
arronax
olafsen
wilbur
lindegren
sgouros
sourcetarget
chouin
settingadditional
miceclostridium
cdad
basedc
cellsinsights
antigsc
therapyies
gsctargeting
practicesthis
abounds
decisionprocess
hospitalsobjective
pvalue0028
loadone
presenilin1
failurewe
3111
bloodtransplanted
micehumanized
nodltszprkdcscidj
10×105
ucbchimeric
igmigdcd24hicd38hi
cd5igmigdcd24intcd38intcd19
campaignscontrol
metapopulations
patchoccupancy
singlepulse
pervillage
nicolau
33385
28647
24910
4283
102377
060091
106154
yoruba
119426
106312
045096
050087
021054
045097
020057
genderdiscriminatory
foundationevidencebased
ebdm
ruleutilitarianism
failuredespite
deliveryhere
islettargeting
islethoming
analysischildhood
dawnrecurrent
mooted
miscarriagerecurrent
ndclone
ibh120
lprotein
ndvmatrix
ibvnucleocapsid
ibvglycoprotein
pangraf®panacea
mycept®panacea
28705
8820
17250
igemeditated
fcεrs
ageactivating
searchterms
googlesearch
atherosclerosisprevious
protein65hsp65
cholesteryl
anticetp
lipidregulating
n3372
antiah5n1
20052010objective
18746
37times
9003
ultrasoundtreated
metastasismelanoma
perfluoropropane
gasentrapping
blultrasoundtreated
h5n1background
clusterspecific
evaluationsthe
us6896
us8592
us1041005
us26565
us50512
intracoronary
fractionsince
immunotherapyuntil
microenvironmentglioblastoma
tumorsunraveling
undertakings
proresolution
resolutionassociated
patternsappropriate
bip
glucoseregulated
protein78
grp78
antigensmicroneedle
therajects
vaxmat
carboxymethyl
effectsin
rhod
warn
th2directed
micromilieu
issuesmany
contacta
002135
006137
007098
014118
ttsuv2anelloviruses
ttsuv2
vaccinationmonkeypox
mpx
disabilitythe
108234
120445
102263
103240
globulintcelldepleting
diseaseparkinsons
nitrated
diseaseidiopathic
incriminated
synucleopathies
affiris
asynspecific
affitopes®
βsynuclein
bsyn
affitome®
pd01
therapytwo
cyclosporinobjective
pfrh5
vaccineinducible
antibodycurrent
antipfrh5
kenyans
degenerate
thoughin
modelsonly
appalachiahuman
scripting
comanaging
lymphohistiocytosisbackground
kyushu
daysafebrile
months41
ebvtcell
ebvreactivated
hopethe
perceptionbackground
nonimmunisers
uncontrollability
unproductive
unbelievable
grapple
bacterinbased
4serovar
culturebased
kirschneri
m2emap
m2emapinduced
m2emaps
antim2e
m2specific
bulletsradioimmunotherapy
nonhodgkin´s
gearcancer
hsctlittle
temozolomidetopotecan
haplonk
biotreatment
vaccinationlentiviral
lvmgfp
dcsigntargeted
hiv1based
dclvs
concatemeric
tuml
1deoxymannojirimycin
dmj
mscv
ubiquitinc
ubi
pathwaysbackground
cd4cd45rbhi
inflammationimmune
turbotsin
turbots
scophtalmi
harveyi
homeschooling
homeschoolers
20117
36191
10562
ncfm
109cfudose
practiceestimation
arti
differencebackground
119362
106424
113527
4481092
20102011we
ampule
debatethe
2006objective
parentclaimed
multistaged
populationproportionate
n2900
64367
aor23
childbirths
aor36
aor39
vaccinehurt
0934
aor02
exemptionrate
mediumrate
54340
highrate
aor97
37254
pyruviciproducens
responsecorynebacterium
nonflagellate
nonsporeforming
corynebacteria
tuberculostearic
d2sc1
rhpiv3nb
rbhpiv3
cdnaderived
1037pfuml
interruptionin
propulsive
cryopreservationobjective
echography
tissueprocessing
0521
0522
0527
0529
celldelivery
strategiesstemcell
271495
184312
129138
117133
medulloblasoma
immunologicbased
osteosarcomadespite
sarcosphere
neuneg
neutolerant
programsa
timetetanus
2863
6510
4037
6414
peertopeer
modeldenileukin
ontak®
18μgkg
celllysate
200425
polypolyribosylribitol
responsessystemic
4586
mhrr
cytodiagnostic
therapycytodiagnostic
cdu
48±13
lymphocyteshpf
112579
demonstrating5
1761050
nephrotoxcity
44111163
vaccinationantigenloaded
dmna
treginducing
lmg13195
cd25highfoxp3highcd127low
rattiinfected
rattispecific
th1inducing
n773
modelrelated
paradigman
tropes
movementwebsites
prosafe
disingenuous
bevacizumabbackground
leypositive
μci150
90yb3
fluor
647b3
schemeobjective
n82128403
025056
012040
quorom
27152
ful
nervosaresults
levelsfunction
phaand
nonresponses
hyposecretion
biomarkersreversing
immunotherapyscientific
vetted
patna
housethe
xix
variolations
patternrecognizing
immunitypatternrecognizing
infectionshigh
rino
037067
040072
049093
glomerulonephritisthe
espressed
hlaincompatibility
hladr2
drβ11501
rtl342m
eaeon
tcelltolerizing
immunosuppressionlarge
noveltasting
multipleregression
dihydroxyvitamin
bronchoalvolar
104ml
3691
4197
6774
4462
migraineurs
antiepileptics
tricyclics
physicianformulated
individuallyprepared
flufree
zoneschools
refreshed
honam
6391
antigalαgal
interactionantigal
galα13galβ14glcnacr
ikkβinduced
vectormicrobial
adikk
ikkβnfκb
applicationsplasmid
lbmi
infectioncd4
allomhc
restrictionimmunotherapies
allohlaa2restricted
nb20
allopeptide
nb20hlaa2
tcrmhc
allomhcrestricted
litaf
endotoxic
arthritislpsinduced
litafdeficient
maclitaf
litafproducing
tamoxifeninduced
tamlitafi
lysmcrepositive
diseasenamely
antilitaf
chimericantigenreceptortransduced
horizonallogeneic
enhancimg
controversiesallogeneic
tumorsinterferonactivated
posttumor
cd31cd68
ifnsactivated
lox
trimixdendritic
ivm1c
patientdendritic
trimixdc
antimagec2
18fluorodeoxyglucosepositron
emissioncomputed
18ffdguptake
111incg250
imagingunlabelled
90ycg250
tumortored
marrowabsorbed
ifnγil17
psspecific
menccrm197cpg1826
bromodeoxyuridine
cd138b220
0286
cellsmostly
cellsby
psinduced
conditioningan
nct01063660
immunoglobulinobjective
groupincompatible
nonrituximabtreated
vulval
immunodeviation
il10transforming
subcutanous
parentsparentattributable
peaktrough
thistogether
nsclchas
aramco
samso
asianfar
dukes
leftward
hstc
±54
±35
1401260
toxicityautologous
nmt
asctnmt
cibmtrwe
irridiation
outcometo
cellalloreactivity
advancedhighrisk
mgmgm2day
physicianshould
knowmorbidity
isoenzyme
caribbeanin
timeless
fertilityassociated
fgt
nasopharynxbronchial
vaginocervix
interconnecting
nasalbronchial
protectionpassive
h1n1the
telephoning
h1ni
researche
vmdb
purdue
1396
repairuvinduced
lugdunensis
mitral
profileallergen
reorients
slitassociated
psychoneuroendocrinoimmunotherapy
neuroimmunotherapy
pineal
trovax®
trovax
processpresent
diseaseovine
indiaindias
privatelypracticing
cttbi
tbict
p0833
reactiondiscomfort
tractinfection
strategiesmechanisms
2039yr
612yr
adenosinepge2
experiencegraft
campath1
transplantationhigh
adrenocorticotropin
vaccinoprophylaxis
developmentallergen
hematemesis
nodulary
3105kg
5105
toxinotypes
ribotypes
ribotype
dysfunctionimmunoproteomics
actinin
αactn4
hspa5
actb
aoapositive
24±01
24±02
2±01
24±05
17±03
24±03
preantral
23±05
34±03
29±03
09±02
16±08
23±06
corpora
28±08
46±23
atretic
55±04
49±18
actn4
actbimmunized
30±02
35±06
3±01
36±02
47±03
15±03
αdecay
zealanddespite
th1driven
reportimmunotherapy
mage3specific
wedgeresection
failuresobjective
hatgcya
rabbitatg
igvh
rdotap
enantiomer
racemic
rdotaptrp2
symptomsmedication
cd4cd25foxp3positive
vaccinationsa
m2based
3m2ec
17110
immunotherapyil10
immunoprophylaxisdespite
applicationtherapeutic
krestin®
akir
ligandligand
2ds2
2ds1
2ds5
3ds1
tcdric
photoallodepletion
onehaplotypemismatched
decaying
donorvsrecipient
limitingdilution
lda
h3thymidine
ebvlymphoproliferative
ebvlpd
ebvctlp
ebvctlps
blcls
b958
rituxanresistant
pahklh
benzoapyrenepolycyclic
pollutants
pahdna
pahkeyholelimpet
antipah
bapspecific
antibap
nigeriathis
aor226
ci127403
aor772
ci4431344
aor222
ci111442
aor234
ci112447
aor171
ci101289
benralizumaba
cytotoxicitya
eosinophildepleting
embryonicand
mechanismobjective
hescmsc
cells100
concentrationic50
terminological
sharingbackground
reconstitutiondrug
latentinfections
adolescencevaccines
irreplaceable
turmeric
promoterconjugated
2007in
teikyo
indiahepatitis
γbeam
0270
15006560
conditioningassociated
clinicaltrialsgovregistered
nct00467961
nct00378534
fishas
gillassociated
gialt
igtigz
monkeysthe
fuzzytrace
okay
feelingokay
allais
boils
modulationallergenspecific
specificimmunoglobulin
yearsantibody
memoryobjective
vhb
vhavhb
hab
enghav
hbvxvaq
61105
apr8
hviruses
h1specific
therapynewcastle
practicesone
saskatchewan
interferonαbased
situobjective
0432
nonparental
pennsylvaniaa
predisease
higheravidity
oitb
oita
60week
slitoitb
devicethe
cancertwentyseven
dc1polarized
immunosorbentassays
hlaa21binding
cocktailactivated
688975
64998
ipolarized
bivirusspecific
trivirusspecific
cd25enriched
hthymidine
il6inducing
pamcys
pam3cysdriven
il12associated
spaceowing
mosecs
coexposed
mosecspecific
measleseuropean
26074
vnp20009
overproduce
afx
moreaggressive
clinicjacksonville
2006–2010
1077
201253
124193
beamatg
08126
othersbackground
altruistically
5t4ko
adm5t4
adm5t4immunized
fr4
b16m5t4
c6mh3b1
d2f2e2
ecdher2
timetransplantation
promisingand
myelodysplasiaa
int2
colostrumdeprived
parasuisobjective
infb
frandoloso
5058
npapt
peshawarhepatitis
coreceptorcostimulation
immunizedthe
stirs
ceu
anegative
colonizationtoxin
169243
triannual
86140
genesegment
ablationa
vsegment
segmentuse
regionh3
vsegments
needy
059090
127222
quadravalent
c5c9
montague
aciss
2physician
acetaminophenobjective
oligodeoxinucleotides
igg2algg1
punctual
boosterinformation
250260
colonymacrophage
slipt
carbohydrateassociated
ca215rp215
oc3vgh
ca215
rca10
rca
periodatesensitive
rp215
rca100
rca110
antica215
infectioncd4t
cd127cd25
cd127cd25low
cd127lowcd25high
initiativeachieving
2009crosssectional
13006
12102
serotest
darbhanga
toxicitytreatment
noncml
lddli
25mgm2day
lymphocytesovarian
unravelled
remarked
abnormalitiesalterations
potencyt
effectivenesspotency
vigour
0299
freeware
6085
tamsrecognizing
processbackground
pentavac®
teenagebooster
agecontact
agemixing
hivwe
03dose
underfiveyear
debt
20082009data
n7594
females13
phus
43s
05s
17s
ego
superego
ifnβdegrading
cuffs
emmprin
coam
mesobuthus
eupeus
antivenomimmunotherapy
ultrapure
myocytolysis
ckmb
inverted
agonistregulatory
p2x7
childhoodinfectious
pretx
treatmentimmunosuppressive
antimetabolic
statural
anticalcineurin
433491
cellschances
diseasefopx3
strongagonist
mimetopes
amm
schedulemycobacterium
ag85bmpt64
190198mtb84
dimothylidioctyl
bcgpsn
nanoweaponssome
tag7
policywith
swindon
90·6
cd27bearing
41bbcostimulated
vaccinesite
b7dcfc
b7h1mediated
evpcrc
loweggpassage
flury
evelynrokitnickiabelseth
demilitarized
17211840
acelluar
naïvegroup
antifim
nct00712959
vaccinemultiple
th17il17
50mgkgday
enteroclysis
enterography
updatein
cryopreservedthawed
harich
melatonintreated
c3ac3
abplasma
aboantigenantibody
foxp3egfp
ovalbumintransfected
recipientvaccination
infectionspertussis
perspectiveson
beautiful
plaza
américa
meliá
varadero
diagnosticsbackground
heamagglutinin
elispotassay
igamemory
igapertussisspecific
igapt
recombine
icer2111qaly
icer1612qaly
oncologygastrointestinal
cellpulsed
wtc
wtcpulsed
mage1
cmdcs
cldcs
cmdc
p00030
p00055
leukemiacd33
67kda
haziness
hicpac
199746no
rr18
myelodysplasiaperipheral
advancedactive
118months
68174
397698
145413
308692
93378
023079
unfavorableunknown
2202
119406
024099
leftouts
subdistricts
realitiesthis
strategyeven
zanzibardespite
vignettebased
thirst
21262
householdinterviews
130±41
60±48
79±12
twinrix®
hepab
n611
dayshell
077627
311836
malignancieslimited
12weekold
chickenstwelveweekold
nonimmunesuppressed
10322t
sacs
heterophils
mlkgday
stomal
highoutput
ovomucoiddepleted
homew
ewspecific
programmevaccines
upi
7985
proregions
gdf9
bmp15
proregion
ovulatory
pediarix
prussia
remittance
privatepractice
90465
90466
nonagespecific
90471
90472
nfatregulated
33157
2541228
preparationsbackground
maldimsi
cryosectioned
secapin
biogenic
hvb
challengebacterial
59909background
59909
bcl1jh
1079
aor194
ci105360
ci130458
aor253
ci138465
ci161433
aor897
ci6051329
aor3072
ci19244904
artfood
tnfαmediated
balancetumour
htnftg
htnftgil1
boneprotective
derivativeshundred
literatureoral
plgapla
lnovel
retaindepot
adjuvantic
1000nm
8μm
packageinjection
radiotracing
i125labelled
dcmφlike
perpendicularly
100200μl
jetinjectors
flushes
clawed
xenopus
laevis
igxthe
igx
frogs
coelom
receptorshematological
367419
268423
cbtregs
cbtregtreated
leukemiatumors
nkdli
nkdliunstim
nkdliil2
stim
nkdlis
cd56brightcd16dim
ncrlowcd62l
cd56brightcd16cd69ncrhighcd62l
usalthough
downturn
newsletters
immunizationnothing
postviral
goodamong
frustrations
itinerarybased
populationsaccording
advancementschanges
knowledgable
ravages
serologybased
19902002
20032008
spn14
spn19
hsp65specific
immunosuppressionsm
dpte
dfar
dptedfar
serumsaliva
extractsbased
n405
ps001
transplantationorgans
nonparenchymal
elementscell
immunotherapycontroversy
e7dendritic
sodiumiodide
dce7
hnis
noinsert
dcno
tc1fng
dce7i131
blis
diseaseimmunizations
diyarbakır
turkeyin
fatigueweakness
necessaryi
believetrust
virusto
highjevrisk
jevlp
γpganps
antijev
43kilodalton
brasiliensisvaccination
gradient2specific
adagr2
adagr2dcs
agr2specific
agr2expressing
378462
9106
65104
737758
693735
789822
814853
094097
103109
101105
immunossupressant
immunophilins
therapiessince
immunossupresors
immnunossupressant
immunophilintargeting
αradioimmunotherapyobjective
avidincoupled
125iavidinmx35
rbm
atcv
schoolchildrenbackground
hightransmitter
19781994
socioeconomics
4001800
semiselective
bgspecific
aboia
immunoglobulinbased
aboiatreated
c4dfixing
aboiabased
noncomplementfixing
adsorber
lucky
criteriawe
granulocytemacrophagecolonystimulatingfactor
immuneresponding
cd107degranulation
anticll
vaccinebaits
aircraft
63000
2751
cub
travelersrabies
expatriates
00123
developmentmucosal
countriesto
absenteeismspecial
esac
absentee
dppivcd26
cxcl12stromal
ectopeptidase
dppiv
dipeptides
diprotin
sitagliptin
januvia
cd45congenic
1gy
44431
4002349250
296019
252307355930
vaccinationcoverage
20062009background
needednecessary
distributionsunderstanding
nong1
reinfusionmodulated
cd3cd4cd25
cd4cd25foxp3il10
cd4cd25cd45rofoxp3
peptiderestimulated
cd4mediated
twistsairway
experiencebu
rejectionfailure
crmcc
trialsmonitoring
dosevaccinated
bindingdeficient
aindonesia052005
nonnaïve
cpmp
regimenchildren
128160
9392305
21164
208736
110902
95ci20133242
95ci10182222
averagesized
sibships
childrenextracorporeal
photoapheresed
deerred
elaphus
virginianus
hyalomma
e76
e83
developmentnumerous
rhemautoid
necessarypatients
therapyadalimumab
65kd
mybobacterium
rubra
pilaris
17monthold
keratoderma
evocative
acanthosis
infundibulum
tetragrip
20062011there
225000434000
blockadepotentiated
iggassociated
cd23dependent
symptomrescue
taub
btgh
pertussisinfected
slaughterage
lowvirulent
20022008objective
2385102
7644098
rr100
rr103
rr083
rr071
rr070
cpghh2
adjuvantedsubunit
cpaf
adcpaf
rcpaf
hh2
rcpafcpghh2
usersdespite
notintreatment
primatescigb247
μgvaccination
hmec
countrieschildren
carrierthe
co3ap
ovacontaining
alumina
immunizationsschool
37·7
45·1
60·8
61·3
blamedbackground
overrated
varese
4246
sensationalism
patientsvaccinations
vaccineefficacious
profileis
networkwide
spies
vaccinepulmonary
graftversusleukemic
modelamong
transductiontransplantation
cmllike
bcrabl1transduced
micemyeloablative
pmogbone
275cgy
pmogbmt
50cgy
eaeresistant
prepubescent
2010the
kcyclin
kcyc
croton
bcgjapan
cd107expressing
graduating
phns
polytechnics
bcgrevac
notvaccinated
20622
18507
45·366·7
62·886·8
11980
gra6
h2ld
hf10h2ld
gra6based
pcdna31hisgra6
antigra6
studyhistorically
19831989
03100000
80959
anthraxanthrax
linesprecursor
cd19based
hd37
rrta
psaefi
aefit
sever
citieshospitals
spell
brokenthe
epigeneticmodifying
routewhereas
httpwwwchildinnovacorg
burnetiiinactivated
situationa
coxevac®
ceva
3–4
nonshedders
urovaxom
systemour
prostatitisurethroprostatitis
urolithiasis
evidencespecific
th2responses
controindications
yearbook
ccl28
particlesmucosaeassociated
igaascs
hiv1iiib
vplccl28treated
vlpccl28treated
hiv1bsubtype
hiv1csubtype
gmcsfindependent
immunizationdendritic
cd11blowcd103
cd11blowlangerincd103
csf2rb
cd11blowlangerin
thymusdeveloped
contactmediated
immunosuppressionto
inosexpressing
tovaxin
dmtnaïve
arr1
treatmentdependent
dmttreatmentnaïve
choleracholera
earlygeneration
practicaleven
radioimmunotherapythe
radiobiologyconventional
a13
selectionepidermal
egfinduced
sc414
er414
agewhooping
cohorts19982007
200865
unstated
postbroadcast
overselling
15120
acalifornia72009h1n1
awisconsin152009
h3n2aperth162009
aperth162009h3n2
lbl
organismbased
67550
6cellsμl
130450
09500
nonleukopenia
initiallydocumented
adultspsychological
biobehavioral
age74
t132309
t156296
t130246
placethe
takenforgranted
multisited
fieldwork
2010unlabelled
ncims
suborganism
dba2the
dba2immunosuppressed
disagreepersistent
regimentwentyseven
survivaleosinophils
moleculesthree
centersystemic
cumulations
edss70
72month
030075
hditahct
compliancebackground
tumorssolid
tumorsupporting
cd11bf480hi
cd11bmhciihicd11chi
cd11bgr1hi
diseasesimmunoglobulin
modifiersvaccines
markersthe
unsurpassed
tcrms
hlabased
fundaments
agentsin
mcms
eev
149pm
177luthe
mabstreptavidin
scfvsa
radiolanthanides
biotingalnac16
177lumeodotacc49
149pm166ho
177lubiotin
2cancer
powerfull
responseto
il12il23
steap281296
ezh295109
hladr1
dr53
ezh295109reactive
steapreactive
dendric
lifeit
increasesalthough
allergometric
toleranceon
ept
reactioncomparing
epts
dilutionswe
ofcinduced
dietetic
bublak
milkthe
anaflatoxin
anafb1
anafb1klh
afm1
foodstuffs
aflatoxins
afb11ocarboxymethyl
antiafb1
afg1
afg2
mid2010
panvax
0016049
003518
07789
3767
9479
myeloidlineage
tumorigenesisperoxisome
dnpparγ
dnpparγflag
il7rαlinckitsca1
linscalckit
cd11bly6g
doxycyclinetreated
myeloidautonomous
2011rabies
societyvaccines
580bed
rescheduling
cabinets
contraindicationsprecautions
13glucan
4e12
2g8
chxa
b11
213bimabs
213bi6d2
patientstwentyfour
monthsselected
20102011on
pcv13type
2527
diseasechildren
schooldelivered
1950present
1974present
astray
fkbinding
ap1903
bioinert
cellsuicide
nct00710892
adultsvaccinepreventable
polyvalent23
sheepbackground
cattleborne
trypanosomatidbased
systemtrypanosomatid
trypanosomatids
megatrypanum
theileri
bovids
brucei
trypanosomatid
108231
110254
143343
communityfew
joão
n1720
n2819
005029
735973
phcvs
or07
ci0610
or04
ci0305
ci0406
doctorsclinicians
ci0407
suboptimum
4977
35285
playground
fungiinvasive
schedulesconjugate
carrierinduced
coadministrations
crm197induced
goingvaccine
neiserria
diseasefighting
bonanza
rapidresponse
fearfree
lauren
constable
moleculesα13galactosyltransferase
geneknockout
pctla4ig
ctla4igexpressing
hcd4
hctla4ig
pb7
hb7
paecs
nonpctla4ig
pctla4igexpressing
vzvoka
orf62
ch50
inktcd1d
vp16cyclophosphamidetotal
vpcytbi
008059
hemocyaninbackground
excuses
nonprivileged
mus
1y120a
1y120f
hdmsige
reactivitiy
fondation
mérieux
pensières
veyrierdulac
infectiontwo
multicat
environmentsfeline
fecv
allohctpatient
highcost
125252
167413
137292
136210
riskstandardized
leukemiaadolescents
19801988
19891997
hull
20022009introduction
164100
143100
207100
nct00848692
xenotropic
xmrv
physicianassessed
withincampaign
withinactivity
countryreported
organizationadjusted
federationby
hospitalresidual
bodyare
153sm
companions
ψply
10¹¹
00010
nonopsonizing
ppsv23immunized
k1443
ψplyimmunized
plyspecific
antiply
merozoitespecific
immunodeficiencytheileria
futurefor
tnfgfp
hpc4
tlg
hpc4tlg
apelinapj
therapyimmature
apj
apelininduced
normalstate
vascularspecific
acr50the
mtxpoor
swapping
assessmentwill
consensually
lightrituximab
mabthera
predicaments
2011immunizations
nonadjuvantcontaining
farr
antirnp
antila
antiscl70
antijo1
clinicsamerican
lymphocytessuppression
athletesthe
athlets
esposures
adolescency
circustamces
intercontinental
tournaments
vaccine128
vaccine120
evaluationsobjective
editorials
embasecom
cellsepha2
epha2883891
tladfdprv
γglobulin
iig34
pfpt
dystocia
safty
miteallergen
cased
mmef
prepopulated
outcomepretransplant
09836
65442
59899
21727
signallingthe
loosing
binuclear
culturesculturing
bnidcs
bnidc
dcstamp
p28
ehrlichiosisthe
obligately
monocytotropic
hme
ehrlichiaspecific
p28omp1
p289
p2812
p2819
p28s
p2814
orthologs
ehrlichial
mycopar
paratuberculosisspecific
boppd
mpb83
vettb
bovidtb
licensinghuman
cd3cd28driven
vgc
shigatoxinmediated
diseasesshiga
stxs
antistx1
crosssuppressive
stxmediated
rhyr1pn
hyr1
antihyr1p
hyr1p
polymerizedtype
arthritisprevious
clinimorphometric
ciamice
methotrexatepolymerized
vaccinesesrd
vasculitisa
smallvessel
murinehuman
24×10
dualinduction
atgdaclizumab
atgdac
atgalemtuzumab
9283
721±33
675±33
withhelddiscontinued
arenaobjective
reexpressed
publicprofessional
webbridge
safetyvacunasorg
httpwwwvacunasorg
questioners
282893
025076
moretailored
thirteenvalent
403850859
438762712
12794lyg
10407qaly
contextbackground
singlehead
twoperson
coresidents
n354
coresidentspouse
quantitativereverse
polymerasechain
abin3
ly64
perspectivesimmunotherapy
tunnel
somersetbeginning
somerset
bvdvfree
informationfor
nnii
weicks
nonbranding
nonsummativity
lptld
noneliverptld
nlptld
patientreactivation
limfovir
410122007
matei
bucharest
carol
victor
babeş
polytechnic
aramă
reactivityaurora
aurka207215specific
aurkaoverexpressing
targetresponsive
zoledronatedespite
policiesseasonal
correlation131
enfuvirtide
controljohne
johne
immunotherapyadhesion
3164±782
2947±779
aspergillosismanagement
allohctdue
patientswhich
19942004prospective
lymphadenopathic
ricallo
postalloric
reparameterised
9695
72100
20156
controlthere
101853
cdcestimated
opinionated
cspg4cell
scfvfcc21
criticises
epidemicsoptimal
outbreakepidemic
theoryguided
studygardasil
stepsthe
provideclinical
responsesselective
quinazoline
ao349
2345trimethoxyphenylnptolylquinazolin4amine
7890
onlinebackground
askcom
denmarkin
hbvscreening
hbvimmunizations
prevalenceestimate
140376
trialperiod
hbvimmunization
complicationscytokines
groupssubsets
gainfluid
reincreasing
immunotherapyinvestigating
extractswhich
dilutedthan
19932009background
27788
sinusitisbackground
acaaiaaaai
frs
srsfrs
2261519
54538
onwardobjective
scoresobjective
1scit
1slit
scoradindex
workobjective
gardasilhuman
gardasilsilgard
nmi
036101
nonwithstanding
optionsthree
yearsthat
vaccinationtyphoid
effectimmature
imdcmesenchymal
imdcmscsplenocyte
imdcsplenocyte
bol
brač
2011at
chukar
partridges
kofoidi
legionensis
oocystsexperiments
partridge
alectoris
100dose
coccivact
dispersa
competitiveexclusion
floorpen
graftsthere
outcomeswith
iexpression
dnmti
5ac
machineryrelated
ifnγsignalling
5actreated
7696
or427
or499
or288
or498
33838
hpvdoses
adjhr
071087
eueftacountries
067082
61368100000
40048
nonsynthetic
datathis
marrowderivedmscs
carbohydratemonophosphoryl
mousetumorassociated
monophosphorylated
mplataca
gmcsfifnγdifferentiated
cultureddcs
b71b72
survivalb7h4
inducibly
effectsrecently
interleukin28
ifnλsmediated
st28
19258
modelsoptimum
deferralshortterm
girlsthis
atherosclerosisspecific
lipidantigens
inflammationderived
statusquo
scalein
chiavaresebackground
chiavarese
nocchiero
16118
healthcharge
5007
meditations
regionin
registerthis
2009this
tim3targeted
downmodulate
conbr
secretionlectins
canavalia
dmannose
dglucose
cellsdesensitization
4hydroxy3nitrophenylacety
4hydroxy3nitrophenylacetybsa
fcεridependent
crossdesensitizes
immunogenicitysince
admifnβ
mifnβ
vvmifnβ
vvmifnβinduced
lkrm2
donorstem
locusspecific
068106
singlehladrb1mismatched
042060
042072
050092
093176
infants13valent
clinicaleconomic
meningitissepsis
nonhospitalised
12250
22093
il23k1
il23k2
ciib
anticiib
changedthe
adolescentfriendly
educationhuman
exanthemadue
infectiosum
roseola
173330
155291
024061
hormonefemale
βsubunit
serumsalivary
colito
anticolonization
anticfai
technologiesobjective
recentness
20082009objective
18228
nonintent
213bi18b7
188re18b7
ddcd3
110μl
registryautologous
5867
4353
tacitus
casuistic
18841
428484
073105
074099
mellitusdna
il4mcp1
1011weekold
cd25and
chickensregulatory
mgbird
carriersvaccination
trendswhen
twounit
malignanciesas
oneucb
minima
cd56cd3neg
posthemopoietic
bkvrelated
vp3
immunotherapyattenuated
acidtreated
interleukin2agonist
treatedtumors
responsestargeting
treatedsite
abdriven
twotumor
il2treatedsite
rechallengedepletion
cd40il2activated
hilton
jacob
proclivity
mostbut
allcdc
poultryhighly
subclades
n309
407×103
323491
887×103
701072×103
undeliverable
notificationsobjective
months19
20377
5182
or303
or494
nonenrolled
or243
hprtdeficient
marrowpurine
6tg
hypoxanthineguanine
phosphoribosyltransferase
hprt
extrahematopoietic
pentaxim®
n719
imovax®
n231
876100
erawhile
vaccinationaluminum
rocks
earths
antacids
keith
mrls
fulllung
779s
auditadverse
vasovagal
unduly
halfyearly
200901123512
antiglycan
lrha
nacetyllactosamine
givsbackground
malariabackground
3172
csspecific
nct00380393
as01e
049086
062103
0084
062089
pzq
antischistoma
pzqprimed
008091
antinma
1904591
kitchen
processimprovement
directives
guideobjective
canadaapproved
adoubleblind
pertussisthis
selfpreservative
stromalymphocyte
bifronsdendritic
badmacrophages
disordersnkt
implicationsincreased
celldeathsensitizing
betterment
eradicationbiotherapy
citim2011
egfr2neuregulin
responseswhile
appsw
appswnos2
vivoit
cancerimmunogenic
restingnaïve
capri
quartet
10¹
1024019
921005
hypoaesthesia
hdrallo
linfomastrasplante
médula
osea
httpseudractemaeuropaeu
020036
antigensdnabased
combi
challengesaustralia
women18
20079
adolescentsalthough
hostversustumor
c57bl6cb6f1
5gyirradiated
h2dkh2bd
enhancementtreatment
cd8cd62l
interleukin2expanded
nonmelanomacell
p53specific
patientsmutation
antip53
p536573
p53187197
p53264272
hlaa0101
p53226234
p537482
applicationsantibodydrug
uncleavable
drugcontaining
unaffecting
1dof
5011
4351347
2048
23617767
hangzhouobjective
argentinavaricela
varicela
okarit
120365
2534218
71253
transplantunrelated
20002009objective
20009
222755
31726
12035
20012009
22102
12106
methylphenidate
atomoxetine
analysisallogeneic
cp2
prehematopoietic
133897
25943893
risktobenefit
tbi2gy±fludarabine
unv
rfel
1vd3
carctls
caratcs
wwwclinialtrialsgov
nct00085930
mononegaviruseswhat
controlsthe
mononegaviruses
mononegavirus
028078
014070
niloticus×oaureus
vvulnificus
vcg
vvha
15gl
notchtransfected
sb623
nicdexpressing
nicdtransfected
senescentlike
monocytedendritic
tolerancet
hydrogelin
bfgfloaded
bfgfnps
bfgfnpshydrogel
sol
nonflowing
npshydrogel
ecrit
alternariain
nongrass
slitone
polisensitive
monosensitive
300o
requirementsthe
aurti
policlinics
profdrrd
kandou
manado
sulawesi
internalin
rhinitisworkrelated
workexacerbated
ofexposure
allergensare
proteinspecificthe
sublinguallyadministered
cowx0027s
henx0027s
cookedboiled
placebovaccine
vaccineno
em2
klhem2
antiklhem2
antiem2
birthdayin
chibanishi
interviewwe
vaccinecosts
us165
dticloaded
dticnps
dticpladr5
dticnpsdr5
dr5overexpressing
dr5positive
agsps
ethylenecarbodiimide
ovaaluminduced
vivocd24
tetracyclineinduced
pcdna4tocd24
repressorexpressing
293trex
tetracyclinedependent
cd24induced
tetracyclinefed
haplohematopoiesis
haplochimerism
haplocd34
nct00943800
savbiotin
dotabisbiotin
y43asav
s45asav
111indotabisbiotin
idgm
22idg
wtsav
16idg
90ydotabisbiotin
mutantsav
bisbiotin
bfreenyc
embaseovid
responseschemoattractant
productionare
vlpsbackground
encapsidate
baculovirusbased
encapsidating
moleculesvlp
rnaμg
gagcat
baculovirusproduced
3we
inhαtag
nontreatedvehicletreated
rhzp3
n036
antizp3
angelan
recipientshepatitis
cikil2
cikil15
europium
molt4
pbcell
tanoue
costaccording
bouaké
phaseshifts
φ
phaseshift
isobologram
loewe
tallarida
319117
casematched
gratwohl
macgiven
donormale
sm16
metastasiseffective
neuroblastomaobjective
kidneypaired
ivigrituximabbased
apheresisbased
doseobjective
bioavailabilities
troughs
1218yearold
mid2004
mid2011
52454
immunotherapydecreased
apb
hlanonidentical
hemopathic
transplantpulmonary
activitycostimulatory
rhcd137l
rhcd137ls
pgtf2
radiationimmunosuppression
290320
waveband
320400
antagonise
photoimmune
hairless
sunburn
ssuv
290400
cisurocanic
viruseskilled
vaccies
monterrey
14600
cmica
compedia
nonreferring
regimenxlinked
crackles
gm2d
steroidcalcineurin
cellscm3
lymphocele
armsnew
lactoserum
odor
foul
shampoo
timeuse
cleanliness
pleasing
argentinawe
boliviaover
3826083
20012008background
teratogenicity
liveattentuated
48748253
39542253
30139
rubellameasles
womenchile
guatemalathis
epitopebackground
ch401
167175
epitopemapping
her2neurelated
immeasurable
protectionby
systemmeans
geneswe
stat1irf1
microdisected
cbsc
clinicwe
lymphomasautologous
influenzapandemic
crazy
yearshuman
negativesense
ns2
rsvneutralizing
suppl
flamsabased
regimenpatients
melthio
106172
transplantrecipients
nonpreviously
netherton
intestineinterleukin
subserosa
outcomesto
aipp
immunologyjoint
moldfungi
proteolyticcontaining
comparativeeffectiveness
n7606
ci040
aor075
ci064
aor076
ci063
povertyyear
availabilityallogeneic
nodonor
landing
perspectiveafter
127511038
adjuvantsthe
exampletherapeutic
vaccinationbesides
studiesadoptive
hgp100hlaa2specific
proteinlabeled
hgp100hlaa2
netherlandsduring
388degree
signc
technologyscience
assignees
usissued
tuberculosisenumeration
azd2281
abt888
3036
0185
¹³¹itositumomab
5yearlong
400bed
strategiesindia
therapyinterleukin15
phi2il15cmvtat
phi2spil15cmvtat
promoteramplified
phi2il15ceatat
phi2spil15ceatat
twentyfourhour
0·477
0·003
0·352
0·028
0·331
0·040
0·377
institutionadoptive
tnfαifnγcd107a
expressionobjective
tissure
rtpolymerase
cancersafter
patientsdiabetes
peshawarbackground
saddar
hashtnagri
naway
kalay
pawaka
problemmother
cancermerkel
rituximabunlabelled
cd19cd20cd27high
plasmablastsplasma
dr4ietransgenic
uncitrullinated
complexdeficient
cep1
argininebearing
rep1
hindankle
anticep1
questionstumorassociated
tumorpropelling
therapymacrophages
nonclassically
environmentinterest
mφs
macrophagestolllike
dysregualtion
reachincreased
intraclonal
stemnessassociated
foefew
immunotherapists
moreisbetter
hematooncologyhematologic
immunitybone
intrabm
diabeticscidγcnull
magea4expressing
immunisationchildhood
wellheralded
157171
1571713
sptreated
igg2related
immunoregulator
poliovirusdespite
adopteesthe
babysitters
teloaded
te90
pefs
5376
mixedprofile
typeiipolarized
typeipolarized
t1t2
hlaidenticalsibling
il2il4supplemented
milne
christopher
moyes
4969
rr035
rr040
rr352
armeniathe
rotarixr
830000
adacel®
grouptargeted
strategiesa
typereproduction
t1v
hospitalsbackground
institutionallevel
prerequirement
postrequirement
rlepg
43fold
lepderived
tlymphocyteassociatedantigen
rodentborne
ectla4
ectla4htnvngp
extraosseous
infusionsyear
microfoldcell
immunizationpresent
europaeus
uea1
alginatecoated
aluminiumbased
ueaalginatecoated
immunocell
therapyfalse
tosoh
hbr1
makabsorbents
immunomodulaton
heterophileantibodyproducing
consign
nasty
talesemerging
pathogenmediated
nurserybackground
64425
149185
113130
stipulating
213230
forumadvance
programvaccines
criticalness
kenyamalaria
motherinlaws
istat
usewe
5935
n670
n2796
highereducated
heber
havana
euvaxb
hepavaxgene
greencross
hyperresponders
goodresponders
rpcec00000075
ferrol
approachinfluenza
m17
fhlap
catabolizing
endopeptidases
anabolism
corriedale
rfhlap
deaed
futureleukaemia
tcrderived
calculationshigh
dpmmc
crossirradiation
computerintensive
slitsublingual
postescalation
behaviorsinfluenza
30march
unpublishedinprogress
quasirct
igaimmunoglobulin
polymerize
igabased
vaccineon
hdma
karyotyping
4396
us128
73845
us109
114225
35196
us10261
71761
us20922
wap
proteinsprostate
impotence
prostates
ps20
immunotherapyretrospective
symptomsrelieving
variantsadoptive
karyotypic
asai
roostersthe
neuropeptides
roosters
uricase
ureasethis
ue
manuren
nh3
acres
yolkspecific
antiucigy
ucimmunized
ueimmunized
antiueigy
metaanalysispneumococcal
melonomaassociated
mageas
vaccinatorsbackground
337432
298424
103189
125278
developmentimmunotherapies
responsesimmunity
hydrolyzates
wheyspecific
wheysensitized
malignanciespreengraftment
383°c
ci789941
ci380700
ci69417
hbcagpres1
ifnγstat1mediated
autophagybackground
celleducated
ifnγstat1
tlr49
capacityallergy
igeantibodies
directcare
stafftoresident
hypervaccinated
onrates
lognormal
kon
as03adjuvants
74242
sitcisbtc
discoveryrecent
isbtc
163587
virussplitting
deoxycholatesplit
garners
ontak
her2neutolerant
micedisrupting
hlaa21hladr1
a21dr1
balb
neut
her28594
p85
her2776790
p776
tuboa2
ctlsteffs
ontakvaccine
snell
0561
filovirusesdeveloping
nonlucrative
xxi
transplantationcytoreductive
kgf
pret
thymii
bioscaffolds
cd4cd25tregs
developedgrade
13154
15250
gvhdgeneengineering
genemanipulated
cellsviral
donorslytic
cd34selection
8×103kg
cd56μl
cd3μl
2il2
haploidenical
phenotypehaploidentical
3rdparty
cellsdepleted
transplantstransplants
sbae
isolex
hlahaplotype
needallogeneic
alkylatingagent
patientscurrently
hlamismatchedhaploidentical
lymphocytenatural
alloreactivitynoninherited
hlapartially
preventiontreatment
opportunisticviral
beyondmuch
immunomyeloablative
inhibinthe
norgestomet
pfsh
flushed
doe
inhibinimmunized
intraovarian
limitedobjective
38item
always76100
other075
rate678
haploidenticalmismatched
awarethe
necrosed
cb17scid
spioloaded
morphometry
anticd20rituximab
negativeantibody
hbsabappearance
hivhcvcoinfected
co13
hepavih
231265
10091103
103124
experienceseveral
140200
23523048
basophilbased
reviewssystematic
vaccinesinvasive
vectorsrecombinant
rhuad5
consto
selfnature
groupsa
nranitag
officio
holder
licenseholder
2402binding
peptidesensitized
e76175
cdstlrlcvqsthvd
e76781
lcvqsthvdirtled
e76169
cdstlrlcv
e76776
lcvqsthvdi
effectsimmunotherapy
addictionrelated
62r3s3benzoyloxy8methyl8azabicyclo
octane2carboxamidohexanoic
3hcocaine
dad5
hyperlocomotor
progressiveratio
cocaineseeking
swinein
ltk63
ltr72
inactivatedvirus
blockadelpbm5
lpbm5
lpbm5induced
antigenvaccinated
reconstitutiondonor
h60
tmmediated
cpcml
bccml
lcmvimmune
h60vaccinated
2011highdose
physiciansunlabelled
341fps
grandchild
cd40ligandinterleukin2
drugsdmdbetainterferons
glatirameracetatethe
glatimer
hypothyreosis
okrug
betainterferon
copaxon
preventionpneumococcal
worldwidemore
isotypebased
yearslongterm
108111
hlnhl
ssx2
taadirected
prosurvivalproliferative
polycytokineproducing
monocultures
sracd204deficient
sracd204targeting
tvp
alternativescenario
859000
825000
8100
15900
46925
αimmunoconjugate
213bicdtpa9227
monogrippol
il1alpha
trophoblasitc
beta1glycoprotein
tbg
261general
agoniststlr
9objective
moleculescd83
recidives
nosological
rsvirus
uveitisautoimmune
aiu
immunesuppressors
strategizing
lymphomato
pantcell
beclomethasone
s1p5
traffickingduring
sphingosine1
cxcr4independent
childrenautoimmune
postconditioningprotected
stressresponse
postcon
postcondependent
znpppostcon
pigsstreptococcus
ss9
immunoproteomebased
gz0565
desorption
sortases
proteinmaltosemaltodextrin
chap
peptidoglycanbinding
lysm
ssu982184
whomfollicular
sj23lhdgst
nirb
pagc
nirbsope1104sj23lhdgst
nirbdriven
malignancyallogeneic
agallele
cdr3δ
γ9δ2t
reactivityadoptive
γδtcell
δ2
oecderived
cdr3δgrafted
γ9δ2tcr
oec
oxidezinc
outcomedendritic
134613
dthnegative
rank726
positivedth
counterregulationintratumoral
il12gmcsf
postil12gmcsf
ctlt
magea4objective
magenegative
decitabinepreviously
hldid
directionssystemic
diseasesbiological
pge2dependent
cancercoxderived
prostanoids
pge2mediated
109144
114218
waxingbased
depilationtranscutaneous
plucking
pa63
antipa63
plucked
depilation
interfollicular
fcreceptorexpressing
gynecologistsobjective
01511
026076
schedulefinding
studyyoung
occurrencebackground
zymography
intracerbral
ganciclovirvalganciclovir
14121
6259
regionmeningococcal
1524yearolds
serogroupable
antismooth
antindna
antimicrosomal
gondiiinduced
il10acute
il2dependent
coformulation
regimenhematopoietic
syngeneiccontrol
admittances
effectrescue
ptclnototherwise
interferonconditioned
angiopathyobjective
microbleeds
dipyridamole
microhemorrhagic
2011from
postwar
1992–1998
treatmentimmunoglobulin
cgn
nephriticrange
cb4
urokinase
hlaa2specific
cd138260268
glvglifav
cd138ctl
activatedmemory
recommendationsstrains
vaccinationantibodybased
phosphataseskinases
prl3
dogmain
guo
corepres1
plasmidsto
hbcs1
idep
cspecific
efficacymycobacterium
igg2aigg2b
twoweekold
inflammationcostimulationdeficient
costimulationdeficient
relbdeficient
cd3cd28coated
cd80cd86sufficient
influenzavaccineobjective
624monthold
518yearolds
verysomewhat
particlesbackground
envclade
seroneutralisation
v3sensitive
sf162
fp9
mithridates
eupator
pontus
mithridatism
indonesias
mtd2
mtd2derived
tagexpressing
aspartateβhydroxylaseloaded
cholangiocarcinomaunlabelled
asphcoated
ox62
interleukin12a
bdeneu
cholangiocyte
bdeneucl24
fisher344
transplantwe
acgvhd
csa21
celerybackground
celery
apium
graveolens
stalks
rart
npru
crossinhibitions
ltps
rbl2h3
ltprelated
ltpsensitized
plantfood
avma
singlepage
subjectiveobjectiveassessmentplan
disciplined
catchedup
sarcomassome
epochfludarabine
cyclophosphamidefludarabinemelphalan
epochf
eoch
vp1background
virusfmdv
h2dd
pk1
ayhkgpftrl
pd7
gfimdrfvki
schedulea
cellculturebased
needsbackground
visittravel
52695ci
270410262p
jleaps
jgdleaps
trialvaccination
nonpriming
dpcoated
p2triggered
tpmediated
p2triggering
rtyr
sidestepping
transplantationil17
sil17
usannual
cect7121
th2exaggerated
meningococcalcontaining
livestockvaccines
disabilityfree
crimmins
finch
498503
kirkwood
11771185
containmentpassive
adultdirected
superstition
19992009objective
21cfr§31480
dtime
ipsi
fdgpositive
08160983
youden
173196
diyarbakir
1691
beninthree
35dayold
boleni
theileriosisthe
crossimmunization
cattlederived
stabilates
cvl
kasoba
8×
9×
14×
piroplasm
crossprotected
boxdeployed
spirochetal
competencemodulating
antiouter
butterscented
blueberryscented
hectare
rhodaminecontaining
vibrissae
hardened
immunodeficiencyinfluenzaspecific
cvidpatients
hcalcium
antigenprotein
βglucanpolymeric
tnplph
300400nm
winnipeg
nrv
nrvs
seasonalph1n1
ato
policyobjective
deducted
sums
2801516
iggbackground
iggavidity
mva85avaccination
postmva85a
ectonucleosidease
metabolises
ectonucleosidase
coproduction
crf02ag
reviewtetanus
diseasesvirusassociated
viralderived
centuryadverse
clofarabinearac
tbicyclophosphamideatg
clarac
gvhdincidence
comorbiditiesobjective
int1
iric
0689
0480
pfalciparum
strategiescarboxyterminus
rpvmsp119
rpfmsp119
hygropvmsp119
hygropfmsp119
pvmsp119
cytofluorometry
approachesrecent
syndromecutaneous
disinfectantsimmunizations
2007july
childreninfection
myelotoxic
2162
64×106kg
ganciclovirrelated
ssx5
p103111
a2dr1
reportth9
elderlythere
goodwin
transplantationeffect
dnrvcrpsl
dnr
invests
mellitusa
statesfollowing
causeunspecified
1524year
infliximabobjective
±40
±3506
dissipative
structurecervical
timespace
infectiously
immunopotentialization
dissipathogenic
lactovaginal
menstruating
recipientsdermatological
n18628
wlrd
nonfragile
052088
053094
046106
0690998
071105
072098
078098
023070
071095
073096
0700997
hibhepatitis
mphbvhib
hbvhib
comvax
μg05
prpompc
4204
34115182
13502099
selfprediction
audiocomputerassisted
highbarriers
lowbarriers
kashan
irantetanus
anthraquinonederivatives
immunotherapyappropriate
cd34cd14
mutz3
anthracenedione
anthracyclin
mitoxantronegenerated
osteoactivin
inhibitorsmultiple
antiosteoactivin
umin000005820
retransplantationwe
\euro141493
ci125019157967
\euro84773
ci7114598400
\euro249775
ci166824332727
mdsbu
idoimatinib
kitdriven
12005122007
102010
0269
stillongoing
11665
pseudomembranes
cpah
vasodilator
dyne·s·cm
lupusb
anticd20based
a3targeting
paradigmatically
lysosomerelated
organelleassociated
abca3
abca3dependent
wt1human
cd14cd16cd33cd85
phagocytelymphocyte
ϱ0275
cancercytotoxic
hlaa24matched
rtbthe
galactosenacetyl
galactosaminespecific
rtype
haemagglutinins
cytolethal
distending
5×ld50s
rtbspecific
24b11
sylh3
5×ld50
rtbs
2γ
dosepreviously
oradj222
164301
oradj177
120261
oradj141
102193
oradj164
113237
therapiesmany
ciu
isentress
cellslowdose
agentsmodalities
hdasct
erasalvage
posthdasct
spectroscopyvaccines
eaccell
apccells
tumorboth
eactumor
postimmunized
annexinvfitc
eacgangliosides
bioelements
leukemiarisk
curious
248224
n217219
n31005
modelsesophageal
hrasg12v
cyototoxic
advtkgcv
dosingstudies
nct00429143
ibmi
firstmatched
11204
lackdna
chagasilack
pcineo
vaccinationfinancing
cd4cd25highcd127
immunoprotectionobjective
biotinpolyethylene
glycolnhydroxysuccinimide
biotinpegnhs
diacetatepropidium
perifusion
tregcoated
controlsnative
lessonthe
αgelcer
vaccinemucosal
intaranasal
brazila
sv1
astreptococcus
fourweekold
10dayold
antipspaspecific
pspaimmunized
developmentnasal
p6specific
nthispecific
bedsidesublingual
ipexfoxp3
cd4cd25bright
lowlevels
thymicallyderived
ahlta
6792
16565088
2750years
pediatricsadolescent
naivety
38mg
rtmut
108pfu
idprimed
envantibody
humanistic
65598
349171204104
26430400454
immunizationdo
knowbackground
nonpanel
tying
gc1107
yongin
comparatorcontrolled
capacityrecent
cd4cd25hicd127
cd4cd25hiicos
cd4cd25hicd45ra
cd49dcd127
rituximabdependent
betamediated
immunosuppressionchemoimmunotherapy
rituximabcoated
51chromium
158ff
158vf
inaddition
readying
deluge
telephoned
newsprint
curetype
rebalanced
outcomethis
024075
018074
012059
postr
prer
00089
222211
h5n1as03a
lymphohistocytosisallogeneic
munc134
fhl3
blastderived
cellsimmunotherapeutic
nonmatched
dwindled
motherswomen
hyposensitizationspecific
basophile
malignanciestherapyrelated
tmns
pn23
cea424sv40
lrast
immunotherapydrugs
cardioselective
aceinhibitors
newalthough
updateanimal
catallergens
noncatkeeping
childhoodallergic
vx001vx001
tert572
vx001
tertreactive
postvaccinationinduced
radionuclideobjective
reductionpolyomavirusassociated
018206
outcomein
postpvan
n20066
aldhbright
carcinomainitiating
aldh1a1specific
aldh13
aldh1a1
aldh1a1based
alloprimed
micealloreactive
anticd154lfa1
1137days
232days
125days
diseaseseffective
dhcps
vpids
dhcp
vipds
sicilydespite
adjor146
ci105204
ci108175
adjor149
ci105212
habitually
127854
or45
ci3559
ci121212
or60
ci36101
hhc
2011on
af03
pigletswhooping
coformulating
transplantationsignaling
2008january
rr164
ci105
rr555
ci360
rr174
llactide
plsp
bma
f6
plspf6
plspbma
fcaf6
fcabma
fcaf6bma
obviates
intradermallly
virosomaladjuvanted
vativ
idtiv
32149
rv25
hu1418il2
clinicalpathological
infantschildren
5545
19901999
neuropathologist
dtpdtap
illnessdeath
positional
superfine
immunobiologics
cytarabineinduced
rinse
mauritianderived
uncloned
sivmac251c8
mhccharacterised
soonswitching
shortnotice
infectionsby
recipientsconclusions
transplantationconclusions
diseaseconclusions
corticosteroidresponsive
hydrazidederivatized
toxoidthe
reductive
hydrazides
seasonwomen
hcptransmitted
leukemiaswe
wwwclinicaltrialsorg
nct00466531
subtypesubgroup
geqml
bkvpositive
subtypessubgroups
ivc2
exchangebackground
immunohematologic
pcirelated
pciassociated
26·8
0·008
3958
n2011
n1947
000069
socc
bsaci
babyand
toddlersteps
mpacyclosporine
nacetylβdglucosaminidase
foresightvaccinomics
foresight
interventionist
researchat
applicationsuggest
postgenomics
stakes
sociotechnical
coproduce
dataenabled
vaccinesfarmers
indium111oxinelabelled
aminobisphosphonateactivated
laks
adaptivespecific
laksdcs
eventful
benchside
strategiesdendritic
immunechaperone
70a
reviewhandfootmouth
infectiological
vaccinationssince
fty
gilenya®
premarketing
her2fc
364391
ctrlfcvaccinated
o6methylguaninedna
therapybrain
factbr
hivadenovirus
undetectablemany
primeboosts
ibdvimmunosuppressive
ibdvspeciﬁc
proinﬂammatory
pr81
912±38
831±34
762±36
834±24
852±34
177ludotapr81
tlymphoblasts
18f2fluoro2deoxydglucose
tomographybackground
preincubating
coadministrating
18ffdglabeled
postmyeloablative
transplantmany
lymphoidmyeloid
chromium51
cr51
pscanegative
9518
determinationaspects
subsetslineages
subsetscell
galactoxylomannan
immunotherapycryptococcus
gxm
galxm
mannoproteins
exopolysaccharides
rhus
flea
preparationsobjective
boratebuffered
coprophilus
sautons
autoclaved
weightml
spainthe
tnftnfr
transplantationcomposite
itinfluenza
sivinduced
cellsgenerating
sl5928flicesat
flagella
swarming
practicereactivation
negativeantihbc
nct00556452
progressionthe
neurospheroids
antitnftreated
dsdnathe
iggreactive
4b
iggsepharose
coincubated
400fold
removalreduction
transportercarrier
efrhds
monodioligomeric
reactionsthe
elisaantibody
iibearing
stimulusantigen
regulatorysuppressor
cd90mhcii
cd90hsa
cdcthe
clinicianpatient
communicationwe
n430
n208
ageism
dfppivig
mgbody
cfsemlr
patientsinitial
th1th17associated
eosinophily
kingston
frontenac
lennox
addington
2519
404592
028072
apcps
8418
5304
5824
familiarizing
clearwatery
pilottrial
cmvprophylaxis
143±031mgdl
129±056mgdl
123±053mgdl
203±32mgdl
199±40mgdl
223±97mgdl
elderlymost
stageschildhood
sevenyrold
loes
brainsparing
sixyrold
d388neutralizing
josephignace
guillotin
17381814the
freemason
penal
exercice
designdendritic
immunoglobulinproducing
offspringforty
0ml
20ml
30ml
40ml
50iu
dlalphatocopheryl
paraaminosalicylic
substancebackground
halfmaximal
menorrhagialack
neumega®
haemostatic
pbac
vwfrco
r0116
r0318
r0295
r0003
uairvaupper
acromion
tuberosity
abducted
60°
pollenfruit
dau
poorlytransplantation
cd34cellskg
patientsdonors
hscprogenitor
cellbm
fullreevaluation
micemonoclonal
sp20
hlj018
2de
candidiasispreviously
β12mannotriose
βman3
xin
dziadek
cutler
1051352613531
fructosebisphosphate
aldolase
antifba
fbavaccinated
preabsorbed
e29
overlay
dosevolume
inhomogeneity
obstructionaffected
cpgclasses
nanoparticlesrecurrent
rao
aclass
micepresensitization
signaltransduction
15×105
gammaherpesvirus
infectioninterferonγ
pfp
ifnγpfp
gammaherpesvirus68
mhv68
cd4deficient
slealthough
cocrosslinking
immunerestricted
cr1specific
dweysvwlsn
cocrosslink
isletalone
pedicatic
26item
800052000qaly
fulfillmentunited
2008us
studentwritten
lymphohistiocytosishemophagocytic
dysregulatory
networkunlabelled
ritn
göttingen
7000μl
22μl
vaccinationcollege
diabetesnumerous
extractsthe
latexallergic
latexsublingual
glovesuse
yearstudy
actrn12611000543987
moleculardefined
neovasculatureassociated
cancerrenal
postgenomic
transconjunctival
igapositive
proteinarray
thymusexpressed
tcell17associated
biomembranes
macrodevices
sizeconfiguration
physicalchemical
approachesalthough
optima
infectionsepidemic
asymmetries
systemsin
elaphusred
btcompatible
inapparent
firewall
autoblood
urticariaobjective
aja
dazhui
gv
fengfu
feishu
neiguan
acupoints
setastine
hanang
handeni
tanzaniaeast
ecfimmunised
nonecf
mvabn®her2
cellsmvabn®her2
mvabn®her2induced
cd8cd11c
mvabn®her2mediated
deliverydry
mucoadhesives
chainindependent
lifesupporting
xenograftsurvival
galtko
pigtobaboon
thymokidney
locd2
locd2based
250μl
xenothymokidney
allograftderived
childrenbetween
swept
humansmonoclonal
catastrophethe
eradication…
unmindful
runaway
adolescentsduring
10505
h1n1tiv
029072
013049
echographic
childrenwhereas
suprascapular
129mm
122mm
139mm
131mm
2p
3p
housevisits
191standard
interferonlambda
infectioninterferon
vaccinationpediatric
therapythirtyone
rhinosinusitisdermatophagoides
emtu
edp
vfitc
pharmingen
165fold
e2anti
hvr1
p412
412419
p430
430447
p517
517531
huh75
e2epitopes
2010for
gisrs
nics
whoccs
erls
nonmechanistic
nonhabased
highgrowth
impactof
kuming
qhs
immunizednonimmunized
preseasoninfluenzapostseason
agesexincomeresidenceprior
immunizationmedical
visitscomorbidity
hospitalizationmortality
95ci048075
053064
069086
066077
114173
221272
161196
ballsy
horny
rationalization
cd123cd131
111innuclear
nls7g3
αsubchain
cd131
βsubchain
7g3
13mer
111innls7g3
aml3
microspect
nodsevere
rajicd123
aml5
111in7g3
resistantrelapsed
24155
200800273615
anthraxbacillus
inhaling
tumorspersistent
pentarix
e7positive
mexicoviruslike
n2537
n1011
spodoptera
frugiperda
sf9baculovirusbased
vaccinationneonatal
hepbvax
twentyfouryearold
hbsagantihbcantihbs
d1012
costpercase
juvenileonset
23600
184300
reservoirtargeted
diseaselyme
diseaseadvisory
menacwydmenactra
adenovirusa
proteininadjuvant
abisco
covaccine
emulsionglucopyranosyl
5protein
diseasesevidencebased
paedrd
rheumatologistsimmunologists
epidemiologist
gymin
dtlnks
nh1n1
colognebonn
bonn
freiburg
285475
48475
indecisiveness
nh1n1influenza
gdeficient
dropinfectious
δggiltv
sa2iltv
a20iltv
servailtv
vaccinespreviously
carcinomatraditional
haplopbscs
haplopbsc
55×1010
20052007objective
snvcs
8286
10314
8687
8990
tybe
183616
onesixth
triplexforming
tfo
targetsto
tachyzoitebradyzoite
tzbz
ncspain7
hydroxideginseng
bradyzoitespecific
rncsag4
rncbsr4
exporting
103118
interferoninduction
autoalteration
periodimmunization
vaccinesviruslike
aitwe
cane
analysisthere
cauca
macrodeterminants
violencerelated
planted
edwardsvenn
colitisstudies
cncm
i2116
cfudaya
nonfed
st11fed
cancerwhat
knowcancer
leicester
5743
discontent
capacitybackground
sirlike
datainformed
immunitymonoclonal
immunobody
platformbaculovirus
formulationgiven
worldwe
lowprobability
subunitcomponent
prothymosin
immunotherapiesprothymosin
protα
125kda
secretionsignal
hyposensitizationaccording
finlandnational
executedhyposensitization
hyposensitizations
hyposensitizationnew
allergiesalthough
moleculestumorinduced
transplantationprimary
ageamong
immunotherapyrevisitedour
matgmediated
healthobjective
modelsone
recipientsregulatory
iotriset
toag1
nonrejection
immuneconditioning
patientsknown
peroxynitrites
bvaccination
vamengocbc
cd4cd45ccr7
aβ143il10
cdnabased
aβ143
ethylenimine
saponized
cowsa
papillomavirus2
ebh
phytohaemagglutination
vaccinationcoxsackievirus
010iuml
50euml
infusionsobjective
myozyme®
ventilatorfree
iars
ertrelated
microdilutions
fluidvolume
pigsgonadotropinreleasing
weeksofage
bulbourethral
tubuli
seminiferi
pycnotic
spermatocyte
homephase
constitutions
strategynicotine
nicotinespecific
nicab
nic311
japanwhen
streptcoccus
measleszero
experiencesthe
nglycolylatedglycoconjugatesgangliosides
nglycolyl
ngc
nglycolylgm3
oncosislike
ngcgm3expressing
transfectoma
cmpnacetylneuraminic
ngcglycoconjugates
20042009background
cccr
cdcfunded
3576
dosingintravenous
2schedules
auc5
5500μm·min
transplantationclofarabine
2010outbreaks
basedinterventions
poniesobjective
tetracyclineresistant
equiwas
bacteriologic
pony
sensitizationbiochemically
sidestream
smokeless
tuberculosisspecific
rv1860
apainduced
apabased
kineticbackground
pctla4hbc
phbc
paavhbv12
th1th2balanced
breached
needleandsyringes
immupatch
immupatchmediated
ama1c1alhydrogelcpg
7909background
growthinhibitory
nct00984763
dardar
preparationssecreted
ag85
nct0052195
protectiona
hivc
crossnab
sciencesobjective
89145
35166
10117
44232
19110
latertuberculosis
constructspossible
biomics
5101
ch296
ifnγamplified
tcrstimulating
rnciks
rnciksdel
1695±610
managementadvancing
l1camtargeted
177luradioimmunotherapy
l1camexpressing
177luchce7
growthinhibiting
chce7agl
14710tetraazacyclododecanennnn‴tetraacetic
skov3ip1
177luchce7agl
177ludotachce7agl
177luimmunoconjugate
ebvbmlf1
childrenoregon
20062008starting
followback
prams2
v3scaffold
dnathe
v3cholera
v3ctbs
v3ctb
v3cctb
pbmcgrown
fundación
colombiathe
dialysisonly
dialysisortransplantation
bauer
abil2
celleffector
interfacethe
huksil2
il2rs
50200
iccoated
indiavaricella
strep
ligandmismatched
patientsthirteen
nct00799799
hiv1therapeutic
buffaloesthis
immunoneutralisation
follistatin
multiparity
inhibinimmunised
unfertilised
45±06
28±06
41±07
32±05
16±07
antiinhibin
antifollistatin
parthenogenic
blastocyst
transplantationsbackground
basosquamous
nmscspecific
responsestreatment
rhinoconjunctivitisoralair®
irday
pleomorphism
immunoprophylaxisa
measeles
haemophilis
diarrheas
responsesprevious
itregsuppressive
enhancingpromoting
gp96based
conversionbackground
brainstormed
postworkshop
vendorsconsultants
activeinactive
charcot
neuroarthropathy
19901994
hyperhidrosis
yersina
atreated
ycw
control0·3
csachallenged
csachallenged0·3
dwg
csainduced
blastogenic
polycations
ovalbuminvaccine
modeloligonucleotides
polyarginine
polyhistidine
odnpolyarginine
angers
mostcited
cvhc
aminophthalhydrazides
galavit
tamerit
glymuride
seasoninfluenza
viva
harlem
samethus
outlays
busulfanto
stbi
08±05
stbicy
11±06
hngrfc
cordinjured
ratsas
ngrfc
antingr
prospectsallergic
sensitizationformation
knit
antileukotrienes
antibodycombination
alemtuzumabc1h
thymoglobulinratg
daclizumabdac
ratgc1h
ratgdac
c1h
ratg7
cd56cd16
cd4cd25hicd4cd25lo
teamoriented
workflowembedded
09530991
02410448
10131065
lunghouse
plaguethis
ci1012
pvalue0021
beginsmaintenance
disintegrate
phlogistic
081144
infarctionobjective
bmepc
lvds
010mm
lvdd
214mm²
168mm²
1378
µg×kg1×d1
syndromeaml
embryoobjective
transplantationbmt
allogenous
scpprnobjective
scpprn
easytolocate
epinephrinethe
emanations
14707
myelomaabstract
modelsmonoclonal
protooncogen
mmcmodel
relaxin
hscbased
antictla4hsc
challengesseveral
vgkcs
nmdars
ampars
gababrs
glyrs
seasonfor
geig
groupement
dexpertise
grippe
4382443
832443
3662218
71225
californiadavis
19912008this
doxepin
antipruritic
sinks
preloads
marrowoverliver
oddrecently
shoenfeld
agmonlevin
cd11bcd11c
class2
raldh2
interferonγinterleukin10
ifnγil10producing
vectorlinked
plasmiddna
plasmidencoded
gonadotrophins
ovulationssheep
oestrous
bmp15keyhole
bmp15bsa
bmp15immunised
nonatretic
controlimmunised
luteinisation
receptorepsteinbarr
her2carmodified
her2ctls
pbmodified
2loci
filariaisisobjective
glutathionstransferase
setaria
digitata
sdgst
chacterized
nanolc
dirofilaria
immitis
sapiens
microfilaraemics
microfilariae
normals
mastomys
systemsrelated
armies
navyit
infantmeasles
vaccineresistant
growup
epidemical
futureand
disowned
antimmr
theorethical
champustricare
tricare
tricarecovered
rifle
akii
akif
131719424
140318998
00095
mercknicaragua
19782007
19672007
076150
937100
765100
532100
564966
924100
653100
518837
humanslymphodepletion
il2rαcd25
0154
antiil2rα
himisha
beltran
tomasz
beer
carducci
20116027990
immunizationmemory
crmneoglycoconjugate
tetrasaccharide
pn14ps
neoglycoconjugate
antipn14ps
polysaccharideboosted
crmneoglycoconjugateboosted
leishmaniasisa
lowry
18±10μm
almcpgodn
almcpgalg
almalg
almalgcpg
almcpg
h2bd
l1214
p815specific
βcarotene
gshstransferase
progressit
deceptively
ns1122130
pa4655
equalized
m15866specific
koreachildren
ppdinduced
rr144
rr167
rop18toxoplasma
rop18
pvaxrop18
279±151
synergycurrent
spag1
tams1
egyptin
australiato
donorsalthough
180210
12132
88177
aeroallergensallergen
ckitmast
tgfβtreg
delayedintime
bsacipag
proformas
btssign
todayimmunoglobulin
serumal
microgl
tumorspreferentially
mkc1106pp
pprapsm
epra
epsm
antigena0201
tumorantigenpositive
enzymaticlinked
131isodium
iranexternal
physicists
maynovember
µsv
epilepsyintrahippocampal
kainic
hilus
kainduced
zattoni
mhciiknockout
β2microglobulinknockout
rag1knockout
β2microgloblinknockout
signalsimmunosuppression
vitrotherapeutic
intensitiesobjective
0233
perspectivessignificant
immunobiochemical
serotherapeutic
patientsstings
apamin
mcdpeptide
mastoparan
skinbackground
vαvβ
chainstransduction
sctv
bounding
principalstratification
102296
105241
154445
electroporationin
p37gag
chengda
autogenously
vaccineswhereas
treatmentcytokines
allergensigemediated
harmbenefit
immunoglobulinsprimary
dialysed
gigantica
proteinfasciola
mvg
n131333
472009
32010
15021
akha
16913
tbcasct
7598
7296
7±41
3±12
9±75
32±123months
leukaemiadespite
pll
fer
4384
trisomy
healthexposure
nonuridinerich
motifmicrobial
oligoribonucleotides
orns
guanosineuridine
adenosineuridine
doublestrands
tlr7biased
rnamediated
therapeuticsin
rnaimediated
lirna
survivintargeting
rnaitriggering
5bp
5ugugu3
5end
3end
pb12257
nontagged
antieso
esobased
hepbsag
pathlab
dtapdiphtheriatetanusacellular
vaccinehepbipv
localgeneral
31week
crunch
melanomamost
lvexpressing
lvprimed
lvvv
tumorprone
lebanonbackground
infectionmouse
milkborne
betaretrovirus
sagspecific
puvabexarotene
puva
bexarotene
envenomingsanimalderived
medicallyrelevant
pepsin
globulinunlabelled
5x106kg
surfacesviruslike
inactivatedsubunit
chimerismpediatric
ladi
transplantationreducedintensityconditioning
alumtuzumab
prhighrisk
2objective
aspectsthe
interventioninvasive
experiencehighly
untransplanted
globulinenhanced
fxm
lcxm
postprotocol
cmx
multipara
preprotocol
ahgxm
tcxm
bcxm
100882
cellsmonoclonal
fcrnonbinding
fnb
anticd3induced
23dioxygenasespecific
subcutaneouslybackground
9montholds
441843
367597
immunityour
sensitizationunderstanding
prehaptens
prohaptens
hacat
preprohaptens
eugenol
2methoxy4methylphenol
24dinitrochlorobenzene
bandrowskis
prehapten
isoeugenol
nadphquinone
prohaptenmediated
expressionduring
reengaged
154163
831839
intime
sykcard9activating
questionspathogen
tlrtriggering
sykcard9
kir2d
cd8cd28kir2d
immobilize
vaccinecured
foerecent
aquired
saimiri
immobilised
airdrying
endotheliumderived
tysabriavastinherceptincampath1htgn1412
barrierstranscutaneous
genetransfected
dcil12ag
pheotypes
thiazolys
il12transfected
plused
waysadherence
olufsen
medicom
cd27positive
study402
5697
vaccinatedagainst
varilrix
rik
reforming
jerseys
cercaria
librarytwo
sjcwl05
sjcwl06
wsvaccine
iew
pgex4t1sjcwl05
pgex4t1sjcwl06
pcdna3sjcwl05
pcdna3sjcwl06
elisaspecific
siea
3945
3002
tauopathiespathological
18ffdgpet
mrglu
gammachain
temozolomideobjective
cellsmm3at
sarcoid
holter
signalaveraged
pleuropneumoniaethe
nineweekold
acclimatisation
enrofloxacin
pigmajor
mannanbinding
lectina
neverthe
reconditioningbackground
gj
aerodynamic
t120
nonperfused
caustic
sublingualnumerous
choicesbackground
accepters
n1227
n1900
effectsharmful
recipientsdaily
idkeyhole
4with
cellcaco2
systembifidobacterium
bifidobacterial
angulatum
catenulatum
caco2pbmc
qassim
fro
pertussisincrease
wwwthecochranelibrarycom
illumnia
nrcts
interruptedtimeseries
provideroriented
trivialised
wwwactrorgau
brazildengue
200209
3335
78629
129425
108360
agtargeted
primeviral
regimendna
dnarad5
pdnasiv
rad5siv
blips
cytokineactivating
pdpsthe
pdps
vaccinomicsguided
sciencevaccines
outbreaksimulation
premovement
postmovement
1200000
ruckeria
gnathostomes
challengerainbow
immersionvaccinated
ruckeriml
o157escherichia
oralgastric
ttsps
nicuwith
verifiable
ted
guidelinespractice
emiratesit
dhabi
tnfαifnγ
cd3tnfα
venomhymenoptera
dataintensive
clinicianresearchers
vaccinomicsvaccinomics
studydiscoveries
nonclinician
lawwith
liabilityas
girlsvaccination
preproduction
cellsready
scaffoldsnonimmunoglobulin
cysteinefree
isletallograft
antiinducible
rejector
agesit
spectratype
14886
applicationsallergen
hicon1
viiiggfc
factorwe
realtimepcr
membraneboundcomplementregulatoryproteins
hicon1dependentcellmediatedcytotoxicity
idcc
complementdependentcellcytotoxicity
γimmunoglobulin
51chromiumreleaseassays
ovariantissue
smallinterferingrnamediated
hicon1mediated
rinderpests
cousin
mems
timingadherence
selfcare
virusvirusspecific
hock
m1specific
progestogens
spleenosomatic
levonorgestrel
lev
halallergy
9alpha
11betapgf2
tetranorpgdm
centersunlabelled
hcpuc
healtheare
inclusión
challengeto
cd4cd44hicd62llocd27
uzbekistanbackground
selffinancing
3069
9323
dtcontaining
nextline
14620
presupposing
detaining
dedritic
escell
nonvirusmediated
immunizationstudies
nonpediatricnonmedical
onrab
baitaerial
mephitis
onrab®
vrg®
transects
fieldforest
july2
2430
90yanticd66
planningdosimetry
chickenthe
interleukin18the
swifnα
swil18
countingthere
alumni
modellive
xrx001
64year
tbiobjective
ussr
sssr
1211279
africaeastern
dollarsyear
transplantsdendritic
vivoeducated
commongamma
immunotherapynk
equoral®
equoral®based
lurd
lrd60
lurd40
rituximabivig
tincture
plasmapheresisfree
19832006
mmftacp
oomycete
insidiosuma
mip1alpha
mip1beta
chemicalinduced
tgmmtvneu
tlr9mediated
helperdependent
wrvfire
organswholebody
vigiv
rvig
symphogen
humabs
humab
antiev
minoritybackground
denomination
1778
n2129
syndromeany
168788
nct00521430
nct00732316
infectionchlamydophila
6histagged
cwl029
hisselect
talon
cellthru
pδrc
pδrclcre
lcrespecific
proteinimmunization
proteinboosted
gliomaprevious
10injection
16×107
astalanine
nct00529399
0·412
0·3490·478
0·382
0·3220·446
0·413
0·3510·477
0·998
0·7791·22
p0·98
0·926
0·7201·13
p0·50
childrenmyocarditis
diseasehost
takersparents
formers
cementless
arthroplasty
immunotherapyrates
basophiles
vaccinationexposure
predeployment
virallikeparticle
melanomalongterm
cd34vegfr2
microcytotoxicity
anticd34vegfr2
antihlaclass
micelymphodepletion
helminthinfected
inflammationour
sj
sjinfected
sjdcs
cd4cd25il10
sjdc
observes
amicable
177lunimotuzumab
receptoroverexpressing
s24isothiocyanatobenzyl14710tetraazacyclododecane
2bis2biscarboxymethylaminoethylaminoacetic
1142mbqmg
cd83positive
thailandconjugate
740109
thb
fcmpositive
fcmnegative
r08139
eyeultraviolet
automimmune
photokeratitis
holmes
n70468
48392455
106129
124169
asthmaexacerbations
2878
72nd
adjectives
nervousanxious
sadblue
tireddrowsy
infarctionautologous
bmcstx
bmcpcs
cd3445
cd13345circulating
ventriculography
cd13345
cwp84
antigenclostridium
clindamycintreated
forwardhaemophagocytic
cellsaccording
monoclonalrecombinant
pcramplified
12170
11414
28822
patientskv13
chord
venomsensitive
9581790
9971531
victimization
indiaempirical
nfhs3
n6947
inductionallogeneic
188relipid
nanocapsulesto
radiopharmaceutics
lnc188resss
cedwe
nanovectorized
systemslactic
campaigninfluenza
patientsrituximab
norituximab
infectionsbacillus
subcultures
tbetexperimental
mogp3555
lnc
mogp3555specific
medicalthe
cpss
mtfs
polymermediated
immunocamouflage
cellsdeveloping
immunocamouflaging
mpegdose
mpegs
mpegmodified
mpegsrbcs
nonhcw
3227
6351430
hivrna50
116209
100104
196334
387668
denmarkthe
vaesco
155294
1641004
plateaus
biomarkercentric
characterisations
investigationallergenspecific
transcutaneousepicutaneous
tcit
tabletsallergy
aitsublingual
asthmaallergy
allergenaluminium
ratioallergen
allergentoaluminium
34day
markersunderstanding
postwithdrawal
olcs
igereceptor
vestibulum
olc
processnatural
engraftmentenhancing
flourescent
infantsnew
cellinducing
effectsimmunization
aβ36
amyloidcontaining
immunotherapyantibodydependent
chitn
receptorsassociated
fcrγdeficient
chainexpressing
phosphotyrosines
placeholder
2114e
cellschlamydia
nationalwide
5423127
251347
211726
craftsmen
tradesmen
232026
131016
251444
060408
leukocytapheresis
lcap
halfvolume
frequencyhematochezia
matts
rootplaning
coronainduced
lossdetermining
reimmunisation
factorbackground
antibodylikemolecule
viiviia
fvii
timepcr
hicon1dependent
5hrs51chromiumreleaseassays
p00023
killing±sd
562±159
324769
rituximabcontrolantibody
p0597
nonepileptic
lennoxgastaut
doose
glioblastomavaccination
recipientsmanagement
immunominimization
reducedcost
biorbis
sgn35
cmc544
bloodstable
cdx011
basedadcs
antibodyconjugated
syntarga
algeta
stuttgart
schoolbackground
19842007
19841987
quasicompulsory
19881994
389786
3839
bvdv1f
22146han81
refractoryacute
stemcelltransplantationobjective
graftversusgvhd
nickelbackground
nickelallergic
niso4
·6h2
emepepimuts
biomira
emepepimut
electroporationaided
receptorendothelin
etbr
vasomotor
cardiotoxin
hetbr
immunotherapynon
elucidateda
emtcancer
vaccinationachieving
th9402
alloactivations
hostreacting
postallografting
45dibromorhodamine
syndromecomplete
fulfillment
cr1p
cr2p
boaroral
riems
evidentiary
island2
proteinsseveral
spi1
toduring
infectioninvasion
countable
viplike
gp120derived
antivipntm
prooncogenic
transplantationdifferentiating
ibdcytomegalovirus
foscarnet
isrctn45563569
immunityinterindividual
microbiotahost
melanomacomplete
suppressionand
kickstart
ivigplasmapheresis
prografmmfpred
peptidedendritic
streptococcuspyogenes
opadc
dkk1
cancerpolyfunctionality
dickkopf1
tc1th1
vinorelbineplatinum
605613
insulinrequiring
survivalwith
moreappropriate
lessaggressive
singleage
286000
rotavirusattributable
prioritysetting
17plenalidomide
17pcll
alemtuzumabmethylprednisolone
practicesymptom
immunotherapyabstract
dtapipvprp
seroconversionvaccine
infliximabmediated
th17inducing
tunelpositive
activitywaning
1649
3604
8334
h1n1vaccinationbackground
h1n1vaccine
h1n1vaccination
20082009an
refuseddelayed
weeks60
1631
hweek
vulnerableunvaccinated
rubellawe
systemselimination
trickleup
outbreaksierra
coefficient063
maroua
2009a
2008april
nineday
epidemicbackground
700783
867974
004064
005091
24604665
29516609
252396
safetybrief
swissmedics
paniflow
ospaa
lymerix
fluin
2788
semblance
silencers
safetyadoptive
wt1sitcrtransduced
wt1cotcr
wt1sitcr
geneimmunotherapy
63108
21115
3489
donorlivingdonor
ldllt
nonsd
ldllts
fvbn202
mouseattempts
agfree
bryostatin
1ionomycin
rateswe
efficacymvabnpro
lactadherin
mvabnpro
mvabnpsac1c2
mvabnpapc1c2
antipap
papspecific
plb
alsprevious
6067
postop
hnumapositive
doublecortin
dcx
dcxpositive
axodendritic
sprouting
intraspinal
0·0390·85
0·031
0·5481·008
0·056
contibutes
impactrotaviruses
patientsnosocomial
toxoplasmosistoxoplasma
ad5psapsca
rm11
rm11psa
rm11psapsca
serviceparent
phcr
lifeways
phcrs
stoppage
nigeriasuccessful
forprofits
philanthropy
selfserving
arabialittle
biologysexually
antiγδ
antibodyexpanded
malignanciescellbased
phosphoantigenexpanded
phosphoantigenstimulated
ccl22expressing
diseasesincidences
familya
desensitizationobjective
dhsas
spi
dhsa
minimalisation
ratesoptimizing
superconvenient
beyondunderstanding
loom
amalgam
challengesincluding
approacheswill
touchstone
gapvaccinesoften
interventionsare
vaccinesmechanisms
financingvaccines
vaccinessuch
celltransplantationdonor
cd314
91fold
515fold
cd3cd314
outcomescord
106283
155591
093383
orcgvhd
083382
124482
143715
067320
cellsadministration
sophiology
uvattenuated
landraceyorkshireduroc
μw
5933
8987
8627
7762
9978
schistosomespecific
dvs
augustdecember2008
vaccinecard
cytotoxicitynatural
mabcytokine
2010february
nonofficebased
3×14
5×30
blasts2
sideroblasts
blasts1
nct01062490
pathogenscurrent
preoteasome
citomegalovirus
reviewreducedintensity
preallografting
nhlfollicular
hemocyaninconjugated
radioimmunconjugates
lymphomamyeloablative
marrowablative
nhlhighdose
resistancerituximab
siglecsa
glycotherapythe
differentiationdependent
glycotherapeutics
realisto
pneumoallergists
18233200
hospitalunlabelled
objektives
robertkochinstitute
n5349
digitalized
siynegative
rapamycinenhanced
recoveredtype
339689
trialling
macaquesplasmodium
pfama1
pkama1
hstrain
ama1related
nuri
jbe
bcg1hepb3dtap4polio3mmr1
pnemorc
transplantviral
2x105kg
manufacturetotal
ropporin
testisspecific
antibodyavidin
ch1281av
tfr1
ch1281
cellinitiating
prophylaxisonly
aerophobia
negri
canand
shouldbe
donealthough
krn7000pulsed
vα24vβ11
krn7000
allotbodies
teenagersunlabelled
icity
dcc
dcdendritic
cellcik
bel27402
bel7402
7224
groupp
apop
tosis
p58ipk
p58ipk58kdainhibitor
frameorf
nohq287801
petp58ipk
hisp58ipk
doubleimmunodiffusion
youve
womennational
nhfswe
70089
dmardresistant
dmardnaïve
9100000year
120200100000
ileocolonoscopy
blanksthe
blanks
ruti®
postprevnar7
preprevnar7
infectionintrathecal
abproducing
oncolysisassisted
odc
odcelicited
odcmediated
fineadjusted
gestationmetastasis
gestant
7546
nct00581347
cellsfunctionally
ifnproducing
granzymebdependent
il4induced
ducreyi
chancroidhaemophilus
tonbdependent
hgba
nhgba
antinhgba
menakin
pavlovian
humansdays
canvass
zoology
gingivalisobjective
anaerobe
subgingival
hbp35
transchromo
tcmabh13
redoxrelated
tcmabs
cystoser
wcgxcx
braintargeting
μg125
phf1total
cp13total
ligandsnatural
tumourtransformed
cd94nkg2c
illdesigned
nobenefit
quandaries
piddresults
multipathogenspecific
cd154viral
aptamerdendrimer
bioconjugateswe
dnaa9
dynamisms
mykissto
totalserum
tetramerized
routesbackground
4groups
estrogens
dysmenorrhea
del13q12q22
hemoglobinuriatype
anticoccidials
littersthe
ionophores
37×103
70×104
praecox
synflorix®
41513
36324
therapyapproaches
solutionsadoptive
aps1
aps2
aps3
10minute
unsalted
crackers
cleanse
tasting
phenolated
motherisk
teratology
motherisks
herdsin
compulsary
perspectivescurrently
mlvato
wzh
primersets
oxides
spios
endorem
relaxometry
postdc
therapylenalidomide
yearhealthy
iid10
dtpdtapdt
rates1
safetynewcastle
ndvvector
endotoxinfree
crtmediated
chaperokines
tilfragment
memorysleep
wakefulness
polysomnographically
slowwave
739–989
622–974
developmentoptimizing
bioinformaticians
electrotransferthe
reproliferate
antihbepositive
lowtiterpositive
neointima
neointimal
cd4cd44hi
autoantigenfty720
relapseassociated
nursesa
7808
3480
sporozoiteinduced
cycledna
practicesboth
polycentric
r087
recipientsdespite
diseasesigemediated
valdereuil
n1706
n1072
apo2l
apoptosissensitizing
velcade
camouflage
sabotage
immunesubversion
odnthe
tumorchallenged
ad5ova
35×
kbovaspecific
cocontributors
vacinations
trypomastigotes
triatomines
parasiteand
tcvac1vaccinated
tcvac1immunized
histopatholgic
ekg
anatomohistopathological
chronicallyinfectednonvaccinated
4616375
1232759
48804
48773
6751
us381
us19410
bolivias
inservices
countriesin
phosphatidylglycerol
phosphatidylinositol4phosphate
anatural
antilipid
dimyristol
dmpc
dimyristoyl
dmpg
antidmpg
rubellasprs
bantibody
mumpsantibodies
mmrvaccination
hbsantibodies
zimbabwegokwe
underyearling
fw
fw10
fw16
grouptagged
ongrowth
cancerhistorically
aut
standbk
flouroquinolones
prudence
recipientsa
immunoadsorptions
brcscs
biologicalimmunological
otorhinolaryngologic
weightings
galphimia
glauca
dilutionsdynamizations
oculorhinitis
barbariae
dilutiondynamization
lowpotency
transplantaionthe
malignanciesdendritic
rsev
sipuleucelts
statesearly
ah1n1related
advertisers
psychodemographics
eicosanoidsobjective
normocholesterolemic
12lipoxygenase
f2α
5hydroxyeicosatetraenoic
hepoxilin
12hydroxyeicosatetraenoic
counteracts
immunotherapytraditionalimmunotherapy
selfish
riskthis
abmtrr
116634
sloveniachallenge
policyslovenia
267100000
572100000
769100000
5564
334100000
cosines
p0149
284408
antifolates
metaanalysesbackground
antisymptomatic
systemvarious
guillainbarrésyndrome
autoimmunological
binterferon
bickerstaff
bbe
neurophysiological
growthmalignant
ak7
sahavorinostat
conglomerates
paarl
umlazi
rietvlei
nct00397150
philippinesmolecular
beneficialb
mogexpressing
hsfc
2011japanese
jeendemic
4302
3939
middleage
trialbcg
ntmb
licensingacceptance
childrenintralesional
cercariaerabbit
32764364
tegumental
cercariaemouse
tubercles
sucker
peeling
protruded
suckers
mean2se
haemolyticainduced
pneumoniamannheimia
aries
populationlimiting
leukotoxinneutralizing
modelpretargeted
abstreptavidin
213bidotabiotin
absa
thailandwe
panenza
reuil
cedex
fatigueuncomfortable
hun4
ch1r
facsimile
sedgwick
χ²20224
p0894
24363
910435
χ²41861
ah1n1this
ccdd
presentlyor
futureform
reconstitutionthe
peruoperational
piura
physicianinvestigators
or147
44495
or35
62639
chemoimmunotherapybackground
nonvulnerable
chemotherapeutric
id8vegf
recipientssolid
nonabsorbable
ultrashortterm
uscitmpl4
2111000
compliancemyasthenia
infectionsin
cancerfailure
immunityphacilitate
hyatt
24–26
chitosanglycated
araguaia
barra
garças
chemokinelike
crossdesensitize
cxcr4cklf1
cklf1
c19
c27
sdf1induced
cxcr4mediated
pi3kpkc
c27induced
cattleq
herda
vaccinatedour
genotypeobjective
infancythe
polysaccharideencapsulated
vaccineschallenges
bcghiva²²²
mvahiva
routeswe
bcghiva222
bcgwt
americahighdose
hdcascr
bm6
bone4
orbit5
cns4
postascr
donorsumbilical
myelomasingle
con1
vgprcr
premobilization
evaluationdue
rrig
post90yttrium
fluatgbu
3676
analysisduring
perpetuates
rabiespreventive
cleansing
europealthough
hks
cellline
mact
pam2csk4
diacylated
sparkle
reportradioimmunotherapy
radiationemitting
lowbulk
hematologistsoncologists
mpoancapositive
therapyantiglomerular
rpgn
mpoanca
antifibrin
perspectivesallergic
sitspecific
transferfactorthe
transferfactor
tfp
tumorlung
lewismice
pgbody
cytostaic
diseasesrheumatologists
b7h3background
b7h
b7dc
1970march
idn6556
pf3491390
influenzamass
childdays
003078
008326
visitshospitalizations
vaccinepreviously
pcmv4rzpc
zpc
263415
rzpc
pcmv4rzpcimmunized
spermoocyte
zpfree
preneutralized
spermegg
olderhealthy
n443
pcv7pcv9
pcv72
tpf
oro
larynxtpfchitbackground
tpfchit
imrtcarbon
gyfraction
ersescmid
surveywe
4511285
developmentscurrent
replacementimmunomodulatory
spermatogonial
shockrecipient
busulfantreated
egfpexpressing
shocktreated
immunityoral
blsgk1
gk1immunized
hkc
grubii
nodesour
hkccfa
anticryptococcal
cfaphosphatebuffered
cfapbs
australiaaccurate
georgiabackground
bapineuzumabrecent
2009bluetongue
btlacd160herpes
hvembtlacd160
irremediable
agedrelated
gerontology
iagger
patientsliver
aminotransaminase
gammaglutamyl
ggtap
4ynrm
throw
nhlobjective
ffludeoxyglucose
00295
umeå
swedens
16735
moroccoatypical
leishmaniasisendemic
clinicallaboratory
northcameroonthe
garoua
méningococcus
acw135
northcameroon
leukemialower
tbicyclophosphamideantithymocyte
flamsatreosulfancyclophosphamideatg
ponta
grossa
conceptprogram
fhu
ratessince
hovered
μgm224
cellsvibrio
carbohydraterich
23butanediol
23bd
intreleukin8
o395
nfκbresponsive
childrenbetter
issuesobjective
scoretested
compartmentalised
advantageously
vectorprogrammed
hcmvreactive
smartdcpp65
hcmvpp65
fame
pyrophosphates
remissionunlabelled
86107
hygienist
pigsan
efficacyfootandmouth
problematical
belgiumrotavirus
602626
787814
tumorsan
muc1spl
vxl100
si2
da3
muc1derived
sakaguchi
108m
cellcontaining
cd25celltransferred
gα12
antigα12
radiotherapyobjective
nonbulky
gainesville
bulkier
kmp11
leishmaniasisthe
1231aa
kinetoplastid
kmp111231aa
peptidecpg
odnspulsed
hops
19992008background
mean35
appraisalthe
lymphomacytotoxic
lmis
lmi
areataa
aspectsunder
legality
2010refusal
lesserknown
restructure
refusalthe
fallacious
slander
patientswu
smdsaml
hdrit
vaccinesspecific
immunotherapygranulocytemacrophage
macrocapsules
nonfrozen
immunotherapycd3cd56
perforindependant
receptormajor
βtcr
γ9δ2tcrtransduced
biphosphonates
f1atpase
nephritisalthough
interlukin18
abortusbrucellosis
dismuatse
escheriosomes
rsod
ril18
blockerinduction
earlyacting
routesallergenspecific
treegrass
adjuvantsvector
multiday
halfdays
envenomationbackground
antivenin
difference022
difference053
difference005
zvalue
envenomated
difference0007
intervalthe
catus
ainos
byozan
hirasawa
artsin
norimasa
muragaki
18131880
magistrate
hakodate
tokugawa
shougunate
dispatched
ryusai
kuwata
18111868
ezo
merchant
kashichi
sugiura
kuwatas
18221876
sketches
seizuresthe
diseasedementia
9e4
calpaincleaved
lfurunculosis
aeromonoas
fullsib
dentistsunlabelled
nsii
crossinfection
toolsfor
screensaver
¹³¹irituximab
017021
¹³¹
androgendependent
adpc
0936
143673
isbtcsitcfdanci
biomarkersobjective
isbtcsitc
cancersociety
assessmentqc
malignanciesimproving
cd62lcd28
vaccineswhole
uvbirradiation
beyondsperm
17specific
vasectomized
pitfallsthis
immunotherapiesdespite
microenvironmentalthough
chronicitydespite
muskaan
ek
abhiyan
fillip
bst2
immunityplasmacytoid
bst2cd317
bst2mediated
agfused
antibst2
monthsone
n469
tocopherol
aturkeyturkey12005
safetyreactogenicity
nct00771615
enoughmumps
allotransplantationoverall
handforearmarm
incompliance
esthetic
yamazhan
71100
melanomaimmunotherapeutics
anaphylaxissystemic
sorterpurified
stat3driven
5aza2deoxycytidinethe
pra100108
hlaa0201negative
immunogenocity
tbithe
ussrs
sssrs
05mlmin
01mlmin
or649
ci14030
or657
ci12634
402405
398398
400406
398400
7482
8331
9815
8910
10812
3768
5566
4918
phel
criteriafor
immunizationthere
clinicaloffice
epitopegrafted
antigenized
20057
145972
116893
108821
297903
polio1
105810
223911
therapymuirtorre
intermediateendemicity
nonagglutinating
challengeleptospira
llpsspecific
l8h4
l9b11
22kda
llps
l4c1
8kda
19931996
033076
regiontickborne
ricinus
persulcatus
13patients
1of
pap2024
phosphataase
yearsfrom
diseasegrowing
corticosteroidrefractory
extremenly
hvjehsp65dnail12dna
hsp65dnail12
hvjenvelopehsp65
dnail12
augmentated
dnademethylating
repressionactivation
geneinduction
polycombgroup
heterochromatin
euchromatin
kmt
demethylases
kdm
kmt6
kdm1
kdm5b
deoxyazacytidine
dacmediated
dacdznep
41bbhuman
mov19
mov19ζ
mov19bbζ
lunginvolved
tatfusion
eaeantigenimmunoglobulin
tatmog3555
glycoproteinig
tatb923b
tatovalbumin
exerciseobjective
disfigurements
agiii
enterotoxinsintragastric
salivabinding
sbr
ltiia
ltiib
sbrltiiaa2b
sbrltiiba2b
sbrcta2b
proceduresthis
lairage
calmetteguérinprevious
rgptnfαenhanced
pluritis
rgptnfα
µganimal
asthmat
dcctla4ig
dcgreen
esosinophils
ovasensitizedchallenged
dcctl4ig
plk1
modelspololike
plk1rna
mplk1rnadc
plk1specific
plk1expressing
plk1rnaelectroporated
overtake
adefovir
allomudpbsct
rituximab®
nonhodkins
leuceran
nondestructive
nanoemulsionbased
adjuvantnb1008
surfactantstabilized
w805ec
w805ecadjuvanted
worldyet
0992
tukeykramer
phasingout
87228
smallpoxunvaccinated
076110
102110
virusoral
orf7specific
201011the
239712
allotransplantationrecent
cd8cd45rclow
depletionimmunotherapy
dnamafp704
cancerheme
oxygenases
hos
biliverdin
chemovaccination
prophylaxispreexposure
noprep
chemovaccinationinduced
sfu106
chemovaccinated
viruschallenged
prepinduced
applicationsnatural
incidencebackground
035054
026046
032046
022036
leukemiadonor
agrestricted
receptorabl
nct00460629
interventionscholera
educationinduced
1918like
19571968like
2009like
flustrain
oregonobjective
tilling
selftumorspecific
rlv
18031810
salvany
unquestionably
pineault
daveluy
trialsclinical
cochrans
207305
162480
188244
skinpatients
ovaactivated
oncologistsunlabelled
emailbased
13221
3418
3413
31275
infusionsecond
graphsa
reedfrost
wuv
wvu
iid
vertices
ultrashortspecific
3002000
unitsinjection
modelmesenchymal
hucmscmediated
hucmsctreated
dba2h2kd
placei
hcontortusa
wormfree
hapabased
homebound
cityseasonal
hbpc
msvd
immunoisolated
polyomavirusobjective
nonpml
imodified
bioadhesion
ueai
bsaencapsulating
ueaimodified
ueailip
ueaiconjugated
αlfucose
immunotoxicities
2010t
rac
chartreview
skg
preassociation
recombinantsynthetic
hypersensitivityfood
diseasefuture
trialsvarious
welldays
provocationtests
indicationssublingual
safetysubcutaneous
benefitsafety
premedicationsubcutaneous
effectivenessimmunotherapy
learnedmetaanalysis
yearsallergenspecific
honor
constanta
cosvn
3342max
ys1646shstat3
graftsthe
haplomarrow
nct00864227
nct00849147
n258
nonsti
midapril
reportfrom
cmldc
0821
tumorsovarian
polyriboinosinicpolyribocytidylic
mosec
under5y
smallpoxvaccination
virusadverse
fullyreplicative
µmt
visfatin
pbef
colonyenhancing
rs0417
rs0486
rs0438
rs0452
kaoshiung
wartime
19921995a
middecember
9451900
49·73
5631900
29·63
178389
19921995
ventilators
chnri
answerability
deliverability
anonymity
endusers
unrelateddonorsthe
mpb
59707
hladisparity
spainwith
rvve
oct2008jun2009
regalipwwwregaliporg
rrve
837956
856986
hlaa2matched
nodscidγcnullhlaa2
nodscidγcnullhlaa0201
nodscidγcnulla2
cd8totreg
studiesunlabelled
048091
1661091
027078
vγ2vδ2bearing
pyrophosphomonoester
teceleukin
leukaemiaimmunotherapy
diabetesthere
nonacetylated
leukemiail2
nanoparticleinterleukin2
obstruct
nanopolymer
h1pil2
radvil2
optnunos
twoside
statacorp
77845
100143
49139
childrensubcutaneous
anticd3cd28cd137
beadsadoptive
144fold
beadactivated
tumourstimulated
beadinduced
chemoimmunosensitizing
chemosensitization
payrolls
wavering
virusjapanese
populationsevaluation
carcinomainduced
il12immunotherapybased
gic
hepatotoxicological
prei
58postimmunization
0prei
58posti
immunotherapyimmunostimulatory
immunoagonist
anticd40cpgliposomes
tumorproximal
nct00757887
rtpcrbased
dioraphte
dtwpipvhib
crèche
rabieswhile
erag3m
signalingin
cd7targeted
scfvcd7sfasl
fassignaling
hepatectomyobjective
dppivluminescence
dppivpositive
straininfectious
disesase
griess
gifn
nonigereactive
hemocyanincoupled
nole
nonigebinding
ofoleaceae
dsabased
5011000
10013000
d1d5
nodsz
hb4c5
121°c
productionstimulating
anionexchange
kdaprotein
tropomyosin4
immunosuppressionimmunosuppressive
attributesbackground
websurvey
tradedoff
laivlike
embolia
medicamentosa
20022007background
rehospitalisation
49608
10686
2341
3206620
1980th
nonmyelablative
ricallogeneic
asctricallo
nigeriahepatitis
eiuml
qualityhepatitis
52186
acpe
ippes
appes
uams
ippe
appe
securityduring
legitimise
peptidesspecific
lettyae
bobwhites
inoculationsinoculation
bobwhite
quail
colinus
12wkold
productionbird
producedoocyst
canadacentre
podium
pneumoccous
varizella
rubellamumpsmeasles
cmvigm
receptorengrafted
ctct
absorptionirrespective
thunder
lightning
collidefor
hlaig
ctlctl
hlaa2ig
anticd28mab
buffalos
molecularscale
xenoautoantibodies
nacetylneuraminic
neu5ac
neu5gcdeficient
neu5gcexpressing
sialoglycan
neu5gcglycans
neu5acglycans
neu5gcα26galnacα1oserthr
gcstn
antigcstnreactivity
gcstnexpressing
xenoautoantigens
prognostics
austriaat
urotechnology
esut
heilbronn
organsobjective
1frac12
vaccineinformation
4556
7004
biostatistics
loving
ibrs
counterbioterrorism
noninternetbased
nibrs
9008
subjectmatter
immunizationsafety
vaccinationfollowing
regimensthis
rhinitiswe
costspecifically
studiestcell
naivememorystem
tntscm
cd62lhicd44low
cd62lhicd44hi
msgv1
complexclass
melanocytedifferentiation
msgv1pmel1
msgv1trp1
pt4n2m0
esophagectomy
mesenterium
radiotherapy50
gywas
orbita
thair
celldcbased
vaccineprovenge®
aninconvenient
responsethat
patientsbk
clots
bkviruria
myeoblative
45507
©2011
indo052005h5n1pr8ibcdcrg2
gooseqinhai
lake1a05
sj163222
anhui012005h5n1pr8ibcdcrg5
1primed
atriskpatients
insurancein
facilitiesample
level6
n571
080164
titer40
086180
mannanmodified
vecadherinantiangiogenesis
endothelialspecific
vecad
advecm
antivecad
vecadspecific
oldobjective
46year
petra
180260
176280
89161
4499
hyopneumoniaethe
mhyo
mhyonaïve
pcv2infected
vacpcv2i
mhyopcv2coinfected
vacmhyopcv2coi
mucopurulent
mhyopcv2coi
pcv2i
n696
thailandimportant
23700
2113636
dpthepatitis
92178
106181
dpt3hepatitis
lowliterate
ariaga2
statementspecific
vialsmultidose
mdvs
doha
indemnity
regimenssevere
falciparumspecific
gabonese
rtssas02dunlabelled
nct00307021
aldehydemodified
atherosclerosisobjective
apoedeficient
mdafibronectin
2008a
anglia
cumbria
holdinglevel
n1623
n633
n664
nalf
barrierswe
immunodeficienciesimmunoglobulin
igtreated
612month
pseudotuberculosisthe
vaccinatedinoculated
rher2
rher2transduced
rm1mher2
rher2dc
miceepicutaneous
sfvg
vsvsfvg
solvebut
longthe
anergydeletion
familypositive
cellsexposure
cellssignaling
assimilate
il2rdependent
phosphatidyinositol
tolerancestrategies
upswings
hostdonor
malignancyhuman
immunodeficientbeige
ntregmediated
hlaabcdrdq
hlareactivity
hlareactive
72fold
166fold
naïvedepleted
immunosuppressionbecause
tasocitimib
trlbased
taipeibackground
0864
0701the
cram
afflictions
immunizationnanoparticles
sizestable
shenghua
methotrexateinduced
metomaternal
interferongammaifngamma
cd3cdifngamma
cd3cd4ifngamma
3561
2423
7138
ifngammath1
modena
2007april
withinindividual
ccrs
nonvt
076149
resultsconventional
immunotransplantation
worldin
3320
immunosuppressionherpes
rapamycine
ucds
hyperammonemic
haes
ucd
080213
074147
metabolismbackground
permanentes
emergencydepartment
sickest
diseaseschildren
transplantationthese
hadintended
reassuranceeducation
profilingparatuberculosis
tofms
vaccinatedexposed
7590
multithreshold
cmps
diamyd®
discontinuationbackground
nonscit
pind
nodesregional
therapiesalthough
lookalikeallogeneic
sctrelated
lthreitol14bismethanesulfonate
dihydroxybusulfan
noncommitted
3670
p0981
p0526
adolescenceinfertility
childhoodadolescence
4181
unexamined
vaccinedispensing
coop
protectionross
ifnαβr
organizationcomparative
postantigen
differentiative
sirsvs
definiteness
192631
nonwbrt
publicfollowing
twowave
cpgc
etodolac
madb106
marginatingpulmonary
b16f109
cpgcvehicle
pevehicle
rejectionantibodymediated
multiregimen
experienceglobally
588813
114sd
cellsmm³
6221026
2009conflicting
regionturkey
hesitationamong
vaccinatedindecisive
jamaicaobjective
vaccinationintradermal
projectile
fludarabin
tetraploidy
xxxxa
gbanding
xxxx
2424
ricbt
neartetraploidy
tetraploid
interferonvaccineinduced
polyi
·
receptorstimulated
trochanteric
xenopi
rajendra
prasad
proteinenergy
2191
bilaterality
20022006we
043068
056093
014056
netherlandsto
gliomamediated
proteinmimicking
postpones
virusperiodic
responseinducing
espania
gae50cm3
antiwhole
applicationsa
regiospecific
aziridinium
patientsprospective
rhinologists
perspectiveunlabelled
objectivesproblem
polypoid
ccbs
nifedipine
amlodipine
verapamil
diseaseinfected
elisathe
otw99
tissueengineered
lwd
modelschemoimmunotherapy
antibodysn38
antitrop2sn38
raits
toussaint
galtier
villageobjective
nurpur
shahan
developmenttraditional
imf24
gp100209217
imf32
imf11
itdqvpfsv
tyrosinase369377
ymdgtmsqv
ccr7locd45ralo
tetramercd8
nonnationals
60kda
mapro60
tailbase
antimapro60
legume
copper64
twoantibody
dotacbr96
dotact8466
0890
g1arrest
surveysto
telephonesurveys
13010
7488
114144
72108
isa70
aivinfected
vaccinesbut
proportionality
targetssuch
illnessrequire
hmrs
noncd8depleted
neuroaids
tban
rosario
immunotherapeuticspancreatic
cancertherapies
nonretroviral
racesex
providermanagement
barriersinfluenza
m39m
erms
m39mpulsed
magec1
ct7
ct7specific
eczemaaeroallergens
proteinheterologous
paragonimiasis
triclabendazole
praziquantelparagonimiasis
trematodes
paragonimus
westermani
1321105
105cells
biologicsinduced
6280
064105
072110
rr053
031090
choiceconditioning
championing
medstar
diem
polysaccharidepolyic
nanoparticlesimmunostimulatory
nanocomplexed
psovalbuminpic
psova
picova
n477
casi
adultsunited
nisadult
cellstreating
peritumoural
renoprotective
regimensboth
infectionepsteinbarr
holdthis
populationdespite
2789
3643
4291
4646
8920
9152
9947
9887
9885
8301
8641
8416
9862
9784
285321
625423
358140
302132
27308
64852
38787
24536
63230
234114
56397
39408
andersennewmanwhich
25183
85year
helpers
whitesige
mht
viralassociated
20082009major
minneapolisst
multiperson
diabeticantigen
pigsexperimental
insulintreated
exsanguination
triplering
sgd275
sgd12866
12488
10392
5642
3421
treatmentdiagnosis
aerata
oval
exclamation
watchandwait
steroidmaintenance
cyclosporinedexamethasone
immunopharmacologic
etiologyguillainbarré
selfcomponent
unlucky
biosprayed
modelsbioelectrospraying
bes
aerodynamically
biojetting
aabj
inertness
biosprays
biotechniques
cellinteractions
utc
complexdefined
bustsipuleucelt
bemoan
awry
egalitarian
kilometers
networkobjective
halfday
homesobjective
objective1
objective2
nhc
firstdifferenced
endothelialized
modelsmodular
moduledriven
omental
lumens
extendedcriteria
calcineurinbased
belatacepts
adverseeffect
immunizationvarious
instantaneously
bvallergic
postings
emotionality
suppressionthis
p45145
reticulumderived
allergenimmunized
nasn
immunizationsit
epilepsybackground
squeal
communicationcommunicating
pediatriciansin
coughbackground
garrisons
tehra
triton
x100
tx100
gluconeogenesis
cyclophosphamidecertain
methodically
cd25cd4foxp3
969519
080090
069079
ivanhoe
epidemictoepidemic
brest
210000
4684
156266
nct00740935
slitallergic
abstarcts
macroglubulinemia
immunosuppressionfk506
mdsalthough
3731
dnapcr
85438
921277
sctbu
gluthatione
hgsta1
313ag
15mgm2
18gm2
bucy2conditioning
simponi®
ilaris®
obinutuzumabga101
farletuzumabmorab003
itolizumabt1
glycartroche
morphotek
biocon
fastexpanding
tufts
wilex
kenta
protagen
wyethpfizer
ablynx
adalta
domantisglaxosmithkline
pieris
scil
genovis
druggability
chugai
icosagen
triskel
imclonelilly
vaccinex
tgfbrii
sema4d
medimmuneastra
zeneca
regimenposthoc
rv5placebo
6399
revaxis
phaseiiib
turkeypneumococcal
ytl
effectsurges
singletimepoint
praziquantelcontaining
eaten
mabsdaclizumab
basiliximabon
1543
30±137
27±20
nephropathies
11949
137289
1½8
hrr110
077159
hrr139
116166
hrr160
115224
hrr151
116197
075107
hrr085
072100
hrr108
096122
importationswe
controlsubjects
amor
12136
wildlifedespite
ungulates
waterholes
baitdeployment
transplantationpractice
insurancerelated
8069
raceadjusted
imbuing
chemokinedirected
uncontroversial
hospitalspecific
supralingual
supralingually
6789
reportsin
x179a
influenzaresponsive
scrubjays
aphelocoma
insularisthe
avifauna
conservationists
scrubjay
insularis
corvid
congeneric
jays
nileinnovator®
pcbwn
recombitek®
wnvrelated
nileinnovator
recombitek
nonwnv
corvids
cruz
literaturehighrisk
subunitbased
rubbish
collectionbackground
assessmenthaving
fixtures
analize
strategiesvaccine
dyphteria
practicesbiohazard
vaccinesmore
leukoencephalopathyconflicting
2004may
2007may
agedriven
bexaartositumomab
bexaar
epitopesmany
hairycell
deimmunize
ha22lr8m
workersinfluenza
2739
illnessili
mhcpeptides
lowbinding
dimerized
iipeptides
cyclins
antigenscontinuous
vaccineshyporesponsiveness
interferonalphaa
38474
necroticlike
fingertips
ifnαrelated
1966january
1977january
1961january
datasheet
069134
074137
077123
064161
061125
072153
054084
089172
contraindicationssmallpox
postvaccinial
cd105the
genentechroche
lmllocd105a
lmllocd105b
4t1luc
nt2
27th30th
catharines
hosttumour
vitamine
bacteriaimmunizationobjective
vitaminea
actinomycetetemcomitansaa
adepleted
antibodyigg
cintilography
immunizedrd
immunizedvad
no20092139
nof10149932
dependenceobjective
abstinent
34aspecific
ns34aspecific
ns34atransgenic
il12primed
transfermediated
tumorsstrategies
envbased
criteriabackground
utilizationparticularly
10911
076061090
035030043
significantlyz
13950
corticosteroidin
cd151
immunotherapycd151
lamininbinding
α3β1
anticd151
interleukin25
gutalthough
tissuedamaging
il9mast
medi528
postrapid
3500fold
florfenicol
miceflorfenicol
fmdvimmunized
6the
areaand
environmentthrough
immunophysiotherapy
infectionwe
15002000
date2013
revaccinationsbackground
notake
elisauml
6775
2827
collinearity
childrenmodification
namedpatient
autoimmunitytregs
sitges
wilde
tagikistan
deathtocase
periodpreventive
propertiesunlabelled
apoai
srbi
robotized
productionwe
somaticcell
plating
cnsresident
inflammationrepeated
2°
1°
mesotheliomanovel
activityfusion
atvndv
bsfgmcsf
tshnil2gmcsf
hemagglutininneuraminidase
il2activities
bshncd3
rpb27
termally
petdest
drugrpb27
infectedonly
antirpb27
rpb27based
cra
34103
gvhdas
004073
015100
busulphanbased
heartbeat
nondeveloping
cliniccancer
5315
answersthe
pseudopiano
serumcsf
nonjerky
corticostriatal
aa92
aa97
europeae
gata3carrying
th1originated
th2originated
p0649
celloriginated
signifant
p0296
micetransgenic
ediblebase
canola
igcd45r
nonplasma
immunizationsto
ctbfitc
fitcspecific
antifitc
miceeven
virushbv
hbsfclv
antihbsab
n297
catapult
possums
studyprotection
yards
femaleandmale
vaccinationconferred
patientsglypican3
glypican3specific
cd4directed
pregnancywe
asianother
diseasesdendritic
vd3modulated
vd3dcs
vd3dc
percutaneousparenteral
148672
491723
94472
pigscontaminated
lpsbased
112910a
δrfba
δrfal
δrfaj
δrfai
δrfag
δrfaf
nctc12023
rfaj
clusteredlqas
capitol
reportmerkel
opportunists
dreambackground
cot
crossmatchpresensitization
standobjective
deliverydisease
peanutsday
30week
proteinday
ige273
6459
nct01259804
genetransferred
indept
managementpolicy
amomg
tnfblockers
kiggsbackground
jugendgesundheitssurvey
nonimmigrant
4144
50283
136164
129558
228260
101366
284315
infectioncurrent
iviat
0187
virj
afua
mlta
terra
incognita
strategiesdespite
eclipse
pointofnoreturn
cd4ccr5
infectedtransformed
killerlike
marrowkidney
toxicites
syndromealthough
60549
cd56negative
infectionnatural
dance
promoterskiller
p53s
cd40activating
cd40stimulating
amyloidbearing
tetoff
virosomeformulated
yearsboosting
presbackground
vaccinationring
imitate
caseseven
nonimitative
magnifying
unpredictably
wcp
122249
3118
anticd23
receptorchronic
cd19cd5cd20dim
cd23car
1445fold
tnfβ
mec1
gosling
geesenew
ngvev
goslings
ngvevrecombinant
ngve
farmacovigilanza
924057
8737
groupsinfluenza
48617
resultsa
7vpncv
gmla
studywas
experienceclinical
semiallogenic
allergenssubcutaneous
rop2
rrop2sag1
pcrop2sag1
antitla
acrped
plaquetype
cpgodnepidemiological
cfp
ovachallenged
cpgcfp
cfpspecific
indigenously
dtwphbvhib
competitor
tritanrixhbhiberix
smithkline
dtwphbv
prphib
deans
mdgranting
dogranting
w16
pvls
rad5hiv
nct00080106
7179
8691
8187
regimensbalance
symphony
tacrmmf
immunoglobulinsecreting
aazathioprine
tacraza
tacr
cowan
cryoimmunology
tumorsseveral
cryotreatment
sloveniabackground
educationtraining
plateletsobjective
antirat
alabamaobjective
vitromesothelin
mslnspecific
dcaxcamsln
cfpac1
mslnepitope
mslnderived
pakistanmeasles
doseprotection
transplantationparainfluenza
cd8memory
4732±428
2318±277
3410±271
1219±352
946±148
immunosuppressionpancreatic
graftversustumorleukemia
nonvaccinebased
immunotherapytelomeres
quasiprimary
nanoparticulatemediated
antibodynanoparticle
radioimmunotherapytargeting
mellitusglutamic
diamyd
adjuvantformulated
mutationspolymorphisms
urist
modelstumorassociated
sitelocated
isps
αcd3
cytochemokines
mda7
adenovirusadmediated
adisp
adzero
adαctla4
adαctla4mediated
evi1
expressionecotropic
evi1high
cd52positive
kbpa101
igmbased
netherlandsrecently
25th75th
centile
ursolic
micenuclear
superrepressor
iκbαδntg
tcrtriggered
84·6
donorreactivity
outcomerecurrent
rrtis
bactek®
ssige
tenmonth
antialphabeta
antic41
euthanization
nkg2dligand
tall104
smicb
prescreen
spd1
virus16
typeindependent
transplantationopportunistic
cmvebvspecific
hadvfluspecific
proteinspanning
cd137based
etiopathogenic
dtapipvhepb
hibhepb
pretesting
therapycoxsackievirus
plusstrand
woodchucksthe
epbased
whsagpdna
whsagstimulated
pdnawhsag
fibrosisnonimmediate
tazocin
candidateswe
guaba
sen
seroresponders
ipab
19992009the
emissive
taret
epubmed
90ytherapies
80±15
235±14
40±25
42±20
cellsimplications
transferthe
doseresponses
bremsstrahlung
mkc1106mt
pmeltyr
emel
etyr
diabetessevere
immunodeficiencyγcnull
cotransferring
2edged
graphversushost
pharmacokinetictargeted
2980
3969
4581
federationvaccine
tumorscervical
tete71cd81
interferongammasecreting
diseasesingle
kilogramme
neutrophile
aden
tcrcd28stimulation
nontcr
nontcrtransgenic
nonlymphodepleted
outcomeacute
fanconis
acnescontaining
foalproduction
immunomostimulant
eqstim®
insurancebackground
sniiram
patientsincluding
drugsby
2900000
βdefensin2
vaccinesour
unfused
mbd2fusion
mmrv4w
mmrv12m
oct4negative
micemultipotent
mmapc
mmsc
oct4expressing
mclone3
tcelldendritic
stomachache
selfresolve
10912fold
119in
polyetiologic
angiological
photoplethysmography
tcpco2
3017
18110
2237
photopletysmographic
antiig
544935
514932
537686
implantationcochlear
sialastic
positioner
innerear
yt
mm1s
immunotherapyrecombinant
vsvsivmvasiv
macaquesdespite
vsvsiv
mvasiv
primesystemic
cd25foxp3cd4
aalthough
bagg
mplaplga
01900
foxp3intermediate
2010understanding
blackafricanamerican
cancersheparanase
heparanasetargeted
vaccinationrotavirus
r2049
adssd
rtssd
adssd1
rtssd1
adsss
longwave
wavebands
misds
narrowbands
1misd
abuts
sunscreens
trialsamyloidβ
delimitation
antiaβapp
karachiobjective
thirtycluster
melanomalentivectors
nondividing
pseudotyping
cysteinylleukotriene
allergydominant
steadier
influenzaacute
ophthalmoplegia
longitudinallyextensive
horseseuropean
annualsemiannual
toofrequent
bioincompatible
therapycontrolled
hemodynamically
polistesvespula
homologies
mt201
adecatumumab
mt201mediated
interestbackground
typeiv
ca9
abompa
ctla4cd8
napncd13
surgeryassociated
deemphasize
23vp
23vppcv7pcv7
pcv723vppcv7
pcv7pcv723vp
rationalebased
modelbcg
antibcg
vaccinationpresent
crf12bf
cladespecificity
envbf
cladespecific
polifunctionality
cellsembryonic
escipscs
immunotherapydifferent
cd3cd8cd45ro
cd3cd8cd45ra
cd3cd30
mad1
ifnγth1
il4th2
differentiationrelated
pulmonitis
regimenassociated
podsin
yorkers
toxicityintensity
08mgkgdose
iv×8
moreintense
pvalue054
pvalue030
cumulativeincidence
pvalue021
pvalue039
intrafamilial
phyogenetic
g145a
preplasma
asthmapatients
131ianticd20
rescuea
dexabeam
131icoupled
nanosilicon
nanotoxicity
ultrafine
nanosio
cldyn
nanosiointroduced
measuresbovine
metaphylaxis
againmore
coppez
danis
biodistributionin
recount
bloodretina
latium
italydefinition
donabedian
structureprocessoutcome
mqs
misure
qualità
sanitàquality
researchquavatar
karyotyperesults
ckaml
0222±0098
0235±0104
0367±0120
0481±0123
lymphomasamong
duarte
immunotherapiesplantbased
bcellepitopecontaining
bcgtuberculosis
wealthy
protector
preventionintestinal
dysentery
omp38
b100loaded
hub100tg
apob100reactive
apob100pulsed
inhibitoryregulatory
cruzirecently
15week
plasmodiumspecific
immunizationsterile
immunotherapybee
msplga
triphasic
34kdacooh
211atradioimmunotherapythe
midcell
subsources
underdose
vertex
cube
biotherapyimmunotherapy
advantagefor
desensitisationthere
lyophilisates
nct00700167
lcbased
tyrosinasehlaa0201
puppiesthe
syrup
plerasan
pleuran
evaluat
csamethotrexate
210±108
137±108
660±124
vulgarispropionibacterium
christieatkinsmunchpeterson
agroinfiltration
radishes
macrophageinflammatory
commensalism
uptakeschool
uncooperative
semiqualitative
lecithin
ecps
63days
applicationin
microsporidian
glucans
loma
salmonae
sporebased
microsporidial
antimicrosporidian
responsestraditionally
patternsin
farmtofarm
kilometres
contentment
infraction
hsppeptides
hspps
mhspps
hsp110
facscan
antimüllerian
spermogram
bseven
girlsfsh
equalling
primateslymphocyteactivation
a9h12
cmvactivated
adultscovaxis®
lpds
dna105
copies105
921542
risk49
11210
305668
cancerinvariant
ligandpulsed
pejorative
guerrero
akdeniz
4282082
7373308
vaccinationseach
17641participants
108239
108204
228475
15958
33221
aguangdong
liwanswl15382009h1n1
χ278
χ223
χ238
χ2032
χ239
t092
t45
t51
χ211
χ259
t60
t36
vectorsattenuated
hostrange
interferonbinding
influenzapufa
sunflower
linseed
αlinolenic
tallow
sfa
ovasensitization
asr
helper2
sfarich
allergencytotoxic
combinationallergenspecific
ctla4encoding
allergenctla4
ovactla4pcdna
cos7
ovactla4
allergenctla4encoding
gvhdpatients
germanaustrianswissconsensus
embryopathy
clinicthis
hm3f8
tuningin
pchc
hermeneutic
mutuality
nonvaccinetypes
2346
shi1
ndvinfected
sparsate
convulsive
shonika
ikai
feverassociated
il17ifnγ
17th1
fiocruzmanguinhosthe
fundação
oswaldo
manguinhos
12904
cstdirehfiocruz
unities
actingaccording
famerp
biopsychosociocultural
werent
july2006
notificated
blush
enduration
capacitating
perfection
strategyit
cachoeirinha
062173
techniciansassistants
19601990this
19601976
affirmation
hegemonythis
discursive
hegemony
contemporaries
porfiriato
postrevolution
18801940the
porfirio
díaz
18771911
19101920
19201940
acquisitions
18701910this
hygienists
1960through
heroic
postcolonial
19661973
revolt
vaccinationpertussis
shortageobjective
equestionnaire
curve0843
medicinean
motheringthe
outcomethe
01898
transplantpediatric
ecrcl
4394
1376
159742
logiuml
logsiuml
lcit
0591
0885
rhinasthma
gav
usein
ethnics
glycyphagid
pyroglyphid
molecularlydefined
usud
spacings
gesid
cancervγ9vδ2
womenlittle
1824yearold
malignanciessince
nonebv
evb
strategiesrenal
noncontingently
cy60
μgkgd
phsp
workshopmode
australiausing
2203
hot…therapeutic
sepsisbackground
rflaa
opsonin
rflagellin
postburn
spainwe
21948
364438
245337
518662
435ci
343527
146261
h1n1background
thereupon
cellsexpand
preeclampsiail10
hypoxicinjury
preeclampsialike
aquasomes
cellularinduced
mg1
aquasometreated
abomasum
antigenswe
alns
farinaesensitive
1d
medicationsymptom
nontreatmentascribed
treatmentascribed
neutrophilsbackground
polymophonuclear
disinfecting
welljustified
linesin
b13
b130
b201
ct8
2398
immunmodulators
immunmodulator
sitrelated
weekslocality
87122
99232
601155
immunosuppressionhiv
cd415
3443676
4944041
p074
3981244
7942198
10302393
32406470
14118
seasonunlabelled
backgraund
influenzaewe
adhesinderived
pilustargeted
chinchillas
adhesindirected
cmcv
754942
gapcurrent
vaccinationadolescent
diseasesamong
experiencechildren
12175
myocytes
casp12
019070
ctep
monomethoxypolyethylene
glycolpeptide
conjugatesrecently
547565
785803
c15
10511069
c31
12751296
mpegpeptide
untolerized
mpegn8
mpegpeptides
postit
igg4igg1
immunosuppressionunlike
postuv
everolimustreated
pyrimidine64pyrimidone
photoproduct
atreatment
signallingdependent
pzn
p00152
polyclonalmonoclonal
individualswhile
tlr3mucosal
storied
immunotherapyfolate
αdirected
immunitychlamydia
landscapethe
decadeundoubtedly
rchop21
tnhls
cd11bgr1intf480
cd11bgr1intf480abbreviated
mycloidderived
0303graftversushost
cell‒depleted
wninob
caligus
rogercresseyi
licesea
copepoda
caligidae
chiles
caligid
copepods
my32
my32dsrna
austriaaustria
hospitalizationrates
coxevac®q
dnalactia
asithundred
leonhard
13263
freemans
preventionrespiratory
immunoprophylaxisrespiratory
rsvenriched
cancerslung
csathe
c8
d15d25
d40d80
auc04h
auc08h
r2015
r2021
r2088
r2076
r2083
thalassemiawe
csashortmtx
14147
14127
casesmetastatic
α2b
1012007
3312008
1012008
3312009
nonindependence
ontakmediated
hcil15activated
dx5
nktreated
hcil15expanded
rb51sod
levelsunits
antisbc
hypergamamglobulinemia
rungekutta
challengeshuman
gp41subunit
selfadjuvant
simianhiv
p27gagsiv
placebovaccinated
transcytosisblocking
cellularcytotoxicity
hiv1aids
imagingbackground
prelocalize
2d125
reformatted
nearmaximal
dotayttrium
82±19
111indota
dotachelatebinding
linebackground
dusseldorf
turku
plxsn16e6e7
tumorigenecity
welltodo
literaturein
70128228
vaccinatumbackground
antih3
antib5
foreshortening
autoimmunitymyeloid
cancerwhere
corollary
globulinfactors
1a3b7
mucambo
hu1a3b7
trd
rs3077
rs9277535
rs6789153
physicianbased
testingbackground
amoxicillinassociated
aminopenicillins
3t3l1
calorie
19week
diarrheamucosal
kamenz
basisways
21783
immunotherapycellbased
n944
221944
or700
4181173
or228
110473
150723
responsesit
vsvδm51
vsvδm51infected
il15mediated
dosedependence
factortu
sufb
fes
synthaseβ
sialitis
insulitisdiabetes
teffdominance
cpv2b
cpv2cmutations
cpv2c
nl35d
n274
intakeweight
160173
intakekg
pfemp1
rosetteinhibiting
phagocytosisinducing
rosetting
rosettemediating
itvar9r29var1
r29
phagocytosisinduction
002156
duffybindinglike
156625
ntsdbl1α
modelgamma
gdtc
vgamma9vdelta2
em2egfpluc
nodcgprkdcscid
il2rgtm1wjlszj
diseasesseveral
formulationit
tumors12
responses3
bryostatin1ionomycin
respectively4
biactivated
antihepatocellular
autoserum
repliconcontaining
cancercostimulatory
translationwe
high41bbls
highproducing
sulfoximine
vitrosodium
preinvestigational
drb5
dqa1
drb1030104010402040711011501progression
sensitivity100
specificity58
zoledronateexpanded
studyhuman
157×10
youngtil
engineeringtherapeutics
sym004
mm111
pro140
cvx241
asg5me
u31287
amg888
r1507
biobetter
cd70positive
malignanciestcell
cd70specific
travelersa
2286
pitfallsherpesviruses
nearidentical
19922008prevention
0110000
pigsclassical
fattened
epidemicsin
indexcase
antivibrio
igyencapsulated
feedsmall
supertexta
abalones
20052008in
miceliveattenuated
followedthe
138823
hovering
schoolshpv
rate66
n496
428604
296402
352410
trialimmunotherapy
poststi
wellmonitored
neuropathybackground
immunoglobuin
nextdendritic
–update
efficactive
rr15
rr22
mpges1
partythis
30gm2
3642gm2
mudhsct
otorrheabackground
decrease25
penicillinresistant
prophylaxisto
verorab
109901cancer
cllpll
applicationsin
glycancontaining
proteinglycan
structurallydivergent
functionallyrelated
differentobjective
n12164
noncam
nonchiropractic
or09395
ci076113
or090
ci064120
postweaned
glässers
surveyrandomdigitdial
wireless
nonsampling
cent95
5367
200655no
199140no
rr12
ratesassessment
19964521920
yearslinkage
1996452178
199645no
rr13
199948no
rr5
misperceived
reordering
httpwwwcdcgovvaccines
essentialobjective
antiendotoxins
extracta
allergentriggered
transplantationsyngeneic
addressin
scirus
medscape
englandthis
swabbingweek
nanoscopic
a5132
setpoints
nurseteachers
goethe
n95324
measlesvaccination
immunotherapeuticsrnas
immunobioavailability
graftfacilitating
mcrm
treatmentpreclinical
anticd3based
aaichi268
mnimmunized
shavaccinated
293000
328000
2141
66294
2009january
11174
tdapeligible
cattletick
infesting
subolesinknockdown
acarine
ixiaro®
ic51background
ic51
surveyadult
396538
639761
525702
immunotherapyproducts
minilaparotomy
81±63
28±53
nisto
ftest
ztest
nonimmunizedto
36200
63200
vrt
nontypablenoncapsule
environmentinterleukin12
nfathil12pa2
nfatresponsive
nfatmurineil12
nfatmil12pa2
stenotrophomonas
maltophilia
spainhepatitis
19911998
19695ci
67325
60275
213559
statementrecommended
immunoimaging
tg4001
dnamessenger
conization
mtorinhibitor
multipleactive
autoimmunitychagas
hktc
cruziinfected
hktcimmunized
6sulfo
lacnacpositive
slandcsbackground
slandcs
schäkel
767777
slan
lacnac
psgl1
decavalent
antislan
antislandc
scbsdb
scbsdbantigen
endemicityzimbabwe
tanzaniawere
98591
4288
34900
drawnout
20062009we
3f11
177ludota3f11
dota3f11
tumourtomuscle
tumourtoblood
cellsproceeding
lastingly
nyeso1objective
lymphocyterelated
tencolor
strainspneumonic
lvsvaccinated
1710
prednisonemontelukast
igegrass
nearpreimmunotherapy
alternatainduced
novohelisen
nct00947908
ncsrs2
caninumneospora
antigensneospora
nccyp
immumaxsr
ncspecific
elisawestern
rnccyp
rncsrs2
phramongkutklao
antiinterleukin17
shamji
literatureinsulin
nonattendancethe
documentaries
shopkeepers
yates
577p
599p
childbearingaged
1398p
184in
123p
0266
rerun
1726p
000003
969p
inpharmacy
esapregistered
citynew
racialsocioeconomic
esap
nonprescription
pharmlink
nonpharmacist
139204
foreignbornimmigrant
antinephrin
nephrin
ptarget
glycosylationdisturbed
tunicamycin
jabinfluenza
countriesnone
dimercaptosuccinic
acidcoated
dmsacoated
ifnγadsorbed
chaperoning
tattetramer
gp96sivig
sivhiv
patchtuberculosis
bcgcoated
cd4tnfα
modelsschistosomiasis
smp80pcdna3
b10129s2
b6igh6tm1cgnj
cpgmotif
runup
nonnhs
vaccinationreconciling
pathintegral
populationdynamic
antigenimmunization
immunephage
vifimmune
womenimmunotherapy
type6
20022006objective
20022006
cirrhosisunlabelled
apotope
anticd79
xenobioticinduced
anticd20cd79treated
micemetastatic
assumingly
bmsplt
cisplatinum
nct00552279
118847
103119
45013
39636
userenal
spearing
ppmswe
hood
ciisgenerated
modelincreasing
rhinoconjunctivitissublingual
recommendationbackground
pnm
teresópolis
2010on
properidin
crtcoated
crtcoating
vgpcr
pcdna31mcrt
mcrtvgpcr
membranelocating
rlisteria
galmetteguérin
is6110
primeformalininactivatedhsv2
fihsv2
gd2t
ul5
ul30
ul29
primase
ul52
mplalum
fimock
pvaxfimock
pvaxfihsv2
dnafihsv2
sivmac239deltanef
tat2835sl8specific
macaquesdifferent
mamua
dnaad5
modelgeneration
betaglobin
rs660
rs660ct
abates
cellsstimulation
mogpσ1
mogpσ1s
mogpσ1induced
rmog
pσ1rmog
pσ1based
mogpσ1treated
il28
patientsome
prophylaxisinactivated
multiplesite
foursite
vaccineseukaryotic
antiliver
responsesprostate
psaspecific
plasmidsthe
electrotransferred
50standard
cd4cell
13497
ct00230061
libreville
gabonunlabelled
estuary
mélen
outskirts
nkembo
3rdd
heb3
nonepv
hib4
heb4
ipv4
120±131
826children
dtcvpoipv
n283
42245
54800
84euros
antiβglucan
humansthere
abkg
βglucanbinding
β13linked
56question
sharings
4278
4178
donorsgraft
statessolidorgan
piezoelectric
immunogenicityelectropermeabilization
electropermeabilization
amarasinghe
745753recent
doublecounting
premedical
staffobjective
chime
109264
151344
314734
129280
recipientthe
lacunar
selditof
infectioncells
pointsalthough
micecd4cd25foxp3
c57bl6b6
perorally
tgondii
nonallergicinduced
msdiseasemodifying
scidwe
lymphomareducedintensity
inclusively
4066
±19
±12
±13
pmwa
postpmwa
headshaking
horsesthe
luteinising
buyingin
walesduring
bhv2
594of
changechanges
flukeinduced
buffaloesdiseaserelated
yearling
murrah
infectionspecific
bubaline
prepatency
orkney
2008the
orkneys
ola
wholeherd
orcadian
biobest
immunotherapyoligodeoxynucleotides
iontophoretic
transdermally
20062007evaluation
mean87
mean66
vvpl
vplv
plplpl
plvv
cutoff20
543716
73488
6178
49868
posteach
31day
inmatesthe
aisf
simit
federserd
simspe
arecombinant
1812
freshman
deliverypulmonary
hyporesponsivenessbackground
opk
revaccinees
definitionbackground
nvicp
cdr2
retrovirallytransduced
cdr2α
aa109
109yf
aa112
112sk
109yf112sk
hc2g1
virusesmass
posthatching
achalasia
facialpredominant
anhidrosis
incoordination
wagrij
cc531
lulabelled
0·48
0·024
0·911
adulthoodthe
motherto
cd207langerin
langerinneg
specializations
immunoextravasation
malihuman
donorlike
cd4cd25cd8foxp3
injuryconventional
cd4mhc
cd4csa
20092010following
5982
immunotherapywithin
oris
schedulesgiven
mptb
wethers
ojdinfected
gudairtm
reviewwhile
dare
u20ac168
u20ac4214
20952
118000
toleranceexhaustion
7b12
pmacpsscfv
scfvtransfected
deliveryphotodynamic
highfluencerate
5aminolaevulinic
aminolaevulinate
backs
mantouxpositive
photolesions
115124
sf162p3n
shivsf162p3ninfected
8186218633
trunova
gettie
blanchard
chengmayer
8256535656
ren
84340351
shivsf162p3n
r5tox4
apobec1ldl
atherosclerosisimmune
25week
cbsa
apobigg1
foxp3foxp3
immunizationabstract
complicationswe
75170mgm2
35006000μmolmin
40mgm2×4days
buflurituximab
3568years
displayrepeated
tickimmune
nymphimmune
rp8
rp23
rp19
tickimmunity
modilon
54million
100millionyear
immunopriviledged
autotolerance
databanks
as03vaccines
dnavaccines
mf59adjuvant
hibernation
sphingosine1phosphatehibernation
energyconserving
torpor
euthermia
w146
abctransporters
rewarming
djungarian
summeractive
nonhibernator
gastricresistant
orogastric
vitroreleased
parj
sensitizedtreated
ovalbumintreated
intragastricrestricted
singlestrength
rql
pm42
pm120
nb90
antigd2antibody
nb97
melphalanetoposide
vincristinecyclophosphamide
ch1418treated
9yos
fieldvaccine
outnumbers
regrafting
sensitivitythe
acquirer
ugandawe
10796
94071
94729
3886
015dose
postmasturbation
autoimmunogenicallergic
autoallergy
ielt
immunogenicallergic
nplysate
npl
tolerizationexhaustion
hram
isoallergens
femtomole
isoallergen
fron
practicesystemic
pneumoniaeincreasing
surveillances
ataacc
cibum
accacc
influenzaespecific
nasopharynxnasal
egyvarh5n1
eid5001
β2agonists
p00278
p00081
paqlq
photoimmunosuppression
receptor4uvb
mjcm²
riskelevating
bbg01
yakult
serumfecal
95±32
rastcap
injectionintervals
6±35
35±29
32±14
lisoleucine
xmdr
250µg
transcriptionquantitative
subtypesinterferons
singlegrowth
ifnsensitive
akzo
targettonontarget
killernatural
ciknk
preinjected
immunologycurrently
rectify
ad5e1
e2bher2neu
antitaa
riucbt
indiafollowing
mid1960s
19731975
disbursement
privatepublic
ykl40
transplantationincreased
chitinase3like1
chi3l1
myelablative
12001320
antiangiogenetic
resistancesensitivity
2010despite
16858
2009an
interoperate
chickensobjective
aviantype
achickenguangdong04
mbp3·m2e
rejuvenates
blymphopoiesis
diseasepersistent
pollinosisjapanese
adjuvantconjugated
debacle
kingdomin
1307
fortuitous
pressuregroup
10091
oradj
immunizationrecently
trancutaneous
cellsadoptively
cpgoligonucleotide
patientshyperthermic
20057200912
linkedsuppression
micenaturally
agspecificity
alloag
bm12
merckcsl
nonrotaviruscoded
impactbackground
laboratorydiagnosed
5972
carcinomasobjective
astatinated
u36
211atcmab
211atcmabu36
fathe
regimencyclophosphamide
dlaidentical
gpbmc
5c8
6of
forcefully
effectivenessestimates
physicianordered
disorderreduction
response37
response8
ricontaining
outcomeage
cayman
4057
10993
987711958
limitationsthe
antitumoreffector
engineeringbased
146228
212316
hlaa2patients
tumorectomy
80kda
177lumg1
upc10
177luupc10
p0886
vaccinationextracorporeal
ecptreated
infusiondependent
autologus
antigena2402positive
technologyproteintransduction
ptds
ptdcontaining
molecularcarrier
nonaarginine
r9
jeopardises
withstandsbackground
clinicalsymptomatic
lymphadenitiscaseous
goatscontrol
sheepclostridia
enterotoxemias
toxemia
bpdc
intensityblastic
5580
cbcikchemotherapy
0716
230460
9051328
123282
597906
a549cddp
frequented
reviewlivestock
streptomyces
farmrelated
histaminereleasing
investigatordiagnosed
shockrespiratory
festucoideae
vass
chinadue
10081657
studyantigenicity
ultrasoundimmersion
usi
apbased
ballastfree
staunchly
vesta
vaccinatednonvaccinated
acceptdecline
auxiliaries
agesobjective
leadersthe
screenedvaccinated
nswover
westmeadspecialist
19912009
385899
knoxsurrounding
10341444
027083
056084
ratedifference
5t33mmgreen
wtnkg2d
5t33mm
drifta
ecaii
epitopesof
nonconservativewhile
kcatkm
lasn
antiecaii
jumps
iiicapsid
den2use
ascitesmalignant
ascitis
immunotherapyresistant
vegfavascular
tryrosine
vegfasflt1
fgenedeleted
rsevdfmediated
835100
00020320
balderived
lungtransplanted
amphetaminetype
dependenceabuse
34methylenedioxymethamphetamine
mdma
ecstasy
methrelated
gabaergic
midlife
microspheresan
adjuvantin
plgams
msovacpg
mspolyic
diseasegoodpastures
conformeropathy
α345nc1
pulmonaryrenal
5mgdl
icifnγstimulated
archaeal
challengearchaeal
amvad
lvsce
lvsceamvad
tularensisspecific
1monthold
rhinitissubcutaneous
extenesively
patientsindia
societiesthis
sultanabad
rehri
goth
khairpur
gambat
95ci681757
or1219
95ci157943
taluka
vlp26
primevlp26
radvlp
primerad
vlprad
095773
004227
096137
0038663
nuhdss
aphrc
fermentations
speculative
murinederived
murononab
menacwytt10
hsbamena
connecticut20052008in
casespecific
glioblastomaspecific
chemoimmunotherapeutics
or16
ci1321
nursestechniciansadministrative
or17
ci1322
doctorsbiologists
ci3765
190209
paralysing
miceexperimental
activelyinduced
plp190209
plp
costimulationresistant
backthe
propertiesattempts
nanovesicular
dichromate
dinitrochlorobenzene
dncb
7602
2658
acetoneolive
5633
3668
dncbloaded
nocardias
bllbc
tnfalfa
effecrmemory
salmonellashedding
dt104
cerro
agona
cellar
holocnemus
pluchei
asthmacausing
spiders
tegenaria
domestica
17kda
attributesinfluenza
mercurycontaining
recommendationthe
semiinvariant
spongederived
glycosphingolipid
6609
12932
12611
nonllr
398747
395998
19117
tollefson
20107513731377
departmentobjective
bedteaching
dijon
ccr7cd62l
cd4foxp3cd45ro
vitactivated
venomdriven
bviral
ringstudy
laboratoriesdue
chemico
akr1c2
sensitizernonsensitizer
injectionsthere
dptaphib
viewings
autoimmunity2010
updateb
sarscoronaviruspolyethylenimine
25k
pcis
peipcis
kvg
p001than
2949
mpd
tacrolimusminimethroxate
minimtx
trfia
workersdetermination
7996
fama
5464
20062009to
controllingeliminating
b31
biopharming
bananas
banana
fooddrug
dividethis
biopharmed
straddles
colon26
rabbitobjective
methylpredmisolone
tgo
rechallengea
famciclovir
postvaccional
teovac
arbidol
ridostin
immunogeneity
someway
systemsince
rnainduced
sirnarelevant
minigraftallogeneic
minitransplant
seachange
fruiting
obliquusin
pfio
pfiomediated
noros
comitogenic
antitlr2
mcchaemophilus
mcchib
hibpolyribosylribitol
chabaudione
mbi
carcinoembryogenic
ceaderived
carbopol
formulationoptimum
hiv1cn54
intermenses
mucosallydetected
eventuality
instrumentobjective
lacuna
postaltelephone
attitudeprevious
pctrecorded
alpha055075
060080
concurrentconstruct
predictivecriterion
interval048092
or197
ci118331
ci115330
ci240719
or163
ci100266
ci118131
or164
ci123240
or172
ci113238
acceptancerejection
immunotherapyvα24
vα24
tumorfeeding
malignanciestcelldepleted
hhsct
restoreenhance
lipidreactive
intiminγ
sheddingenterohaemorrhagic
translocon
uai
01042009
31032010
3570
uri
allograftlimb
transfusionthe
tgfbmodified
allolimb
responsing
tgfbtransduced
impairedthe
5¥106
cellswell
gvhdinducer
leukemiasarcoma
leukemiainducing
leukemogenicsarcomagenic
leukemiassarcomas
remissioninducing
leukemiaslymphomas
hcthsct
cellstem
reenforced
gvlgvtinducing
quotation
rezvani
storb
30172179
gvlt
functionobjective
03mgdl
11mgdl
0519
1114632
162616
aiirdpatients
19982006a
factorstimulated
hivcoinfected
tbthis
00000001
57e007
10907
14534
036080
cancerinoculated
diseaseestrogens
switchedon
odco
diabeteshistopathological
isletassociated
promoterlymphocytic
immunotherapeuticobjective
anx
cycloheximide
chx
aktspecific
cflip
tmvirx2
tmvinduced
mocktransfected
modelexperimental
metastasesbearing
usat
31september
sectorsmanufacturers
consumerswill
vaccinationfootandmouth
mhcfmdv
allantoic
hatcheries
embrex
inovoject
intelliject
avitech
salisbury
proteinstaining
allantois
newton
9462
6116
jamesway
magee
9104
7198
toleranceinduction
tysabri®
lyssavirus
boaroperatedsystem
swineferal
toxicants
prebaiting
prebaited
thmarked
554100
965100
019100
1687100
36213
1781100
1153100
98849
365100
899100
27300
061100
2206100
85385
9190
295321
allobmtthe
cd45lowcd133cd31
dilacldl
fitcuea1
intramedullary
58folds
surrogated
hbcag1827
scd40lactivated
tgfalphaderived
tgfalphal3
sead227a
tgfalphal3sead227a
rsea
tumourinhibitory
tgfαl3
tgfαl3sead227a
recipientspandemic
wk7
congenitadc
p0vaccinated
antip0
alloimmunizationtransplantation
balbcf1
cancersselection
factorαconverting
desensitizationallergen
previewed
recounts
antigensinvariant
dualtransduced
squarewave
37530
h5n1specific
bioeffect
modelmaltose
studyacute
8180
060078
075090
provencealpescôte
azur
provencealpescote
hbv2d
hbv3d
nct00343915
nct00524576
potentialobjective
phatreated
phapbmc
methyl3hthymidine
09308
09502
il10treated
serumobjective
irma
doubleantibody
9722
accentuation
nobalance
teheranobjective
teheran
laziness
20042008background
anticd95
phycoerythrincyanin
±167
±74
±154
developmentsmodern
th1immunityinducing
dispelled
allevidence
86adult
sheddingthe
pcv2positive
titerml
reoccurring
virus1vaccine
formulationsas
advaxm
advaxp
gp120advaxm
gp120advaxp
wholevirion
3·75
isrctn92328241
85·498·4
59·481·6
65·386·7
27·151·5
34·468·1
17·450·5
94·4100
60·983·2
81·096·5
43·9
31·756·7
58·888·2
20·454·9
91·5100
66·787·3
70·490·2
42·667·4
39·572·9
15·147·5
assessmentrecent
passiveness
as02vadjuvanted
trialsan
hbas02
3192
2992
1895miuml
sadenosyllhomocysteine
infectiondue
brucellaprotective
adohcyase
radohcyase
modelsshiga
subscribe
democracies
5600000
cellsrelated
chinamade
203‰
137193
allergyimmunotherapy
hoersholm
gt08
länder
bund
contracts
logbook
responsethere
12million
sepsismurine
postseptic
icospositive
australiahepatitis
nontested
angiogenesisthe
applicationabundant
vaccineeconomic
diphteriapertussistetanushepatitis
dpthbhib
dpthbhib1
dpthbhib2
polio2
dpthbhib3
leukemiaetoposide
fourh
14804070
overproducing
microhaemorrhage
antiaß
beijingbackground
95244
panflu1
sinovac
passivesurveillance
244091
2814
reintroduces
involvedindia
vap
dumped
pollentherapeutic
challengesour
detenteantibodies
hlapositive
13valentpneumococcal
7valentpneumococcal
110114
71–37
119120
117118
110113
agglutinogens
nonsan
2003allergic
fibrosarcomatumordraining
tdlnderived
faqsallergenspecific
vaccinationresponsive
r20972
modelsuggested
engraftmentextracorporeal
100cgy
607964
weeks71
6071
childrenadvisory
20105925861
200049no
rr9
2008573434
spermassociated
spag6
spag8
spag15
spag17
testisassociated
spag16
responderssurvivors
guaranteetime
1650g
1650autologous
importationprenatal
alternativemost
administion
lifespanthe
glioblastomawith
3mediated
bcl2interacting
autoantigendriven
revisionperipheral
cd4vβ5
bimmediated
vβ5
transgeneencoded
dualtcrexpressing
ragexpressing
ragdependent
infectionprogressive
nct01017172
596759
859959
inhresistant
clothing
cytomegalovirusreactive
stipulations
leucapheresates
tcrbv
γcapture
summun
bonum
modelharnessing
tautangle
m146l
presenilin
surgerylaser
lightabsorbing
s0wk
s1wk
italyduring
haematologyoncology
ccommercial
ampvc
virusexposed
ampvcspecific
julynovember
decadesbackground
10³mm³
symptomssigns
vaccinationtothrombocytopenia
or65
ci17
initiativerotavirus
useeuropean
edqm
15v
venice2
virusbacteria
bandolier
direcção
geral
dgs
hypotheticaltheoretical
immunitydeveloping
coregulation
immuneinhibiting
intranasallyadministered
coccidioides
posadasii
coccidioidesag2pracdna
dcmarkers
ag2pra
dotimmunoblotting
tkexpressing
18ffiau
petprobe
ag2praspecific
survivin2b8088
ayacntstl
survivin2b8088specific
hlaa24positive
hlaa24peptide
umin000000976
relapsewe
2470
reenter
forcethe
governmentalregulatory
transplantationnew
progressionregression
discherpes
malditofms
esimsms
progressorregressor
immunovalidation
tumorbearer
vaccineyou
conditioningrelapse
dsms
unsorted
udc
8291
clinicsthis
responsessuccessful
replicationincompetent
dracma
aconsensus
offing
emulsionsthe
2an
painrecent
nociceptive
nonnerve
chromic
cciinduced
cd8cd45raccr7
singletandem
vβchain
hl243γ4p
immu114
progressingrelapsing
pylorieradication
therapieswithin
salmonellainduced
salmonellas
wehi
p60217225
wehip60
5052
p60217225specific
tumorinvading
gvhdto
flubu4the
5300μmmin
25mlminkg
therapyover
rheumatologistclinical
paediatricianrheumatologist
pseudopeptidebsa
modelfab2immunoglobulin
amide
pseudopeptides
fab2ig
msp1derived
injectionproteinbased
tailormadeboth
macrolideallergic
vaccinationenhanced
potentiators
tlrtransfected
cd11acd18
cd4cd11a
cd8cd11a
cd8cd18
onehour
dtappoliohib
programmea
ci048143
014077
agaricus
blazei
murill
andosan
abmbased
12440
1117013710
monoxidereleasing
transitionmetal
ruco3clglycinate
ruco3cl22
feη42pyroneco3
coreleasing
ruco3clamino
acidate
triblock
polyornithine
acrylamide
ruco3clornithinate
polynbutylacrylamide
corelease
100800100000
19902008we
hypothesistesting
2004december
150068
departamento
reumatologia
sociedade
pediatria
twocentre
participantblind
korogwe
51447
88447
ag85besat6
bioneedles
tuberculosisbioneedles
bioneedleincorporated
bioneedle
devises
cd4cd25mtgfbeta
specificproliferation
mtgfβ
cd4cd25mtgfβ
temderived
teme
immuknow®
ivigrituximabdesensitization
colitisa
prophylaxishere
colitiskaposis
hstcl
phrases
aza6mp
unquantifiable
endotherapia
diseasescurrently
riskrefractory
fivetyseven
hdarac
cytomegaloviremia
175month
influenzavirus
toleranceanergy
nanotargeting
androgenresponsive
lhrhttnanoparticle
fitcpeptide
cfamily
30–90–150–300
pfr
modelnearly
easytoestablish
iransince
approachmedia
educationfor
1709337
1673571
allergyat
modellingin
stat3in
stat3silenced
markings
chadbackground
rotary
bathing
milezi
0335
01820617
02080697
cellssurgical
il2containing
mkn74
¹crrelease
diseasenaturally
marrowsignal
fasassociated
tspecific
fadddeficient
mx1cre
progenitorenriched
suppressionboth
tregderived
nephroprotective
il9mediated
kidneydraining
noninduced
03084
fungalcytomegalovirus
dsjis
polyicthe
filipinos
lyingin
55719
por47
ci12180
por48
ci13181
por189
ci53670
metromanila
pigsincreasingly
ebohv4
sadsc
antibohv4
ebohv4preinfected
sadscs
carrierproducer
corticosteroidavoiding
recipientscurrent
steroidavoiding
belataceptmycophenolate
belataceptmmf
belataceptsrl
nephropathyearly
pyvan
bkvloads
bkvviremia
3538
bkvreplication
updateincreased
cuneo1
ambito
cuneo
lhu
cn1ambito
sctlarge
lpe
lpes
42525
sctrapid
150μl
021095
tcellsμl
simpsongolabibehmel
sgbs
developtoo
ga2len
articlebackground
11cacetate
18ffluoride
childrenpreterm
dtcoqpoliohib
6471
or50
2985
neoglycoconjugatesa
tubewelding
vaxed
77item
indicationscontraindications
mdscinducing
phenotypecd4
edemas
bladdervaginal
hcik
1x105
poliovirusinfected
daratumumabbackground
um9
daratumumabdependent
daratumumabinduced
omenns
reportomenns
bcgosis
alliums
sativum
ol
antiba
garlicsupplemented
tattooingover
herbicideresistant
lettuce
formulationefficient
vlpassembled
mrpwi
mrdwi
hggimmuno2003
0obtained
1aobtained
progressivetumour
1bobtained
rcbv
925±268
487±161
122±047
062±006×103mm2s
103±043×103mm2s
076±008
flairhyperintense
062±006
076±016
068±007
insulatard®
asparte
maunsells
osseoreducedintensity
phasenonspecific
diseaselateonset
1018iss
oblimersen
veltuzumab
therapieshead
morbidtoxic
basictranslational
dormantresidual
immtrac
dshs
spokesperson
aqp1directed
cnsobjective
aqp1
antiaqp1
spdp
superdex
s200
wst1
mabrca
nonaqp1expressing
iggrca
aqp1expressing
antimeningococcus
monocytesil10
allergicbackground
131itositumomabunlabelled
autoimmunityadoptive
24jk
cellsprotracted
stresscorticosterone
stresscorticosteroneexposed
iova257264specific
crosspresentationpriming
corticosteronetreated
cd11bcd24cd8α
characterizationthe
aneuploid
nontrisomy
istresponsive
lm3
hevein
heveinlike
chitinases
latexassociated
allergyallergies
avocado
chestnut
kiwi
hlds
bananaallergic
16408
heveinspecific
heveinsensitized
ox40ox40
adox40ig
unincorporated
ox40ig
pigtomonkey
meishan
minidose
electroporationadvax
advaxep
administrationdegradable
ovalbuminconjugated
coconjugation
botulinic
speciesabnormalities
prodigious
ifndc
therapeuticbackground
hladiverse
succinimidylesterbased
cysteinetoserine
degeneracy
endotoxaemia
horsesendotoxaemia
90min
30ngkg
plasmatreated
104444±19393pgml
137392±10763pgml
fertilizationobjective
hospitalary
198701200912
6235
188141
shawi
formsthe
amaag
proag
nitrate
nitrates
proagchallenged
programhealthy
hfdmp
pov
ethosomesbackground
ethanolwater
methyldibromoglutaronitrile
penetrationabsorption
sensitizationelicitation
ethosome
approachesadult
lymphomatype
zidovudineifnα
graftversushuman
cellpeptide
usaof
sclerosisscleroderma
rituximabtargeted
immunotherapymeasuring
decisionvaccinated
decisionbehavior
nonagreement
2008this
micederived
tumortissue
trampc2primed
impairmentbackground
csa1
nogoa
strokeimpaired
11c7
nonlesioned
strokeonly
aminelabeled
corticorubral
deafferented
promiseinvariant
diseasetailored
studiesvaccine
20082009in
ok432stimulated
embolizationdespite
streptococcusderived
keml
0·046
ccl11
pfss
us8596
us892021
us1111
stbcurrently
staltbstb
disulfidebridgeforming
stbassociated
βhemolysin
factorthe
commandeer
ebvlymphoma
hsctepsteinbarr
simplifyingshortening
946±20
882±38
graftsurvival
higherthanexpected
nct00074386
leukemiamost
countersuppressive
controversiesthis
chemoablation
lifelimiting
csos
sipuleuceltbackground
epithelialization
denuded
dkma
2600
19602005
countryyear
161227
325176
progressdiseases
nextin
infantbackground
densa
traumainduced
milia
dyspigmentation
2dayold
tense
immunosuppressiongraftversushost
antibtla
precommitted
absorbeddose
organabsorbed
pinwheels
shotblockers
smallgroup
changesobjective
fischers
seroimmune
seroconvertion
vaccineesmeasles
lareb
immunityadoptive
kidneyspecific
nonsystemic
immunocloaking
lymphocytevascular
igg4sublingual
terminationthe
gaybisexual
serumigg
stimulusevoked
crpsigg
rears3
rotarod
controligg
uka
responsepatients
accumulationregulatory
101±31
39±13
48±12
strategiesat
priorityhigh
tumorsthere
foxp3lucidtr4
neutropeniabackground
mdsl
2828
hax1
177luimmunotherapy
213biimmunotherapy
213biobjective
213bid9mabimmunoconjugates
177lud9mab
213bid9mab
hsc45m2
d9ecadherin
177lud8mab
177luimmunoconjugates
tnvc
mean00250
p9500404
mean00071
p9500162
mean00017
p9500042
mean00001
p9500004
assertions
vaccinatedtotal
existences
strainsbackground
ptxp3
ptxp1
pathogenicityassociated
urologistsa
aminobisphosphonatesensitized
cellsaminobisphosphonates
aminobisphosphonatetreated
zoledronatetreated
icami
concanamycin
agehibprimed
mencnaive
hemagglutinination
pa9
054226
nct00792051
mϕ
studiessevere
flairups
vaccine3
pertusis
tetanus3
or1471
8502544
022077
immunocolloidal
strip
rbp4
cellsalloreactive
allonks
chemotreated
mpnthe
cimf
jak2inhibitors
egfbased
treatmenttherapeutic
tumorsmhc
iunrestricted
15501734
russiaanalytic
malignanciesstem
rapture
markurdi
intermenstrual
hypermenorrhea
postcoital
oligomenorrhea
cofounders
pontryagin
¹ffdgpet
10±8
countsthe
typematch
28770
nonptld
cytometrydetermined
atgnonmyeloablative
ratios229
interval129408
ncadherinspecific
lowinduction
highinduction
ratgespecially
steroidsseem
syndromedown
nonea
precipitin
adjustmentsbackground
12895
postsr
buffers
177luherceptin
waleswe
£23000
£10000£140000
£28000
£13000£200000
£15000
£6000£93000
secondgraders
26100000
288100000
22100000
11341524
unvaccinated192
vaccinated76
vaccinated732
infants335
ratewe
anther
vennvax
peptideboost
multitcell
alonethe
vacciniavariola
dnaprimepeptideboost
spss130
intakes
7874
tderp
tderf
10150
headachebackground
disorders2
ichd2
ageimmunotherapy
08195
communitysupported
prek
tissuesthe
addressins
cellswhile
antigenenhancing
1daybased
womenpreventive
737975
dnanegative
vinvain
reimburses
mbqmousecycle
diagnosisto
instar
lineatum
infestationssoluble
instars
grubs
pupae
postinfestation
afrocaribbeanafrican
racesethnicities
laboratorydefined
10321442
11231505
007085
11545
nonfamily
cfsestained
ionomycinactivated
membranoproliferative
cocker
spanielmembranoproliferative
spaniel
electrondense
transmissionin
100216
176292
assessorblinded
47±
antingccontaining
1e10
ngcgangliosides
boostersdendritic
myeloidtype
dermatosescytokineinduced
jst
chugokushikoku
ga101overall
cikmediated
lymphomasreducedintensity
cytomegalovirusseropositive
cetuximabbackground
adjuvantdefinitive
egfrexpression
egfrinhibitor
localdistant
°iii
mucositisdysphagia
responseremission
chisys®
bioadhesive
adolescentsan
25922
047079
040075
059094
genemarking
reisolate
lrhamnose
antilrhamnose
antirha
rhaconjugated
antigenantibodymediated
hbxhbx
hbxpositive
pcdnahbx
adhbx
cr4
23montholds
19902006
monkeysbreast
hormoneinduced
mamu
depletionactivated
ciitaexpressing
supt1
gp160cd4dependent
hladrciita
cancerexpanded
cd356
errorslessons
londoncorrect
zealands
aristotles
sequitur
argumentum
hominem
preempting
summarynonsystemic
nsvn
smalltomedium
hemosiderin
peroneus
brevis
sensorymotor
asymmetricmultifocal
lowerlimb
distalpredominance
nondemyelinating
nsvnfavoring
neuropathywere
otherorgan
cryoglobulins
conditiondrug
underexploited
betterstandardized
ga²
leneaaci
ga2
macrophageswe
cytosinephosphateguanosinecontaining
asccp
ranzcog
rpls
typhimuriumbased
stomachs
adolescentsinfection
deficienciesthe
hnsccinduced
shameful
numberofdoses
imtmi
ptv
midfemur
oar
contoured
threeisocenter
planner
128040
macroregion
06970701
00720073
00960097
0910
09080913
07570763
08590875
livereplicating
doseis
infantswhooping
diseaseinduced
epidemically
wavelet
hpiv3gp
ndvgp
ebovspecific
ebovneutralizing
allergologist
targetradioimmunotherapy
¹³¹i
radioimmunotherapyradioimmunotherapy
rituxan®
augerelectron
augerelectronemitters
nucleoplasm
augerelectronemitting
thresholdrecently
physics
variational
setsthis
nanodispersionwe
syngeneically
replaceable
dcmultiple
146247
nct00499577
boxwith
labors
researchersor
responsesthere
preeradication
adch63
primatesmalaria
5256
adenovirusprimed
immunotherapyspontaneous
meyersons
interchain
itpintravenous
thrombocytopeniaameliorating
ssulfonated
sgg
salkylated
agg
ssulfonation
salkylation
fcγria
cd64a
hchain
viralencoded
pandrepitope
iipadre
iipadree6
e6expressing
iie6
advantageneurodegenerative
neurofirillary
oldthis
concomitantnonconcomitant
061080
icostomizing
th17new
paulos
relblo
dysregulates
14weekold
isletautoreactive
mhcsusceptible
il1βil17
turks
funduscopic
fundal
exudates
bence
proteink
lcdd
ci12936421
hr2463
ci17574320
hr3553
ci18096978
hr3215
ci11896333
hr3487
ci13926524
hr1684
ci06484378
esophagitisfirst
oversuppressed
boxtreatment
nonantimicrobial
fidaxomicin
chickenshighaffinity
vaxgen
vectorsobjective
cd4cd25brightfoxp3
cd4cd25negative
kg¹
asthmaticsprevious
nonexacerbation
allergyan
historynatural
spina
bifida
powderfree
latexpoor
latexfree
igeproduction
diseaseinherited
meningi
deliverywithin
lifil6
lifloaded
il6driven
lais®
tabletslais®
carbamylation
databank
trialssome
placebocontrolledregarding
tolerabieity
cercariaebackground
artiodactyl
µw
nklysin
cytotoxicityrelated
pollensensitive
ncts
malignanciescancerrelated
bioprevention
systemsa
homestead
antitheilerial
tzs
usd1300
voicerelated
intercorrelation
jorrp
068084
adultsreducedantigencontent
wwwclinicaltrialscom
nct00548171
animalsource
ifnγlpsmatured
centralmemorylike
tumorantigenprimed
mcvac
541512
586888
468782
immunotherapycluster
naivederived
influenzah1n1
isht
workersdespite
opout
adoptivespecific
practicecertified
leukemiaresults
rhammcd168
fibromodulin
syntaxin
nyren60
5590
mpp11
rhammspecific
rhammderived
r3specific
peptidehlaa2
autoimmunitystroke
1relative
risk×100
n19108
identitytcell
diseasesone
ulcerationcutaneous
aethiopica
nonulcerative
leishmaniainduced
parasiteinduced
aβppsweps1de9
maergic
7b6
misrepresenting
deception
postcombination
pltk471
vpc
nt8e
hsvtkgcv
learnedlast
beyondallergenspecific
igfir
igfr
strainas
leukopoiesis
musculus
gammaray
helperinducer
cytotoxicsuppressor
sjlspecific
tragedythe
fasteracting
tbrelated
7mm
limitsnew
lfa1intercellular
cd2lfa3
therapyposttransplantation
rirituximab
rirituximabchemotherapy
uruguayobjective
prevalenceincidence
733460
465580
bacteremiasepsis
viaskin®
resistancecompliance
metacholine
2005the
metres
repositioned
diethylnitrosamine
multinodular
deninjected
afpencoding
dnamafp704treated
cicp
commentsthe
approachesspecific
nucleosidenucleotide
nrti
nrtis
lymphocytesprevious
2chloroadenosine
cado
ep2
ep2rs
csk
ep2ra2ar
ep2r
butaprost
cgs21680
lu1205
cytoxaninduced
luciferasecoding
nakeddna
antithy12
thy12
cellsthy11
b6pl
ivtransferred
allotypic
injectionovalbumin
indolicidin
indol
polypdicarboxylatophenoxyphosphazene
pp4
cpgindolpp4
cellsbacillus
nonmuscleinfiltrating
nicotinetreated
dcsdependent
tumorlysatespecific
il12p40p70
cd40cd11b
imdcsdependent
nicotinestimulated
disorderallogeneic
nonhl
reactivationparaproteinaemia
reactivationmore
recipientswas
p0087
studentsneonatal
umbilicus
orcs
447097
51136
dissatisfactory
185mbq
125i35a7
125ipx
photonss
125imab
tumortohealthy
radiationsynergistic
niss
nearpoor
64percentage
modelseffective
mhcdependent
insharag
cd4hatcr
mdsctreated
pancreata
thist
havendemic
canadianborn
n3320
n2383
crossimmunizations
hibantigens
19972008
hemophiliabone
peptideigg
celldelivered
tomorrowbackground
plasmapheresisa
tortuosity
intraretinal
wool
cryoglobulin
microaneurysms
hyperviscosity
glycolsuccinimidylpropionic
mpegspa
mcab
dualtreated
trastuzumabdm1
glioblastomahigh
transcytotic
ligandfused
co1
antigp2
1271411
interactionsregulatory
stroboscobic
avietnam119404
2551470
425fold
891423525
nibrg23
ibcdcrg2
aindonesia505like
menprior
pandemicduring
15770
1000105
licking
mucosis
historybrief
prpcontent
polyribosylribitolphosphate
dtpwhbvhib25
tritanrixtmhepbhiberixtm
nct00473668
dtpwbased
tritanrixhbvhib
seroprotectionvaccine
nct00332566
acyanotic
cyanotic
schedulessublingual
elapse
noupdosing
2008in
mgitr
mgitrl
antifapmgitrl
12μm
45nm
culturedtils
ebvantigen
75mo
discernibly
httpclinicaltrialsgovct2
erythematosusinfections
brainreactive
strategiesneurological
antiribosomal
hrgp100
permeates
hrgp100based
buresistant
4arm
icloflu
ii2020
iii3010
ivsingleagent
werewas
minimethorexate
particlesgrampositive
004μg
hagem
resectionspecialized
syndromesautologous
bmncs
20q
provided2
product2
558±067
526±054
1868±854
1320±620
concentrations1000
psma×cd3
diabodybackground
tcrassociated
psmanegative
xenograftscid
receptorvβ
hlaa21positive
wt1rnaloaded
tlr24dependent
aβ142cfa
mog3555cfa
habituation
spatiallearning
nonfocal
aβ142cfaimmunized
pbscfa
cd11bcd14
cd45high
tlr24deficient
aβ142dependent
boosterthis
23vpps
trialsublingual
mitemonosensitized
lofarma
allergeni
adenovirus85abackground
ad85a
antigenresponding
immunochemotherapymale
timetoengraftment
carcinomanatural
6b11
vitroαgalcer
59533
motorbike
variantsthe
sitesthe
barricade
stormadoptive
viihuman
tca8113
iconnk
iconcdc
levelactivity
batten
miceautoantibodies
ceroid
lipofuscinosis
cln3
diseasesdefinitive
mgyolk
ev71challenged
ev71specific
apoptoticnecrotic
tissueantigen
dcaponec
addresin
vaccinecurrently
antigenantibodybased
yic
hbeagseroconversion
nonconverted
001062
campaigna
drugusing
dash
fluidobjective
jco
255465
singlecompartment
jnm
501324
aucciar
auccia
aucciarauccia
r095±003
r092±011
077±021
areasin
postproof
signaljoint
5160
neogeneration
parameteradverse
idiosyncrasy
marylandspecial
iiop
transplantationmethotrexate
mtxtacrolimus
p160
allotransplantion
mtxcalcineurin
10691
±gvhd
nrs1
c3hheslc
mevnucleon
6cm
spreadout
bragg
ionirradiated
deactivated
riset
perceptionswe
2007the
invp
vz
denominationjews
or388
educationparents
or191
observancenonobservant
or27
costparents
or341
vaccinatewhen
or294
2010australian
difficulttocontrol
dogallergic
petallergic
betaagonists
fcgammafel
minoritiesobjective
n177417
n81762
cases1
usresident
courage
roy
calne
linda
ohler
nazareth
imaginggenetically
nk92scfvmoc31ζ
ironoxides
ferumoxides
15×107
contrasttonoiseratio
spiolabeled
epcamdirected
therapyazathioprine
6thioguinine
6thiouric
6methylmercaptopurine
immunosuppressionfor
cesame
falk
tnfαdirected
conditioningrisks
4318
108179
tumorredirecting
integrationassociated
carelectroporated
leukemiaoptimal
μmlmin
rituximabplussteroid
chemotherapyreactivation
positivebut
hbsagnegativelymphoma
20072008a
growthfoxp3
receptorenhanced
novoestablished
melanomatumorbearing
ripovalow
neoselfantigen
costx2013effectiveness
fluzonex00ae
fourtimes
sandostatin
sandostatinsandostatin
sensitivityintolerance
kuwait
allosctin
jctargeted
recipientprogressive
jcvassociated
jcvdna
jcvspecific
jcvtargeted
phasecancers
il2anticd40
immunotherapyusing
il2αcd40
jsk
il2αcd40mediated
rcasntva
pdgfb
glioneuronal
nestin
wp1066
rcas
bcl2that
engagementfor
rf1vpassive
rf1v
fecally
aβamyloid
protofibril
pfa1
neuropathologies
techniquesobjective
marginalespecific
parasitemic
diseasedisease
fludarabinealemtuzumab
µmolminl
aucmax
aucavg
µmolminlhigher
regimenswas
busulfanfludarabinealemtuzumab
macaquesmaternal
igg1b12
studymetastatic
200cm2
pcv2the
ens
12931
tdiinduced
dermally
tdi
tdisensitized
leukotrien
50yearoldsinfluenza
comorbiditybased
5300qaly
36636
45834
dualvaccinees
055077
051064
054083
038071
044079
022094
4‐site
single‐visit
4x2010site
singlex2010visit
2x2010booster
2x2010visit
mumpsthe
vacinees
peripubertal
gnrhproteinconjugate
supportthis
crosstabulations
commodityrecipient
cashrecipient
ghps
interferonγdependent
melanomaantitumor
tumordeveloping
ifnγinterleukin10
il10knockout
pcdna3sil10r
plasmidtreated
melanomachallenged
tagactivated
tagprimed
proteina
dras
neoplasiamany
cocarcinogenesis
kokmen
electroencephalographic
farm67nfpn
351417
805860
896946
898987
p0·6
dbdb
marrowbone
ibmbmt
ibmbmttt
plkb1
bumps
skinscaling
0368
31579
noncat
trialsonly
12600
404000
teenagersthe
097130
118153
133198
119213
cdcxm
cdcxmpositive
cdcxmnegative
cdcxmnegativedsapositive
cdcxmnegativedsanegative
hdmallergenspecific
hdmallergen
δigeblocking
typhimuriumculture
anticfp10
candidatechronic
hbsagtransgenic
maine
071102
lowespecially
transmissiontreatment
517yearolds
1849yearolds
nct00448981
beneficiaryrelated
papum
pare
arunachal
indiavaccination
fixedday
requirementobjective
timoneenfants
3c10
3c10cd3ζ
crrelease
intrabrain
tbodybased
uc7
ncimb8826
mothertooffspring
monocolonization
standardtherapy
66±5
46±5
86±4
75±5
nct00026312
intentionswillingness
n296
004033
unimportance
helmeted
fowls
numida
meleagris
oiled
riceonfarm
49log2
30log2
76log2
metoprolol
omeprazole
furosemide
outflow
fractiontime
singlepassperfused
barrierlimited
spacedistributed
ccl4treated
permeabilitysurface
cpgloaded
reg2
miceinsulinproducing
exendin4
neogenesisassociated
streptozotocintreated
reg2mediated
erasunlabelled
pedvaxhib®
mannosaminebiotin
responsepassive
mba
mbacoated
antiviper
hsigg
uncoated
hsiggmba
pegcoated
venomneutralization
13210
mae
timedependant
costreductions
tdtt
membersmalignant
unusable
il12related
immunointerventionsevere
activinfssystem
gproteinrespiratory
rsvinfected
blockerin
linsley
2010immunotherapy
charasteristics
humate
artallogeneic
vaccineseveral
lampgag
lysosomeassociated
humanmonoclonalantibody
chromiumrelease
killerdependent
2766
podoplaninaggrus
sialoglycoprotein
125inz1iodogen
4guanidinomethyl
3131iiodobenzoate
131isgmibnz1
pairedlabel
d397mg
d2159mg
rometranscutaneous
immunotherapyallergy
cloudy
polysorbate
myr
11mgml
statemaintained
conditioninghigh
2058
5891
ratesat2years
cgyflu
timeperiodic
resonantly
fluctuationinduced
europeobjective
immunogenicitya
stamaril®
serumdilution
jeyf
yfje
phishivae
rfpvhivae
matsutakeinduced
ony
patientsradioimmunotherapy
crunconfirmed
tissuemarginal
proteintransduction
antigenepitopes
r9ptd
proteinantigen
r9ptdcontaining
rr9ova
ovaepitopes
rr9containing
siinfeklspecific
rr9ovatreated
b16tumor
trp2epitopeb16
rr9ptdcontaining
findingsbackground
stai
antiavidin
humanshen
hava
lognormally
havapositive
intratissueinjected
collagenpulsed
yibritumomabtiuxetanradioimmunotherapies
ritz
nonrituximabnaïve
e6objective
betaemitter
¹re
¹rec1p5
¹re18b7
isotypematching
dsmivtr
11126
099107
mtb72fas02a
derivativenegative
adultstuberculosis
ppdnegative
mtb72fsaline
mtb72fspecific
tbnaïve
agepreterm
nonboosted
fmdvvaccinated
fmdvderived
p1d
ukg2001
n02201
ovaccinated
gkimmunized
baculovirusexpressed
pfueye
cd4pd1
gdvaccinated
immunosuppressionfsgs
rfsgs
uptitrating
areatapigmentary
aau
melanophages
maturationtherapeutic
tlrl
tlr78l
ccinduced
ccmediated
counterindicated
ascribing
allergenexposed
pregnancypreventing
islandobjective
n2692
n2732
159211
298340
040089
5662
37438563
125294
bismuth213lintuzumab
hum195
1854625
mbkg
antiretina
flatmounts
sarrestin
venomobjective
hbvit
advisible
continuos
epitopesfrequent
magea3111125
magea3161175
freerider
24montholds
jechimeric
vaccinationnaive
19283600
219362
jenaive
jeprimed
206989
hepcidin
10468
hio
mggdw
misdiagnosisthe
measuresafter
immunotherapydc
rnadnaimmunocomplexes
potentialthis
hs578t
sum149
22528
445908
1659508
μm2
1213600
910107
1517094
microneedlesto
valenced
annenberg
childrenpolysaccharideencapsulated
yearsa
swedenacceptability
januarymay
10567
hpvvaccinating
diseasesnearly
antigensit
vaccinesexperimental
parasitedriven
trypomastigote
skintargeted
denselypacked
arrayshsv2gd2
immunomicroscopy
riskstatus
c179
extractobjective
medicaidmanaged
piecerate
medicaidfocused
casecomparison
superadditive
flunitrazepam
therapeuticwhile
sedative
antianxiety
coingestion
notoriety
antiflunitrazepam
rca3a3
fluinduced
kdapp
tenuous
cointoxication
etoh
codrug
flutreated
etohtreated
2006july
babol
hbeagseropositive
antihbeseropositive
hbsagseronegative
gavacplus
acaricideresistant
antibm86
engorging
181920
i01
i02background
e75peptide
antigena2immunoglobulin
eri
n5589
schoolspaediatricians
respectivelyin
mcells
nonlectinized
interleukin12monoclonal
microseconds
farthest
nanometers
therapyoptimized
anticd2328
zetachainassociated
anticd27treated
ccr2bfor
ccr2b
sknsh
sknas
ccr2bexpressing
ccl2secreting
ccr2negative
comodified
antibodyan
gitrinduced
jhd
cp870893anticd40
cd40positive
cp870893
dosescourse
coursescycle
intervalscycle
dctomyeloidderived
dctomdsc
adenocarcinomanew
colitis1
encephalitis1
hypohysitis1
strategiestreatment
granulomanegative
ziehl
neelson
tiladoptive
gastrointestinalderived
cellsimproving
myeloidb
cpgstat3sirna
narrativesdrawing
articulating
stigmatizing
mtorinhibition
patronstudybackground
pilotstudy
patron07
cnifreebottomup
lthttpwwwclinicaltrialsgovidentifier
nct00604357
derestricting
hostanticancer
micevaccinations
nonmetallated
wtapo
lowcopy
salineadjuvant
sod1vaccinated
wtapovaccinated
statementrecommendation
thymoglobulinatg
diseasesunrelated
19892008background
19892000
cd62lhigh
eaethe
cnsautoimmunity
influenzastarting
untraditional
orchestra
8891000
patientsumbilical
peptidewe
constantregion
catalysing
mhcdefined
cd28cd40directed
foxp3poscd27highcd25poscd127low
cobs
cobstreated
cobsresistant
37234
387848
370848
258848
extremadura
χ22636
mutationsobjective
newbornspregnant
hospitalizationvaccination
16220
33135
vaccidents
weycker
paperrecommendationsthis
httpwwwwhointimmunizationdocumentspositionpapersenindexhtml
malignanciesrapid
115456
099386
1651160
13341
101249
125721
oscillate
antiphase
strategists
saturates
choicerather
accessibilityis
rtxtoxins
apxi
rtxtoxin
apxiii
apxiv
apfa
rapxi
rapxii
rapxiii
romp
rapxiv
rapfa
app1
shope
4074
s1536
mmrii®
enzygnost®
dade
schwalbach
9791000
851889
83161
278316
400482
421611
vγ9γδ
tumorsgammadelta
perfluoroalkylated
leucogen
nonglycosylated
peptideproximal
hladrhigh
26119
statelike
selfsufficient
immigrating
immunodiseases
therapeuticsbits
pervading
enjoyable
showerheads
epicutaneoustranscutaneous
desensitizationseveral
26s
trialsunlike
lymphocytescellular
ebvctlkg
postebvptld
7629
cpap
guidancein
pointof
nycs
commissioner
update2009
erspc
rpx
superantiandrogens
localnational
societylevel
cardioankle
syndromeaortitis
stiffening
cavi
18ffdgpositron
cavis
34week
mechanisticrelated
8f5
4256
ptendeficient
alsatian
alsace
corevih
hiv1challenges
experiencemeasles
finlands
2010a
march2
worldrenowned
cancergv1001
caliciviruses
23wider
25narrower
lengthsobjective
092547
nanodiagnostics
nanobiopharmaceuticals
lymphomanowadays
presentvalue
718146252
isk
565026552
153119700
228878476
7253420
eveningweekend
adolescenceobjective
avietnam11942004like
significiently
drugcontrolled
gammafood
nfas
contusive
rostralcaudal
trialschronic
0454
0718
bloodbecause
mandateslawmaking
41month
nct00065442
sctresults
studyoral
19member
mucostitis
bufludarabinealemtuzumab
bfareduced
adventitia
γchaindeficient
eu25
interventionsincluding
hcwscan
abthe
bontb1
transplantationmesenchymal
mscskgday
superimposable
gambiabackground
supporteligible
anticd20scfvfccd28cd3zeta
anticd20scfvfc
emsa
meningitisbackground
19901995
2haplotypes
livedonors
rkt
2hp
retrolective
immunosupresive
azatioprin
significative
switzerlandswitzerland
denizli
seroposivity
8graders
macaquesaging
menopauseassociated
ovaryintact
ppsv23invasive
43500
miceinherited
ldir
xcgd
transplantsallogeneic
221282
94164
gestationisbackground
immunoapheresisimmunoadsorption
gestationis
autismmuch
nothingthe
organomercury
plagueto
dcir2
dcir2targeted
antilcrv
alhydrogelvaccinated
australiawe
beddays
atadenovirus
virusrecombinant
atadenoviruses
roadv
elderlyimmunogenicity
aturkeyturkey12005like
allergensitmore
activetreatment
c4a
apoaiv
levelsof
mrp3
mrp3specific
5967
mrp3expressing
antimrp3
154480
experienceshepatitis
biennially
vectorresulting
mvah1ca
mvan1ca
bergheibackground
celltraversal
ookinetes
traversal
codonharmonized
celtosspecific
tgfbetabackground
foreignantigens
or5
bcrabl1derived
b2a2
breakpointderived
cmlb2a225
b2a225
inem
trailexpressing
deletionperipheral
cfaova
shea
annecy
statementrecommendations
20102011the
bbrisbane602008like
residentsa
bni
cmac
cnj
hyriopsis
cumingiithe
cumingii
hcps1
hcps2
hcps3
devour
colocalise
modelmurine
healingassociated
chanceprotect
ibdbackground
5acetylsalicylic
476905
476762
implantsobjective
cetriaxone
amoxicillinclavulanate
meropenem
miceallergenspecific
fcγrifcγriii
itinduced
phenologybackground
phenologic
flowering
barren
brome
fog
bulbous
meadowgrass
bluegrass
stereomicroscopybased
stamens
routeinformation
triviraten
oxaliplatinresistant
lohp
pathomorphology
omana
pregnancyreview
feverobjective
polycomponent
nasaloral
watersaline
hibcontaining
3hib
glomerulonephritisto
antirnpassociated
u170kd
snrnp
antigenselected
trbv
revaccinatedno
or2fold
capsulespecific
or1000
nct00622843
pyodermaobjective
hydradenitis
ulcerativevegetans
immunoduffusion
bubom
toxoidsby
micromethod
personseither
profilecurrently
tasocitinib
nephroprotection
viruspatients
factorbeta2
desensitizationchallenge
anginaaspirin
wongmodified
marmosetsdepletion
7d8treated
ricspecific
ah1n1objective
influvir
pandeflu
mediaroutine
abrs
clinicrecent
anemiathirtyeight
06067
aplais
volunteersin
macintosh
tumourwe
hbcvlp
hbcvlpcpg
b16hbc
cd127expressing
birdshot
chorioretinopathyobjective
bscr
sdoct
dtpwhepbhibopv
diaper
106369
malaria050
landscapeassessment
k21
k34
k43
decoupled
k34k43
k12k21
lipophilicity
hypercellular
cd45racd28
hibinfectionobjective
acthib
forprevention
hibinfection
orderly
aphthous
ophthalmopathythe
ivgc
maxt2rt
immunotherapygammadeltat
vgamma9vdelta2t
gammadeltatcr
pvaxmil2
desensitizationthe
rhabdomyosarcomaobjective
rmsspecific
antifachr
mttbased
fachrspecific
401380
201380
strate
gies
euro4600
6400qaly
euro3500
4900qaly
euro7200
euro5000
euro211900
296700qaly
euro81600
114200qaly
atbirth
euro329900
461900qaly
euro330100
462100
receptorreactive
achrfc
vitroachrreactive
achrreactive
immunostimulated
micepregnant
polyicinjected
tc1lymphocytes
multipeptideifa
foxp3tcells
nct00705640
lymphocyteinfiltration
sheepmultidose
alphahemolysin
usa300
modelcommunityassociated
camrsa
hlanegative
deltahla
newman
dermonecrosis
childrenresults
vaccineto
strenghtened
49024
seriesthis
compulsiondevelopments
homeobjective
atlantaobjective
catchall
crafting
incidenttoincident
infectionimmune
tces
neededwe
9534
±114
9145
9744
cerevisiaerecombinant
engerix40
engerix20
chinese20
chinesemade
yeastrecombinant
chinese10
metastatectomy
victoriain
deliverable
posthuman
reserving
labourefficient
papnegative
perspectivemathematical
vaccinationepidemiologic
376438
350415
120231
140283
101191
vaccinationcytological
aihw
surveillanceaustralia
gardasilr
608647
363404
641679
482521
425465
achievability
adherencethis
transplantationhepatocyte
pruritis
tearing
00183
00030
icuacquired
infectionssepsis
pcarelevant
il1βtnfαil6pge
αdc1polarizing
il1βtnfαifnαifnγpolyic
pcaspecific
pap135143
pap112120
psa141150
psa146154
gmcsfil4generated
copdvaccines
statementdrug
eaacihomepage
antibodiesfusion
pregnancyincreased
antitrailr2
minibodya
mb223
limbsparing
influenzainfluenzarelated
brainto
adjuvantsthis
igaimmunoglobulins
ipinfected
mucosallyencountered
teffectormemory
tregtem
lobule
ductlike
rgp120
checkerboard
cn97001
asthmasince
antihematopoietic
alloreactivitycotransplantation
antihsc
milteny
ha1expressing
ha1mismatched
statesrecipients
normotensive
nephrotoxins
vaccinationmycobacterium
venison
therapysummation
zirconium89
124iimmunopet
96217
539726
127150
025039
filgrastimto
00079
pegfilgrastimtreated
000065
micegiven
caseipgsae6
caseipgsa
caseipgsatreated
caseipgsae6immunized
ifngammasecreting
caseipgsae6induced
reactogenicitybackground
cano
ev91
in16
site2
mnspecific
nct00000886
cefditoren
tmic
gammaglobulins
subinhibitory
mgkg100
dilutiondose
hsnp
cdnnp
totalfree
228143
268160
224127
tolerancemyeloid
calmetteguerinbcg
bcgova
administerd
nct00610168
cancerhlamismatched
1st2nd
106kgdose
16526
il15hc
saccheri
diseaseradioimmunotherapy
1f5scfv4sa
dendrimeric
²¹³bidotabiotin
1f5scfvsa
20338
8303
mm³
²¹³bilabeled
revindependent
virusindian
cd45racd28cd95ccr7
carcinomacytokineinduced
25123
skrc42
therapycellbased
uspc
5hourchromium
killingsd
65637
575770
risksdesensitization
cdccxm
oxalosis
goatsthis
106cfuml
pet32lic
109cfuml
haemopathies
imids®
scthematopoietic
300600
300ngml
300600ngml
fludarabinemelphalanantithymocyte
amltreatment
immunoescapeobjective
yearssocioeconomic
59·9
1·72
6·64
1·58
annuals
2·65
3·83
ratsmodular
long×05mm
eccovered
gfppositive
childrencrimeancongo
cchf
thrombostasin
thrombostasinvaccinated
cattlethrombostasin
anticlotting
haematobia
irritans
ts10
ovalbuminvaccinated
rts9
rtb8
ts2
ts9
tb8
ts8
rtb8vaccinated
flycattle
cancercytokines
gammac
immunorestorative
clonestcell
judiciously
melanomafood
immunityregulatory
antiinterleukin2r
specificitybuilding
relevantcancer
chemoimmunotherapycancer
cellsrechallenge
vhdjh
taacontaining
freshlyisolated
immmunoinhibitory
clinicallytranslatable
highlyefficient
18232
1481
10401794
uvainduced
364385
bellshaped
89193
158193
6072
rop1
genesinfection
rop1specific
tcrvbeta
sporozoitesprotection
pbgammaspz
exoerythrocyticstage
gammaspz
vbeta4
gammaspzinduced
pollinosisgrass
humansit
1ido1
1methylltryptophan
14149fold
25266
27346
11293
haystack
recipientsnonadherence
forgettingnot
immunotherapywnt
lipidmodified
tetracyclinea
collins
epitetracycline
sd124
puregrade
sd137
appointmenttemporal
527769
584768
patientsmalignant
varmland
reactivityhepatitis
ns310731081reactive
ns310731081
b7h1dependent
responsescd4cd25foxp3
b7homologue
hormoneindependent
estrogenmediated
aerogenically
tuberculosismycobacterium
60monthold
bcgtokyo
injuryrecent
selfrepair
subependyma
factortreated
treosulfanflu
myocardiac
lymphoprolifarative
nct00737685
nct00882323
transplantationfive
toxicitywe
intratonsilar
bovisvaccination
necropsies
alergic
igedependant
micecutaneous
disfiguration
lmcpg
lmcpgvaccinated
il17rdeficient
chickensformulation
thermostabilisers
eid5001ml
2534°c
bl6
componentrelated
sensitivityobjective
d37
panitumumabpanitumumab
abxegf
vectibix
gammaimaging
111indotapanitumumab
90ydotapanitumumab
5911
4038
microci
5602
3995
suppressiontransforming
smadindependent
mhcmediated
hostregulatory
cellsmicrol
analysisrecombinant
kunjin
tyqrtralv
syipsaeki
yphfmptnl
rpqasgvym
vlprvv
dnavlp
rvvvlp
modelcytokine
antiangiogenesisbased
patientsleukemiaassociated
vialsthe
37722
sharedspecific
sorbitan
monooleate
nh2
isa51vg
panhla
000000619
lymphocyteseparating
rnintroduced
rninduced
cd3cd16cd56t
cd3cd4t
srcabl
sfks
fpvovadasatinib
fpvova
tumorextrinsic
nettleton
2971
jeangerard
guillet
cochinpasteur
vs19
100002we
suvival
0395
angioembolisation
embolisation
howelljolly
hj
ceus
nom
intraparenchymal
majordendritic
crossactivation
majorsusceptible
nkcellderived
tumorsregulatory
diseasesmucosal
needleassociated
beliaghata
antidiphtheritic
treatmentall
ltr192gltr192g
26vlp
ltr192g
26vlpspecific
skokie
16december
2009on
shd
40850
8904
12876
shds
mvvc
neuromediator
dermatitisfood
periodontitisobjective
vasoconstrictor
fessobjective
lundkennedy
lundmackay
necroinflammatory
antibodyantihepatitis
364log
cd19adoptive
anticd19carexpressing
micehighly
dpjy01
unscreened
publicgoods
plummets
a21restricted
diabeteshow
t1din
routesobjective
seabased
stract
a260a280
a492
mgnml
151200
nanopatchtargeted
needleswhich
diffuses
dnadelivered
partridgeas
perdix
erythrosedimentation
ndvtreated
selfmaintenance
arraystargeting
devicesmuch
miniaturization
layering
microprojections
micrometer
dnps
fluvax2008
hgnhl
p400
trc3
centerarthur
solove
blackwell
httpwwwosucccosuedutrc3indexhtm
predoctoral
abramson
barbara
wayne
taussig
wilmot
babb
randolph
withdrawalinduced
proteinadoptive
dmf5
cotransduction
dmf5transduced
dmf5alone
p00064
bcl2transduced
expansionperipheral
chitosanil12il12
chitosanil12
mc32a
chitosanil12mediated
adenovirustargeted
cells1
cd40admart1
hcd40
mcd40l
cd40ad
melanamart1specific
inversions
goirc
mium²
mium²d
pretermobjective
elga
vlga
heartrate
pethemagem2000
gem2000
nct00560053
irresistibly
proofofprincipal
frustrate
mydriatics
transplantationwhile
41147
66128
128236
survivalmedian
194ne
114226
alpha1
antitrypsin
aatd
391±101
451±109
14±17
05105
32±24
l3derived
6week6month
nz98124
760676
ad5ha
19952006this
26653
15973
10680
543555
199519972006
109116
106115
n810
gptrainees
sporozoitesradiationattenuated
rasinduced
rasvaccineinduced
rasimmune
rasimmunization
antiplasmodial
latexspecific
nonammoniated
ammoniated
28990
catsthis
vaccine7
iggreplacement
nonlicensed
φx174neoantigen
tbeigg
iggpreparations
28157100
vieu05
vieu
usebidirectional
cpgctreated
33d1
mpdca1
plasmacytoidderived
33d1mpdca1
nostress
treatmentnatural
blysdirected
attests
tolerancesusceptible
repertoiredirected
blymphocytedirected
igevenom
5619
95cl
119175
114165
101142
112168
166year
01156
4hcpurged
nct00349934
mason
4703
micemale
mompspecific
intrapenile
areaswe
actioncatumaxomab
mcts
volumedecreased
tricell
catumaxomabs
admomp
admompdc
biberstein
wt1235
il10type
ifngammatype
dominancy
immunoliposomal
traversals
liposomalchxadtpa
7164
ratneu
macrophagedepleted
muci
liposomechxadtpa213bi
liposomechxadtpa213bi7164
213bi7164
liposomechxadtpa7164
liposometreated
xenorepopulation
fahrag2
immunosuppressionfunctional
xenoengrafted
fah
rag2il2rg
hardy
n953
ovalbuminlhrh7
kıvırcık
lambsthe
spainusing
5102568
n528095
vivomicroneedles
200920
evaluationfox
westward
bolzano
altitudes
prohormone
proct
tavares
miñano
nproct
aminoprocalcitonin
epiphenomena
lipidadjuvanted
mplascit
allerslit
sublivac
5positive
phlp
hoststcellbased
il12engineered
perist
infectioninterferonalpha
parotids
polismail
patientspolysensitization
counterindication
mitessublingual
3682
104000
auyear
p0000003
p05226
0734
mgc3
citiesobjective
therapyautism
treatmentautism
13000000
sbtx
pbmcproducing
58103
86162
mtarget
transplantationmaintenance
mtors
cniminimization
tolerancerelated
tmem176b
diseasevaccinebased
176b
plaqueassociated
thioflavinespositive
unactivated
apposition
systeminfiltrating
lithuaniabackground
216741
299974
immunotherapyintrapatient
hdmr
2389
responsedespite
interferóngamma
cellsmounting
7184
ifncontaining
a5962this
450300
autologlous
humancd4cell
cd45cd3cd4cd147aad
cd4kg
19922005background
19921997
29410
adolescents300
hab2d
hab3d
greecevaccination
12665468
multigenotypes
continuance
24215
defenseregulator
hh2cpgodn
crossgeneration
176398
childrenready
immunodrugs
vaccinespathology
antimonoclonal
missileat
missiles
noncellbased
thymopoietic
arcelis
infectionantiretroviral
argos
obstaclestransmissible
bse
selfepitope
immunoparesis
tlymphocytenk
prospectsin
p210bcrabl
her2neubased
cscstumorinitiating
cscstics
noncsctic
cscticspecific
csctictargeting
immunoprophylaxisthe
mycograb
lipidassociated
antibetaglucan
effectshematopoietic
transientdelayed
deficiencydependent
syndromerelated
manifestationsalthough
estrogendeficient
rbap48
rbap48inducible
ser9
alphafodrin
ssb
nonimmunizationreasons
consecutivelyadmitted
partiallyimmunized
1784
3415
completelyimmunized
opvdpt1
opvdpt2
opvdpt3
or694
31151
mesothelinmesothelin
hn1
immuntoxin
laceconditioned
centrehighdose
5mgl
gradeobjective
tetravalen
premandate
4131
postmandate
cosignals
prospectsnatural
a5181this
ifngammaproducing
vaccinationactive
peptidehlaa0201
intersitium
vegfvegfr2
antibioticsmalaria
cyclespecific
shortcut
realitydeveloping
immunochemotherapybackground
cyclophoshamidedoxorubicinvincristineprednisone
mvds
cd31pecam1
rchoptreated
itnjdrf
grouplike
quadritherapy
30805696
39607291
861115977
11833063
17942478
14012491
43677946
11671553
transplantinvasive
fusariosis
126485
survivorbased
librariesinfluenza
a06
muccd
muccdtargeted
muccdspecific
autoinmune
coccidiosiseimeria
phylum
coxabic
netanya
wallforming
macrogametocytes
atcost
subdermal
amyloidenhancing
surfaceengineered
iggcoupled
antibodycoupled
strainswe
betagal
lowcelldensity
pnz8112
surfaceexpression
vp4expression
antivp4
ma104
vp4expressing
anticd20containing
90ydose
crcrus
antigenmismatchedhaploidentical
10³kg
hlaa21kb
diabetesinduction
rebooting
2906
fcepsilonri
receptoriib
allergenigg
m2biased
strokeacute
128593
110304
101345
100310
1081012
prehaartprepcv7
haartprepcv7
lymphocytesprion
transconformation
selfaggregating
ineluctably
impossibility
selfprp
antigentransduced
prpsensitized
elink
recipientbased
transplantationimprovements
cd11cexpressing
gcn2dependent
cellsexerting
activitiesmakes
cd11ccd8cells
influenzaemployers
loath
35vaccinated
1494
departmentwhile
cpoe
approachesmultiple
cattlehandling
cowsincidence
starters
hitchhikers
zcd19
trailreceptors
perforinbased
ca2chelating
egta
paperless
enumerations
pdas
unguja
digitize
portability
6dose
inductionobjective
immunodeficiencythis
polysensitizationpolysensitization
extractsconventional
leti
spainscit
eruptionpolymorphic
uvrexposed
solarsimulating
aheadobjective
isohemagglutinin
antibodyusing
infected667
fcgammarbindingdependent
claudication
angiograms
extrapyramidal
circulations
dura
betatrefoil
hcbetatre
ad2f
hcbetatrebad2f
hcbetatread2f
bontbspecific
hcbetatreimmunized
hcbetatrebased
stainingbackground
guidelinemarketing
chmpewp245502
cpmpewp292201
preventionan
sofjinlike
p202
hypodermosisa
aspectcattle
warble
myiasis
diana
actaeon
tarandi
roe
grub
passes
endoparasitic
reinfestation
leather
187879this
celloncolytic
tumortrafficking
cellviral
syndrometo
cmin
precipitously
nct00244361
differencethe
huberwhite
acd154
gcsfscf
rubor
cd23expressing
v1ige
biofunctional
cd23ige
fragmentstreated
trimertreated
fragmenttreated
r0492
eira
peptidepositive
multicytokineproducing
repertoiresmall
2009enteric
typhis
dosagebackground
19772006introduction
allery
19772006
landspítali
donorsoptimized
anemiato
tbi800cy120
usct
aconcern
rahc
monocistronic
footandmouthdisease
selfcleavage
hu1a4a1igg12a
microgmouse
phasecoverage
2004since
n600
timetoimmunization
attainablewe
swisqadverse
swisq
organisationinterface
listeningrespecting
retest
abrader
abraded
d49
vaccinationnasal
tmctpp
tmccpgova
tmctppova
ctla4blockade
profileautoimmune
cd4cd25fr4high
cd4cd25highfr4high
mrnaexpression
ctla4blockadeinduced
12879
n1h1
200910the
costimualtory
moleculesthe
medicineimmunology
realms
wholelimb
1000r
cll3x
mrdflow
7102
nct00281983
us1703
infectionradioimmunotherapy
ajcr
nonmelanized
melanized
immunochemotherapywe
014088
015104
vaccinationrotaviruses
us2
vaccinesone
interactionswe
triples
comorbiditieschronic
tositumomabbackground
radiommunoconjugate
24517
modelingadjusting
523591
patientsfor
hepatitischemotherapy
acalculous
reconstitutionin
2compartment
cd52expressing
httpwwwncrnorguk
ukcrn
engraftmentdoubleunit
cobblestone
areaforming
seizuresobjective
83107
376354
143273
immunotherapyinto
patientsimpaired
microgdose
135976026
9233
139361207
4177
128213614
intentionsas
816year
adjuvantthe
depletioninactivation
miceadministration
omls
1omls
1omltreated
il5ifngamma
1oml
1presensitized
involvementobjective
itc
cnsitc
cnsrt
propertiesbackground
5binding
phlp5
nonanatomic
coagulopathyinduced
hemothorax
prednisolonetreated
rationalbased
ilt3
ilt34mediated
csac2
adultswilms
impactwe
re0
aminobisphosphonatepretreated
patientshepatocellular
zoledronatepretreated
testyoung
thesereinforcement
1790
p00455
itype
plasmaphereses
acarbose
209681
chimerivax
mousebrainderived
prerx
postrepopulation
nonrelapsing
baffrpositive
cytopeniasthe
celldeplete
kμl
oscillationsthe
math
235252
hybridstochastic
ia2a
igg3igg4
controlcysteine
wrought
micemultiple
il6tgfβ
rpm
inmunología
pediátricaspanish
melifera
adrenalin
muscleto
tibialis
cetaceans
vaccineclinical
cetacean
oceanariums
dolphins
tursiops
truncatus
mississauga
newspaperwire
vaccineshot
shortagedelay
regionalindividual
modelingrecently
permeabilities
chemotherapythis
3254
raebtaml
dacryoadenitides
autoadoptively
uf
cd4enriched
diseaseuf
iduf
idcd4enriched
idcd4depleted
dinghai
municipalobjective
95020
9082
9140
7437
7640
8046
inteval
supplier
infomation
nestpcr
mothertochildren
shunyi
mtctof
shun
immunigation
8471
13932
capacityvesicular
200300
nonsensitizing
ethosomeencapsulated
melanogasterpostmating
pathogendependent
providencia
rettgeri
alcalifaciens
iiphase
haop
naop
cistronic
hawt
haopm2
naopm1
naspecific
microneutralizing
peripherylittle
childrenimmediate
irml
npct
57aminoacid
npct4457
wellproven
npct157
antinpct4457
antinpct
polyoside
ctx2
thts
gavaging
testrelated
8502
preventionfor
cervarixhpv1618was
approvedin
andvaccination
startedin
papulovesicular
acambis
nearconcurrent
vesiclopustules
spongiotic
lymphomaangioimmunoblastic
40195
86355
140265
rtreg
sessiondoses
unfriendly
vacancies
modelsingledose
purchasers
patientsday
50dose
micromoll
carbonion
cib
kiloelectron
volts
kevmicrom
fm3a
knowledgebackground
patientbasedexperiential
3rdyear
imak
grifola
frondosa
heteropolysaccharide
maitake
zfraction
mzf
mzftreated
dcproduced
eb66
activitymonoclonal
disordersimmunosuppression
ebvnuclear
cd107ab
interferonγbased
adenovirusinfected
rivax
intoxicationricin
ricininduced
cellsreviewnatural
thirtieth
formulationsobjective
dtloaded
tmcdt
300micromlong
dtalum
rhodaminelabelled
toxinneutralising
tmccontaining
antiher2neuspecific
cirelectroporated
cirpbl
ciril2pbl
il2pbl
rhinitissensitivity
odors
smells
sensations
mediumonly
stimulat
vacsatcthe
vacsatc
6611
immunomodulatorscontrol
doxycholic
saponaria
phlebodium
pseudoaureum
hydroalcoholic
pal
butoxycarbonyl
docsv
wateroil
qspal
932994
8688
qsaa0029
737970
qsaa0029docsv
diseasesalong
screeningtesting
guamanianschamorros
samoans
tongans
balmiss
interposed
unintentionally
receptorknockout
micegraveslike
nonidentity
intrathyroidal
sarcomacho
dnam1dependent
modelingunlabelled
carlobased
voxelbyvoxel
deformation
eud
histogram
organizationinfluenza
microgranulomas
mott
pannuslike
interplaythe
immunetumor
nonmatrix
cytotoxicimmunotherapeutic
hsflt3l
thymide
hsflt3lstimulated
adencoded
hsflt3lderived
scenarioforeign
virusoncolytic
adimmunized
cd16singlechain
triplebodies
sctb
bsscfv
fcgammariii
33xds16
33xds16x33
600fold
immunotherapydickkopf1
antidkk1
patientcounseling
6239
3761
6973
breakfast
4411
6514
9083
7156
memorydc
hla1locus
dcszol
dcszolcik
idcsmdcszolcik
mdcscik
cikzol
50879
48247
31951
20536
idcszolcik
715113
67793
51362
47157
6921
ligandmica
mdcszolcik
zoltreated
idcsmdcs
infectedcellantibody
immunotherapyantiviral
gammarmediated
infectedcellsantibody
sctbucy
cybu
029482
cellsil2
il2rbetagamma
markernegative
alphabetagamma
il2ralpha
il2rbetagammadirected
il2ralphabetagamma
dsrnaactivated
infectionsantibioticresistant
walllinked
piapnag
pantonvalentine
leukocidin
cytokinesgraftversushost
thalassemiato
nnk
gage12i
immunotherapygage
gage12ihis
methodefficacy
640966
34961
2061000
697995
idal®
cd3cd8α
cd4cd8αlow
measuresbetween
16352
us0·010·15
campaignunlabelled
critiquethe
consultationin
tact
il10tgfbetatreated
aadcs
10tgfdc
insulinloaded
10tgfdcstimulated
il2lowifngammalowil10high
41bbdeficient
irrelevance
nkgd2
32143
tryptasebackground
115211
128426
konga
cp12
cp21
challengecp12
cp12cp21
odncp12cp21
pvax1cp12
pvax1cp21
pvax1cp12cp21
pvax1ccp12cp21
ccp12cp21dna
ic51ic51
jespect
twovaccine
prnt50110
travellersthis
neckobjective
dosesd
safetyintenttotreat
antischistosomasis
swap
gelswapil12
antischistosomal
il12swap
il12f2
europethis
rix4414placebo
quintameningitec
86595
839888
94695
900975
92395
640998
approachgammadelta
iiprogress
therapiesgene
timehonored
ethab
fty720dcs
ctrldcs
nonconditioned
balancer
recipientsin
arthritisinternational
interferonalphaifnalpha
ifndcbased
tumorpulsed
ppdc
networkantitumor
clinicagainst
icbetween
01102006
31032007
118410
86410
234410
childfamily
parentsguardian
graftfunction
gfys
precalcineurin
conventionallytreated
2008objective
pr156
ci148
ci135
flexivent
betweenstrain
desensitizationanaphylacticanaphylactoid
metalchelated
dotabased
didota
dotaaminobenzene
01mgymbq
aminobenzene
tyrosinelysine
177ludota
immunotherapycytokineinduced
therapyeach
lymphomacanine
dtert
ad6
dnaep
dtertspecific
vaccinechemotreated
ad6dnaepbased
wegener
cancermucin
immunogenetically
galalpha13galbeta14glcnacr
alpha13galactosyltransferase
alpha13gt
studyforty
kaplanmeierestimated
epics
treatmentseeking
her2reactive
her2plasmid
signalingdeficient
her2pdna
lambdasubclass
leukaemiawhile
immunotherapyinfections
gdependent
neurotoxintetanus
blooded
snare
synaptobrevin
interneuron
boundhuscfv
huscfvphagemid
tenthuscfv
recomended
stil
polen
areatabackground
ladislao
pascua
tbgiven
03123
ng·hml
6851876
162600
lhkg
peptidesmhc
100a
alexa488
alexa546conjugated
acceptorlabelled
peptidepresenting
selfpeptidepresenting
tritransgenic
doxycyclinedependent
ratesin
rctsobjective
scrutinised
0606783
0317733
1158791
autoimmunityvaccinations
inductionreactivation
insulindependentdiabetesmellitus
vaccinationautoimmune
latexinduced
microgml1
malignanciesepsteinbarr
killert
individualsmechanisms
priorlycommitted
attackbackground
20067
20060
hu12f6mu
allograftshu12f6mu
fcmutated
vaccinationnewborn
pathogenimmunogen
adultequivalent
prematureterm
venomsinsect
newbornsthe
htadjuvanted
ferretshighly
avn119404
immunisationsobjective
crossgenerational
4165
whoqol
celllysates
immunosuppressionthis
xt
xtno
immunisationwhile
trick
vzb
misstatements
productsmonitoring
noncss
153smedtmp
153samarium
ethylenediaminetetramethylenephosphonate
37951
parallelization
pipetted
polymercoated
cellimpermeant
antigenexpanded
perspectivesfeline
polioa
precipice
n3917
depletioninitially
ncluding
bmhcgi
bmmnc
\tail
instabilities
1256dibenzanthracene
mice1256dibenzanthracene
combustion
organics
asphalt
afc
dispensaries
octdec
8933
8725
5975
9737
freezesensitive
oldaged
onethirdonehalf
wallobjective
sahil2
perfusing
sahil2cured
sahil2treated
indicesgroups
lect2
il17ar
th2profile
pemphigushighdose
summerizes
adhesionthe
malp2
lipopeptide2
s23bispalmitoyloxypropylcys
p2c
gnndesnisfkek
rgds
p2crgds
lymphomaspatients
0380
graftversustcell
lungthe
pheniramine
maleate
ium2
dosespatient
doseas
hbsspecific
vsvms
costneutrality
euro13190
protocolsvaccination
dgti
lymphocytesdetailed
advancedcourse
mihms
modelanthelmintic
parasitegenes
hostpopulation
autosomes
1965february
mundane
parasitehost
malariaspecific
plasmodiuminfected
solidly
skinstageinitiated
eliminations
058098
091100
043005
combinated
lmyphocytes
158010
153013
64674
3141269
61973
techniqueobjective
htnfalpha
sagfp
sahtnfalpha
cytotoxiciy
htnfalphatreated
inactived
ev71hn2
hn2
4e8
twodayold
inflammationcurrent
antissaro
ovodonation
notantissaro
chbaffected
profibrosing
lymphomaaddition
rchemo
ci103131
ci099136
rr119
ci099199
ci111151
rr189
ci152235
rr127
ci105154
rr221
ci168290
galectin8
trap1
g9803
g0010
g9802
nironly
signaltobackground
birdtohuman
sh53
skindepigmenting
monobenzone
cpgbackground
skinbleaching
infectionsince
3yearefs
cypatients
160mgkg
16146
promisemetastatic
0568
miceliver
noteworthily
slitics
corticotherapy
nonidentified
nondiagnosed
fascinated
bapineuzumabbackground
antibetaamyloid
variablesobjective
skid
nursecasemanaged
malleable
validnovel
leeway
injunction
barring
experiencefollowing
antibodyegfr
2007background
cff
16435
015087
055098
046098
038078
055086
192284
171247
rattranscutaneous
perioddependent
toxinchallenge
632p
487p
738p
gammadeltaagonists
ca153
shaanxi
chinabetween
kirpositive
clinimacspurified
airpermeable
leukaphereses
2683
668fold
482fold
140fold
161microl
612yearolds
tsuchiura
n2607
rapidtestconfirmed
orbitocranial
microplusa
teleogine
alternariosis
ventriculoencephalitis
fluidattenuated
hyperintensity
infectiondysfunctional
costimulatoryinhibitory
recipientsan
victortrial
151460
1042935
101287
tacrolimuscyclosporine
026098
022093
valganciclovirganciclovir
bangladeshobjective
cancersperm
sp17based
cpgadjuvated
regulationa
autoimmunebased
modelsuccessful
vacuna
gecvph
gecvphadapted
idiosyncrasiesmight
hematologistsunlabelled
4239
andit
appearsto
clandestine
politicalpublic
reallocating
primatesmany
aidsresistant
aidssensitive
repli
patientsgranulocyte
ad5d24gmcsf
prehairpin
isolateseliciting
neutralizationhypersensitive
infectionone
nucleotidic
humanvaccination
immunotherapypam3csk4
cd8cd25foxp3
pam3csk4treated
cellcontact
cd4cd45rohi
primatesaging
pathogenexposed
projecttype
11133pentafluoropropane
1112tetrafluoroethane
por005
kingdomduring
113273
37273
tyndall
glucocorticoidsparing
intentionbehavior
2822450
117776
123441
192329
003030
beta32
beta18
beta09
beta08
poissondistributed
dta1treated
dta1mediated
acuteearly
actg
a5187
vrchvdna
00900vp
nct00125099
rna50
vrchivdna
newprogressive
hemangiomasbackground
hemangiomas
birthmark
sulfamethoxazole
incentivesobjective
148382
68379
50860
pound16
euro19
irsctn87759937
033066
044077
vernonia
cinerea
micecyclophosphamide
alphaesterase
ctxtreated
infact
arteriosclerosiswe
ifngammaconditioned
cbaca
cbarag
daughtersobjective
perspectiveofficial
medicineimmunomodulators
catsadverse
metaanalysisclinical
retrospection
i2827
coefficient21
coefficient14
coefficient17
immunotherapiesalzheimers
betasheet
sabeta
hospitalinfluenza
octubre
014052
004019
005050
135265
cvids
gkgmo
virusregulatory
antifeline
fivspecific
sheepthe
ovines
oestrussynchronized
teratogeny
protein1based
immunizationhigh
hmgb1conjugated
hmgb1ova
releasetype
mutantconjugated
hmgb1based
applicationsradioimmunotherapy
radiationenhancing
diseasesome
diseaseslike
aspleniapresent
ofsps
mansonimice
cercarial
capimmunized
swapims
seaims
cancercd4
carengrafted
lymphoceles
vaccinescattle
autotoxicus
readjust
kafkaesque
stagesfrom
2030analytic
diphtheriaobjective
guineapigs
guineapig
mumpsobjective
grifor
areactogenicity
rate90
factor65
countermeasuresobjective
termly
4519
analysispreterm
vaccinationrecord
monitoringobjective
kruskall
immunotherapythirty
tgammadelta
eot
pblctc
rtxdependent
postfcr
mec2
lblctc
micenephrotoxicity
infantalthough
300mgm2
itchiness
naranjo
arginase1earlier
aamacs
aamac
typhimuriumtherapeutic
prokaryote
eukaryote
polypeptidebinding
lowcopynumber
hsp70taa
sl3261
eraicated
ifnalpha2bifnalpha2
derivatization
1signal
m92047
mel28
25oligo
ifnalpha2
pathwayantitumor
lysatepulse
thereafterinoculated
procaspase
antirae1
antinatural
neuetvrp
neuexpressing
neuetvrps
neuspecific
cellsprimed
dcleu
knownunknown
dcdcleuinduced
tcellresponse
antileukemicactivity
subtypesqualities
dcdcleu
infusiontherapy
culturepriming
microcultures
at2inactivatedhiv1
fasciawb
fasciapbmc
3838
isotoperestricted
combinationbackground
combinationmumps
nonrecalcitrant
soles
suppose
cd20tcd34
immunotherapytcellbased
cd20op
tcd34
rtxinduced
interventionlongterm
adascidthe
antigd3
sfvcd28tcell
gd3specific
sfvtcrzeta
nontdependent
sfvcd28tcrzeta
therapygeneengineered
caixpositive
caixnegative
donorindependent
2010since
2009during
pulawy
haringey
sivagminfected
replicationbackground
chronicallyinfected
sivagmsab
cmt807
sivagm
107108
104105
sivagmsabinfected
jyotiba
phule
nagar
360937
34643
36475
18194
16449
14887
17847405
1435057
612yearold
211399
680435
httpwwwcontrolledtrialscom
isrctn72858898
ptms
microdifferences
collision
lcmse
sellby
nonanthracyclinecontaining
monthsare
seniorsthis
beta0040
onepercentage
beta0045
00110077
transplantationstable
cd13
cd73sh3
cd90thy1
cd106vcam1
4dogs
antiigd
tolerancemembrane
migd
cruzilike
eosinophiles
eosinophile
nonisogeneic
reinoculations
allergensa
3412
631671
871897
851879
chemokinefused
peptidecocktail
nasogastric
recipientsneurologic
75384
tia
myoclonia
subdural
cotard
okt3atg
polyendocrine
13bp
c967979del13
pep5
ceditestr
ubir
9859
liposomedna
challengehaving
cldc
weevmcmillan
ifacs
113200
652182
pngs
attitudespromotional
59108
ethnicsensitive
detrimentalgranulocytemacrophage
applicationdna
safetyas
typhoidendemic
americaoral
rempfer
sharfstein
months12
20085725860
23002600
httpwwwcdcgovvaccinesrecsprovisionaldownloadscombovaxaug2009508pdf
ipvbackground
dtacellular
dtpavaccines
boostrixtm
glaxosmithklinebooster
subjectsduring
4–8
nct00635128
hbha
hbhaspecific
infancyinduced
memoryto
infanttriggered
mfou
010uiml
infantinduced
kvsentinel
aships
breastovarian
tregtr1type
waterfree
dpx0907
hlaa0201h2dd
ifngammacd8
sitedraining
dpx0907based
cytopaenia
seriesautoimmune
levelcutoffs
opfc
ibalpha
fragmentglycoprotein
gpibalpha
sz2
ristocetin
botrocetininduced
dihydrofolate
reductasedeficient
gpibexpressing
ristocetininduced
nparticle
clusterkilling
90y2o3
oxygenated
germanya
20844
meda
medb
195319
604643
5821
200007
nmchcts
meetinghematopoietic
saxonian
20052006vaccination
offwork
bdt
crosschecking
anonymisation
saxonians
antigenour
agholding
peptideinteracting
grp94gp96
grp170tyrosinaserelated
trp2175192
trp2derived
chaperoningbased
receptorinfusions
reviewsuboptimal
officiallyendorsed
nonofficial
unrepresentative
ginbuna
virusclonal
langsdorfii
chnv
chnvinfected
eel
evainfected
kielce
polandthis
41481000
6151000
trialrelapsed
26180
engrafts
registriesa
cbts
rmethuscf
engraftmentscf
methionyl
ancestim
rmethugcsf
bloodcirculating
threelineage
interferencemodulated
l130
l133
5color
grater
immunizationchronic
psychlit
immuniz
immunis
adolescen
superhigh
antibodymg
fmsantictla4
nissle
pathwayexperimental
ecn
ecninduced
nfkappab
allergenrestimulated
abusesconfirming
immunosuppressionpharmacokinetic
inosine5monophospahte
p70s6
22329
20626
vfceligible
59month
linkagewe
postmmr
6753
gynaecologic
10001
closings
morbiditybased
damageaccumulating
antiheat
437460
shadows
100740
perspectivestherapeutic
phasealthough
mer
modifiedtype
2weekadministration
4weekadministration
rqrtpcr
wt1mhc
recurrenceprogressive
6168
datesimultaneous
rsw
3locimismatched
genetherapeutic
myelofibrosishematopoietic
transplantderived
clinicomorphologic
mib1
2009malignant
brfssobjective
n6138
weighthaving
185249
behaviorsnot
moderatetovigorous
servicesreceiving
cellschemotherapyresistant
malignanciesradioimmunotherapy
pritbased
marketrecombinant
paramyxovirus1newcastle
incongruence
dissonancebackground
pandemicinfluenza
nonclerical
crisisearthquakes
postearthquake
neuralrestrictive
silencer
rest68
ncl
restncl
pbmcmediated
rest68pkc
225249
347374
personsweek
200909
sitesthis
monkeysas
cd20b
cd4tcell
cd45rahicd62lhi
cd45ralocd62llo
depletionrepopulation
tumorcellselective
ingn225
p53modified
adenovirustranduced
ingn225s
orgrade
1843
postingn225
multivaccine
pollenoralair
licensee
paladin
iibiii
membranousproliferative
wardoutpatients
mandateswe
betweenpen
pigsmany
walkway
withinpen
pentoadjacent
immunityoligodeoxynucleotides
turboteffective
pcn5
calciumindependent
degq
iialpha
dahlem
hypothesisinsulindependent
substitutive
exogenousunrelated
microbialderived
cry1ac
protoxincry1ac
disorderspublic
barabas
downregulatedterminated
inflammationnew
exploitations
cardiomyopathyalthough
heartdirected
beta1adrenergic
beta1aabs
allosterically
sarcoplasmatic
dilative
cardiomyopathic
beta1autoantibodyinduced
immunitymyeloidderived
selectin
selectinhigh
112367
176586
2431067
155401
102321
strategiesvarious
kacip
specialtopics
subcommittees
institutionalizing
fundingthe
atagi
acipthe
hondurasthe
panamerican
ncci
processesthis
nacis
proceduresthe
fédérale
factsheets
ctvthis
makingmultiple
strengtheningthe
itags
itag
programme2009
months5
acceptabilitybackground
psychoinfo
128289
goingtype
antibodyopsonized
helsrbcs
helrbcs
1immunostimulatory
aictreated
cd3cd4cd154
wheyallergic
chaindependentbackground
igfree
f991
anticd25treated
iglcdependent
igeindependent
subcutaneousspecific
semidepotallergen
nonpurified
nowschoollocated
initiativesthe
antibodydue
nodscidgammacnull
huhsc
2g12encoding
hiv1jrcsf
2g12transduced
huhsctransplanted
multipledrugresistant
formulateddna
pvaxig
pvaxigmag1
pvaxovil6
feverrecent
nowdiscontinued
musical
headphones
paindistraction
headphone
dualism
immunoredirecting
immunoregulating
predictedbackground
219×107
52×1010
72×106
21×1010
91384
switzerland19912001in
n513
severityaeroallergen
pc20
pathophysiologya
regimenssublingual
perspectivesafter
vaccinetoolbox
responsescd4
invitrogenerated
ctlsactivationinduced
genearray
aidsilenced
aidpositive
lymphocytesvulvovaginal
candidaimmunized
candidainfected
mannoprotein
antimp
dermatitiscontact
neuropathiesthis
diseasesmesenchymal
mesodermal
tissuetrophic
7887
autoimmunityintravenous
panniculits
mesotherapywe
aphthouslike
mesotherapy
myelodysplasiawe
10001260
13201500
atlla
postric
mdsrelated
55kg
nonallografted
sepv
dtapdtap
phasedependent
ddcs
mjcm2
haptenpainted
il10neutralizing
ox40lblocking
langerindiphtheria
receptorknockedin
ox40lexpressing
cd40mediated
cancerinfiltrating
tumorprimed
cd40deficient
cd40ldependent
vaccinesof
cvmp
9cfr
sociale
managersprivate
sheddingan
duvaxyn
iet
aeq2sydney2888807
acdp
infustion
salvageable
vaccinationpreadolescent
nonviewers
claudin4targetingmucosaassociated
claudin4binder
ovaccpe
claudin4binding
agendasgoals
atak
217744083
eoma
asplenocytes
eomabearing
15x106
microl
47759
42826
45322
asplenocytestreated
25027
27538
6803680
8252718
5353745
3515795
melanomasimmunotherapy
hmwmaaspecific
22528s
hmwmaaexpressing
iranduring
fars
122148
vaccineporcine
germanyroutine
effectniemannpick
npc2
correctable
16monthold
pe20x
walked
polyradiculoneuropathyunlabelled
837882
151108
mgkgweek
533733
170109
oculooral
methodsavian
oculooralvaccinated
infusiona
abetaabetap
aggregationoligomerization
channelopathies
neuromyotonia
siea2628
genesto
antischistosomiasis
kuscfv
pet32ascfv
sjrps4
l7
sjrpl7
gdrstyle
crep
trep
tgfbeta1expanded
cap1
immunotherapycarcinoembryonic
ylsganlnl
cap1specific
immunotherapyadenovirus
antiadv
mean56
yield51
mean42
nonloaded
chemoimmunotherapyantitumor
golfig
5fluorouracilfolinic
aldesleukine
golfig2
tregfoxp3
treatmentrelative
survivalmean
pfsmean
lymphomatherapeutic
mlminkg
curve0infinity
9170
10900
lkg
targetconcentration
agonistdendritic
vkas
nct00222638
lineinduced
ptldlike
submyeloablative
dexamethazone
mel100
nfusion
225554
105376
214235
604278
354650
challengefor
selfaltered
epithelitis
helix
congenitadyskeratosis
sctallogeneic
hbsagnegativeantihepatitis
hbsagnegativeantihbcpositive
seroreverted
studyinvasive
aerodamb
il10blood
surgicalgynecologic
pomerania
cancermonoclonal
x03b22
cotransfusion
aplastica
locusmismatched
cellstransfer
sctcr
tcralpha
calpha
doublechain
dctcrcd3
murinization
gp100calpha
dctcr
melanomaengrafted
dwarf
savanna
contortuswe
wad
lfec
hfec
d56
d63
d81
anthelmintictreated
d18
ecotype
introgression
parasitesusceptible
childhoodwe
103221
mgmmol
alpha1microglobulin
amgurine
vivonatural
rkik
rag2gammac
eczemaobjective
meningococcalc
lifewe
titersserum
4105
27346163
285713
yen18
yen28
responsesnkt
tlr2dependent
activationlangerhans
intdcs
monocytecommitted
myeloiddc
sarcomaslimited
jumble
receptorgrafted
cellsharnessing
releaseobjective
polydicarboxylatophenoxyphosphazene
pcppcoated
proteinpcpp
proteinfriendly
figureground
cancerimmunology
majorhistocompatilibity
freamework
sharpening
angiogenesisalthough
5305
goneendotoxin
nomv
mmuds
betachain
b3ztcr53
tcr53engineered
protein1beta
pbltcr53
tcr53
childreneffective
considerationseffective
cd147emmprin
cellecm
immunizationantibody
hypoimmunoglobulinemia
28amino
bedsidecytokineinduced
radiationmediated
irradiationmediated
repairmesenchymal
cytokinestimulated
systemselectronic
waldenstrom
chemorefractoriness
cd1dhicd5
cd1dhicd5b220
sidepopulation
lymphomasidepopulation
perplexitiesbackground
cd162
bmmicroenvironment
mmassociated
diseasecrohns
aliplasmidbackground
vical
plasmidlipid
cd1656
26162
isomerizationcyclophilin
cistrans
acetyllysyltrna
synthetasetrnacua
atomicresolution
isomerization
binderbcell
pa2036
devicesmechanical
patienthuman
vxm
rituximabreactivation
komarovs
bisonin
1011cfu
100m
355cm
deformed
bisonconcerns
wildlifehuman
u16480
injectionpreviously
midgeth1
midgehbsagth1
pyridinium
amphiphile
saint18
mencmemory
muench
e2bceaadenovirus
e1cea
ad5immune
changesa
pathologyantiamyloidbeta
amyloidbetainduced
braakstage
densecore
straighter
06060
filament1positive
alz50
miceantigenspecific
preproinsulin1
l724
successlaboratory
dpgpol
heplml
sitbackground
axotomy
trkbphosphotyrosine
domainoptical
adjuvantnovel
mvail155mtb
85b
mtb39
esat6antigen
e685
dimethyldiotacylammonium
bromidemonophosphoryl
e685mvail155mtb
monofunctional
ifngammatumor
tnfalphail2
ifngammatnfalphail2
ifngammatnfalpha
contraindicating
2006background
maculopapulovesicular
342370
9187
4399
4490
oronasopharynx
19861988
sampletaking
yearslong
connecticutlicensed
nssnp
hlabrestricted
nssnps
netmhcpan
pracpra
tlrtargeting
hivimmunotherapyhiv
lahorebackground
fillin
pricksharp
carelessness
chemotherapyelevated
noncatheter
deepvein
11gl
198479
virus2background
xenograftunlabelled
131if6
cyclopeptidic
cbop11
forcefeeding
minipumps
131i734
125if6
volumequadrupling
tvqt
cbop11radioimmunotherapy
tacrolimusmini
infectiongerminal
gcderived
4hydroxy3nitrophenyl
experiencethere
epidemicthe
semiendemic
endemicsemiendemicdiseasefree
trifab
131itrifab
firstinpatient
virushuman
vaccineenhancing
sl7207pcdna31f
fgadf
primefgadf
fgad
201011providing
russel
wallace
englandalfred
naturalist
codiscoverer
19thcentury
reformism
provaccinationists
wallaces
campaigners
acam3000
dryvaxbackground
dryvax
adultsolder
immunotherapycatumaxomab
fcγrpositive
selfsupporting
killerslaks
foxp3level
nonseparated
serotype23the
btvinduced
annexinpropidium
caninedcs
animalmodel
strategiesanimalmodels
caninedcgeneration
dogpbmcs
dcquality
expressionprofiles
dccostimulatory
maturationantigens
cmabshmabs
dcagsdcantigensexpressionprofiles
caionophore
dcamounts
cmabs
stainingquantification
caninecellsdcs
tcellactivation
ctlresponses
dcgeneration
tcellvaccinationstrategies
amlpatients
dcvaccinationstrategies
colombiaa
1293159
105378
295560
usd8
usd75
usd663daly
usd1391
usd7
usd1063daly
usd7787daly
usd3
alemtuzumabgraftversusleukaemia
childrenspecific
mpladjuvanted
igggrass
igg4grass
agentthe
tmzrit
toat
therapycondylomata
hungarythe
jeopardised
edsv
rd114
319354
9092
131181
111129
feedingflying
hematophagous
sp15
mdsred
antisp15
salivamalaria
organobjective
tumorindependent
monkeyschronic
alphacd20
rejectionbelying
alloantibodymediated
alloantibodyassociated
kelishadi
tssmburkholderia
saprophyte
tssm
factor6
ikappabalpha
mutantinfected
bacteriainfected
peidna
10foldgreater
lungassociated
hpvthis
transvenular
bmuscle
aavfix
antiaav2
approachfreedom
resystemic
48071
herdbackground
pleurisies
actinobacillosis
saaresponse
myxomavirus
bestvaccination
fibroma
sg33
aict
dccat
hladrcd86cd14
cd80lowcd83low
ok
432stimulated
fcgammar
ct26her2neu
fcgammarmediated
fcgammari
fcgammariia
gammasubunit
fcgammariib
superadditively
asyetundiscovered
yearsbecause
immuneresponsiveness
tc1tc2
evidencecurrent
nabsabeta
043086
259397
28418
18338
29168
10158
76129
27140
teachable
interventionscervical
leukocytesat
ccli1
ccli2
cxcli1
cxcli2
factorbeta4
tgfbeta4
cortisosteronetreated
th2t
microenvironmentpilot
c57bl6n
scpdc
itpdc
undervaccinatedobjective
measlestransmission
uppersocioeconomic
pvax1s1
pvax1m
pvax1n
primely
cd8cd3
endothelina
mum2dose
hepatits
sctsurveillance
diseasebusulfan
μmol
7801305
0153
alloantigenstimulated
proteintyrosine
lancing
abscessesa
riskanalysis
herdsa
repi
blunder
cd20cd19specific
humansimmunotherapeutic
recognitionkilling
electrotransferdrug
fdaauthorized
neor
hytk
hygromycin
108cellsm2
109cellsm2
preventdelay
steap102116
steap192206
anticellular
vaccineafter
dtaphepatitis
hbvinactivated
ipvhaemophilus
n1161
apr138
apr166
nationalstate
19952005
stemprecursor
cellsstemprecursor
spcs
spcmediated
preventionunited
200857no
rr3
hdcv
noncellculture
listeriamonocytogenes
moderatesized
fayette
24195
8976
interventionseducation
alcoholbased
sanitizer
maskson
5034
toxoidloaded
arrayobjective
arraytreated
surfactantbased
ζpotential
arraypretreated
cxcl2
tc17derived
enoxaparin
emergingthree
carriersmultiple
mvnis
mvnisinfected
368696
256806
immunotherapyuse
fhsv
solubletype
snrp1
her2neucontaining
bacterialviral
cryoimmunologic
limbsalvage
reimplantation
guineabissauobjective
ica4ct200210053revac
imagingobjective
nct00703742
crus
subgyral
mandatespolicies
immunizationsinstead
erupt
diamyda
secretionbackground
epia
200220032008
246trinitrobenzenesulfonic
getmon
01207
ivigrelated
dendriticpancreatic
fusionsfetal
fcsindependent
ppfsupplemented
artdespite
caseiexpressing
vp2ltb
ppg611
ppg612
rlcppg611vp2ltb
rlcppg612vp2ltb
cd40silenced
cancerchildren
vaxisenior
physicianshealthcare
vaccinatedvaccination
supportnotification
housebound
managerspersonnel
europethere
geriatricseuropean
pv23
vitrocd44v6
cellbinding
inductionengineering
cytokinepretreated
fluspotter
1474100000
10521100000
determinative
hypersensitivityregulatory
cellsprevious
dctinduced
doseinfected
c0h
c2h
romasinti
fieldlentiviruses
lymphomaalpha
postautograft
meloe1a2specific
valpha121
meloe13644
meloe1a2
patientstransplantrelated
fludarabineric
mismatchedhaplocd3cd19depleted
scc1
90ydotacetuximab
cetuximabinduced
alyaly
adjuvantas
diclofenac
fr122047
lumiracoxib
bronchoprotective
precisionobjective
computersimulated
1put
1plt
hypothesising
unclustered
staphylococcalderived
ovaseb
th1deficient
k01
k100
fluorocytometry
hypoproliferation
toxicityevaluation
enrolls
listeriaderived
actinnucleating
actadependent
iviral
cd8alpha
dcexpressed
il15ralpha
aligarh
unicefthe
outreachsessionbased
shahjamal
bhojpura
pertussiswho
scuticociliatosis
iiscuticociliatosis
ciliophora
philasterides
dicentrarchi
miamiensis
avidus
uronema
ciliates
yellowish
bleached
gentamycine
amoxycililin
cefazolin
malachite
jenoclean
prophylaxic
6029
reactivityallergenspecific
studentsunlabelled
019098
006064
amlto
is20
hr27
ci1101429
ci0981217
53item
infectionever
tumorself
2160cgy
intraommaya
noncsi
iorit
diedone
bigeminaserological
liveblood
or180
mpps
postmpps
9n
prempps
leish111fmplseimmunotherapy
leish111fmplse
4395
3189
ibim
n159
tpbbased
dendritomas
postturbt
cytoablation
expending
treatmentsthe
tlrmatured
injurylingo1
rhoa
ngrmediated
intrathecally
ratbackground
bitartrate
3aminomethylnicotinerecombinant
exoprotein
nicvax
nabi
rockville
mecamylamine
mecamylamineprecipitated
mip1alpharecruited
b16mage1
usaduring
nonbite
midland
micepemphigus
jawlike
bronj
bronjlike
socket
sequestra
radiopaque
thelperproducing
vaccinatorinchief
lewisy
leyexpressing
adolescentstwo
infancyfijian
zosterin
youthsobjective
cchs
coupon
foodmedicine
195248
noincentive
autoimmunitydendritic
nyeso1b
vitroimmunotherapy
gemistocytic
adifngamma
walestwo
primateswe
tumortake
chlorocebus
sabaeus
gnbvc
vinorelbinecontaining
bcnurelated
riskmodeled
ie1pp65
b8
fray
melanomainhibition
uhc
agra
112366
155350
uhcs
af03adjuvanted
micepandemic
tivprimed
retroinversion
bac2ahost
hdps
ribac2a
lbac2a
cpgribac2a
cpglbac2a
cpgdbac2a
medicineimmunity
nonclonal
inhibitionangiogenesis
antibodyproteinbased
directionscatumaxomab
pegolcertolizumab
cimzia®
miceinterleukin5
eosinophilactivity
qbeta
eosinophilinfiltration
foma
halitosisthe
misbalancing
coinfectioninduced
coopts
dicistronic
cystogenic
rvfvmp12
pcmvm4
pcmvn
pcmvm4pcmvn
087100
091106
081098
immunotherapyred
rbcova
doseamount
gravisacquired
8590
immunoadsorbing
autoimmunityinterferons
ifnsalpha
ifntreated
inductionpromotion
ifnalphadc
productionaction
dynamicspublic
cellularbacteria
seistype
momase
guineaa
morale
allprogram
nonhcc
04509
031092
cd122cd8
micelymphodeleption
inactivationobstacles
electrically
lifetimeas
typeihypersensitivity
igesecreting
igetiters
administrativebased
planningbackground
2e2immunotherapy
cocainebinding
gamma1
chainmurine
2e2
2e2s
singledouble
implicationsthere
repliconbased
immunizationvenezuelan
vrp
vrpmediated
efacilitated
atopics
cd303
aa1
kpmcp
apneic
bradycardic
viruseighty
n20group
captureelisa
fbssupplemented
fbsrelated
nmssupplemented
insulinpeptide
karyotypeto
cohortto
234years
60213
hospitalaffiliated
erbb2in
intubated
influenzareactive
paploaded
gvaxdocetaxel
papencoding
30–december
immunogenicty
oncogenicityobjective
adher2ecdtm
adher2ki
her2tolerant
anchoragedependent
her2transgenic
her2ki
her2wt
attackadoptive
weightmelanomaassociated
noxa
mitochondriaderived
noxamediated
calmetteguèrin
ialtered
syndecan4
toxinbearing
proteoglycandependent
diseasebecause
dchil
dchilsd4
dchilsap
haptensensitized
toxinconjugated
settingswe
rs11209026
rs8193036
hr368
hr708
mellituswhat
antibodiestype
substitutivechronic
insulinwhich
ns3dependent
tollil1
adapterinducing
ifnbeta
stimulator1
myd88coupled
il2secretion
immunecontrolled
erythematosusautoimmune
lupusrelated
busulfanmutations
npmflt3
bui
npm
nmp1flt3
kir2dl2
practicesgrade
selfawareness
vegfr2cytotoxic
scfvctl
vegfr2flk1
vegfr2flk1expressing
scfvexpression
tumorevasion
avidityusing
lace7
01100mghead
gammaproducing
e7type
e7ctl
fiftieth
nct00280982
svcam1
stnfri
stnri
4561000
5923
countyobjective
transplantnot
12327
7543
suppositions
glutathioneredox
creldriven
p40p70
antibacillus
overrules
nonuraemic
uraemiainduced
cu2oxidized
bderived
apobpeptide
cu2oxldl
nldl
pbsimmunized
oxldlimmunized
antimdaldl
irstandardised
cclg
99105
3560
3058
lessso
372680
mycofenylate
0690
flubu2tbi
patientsreduced
canadaactive
splenectomyindividuals
effectivenesseconomists
externalresponse
minimaxregret
undominated
leukemialymphomaobjective
anticc
149177
dcdifferentiation
hark
p110
subsetswe
p110delta
p110deltad910a
leishmaniareactive
cd62hi
gmcsfs
overlaping
multiclone
prscgmcsfs
prscil21gpigmcsfs
b16f10il21gpigmcsfs
vaccinesome
promisesthe
phtx
drugherb
drugfood
photochemistryextracorporeal
photosensitising
pce
photochemistry
oralmucosal
ragweedsensitive
analysisat
neoimmunequoral
icg250
icurrently
periaortic
bloodpool
activitiesboth
myeloablativewere
geant
0637
14105
94114
slednaspecific
antinative
oscillates
tregtherapy
conditioningestablishment
drugsmabs
diseaseone
sivsab9315br
tmzm
antigenreacting
unmasks
opsonizationbackground
eculizumabtreated
c3positive
9603
11004
regulationopportunities
immunotherapyendogenously
mir1792
mir146
moleculeassociated
mir34c
mir214
mir222
mir339
systemsubcutaneous
nahexchange
glucocorticoidsglucocorticoids
nhe1
nhe1dependent
phainduced
phaactivated
dexamethasonebovine
clientsthis
interviewingsingle
misingle
interviewinggroup
migroup
threeseries
ligandcancer
alphagalcer
transplantgraft
trendsdeveloping
augmentingimproving
donorag
siblingsmycophenolate
miceimplications
modelscelltype
toleratedis
therapybiologic
240850
median401
chemotherapyalone
cyetbi
respectivey
threeway
surveymonkeycom
riverine
buffaloessixteen
gri
week6
griv
diastomes
griii
adolescercariae
sonoporation
tumorsdevelopment
usmediated
wcm2
noninjurious
baffrig
immunotherapycancerinduced
mls1a
vbeta81tg
p38chemical
p38inhibitor
itreginduced
ivinjection
ct26bearing
tregfunctions
infusionbackground
leukotypes
contaminantfree
il10mrna
inclusionbody
recoveryobjective
subcompartments
ukg
microgm2d
netherlandsafter
top5
btproblems
thickensthe
sentinelnodebased
sentinelnodeacquired
th1lymphocytes
phenotypethe
1hi
mothersgrandmothers
lied
wont
encephalitissuccessive
st36
eatreated
th1th2th17treg
livestockwelldesigned
indicesmodulation
obesitymain
tableted
1205mgdl
485mgdl
p0000002
6787
6658
midarm
circumferences
161mgdl
13251319
2642
picogramscell
p000009
407402
522505
106cellsmm3
105per
publicattitudes
or438
244467
mandatesobjective
australiaover
zevalinradioimmunotherapy
cytomegaloviruspp65
adenovirushexon
sfcs105
cur
epidemicsize
conditioningrecent
aspergillosisto
hypodense
hepatitiscurrent
corticosteroidbased
cyp2d6
diseasetriggering
3462
44100
analysisprion
prnp00
tga20
prpcantibody
petsthe
ervs
hrcp
toxoidantigenspecific
buffeted
hnsg
envas
envasmodified
hiv1nl43
hiv1bal
454roche
serumfrom
84074
31290
atog
envastreated
prophylaxistacrolimus
semicaptive
cellsil21
gp100hlaa2
asthmaticrhinitis
bronchialnasal
totalspecific
hdmige
1driven
114177
19638
26395
managementanaphylaxis
sphyngosine
mmrassociated
macrophagesin
odn2007
hsp90alpha
hsp90beta
geldanamycin
pi3akt
pd985009
erk2
mip3alpha
evaluationdecisions
16004500
sunk
β1adrenoceptor
β1adrenoceptors
β1ars
7transmembrane
7tm
β1ar
β1arecii
seranegative
antiβ1arecii
th2polarisation
thmemory
polysaccharidicbased
csbased
polysaccharidic
perspectivesallergen
downmodulating
artallergic
aavil7
aavil7altered
6521898
vaccinecaused
decadesover
legolike
expansionrecent
mhcmultimers
mhcig
mhcigbased
exchangehuman
vvovalbumin
sfvova
vvova
primatesrepeated
retransfer
immunizedbackground
middleschool
prevnarseveral
prevnarr
netindirect
euro72360
euro50000
sitedependent
pcmvluc
pcmvova
ppeper
incriminating
psychophysiological
immunizationhighrisk
05676
gmonth
192896
115306
12258
polyic12u
polylpolyc12u
rintatolimod
ampligen
hemispherx
productsgvax
cg1940
cg8711
cryogenic
cytometerbased
deficiencymajor
regimensregimen
6220
357000
nhlbi
bostonquestions
agereducedintensityconditioning
medianfollowup
120857
coxmodel
cellsemerging
cd115ly6c
gr1cd115f480
hsmdscs
synthasemediated
esmdscs
cesensitized
autocreate
allotransplantaccepting
zevalinobjective
cos
activityescalation
80110
92167
halftime
tmu
bedbedlimit
secondorgan
canadato
128677
immunitysmallpox
mousepox
ectv
crmbased
argentinaunlabelled
696451
559942
7382380600
bacteriemias
84769
sparc
cancersto
immunotherary
a2402restricted
sparcderived
h2kdrestricted
h2kdbinding
sparcreactive
sparca241143151
dyigpckyi
sparca244225234
myifpvhwqf
peptidesreactive
sparcspecific
mtxfractionated
ftbivp16
5442
plttransfusion
leukemiamyelodysplasiaa
cyfludarabine
n19mycophenolate
050058
040046
037043
037041
scttcell
tcdhsct
saaipi
conditioningacute
7baseline
day7baseline
hr22
hr29
tetramerbinding
prevenar®
8951
6038
fascioliasisuse
greenbased
fhsap2
gapdh
fascioliasis
43133
11622
schedulein
behaviourhealthcare
year26
year5
year6
recommendationamong
leish111f
leish111fct
immunotreatmentdendritic
rs10824792
nos1
rs693534
nkca
nonpostpartum
microchimeric
hybridsbackground
tumorsharing
b4b8
subdermally
tumordc
intramarrow
betacateninactivated
intrafemoral
intrafemorally
anythingthe
chymase
epitheliomorf
cd34based
targetingobjective
cd34t
beadsbased
statusresults
cholesterols
ci302347
lorhen
registrynew
turkeysthe
ampvinfection
ampvpathogenesis
tcellsuppression
tcellintact
8544
csatreatment
ampvinduced
dtap5ipvhibtt
immunosuppressionparamyxovirus
nglycandeficient
tunisiain
manouba
kassrine
mednine
kasserine
medenine
necklaces
il2rbeta
miceil21
il21transduced
neuro2ail21
vaccineanticd4
neuro2aparental
il21driven
il2missingselfreactivity
ly49ci
5e6
iexpressing
phagocytesdepletion
abdependentcellularcytotoxicity
abdependentcellularphagocytosis
micepneumococcal
caseinolytic
clpp
deltaa146
lipoateprotein
workshopmantle
t1114
12222
hierarchic
hlm
oncologyplatinumbased
sperlonga
histologycytology
myelitistransverse
geoepidemiology
hepaticaglutathione
fhgst
specificfhgst
golgicox
pyramidal
naringenin
chalcone
tomatoes
antibodyprolonged
antirsa
antigenmaternal
lungsbackground
lpsgroup
mglung
salinegroup
salinelung
shamgroup
17h
t17
31h
t31
pulmoplegia
weightbody
shamp
diseaseswhat
doto
nct00209222
nct00209209
diabetesdendritic
autoantigensare
nit1
jsi124
immunotherapyconstitutively
plgajsi124
pstat3high
b16cmdcs
6694
3056
3463
gramineae
tim1tim4
tim4
antigenigg
fcgammarii
miceprion
antiprpc
incentivescontrol
thyroiditisautoimmune
aitds
cysteinestabilized
allergyplants
twodomain
defensinlike
prolinehydroxyprolinerich
c22s
c47s
c49s
1x105fold
hypoallergenbased
tumorsmanaging
antiabeta
lvr
euro1100qaly
intervenes
cd45racd31
sivmac251background
immunosuppressionknowledge
modelsalzheimers
responsefusion
advcd40l
fccd40l
nct00197808
classificationbased
groupsapv
auxotrophycandida
auxotrophies
gitmobackground
30240
mebmt
allotransplantationa
4872h
rnainoculated
immunizedobjective
23000
ci055083
gong
diseasecomplement
autoantibodyinitiated
igadominant
henoch
schönlein
sscassociated
micean
sscexhibit
aetiopathogenesis
immunoglobulinkawasaki
fcgammariibthe
nonfcr
middleagea
tahs
igeigg2a
antiox40mab
antictla4mabboosting
rhenium
radioimmmunotherapy
muristrichuris
trichuriasis
esifa
pbsifa
orig
faithfulness
quitted
cyslt1
monocytescysteinylleukotrienes
cysteinyllt
monocytemacrophagelike
cyslt1rinduced
transients
transregulation
gicoupled
fpr1
unidirectionally
pafr
gq
cyslt1r
gscoupled
beta2ar
h12r
ep24r
gimediated
playgroups
playgroup
scd70
scd70releasing
tdp
nord
a5l
myelocytic
006052
022091
diphteriatetanusacellular
dtpahibcontaining
hi164ov
purulence
wwwanzctrorgau
actrn012606000074594
cr2cr3
manipulable
upbackground
0152
00120360
caws
panvasculitis
cawsinduced
alphas
3738
9047
cellsinvariant
therapyresults
dgfitbackground
gfknürnberg
dgfit
gp100280288
melanamart12735
tyrosinase19
x105
cd11chighcd8αhighcd11blow
cd4cd25icosfoxp3il10
cd4il17il23rcd25
socs5
cd4il17il23rrorγtcd25
formulationsthe
tmcantigen
tmcova
reportsrecipients
riskbackground
drcc
prtr
hep11
hep12
autologousactivated
tilmediated
infectionsafe
gemlcrv
lcrvspecific
alloricpatient
riskscoring
restratified
0672
0595
cd40lmediated
melanocytemelanoma
vsvcd40l
vsvgfp
adcd40lmediated
vsvassociated
postlymphodepletion
vaccinationadoptive
vectoractive
highload
lowerload
tnfalphatreated
dctnf
dctnftreated
cd4il
transplantstwo
241977
globulinalemtuzumb
transplantationgvhd
immunologythere
colostrumderived
antipcv2antibodies
pcv2antigen
pcv2dna
antipcv2antibody
patientladi
pmwsin
polyinosinepolycytadilic
multipleassociated
withindays
828836
qiakgmsyl
her2neu828836
her29828
offkinetic
her29828specific
skov3a2
rsa21dr1
alca21her
cd14hladrlow
upca
tpca
hladrlow
lhrhagonist
cd14hladr
trialhlamismatched
studybeam
chloroethylnitrosourea
ftm
eightymonth
10382
speciesrestricted
semirestricted
adenovirusinterferonbetagenetic
crad
adifnbeta
delta24rgd
llcdelta24rgdadifnbeta
llcadifnbetadelta24rgd
adcytokines
32585820
37845085
neuroblastomainnovation
critcontaining
131imonoclonal
critsalvage
mllassociated
noncrit
rivastigmines
graza
cellin
factorb1
sema3a
np1
5aza2deoxycytidinetumorrecruited
postaza
f480cd11cmhc
transplantationinhaled
aer
airliquid
gasphase
pseudostratified
aertreated
lowerchamber
cd4cd49bexpressing
idcinduced
idcinducible
ills
vaccinationantivaccination
attributions
facevalue
bibliographical
pimecrolimus
25349
eurosqaly
30460
36548
45237
immunomonitoringusing
polyanion
chds
polyions
colloids
pigseffective
reimann
13dpv
63dpv
bvdvspecific
11dpv
15dpv
98dpv
tasksvarious
betaantibodies
beta4042
betaspecific
objectrelated
spover
viroprevalence
virusesexisting
vaccinationinfection
uk200071
mgr
4357129
mgrml
reactionstotal
easytoperform
1041208
interleukin1beta
200250
20mm
scalesepidemics
redundantly
wired
systempreferred
networkpervading
igantibe
or150
fludarabinebusulfan16
acuteadvanced
vivoregression
510fold
90labeled
suvmean
lvol
tlgcum
tvol
iwc
pi103
cellsmelanoma
p110alphamtor
bh3
ku7080
multiformeantibodies
ku7080antigen
ku7080specific
paperadults
tapp
bumelphalan
studyaml
zosterit
casenotification
ovalbumintagged
collagenrich
tfptd
035081
041098
060131
pd5
dengue2
alumcpsa
amlwe
pvalue004
conceptbackground
pn2
metinel
t2t4b
m0m1
pdef
pdefinduced
ceacam6
s100a7
alphabetat
radioisotopelabeled
tcrdependant
2lmp
providersthis
oncologycryoablation
rvfceatricom
yeastcea
mesothelinca125
morab009
125400mgm2
weeklyx4
dpcbackground
survey2
allweather
transplantationgf
limited1
extensive2
5921127
hr101
hr16
transplantationantibiotic
viridans
allograftingwe
cmmol
nonintensive
virusclinical
oned2001
hivibd
0016year
0053year
ibdmatched
hivpositiveibd
timecourses
cfugm
us77
us286
us223
us2107
us6338
urbandwelling
444100
foxm1derived
foxm1362370
ylvpiqfpv
foxm1373382
slvlqpsvkv
foxm1640649
glmdlsttpl
foxm1transfectants
transplantationwhen
day12
ckitsca1lineage
ksl
syndromenijmegen
allotransplantationdonor
cd8depl
cd52negative
blount
childrated
vivoto
midflank
6036
121033
2551
scthaploidentical
cmvi
cmvd
allohsctric
pp65ag
quantpcr
hepaticafluke
rcl1
9253
20930
21034mm
525533
7586778
43509
1221376
gmcsfin
biotinlinked
sagmcsf
sagmcsfcured
dosea
statescontinuous
3724
supraregional
audacious
02778
colorectalanal
adrenoleukodystrophythe
ccald
abcd1
peroxisomal
rabiespositive
vectorattenuated
mgn707
mb9
szpmb9
stlps
flushings
expressorvaccinated
iteratively
denditric
mfas
mfasl
pcdna31mfasl
dccm
pcdna31dc
pcdna31fasldc
pcdna31mfasldc
mfasldc
2008noninfectious
nime
muo
clinicallydefined
sowsthis
anticysticercal
iggtotal
5sow
modelantiidiotypic
pretreatmentbackground
edta
autoproteolysis
cambodiathis
cdhs
esciipivac
freedombackground
serviceman
miceenteroaggregative
eaec
aggregative
fimbriaes
aafs
aafi
aafii
levelsinterventions
etrack
444563014nct00346892
rix4414opv
rix4414ipv
placeboopv
5561
subspecialistsdespite
stockers
nonstockers
formulationbooster
dtpaprimed
vaccineresponse
populationconcerns
militaryrelated
253973
44332
083106
094128
humansanimal
allometric
neuralgiaa
costcourse
33000
1900063000
tenpeptide
singlevial
ep2101
pursuant
homogenizationbased
hlaa0201kb
